Citrus Sinensis ID: 013941
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 433 | 2.2.26 [Sep-21-2011] | |||||||
| P51566 | 467 | Serine/threonine-protein | yes | no | 0.979 | 0.907 | 0.836 | 0.0 | |
| P51567 | 427 | Serine/threonine-protein | no | no | 0.967 | 0.981 | 0.713 | 0.0 | |
| P51568 | 400 | Serine/threonine-protein | no | no | 0.898 | 0.972 | 0.640 | 1e-152 | |
| Q10156 | 690 | Dual specificity protein | yes | no | 0.785 | 0.492 | 0.468 | 1e-93 | |
| O35491 | 499 | Dual specificity protein | yes | no | 0.771 | 0.669 | 0.48 | 6e-89 | |
| P49760 | 499 | Dual specificity protein | yes | no | 0.773 | 0.671 | 0.478 | 8e-89 | |
| P49762 | 832 | Serine/threonine-protein | no | no | 0.787 | 0.409 | 0.470 | 8e-88 | |
| O35493 | 481 | Dual specificity protein | no | no | 0.769 | 0.692 | 0.475 | 2e-86 | |
| Q9HAZ1 | 481 | Dual specificity protein | no | no | 0.769 | 0.692 | 0.469 | 2e-86 | |
| P49759 | 484 | Dual specificity protein | no | no | 0.769 | 0.688 | 0.469 | 5e-84 |
| >sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/429 (83%), Positives = 394/429 (91%), Gaps = 5/429 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376
Query: 356 GARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 415
GA+LDWP+GATSRDS++AVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP ER KARE
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKARE 436
Query: 416 ALRHPFFTR 424
AL HPFFTR
Sbjct: 437 ALNHPFFTR 445
|
Activator of yeast transcription factor, STE12. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 643 bits (1658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 307/430 (71%), Positives = 362/430 (84%), Gaps = 11/430 (2%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGN------GGMPN 54
ME +R+ EFPH +MD+RPRKR RL WDV P +V ++C QE GN G P+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
SS+ + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D
Sbjct: 59 DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG RCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LG SLYDFLRKN+YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
+P+YK SR +D Y K +PKSSAIK+IDFGSTT+E QD +Y+VSTRHYRAPEVILGLG
Sbjct: 239 IPEYKG-SRLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296
Query: 295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 354
W+YPCD+WSVGCI+VELC+GEALFQTHENLEHLAMMERVLGP P M+ + DR +EKY R
Sbjct: 297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356
Query: 355 RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 414
RG RLDWPDGATSRDS++AV KL RL NLIMQHVDHSAG+LI+++QGLLR+DP+ER+ AR
Sbjct: 357 RG-RLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQGLLRFDPSERITAR 415
Query: 415 EALRHPFFTR 424
EALRHPFF R
Sbjct: 416 EALRHPFFAR 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 537 bits (1384), Expect = e-152, Method: Compositional matrix adjust.
Identities = 264/412 (64%), Positives = 323/412 (78%), Gaps = 23/412 (5%)
Query: 12 KNMDK-RPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGS 70
++MDK R RKRPR+TWD P P K ++ G+ G R S
Sbjct: 7 ESMDKERVRKRPRMTWDEAPAEPEAKRA----VIKGHGSDG---------------RILS 47
Query: 71 PPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK 130
PP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VAIKI+RSI K
Sbjct: 48 PPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVAIKIIRSIKK 107
Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
YR+AAMIEIDVLQ+L + D G TRCVQ++NWFDYRNHICIVFEKLGPSL+DFL++N Y +
Sbjct: 108 YRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFDFLKRNKYSA 167
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K RS+ + ++
Sbjct: 168 FPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK---RSAANETH 224
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
F+ LPKSSAIKLIDFGST +++ H +V TRHYR+PEVILGLGW+Y CDLWS+GCIL E
Sbjct: 225 FRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDLWSIGCILFE 284
Query: 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 370
LC+GEALFQTH+NLEHLAMMER LGPLP HM +A R AEKYFRRG RL+WP+GA SR+S
Sbjct: 285 LCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKASRGAEKYFRRGCRLNWPEGANSRES 344
Query: 371 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+RAV +L RL +++ +HVD++ DLL GLL YDP+ERL A EAL HPFF
Sbjct: 345 IRAVKRLDRLKDMVSKHVDNTRSRFADLLYGLLAYDPSERLTANEALDHPFF 396
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 343 bits (881), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 166/354 (46%), Positives = 237/354 (66%), Gaps = 14/354 (3%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGHY RY ++ +G GTFG+V++C+D AIK+ R+I KYREA+
Sbjct: 344 DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREAS 403
Query: 136 MIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+IE+ VLQ +A D +C+Q+R++FDYR HICIV + G S++DFL+ N+Y FP+
Sbjct: 404 LIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLK 463
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKFLSRSSKDGSYFK 252
++ L +QL +SVAF+H L L+HTDLKPEN+LLVS + +++P Y+ +Y +
Sbjct: 464 HIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YR---------NYSQ 513
Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
+ S I+LIDFGS TFE + HS VVSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL
Sbjct: 514 KVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVELF 573
Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
+G+ALFQTHE+ EHL MME++LGP +M+ R+ R ++++F+ ++ +P T + S+
Sbjct: 574 TGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKSIN 633
Query: 373 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426
+ L L I L+DLL+ + YDP R+ A+EAL HPFFT+ +
Sbjct: 634 YLQSLQTL-EQIFAVSSPEVALLLDLLKKVFVYDPKRRITAKEALWHPFFTQPI 686
|
Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 6e-89, Method: Compositional matrix adjust.
Identities = 168/350 (48%), Positives = 238/350 (68%), Gaps = 16/350 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 144 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEA 203
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 204 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 263
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y + L + + S
Sbjct: 264 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERS---- 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 317 -VKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 375
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTH+N EHLAMMER+LGP+P M+ + R +KYF RG RLDW + ++ +R
Sbjct: 376 GFTLFQTHDNREHLAMMERILGPVPSRMIRKT--RKQKYFYRG-RLDWDENTSAGRYVRE 432
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
K LR L + DH L DL++ +L Y+PA+RL EAL+HPFF
Sbjct: 433 NCKPLR-RYLTSEAEDHHQ--LFDLIENMLEYEPAKRLTLGEALQHPFFA 479
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 8e-89, Method: Compositional matrix adjust.
Identities = 168/351 (47%), Positives = 239/351 (68%), Gaps = 16/351 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y + L + + S
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERS---- 317
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 318 -VKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 376
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTH+N EHLAMMER+LGP+P M+ + R +KYF RG RLDW + ++ +R
Sbjct: 377 GFTLFQTHDNREHLAMMERILGPIPSRMIRKT--RKQKYFYRG-RLDWDENTSAGRYVRE 433
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 434 NCKPLR-RYLTSEAEEHHQ--LFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2 | Back alignment and function description |
|---|
Score = 324 bits (830), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 168/357 (47%), Positives = 238/357 (66%), Gaps = 16/357 (4%)
Query: 72 PWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY 131
P DD DGH ++ G+ L RY+I++ +GEGTFG+VV+ D E+ +A+KI++++ KY
Sbjct: 457 PVIQDDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKY 516
Query: 132 REAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
REAA +EI+ L+++A+ D CV++ +WFDY H+CIVFE LG S++DFLR+N+Y
Sbjct: 517 REAAKLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEP 576
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
+P+D VR + QL SV F+H+ RL HTDLKPENIL V ++Y ++K ++R +
Sbjct: 577 YPLDQVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHK-INREVRRV-- 633
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
K++ ++LIDFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL E
Sbjct: 634 -----KNTDVRLIDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFE 688
Query: 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMV---IRADRRAEKYFRRGARLDWPDGATS 367
L G LFQTH+N EHLAMMER+LG +P+ M + KYF G +LDW + +++
Sbjct: 689 LYLGITLFQTHDNREHLAMMERILGQIPYRMARNHTLYSKTKTKYFYHG-KLDWDEKSSA 747
Query: 368 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+R K L L L DH +L L++ +L Y+P+ R+ EAL HPFF R
Sbjct: 748 GRYVRDHCKPLFLCQL-SDSEDHC--ELFSLIKKMLEYEPSSRITLGEALHHPFFDR 801
|
Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35493|CLK4_MOUSE Dual specificity protein kinase CLK4 OS=Mus musculus GN=Clk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 166/349 (47%), Positives = 233/349 (66%), Gaps = 16/349 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D+ L VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV K+ S+ +D KN
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV----VKYNSKMKRDERTLKN 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 317 ----TDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 372
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G +FQTH++ EHLAMMER+LGP+P HM+ + +R KYF +LDW + +++ +R
Sbjct: 373 GFTVFQTHDSKEHLAMMERILGPIPAHMIQKTRKR--KYFHHN-QLDWDEHSSAGRYVRR 429
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
K L+ ++ H D L DL++ +L YDPA R+ EAL+HPFF
Sbjct: 430 RCKPLK--EFMLCH-DEEHEKLFDLVRRMLEYDPARRITLDEALQHPFF 475
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9HAZ1|CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 164/349 (46%), Positives = 233/349 (66%), Gaps = 16/349 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D+ + VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV K+ S+ +D KN
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV----VKYNSKMKRDERTLKN 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 317 ----TDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 372
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G +FQTH++ EHLAMMER+LGP+P HM+ + +R KYF +LDW + +++ +R
Sbjct: 373 GFTVFQTHDSKEHLAMMERILGPIPQHMIQKTRKR--KYFHHN-QLDWDEHSSAGRYVRR 429
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
K L+ ++ H D L DL++ +L YDP +R+ EAL+HPFF
Sbjct: 430 RCKPLK--EFMLCH-DEEHEKLFDLVRRMLEYDPTQRITLDEALQHPFF 475
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49759|CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 164/349 (46%), Positives = 232/349 (66%), Gaps = 16/349 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
DD++GH + G+ L+ RY I+ +GEG FG+VVEC D++ VA+KIV+++++Y EA
Sbjct: 143 DDEEGHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA 202
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D T RCVQ+ WF++ HICIVFE LG S YDF+++N + F +
Sbjct: 203 ARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRL 262
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D +R++ Q+ +SV F+H +L HTDLKPENIL V ++Y + + K +D N
Sbjct: 263 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI----KRDERTLIN 318
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 319 ----PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 374
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G +F TH++ EHLAMMER+LGPLP HM+ + +R KYF RLDW + +++ +
Sbjct: 375 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHD-RLDWDEHSSAGRYVSR 431
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
K L+ ++ Q V+H L DL+Q +L YDPA+R+ REAL+HPFF
Sbjct: 432 RCKPLK-EFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFF 477
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 433 | ||||||
| 225439856 | 429 | PREDICTED: serine/threonine-protein kina | 0.990 | 1.0 | 0.896 | 0.0 | |
| 224138498 | 433 | predicted protein [Populus trichocarpa] | 0.986 | 0.986 | 0.879 | 0.0 | |
| 449439980 | 433 | PREDICTED: serine/threonine-protein kina | 1.0 | 1.0 | 0.886 | 0.0 | |
| 147800314 | 448 | hypothetical protein VITISV_001943 [Viti | 0.974 | 0.941 | 0.896 | 0.0 | |
| 449439982 | 428 | PREDICTED: serine/threonine-protein kina | 0.988 | 1.0 | 0.887 | 0.0 | |
| 356505140 | 427 | PREDICTED: serine/threonine-protein kina | 0.983 | 0.997 | 0.845 | 0.0 | |
| 356505138 | 444 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.975 | 0.833 | 0.0 | |
| 255638456 | 444 | unknown [Glycine max] | 1.0 | 0.975 | 0.826 | 0.0 | |
| 224088571 | 434 | predicted protein [Populus trichocarpa] | 0.960 | 0.958 | 0.831 | 0.0 | |
| 15231839 | 467 | serine/threonine-protein kinase AFC1 [Ar | 0.979 | 0.907 | 0.836 | 0.0 |
| >gi|225439856|ref|XP_002278124.1| PREDICTED: serine/threonine-protein kinase AFC1 [Vitis vinifera] gi|297741539|emb|CBI32671.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2048), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/433 (89%), Positives = 414/433 (95%), Gaps = 4/433 (0%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF + NY SS+
Sbjct: 1 METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57 FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYKF
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSR+ KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 237 LSRTIKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTRHYRAPEVILGLGWNYPCD 296
Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
LWSVGCIL+ELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFRRGARLD
Sbjct: 297 LWSVGCILIELCSGEALFQTHENLEHLAMMERVLGPLPQHMVLRADRRAEKYFRRGARLD 356
Query: 361 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 420
WP+GATSR+SMRAVWKL RL NL+MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP
Sbjct: 357 WPEGATSRESMRAVWKLPRLQNLVMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 416
Query: 421 FFTRDVRRCGFPL 433
FFTRD RRCG+PL
Sbjct: 417 FFTRDARRCGYPL 429
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138498|ref|XP_002322829.1| predicted protein [Populus trichocarpa] gi|222867459|gb|EEF04590.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/439 (87%), Positives = 409/439 (93%), Gaps = 12/439 (2%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPP----LPPPKVLPALYCVQEFGNGG--MPN 54
METQRI EFPHKNMDKRPRKR RLTWD+PPP L P KV+P ++C QEFGNG +PN
Sbjct: 1 METQRITEFPHKNMDKRPRKRQRLTWDIPPPPPPFLAPAKVVPGMFCGQEFGNGNGVIPN 60
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
Y +FY R GSPPWRPDDKDGHYVFAIG+NLTPRYRILSKMGEGTFGQV+ECFDN
Sbjct: 61 YG---LFYN---RNGSPPWRPDDKDGHYVFAIGDNLTPRYRILSKMGEGTFGQVLECFDN 114
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
EKKELVAIKIVRSI+KYREAAM EIDVLQRLARHDIG TRCVQIRNWFDYRNHICIVFEK
Sbjct: 115 EKKELVAIKIVRSIHKYREAAMTEIDVLQRLARHDIGSTRCVQIRNWFDYRNHICIVFEK 174
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH+L LIHTDLKPENILLVS+EY+K
Sbjct: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLHLIHTDLKPENILLVSSEYIK 234
Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
VPDYKFLSRS+KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG
Sbjct: 235 VPDYKFLSRSTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
Query: 295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 354
WNYPCD+WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFR
Sbjct: 295 WNYPCDIWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPQHMVVRADRRAEKYFR 354
Query: 355 RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 414
RG RLDWP+GATSR+SM+AV KL RLPNLIMQHVDHSAG+LIDLLQGLLR+DPAERLKAR
Sbjct: 355 RGMRLDWPEGATSRESMKAVMKLPRLPNLIMQHVDHSAGELIDLLQGLLRHDPAERLKAR 414
Query: 415 EALRHPFFTRDVRRCGFPL 433
EALRHPFF+RD+RR G+PL
Sbjct: 415 EALRHPFFSRDLRRYGYPL 433
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439980|ref|XP_004137763.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2020), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/433 (88%), Positives = 408/433 (94%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP YC QEFGNG +PNYA SM
Sbjct: 1 METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
+ PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61 YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRE RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+KF
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSRS KDGSYFKNLPKS+AIKLIDFGSTT EHQDHSY+VSTRHYRAPEVILGLGWNYPCD
Sbjct: 241 LSRSVKDGSYFKNLPKSAAIKLIDFGSTTTEHQDHSYIVSTRHYRAPEVILGLGWNYPCD 300
Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
LWSVGCILVELCSGEALFQTHENLEHLAMME+VLGPLP HMV+RADRRAEKYFRRG +LD
Sbjct: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMEKVLGPLPQHMVLRADRRAEKYFRRGMQLD 360
Query: 361 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 420
WP ATSR+SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP+ERL AREALRHP
Sbjct: 361 WPQSATSRESMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPSERLMAREALRHP 420
Query: 421 FFTRDVRRCGFPL 433
FFTRD+RRCG+PL
Sbjct: 421 FFTRDLRRCGYPL 433
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147800314|emb|CAN73108.1| hypothetical protein VITISV_001943 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2015), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/426 (89%), Positives = 408/426 (95%), Gaps = 4/426 (0%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF + NY SS+
Sbjct: 1 METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57 FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYKF
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSR+ KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 237 LSRTIKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTRHYRAPEVILGLGWNYPCD 296
Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
LWSVGCIL+ELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFRRGARLD
Sbjct: 297 LWSVGCILIELCSGEALFQTHENLEHLAMMERVLGPLPQHMVLRADRRAEKYFRRGARLD 356
Query: 361 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 420
WP+GATSR+SMRAVWKL RL NL+MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP
Sbjct: 357 WPEGATSRESMRAVWKLPRLQNLVMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 416
Query: 421 FFTRDV 426
FFTRD+
Sbjct: 417 FFTRDI 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439982|ref|XP_004137764.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1993), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/428 (88%), Positives = 403/428 (94%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP YC QEFGNG +PNYA SM
Sbjct: 1 METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
+ PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61 YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRE RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+KF
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSRS KDGSYFKNLPKS+AIKLIDFGSTT EHQDHSY+VSTRHYRAPEVILGLGWNYPCD
Sbjct: 241 LSRSVKDGSYFKNLPKSAAIKLIDFGSTTTEHQDHSYIVSTRHYRAPEVILGLGWNYPCD 300
Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
LWSVGCILVELCSGEALFQTHENLEHLAMME+VLGPLP HMV+RADRRAEKYFRRG +LD
Sbjct: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMEKVLGPLPQHMVLRADRRAEKYFRRGMQLD 360
Query: 361 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 420
WP ATSR+SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP+ERL AREALRHP
Sbjct: 361 WPQSATSRESMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPSERLMAREALRHP 420
Query: 421 FFTRDVRR 428
FFTRD+RR
Sbjct: 421 FFTRDLRR 428
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505140|ref|XP_003521350.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1987), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/434 (84%), Positives = 399/434 (91%), Gaps = 8/434 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPH+NMDKRPRK+ RLTWD+ VLP +YC QE GNG +PN+A S+
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDM-------HVLPTMYCKQEVGNGVVPNHAYPSL 53
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+EC DNEK+E+V
Sbjct: 54 FYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLECLDNEKEEIV 113
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 114 AIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICIVFEKLGPSLY 173
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+E++KVPDYKF
Sbjct: 174 DFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISSEFIKVPDYKF 233
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 234 LSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 293
Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYF+RG RL
Sbjct: 294 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVVRADRRAEKYFKRGTRLS 353
Query: 361 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 420
WPD +TSR+SMRAVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP+ERLKA+EALRHP
Sbjct: 354 WPDSSTSRESMRAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPSERLKAKEALRHP 413
Query: 421 -FFTRDVRRCGFPL 433
FFTRD +R G+PL
Sbjct: 414 FFFTRDTKRYGYPL 427
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505138|ref|XP_003521349.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/444 (83%), Positives = 403/444 (90%), Gaps = 11/444 (2%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
METQRIIEFPH+NMDKRPRK+ RLTWD+ P P P +VLP +YC QE GNG
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60
Query: 51 GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
+PN+A S+FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61 VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120
Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170
C DNEK+E+VAIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICI
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180
Query: 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230
VFEKLGPSLYDFLRKNSYRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240
Query: 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI 290
E++KVPDYKFLSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVI
Sbjct: 241 EFIKVPDYKFLSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVI 300
Query: 291 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 350
LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAE
Sbjct: 301 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVVRADRRAE 360
Query: 351 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410
KYF+RG RL WPD +TSR+SMRAVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP+ER
Sbjct: 361 KYFKRGTRLSWPDSSTSRESMRAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPSER 420
Query: 411 LKAREALRHP-FFTRDVRRCGFPL 433
LKA+EALRHP FFTRD +R G+PL
Sbjct: 421 LKAKEALRHPFFFTRDTKRYGYPL 444
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255638456|gb|ACU19537.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/444 (82%), Positives = 400/444 (90%), Gaps = 11/444 (2%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
METQRIIEFPH+NMDKRPRK+ RLTWD+ P P P +VLP +YC QE GNG
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60
Query: 51 GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
+PN+A S+FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61 VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120
Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170
C DNEK+E+VAIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICI
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180
Query: 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230
VFEKLGPSLYDFLRKN YRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNCYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240
Query: 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI 290
E++KVPDYKFLSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVI
Sbjct: 241 EFIKVPDYKFLSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVI 300
Query: 291 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 350
LGLGWNYPCDLWSVGCILVELCSGEALFQTHENL HLAMMERVLGPLP HMV+RADRRAE
Sbjct: 301 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLGHLAMMERVLGPLPPHMVVRADRRAE 360
Query: 351 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410
KYF+RG RL WPD +TSR+SMRAVWKL RLPNLIMQHVDH AGDLIDLLQGLLRYDP+ER
Sbjct: 361 KYFKRGTRLSWPDSSTSRESMRAVWKLPRLPNLIMQHVDHFAGDLIDLLQGLLRYDPSER 420
Query: 411 LKAREALRHP-FFTRDVRRCGFPL 433
LKA+EALRHP FFTRD +R G+PL
Sbjct: 421 LKAKEALRHPFFFTRDTKRYGYPL 444
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224088571|ref|XP_002308478.1| predicted protein [Populus trichocarpa] gi|222854454|gb|EEE92001.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/451 (83%), Positives = 396/451 (87%), Gaps = 35/451 (7%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPP------------------PKVLPALY 42
METQRI EFPHKNMDKRP+KR RLTW VPPPL +V+P ++
Sbjct: 1 METQRITEFPHKNMDKRPKKRQRLTWGVPPPLLAPPKKSETFNFNFDFNFLLQQVIPGMF 60
Query: 43 CVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGE 102
C F NG GSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGE
Sbjct: 61 CGYGFYNG-----------------NGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGE 103
Query: 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162
GTFGQV+ECFDNEKKE VAIKIVRSI+KYREAAMIEIDVLQRLARHD G TRCVQIRNWF
Sbjct: 104 GTFGQVLECFDNEKKEGVAIKIVRSIHKYREAAMIEIDVLQRLARHDFGSTRCVQIRNWF 163
Query: 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222
DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKP
Sbjct: 164 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKP 223
Query: 223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTR 282
ENILLVS+EY+KVPDYKFLSRS+KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTR
Sbjct: 224 ENILLVSSEYIKVPDYKFLSRSTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTR 283
Query: 283 HYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMV 342
HYRAPEV+LGLGWNYPCD+WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HM
Sbjct: 284 HYRAPEVVLGLGWNYPCDIWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPQHMA 343
Query: 343 IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402
IRADRRAEKYFRRGARLDWP+GATSR+SMRAV KL RLPN+IMQHVDHSAGDLIDLLQGL
Sbjct: 344 IRADRRAEKYFRRGARLDWPEGATSRESMRAVTKLPRLPNIIMQHVDHSAGDLIDLLQGL 403
Query: 403 LRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
LRYDPAERLKAREALRHPFF+RD+RR G+P+
Sbjct: 404 LRYDPAERLKAREALRHPFFSRDLRRYGYPV 434
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231839|ref|NP_190925.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|42570490|ref|NP_850695.2| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|79314891|ref|NP_001030853.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|26454604|sp|P51566.2|AFC1_ARATH RecName: Full=Serine/threonine-protein kinase AFC1 gi|642132|dbj|BAA08215.1| protein kinase [Arabidopsis thaliana] gi|6729508|emb|CAB67664.1| protein kinase (AME2/AFC1) [Arabidopsis thaliana] gi|222424132|dbj|BAH20025.1| AT3G53570 [Arabidopsis thaliana] gi|332645589|gb|AEE79110.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645590|gb|AEE79111.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645591|gb|AEE79112.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/429 (83%), Positives = 394/429 (91%), Gaps = 5/429 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376
Query: 356 GARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 415
GA+LDWP+GATSRDS++AVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP ER KARE
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKARE 436
Query: 416 ALRHPFFTR 424
AL HPFFTR
Sbjct: 437 ALNHPFFTR 445
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 433 | ||||||
| TAIR|locus:2084006 | 467 | FC1 "FUS3-complementing gene 1 | 0.979 | 0.907 | 0.822 | 2.2e-199 | |
| TAIR|locus:2121984 | 427 | FC2 "FUS3-complementing gene 2 | 0.967 | 0.981 | 0.706 | 1.4e-167 | |
| TAIR|locus:2125622 | 400 | AME3 [Arabidopsis thaliana (ta | 0.826 | 0.895 | 0.686 | 9.1e-141 | |
| UNIPROTKB|F1RLJ5 | 500 | CLK2 "Uncharacterized protein" | 0.773 | 0.67 | 0.487 | 6.9e-86 | |
| POMBASE|SPAC1D4.11c | 690 | lkh1 "dual specificity protein | 0.803 | 0.504 | 0.464 | 6.9e-86 | |
| UNIPROTKB|E1B9Q2 | 500 | CLK2 "Uncharacterized protein" | 0.773 | 0.67 | 0.487 | 8.9e-86 | |
| UNIPROTKB|F1P919 | 612 | CLK2 "Uncharacterized protein" | 0.773 | 0.547 | 0.487 | 8.9e-86 | |
| UNIPROTKB|B1AVT0 | 497 | CLK2 "Dual-specificity protein | 0.773 | 0.674 | 0.487 | 8.9e-86 | |
| UNIPROTKB|P49760 | 499 | CLK2 "Dual specificity protein | 0.773 | 0.671 | 0.487 | 8.9e-86 | |
| MGI|MGI:1098669 | 499 | Clk2 "CDC-like kinase 2" [Mus | 0.769 | 0.667 | 0.489 | 1.4e-85 |
| TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1930 (684.5 bits), Expect = 2.2e-199, P = 2.2e-199
Identities = 353/429 (82%), Positives = 388/429 (90%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDXXXXXXX-----XXXXXALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376
Query: 356 GARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 415
GA+LDWP+GATSRDS++AVWKL RLPNLIMQHVDHSAGDLIDLLQGLLRYDP ER KARE
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKARE 436
Query: 416 ALRHPFFTR 424
AL HPFFTR
Sbjct: 437 ALNHPFFTR 445
|
|
| TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1630 (578.8 bits), Expect = 1.4e-167, P = 1.4e-167
Identities = 304/430 (70%), Positives = 358/430 (83%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDXXXXXXXXXXXXALYCVQEFGN------GGMPN 54
ME +R+ EFPH +MD+RPRKR RL WD ++C QE GN G P+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
SS+ + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D
Sbjct: 59 DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG RCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LG SLYDFLRKN+YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
+P+YK SR +D Y K +PKSSAIK+IDFGSTT+E QD +Y+VSTRHYRAPEVILGLG
Sbjct: 239 IPEYKG-SRLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296
Query: 295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 354
W+YPCD+WSVGCI+VELC+GEALFQTHENLEHLAMMERVLGP P M+ + DR +EKY R
Sbjct: 297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356
Query: 355 RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 414
RG RLDWPDGATSRDS++AV KL RL NLIMQHVDHSAG+LI+++QGLLR+DP+ER+ AR
Sbjct: 357 RG-RLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQGLLRFDPSERITAR 415
Query: 415 EALRHPFFTR 424
EALRHPFF R
Sbjct: 416 EALRHPFFAR 425
|
|
| TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1335 (475.0 bits), Expect = 9.1e-141, Sum P(2) = 9.1e-141
Identities = 248/361 (68%), Positives = 303/361 (83%)
Query: 62 YGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVA 121
+G+ R SPP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VA
Sbjct: 39 HGSDGRILSPPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVA 98
Query: 122 IKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYD 181
IKI+RSI KYR+AAMIEIDVLQ+L + D G TRCVQ++NWFDYRNHICIVFEKLGPSL+D
Sbjct: 99 IKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFD 158
Query: 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
FL++N Y +FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K
Sbjct: 159 FLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK-- 216
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDL 301
RS+ + ++F+ LPKSSAIKLIDFGST +++ H +V TRHYR+PEVILGLGW+Y CDL
Sbjct: 217 -RSAANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDL 275
Query: 302 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW 361
WS+GCIL ELC+GEALFQTH+NLEHLAMMER LGPLP HM +A R AEKYFRRG RL+W
Sbjct: 276 WSIGCILFELCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKASRGAEKYFRRGCRLNW 335
Query: 362 PDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
P+GA SR+S+RAV +L RL +++ +HVD++ DLL GLL YDP+ERL A EAL HPF
Sbjct: 336 PEGANSRESIRAVKRLDRLKDMVSKHVDNTRSRFADLLYGLLAYDPSERLTANEALDHPF 395
Query: 422 F 422
F
Sbjct: 396 F 396
|
|
| UNIPROTKB|F1RLJ5 CLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 859 (307.4 bits), Expect = 6.9e-86, P = 6.9e-86
Identities = 171/351 (48%), Positives = 240/351 (68%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIISTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + + S
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 318
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 319 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 376
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++ +R
Sbjct: 377 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 433
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 434 NCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| POMBASE|SPAC1D4.11c lkh1 "dual specificity protein kinase Lkh1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 859 (307.4 bits), Expect = 6.9e-86, P = 6.9e-86
Identities = 168/362 (46%), Positives = 240/362 (66%)
Query: 68 TGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127
T P DD DGHY RY ++ +G GTFG+V++C+D AIK+ R+
Sbjct: 336 TAFDPSTFDDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRA 395
Query: 128 INKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKN 186
I KYREA++IE+ VLQ +A D +C+Q+R++FDYR HICIV + G S++DFL+ N
Sbjct: 396 IPKYREASLIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNN 455
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKFLSRS 244
+Y FP+ ++ L +QL +SVAF+H L L+HTDLKPEN+LLVS + +++P Y+
Sbjct: 456 NYIPFPLKHIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YR----- 509
Query: 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304
+Y + + S I+LIDFGS TFE + HS VVSTRHYRAPE+ILGLGW+YPCD+WS+
Sbjct: 510 ----NYSQKVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSI 565
Query: 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 364
GCILVEL +G+ALFQTHE+ EHL MME++LGP +M+ R+ R ++++F+ ++ +P
Sbjct: 566 GCILVELFTGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLS 625
Query: 365 ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
T + S+ + L L + A L+DLL+ + YDP R+ A+EAL HPFFT+
Sbjct: 626 NTPKKSINYLQSLQTLEQIFAVSSPEVAL-LLDLLKKVFVYDPKRRITAKEALWHPFFTQ 684
Query: 425 DV 426
+
Sbjct: 685 PI 686
|
|
| UNIPROTKB|E1B9Q2 CLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 171/351 (48%), Positives = 240/351 (68%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + + S
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 318
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 319 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 376
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++ +R
Sbjct: 377 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 433
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 434 NCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|F1P919 CLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 171/351 (48%), Positives = 240/351 (68%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 257 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 316
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 317 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 376
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + + S
Sbjct: 377 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 430
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 431 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 488
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++ +R
Sbjct: 489 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 545
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 546 NCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 593
|
|
| UNIPROTKB|B1AVT0 CLK2 "Dual-specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 171/351 (48%), Positives = 240/351 (68%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 143 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 202
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 203 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 262
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + + S
Sbjct: 263 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 317 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 374
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++ +R
Sbjct: 375 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 431
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 432 NCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 479
|
|
| UNIPROTKB|P49760 CLK2 "Dual specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 171/351 (48%), Positives = 240/351 (68%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + + S
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 318
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 319 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 376
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++ +R
Sbjct: 377 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 433
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
K LR L + +H L DL++ +L Y+PA+RL EAL+HPFF R
Sbjct: 434 NCKPLRR-YLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| MGI|MGI:1098669 Clk2 "CDC-like kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 171/349 (48%), Positives = 239/349 (68%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 144 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEA 203
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 204 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 263
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y Y L + + S
Sbjct: 264 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 317
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 318 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 375
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTH+N EHLAMMER+LGP+P M IR R+ +KYF RG RLDW + ++ +R
Sbjct: 376 GFTLFQTHDNREHLAMMERILGPVPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 432
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
K LR L + DH L DL++ +L Y+PA+RL EAL+HPFF
Sbjct: 433 NCKPLRR-YLTSEAEDHH--QLFDLIENMLEYEPAKRLTLGEALQHPFF 478
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P51567 | AFC2_ARATH | 2, ., 7, ., 1, 2, ., 1 | 0.7139 | 0.9676 | 0.9812 | no | no |
| P51566 | AFC1_ARATH | 2, ., 7, ., 1, 2, ., 1 | 0.8368 | 0.9792 | 0.9079 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 433 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-71 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-66 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-57 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-51 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-51 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-51 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-49 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-39 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-39 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-37 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-36 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-36 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-32 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-32 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-31 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-30 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-28 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-28 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-27 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-27 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-25 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-24 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-24 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-23 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-23 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-23 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-22 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-22 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-20 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-19 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.001 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.002 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 1e-71
Identities = 98/334 (29%), Positives = 146/334 (43%), Gaps = 85/334 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIG 151
Y IL K+GEG+FG+V D + +LVAIK+++ I K RE + EI +L++L +H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHP-- 57
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V++ + F+ + + +V E G L+D L+K D R RQ+L ++ ++
Sbjct: 58 --NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYL 113
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++H DLKPENILL +DG +KL DFG
Sbjct: 114 HSKGIVHRDLKPENILL-----------------DEDGH----------VKLADFGLARQ 146
Query: 271 EHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
V T Y APEV+LG G+ D+WS+G IL EL +G+ F + L
Sbjct: 147 LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL--E 204
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ +++ P P P+ S
Sbjct: 205 LFKKIGKPKPP-------------------FPPPEWDISP-------------------- 225
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ DL++ LL DP +RL A EAL+HPFF
Sbjct: 226 -----EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 7e-66
Identities = 128/358 (35%), Positives = 194/358 (54%), Gaps = 43/358 (12%)
Query: 78 KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
++GH+ +GE++ T R++ILS +GEGTFG+VVE +D ++KE A+KIVR++ KY
Sbjct: 112 EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRD 171
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
A IEI ++++ + D ++I+ +F + H+CIV K GP L D++ K+ S
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH- 230
Query: 193 IDLVRELGRQLLESVA----FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
R L + + ++ F EL L+HTDLKPENIL+ +++ + D
Sbjct: 231 ----RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD------------TVVDP 274
Query: 249 SYFKNLPKSSA-IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307
+ LP +++ D G E + +VSTRHYR+PEV+LGLGW Y D+WS+GCI
Sbjct: 275 VTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334
Query: 308 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDW---PD 363
+ EL +G+ L+ TH+NLEHL +ME+ LG LP R A + +L P
Sbjct: 335 IYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPK 394
Query: 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
R V +++R L DL+ GLL YD +RL AR+ HP+
Sbjct: 395 HLARIARARPVREVIRDDL------------LCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 4e-57
Identities = 91/338 (26%), Positives = 144/338 (42%), Gaps = 87/338 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD- 149
Y +L K+G G+FG V + ++VA+KI+ RS K + A EI +L+RL H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V++ + F+ ++H+ +V E L+D+L + D +++ Q+L +
Sbjct: 60 I-----VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLE 112
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
++H +IH DLKPENILL +K+ DFG +
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGV---------------------------VKIADFGLA 145
Query: 268 TTFEHQDHSY--VVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
S V T Y APEV+L G G+ D+WS+G IL EL +G+ F L
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL 205
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
+ L ++ R+LGP D P ++ +
Sbjct: 206 DQLQLIRRILGPPLE-------------------FDEPKWSSGSE--------------- 231
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ DL++ L DP++R A E L+HP+F
Sbjct: 232 ---------EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-51
Identities = 103/340 (30%), Positives = 158/340 (46%), Gaps = 63/340 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
RY+IL ++GEG G V + D E E VA+K + R A+ EI LQ
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ V++ + F + + +V E + L + LR + R P V+ R LL+ VA+
Sbjct: 61 V-----VKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAY 114
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
MH ++H DLKP N+L+ + +K+ D+ L+R +
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFG-LARLFSEE-----------------EPRL 156
Query: 270 FEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+ HQ V+TR YRAPE++ G ++ DLW+VGCI EL +G LF ++E LA
Sbjct: 157 YSHQ-----VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211
Query: 329 MMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN----L 383
++ R LG P WP + D + + P
Sbjct: 212 IVFRTLGTPNEE--------------------TWPGLTSLPD-----YNKITFPESKPIP 246
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+ + ++ + +DLL+GLL YDP++RL A EALRHP+FT
Sbjct: 247 LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-51
Identities = 95/337 (28%), Positives = 163/337 (48%), Gaps = 62/337 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA-AMIEIDVLQRLARHDIG 151
Y+++ ++G+GTFG V + E ELVAIK + + + E + E+ L++L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+++ F + + VFE + +LY ++ + F ++R + Q+L+ +A +H
Sbjct: 59 --NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ H DLKPEN+L+ E VK+ D+ L+R + + T +
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFG-LAREIRSRPPY----------------TDY- 158
Query: 272 HQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
VSTR YRAPE++L + P D+W++GCI+ EL + LF ++ L +
Sbjct: 159 -------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211
Query: 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL-LRLPN----LIM 385
VLG P + DWP+G + KL R P +
Sbjct: 212 CSVLGT-P------------------TKQDWPEG------YKLASKLGFRFPQFAPTSLH 246
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
Q + +++ + IDL++ +LR+DP +R A +AL+HP+F
Sbjct: 247 QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 7e-51
Identities = 99/339 (29%), Positives = 160/339 (47%), Gaps = 67/339 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARHD 149
Y L K+GEGT+G V + D + E+VA+K +R ++ E A+ EI +L+ L +H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALREISLLKEL-KHP 58
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V++ + + +VFE L +L K +L++ + QLL +A
Sbjct: 59 NI-----VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLA 112
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
+ H R++H DLKP+NIL+ ++DG +KL DFG +
Sbjct: 113 YCHSHRILHRDLKPQNILI-----------------NRDGV----------LKLADFGLA 145
Query: 268 TTFEHQDHSY--VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
F +Y V T YRAPE++LG ++ D+WSVGCI E+ +G+ LF +
Sbjct: 146 RAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205
Query: 325 EHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
+ L + ++LG P WP G T + + P
Sbjct: 206 DQLFKIFQILGTPTEE--------------------SWP-GVTKLPDYKPTFP-KFPPKD 243
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + + + IDLL +L+Y+PA+R+ A+EAL+HP+F
Sbjct: 244 LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 99/335 (29%), Positives = 160/335 (47%), Gaps = 53/335 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
+Y +L +GEG +G V++C + E+VAIK ++ A+ E+ VL++L +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V ++ F + + +VFE + +L + L + P D VR QLL+++A+
Sbjct: 62 I-----VNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H +IH D+KPENIL+ + +K+ D+ F + L A L D+
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFA----------RALRARPASPLTDY---- 161
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHL 327
V+TR YRAPE+++G NY P D+W++GCI+ EL GE LF +++ L
Sbjct: 162 ---------VATRWYRAPELLVG-DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
++++ LGPLP F A + +S+ R P +
Sbjct: 212 YLIQKCLGPLPPSHQELFSS--NPRFAGVAFPEPSQ----PESL-----ERRYPGKV--- 257
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ +D L+ LR DP ERL E L+HP+F
Sbjct: 258 ----SSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 7e-48
Identities = 100/339 (29%), Positives = 152/339 (44%), Gaps = 66/339 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDI 150
Y+ L K+GEGT+G V + D E+VAIK ++ + + A+ EI +L+ L +I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+++ + F ++ + +VFE + LY ++ R P L++ QLL+ +AF
Sbjct: 61 -----IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFC 114
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++H DLKPEN+L + +KL DFG
Sbjct: 115 HSHGILHRDLKPENLL---------------------------INTEGVLKLADFGLARS 147
Query: 271 EHQDHSYV---VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
V TR YRAPE++LG G++ P D+WSVGCI EL S LF ++
Sbjct: 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207
Query: 327 LAMMERVLG-PLPHHM-VIRADRRAEKY-FRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
L + R LG P P + R K+ F + A + P PN
Sbjct: 208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLP---------------KLFPNA 252
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ +DLL +L YDP +R+ A +AL HP+F
Sbjct: 253 --------SPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-44
Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
GEG FG V D + + VAIKI++ + E + EI++L++L H V++
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHP----NIVKL 56
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F+ NH+ +V E G SL D L++N + D + + Q+LE + ++H +IH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DLKPENILL S +KL DFG + D S
Sbjct: 116 RDLKPENILLDSDNGK--------------------------VKLADFGLSKLLTSDKSL 149
Query: 278 VVS---TRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 311
+ + T Y APEV+LG G ++ D+WS+G IL EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 100/339 (29%), Positives = 156/339 (46%), Gaps = 67/339 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
Y+IL K+GEGTF +V++ + + AIK ++ + EI L+RL+ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 150 --IGGTRCVQIRNWFDYR-NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ + FD + + +VFE + +LY+ + K R P V+ QLL+S
Sbjct: 59 NILRLIEVL-----FDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYMYQLLKS 112
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ MH + H D+KPENIL+ K +KL DFG
Sbjct: 113 LDHMHRNGIFHRDIKPENILI----------------------------KDDILKLADFG 144
Query: 267 S--TTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
S + ++ +STR YRAPE +L G + D+W+VGC+ E+ S LF
Sbjct: 145 SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
L+ +A + VLG P D K FR+ ++ + + + + + KLL
Sbjct: 205 LDQIAKIHDVLG-TP-------DAEVLKKFRKSRHMN-YNFPSKKGT--GLRKLL----- 248
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ +DLL+ LL YDP ER+ A++ALRHP+F
Sbjct: 249 --PNASAEG---LDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 96/359 (26%), Positives = 152/359 (42%), Gaps = 102/359 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDI 150
Y ++++GEGT+GQV + + + ELVA+K +R N+ A+ EI +LQ+L RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHP- 58
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLY--------DF---LRKNSYRSFPIDLVREL 199
V++ IV K S+Y D L + F ++
Sbjct: 59 ---NIVRL---------KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCY 105
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+QLLE + ++H ++H D+K NIL+ + DG
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILI-----------------NNDGV---------- 138
Query: 260 IKLIDFG---STTFEH-QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG 314
+KL DFG T + D++ V T YR PE++LG + D+WSVGCIL EL G
Sbjct: 139 LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
Query: 315 EALFQTHENLEHLAMMERVLGP-----------LPHHMVIRADRRAEKYFRRGARLDWPD 363
+ +FQ LE L + + G LP ++ + ++
Sbjct: 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRL---------- 248
Query: 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
R+ + + +D SA +DLL LL DP +R+ A +AL+H +F
Sbjct: 249 ----REFFKHL-------------IDPSA---LDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 99/343 (28%), Positives = 151/343 (44%), Gaps = 70/343 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMI-EIDVLQRLARH- 148
Y L+++GEG +G V + D VA+K VR E + + EI +L++L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFE 59
Query: 149 --------DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
D+ C R D + +VFE + L +L K P + +++L
Sbjct: 60 HPNIVRLLDV----CHGPRT--DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLM 113
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
RQLL V F+H R++H DLKP+NIL+ S VK+ D+ L+R Y + +S
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG-LARI-----YSFEMALTS-- 165
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
VV T YRAPEV+L + P D+WSVGCI EL LF+
Sbjct: 166 -----------------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208
Query: 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP-DGATSRDSMRAVWKLLR 379
+ L + V+G LP + +WP + + R S + R
Sbjct: 209 TSEADQLDKIFDVIG-LP------------------SEEEWPRNVSLPRSSFPS--YTPR 247
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + DLL+ +L ++P +R+ A EAL+HP+F
Sbjct: 248 SFKSFVPEICEEGL---DLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 98/344 (28%), Positives = 165/344 (47%), Gaps = 73/344 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---------IVRSINKYREAAMIEIDVLQ 143
+Y LSK+GEG++G V +C + E ++VAIK +++ I A+ EI +L+
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI------ALREIRMLK 55
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L ++ V + F + + +VFE ++ + L KN R P L++++ Q
Sbjct: 56 QLKHPNL-----VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQT 109
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L++V F H+ IH D+KPENIL+ K IKL
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---------------------------KQGQIKLC 142
Query: 264 DFG-STTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ 319
DFG + Y V+TR YRAPE+++G + P D+W++GC+ EL +G+ L+
Sbjct: 143 DFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202
Query: 320 THENLEHLAMMERVLGPL-PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 378
+++ L ++ + LG L P H I ++F +G + P +R+ + +
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQI---FSTNQFF-KGLSIPEP---ETREPLES----- 250
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ PN+ + + L+G L+ DP ERL E L HP+F
Sbjct: 251 KFPNI--------SSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 97/358 (27%), Positives = 149/358 (41%), Gaps = 87/358 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
RY K+GEGT+ V + D E +VAIK ++ + A+ EI +LQ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H I G V F ++++I +VFE + L ++ S P D ++ L
Sbjct: 60 KHPNIIGLLDV-----FGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTLR 113
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++H ++H DLKP N+L+ S +K+ D+ L+RS F
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFG-LARS--------------------F 152
Query: 266 GS--TTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHE 322
GS HQ V TR YRAPE++ G + D+WSVGCI EL
Sbjct: 153 GSPNRKMTHQ-----VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207
Query: 323 NLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
+++ L + LG P +WP + LP
Sbjct: 208 DIDQLGKIFEALGTPTEE--------------------NWPG-------------VTSLP 234
Query: 382 N-LIMQHVDH--------SAG-DLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429
+ + + +A D +DLLQ LL +P +R+ AR+AL HP+F+ D
Sbjct: 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 93/336 (27%), Positives = 167/336 (49%), Gaps = 56/336 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ +L +GEG +G V++C E KE+VAIK + + +E + E+ +L+ L + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V+++ F R + +VFE + ++ + L + P + VR QL++++ +
Sbjct: 62 I-----VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHW 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H+ ++H D+KPEN+L+ + +K+ D+ F +R+ +GS
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGS-------------------- 154
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
+ +++ V+TR YR+PE++LG + D+WSVGCIL EL G+ LF ++ L
Sbjct: 155 --NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
Query: 330 MERVLGPLPHHMVIRADRRAEKYFRRGAR---LDWPDGATSRDSMRAVWKLLRLPNLIMQ 386
+++VLGPLP + K F R L +P + R +L
Sbjct: 213 IQKVLGPLPAEQM--------KLFYSNPRFHGLRFPAVNHPQSLERRYLGIL-------- 256
Query: 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+G L+DL++ LL+ +P +R + L HP F
Sbjct: 257 -----SGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 99/338 (29%), Positives = 151/338 (44%), Gaps = 70/338 (20%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGT 153
+ K+GEGT+G V + + E+VA+K +R A+ EI +L+ L +I
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI--- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + N + +VFE L L F+ + P+ L++ QLL+ +AF H
Sbjct: 62 --VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST----- 268
R++H DLKP+N+L+ + +G AIKL DFG
Sbjct: 120 RVLHRDLKPQNLLI-----------------NTEG----------AIKLADFGLARAFGV 152
Query: 269 ---TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENL 324
T+ H+ V T YRAPE++LG ++ D+WS+GCI E+ + ALF +
Sbjct: 153 PVRTYTHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
+ L + R LG P +V Y + + W R V +P L
Sbjct: 208 DQLFRIFRTLGT-PDEVVWPGVTSLPDY--KPSFPKWA-----RQDFSKV-----VPPL- 253
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
D DLL +L YDP +R+ A+ AL HPFF
Sbjct: 254 -------DEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 88/351 (25%), Positives = 144/351 (41%), Gaps = 80/351 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQR 144
RY +L +G G +G V D VAIK + ++ RE I +L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-----IKLLRH 55
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR--- 201
L +I G + + N + IV E + L+ ++ P L + +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFL 109
Query: 202 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
Q+L + ++H +IH DLKP NIL+ N + +
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILV-------------------------N--SNCDL 142
Query: 261 KLIDFG-----STTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC 312
K+ DFG + + YVV TR YRAPE++L + D+WSVGCI EL
Sbjct: 143 KICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
+ + LF + ++ L ++ VLG L + +R+ ++
Sbjct: 202 TRKPLFPGRDYIDQLNLIVEVLGTPSEED-----------------LKFITSEKARNYLK 244
Query: 373 AVWKLLRLP-NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
++ K + P + + A IDLL+ +L +DP +R+ A EAL HP+
Sbjct: 245 SLPKKPKKPLSKLFPGASPEA---IDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 2e-33
Identities = 89/348 (25%), Positives = 134/348 (38%), Gaps = 88/348 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
YRIL K+GEG+FG+V D + VA+K++ S +K E + EI +L L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR-SFPIDLVRELGRQLLESV 207
V++ ++F + +V E + G SL D L+K + + Q+L ++
Sbjct: 59 ----NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
++H +IH D+KPENILL +KLIDFG
Sbjct: 115 EYLHSKGIIHRDIKPENILLD--------------------------RDGRVVKLIDFGL 148
Query: 267 --------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC---DLWSVGCILVELCSGE 315
ST+ S V T Y APEV+LGL Y D+WS+G L EL +G
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
Query: 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
F+ +N + +++ LP +
Sbjct: 209 PPFEGEKNSSATSQTLKIILELPTPSL--------------------------------- 235
Query: 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
L + + + DLL+ LL DP RL + L H
Sbjct: 236 ----ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 79/332 (23%), Positives = 137/332 (41%), Gaps = 84/332 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGG 152
+ IL K+G+G FG+V + + VAIK+++ + +E + EI +L++ +I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI-- 59
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+ + ++ + IV E G SL D L K++ ++ + + ++LL+ + ++H
Sbjct: 60 ---VKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
+IH D+K NILL + DG +KLIDFG S
Sbjct: 116 SNGIIHRDIKAANILL-----------------TSDGE----------VKLIDFGLSAQL 148
Query: 271 EH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
+ + +V T ++ APEVI G ++Y D+WS+G +EL G+ + E A+
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--SELPPMKAL 206
Query: 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389
+ P L P + D
Sbjct: 207 FKIATNGPP-------------------GLRNP----------------------EKWSD 225
Query: 390 HSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
D L+ L+ +P +R A + L+HPF
Sbjct: 226 E----FKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 80/334 (23%), Positives = 125/334 (37%), Gaps = 94/334 (28%)
Query: 101 GEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQ 157
G G+FG V D + EL+A+K + + EA EI +L L +H V+
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP----NIVR 63
Query: 158 IR--NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
+ +N + I E + G SL L+K + P ++R+ RQ+LE +A++H
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------ST 268
++H D+K NIL+ S +KL DFG
Sbjct: 122 IVHRDIKGANILVDS---------------------------DGVVKLADFGCAKRLGDI 154
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
S V T ++ APEVI G + D+WS+GC ++E+ +G+
Sbjct: 155 ETGEGTGS-VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP------------ 201
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
P + M A++K+
Sbjct: 202 -------PWSELG---------------------------NPMAALYKIGSSGEPPEIPE 227
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
S + D L+ LR DP +R A E L+HPF
Sbjct: 228 HLSE-EAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 102/340 (30%), Positives = 149/340 (43%), Gaps = 59/340 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
Y L K+GEGT+G+V + D +LVA+K R A+ EI +LQ L+ I
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESI 61
Query: 151 GGTRCVQIRNWFDYRNHICI--VFEKLGPSLYDFL---RKNSYRSFPIDLVRELGRQLLE 205
R + + + + + VFE L L F+ + R P ++ QLL+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 206 SVAFMHELRLIHTDLKPENILL-VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
VA H+ ++H DLKP+N+L+ +K+ D L R+ I
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG-LGRAFS----------------IP 164
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
S T E + T YRAPEV+LG ++ P D+WSVGCI E+ + LF
Sbjct: 165 VKSYTHE-------IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVWKLLRLPN 382
L+ L + ++LG P V WP + RD WK L
Sbjct: 218 LQQLLHIFKLLGT-PTEQV------------------WPGVSKLRDWHEFPQWKPQDLSR 258
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ +DLLQ +LRYDPA+R+ A+ AL HP+F
Sbjct: 259 AVPDLSPEG----LDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 105/359 (29%), Positives = 164/359 (45%), Gaps = 79/359 (22%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----------RSINKYREA 134
I +++ +Y IL K+G+G +G V + D KE+VA+K + R+ +RE
Sbjct: 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT---FRE- 56
Query: 135 AMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNH--ICIVFEKLGPSLYDFLRKNSYRSF 191
I LQ L H I V++ N N I +VFE + L+ +R N
Sbjct: 57 ----IMFLQELGDHPNI-----VKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN----- 102
Query: 192 PIDLVRELGR-----QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
++ ++ + QLL+++ ++H +IH DLKP NILL S VK+ D+ L+RS
Sbjct: 103 ---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG-LARS-- 156
Query: 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVG 305
+ E+ + V+TR YRAPE++LG D+WSVG
Sbjct: 157 ----------------LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG 200
Query: 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA 365
CIL E+ G+ LF L L + V+GP D + + P A
Sbjct: 201 CILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS-----AEDIES---------IKSPFAA 246
Query: 366 TSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
T DS+ R + + + ++ D +DLL+ LL ++P +RL A EAL HP+ +
Sbjct: 247 TMLDSL-----PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 92/341 (26%), Positives = 154/341 (45%), Gaps = 70/341 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIG 151
++ L K+GEGT+ V + + E+VA+K + + A+ EI +++ L +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI- 60
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR-SFPIDLVRELGRQLLESVAFM 210
V++ + N + +VFE + L ++ + R + + V+ QLL+ +AF
Sbjct: 61 ----VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---- 266
HE R++H DLKP+N+L+ +K G +KL DFG
Sbjct: 117 HENRVLHRDLKPQNLLI-----------------NKRGE----------LKLADFGLARA 149
Query: 267 ----STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
TF ++ V T YRAP+V+LG ++ D+WSVGCI+ E+ +G LF
Sbjct: 150 FGIPVNTFSNE-----VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
N + L + R++G P + +Y + +P P
Sbjct: 205 NNEDQLLKIFRIMGT-PTESTWPGISQLPEY-----KPTFP---------------RYPP 243
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ Q H+ IDLL LL+ +P R+ A +AL+HP+F
Sbjct: 244 QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 99/346 (28%), Positives = 152/346 (43%), Gaps = 80/346 (23%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD 149
Y+ + K+GEGT+G V + D E+VA+K +R + E A+ EI +L+ L H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKEL-NHP 58
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V++ + N + +VFE L L ++ + L++ QLL+ +A+
Sbjct: 59 ----NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST- 268
H R++H DLKP+N+L + + A+KL DFG
Sbjct: 115 CHSHRVLHRDLKPQNLL---------------------------IDREGALKLADFGLAR 147
Query: 269 -------TFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQ 319
T+ H+ V T YRAPE++LG Y P D+WS+GCI E+ + LF
Sbjct: 148 AFGVPVRTYTHE-----VVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFP 201
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV---WK 376
++ L + R LG P V WP G TS + W
Sbjct: 202 GDSEIDQLFRIFRTLGT-PDEDV------------------WP-GVTSLPDYKPTFPKWA 241
Query: 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
L ++ D +DLL +L YDPA+R+ A+ AL+HP+F
Sbjct: 242 RQDLSKVVPNL-DEDG---LDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 95/346 (27%), Positives = 152/346 (43%), Gaps = 76/346 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD 149
Y L+++ EGT+G V D + E+VA+K ++ + K +E ++ EI++L +L +H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKL-QHP 64
Query: 150 IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V ++ + I +V E + L + + + F V+ L QLL V
Sbjct: 65 ----NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGV 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
A +H+ ++H DLK N+L L +K+ DFG
Sbjct: 120 AHLHDNWILHRDLKTSNLL---------------------------LNNRGILKICDFGL 152
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
+ + Y +V T YRAPE++LG ++ D+WSVGCI EL + + LF
Sbjct: 153 AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD-----GATSRDSMRAVWKLL 378
++ L + ++LG P EK WP GA + + + L
Sbjct: 213 IDQLNKIFKLLG-TP----------TEK--------IWPGFSELPGAKKKTFTKYPYNQL 253
Query: 379 R--LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
R P L + DLL LL YDPA+R+ A +AL+HP+F
Sbjct: 254 RKKFPALSLSDNGF------DLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 101/343 (29%), Positives = 160/343 (46%), Gaps = 71/343 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--IVRSINKY-REAAMIEIDVLQRLARHD 149
+Y L +GEG++G V++C E ++VAIK + +K ++ AM EI +L++L RH+
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHE 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V + F + + +VFE + ++ D L K VR+ Q+L + F
Sbjct: 61 ----NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEF 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
H +IH D+KPENIL VS +S +KL DFG +
Sbjct: 116 CHSHNIIHRDIKPENIL-VS--------------------------QSGVVKLCDFGFAR 148
Query: 269 TFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
T Y V+TR YRAPE+++G + D+W+VGC++ E+ +GE LF +++
Sbjct: 149 TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208
Query: 326 HLAMMERVLGPL-PHHMVIRADRRAEKYFRR-----GARLDWPDGATSRDSMRAVWKLLR 379
L + + LG L P H I F++ G RL P+ + + R
Sbjct: 209 QLYHIIKCLGNLIPRHQEI---------FQKNPLFAGMRL--PE-VKEIEPLEK-----R 251
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
P L +G ++DL + LR DP +R + + L H FF
Sbjct: 252 FPKL--------SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 91/366 (24%), Positives = 155/366 (42%), Gaps = 64/366 (17%)
Query: 85 AIGENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------ 137
+ +++ RY +GEGT+G+V + +D ++VAIK V+ I +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVG 59
Query: 138 ----------EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK-- 185
E+ ++ + +I G V + F I +V + + D L+K
Sbjct: 60 MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-----INLVMDIMA---SD-LKKVV 110
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
+ V+ + Q+L + +H+ +H DL P NI + S K+ D+ L+R
Sbjct: 111 DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG-LARRY 169
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSV 304
Y L K ++ ++ + V T YRAPE+++G +++ D+WSV
Sbjct: 170 GYPPYSDTLSKDETMQR---------REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
Query: 305 GCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPD 363
GCI EL +G+ LF ++ L + +LG P +WP
Sbjct: 221 GCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNED--------------------NWPQ 260
Query: 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
A R P + +++ D IDLLQ LL+ +P ER+ A+EAL+H +F
Sbjct: 261 -AKKLPLYTEFTP--RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317
Query: 424 RDVRRC 429
D C
Sbjct: 318 SDPLPC 323
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 96/342 (28%), Positives = 157/342 (45%), Gaps = 71/342 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
Y + K+GEGT+G V + + + ++VA+K +R ++ A+ EI +L+ L +I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSL---YDFLRKNSYRSFPIDLVRELGRQLLESV 207
V +++ + + ++FE L L D L K Y +LV+ Q+L+ +
Sbjct: 62 -----VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGI 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H R++H DLKP+N+L+ IKL DFG
Sbjct: 115 LFCHSRRVLHRDLKPQNLLI---------------------------DNKGVIKLADFGL 147
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
+ + +++ V T YRAPEV+LG ++ P D+WS+G I E+ + + LF
Sbjct: 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV---WKLLRL 380
++ L + R+LG P V WP G TS + WK
Sbjct: 208 IDQLFRIFRILGT-PTEDV------------------WP-GVTSLPDYKNTFPKWK---- 243
Query: 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ V + D +DLL+ +L YDPA+R+ A++AL HP+F
Sbjct: 244 KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 93/335 (27%), Positives = 139/335 (41%), Gaps = 62/335 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHDIGG 152
L+++GEGT+G V D E+VA+K VR ++ R+ I EI +L L +I
Sbjct: 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNLRHPNIVE 70
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ V + D I +V E L L N F V+ L QLL + ++HE
Sbjct: 71 LKEVVVGKHLD---SIFLVMEYCEQDLASLL-DNMPTPFSESQVKCLMLQLLRGLQYLHE 126
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 271
+IH DLK N+LL +K+ DFG + T+
Sbjct: 127 NFIIHRDLKVSNLLLTD---------------------------KGCLKIADFGLARTYG 159
Query: 272 HQDHSY--VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
V T YRAPE++LG + D+W+VGCIL EL + + L +E L
Sbjct: 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-NLIMQH 387
++ ++LG P+ + WP S + + L + P N +
Sbjct: 220 LIIQLLGT-PNESI------------------WPG--FSDLPLVGKFTLPKQPYNNLKHK 258
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + LL LL YDP +R A EAL +F
Sbjct: 259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 81/339 (23%), Positives = 143/339 (42%), Gaps = 90/339 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y I+ ++G+G+FG+V +L +K + N K RE A+ E+ +L++L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSFPIDLVRELGRQLLES 206
++ F+ + +CIV E G L + +K + FP + + + QL +
Sbjct: 60 ----NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H +++H D+KP+NI L + +G +KL DFG
Sbjct: 116 LKYLHSRKILHRDIKPQNIFL-----------------TSNGL----------VKLGDFG 148
Query: 267 -STTFEH-QDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
S D + VV T +Y +PE+ +NY D+WS+GC+L ELC+ + F+ EN
Sbjct: 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GEN 207
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
L LA+ +++ +P+
Sbjct: 208 LLELAL-----------KILKGQYPP------------------------------IPS- 225
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ +L +L+ LL+ DP ER + L+ PF
Sbjct: 226 ------QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 81/334 (24%), Positives = 135/334 (40%), Gaps = 97/334 (29%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMI--EIDVLQRLARHDIGGTRCV 156
G+G+FG+V+ + +L A+K+++ I K +E E ++L R+ H V
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPF----IV 56
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + +V E G L+ L K F + R +++ ++ ++H L +
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS----TTFE 271
I+ DLKPENILL DG IKL DFG ++
Sbjct: 115 IYRDLKPENILL-----------------DADGH----------IKLTDFGLAKELSSEG 147
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331
+ +++ T Y APEV+LG G+ D WS+G +L E+ +G+ F + E + E
Sbjct: 148 SRTNTF-CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE 203
Query: 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391
++L L +P+ +
Sbjct: 204 KIL---------------------KDPLRFPEFLSP------------------------ 218
Query: 392 AGDLIDLLQGLLRYDPAERLKAREA---LRHPFF 422
+ DL+ GLL+ DP +RL + A HPFF
Sbjct: 219 --EARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 94/339 (27%), Positives = 148/339 (43%), Gaps = 50/339 (14%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRL 145
++ PRY+ LS +GEG +G V VAIK + + + + EI +L+R
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I G + F+ N + IV E + LY ++ + D ++ Q+L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN---DHIQYFLYQILR 117
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++H ++H DLKP N+LL + +K+ D+ L+R A D
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFG-LAR--------------IADPEHDH 162
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 324
E+ V+TR YRAPE++L G+ D+WSVGCIL E+ S LF + L
Sbjct: 163 TGFLTEY------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216
Query: 325 EHLAMMERVLGPLPHHMVIRA--DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
L ++ VLG P + RA Y + L + W L P
Sbjct: 217 HQLNLILGVLGT-PSQEDLNCIISLRARNYIK---SLPFKPKVP--------WNKL-FP- 262
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
+ D A +DLL +L ++P +R+ EAL HP+
Sbjct: 263 ----NADPKA---LDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 99/347 (28%), Positives = 161/347 (46%), Gaps = 71/347 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMI--EIDVLQRLARH- 148
RY+I +G+G++G V D E VAIK + + ++ +A I EI +L RL RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLL-RLLRHP 59
Query: 149 DIGGTRCVQIRNWF------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR- 201
DI V+I++ ++++ I +VFE + L+ ++ N DL E +
Sbjct: 60 DI-----VEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQF 107
Query: 202 ---QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
QLL ++ ++H + H DLKP+NIL + +K+ D+ L+R + F + P +
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVA-----FNDTP--T 159
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEA 316
AI D+ V+TR YRAPE+ Y D+WS+GCI E+ +G+
Sbjct: 160 AIFWTDY-------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIRA-DRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
LF + L ++ +LG + R + +A +Y SMR
Sbjct: 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL---------------SSMRK-- 249
Query: 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ P Q ++ + LL+ LL +DP +R A EAL P+F
Sbjct: 250 ---KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 21/233 (9%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYR--EAAMIEIDVLQRLARHD 149
++ +GEG+F VV + E + AIKI+ R + K + + IE +VL RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH- 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+++ F ++ V E L ++RK Y S R ++L ++
Sbjct: 62 ---PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALE 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++H +IH DLKPENILL ++K+ D+ K L +S S N ++ I
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES---NKGDATNIDSQIE 173
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
+ + V T Y +PE++ DLW++GCI+ ++ +G+ F
Sbjct: 174 KNRRR----FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 87/361 (24%), Positives = 148/361 (40%), Gaps = 67/361 (18%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLA 146
+ RY+ + +G G +G V D + VAIK I + + A + E+ +L+
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I R + D++ + +V + + L+ + + + + +R QLL
Sbjct: 63 HDNIIAIRDILRPPGADFK-DVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRG 119
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLI 263
+ ++H +IH DLKP N+L+ +++ D+ + LS S + YF
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT---------- 169
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHE 322
E+ V+TR YRAPE++L L + D+WSVGCI E+ LF
Sbjct: 170 -------EY------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216
Query: 323 NLEHLAMMERVLGPLPHHMV--IRADRRAEKY---FRRGARLDWPDGATSRDSMRAVWKL 377
+ L ++ VLG ++ I +D R KY R + W
Sbjct: 217 YVHQLKLILSVLGSPSEEVLNRIGSD-RVRKYIQNLPRKQPVPWSKIFPKASP------- 268
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR-----DVRRCGFP 432
+ +DLL +L++DP ER+ +AL+HPF + D C P
Sbjct: 269 ----------------EALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPP 312
Query: 433 L 433
Sbjct: 313 F 313
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 87/354 (24%), Positives = 145/354 (40%), Gaps = 75/354 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
Y IL K+GEGTFG+V + + +VA+K + ++ ++ A+ EI +L++L
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHP 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI---DLVRELG----- 200
++ V + I + E+ P R + Y P DL L
Sbjct: 68 NV-----VPL---------IDMAVER--PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK 111
Query: 201 ----------RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
QLLE + ++HE ++H D+K NIL+ + +K+ D+ L+R
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG-LARPYDGPPP 170
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCIL 308
N G T ++ +V TR YR PE++LG Y D+W +GC+
Sbjct: 171 --NPKGGGG------GGTR----KYTNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVF 217
Query: 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 368
E+ + + Q +++ L ++ ++ G WP G S
Sbjct: 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEE-------------------TWP-GWRSL 257
Query: 369 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
V P + + + +DLL LL DP +RL A +AL HP+F
Sbjct: 258 PGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 79/331 (23%), Positives = 131/331 (39%), Gaps = 83/331 (25%)
Query: 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHDIGGTRCVQI 158
G +G+V ++ AIK+++ + R+ + E D+L + + V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-----VKL 58
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F + ++ +V E L G L L + S D+ R +++ ++ ++H +IH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DLKP+NIL+ S ++K+ D+ SK G + + + K +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGL----SKVGLVRRQINLNDDEK------------EDKR 160
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 337
+V T Y APEVILG G + D WS+GCIL E G F
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH------------------ 202
Query: 338 PHHMVIRADRRAEKYFR--RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395
E+ F+ +++WP+ D +
Sbjct: 203 --------GETPEEIFQNILNGKIEWPEDVEVSD------------------------EA 230
Query: 396 IDLLQGLLRYDPAERLKAR---EALRHPFFT 423
IDL+ LL DP +RL A+ E HPFF
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 91/339 (26%), Positives = 140/339 (41%), Gaps = 60/339 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHD 149
+Y ++++G G +G V + D VA+K VR + + E+ +L+RL D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 150 IGGTR-----CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
C R D + +VFE + L +L K P + +++L RQ L
Sbjct: 61 HPNIVRLMDVCATSRT--DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ F+H ++H DLKPENIL+ S VK+ D+ ++ S
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGL----ARIYSC-------------- 160
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
+ VV T YRAPEV+L + P D+WSVGCI E+ + LF +
Sbjct: 161 -------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP-DGATSRDSMRAVWKLLRLPNL 383
+ L + ++G LP DWP D R + R P
Sbjct: 214 DQLGKIFDLIG-LP------------------PEDDWPRDVTLPRGAFSP-----RGPRP 249
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ V LL +L ++P +R+ A AL+HPFF
Sbjct: 250 VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 96/359 (26%), Positives = 156/359 (43%), Gaps = 90/359 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L+K+G+GTFG+V + + K++VA+K V N+ +E A+ EI +LQ L +H
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLL-KH 70
Query: 149 D-------IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ I T+ Y+ +VFE L L N F + ++++ +
Sbjct: 71 ENVVNLIEICRTKATPYNR---YKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMK 126
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
LL + ++H +++H D+K NIL+ +KDG +K
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILI-----------------TKDG----------ILK 159
Query: 262 LIDFG-----STTFEHQDHSYV--VSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELC 312
L DFG S + + + Y V T YR PE++LG +Y P D+W GCI+ E+
Sbjct: 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMW 218
Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
+ + Q + L ++ ++ G + + WP G +
Sbjct: 219 TRSPIMQGNTEQHQLTLISQLCGSITPEV-------------------WP-GVDKLE--- 255
Query: 373 AVWKLLRLPNLIMQHV---------DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
++K + LP + V D A DLID LL DPA+R+ A AL H FF
Sbjct: 256 -LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDK---LLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 96/362 (26%), Positives = 155/362 (42%), Gaps = 89/362 (24%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVL 142
G+ ++ I+ ++GEGT+GQV + D + ELVA+K VR N+ +E A+ EI +L
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKIL 60
Query: 143 QRLARHDIGGTRCVQI----RNWFDYRNH---ICIVFEKLGPSLYDFLRKNSYRSFPIDL 195
++L +I +I ++ D++ +VFE + L L ++ F D
Sbjct: 61 RQLNHRNI--VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDH 117
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
++ +QLLE + + H+ +H D+K NILL
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---------------------------N 150
Query: 256 KSSAIKLIDFGSTTFEHQDHS--YV--VSTRHYRAPEVILGLGWNYPC-DLWSVGCILVE 310
IKL DFG + + S Y V T YR PE++LG P D+WS GCIL E
Sbjct: 151 NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 210
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP-----------LPHHMVIRADRRAEKYFRRGARL 359
L + + +FQ ++ L L ++ R+ G LP+ + + +K +RR R
Sbjct: 211 LFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTM----KPKKQYRRRLRE 266
Query: 360 DWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
++ +DLL +L DP++R A EAL
Sbjct: 267 EF---------------------------SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 420 PF 421
P+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 95/348 (27%), Positives = 150/348 (43%), Gaps = 82/348 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + + E E+VA+K VR ++ E +A+ EI +L+ L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHK 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK-NSYRSFPIDLVRELGRQLLESV 207
+I V++ + + +VFE L + N I V+ QLL+ +
Sbjct: 60 NI-----VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI--VKSFMFQLLKGL 112
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
AF H ++H DLKP+N+L+ +K+G +KL DFG
Sbjct: 113 AFCHSHNVLHRDLKPQNLLI-----------------NKNGE----------LKLADFGL 145
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHE 322
+ + +S V T YR P+V+ G ++ D+WS GCI EL +G LF ++
Sbjct: 146 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
+ L + R+L G + +S V KL
Sbjct: 206 VDDQLKRIFRLL-----------------------------GTPTEESWPGVSKLPDYKP 236
Query: 383 LIMQHVDHSAGDLI--------DLLQGLLRYDPAERLKAREALRHPFF 422
M S +++ DLLQ LL +P +R+ A EAL+HP+F
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 93/350 (26%), Positives = 160/350 (45%), Gaps = 76/350 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y + K+GEGT+G V + D E +A+K +R + + E A+ EI +L+ +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHG 61
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+I V++++ + +VFE L L + + + L++ Q+L +A
Sbjct: 62 NI-----VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+ H R++H DLKP+N+L + R ++A+KL DFG
Sbjct: 117 YCHSHRVLHRDLKPQNLL--------------IDRR------------TNALKLADFGLA 150
Query: 269 --------TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ 319
TF H+ V T YRAPE++LG ++ P D+WSVGCI E+ + + LF
Sbjct: 151 RAFGIPVRTFTHE-----VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
++ L + R+LG WP G TS ++ +
Sbjct: 206 GDSEIDELFKIFRILGTPNEET-------------------WP-GVTSLPDYKSAFPKWP 245
Query: 380 LPNL--IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427
+L ++ ++ + +DLL +LR DP++R+ AR AL H +F +D+
Sbjct: 246 PKDLATVVPTLEPAG---VDLLSKMLRLDPSKRITARAALEHEYF-KDLG 291
|
Length = 294 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 81/348 (23%), Positives = 141/348 (40%), Gaps = 94/348 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
Y+ L K+GEG G+V + D + VAIK +R + +E + EI +++ +I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI--- 77
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE----LGRQLLESVA 208
V + + + + +V E + G SL D + +N + + + R++L+ +
Sbjct: 78 --VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLE 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
++H +IH D+K +NILL SKDGS +KL DFG
Sbjct: 131 YLHSQNVIHRDIKSDNILL-----------------SKDGS----------VKLADFGFA 163
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
T E + VV T ++ APEVI + D+WS+G + +E+ GE
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE---------- 213
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-MRAVWKLLRLPNLI 384
P ++ R+ +RA++ +
Sbjct: 214 ------------PPYL--------------------------REPPLRALFLITTKGIPP 235
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432
+++ + + + D L L DP +R A E L+HPF + + F
Sbjct: 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 92/334 (27%), Positives = 149/334 (44%), Gaps = 57/334 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKNLKHAN 64
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L +L N + V+ QLL +++
Sbjct: 65 I-----VTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H+ +++H DLKP+N+L+ +K+ D+ L+R+ K++P +
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFG-LARA-------KSVPTKT----------- 159
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+S V T YR P+V+LG ++ P D+W VGCIL E+ +G +F E L
Sbjct: 160 -----YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH 214
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
++ R+LG WP G TS + R+ ++ H
Sbjct: 215 LIFRLLGTPTEE-------------------TWP-GITSNEEFRSYLFPQYRAQPLINHA 254
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
D IDLL LL Y+ R+ A ALRH +F
Sbjct: 255 PRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 43/230 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLARHD 149
Y++ +G G FG V + + E + VAIK + EA M EID+L+ L +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V+ + + + I+ E SL ++K + FP LV Q+L+ +A
Sbjct: 61 I-----VKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLA 113
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++HE +IH D+K NIL +KDG +KL DFG
Sbjct: 114 YLHEQGVIHRDIKAANILT-----------------TKDGV----------VKLADFGVA 146
Query: 269 T----FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
T D S VV T ++ APEVI G + D+WS+GC ++EL +G
Sbjct: 147 TKLNDVSKDDAS-VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 87/354 (24%), Positives = 154/354 (43%), Gaps = 68/354 (19%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLAR 147
+L RY L +G G+ G V D++ + VA+K IV + + + A+ EI +++RL
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDH 61
Query: 148 HDI---------GGTRCVQ-IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
+I G+ + + + + + + IV E + L + L + + R
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQGP---LSEEHAR 117
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
QLL + ++H ++H DLKP N+ + + + V
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV------------------------ 153
Query: 258 SAIKLIDFG-----STTFEHQDH-SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVE 310
+K+ DFG + H+ + S + T+ YR+P ++L + D+W+ GCI E
Sbjct: 154 --LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 211
Query: 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 370
+ +G+ LF LE M+ +L +P V+R + R E DG R
Sbjct: 212 MLTGKPLFAGAHELE---QMQLILESVP---VVREEDRNE-LLNVIPSFVRNDGGEPRRP 264
Query: 371 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+R + LP V+ A +D L+ +L ++P +RL A EAL HP+ +
Sbjct: 265 LRDL-----LPG-----VNPEA---LDFLEQILTFNPMDRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 89/348 (25%), Positives = 156/348 (44%), Gaps = 76/348 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ L+ +G G +G V +D ++ VA+K ++ + YRE + +L+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE-----LRLLKH 70
Query: 145 LARHDIGG-----TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
+ ++ G T I N+ N + +V +G L + ++ + + V+ L
Sbjct: 71 MKHENVIGLLDVFTPATSIENF----NEVYLVTNLMGADLNNIVK---CQKLSDEHVQFL 123
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
QLL + ++H +IH DLKP N+ + +
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAV---------------------------NEDCE 156
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
++++DFG + + V+TR YRAPE++L + +N D+WSVGCI+ EL G+ALF
Sbjct: 157 LRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
Query: 319 QTHENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
++ ++ L +ME V P P + + A KY + L
Sbjct: 217 PGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ---------------------SL 255
Query: 378 LRLPNLIMQHVDHSAGDL-IDLLQGLLRYDPAERLKAREALRHPFFTR 424
+P ++ + A L IDLL+ +L D +R+ A EAL HP+F++
Sbjct: 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 66/259 (25%), Positives = 110/259 (42%), Gaps = 54/259 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARH 148
R++ +K+G GTFG+V + + EL+A+K +R I + E+ VL+ L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHP 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
++ V++ +R + I E G +L + L R ++R QLLE +
Sbjct: 60 NLVKYYGVEV-----HREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGL 112
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
A++H ++H D+KP NI L + IKL DFG
Sbjct: 113 AYLHSHGIVHRDIKPANIFLD---------------------------HNGVIKLGDFGC 145
Query: 268 -------TTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSG--- 314
TT ++ + T Y APEVI G G D+WS+GC+++E+ +G
Sbjct: 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
Query: 315 -EALFQTHENLEHLAMMER 332
L + + H+ +
Sbjct: 206 WSELDNEFQIMFHVGAGHK 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 90/341 (26%), Positives = 143/341 (41%), Gaps = 67/341 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
RY L ++G G +G V D E VAIK + R + + A E+ +L+ + +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 150 IGGTRCVQI-----RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ G V + D F + P + L+K D V+ L Q+L
Sbjct: 76 VIGLLDVFTSAVSGDEFQD--------FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML 127
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H +IH DLKP N+ + + +K++D
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAV---------------------------NEDCELKILD 160
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
FG + + V TR YRAPEVIL + +N D+WSVGCI+ E+ +G+ LF+ +
Sbjct: 161 FGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220
Query: 324 LEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
L+ L + +V G P P + D+ A+ Y + L + P
Sbjct: 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK---------------------SLPKYPR 259
Query: 383 LIMQHVDHSAGDL-IDLLQGLLRYDPAERLKAREALRHPFF 422
+ A +DLL+ +L D +RL A EAL HP+F
Sbjct: 260 KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 91/382 (23%), Positives = 143/382 (37%), Gaps = 118/382 (30%)
Query: 93 RYRILSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINK---------YREAAMI-EID 140
+Y I +G GT+G+V + + + + AIK + + RE A++ E+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 141 -----VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFL------RKNSYR 189
L + + V + FDY H D R+
Sbjct: 61 HENVVSLVEVFLEH--ADKSVYLL--FDYAEH-------------DLWQIIKFHRQAKRV 103
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
S P +V+ L Q+L V ++H ++H DLKP NIL++ +G
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMG-----------------EG- 145
Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLG-WNYPCDLW 302
P+ +K+ D G + D VV T YRAPE++LG + D+W
Sbjct: 146 -----PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIW 200
Query: 303 SVGCILVELCSGEALFQTHE------NLEHLAMMER---VLGP-----------LPHHMV 342
++GCI EL + E +F+ E N +ER VLG +P +
Sbjct: 201 AIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT 260
Query: 343 IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI--MQHVDHSAGDLIDLLQ 400
+ D + + Y +L M+ DLL+
Sbjct: 261 LMKDFKTKTY--------------------------PSNSLAKWMEKHKKPDSQGFDLLR 294
Query: 401 GLLRYDPAERLKAREALRHPFF 422
LL YDP +R+ A EAL HP+F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 82/344 (23%), Positives = 151/344 (43%), Gaps = 68/344 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ LS +G G +G V FD + VA+K I+ + YRE ++ +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL------K 71
Query: 145 LARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+H+ IG + N + +V +G L + ++ + D V+ L Q
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 128
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+L + ++H +IH DLKP N+ + + +K+
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAV---------------------------NEDCELKI 161
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
+DFG + + V+TR YRAPE++L + +N D+WSVGCI+ EL +G LF
Sbjct: 162 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
++++ L ++ R++G ++ + + + + + L ++P
Sbjct: 222 DHIDQLKLILRLVGTPGAELLKKISSESARNY--------------------IQSLTQMP 261
Query: 382 NLIMQHVDHSAGDL-IDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ +V A L +DLL+ +L D +R+ A +AL H +F +
Sbjct: 262 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 7e-23
Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 46/258 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD 149
+++L K+G+G++G V + + A+K V S++ K RE A+ EI +L + +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSY--RSFPIDLVRELGRQLLE 205
I + + F N +CIV E G L + K + P + + QLL
Sbjct: 61 I-----ISYKEAFLDGNKLCIVMEYAPFG-DLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ +HE +++H DLK NILLV+ + VK+ D +S+ K KN+ K+
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLG-ISKVLK-----KNMAKT-------- 160
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
+ T HY APEV G ++Y D+WS+GC+L E+ + F+ +++
Sbjct: 161 ------------QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQ 207
Query: 326 HLAMMERVLG----PLPH 339
L +V P+P
Sbjct: 208 DLRY--KVQRGKYPPIPP 223
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 88/367 (23%), Positives = 144/367 (39%), Gaps = 118/367 (32%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ LS +G G +GQV FD + VAIK + + YRE R
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL---------R 66
Query: 145 LARHDIGGTRCVQIRNWFDYRNHIC------------------IVFEKLGPSLYDFLRKN 186
L +H D+ N I +V +G L + ++
Sbjct: 67 LLKH-------------MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC- 112
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
+ D ++ L Q+L + ++H +IH DLKP NI
Sbjct: 113 --QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI--------------------- 149
Query: 247 DGSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLW 302
+ + +K++DFG T E + V+TR YRAPE++L + +N D+W
Sbjct: 150 ------AVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIW 200
Query: 303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 362
SVGCI+ EL +G+ LF ++++ L + ++G ++ + + + + +
Sbjct: 201 SVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQS------ 254
Query: 363 DGATSRDSMRAVWKLLRLPNLIMQHVD-------HSAGDLIDLLQGLLRYDPAERLKARE 415
LP M D + IDLL+ +L DP +R+ A E
Sbjct: 255 -----------------LP--QMPKKDFKEVFSGANP-LAIDLLEKMLVLDPDKRITAAE 294
Query: 416 ALRHPFF 422
AL HP+
Sbjct: 295 ALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 9e-23
Identities = 87/341 (25%), Positives = 142/341 (41%), Gaps = 63/341 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLAR 147
+Y ++++GEG +G+V + D VA+K VR + E + + E+ VL+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 60
Query: 148 HDIGGTR-----CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ C R D + +VFE + L +L K P + ++++ Q
Sbjct: 61 FEHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
LL + F+H R++H DLKP+NIL+ S+ +K+ D+ ++
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-------------------ARI 159
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
F + VV T YRAPEV+L + P DLWSVGCI E+ + LF+
Sbjct: 160 YSFQMAL------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213
Query: 323 NLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
+++ L + V+G P DWP +
Sbjct: 214 DVDQLGKILDVIGLPGEE--------------------DWPRDVALPRQAFHSKSAQPIE 253
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + DLL L ++PA+R+ A AL HP+F
Sbjct: 254 KFVTDIDELGK----DLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 84/341 (24%), Positives = 137/341 (40%), Gaps = 65/341 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAA-MIEIDVLQRLARH 148
+ ++ +G G FG+V D + ++ A+K++R I + + A E D+L
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ F H+ +V E + G L + L + FP + R +L+ ++
Sbjct: 62 WI-----VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVLAL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR--SSKDGSYFKNLPKSSAIKLIDF 265
+H+L IH D+KP+NIL+ + ++K+ D+ + +KD Y+ N + +
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 266 GSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
Q V T Y APEV+ G + CD WS+G IL E+ G F
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY--- 231
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
+D E Y + ++W + LR P
Sbjct: 232 ----------------------SDTLQETYNK---IINWK-------------ESLRFP- 252
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLK-AREALRHPFF 422
S + IDL+ LL DP +RL E HPFF
Sbjct: 253 ---PDPPVSP-EAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 86/337 (25%), Positives = 148/337 (43%), Gaps = 58/337 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
RYR L ++G G +G V D VAIK + R + + A E+ +L+ + +H+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHE 74
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
IG D + +V +G L ++ + D ++ L Q+L+ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVYQMLKGL 131
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H +IH DLKP N L V+ + +K++DFG
Sbjct: 132 KYIHAAGIIHRDLKPGN-LAVNED--------------------------CELKILDFGL 164
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
+ + V TR YRAPEVIL + + D+WSVGCI+ E+ +G+ LF+ H++L+
Sbjct: 165 ARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224
Query: 327 LAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
L + +V G V + A+ Y ++ R D + ++
Sbjct: 225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS-----------------LL 267
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + A +++L+ +L D R+ A EAL HP+F
Sbjct: 268 PNANPLA---VNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 94/364 (25%), Positives = 144/364 (39%), Gaps = 75/364 (20%)
Query: 81 HYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSIN 129
Y +G++ + RY+ L +G G G V +D + VAIK + +
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 130 KYREAAMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS 187
YRE VL +L H IG + + + +V E + +L ++
Sbjct: 62 AYREL------VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--- 112
Query: 188 YRSFPIDLVRE----LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
+DL E L Q+L + +H +IH DLKP NI++ S
Sbjct: 113 -----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------------- 153
Query: 244 SSKDGSYFKNLPKSSAIKLIDFG-----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYP 298
+K++DFG T+F YVV TR+YRAPEVILG+G+
Sbjct: 154 -------------DCTLKILDFGLARTAGTSFMMTP--YVV-TRYYRAPEVILGMGYKEN 197
Query: 299 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR-RGA 357
D+WSVGCI+ E+ G LF ++++ + LG + R Y R
Sbjct: 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPK 257
Query: 358 RLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 417
+ D + P H A DLL +L DP +R+ +AL
Sbjct: 258 YAGYSFEELFPDVL--------FPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309
Query: 418 RHPF 421
+HP+
Sbjct: 310 QHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 90/343 (26%), Positives = 148/343 (43%), Gaps = 72/343 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLAR--- 147
Y+ L K+GEG++ V + +LVA+K +R + A A+ E +L+ L
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREASLLKDLKHANI 65
Query: 148 ---HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
HDI T + + +VFE L L ++ + VR QLL
Sbjct: 66 VTLHDIIHT-----------KKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLL 113
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+A+ H+ R++H DLKP+N+L+ +K+ D+ L+R+ K++P
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFG-LARA-------KSVP--------- 156
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
S T+ ++ V T YR P+V+LG ++ D+W VGCI E+ +G LF +
Sbjct: 157 --SKTYSNE-----VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 324 -LEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
+ L + RVLG P WP G +S + P
Sbjct: 210 VEDQLHKIFRVLGTPTEE--------------------TWP-GVSSNPEFKPYSFPFYPP 248
Query: 382 NLIMQHVDH--SAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
++ H +L L+Y+P +R+ A EA++HP+F
Sbjct: 249 RPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 87/339 (25%), Positives = 152/339 (44%), Gaps = 51/339 (15%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLA 146
+ +Y + +G G +G V ++E E VAIK I + + +A + EI +L+ L
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD 62
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
++ + + + N + IV+E + L+ +R + ++ D + QLL
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRG 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H ++H DLKP N+LL + +K+ D+ L+R++ + F
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARTTSEKGDFMT------------- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
YVV TR YRAPE++L + D+WSVGCI EL + LF + +
Sbjct: 167 ---------EYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216
Query: 326 HLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
L ++ +LG P + + +A +Y R T R S ++
Sbjct: 217 QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPY-------TPRQSFARLFP-------- 261
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
H+ IDLL+ +L +DP++R+ EAL HP+
Sbjct: 262 -----HANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 88/340 (25%), Positives = 145/340 (42%), Gaps = 65/340 (19%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQR 144
+T RY L +G G FG V D + VAIK + + + + E+ +L+
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
L +I + I D I V E LG L+ L R ++ Q+L
Sbjct: 66 LRHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQIL 118
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H ++H DLKP NIL+ ++ +K+ D
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILI---------------------------NENCDLKICD 151
Query: 265 FG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE 322
FG + + Q YV STR+YRAPE++L ++ D+WS GCI E+ G+ LF +
Sbjct: 152 FGLARIQDPQMTGYV-STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL-LRLP 381
++ +++ +LG P ++ S +++R V L R P
Sbjct: 211 HVNQFSIITDLLGTPPDDVINTI--------------------CSENTLRFVQSLPKREP 250
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
+ ++ IDLL+ +L +DP +R+ A EAL HP+
Sbjct: 251 VPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-22
Identities = 91/345 (26%), Positives = 153/345 (44%), Gaps = 74/345 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR------ 147
Y++ + +G G+FG V E + E VAIK V +Y+ E+ +++ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124
Query: 148 HDIGGTRCVQI--RNWFDYRNHICIVFEKLGPSLYDFLRKNSY--RSFPIDLVRELGRQL 203
D T C + +N F + +V E + +++ +++ + + P+ LV+ QL
Sbjct: 125 KDYYYTECFKKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
++A++H + H DLKP+N+L+ P + +KL
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID--------------------------PNTHTLKLC 213
Query: 264 DFGSTT---FEHQDHSYVVSTRHYRAPEVILGLGWNYPC--DLWSVGCILVELCSGEALF 318
DFGS + SY+ S R YRAPE++LG NY DLWS+GCI+ E+ G +F
Sbjct: 214 DFGSAKNLLAGQRSVSYICS-RFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIF 271
Query: 319 QTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
+++ L + +VLG P + A+ F PD +D ++ V+
Sbjct: 272 SGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKF--------PD-VKPKD-LKKVFP- 320
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ D I+ + L+Y+P +RL EAL PFF
Sbjct: 321 -----------KGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 7e-22
Identities = 79/332 (23%), Positives = 130/332 (39%), Gaps = 88/332 (26%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRCV 156
G G FG+V K A+K V R I + + I E ++L+ H V
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPF----IV 56
Query: 157 QIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + +I ++ E LG L+ LR F R ++ + ++H +
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
I+ DLKPEN+LL S YVK+ D+ F K + G T+
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGF-------------------AKKLKSGQKTWT---- 151
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 335
T Y APE+IL G+++ D WS+G +L EL +G F ++ + + + +L
Sbjct: 152 --FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE-DDEDPMEIYNDIL- 207
Query: 336 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395
+ +L++P ++D +A DL
Sbjct: 208 ------------------KGNGKLEFP-----------------------NYIDKAAKDL 226
Query: 396 IDLLQGLLRYDPAERL-----KAREALRHPFF 422
I LLR +P ERL ++ +H +F
Sbjct: 227 IK---QLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 85/334 (25%), Positives = 146/334 (43%), Gaps = 57/334 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L +L + S + V+ QLL + +
Sbjct: 66 I-----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H +++H DLKP+N+L+ +K+ D+ L+R+ K++P +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFG-LARA-------KSIPTKT----------- 160
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+S V T YR P+++LG ++ D+W VGCI E+ +G LF E L
Sbjct: 161 -----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ R+LG WP G S + ++ + + H
Sbjct: 216 FIFRILGTPTEET-------------------WP-GILSNEEFKSYNYPKYRADCLHNHA 255
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
D +LL LL+++ +R+ A EA++HP+F
Sbjct: 256 PRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 77/345 (22%), Positives = 127/345 (36%), Gaps = 103/345 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARH 148
+ +L +G+G+FG+V + D ++VAIK++ E A EI+ +Q+ L+
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLS-- 54
Query: 149 DIGGTRCVQIRNWF-----DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
R I ++ + + I+ E G S D L+ + + R+
Sbjct: 55 ---QCRSPYITKYYGSFLKGSK--LWIIMEYCGGGSCLDLLK---PGKLDETYIAFILRE 106
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+L + ++HE IH D+K NILL S++G +KL
Sbjct: 107 VLLGLEYLHEEGKIHRDIKAANILL-----------------SEEGD----------VKL 139
Query: 263 IDFGST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
DFG + T + V T + APEVI G++ D+WS+G +EL GE
Sbjct: 140 ADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP--- 196
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
PL MR ++ + +
Sbjct: 197 ----------------PLSDL----------------------------HPMRVLFLIPK 212
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
++ S D + L DP ER A+E L+H F +
Sbjct: 213 NNPPSLEGNKFSK-PFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 75/336 (22%), Positives = 128/336 (38%), Gaps = 90/336 (26%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMIEIDVLQRLARHDIGG 152
+ +G+G+ G V + ++ A+K V ++R+ + E+ L+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-- 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+ F I IV E + G SL D L+K P ++ + RQ+L+ + ++H
Sbjct: 62 ---VKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLH 116
Query: 212 -ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 269
+ +IH D+KP N+L+ + G +K+ DFG S
Sbjct: 117 TKRHIIHRDIKPSNLLI-----------------NSKGE----------VKIADFGISKV 149
Query: 270 FEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
E+ Q +++V T Y +PE I G ++Y D+WS+G L+E G+ F
Sbjct: 150 LENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208
Query: 327 LAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+M+ + GP P P S
Sbjct: 209 FELMQAICDGPPP---------------------SLPAEEFSP----------------- 230
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
+ D + L+ DP +R A E L+HPF
Sbjct: 231 --------EFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 5e-21
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLARHDIGGT 153
+G+G FG+V C+D + +A+K V K A EI +L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHE---- 64
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
R VQ + I E + G S+ D L+ +Y + + R+ RQ+LE V ++H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHS 122
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
++H D+K NIL SA VK+ D+ +SK + I S T
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFG----ASK---------RLQTICS----SGTGM- 164
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T ++ +PEVI G G+ D+WSVGC +VE+
Sbjct: 165 ---KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 79/332 (23%), Positives = 126/332 (37%), Gaps = 92/332 (27%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------EIDVLQRLARHDIGGT 153
+G G+FG V E + + + A+K V + + EI +L +L +I
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI--- 64
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
VQ +++ I E + G SL L+K Y SFP ++R RQ+L + ++H+
Sbjct: 65 --VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--TF 270
+H D+K NIL+ +G +KL DFG
Sbjct: 121 RNTVHRDIKGANILV-----------------DTNG----------VVKLADFGMAKQVV 153
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
E + ++ APEVI G + D+WS+GC ++E+ +G+ + LE +A
Sbjct: 154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS---QLEGVAA 210
Query: 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389
+ F+ G + P I H+
Sbjct: 211 V----------------------FKIGRSKELP--------------------PIPDHLS 228
Query: 390 HSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
A D I L+ DP+ R A E L HPF
Sbjct: 229 DEAKDFILK---CLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 85/334 (25%), Positives = 148/334 (44%), Gaps = 57/334 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L ++ + + V+ Q+L +A+
Sbjct: 66 I-----VTLHDIVHTDKSLTLVFEYLDKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H +++H DLKP+N+L+ +K+ D+ L+R+ K++P +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFG-LARA-------KSVPTKT----------- 160
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+S V T YR P+V+LG ++ D+W VGCI E+ SG LF + L
Sbjct: 161 -----YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH 215
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
++ R+LG WP G +S D + P ++ H
Sbjct: 216 LIFRLLGT-------------------PTEETWP-GISSNDEFKNYNFPKYKPQPLINHA 255
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ I+LL L+Y+ +R+ A EA++H +F
Sbjct: 256 PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 88/337 (26%), Positives = 144/337 (42%), Gaps = 60/337 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDI 150
Y L K+GEG++ V + +LVA+K++ S+ A+ E +L+ L +I
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVI-SMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + + + VFE + L ++ ++ P + VR QLL +A++
Sbjct: 66 -----VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYI 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---S 267
H ++H DLKP+N+L+ SY L KL DFG +
Sbjct: 120 HGQHILHRDLKPQNLLI---------------------SYLGEL------KLADFGLARA 152
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ-THENLE 325
+ Q +S V T YR P+V+LG ++ D+W GCI +E+ G+ F + E
Sbjct: 153 KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
L + VLG +P + Y + +W + +R VWK L P
Sbjct: 213 QLEKIWTVLG-VPTEDTWPGVSKLPNY-----KPEWFLPCKPQ-QLRVVWKRLSRPP--- 262
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
DL +L P +R+ A++AL HP+F
Sbjct: 263 --------KAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 50/233 (21%)
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D V+ Q+L + ++H ++H D+KP N+L+ S
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS------------------------ 138
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYV----VSTRHYRAPEVILGLG-WNYPCDLWSVGCIL 308
+ +K+ DFG E D S V T++YRAPE+++G + D+WSVGCI
Sbjct: 139 ---NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195
Query: 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 368
EL LFQ ++ L ++ +LG + A A + RG P S
Sbjct: 196 AELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG-----PHKPPSL 250
Query: 369 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
+ + H A + LL +L +DP +R+ A +AL HP+
Sbjct: 251 PVLY----------TLSSQATHEA---VHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 46/230 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ IL K+GEG++G V + E ++VAIK+V + + + + EI +L++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ--------C 55
Query: 154 RCVQIRNWFD---YRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I ++ + IV E G S+ D ++ + ++ + + + Q L+ +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAG-SVSDIMKITN-KTLTEEEIAAILYQTLKGLE 113
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
++H + IH D+K NILL +++G KL DFG S
Sbjct: 114 YLHSNKKIHRDIKAGNILL-----------------NEEG----------QAKLADFGVS 146
Query: 268 TTFEH--QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
+ V+ T + APEVI +G+N D+WS+G +E+ G+
Sbjct: 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-19
Identities = 90/341 (26%), Positives = 153/341 (44%), Gaps = 66/341 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRLARHDIG 151
Y L K+GEG++ V + +LVA+K++R + A+ E +L+ L +I
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI- 65
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + + + + +VFE + L ++ K+ P + V+ QLL ++++H
Sbjct: 66 ----VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIH 120
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ ++H DLKP+N+L+ +K+ D+ L+R+ K++P S T+
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFG-LARA-------KSVP-----------SHTYS 161
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPC-DLWSVGCILVELCSGEALFQTHENLE-HLAM 329
++ V T YR P+V+LG C D+W VGCI VE+ G A F ++++ L
Sbjct: 162 NE-----VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216
Query: 330 MERVLG-------PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
+ VLG P H + R Y S ++R W L
Sbjct: 217 IFLVLGTPNEDTWPGVHSLPHFKPERFTLY--------------SPKNLRQAWNKL---- 258
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+V+H+ DL LL+ P RL A+ AL H +F+
Sbjct: 259 ---SYVNHAE----DLASKLLQCFPKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 99/363 (27%), Positives = 154/363 (42%), Gaps = 60/363 (16%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
R + Y IG++ + RY+ L +G G G V +D + VAIK + R
Sbjct: 3 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ VL + H IG + + + IV E + +L ++
Sbjct: 63 NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
+ + L Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++
Sbjct: 122 ----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
G+ F P YVV TR+YRAPEVILG+G+ D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM------VIRADRRAEKYFRRGAR 358
CI+ E+ G LF ++++ ++E++ P P M V KY
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE 272
Query: 359 LDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418
+PD DS +H A DLL +L D ++R+ EAL+
Sbjct: 273 KLFPDVLFPADS---------------EHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 419 HPF 421
HP+
Sbjct: 318 HPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 47/229 (20%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA---------------- 173
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
T F YVV TR+YRAPEVILG+G+ D+WSVGCI+ EL G +FQ
Sbjct: 174 -----CTNFMMT--PYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD-------WPDGATSRDSMRAV 374
++++ + LG + R Y + +PD +S R
Sbjct: 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDK 285
Query: 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
K DLL +L DP +R+ EALRHP+ T
Sbjct: 286 LK---------------TSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 40/227 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
++I K+G+G F V + +VA+K V+ K R+ + EID+L++L +
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR-----KNSYRSFPIDLVRELGRQLL 204
+ ++ F N + IV E L + D R K R P + + QL
Sbjct: 64 V-----IKYLASFIENNELNIVLE-LADA-GDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
++ MH R++H D+KP N+ + + VK+ D G +F SS
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL-------GRFF-----SS------ 158
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
TT H +V T +Y +PE I G+N+ D+WS+GC+L E+
Sbjct: 159 --KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 90/356 (25%), Positives = 152/356 (42%), Gaps = 83/356 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKK--ELVAIK-IVRSINKYREA--AMIEIDVLQRLAR 147
RY ++ ++G+G +G V + E E VAIK I +K A A+ E+ +L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 148 HD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS------YRSFPIDLVRELG 200
H I + I + N + + E + L+ +R ++SF
Sbjct: 61 HKNITCLYDMDIV-FPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY------- 112
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
Q+L + ++H ++H DLKP N+L+ + +K+ D+ L+R F P +A
Sbjct: 113 -QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG-LARG------FSENPGENAG 164
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC----DLWSVGCILVELCSGEA 316
+ ++ V+TR YRAPE++L D+WSVGCIL EL +
Sbjct: 165 FMTEY-------------VATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAELLGRKP 208
Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
+F+ + ++ L + +VLG + R +A+ Y R
Sbjct: 209 VFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR--------------------- 247
Query: 376 KLLRLPNL-------IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
LPN+ I + + A +DLL+ LL +DP +R+ EAL HP+
Sbjct: 248 ---SLPNIPKKPFESIFPNANPLA---LDLLEKLLAFDPTKRISVEEALEHPYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 83/347 (23%), Positives = 130/347 (37%), Gaps = 90/347 (25%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
N + I+ ++G+G FG+V + E A KI++ I E M+EID+L
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ-IESEEELEDFMVEIDILSEC 59
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H V + + Y N + I+ E D + R +R + RQ+LE
Sbjct: 60 -KHP----NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ F+H ++IH DLK NILL DG +KL DF
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTL-----------------DGD----------VKLADF 147
Query: 266 GST---TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEAL 317
G + Q + T ++ APEV+ ++Y D+WS+G L+EL E
Sbjct: 148 GVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP- 206
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
PHH + + MR + K+
Sbjct: 207 --------------------PHHEL--------------------------NPMRVLLKI 220
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
L+ + + D L+ L DP +R A E L+HPF +
Sbjct: 221 LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 47/227 (20%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++ G+ F P
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 177
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
YVV TR+YRAPEVILG+G+ D+WSVGCI+ E+ + LF
Sbjct: 178 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 322 ENLEHL-AMMERVLGPLPHHM------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
+ ++ ++E++ P P M V KY +PD DS
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS---- 277
Query: 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
+H A DLL +L DPA+R+ EAL+HP+
Sbjct: 278 -----------EHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 86/346 (24%), Positives = 133/346 (38%), Gaps = 101/346 (29%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKI-----VRSINKYREAAMIEIDVLQRLARH 148
++IL+++G+G +GQV + E+VA+K + +N+ R + E D+L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV-LTERDILTT-TKS 60
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V++ F ++ + E + G L N+ D R ++ E+V
Sbjct: 61 EW----LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAV 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
+HEL IH DLKPEN L+ G IKL DFG
Sbjct: 115 DALHELGYIHRDLKPENFLI-----------------DASGH----------IKLTDFGL 147
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE-LC-----SGEALFQT 320
S +S VV + Y APEV+ G G+++ D WS+GC+L E LC SG +T
Sbjct: 148 SKGIVTYANS-VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206
Query: 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV-WKLLR 379
ENL++ L P R ++ W L+
Sbjct: 207 WENLKYWKET----------------------------LQRPVYDDPRFNLSDEAWDLIT 238
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR-HPFFTR 424
LI DP+ R + E ++ HPFF
Sbjct: 239 --KLIN--------------------DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 43/269 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMI-----EIDVLQRLARHD 149
+G G+FG V + EL+A+K V + +K R+ +M+ EI +L+ L +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I VQ +H+ I E + G S+ L N+Y +F LVR RQ+L+ +
Sbjct: 68 I-----VQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++H +IH D+K NIL+ + +K+ D+ K L +S P
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS--------L 172
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
+ F + APEV+ + D+WS+GC++VE+ +G+ F L+
Sbjct: 173 QGSVF-------------WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
Query: 326 HLAMM-ERVLGPLPHHMVIRADRRAEKYF 353
+ + E +P ++ A EK F
Sbjct: 220 AIFKIGENASPEIPSNISSEAIDFLEKTF 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 43/275 (15%)
Query: 93 RYRILSKMGEGTFGQ---VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+Y +L +GEG+FG+ V ++K + I++ +S + E + E +L ++ +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV-EDSRKEAVLLAKMKHPN 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V + F+ H+ IV E G L ++ + FP D + + Q+ V
Sbjct: 60 I-----VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+HE R++H D+K +NI FL+++ K +KL DFGS
Sbjct: 115 HIHEKRVLHRDIKSKNI--------------FLTQNGK-------------VKLGDFGSA 147
Query: 269 TFEHQDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH--EN 323
+Y V T +Y PE+ + +N D+WS+GCIL ELC+ + FQ + +N
Sbjct: 148 RLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGAR 358
L L + + PLP H ++ F+R R
Sbjct: 208 LI-LKVCQGSYKPLPSHYSYELRSLIKQMFKRNPR 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
Y + +G+G FG+ E LV K V R K R A+ EI +L L +
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + N F N + I E G +LYD + + + F ++V Q++ +V+
Sbjct: 61 I-----IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H+ ++H D+K NI L A +K+ D+ S GS + +
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGI---SKILGSEYS-------------MAE 159
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
T VV T +Y +PE+ G+ +N+ D+W++GC+L EL
Sbjct: 160 T--------VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 77/341 (22%), Positives = 134/341 (39%), Gaps = 88/341 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
+ I+ ++G+G FG+V + + E L A K++ + ++ E M+EID+L +I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ + F Y N++ I+ E D + R +R + +Q LE++ ++HE
Sbjct: 65 ---VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STT 269
++IH DLK NIL + DG IKL DFG T
Sbjct: 122 NKIIHRDLKAGNILF-----------------TLDGD----------IKLADFGVSAKNT 154
Query: 270 FEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
Q + T ++ APEV++ ++Y D+WS+G L+E+ E
Sbjct: 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP-------- 206
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
PHH + + MR + K+ +
Sbjct: 207 -------------PHHEL--------------------------NPMRVLLKIAKSEPPT 227
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ + + D L+ L + R + L+HPF T +
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 75/337 (22%), Positives = 134/337 (39%), Gaps = 89/337 (26%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSI-------NKYREAAMIEIDVLQRLARHDI-- 150
+G G F + D + L+A+K V + + EA EI ++ RL I
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G T +H + E + G S+ L K Y +F ++ QLL +
Sbjct: 68 MLGATC---------EDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGL 116
Query: 208 AFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+++HE ++IH D+K N+L+ S + +++ D+ +A +L G
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADF------------------GAAARLAAKG 158
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
+ E Q ++ T + APEV+ G + CD+WSVGC+++E+ + + + ++ H
Sbjct: 159 TGAGEFQGQ--LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216
Query: 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386
LA++ F+ + P +P
Sbjct: 217 LALI----------------------FKIASATTAPS----------------IP----- 233
Query: 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+H + L D+ L P +R +RE L+HP F
Sbjct: 234 --EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 70/266 (26%), Positives = 111/266 (41%), Gaps = 63/266 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREA--AMIEIDVLQRLA 146
RY + ++G+G+FG V D + +K+++ I E A E +L +L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQL 203
I V+ F R+ CI+ E G L L K++ ++ + V E QL
Sbjct: 61 HPAI-----VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L V +MH+ R++H DLK +NI L K++ +K+
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFL----------------------------KNNLLKIG 147
Query: 264 DFG-----------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
DFG +TTF T +Y +PE + G++ D+WS+GCIL E+C
Sbjct: 148 DFGVSRLLMGSCDLATTF--------TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199
Query: 313 SGEALFQTHENLEHLAMMERVLGPLP 338
F+ L ++ V GP P
Sbjct: 200 CLAHAFEGQNFLS--VVLRIVEGPTP 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
+Y + K+GEG+FG+ + E + IK I + K RE + E+ VL + +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I VQ + F+ ++ IV + G LY + FP D + + Q+ ++
Sbjct: 61 I-----VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
+H+ +++H D+K +NI L +KDG IKL DFG
Sbjct: 116 HVHDRKILHRDIKSQNIFL-----------------TKDG----------TIKLGDFGIA 148
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
++T E + T +Y +PE+ +N D+W++GC+L E+C+ + F+
Sbjct: 149 RVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 74/268 (27%), Positives = 111/268 (41%), Gaps = 66/268 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
F+ + H+C+V E + L KN + P+D+ R + + ++ ++H ++H DLK
Sbjct: 70 FETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVST 281
P+N+L+ S ++K+ D+ SK G +L + I+ T E D V T
Sbjct: 129 PDNLLITSMGHIKLTDFGL----SKIG--LMSLTTNLYEGHIE--KDTREFLDKQ-VCGT 179
Query: 282 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHM 341
Y APEVIL G+ P D W++G IL E G F G P +
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---------------FGDTPEEL 224
Query: 342 ---VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398
VI D ++WP+G + LP D DL
Sbjct: 225 FGQVISDD------------IEWPEGDEA------------LPA-----------DAQDL 249
Query: 399 LQGLLRYDPAERL---KAREALRHPFFT 423
+ LLR +P ERL A E +H FF
Sbjct: 250 ISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 79/335 (23%), Positives = 127/335 (37%), Gaps = 95/335 (28%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + + A+KI++ I E A + E VLQ RH
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPF----L 57
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
++ F + +C V E G L+ L + R F D R G +++ ++ ++H
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLK EN++L ++K+ D+ K+G I G+T
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGL----CKEG--------------ISDGATM----- 152
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMER 332
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392
+R P +
Sbjct: 212 ---------------------------------------------IRFPRTLSP------ 220
Query: 393 GDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
+ LL GLL+ DP +RL A+E + H FF
Sbjct: 221 -EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 40/256 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
+Y + +G G FG V C ++LV IK + + R AA E VL+ L+ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I ++ F + IV E G +L ++++K D + Q+L ++
Sbjct: 61 I-----IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
+H ++H DLK +NILL + V +K+ DFG S
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMV--------------------------VKIGDFGIS 149
Query: 268 TTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
+ +Y VV T Y +PE+ G +N D+W++GC+L EL S + F+ NL
Sbjct: 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPA 208
Query: 327 LAM--MERVLGPLPHH 340
L + M P+
Sbjct: 209 LVLKIMSGTFAPISDR 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 57/245 (23%), Positives = 106/245 (43%), Gaps = 42/245 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
Y +L +G+G+FG V + +++ K + N K ++ + E+++L+ L +I
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 151 GGTRCVQIRNWF-DYRNH-ICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLE 205
V+ + D N + IV E G L ++K + + + + QLL
Sbjct: 62 -----VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 206 SVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
++ H ++H DLKP NI L + VK+ D+ L++ S F
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG-LAKILGHDSSF--------- 166
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
+ T+ V T +Y +PE + + ++ D+WS+GC++ ELC+ F
Sbjct: 167 ------AKTY--------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212
Query: 321 HENLE 325
L+
Sbjct: 213 RNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 37/227 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLAR 147
+R+ +G+G FG+V C+D + +A+K V+ +K A EI +L+ L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 148 HDIGGTRCVQIRNWF-DYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLL 204
R VQ D +F + P S+ D L+ SY + ++ R+ RQ+L
Sbjct: 64 E-----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQIL 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
E V+++H ++H D+K NIL S VK+ D+ S ++ I
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG----------------ASKRLQTIC 160
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T + V T ++ +PEVI G G+ D+WSVGC +VE+
Sbjct: 161 LSGTGMKS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 58/233 (24%), Positives = 107/233 (45%), Gaps = 45/233 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
+ I+ ++G+G FG+V + + E L A K++ + ++ E M+EI++L I
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI-- 71
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ F + + I+ E D + R ++ + RQ+LE++ ++H
Sbjct: 72 ---VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST---- 268
+++IH DLK N+LL + DG IKL DFG +
Sbjct: 129 MKIIHRDLKAGNVLL-----------------TLDGD----------IKLADFGVSAKNV 161
Query: 269 -TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315
T + +D + T ++ APEV++ ++Y D+WS+G L+E+ E
Sbjct: 162 KTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-15
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 33/229 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHDI 150
+ IL+K+G+G+FG V + K + A+K + +N + RE A+ E VL +L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
++ F + + IV E L+ L+ R P D V Q+L +A
Sbjct: 62 -----IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H +++H D+K N+ L + + VK+ D +++ D + F N
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLG-VAKLLSDNTNFANT--------------- 160
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
+V T +Y +PE+ +N D+W++G +L E C+G+ F
Sbjct: 161 --------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 48/241 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDI 150
Y ++ ++G GT+G V + D ELVAIK++ + + +I EI +L+ RH
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKE-CRHP- 60
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V + R+ + IV E G SL D + + + R+ L+ +A+
Sbjct: 61 ---NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAY 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
+HE IH D+K NILL ++DG +KL DFG
Sbjct: 117 LHETGKIHRDIKGANILL-----------------TEDGD----------VKLADFGVSA 149
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCSGE-ALFQT 320
+ T + T ++ APEV G++ CD+W++G +EL + +F
Sbjct: 150 QLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207
Query: 321 H 321
H
Sbjct: 208 H 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARH 148
+ K+GEG FG+V + + K+ VA+K ++ ++ E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + IV E G L D+LRKN + + +
Sbjct: 61 PNIVKLLGV--CTE-------EEPLMIVMEYMPGG-DLLDYLRKNRPKELSLSDLLSFAL 110
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAI 260
Q+ + ++ IH DL N L+ VK+ D F LSR D Y+K I
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD--FGLSRDLYDDDYYKVKGGKLPI 168
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + APE + + D+WS G +L E+ +
Sbjct: 169 R----------------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 64/265 (24%), Positives = 100/265 (37%), Gaps = 80/265 (30%)
Query: 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220
F ++++ +V E L G ++ P D ++ +++ V +H+ +IH D+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 280
KPEN+L+ ++K+ D+ LSR+ + F V
Sbjct: 124 KPENLLIDQTGHLKLTDFG-LSRNGLENKKF---------------------------VG 155
Query: 281 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHH 340
T Y APE ILG+G + D WS+GC++ E G F P
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDA 200
Query: 341 MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400
+ R R++WP+ S AV DL+
Sbjct: 201 VFDNILSR---------RINWPEEVKEFCSPEAV----------------------DLIN 229
Query: 401 GLLRYDPAERLKA---REALRHPFF 422
LL DPA+RL A +E HPFF
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 39/228 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLAR 147
+R+ +G G FG+V C+D + +A+K V + +K A EI +L+ L R
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-R 62
Query: 148 HDIGGTRCVQ----IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
HD R VQ +R+ + + I + + G S+ D L+ +Y + ++ R RQ+
Sbjct: 63 HD----RIVQYYGCLRDPEEKKLSIFVEYMP-GGSIKDQLK--AYGALTENVTRRYTRQI 115
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L+ V+++H ++H D+K NIL SA VK+ D+ S I+ I
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG----------------ASKRIQTI 159
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T + V T ++ +PEVI G G+ D+WSV C +VE+
Sbjct: 160 CMSGTGIKS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-14
Identities = 76/263 (28%), Positives = 124/263 (47%), Gaps = 40/263 (15%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVL 142
GE+ Y ++ K+G G FG+V +E K + R + K RE + +IE++V+
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVM 66
Query: 143 QRLARHDIGGTRCV-QIRNWFDYRNHICIVFEKLGPSLYDFLR--KNSYRSF-PID--LV 196
+ L +I R + + N + + +I + F G D R + Y+ F I+ +
Sbjct: 67 RELKHKNI--VRYIDRFLNKANQKLYILMEFCDAG----DLSRNIQKCYKMFGKIEEHAI 120
Query: 197 RELGRQLLESVAFMHEL-------RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
++ RQLL ++A+ H L R++H DLKP+NI L + + K +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG----------IRHIGKITA 170
Query: 250 YFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSV 304
NL K+ DFG + E HS V T +Y +PE++L +Y D+W++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 305 GCILVELCSGEALFQTHENLEHL 327
GCI+ ELCSG+ F N L
Sbjct: 230 GCIIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 40/234 (17%)
Query: 94 YRILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHD 149
++I K+G G F +V D + L ++I ++ K R+ + EID+L++L +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ ++ + F N + IV E L + F K R P V + QL
Sbjct: 64 V-----IKYLDSFIEDNELNIVLELADAGDLSQMIKYF--KKQKRLIPERTVWKYFVQLC 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+V MH R++H D+KP N+ + + VK+ D G +F +
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS----------- 158
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
TT H +V T +Y +PE I G+N+ D+WS+GC+L E+ + ++ F
Sbjct: 159 --KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 35/120 (29%), Positives = 59/120 (49%), Gaps = 14/120 (11%)
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAIKLIDFG 266
+H+L IH D+KP+N+LL + ++K+ D+ + + S +++ L + +DF
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 267 STTFEHQD--HSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
S + ++ V T Y APEV L G+N CD WS+G I+ E+ G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 66/253 (26%), Positives = 115/253 (45%), Gaps = 39/253 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLARHDIGGT 153
+G+G FG+V C+D + +A K V+ +K A EI +L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHE---- 64
Query: 154 RCVQIRNWF-DYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
R VQ D +F + P S+ D L+ +Y + + R+ RQ+LE ++++
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYL 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++H D+K NIL SA VK+ D+ S ++ I T
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFG----------------ASKRLQTICMSGTGI 166
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
V T ++ +PEVI G G+ D+WS+GC +VE+ + + + +E + + +
Sbjct: 167 RS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221
Query: 331 --ERVLGPLPHHM 341
+ LP H+
Sbjct: 222 ATQPTNPQLPSHI 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 59/261 (22%), Positives = 112/261 (42%), Gaps = 72/261 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ ++ +GEGT+G+V + + +LVAIKI+ I E E ++L++ + H
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH---- 62
Query: 153 TRCVQIRNWFDY------RNHIC------IVFEKL-GPSLYDFLR--KNSYRSFPIDLVR 197
N + +N +V E G S+ D ++ + + + +
Sbjct: 63 ------PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
+ R+ L +A++HE ++IH D+K +NILL K+
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLT---------------------------KN 149
Query: 258 SAIKLIDFG----STTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCIL 308
+ +KL+DFG + + +++ + T ++ APEVI ++ D+WS+G
Sbjct: 150 AEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208
Query: 309 VELCSGE----------ALFQ 319
+EL G+ ALF+
Sbjct: 209 IELADGKPPLCDMHPMRALFK 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 40/225 (17%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR-SIN-KYREAAMIEIDVLQRLARHDIGGTR 154
L ++G G G V + +++A+K +R IN ++ + E+D+L +
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK--------CN 57
Query: 155 C---VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V F I I E + D + K P ++ ++ +L+ + ++H
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 212 E-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
E ++IH D+KP NIL+ S +K+ D+ +S +L++ + TF
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFG-VSG-----------------QLVNSLAKTF 159
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
V T Y APE I G ++ D+WS+G L+EL +G
Sbjct: 160 --------VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 75/340 (22%), Positives = 133/340 (39%), Gaps = 96/340 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
+ + +G G+FG+V+ + A+KI+ I K ++ + E +LQ + RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61
Query: 150 IGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F D N + +V E + G L+ LRK+ FP + R Q++ ++
Sbjct: 62 F----LVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLAL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H L +++ DLKPEN+LL S Y+K+ D+ F K + +
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGF-------------------AKRVKGRT 155
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
T + T Y APE+IL G+ D W++G ++ E+ +G F +
Sbjct: 156 YT--------LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD---NPI 204
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
+ E++L ++ +P
Sbjct: 205 QIYEKIL---------------------EGKVRFP-----------------------SF 220
Query: 388 VDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
D DL++ LL+ D +RL + HP+F
Sbjct: 221 FS---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 45/230 (19%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKY-------REAAMI-----EIDVLQRLAR 147
+G+GT+G+V + E++A+K V + R+ M+ EI+ L+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I VQ + ++ I E + G S+ LR Y F LVR Q+LE
Sbjct: 68 LNI-----VQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEG 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+A++H ++H DLK +N+L+ + K+ D+ +S+ S D + N S
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFG-ISKKSDD--IYDNDQNMS------MQ 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVI--LGLGWNYPCDLWSVGCILVELCSG 314
+ F + APEVI G++ D+WS+GC+++E+ +G
Sbjct: 172 GSVF-------------WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 85/350 (24%), Positives = 144/350 (41%), Gaps = 66/350 (18%)
Query: 99 KMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
K+G GT+G V + D + ++ A+K + +A EI +L+ L ++ + V
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKV 66
Query: 157 QIRN-----W--FDYRNHI---CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ + W FDY H I F + + P +V+ L Q+L+
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPMQLPRSMVKSLLYQILDG 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H ++H DLKP NIL++ P+ +K+ D G
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMG 157
Query: 267 STTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 319
+ D VV T YRAPE++LG + D+W++GCI EL + E +F
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
Query: 320 THE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT-SRDSMR 372
+ N H ++R+ M AD+ E + P+ T +D R
Sbjct: 218 CRQEDIKTSNPFHHDQLDRIFSV----MGFPADKDWEDIRKM------PEYPTLQKDFRR 267
Query: 373 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ L + +H + LLQ LL DP +R+ + +AL+ P+F
Sbjct: 268 TTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 85/351 (24%), Positives = 144/351 (41%), Gaps = 68/351 (19%)
Query: 99 KMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
K+G GT+G V + D + A+K + +A EI +L+ L ++ + V
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKV 66
Query: 157 QIRN-----W--FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDL----VRELGRQLLE 205
+ + W FDY H + F R + P+ L V+ L Q+L+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLW-------HIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++H ++H DLKP NIL++ P+ +K+ D
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADM 156
Query: 266 GSTTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF 318
G + D VV T YRAPE++LG + D+W++GCI EL + E +F
Sbjct: 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 319 QTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT-SRDSM 371
+ N H ++R+ + M AD+ E + P+ +T +D
Sbjct: 217 HCRQEDIKTSNPYHHDQLDRIF----NVMGFPADKDWEDIKKM------PEHSTLMKDFR 266
Query: 372 RAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
R + L + +H LLQ LL DP +R+ + +A++ P+F
Sbjct: 267 RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 80/342 (23%), Positives = 129/342 (37%), Gaps = 105/342 (30%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDVLQRLARHDIG- 151
+G+G +G V C + +L+A+K V + K E E+D+L+ L +I
Sbjct: 8 LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 152 --GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
GT C+ N I I E + G S+ L N + P + + +Q+L+ VA
Sbjct: 67 YLGT-CLD-------DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H ++H D+K N++L+ + IKLIDFG
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMP---------------------------NGIIKLIDFGCA 149
Query: 269 -----TFEHQDHSYVVSTRH----YRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
H HS ++ + H + APEVI G+ D+WS+GC + E+ +G+
Sbjct: 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+ + L + + G +P R
Sbjct: 210 SMDRLAAMFYIGAHRGLMP----------------------------------------R 229
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
LP D + ID + L D ER A + LRH F
Sbjct: 230 LP-------DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 55/233 (23%), Positives = 93/233 (39%), Gaps = 50/233 (21%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ K+GEG FG+V + +KK VA+K ++ + + E + E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + IV E + G L +LRKN + DL+
Sbjct: 61 PNVVKLLGV--CTE-------EEPLYIVMEYMEGG-DLLSYLRKNRPKLSLSDLL-SFAL 109
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAI 260
Q+ + ++ IH DL N L+ VK+ D F LSR D Y++ I
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD--FGLSRDLYDDDYYRKRGGKLPI 167
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + APE + + D+WS G +L E+ +
Sbjct: 168 R----------------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHD 149
+RI K+G G F +V VA+K V+ + K R + EID+L++L +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQLLES 206
+ ++ F N + IV E L ++ K R P V + QL +
Sbjct: 64 V-----IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ MH R++H D+KP N+ + + VK+ D G +F +
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS------------- 158
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
TT H +V T +Y +PE I G+N+ D+WS+GC+L E+ + ++ F
Sbjct: 159 KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (166), Expect = 9e-13
Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 51/235 (21%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ K+GEG FG+V + + VA+K ++ + + RE + E ++++L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C Q + IV E G L DFLRK+ + + ++
Sbjct: 61 PNIVRLLGV--CTQ-------GEPLYIVTEYMPGG-DLLDFLRKHG-EKLTLKDLLQMAL 109
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS-SA 259
Q+ + + ++ +H DL N L+ VK+ D F LSR + Y++
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISD--FGLSRDIYEDDYYRKRGGGKLP 167
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
IK + APE + + D+WS G +L E+ +
Sbjct: 168 IK----------------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 67/250 (26%), Positives = 104/250 (41%), Gaps = 57/250 (22%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
+G+GT+G V D + +AIK I ++Y + EI + L +I VQ
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-----VQY 70
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLESVAFMHELRLI 216
I E++ G SL LR K + +Q+LE + ++H+ +++
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-------- 268
H D+K +N+L V Y S +K+ DFG++
Sbjct: 131 HRDIKGDNVL--------VNTY------------------SGVVKISDFGTSKRLAGINP 164
Query: 269 ---TFEHQDHSYVVSTRHYRAPEVI-LGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323
TF T Y APEVI G G+ P D+WS+GC +VE+ +G+ F E
Sbjct: 165 CTETF--------TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IEL 214
Query: 324 LEHLAMMERV 333
E A M +V
Sbjct: 215 GEPQAAMFKV 224
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 81/332 (24%), Positives = 132/332 (39%), Gaps = 89/332 (26%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ + A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + + V + + G L+ L++ RSFP R ++ ++ ++H L
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+I+ DLKPENILL S +V + D+ K+G I+ TT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGL----CKEG--------------IEHSKTT----- 153
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 334
S T Y APEV+ ++ D W +G +L E+ G F + + E M + +L
Sbjct: 154 -STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNIL 209
Query: 335 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394
K LRL I H
Sbjct: 210 N----------------------------------------KPLRLKPNISVSARH---- 225
Query: 395 LIDLLQGLLRYDPAERLKAREALR----HPFF 422
LL+GLL+ D +RL A++ H FF
Sbjct: 226 ---LLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 73/344 (21%), Positives = 127/344 (36%), Gaps = 94/344 (27%)
Query: 94 YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARH 148
Y ++ +G G V C N E VAIK + + K + + E+ + +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPN--NEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLES 206
++ F + + +V L G SL D ++ ++ + +++L+
Sbjct: 60 NVVKYYTS-----FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H IH D+K NILL +DGS +K+ DFG
Sbjct: 115 LEYLHSNGQIHRDIKAGNILL-----------------GEDGS----------VKIADFG 147
Query: 267 --STTFEHQDHSY-----VVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVELCSGEALF 318
++ + D + V T + APEV+ G+++ D+WS G +EL +G A +
Sbjct: 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 378
M+ ++ L + D P T D + K
Sbjct: 208 S------KYPPMKVLMLTLQN--------------------DPPSLETGAD-YKKYSKSF 240
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
R +I L L+ DP++R A E L+H FF
Sbjct: 241 R--------------KMISL---CLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 84/341 (24%), Positives = 132/341 (38%), Gaps = 90/341 (26%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG--- 151
L ++G+G+FG+V + DN KE+VAIKI+ E I EI VL + I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G+ + W I+ E L G S D L+ I + R++L+ + ++
Sbjct: 69 GSYLKGTKLW--------IIMEYLGGGSALDLLKPGPLEETYIATIL---REILKGLDYL 117
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H R IH D+K N+LL VK+ D+ + + + IK F T F
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----------DTQIKRNTFVGTPF 166
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
+ APEVI +++ D+WS+G +EL GE + +L +
Sbjct: 167 -------------WMAPEVIKQSAYDFKADIWSLGITAIELAKGEP---PNSDLHPM--- 207
Query: 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390
RVL +P + P L Q+
Sbjct: 208 -RVLFLIPKN--------------------------------------SPPTLEGQY--- 225
Query: 391 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGF 431
+ + ++ L DP R A+E L+H F TR ++ F
Sbjct: 226 -SKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 39/244 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
RY I+ K+GEG+FG++ E IK + + K +EA+ E+ +L ++ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V F + IV E G L + + F D + Q+ +
Sbjct: 61 I-----VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H+ +++H D+K +NI FLS++ KL DFG
Sbjct: 116 HIHDRKILHRDIKSQNI--------------FLSKNGM------------VAKLGDFGIA 149
Query: 269 TFEHQDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
+ V T +Y +PE+ +N D+WS+GC+L ELC+ + F+ + NL
Sbjct: 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLH 208
Query: 326 HLAM 329
L +
Sbjct: 209 QLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 36/243 (14%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCV 156
+G+GTFG+V+ + + A+KI++ I K A + + + RH
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF----LT 58
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F ++ +C V E + G L+ L + R F D R G +++ ++ ++H ++
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
++ DLK EN++L ++K+ D+ D + K
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--------------------- 155
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMERV 333
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME +
Sbjct: 156 ---CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI 212
Query: 334 LGP 336
P
Sbjct: 213 KFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 32/233 (13%)
Query: 94 YRILSKMGEGTFGQVV-ECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ + +G G+FG+V+ + NE VAIK ++ + + +++ + I
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-INH 90
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
CV + F +++ +V E +G + FLR+N + FP D+ Q++ ++
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
L +++ DLKPEN+LL KDG IK+ DFG
Sbjct: 149 SLNIVYRDLKPENLLL-----------------DKDG----------FIKMTDFGFAKVV 181
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
+ T Y APE++L +G D W++G + E+ G F +E L
Sbjct: 182 DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 39/224 (17%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHDIGG 152
L ++G+G+FG+V + DN +++VAIKI+ E A EI+ +Q+ L++ D
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--S 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
+ + + I+ E L G S D LR + F I + +++L+ + ++H
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLH 118
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ IH D+K N+LL VK+ D+ + + + IK F T F
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----------DTQIKRNTFVGTPF- 166
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
+ APEVI ++ D+WS+G +EL GE
Sbjct: 167 ------------WMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 44/250 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + A+KI++ I E A + E VLQ +RH
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF----L 57
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-EL 213
++ F + +C V E G L+ L + R F D R G +++ ++ ++H E
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+++ DLK EN++L ++K+ D+ KDG+ K TF
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------------TF--- 156
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMME 331
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 157 -----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
Query: 332 -----RVLGP 336
R L P
Sbjct: 212 EIRFPRTLSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 78/336 (23%), Positives = 124/336 (36%), Gaps = 95/336 (28%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + A+KI+R I K A + E VLQ RH
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA-- 59
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
++ F + +C V E G L+ L + R F + R G +++ ++ ++H
Sbjct: 60 --LKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ D+K EN++L ++K+ D+ DG+ K TF
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK----------------TF---- 155
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMER 332
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392
+ R P +
Sbjct: 212 I---------------------------------------------RFPRTLSPEAK--- 223
Query: 393 GDLIDLLQGLLRYDPAERL-----KAREALRHPFFT 423
LL GLL+ DP +RL A+E + H FF
Sbjct: 224 ----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 73/337 (21%), Positives = 127/337 (37%), Gaps = 94/337 (27%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V C ++ A K ++K R + A+ E +L++++ I
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACK---KLDKKRLKKRKGEQMALNEKKILEKVSSRFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + F+ ++ +C+V + G L + FP Q++ + +H
Sbjct: 56 ---VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ R+++ DLKPEN+LL V++ D A++L G
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGL------------------AVELKG-GKKI-- 151
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-ENLEHLAMM 330
T Y APEV+ G +++ D +++GC L E+ +G + F+ E +E +
Sbjct: 152 ---KGR-AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207
Query: 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390
R L A +Y PD +
Sbjct: 208 RRTL------------EMAVEY---------PDKFSP----------------------- 223
Query: 391 SAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
+ DL + LL+ DP +RL A E HP F
Sbjct: 224 ---EAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 47/247 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
Y+ L +G G +G V +VA+KI+ + + I E+ +L +L +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 152 GTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ + Y + I+ E G S+ ++ I ++ R++L ++
Sbjct: 63 NI----TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVII---REVLVALK 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY----KFLSRSSKDGSYFKNLPKSSAIKLID 264
++H++ +IH D+K NIL+ + VK+ D+ SSK
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK------------------ 157
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
+TF V T ++ APEVI G ++ D+WS+G + E+ +G + +
Sbjct: 158 --RSTF--------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD- 206
Query: 324 LEHLAMM 330
AMM
Sbjct: 207 -AFRAMM 212
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 82/344 (23%), Positives = 136/344 (39%), Gaps = 85/344 (24%)
Query: 92 PRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
PR + K+GEG+ G V D VA+K + + R + V+ R +H
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ + + + + +V E L G +L D + I V +L++++
Sbjct: 77 ----NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLAVLKALS 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+H +IH D+K ++ILL S VK+ D+ F ++ SK+ +P+ ++
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSL-------- 175
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
V T ++ APEVI L + D+WS+G +++E+ GE + N L
Sbjct: 176 ----------VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP---PYFNEPPLQ 222
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
M+R+ RD+ LP +
Sbjct: 223 AMKRI----------------------------------RDN---------LPPKLKNLH 239
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432
S L L +L DPA+R A E L HPF + G P
Sbjct: 240 KVSP-RLRSFLDRMLVRDPAQRATAAELLNHPFL----AKAGPP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 47/237 (19%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRC 155
+G G+FG+V E AIK ++ K + E +L L+ I
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI----- 80
Query: 156 VQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F N + + E +G L+ LRK FP D+ + +L+ + ++H
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+I+ DLKPEN+LL + +VKV D+ F + D
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----------------------------D 170
Query: 275 HSYVV-STRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG------EALFQTHENL 324
++ + T Y APEVI G D W++G +L E +G + F+ +E +
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAIK + + ++ +I EI V++ L +I
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + F + + +V E L G SL D + + I V R+ L+++ F+
Sbjct: 79 ----VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFL 131
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++IH D+K +N+LL VK+ D+ F ++ T
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ------------------------ITP 167
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
E S +V T ++ APEV+ + D+WS+G + +E+ GE + L L ++
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 44/230 (19%)
Query: 97 LSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ ++GEG FG+V C + E VA+K + ++R EI++L+ L +I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 151 GGTRCVQIRNWFD--YRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVREL--GRQLLE 205
V+ + + + ++ E L SL D+L+++ + I+L R L Q+ +
Sbjct: 69 -----VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR--SSKDGSYFKNLPKSSAIKLI 263
+ ++ R IH DL NIL+ S + VK+ D+ L++ Y+ P S I
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFG-LAKVLPEDKDYYYVKEPGESPIF-- 177
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE + ++ D+WS G L EL +
Sbjct: 178 --------------------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 73/348 (20%), Positives = 127/348 (36%), Gaps = 78/348 (22%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
Y ++ + G+ G+V + + V +KI + + +IE +LQ + +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ-----KGTTLIEAMLLQNVNHPSV--- 119
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+++++ C+V LY +L K S R PID + +Q+LE + ++H
Sbjct: 120 --IRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
R+IH D+K ENI + + + D G+ F
Sbjct: 177 RIIHRDVKTENIFINDV---------------------------DQVCIGDLGAAQFPVV 209
Query: 274 DHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL------------CSGEALFQ 319
++ + T APEV+ +N D+WS G +L E+ + E +
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+ + HL + L P R + F A L+ R
Sbjct: 270 SCHS--HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLE------------------R 309
Query: 380 LPNL---IMQHVD-HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
P Q V+ G+ L+ +L +D A R A E L +P F
Sbjct: 310 QPYTRYPCFQRVNLPIDGEF--LVHKMLTFDAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+Y K+G+G G V D + VAIK + + ++ +I ++ R +H
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP--- 76
Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 77 ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
F+H ++IH D+K +NILL DGS +KL DFG
Sbjct: 130 FLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGFC 162
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
T E S +V T ++ APEV+ + D+WS+G + +E+ GE
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 76/337 (22%), Positives = 135/337 (40%), Gaps = 80/337 (23%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+GEG+ G V + VA+K++ + R + V+ R +H V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----QNVVEM 83
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
+ + ++ E L G +L D + + I V E +L+++ ++H +IH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---SVLQALCYLHSQGVIH 140
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
D+K ++ILL VK+ D+ F ++ SKD +PK ++
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKD------VPKRKSL----------------- 177
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 337
V T ++ APEVI + D+WS+G +++E+ GE
Sbjct: 178 -VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP--------------------- 215
Query: 338 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397
YF S ++A+ +L P +++ + L D
Sbjct: 216 -------------PYF-------------SDSPVQAMKRLRDSPPPKLKNAHKISPVLRD 249
Query: 398 LLQGLLRYDPAERLKAREALRHPFFTR-DVRRCGFPL 433
L+ +L +P ER A+E L HPF + + C PL
Sbjct: 250 FLERMLTREPQERATAQELLDHPFLLQTGLPECLVPL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 46/246 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAIK + + ++ +I EI V++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE------- 72
Query: 152 GTRCVQIRNWFDYR---NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 128
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F+H ++IH D+K +NILL DGS +KL DFG
Sbjct: 129 DFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGF 161
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
T E S +V T ++ APEV+ + D+WS+G + +E+ GE + L
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 325 EHLAMM 330
L ++
Sbjct: 222 RALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 48/266 (18%)
Query: 94 YRILSKMGEGTFGQVVEC-FDNEKKELVAIKIV-----------RSINKYREAAMIEIDV 141
Y +L +G G FG V + N + L+A+K + R +K + E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRE 198
++ RH V+ F + + IV + + G L + K + F + +
Sbjct: 62 IKEQLRH----PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 199 LGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
+ Q++ ++ ++H E R++H DL P NI+L + V + D+ L++ + S +
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG-LAKQKQPESKLTS---- 172
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
VV T Y PE++ + D+W+ GCIL ++C+ +
Sbjct: 173 --------------------VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 318 FQTHENLEHLAM--MERVLGPLPHHM 341
F + N+ LA +E V PLP M
Sbjct: 213 FYS-TNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 46/246 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAI+ + + ++ +I EI V++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73
Query: 152 GTRCVQIRNWFDYR---NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F+H ++IH D+K +NILL DGS +KL DFG
Sbjct: 130 EFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGF 162
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
T E S +V T ++ APEV+ + D+WS+G + +E+ GE + L
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 325 EHLAMM 330
L ++
Sbjct: 223 RALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 76/328 (23%), Positives = 129/328 (39%), Gaps = 81/328 (24%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+GEG+ G V +LVA+K + + R + V+ R +H+ V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEM 82
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
N + + + +V E L G +L D + I V +L++++ +H +IH
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGVIH 139
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
D+K ++ILL VK+ D+ F ++ SK+ K+L
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL----------------------- 176
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 337
V T ++ APE+I L + D+WS+G +++E+ GE + L+ + M+ L P
Sbjct: 177 -VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP- 234
Query: 338 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397
+L NL H +
Sbjct: 235 -----------------------------------------KLKNL------HKVSPSLK 247
Query: 398 -LLQGLLRYDPAERLKAREALRHPFFTR 424
L LL DPA+R A E L+HPF +
Sbjct: 248 GFLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMI--EIDVLQRLARHD 149
+ +G GTFG+V D + A+K+ + + + ++ + E VL+ ++
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I D + + ++ E + G L+ +LR + F +++ ++
Sbjct: 63 IIRLFW----TEHD-QRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALE 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H +++ DLKPENILL ++K+ D+ F A KL D T
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGF------------------AKKLRDRTWT 157
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
+ T Y APEVI G N D W++G ++ E+ G
Sbjct: 158 ---------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 77/344 (22%), Positives = 135/344 (39%), Gaps = 97/344 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLAR 147
+ L ++G G+FG V D E+VAIK + +S K+++ + E+ LQ+L R
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQQL-R 73
Query: 148 HDIGGTRCVQIRNWFDYRNHIC-IVFEKLGPSLYDFL--RKNSYRSFPIDLVRELGRQLL 204
H ++ + + R H +V E S D L K + I + L
Sbjct: 74 H----PNTIEYKGCY-LREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GAL 125
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ +A++H IH D+K NILL ++ G+ +KL D
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILL-----------------TEPGT----------VKLAD 158
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALFQTH 321
FGS + +S+ V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 159 FGSASLVSPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---------- 207
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
A+R+ F + ++M A++ + +
Sbjct: 208 -----------------------AERKP-PLF-------------NMNAMSALYHIAQND 230
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ + D S + + L+ P +R + E L+H F R+
Sbjct: 231 SPTLSSNDWSD-YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 68/261 (26%), Positives = 116/261 (44%), Gaps = 43/261 (16%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI----GG 152
+ +G G FG+V + K L A+K +R ++ ++ V A DI
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLR-----KKDVLLRNQVAHVKAERDILAEADN 60
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V++ F ++++ V + + G + L + FP DL R +L +V +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVH 118
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFK--NLPKSSAIKLIDFGS 267
++ IH D+KP+NIL+ ++K+ D+ + R + D Y++ + + ++ DF +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM---DFSN 175
Query: 268 --------------------TTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304
+HQ HS +V T +Y APEV+L G+ CD WSV
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHS-LVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 305 GCILVELCSGEALFQTHENLE 325
G IL E+ G+ F LE
Sbjct: 235 GVILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 35/241 (14%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+GEG+ G V + + VA+K + + R + V+ R H+ V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHE----NVVDM 84
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
N + + + +V E L G +L D + I V +L +++++H +IH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLSVLRALSYLHNQGVIH 141
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
D+K ++ILL S +K+ D+ F ++ SK+ +PK ++
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKSL----------------- 178
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 337
V T ++ APEVI L + D+WS+G +++E+ GE + N L M R+ L
Sbjct: 179 -VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYFNEPPLQAMRRIRDNL 234
Query: 338 P 338
P
Sbjct: 235 P 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 46/229 (20%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRC 155
LS++GEG G V +C + A+K + + ++ +L+ L
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITT----DPNPDLQKQILRELEINKSCKSPYI 61
Query: 156 VQIRNWF--DYRNHICIVFEKLG----PSLYDFLRKNSYRSFPIDLVRELGR---QLLES 206
V+ F + + I I E S+Y ++K R + LG+ +L+
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE----KVLGKIAESVLKG 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
++++H ++IH D+KP NILL ++ G +KL DFG
Sbjct: 118 LSYLHSRKIIHRDIKPSNILL-----------------TRKG----------QVKLCDFG 150
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
S + T Y APE I G ++ D+WS+G L+E+
Sbjct: 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 54/242 (22%), Positives = 104/242 (42%), Gaps = 58/242 (23%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ ++ +G GT+GQV + + +L AIK++ E +EI++L++ + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH----- 72
Query: 154 RCVQIRNWFDY------------RNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELG 200
RN Y + + +V E G S+ D ++ + D + +
Sbjct: 73 -----RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
R++L +A +H ++IH D+K +N+LL +++ +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLT---------------------------ENAEV 160
Query: 261 KLIDFG-STTFEHQ--DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELC 312
KL+DFG S + + + T ++ APEVI ++Y D+WS+G +E+
Sbjct: 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220
Query: 313 SG 314
G
Sbjct: 221 EG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 69/336 (20%), Positives = 122/336 (36%), Gaps = 96/336 (28%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYR--EAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ EL A+K+++ I + E M E VL +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
Q+ + F ++ + V E + G ++ R F R +++ + F+HE
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+I+ DLK +N+LL S ++K+ D+ K+G I G TT
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGM----CKEG--------------ILGGVTT---- 153
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMME 331
S T Y APE++ + D W++G +L E+ +G++ F + L + +
Sbjct: 154 --STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
Query: 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391
V P + A
Sbjct: 212 EVR--YPRWLSKEA---------------------------------------------- 223
Query: 392 AGDLIDLLQGLLRYDPAERLKA-----REALRHPFF 422
+L+ L +P +RL ++ HPFF
Sbjct: 224 ----KSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHDIGG 152
L K+G+G+FG+V + DN +++VAIKI+ E A EI+ +Q+ L++ D
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--S 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAF 209
+ + + I+ E L G S D L P+D + + R++L+ + +
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDY 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H + IH D+K N+LL VK+ D+ G T
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQLT 152
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
+ V T + APEVI ++ D+WS+G +EL GE
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 21/148 (14%)
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDG 248
F DL R +L ++ +H++ IH D+KP+NIL+ ++K+ D+ + R + D
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 249 SYFK--NLPKSSAIKLIDFGS-------TTFE------HQD---HSYVVSTRHYRAPEVI 290
Y++ + + +++ + S E HQ HS +V T +Y APEV+
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS-LVGTPNYIAPEVL 216
Query: 291 LGLGWNYPCDLWSVGCILVELCSGEALF 318
L G+ CD WSVG IL E+ G+ F
Sbjct: 217 LRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 74/353 (20%), Positives = 136/353 (38%), Gaps = 85/353 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSI---NKYREAAMIEIDVLQRLAR 147
++ + +G+G G+V +L A+K++ + + NK + E ++L L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATL-D 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + F ++C+V + G L+ L++ + ++ R ++L +
Sbjct: 60 HPF----LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY----------KFLSRSSKDGSYFKNLPK 256
+ ++H L +++ DLKPENILL + ++ + D+ +S++ + GS ++
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 257 SS---AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ F S +F V T Y APEVI G G D W++G +L E+
Sbjct: 176 IPSETFSEEPSFRSNSF--------VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G F + R E +
Sbjct: 228 GTTPF-------------------------KGSNRDETFSN------------------- 243
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL----KAREALRHPFF 422
+L+ S+ DL++ LL DP++RL A E +HPFF
Sbjct: 244 ---ILKKEVTFPGSPPVSS-SARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 79/338 (23%), Positives = 128/338 (37%), Gaps = 99/338 (29%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID--VLQRLARHDIGGTRCVQ 157
+G+G+FG+V++ K++ I +++I K + E+ + +R + V
Sbjct: 1 IGKGSFGKVMQV---RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57
Query: 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRK----NSYRSFPIDLVRELGRQLLESVAFMHE 212
++ F + +V + G L+ L++ + R+ R +LL ++ +H+
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYTAELLCALENLHK 111
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+I+ DLKPENILL DY I L DFG
Sbjct: 112 FNVIYRDLKPENILL---------DY------------------QGHIALCDFGLCKLNM 144
Query: 273 QDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
+D T Y APE++LG G+ D W++G +L E+ +G
Sbjct: 145 KDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG--------------- 189
Query: 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389
LP D + +R K+L+ P D
Sbjct: 190 -------LPPFY----DENVNEMYR---------------------KILQEPLRFPDGFD 217
Query: 390 HSAGDLIDLLQGLLRYDPAERL---KAREALRHPFFTR 424
A DLL GLL DP RL A+E HPFF++
Sbjct: 218 RDAK---DLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 79/342 (23%), Positives = 131/342 (38%), Gaps = 69/342 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ IL G G C DN+ E V IK + R E +L+ + I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSI--- 145
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+Q++ F Y C++ + LY +L + R+ I + + R +L ++ ++HE
Sbjct: 146 --IQLKGTFTYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYLHEN 201
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE-- 271
R+IH D+K ENI F N P + L DFG+ F
Sbjct: 202 RIIHRDIKAENI-------------------------FINHPGD--VCLGDFGAACFPVD 234
Query: 272 -HQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE-ALFQTH------E 322
+ + Y T APE++ + D+WS G +L E+ + +LF+ +
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVW-KLLRL 380
+ + ++ R G P+ I A ++ + A+ +SR R +W L L
Sbjct: 295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAK------KSSRKPGSRPLWTNLYEL 348
Query: 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
P DL L+ +L +D R A L F
Sbjct: 349 PI-----------DLEYLICKMLAFDAHHRPSAEALLDFAAF 379
|
Length = 391 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 34/225 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
+G+GTFGQV + + + + A+K++ + I +E A E ++L R +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE--SPFI 58
Query: 156 VQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V ++ F + + +V + G L+ L+K F D + +L+ ++ +H+
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLKPENILL + ++ + D+ LS++ NL + + TF
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFG-LSKA--------NLTDNKT-------TNTF---- 156
Query: 275 HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
T Y APEV+L G+ D WS+G ++ E+C G + F
Sbjct: 157 ----CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 39/251 (15%)
Query: 94 YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLAR 147
+ + +G+G FG+V V+ D K + A+K + +++ + E DVL A
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVL---AE 57
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
D V + F ++ ++ E L G L L K Y +F D+ R + + +
Sbjct: 58 SD--SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLA 113
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK--DGSYFKNLPKSSAIK--- 261
+ +H+L IH D+KP+NIL+ ++K+ D+ + K D +Y++ L + + K
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 262 ------LIDFGSTTFEHQDH-----------SY-VVSTRHYRAPEVILGLGWNYPCDLWS 303
+D + T +D +Y V T Y APE+ L G+ CD WS
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 304 VGCILVELCSG 314
+G I+ E G
Sbjct: 234 LGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 37/248 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDI-- 150
+ L +G G FG+V + + A+KI+R +A M+E + + + A DI
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILV 56
Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES- 206
G V++ F + ++ ++ E L G + L K D + E Q +
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAE 109
Query: 207 ----VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAI 260
+ +H+L IH D+KP+N+LL + +VK+ D+ + + + +++NL +
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 261 KLIDFGSTTFEHQDHSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
F + + + ++ V T Y APEV + G+N CD WS+G I+ E
Sbjct: 170 DF-SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 311 LCSGEALF 318
+ G F
Sbjct: 229 MLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 51/232 (21%), Positives = 106/232 (45%), Gaps = 38/232 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGG 152
+ ++ +G GT+GQV + + +L AIK++ E EI++L++ + H +I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 153 TRCVQIR-NWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
I+ N + + +V E G S+ D ++ + + + + R++L ++ +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H+ ++IH D+K +N+LL +++ +KL+DFG +
Sbjct: 128 HQHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQ 160
Query: 271 EHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 314
+ + + T ++ APEVI +++ DLWS+G +E+ G
Sbjct: 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 32/240 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ K+G G FG+V N + VA+K ++ E+ + E ++++L RHD +
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKL-RHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ R+ + + ++ Q+ +A++ +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
IH DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFG-LARLIEDNEYTARQGAKFPIK------------ 168
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
+ APE L + D+WS G +L EL + G + N E L +ER
Sbjct: 169 ----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---IN-KYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ + A+K+++ +N K ++ M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + V + + G L+ L++ RSFP R ++ ++ ++H +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLKPENILL S +V + D+ K+G I D +TTF
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGL----CKEG-----------IAQSD-TTTTF---- 156
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF---QTHENLEHLAMME 331
T Y APEVI ++ D W +G +L E+ G F E +++
Sbjct: 157 ----CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 332 RVLGP 336
VL P
Sbjct: 213 LVLRP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 70/282 (24%), Positives = 116/282 (41%), Gaps = 70/282 (24%)
Query: 97 LSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
L +G+G+FG+V + + +L A+K+++ + R +E D+L
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL-------- 52
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLY---DFLRKNSYRSFPIDLVRELGRQLL--- 204
++ + F + H F+ G LY DFLR DL L ++++
Sbjct: 53 -----AEVNHPFIVKLHY--AFQTEG-KLYLILDFLRGG-------DLFTRLSKEVMFTE 97
Query: 205 ESVAF-----------MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
E V F +H L +I+ DLKPENILL ++K+ D+ LS+ S D
Sbjct: 98 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG-LSKESIDH----- 151
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
E + +S+ T Y APEV+ G D WS G ++ E+ +
Sbjct: 152 -----------------EKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
G FQ + E + M+ + +P + A F+R
Sbjct: 194 GSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ I+ +G G FG+V + + A+KI +NK+ E R R+ +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKI---LNKWEMLKRAETACF-REERNVLVNG 58
Query: 154 RCVQIRNW---FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
C I F N++ +V + +G L L K R P D+ R +++ ++
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHS 117
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H+L +H D+KP+N+LL ++++ D+ + ++DG+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV------------------- 158
Query: 270 FEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVGCILVELCSGEALFQTHENL 324
S V T Y +PE++ G+G P CD WS+G + E+ GE F +
Sbjct: 159 ----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 325 E 325
E
Sbjct: 215 E 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 25/152 (16%)
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDG 248
FP L R +L ++ +H++ IH D+KP+NIL+ ++K+ D+ + R + +
Sbjct: 98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157
Query: 249 SYFK--NLPKSSAIKLIDF-----------------GSTTFEHQD---HSYVVSTRHYRA 286
Y++ + + +++ D T +HQ HS +V T +Y A
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS-LVGTPNYIA 216
Query: 287 PEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
PEV+L G+ CD WSVG IL E+ G+ F
Sbjct: 217 PEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 52/237 (21%), Positives = 99/237 (41%), Gaps = 42/237 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ + S +G G FG+V + ++ A+K+++ + + + V DI
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-----KSVLLAQETVSFFEEERDILSI 57
Query: 154 R----CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESV 207
Q++ F ++++ +V E G L L N Y F D+ + +L+ ++
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAI 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H++ +H D+KPEN+L+ ++K+ D+ +R + + LP
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP------------ 163
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVELCSGEALF 318
V T Y APEV+ + + CD WS+G I E+ G + F
Sbjct: 164 -----------VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 51/227 (22%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGG 152
+S +G G G V + ++A K+V + + R+ + E+ ++ H+
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM-----HECRS 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH- 211
V F N+IC+ E + D + K P++++ ++ ++E + +++
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
R++H D+KP NIL+ S +K+ D+ + +LI+ + TF
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDF------------------GVSGELINSIADTF- 162
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
V T Y +PE I G + D+WS+G ++EL G+ F
Sbjct: 163 -------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++ K+G G FG+V N + VA+K ++ EA + E ++++L RHD +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKL-RHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ + + + ++ Q+ E +A++
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA---IKLIDFGSTTF 270
IH DL NIL+ K+ D+ L+R +D Y + A IK
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFG-LARLIEDDEY---TAREGAKFPIK--------- 169
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ APE + D+WS G +L E+
Sbjct: 170 -------------WTAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 65/270 (24%), Positives = 108/270 (40%), Gaps = 53/270 (19%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ K E A+K ++ I+ E M+E VL +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRE--LGRQLLESVAFMH 211
+ F + H+ V E L G ++ K + DL R +++ + F+H
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-----DLYRATFYAAEIVCGLQFLH 113
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---ST 268
+I+ DLK +N++L +DG IK+ DFG
Sbjct: 114 SKGIIYRDLKLDNVML-----------------DRDGH----------IKIADFGMCKEN 146
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
F S T Y APE++ GL + + D WS G +L E+ G++ F + E
Sbjct: 147 VFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--- 203
Query: 329 MMERVLGPLPHH---MVIRADRRAEKYFRR 355
+ E + PH+ + + EK F R
Sbjct: 204 LFESIRVDTPHYPRWITKESKDILEKLFER 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 37/248 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDI-- 150
+ L +G G FG+V + + A+KI+R +A M+E + + + A DI
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR------KADMLEKEQVGHIRAERDILV 56
Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL---- 203
V++ F + ++ ++ E L G + L K D + E Q
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAE 109
Query: 204 -LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAI 260
+ ++ +H+L IH D+KP+N+LL S +VK+ D+ + + + +++NL S
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 261 KLIDFGSTTFEHQDHSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
F + + + ++ V T Y APEV + G+N CD WS+G I+ E
Sbjct: 170 DFT-FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 311 LCSGEALF 318
+ G F
Sbjct: 229 MLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 51/222 (22%), Positives = 104/222 (46%), Gaps = 37/222 (16%)
Query: 93 RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+Y ILS + G+ G+V C D ++K++ IV+++ + EID+L+ ++
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKV----IVKAVTGGKTPGR-EIDILKTISHRA 147
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I + + + + +++ +C+V K L+ ++ ++ P++ + R+LLE++A+
Sbjct: 148 I-----INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAY 200
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H +IH D+K ENI L E + D+ +A KL +
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDF------------------GAACKL---DAHP 239
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
Q + + T +PE++ + D+WS G +L E+
Sbjct: 240 DTPQCYGW-SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 63/289 (21%)
Query: 93 RY-RILSKMGEGTFGQV-VECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL 145
RY + + +GEG FG+V + C+D + E+VA+K ++ + EI++L+ L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 146 ARHDI---------GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
+I G + +Q+ + + LG SL D+L K+ ++L
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQL----------IMEYVPLG-SLRDYLPKHK-----LNLA 107
Query: 197 REL--GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
+ L +Q+ E +A++H IH DL N+LL + VK+ D+ L+++ +G + +
Sbjct: 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG-LAKAVPEGHEYYRV 166
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
+ D S F + A E + ++Y D+WS G L EL
Sbjct: 167 RE-------DGDSPVF-------------WYAVECLKENKFSYASDVWSFGVTLYEL--- 203
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
L E ++GP M + R + RG RL P
Sbjct: 204 --LTHCDSKQSPPKKFEEMIGPKQGQMTV---VRLIELLERGMRLPCPK 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 64/241 (26%), Positives = 107/241 (44%), Gaps = 34/241 (14%)
Query: 95 RILSKMGEGTFGQV-VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
R+ K+G+G FG+V + ++ K VAIK ++ EA + E ++++L RHD
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHD---- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ V + I IV E +G SL DFL++ + + + ++ Q+ + +A++
Sbjct: 62 KLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+ IH DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFG-LARLIEDNEYTARQGAKFPIK----------- 168
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 331
+ APE L + D+WS G +L EL + G + N E L +E
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
Query: 332 R 332
R
Sbjct: 218 R 218
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 41/243 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
+ IL +G G FG+V ++ A+KI+ + A E DVL
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----- 57
Query: 150 IGGTRCVQIRNW-FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G + + ++ F N++ +V + +G L L K R P D+ R +++ ++
Sbjct: 58 -GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAI 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H+L +H D+KP+NIL+ ++++ D+ S +KL++ G+
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADF------------------GSCLKLMEDGT 157
Query: 268 TTFEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVGCILVELCSGEALFQTHE 322
S V T Y +PE++ G G P CD WS+G + E+ GE F
Sbjct: 158 V-----QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
Query: 323 NLE 325
+E
Sbjct: 213 LVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 60/238 (25%)
Query: 99 KMGEGTFGQVVECF---DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHD---- 149
K+GEG FG+V + + K VA+K ++ + R+ + E V+++L H
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVR 60
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+G C + + +V E + G L D+LRK+ FP L + L S
Sbjct: 61 LLGV--CTE-------EEPLYLVLEYMEGG-DLLDYLRKSR-PVFPSPEKSTLSLKDLLS 109
Query: 207 VA--------FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS 257
A ++ + +H DL N L+ VK+ D F LSR D Y++ K
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD--FGLSRDVYDDDYYR---KK 164
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYR--APEVILGLGWNYPCDLWSVGCILVELCS 313
+ KL R APE + + D+WS G +L E+ +
Sbjct: 165 TGGKL--------------------PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 50/231 (21%), Positives = 100/231 (43%), Gaps = 41/231 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V ++ A K ++K R + A++E ++L+++ I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACK---KLDKKRLKKKSGEKMALLEKEILEKVNSPFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + F+ + H+C+V + G L + R ++ V Q+ + +H
Sbjct: 56 ---VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ +++ D+KPEN+LL ++ D A++L D + T
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGL------------------AVELKDGKTITQR 154
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
T Y APE++ ++YP D +++GC + E+ +G F+ H+
Sbjct: 155 -------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 33/241 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++L K+G G FG+V E N VA+K ++ + + E ++++L RH +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RH----PK 62
Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+Q+ I IV E K G SL ++L+ + R+ + + ++ Q+ +A++
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYG-SLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
IH DL N+L+ KV D+ L+R K+ Y IK
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFG-LARVIKEDIYEAREGAKFPIK----------- 169
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 331
+ APE L ++ D+WS G +L E+ + G + N E L ++
Sbjct: 170 -----------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
Query: 332 R 332
+
Sbjct: 219 Q 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 39/236 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMI--EIDVLQRLARHD 149
+ +L +G+G FG+V + K++ A+K + + + E +LQ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSL-YDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F ++ +V + LG L Y +K F + V+ +++ ++
Sbjct: 61 F----LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLAL 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H +IH D+KP+NILL +V + D+ N+ A K+ +
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDF--------------NI----ATKVTP-DT 154
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
T T Y APEV+ G++ D WS+G E G+ ++ H
Sbjct: 155 LTTS------TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ + + + ++ Q+ +A++ +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+H DL+ NIL+ KV D+ L+R +D Y IK
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 168
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
+ APE L + D+WS G +L EL + G + N E L +ER
Sbjct: 169 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 59/240 (24%), Positives = 102/240 (42%), Gaps = 51/240 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ I+ +G+GT+G+V + + + A+KI+ I+ E E ++L+ L+ H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDH----P 75
Query: 154 RCVQIRNWF---DYRN--HICIVFEKL-GPSLYD----FLRKNSYRSFPIDLVRELGRQL 203
V+ + D +N + +V E G S+ D FL++ PI + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEA 133
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L + +H + IH D+K NILL + +KL+
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTT---------------------------EGGVKLV 166
Query: 264 DFGST---TFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSGE 315
DFG + T + V T + APEVI L ++ CD+WS+G +EL G+
Sbjct: 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 67/264 (25%), Positives = 106/264 (40%), Gaps = 57/264 (21%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
L ++G GT GQV + + ++A+K + R+ NK E I +D+ L HD
Sbjct: 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHD----- 72
Query: 155 C---VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
C V+ +F + + I E + L D L K P D+ LG+ + V +H
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDI---LGKMTVAIVKALH 128
Query: 212 ELR----LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
L+ +IH D+KP NILL S +KL DFG
Sbjct: 129 YLKEKHGVIHRDVKPSNILL---------------------------DASGNVKLCDFGI 161
Query: 268 TTF--EHQDHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
+ + + + Y APE I ++ D+WS+G LVEL +G+ F
Sbjct: 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYK 219
Query: 322 ENLEHLAMMERVLGP----LPHHM 341
++ ++L LP +
Sbjct: 220 NCKTEFEVLTKILQEEPPSLPPNE 243
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 99 KMGEGTFGQVVEC-FDNEKKEL--VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153
K+G+G+FG V + ++ VA+K ++S + + E ++ L ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL--- 58
Query: 154 RCVQIRNWFDYRNH-ICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
IR + H + +V E L P SL D LRK++ F I + + Q+ + ++
Sbjct: 59 ----IRLYGVVLTHPLMMVTE-LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
R IH DL NILL S + VK+ D+ L R+
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFG-LMRALPQN 150
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V + AIK ++ ++ E M+E VL H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE--LGRQLLESVAFMHEL 213
+ F + ++ V E L F ++ ++ DL R +++ + F+H
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSK 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+++ DLK +NILL + ++K+ D+ + L D + TF
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKEN----------------MLGDAKTCTF--- 156
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
T Y APE++LG +N D WS G +L E+ G++ F H+ E
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/251 (22%), Positives = 110/251 (43%), Gaps = 38/251 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+YR+L G+G FG+V C ++ A K + + I K + +M E +L+++
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V + ++ ++ +C+V + G L + F ++ +
Sbjct: 61 FV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H+ R+++ DLKPENILL ++++ D ++P+ IK G
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV----------HVPEGQTIK----GR 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
V T Y APEV+ + + D W++GC+L E+ +G++ FQ +
Sbjct: 162 -----------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 210
Query: 328 AMMERVLGPLP 338
+ER++ +
Sbjct: 211 EEVERLVKEVQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 44/245 (17%)
Query: 99 KMGEGTFGQVVECFDNEKK--ELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGT 153
++G G FG V + KK + VA+KI+++ N ++ + E +V+Q+L I
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI--V 59
Query: 154 RCVQI---RNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
R + I +W +V E +LGP L FL+KN + + EL Q+ +
Sbjct: 60 RMIGICEAESWM-------LVMELAELGP-LNKFLQKN--KHVTEKNITELVHQVSMGMK 109
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++ E +H DL N+LLV+ Y K+ D+ D +Y+K
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA--------------- 154
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
+ H + APE + ++ D+WS G ++ E S G+ ++ + E
Sbjct: 155 ----KTHGK--WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
Query: 328 AMMER 332
M+E
Sbjct: 209 QMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 47/248 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V C +L A K +NK R E AM+E +L ++ I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACK---KLNKKRLKKRKGYEGAMVEKRILAKVHSRFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F + +C+V L +Y+ +N FP Q++ +
Sbjct: 56 ---VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGL 110
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H+ R+I+ DLKPEN+LL + V++ D A++L D S
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISDLGL------------------AVELKDGQS 152
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-ENLEH 326
T + T + APE++ G +++ D +++G L E+ + F+ E +E+
Sbjct: 153 KTKGY------AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 206
Query: 327 LAMMERVL 334
+ +R+L
Sbjct: 207 KELKQRIL 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLARHDIG 151
L ++G G+FG V D E+VAIK + +S K+++ + E+ LQR+ +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVKFLQRIKHPN-- 86
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
++ + + + +V E S D L + +++ + L+ +A++H
Sbjct: 87 ---SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH 142
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+IH D+K NILL + +KL DFGS +
Sbjct: 143 SHNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASIA 175
Query: 272 HQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
+S+ V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 176 SPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 63/252 (25%), Positives = 106/252 (42%), Gaps = 60/252 (23%)
Query: 93 RYRILSKMGEGTFGQVVECF------DNEKKELVAI------KIVRSINKY-----REAA 135
+R++ + G FG++ C + E + V K R I K R A
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208
Query: 136 MIE--IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS--YRSF 191
+E I L RL +I ++I + ++ +K LY F+ + ++
Sbjct: 209 QLENEILALGRLNHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263
Query: 192 P-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
P + R + +QLL +V ++H+ +LIH D+K ENI L + DG
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL-----------------NCDGK- 305
Query: 251 FKNLPKSSAIKLIDFGS-TTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
I L DFG+ FE + D+ +V T +PE++ G G+ D+WS G
Sbjct: 306 ---------IVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCG 355
Query: 306 CILVELCSGEAL 317
IL+++ S +
Sbjct: 356 LILLDMLSHDFC 367
|
Length = 501 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 65/255 (25%), Positives = 105/255 (41%), Gaps = 62/255 (24%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
T + I+ +G+GT+G+V + + + L A+KI+ I+ E E ++LQ L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH-- 78
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL---GRQLLESV 207
V+ F Y+ + G L+ L + S +LV+ L G++L E++
Sbjct: 79 --PNVVKFYGMF-YKADKLV-----GGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAM 129
Query: 208 ------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
+H R+IH D+K NILL +
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT-------------------------- 163
Query: 256 KSSAIKLIDFGST---TFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCI 307
+KL+DFG + T + V T + APEVI ++ CD+WS+G
Sbjct: 164 -EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222
Query: 308 LVELCSGE-ALFQTH 321
+EL G+ LF H
Sbjct: 223 AIELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
L ++G G+FG V D E+VAIK + + N+ + + E+ LQ+L RH
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RH---- 74
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+Q R + + +V E S D L + +++ + L+ +A++H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS 133
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+IH D+K NILL + +KL DFGS +
Sbjct: 134 HNMIHRDVKAGNILLS---------------------------EPGLVKLGDFGSASIMA 166
Query: 273 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
+ + V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 167 PANXF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 58/250 (23%), Positives = 109/250 (43%), Gaps = 33/250 (13%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDI 150
Y + +G+G++G+V + IK + + + R+AA E +L +L +I
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
R +W + IV G LY L++ + P + V E Q+ ++ +
Sbjct: 62 VAYR----ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+HE ++H DLK +N+ L +KV D ++R ++ D ST
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLG-IARVLENQC--------------DMAST- 161
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE-NLEHLA 328
++ T +Y +PE+ +NY D+W++GC + E+ + + F + N
Sbjct: 162 --------LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR 213
Query: 329 MMERVLGPLP 338
++E L P+P
Sbjct: 214 IIEGKLPPMP 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 34/245 (13%)
Query: 92 PR--YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
PR +++ K+G G FG+V + N + VAIK ++ + EA + E +++++L +H
Sbjct: 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQL-QHP 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
R V++ + I I+ E + SL DFL+ I+ + ++ Q+ E +A
Sbjct: 62 ----RLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+ IH DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFG-LARLIEDNEYTAREGAKFPIK------- 168
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
+ APE I + D+WS G +L E+ + G + N E +
Sbjct: 169 ---------------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
Query: 328 AMMER 332
+ER
Sbjct: 214 QNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 42/234 (17%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
++G G FG V + EK++ VAIK +R E + E V+ +L+ + VQ+
Sbjct: 11 EIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSH-----PKLVQL 64
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
R+ IC+VFE + L D+LR F + + + + E +A++ +IH
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DL N L + ++ +K+ DFG T F D Y
Sbjct: 124 RDLAARNCL---------------------------VGENQVVKVSDFGMTRFVLDDQ-Y 155
Query: 278 VVSTR-----HYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
ST + +PEV ++ D+WS G ++ E+ S G+ ++ N E
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 62/282 (21%), Positives = 106/282 (37%), Gaps = 84/282 (29%)
Query: 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPE 223
I I E + G SL L+K P +++ ++ +L + ++ E +++H D+KP
Sbjct: 72 GEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRH 283
NIL+ S +K+ D+ + +LID + +F V TR
Sbjct: 130 NILVNSRGEIKLCDF------------------GVSGQLIDSMANSF--------VGTRS 163
Query: 284 YRAPEVILGLGWNYPCDLWSVGCILVELCSG------------EALFQTHENLEHLAMME 331
Y +PE + G + D+WS+G LVE+ G EA+F +
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223
Query: 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL---------RLPN 382
R + P S M A+++LL +LP+
Sbjct: 224 RPVSGHPP--------------------------DSPRPM-AIFELLDYIVNEPPPKLPS 256
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ + D + L+ +P ER +E +HPF R
Sbjct: 257 ------GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 58/226 (25%), Positives = 90/226 (39%), Gaps = 39/226 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ E AIK ++ + E M+E VL H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
+ F + H+ V E L F ++S R F R +++ + F+H+ +
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGI 117
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE---H 272
I+ DLK +N+LL KDG IK+ DFG
Sbjct: 118 IYRDLKLDNVLL-----------------DKDGH----------IKIADFGMCKENMNGE 150
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
S T Y APE++ G +N D WS G +L E+ G++ F
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 6e-08
Identities = 53/249 (21%), Positives = 86/249 (34%), Gaps = 78/249 (31%)
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
L+D L+K V+++ RQL+E++ +H+ +IH D+K EN+L
Sbjct: 93 DGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--------- 141
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
Y + + I L D+G Y T Y +PE I G +
Sbjct: 142 --------------YDRAKDR---IYLCDYGLCKIIGTPSCY-DGTLDYFSPEKIKGHNY 183
Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFR 354
+ D W+VG + EL +G+ F+ E+ E L + +
Sbjct: 184 DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK---------------------- 221
Query: 355 RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-KA 413
R S A D +Q +L+Y+ RL
Sbjct: 222 ---RQQKKLPFIKNVSKNAN----------------------DFVQSMLKYNINYRLTNY 256
Query: 414 REALRHPFF 422
E ++HPF
Sbjct: 257 NEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ +++ A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + + V + + G L+ L++ R F R ++ ++ ++H L
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLKPENILL S ++ + D+ + I+ TT
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKEN------------------IEHNGTT----- 153
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
S T Y APEV+ ++ D W +G +L E+ G F + E
Sbjct: 154 -STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 32/236 (13%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+G G FG+V N K VA+K ++ + EA + E +V++ L +HD + V++
Sbjct: 13 KLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHD----KLVKL 66
Query: 159 RNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
+ + I I+ E + SL DFL+ + P+ + + Q+ E +AF+ + IH
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DL+ NIL+ ++ K+ D+ L+R +D Y IK
Sbjct: 126 RDLRAANILVSASLVCKIADFG-LARVIEDNEYTAREGAKFPIK---------------- 168
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
+ APE I + D+WS G +L+E+ + G + N E + +ER
Sbjct: 169 ------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 73/268 (27%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHDIGGTR 154
L ++G G FG V + ++A+K +RS +E ++++DV+ R +
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR-------SSD 61
Query: 155 CVQIRNWFDYRNH-----IC-----IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
C I ++ IC I +K +Y+ L+ P ++ LG+ +
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV----IPEEI---LGKIAV 114
Query: 205 ESVAFMH----ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+V ++ EL++IH D+KP NILL ++ I
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILL---------------------------DRNGNI 147
Query: 261 KLIDFG------STTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVEL 311
KL DFG + + +D R Y APE I G++ D+WS+G L E+
Sbjct: 148 KLCDFGISGQLVDSIAKTRD----AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
Query: 312 CSGEALFQTHENL-EHLAMMERVLGPLP 338
+G+ + ++ + L + V G P
Sbjct: 204 ATGKFPYPKWNSVFDQLTQV--VKGDPP 229
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 54/240 (22%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ K+G G FG+V + N + VA+K ++ +A + E ++++ L +HD +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTL-QHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ I I+ E + SL DFL+ + + + + Q+ E +A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
IH DL+ N+L+ + K+ D+ L+R +D Y IK
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFG-LARVIEDNEYTAREGAKFPIK------------ 169
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
+ APE I + D+WS G +L E+ + G+ + N + ++ ++R
Sbjct: 170 ----------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 50/225 (22%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEID--VLQRLARHD--IGGT 153
+G G++ +V+ + + + A+K+V+ +N + ++ + V ++ + H +G
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
C Q + R I + G ++ R+ R P + R ++ ++ ++HE
Sbjct: 63 SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+I+ DLK +N+LL S ++K+ DY K+G + G TT
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDTT---- 153
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
S T +Y APE++ G + + D W++G ++ E+ +G + F
Sbjct: 154 --STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 41/238 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + V + + G L+ L++ R F R ++ ++ ++H L
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+I+ DLKPENILL S +V + D+ K+G ++ TT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGL----CKEG--------------VEPEETT----- 153
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF------QTHENLEH 326
S T Y APEV+ ++ D W +G +L E+ G F Q ++N+ H
Sbjct: 154 -STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 83/345 (24%), Positives = 140/345 (40%), Gaps = 65/345 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
+S++G G G V + ++A K++ K R + E+ VL H+
Sbjct: 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPY 64
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V F I I E + G SL L++ + P +++ ++ +L +A++ E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK 122
Query: 214 -RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+++H D+KP NIL+ S +K+ D+ + +LID + +F
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQLIDSMANSF-- 162
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332
V TR Y +PE + G ++ D+WS+G LVEL G + E A+ R
Sbjct: 163 ------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216
Query: 333 VL----GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL---------R 379
+ PH + R R R G SR +M A+++LL +
Sbjct: 217 PVVDGEEGEPHSISPRP--------RPPGRPVSGHGMDSRPAM-AIFELLDYIVNEPPPK 267
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
LPN + D + + L +PAER + + H F R
Sbjct: 268 LPNGVF------TPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 51/235 (21%), Positives = 103/235 (43%), Gaps = 39/235 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ ++ ++G GT+G V + + EL AIK+++ + + A+++ +++ D +
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEIIMM---KDCKHS 66
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPID--LVRELGRQLLESVAFM 210
V + R+ + I E G SL D + + P+ + + R+ L+ + ++
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYL 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H +H D+K NILL +VK+ D+ ++ + + K+
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF---------------- 166
Query: 271 EHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGE-ALFQTH 321
+ T ++ APEV G+N CD+W+VG +EL + +F H
Sbjct: 167 --------IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIGG 152
+ +G G G V + + + ++A+K++ + ++ M E+++L + I
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI-- 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
+ F N I I E + G SL + YR P ++ + +++ + ++
Sbjct: 62 ---IGFYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLW 112
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
L+++H D+KP N+L+ + V KL DFG ST
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQV---------------------------KLCDFGVSTQL 145
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
+ V T Y APE I G + D+WS+G +EL G
Sbjct: 146 VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
L ++G G+FG V ++ E+VA+K + + N+ + + E+ LQ+L +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT-- 83
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
++ + + + +V E S D L + +++ + L+ +A++H
Sbjct: 84 ---IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS 139
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+IH D+K NILL + +KL DFGS +
Sbjct: 140 HNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASKSS 172
Query: 273 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
+S+ V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 173 PANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 52/244 (21%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ + ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I + V + R ++ +V E L P SL D+L+K+ R L+ Q+ + +
Sbjct: 67 IVKYKGV---CYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLL-LYASQICKGM 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++ R +H DL NIL+ S VK+ DFG
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIG---------------------------DFGL 154
Query: 268 TTFEHQDHSYVV------STRHYRAPEVILGLGWNYPCDLWSVGCILVEL-------CSG 314
T QD Y S + APE + ++ D+WS G +L EL CS
Sbjct: 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214
Query: 315 EALF 318
A F
Sbjct: 215 PAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 51/231 (22%), Positives = 97/231 (41%), Gaps = 38/231 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
YR+L G+G FG+V C ++ A K + + I K + AM E +L++
Sbjct: 5 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK----- 56
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ V + ++ ++ +C+V + G L + F + ++ +
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H R+++ DLKPENILL ++++ D L+ +G +
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLG-LAVEIPEGETIRGR-------------- 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
V T Y APEV+ + + D W +GC++ E+ G++ F+
Sbjct: 162 ----------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 38/228 (16%)
Query: 92 PR--YRILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLAR 147
PR + + K+G G FG+V E + N + VAIKI++S + ++ E+ L+RL R
Sbjct: 4 PREEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-R 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + + + I+ E + SL FLR + P+ + ++ Q+ E
Sbjct: 61 HK----HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYV-KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+A++ E IH DL NI LV + V KV D+ L+R K+ Y L I
Sbjct: 117 MAYLEEQNSIHRDLAARNI-LVGEDLVCKVADFG-LARLIKEDVY---LSSDKKIPY--- 168
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE ++ D+WS G +L E+ +
Sbjct: 169 -----------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 46/221 (20%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
+G G++ +V+ + ++ A+K+V+ + + + + + + V +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 160 NWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
+ F + + +V E + G ++ R+ R P + R ++ ++ F+HE +I+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DLK +N+LL + ++K+ DY K+G + G TT S
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGM----CKEG--------------LGPGDTT------ST 155
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
T +Y APE++ G + + D W++G ++ E+ +G + F
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 64/260 (24%), Positives = 100/260 (38%), Gaps = 78/260 (30%)
Query: 100 MGEGTFGQVVECFDNEK--KEL-VAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
+G G FG VV+ K KE+ VA+K ++ I ++ + E V+ +L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53
Query: 155 CVQIRNWFDYRNHICIV----------------FEKLGPSLYDFLRKNSYRSFPIDLVRE 198
+H CIV LGP L +L+K R P+ ++E
Sbjct: 54 -----------DHPCIVRLIGVCKGEPLMLVMELAPLGP-LLKYLKKR--REIPVSDLKE 99
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
L Q+ +A++ +H DL N+LLV+ K+ D+ +SR+ GS
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFG-MSRALGAGS--------- 149
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELC 312
Y +T R APE I ++ D+WS G L E
Sbjct: 150 -----------------DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192
Query: 313 S-GEALFQTHENLEHLAMME 331
S G + + E +AM+E
Sbjct: 193 SYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 54/268 (20%)
Query: 94 YRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRL 145
+ +L +G G +G+V + ++ +L A+K+++ K E E VL+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
R V + F + ++ + + G L+ L + + F VR +++
Sbjct: 62 RRCPF----LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIAEIV 115
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
++ +H+L +I+ D+K ENILL +G + L D
Sbjct: 116 LALDHLHQLGIIYRDIKLENILL-----------------DSEGH----------VVLTD 148
Query: 265 FG-STTF----EHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEAL 317
FG S F E + +S+ T Y APEVI G G + D WS+G + EL +G +
Sbjct: 149 FGLSKEFLAEEEERAYSF-CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
Query: 318 FQTH-ENLEHLAMMERVLG---PLPHHM 341
F E + R+L P P M
Sbjct: 208 FTVDGEQNSQSEISRRILKSKPPFPKTM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 36/231 (15%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRL--AR 147
+R L+ +G G FG+V+ + EL AIK ++ E+ M E + + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
H V + F +H+C V E + D + F ++ +
Sbjct: 61 HPF----LVNLFACFQTEDHVCFVMEYA--AGGDLMMHIHTDVFSEPRAVFYAACVVLGL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++HE ++++ DLK +N+LL + +VK+ D+ K+G + FG
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL----CKEG--------------MGFGD 156
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
T S T + APEV+ + D W +G ++ E+ GE+ F
Sbjct: 157 RT------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 48/234 (20%)
Query: 13 NMDKRPRKRPRLTWDVP---PPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
RPR+RP LT +P P L P LP P + SS +
Sbjct: 19 TTKSRPRRRPDLTLPLPQRDPSLAVPLPLP-------------PPSSSSSSSSSSSASGS 65
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
+P +L+ R+ +++G G G V + L A+K++
Sbjct: 66 APSAAK-------------SLSELERV-NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 128 INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS 187
+ R EI++L R H V+ + FD+ I ++ E F+ S
Sbjct: 112 EDTVRRQICREIEIL-RDVNH----PNVVKCHDMFDHNGEIQVLLE--------FMDGGS 158
Query: 188 YRSFPIDLVREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
I + L RQ+L +A++H ++H D+KP N+L+ SA+ VK+ D+
Sbjct: 159 LEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 56/292 (19%)
Query: 100 MGEGTFGQVVEC-FDNE---KKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIGGT 153
+GEG FG+V C +D E E VA+K ++ + A + EI++L+ L +I
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 154 R--CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVA 208
+ C + D N I ++ E L SL ++L +N + I+L ++L Q+ + +
Sbjct: 72 KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMD 123
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++ + +H DL N+L+ S VK+ D+ D Y+ +K D S
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-------TVK-DDLDSP 175
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL---CSGEALFQTHENLE 325
F + APE ++ + D+WS G L EL C E+
Sbjct: 176 VF-------------WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES--------S 214
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVW 375
+ + +++GP M + R + G RL P MR W
Sbjct: 215 PMTLFLKMIGPTHGQMTV---TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCW 263
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
Y ++ ++G GT+G V + + EL A+KI++ + + ++I EI +++ +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIFMVKECKHCNI- 68
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
V + R + I E G SL D + + P+ + + R+ L+ +A
Sbjct: 69 ----VAYFGSYLSREKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLA 120
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H +H D+K NILL VK+ D+ ++ + + K+
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF-------------- 166
Query: 269 TFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVEL 311
+ T ++ APEV G+N CD+W+VG +EL
Sbjct: 167 ----------IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 42/149 (28%), Positives = 62/149 (41%), Gaps = 37/149 (24%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDL--VRELGRQLLESVAFMHELRLIHTDLKPENIL 226
C+V K LY +L R P+ L V + RQLL ++ ++H +IH D+K EN+L
Sbjct: 236 CLVLPKYRSDLYTYL---GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292
Query: 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVST 281
+ N P+ I L DFG+ F S + T
Sbjct: 293 V-------------------------NGPED--ICLGDFGAACFARGSWSTPFHYGIAGT 325
Query: 282 RHYRAPEVILGLGWNYPCDLWSVGCILVE 310
APEV+ G + D+WS G ++ E
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 30/121 (24%), Positives = 53/121 (43%), Gaps = 27/121 (22%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
+++ ++ +H + IH D+KP+N+LL + ++K+ D+ + +G
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV----------- 198
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL 317
D + V T Y +PEV+ G + CD WSVG L E+ G+
Sbjct: 199 ----------RCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 318 F 318
F
Sbjct: 247 F 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 51/232 (21%), Positives = 100/232 (43%), Gaps = 38/232 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+YR+L G+G FG+V C ++ A K + + I K + +M E +L+++
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V + ++ ++ +C+V + G L + F + ++L +
Sbjct: 61 FV-----VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H ++ DLKPENILL ++++ D + +P+ +I+ G
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK----------IPEGESIR----GR 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
V T Y APEV+ + D W +GC++ E+ G++ F+
Sbjct: 162 -----------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 25/114 (21%)
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H+ +I+ DLKPENILL + +VK+ D+ L K S I G+ T
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDF--------------GLCKES----IHEGTVT 157
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
H++ T Y APE+++ G D WS+G ++ ++ +G F T EN
Sbjct: 158 -----HTF-CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 53/245 (21%), Positives = 100/245 (40%), Gaps = 60/245 (24%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
YR+L G+G FG+V C ++ A K + + I K + AM E +L++
Sbjct: 5 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK----- 56
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE------------KLGPSLYDFLRKNSYRSFPIDLVR 197
+ V + ++ ++ +C+V +G +D R Y +
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA------- 109
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
+L + + R+++ DLKPENILL ++++ D + +P+
Sbjct: 110 ----ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ----------IPEG 155
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
++ G V T Y APEVI + + D W +GC++ E+ G++
Sbjct: 156 ETVR----GR-----------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
Query: 318 FQTHE 322
F+ +
Sbjct: 201 FRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 58/238 (24%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-----EAAMI--EIDVLQRLA 146
+ IL +G G FG+V ++ A+KI +NK+ E A E DVL
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKI---LNKWEMLKRAETACFREERDVLVNGD 59
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
R I + F N++ +V + +G L L K R P D+ R +++
Sbjct: 60 RRWI-----TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVL 113
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ +H+L +H D+KP+N+LL ++++ D+ S ++L+
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADF------------------GSCLRLLAD 155
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLG-----WNYPCDLWSVGCILVELCSGEALF 318
G+ + V T Y +PE++ + + CD WS+G + E+ GE F
Sbjct: 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 35/246 (14%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
L ++G G FG VV+ + VAIK+++ + + + E V+ +L+ +
Sbjct: 8 FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL----- 61
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
VQ+ + I IV E + L ++LR++ R P L+ E+ + + E +A++ +
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLESKQ 120
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
IH DL N L+ VKV D+ LSR D Y ++ ++
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFG-LSRYVLDDEYTSSVGSKFPVR------------- 166
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA---LFQTHENLEHLAMM 330
+ PEV+L ++ D+W+ G ++ E+ S G+ F E +E ++
Sbjct: 167 ---------WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
Query: 331 ERVLGP 336
R+ P
Sbjct: 218 LRLYRP 223
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 52/231 (22%)
Query: 100 MGEGTFGQVVE--CFDNEKKEL---VAIKIVRSINKY--REAAMIEIDVLQRLARHDIGG 152
+G G FG+VVE + K + VA+K+++ REA M E+ ++ L H+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99
Query: 153 TRCVQIRNWFDYRNH---ICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I N I ++ E G L +FLR+ ++ + Q+ + +
Sbjct: 100 ----NIVNLLGACTIGGPILVITEYCCYG-DLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
AF+ IH DL N+LL + VK+ D+ L+R +
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFG-LARDIMN-------------------- 193
Query: 268 TTFEHQDHSYVV--STR---HYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
D +YVV + R + APE I + + D+WS G +L E+ S
Sbjct: 194 ------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 55/239 (23%), Positives = 103/239 (43%), Gaps = 32/239 (13%)
Query: 99 KMGEGTFGQVVE-CFDNEKKEL-VAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + + KK++ VAIK++++ N+ R+ M E +++ +L I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI---- 57
Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V++ + + ++ G L FL + V EL Q+ + ++
Sbjct: 58 -VRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+H DL N+LLV+ Y K+ D+ D SY+K +S G +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARS-------AGKWPLK--- 163
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
+ APE I ++ D+WS G + E S G+ ++ + E ++ +E+
Sbjct: 164 ---------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 31/130 (23%), Positives = 60/130 (46%), Gaps = 24/130 (18%)
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
R P + R ++ ++ F+HE +I+ DLK +N+LL + ++K+ DY + G
Sbjct: 91 RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG 150
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
++TF T +Y APE++ G + + D W++G ++
Sbjct: 151 DT----------------TSTF--------CGTPNYIAPEILRGEDYGFSVDWWALGVLM 186
Query: 309 VELCSGEALF 318
E+ +G + F
Sbjct: 187 FEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 36/233 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ E L A+K+++ + E M E +L H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
Q+ F + + V E + G L ++K+ R F R ++ ++ F+H+
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+I+ DLK +N+LL + K+ D+ +G ++TF
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT----------------TSTF---- 156
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
T Y APE++ + + D W++G +L E+ G A F+ EN + L
Sbjct: 157 ----CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G G FG+V C + ++ A+K + + + A+ E +L ++ D C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
+ F + +C + + + G L+ L ++ F +R +++ + MH
Sbjct: 62 MTYA--FHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF 117
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLKP NILL +V++ D SK P +S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHAS---------------- 155
Query: 275 HSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
V T Y APEV+ G ++ D +S+GC+L +L G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 56/273 (20%), Positives = 94/273 (34%), Gaps = 89/273 (32%)
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + + + + +V + G L+ + K + + P + V+ +++ ++ +H
Sbjct: 48 VCLHKYIVSEDSVFLVLQHAEGGKLWSHISK--FLNIPEECVKRWAAEMVVALDALHREG 105
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
++ DL P NILL ++++ +YF + E
Sbjct: 106 IVCRDLNPNNILLDDRGHIQL-------------TYFSRW-------------SEVEDSC 139
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 334
V Y APEV CD WS+G IL EL +G+ L + H
Sbjct: 140 DGEAVE-NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH------------- 185
Query: 335 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394
P G + + L +P + V A
Sbjct: 186 ---------------------------PSGINTHTT-------LNIP----EWVSEEARS 207
Query: 395 LIDLLQGLLRYDPAERLKAREA-----LRHPFF 422
L+ Q LL+++P ERL A A HPFF
Sbjct: 208 LL---QQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 56/262 (21%), Positives = 97/262 (37%), Gaps = 81/262 (30%)
Query: 170 IVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENIL 226
I E + SL F +K + + P D++ ++ +++++ ++H L +IH D+KP N+L
Sbjct: 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136
Query: 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRA 286
+ VK+ D+ L S A K ID G + Y A
Sbjct: 137 INRNGQVKLCDF----------GISGYLVDSVA-KTIDAGC--------------KPYMA 171
Query: 287 PEVILG----LGWNYPCDLWSVGCILVELCSGEALFQT-HENLEHLAMMERVLGPLPHHM 341
PE I G++ D+WS+G ++EL +G + + + L + V P P
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV--VEEPSP--- 226
Query: 342 VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401
+LP + + + D +
Sbjct: 227 -------------------------------------QLPA------EKFSPEFQDFVNK 243
Query: 402 LLRYDPAERLKAREALRHPFFT 423
L+ + ER E L+HPFF
Sbjct: 244 CLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 40/234 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
Y ++ +G G FG+V +++ A+K++ K ++A E D++
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 99
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
VQ+ F ++ +V E + G L + + S P R +++ ++
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALD 156
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H + IH D+KP+N+LL + ++K+ D+ + +K+G +
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-------------- 202
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 318
V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 203 ---------AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 39/246 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ E+ AIK+++ + + M E +L A+H
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+ F ++ + V E + G ++ R R F R ++ ++ F+H
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+I+ DLK +NILL + + K+ D+ +G +TTF
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT----------------TTTF--- 156
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT--HENLEHLAMME 331
T Y APE++ L + D W++G ++ E+ +G+ F+ ++L + +
Sbjct: 157 -----CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
Query: 332 RVLGPL 337
VL P+
Sbjct: 212 DVLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 51/219 (23%), Positives = 79/219 (36%), Gaps = 79/219 (36%)
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
MH +++ DLKP NILL +V++ D + K P +S
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHAS----------- 155
Query: 270 FEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
V T Y APEV+ G+ ++ D +S+GC+L +L G + F+ H+ +
Sbjct: 156 ---------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ DR ++ PD +
Sbjct: 207 I----------------DRMTLT-----MAVELPDSFSP--------------------- 224
Query: 389 DHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
+L LL+GLL+ D RL A+E HPFF
Sbjct: 225 -----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 37/228 (16%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGG 152
L +G+G+FG+V+ EL AIKI++ + E M+E VL +
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF-- 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
Q+ + F + + V E + G +Y + ++ P + ++ + F+
Sbjct: 63 --LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-PQAVF--YAAEISVGLFFL 117
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H +I+ DLK +N++L S ++K+ D+ DG + TF
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----------------VTTRTF 161
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
T Y APE+I + D W+ G +L E+ +G+ F
Sbjct: 162 --------CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 52/240 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
Y ++ +G G FG+V +++ A+K++ K ++A E D++
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 99
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
VQ+ F ++ +V E + G L + + S P + +++ ++
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALD 156
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS- 267
+H + LIH D+KP+N+LL K +KL DFG+
Sbjct: 157 AIHSMGLIHRDVKPDNMLL---------------------------DKHGHLKLADFGTC 189
Query: 268 -----TTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 318
T D + V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 190 MKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
+S++G G G V + ++A K++ K R + E+ VL H+
Sbjct: 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPY 64
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V F I I E + G SL L+K P ++ ++ +++ + ++ E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK 122
Query: 214 -RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+++H D+KP NIL+ S +K+ D+ + +LID + +F
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQLIDSMANSF-- 162
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
V TR Y +PE + G ++ D+WS+G LVE+ G
Sbjct: 163 ------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 55/235 (23%), Positives = 103/235 (43%), Gaps = 39/235 (16%)
Query: 94 YRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR-LARHD 149
+ +L +G G +G+V + ++ +L A+K+++ ++A +E +R + H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V + F + ++ + + G ++ L + F D VR +++ ++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALE 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
+H+L +++ D+K ENILL S +V L DFG S
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHV---------------------------VLTDFGLS 152
Query: 268 TTF--EHQDHSY-VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
F E ++ +Y T Y APE+I G G D WS+G ++ EL +G + F
Sbjct: 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL AIKI++ + E M+E VL +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
Q+ + F + + V E + G +Y + ++ + E+ L
Sbjct: 62 F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF-- 115
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
F+H +I+ DLK +N++L S ++K+ D+ + DG K
Sbjct: 116 --FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-------------- 159
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
TF T Y APE+I + D W+ G +L E+ +G+A F+ + E
Sbjct: 160 --TF--------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 53/238 (22%), Positives = 96/238 (40%), Gaps = 32/238 (13%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
+ ++G G FG VV + VAIK + E + E V+ +L+ + V
Sbjct: 9 MKELGSGQFG-VVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-----PKLV 62
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
Q+ + + IV E + L ++LR+ D++ + + + E + ++
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
IH DL N L+ S VKV D+ ++R D Y + +K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFG-MTRYVLDDEYTSSSGAKFPVK-------------- 166
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
+ PEV ++ D+WS G ++ E+ + G+ F+ N E + M+ R
Sbjct: 167 --------WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 47/246 (19%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID------VLQRLARHDI 150
L ++G G FG VV K VAIK++R E AM E D V+ +L+ ++
Sbjct: 9 LKELGSGQFG-VVHLGKWRGKIDVAIKMIR------EGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
VQ+ + I IV E G L ++LR+ + + + ++ + E++
Sbjct: 62 -----VQLYGVCTKQRPIFIVTEYMANG-CLLNYLRERKGK-LGTEWLLDMCSDVCEAME 114
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++ IH DL N L+ VKV D+ L+R D Y + +K
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFG-LARYVLDDQYTSSQGTKFPVK------- 166
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+ PEV ++ D+WS G ++ E+ S + +E +
Sbjct: 167 ---------------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM--PYERFSNSE 209
Query: 329 MMERVL 334
++E V
Sbjct: 210 VVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 39/142 (27%), Positives = 61/142 (42%), Gaps = 27/142 (19%)
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+L FLR+N + I LV L R + + ++ E+ +H DL NIL+ S KV D
Sbjct: 91 ALDSFLRQNDGQFTVIQLVGML-RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 238 Y---KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
+ +FL + D +Y +L I+ + APE I
Sbjct: 150 FGLSRFLEDDTSDPTYTSSLGGKIPIR----------------------WTAPEAIAYRK 187
Query: 295 WNYPCDLWSVGCILVELCS-GE 315
+ D+WS G ++ E+ S GE
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 37/191 (19%)
Query: 92 PRYRIL--SKMGEGTFGQVVEC---------------FDNEKKELVAIKIVRS-INKY-R 132
PR ++ K+GEG FG+V C FD + LVA+K++R+ + K R
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDG-QPVLVAVKMLRADVTKTAR 61
Query: 133 EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK------ 185
+ EI ++ RL +I V + + + +C++ E + L FL +
Sbjct: 62 NDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIEST 116
Query: 186 ----NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
N+ S I + + Q+ + ++ L +H DL N L+ + +K+ D+ +
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG-M 175
Query: 242 SRSSKDGSYFK 252
SR+ G Y++
Sbjct: 176 SRNLYSGDYYR 186
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 28/168 (16%)
Query: 100 MGEGTFGQVVECF--DNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTR 154
+GEG FGQV+ + K AIK+++ S N +R+ A E++VL +L H
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG-ELEVLCKLGHH----PN 64
Query: 155 CVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG-------RQLLE 205
+ + + R ++ I E P +L DFLRK+ +E G +QLL+
Sbjct: 65 IINLLGACENRGYLYIAIE-YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 206 -------SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
+ ++ E + IH DL N+L+ K+ D+ LSR +
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFG-LSRGEE 170
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 50/233 (21%), Positives = 96/233 (41%), Gaps = 48/233 (20%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGG 152
+L ++G+G +G V + +A+K +R +K+ + M E+D+L + I
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYI-- 61
Query: 153 TRCVQIRNWFDYRN--HICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V F ++C+ + G LY + P D++R + +++ +
Sbjct: 62 ---VDFYGAFFIEGAVYMCMEYMDAGSLDKLYA--GGVATEGIPEDVLRRITYAVVKGLK 116
Query: 209 FMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
F+ E +IH D+KP N+L+ VK+ D+ G+ +L K++
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV------SGNLVASLAKTN--------- 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVELCSG 314
+ + Y APE I G + D+WS+G ++E+ G
Sbjct: 162 -----------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 38/142 (26%), Positives = 58/142 (40%), Gaps = 37/142 (26%)
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H+L +I+ D+K ENILL S +G + L DFG +
Sbjct: 121 LHKLGIIYRDIKLENILLDS-----------------NGH----------VVLTDFGLSK 153
Query: 270 FEHQDHSY----VVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTH-E 322
H+D T Y AP+++ G G + D WS+G ++ EL +G + F E
Sbjct: 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
Query: 323 NLEHLAMMERVLG---PLPHHM 341
+ R+L P P M
Sbjct: 214 KNSQAEISRRILKSEPPYPQEM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 65/246 (26%)
Query: 100 MGEGTFGQVVECFDNEKKEL-----VAIKIVR---SINKYREAAMIEIDVLQRLARHDI- 150
+GEG FG+VV+ K VA+K+++ S ++ R + E ++L+++ +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR-DLLSEFNLLKQVNHPHVI 66
Query: 151 ---GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR---------------KNSY---- 188
G C Q D + + + K G SL FLR +NS
Sbjct: 67 KLYGA--CSQ-----DGPLLLIVEYAKYG-SLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 189 ---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
R+ + + Q+ + ++ E++L+H DL N+L+ +K+ D+
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
++ SY K +K + S DH Y + D+WS G
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLF----DHIYTTQS------------------DVWSFG 216
Query: 306 CILVEL 311
+L E+
Sbjct: 217 VLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 42/141 (29%), Positives = 63/141 (44%), Gaps = 29/141 (20%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+L +V +H +IH D+K NILL S VK+ D+ F K A
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF--------------SKMYAAT 196
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
+ D TF T +Y APE+ ++ D++S+G +L EL + + F
Sbjct: 197 VSDDVGRTF--------CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG- 247
Query: 322 ENLEHLAMMERVLG----PLP 338
EN+E + M + L PLP
Sbjct: 248 ENMEEV--MHKTLAGRYDPLP 266
|
Length = 496 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 37/231 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL AIKI++ + E M+E VL +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-- 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
Q+ + F + + V E + G +Y + ++ P + ++ +
Sbjct: 60 --PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE-PHAVF--YAAEIAIGL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
F+H +I+ DLK +N++L + ++K+ D+ + G +
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--------------- 159
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
TF T Y APE+I + D W+ G +L E+ +G+ F
Sbjct: 160 -TF--------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 37/218 (16%)
Query: 98 SKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
+ +G+G FG V+ + +K VA+K ++ + +A + E V+ L RH V
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK---VAVKCLKDDSTAAQAFLAEASVMTTL-RHP----NLV 63
Query: 157 QIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
Q+ N + IV E + SL D+LR + + E + ++ E
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
+H DL N+L+ KV D+ L++ + G LP +K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFG-LAKEASQGQDSGKLP----VK-------------- 164
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE + ++ D+WS G +L E+ S
Sbjct: 165 --------WTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 28/168 (16%)
Query: 100 MGEGTFGQVVECFDNEK--KELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTR 154
+GEG FGQV++ + + AIK ++ S + +R+ A E++VL +L H
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEVLCKLGHH----PN 57
Query: 155 CVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG-------RQLLE 205
+ + ++R ++ + E P +L DFLRK+ +QLL
Sbjct: 58 IINLLGACEHRGYLYLAIE-YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 206 -------SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
+ ++ + + IH DL NIL+ K+ D+ LSR +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG-LSRGQE 163
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 64/227 (28%), Positives = 91/227 (40%), Gaps = 48/227 (21%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD-----IG 151
K+G+G FG V + E VA+K RS + + E ++L++ H IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59
Query: 152 GTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
CVQ + I IV E G SL FLRK R V++L + L++ A M
Sbjct: 60 --VCVQ-------KQPIYIVMELVPGGSLLTFLRKKKNRL----TVKKLLQMSLDAAAGM 106
Query: 211 HELR---LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
L IH DL N L+ +K+ D+ +SR + G Y S +K I
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFG-MSREEEGGIY----TVSDGLKQIPIKW 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
T APE + + D+WS G +L E S
Sbjct: 162 T-----------------APEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 34/133 (25%), Positives = 60/133 (45%), Gaps = 25/133 (18%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q++ ++ +H +++H DLK NI L+ +K+ D+ F + S S
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS------------ 224
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
+D S+ T +Y APE+ ++ D+WS+G IL EL + F+
Sbjct: 225 -LDVASS---------FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274
Query: 322 ENLEHLAMMERVL 334
E +M++VL
Sbjct: 275 SQRE---IMQQVL 284
|
Length = 478 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 23/133 (17%)
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L D++R+N R DL+ Q+ + ++++ E+RL+H DL N+L+ S +VK+ D+
Sbjct: 95 LLDYVRENKDRIGSQDLL-NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDF 153
Query: 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP 298
+L+D T + H D V + A E IL + +
Sbjct: 154 GL-------------------ARLLDIDETEY-HADGGKV--PIKWMALESILHRRFTHQ 191
Query: 299 CDLWSVGCILVEL 311
D+WS G + EL
Sbjct: 192 SDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 168 ICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225
+ IV E LG L +L+ N Y S + + QL ++A++ R +H D+ N+
Sbjct: 81 VWIVMELAPLG-ELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV 138
Query: 226 LLVSAEYVKVPDYKFLSRSSKDGSYFK 252
L+ S + VK+ D+ LSR +D SY+K
Sbjct: 139 LVSSPDCVKLGDFG-LSRYLEDESYYK 164
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 56/267 (20%), Positives = 95/267 (35%), Gaps = 104/267 (38%)
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
+++ + RQ+L ++ +H ++H D+KP+NI+
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS-------------------------- 289
Query: 255 PKSSAIKLIDFGSTT-----FEHQDHSYVVSTRHYRAPE---------------VILGLG 294
S + K+ID G+ + +++ R Y APE V L
Sbjct: 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPR-YAAPEQYIMSTQTPSAPSAPVATALS 348
Query: 295 ---W--NYP--CDLWSVGCILVELC-----SGEALFQTHENLEH----LAMMERVLGPLP 338
W N P D++S G I +++ S L Q + L+ L +++ P
Sbjct: 349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-- 406
Query: 339 HHMVIRADRRAEKYFRRGAR-LDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397
RA RRG LD GA W +
Sbjct: 407 ---------RASPDLRRGFEVLDLDGGAG--------W---------------------E 428
Query: 398 LLQGLLRYDPAERLKAREALRHPFFTR 424
LL+ ++R+ +R+ A+ AL HP+F R
Sbjct: 429 LLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 36/148 (24%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDIG 151
I+ + G FG+V +L A+K+V+ INK + E D L L++
Sbjct: 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPF- 65
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + N++ +V E L G + L Y F ++ + ++ ++ ++
Sbjct: 66 ---IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYL 120
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H +IH DLKP+N+L+ + ++K+ D+
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 34/233 (14%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
+G G FG+V K+ VAIK ++ K R+ + E ++ + + H+I
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI---- 68
Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYD-FLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+++ I+ E + D +LR + LV L R + + ++ ++
Sbjct: 69 -IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+H DL NIL+ S KV D+ LSR L D T+
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFG-LSRV-----------------LEDDPEGTYTTS 168
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
+ + APE I + D+WS G ++ E+ S GE + N E
Sbjct: 169 GGKIPI---RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 42/248 (16%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+G G +G+V E + VA+K ++ E + E V++ + ++ VQ+
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQL 67
Query: 159 RNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
I+ E + +L D+LR+ + + ++ + Q+ ++ ++ + IH
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DL N L+ VKV D+ LSR +Y + IK
Sbjct: 128 RDLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK---------------- 170
Query: 278 VVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCS-------GEALFQTHENLEHL 327
+ APE L +N D+W+ G +L E+ + G L Q +E LE
Sbjct: 171 ------WTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221
Query: 328 AMMERVLG 335
MER G
Sbjct: 222 YRMERPEG 229
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 38/141 (26%), Positives = 56/141 (39%), Gaps = 28/141 (19%)
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
SL FLR+N + LV L R + + ++ E+ +H DL NIL+ S KV D
Sbjct: 91 SLDKFLRENDGKFTVGQLVGML-RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 238 YKFLSR--SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
+ LSR + +Y K + APE I +
Sbjct: 150 FG-LSRRLEDSEATYTTKGGKIPI-----------------------RWTAPEAIAYRKF 185
Query: 296 NYPCDLWSVGCILVELCS-GE 315
D+WS G ++ E+ S GE
Sbjct: 186 TSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 433 | |||
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.2 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.85 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.42 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.33 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.29 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.12 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.86 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.86 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.82 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.64 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.51 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.38 | |
| PLN02236 | 344 | choline kinase | 97.3 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.22 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.21 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.07 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.05 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.94 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.91 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.83 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.77 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.49 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.26 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.98 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.98 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.91 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.88 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.84 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.65 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.5 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 95.39 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-65 Score=456.75 Aligned_cols=349 Identities=60% Similarity=1.045 Sum_probs=313.1
Q ss_pred CCCCCCCCCCCCCCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH
Q 013941 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL 145 (433)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l 145 (433)
.+...+++.+++..|+|.+..|+.+.++|.+++.||+|.||.|..+.+..++..||||+++...+.++..+.|+++|+++
T Consensus 63 ~~~~~~~~~~dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki 142 (415)
T KOG0671|consen 63 ARLESRPGRPDDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKI 142 (415)
T ss_pred ccccCCCCCCCCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 56677788889999999999999999999999999999999999999999999999999999889999999999999999
Q ss_pred HhCC-CCCcceeEecceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCc
Q 013941 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (433)
Q Consensus 146 ~~~~-i~~~~~v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~N 224 (433)
.+.. -+...|+.+.+||+..++.|||+|.+|.++.+++..+....++...++.++.||+++++|||+.+++|-||||+|
T Consensus 143 ~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN 222 (415)
T KOG0671|consen 143 NESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN 222 (415)
T ss_pred HhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence 7655 455678999999999999999999999999999999988999999999999999999999999999999999999
Q ss_pred EEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHH
Q 013941 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (433)
Q Consensus 225 Ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (433)
||+.+..+.++.+.+.. ..+....++..++|+|||.|....+..++++.|..|+|||++.+.+++.++||||+
T Consensus 223 ILfvss~~~~~~~~k~~-------~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 223 ILFVSSEYFKTYNPKKK-------VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred EEEeccceEEEeccCCc-------cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceee
Confidence 99998887776554432 12223445668999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 305 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
||||+|+++|...|++.++.+++++|++++|++|..++.+.. .++|+..+ +++|++....++ .+..++..+.....
T Consensus 296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~--~~Kyf~~~-rldw~e~~~~~~-~k~v~~~ckpl~~~ 371 (415)
T KOG0671|consen 296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR--KEKYFRRG-RLDWPEVSSKGK-SKYVFEPCKPLKKY 371 (415)
T ss_pred eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh--hHhhhhcc-cccCcccccccc-chhhhcCCccHHHH
Confidence 999999999999999999999999999999999999887765 78899988 999999887776 55555555555566
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
....+.....+.|||++||.+||++|+|+.|+|.||||+.-
T Consensus 372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred hccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 66666677789999999999999999999999999999863
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-59 Score=450.12 Aligned_cols=324 Identities=40% Similarity=0.699 Sum_probs=272.5
Q ss_pred CCCCCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCc
Q 013941 75 PDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGT 153 (433)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~ 153 (433)
.++.++.|.+..++.+..+|.|.+.||+|+||.|.+|.+..|++.||||++++......+...|+.+|..|+ |.+-...
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~ 248 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY 248 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 455677899999999999999999999999999999999999999999999998888889999999999999 6666678
Q ss_pred ceeEecceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
|+|+++++|.+.+|+|||+|.++.+|+++++.+....++...++.++.||+.||.+||+.||||+||||||||+.+.
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--- 325 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--- 325 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC---
Confidence 99999999999999999999999999999999988899999999999999999999999999999999999999764
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 313 (433)
.+..+||+|||+|.......-+.+.+..|+|||++.|.+|+.+.||||||||++||++
T Consensus 326 ----------------------~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t 383 (586)
T KOG0667|consen 326 ----------------------KRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFT 383 (586)
T ss_pred ----------------------CcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhc
Confidence 3448999999999998887777899999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcC-CccccCCCCCC----c-hhhHHHHH----HhcCch--
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR-GARLDWPDGAT----S-RDSMRAVW----KLLRLP-- 381 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~-~~~~~~~~----~~~~~~-- 381 (433)
|.+.|.+.+..+++..|.+++|.+|..++..+... .+||.+ ........... . ....+... .....+
T Consensus 384 G~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~-~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~ 462 (586)
T KOG0667|consen 384 GEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA-HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPG 462 (586)
T ss_pred CccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc-ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCC
Confidence 99999999999999999999998888888777555 455554 22222111111 0 00111111 111111
Q ss_pred --hhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 382 --NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 382 --~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
.............+.|||.+||.+||.+|+|+.|+|+||||+.
T Consensus 463 ~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 463 SRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred CcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 1111112244567899999999999999999999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-60 Score=432.46 Aligned_cols=260 Identities=30% Similarity=0.492 Sum_probs=220.5
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh--------hHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
.+.+.|.+.+.||+|+||.|-+|..+.||+.||||++++... ......+|++||++|+||+| |++++
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~I-----V~~~d 243 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNI-----VRIKD 243 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCE-----EEEee
Confidence 456679999999999999999999999999999999974321 22335789999999999988 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
+|+..+..||||||+ ||+|.+++-.++ .+.+...+.+++||+.||.|||++||+||||||+|||+..+.
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-------- 313 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-------- 313 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC--------
Confidence 999999999999999 999999998876 788999999999999999999999999999999999997642
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCCC---CCccchHHHHHHHHHHHHhC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~~g 314 (433)
.+..+||+|||+|+..+. ...+.|||+.|.|||++.+.. +..++|||||||+||-+++|
T Consensus 314 ----------------e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG 377 (475)
T KOG0615|consen 314 ----------------EDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG 377 (475)
T ss_pred ----------------cceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence 456799999999998853 346789999999999998765 33588999999999999999
Q ss_pred CCCCCCCChHH-HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 315 EALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 315 ~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
.+||.+..... ..++|.+....+- ...+..++.
T Consensus 378 ~pPFS~~~~~~sl~eQI~~G~y~f~----------------------------------------------p~~w~~Ise 411 (475)
T KOG0615|consen 378 YPPFSEEYTDPSLKEQILKGRYAFG----------------------------------------------PLQWDRISE 411 (475)
T ss_pred CCCcccccCCccHHHHHhcCccccc----------------------------------------------ChhhhhhhH
Confidence 99998765443 4444443221111 122356688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.++||.+||..||++|+|+.|+|+||||+..
T Consensus 412 ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred HHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 99999999999999999999999999999954
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-58 Score=438.03 Aligned_cols=257 Identities=32% Similarity=0.525 Sum_probs=230.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEecc----chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.+|...+.||+|||+.||.+++..+|+.||+|++.+ ....++...+||+|.+.|+|+|| |+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnI-----V~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNI-----VQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcE-----EeeeeEeecCCc
Confidence 579999999999999999999999999999999986 45677889999999999999888 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|||+|+| .++|..++.++. .++|.+++.+++||+.||.|||+++|||||||..|+|+++
T Consensus 93 VYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~----------------- 153 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE----------------- 153 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC-----------------
Confidence 99999999 999999998654 8999999999999999999999999999999999999854
Q ss_pred CCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
+..+||+|||+|.... +...+.|||+.|.|||++....++..+||||+|||||-||.|++||...+-
T Consensus 154 ----------~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 154 ----------NMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred ----------cCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 4578999999987765 455778999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+.+..|...-..+|. ..+.++++||.+||
T Consensus 224 kety~~Ik~~~Y~~P~--------------------------------------------------~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 224 KETYNKIKLNEYSMPS--------------------------------------------------HLSAEAKDLIRKLL 253 (592)
T ss_pred HHHHHHHHhcCccccc--------------------------------------------------ccCHHHHHHHHHHh
Confidence 8888888765555443 34778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCccccCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRDVRRCGFP 432 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~~~~~~~~ 432 (433)
+.||.+|||+++||.|+||++..-....|
T Consensus 254 ~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred cCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 99999999999999999997664444333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-57 Score=408.22 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=219.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEec--cchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC-eE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-HI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~-~~ 168 (433)
...+.++.||+|..|+||+|+++.|++.+|+|++. .......++.+|+++++..++++| |.+++.|...+ .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyI-----V~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYI-----VGFYGAFYSNGEEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe-----eeEeEEEEeCCceE
Confidence 35778899999999999999999999999999994 345667888999999999988877 99999999988 59
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+|||| +|+|.+++...+ .++|.....++.++++||.|||+ ++||||||||+|||+++.|
T Consensus 154 sI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG--------------- 216 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG--------------- 216 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC---------------
Confidence 9999999 999999998764 79999999999999999999995 9999999999999997766
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC--Ch
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH--EN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~--~~ 323 (433)
.+||||||.+..... ...+++||..|||||.+.+..|+.++||||||++++|+++|++||... ..
T Consensus 217 ------------eVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~ 284 (364)
T KOG0581|consen 217 ------------EVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY 284 (364)
T ss_pred ------------CEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC
Confidence 678888888776543 346689999999999999999999999999999999999999999774 23
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC-CchHHHHHHHHHh
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD-HSAGDLIDLLQGL 402 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~ 402 (433)
...+..+..++..+|+.+ +. .+|+++++||..|
T Consensus 285 ~~~~~Ll~~Iv~~ppP~l----------------------------------------------P~~~fS~ef~~FV~~C 318 (364)
T KOG0581|consen 285 LDIFELLCAIVDEPPPRL----------------------------------------------PEGEFSPEFRSFVSCC 318 (364)
T ss_pred CCHHHHHHHHhcCCCCCC----------------------------------------------CcccCCHHHHHHHHHH
Confidence 344555555554333311 12 3688999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCc
Q 013941 403 LRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
|++||.+|+|++|+++|||+++..
T Consensus 319 L~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 319 LRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred hcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999999653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-58 Score=421.81 Aligned_cols=283 Identities=31% Similarity=0.540 Sum_probs=234.1
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHH--HHHHHHHHHHHHH-hCCCCCcceeEecceeccCC
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~ 166 (433)
+.+||.++++||.|.||.||+|+...+++.||||.+++.-...+ .-.+|+..|++|+ |+|| +++.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpni-----ikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNI-----IKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcc-----hhhHHHhhccC
Confidence 45789999999999999999999999999999999975433233 3457999999999 8887 99999998877
Q ss_pred -eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 -HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 -~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+|||||..+|++++..+ ++.|++..++.|+.||++||+|+|.+|+.|||+||+||||..
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---------------- 145 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---------------- 145 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc----------------
Confidence 99999999999999999887 579999999999999999999999999999999999999953
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
+..+||+|||+|+...... +..+.|.+|+|||++... -|+.++||||+|||++|+.+-++.|.|.+
T Consensus 146 -----------~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 146 -----------NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred -----------cceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 3468999999998766544 447999999999998765 58999999999999999999999999999
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
+.+++..|..++|.+-...+..... ....-.+.+|.- .+..........+.++.+||.+|
T Consensus 215 E~Dqi~KIc~VLGtP~~~~~~eg~~-----La~~mnf~~P~~---------------~~~~l~~L~p~~s~~~~~li~~l 274 (538)
T KOG0661|consen 215 EIDQIYKICEVLGTPDKDSWPEGYN-----LASAMNFRFPQV---------------KPSPLKDLLPNASSEAASLIERL 274 (538)
T ss_pred HHHHHHHHHHHhCCCccccchhHHH-----HHHHhccCCCcC---------------CCCChHHhCcccCHHHHHHHHHH
Confidence 9999999999999876543332200 001111112110 01111222344788999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|.|||.+||||.|+|+||||+..
T Consensus 275 l~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 275 LAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hcCCCccCccHHHHhcCcccccc
Confidence 99999999999999999999975
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-57 Score=405.61 Aligned_cols=251 Identities=30% Similarity=0.506 Sum_probs=218.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+.|++++.||+|+||+||+++.+.+++.||+|++++.. ........|..||.+++||.| |.++..|++.+.
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFi-----v~l~ysFQt~~k 99 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFI-----VKLIYSFQTEEK 99 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcE-----eeeEEecccCCe
Confidence 46999999999999999999999999999999998643 345667789999999988888 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|||+||+ ||.|..+|++.+ .+++..++.++..|+.||.|||++|||||||||+|||++.+|+
T Consensus 100 LylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH-------------- 163 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH-------------- 163 (357)
T ss_pred EEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--------------
Confidence 99999999 999999999876 8999999999999999999999999999999999999987775
Q ss_pred CCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
++|+|||+++... ....+++||+.|||||++.+.+|+.++|+||||+++|||++|.+||.+.+.
T Consensus 164 -------------i~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 164 -------------IKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred -------------EEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 5666666665322 234557999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......|.+.....++ .-.+.++++||+++|
T Consensus 231 ~~~~~~I~~~k~~~~p-------------------------------------------------~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 231 KKMYDKILKGKLPLPP-------------------------------------------------GYLSEEARDLLKKLL 261 (357)
T ss_pred HHHHHHHhcCcCCCCC-------------------------------------------------ccCCHHHHHHHHHHh
Confidence 8877777654322111 124778999999999
Q ss_pred ccCCCCCC----CHHHHhcCCCCCCC
Q 013941 404 RYDPAERL----KAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~----ta~ell~hp~f~~~ 425 (433)
..||++|+ .++++.+||||.+.
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccC
Confidence 99999996 68999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-57 Score=393.36 Aligned_cols=282 Identities=31% Similarity=0.586 Sum_probs=232.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|+.+.++|+|+||+||+|+++.||+.||||++...+ ...+..++|++.|++++|+|+ |.++++|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NL-----VnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENL-----VNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchH-----HHHHHHHHhccee
Confidence 46999999999999999999999999999999986433 345778899999999999998 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||+|||..++.+-+.... ..++.+.++.+++|++.|+.|+|++++|||||||+||||+..|
T Consensus 77 hLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g----------------- 138 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG----------------- 138 (396)
T ss_pred EEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-----------------
Confidence 9999999888888888766 4699999999999999999999999999999999999998766
Q ss_pred CcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||||||+|+.... ..+..+.|.+|+|||++.+ ..|+..+||||+||++.||++|.+.|.+.++.
T Consensus 139 ----------vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi 208 (396)
T KOG0593|consen 139 ----------VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI 208 (396)
T ss_pred ----------cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence 567777777765542 2234689999999999998 57999999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+++..|...+|.++++...-... ..+| .|-++.-+...+ ....-....+..+.||+++||.
T Consensus 209 DQLy~I~ktLG~L~prhq~iF~~--N~~F-~Gv~lP~~~~~e----------------pLe~k~p~~s~~~ld~~k~cL~ 269 (396)
T KOG0593|consen 209 DQLYLIRKTLGNLIPRHQSIFSS--NPFF-HGVRLPEPEHPE----------------PLERKYPKISNVLLDLLKKCLK 269 (396)
T ss_pred HHHHHHHHHHcccCHHHHHHhcc--CCce-eeeecCCCCCcc----------------chhhhcccchHHHHHHHHHHhc
Confidence 99999999999988765332211 1111 122222222111 1111223456688999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
.||++|++.+|+|.|+||.+-
T Consensus 270 ~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 270 MDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CCccccccHHHHhcChHHHHH
Confidence 999999999999999999653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=411.82 Aligned_cols=266 Identities=26% Similarity=0.403 Sum_probs=225.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~ 165 (433)
..+|.+.+.||+|+|++|++|+++.+++.||||++.+.. ....-+.+|-.+|.+| .||+| ++++-.|+++
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgi-----vkLy~TFQD~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGI-----VKLYFTFQDE 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCe-----EEEEEEeecc
Confidence 356999999999999999999999999999999997532 2334566799999999 45555 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
..+|+|+||+ +|+|.++|.+.+ .|++..++.++.||+.||+|||++|||||||||+|||++.+++++|+|||-++..
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999 999999999886 8999999999999999999999999999999999999999888777777766554
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
........+.. ..........+++||..|.+||++.++..++.+|||+||||||.|+.|.+||.+.++.
T Consensus 225 ~~~~~~~~~~~-----------~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 225 SPSQKSQENPV-----------DPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred ChhhccccCcc-----------CcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 43321100000 0000111134579999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
..+..|+.+...+|+. .++.++|||+++|.
T Consensus 294 liFqkI~~l~y~fp~~--------------------------------------------------fp~~a~dLv~KLLv 323 (604)
T KOG0592|consen 294 LIFQKIQALDYEFPEG--------------------------------------------------FPEDARDLIKKLLV 323 (604)
T ss_pred HHHHHHHHhcccCCCC--------------------------------------------------CCHHHHHHHHHHHc
Confidence 9999999987777653 35689999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~ 424 (433)
.||.+|+|++||.+||||.+
T Consensus 324 ~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 324 RDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred cCccccccHHHHhhCccccc
Confidence 99999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=407.99 Aligned_cols=290 Identities=30% Similarity=0.485 Sum_probs=237.8
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
+..-.+.|+.+++||+|.||.||+|++..+|+.||+|.++... .......+||.||++|.|+|| +++.+...
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNI-----ikL~eivt 186 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNI-----IKLEEIVT 186 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcc-----cceeeEEE
Confidence 3344567999999999999999999999999999999998544 345567799999999999988 99999877
Q ss_pred cC--CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 164 YR--NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 164 ~~--~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
.. ..+|||+|||..+|..++...+ -.|++.+++.+++||+.||+|||++||+|||||.+||||+.+|
T Consensus 187 ~~~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G---------- 255 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG---------- 255 (560)
T ss_pred ecCCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC----------
Confidence 65 7899999999999999987644 4799999999999999999999999999999999999997666
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.+||+|||+|++.... .+..+-|.+|+|||++.|. .|+.++|+||.||||.||++|++
T Consensus 256 -----------------~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 256 -----------------VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred -----------------CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 5777888887754332 3446889999999999987 69999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
.|.+.++.+++..|.+++|.+.+..+... .+.+....... ........+.....+....
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~------------kLP~~~~~kp~---------~~y~r~l~E~~~~~~~~~l 377 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVS------------KLPHATIFKPQ---------QPYKRRLRETFKDFPASAL 377 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccc------------cCCcccccCCC---------CcccchHHHHhccCCHHHH
Confidence 99999999999999999999887654311 11111111000 1112222233456678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCccccC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRDVRRCG 430 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~ 430 (433)
+|+..||..||.+|.||.++|+|+||+.....|.
T Consensus 378 ~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~ 411 (560)
T KOG0600|consen 378 DLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCD 411 (560)
T ss_pred HHHHHHhccCccccccHHHHhcCcccccCCCCCC
Confidence 9999999999999999999999999977665553
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-55 Score=375.64 Aligned_cols=280 Identities=30% Similarity=0.550 Sum_probs=235.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+|...++||+|.||+||+|++..+|+.||||.++..+. ......+|++.|+.++|+|| +.++++|.+.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nI-----i~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNI-----IELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcch-----hhhhhhccCCCce
Confidence 478999999999999999999999999999999975432 34678899999999999888 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
-||+||+..+|...++.+. ..++..+++.++.++++||+|||++.|+||||||.|+||+++|
T Consensus 77 ~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g----------------- 138 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG----------------- 138 (318)
T ss_pred EEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-----------------
Confidence 9999999999999998665 5799999999999999999999999999999999999998776
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||+|+...... ...+-|.+|+|||++.|. .|+..+||||.|||+.||+.|.+-|.|.++.
T Consensus 139 ----------~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 139 ----------QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred ----------cEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 56777777776654332 223789999999999986 5999999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh-hccCCchHHHHHHHHHhc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM-QHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L 403 (433)
+++..|.+.+|.+-++ .||+-...++...-. ..+.... ......+.++.||+.+||
T Consensus 209 dQL~~If~~LGTP~~~-------------------~WP~~~~lpdY~~~~----~~P~~~~~~lf~aas~d~ldLl~~m~ 265 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTPD-------------------QWPEMTSLPDYVKIQ----QFPKPPLNNLFPAASSDALDLLSKML 265 (318)
T ss_pred HHHHHHHHHcCCCCcc-------------------cCccccccccHHHHh----cCCCCccccccccccHHHHHHHHhhh
Confidence 9999999999987643 455544444332221 1111111 134455778899999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 404 RYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.+||.+|+|+.|+|+|+||++...
T Consensus 266 ~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 266 TYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred ccCchhcccHHHHhcchhhhcCCC
Confidence 999999999999999999997543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=394.15 Aligned_cols=261 Identities=29% Similarity=0.488 Sum_probs=223.8
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|.+.++||+|+||+||+|+++.++..||||.+.+. .+..+.+..|+.+|+.++|+|| |.++++++.++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nI-----V~l~d~~~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNI-----VRLLDCIEDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcce-----eeEEEEEecCCe
Confidence 45799999999999999999999999999999998754 3456777899999999999888 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+||||||| ||+|.++++.++ .+++..++.++.||+.||++||+++||||||||+|||++....
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~-------------- 147 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR-------------- 147 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC--------------
Confidence 99999999 999999999886 8999999999999999999999999999999999999976421
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+....+||+|||+|+...... .+.+|++.|||||++....|+.|+|+||+|+|||+|++|+.||...+..
T Consensus 148 -------~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 148 -------NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred -------CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 0111578999999999876543 5679999999999999999999999999999999999999999988887
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+.+..+.+....+|. .....+..+.+|+...|+
T Consensus 221 eL~~~~~k~~~~~~~-----------------------------------------------~~~~~s~~~~~Ll~~ll~ 253 (429)
T KOG0595|consen 221 ELLLYIKKGNEIVPV-----------------------------------------------LPAELSNPLRELLISLLQ 253 (429)
T ss_pred HHHHHHhccccccCc-----------------------------------------------hhhhccCchhhhhhHHHh
Confidence 776655443221111 112335567799999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCc
Q 013941 405 YDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~~ 426 (433)
.||.+|.+..+-+.|+++..+.
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 254 RNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCccccCchHHhhhhhhcccCc
Confidence 9999999999999999998763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-55 Score=380.01 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=226.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||.|+||.|.+++++.+|..+|+|++.+.. +..+...+|..+|+.+.||.+ +++.+.+.+.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFl-----v~l~~t~~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFL-----VKLYGTFKDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCcee-----EEEEEeeccCCe
Confidence 46999999999999999999999999999999998644 345667789999999999887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+||||||. ||.|..++++.+ +|++..++.++.||+.||+|||+++|++|||||+|||++.+|
T Consensus 119 lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G--------------- 181 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG--------------- 181 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC---------------
Confidence 99999999 999999999876 899999999999999999999999999999999999997766
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||+|+......-+.|||+.|+|||++...+|+.++|+|||||++|||+.|.+||...+....
T Consensus 182 ------------~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 182 ------------HIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred ------------cEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 57888888888877777778999999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...|....-.+|. ..+.++++||.++|+.|
T Consensus 250 Y~KI~~~~v~fP~--------------------------------------------------~fs~~~kdLl~~LL~vD 279 (355)
T KOG0616|consen 250 YEKILEGKVKFPS--------------------------------------------------YFSSDAKDLLKKLLQVD 279 (355)
T ss_pred HHHHHhCcccCCc--------------------------------------------------ccCHHHHHHHHHHHhhh
Confidence 8888776555543 34779999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q 013941 407 PAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~-----ta~ell~hp~f~~~ 425 (433)
-++|. ..++|.+||||++-
T Consensus 280 ~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 280 LTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred hHhhhcCcCCCccccccCcccccc
Confidence 99994 57899999999963
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-54 Score=385.08 Aligned_cols=289 Identities=27% Similarity=0.466 Sum_probs=236.5
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
...+..+|..++.||+|+||.|+.|.++.+|+.||||.+.. .....+...+|+.+|+.++|+|| +.+.+++.
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNI-----i~l~di~~ 91 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENI-----IGLLDIFR 91 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCc-----ceEEeecc
Confidence 34556678889999999999999999999999999998862 33455778899999999999988 88888775
Q ss_pred c-----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 164 Y-----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 164 ~-----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
. -+.+|+|+|+|+.+|...++... .+++..++.+++||++||+|+|+.+|+||||||+|+|++.+.
T Consensus 92 p~~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c------- 162 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC------- 162 (359)
T ss_pred cccccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-------
Confidence 4 45799999999999999998764 699999999999999999999999999999999999997654
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCcccc-----CCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHH
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~ 312 (433)
.+||||||+|+... ...+..+.|.+|+|||++.. ..|+.++||||+|||+.||+
T Consensus 163 --------------------~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL 222 (359)
T KOG0660|consen 163 --------------------DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML 222 (359)
T ss_pred --------------------CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH
Confidence 56777888777663 22355688999999999875 47999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhh-hhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRAD-RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+|++.|.|.+..+++..|...+|.+++..+.... ..+..|...-.. ..+.......+..
T Consensus 223 ~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~--------------------~p~~~f~~~fp~a 282 (359)
T KOG0660|consen 223 TGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQ--------------------IPKQPFSSIFPNA 282 (359)
T ss_pred cCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCC--------------------CCCCCHHHHcCCC
Confidence 9999999999999999999999999887766543 223333322110 0011112234566
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
++.+.+|+.+||.+||.+|+|++|+|+||||..--...
T Consensus 283 ~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 283 NPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 88999999999999999999999999999998754333
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=380.88 Aligned_cols=286 Identities=27% Similarity=0.440 Sum_probs=232.1
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--C
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--R 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--~ 165 (433)
.+.|+.+++|++|+||.||+|+++.|++.||+|.++... ...-...+||.+|.+++|+|| |.+.++... -
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NI-----V~vkEVVvG~~~ 149 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNI-----VEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCe-----eeeEEEEecccc
Confidence 356999999999999999999999999999999997433 233467899999999999988 888887654 4
Q ss_pred CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
+.+|||||||..+|..++.... ..|...+++.++.|+++||+|||.+.|+|||||++|+|++..|
T Consensus 150 d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-------------- 214 (419)
T KOG0663|consen 150 DKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-------------- 214 (419)
T ss_pred ceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC--------------
Confidence 5799999999999999998776 5799999999999999999999999999999999999997666
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||+|+..+.. .+..+-|.+|+|||++.+. .|+.++|+||+|||+.||+++++.|.+.
T Consensus 215 -------------~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 215 -------------ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred -------------cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 5788888888876665 4556889999999999987 5999999999999999999999999999
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC-chHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQ 400 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~ 400 (433)
...+++..|.+.+|.+.+..+. .....+.............++...+... .+....+|+.
T Consensus 282 sE~dQl~~If~llGtPte~iwp-------------------g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln 342 (419)
T KOG0663|consen 282 SEIDQLDKIFKLLGTPSEAIWP-------------------GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLN 342 (419)
T ss_pred chHHHHHHHHHHhCCCccccCC-------------------CccccchhhccccCCCCchhhhhhccccccchhHHHHHH
Confidence 9999999999999988765433 2221111000000000111111111111 4678899999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
.+|.+||.+|.||+|.|+|.||.+....
T Consensus 343 ~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 343 KLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred HHhccCccccccHHHhhcccccccCCCC
Confidence 9999999999999999999999986443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=402.79 Aligned_cols=281 Identities=27% Similarity=0.423 Sum_probs=227.1
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.+.|++++.||+|+||.||+|+.+.||..||+|++++..- ..+.+..|-.+|....++.+ |+++..|++..
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~v-----VKLyYsFQD~~ 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWV-----VKLYYSFQDKE 214 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcE-----EEEEEEecCCC
Confidence 4679999999999999999999999999999999987653 33456668888877666655 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
++||||||+ ||++..+|...+ .|++..++.++.+++.|++.||+.|+|||||||+|+||+..||+||+|||++.-..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999 999999999886 89999999999999999999999999999999999999999999999999985443
Q ss_pred CCCCccc------CCCCCCCeeeecCCCC--cccc------------C---CCcccccCCcccchhhhhCCCCCccchHH
Q 013941 246 KDGSYFK------NLPKSSAIKLIDFGST--TFEH------------Q---DHSYVVSTRHYRAPEVILGLGWNYPCDLW 302 (433)
Q Consensus 246 ~~~~~~~------~~~~~~~~kl~Dfg~a--~~~~------------~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 302 (433)
....... .-......+-.||... .... . -....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 3221110 0001112344455421 0000 0 01126999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchh
Q 013941 303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382 (433)
Q Consensus 303 SlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (433)
|||||+||||.|.+||.+.+..+....|.+....+ .+|.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l----------------------~fP~------------------- 411 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL----------------------KFPE------------------- 411 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc----------------------cCCC-------------------
Confidence 99999999999999999999998888887653211 1111
Q ss_pred hhhhccCCchHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCC
Q 013941 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLK---AREALRHPFFTRD 425 (433)
Q Consensus 383 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~t---a~ell~hp~f~~~ 425 (433)
....+.++.|||.+||. ||++|+. ++||.+||||++-
T Consensus 412 -----~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 412 -----EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred -----cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 12346799999999999 9999984 9999999999963
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=398.44 Aligned_cols=253 Identities=31% Similarity=0.485 Sum_probs=218.2
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc-----h-hhHHHHHHHHHHHHHHH-hCCCCCcceeEecce
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----N-KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW 161 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~ 161 (433)
...++|.+.+.||+|+||+|++|.+..+++.||+|++.+. . ...+.+.+|+.+++++. |+|| ++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI-----~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNI-----IRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCE-----eEEEEE
Confidence 3456899999999999999999999999999999987653 1 23456668999999999 7766 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+.....+|+||||| ||+|.+++...+ .+.+..++.++.||++|++|||++||+||||||+|||++.+
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~---------- 156 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGN---------- 156 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCC----------
Confidence 99999999999999 899999999854 89999999999999999999999999999999999999764
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccc---cCCCcccccCCcccchhhhhCCC-CC-ccchHHHHHHHHHHHHhCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLG-WN-YPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~el~~g~ 315 (433)
...+||+|||++... .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|.
T Consensus 157 ----------------~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~ 220 (370)
T KOG0583|consen 157 ----------------EGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR 220 (370)
T ss_pred ----------------CCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence 046788888888766 23445679999999999999987 86 8999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc-hHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS-AGD 394 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 394 (433)
.||...+.......|.+....+| ..+ +.+
T Consensus 221 ~PF~d~~~~~l~~ki~~~~~~~p--------------------------------------------------~~~~S~~ 250 (370)
T KOG0583|consen 221 LPFDDSNVPNLYRKIRKGEFKIP--------------------------------------------------SYLLSPE 250 (370)
T ss_pred CCCCCccHHHHHHHHhcCCccCC--------------------------------------------------CCcCCHH
Confidence 99998776666665544333333 223 779
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+++||.+||..||.+|+|+.++++||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999998
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=367.41 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=227.5
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.+.|++.+.||+|.|+.|+++.+..+|+.+|+|+++- .....+.+.+|+.|-+.|+||+| +++++.+...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~I-----vrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcE-----eehhhhhccc
Confidence 356789999999999999999999999999999998863 22356788899999999999888 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..|||+|++ |++|..-+-.+. .+++..+-.+++||+.||.|+|.+||||||+||+|+|+.+.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK-------------- 146 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK-------------- 146 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec--------------
Confidence 9999999999 999976665543 68999999999999999999999999999999999999664
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
++...+||+|||+|....... ...+||+.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+
T Consensus 147 ----------~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 147 ----------AKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred ----------cCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 245578999999998766332 33689999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
....++.|.+.-..+|. ..++.++++.++||++|
T Consensus 217 ~~rlye~I~~g~yd~~~----------------------------------------------~~w~~is~~Ak~LvrrM 250 (355)
T KOG0033|consen 217 QHRLYEQIKAGAYDYPS----------------------------------------------PEWDTVTPEAKSLIRRM 250 (355)
T ss_pred HHHHHHHHhccccCCCC----------------------------------------------cccCcCCHHHHHHHHHH
Confidence 88888888775544442 12456788999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|..||++|+|+.|+|+|||+.+.
T Consensus 251 L~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 251 LTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred hccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999874
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=402.47 Aligned_cols=326 Identities=38% Similarity=0.675 Sum_probs=245.7
Q ss_pred CceeeecCCcc---CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC-Ccce
Q 013941 80 GHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GTRC 155 (433)
Q Consensus 80 ~~~~~~~~~~~---~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~-~~~~ 155 (433)
+.+....++.+ .++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.|.++. +.++
T Consensus 114 ~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i 193 (467)
T PTZ00284 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPL 193 (467)
T ss_pred CceeEecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcce
Confidence 44555556554 5789999999999999999999999999999999976555555677899999999887653 3567
Q ss_pred eEecceeccC-CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcc
Q 013941 156 VQIRNWFDYR-NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 156 v~~~~~~~~~-~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~ 233 (433)
+.+++++... +++|+|||+++++|.+++.+.+ .+++..++.++.||+.||+|||+ .|||||||||+|||++.++..
T Consensus 194 ~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 194 MKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred eeeEEEEEcCCceEEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc
Confidence 8888888764 6899999999999999998764 79999999999999999999998 599999999999999876532
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 313 (433)
. ++.... ........+||+|||.+..........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 272 ~--~~~~~~---------~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt 340 (467)
T PTZ00284 272 V--DPVTNR---------ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340 (467)
T ss_pred c--cccccc---------ccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence 1 111000 00123346999999988765555566789999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhh-hhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
|+.||.+.+..+.+..+...++.+|..+...+... ...++......... ................. ...+
T Consensus 341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~------~~~~ 411 (467)
T PTZ00284 341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPC---TDPKHLARIARARPVRE------VIRD 411 (467)
T ss_pred CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccccccc---CCHHHHHhhhcccchhh------hhch
Confidence 99999999999999999999999998776543211 11222211111100 00011111000000000 0124
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
..+.|||.+||++||++|||++|+|+||||.+...
T Consensus 412 ~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 412 DLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 57889999999999999999999999999998543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=374.57 Aligned_cols=285 Identities=32% Similarity=0.549 Sum_probs=232.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCC-CCCcceeEecceeccCC-
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRN- 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~-i~~~~~v~~~~~~~~~~- 166 (433)
..|..+++||+|+||+||+|+++.+|+.||+|.++-... ......+|+.+++.++|.+ | +.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~i-----v~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHI-----VRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcce-----EEEEeeeeeccc
Confidence 458888999999999999999999999999999975433 4567889999999999987 6 99999998876
Q ss_pred -----eEEEEEccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 167 -----HICIVFEKLGPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 167 -----~~~lv~e~~~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
.+++|+||+..+|..++..... ..++...++.+++||+.||+|||++||+||||||.||||++.|
T Consensus 86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-------- 157 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-------- 157 (323)
T ss_pred ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--------
Confidence 8999999999999999987653 3578899999999999999999999999999999999997665
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~ 315 (433)
.+||+|||+|+....+ .+..++|.+|+|||++.+. .|+..+||||+|||++||++++
T Consensus 158 -------------------~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~ 218 (323)
T KOG0594|consen 158 -------------------VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR 218 (323)
T ss_pred -------------------cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence 5677888877654422 3445899999999999997 6999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
..|.+..+.+++..|.+.+|.+.+.. ||.....+.... .+.....+.......+..+++.
T Consensus 219 ~LFpG~se~~ql~~If~~lGtP~e~~-------------------Wp~v~~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~ 278 (323)
T KOG0594|consen 219 PLFPGDSEIDQLFRIFRLLGTPNEKD-------------------WPGVSSLPDYKA-PFPKWPGPKDLSSILPKLDPDG 278 (323)
T ss_pred CCCCCCcHHHHHHHHHHHcCCCCccC-------------------CCCccccccccc-cCcCCCCccchHHhccccCccH
Confidence 99999999999999999999877543 332222111110 0001111222223334445689
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
.+++.+||+.+|.+|.||+.+|.||||.+...+
T Consensus 279 ~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 279 IELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred HHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 999999999999999999999999999987543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=378.82 Aligned_cols=281 Identities=26% Similarity=0.374 Sum_probs=232.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
..|++++.||.|.-|+||+|+...++..+|+|++.+.. +....+..|-+||+.+.||.+ +.++..|+.++.
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFl-----PTLYa~fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFL-----PTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCcc-----chhhheeeccce
Confidence 56999999999999999999999999999999998643 233456679999999999988 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||| ||+|..+++++..+.|++..++.++..++.||+|||-.|||+|||||+||||.++|++.++||.++.+...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999 99999999999989999999999999999999999999999999999999999999999999999876643
Q ss_pred CCCcccCCC-----CCCC---eee----------------ecCCC--------CccccCCCcccccCCcccchhhhhCCC
Q 013941 247 DGSYFKNLP-----KSSA---IKL----------------IDFGS--------TTFEHQDHSYVVSTRHYRAPEVILGLG 294 (433)
Q Consensus 247 ~~~~~~~~~-----~~~~---~kl----------------~Dfg~--------a~~~~~~~~~~~gt~~y~aPE~~~~~~ 294 (433)
..+.....+ .+.. +.+ .|++. |...+.....++||-.|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 222111100 0000 001 12221 111222334579999999999999999
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHH
Q 013941 295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374 (433)
Q Consensus 295 ~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (433)
.+.++|+|+|||++|||+.|..||.+.+..+.+..|......+|.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~----------------------------------- 356 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE----------------------------------- 356 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC-----------------------------------
Confidence 999999999999999999999999999998888777654333332
Q ss_pred HHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCC
Q 013941 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK----AREALRHPFFTRD 425 (433)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~t----a~ell~hp~f~~~ 425 (433)
...++.+++|||+++|.+||++|+. |.||.+||||+.-
T Consensus 357 -------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 357 -------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred -------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 1245679999999999999999998 9999999999963
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=368.83 Aligned_cols=241 Identities=32% Similarity=0.496 Sum_probs=207.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEecc-eeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRN-WFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~-~~~~~~~ 167 (433)
..|+|.++||+|+||+||++++..+|+.||.|.++- +.+.++....|+.+|++|+|+|| |++++ .|..++.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNI-----VqYy~~~f~~~~e 93 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNI-----VQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchH-----HHHHHHhhhccch
Confidence 459999999999999999999999999999998873 34567788899999999999988 99988 5655555
Q ss_pred -EEEEEccC-CCCHHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEecCCCCCcEEEeeCCcccccCcc
Q 013941 168 -ICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHE--LR--LIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 168 -~~lv~e~~-~~~L~~~l~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~--ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
++||||+| +|+|...++ +...+.+++..+++++.|++.||.++|+ .. |+||||||.||+++.+|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-------- 165 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-------- 165 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC--------
Confidence 99999999 999999987 3344679999999999999999999999 44 99999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.+||+|||+++...... .+.+|||+||+||.+.+.+|+++|||||+||++|||+.-++
T Consensus 166 -------------------vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 166 -------------------VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred -------------------ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCC
Confidence 68899999988776554 34799999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcC-CChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 317 LFQTHENLEHLAMMERVLGP-LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
||.+.+-.+....|.+.-.+ +|. +.+|.++
T Consensus 227 PF~g~n~~~L~~KI~qgd~~~~p~-------------------------------------------------~~YS~~l 257 (375)
T KOG0591|consen 227 PFYGDNLLSLCKKIEQGDYPPLPD-------------------------------------------------EHYSTDL 257 (375)
T ss_pred CcccccHHHHHHHHHcCCCCCCcH-------------------------------------------------HHhhhHH
Confidence 99999777777777654221 221 2457899
Q ss_pred HHHHHHhcccCCCCCCCH
Q 013941 396 IDLLQGLLRYDPAERLKA 413 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta 413 (433)
..||..|+..||+.||+.
T Consensus 258 ~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHccCCcccCCCc
Confidence 999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-53 Score=394.90 Aligned_cols=252 Identities=29% Similarity=0.525 Sum_probs=218.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. +....+.+|++|++.++|+|| +.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpni-----v~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNI-----VEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcch-----hhHHHhhcccceE
Confidence 57999999999999999999999999999999997543 344567889999999999988 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|+|.|||-|+|..++...+ .++++.++.++.|++.||.|||+.+|+|||+||.|||+...|
T Consensus 77 ~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~----------------- 137 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG----------------- 137 (808)
T ss_pred EEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-----------------
Confidence 9999999669999999876 899999999999999999999999999999999999987665
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+|+||||+|+...... +.+.||+.|||||++.+.+|+..+|+||||||+||+++|++||....-.+
T Consensus 138 ----------~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~ 207 (808)
T KOG0597|consen 138 ----------TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ 207 (808)
T ss_pred ----------ceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence 56777777776554433 34689999999999999999999999999999999999999998766666
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....|.......| ...+..+.+||+.+|.+
T Consensus 208 Lv~~I~~d~v~~p--------------------------------------------------~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 208 LVKSILKDPVKPP--------------------------------------------------STASSSFVNFLQGLLIK 237 (808)
T ss_pred HHHHHhcCCCCCc--------------------------------------------------ccccHHHHHHHHHHhhc
Confidence 6665544322221 23477899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q 013941 406 DPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||.+|+|..+++.|||.++...
T Consensus 238 dP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred ChhhcccHHHHhcChHHhhhhh
Confidence 9999999999999999987543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=398.93 Aligned_cols=250 Identities=28% Similarity=0.531 Sum_probs=223.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+-|++.+.||.|+.|.|-+|++..||+.+|||++.+. ......+.+|+.||+.+.|||+ +++++++++..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnV-----l~LydVwe~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNV-----LRLYDVWENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCe-----eeeeeeeccCce
Confidence 4599999999999999999999999999999999764 2334567899999999999988 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+|.||+ ||.|++++..++ .+++.++++++.||+.|+.|||..+|+||||||+|+|++..+
T Consensus 87 lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~--------------- 149 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN--------------- 149 (786)
T ss_pred EEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc---------------
Confidence 99999999 999999999887 899999999999999999999999999999999999986533
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.+||+|||+|....... .+.||++.|.|||++.|.+|. .++||||+|||||.|++|+.||.+++-
T Consensus 150 ------------nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi 217 (786)
T KOG0588|consen 150 ------------NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI 217 (786)
T ss_pred ------------CEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH
Confidence 48999999987654432 457999999999999999985 899999999999999999999998887
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
...+.++++....+| ..++.++++||.+||
T Consensus 218 r~LLlKV~~G~f~MP--------------------------------------------------s~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 218 RVLLLKVQRGVFEMP--------------------------------------------------SNISSEAQDLLRRML 247 (786)
T ss_pred HHHHHHHHcCcccCC--------------------------------------------------CcCCHHHHHHHHHHh
Confidence 787877776655544 355889999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
..||++|+|.+||++|||+...
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ccCccccccHHHHhhCchhhcC
Confidence 9999999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=393.99 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=216.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|.++++||+|+||+|++|..+.+++.||||++++.. ...+..+.|..|+.... .||.+++++..|++.+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~----~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN----RHPFLVNLFSCFQTKE 442 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc----cCCeEeecccccccCC
Confidence 367999999999999999999999999999999998753 45577788999988887 3355599999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
++|+||||+ ||++..+.+. ..|++..++.|+..|+.||+|||++||||||||.+|||++.+|+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh------------- 506 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH------------- 506 (694)
T ss_pred eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc-------------
Confidence 999999999 8885444433 37999999999999999999999999999999999999988775
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccc---cCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
+||+|||+++.. +...++++||+.|||||++.+..|+.++|+|||||+||||+.|..||.+++
T Consensus 507 --------------~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 507 --------------VKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred --------------EEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 566666666532 344567899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
+.+....|...-...| ..++.++.++|+++
T Consensus 573 Eee~FdsI~~d~~~yP--------------------------------------------------~~ls~ea~~il~~l 602 (694)
T KOG0694|consen 573 EEEVFDSIVNDEVRYP--------------------------------------------------RFLSKEAIAIMRRL 602 (694)
T ss_pred HHHHHHHHhcCCCCCC--------------------------------------------------CcccHHHHHHHHHH
Confidence 9999888876433332 34477999999999
Q ss_pred cccCCCCCCC-----HHHHhcCCCCCCC
Q 013941 403 LRYDPAERLK-----AREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~t-----a~ell~hp~f~~~ 425 (433)
|.+||++|+. +++|.+||||++.
T Consensus 603 l~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 603 LRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred hccCcccccCCCCCCchhhhhCCccccC
Confidence 9999999995 6899999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-52 Score=391.16 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=218.1
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
-...|....+||+|+.|.||.|+...+++.||||.+..... .++.+.+|+.+|+..+|+|| |.+++.|-..+.+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~Ni-----Vnfl~Sylv~deL 345 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNI-----VNFLDSYLVGDEL 345 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHH-----HHHHHHhccccee
Confidence 34579999999999999999999999999999999986543 45667799999999999888 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ ||+|.+.+... .++|.++..|++++++||+|||.+||+|||||.+|||++.+|.
T Consensus 346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--------------- 407 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--------------- 407 (550)
T ss_pred EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc---------------
Confidence 9999999 99999999876 4999999999999999999999999999999999999987774
Q ss_pred CCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
+||+|||++..... ...+.+||++|||||++....|++++||||||++++||+.|.+||-..+..
T Consensus 408 ------------vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl 475 (550)
T KOG0578|consen 408 ------------VKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 475 (550)
T ss_pred ------------EEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH
Confidence 55666665543322 346689999999999999999999999999999999999999999877766
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
..+..|... ........+.+|..+++||.+||+
T Consensus 476 rAlyLIa~n-----------------------------------------------g~P~lk~~~klS~~~kdFL~~cL~ 508 (550)
T KOG0578|consen 476 RALYLIATN-----------------------------------------------GTPKLKNPEKLSPELKDFLDRCLV 508 (550)
T ss_pred HHHHHHhhc-----------------------------------------------CCCCcCCccccCHHHHHHHHHHhh
Confidence 665555321 112234456779999999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~ 424 (433)
.|+.+|++|.|||+||||+.
T Consensus 509 ~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 509 VDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred cchhcCCCHHHHhcChhhhh
Confidence 99999999999999999964
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=370.31 Aligned_cols=343 Identities=31% Similarity=0.565 Sum_probs=267.7
Q ss_pred CCCCceeeecCCccC-CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCC---CCC
Q 013941 77 DKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---IGG 152 (433)
Q Consensus 77 ~~~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~---i~~ 152 (433)
..+|++++.+|+.+. +||.+.++||.|.|++||+|.|..+.+.||+|+++......+..+.||.+|++++... ...
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 457899999999998 9999999999999999999999999999999999988888899999999999998654 455
Q ss_pred cceeEecceecc----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEE
Q 013941 153 TRCVQIRNWFDY----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILL 227 (433)
Q Consensus 153 ~~~v~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli 227 (433)
.++|++++.|.. +.|+|||+|++|.+|..+|....++.++...++.|++||+.||.|||. .||||-||||+|||+
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 788999999975 569999999999999999999888999999999999999999999995 699999999999999
Q ss_pred eeCCc-----------ccc-----c-----C--------------------------------------c----------
Q 013941 228 VSAEY-----------VKV-----P-----D--------------------------------------Y---------- 238 (433)
Q Consensus 228 ~~~~~-----------~~l-----~-----d--------------------------------------~---------- 238 (433)
..... ++. . + .
T Consensus 222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~ 301 (590)
T KOG1290|consen 222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE 301 (590)
T ss_pred eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence 65410 000 0 0 0
Q ss_pred --------ccc----ccCCCC------C-------C---------------------------ccc--------------
Q 013941 239 --------KFL----SRSSKD------G-------S---------------------------YFK-------------- 252 (433)
Q Consensus 239 --------~~~----~~~~~~------~-------~---------------------------~~~-------------- 252 (433)
..- ..+... + . ...
T Consensus 302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~ 381 (590)
T KOG1290|consen 302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN 381 (590)
T ss_pred ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence 000 000000 0 0 000
Q ss_pred ----CCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC------CC
Q 013941 253 ----NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT------HE 322 (433)
Q Consensus 253 ----~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~------~~ 322 (433)
.-.....+||+|||.|.+....-+.-+.|..|+|||++.+..|+..+||||++|++|||+||...|.. ..
T Consensus 382 p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r 461 (590)
T KOG1290|consen 382 PDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR 461 (590)
T ss_pred CCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence 01123468999999999988777777899999999999999999999999999999999999999953 34
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
+.++++.|..++|.+|..+..........|-+.|.....-....++.. .-+.+ .-....+.+.++.+||.-|
T Consensus 462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~-~VL~e-------KY~~s~e~A~~fsdFL~Pm 533 (590)
T KOG1290|consen 462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLY-EVLIE-------KYEWSEEDAQQFSDFLSPM 533 (590)
T ss_pred cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHH-HHHHH-------HhCCCHHHHHHHHHHHHHH
Confidence 678999999999999998877665444444444433333222222111 11111 1122334467899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 403 LRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
|+++|++|+||.++|+|||+.....
T Consensus 534 Lef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 534 LEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HhcCccccccHHHHhcCccccCCCC
Confidence 9999999999999999999996543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=369.85 Aligned_cols=270 Identities=24% Similarity=0.361 Sum_probs=220.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+.|++...||.|..++||+|+...+++.||||++.... ...+.+.+|+..+..++|||| ++++..|..+..+|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNI-----v~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNI-----VTYHCSFVVDSELW 100 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCc-----ceEEEEEEecceeE
Confidence 45999999999999999999999999999999997433 335778899999999999988 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||.|| +|++.+++...-...++|..+..|++++++||.|||.+|.||||||+.||||+++|.+||+|||+..
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa------ 174 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA------ 174 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee------
Confidence 999999 9999999997766679999999999999999999999999999999999999999988888888753
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
-|.|-|..... .. .+++||++|||||++... .|+.|+||||||++..||.+|..||........
T Consensus 175 ------------~l~~~G~R~~~-rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv 240 (516)
T KOG0582|consen 175 ------------SLFDSGDRQVT-RF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV 240 (516)
T ss_pred ------------eecccCceeeE-ee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH
Confidence 33333311111 11 456999999999996543 699999999999999999999999988776654
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
+. ..+.+.+|..... .+..+....++.+++.+|..||++|
T Consensus 241 Ll--~tLqn~pp~~~t~--------------------------------------~~~~d~~k~~~ksf~e~i~~CL~kD 280 (516)
T KOG0582|consen 241 LL--LTLQNDPPTLLTS--------------------------------------GLDKDEDKKFSKSFREMIALCLVKD 280 (516)
T ss_pred HH--HHhcCCCCCcccc--------------------------------------cCChHHhhhhcHHHHHHHHHHhhcC
Confidence 43 2333444321100 0001111234568999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCc
Q 013941 407 PAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~~ 426 (433)
|++||||+++|+|+||++..
T Consensus 281 P~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 281 PSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred cccCCCHHHHhccHHHhhcc
Confidence 99999999999999999753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=371.75 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=211.6
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh---------------hHHHHHHHHHHHHHHHhCCCCCc
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------YREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
..-++|++++.||+|.||.|-+|++..+++.||||++.+... ..+...+||.||+++.|+|+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV--- 170 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV--- 170 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe---
Confidence 345789999999999999999999999999999999975321 22578899999999999888
Q ss_pred ceeEecceecc--CCeEEEEEccC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 154 RCVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 154 ~~v~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
|+++++.++ .+.+|||+||| .|.+...=.. .. +++.+++.|+++++.||+|||.+|||||||||+|+|+++
T Consensus 171 --V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 171 --VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred --eEEEEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence 999999987 56899999999 7766543222 23 899999999999999999999999999999999999988
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCC----CCccchHHHHH
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVG 305 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG 305 (433)
+|++||+|||.+........ ...+......+||+.|+|||.+.+.. .+.+.||||+|
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~-------------------~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSD-------------------EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred CCcEEeeccceeeecccCCc-------------------cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 88666555554332211100 00001112259999999999998732 35889999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 306 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|+||+|+.|+.||-+....+....|....-.+|.
T Consensus 307 VTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~---------------------------------------------- 340 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPE---------------------------------------------- 340 (576)
T ss_pred hhHHHhhhccCCcccchHHHHHHHHhcCcccCCC----------------------------------------------
Confidence 9999999999999998888888888765433332
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.+++...++|||.+||.+||++|++..+|..|||..+...
T Consensus 341 --~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 341 --NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred --cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 1234678999999999999999999999999999998743
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=382.28 Aligned_cols=266 Identities=32% Similarity=0.513 Sum_probs=230.7
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHH-hCCCCCcceeEecce
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW 161 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~ 161 (433)
...+...|++.+.||+|.||.||+|+++.+|+.+|+|++.+... ..+.+.+|+.+|+++. |+|+ |.+++.
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpni-----v~l~~~ 104 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNI-----VQLKDA 104 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCE-----EEEEEE
Confidence 45666789999999999999999999999999999999975432 3468899999999998 7776 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
|++...+++|||+| ||.|.+.+... .+++..+..++.||+.|++|||+.||+||||||+|+|+....
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~--------- 172 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD--------- 172 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc---------
Confidence 99999999999999 99999999876 399999999999999999999999999999999999996542
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.....+|++|||++..... .....+||+.|+|||++....|+..+||||+||++|.|++|..||
T Consensus 173 --------------~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF 238 (382)
T KOG0032|consen 173 --------------EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPF 238 (382)
T ss_pred --------------CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCC
Confidence 1235799999999988766 345579999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+.......+.+.-..++ ...++.++..+++|
T Consensus 239 ~~~~~~~~~~~i~~~~~~f~----------------------------------------------~~~w~~is~~akd~ 272 (382)
T KOG0032|consen 239 WGETEFEIFLAILRGDFDFT----------------------------------------------SEPWDDISESAKDF 272 (382)
T ss_pred cCCChhHHHHHHHcCCCCCC----------------------------------------------CCCccccCHHHHHH
Confidence 99888777766554322221 22345668899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
|.+||..||.+|+||.++|+|||++.....+
T Consensus 273 i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred HHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 9999999999999999999999999864433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-51 Score=372.64 Aligned_cols=254 Identities=32% Similarity=0.483 Sum_probs=205.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC--eE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--HI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~--~~ 168 (433)
.+|...+.||+|+||.||++.+..+|+.+|||.+...+. ..+.+.+|+.+|.+++|++| |++++...... .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~I-----V~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNI-----VQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCE-----EeeCCccccccCeee
Confidence 358889999999999999999999999999999865421 14567899999999998877 99999755544 69
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee-CCcccccCccccccCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~-~~~~~l~d~~~~~~~~~ 246 (433)
++.|||+ +|+|.+++...++ .+++..++.+.+||++||.|||++|||||||||+|||++. ++
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~--------------- 155 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG--------------- 155 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC---------------
Confidence 9999999 9999999998876 7999999999999999999999999999999999999976 34
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC------CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
.+||+|||.+..... ......||+.|||||++... ...+++|||||||++.||+||..||.
T Consensus 156 ------------~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 156 ------------DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ------------eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 567777776664442 12346899999999999963 33469999999999999999999997
Q ss_pred CC-ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 320 TH-ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 320 ~~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.. .....+..+.... .. ...+..++.++++|
T Consensus 224 ~~~~~~~~~~~ig~~~-~~-----------------------------------------------P~ip~~ls~~a~~F 255 (313)
T KOG0198|consen 224 EFFEEAEALLLIGRED-SL-----------------------------------------------PEIPDSLSDEAKDF 255 (313)
T ss_pred hhcchHHHHHHHhccC-CC-----------------------------------------------CCCCcccCHHHHHH
Confidence 63 2222111111100 00 12334568899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
|.+||..||++||||+++|+|||.+++.
T Consensus 256 l~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 256 LRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999998754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=366.35 Aligned_cols=279 Identities=29% Similarity=0.549 Sum_probs=225.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC--C---
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N--- 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~--~--- 166 (433)
-.|.-.+.+|.|+||.||+|....+++.||||.+-.+... -.+|+++|+.+.|+|| |++.-+|... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNI-----V~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNI-----VRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCe-----eeEEEEEEecCCCchh
Confidence 3589999999999999999999999999999988654432 3469999999999888 9988887642 2
Q ss_pred eEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 167 HICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
...+||||+..+|.++++.. .+..++.-.++-++.||++||.|||+.||+||||||.|||++.
T Consensus 96 ~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~--------------- 160 (364)
T KOG0658|consen 96 YLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP--------------- 160 (364)
T ss_pred HHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC---------------
Confidence 56799999999999999842 2247899999999999999999999999999999999999975
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
..+.+||||||+|+..... ..+...|..|+|||.+.|. .|+.+.||||.||++.||+-|++.|.|.
T Consensus 161 -----------~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 161 -----------DTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred -----------CCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 4567999999999876543 3446789999999999986 6999999999999999999999999999
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+++..|.+++|.+..+.+........ ...+|.... ..| ..-.....++++.+|+.+
T Consensus 230 s~~dQL~eIik~lG~Pt~e~I~~mn~~y~-------~~~~p~ik~------~~~--------~~~~~~~~~~d~~dll~~ 288 (364)
T KOG0658|consen 230 SSVDQLVEIIKVLGTPTREDIKSMNPNYT-------EFKFPQIKA------HPW--------HKVFFKRLPPDALDLLSK 288 (364)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcCcccc-------cccCccccc------ccc--------eeecccCCCHHHHHHHHH
Confidence 99999999999999988755443221110 000110000 000 001234567899999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+|+++|.+|.++.|++.||||..-
T Consensus 289 ~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 289 LLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HhccChhhcCCHHHHhcchhhHHh
Confidence 999999999999999999999863
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=346.40 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=224.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|-||.||+|+.+.++-.||+|++.+.. ....++.+|++|...|+|||| .+++++|.+...
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpni-----lrlY~~fhd~~r 96 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNI-----LRLYGYFHDSKR 96 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccH-----Hhhhhheeccce
Confidence 45999999999999999999999999999999997644 334567789999999999888 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+||++||. +|+|...|+......+++..+..++.|++.||.|+|.++||||||||+|+|++..|
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--------------- 161 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--------------- 161 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC---------------
Confidence 99999999 99999999976667899999999999999999999999999999999999986655
Q ss_pred CCCcccCCCCCCCeeeecCCCCcccc-CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+|++|||.+.... ....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||......+
T Consensus 162 ------------~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 162 ------------ELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred ------------CeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 67889999887663 44567899999999999999999999999999999999999999999888777
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....|.+.--.+| ..++.++.|||.+||.+
T Consensus 230 tYkrI~k~~~~~p--------------------------------------------------~~is~~a~dlI~~ll~~ 259 (281)
T KOG0580|consen 230 TYKRIRKVDLKFP--------------------------------------------------STISGGAADLISRLLVK 259 (281)
T ss_pred HHHHHHHccccCC--------------------------------------------------cccChhHHHHHHHHhcc
Confidence 7777766543333 34577999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013941 406 DPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~ 425 (433)
+|.+|++..|++.|||+...
T Consensus 260 ~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 260 NPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred CccccccHHHHhhhHHHHhc
Confidence 99999999999999999764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=375.02 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=212.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+++ +++++++.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI-----IRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcH-----hhhHhhhccCCe
Confidence 36999999999999999999999999999999986432 234567789999999998887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--------------- 138 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--------------- 138 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---------------
Confidence 99999999 999999998764 799999999999999999999999999999999999996654
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 139 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~ 206 (291)
T cd05612 139 ------------HIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206 (291)
T ss_pred ------------CEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 57788888776655444456899999999999998899999999999999999999999988776555
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+......+ ....+..+++||.+||+.|
T Consensus 207 ~~~i~~~~~~~--------------------------------------------------~~~~~~~~~~li~~~l~~d 236 (291)
T cd05612 207 YEKILAGKLEF--------------------------------------------------PRHLDLYAKDLIKKLLVVD 236 (291)
T ss_pred HHHHHhCCcCC--------------------------------------------------CccCCHHHHHHHHHHcCCC
Confidence 54443321111 1233668999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCC
Q 013941 407 PAERLK-----AREALRHPFFTR 424 (433)
Q Consensus 407 P~~R~t-----a~ell~hp~f~~ 424 (433)
|.+|++ ++++++||||+.
T Consensus 237 p~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 237 RTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHccCCccCCHHHHhcCccccC
Confidence 999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=371.11 Aligned_cols=278 Identities=31% Similarity=0.512 Sum_probs=219.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.++||+|+||.||+|++..+++.||+|+++... .......+|+.++++++|+|+ +++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-----VTLHDIIHTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCE-----eeEEEEEcCCCeEE
Confidence 46999999999999999999999999999999986432 234467789999999988877 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~------------------ 140 (288)
T cd07871 80 LVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG------------------ 140 (288)
T ss_pred EEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC------------------
Confidence 999999779999987654 3589999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||++...... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 141 ---------~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~ 211 (288)
T cd07871 141 ---------ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211 (288)
T ss_pred ---------CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4666677666543221 123468899999999876 468999999999999999999999999988888
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+.+..+.++...+........ +.. ..++.. ............+.++++||.+||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~---------------~~~~~~~~~~~~~~~~~dll~~mL~~ 271 (288)
T cd07871 212 ELHLIFRLLGTPTEETWPGITSNEE-FRS----YLFPQY---------------RAQPLINHAPRLDTDGIDLLSSLLLY 271 (288)
T ss_pred HHHHHHHHhCCCChHHhhccccchh-hhc----cccCcc---------------CCCchHHhCCCCCHHHHHHHHHhcCc
Confidence 8888888888777654433211100 000 000000 00001112235577899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
||.+|+|++|+++||||
T Consensus 272 dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 272 ETKSRISAEAALRHSYF 288 (288)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=380.17 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=212.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++++.|+++ +++++++.+++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI-----VNMMCSFQDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----CcEEEEEEcCCE
Confidence 46999999999999999999999999999999987532 234567789999999998887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--------------- 155 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG--------------- 155 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC---------------
Confidence 99999999 999999998764 789999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 156 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 156 ------------HVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred ------------CEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 57778888776655544556899999999999999999999999999999999999999987766554
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+......+ ...++..+.+||.+||+.|
T Consensus 224 ~~~i~~~~~~~--------------------------------------------------p~~~~~~~~~li~~~L~~d 253 (329)
T PTZ00263 224 YEKILAGRLKF--------------------------------------------------PNWFDGRARDLVKGLLQTD 253 (329)
T ss_pred HHHHhcCCcCC--------------------------------------------------CCCCCHHHHHHHHHHhhcC
Confidence 44433211111 1224668899999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCC
Q 013941 407 PAERLK-----AREALRHPFFTR 424 (433)
Q Consensus 407 P~~R~t-----a~ell~hp~f~~ 424 (433)
|++|++ ++++++||||++
T Consensus 254 P~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 254 HTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHcCCCCCCCHHHHhcCCccCC
Confidence 999997 799999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=366.80 Aligned_cols=280 Identities=31% Similarity=0.606 Sum_probs=219.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.++|+++ +++++++..++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI-----VELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccc-----cchhhhEecCCEE
Confidence 46999999999999999999999999999999987532 334567789999999999887 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|+||||+.+++.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~----------------- 137 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND----------------- 137 (287)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-----------------
Confidence 9999999444444444332 3699999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 138 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~ 207 (287)
T cd07848 138 ----------VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI 207 (287)
T ss_pred ----------cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 4666777766543221 12347899999999999988999999999999999999999999998888
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+....+++|............ .....++...... ..........+.++.+||.+||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-------------~~~~~~~~~~s~~~~dll~~~L~ 269 (287)
T cd07848 208 DQLFTIQKVLGPLPAEQMKLFYSNPR-----FHGLRFPAVNHPQ-------------SLERRYLGILSGVLLDLMKNLLK 269 (287)
T ss_pred HHHHHHHHhhCCCCHHHHHhhhccch-----hcccccCcccCcc-------------cHHHhhhcccCHHHHHHHHHHcc
Confidence 88888888888887655432211100 0011111111000 00111223457789999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013941 405 YDPAERLKAREALRHPFF 422 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f 422 (433)
+||++|||++|+|+||||
T Consensus 270 ~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 270 LNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=381.83 Aligned_cols=286 Identities=23% Similarity=0.390 Sum_probs=220.4
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++++.||+|+||.||+|.+..+++.||+|.... ....+|+.++++++|+|| +++++++......|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSI-----IQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCC-----CCEeEEEEECCeeEE
Confidence 3679999999999999999999999999999997542 346789999999999888 999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+++++|..++.... .+++..++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 161 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~------------------- 219 (391)
T PHA03212 161 ILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG------------------- 219 (391)
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-------------------
Confidence 99999889999987654 689999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccC----CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH----- 321 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~----- 321 (433)
.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 220 --------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~ 291 (391)
T PHA03212 220 --------DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG 291 (391)
T ss_pred --------CEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence 467777777653221 122357999999999999989999999999999999999999887543
Q ss_pred --ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHh-cCch--hhhhhccCCchHHHH
Q 013941 322 --ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL-LRLP--NLIMQHVDHSAGDLI 396 (433)
Q Consensus 322 --~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~l~ 396 (433)
.....+..+....+..|..+...........+. ..... ...+ ..........+.++.
T Consensus 292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~ 353 (391)
T PHA03212 292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYI------------------GLAKKSSRKPGSRPLWTNLYELPIDLE 353 (391)
T ss_pred cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHH------------------HHHhccCCCCCCCCCHHHHhhhhhhHH
Confidence 234556667676776665432211111111100 00000 0000 000011123466899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCccccCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~~~~ 433 (433)
+||.+||++||++||||+|+|+||||++.....+.|+
T Consensus 354 ~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~ 390 (391)
T PHA03212 354 YLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNPM 390 (391)
T ss_pred HHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCCC
Confidence 9999999999999999999999999998777776664
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=346.11 Aligned_cols=267 Identities=27% Similarity=0.444 Sum_probs=220.3
Q ss_pred ccCCCeEEe-ccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc---
Q 013941 89 NLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (433)
Q Consensus 89 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--- 164 (433)
.+++.|.+. ++||-|-.|.|..|.++.||+.+|+|++... ....+|++..-..+ +|+|||.++++|++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s----~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMAS----GHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhc----CCCceEEeehhhhhhcc
Confidence 345667774 6789999999999999999999999998654 34667887765544 44666999999875
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
...+.+|||.+ ||.|...++.++...|++.++..|++||..|+.|||+.+|.||||||+|+|++..+
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~----------- 198 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS----------- 198 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-----------
Confidence 46789999999 99999999999888899999999999999999999999999999999999997754
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+..+||+|||+|+.... ...+.+-|++|.|||++....|+..+|+||+||++|-|++|.+||.+
T Consensus 199 -------------~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 199 -------------PNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred -------------CCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 566799999999987763 33556889999999999999999999999999999999999999987
Q ss_pred CChHH----HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 321 HENLE----HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 321 ~~~~~----~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
..... ....|......+|+ ..++.+|.+.+
T Consensus 266 ~hg~aispgMk~rI~~gqy~FP~----------------------------------------------pEWs~VSe~aK 299 (400)
T KOG0604|consen 266 NHGLAISPGMKRRIRTGQYEFPE----------------------------------------------PEWSCVSEAAK 299 (400)
T ss_pred cCCccCChhHHhHhhccCccCCC----------------------------------------------hhHhHHHHHHH
Confidence 55422 22222222223332 22456688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCccccCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~~~~ 433 (433)
|+|+++|..+|++|+|++|+++|||+.+...=.+.||
T Consensus 300 dlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 300 DLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred HHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 9999999999999999999999999998765444543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=367.84 Aligned_cols=320 Identities=33% Similarity=0.592 Sum_probs=263.4
Q ss_pred CCCCCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCC-CCc
Q 013941 75 PDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGT 153 (433)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~ 153 (433)
.++..|+|.+.+|+.+..+|.|....|+|-|++|..|.+...|..||||+++.++.....-++|++||++|+...- ...
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhh
Confidence 4667899999999999999999999999999999999999999999999999888878888999999999986543 446
Q ss_pred ceeEecceeccCCeEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCc
Q 013941 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~ 232 (433)
||++++..|.+.+|+|||+|-+..+|.++|.+.+. -.|....++.++.||+.||..|-..||+|.||||+|||++.
T Consensus 495 Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--- 571 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--- 571 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc---
Confidence 88999999999999999999999999999987542 45888999999999999999999999999999999999976
Q ss_pred ccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-cccccCCcccchhhhhCCCCCccchHHHHHHHHHHH
Q 013941 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 233 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (433)
....+||||||.|....... +...-+..|.|||++.|.+|+...|+||.||+||||
T Consensus 572 -----------------------~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYEl 628 (752)
T KOG0670|consen 572 -----------------------SKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYEL 628 (752)
T ss_pred -----------------------CcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEe
Confidence 34568999999998766544 334567789999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccC--------------CCCCCchhhHHHHHHh
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW--------------PDGATSRDSMRAVWKL 377 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~ 377 (433)
.||+..|.+.++-+++..++.+-|++|..++.......+.|...-.-+.. ......+.....+...
T Consensus 629 YtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~ 708 (752)
T KOG0670|consen 629 YTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV 708 (752)
T ss_pred eccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc
Confidence 99999999999999999999999999999988766554444322111000 0111112222222222
Q ss_pred cCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
..++... ...-.++++||.+||..||++|.|..|+|+||||+.
T Consensus 709 q~~~deq----~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 709 QRLPDEQ----PKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred CCCCchh----HHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 2222211 122457999999999999999999999999999985
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=374.63 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=210.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCC-cEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ...+.+.+|+.++..++|+++ +++++++.++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC-----VNLYGSFKDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCC-----cceEEEEEeC
Confidence 357999999999999999999876654 689999986432 234567789999999998887 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~------------- 168 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG------------- 168 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-------------
Confidence 9999999999 999999998765 799999999999999999999999999999999999996655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 169 --------------~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 234 (340)
T PTZ00426 169 --------------FIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234 (340)
T ss_pred --------------CEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH
Confidence 567777777766554445568999999999999988999999999999999999999999887665
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+......+ ....+..+.++|.+||+
T Consensus 235 ~~~~~i~~~~~~~--------------------------------------------------p~~~~~~~~~li~~~l~ 264 (340)
T PTZ00426 235 LIYQKILEGIIYF--------------------------------------------------PKFLDNNCKHLMKKLLS 264 (340)
T ss_pred HHHHHHhcCCCCC--------------------------------------------------CCCCCHHHHHHHHHHcc
Confidence 5444443221111 12346688999999999
Q ss_pred cCCCCCC-----CHHHHhcCCCCCCC
Q 013941 405 YDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
.||++|+ |++++++||||.+.
T Consensus 265 ~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 265 HDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred cCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999996 89999999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=366.46 Aligned_cols=283 Identities=28% Similarity=0.468 Sum_probs=211.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|++..+++.||||+++... .......+|+.+++.+.|+|+ +++++++.+.+..|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI-----VLLHDIIHTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCc-----CeEEEEEecCCeEE
Confidence 57999999999999999999999999999999987432 223456789999999998887 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~------------------ 140 (303)
T cd07869 80 LVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG------------------ 140 (303)
T ss_pred EEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------------------
Confidence 999999889998887653 4689999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChH-
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL- 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~- 324 (433)
.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..+.
T Consensus 141 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 211 (303)
T cd07869 141 ---------ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211 (303)
T ss_pred ---------CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 466666766643221 11234689999999998764 5889999999999999999999999876543
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
..+..+....+......+..... ...+... .... .........+. ....+.++.+||.+||+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~----~~~~~~~~~~~-----------~~~~~~~~~dli~~mL~ 273 (303)
T cd07869 212 DQLERIFLVLGTPNEDTWPGVHS-LPHFKPE--RFTL----YSPKNLRQAWN-----------KLSYVNHAEDLASKLLQ 273 (303)
T ss_pred HHHHHHHHHhCCCChhhccchhh-ccccccc--cccc----cCCccHHHHhh-----------ccCCChHHHHHHHHHhc
Confidence 44555555554433221111000 0000000 0000 00000111110 11235688999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
.||++|+|++|+++||||++-
T Consensus 274 ~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 274 CFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cCchhccCHHHHhcCcccccC
Confidence 999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=345.37 Aligned_cols=255 Identities=29% Similarity=0.490 Sum_probs=215.1
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---------hhhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
-++|.-.+.||.|..++|-++.++.+|+.+|+|++... ....+...+|+.||+++. +||+|+.+.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~----GHP~II~l~D~ 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM----GHPYIIDLQDV 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc----CCCcEEEeeee
Confidence 34688889999999999999999999999999998521 123456678999999986 44666999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
|+.+..+++|+|.| .|.|.|++.+.- .+++...+.|++||+.|++|||.++||||||||+|||+++
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd----------- 158 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD----------- 158 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc-----------
Confidence 99999999999999 999999998875 8999999999999999999999999999999999999865
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhC------CCCCccchHHHHHHHHHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~el~ 312 (433)
+..++|+|||+|....... ...|||+.|+|||.+.. .+|+..+|+||+|||+|-|+
T Consensus 159 ----------------n~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 159 ----------------NMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred ----------------ccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence 4467778888777655443 44799999999999864 25889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
.|.+||......-.+.+|++....+. ...+..++
T Consensus 223 aGcpPFwHRkQmlMLR~ImeGkyqF~----------------------------------------------speWadis 256 (411)
T KOG0599|consen 223 AGCPPFWHRKQMLMLRMIMEGKYQFR----------------------------------------------SPEWADIS 256 (411)
T ss_pred cCCCchhHHHHHHHHHHHHhcccccC----------------------------------------------Ccchhhcc
Confidence 99999987776666666665433221 12234567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
...+|||.+||+.||++|+|++|+|+||||.+
T Consensus 257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred ccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 78999999999999999999999999999954
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=365.13 Aligned_cols=255 Identities=25% Similarity=0.460 Sum_probs=229.4
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.+-|.+.+.||+|.|++|-+|++..+|+.||||++.+.. .....+.+|+..++.++|+|| |++|++.+..
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNi-----VRLYEViDTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNI-----VRLYEVIDTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCe-----eeeeehhccc
Confidence 45567999999999999999999999999999999997643 344667889999999999988 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
..+|||+|+- +|+|++||.++. ..+.++.+++++.||+.|+.|+|+..+|||||||+||.+.+
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--------------- 153 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--------------- 153 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee---------------
Confidence 9999999999 899999998876 57999999999999999999999999999999999999854
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCCCCC-ccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
+.+-+||+|||++..... ...+.+|+..|-|||++.|..|+ +++||||||||||-|++|++||...
T Consensus 154 -----------KlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 154 -----------KLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred -----------ecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 445689999998865443 34668999999999999999997 7899999999999999999999999
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
++.+.+.+|+.+...+|.. ++.++++||..
T Consensus 223 NDSETLTmImDCKYtvPsh--------------------------------------------------vS~eCrdLI~s 252 (864)
T KOG4717|consen 223 NDSETLTMIMDCKYTVPSH--------------------------------------------------VSKECRDLIQS 252 (864)
T ss_pred cchhhhhhhhcccccCchh--------------------------------------------------hhHHHHHHHHH
Confidence 9999999999887777643 47799999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||+.||.+|.+.+||..|+|++..
T Consensus 253 MLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HHhcCchhhccHHHHhccccccCC
Confidence 999999999999999999999965
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=373.01 Aligned_cols=243 Identities=26% Similarity=0.430 Sum_probs=202.7
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
+.||+|+||.||+|++..+|+.||||++++.. .......+|+.+++++.|+++ +++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL-----TALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----CCEEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999997532 233456789999999998887 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCccc
Q 013941 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~ 252 (433)
|+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~--------------------- 132 (323)
T cd05571 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG--------------------- 132 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC---------------------
Confidence 99 999999998754 799999999999999999999999999999999999997655
Q ss_pred CCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 253 NLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......
T Consensus 133 ------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~ 206 (323)
T cd05571 133 ------HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (323)
T ss_pred ------CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 46777777665321 122335799999999999999999999999999999999999999987665544433
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
+...... ....++.++.+||.+||+.||++
T Consensus 207 ~~~~~~~--------------------------------------------------~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 207 ILMEEIR--------------------------------------------------FPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred HHcCCCC--------------------------------------------------CCCCCCHHHHHHHHHHccCCHHH
Confidence 3221111 12345678999999999999999
Q ss_pred CC-----CHHHHhcCCCCCC
Q 013941 410 RL-----KAREALRHPFFTR 424 (433)
Q Consensus 410 R~-----ta~ell~hp~f~~ 424 (433)
|| ++.++++||||.+
T Consensus 237 R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 237 RLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred cCCCCCCCHHHHHcCCCcCC
Confidence 99 8999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=369.79 Aligned_cols=279 Identities=30% Similarity=0.517 Sum_probs=216.2
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC----
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---- 165 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~---- 165 (433)
+|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++|+|+ +++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-----VEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCE-----eeecceEeccCCCC
Confidence 599999999999999999999999999999998642 1233457789999999998887 8888877432
Q ss_pred -CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 -NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 -~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
..+|+|||||+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~------------ 141 (338)
T cd07859 76 FKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK------------ 141 (338)
T ss_pred CceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc------------
Confidence 3589999999889999987654 6999999999999999999999999999999999999976664
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhC--CCCCccchHHHHHHHHHHHHhCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
+||+|||++...... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 142 ---------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 142 ---------------LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred ---------------EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 556666655432111 122478999999999876 578999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhh-hhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
||.+.+....+..+....+..+.......... ...++. ...+ ..+..........+..+
T Consensus 207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------------------~~~~--~~~~~~~~~~~~~~~~~ 266 (338)
T cd07859 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS------------------SMRK--KQPVPFSQKFPNADPLA 266 (338)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH------------------hhcc--cCCCchHHhcCCCChHH
Confidence 99998888888888888877766544332110 000000 0000 00000111223456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.++|.+||+.||++|||++|+++||||++-
T Consensus 267 ~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 267 LRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=363.75 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=207.4
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+.|+++ +.+++++.+++..+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----v~~~~~~~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV-----VSLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcE-----EEEEEEEccCCeEE
Confidence 889999999999999999999999999999986432 223456789999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~----------------- 139 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG----------------- 139 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-----------------
Confidence 999999 89999888765445699999999999999999999999999999999999996554
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus 140 ----------~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 140 ----------HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred ----------CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence 4677777776553322 1235789999999999999999999999999999999999999987654332
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+....... ........+.++.+||.+||+.|
T Consensus 210 ~~~~~~~~~~~----------------------------------------------~~~~~~~~s~~~~~li~~~l~~~ 243 (285)
T cd05631 210 REEVDRRVKED----------------------------------------------QEEYSEKFSEDAKSICRMLLTKN 243 (285)
T ss_pred HHHHHHHhhcc----------------------------------------------cccCCccCCHHHHHHHHHHhhcC
Confidence 22222111000 01122345778999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCCC
Q 013941 407 PAERLK-----AREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~t-----a~ell~hp~f~~~ 425 (433)
|++|+| ++++++||||.+.
T Consensus 244 P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 244 PKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999997 9999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=359.35 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=219.5
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++..+|++.+.||+|.||.|-+|+....|+.||||.++++. ...-.+.+|++|+..|+||+| +.++++|++
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhI-----I~IyEVFEN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHI-----IQIYEVFEN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCce-----eehhhhhcC
Confidence 45678999999999999999999999999999999998643 333456789999999999988 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.+.+.|||||. +|.|++++...+ .+++..++.+++||.+|+.|+|.++++|||||.+|||++.++
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~------------ 190 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN------------ 190 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC------------
Confidence 99999999999 999999999886 899999999999999999999999999999999999986544
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCC-ccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+||+|||++...... ..++||++.|.+||++.|.+|. +.+|.|||||+||-|+.|..||.+
T Consensus 191 ---------------NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 191 ---------------NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred ---------------CeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 6788888888665543 3668999999999999999985 899999999999999999999999
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+....+.+|.+.-..-| ..+.++.-||+
T Consensus 256 ~Dhk~lvrQIs~GaYrEP---------------------------------------------------~~PSdA~gLIR 284 (668)
T KOG0611|consen 256 RDHKRLVRQISRGAYREP---------------------------------------------------ETPSDASGLIR 284 (668)
T ss_pred chHHHHHHHhhcccccCC---------------------------------------------------CCCchHHHHHH
Confidence 988888777765322211 12446789999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
.||..||++|.|+++|..|-|+.
T Consensus 285 wmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHhcCcccchhHHHHhhhheee
Confidence 99999999999999999999986
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=380.78 Aligned_cols=282 Identities=27% Similarity=0.492 Sum_probs=218.4
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc----
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~---- 164 (433)
....+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+|+ +++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~ni-----v~l~~~~~~~~~~ 134 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINI-----IFLKDYYYTECFK 134 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCC-----cceeeeEeecccc
Confidence 34568999999999999999999999999999999886433 234579999999999888 888776532
Q ss_pred ----CCeEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 165 ----RNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
...+++||||++++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~------- 207 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT------- 207 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-------
Confidence 235789999998888887753 2234799999999999999999999999999999999999996432
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~ 315 (433)
..+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 208 -------------------~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 208 -------------------HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred -------------------CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 2478888888865432 22335789999999998765 6899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
+||.+....+.+..+.+.++.++............ ...++... ...+........+.++
T Consensus 269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~-------~~~~~~~~--------------~~~l~~~~p~~~~~~~ 327 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA-------DIKFPDVK--------------PKDLKKVFPKGTPDDA 327 (440)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh-------cccCCccC--------------chhHHHHhccCCCHHH
Confidence 99999988888888888888766544332211100 01111100 0011111223457789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
++||.+||++||.+|+|+.|+|+||||.+.
T Consensus 328 ~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 328 INFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 999999999999999999999999999864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.32 Aligned_cols=302 Identities=28% Similarity=0.473 Sum_probs=227.2
Q ss_pred CceeeecCC---ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCc
Q 013941 80 GHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 80 ~~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
.+|.+..++ .+.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++|+|+
T Consensus 6 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--- 82 (359)
T cd07876 6 QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI--- 82 (359)
T ss_pred CcceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCE---
Confidence 345555555 4568999999999999999999999999999999998643 2334567789999999988877
Q ss_pred ceeEecceeccC------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEE
Q 013941 154 RCVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (433)
Q Consensus 154 ~~v~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli 227 (433)
+++++++... ..+|+||||++++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 83 --v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~ 156 (359)
T cd07876 83 --ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 156 (359)
T ss_pred --eeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 9999988643 35799999998788887743 48899999999999999999999999999999999999
Q ss_pred eeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHH
Q 013941 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (433)
Q Consensus 228 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (433)
+.++ .+||+|||++...... .....||..|+|||++.+..++.++||||||
T Consensus 157 ~~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 209 (359)
T cd07876 157 KSDC---------------------------TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209 (359)
T ss_pred CCCC---------------------------CEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHH
Confidence 7655 4667777766543221 2335789999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 306 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|++|+|++|+.||.+.+.......+.+.++.++..+..........+...... ++.. . ....+.....+ ...
T Consensus 210 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~----~~~~~~~~~~~-~~~ 281 (359)
T cd07876 210 CIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQ--YPGI-S----FEELFPDWIFP-SES 281 (359)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCC--CCCc-c----hhhhccccccc-ccc
Confidence 99999999999999988888888888888777766555443333333221111 1000 0 00000000000 000
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
......+..+++||.+||+.||++|||+.|+|+||||...
T Consensus 282 ~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 282 ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred ccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 1112346689999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=360.24 Aligned_cols=276 Identities=32% Similarity=0.522 Sum_probs=210.8
Q ss_pred CCeEEeccccccccEEEEEEEecC-CCcEEEEEEeccch---hhHHHHHHHHHHHHHHH---hCCCCCcceeEecceec-
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLA---RHDIGGTRCVQIRNWFD- 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~---~~~i~~~~~v~~~~~~~- 163 (433)
++|++.+.||+|+||.||+|++.. +++.||+|+++... .......+|+.+++.+. |+|+ +++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpni-----v~~~~~~~~ 75 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDVCTV 75 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCc-----ceEEEEEec
Confidence 369999999999999999999854 56889999986432 22345667888877764 5555 99998874
Q ss_pred ----cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 164 ----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 164 ----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
....+++||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-------- 147 (290)
T cd07862 76 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-------- 147 (290)
T ss_pred ccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC--------
Confidence 34679999999988999999876555789999999999999999999999999999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 148 -------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~ 208 (290)
T cd07862 148 -------------------QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208 (290)
T ss_pred -------------------CEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCC
Confidence 4666777766543222 2335789999999999988999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+..+.+..+....+.++...+..........+. ..............+..+.+
T Consensus 209 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~ 265 (290)
T cd07862 209 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH-----------------------SKSAQPIEKFVTDIDELGKD 265 (290)
T ss_pred cCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhcc-----------------------CCCCCCHHHHccCCCHHHHH
Confidence 9999888888888776654432211110000000000 00001111222346778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
||.+||+.||++|||+.|+|+||||
T Consensus 266 li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 266 LLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHhccCchhcCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=369.68 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=199.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
..|+++++||+|+||.||+|++..+++.||||++... ......+.+|+++++.++|+|| +++++++...+.++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV-----VKCHDMFDHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCc-----ceeeeEeccCCeEE
Confidence 4588899999999999999999999999999998643 2345667899999999998887 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 149 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----------------- 205 (353)
T PLN00034 149 VLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK----------------- 205 (353)
T ss_pred EEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-----------------
Confidence 999999 8888643 2467888899999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-----CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+||+|||++...... .....||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 206 ----------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 206 ----------NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ----------CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 4566666666543321 123579999999998753 2245789999999999999999999974
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....+....+.......+ ......++.++.+||.
T Consensus 276 ~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~l~~li~ 309 (353)
T PLN00034 276 GRQGDWASLMCAICMSQP----------------------------------------------PEAPATASREFRHFIS 309 (353)
T ss_pred CCCccHHHHHHHHhccCC----------------------------------------------CCCCCccCHHHHHHHH
Confidence 332222111111100000 0112345678999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
+||+.||++|||+.|+++||||.+...+.
T Consensus 310 ~~l~~~P~~Rpt~~ell~hp~~~~~~~~~ 338 (353)
T PLN00034 310 CCLQREPAKRWSAMQLLQHPFILRAQPGQ 338 (353)
T ss_pred HHccCChhhCcCHHHHhcCcccccCCccc
Confidence 99999999999999999999999985543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=371.67 Aligned_cols=279 Identities=23% Similarity=0.310 Sum_probs=212.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||+||+|++..+++.||||++++.. .....+.+|+.++..+.|+++ +++++.+.+.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~i-----v~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWV-----VKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCCe
Confidence 36999999999999999999999999999999997532 233456779999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999 999999998764 799999999999999999999999999999999999999999999999988765432
Q ss_pred CCCcccCCCCCCCeeeecCCCCccc------------cCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFE------------HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g 314 (433)
...... ..........|+...... .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 154 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 154 AHRTEF-YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred cccccc-cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 111000 000000011122111100 0011235899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
..||.+.+.......+......+ .++ ....++.+
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~----------------------~~p------------------------~~~~~s~~ 266 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKETL----------------------IFP------------------------PEVPISEK 266 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcCcc----------------------cCC------------------------CcCCCCHH
Confidence 99998877666555443321110 000 01134678
Q ss_pred HHHHHHHhcccCCCC---CCCHHHHhcCCCCCCC
Q 013941 395 LIDLLQGLLRYDPAE---RLKAREALRHPFFTRD 425 (433)
Q Consensus 395 l~~li~~~L~~dP~~---R~ta~ell~hp~f~~~ 425 (433)
+++||.+|+. +|.+ ||+++||++||||++.
T Consensus 267 ~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 267 AKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred HHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 9999999876 4554 5799999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=368.60 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=214.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|++..+++.||||++++.. .....+.+|+.++..+.|+++ +++++++...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----v~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL-----VKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCC-----ccEEEEEEcCCE
Confidence 36999999999999999999999999999999997532 233556789999999988887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--------------- 138 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG--------------- 138 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---------------
Confidence 99999999 999999998654 689999999999999999999999999999999999996554
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.
T Consensus 139 ------------~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 206 (333)
T cd05600 139 ------------HIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206 (333)
T ss_pred ------------CEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence 57888888877655544556899999999999999999999999999999999999999988776655
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+......+ ..+.. ......++.++.+||.+||..+
T Consensus 207 ~~~i~~~~~~~----------------------~~~~~--------------------~~~~~~~s~~~~~li~~~l~~~ 244 (333)
T cd05600 207 WENLKYWKETL----------------------QRPVY--------------------DDPRFNLSDEAWDLITKLINDP 244 (333)
T ss_pred HHHHHhccccc----------------------cCCCC--------------------CccccccCHHHHHHHHHHhhCh
Confidence 54443321100 00000 0000234678999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013941 407 PAERLKAREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~ 425 (433)
|.+|++++++++||||.+.
T Consensus 245 ~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 245 SRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred hhhcCCHHHHHhCcccCCC
Confidence 9999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=366.82 Aligned_cols=301 Identities=27% Similarity=0.447 Sum_probs=226.0
Q ss_pred ceeeecCC---ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcc
Q 013941 81 HYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR 154 (433)
Q Consensus 81 ~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~ 154 (433)
+|.+..++ .+.++|++.+.||+|+||.||+|.+..+++.||||++... ........+|+.+++.++|+|+
T Consensus 3 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni---- 78 (355)
T cd07874 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI---- 78 (355)
T ss_pred ceeeccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCch----
Confidence 45566655 3468999999999999999999999999999999998643 2334567789999999999888
Q ss_pred eeEecceeccC------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe
Q 013941 155 CVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (433)
Q Consensus 155 ~v~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~ 228 (433)
+++++++... ...|+||||+.++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 79 -v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~ 153 (355)
T cd07874 79 -ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_pred -hceeeeeeccccccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC
Confidence 8888877543 45799999997788887754 488999999999999999999999999999999999997
Q ss_pred eCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHH
Q 013941 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (433)
Q Consensus 229 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (433)
.++ .+||+|||++...... .....||..|+|||++.+..++.++|||||||
T Consensus 154 ~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 206 (355)
T cd07874 154 SDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206 (355)
T ss_pred CCC---------------------------CEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHH
Confidence 655 4677777776544332 22357899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhh
Q 013941 307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386 (433)
Q Consensus 307 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
++|+|++|+.||.+.+..+....+...++.....+..........+........ . ..... .... ........
T Consensus 207 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~----~~~~-~~~~~~~~ 278 (355)
T cd07874 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA--G-LTFPK----LFPD-SLFPADSE 278 (355)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccc--c-ccchh----hccc-cccccccc
Confidence 999999999999998887777777777776665554443333333322111100 0 00000 0000 00000011
Q ss_pred ccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 387 ~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.....+.++++||.+||+.||++|||+.|+|+||||...
T Consensus 279 ~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 279 HNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 122346688999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=372.30 Aligned_cols=280 Identities=25% Similarity=0.397 Sum_probs=214.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.++..++|+++ +++++++.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV-----VKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceEEEEEcCCe
Confidence 36999999999999999999999999999999997532 233456789999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999 999999998764 699999999999999999999999999999999999999999999999998765432
Q ss_pred CCCc--ccCCCCCCCeeeecCCCCccccC------------CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHH
Q 013941 247 DGSY--FKNLPKSSAIKLIDFGSTTFEHQ------------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 247 ~~~~--~~~~~~~~~~kl~Dfg~a~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (433)
.... ..........-..++........ .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 2110 00000000000011111100000 111247999999999999989999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|..||.+.+.......+......+ ..+ ....++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------~~~------------------------~~~~~s 267 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKETL----------------------QFP------------------------DEVPLS 267 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCcc----------------------CCC------------------------CCCCCC
Confidence 9999998877655444332211000 000 011346
Q ss_pred HHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLK---AREALRHPFFTRD 425 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~t---a~ell~hp~f~~~ 425 (433)
+++.+||.+||. +|.+|++ ++|+++||||+..
T Consensus 268 ~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 268 PEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred HHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 789999999997 9999998 9999999999863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=364.88 Aligned_cols=291 Identities=27% Similarity=0.451 Sum_probs=221.4
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC-
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~- 165 (433)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.|+|+ +++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----i~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI-----IGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCc-----cccceeecccc
Confidence 457899999999999999999999999999999998643 2334567789999999999888 8888776542
Q ss_pred -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
..+|+||||++++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--------- 163 (364)
T cd07875 97 SLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--------- 163 (364)
T ss_pred cccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC---------
Confidence 46899999998889888754 488999999999999999999999999999999999997655
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 164 ------------------~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 164 ------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred ------------------cEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 4677777777654332 12357899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+..+....+....+.++..+..........+........ . . ......... ............+..+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~----~~~~~~~~~-~~~~~~~~~~~~~~~~~dl 297 (364)
T cd07875 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA--G-Y----SFEKLFPDV-LFPADSEHNKLKASQARDL 297 (364)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcC--C-C----ChHhhCccc-cccccccccccccHHHHHH
Confidence 999888888888887777666554443333222221110000 0 0 000000000 0000011112235688999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
|.+||+.||++|||++|+|+||||..
T Consensus 298 l~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 298 LSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHhcCcCcccCCCHHHHhcCccccc
Confidence 99999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=363.29 Aligned_cols=242 Identities=30% Similarity=0.482 Sum_probs=201.1
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
||+|+||.||+|++..+++.||+|+++.. ......+.+|+.++.+++|++| +++++++...+..|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI-----VPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcE-----eceeeEEecCCeEEEEEcCC
Confidence 79999999999999999999999998643 2233556789999999988877 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~----------------------- 130 (312)
T cd05585 76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG----------------------- 130 (312)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-----------------------
Confidence 999999998754 799999999999999999999999999999999999997655
Q ss_pred CCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~ 331 (433)
.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 131 ----~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 131 ----HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred ----cEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 467777777654221 1233579999999999999999999999999999999999999998766554443332
Q ss_pred HHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCC
Q 013941 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 411 (433)
Q Consensus 332 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ 411 (433)
.... ......+.++.+||.+||+.||++|+
T Consensus 207 ~~~~--------------------------------------------------~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 207 QEPL--------------------------------------------------RFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred cCCC--------------------------------------------------CCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 2110 11134567899999999999999997
Q ss_pred ---CHHHHhcCCCCCCC
Q 013941 412 ---KAREALRHPFFTRD 425 (433)
Q Consensus 412 ---ta~ell~hp~f~~~ 425 (433)
++.|+++||||.+.
T Consensus 237 ~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 237 GYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCCHHHHHcCCCcCCC
Confidence 58999999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=363.72 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=206.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+|++++.||+|+||.||+|++..+++.||||++.+.. ...+....|+.++..+.|++ +++.+++++.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~----~i~~~~~~~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP----FLTQLHSCFQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCC----ceeeeEEEEEcCCEE
Confidence 4899999999999999999999999999999987532 33455677888888887653 348889999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~---------------- 138 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG---------------- 138 (324)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC----------------
Confidence 9999999 999999997664 689999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.++|+|||++.... ......+||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 139 -----------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (324)
T cd05587 139 -----------HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207 (324)
T ss_pred -----------CEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 46677777654321 1223357999999999999999999999999999999999999999887766
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+....... ....+.++.++|.+||.
T Consensus 208 ~~~~~i~~~~~~~--------------------------------------------------~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 208 ELFQSIMEHNVSY--------------------------------------------------PKSLSKEAVSICKGLLT 237 (324)
T ss_pred HHHHHHHcCCCCC--------------------------------------------------CCCCCHHHHHHHHHHhh
Confidence 5554443321111 12346789999999999
Q ss_pred cCCCCCCCH-----HHHhcCCCCCC
Q 013941 405 YDPAERLKA-----REALRHPFFTR 424 (433)
Q Consensus 405 ~dP~~R~ta-----~ell~hp~f~~ 424 (433)
.||++|+++ +++++||||.+
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999976 89999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=358.08 Aligned_cols=282 Identities=28% Similarity=0.487 Sum_probs=221.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.++||+|+||.||+|++..+++.||+|.++... .......+|+.++++++|+++ +++++++..++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIVHTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCc-----ceEEEEEeeCCeEE
Confidence 57999999999999999999999999999999986432 233456789999999998887 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~------------------ 141 (309)
T cd07872 81 LVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG------------------ 141 (309)
T ss_pred EEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------------------
Confidence 999999779999887654 3589999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||++...... .....+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+
T Consensus 142 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 142 ---------ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred ---------CEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4666777766543221 1224678999999998764 58899999999999999999999999988888
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+.+..+..+...+.......... . ...+. ..+.........++.++++||.+||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~ 272 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFK-N----YNFPK---------------YKPQPLINHAPRLDTEGIELLTKFLQY 272 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhh-h----hhcCc---------------cCCCchhhhccCCCHHHHHHHHHhccC
Confidence 888888888777665433221110000 0 00000 000011122245677899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q 013941 406 DPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~ 426 (433)
||.+|+|++|+++||||+...
T Consensus 273 dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 273 ESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred ChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=370.96 Aligned_cols=279 Identities=24% Similarity=0.367 Sum_probs=210.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.|++++.||+|+||+||+|++..+++.||||++.+.. .....+.+|+.+++.+.|+++ +++++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWV-----VKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCe-----eeeEEEEecCCEE
Confidence 5899999999999999999999999999999997532 234567789999999988877 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999 999999998764 6999999999999999999999999999999999999999999999999986543211
Q ss_pred CC--cccC------CCCCC-----CeeeecCCCCc-------c---ccCCCcccccCCcccchhhhhCCCCCccchHHHH
Q 013941 248 GS--YFKN------LPKSS-----AIKLIDFGSTT-------F---EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (433)
Q Consensus 248 ~~--~~~~------~~~~~-----~~kl~Dfg~a~-------~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (433)
.. .+.. ..... ....+.++... . ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 10 0000 00000 00001111000 0 0001123579999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 305 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
||++|||++|..||...+.......+......+ .+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------~~----------------------- 269 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTL----------------------HI----------------------- 269 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc----------------------CC-----------------------
Confidence 999999999999998776554443332211000 00
Q ss_pred hhccCCchHHHHHHHHHhccc--CCCCCCCHHHHhcCCCCCC
Q 013941 385 MQHVDHSAGDLIDLLQGLLRY--DPAERLKAREALRHPFFTR 424 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~--dP~~R~ta~ell~hp~f~~ 424 (433)
.....+++++.+||.+||.. ++..|++++|+++||||++
T Consensus 270 -~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 270 -PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred -CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 01123577899999996654 4555999999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=368.16 Aligned_cols=281 Identities=25% Similarity=0.426 Sum_probs=220.0
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC---
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~--- 166 (433)
.|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++|+|+ +++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV-----LSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCc-----CCHhheecCCCccc
Confidence 378899999999999999999999999999998642 2234567789999999999888 99999988766
Q ss_pred --eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 167 --HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 167 --~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
..|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~------------ 141 (372)
T cd07853 76 FEEIYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV------------ 141 (372)
T ss_pred cceEEEEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC------------
Confidence 899999999889998887654 7999999999999999999999999999999999999976654
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
+||+|||++...... .....+|..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 142 ---------------~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 142 ---------------LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred ---------------EEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 566666655433211 1224678999999999875 47899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
+.+..+.+..+.+.++..+...+.........++...... . .............+.++.+||
T Consensus 207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~-~-----------------~~~~~~~~~~~~~~~~~~~li 268 (372)
T cd07853 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK-P-----------------PSLPVLYTLSSQATHEAVHLL 268 (372)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCC-C-----------------CchHHhcccCCCCCHHHHHHH
Confidence 9999999999998888776544433222222211111000 0 000001112234577899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.+||+.||++|||+.|+++||||.+.
T Consensus 269 ~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 269 CRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=364.95 Aligned_cols=243 Identities=26% Similarity=0.443 Sum_probs=201.7
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
+.||+|+||.||+|++..+++.||+|++.+.. .....+.+|+.+++.+.|+++ +++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL-----TSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997532 233566789999999988887 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCccc
Q 013941 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~ 252 (433)
|+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 y~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--------------------- 132 (328)
T cd05593 76 YVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG--------------------- 132 (328)
T ss_pred CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC---------------------
Confidence 99 999999887654 799999999999999999999999999999999999997655
Q ss_pred CCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 253 NLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......
T Consensus 133 ------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 133 ------HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred ------cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 467777776654221 12235799999999999988999999999999999999999999987665544333
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
+...... ....++.++.+||.+||+.||++
T Consensus 207 ~~~~~~~--------------------------------------------------~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 207 ILMEDIK--------------------------------------------------FPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred hccCCcc--------------------------------------------------CCCCCCHHHHHHHHHHcCCCHHH
Confidence 2211111 12345678999999999999999
Q ss_pred CC-----CHHHHhcCCCCCC
Q 013941 410 RL-----KAREALRHPFFTR 424 (433)
Q Consensus 410 R~-----ta~ell~hp~f~~ 424 (433)
|+ ++.|+++||||..
T Consensus 237 R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 237 RLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=353.98 Aligned_cols=278 Identities=31% Similarity=0.521 Sum_probs=211.3
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-----
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----- 164 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~----- 164 (433)
+|++.+.||+|+||+||+|++..+++.||+|.++... .......+|+.+++.+.+- .|+|++++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF--DHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhc--CCCCeeeeeeeeccccCCC
Confidence 5899999999999999999999999999999986432 2233556788888877421 23455999988754
Q ss_pred CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
...+++||||+.++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~------------- 145 (288)
T cd07863 79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG------------- 145 (288)
T ss_pred CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-------------
Confidence 3568999999977999998876545699999999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|.+||.+..
T Consensus 146 --------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 146 --------------QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred --------------CEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 4666777766543322 223478999999999998899999999999999999999999999888
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+.+..+....+......+.... ..+...- ..............++..+.+||.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (288)
T cd07863 212 EADQLGKIFDLIGLPPEDDWPRDV-------------TLPRGAF----------SPRGPRPVQSVVPEIEESGAQLLLEM 268 (288)
T ss_pred HHHHHHHHHHHhCCCChhhCcccc-------------ccccccc----------CCCCCCchHHhCcCcCHHHHHHHHHH
Confidence 877777777665543321111000 0000000 00000111122345677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 013941 403 LRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f 422 (433)
|+.||++|||+.|+++||||
T Consensus 269 L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 269 LTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=371.87 Aligned_cols=277 Identities=25% Similarity=0.396 Sum_probs=212.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|+++++||+|+||.||+|.+..+++.||||++.+.. .....+.+|+.+++.+.|+++ +++++++.+.++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWV-----VSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCe
Confidence 36999999999999999999999999999999986532 233556789999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999 999999997654 799999999999999999999999999999999999999999999999998754322
Q ss_pred CCC--cccCC----------CCCCCe-------------eeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchH
Q 013941 247 DGS--YFKNL----------PKSSAI-------------KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 247 ~~~--~~~~~----------~~~~~~-------------kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (433)
... .+..+ +....+ ++.+++.+... .....+||+.|+|||++.+..++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--cccccCCCccccCHHHHccCCCCCceee
Confidence 110 00000 000000 01111111100 0112479999999999999899999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCch
Q 013941 302 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381 (433)
Q Consensus 302 wSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (433)
|||||++|||++|..||.+.+..+....+...... ..++.
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~p~------------------ 271 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRET----------------------LYFPD------------------ 271 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc----------------------cCCCC------------------
Confidence 99999999999999999877665554444321100 01110
Q ss_pred hhhhhccCCchHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCC
Q 013941 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAER---LKAREALRHPFFTR 424 (433)
Q Consensus 382 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R---~ta~ell~hp~f~~ 424 (433)
...++.++.+||.+||. +|.+| +|+.|+++||||++
T Consensus 272 ------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 272 ------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred ------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 12346789999999998 77776 59999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=364.14 Aligned_cols=282 Identities=28% Similarity=0.519 Sum_probs=219.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++|+|+ +++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV-----IGLLDVFTPA 86 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCch-----hhhhhhhccc
Confidence 34578999999999999999999999999999999986532 233456789999999999887 8888877532
Q ss_pred ------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
...|++|++++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-------- 155 (343)
T cd07878 87 TSIENFNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-------- 155 (343)
T ss_pred ccccccCcEEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC--------
Confidence 468999999999999888643 599999999999999999999999999999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++...........||..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 156 -------------------~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 156 -------------------ELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred -------------------CEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 4677777777665555555689999999999987 46899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhh-hhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
.+.+..+.+..+....+..+.......... ...+...- +. ... ..........++.+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------------~~~-~~~~~~~~~~~~~~~~ 276 (343)
T cd07878 217 PGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL-----PH--------------MPQ-QDLKKIFRGANPLAID 276 (343)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhcc-----cc--------------ccc-hhHHHhccCCCHHHHH
Confidence 988888888888777766655443322110 01110000 00 000 0001112234567899
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||+.||++|||+.|+++||||.+.
T Consensus 277 li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 277 LLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=364.27 Aligned_cols=250 Identities=28% Similarity=0.449 Sum_probs=210.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.|..++.||+|+||.||+|.+..+++.||+|++.-.. ...+.+.+|+.+|..+.+++| .++++.|..+..+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~i-----t~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNI-----TEYYGSYLKGTKLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchH-----HhhhhheeecccHHH
Confidence 4888899999999999999999999999999997533 345678889999999998777 899999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+|||| ||++.+.+.... .+.+..+..++++++.||.|||.++.+|||||+.|||+...|
T Consensus 89 iMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g------------------ 148 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG------------------ 148 (467)
T ss_pred HHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC------------------
Confidence 99999 999999998765 568999999999999999999999999999999999997765
Q ss_pred cccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||.+..... ...+++||+.|||||++.+..|+.++||||||++.+||++|.+|+........
T Consensus 149 ---------~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv 219 (467)
T KOG0201|consen 149 ---------DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV 219 (467)
T ss_pred ---------cEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE
Confidence 567777777654432 23567999999999999988999999999999999999999999987665322
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
+..| |... .| .....+++.+++||..||++|
T Consensus 220 lflI-------pk~~--------------------------------------PP----~L~~~~S~~~kEFV~~CL~k~ 250 (467)
T KOG0201|consen 220 LFLI-------PKSA--------------------------------------PP----RLDGDFSPPFKEFVEACLDKN 250 (467)
T ss_pred EEec-------cCCC--------------------------------------CC----ccccccCHHHHHHHHHHhhcC
Confidence 2111 1100 00 111256788999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 013941 407 PAERLKAREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~ 425 (433)
|+.||+|.++|+|+|++..
T Consensus 251 P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 251 PEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred cccCcCHHHHhhhHHHHhc
Confidence 9999999999999999983
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=368.24 Aligned_cols=280 Identities=26% Similarity=0.399 Sum_probs=213.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|++..+++.||||+++... .....+..|+.++..+.|+++ +++++++.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI-----VKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCc-----cchhhheecCCe
Confidence 36999999999999999999999999999999997532 334567789999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999 999999998763 799999999999999999999999999999999999999888777777776654433
Q ss_pred CCCcccCCCCCCC-eeeecCC----CCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 247 DGSYFKNLPKSSA-IKLIDFG----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~-~kl~Dfg----~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
............. ....... .............||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 2210000000000 0000000 0000001112357999999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+.......+....... .. .....+++++.+||.+
T Consensus 234 ~~~~~~~~i~~~~~~~----------------------~~------------------------p~~~~~~~~~~~li~~ 267 (350)
T cd05573 234 TLQETYNKIINWKESL----------------------RF------------------------PPDPPVSPEAIDLICR 267 (350)
T ss_pred CHHHHHHHHhccCCcc----------------------cC------------------------CCCCCCCHHHHHHHHH
Confidence 7555444443211100 00 0011247789999999
Q ss_pred hcccCCCCCCC-HHHHhcCCCCCCC
Q 013941 402 LLRYDPAERLK-AREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~t-a~ell~hp~f~~~ 425 (433)
||. ||.+|++ ++++++||||++.
T Consensus 268 ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 268 LLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred Hcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 998 9999999 9999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=363.17 Aligned_cols=244 Identities=25% Similarity=0.413 Sum_probs=201.2
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
+.||+|+||.||+|++..+|+.||+|+++... .....+.+|+.+++.+.|+++ +++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----cceeeEEecCCEEEEEEe
Confidence 46999999999999999999999999987532 233456679999999998887 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCccc
Q 013941 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~ 252 (433)
|+ +++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-------------------- 133 (323)
T cd05595 76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-------------------- 133 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--------------------
Confidence 99 999999887654 7999999999999999999999999999999999999977664
Q ss_pred CCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 253 NLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......
T Consensus 134 -------~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~ 206 (323)
T cd05595 134 -------IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206 (323)
T ss_pred -------EEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 55556655443211 11234789999999999998999999999999999999999999987665554443
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
+...... ....+++++.+||.+||+.||++
T Consensus 207 ~~~~~~~--------------------------------------------------~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 207 ILMEEIR--------------------------------------------------FPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred HhcCCCC--------------------------------------------------CCCCCCHHHHHHHHHHccCCHHH
Confidence 3221111 11245678999999999999999
Q ss_pred CC-----CHHHHhcCCCCCCC
Q 013941 410 RL-----KAREALRHPFFTRD 425 (433)
Q Consensus 410 R~-----ta~ell~hp~f~~~ 425 (433)
|+ ++.++++||||.+.
T Consensus 237 R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 237 RLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCC
Confidence 98 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=371.41 Aligned_cols=278 Identities=27% Similarity=0.413 Sum_probs=212.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+|+++++||+|+||.||+|++..+++.||+|++.+.. .....+.+|+.+++.+.|+++ +++++.+.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~i-----v~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWV-----VRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcC-----CeEEEEEEeCCEE
Confidence 5999999999999999999999999999999987532 234567789999999988877 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||| +|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999 999999997754 6899999999999999999999999999999999999999999999999986533211
Q ss_pred CC--cccCCCCCCCeeeecCCC---------------------Ccc-ccCCCcccccCCcccchhhhhCCCCCccchHHH
Q 013941 248 GS--YFKNLPKSSAIKLIDFGS---------------------TTF-EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303 (433)
Q Consensus 248 ~~--~~~~~~~~~~~kl~Dfg~---------------------a~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 303 (433)
.. .... .....-...+|.. +.. ........+||+.|+|||++.+..++.++||||
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 155 HDSKYYQS-GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccc-ccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 10 0000 0000000001100 000 000112357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhh
Q 013941 304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383 (433)
Q Consensus 304 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
|||++|||++|+.||.+.+..+....+....... ..
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------~~---------------------- 269 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL----------------------HI---------------------- 269 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc----------------------CC----------------------
Confidence 9999999999999998876655443332211100 00
Q ss_pred hhhccCCchHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCC
Q 013941 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLK---AREALRHPFFTRD 425 (433)
Q Consensus 384 ~~~~~~~~~~~l~~li~~~L~~dP~~R~t---a~ell~hp~f~~~ 425 (433)
.....+++++.++|.+|+ .||.+|++ ++|+++||||+..
T Consensus 270 --p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 270 --PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred --CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 011245778999999986 59999997 9999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=359.52 Aligned_cols=298 Identities=23% Similarity=0.317 Sum_probs=211.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.++|++++.||+|+||.||+|++..++..||+|++... ......+.+|++++++++|+|+ +++++++..++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEECCEE
Confidence 36799999999999999999999999999999998753 2345678899999999998888 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
++||||+ +++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--------------- 141 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG--------------- 141 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC---------------
Confidence 9999999 899999998754 689999999999999999999986 699999999999997665
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus 142 ------------~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 142 ------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred ------------cEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 456666666543322 2233578999999999999899999999999999999999999998766544
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCC-CCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG-ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
....+..................... .......... ..........................++.++++||.+||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 286 (331)
T cd06649 210 LEAIFGRPVVDGEEGEPHSISPRPRP---PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLI 286 (331)
T ss_pred HHHHhcccccccccCCccccCccccc---ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHcc
Confidence 32222110000000000000000000 0000000000 0000000000000000000000112457799999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||++|||++|+++||||+..
T Consensus 287 ~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 287 KNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred CCcccCCCHHHHhcChHHhhc
Confidence 999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=363.46 Aligned_cols=252 Identities=31% Similarity=0.552 Sum_probs=224.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe-
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH- 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~- 167 (433)
++|.+++.+|+|+||.+++++++..++.|++|.+.- ....+....+|+.+++++.||+| |.+.+.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~i-----v~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNI-----VEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCe-----eeeccchhcCCce
Confidence 579999999999999999999999999999999864 33455678899999999999988 999999998887
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+||||+|| ||+|.+.+.+.....++++.+..++.||+.|+.|||+++|+|||||+.|||++.++
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~--------------- 143 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK--------------- 143 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC---------------
Confidence 99999999 99999999877767899999999999999999999999999999999999986544
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.|+|+|||+|+...... .+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|.+.+.
T Consensus 144 ------------~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 144 ------------KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred ------------ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 57889999888766543 557999999999999999999999999999999999999999999998
Q ss_pred HHHHHHHHHHh-cCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 324 LEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 324 ~~~~~~i~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
......|.+.. .++| ..++.+++.+|..|
T Consensus 212 ~~Li~ki~~~~~~Plp--------------------------------------------------~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 212 SELILKINRGLYSPLP--------------------------------------------------SMYSSELRSLVKSM 241 (426)
T ss_pred HHHHHHHhhccCCCCC--------------------------------------------------ccccHHHHHHHHHH
Confidence 88888777654 2332 34577999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|..+|..||+|.++|.+|.+...
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999988743
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=361.27 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=200.2
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..+++.||||++.+.. ........|..++..+ .|+++ +++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----v~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-----TQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCch-----hceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999987532 2334556788888766 46655 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-------------------- 133 (320)
T cd05590 76 EFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-------------------- 133 (320)
T ss_pred cCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--------------------
Confidence 999 899999987764 799999999999999999999999999999999999997665
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.++|+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 134 -------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (320)
T cd05590 134 -------HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206 (320)
T ss_pred -------cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 46666776654321 12233579999999999999899999999999999999999999998877666555
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+....... ....+.++.+||.+||+.||+
T Consensus 207 ~i~~~~~~~--------------------------------------------------~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 207 AILNDEVVY--------------------------------------------------PTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred HHhcCCCCC--------------------------------------------------CCCCCHHHHHHHHHHcccCHH
Confidence 443211111 123467899999999999999
Q ss_pred CCCCH------HHHhcCCCCCC
Q 013941 409 ERLKA------REALRHPFFTR 424 (433)
Q Consensus 409 ~R~ta------~ell~hp~f~~ 424 (433)
+|+++ +++++||||+.
T Consensus 237 ~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 237 MRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HCCCCCCCCCHHHHHcCCCcCC
Confidence 99998 99999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=371.10 Aligned_cols=277 Identities=24% Similarity=0.375 Sum_probs=211.3
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+|++++.||+|+||.||+|++..+++.||||++.+.. .....+.+|+.++..+.|+++ +++++.+.+++.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~~~~~~~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWV-----VKLYYSFQDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCEE
Confidence 6999999999999999999999999999999986532 234557789999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999 999999998764 6899999999999999999999999999999999999999999999999886432211
Q ss_pred --CCcccCCCCCCCeeeecCCCC---------------cc---ccCCCcccccCCcccchhhhhCCCCCccchHHHHHHH
Q 013941 248 --GSYFKNLPKSSAIKLIDFGST---------------TF---EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307 (433)
Q Consensus 248 --~~~~~~~~~~~~~kl~Dfg~a---------------~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 307 (433)
...+... ........+.... .. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 155 HDSKYYQKG-DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred ccccccccc-cccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0000000 0000000000000 00 0001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 308 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 308 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
+|||++|+.||.+.+..+....+....... ....
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------------------~~~~ 267 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETTL----------------------------------------------HIPS 267 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCccc----------------------------------------------cCCC
Confidence 999999999998876655443332111000 0011
Q ss_pred cCCchHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCC
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERL---KAREALRHPFFTR 424 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~---ta~ell~hp~f~~ 424 (433)
...++.++.++|.+|+ .+|.+|+ |+.|+++||||+.
T Consensus 268 ~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 268 QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 1245778999999976 5999999 9999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=359.91 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=201.6
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
|++++.||+|+||.||+|.+..+++.||||++++.. ...+.+.+|+.++..+. .+.|+|++++++++.+.+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~--~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN--SERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc--ccCCCChhceeeEEEcCCEEE
Confidence 788999999999999999999999999999997532 22345566766665432 123344499999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~----------------- 138 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG----------------- 138 (324)
T ss_pred EEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-----------------
Confidence 999999 99999888653 599999999999999999999999999999999999997665
Q ss_pred CcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 139 ----------~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~ 208 (324)
T cd05589 139 ----------FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208 (324)
T ss_pred ----------cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence 45666666654321 12234579999999999999899999999999999999999999998877665
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+....... ...++..+.+||.+||+.
T Consensus 209 ~~~~i~~~~~~~--------------------------------------------------p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 209 VFDSIVNDEVRY--------------------------------------------------PRFLSREAISIMRRLLRR 238 (324)
T ss_pred HHHHHHhCCCCC--------------------------------------------------CCCCCHHHHHHHHHHhhc
Confidence 554443221111 123467899999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCCC
Q 013941 406 DPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~-----ta~ell~hp~f~~~ 425 (433)
||++|| +++++++||||++.
T Consensus 239 dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 239 NPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999 79999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=359.04 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=197.8
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..+++.||+|+++... ........|..++..+ .|+++ +++++++.+.+++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFL-----THLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCc-----cCeeEEEEeCCEEEEEE
Confidence 47999999999999999999999999997532 2334456677777654 55555 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-------------------- 133 (316)
T cd05620 76 EFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-------------------- 133 (316)
T ss_pred CCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--------------------
Confidence 999 999999987754 689999999999999999999999999999999999997665
Q ss_pred cCCCCCCCeeeecCCCCccc---cCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.++|+|||++... ........||..|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~ 206 (316)
T cd05620 134 -------HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206 (316)
T ss_pred -------CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 4566666665432 112234579999999999999999999999999999999999999998776655444
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+....... ....+.++.+||.+||+.||+
T Consensus 207 ~~~~~~~~~--------------------------------------------------~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 207 SIRVDTPHY--------------------------------------------------PRWITKESKDILEKLFERDPT 236 (316)
T ss_pred HHHhCCCCC--------------------------------------------------CCCCCHHHHHHHHHHccCCHH
Confidence 332211111 123466899999999999999
Q ss_pred CCCCH-HHHhcCCCCCCC
Q 013941 409 ERLKA-REALRHPFFTRD 425 (433)
Q Consensus 409 ~R~ta-~ell~hp~f~~~ 425 (433)
+|+++ +++++||||...
T Consensus 237 ~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 237 RRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HcCCChHHHHcCCCcCCC
Confidence 99997 589999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=365.96 Aligned_cols=254 Identities=25% Similarity=0.415 Sum_probs=207.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++.+.||+|+||.||+|++..+++.||+|++.+.. .....+.+|+.+++.++|+++ +++++++.+++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~i-----v~~~~~~~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI-----VQLHYAFQDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCC
Confidence 357999999999999999999999999999999986432 223446689999999988887 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-------------- 179 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------------- 179 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC--------------
Confidence 999999999 99999998764 589999999999999999999999999999999999997665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCC----CCCccchHHHHHHHHHHHHhCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL----GWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|..|
T Consensus 180 -------------~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 246 (370)
T cd05596 180 -------------HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (370)
T ss_pred -------------CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence 4666677666543221 1235799999999998754 378999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+.......+...... ..++. ...++.++.+
T Consensus 247 f~~~~~~~~~~~i~~~~~~----------------------~~~~~------------------------~~~~s~~~~~ 280 (370)
T cd05596 247 FYADSLVGTYSKIMDHKNS----------------------LTFPD------------------------DIEISKQAKD 280 (370)
T ss_pred cCCCCHHHHHHHHHcCCCc----------------------CCCCC------------------------cCCCCHHHHH
Confidence 9887765554444321110 01111 1235779999
Q ss_pred HHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAE--RLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~--R~ta~ell~hp~f~~~ 425 (433)
||.+||+.+|.+ |+|++|+++||||++.
T Consensus 281 li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 281 LICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=362.54 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=201.0
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
+.||+|+||.||+|++..+++.||+|++.... .......+|+.++..+.|+++ +++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i-----~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-----TALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----CceEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997532 223456678899999888877 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
|+ +++|..++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 76 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-------------------- 133 (325)
T cd05594 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-------------------- 133 (325)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC--------------------
Confidence 99 999999887654 79999999999999999999997 7999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 134 -------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~ 206 (325)
T cd05594 134 -------HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206 (325)
T ss_pred -------CEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH
Confidence 467777776653211 1223579999999999999899999999999999999999999998766554443
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+...... ....+++++.+||.+||+.||+
T Consensus 207 ~i~~~~~~--------------------------------------------------~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 207 LILMEEIR--------------------------------------------------FPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred HHhcCCCC--------------------------------------------------CCCCCCHHHHHHHHHHhhcCHH
Confidence 33221111 1123467899999999999999
Q ss_pred CCC-----CHHHHhcCCCCCCC
Q 013941 409 ERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 409 ~R~-----ta~ell~hp~f~~~ 425 (433)
+|+ ++.++++||||.+.
T Consensus 237 ~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 237 QRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HhCCCCCCCHHHHhcCCCcCCC
Confidence 997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=359.08 Aligned_cols=243 Identities=22% Similarity=0.362 Sum_probs=200.1
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..+++.||+|++.+.. ........|..++..+ .|+++ +++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i-----~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL-----TALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCeEEEEE
Confidence 46999999999999999999999999987532 2334556788888765 45555 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-------------------- 133 (321)
T cd05591 76 EYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-------------------- 133 (321)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--------------------
Confidence 999 899999987654 799999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.++|+|||++.... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 134 -------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 206 (321)
T cd05591 134 -------HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206 (321)
T ss_pred -------CEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 46677777665321 11233578999999999999899999999999999999999999999877666555
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+....... ....+.++.+||.+||+.||+
T Consensus 207 ~i~~~~~~~--------------------------------------------------p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 207 SILHDDVLY--------------------------------------------------PVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred HHHcCCCCC--------------------------------------------------CCCCCHHHHHHHHHHhccCHH
Confidence 443321111 122466899999999999999
Q ss_pred CCC-------CHHHHhcCCCCCC
Q 013941 409 ERL-------KAREALRHPFFTR 424 (433)
Q Consensus 409 ~R~-------ta~ell~hp~f~~ 424 (433)
+|+ +++++++||||..
T Consensus 237 ~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 237 KRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HcCCCCCCCCCHHHHhcCCccCC
Confidence 999 9999999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=356.53 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=204.0
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+|++.+.||+|+||.||+|++..+++.||+|++.+.. ........|..++..+.|+ ++++.+++++...+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~----~~i~~~~~~~~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP----PFLTQLHSCFQTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCC----CeEeeEEEEEecCCEE
Confidence 4889999999999999999999999999999987532 2223455677777776543 4458899999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~---------------- 138 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG---------------- 138 (323)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC----------------
Confidence 9999999 999999987664 699999999999999999999999999999999999997665
Q ss_pred CCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 139 -----------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 139 -----------HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred -----------cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 46666666665321 1223357999999999999999999999999999999999999999887766
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+......+ +...+.++.+||.+||+
T Consensus 208 ~~~~~i~~~~~~~--------------------------------------------------p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 208 ELFQSIMEHNVAY--------------------------------------------------PKSMSKEAVAICKGLMT 237 (323)
T ss_pred HHHHHHHhCCCCC--------------------------------------------------CCcCCHHHHHHHHHHcc
Confidence 6555444322111 12346789999999999
Q ss_pred cCCCCCCC-----HHHHhcCCCCCC
Q 013941 405 YDPAERLK-----AREALRHPFFTR 424 (433)
Q Consensus 405 ~dP~~R~t-----a~ell~hp~f~~ 424 (433)
.||++|++ ..++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999997 489999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=364.00 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=205.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++.+.||+|+||.||+|++..+++.||+|++.+.. .....+.+|+.+++.+.|+++ +++++++.+++
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-----v~~~~~~~~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFCAFQDDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCC
Confidence 468999999999999999999999999999999986422 223456789999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-------------- 179 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-------------- 179 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--------------
Confidence 999999999 99999999754 589999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCC----CCccchHHHHHHHHHHHHhCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 180 -------------~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~P 246 (370)
T cd05621 180 -------------HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246 (370)
T ss_pred -------------CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCC
Confidence 4677777766543221 12457999999999997643 78999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+.......+...... ..++. ...++..+++
T Consensus 247 f~~~~~~~~~~~i~~~~~~----------------------~~~p~------------------------~~~~s~~~~~ 280 (370)
T cd05621 247 FYADSLVGTYSKIMDHKNS----------------------LNFPE------------------------DVEISKHAKN 280 (370)
T ss_pred CCCCCHHHHHHHHHhCCcc----------------------cCCCC------------------------cccCCHHHHH
Confidence 9887765555444331110 11111 1234678999
Q ss_pred HHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAE--RLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~--R~ta~ell~hp~f~~~ 425 (433)
+|.+||..++.+ |+|+.|+++||||+..
T Consensus 281 li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 281 LICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999865544 8899999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=357.00 Aligned_cols=304 Identities=27% Similarity=0.459 Sum_probs=231.3
Q ss_pred CceeeecCC---ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCc
Q 013941 80 GHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 80 ~~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
++|++..|+ .+.++|++.+.||+|+||.||+|.+..+++.||+|++.+. ......+.+|+.+++++.|+++
T Consensus 1 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--- 77 (353)
T cd07850 1 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI--- 77 (353)
T ss_pred CceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCC---
Confidence 356677766 5578999999999999999999999999999999998642 2333556789999999999887
Q ss_pred ceeEecceeccC------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEE
Q 013941 154 RCVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (433)
Q Consensus 154 ~~v~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli 227 (433)
+++++++... ...|+||||+.++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 78 --v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~ 151 (353)
T cd07850 78 --IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 151 (353)
T ss_pred --cceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 8888877543 46799999998899988864 38899999999999999999999999999999999999
Q ss_pred eeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHH
Q 013941 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (433)
Q Consensus 228 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (433)
+.++ .++|+|||++....... ....+|..|+|||++.+..++.++||||||
T Consensus 152 ~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 204 (353)
T cd07850 152 KSDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (353)
T ss_pred CCCC---------------------------CEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHH
Confidence 7655 46666776665433222 224678899999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 306 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|++|+|++|+.||...+.......+...++.++..+..........+........... ..........+....
T Consensus 205 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 277 (353)
T cd07850 205 CIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYS-------FEELFPDVLFPPDSE 277 (353)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcc-------hhhhCcccccCcccc
Confidence 9999999999999988888888888888888887776655444333332211110000 000000000001111
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
......+..+++||.+||+.||++|||+.|+|+||||+...
T Consensus 278 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 278 SHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred cccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 11234467889999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=360.63 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=206.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||+||+|++..+++.||+|+++.... ....+.+|+.+++.+.|+++ +++++++.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i-----~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI-----PQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceeeEEecCCe
Confidence 369999999999999999999999999999999975432 34556788999998888877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~--------------- 139 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG--------------- 139 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC---------------
Confidence 99999999 999999998753 3699999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhh------CCCCCccchHHHHHHHHHHHHhCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL------GLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|+|++|..
T Consensus 140 ------------~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 140 ------------HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred ------------CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence 46667777665433221 2247899999999987 4467899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||...+.......+..... ...++ ....++.++.
T Consensus 208 Pf~~~~~~~~~~~i~~~~~----------------------~~~~~------------------------~~~~~~~~~~ 241 (330)
T cd05601 208 PFHEGTSAKTYNNIMNFQR----------------------FLKFP------------------------EDPKVSSDFL 241 (330)
T ss_pred CCCCCCHHHHHHHHHcCCC----------------------ccCCC------------------------CCCCCCHHHH
Confidence 9987766554444332110 00011 1123567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+||.+||+ ||++|+|++++++||||++
T Consensus 242 ~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 242 DLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 99999998 9999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=348.78 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=207.0
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++|+++ +.+++.+..++.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-----VSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCE-----eeeeeeecCCCeE
Confidence 4899999999999999999999999999999986432 122446679999999988877 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+||++++++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---------------- 139 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG---------------- 139 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC----------------
Confidence 9999999 89999988765445699999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||++....... ....||..|+|||++.+..++.++||||+||++|+|++|..||.+.....
T Consensus 140 -----------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 140 -----------HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred -----------CEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 46677777665432221 23478999999999998889999999999999999999999998765543
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.......+ ......++..+.+||.+||+.
T Consensus 209 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05605 209 KREEVERRVKEDQ----------------------------------------------EEYSEKFSEAARSICRQLLTK 242 (285)
T ss_pred HHHHHHHHhhhcc----------------------------------------------cccCcccCHHHHHHHHHHccC
Confidence 3333322111000 011233567899999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCC
Q 013941 406 DPAERL-----KAREALRHPFFTR 424 (433)
Q Consensus 406 dP~~R~-----ta~ell~hp~f~~ 424 (433)
||++|| +++++++||||..
T Consensus 243 ~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 243 DPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred CHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999 9999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=352.77 Aligned_cols=283 Identities=25% Similarity=0.464 Sum_probs=203.6
Q ss_pred eccccccccEEEEEEEec--CCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--CCeEEEEE
Q 013941 97 LSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVF 172 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--~~~~~lv~ 172 (433)
.++||+|+||+||+|++. .+++.||+|.+.... ......+|+.++++++|+|+ +++++++.. +..+|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNV-----ISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCC-----cceeeeEecCCCcEEEEEE
Confidence 468999999999999965 467899999986533 23456789999999999888 999888753 56799999
Q ss_pred ccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 173 EKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 173 e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
||++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+...+
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~-------------- 145 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-------------- 145 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC--------------
Confidence 999889998886321 12589999999999999999999999999999999999995432
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
+....+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ---------CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 23446888888888654322 1235789999999999874 5899999999999999999999999
Q ss_pred CCCCh---------HHHHHHHHHHhcCCChhhHHhhhhhhhh--hhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 319 QTHEN---------LEHLAMMERVLGPLPHHMVIRADRRAEK--YFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 319 ~~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
..... ...+..+...++.++...+......... .........+. ...........
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~ 282 (317)
T cd07868 217 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT--------------NCSLIKYMEKH 282 (317)
T ss_pred cCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccC--------------cccccchHHhc
Confidence 75432 2445556666655444332221100000 00000000000 00000000111
Q ss_pred cCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
....+.++.+||.+||++||++|+|++|+|+||||
T Consensus 283 ~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 283 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 12235578999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=362.01 Aligned_cols=275 Identities=25% Similarity=0.353 Sum_probs=201.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.++++++|+|| +++++++..++..|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnI-----v~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAV-----LALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCC-----CcEEEEEEECCEEEE
Confidence 4579999999999999999999999999999996432 235679999999999888 999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||++.++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 238 v~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~------------------- 297 (461)
T PHA03211 238 VLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE------------------- 297 (461)
T ss_pred EEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-------------------
Confidence 99999889999887643 3699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE--- 322 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~--- 322 (433)
.++|+|||++...... .....||..|+|||++.+..++.++|||||||+||||++|..++....
T Consensus 298 --------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 298 --------DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred --------CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 4566666666543221 122479999999999999999999999999999999999876543221
Q ss_pred ----hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHH---hcCch---hhhhhccCCch
Q 013941 323 ----NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK---LLRLP---NLIMQHVDHSA 392 (433)
Q Consensus 323 ----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~ 392 (433)
....+..+.+....... .++.....+ ....... ....+ ..........+
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~--------------------~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVD--------------------EFPQHAGSR-LVSQYRHRAARNRRPAYTRPAWTRYYKLD 428 (461)
T ss_pred ccCCcHHHHHHHHHhhccccc--------------------cCCCCcchH-HHHHHHhhhhcccCCccCCcchhhhcccc
Confidence 11223333222111100 000000000 0000000 00000 00000111345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
.++.+||.+||++||++|||+.|||+||||++
T Consensus 429 ~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 429 LDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 68999999999999999999999999999975
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=363.74 Aligned_cols=276 Identities=25% Similarity=0.387 Sum_probs=212.0
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.|++++.||+|+||.||+|++..+++.||+|+++... .....+..|+.++..+.|+++ +++++.+.+.+.+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----v~~~~~~~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWV-----VKMFYSFQDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCEE
Confidence 5999999999999999999999999999999997432 233556779999999888777 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999 999999998764 6999999999999999999999999999999999999999999999999987644322
Q ss_pred CCc--ccCCCCCCCeeeecCCCCcc------------ccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh
Q 013941 248 GSY--FKNLPKSSAIKLIDFGSTTF------------EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 248 ~~~--~~~~~~~~~~kl~Dfg~a~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 313 (433)
... ...... ..-.++.+... ........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 155 HRTEFYRNLTH---NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccc---CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 110 000000 00011111000 0001123579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|..||.+.+.......+...... ..++ .....+.
T Consensus 232 G~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~p------------------------~~~~~s~ 265 (360)
T cd05627 232 GYPPFCSETPQETYRKVMNWKET----------------------LVFP------------------------PEVPISE 265 (360)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCc----------------------eecC------------------------CCCCCCH
Confidence 99999887765554444321100 0000 0112467
Q ss_pred HHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCC
Q 013941 394 DLIDLLQGLLRYDPAERL---KAREALRHPFFTRD 425 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~---ta~ell~hp~f~~~ 425 (433)
++++||.+|+. ||.+|+ +++|+++||||++.
T Consensus 266 ~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 266 KAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred HHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 89999999874 999998 58999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=354.55 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=197.9
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||+||+|++..+++.||||+++... ........|..++..+ .|+++ +++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcC-----cceEEEEEeCCEEEEEE
Confidence 46999999999999999999999999987532 2234455677777654 56666 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-------------------- 133 (316)
T cd05619 76 EYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-------------------- 133 (316)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--------------------
Confidence 999 999999998654 689999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.++|+|||++.... .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (316)
T cd05619 134 -------HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206 (316)
T ss_pred -------CEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 46666776654321 12233578999999999999899999999999999999999999998776655444
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+....... ....+.++.+||.+||+.||+
T Consensus 207 ~i~~~~~~~--------------------------------------------------~~~~~~~~~~li~~~l~~~P~ 236 (316)
T cd05619 207 SIRMDNPCY--------------------------------------------------PRWLTREAKDILVKLFVREPE 236 (316)
T ss_pred HHHhCCCCC--------------------------------------------------CccCCHHHHHHHHHHhccCHh
Confidence 332211000 122466889999999999999
Q ss_pred CCCCHH-HHhcCCCCCCC
Q 013941 409 ERLKAR-EALRHPFFTRD 425 (433)
Q Consensus 409 ~R~ta~-ell~hp~f~~~ 425 (433)
+|+++. ++++||||++.
T Consensus 237 ~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 237 RRLGVKGDIRQHPFFREI 254 (316)
T ss_pred hcCCChHHHHcCcccCCC
Confidence 999996 89999999873
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=354.36 Aligned_cols=244 Identities=27% Similarity=0.393 Sum_probs=197.4
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..+++.||+|+++... ...+....|..++..+ .|++| +++++++..++.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i-----~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL-----THLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999987532 2233445566666544 45555 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-------------------- 133 (316)
T cd05592 76 EYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-------------------- 133 (316)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC--------------------
Confidence 999 999999997654 799999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 134 -------~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~ 206 (316)
T cd05592 134 -------HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206 (316)
T ss_pred -------CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 46777777765322 12233579999999999999899999999999999999999999998877655554
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+......+ ...++.++.+||.+||+.||+
T Consensus 207 ~i~~~~~~~--------------------------------------------------~~~~~~~~~~ll~~~l~~~P~ 236 (316)
T cd05592 207 SILNDRPHF--------------------------------------------------PRWISKEAKDCLSKLFERDPT 236 (316)
T ss_pred HHHcCCCCC--------------------------------------------------CCCCCHHHHHHHHHHccCCHH
Confidence 443211111 123466889999999999999
Q ss_pred CCCCH-HHHhcCCCCCCC
Q 013941 409 ERLKA-REALRHPFFTRD 425 (433)
Q Consensus 409 ~R~ta-~ell~hp~f~~~ 425 (433)
+|+++ .++++||||...
T Consensus 237 ~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 237 KRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HcCCChHHHHcCcccCCC
Confidence 99986 589999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=355.26 Aligned_cols=296 Identities=23% Similarity=0.335 Sum_probs=211.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.++|++.++||+|+||.||+|.+..++..+|+|++... ......+.+|+++++.++|+|+ +++++++..++.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcc-----cceeEEEEECCEE
Confidence 46799999999999999999999999999999988643 2344668899999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
++||||+ +++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~--------------- 141 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--------------- 141 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC---------------
Confidence 9999999 999999998754 689999999999999999999985 799999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 142 ------------~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 142 ------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred ------------CEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 467777777654322 2233578999999999998889999999999999999999999998665433
Q ss_pred HHHHHHHHh-cCCChhhHHhhhhhhhhhhcCCccc-cCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 326 HLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARL-DWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 326 ~~~~i~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
....+.... +..+... .. .......... .+..............................+.++++||.+||
T Consensus 210 ~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 283 (333)
T cd06650 210 LELMFGCPVEGDPAESE-----TS-PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCL 283 (333)
T ss_pred HHHHhcCcccCCccccc-----cC-cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhc
Confidence 322221110 1100000 00 0000000000 00000000000000111000000000011235678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCc
Q 013941 404 RYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
++||++|||+.|+++||||+...
T Consensus 284 ~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 284 IKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCcccCcCHHHHhhCHHHhcCc
Confidence 99999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=355.26 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=199.9
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|.+..+++.||||++++.. .......+|+.++..+ .|+++ +++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i-----~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL-----TQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999997532 2334556788888877 35555 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-------------------- 133 (318)
T cd05570 76 EYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-------------------- 133 (318)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC--------------------
Confidence 999 999999987764 799999999999999999999999999999999999997665
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.++|+|||++.... ......+||..|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 134 -------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~ 206 (318)
T cd05570 134 -------HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206 (318)
T ss_pred -------cEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 45666666654321 11223578999999999999999999999999999999999999998776555444
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+...... .....+..+.+||.+||+.||+
T Consensus 207 ~i~~~~~~--------------------------------------------------~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 207 SILEDEVR--------------------------------------------------YPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred HHHcCCCC--------------------------------------------------CCCcCCHHHHHHHHHHccCCHH
Confidence 33221110 1123467899999999999999
Q ss_pred CCCCH-----HHHhcCCCCCCC
Q 013941 409 ERLKA-----REALRHPFFTRD 425 (433)
Q Consensus 409 ~R~ta-----~ell~hp~f~~~ 425 (433)
+|||+ .++++||||+..
T Consensus 237 ~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 237 KRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HcCCCCCCCHHHHhcCCCcCCC
Confidence 99999 999999999873
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=357.75 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=198.9
Q ss_pred CeEEeccccccccEEEEEEEec---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceec
Q 013941 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~ 163 (433)
+|++++.||+|+||.||+|++. .+++.||+|++.+.. ...+....|+.++..+. |+++ +++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-----~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL-----VTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCc-----ccEEEEEe
Confidence 4899999999999999999864 478999999986432 22345677999999885 5555 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
.++.+++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~----------- 142 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG----------- 142 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-----------
Confidence 999999999999 999999997654 699999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccC----CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+||+|||++..... ......||..|+|||++.+. .++.++|||||||++|||++|..|
T Consensus 143 ----------------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 206 (332)
T cd05614 143 ----------------HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206 (332)
T ss_pred ----------------CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCC
Confidence 466777776653221 11235799999999999875 478999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...........+...... ........++..+.+
T Consensus 207 f~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 240 (332)
T cd05614 207 FTLEGERNTQSEVSRRILK----------------------------------------------CDPPFPSFIGPEAQD 240 (332)
T ss_pred CCCCCCCCCHHHHHHHHhc----------------------------------------------CCCCCCCCCCHHHHH
Confidence 9653322111111110000 000112345778999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
||.+||+.||++|+ +++++++||||++.
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 88999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=354.03 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=204.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.|++.+.||+|+||.||+|++..+++.||+|++.+.. ...+....|+.++..+.|++ +++++++++.+.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~----~i~~~~~~~~~~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----FLTQLHSCFQTVDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCC----chhheeeEEecCCEE
Confidence 3788999999999999999999999999999987532 22345667888888877653 347888999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~---------------- 138 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG---------------- 138 (323)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----------------
Confidence 9999999 999999997764 699999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 139 -----------~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (323)
T cd05615 139 -----------HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207 (323)
T ss_pred -----------CEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 466777776653221 122357899999999999989999999999999999999999999887765
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+....... ....+.++.+++.+||+
T Consensus 208 ~~~~~i~~~~~~~--------------------------------------------------p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 208 ELFQSIMEHNVSY--------------------------------------------------PKSLSKEAVSICKGLMT 237 (323)
T ss_pred HHHHHHHhCCCCC--------------------------------------------------CccCCHHHHHHHHHHcc
Confidence 5554443321111 12346688999999999
Q ss_pred cCCCCCCC-----HHHHhcCCCCCCC
Q 013941 405 YDPAERLK-----AREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~t-----a~ell~hp~f~~~ 425 (433)
.||++|++ .+++++||||+..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999997 5799999999963
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=356.68 Aligned_cols=245 Identities=25% Similarity=0.407 Sum_probs=201.1
Q ss_pred eccccccccEEEEEEEec---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 97 LSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++.||+|+||.||+|++. .+++.||+|+++... .....+..|+.+++.+.|+|| +++++++..++.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~~~~~~~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI-----VDLIYAFQTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCch-----hceeeEEecCCeE
Confidence 368999999999999864 478899999987532 223456689999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---------------- 137 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG---------------- 137 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----------------
Confidence 9999999 899999997764 689999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 138 -----------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~ 206 (323)
T cd05584 138 -----------HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206 (323)
T ss_pred -----------CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH
Confidence 466677776543211 122357999999999999888999999999999999999999999887665
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+...... .....+.++.+||.+||+
T Consensus 207 ~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 207 KTIDKILKGKLN--------------------------------------------------LPPYLTPEARDLLKKLLK 236 (323)
T ss_pred HHHHHHHcCCCC--------------------------------------------------CCCCCCHHHHHHHHHHcc
Confidence 544443321111 112346789999999999
Q ss_pred cCCCCCC-----CHHHHhcCCCCCCC
Q 013941 405 YDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
.||++|+ +++++++||||...
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999 89999999999763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.76 Aligned_cols=283 Identities=29% Similarity=0.481 Sum_probs=219.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.++||+|+||.||+|.+..+++.||+|.++... .......+|+.+++.++|+|| +++++++...+..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----~~~~~~~~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIIHTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCc-----ceEEEEEecCCeEE
Confidence 46999999999999999999999999999999986432 233456789999999999887 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++
T Consensus 81 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~------------------ 141 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG------------------ 141 (301)
T ss_pred EEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC------------------
Confidence 999999889999887653 3689999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||++...... .....++..|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+
T Consensus 142 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 142 ---------ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred ---------cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4566666665433221 1223578899999998764 47899999999999999999999999888877
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+.++.++...+........ + ....++.. ...........++..+.+||.+||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~ml~~ 272 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEE-F----KSYNYPKY---------------RADCLHNHAPRLDSDGAELLSKLLQF 272 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhcccc-c----cccccCcc---------------ccccHHhhcCCCCHHHHHHHHHHhcC
Confidence 7777777776655433221110000 0 00000000 00001112245677899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q 013941 406 DPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||.+|||++|+++||||+.-.+
T Consensus 273 dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 273 EGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred CcccCcCHHHHhcCcccccccc
Confidence 9999999999999999987544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=351.55 Aligned_cols=244 Identities=27% Similarity=0.371 Sum_probs=200.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcE-EEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC-e
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-H 167 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~-~ 167 (433)
...+.+.||+|+||+||+|.+. |.. ||+|++.... ...+.+.+|+.+|.+++|+|| |++++++.... .
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNI-----VQFYGACTSPPGS 114 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEcCCCCc
Confidence 3556677999999999999865 444 9999997533 225689999999999999988 99999999877 7
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
++|||||+ +|+|.+++.......++...+..++.||++||.|||+++ ||||||||+|||++.++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-------------- 180 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-------------- 180 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--------------
Confidence 99999999 999999998844458999999999999999999999999 99999999999996543
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhh--CCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL--GLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
..+||+|||+++.... ..+...||+.|||||++. ...|+.++||||||+++|||+||..||.+
T Consensus 181 ------------~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 181 ------------KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred ------------CEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 2578888888876553 334468999999999999 55899999999999999999999999998
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....+....+... +..| .....+++.+..||.
T Consensus 249 ~~~~~~~~~v~~~-~~Rp-----------------------------------------------~~p~~~~~~l~~l~~ 280 (362)
T KOG0192|consen 249 LAPVQVASAVVVG-GLRP-----------------------------------------------PIPKECPPHLSSLME 280 (362)
T ss_pred CCHHHHHHHHHhc-CCCC-----------------------------------------------CCCccCCHHHHHHHH
Confidence 8874444333221 1111 011235678999999
Q ss_pred HhcccCCCCCCCHHHHh
Q 013941 401 GLLRYDPAERLKAREAL 417 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell 417 (433)
+||..||++||+..+++
T Consensus 281 ~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 281 RCWLVDPSRRPSFLEIV 297 (362)
T ss_pred HhCCCCCCcCCCHHHHH
Confidence 99999999999998876
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=356.17 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=195.5
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..+++.||+|++++.. .....+..|..++..+ .|++| +++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~I-----v~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFL-----VGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCC-----CceEEEEEcCCEEEEEE
Confidence 46899999999999999999999999997532 2334567788888888 46666 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-------------------- 133 (329)
T cd05588 76 EFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-------------------- 133 (329)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--------------------
Confidence 999 999999887654 799999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCccc---cCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH---
Q 013941 252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE--- 325 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~--- 325 (433)
.+||+|||++... ........||..|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 134 -------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05588 134 -------HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206 (329)
T ss_pred -------CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc
Confidence 4666666665431 112234579999999999999999999999999999999999999996321100
Q ss_pred --HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 326 --HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 326 --~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
....+.+. .. .........++..+.++|.+||
T Consensus 207 ~~~~~~~~~~----------------------------------------~~------~~~~~~p~~~~~~~~~li~~~L 240 (329)
T cd05588 207 QNTEDYLFQV----------------------------------------IL------EKQIRIPRSLSVKASSVLKGFL 240 (329)
T ss_pred ccchHHHHHH----------------------------------------HH------cCCCCCCCCCCHHHHHHHHHHh
Confidence 00000000 00 0001112345778999999999
Q ss_pred ccCCCCCCC------HHHHhcCCCCCC
Q 013941 404 RYDPAERLK------AREALRHPFFTR 424 (433)
Q Consensus 404 ~~dP~~R~t------a~ell~hp~f~~ 424 (433)
+.||++|+| ++++++||||..
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 241 NKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred ccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999987 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=331.09 Aligned_cols=289 Identities=29% Similarity=0.527 Sum_probs=226.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCC----cEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..|+++++||+|.||.||+|...+++ +.+|||.++... .......+|+.+++.++|+|+ +.+..+|-.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nv-----i~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNV-----ISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcc-----hhHHHHHhc
Confidence 35999999999999999999765543 378999987542 344678899999999999988 888888876
Q ss_pred -CCeEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 165 -RNHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 165 -~~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+..+++++||...+|.++|..+. .+.++...++.|+.||+.|+.|||++-|+||||||+|||+..+|
T Consensus 99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg--------- 169 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG--------- 169 (438)
T ss_pred cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC---------
Confidence 88999999999999999997432 24689999999999999999999999999999999999998876
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHh
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~ 313 (433)
+..+.+||+|||+++...... ..++-|.+|+|||++.|. .|+.+.||||+|||+.||+|
T Consensus 170 --------------perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 170 --------------PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred --------------CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 467889999999998766543 235779999999999987 59999999999999999999
Q ss_pred CCCCCCCCC---------hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhh---HHHHH----Hh
Q 013941 314 GEALFQTHE---------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS---MRAVW----KL 377 (433)
Q Consensus 314 g~~pf~~~~---------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----~~ 377 (433)
-.+.|.+.. ..+++..|..++|.+... .||+...-++. +..+. ..
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~-------------------~Wp~lkk~Pe~q~~ls~f~~~~~~n 296 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDK-------------------DWPDLKKMPEYQTLLSDFRRHYYDN 296 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccc-------------------cchhhhhCcchHHHHHHhHHhhcCc
Confidence 999997643 245777888888876543 34433322221 11111 01
Q ss_pred cCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
..+.+.. .....-++...+|+.+||..||.+|+|++|+|+|+||++....
T Consensus 297 ~sL~~~~-~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 297 VSLHKYY-HKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred chHHHHH-HHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 1111111 1122234568899999999999999999999999999987543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=330.34 Aligned_cols=277 Identities=26% Similarity=0.447 Sum_probs=218.5
Q ss_pred CeEE-eccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRI-LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
-|++ .+.||+|+|+.|--|....++..||||++.+.. ..+..+.+|++++.+.+ +|+||++++++|+++..+||
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq----gh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ----GHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc----CCccHHHHHHHhcccceEEE
Confidence 3555 357899999999999999999999999998654 45677889999998776 44666999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
|||-| ||+|...|+++. .|++.++.++.++|+.||.|||.+||.||||||+|||..+.+.
T Consensus 154 VfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~----------------- 214 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNK----------------- 214 (463)
T ss_pred EEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCC-----------------
Confidence 99999 999999998875 7999999999999999999999999999999999999876543
Q ss_pred cccCCCCCCCeeeecCCCCccccC----------CCcccccCCcccchhhhh---C--CCCCccchHHHHHHHHHHHHhC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVIL---G--LGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwSlG~il~el~~g 314 (433)
-..+|||||.+..-... ...+.+|+..|||||+.. + .-|+.++|.||||||||-|+.|
T Consensus 215 -------vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsG 287 (463)
T KOG0607|consen 215 -------VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSG 287 (463)
T ss_pred -------cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhC
Confidence 33578888876543211 112358999999999874 2 2489999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc--hhhhhhccCCch
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL--PNLIMQHVDHSA 392 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 392 (433)
.+||.+.-. ....|..+...+.=...+++..+. -.+....+..+|
T Consensus 288 YpPFvG~Cg---------------------------------~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS 334 (463)
T KOG0607|consen 288 YPPFVGHCG---------------------------------ADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHIS 334 (463)
T ss_pred CCCccCccC---------------------------------CcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhh
Confidence 999987532 223444444443333333333221 122233456778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccccCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~~~ 432 (433)
.+.++||..+|..|+.+|.+|.++++|||++.....+.+|
T Consensus 335 ~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp 374 (463)
T KOG0607|consen 335 SEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP 374 (463)
T ss_pred HHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence 9999999999999999999999999999999876544443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=344.66 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=197.5
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
||+|+||+||+|.+..+++.||+|++.... ...+.+..|+.+++.++|+++ +++.+++...+.+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI-----VSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcE-----eeeeEEEcCCCeEEEEEeCC
Confidence 799999999999999999999999986432 122456679999999988777 99999999999999999999
Q ss_pred -CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCccc
Q 013941 176 -GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (433)
Q Consensus 176 -~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~ 252 (433)
+++|.+++... ....+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--------------------- 134 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--------------------- 134 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---------------------
Confidence 99999887532 224689999999999999999999999999999999999997655
Q ss_pred CCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 253 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 135 ------~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 208 (280)
T cd05608 135 ------NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208 (280)
T ss_pred ------CEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 4677777766543221 1234789999999999999999999999999999999999999976543221111
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
+....... .......++..+.+|+.+||+.||++
T Consensus 209 ~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~ 242 (280)
T cd05608 209 LKQRILND----------------------------------------------SVTYPDKFSPASKSFCEALLAKDPEK 242 (280)
T ss_pred HHHhhccc----------------------------------------------CCCCcccCCHHHHHHHHHHhcCCHHH
Confidence 11110000 00112345778999999999999999
Q ss_pred CC-----CHHHHhcCCCCCCC
Q 013941 410 RL-----KAREALRHPFFTRD 425 (433)
Q Consensus 410 R~-----ta~ell~hp~f~~~ 425 (433)
|+ |++++++||||++-
T Consensus 243 R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 243 RLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred hcCCCCCCHHHHhcChhhhcC
Confidence 99 89999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=354.14 Aligned_cols=243 Identities=27% Similarity=0.417 Sum_probs=195.9
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHH-HHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~-~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||+||+|++..+++.||+|++..... ....+..|.. +++.++|+++ +++++.+...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~i-----v~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL-----VGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCC-----CCeeEEEEeCCEEEEEE
Confidence 469999999999999999999999999875321 1223344444 4466777766 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-------------------- 133 (323)
T cd05575 76 DYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-------------------- 133 (323)
T ss_pred cCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--------------------
Confidence 999 999999997654 799999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 206 (323)
T cd05575 134 -------HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206 (323)
T ss_pred -------cEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 46677777665321 11233579999999999999899999999999999999999999998776555444
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+..... ......+..+.++|.+||+.||+
T Consensus 207 ~i~~~~~--------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 207 NILNKPL--------------------------------------------------RLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred HHHcCCC--------------------------------------------------CCCCCCCHHHHHHHHHHhhcCHH
Confidence 3322110 01123467899999999999999
Q ss_pred CCCCH----HHHhcCCCCCC
Q 013941 409 ERLKA----REALRHPFFTR 424 (433)
Q Consensus 409 ~R~ta----~ell~hp~f~~ 424 (433)
+|+++ .++++||||..
T Consensus 237 ~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 237 KRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCC
Confidence 99987 69999999976
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=353.76 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=194.4
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..+++.||+|++++.. .....+..|+.++.++ .|+++ +++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcC-----CceeeEEEeCCEEEEEE
Confidence 46999999999999999999999999997532 2334566788887766 56666 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-------------------- 133 (329)
T cd05618 76 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-------------------- 133 (329)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--------------------
Confidence 999 999998887654 799999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH----
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL---- 324 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~---- 324 (433)
.+||+|||++.... .......||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 134 -------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05618 134 -------HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206 (329)
T ss_pred -------CEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc
Confidence 46777777665321 1223357999999999999999999999999999999999999999531110
Q ss_pred -HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 325 -EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 325 -~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.....+.+. .. ......+...+..+.+||.+||
T Consensus 207 ~~~~~~~~~~----------------------------------------i~------~~~~~~p~~~~~~~~~ll~~~L 240 (329)
T cd05618 207 QNTEDYLFQV----------------------------------------IL------EKQIRIPRSLSVKAASVLKSFL 240 (329)
T ss_pred cccHHHHHHH----------------------------------------Hh------cCCCCCCCCCCHHHHHHHHHHh
Confidence 000000000 00 0001122345678999999999
Q ss_pred ccCCCCCCC------HHHHhcCCCCCC
Q 013941 404 RYDPAERLK------AREALRHPFFTR 424 (433)
Q Consensus 404 ~~dP~~R~t------a~ell~hp~f~~ 424 (433)
+.||++|+| +.++++||||++
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 241 NKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred cCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999998 589999999976
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=303.97 Aligned_cols=279 Identities=32% Similarity=0.519 Sum_probs=226.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|.-.++||+|.||+||+|++..+++.||+|.++.++ .......+|+-+|+.+.|.|| |++++....++.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhkni-----vrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcce-----eehhhhhccCceeE
Confidence 4677899999999999999999999999999997533 345678999999999999988 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+|+|||..+|..+..... +.++.+.++.++.|+++||.|+|++++.|||+||.|+||+.+|
T Consensus 78 lvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng------------------ 138 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG------------------ 138 (292)
T ss_pred EeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC------------------
Confidence 999999999999988654 4799999999999999999999999999999999999997766
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCC-CCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
.+||+|||+++..+.+- +..+-|.+|++|.++.+.. |+...|+||.|||+.|+.. |++.|.+.+..
T Consensus 139 ---------elkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 139 ---------ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred ---------cEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 56777777776554433 2236799999999999875 8999999999999999986 89999999999
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+++..|.+.+|.+.+.- ||.....++.... ........-.+..+..+..-+||++++|.
T Consensus 210 dqlkrif~~lg~p~ed~-------------------wps~t~lpdyk~y--p~ypattswsqivp~lns~grdllqkll~ 268 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQ-------------------WPSMTKLPDYKPY--PIYPATTSWSQIVPKLNSTGRDLLQKLLK 268 (292)
T ss_pred HHHHHHHHHhCCCcccc-------------------CCccccCCCCccc--CCccccchHHHHhhhhcchhHHHHHHHhc
Confidence 99999999999876533 3332222111000 00000000112233445577899999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
-+|.+|++|+++++||||.+-
T Consensus 269 cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 269 CNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCcccccCHHHHhcCcccccc
Confidence 999999999999999999873
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=357.78 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=205.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++.+.||+|+||.||+|++..+++.||+|++.+.. .....+.+|+.+++.++|+++ +++++.+.+++
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-----v~~~~~~~~~~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFYAFQDDR 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEcCC
Confidence 468999999999999999999999999999999986422 223446678999999988887 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-------------- 179 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------------- 179 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--------------
Confidence 999999999 99999998764 489999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCC----CCccchHHHHHHHHHHHHhCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 180 -------------~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 246 (371)
T cd05622 180 -------------HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (371)
T ss_pred -------------CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCC
Confidence 4677777776543321 12357999999999997643 78999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+.......+......+ .++ ....++..+++
T Consensus 247 f~~~~~~~~~~~i~~~~~~~----------------------~~~------------------------~~~~~s~~~~~ 280 (371)
T cd05622 247 FYADSLVGTYSKIMNHKNSL----------------------TFP------------------------DDNDISKEAKN 280 (371)
T ss_pred CCCCCHHHHHHHHHcCCCcc----------------------cCC------------------------CcCCCCHHHHH
Confidence 98877655554443321110 011 11245778999
Q ss_pred HHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAE--RLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~--R~ta~ell~hp~f~~~ 425 (433)
||.+||..++.+ |++++|+++|+||++.
T Consensus 281 li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 281 LICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999844433 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=356.61 Aligned_cols=280 Identities=25% Similarity=0.412 Sum_probs=210.5
Q ss_pred CccCCCeEEeccccccccEEEEEEEec--CCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
..+..+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+.++++++|+++ +++++++...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~i-----v~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAI-----INLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCc-----cceeeeEeeC
Confidence 345568999999999999999999754 45678999987643 234679999999999887 9999999999
Q ss_pred CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
+..|+|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-------------- 222 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-------------- 222 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--------------
Confidence 9999999999889999985543 799999999999999999999999999999999999997665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||++...... .....||..|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 223 -------------~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 223 -------------NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred -------------CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4566666665433221 1235799999999999998999999999999999999999999976
Q ss_pred CCh---HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC----chhhhhhccCCchH
Q 013941 321 HEN---LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR----LPNLIMQHVDHSAG 393 (433)
Q Consensus 321 ~~~---~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 393 (433)
... ...+..+.+.++..|..+...........+ .......+ .+... .....+.
T Consensus 290 ~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~--~~~~~~~ 349 (392)
T PHA03207 290 KQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF------------------KQYAIVLRPPYTIPPVI--RKYGMHM 349 (392)
T ss_pred CCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH------------------HhhcccccCCccccchh--hccCcch
Confidence 543 345555555555444322111100000000 00000000 00000 0113456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
++.+||.+||..||++|||+.|+|+||||.+.
T Consensus 350 ~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 350 DVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 88999999999999999999999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=347.04 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=217.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.+.|+..+.||+||||.||-++-+.||+.||+|.+.+. .......++|..||.+++.+.| |.+--.|++.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~Fi-----VslaYAfeTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFI-----VSLAYAFETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcE-----EEEeeeecCCC
Confidence 35689999999999999999999999999999988642 2344567889999999988866 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||..| ||+|.-+|...+...|++..++.++.+|+.||++||+.+||+||+||+|||+++.|++.|
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRI---------- 328 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRI---------- 328 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEe----------
Confidence 999999999 999999998888788999999999999999999999999999999999999988776555
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
+|+|+|..... .....+||.+|||||++.+..|+..+|+|||||+||||+.|+.||.....
T Consensus 329 -----------------SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 329 -----------------SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred -----------------eccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 55555543322 22335999999999999999999999999999999999999999987766
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
....+.+.+..-..+ .+.++..|+++++|.+.+|
T Consensus 392 Kvk~eEvdrr~~~~~----------------------------------------------~ey~~kFS~eakslc~~LL 425 (591)
T KOG0986|consen 392 KVKREEVDRRTLEDP----------------------------------------------EEYSDKFSEEAKSLCEGLL 425 (591)
T ss_pred hhhHHHHHHHHhcch----------------------------------------------hhcccccCHHHHHHHHHHH
Confidence 655555554432222 2234566889999999999
Q ss_pred ccCCCCCC-----CHHHHhcCCCCCCC
Q 013941 404 RYDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
++||++|+ +++++.+||||++-
T Consensus 426 ~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 426 TKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred ccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999998 58899999999973
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=344.42 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=204.0
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++|+++ +.+++.+.+.+..|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFV-----VSLAYAYETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCe-----eeeeEEEecCCEEE
Confidence 788899999999999999999999999999986432 223446679999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~----------------- 139 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG----------------- 139 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-----------------
Confidence 999999 99999998765545699999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 140 ----------~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~ 209 (285)
T cd05630 140 ----------HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 209 (285)
T ss_pred ----------CEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch
Confidence 46777777665433221 234789999999999998999999999999999999999999976443211
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
........... ........+.++.+||.+||+.|
T Consensus 210 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05630 210 REEVERLVKEV----------------------------------------------QEEYSEKFSPDARSLCKMLLCKD 243 (285)
T ss_pred HHHHHhhhhhh----------------------------------------------hhhcCccCCHHHHHHHHHHhhcC
Confidence 11111110000 00112345678999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCC
Q 013941 407 PAERLK-----AREALRHPFFTR 424 (433)
Q Consensus 407 P~~R~t-----a~ell~hp~f~~ 424 (433)
|++|+| ++|+++||||++
T Consensus 244 p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 244 PKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHccCCCCCchHHHHcChhhhc
Confidence 999999 999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.70 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=202.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||.||++++..+++.||+|++.+.. ...+.+.+|+.++..+.|+++ +.+++++.++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWI-----TNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----CceEEEEecCCe
Confidence 36999999999999999999999999999999987532 223456778999988888877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--------------- 139 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--------------- 139 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC---------------
Confidence 99999999 999999997643 3689999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhC-----CCCCccchHHHHHHHHHHHHhCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.++|+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 140 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 140 ------------HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred ------------CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 46777777765432211 22469999999999973 3578899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+..+....+...... ...+ .....++.++++
T Consensus 208 f~~~~~~~~~~~i~~~~~~----------------------~~~~-----------------------~~~~~~~~~~~~ 242 (331)
T cd05597 208 FYAESLVETYGKIMNHKEH----------------------FQFP-----------------------PDVTDVSEEAKD 242 (331)
T ss_pred CCCCCHHHHHHHHHcCCCc----------------------ccCC-----------------------CccCCCCHHHHH
Confidence 9876655544433221100 0000 011235778999
Q ss_pred HHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 013941 398 LLQGLLRYDPAE--RLKAREALRHPFFTR 424 (433)
Q Consensus 398 li~~~L~~dP~~--R~ta~ell~hp~f~~ 424 (433)
||.+||..++++ |++++++++||||.+
T Consensus 243 li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 243 LIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999765544 789999999999976
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=354.74 Aligned_cols=244 Identities=29% Similarity=0.462 Sum_probs=201.9
Q ss_pred ccccccccEEEEEEEe---cCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 98 SKMGEGTFGQVVECFD---NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
+.||+|+||.||++++ ..+|+.||+|++.... .......+|++++++++|+|| +++++++.+++.+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI-----VKLHYAFQTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCc-----ccEEEEEEcCCEEEEE
Confidence 6799999999999986 3578999999997533 223456679999999998887 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~------------------- 135 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------------------- 135 (318)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-------------------
Confidence 9999 899999997654 699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~ 327 (433)
.++|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 136 --------~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 207 (318)
T cd05582 136 --------HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207 (318)
T ss_pred --------cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH
Confidence 4677777776543322 22357899999999999888999999999999999999999999887665555
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+.+....+ ....+..+.+||.+||+.||
T Consensus 208 ~~i~~~~~~~--------------------------------------------------p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 208 TMILKAKLGM--------------------------------------------------PQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred HHHHcCCCCC--------------------------------------------------CCCCCHHHHHHHHHHhhcCH
Confidence 4443221111 12346789999999999999
Q ss_pred CCCCC-----HHHHhcCCCCCCC
Q 013941 408 AERLK-----AREALRHPFFTRD 425 (433)
Q Consensus 408 ~~R~t-----a~ell~hp~f~~~ 425 (433)
++||| ++++++||||...
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999 7889999999763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=334.51 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=213.8
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
-+.|..++.||+|.||.|.+|+.+.+++.||+|++++.- ........|-++|+..+||.+ ..+.-.|+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFL-----t~LKYsFQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFL-----TSLKYSFQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHH-----HHhhhhhccCc
Confidence 367999999999999999999999999999999998643 223345568889999988877 88888899999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
++|+||||. ||.|.-++.+.. .+++..++.+...|+.||.|||+++||+||||.+|+|++.+|++||+
T Consensus 242 rlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKit--------- 310 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKIT--------- 310 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEee---------
Confidence 999999999 999998888754 89999999999999999999999999999999999999887765554
Q ss_pred CCCCcccCCCCCCCeeeecCCCCcc---ccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTF---EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
|||+++. ......++|||+.|+|||++....|+.++|+|.+||++|||++|+.||...+
T Consensus 311 ------------------DFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 311 ------------------DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred ------------------ecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 5554432 1234456899999999999999999999999999999999999999999888
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
....+..|.-.--.+ +..++++++.|+..+
T Consensus 373 h~kLFeLIl~ed~kF--------------------------------------------------Pr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 373 HEKLFELILMEDLKF--------------------------------------------------PRTLSPEAKTLLSGL 402 (516)
T ss_pred hhHHHHHHHhhhccC--------------------------------------------------CccCCHHHHHHHHHH
Confidence 777776665432222 235578999999999
Q ss_pred cccCCCCCC-----CHHHHhcCCCCCCC
Q 013941 403 LRYDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
|.+||.+|+ .|.||.+|+||...
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 999999998 48999999999864
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.96 Aligned_cols=278 Identities=23% Similarity=0.373 Sum_probs=203.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
.+|++++.||+|+||.||+|++..+++.||+|+.... ....|+.++++++|+|+ +++++++...+..++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSV-----IRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCC-----cChhheEEeCCeeEEE
Confidence 4799999999999999999999999999999985432 23568999999998887 9999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||++.++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 136 ~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-------------------- 194 (357)
T PHA03209 136 LPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-------------------- 194 (357)
T ss_pred EEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--------------------
Confidence 9999889999887643 4689999999999999999999999999999999999996654
Q ss_pred cCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC-CCCCCCh-----
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA-LFQTHEN----- 323 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~-pf~~~~~----- 323 (433)
.++|+|||.+...... .....||..|+|||++.+..++.++|||||||++|||+++.. +|.....
T Consensus 195 -------~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~ 267 (357)
T PHA03209 195 -------QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY 267 (357)
T ss_pred -------CEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence 4677777777543222 223578999999999999899999999999999999998544 4443221
Q ss_pred ----HHHHHHHHHHhcCCChhhHHhhhh-hhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 324 ----LEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 324 ----~~~~~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
...+..+...++..|..+...... ....++....... ..............+.++.+|
T Consensus 268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l 330 (357)
T PHA03209 268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLER-----------------QPYTRYPCFQRVNLPIDGEFL 330 (357)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCC-----------------CcccccHHHhccCCCchHHHH
Confidence 112223333333333222100000 0000000000000 000000001112346678899
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
|.+||+.||++||||.|||+||||++
T Consensus 331 i~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 331 VHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHcCCcccCcCHHHHhcCchhcc
Confidence 99999999999999999999999985
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=337.64 Aligned_cols=252 Identities=36% Similarity=0.598 Sum_probs=205.3
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHH---HHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
|++++.||+|+||+||++.+..+++.||+|++........ ...+|+.+++++.|+++ +++++++.+....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNI-----VQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTB-----CHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccc-----ccccccccccccccc
Confidence 8899999999999999999999999999999986553332 23459999999988887 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
|||++ +++|.+++.... .+++..+..++.||+.||.+||++||+|+||||+||+++.++
T Consensus 76 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~------------------ 135 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG------------------ 135 (260)
T ss_dssp EEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS------------------
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccc------------------
Confidence 99999 669999998443 699999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccc---cCCCcccccCCcccchhhhh-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+... ........+|..|+|||++. +..++.++||||||+++|+|++|..||......+
T Consensus 136 ---------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 136 ---------EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp ---------EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred ---------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 4677777776532 22223357899999999998 7789999999999999999999999998875445
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+....... ............+.++|.+||+.
T Consensus 207 ~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~l~~li~~~l~~ 243 (260)
T PF00069_consen 207 QLEIIEKILKRPLP-------------------------------------------SSSQQSREKSEELRDLIKKMLSK 243 (260)
T ss_dssp HHHHHHHHHHTHHH-------------------------------------------HHTTSHTTSHHHHHHHHHHHSSS
T ss_pred hhhhhhhccccccc-------------------------------------------ccccccchhHHHHHHHHHHHccC
Confidence 44444433211100 00001112236899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
||++|||+.++++||||
T Consensus 244 ~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 244 DPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SGGGSTTHHHHHTSGGG
T ss_pred ChhHCcCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=366.44 Aligned_cols=294 Identities=24% Similarity=0.329 Sum_probs=202.6
Q ss_pred eecCCccCCCeEEeccccccccEEEEEEEecCCC-cEEEE------------------EEeccchhhHHHHHHHHHHHHH
Q 013941 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAI------------------KIVRSINKYREAAMIEIDVLQR 144 (433)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vav------------------K~~~~~~~~~~~~~~E~~~l~~ 144 (433)
...++.+.++|+++++||+|+||+||+|..+... ..+++ |.+.........+.+|+.++++
T Consensus 140 ~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~ 219 (501)
T PHA03210 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR 219 (501)
T ss_pred cccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh
Confidence 3445566789999999999999999998754322 11222 2222222344567789999999
Q ss_pred HHhCCCCCcceeEecceeccCCeEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCC
Q 013941 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221 (433)
Q Consensus 145 l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik 221 (433)
++|+|| +++++++.+.+..|+|+++++++|.+++.... ........++.++.||+.||+|||++||||||||
T Consensus 220 l~HpnI-----v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK 294 (501)
T PHA03210 220 LNHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK 294 (501)
T ss_pred CCCCCc-----CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999888 99999999999999999999889988876432 1123467788999999999999999999999999
Q ss_pred CCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCc
Q 013941 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNY 297 (433)
Q Consensus 222 p~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~ 297 (433)
|+|||++.++ .+||+|||++....... ....||..|+|||++.+..++.
T Consensus 295 P~NILl~~~~---------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 347 (501)
T PHA03210 295 LENIFLNCDG---------------------------KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE 347 (501)
T ss_pred HHHEEECCCC---------------------------CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCc
Confidence 9999997655 46777777775443221 2357999999999999999999
Q ss_pred cchHHHHHHHHHHHHhCCCC-CCCC--ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHH
Q 013941 298 PCDLWSVGCILVELCSGEAL-FQTH--ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374 (433)
Q Consensus 298 ~~DiwSlG~il~el~~g~~p-f~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (433)
++|||||||++|||++|..+ |... .....+..+...++..+..+..... ....++... .+.. ....
T Consensus 348 ~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~i~~~---~~~~---~~~~---- 416 (501)
T PHA03210 348 ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPC-KLFDYIDSA---EIDH---AGHS---- 416 (501)
T ss_pred HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHH-HHHHHhhhh---hccc---Cccc----
Confidence 99999999999999998754 4322 2333344433333322211100000 000011000 0000 0000
Q ss_pred HHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.+... .....+.++.++|.+||++||++|||+.|+|+||||.....
T Consensus 417 -----~~~~~--~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~ 462 (501)
T PHA03210 417 -----VPPLI--RNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE 462 (501)
T ss_pred -----hhhHH--HhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence 00000 01124567899999999999999999999999999987544
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=348.85 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=195.7
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..+++.||+|++++.. ...+.+.+|+.++.++. |+++ +.+++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFL-----VGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCE-----eeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999997532 23345677888888885 5544 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-------------------- 133 (327)
T cd05617 76 EYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-------------------- 133 (327)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC--------------------
Confidence 999 999999887654 699999999999999999999999999999999999997665
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH---
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE--- 325 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~--- 325 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~ 206 (327)
T cd05617 134 -------HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206 (327)
T ss_pred -------CEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc
Confidence 46677777665321 12234579999999999999999999999999999999999999996422110
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+.... .....+...+..+.++|.+||+.
T Consensus 207 ~~~~~~~~~~~----------------------------------------------~~~~~p~~~~~~~~~li~~~L~~ 240 (327)
T cd05617 207 TEDYLFQVILE----------------------------------------------KPIRIPRFLSVKASHVLKGFLNK 240 (327)
T ss_pred cHHHHHHHHHh----------------------------------------------CCCCCCCCCCHHHHHHHHHHhcc
Confidence 00000000000 00011234567899999999999
Q ss_pred CCCCCCC------HHHHhcCCCCCCC
Q 013941 406 DPAERLK------AREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~t------a~ell~hp~f~~~ 425 (433)
||++|++ ++++++||||+..
T Consensus 241 dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 241 DPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred CHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999998 5799999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=351.05 Aligned_cols=243 Identities=26% Similarity=0.391 Sum_probs=195.4
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHH-HHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||+||+|++..+|+.||+|++.+.. .....+..|.. +++.+.|+++ +++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL-----VGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEecCCEEEEEE
Confidence 46999999999999999999999999986532 22233444544 3556667766 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-------------------- 133 (325)
T cd05604 76 DFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-------------------- 133 (325)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--------------------
Confidence 999 999999887654 799999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.+||+|||++.... .......||..|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 134 -------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (325)
T cd05604 134 -------HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206 (325)
T ss_pred -------CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence 46677777665321 12233579999999999999999999999999999999999999998776555443
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+..... ......+..+.++|.+||+.||.
T Consensus 207 ~~~~~~~--------------------------------------------------~~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 207 NILHKPL--------------------------------------------------VLRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred HHHcCCc--------------------------------------------------cCCCCCCHHHHHHHHHHhccCHH
Confidence 3322100 01123466889999999999999
Q ss_pred CCCCH----HHHhcCCCCCC
Q 013941 409 ERLKA----REALRHPFFTR 424 (433)
Q Consensus 409 ~R~ta----~ell~hp~f~~ 424 (433)
+||++ .++++||||..
T Consensus 237 ~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 237 RRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred hcCCCCCCHHHHhcCCCcCC
Confidence 99976 59999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=338.79 Aligned_cols=276 Identities=30% Similarity=0.481 Sum_probs=208.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||+|+||.||+|++..+|+.||+|.++... .....+.+|+.++++++|+++ +++++++.+.+.++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCe-----eeHHHHhccCCceE
Confidence 5899999999999999999999999999999986432 223456789999999988877 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+|+||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 76 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~----------------- 137 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE----------------- 137 (284)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc-----------------
Confidence 999999889998887543 36999999999999999999999999999999999999976664
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCC-CCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF-QTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf-~~~~~~ 324 (433)
++|+|||++....... ....++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..
T Consensus 138 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 138 ----------LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred ----------EEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 5555555554332211 223578899999998775 4789999999999999999988875 555555
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
..+..+.+..+..+...+......... ..++... ......+.....+.++.+||.+||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~ 266 (284)
T cd07839 208 DQLKRIFRLLGTPTEESWPGVSKLPDY-------KPYPMYP--------------ATTSLVNVVPKLNSTGRDLLQNLLV 266 (284)
T ss_pred HHHHHHHHHhCCCChHHhHHhhhcccc-------cccCCCC--------------CcchhhhhcccCCHHHHHHHHHHhc
Confidence 666666666555443322111100000 0000000 0000011223567899999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013941 405 YDPAERLKAREALRHPFF 422 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f 422 (433)
.||.+|||++|+++||||
T Consensus 267 ~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 267 CNPVQRISAEEALQHPYF 284 (284)
T ss_pred CChhhcCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=348.72 Aligned_cols=242 Identities=25% Similarity=0.374 Sum_probs=204.6
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
+.+++.||+|.||.||+|....+. .||+|.++......+.+.+|+++|++|+|++| |++++++..++.+|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~l-----V~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKL-----VKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhCcccCe-----EEEEEEEecCCceEEEEE
Confidence 566889999999999999976543 59999998766667888999999999999988 999999999889999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCccc
Q 013941 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~ 252 (433)
|| .|+|.++|+......+...+...++.||++|++||+++++|||||-..||||+++..
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~-------------------- 341 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV-------------------- 341 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--------------------
Confidence 99 999999999866678999999999999999999999999999999999999977664
Q ss_pred CCCCCCCeeeecCCCCccccCCCcc-cc---cCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 013941 253 NLPKSSAIKLIDFGSTTFEHQDHSY-VV---STRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327 (433)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~~~~~-~~---gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~ 327 (433)
+||+|||+|+...+..-. .. -...|.|||.+....++.+||||||||+||||+| |+.||.+.+..+.+
T Consensus 342 -------vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~ 414 (468)
T KOG0197|consen 342 -------VKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL 414 (468)
T ss_pred -------EEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH
Confidence 555555555533222211 11 2356999999999999999999999999999999 99999999998888
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+.+.. ++. .++.+++++.+++..||..+|
T Consensus 415 ~~le~Gy-----------------------Rlp--------------------------~P~~CP~~vY~lM~~CW~~~P 445 (468)
T KOG0197|consen 415 ELLERGY-----------------------RLP--------------------------RPEGCPDEVYELMKSCWHEDP 445 (468)
T ss_pred HHHhccC-----------------------cCC--------------------------CCCCCCHHHHHHHHHHhhCCc
Confidence 7776532 222 234568899999999999999
Q ss_pred CCCCCHHHHh
Q 013941 408 AERLKAREAL 417 (433)
Q Consensus 408 ~~R~ta~ell 417 (433)
++|||.+.+.
T Consensus 446 ~~RPtF~~L~ 455 (468)
T KOG0197|consen 446 EDRPTFETLR 455 (468)
T ss_pred ccCCCHHHHH
Confidence 9999998664
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=337.18 Aligned_cols=277 Identities=31% Similarity=0.520 Sum_probs=210.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||+|++|.||+|++..+++.||+|+++... .....+.+|+.+++.+.|+++ +++++++..++..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI-----VCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCE-----eeeEEEEeeCCeEE
Confidence 4899999999999999999999999999999986432 233567789999999988777 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+.++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---------------- 139 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV---------------- 139 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc----------------
Confidence 999999779998887533 246899999999999999999999999999999999999977665
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
++|+|||++...... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 140 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 140 -----------IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred -----------EEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 455555554432211 1123568899999998764 4789999999999999999999999988777
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+.+..+......+..... ...+ ....... ...........++.++.+||.+||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~-------------------~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 267 (285)
T cd07861 209 DQLFRIFRILGTPTEDVWPGVTS-LPDY-------------------KNTFPKW-KKGSLRSAVKNLDEDGLDLLEKMLI 267 (285)
T ss_pred HHHHHHHHHhCCCChhhhhcchh-hHHH-------------------Hhhcccc-CcchhHHhcCCCCHHHHHHHHHHhc
Confidence 76666666555443322211100 0000 0000000 0001111233467899999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013941 405 YDPAERLKAREALRHPFF 422 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f 422 (433)
.||++|||+.+|++||||
T Consensus 268 ~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 268 YDPAKRISAKKALNHPYF 285 (285)
T ss_pred CChhhCCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=348.89 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=195.5
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHH-HHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~-~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||+||+|++..+++.||+|++.+... .......|.. +++.+.|++| +++++++...+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~I-----v~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL-----VGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCC-----CceeEEEEcCCeEEEEE
Confidence 479999999999999999999999999875321 1223333433 4566667766 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-------------------- 133 (325)
T cd05602 76 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-------------------- 133 (325)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--------------------
Confidence 999 999999998654 689999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.++|+|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 134 -------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (325)
T cd05602 134 -------HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206 (325)
T ss_pred -------CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence 46677777665321 12233579999999999999999999999999999999999999998777655444
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+..... .....++..+.++|.+||+.||.
T Consensus 207 ~i~~~~~--------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 207 NILNKPL--------------------------------------------------QLKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred HHHhCCc--------------------------------------------------CCCCCCCHHHHHHHHHHcccCHH
Confidence 4322110 11134567899999999999999
Q ss_pred CCCCHH----HHhcCCCCCC
Q 013941 409 ERLKAR----EALRHPFFTR 424 (433)
Q Consensus 409 ~R~ta~----ell~hp~f~~ 424 (433)
+|+++. ++++|+||..
T Consensus 237 ~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 237 KRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HCCCCCCCHHHHhcCcccCC
Confidence 999876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.19 Aligned_cols=246 Identities=27% Similarity=0.438 Sum_probs=193.3
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
||+|+||+||+|++..+++.||||++.+... .......|..++..+... .|++++.+++++.+.+.+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~--~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLD--ESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccC--CCCcCcceEEEEecCCeEEEEEcCC
Confidence 7999999999999999999999999864321 122334566666655310 2344499999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~----------------------- 133 (330)
T cd05586 79 SGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG----------------------- 133 (330)
T ss_pred CCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-----------------------
Confidence 999999987654 799999999999999999999999999999999999997655
Q ss_pred CCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i 330 (433)
.++|+|||++..... .....+||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 134 ----~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 134 ----HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred ----CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 467777776653211 12345799999999999765 4899999999999999999999999876655444333
Q ss_pred HHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCC
Q 013941 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410 (433)
Q Consensus 331 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 410 (433)
......+| ...++.++.+||.+||+.||++|
T Consensus 210 ~~~~~~~~-------------------------------------------------~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 210 AFGKVRFP-------------------------------------------------KNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred HcCCCCCC-------------------------------------------------CccCCHHHHHHHHHHcCCCHHHC
Confidence 21111110 01246688999999999999999
Q ss_pred C----CHHHHhcCCCCCCC
Q 013941 411 L----KAREALRHPFFTRD 425 (433)
Q Consensus 411 ~----ta~ell~hp~f~~~ 425 (433)
+ +++++++||||.+.
T Consensus 241 ~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 241 LGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCHHHHhcCccccCC
Confidence 8 79999999999863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=338.73 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=207.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.|+..+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++|+++ +.+.+.+..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV-----VNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCc-----eeEEEEEecCCEE
Confidence 3788899999999999999999999999999986532 223446789999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~---------------- 139 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG---------------- 139 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC----------------
Confidence 9999999 89999888765545799999999999999999999999999999999999996544
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 140 -----------~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 140 -----------HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred -----------CEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4677777766543221 123478999999999998889999999999999999999999998766544
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+........ .......+.++.+|+.+||+.
T Consensus 209 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05632 209 KREEVDRRVLETE----------------------------------------------EVYSAKFSEEAKSICKMLLTK 242 (285)
T ss_pred HHHHHHHhhhccc----------------------------------------------cccCccCCHHHHHHHHHHccC
Confidence 4333322111100 011234466889999999999
Q ss_pred CCCCCCC-----HHHHhcCCCCCCC
Q 013941 406 DPAERLK-----AREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~t-----a~ell~hp~f~~~ 425 (433)
||++||| +.++++|+||++-
T Consensus 243 ~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 243 DPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred CHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999 8999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=347.88 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=201.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.++||+|+||.||++++..+++.||+|++.+.. .....+..|+.++..+.|+++ +.+++.+.+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWI-----TTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCE-----eeEEEEEecCCE
Confidence 36999999999999999999999999999999986422 222346678888888877766 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~--------------- 139 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--------------- 139 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC---------------
Confidence 99999999 999999997643 3689999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhC-----CCCCccchHHHHHHHHHHHHhCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.++|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 140 ------------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 140 ------------HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred ------------CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 4667777766432211 122479999999999863 4578999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...+..+....+..... ...++. ....++.++.+
T Consensus 208 f~~~~~~~~~~~i~~~~~----------------------~~~~p~-----------------------~~~~~s~~~~~ 242 (332)
T cd05623 208 FYAESLVETYGKIMNHKE----------------------RFQFPA-----------------------QVTDVSEDAKD 242 (332)
T ss_pred CCCCCHHHHHHHHhCCCc----------------------cccCCC-----------------------ccccCCHHHHH
Confidence 987766555444432110 001110 11345778999
Q ss_pred HHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 013941 398 LLQGLLRYDPAE--RLKAREALRHPFFTR 424 (433)
Q Consensus 398 li~~~L~~dP~~--R~ta~ell~hp~f~~ 424 (433)
||.+||..++++ |++++|+++||||.+
T Consensus 243 li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 243 LIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999765554 689999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=357.05 Aligned_cols=254 Identities=26% Similarity=0.479 Sum_probs=214.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEec-cchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+-|.|+..||.|+||.||+|.++.++-..|-|++. +.....+.+..||+||..+.||+| |++++.|..++.++|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~i-----vkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVI-----VKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHH-----HHHHHHHhccCceEE
Confidence 45899999999999999999999999888999886 445667888999999999998887 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+.||| ||-...++-.-+ +.+.+.++..+++|++.||.|||+++|||||||..|||++-+|
T Consensus 107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG------------------ 167 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG------------------ 167 (1187)
T ss_pred EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC------------------
Confidence 99999 777777766554 5899999999999999999999999999999999999998877
Q ss_pred cccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.++|+|||.+.... ....++.||++|||||+.. ..+|+.++||||||++|.||..+.+|-...
T Consensus 168 ---------dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 168 ---------DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred ---------cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 46777777665432 2345579999999999975 457999999999999999999999999887
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+....+..|...-. |. .-.+..++..+.|||.+
T Consensus 239 npMRVllKiaKSeP--PT---------------------------------------------LlqPS~Ws~~F~DfLk~ 271 (1187)
T KOG0579|consen 239 NPMRVLLKIAKSEP--PT---------------------------------------------LLQPSHWSRSFSDFLKR 271 (1187)
T ss_pred chHHHHHHHhhcCC--Cc---------------------------------------------ccCcchhhhHHHHHHHH
Confidence 77776665544211 11 11223457799999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||..||++.++|+||||++.
T Consensus 272 cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 272 CLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999999964
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=336.32 Aligned_cols=252 Identities=25% Similarity=0.439 Sum_probs=212.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
-|.++.+||+|+||.||+|.++.+|+.+|||.+.- +...+++.+|+.|++++..+.+ |++++.|-....+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yV-----VKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYV-----VKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchh-----hhhhhhhccCCceEeeh
Confidence 48899999999999999999999999999999865 3445778899999999987766 99999998889999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||| .|++.++++.+. +.+++..+..+++.-+.||+|||...-||||||..|||++.+|+
T Consensus 108 EYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~------------------- 167 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI------------------- 167 (502)
T ss_pred hhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch-------------------
Confidence 999 899999998654 68999999999999999999999999999999999999987774
Q ss_pred cCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.||+|||.|....+ ...++.||+.|||||++..-.|+.++||||||++..||..|++||........+.
T Consensus 168 --------AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF 239 (502)
T KOG0574|consen 168 --------AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF 239 (502)
T ss_pred --------hhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence 56666666654433 3466899999999999999999999999999999999999999998755443322
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
+| .-.+|+ ...-+..++.++.|||++||.++|+
T Consensus 240 MI---PT~PPP--------------------------------------------TF~KPE~WS~~F~DFi~~CLiK~PE 272 (502)
T KOG0574|consen 240 MI---PTKPPP--------------------------------------------TFKKPEEWSSEFNDFIRSCLIKKPE 272 (502)
T ss_pred ec---cCCCCC--------------------------------------------CCCChHhhhhHHHHHHHHHhcCCHH
Confidence 22 111111 1112234578999999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q 013941 409 ERLKAREALRHPFFTRD 425 (433)
Q Consensus 409 ~R~ta~ell~hp~f~~~ 425 (433)
+|-||.++++|||+++.
T Consensus 273 ~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 273 ERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHHHHHHhhhhhhcCC
Confidence 99999999999999874
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=347.00 Aligned_cols=243 Identities=27% Similarity=0.399 Sum_probs=194.9
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHH-HHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..+++.||+|++.+.. .....+..|.. +++.+.|+++ +++++++.+.+..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~i-----v~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL-----VGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCc-----cceeeEEEcCCEEEEEE
Confidence 47999999999999999999999999987532 12233444443 5667777776 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|...+.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-------------------- 133 (321)
T cd05603 76 DYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-------------------- 133 (321)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--------------------
Confidence 999 899998887654 689999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+......
T Consensus 134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (321)
T cd05603 134 -------HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206 (321)
T ss_pred -------CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 46677777665321 11233578999999999998889999999999999999999999998876554443
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+..... ......+.++.++|.+||+.||.
T Consensus 207 ~i~~~~~--------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 207 NILHKPL--------------------------------------------------QLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred HHhcCCC--------------------------------------------------CCCCCCCHHHHHHHHHHccCCHh
Confidence 3322110 11123466899999999999999
Q ss_pred CCCCH----HHHhcCCCCCC
Q 013941 409 ERLKA----REALRHPFFTR 424 (433)
Q Consensus 409 ~R~ta----~ell~hp~f~~ 424 (433)
+|+++ .++++|+||..
T Consensus 237 ~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 237 RRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred hcCCCCCCHHHHhCCCCcCC
Confidence 99875 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=347.72 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=202.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||++++..+++.||+|++.+.. .....+..|+.++..+.|+++ +.+++++.+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWI-----TTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCE
Confidence 46999999999999999999999999999999986532 223346678888888877776 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~--------------- 139 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG--------------- 139 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC---------------
Confidence 99999999 999999998643 3689999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhC-----CCCCccchHHHHHHHHHHHHhCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 140 ------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 140 ------------HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred ------------CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 46677777665432221 22479999999999876 4578999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...+..+....+...... ..++ .....++.++++
T Consensus 208 f~~~~~~~~~~~i~~~~~~----------------------~~~p-----------------------~~~~~~~~~~~~ 242 (331)
T cd05624 208 FYAESLVETYGKIMNHEER----------------------FQFP-----------------------SHITDVSEEAKD 242 (331)
T ss_pred ccCCCHHHHHHHHHcCCCc----------------------ccCC-----------------------CccccCCHHHHH
Confidence 9877665544433321100 0011 011235678999
Q ss_pred HHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 013941 398 LLQGLLRYDPAE--RLKAREALRHPFFTR 424 (433)
Q Consensus 398 li~~~L~~dP~~--R~ta~ell~hp~f~~ 424 (433)
||.+||..++++ |++++++++||||+.
T Consensus 243 li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 243 LIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999976654 469999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=336.71 Aligned_cols=248 Identities=23% Similarity=0.414 Sum_probs=196.5
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
||+|+||.||++++..+|+.||+|.+.... ........|++++++++|+++ ++++++++.+.++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFI-----VNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcE-----EEEEEEEecCCeEEEEEecC
Confidence 799999999999999999999999986422 122345569999999988877 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~----------------------- 132 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG----------------------- 132 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-----------------------
Confidence 99999988766555689999999999999999999999999999999999997655
Q ss_pred CCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~ 332 (433)
.++|+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|..||...........+.+
T Consensus 133 ----~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05607 133 ----NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208 (277)
T ss_pred ----CEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence 46667777665433221 224689999999999988899999999999999999999999976433211111111
Q ss_pred -HhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCC
Q 013941 333 -VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 411 (433)
Q Consensus 333 -~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ 411 (433)
..... .......++.++++||.+||+.||++||
T Consensus 209 ~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~L~~~P~~R~ 242 (277)
T cd05607 209 RTLEDE----------------------------------------------VKFEHQNFTEESKDICRLFLAKKPEDRL 242 (277)
T ss_pred Hhhccc----------------------------------------------cccccccCCHHHHHHHHHHhccCHhhCC
Confidence 00000 0000123567899999999999999999
Q ss_pred CH----HHHhcCCCCCCC
Q 013941 412 KA----REALRHPFFTRD 425 (433)
Q Consensus 412 ta----~ell~hp~f~~~ 425 (433)
++ ++++.||||+..
T Consensus 243 ~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 243 GSREKNDDPRKHEFFKTI 260 (277)
T ss_pred CCccchhhhhcChhhcCC
Confidence 99 678899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=348.20 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=217.2
Q ss_pred CCeEE--eccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.-|+| .+.||+|.||+||-|.++.+|+.||||++.+. .+......+|+.||+.+.||+| |.+...|++.+
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGi-----V~le~M~ET~e 636 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGI-----VNLECMFETPE 636 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCe-----eEEEEeecCCc
Confidence 34655 47899999999999999999999999999753 2445778889999999999998 99999999999
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.+++|||.+.|++.+.+-.....++++...+.++.||+.||.|||.++|+|+||||+|||+.+.
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~---------------- 700 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA---------------- 700 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC----------------
Confidence 9999999997776666654445689999999999999999999999999999999999999653
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
+.-.++||||||+|++..+. ..+++||+.|+|||++.+..|+..-|+||.|||+|.-+.|..||....+
T Consensus 701 --------~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd- 771 (888)
T KOG4236|consen 701 --------SPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED- 771 (888)
T ss_pred --------CCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-
Confidence 34568999999999987754 3568999999999999999999999999999999999999999975544
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+..+|++.-.-.|. ..+.+++..+.|||..+|+
T Consensus 772 -IndQIQNAaFMyPp----------------------------------------------~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 772 -INDQIQNAAFMYPP----------------------------------------------NPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred -hhHHhhccccccCC----------------------------------------------CchhhcCHHHHHHHHHHHH
Confidence 33444332111111 1235668899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
..-.+|.|.++.|.|||+++.
T Consensus 805 Vkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 805 VKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHhcchHhhccchhhhcc
Confidence 999999999999999999974
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.53 Aligned_cols=254 Identities=24% Similarity=0.273 Sum_probs=204.2
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
..++|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.++..+.|+++ +++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~i-----v~~~~~~~~~~ 104 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI-----VKCHEDFAKKD 104 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcE-----EEeecceeccc
Confidence 346899999999999999999999999999999998643 2334556788988888887776 88777664322
Q ss_pred --------eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccc
Q 013941 167 --------HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 167 --------~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l 235 (433)
.+++||||+ +|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~---- 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG---- 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC----
Confidence 478999999 999999987432 34689999999999999999999999999999999999997655
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHH
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (433)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 181 -----------------------~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilye 237 (496)
T PTZ00283 181 -----------------------LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYE 237 (496)
T ss_pred -----------------------CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 466777776654321 1234579999999999999899999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 311 l~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
|++|+.||.+.+....+..+..... ......
T Consensus 238 LltG~~Pf~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~ 268 (496)
T PTZ00283 238 LLTLKRPFDGENMEEVMHKTLAGRY-------------------------------------------------DPLPPS 268 (496)
T ss_pred HHHCCCCCCCCCHHHHHHHHhcCCC-------------------------------------------------CCCCCC
Confidence 9999999987665544433321100 001234
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+++++.+||.+||+.||++||++.++++|||++.
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 5678999999999999999999999999999874
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=340.74 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=200.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEec---cchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~---~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
..|+++++||+||.+.||++... +.+.||+|.+. .++....-+.+|+..|.+|+.+ .+||++++|-..++.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~----~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGH----DKIIQLYDYEVTDGYL 435 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC----ceEEEEeeeeccCceE
Confidence 35999999999999999999854 44567777654 3445667788999999999843 5669999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|||||+-..+|..+|++... .++.-.++.+..||+.|+.++|..||||.||||+|+|+..
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk------------------- 495 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK------------------- 495 (677)
T ss_pred EEEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-------------------
Confidence 99999999999999998762 3444589999999999999999999999999999999854
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCCcc-----cccCCcccchhhhhCCC-----------CCccchHHHHHHHHHHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLG-----------WNYPCDLWSVGCILVELC 312 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~el~ 312 (433)
+.+||+|||+|.......+. -+||+.|||||.+.... .++++||||||||||+|+
T Consensus 496 ---------G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 496 ---------GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred ---------eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 46899999999766555433 48999999999996432 568999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
.|+.||.... .....+..+..+ +..+.||+.. ..
T Consensus 567 YgktPf~~~~--n~~aKl~aI~~P-------------------~~~Iefp~~~-------------------------~~ 600 (677)
T KOG0596|consen 567 YGKTPFGQII--NQIAKLHAITDP-------------------NHEIEFPDIP-------------------------EN 600 (677)
T ss_pred hcCCchHHHH--HHHHHHHhhcCC-------------------CccccccCCC-------------------------Cc
Confidence 9999996432 233333333221 1122222211 11
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
.++.++++.||.+||.+|||+.++|+|||++-
T Consensus 601 ~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 601 DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 24899999999999999999999999999985
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=342.14 Aligned_cols=285 Identities=25% Similarity=0.463 Sum_probs=200.3
Q ss_pred eccccccccEEEEEEEecC--CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec--cCCeEEEEE
Q 013941 97 LSKMGEGTFGQVVECFDNE--KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--YRNHICIVF 172 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~--~~~~~~lv~ 172 (433)
..+||+|+||.||+|++.. ++..||+|.+.... ......+|+.+++.++|+|+ +++++++. .+..+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNV-----IALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCe-----eeEEEEEeccCCCeEEEEE
Confidence 3689999999999999654 56789999986533 23457789999999998887 99999874 457899999
Q ss_pred ccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 173 EKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 173 e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+..++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~-------------- 145 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-------------- 145 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC--------------
Confidence 999889988875321 12588999999999999999999999999999999999995432
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
+.+..+||+|||++...... .....||..|+|||++.+. .++.++|||||||++|||++|.+||
T Consensus 146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ---------CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 23446888888887654322 1235789999999999774 5899999999999999999999999
Q ss_pred CCCCh---------HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 319 QTHEN---------LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 319 ~~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
..... ...+..+...++......+....... .+...... +.... ...............
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~---------~~~~~~~~~~~~~~~ 284 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMP-EYPTLQKD--FRRTT---------YANSSLIKYMEKHKV 284 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcc-cchhhhhh--hcccc---------cCCchhhhhhhcccC
Confidence 75432 23344444444443332221111000 00000000 00000 000000000111112
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 390 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
..+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 285 ~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 285 KPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=359.64 Aligned_cols=252 Identities=23% Similarity=0.264 Sum_probs=205.9
Q ss_pred CCeEEeccccccccEEEEEEEecCC-CcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+.+|+.+++.+.|+|| +++++++...+.+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpni-----v~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGI-----VKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEEECCEEE
Confidence 3599999999999999999998877 7889999775433 333456779999999998887 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 170 IVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
|||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~--------------- 206 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG--------------- 206 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC---------------
Confidence 999999 99999988642 223689999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 207 ------------~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 207 ------------IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ------------cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4667777766543321 23357999999999999989999999999999999999999999876
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+.+..+.... .+ .....++.++.+||.+
T Consensus 275 ~~~~~~~~~~~~~--~~-----------------------------------------------~~~~~~s~~~~~li~~ 305 (478)
T PTZ00267 275 SQREIMQQVLYGK--YD-----------------------------------------------PFPCPVSSGMKALLDP 305 (478)
T ss_pred CHHHHHHHHHhCC--CC-----------------------------------------------CCCccCCHHHHHHHHH
Confidence 6555444332210 00 0112346789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
||..||++|||+++++.|+|++.
T Consensus 306 ~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 306 LLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999863
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=336.87 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=210.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+++++++.|+++ +++++++.+++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL-----VNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCc-----cceeeEEEcCCe
Confidence 36999999999999999999999999999999986432 334567789999999998877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+|||++.++
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~--------------- 138 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--------------- 138 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---------------
Confidence 99999999 999999998764 799999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||++...........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+....
T Consensus 139 ------------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 206 (290)
T cd05580 139 ------------YIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206 (290)
T ss_pred ------------CEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 46777777776554444456789999999999888889999999999999999999999987664433
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+...... .....+..+.++|.+||+.|
T Consensus 207 ~~~~~~~~~~--------------------------------------------------~~~~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 207 YEKILEGKVR--------------------------------------------------FPSFFSPDAKDLIRNLLQVD 236 (290)
T ss_pred HHHHhcCCcc--------------------------------------------------CCccCCHHHHHHHHHHccCC
Confidence 3333211111 11233668999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q 013941 407 PAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~-----ta~ell~hp~f~~~ 425 (433)
|++|+ +++|+++||||+..
T Consensus 237 p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 237 LTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHccCcccCCHHHHHcCcccccC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=344.56 Aligned_cols=300 Identities=19% Similarity=0.242 Sum_probs=208.4
Q ss_pred Eecccccc--ccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 96 ILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 96 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
++++||+| +|++||++.+..+|+.||+|+++.. ......+.+|+.+++.++|+|| +++++++..++..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpni-----v~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNI-----VPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEEECCEEEE
Confidence 56789999 7899999999999999999998753 2334567789999999998887 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~------- 149 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL------- 149 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh-------
Confidence 99999 8999999976544568999999999999999999999999999999999999988888777776432
Q ss_pred cccCCCCCCCeeeecCCCCccc-cCCCcccccCCcccchhhhhC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+.++|..... ........++..|+|||++.+ ..++.++|||||||++|||++|..||........
T Consensus 150 -----------~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 150 -----------SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred -----------ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 22222221111 111122357788999999976 3589999999999999999999999986554433
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhh----cCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.... ..+..|....... ...+... ..+....+......... ...............+++++.+||.+|
T Consensus 219 ~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~ 290 (327)
T cd08227 219 LLEK--LNGTVPCLLDTTT-IPAEELTMKPSRSGANSGLGESTTVSTP-----RPSNGESSSHPYNRTFSPHFHHFVEQC 290 (327)
T ss_pred HHHH--hcCCccccccccc-hhhhhcccCCcccCCcCCCCcccccCCc-----CccccCCcccccccccCHHHHHHHHHH
Confidence 2222 2222221110000 0000000 00000000000000000 000000000112234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCc
Q 013941 403 LRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
|+.||++|||++|+++||||++-.
T Consensus 291 l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 291 LQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred HhhCchhcCCHHHHhcChhhhhcc
Confidence 999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=333.90 Aligned_cols=253 Identities=22% Similarity=0.403 Sum_probs=202.0
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceecc----
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY---- 164 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~---- 164 (433)
..++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.++.++ .|+|+ +++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI-----ATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCe-----eeEeeEEeecCCC
Confidence 34679999999999999999999999999999999976655566788899999988 46666 999988764
Q ss_pred --CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
...+|+||||+ +++|.+++.......+++..+..++.||+.||+|||+++|+||||||+||+++.++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~---------- 148 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA---------- 148 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC----------
Confidence 35789999999 88999999875545789999999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhC-----CCCCccchHHHHHHHHHHHHh
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~ 313 (433)
.++|+|||++..... ......|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 149 -----------------~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~ 211 (272)
T cd06637 149 -----------------EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211 (272)
T ss_pred -----------------CEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh
Confidence 467777776654322 1233578999999999863 357889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|..||...........+.... . ........+.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~--~----------------------------------------------~~~~~~~~~~ 243 (272)
T cd06637 212 GAPPLCDMHPMRALFLIPRNP--A----------------------------------------------PRLKSKKWSK 243 (272)
T ss_pred CCCCccccCHHHHHHHHhcCC--C----------------------------------------------CCCCCCCcCH
Confidence 999997554332222111100 0 0000123456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
++.+||.+||..||.+|||+.++++||||
T Consensus 244 ~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 89999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=369.09 Aligned_cols=277 Identities=26% Similarity=0.437 Sum_probs=214.5
Q ss_pred ecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
..++...++|++++.||+|+||+||+|++..+++.||+|++... ......+..|+.+++.|.|++| ++++++
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNI-----Vrl~d~ 80 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI-----VRYIDR 80 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCc-----CeEEEE
Confidence 34566677899999999999999999999999999999998642 2345667889999999999888 999998
Q ss_pred ecc--CCeEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEecCCCCCcEEEee
Q 013941 162 FDY--RNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHEL-------RLIHTDLKPENILLVS 229 (433)
Q Consensus 162 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-------~ivHrDikp~NIli~~ 229 (433)
|.+ ...+||||||+ +++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 754 46799999999 899999987531 24699999999999999999999984 4999999999999975
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCC--CCCccchHHHHH
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVG 305 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG 305 (433)
... .+.+... .....+....+||+|||++...... .....||+.|+|||++.+. .++.++||||||
T Consensus 161 ~~~-~lg~i~~---------~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG 230 (1021)
T PTZ00266 161 GIR-HIGKITA---------QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230 (1021)
T ss_pred Ccc-ccccccc---------cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHH
Confidence 321 1111100 0011234456899999998765432 2345799999999998653 588999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 306 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
||||+|++|..||...+....+.........+|
T Consensus 231 ~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp----------------------------------------------- 263 (1021)
T PTZ00266 231 CIIYELCSGKTPFHKANNFSQLISELKRGPDLP----------------------------------------------- 263 (1021)
T ss_pred HHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC-----------------------------------------------
Confidence 999999999999986655443322211100000
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
....+.++.+||..||+.+|.+|||+.|+|.|+||+..
T Consensus 264 --i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 264 --IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred --cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 12236689999999999999999999999999999854
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=349.03 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=215.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
..|.-++.||.|+||.||.|++..+.+.||||.+... ...-+.+.+|+..|+++.|||+ |.+.++|-.+..
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnt-----ieYkgCyLre~T 100 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNT-----IEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCc-----ccccceeeccch
Confidence 4588899999999999999999999999999998632 2344678899999999999988 999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
.|||||||-|+-.|++.-.. +.+.+..+..|+.+.+.||.|||+.+.||||||..|||+++.|
T Consensus 101 aWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g---------------- 163 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG---------------- 163 (948)
T ss_pred HHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC----------------
Confidence 99999999888888887443 4799999999999999999999999999999999999997665
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.|||+|||+|.+... ..+++||++|||||++.. +.|+-++||||||++..||...++|+-..+..
T Consensus 164 -----------~VKLaDFGSAsi~~P-AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM 231 (948)
T KOG0577|consen 164 -----------LVKLADFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 231 (948)
T ss_pred -----------eeeeccccchhhcCc-hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH
Confidence 678899998876544 345699999999999974 46999999999999999999999998877777
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
..+..|.+.-.+. -....++..+++||..||+
T Consensus 232 SALYHIAQNesPt------------------------------------------------Lqs~eWS~~F~~Fvd~CLq 263 (948)
T KOG0577|consen 232 SALYHIAQNESPT------------------------------------------------LQSNEWSDYFRNFVDSCLQ 263 (948)
T ss_pred HHHHHHHhcCCCC------------------------------------------------CCCchhHHHHHHHHHHHHh
Confidence 7766665422110 0123557899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
+-|.+|||.+++|.|+|+...
T Consensus 264 KipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 264 KIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred hCcccCCcHHHHhhcchhccC
Confidence 999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=336.98 Aligned_cols=283 Identities=29% Similarity=0.441 Sum_probs=215.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC--C
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~--~ 166 (433)
++|++.+.||+|+||.||+|.+..+|+.||+|+++.... ......+|+.++++++|+++ +++++++... +
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~ 81 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI-----VELKEVVVGKHLD 81 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCC-----cceEEEEecCCCC
Confidence 569999999999999999999999999999999864321 22345679999999999888 8999888654 5
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.+++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-------------- 146 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC-------------- 146 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--------------
Confidence 789999999879999887643 46899999999999999999999999999999999999976654
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
++|+|||.+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+
T Consensus 147 -------------~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 147 -------------LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred -------------EEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 566666655443321 122345788999999876 457899999999999999999999999988
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+.+..+....+..+..++........ ......+.. ... .........+.++.+||.+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~--------------~~~-~~~~~~~~~~~~~~~li~~m 273 (309)
T cd07845 214 EIEQLDLIIQLLGTPNESIWPGFSDLPL-----VGKFTLPKQ--------------PYN-NLKHKFPWLSEAGLRLLNFL 273 (309)
T ss_pred HHHHHHHHHHhcCCCChhhchhhhcccc-----cccccccCC--------------CCC-chHHhccccCHHHHHHHHHH
Confidence 8888888888777655443222111000 000000000 000 00011123477899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 403 LRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
|++||++|||++|+++||||++...
T Consensus 274 l~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 274 LMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred hcCChhhCcCHHHHhcChhhccCCC
Confidence 9999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=334.86 Aligned_cols=283 Identities=30% Similarity=0.481 Sum_probs=215.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh------hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
+|++.+.||+|+||.||+|.+..+++.||+|.++.... ....+..|+.++++++|+++ +++++++.+.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI-----IGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCC-----hhhhheeecCC
Confidence 58899999999999999999999999999999875432 23456679999999988887 99999999999
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
..++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~-------------- 140 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV-------------- 140 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--------------
Confidence 999999999889999997653 36999999999999999999999999999999999999977664
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.++|.+..
T Consensus 141 -------------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 141 -------------LKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred -------------EEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 555666655433221 122356788999999865 357899999999999999999999998877
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+.+..+.+..+......+....... .+.. +. ..............+..+.+||.+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~------~~---------------~~~~~~~~~~~~~~~~~~~~li~~~ 265 (298)
T cd07841 208 DIDQLGKIFEALGTPTEENWPGVTSLP-DYVE------FK---------------PFPPTPLKQIFPAASDDALDLLQRL 265 (298)
T ss_pred cHHHHHHHHHHcCCCchhhhhhccccc-cccc------cc---------------ccCCcchhhhcccccHHHHHHHHHH
Confidence 777666666555444332221110000 0000 00 0000001112234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCccccC
Q 013941 403 LRYDPAERLKAREALRHPFFTRDVRRCG 430 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~~~~~ 430 (433)
|++||++|||+.|+++|+||++.....+
T Consensus 266 l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 266 LTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred hcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 9999999999999999999999765544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=334.17 Aligned_cols=278 Identities=36% Similarity=0.596 Sum_probs=214.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++.|+++ +++++++..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV-----VKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCC-----cceeeEEecCCeeE
Confidence 5899999999999999999999999999999987532 234567889999999988877 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||++++|.+++.... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.
T Consensus 76 ~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~----------------- 137 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV----------------- 137 (286)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc-----------------
Confidence 999999999999987644 46999999999999999999999999999999999999976554
Q ss_pred cccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
++|+|||.+...... .....|+..|+|||++.+. .++.++|||||||++|+|++|.++|.+..+.
T Consensus 138 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 207 (286)
T cd07832 138 ----------LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI 207 (286)
T ss_pred ----------EEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence 566666665543322 1234688999999998765 4689999999999999999999999888877
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
..+..+....+......+...... .. .....++... ...........+.++.+||.+||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~ 267 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSL-PD----YNKITFPESK---------------PIPLEEIFPDASPEALDLLKGLLV 267 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCc-ch----hhcccCCCCC---------------cchHHHhCCCccHHHHHHHHHHhc
Confidence 777776666554433221111000 00 0000111000 000111223456799999999999
Q ss_pred cCCCCCCCHHHHhcCCCCC
Q 013941 405 YDPAERLKAREALRHPFFT 423 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~ 423 (433)
.||++|||++++++||||.
T Consensus 268 ~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 268 YDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cChhhCCCHHHHhhCcCcC
Confidence 9999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=340.78 Aligned_cols=285 Identities=29% Similarity=0.518 Sum_probs=214.1
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc---
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--- 164 (433)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++++++|+|+ +++++++..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~ 77 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI-----IGILDIIRPPSF 77 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCc-----Cchhheeecccc
Confidence 456899999999999999999999999999999998642 2334567789999999998887 888876543
Q ss_pred --CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 165 --RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 165 --~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
....|+|+||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~--------- 145 (336)
T cd07849 78 ESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDL--------- 145 (336)
T ss_pred cccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCE---------
Confidence 3468999999988998888654 59999999999999999999999999999999999999876655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~ 315 (433)
+|+|||++...... .....||..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 146 ------------------kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~ 207 (336)
T cd07849 146 ------------------KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207 (336)
T ss_pred ------------------EECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 55555544332111 122468899999998765 46889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhh-hhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
.||.+.+.......+...++..+......... ....+.... .. .............+.+
T Consensus 208 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----------------~~~~~~~~~~~~~~~~ 267 (336)
T cd07849 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSL---PF-----------------KPKVPWNKLFPNADPK 267 (336)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhc---Cc-----------------CCcccHHHHhcccCcH
Confidence 99998887777777777776654432221110 000010000 00 0000001112344778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
+.+||.+||+.||++|||+.|+++||||.+-...+
T Consensus 268 ~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~ 302 (336)
T cd07849 268 ALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302 (336)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccccCCCC
Confidence 99999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=332.80 Aligned_cols=277 Identities=32% Similarity=0.532 Sum_probs=213.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++++.||.|++|.||+|++..+++.||||.++... .....+.+|++++++++|+++ +++++++.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCC-----cchhhhcccCCcEE
Confidence 4899999999999999999999999999999886432 223567789999999998887 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||+.++|.+++.......+++..++.++.||+.||+|||++|++||||+|+||+++.++.
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~----------------- 138 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA----------------- 138 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-----------------
Confidence 999999779999987765567999999999999999999999999999999999999976664
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCC-CCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
++|+|||.+...... .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+
T Consensus 139 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 208 (284)
T cd07860 139 ----------IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208 (284)
T ss_pred ----------EEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 566666655433221 12235678899999887654 6889999999999999999999999888877
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+..+..+............ +.. .++.. ............+.+++++|.+||+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~ 267 (284)
T cd07860 209 QLFRIFRTLGTPDEVVWPGVTSLPD-YKP-----SFPKW---------------ARQDFSKVVPPLDEDGRDLLSQMLHY 267 (284)
T ss_pred HHHHHHHHhCCCChhhhhhhhHHHH-HHh-----hcccc---------------cccCHHHHcccCCHHHHHHHHHhcCC
Confidence 7777777666554433221111000 000 00000 00001111234567899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
||++|||++++++||||
T Consensus 268 ~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 268 DPNKRISAKAALAHPFF 284 (284)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=338.14 Aligned_cols=280 Identities=23% Similarity=0.378 Sum_probs=215.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|++++..+.|+++ +++++.+..++.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL-----PTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCc-----hhheeeeecCCE
Confidence 36999999999999999999999999999999987533 234567789999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.......+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999 99999999865555799999999999999999999999999999999999999999888888887665433
Q ss_pred CCCcccCCCCCCC-----ee-eecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 247 DGSYFKNLPKSSA-----IK-LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 247 ~~~~~~~~~~~~~-----~k-l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
............. .+ ...+ .............||..|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSET-FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred cccccccccccccccccccccchhh-hcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 2211000000000 00 0000 000001112235789999999999988899999999999999999999999987
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+....+..+.......+ .....+..+.++|.
T Consensus 235 ~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~li~ 266 (316)
T cd05574 235 SNRDETFSNILKKEVTFP------------------------------------------------GSPPVSSSARDLIR 266 (316)
T ss_pred CchHHHHHHHhcCCccCC------------------------------------------------CccccCHHHHHHHH
Confidence 765544433321110000 01124678999999
Q ss_pred HhcccCCCCCCC----HHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLK----AREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~t----a~ell~hp~f~~~ 425 (433)
+||+.||++||| ++|+++||||++.
T Consensus 267 ~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 267 KLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.99 Aligned_cols=287 Identities=25% Similarity=0.370 Sum_probs=207.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+|++.+.||+|+||.||++.+..++..+|+|.+... ......+.+|++++.+++|+++ +++++.+..++.+|+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI-----VGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCCEEEE
Confidence 699999999999999999999999999999998643 2334567889999999999888 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
||||+ +++|.+++.+.. .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.
T Consensus 77 v~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~---------------- 138 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---------------- 138 (308)
T ss_pred EeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc----------------
Confidence 99999 899999998764 68999999999999999999997 59999999999999976654
Q ss_pred CcccCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~ 327 (433)
++|+|||++..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.....
T Consensus 139 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 139 -----------IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred -----------EEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 56666665543322 123357889999999998888999999999999999999999999765533322
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+.......+... .. ........... ........................++.++.+||.+||..||
T Consensus 208 ~~~~~~~~~~~~~~----~~-------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 275 (308)
T cd06615 208 AMFGRPVSEGEAKE----SH-------RPVSGHPPDSP-RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNP 275 (308)
T ss_pred HhhcCccccccccC----Cc-------ccccCCCCCcc-chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCCh
Confidence 22211110000000 00 00000000000 00000000000000000000011256789999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013941 408 AERLKAREALRHPFFTRD 425 (433)
Q Consensus 408 ~~R~ta~ell~hp~f~~~ 425 (433)
++|||+.|+++||||.+.
T Consensus 276 ~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 276 KERADLKELTKHPFIKRA 293 (308)
T ss_pred hhCcCHHHHhcChhhhhc
Confidence 999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=331.67 Aligned_cols=278 Identities=29% Similarity=0.492 Sum_probs=209.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... .....+.+|+.+++.++|+++ +++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI-----VTLHDIIHTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcce-----eeEEEEEecCCeEE
Confidence 57999999999999999999999899999999986432 223456789999999998877 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 80 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~----------------- 141 (291)
T cd07844 80 LVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE----------------- 141 (291)
T ss_pred EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC-----------------
Confidence 999999779999887654 36899999999999999999999999999999999999977664
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC-hH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE-NL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~-~~ 324 (433)
++|+|||.+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..
T Consensus 142 ----------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 211 (291)
T cd07844 142 ----------LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211 (291)
T ss_pred ----------EEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 566666655432211 112356788999999876 458899999999999999999999997665 44
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch--HHHHHHHHHh
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA--GDLIDLLQGL 402 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~ 402 (433)
+.+..+.+..+.+....+............ .+.. . ............+ .++.++|.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--------------~-~~~~~~~~~~~~~~~~~~~~li~~~ 271 (291)
T cd07844 212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPY-----SFPF--------------Y-PPRPLINHAPRLDRIPHGEELALKF 271 (291)
T ss_pred HHHHHHHHhcCCCChhhhhhhhhccccccc-----cccc--------------c-CChhHHHhCcCCCCchhHHHHHHHH
Confidence 555556566555444332222111000000 0000 0 0000011111223 6889999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 013941 403 LRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f 422 (433)
|+.||++|||+.|+++||||
T Consensus 272 L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 272 LQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccCcccccCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.81 Aligned_cols=249 Identities=30% Similarity=0.427 Sum_probs=202.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... .....+.+|+.+++++.|+++ +++++++..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI-----VQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCe-----eeeEEEEccC
Confidence 46999999999999999999999999999999986432 123457789999999988877 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~------------ 142 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN------------ 142 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC------------
Confidence 9999999999 899999998764 6899999999999999999999999999999999999976654
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
++|+|||.+...... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 143 ---------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 207 (263)
T cd06625 143 ---------------VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207 (263)
T ss_pred ---------------EEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 566666655432211 02246788999999999988999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
...+.......+..... ........+..+.++
T Consensus 208 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~l 239 (263)
T cd06625 208 AEFEAMAAIFKIATQPT------------------------------------------------NPQLPSHVSPDARNF 239 (263)
T ss_pred cccchHHHHHHHhccCC------------------------------------------------CCCCCccCCHHHHHH
Confidence 76544333222211000 001123456789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f 422 (433)
|.+||..+|++|||+.|+++||||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=324.09 Aligned_cols=249 Identities=25% Similarity=0.415 Sum_probs=201.7
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-CCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-~~~~ 168 (433)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.++++++|+++ +++++.+.. ++.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI-----VAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeecCCCCEE
Confidence 4899999999999999999999999999999986432 334567789999999988877 888887764 5578
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++.......+++.+++.++.||+.||++||++||+||||||+||+++.++.
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--------------- 140 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--------------- 140 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc---------------
Confidence 9999999 899999998755456899999999999999999999999999999999999976664
Q ss_pred CCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
++|+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 141 ------------~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 208 (257)
T cd08223 141 ------------IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN 208 (257)
T ss_pred ------------EEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 55666665543321 122346888999999999988999999999999999999999999876554
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+... ..+ ......+..+.++|.+||+
T Consensus 209 ~~~~~~~~~--~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 209 SLVYRIIEG--KLP-----------------------------------------------PMPKDYSPELGELIATMLS 239 (257)
T ss_pred HHHHHHHhc--CCC-----------------------------------------------CCccccCHHHHHHHHHHhc
Confidence 433322211 000 0112346789999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013941 405 YDPAERLKAREALRHPFF 422 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f 422 (433)
.||++|||+.++++||||
T Consensus 240 ~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 240 KRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCcccCCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.75 Aligned_cols=285 Identities=27% Similarity=0.508 Sum_probs=222.6
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.++|++.+.||+|++|.||+|++..+++.||+|++... ......+.+|+.+++++.|+++ +++.+++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV-----IGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCH-----HHHHHHhhcc
Confidence 3567899999999999999999999999999999998642 2233556789999999998887 8888877665
Q ss_pred Ce------EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 166 NH------ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 166 ~~------~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
+. .++|+||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-------- 155 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-------- 155 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--------
Confidence 44 8999999999999998763 599999999999999999999999999999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.++|+|||.+...........+|..|+|||.+.+. .++.++|||||||++|+|++|+.||
T Consensus 156 -------------------~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 216 (343)
T cd07851 156 -------------------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216 (343)
T ss_pred -------------------CEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 46777777766554444445788899999998764 6789999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhc-Cch-hhhhhccCCchHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL-RLP-NLIMQHVDHSAGDLI 396 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~l~ 396 (433)
.+.+....+..+....+..++.+.......... ...... ... ..........+..+.
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~s~~l~ 275 (343)
T cd07851 217 PGSDHIDQLKRIMNLVGTPDEELLQKISSESAR---------------------NYIQSLPQMPKKDFKEVFSGANPLAI 275 (343)
T ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhccchhHH---------------------HHHHhccccCCCCHHHHhccCCHHHH
Confidence 988888888888777776665544332211100 000000 000 000111123477899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
+||.+||+.||++|||+.||++||||.+.....
T Consensus 276 dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 276 DLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred HHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=338.06 Aligned_cols=286 Identities=28% Similarity=0.511 Sum_probs=218.5
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC-
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~- 165 (433)
+..+|.+.+.||+|+||+||+|++..+++.||||.+... ........+|+.+++.++|+|+ +++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV-----IAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCc-----cchHHheeccc
Confidence 456899999999999999999999999999999998642 2233456789999999998887 8888877643
Q ss_pred ----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 166 ----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
...|+||||++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~---------- 145 (337)
T cd07858 78 REAFNDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---------- 145 (337)
T ss_pred ccccCcEEEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----------
Confidence 3589999999889999987654 799999999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.|
T Consensus 146 -----------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 208 (337)
T cd07858 146 -----------------DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208 (337)
T ss_pred -----------------CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence 4566666665543222 123467889999999875 4688999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhh-hhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchh-hhhhccCCchHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRA-DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN-LIMQHVDHSAGDL 395 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 395 (433)
|.+.+.......+....+..+...+... ......+... ...... ......+..+.++
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~ 267 (337)
T cd07858 209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS---------------------LPYTPRQSFARLFPHANPLA 267 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHh---------------------cCcccccCHHHHcccCCHHH
Confidence 9988877777777777776654332110 0000000000 000000 0011223567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCCccccC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCG 430 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~ 430 (433)
.+||.+||+.||++|||++|+++||||..-.....
T Consensus 268 ~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 268 IDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred HHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 99999999999999999999999999987544433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.67 Aligned_cols=285 Identities=26% Similarity=0.502 Sum_probs=219.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc---
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--- 164 (433)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++|+++ +++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI-----IAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCc-----cCHHHhccccCC
Confidence 467999999999999999999999999999999986532 234566789999999998887 888887753
Q ss_pred -CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 -RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 -~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
...+++||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 79 ~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~----------- 145 (334)
T cd07855 79 DFKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE----------- 145 (334)
T ss_pred CCceEEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-----------
Confidence 45789999999879999987654 6999999999999999999999999999999999999987665
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC-------CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~ 315 (433)
++|+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 146 ----------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~ 209 (334)
T cd07855 146 ----------------LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209 (334)
T ss_pred ----------------EEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCC
Confidence 455555554332111 122478889999999866 45889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhh-hhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
.||.+.+....+..+....+.+|.......... ...+... ++. .............+.+
T Consensus 210 ~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~-----~~~---------------~~~~~~~~~~~~~~~~ 269 (334)
T cd07855 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN-----LPR---------------KQPVPWSKIFPKASPE 269 (334)
T ss_pred CccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhh-----ccc---------------CCCCCHHHHcccCCHH
Confidence 999998888888888888888776654332211 1111000 000 0000001112345788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
+.++|.+||+.||++|||+.+++.||||.+...+.
T Consensus 270 ~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 270 ALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 99999999999999999999999999998754443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=340.60 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=190.5
Q ss_pred CCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
++|++.++||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.++..+ +|+|| +++++++.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~~ 81 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV-----VNLLGACT 81 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcce-----eeEEeEec
Confidence 5799999999999999999975 2445789999987432 3345678899999999 67776 99999876
Q ss_pred c-CCeEEEEEccC-CCCHHHHHHhcC------------------------------------------------------
Q 013941 164 Y-RNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------ 187 (433)
Q Consensus 164 ~-~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------ 187 (433)
. .+.+++||||+ +|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 5 45689999999 999999997532
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCee
Q 013941 188 ------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261 (433)
Q Consensus 188 ------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~k 261 (433)
...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~---------------------------~~k 214 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN---------------------------VVK 214 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC---------------------------cEE
Confidence 12477888999999999999999999999999999999997655 456
Q ss_pred eecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhc
Q 013941 262 LIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLG 335 (433)
Q Consensus 262 l~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~ 335 (433)
|+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+............. +
T Consensus 215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~ 293 (338)
T cd05102 215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-G 293 (338)
T ss_pred EeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-C
Confidence 6666665432211 112345678999999999899999999999999999997 99999875432222111100 0
Q ss_pred CCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHH
Q 013941 336 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 415 (433)
Q Consensus 336 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~e 415 (433)
.. .......+.++.+||.+||+.||++|||+.|
T Consensus 294 ~~-----------------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 294 TR-----------------------------------------------MRAPENATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred CC-----------------------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 00 0011234678999999999999999999999
Q ss_pred Hhc
Q 013941 416 ALR 418 (433)
Q Consensus 416 ll~ 418 (433)
+++
T Consensus 327 l~~ 329 (338)
T cd05102 327 LVE 329 (338)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=328.19 Aligned_cols=278 Identities=31% Similarity=0.589 Sum_probs=209.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++++.|+|+ +++++++...+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL-----VNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCE-----eeeeeEEeeCCEE
Confidence 47999999999999999999999999999999886432 233557789999999988777 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||+ ++.|..++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~---------------- 137 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG---------------- 137 (286)
T ss_pred EEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC----------------
Confidence 9999999 666666655433 689999999999999999999999999999999999997665
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 138 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 138 -----------QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred -----------cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 45666666655433221 22357889999999876 4578999999999999999999999998887
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+....+....+............ ..+. .......+.. . ..........+..+.+||.+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~--~--------------~~~~~~~~~~~~~~~~li~~~l 267 (286)
T cd07847 207 VDQLYLIRKTLGDLIPRHQQIFST--NQFF-KGLSIPEPET--R--------------EPLESKFPNISSPALSFLKGCL 267 (286)
T ss_pred HHHHHHHHHHhCCCChHHhhhccc--cccc-ccccCCCccc--c--------------cCHHHHhccCCHHHHHHHHHHh
Confidence 777776666655443211100000 0000 0000000000 0 0000112345778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013941 404 RYDPAERLKAREALRHPFF 422 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f 422 (433)
+.||++|||+.|++.||||
T Consensus 268 ~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 268 QMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCccccCCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=322.65 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=205.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.|.+.+.||+|++|.||+|.+..+++.|++|.+... ......+.+|+.+++.++|+++ +++++++...+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI-----IRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCe-----ehheeeeccCCEEE
Confidence 388999999999999999999999999999998642 3445677889999999988887 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~---------------- 139 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---------------- 139 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC----------------
Confidence 999999 999999998764457999999999999999999999999999999999999977664
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
++|+|||++....... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 140 -----------~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 208 (256)
T cd08529 140 -----------VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208 (256)
T ss_pred -----------EEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5666666554332211 22467889999999999889999999999999999999999998776544
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+. ..+ .....++.++.++|.+||+.
T Consensus 209 ~~~~~~~~--~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 209 LILKIIRG--VFP-----------------------------------------------PVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred HHHHHHcC--CCC-----------------------------------------------CCccccCHHHHHHHHHHccC
Confidence 33332211 000 00113466899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
+|++||++.++++|||+
T Consensus 240 ~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 240 DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CcccCcCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=330.58 Aligned_cols=252 Identities=25% Similarity=0.454 Sum_probs=201.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceeEecceec------
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD------ 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~------ 163 (433)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.........+..|+.+++++. |+++ +++++++.
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~ 89 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI-----ATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcE-----EEEeeehhcccccC
Confidence 35799999999999999999999999999999998766555567788999999884 6655 99999884
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
..+.+|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~----------- 158 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA----------- 158 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----------
Confidence 356899999999 88999999875555689999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHHhC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g 314 (433)
.++|+|||.+..... ......|+..|+|||++. +..++.++|||||||++|+|++|
T Consensus 159 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g 222 (282)
T cd06636 159 ----------------EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222 (282)
T ss_pred ----------------CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence 467777776654321 123357899999999986 34578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
..||...........+.+.. +. . .....++.+
T Consensus 223 ~~p~~~~~~~~~~~~~~~~~---~~------------------------------------------~---~~~~~~~~~ 254 (282)
T cd06636 223 APPLCDMHPMRALFLIPRNP---PP------------------------------------------K---LKSKKWSKK 254 (282)
T ss_pred CCCccccCHHhhhhhHhhCC---CC------------------------------------------C---CcccccCHH
Confidence 99997654433222211100 00 0 001234678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
+.+||.+||+.||.+|||+.|+++||||
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 255 FIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=337.02 Aligned_cols=282 Identities=27% Similarity=0.509 Sum_probs=220.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.|+++ +++++++..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV-----IGLLDVFTPD 86 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc-----cceeeeecCC
Confidence 4567899999999999999999999999999999998542 2234567789999999999887 8888888654
Q ss_pred C------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 166 N------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 166 ~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
. .+++||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-------- 155 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-------- 155 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--------
Confidence 3 46999999988999888653 599999999999999999999999999999999999996554
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.++|+|||++...........++..|+|||++.+ ..++.++|+|||||++|+|++|..||
T Consensus 156 -------------------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 216 (343)
T cd07880 156 -------------------ELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216 (343)
T ss_pred -------------------CEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 5677788877665544444577899999999876 35889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhh-hhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
.+.+.......+....+..+..+........ ..+.. .... . ............+..+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~-~-~~~~~~~~~~~~~~~~~~ 276 (343)
T cd07880 217 KGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK------------------KLPR-F-RKKDFRSLLPNANPLAVN 276 (343)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHH------------------hccc-c-CcchHHHhccCCChHHHH
Confidence 9888777777777766666655433321110 00000 0000 0 000111223456778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+|.+||+.||++|||+.++++||||+..
T Consensus 277 li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 277 VLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=317.89 Aligned_cols=289 Identities=26% Similarity=0.466 Sum_probs=222.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc---
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--- 164 (433)
.+.|+-..+||+|.||.||+|+.+.+|+.||+|++-- .........+|+.+|..+.|+|+ +.+++.+..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv-----~nliEic~tk~T 90 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKAT 90 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhH-----HHHHHHHhhccC
Confidence 3568888999999999999999999999999987643 23445678899999999999988 666666542
Q ss_pred -----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
...+|+||.+|..+|..++.... .+++..+++.++.+++.||.|+|.+.|+|||+|++|+||+.+|.+
T Consensus 91 p~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgil------ 163 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGIL------ 163 (376)
T ss_pred CcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceE------
Confidence 34699999999999999997653 479999999999999999999999999999999999999887754
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccC-------CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHH
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el 311 (433)
||+|||+++.... ..+..+-|.+|++||.+.|. .|+++.|||..|||+.||
T Consensus 164 ---------------------klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeM 222 (376)
T KOG0669|consen 164 ---------------------KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEM 222 (376)
T ss_pred ---------------------EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHH
Confidence 5555555532221 12335679999999999886 599999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|.+.|++.++.+++..|..++|.+..+.+..++...-. ..-.....+.+.. ..+.... ... -.
T Consensus 223 wtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~--~sie~ePl~~~~~--rkv~n~~---------kp~--~k 287 (376)
T KOG0669|consen 223 WTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLY--QSIELEPLPKGQK--RKVKNRL---------KPY--VK 287 (376)
T ss_pred HccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHH--HhccCCCCCcchh--hhhhhhc---------ccc--cC
Confidence 9999999999999999999999999887665554321110 0000000111110 0000000 000 11
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
+++..+|+.+||..||.+|++++++++|.||..+.-
T Consensus 288 d~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 288 DDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred ChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 457889999999999999999999999999998743
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=346.69 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=208.9
Q ss_pred cccccccEEEEEEEecCCCcEEEEEEec-cchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-C
Q 013941 99 KMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~ 176 (433)
+||+|.||+||.|++..+...+|||-+. +.....+.+..|+.+.++|+|.|| |++++.+..++++-|.||-+ |
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNI-----VrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNI-----VRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhH-----HHHhhccCCCCeEEEEeecCCC
Confidence 7999999999999999999999999886 444566778889999999999998 99999999999999999999 9
Q ss_pred CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 177 PSLYDFLRKNSYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 177 ~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
|+|.++++..- +.+ .+.++..+.+||++||.|||++.|||||||-+||||+.
T Consensus 657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT------------------------- 710 (1226)
T KOG4279|consen 657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT------------------------- 710 (1226)
T ss_pred CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-------------------------
Confidence 99999998654 356 88999999999999999999999999999999999953
Q ss_pred CCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
-.+.+||+|||.++.... -..++.||..|||||++..+ +|+.++|||||||++.||.||++||..-...+. ++
T Consensus 711 -ySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AM 788 (1226)
T KOG4279|consen 711 -YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AM 788 (1226)
T ss_pred -ccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hh
Confidence 234678888888765432 22347899999999999865 589999999999999999999999965433221 11
Q ss_pred HH----HHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 330 ME----RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 330 i~----~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.. +.-.++ +.+.+.+++.||.+|+..
T Consensus 789 FkVGmyKvHP~i--------------------------------------------------Peelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 789 FKVGMYKVHPPI--------------------------------------------------PEELSAEAKNFILRCFEP 818 (1226)
T ss_pred hhhcceecCCCC--------------------------------------------------cHHHHHHHHHHHHHHcCC
Confidence 11 111222 234577899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccccCCC
Q 013941 406 DPAERLKAREALRHPFFTRDVRRCGFP 432 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~~~~~~ 432 (433)
||.+||+|.++|..||++...++...+
T Consensus 819 d~~~R~sA~~LL~DpFlq~~~kk~r~~ 845 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQDPFLQHNNKKPRPK 845 (1226)
T ss_pred CcccCccHHHhccCcccccCCCCCCCC
Confidence 999999999999999999886655443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=331.30 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=205.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.+.|+++ +++++.+..+...|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v-----~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCE-----eeEEEEEEeCCEEE
Confidence 358999999999999999999999999999999887533 334567789999999988776 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~----------------- 153 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----------------- 153 (296)
T ss_pred EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-----------------
Confidence 999999 99999998654 589999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus 154 ----------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~ 223 (296)
T cd06654 154 ----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (296)
T ss_pred ----------CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4566666665432221 123478899999999998889999999999999999999999997765433
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+... ..+ .......++..+.+||.+||..
T Consensus 224 ~~~~~~~~--~~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~ 256 (296)
T cd06654 224 ALYLIATN--GTP---------------------------------------------ELQNPEKLSAIFRDFLNRCLDM 256 (296)
T ss_pred hHHHHhcC--CCC---------------------------------------------CCCCccccCHHHHHHHHHHCcC
Confidence 32221110 000 0011123466899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013941 406 DPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~ 425 (433)
||++|||+.++++||||...
T Consensus 257 ~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 257 DVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CcccCcCHHHHhhChhhhcc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=332.15 Aligned_cols=279 Identities=29% Similarity=0.490 Sum_probs=212.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC--C
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~--~ 166 (433)
++|++.+.||+|+||.||+|.+..+++.+|+|.++... .....+.+|+.++.++.|+|+ +++++++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNI-----VTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCE-----EEEEEEEEecCCC
Confidence 46999999999999999999999999999999987432 223345689999999988877 9999988776 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
..|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++
T Consensus 80 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--------------- 143 (293)
T cd07843 80 KIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG--------------- 143 (293)
T ss_pred cEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC---------------
Confidence 999999999779999987654 3689999999999999999999999999999999999997665
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.++|+|||.+...... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 144 ------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 144 ------------ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred ------------cEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4566666665543322 1224578899999998765 46899999999999999999999999888
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC-chHHHHHHHHH
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQG 401 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~ 401 (433)
..+....+....+.++...+....... ......+.. ............. .+..+.+||.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~ 272 (293)
T cd07843 212 EIDQLNKIFKLLGTPTEKIWPGFSELP-----GAKKKTFTK--------------YPYNQLRKKFPALSLSDNGFDLLNR 272 (293)
T ss_pred hHHHHHHHHHHhCCCchHHHHHhhccc-----hhccccccc--------------ccchhhhccccccCCChHHHHHHHH
Confidence 887777777766655443322211000 000000000 0000011111111 47789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f 422 (433)
||+.||++|||+.|+++||||
T Consensus 273 ~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 273 LLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HhccCccccCCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=328.60 Aligned_cols=277 Identities=34% Similarity=0.550 Sum_probs=208.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHh-CCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~-~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+++.+.| +++ +++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i-----~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI-----VRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCc-----cceeeeEeecCC
Confidence 36999999999999999999999999999999886432 223567789999999965 565 899888876555
Q ss_pred -----EEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee-CCcccccCc
Q 013941 168 -----ICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDY 238 (433)
Q Consensus 168 -----~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~-~~~~~l~d~ 238 (433)
.|+||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~------- 148 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG------- 148 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC-------
Confidence 89999999778999886542 235899999999999999999999999999999999999975 33
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g 314 (433)
.++|+|||.+....... ....+++.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 149 --------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 208 (295)
T cd07837 149 --------------------LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208 (295)
T ss_pred --------------------eEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcC
Confidence 56777777765432211 123568889999988764 578999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC-chhhhhhccCCchH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR-LPNLIMQHVDHSAG 393 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 393 (433)
..||.+.+.......+.+..+..+.... +....... ...... .+.......+..+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 265 (295)
T cd07837 209 QPLFPGDSELQQLLHIFKLLGTPTEQVW-------------------PGVSKLRD----WHEFPQWKPQDLSRAVPDLSP 265 (295)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhC-------------------cchhhccc----hhhcCcccchhHHHhccccCH
Confidence 9999988877776666655543332211 10000000 000000 00111112235678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
++.+||.+||+.||++|||+.|++.||||+
T Consensus 266 ~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 266 EGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=331.37 Aligned_cols=287 Identities=29% Similarity=0.502 Sum_probs=209.2
Q ss_pred CeEEeccccccccEEEEEEEecC--CCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC-
Q 013941 93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~- 165 (433)
+|++.++||+|+||.||+|.+.. +++.||+|.+.... ...+...+|+.++..++|+++ +++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV-----VSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCc-----cceEEEEeCCC
Confidence 58999999999999999999988 89999999987532 334567789999999999887 9999999887
Q ss_pred -CeEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 166 -NHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 166 -~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
+.+++||||++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~---------- 145 (316)
T cd07842 76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG---------- 145 (316)
T ss_pred CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC----------
Confidence 8899999999878888775332 13689999999999999999999999999999999999997732
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g 314 (433)
+.+..+||+|||++....... ....+|..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 146 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~ 212 (316)
T cd07842 146 -------------PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL 212 (316)
T ss_pred -------------CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence 124457777777765433221 234678899999998764 578999999999999999999
Q ss_pred CCCCCCCChH---------HHHHHHHHHhcCCChhhHHhhhhhhhhh--hcCCccccCCCCCCchhhHHHHHHhcCchhh
Q 013941 315 EALFQTHENL---------EHLAMMERVLGPLPHHMVIRADRRAEKY--FRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383 (433)
Q Consensus 315 ~~pf~~~~~~---------~~~~~i~~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
+.||.+.... ..+..+...++................. ........++. .....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~---------- 277 (316)
T cd07842 213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS-----NSLAK---------- 277 (316)
T ss_pred CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCC-----ccHHH----------
Confidence 9999765432 2334444444443332221111100000 00000000000 00000
Q ss_pred hhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 384 ~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
........+..+.++|.+||+.||++|||+.|+++||||
T Consensus 278 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 278 WMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 001112557789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=366.53 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=208.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+.|.|++.||+|+||.|.+++++.+++.||+|++++.. .....+..|-.+|..-..+-| +.++-.|++.++
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi-----v~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI-----VQLHYAFQDERY 149 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH-----HHHHHHhcCccc
Confidence 57999999999999999999999999999999998632 233456677778766555544 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||| ||+|..++.+.. .+++..+++|+..|+.||.-||+.|+|||||||+|||++..|++
T Consensus 150 LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHi------------- 214 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHI------------- 214 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcE-------------
Confidence 99999999 999999999876 79999999999999999999999999999999999999887765
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhC-----CCCCccchHHHHHHHHHHHHhCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
||+|||.+...... ....+|||.|.|||++.. +.|+..+|+||+||++|||+.|..|
T Consensus 215 --------------kLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 215 --------------KLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred --------------eeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 55555554433322 233599999999999963 4589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...+-.+.+..|++.. ..+.+|+ ...+|.++++
T Consensus 281 FYadslveTY~KIm~hk----------------------~~l~FP~------------------------~~~VSeeakd 314 (1317)
T KOG0612|consen 281 FYADSLVETYGKIMNHK----------------------ESLSFPD------------------------ETDVSEEAKD 314 (1317)
T ss_pred chHHHHHHHHHHHhchh----------------------hhcCCCc------------------------ccccCHHHHH
Confidence 99887777777666531 1112221 1236889999
Q ss_pred HHHHhcccCCCCCCC---HHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLK---AREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~t---a~ell~hp~f~~~ 425 (433)
||.++|. +|+.|+. ++++..||||.+.
T Consensus 315 LI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 315 LIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred HHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 9999777 7889998 9999999999974
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=332.56 Aligned_cols=289 Identities=28% Similarity=0.493 Sum_probs=225.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~- 164 (433)
.+.++|++.+.||.|+||.||+|.+..+++.||+|++.+. ......+.+|+.+++.+.|+++ +++.+++..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-----ISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCe-----eeEeeeEecC
Confidence 3567899999999999999999999999999999987542 2234567789999999998877 999998865
Q ss_pred CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.+..|+||||++++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~------------- 145 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC------------- 145 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-------------
Confidence 5689999999988999888653 588999999999999999999999999999999999996554
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||.+...........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 146 --------------~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 146 --------------DLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred --------------CEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4677777776654444344577889999998766 5689999999999999999999999998888
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhh-hhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
......+.+.++.+|..+....... ...++.... ..............+.++.++|.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~ 271 (328)
T cd07856 212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP--------------------KREPVPFSEKFKNADPSAIDLLEKM 271 (328)
T ss_pred HHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc--------------------ccCCCcHHHHcCCCCHHHHHHHHHH
Confidence 8888888888888877664432111 011100000 0000011112234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCccccCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRDVRRCGFP 432 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~~~~~~~ 432 (433)
|+.+|++|||+++++.||||.....+..-|
T Consensus 272 l~~~P~~R~t~~ell~~~~~~~~~~~~~~~ 301 (328)
T cd07856 272 LVFDPQKRISAAEALAHPYLAPYHDPTDEP 301 (328)
T ss_pred cCCChhhCCCHHHHhcCCccccccCCcccc
Confidence 999999999999999999998765554433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=331.20 Aligned_cols=280 Identities=28% Similarity=0.518 Sum_probs=210.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC---
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--- 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~--- 165 (433)
++|++.++||+|+||.||+|.+..+++.||||.+.... .......+|+.+++++.|+++ +++++++...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~ 86 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKATP 86 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCc-----cceEEEEeccccc
Confidence 46999999999999999999999999999999886432 223345679999999999888 8888876543
Q ss_pred -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
...++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~------- 158 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGIL------- 158 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcE-------
Confidence 3569999999889998887543 368999999999999999999999999999999999999776655
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC-------CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~ 312 (433)
+|+|||.+...... .....++..|+|||++.+. .++.++||||||+++|+|+
T Consensus 159 --------------------kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~ 218 (310)
T cd07865 159 --------------------KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218 (310)
T ss_pred --------------------EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence 55555544322111 1123578889999998765 4789999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|..||.+.+.......+....+.+|..+......... +. ....+.... .... ..-.....+
T Consensus 219 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~--~~~~-----------~~l~~~~~~ 280 (310)
T cd07865 219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLEL--FK---KMELPQGQK--RKVK-----------ERLKPYVKD 280 (310)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhh--hh---hccCCCccc--hhhH-----------HhcccccCC
Confidence 99999999888888888888888777654332211000 00 000000000 0000 000001135
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
..+.+||.+||..||++|||++|+++||||
T Consensus 281 ~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 281 PHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=330.11 Aligned_cols=253 Identities=28% Similarity=0.434 Sum_probs=207.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.+|++.+.||.|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++|+++ +++++++...+.+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI-----VNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCce-----eeeeeeEecCceEEE
Confidence 57999999999999999999999999999999886432 334567789999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
|+||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~----------------- 153 (296)
T cd06655 94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS----------------- 153 (296)
T ss_pred EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-----------------
Confidence 99999 99999988754 5899999999999999999999999999999999999976664
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
++|+|||++...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+....
T Consensus 154 ----------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 154 ----------VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred ----------EEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 566666655432221 1234688899999999988899999999999999999999999987765444
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+.... .+ .......++..+.+||.+||..|
T Consensus 224 ~~~~~~~~--~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~d 256 (296)
T cd06655 224 LYLIATNG--TP---------------------------------------------ELQNPEKLSPIFRDFLNRCLEMD 256 (296)
T ss_pred HHHHHhcC--Cc---------------------------------------------ccCCcccCCHHHHHHHHHHhhcC
Confidence 33222110 00 00112345678999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCc
Q 013941 407 PAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~~ 426 (433)
|++|||+.++++||||+...
T Consensus 257 p~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 257 VEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hhhCCCHHHHhhChHhhhcc
Confidence 99999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=325.91 Aligned_cols=274 Identities=33% Similarity=0.567 Sum_probs=211.2
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccC--CeE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR--NHI 168 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~--~~~ 168 (433)
|+++++||+|+||.||+|.+..+++.||+|+++... .......+|+.++.++. |+|+ +++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI-----LRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCc-----cceEEEEecCCCCcE
Confidence 678999999999999999999999999999987532 22233456888888885 6666 9999999887 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++. +
T Consensus 76 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~----------------- 136 (282)
T cd07831 76 ALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D----------------- 136 (282)
T ss_pred EEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-----------------
Confidence 9999999779988887643 36899999999999999999999999999999999999965 4
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+....... ....++..|+|||++.. ..++.++|||||||++|||++|..||.+.+..+
T Consensus 137 ----------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~ 206 (282)
T cd07831 137 ----------ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206 (282)
T ss_pred ----------CeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH
Confidence 46777777665443222 22467889999998754 457899999999999999999999999988888
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+....+..+..+....... ......++.... ..........+.++.+||.+||+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~ 265 (282)
T cd07831 207 QIAKIHDVLGTPDAEVLKKFRKS------RHMNYNFPSKKG---------------TGLRKLLPNASAEGLDLLKKLLAY 265 (282)
T ss_pred HHHHHHHHcCCCCHHHHHhhccc------ccccccCccccc---------------ccHHHHcccccHHHHHHHHHHhcc
Confidence 88888887777766542211100 000111111000 000111234578999999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
||++|||++++++||||
T Consensus 266 ~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 266 DPDERITAKQALRHPYF 282 (282)
T ss_pred CcccccCHHHHhhCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=329.54 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=205.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++++++|+++ +++++.+..++..|+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI-----VGLYEAYFYENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCce-----eEEEEEEecCCeEEE
Confidence 57999999999999999999998899999999987433 344567789999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++
T Consensus 80 v~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~------------------ 140 (280)
T cd06611 80 LIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG------------------ 140 (280)
T ss_pred EeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC------------------
Confidence 99999 889999987643 3699999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhC-----CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.++|+|||.+..... ......||..|+|||++.. ..++.++|||||||++|+|++|..||...
T Consensus 141 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 141 ---------DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ---------CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 456666665543222 1223468899999999853 34778999999999999999999999876
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+.......+... ..| .......++.++.++|.+
T Consensus 212 ~~~~~~~~~~~~--~~~---------------------------------------------~~~~~~~~~~~~~~li~~ 244 (280)
T cd06611 212 NPMRVLLKILKS--EPP---------------------------------------------TLDQPSKWSSSFNDFLKS 244 (280)
T ss_pred CHHHHHHHHhcC--CCC---------------------------------------------CcCCcccCCHHHHHHHHH
Confidence 554433322211 000 001112346689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
||+.||++||+++++++||||.+..
T Consensus 245 ~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 245 CLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HhccChhhCcCHHHHhcChhhcccc
Confidence 9999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=328.01 Aligned_cols=282 Identities=30% Similarity=0.478 Sum_probs=216.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... .....+.+|+.+++++.|+++ +++++++...+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-----VRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCE-----eeEEEEEecCCeE
Confidence 46999999999999999999999999999999986432 233567789999999988877 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++..+
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~----------------- 139 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT----------------- 139 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-----------------
Confidence 999999987999988765544578899999999999999999999999999999999997432
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
..+||+|||++....... ....++..|+|||++.+. .++.++|||||||++|+|++|..||...+..
T Consensus 140 ---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 140 ---------NALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred ---------CEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 246788888775432221 223678899999998764 5789999999999999999999999888777
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+....+......+..... ........ . ..............+.++.++|.+||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~i~~~l~ 269 (294)
T PLN00009 211 DELFKIFRILGTPNEETWPGVTS-------------------LPDYKSAF-P-KWPPKDLATVVPTLEPAGVDLLSKMLR 269 (294)
T ss_pred HHHHHHHHHhCCCChhhcccccc-------------------chhhhhhc-c-cCCCCCHHHhCcCCChHHHHHHHHHcc
Confidence 76666666555444332211100 00000000 0 000001111234567789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
.||++||++.++++||||.+-
T Consensus 270 ~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 270 LDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred CChhhCcCHHHHhcCchHhHH
Confidence 999999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=334.54 Aligned_cols=284 Identities=26% Similarity=0.512 Sum_probs=219.2
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~- 164 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++.+++|+|+ +++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i-----v~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc-----cceeeeeeec
Confidence 45678999999999999999999999999999999986532 223556789999999999887 888887753
Q ss_pred -----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
.+..|+++++++++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-------- 157 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-------- 157 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC--------
Confidence 2458999999999999888654 589999999999999999999999999999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.++|+|||++...........||..|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 158 -------------------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 218 (345)
T cd07877 158 -------------------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218 (345)
T ss_pred -------------------CEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 4677777776655444444578899999999876 46889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhh-hhhhcCCccccCCCCCCchhhHHHHHHhcCchhh-hhhccCCchHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL-IMQHVDHSAGDLI 396 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 396 (433)
...+....+..+.+..+..+..+........ ..+.. .. ...+.. ........+.++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~---~~~~~~~~~~~~~~~~~~~~ 277 (345)
T cd07877 219 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ------------------SL---TQMPKMNFANVFIGANPLAV 277 (345)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHH------------------Hh---cccCCcchhhhcCCCCHHHH
Confidence 8887777777777777666554432221110 00000 00 000000 0011123467899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
+||.+||+.||.+|+|+.++++||||++...+
T Consensus 278 ~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 278 DLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred HHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 99999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=327.52 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=199.3
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++++.|+++ +++++.+...+..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI-----IGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEECCEEEE
Confidence 588999999999999999999999999999998643 2334567889999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|..+. .+++..+..++.||+.||.|||+.||+|+||||+|||++.++
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~------------------ 132 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG------------------ 132 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC------------------
Confidence 99999 88886542 578999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH-
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL- 327 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~- 327 (433)
.++|+|||++..... ......||..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 133 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 203 (279)
T cd06619 133 ---------QVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203 (279)
T ss_pred ---------CEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc
Confidence 467777776654332 223357899999999999888999999999999999999999999653211100
Q ss_pred --HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 328 --AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 328 --~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
......... ...+. ......+.++.++|.+||+.
T Consensus 204 ~~~~~~~~~~~-----------------------------------------~~~~~---~~~~~~~~~~~~li~~~l~~ 239 (279)
T cd06619 204 MPLQLLQCIVD-----------------------------------------EDPPV---LPVGQFSEKFVHFITQCMRK 239 (279)
T ss_pred chHHHHHHHhc-----------------------------------------cCCCC---CCCCcCCHHHHHHHHHHhhC
Confidence 000000000 00000 00123466899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013941 406 DPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~ 425 (433)
||++||+++|+++||||...
T Consensus 240 ~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 240 QPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ChhhCCCHHHHhcCcccccc
Confidence 99999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=331.42 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=204.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
..+|++++.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.+.|+++ +++++++..++..|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCEEE
Confidence 468999999999999999999999999999999986433 334567789999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.+. .+++..+..++.|++.||.|||+.||+||||||+|||++.++.
T Consensus 93 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~---------------- 153 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS---------------- 153 (297)
T ss_pred EeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----------------
Confidence 999999 99999998764 5899999999999999999999999999999999999976654
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
++|+|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 154 -----------~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~ 222 (297)
T cd06656 154 -----------VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (297)
T ss_pred -----------EEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 566666655432221 123468889999999999889999999999999999999999997654432
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+... + .| ........+..+.+||.+||..
T Consensus 223 ~~~~~~~~-~-~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~ 255 (297)
T cd06656 223 ALYLIATN-G-TP---------------------------------------------ELQNPERLSAVFRDFLNRCLEM 255 (297)
T ss_pred heeeeccC-C-CC---------------------------------------------CCCCccccCHHHHHHHHHHccC
Confidence 21111000 0 00 0011223466889999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q 013941 406 DPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~ 426 (433)
||++|||++++++||||....
T Consensus 256 ~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 256 DVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ChhhCcCHHHHhcCchhcccc
Confidence 999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=326.84 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=207.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+.|+++ +++++++.++...|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI-----TKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCe-----eeeeEEEEECCeEE
Confidence 36899999999999999999999999999999987533 233567789999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+|+||+ +++|.+++... .+++..++.++.||+.||.|||+++|+|+||+|+||++++++
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~----------------- 135 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG----------------- 135 (274)
T ss_pred EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-----------------
Confidence 999999 89999999765 689999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 136 ----------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~ 205 (274)
T cd06609 136 ----------DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205 (274)
T ss_pred ----------CEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence 4667777766544322 233578889999999998889999999999999999999999997655433
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC-chHHHHHHHHHhcc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQGLLR 404 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~ 404 (433)
....+.....+ ..... ++.++.++|.+||.
T Consensus 206 ~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 206 VLFLIPKNNPP-------------------------------------------------SLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred HHHHhhhcCCC-------------------------------------------------CCcccccCHHHHHHHHHHhh
Confidence 32222111000 00011 46689999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCcc
Q 013941 405 YDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.||++|||++++++||||++..+
T Consensus 237 ~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 237 KDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred CChhhCcCHHHHhhChhhcCCCc
Confidence 99999999999999999998644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=327.20 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=199.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.+.|+++ +++++.+...+.+|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----i~~~~~~~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI-----VAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEeCCEEEE
Confidence 47999999999999999999999999999999987543 233456789999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+|+||||+||+++.++.
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~----------------- 144 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH----------------- 144 (267)
T ss_pred EEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-----------------
Confidence 99999 889999987665 7999999999999999999999999999999999999976654
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
++|+|||++...... .....|+..|+|||++. ...++.++|||||||++|+|++|..||.....
T Consensus 145 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 145 ----------VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ----------EEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 556666655432211 12347899999999985 44588999999999999999999999965443
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+.......+ .......++..+.++|.+||
T Consensus 215 ~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l 249 (267)
T cd06645 215 MRALFLMTKSNFQPP---------------------------------------------KLKDKMKWSNSFHHFVKMAL 249 (267)
T ss_pred hhhHHhhhccCCCCC---------------------------------------------cccccCCCCHHHHHHHHHHc
Confidence 322221111000000 00001134568899999999
Q ss_pred ccCCCCCCCHHHHhcCCC
Q 013941 404 RYDPAERLKAREALRHPF 421 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~ 421 (433)
+.||++|||++++++|||
T Consensus 250 ~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 250 TKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cCCchhCcCHHHHhcCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=327.28 Aligned_cols=254 Identities=27% Similarity=0.473 Sum_probs=203.7
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
-|++.+.||+|+||.||+|.+..++..+++|.+.... ...+.+.+|+.+++.+.|+|+ +++++++..++..++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----i~~~~~~~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-----VKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCe-----eeEEEEEeeCCEEEEE
Confidence 3788999999999999999999999999999986433 345567789999999988877 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|..++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~------------------ 141 (282)
T cd06643 81 IEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD------------------ 141 (282)
T ss_pred EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC------------------
Confidence 9999 889988876533 36899999999999999999999999999999999999976654
Q ss_pred ccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
++|+|||++..... ......||..|+|||++. +..++.++|||||||++|+|++|..||...+
T Consensus 142 ---------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 142 ---------IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ---------EEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 56666665543221 112346889999999984 3457889999999999999999999998766
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.......+....... ......++.++.+||.+|
T Consensus 213 ~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~~ 245 (282)
T cd06643 213 PMRVLLKIAKSEPPT-----------------------------------------------LAQPSRWSSEFKDFLKKC 245 (282)
T ss_pred HHHHHHHHhhcCCCC-----------------------------------------------CCCccccCHHHHHHHHHH
Confidence 554443332211100 001123466899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCc
Q 013941 403 LRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
|+.||++|||+.++++||||+...
T Consensus 246 l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 246 LEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred ccCChhhCcCHHHHhcCCCEeccC
Confidence 999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=329.27 Aligned_cols=254 Identities=26% Similarity=0.474 Sum_probs=203.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.++|+++++||.|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+.|+++ +++++.+..++..|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI-----VKLLGAFYWDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcE-----eeeEEEEEeCCeEE
Confidence 357999999999999999999999999999999987543 345667789999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|..++.+.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~----------------- 147 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG----------------- 147 (292)
T ss_pred EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-----------------
Confidence 999999 889988876543 3689999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||++..... ......++..|+|||++. ...++.++|||||||++|+|++|..||..
T Consensus 148 ----------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 148 ----------DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred ----------CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 466666666543221 112346788999999985 33478899999999999999999999977
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+.......+... ..| .......++.++.+||.
T Consensus 218 ~~~~~~~~~~~~~--~~~---------------------------------------------~~~~~~~~~~~~~~li~ 250 (292)
T cd06644 218 LNPMRVLLKIAKS--EPP---------------------------------------------TLSQPSKWSMEFRDFLK 250 (292)
T ss_pred ccHHHHHHHHhcC--CCc---------------------------------------------cCCCCcccCHHHHHHHH
Confidence 6543333222111 000 00112244668999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+||..||++||+++++++||||..
T Consensus 251 ~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 251 TALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=335.77 Aligned_cols=300 Identities=27% Similarity=0.476 Sum_probs=219.1
Q ss_pred ccCCCeEE-eccccccccEEEEEEEecCCCcEEEEEEeccchhhH---------------HHHHHHHHHHHHHHhCCCCC
Q 013941 89 NLTPRYRI-LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---------------EAAMIEIDVLQRLARHDIGG 152 (433)
Q Consensus 89 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~~~~i~~ 152 (433)
.+.++|.. .+.||+|+||+||+|.+..+++.||||+++...... ..+.+|+.+++.+.|+++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-- 82 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI-- 82 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce--
Confidence 34567875 467999999999999999999999999986432211 246789999999988877
Q ss_pred cceeEecceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCc
Q 013941 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (433)
Q Consensus 153 ~~~v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~ 232 (433)
+++++++..++..|+||||+.++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+||+++.++.
T Consensus 83 ---v~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 83 ---MGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred ---eeeeEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC
Confidence 99999999999999999999889999997654 6999999999999999999999999999999999999988887
Q ss_pred ccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHH
Q 013941 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 233 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el 311 (433)
++++|||++........... .-.+.+.. .........++..|+|||.+.+. .++.++|||||||++|+|
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDT--------LSKDETMQ--RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred EEECCccceeeccccccccc--------cccccccc--ccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 77777776544321110000 00000000 00111223568899999998764 468999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|..||.+.+..+.+..+....+.++...+...... ..+. .+.. ..+..........
T Consensus 228 ~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~------~~~~---------------~~~~~~~~~~~~~ 285 (335)
T PTZ00024 228 LTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLYT------EFTP---------------RKPKDLKTIFPNA 285 (335)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhc-cccc------ccCc---------------CCcccHHHhCcCC
Confidence 9999999998888877777776665443211110000 0000 0000 0000111122345
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
+.++.++|.+||+.||++|||++|++.||||++...
T Consensus 286 ~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 286 SDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred ChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 678999999999999999999999999999998643
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=329.17 Aligned_cols=256 Identities=21% Similarity=0.364 Sum_probs=205.2
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+|++++.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++++.|+++ +++++.+...+..++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYI-----VDFYGAFFIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcH-----HhhhhheecCCeEEE
Confidence 689999999999999999999999999999988642 2334567889999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
||||+ +++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---------------- 140 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG---------------- 140 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC----------------
Confidence 99999 899999887631 2368999999999999999999997 5999999999999997654
Q ss_pred CCcccCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCC------CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGL------GWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||.+..... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 141 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 141 -----------QVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred -----------CEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 467777777654322 22334688899999998654 357899999999999999999999976
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.........+.......+. .....++.++.+||.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~ 243 (286)
T cd06622 210 ETYANIFAQLSAIVDGDPP----------------------------------------------TLPSGYSDDAQDFVA 243 (286)
T ss_pred cchhhHHHHHHHHhhcCCC----------------------------------------------CCCcccCHHHHHHHH
Confidence 5544433333322211110 011235678999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+||+.+|++||+++++++||||....
T Consensus 244 ~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 244 KCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=339.77 Aligned_cols=254 Identities=27% Similarity=0.383 Sum_probs=215.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.-.+.|.+.+.||+|.|+.|.+|++..++..||||++.+.. .......+|+++++.++|||| |+++.+.+..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnI-----vkl~~v~~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNI-----VKLFSVIETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcce-----eeeeeeeeec
Confidence 33467999999999999999999999999999999998643 334557889999999999988 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
..+|+||||+ +|.+++++.+++ .+.+..++.++.|+++|++|||+++|||||||.+|||++.
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~--------------- 190 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE--------------- 190 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc---------------
Confidence 9999999999 999999999887 7888999999999999999999999999999999999854
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCC-ccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
+..+||+|||++...... ..+.+|++.|.|||++.+..|. +++|+||+|++||-|+.|..||.+.
T Consensus 191 ------------~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 191 ------------NMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred ------------ccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 445888888888766543 3557999999999999998874 8999999999999999999999986
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+-............ ...-..+.++.+||.+
T Consensus 259 ~lk~Lr~rvl~gk~--------------------------------------------------rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 259 NLKELRPRVLRGKY--------------------------------------------------RIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccchheeeee--------------------------------------------------cccceeechhHHHHHH
Confidence 64432222111111 1112346689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+|..+|.+|++.+++++|.|.....
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhh
Confidence 9999999999999999999998653
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=320.57 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=205.5
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+.++++++|+++ +++++++...++.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI-----VQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCe-----eeeEeeecCCCeEE
Confidence 589999999999999999999999999999998642 2334567889999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~----------------- 138 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG----------------- 138 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-----------------
Confidence 999999 89999999765544689999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+....... ....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus 139 ----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08218 139 ----------TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208 (256)
T ss_pred ----------CEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence 46667776665432221 22467889999999998889999999999999999999999997665554
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.. +..+ ......+.++.++|.+||+.
T Consensus 209 ~~~~~~~--~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 209 LVLKIIR--GSYP-----------------------------------------------PVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred HHHHHhc--CCCC-----------------------------------------------CCcccCCHHHHHHHHHHhhC
Confidence 4433321 1110 01123466899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
+|++||++.+|++||||
T Consensus 240 ~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 240 NPRDRPSVNSILEKNFI 256 (256)
T ss_pred ChhhCcCHHHHhhCcCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.29 Aligned_cols=260 Identities=24% Similarity=0.431 Sum_probs=202.4
Q ss_pred eecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceeEeccee
Q 013941 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (433)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~ 162 (433)
+..-....++|++.+.||+|+||.||+|.+..+++.+|+|++.........+.+|+.+++.+. |+|+ +++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV-----VKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCe-----eeeeeee
Confidence 333445667899999999999999999999999999999998765444566778999999994 7776 9999877
Q ss_pred -----ccCCeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 163 -----DYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 163 -----~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
..++..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--- 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG--- 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC---
Confidence 3456899999999 99999987632 224688999999999999999999999999999999999997655
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhC-----CCCCccchHHHHHH
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGC 306 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~ 306 (433)
.++|+|||++..... ......|+..|+|||++.. ..++.++|||||||
T Consensus 162 ------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 217 (286)
T cd06638 162 ------------------------GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217 (286)
T ss_pred ------------------------CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHH
Confidence 366677776654322 1123468999999999853 34789999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhh
Q 013941 307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386 (433)
Q Consensus 307 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
++|+|++|..||........+..+... ..+ ...
T Consensus 218 i~~el~~g~~p~~~~~~~~~~~~~~~~--~~~---------------------------------------------~~~ 250 (286)
T cd06638 218 TAIELGDGDPPLADLHPMRALFKIPRN--PPP---------------------------------------------TLH 250 (286)
T ss_pred HHHHHhcCCCCCCCCchhHHHhhcccc--CCC---------------------------------------------ccc
Confidence 999999999999765443322111100 000 000
Q ss_pred ccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 387 ~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
....++..+.+||.+||+.||++|||+.|+++|+||
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 112235689999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=325.98 Aligned_cols=280 Identities=34% Similarity=0.644 Sum_probs=213.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+++++++.|+++ +++++++..++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI-----VNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCe-----eehhheEEECCEE
Confidence 3699999999999999999999999999999988643 2334678889999999998877 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||+++++.+.+.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++
T Consensus 76 ~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~----------------- 137 (288)
T cd07833 76 YLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG----------------- 137 (288)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-----------------
Confidence 9999999445444443332 3689999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||.+....... ....++..|+|||++.+. .++.++||||||+++|+|++|..||.+...
T Consensus 138 ----------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 138 ----------VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred ----------CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 45666666655433221 234678899999999888 789999999999999999999999998887
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+.+..+....+.++............ + ....++.... ...........++.++.+||.+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l 269 (288)
T cd07833 208 IDQLYLIQKCLGPLPPSHQELFSSNPR--F---AGVAFPEPSQ-------------PESLERRYPGKVSSPALDFLKACL 269 (288)
T ss_pred HHHHHHHHHHhCCCCHHHhhhcccCcc--c---cccccCCCCC-------------cHHHHHhcCCccchHHHHHHHHHh
Confidence 777777777777666533221110000 0 0000110000 000011122334788999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013941 404 RYDPAERLKAREALRHPFF 422 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f 422 (433)
..||++|||++++++||||
T Consensus 270 ~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 270 RMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCchhcccHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=325.18 Aligned_cols=280 Identities=28% Similarity=0.481 Sum_probs=207.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+|+.+++.+.|+|+ +++++++..++..|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI-----VLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCE-----eEEEEEEecCCeEE
Confidence 57999999999999999999999999999999986432 223456789999999988877 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~------------------ 140 (291)
T cd07870 80 FVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG------------------ 140 (291)
T ss_pred EEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC------------------
Confidence 999999888888776543 3578899999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh-H
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN-L 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~-~ 324 (433)
.++|+|||++...... .....++..|+|||++.+. .++.++|||||||++|+|++|..||.+... .
T Consensus 141 ---------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~ 211 (291)
T cd07870 141 ---------ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211 (291)
T ss_pred ---------cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH
Confidence 4677777766542221 1223578899999998764 578899999999999999999999976543 3
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+.+..+....+.++......... ...+... +... .........+. . -..+.++.++|.+||+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~-~~~~~~~~~~~----------~-~~~~~~~~~ll~~~l~ 273 (291)
T cd07870 212 EQLEKIWTVLGVPTEDTWPGVSK-LPNYKPE-----WFLP-CKPQQLRVVWK----------R-LSRPPKAEDLASQMLM 273 (291)
T ss_pred HHHHHHHHHcCCCChhhhhhhhh-cccccch-----hccc-cCCcchhhhcc----------c-cCCChHHHHHHHHHhC
Confidence 44555555555444332221110 0000000 0000 00000001000 0 0125688999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013941 405 YDPAERLKAREALRHPFF 422 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f 422 (433)
.||++|||++|++.||||
T Consensus 274 ~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 274 MFPKDRISAQDALLHPYF 291 (291)
T ss_pred cCcccCcCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.90 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=201.6
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccC--
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR-- 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~-- 165 (433)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.........+.+|+.+++++ .|+|+ +++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni-----~~~~~~~~~~~~ 93 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV-----VKFYGMFYKADK 93 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEEeccc
Confidence 346789999999999999999999999999999999876554556677899999988 56666 9999987642
Q ss_pred ---CeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 166 ---NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 166 ---~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
+..++||||+ +++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.++
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-------- 165 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-------- 165 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--------
Confidence 4689999999 89999988632 224689999999999999999999999999999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-----CCCccchHHHHHHHHHHH
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el 311 (433)
.++|+|||.+...... .....|+..|+|||++... .++.++|||||||++|+|
T Consensus 166 -------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el 226 (291)
T cd06639 166 -------------------GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226 (291)
T ss_pred -------------------CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence 4667777766543221 1234688899999998643 368999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|+.||........+..+.+. ..+ ........
T Consensus 227 ~~g~~p~~~~~~~~~~~~~~~~--~~~---------------------------------------------~~~~~~~~ 259 (291)
T cd06639 227 GDGDPPLFDMHPVKTLFKIPRN--PPP---------------------------------------------TLLHPEKW 259 (291)
T ss_pred hhCCCCCCCCcHHHHHHHHhcC--CCC---------------------------------------------CCCccccc
Confidence 9999999876544333322111 000 00011234
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
+..+.+||.+||+.||++||++.|+++||||+
T Consensus 260 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 260 CRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 56799999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=321.43 Aligned_cols=250 Identities=27% Similarity=0.462 Sum_probs=204.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|+||.||+|.+..+++.|++|.+..... .+.+.+|+.++++++|+++ +++++++......|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYI-----VKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcE-----eeeeeeeecCCcEEEE
Confidence 579999999999999999999998899999999876543 6778899999999988777 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
+||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++
T Consensus 77 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~------------------- 136 (256)
T cd06612 77 MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG------------------- 136 (256)
T ss_pred EecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-------------------
Confidence 9999 889999987543 4789999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~ 327 (433)
.++|+|||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 137 --------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~ 208 (256)
T cd06612 137 --------QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208 (256)
T ss_pred --------cEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence 4566666665543322 12346788999999999888999999999999999999999999765443322
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+... .+ ........++..+.++|.+||+.||
T Consensus 209 ~~~~~~---~~--------------------------------------------~~~~~~~~~~~~~~~~i~~~l~~~P 241 (256)
T cd06612 209 FMIPNK---PP--------------------------------------------PTLSDPEKWSPEFNDFVKKCLVKDP 241 (256)
T ss_pred hhhccC---CC--------------------------------------------CCCCchhhcCHHHHHHHHHHHhcCh
Confidence 211100 00 0000112345689999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q 013941 408 AERLKAREALRHPFF 422 (433)
Q Consensus 408 ~~R~ta~ell~hp~f 422 (433)
++|||+.|+++||||
T Consensus 242 ~~Rps~~~il~~~~~ 256 (256)
T cd06612 242 EERPSAIQLLQHPFI 256 (256)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=326.71 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=215.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
..|..+.+||+|+||.|.+|..+.+.+.||||+++++- ...+..+.|-++|.....+ +.+++++.+|++-+.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kp----pFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP----PFLVQLHSCFQTMDR 424 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCC----chHHHHHHHhhhhhh
Confidence 46899999999999999999999999999999998642 3334556677777766554 556999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ ||+|.-.+++-+ .+.+..+..++..|+-||-|||++|||+||||.+|||++.+|+
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH-------------- 488 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-------------- 488 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--------------
Confidence 99999999 999999998876 8999999999999999999999999999999999999987775
Q ss_pred CCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
+||+|||+++..- ....+++||+.|+|||++.-++|+.++|+||+||+||||+.|++||.+.++
T Consensus 489 -------------iKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 489 -------------IKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred -------------eEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 5666666665322 234557999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+.+..|.......| ...|.++.++++..|
T Consensus 556 ~elF~aI~ehnvsyP--------------------------------------------------KslSkEAv~ickg~l 585 (683)
T KOG0696|consen 556 DELFQAIMEHNVSYP--------------------------------------------------KSLSKEAVAICKGLL 585 (683)
T ss_pred HHHHHHHHHccCcCc--------------------------------------------------ccccHHHHHHHHHHh
Confidence 998888876544333 344778999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCCCCC
Q 013941 404 RYDPAERLK-----AREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~t-----a~ell~hp~f~~~ 425 (433)
.+.|.+|+. -.+|-.||||+..
T Consensus 586 tK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 586 TKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred hcCCccccCCCCccccchhhCcchhhc
Confidence 999999984 4689999999863
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.51 Aligned_cols=269 Identities=26% Similarity=0.395 Sum_probs=206.4
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.+.|+++ +++++.+..++.+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFV-----VSMFCSFETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-----eeeEEEEecCCEE
Confidence 6999999999999999999999999999999987543 233456789999999888777 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++......
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999 899999997764 6899999999999999999999999999999999999988776666666654321100
Q ss_pred CCcccCCCCCCCeeeecCCCCccc-cCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.. ..+.+....... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||.+....+.
T Consensus 155 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~ 224 (305)
T cd05609 155 LT----------TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224 (305)
T ss_pred cc----------ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00 000000000000 0011124678899999999888899999999999999999999999987665544
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+.......| . .....+.++.++|.+||+.|
T Consensus 225 ~~~~~~~~~~~~------------------------~-----------------------~~~~~~~~~~~li~~~l~~~ 257 (305)
T cd05609 225 FGQVISDDIEWP------------------------E-----------------------GDEALPADAQDLISRLLRQN 257 (305)
T ss_pred HHHHHhcccCCC------------------------C-----------------------ccccCCHHHHHHHHHHhccC
Confidence 433322111111 0 01134678999999999999
Q ss_pred CCCCCC---HHHHhcCCCCCCC
Q 013941 407 PAERLK---AREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~t---a~ell~hp~f~~~ 425 (433)
|++||+ +.++++||||...
T Consensus 258 P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 258 PLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred hhhccCccCHHHHHhCccccCC
Confidence 999997 8999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=322.53 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=200.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+.... .....+.+|+++++.++|+++ +++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI-----VQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCE-----eeEeeEeecC
Confidence 478899999999999999986 578889999886322 223457789999999988877 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..++||||+ +++|.+++.+.. .+++..+..++.||+.||+|||+.||+|+||||+||++++++.++++|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999 999999997754 6899999999999999999999999999999999999987776555555543322
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
..... ............|+..|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 153 ~~~~~------------------~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 153 AWVGL------------------HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred hhccc------------------cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 11000 000001112246889999999999888999999999999999999999999765544
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+....+..| .....++.++.++|.+||.
T Consensus 215 ~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~ 247 (265)
T cd06631 215 AAMFYIGAHRGLMP-----------------------------------------------RLPDSFSAAAIDFVTSCLT 247 (265)
T ss_pred HHHHHhhhccCCCC-----------------------------------------------CCCCCCCHHHHHHHHHHhc
Confidence 33322222111111 1123456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 013941 405 YDPAERLKAREALRHPFF 422 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f 422 (433)
.+|++|||+.|+++||||
T Consensus 248 ~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 248 RDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.60 Aligned_cols=282 Identities=29% Similarity=0.528 Sum_probs=217.1
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.++|.+.+.||+|+||.||+|++..+++.||+|++.+. ......+.+|+.+++.+.|+|+ +++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~~~~~~~ 86 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV-----IGLLDVFTSA 86 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCc-----cchhheeccc
Confidence 3457899999999999999999999999999999998642 2233457789999999999887 8888887653
Q ss_pred ------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
..+|+||||+..+|..++. ..+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-------- 154 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-------- 154 (342)
T ss_pred ccCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--------
Confidence 3579999999778877653 2589999999999999999999999999999999999996554
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.++|+|||++...........+|..|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 155 -------------------~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf 215 (342)
T cd07879 155 -------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215 (342)
T ss_pred -------------------CEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence 5777788777655444444578889999999876 45889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCch-hhhhhccCCchHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-NLIMQHVDHSAGDLID 397 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 397 (433)
.+.+....+..+....+..+..+...........+... ....+ ..........+.++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~ 275 (342)
T cd07879 216 KGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS--------------------LPKYPRKDFSTLFPKASPQAVD 275 (342)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhh--------------------cCCcccchHHHHhcCCCHHHHH
Confidence 98887777777777766655544333221110000000 00000 0001112245678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
||.+||+.||++|||+++++.||||....
T Consensus 276 li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 276 LLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=302.43 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=196.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-----
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----- 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~----- 164 (433)
.+||++.+.||+|||+.||++++..+++.||+|++.... +..+..++|++..++++|+|+ ++++++...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~v-----l~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNV-----LRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcch-----HHHHHHHHHhhccC
Confidence 368999999999999999999999999999999987544 667888999999999999887 888776543
Q ss_pred CCeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCcc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
....||+++|+ .|+|.+.+... .+..+++.++..|+.+|++||++||+.. ++||||||+|||+.+.+
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-------- 166 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-------- 166 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC--------
Confidence 34699999999 99999998743 3346999999999999999999999999 99999999999986544
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC------------cccccCCcccchhhhhCC---CCCccchHHHH
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------------SYVVSTRHYRAPEVILGL---GWNYPCDLWSV 304 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------------~~~~gt~~y~aPE~~~~~---~~~~~~DiwSl 304 (433)
.++|+|||++......- ..-..|..|+|||++.-. ..+.++|||||
T Consensus 167 -------------------~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL 227 (302)
T KOG2345|consen 167 -------------------LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL 227 (302)
T ss_pred -------------------ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence 57888888775432111 112468899999998643 46899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 305 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
||+||.|+.|..||...- ..|+.+.... ...+..
T Consensus 228 GCtLYa~mf~~sPfe~~~-------------------------------~~GgSlaLAv---------------~n~q~s 261 (302)
T KOG2345|consen 228 GCTLYAMMFGESPFERIY-------------------------------QQGGSLALAV---------------QNAQIS 261 (302)
T ss_pred hHHHHHHHHcCCcchHHh-------------------------------hcCCeEEEee---------------eccccc
Confidence 999999999999995211 0111111000 000011
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
......++..+.+||+.||+.||.+||++.+++.+
T Consensus 262 ~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 262 IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11123468899999999999999999999999864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=323.24 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=200.7
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----------hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
+|.+...||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++++.|+++ +++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENI-----VQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEE
Confidence 4788899999999999999998899999999886422 122457789999999998877 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
...+..++||||+ +++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999 889999998754 6899999999999999999999999999999999999987765555555543
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
........ ............|+..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~------------------~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 154 KKLEANSL------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccccc------------------cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 32211100 000000112246788999999999888999999999999999999999999875
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+.......+.... . .......+..+.++|.+
T Consensus 216 ~~~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~~~~~~li~~ 246 (267)
T cd06628 216 TQLQAIFKIGENA--S-----------------------------------------------PEIPSNISSEAIDFLEK 246 (267)
T ss_pred cHHHHHHHHhccC--C-----------------------------------------------CcCCcccCHHHHHHHHH
Confidence 5433322221100 0 00112346789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f 422 (433)
||+.||++||++.|+++||||
T Consensus 247 ~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 247 TFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=331.69 Aligned_cols=281 Identities=25% Similarity=0.439 Sum_probs=206.5
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC---
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--- 165 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~--- 165 (433)
+..+|++.+.||.|+||.||+|++..+++.||+|++.... ...+.+.+|++++++++|+++ +++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i-----~~~~~~~~~~~~~ 77 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI-----VKVYEVLGPSGSD 77 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcc-----hhhHhhhcccccc
Confidence 3578999999999999999999999999999999886433 334567789999999998887 8887765543
Q ss_pred -----------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 166 -----------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 166 -----------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
...|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++..+
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~--- 151 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED--- 151 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC---
Confidence 468999999987999888653 589999999999999999999999999999999999996432
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhC-CCCCccchHHHHHHH
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCI 307 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~i 307 (433)
..++|+|||.+...... .....|+..|+|||++.+ ..++.++|||||||+
T Consensus 152 -----------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvi 208 (342)
T cd07854 152 -----------------------LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 208 (342)
T ss_pred -----------------------ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHH
Confidence 24677777776543211 112367889999998765 467899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 308 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 308 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
+|+|++|+.||.+.+.......+.......................... ...........
T Consensus 209 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~ 268 (342)
T cd07854 209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRND--------------------GGEPRRPLRDL 268 (342)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc--------------------ccccCCCHHHH
Confidence 9999999999988777665554443322211111000000000000000 00000001112
Q ss_pred cCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
....+.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 269 ~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 269 LPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 2346778999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=334.54 Aligned_cols=282 Identities=28% Similarity=0.484 Sum_probs=220.4
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC---
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~--- 166 (433)
+|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++|+++ +++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI-----IGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcch-----hhhhhhhcccCccc
Confidence 5899999999999999999999899999999987532 334567889999999998877 99999887765
Q ss_pred --eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 167 --HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 167 --~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~------------ 141 (330)
T cd07834 76 FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD------------ 141 (330)
T ss_pred ccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC------------
Confidence 899999999879999987654 7999999999999999999999999999999999999977664
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~p 317 (433)
++|+|||.+...... .....+|..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 142 ---------------~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 142 ---------------LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred ---------------EEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence 555555555433222 1224678899999999887 789999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhh-hhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
|.+.+..+....+....+.++...+..... ....+.... ...............+.++.
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~ 266 (330)
T cd07834 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSL--------------------PKKPKKPLSKLFPGASPEAI 266 (330)
T ss_pred cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhc--------------------ccCCcchhHHhcccCCHHHH
Confidence 999998888888888777766543321110 000000000 00000011112234678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
+||.+||++||++|||++++++||||++....
T Consensus 267 ~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 267 DLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 99999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=323.00 Aligned_cols=253 Identities=26% Similarity=0.470 Sum_probs=203.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++++++|+++ +++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI-----IRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCce-----ehhhceeccC
Confidence 4788899999999999999999999999999986422 134667889999999998887 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~------------- 140 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG------------- 140 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------
Confidence 9999999999 899999997654 689999999999999999999999999999999999996543
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC-------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
..++|+|||.+...... .....||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 141 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 207 (268)
T cd06630 141 -------------QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207 (268)
T ss_pred -------------CEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 23677777766543221 1224678899999999888899999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...........+.+..... .........+.++.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~ 242 (268)
T cd06630 208 WNAEKHSNHLALIFKIASAT---------------------------------------------TAPSIPEHLSPGLRD 242 (268)
T ss_pred CCCCCCcchHHHHHHHhccC---------------------------------------------CCCCCchhhCHHHHH
Confidence 97544332222221110000 000111234678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
+|.+||..||++|||+.++++||||+
T Consensus 243 ~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 243 VTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=322.71 Aligned_cols=277 Identities=31% Similarity=0.522 Sum_probs=211.3
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+|++.++||.|++|.||+|++..+++.||||+++... .....+.+|+.++++++|+|+ +++++++...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI-----VRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCE-----eeeeeeEeeCCcEEE
Confidence 4899999999999999999999999999999987543 234566789999999988877 999999999999999
Q ss_pred EEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+.++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||++++++
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~------------------ 137 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG------------------ 137 (284)
T ss_pred EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC------------------
Confidence 99999779999887543 23589999999999999999999999999999999999997665
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+...... .....+|..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus 138 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 208 (284)
T cd07836 138 ---------ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208 (284)
T ss_pred ---------cEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 4566666655432221 1223578899999998764 47899999999999999999999999888777
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+....+....+.... ....+. ...+.. .. ..........+..+.++|.+||+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~--~~-------------~~~~~~~~~~~~~~~~~i~~~l~~ 267 (284)
T cd07836 209 QLLKIFRIMGTPTESTWPGIS-QLPEYK-----PTFPRY--PP-------------QDLQQLFPHADPLGIDLLHRLLQL 267 (284)
T ss_pred HHHHHHHHhCCCChhhHHHHh-cCchhc-----ccccCC--Ch-------------HHHHHHhhhcCcHHHHHHHHHhcC
Confidence 777666655444332221111 000000 000000 00 000111223467899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
||.+|||+.|+++||||
T Consensus 268 ~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 268 NPELRISAHDALQHPWF 284 (284)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.26 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=207.0
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++.++|+++ +++++.+..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI-----IEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCch-----hheeeeEecCCEEE
Confidence 589999999999999999999999999999998643 2334567889999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.......+++..+..++.|++.||+|||++||+|+||||+||+++.++
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~----------------- 138 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK----------------- 138 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----------------
Confidence 999999 89999999876545689999999999999999999999999999999999996432
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
..++|+|||.+....... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+....
T Consensus 139 ---------~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 209 (256)
T cd08220 139 ---------MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL 209 (256)
T ss_pred ---------CEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence 246788888776543322 234688899999999988889999999999999999999999987655443
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+..... .......+.++.++|.+||..|
T Consensus 210 ~~~~~~~~~-------------------------------------------------~~~~~~~~~~l~~li~~~l~~~ 240 (256)
T cd08220 210 VLKIMSGTF-------------------------------------------------APISDRYSPDLRQLILSMLNLD 240 (256)
T ss_pred HHHHHhcCC-------------------------------------------------CCCCCCcCHHHHHHHHHHccCC
Confidence 332221100 0011234678999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013941 407 PAERLKAREALRHPFF 422 (433)
Q Consensus 407 P~~R~ta~ell~hp~f 422 (433)
|++|||+.|+++||||
T Consensus 241 p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 241 PSKRPQLSQIMAQPIC 256 (256)
T ss_pred hhhCCCHHHHhhCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=324.80 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=198.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++++.|+++ +++++++...+.+++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----i~~~~~~~~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI-----VAYFGSYLSREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCe-----eeeeEEEEeCCEEEE
Confidence 46999999999999999999999999999999986432 334557789999999988887 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~------------------ 143 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG------------------ 143 (267)
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC------------------
Confidence 99999 889999987654 689999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||++...... .....|+..|+|||.+. ...++.++|||||||++|+|++|..||.....
T Consensus 144 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 144 ---------DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ---------CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 4666666666533211 12346888999999985 34578899999999999999999999965433
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+....... + .......++..+.+||.+||
T Consensus 215 ~~~~~~~~~~~~~~------------------------~---------------------~~~~~~~~~~~~~~li~~~l 249 (267)
T cd06646 215 MRALFLMSKSNFQP------------------------P---------------------KLKDKTKWSSTFHNFVKISL 249 (267)
T ss_pred hhhheeeecCCCCC------------------------C---------------------CCccccccCHHHHHHHHHHh
Confidence 22111110000000 0 00011234678999999999
Q ss_pred ccCCCCCCCHHHHhcCCC
Q 013941 404 RYDPAERLKAREALRHPF 421 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~ 421 (433)
+.||++|||++++++|+|
T Consensus 250 ~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 250 TKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hCChhhCcCHHHHhcCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=323.98 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=201.4
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceecc-----
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY----- 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~----- 164 (433)
.++|++.+.||+|++|.||+|.+..+++.+++|++.......+.+.+|+.+++++ .|+++ +++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI-----ATFYGAFIKKNPPG 79 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCCh-----heEEEEEEecCCCC
Confidence 4689999999999999999999998999999999987666667788999999998 57777 999998865
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+..+++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--------- 150 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--------- 150 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC---------
Confidence 34599999999 889999987532 35789999999999999999999999999999999999997655
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-----CCCccchHHHHHHHHHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~ 312 (433)
.++|+|||++...... .....|+..|+|||++... .++.++|||||||++|+|+
T Consensus 151 ------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 151 ------------------EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred ------------------eEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 4566666665432211 1234688999999998642 4678999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|..||...........+... .+. .......++
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~---~~~--------------------------------------------~~~~~~~~~ 245 (275)
T cd06608 213 DGKPPLCDMHPMRALFKIPRN---PPP--------------------------------------------TLKSPENWS 245 (275)
T ss_pred hCCCCccccchHHHHHHhhcc---CCC--------------------------------------------CCCchhhcC
Confidence 999999765443333222111 000 000112246
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
..+.+||.+||..||++|||++|+++|||+
T Consensus 246 ~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 246 KKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 689999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.46 Aligned_cols=278 Identities=30% Similarity=0.532 Sum_probs=210.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++.++||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.++|+++ +++++++..++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL-----VNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcch-----hhHHHhcccCCeE
Confidence 46999999999999999999999899999999876432 234567789999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|..+..... .+++..+..++.||+.||.|||+.||+|+||+|+||++++++
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~---------------- 137 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG---------------- 137 (286)
T ss_pred EEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----------------
Confidence 9999999 777777665443 589999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||++...... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.....
T Consensus 138 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~ 206 (286)
T cd07846 138 -----------VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206 (286)
T ss_pred -----------cEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence 4566666665433221 1224678899999998764 478899999999999999999999988877
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+....+....+.++........... .. .+ ...+.. ............++..+.+||.+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~--~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l 267 (286)
T cd07846 207 IDQLYHIIKCLGNLIPRHQEIFQKNP--LF-AG--MRLPEV--------------KEIEPLEKRFPKLSGLVLDLAKQCL 267 (286)
T ss_pred HHHHHHHHHHhCCCchhhHHHhccch--Hh-hc--cccccc--------------cCcchHHHhCCCcCHHHHHHHHHHh
Confidence 77766666665554432111000000 00 00 000000 0000011123456788999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013941 404 RYDPAERLKAREALRHPFF 422 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f 422 (433)
+.||++|||+.++++||||
T Consensus 268 ~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 268 RIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cCCcccchhHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=322.92 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=203.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.. ...+.+.+|++++++++|+|+ +++++.+..++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL-----VNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCCh-----HHHHHhhcCCCeE
Confidence 4899999999999999999999999999999987532 344677889999999998888 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--------------- 138 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--------------- 138 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC---------------
Confidence 9999999 999999998763 7999999999999999999999999999999999999976654
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
++|+|||.+...... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+...
T Consensus 139 ------------~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 206 (258)
T cd05578 139 ------------VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206 (258)
T ss_pred ------------EEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH
Confidence 566666655443222 123467889999999998889999999999999999999999998765421
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
........... ........+..+.++|.+||+.
T Consensus 207 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 207 RDQIRAKQETA-----------------------------------------------DVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred HHHHHHHhccc-----------------------------------------------cccCcccCcHHHHHHHHHHccC
Confidence 11111100000 0011223467899999999999
Q ss_pred CCCCCCCH--HHHhcCCCC
Q 013941 406 DPAERLKA--REALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta--~ell~hp~f 422 (433)
||.+|+++ +|+++||||
T Consensus 240 ~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ChhHcCCccHHHHhcCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=323.69 Aligned_cols=276 Identities=32% Similarity=0.548 Sum_probs=212.7
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
|++.+.||.|++|.||+|.+..+|+.||+|++.... .....+.+|+.+++.++|+++ +++++++.+++..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-----v~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI-----VRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCc-----cCHhheeccCCeEEE
Confidence 678899999999999999999999999999986432 223567789999999998887 999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
||||++++|.+++.......+++..+..++.||+.||+|||+++++||||+|+||+++.++
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~------------------- 136 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG------------------- 136 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-------------------
Confidence 9999988999999876545689999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||.+....... ....++..|+|||++.+. .++.++|||||||++|+|++|..||...+....
T Consensus 137 --------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 208 (283)
T cd07835 137 --------ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208 (283)
T ss_pred --------cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45666666664332211 223568899999988764 578999999999999999999999998887777
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
+..+.+..+.+.+..+....... .+... .+. .. ..........++.++.++|.+||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~--------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 267 (283)
T cd07835 209 LFRIFRTLGTPDEDVWPGVTSLP-DYKPT-----FPK--------------WA-RQDLSKVVPNLDEDGLDLLSKMLVYD 267 (283)
T ss_pred HHHHHHHhCCCChHHhhhhhhch-hhhhh-----ccc--------------cc-ccchhhhcCCCCHHHHHHHHHHhcCC
Confidence 66666665554443221110000 00000 000 00 00111223456778999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013941 407 PAERLKAREALRHPFF 422 (433)
Q Consensus 407 P~~R~ta~ell~hp~f 422 (433)
|++|||++|+++||||
T Consensus 268 P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 268 PAKRISAKAALQHPYF 283 (283)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=317.01 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=205.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++++.||.|+||.||.+++..+++.+++|.+... ......+.+|+.++++++|+++ +++++++.+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI-----IAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCe-----eEEEeEEecCCeEE
Confidence 599999999999999999999999999999987642 3344567789999999988777 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~---------------- 139 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL---------------- 139 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC----------------
Confidence 999999 899999998764457899999999999999999999999999999999999977664
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
+||+|||.+...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 140 -----------~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08221 140 -----------IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208 (256)
T ss_pred -----------EEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 556666655433221 123468899999999988888999999999999999999999998766555
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.. +..+ ......+.++.++|.+||..
T Consensus 209 ~~~~~~~--~~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 209 LVVKIVQ--GNYT-----------------------------------------------PVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred HHHHHHc--CCCC-----------------------------------------------CCccccCHHHHHHHHHHccc
Confidence 4443321 1110 00123466899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
||++||+++++++|+|+
T Consensus 240 ~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 240 DPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=347.69 Aligned_cols=244 Identities=30% Similarity=0.395 Sum_probs=197.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEecc-chhhHHHHHHHHHHHHHHH-hCCCCCcceeEecce-ecc----
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW-FDY---- 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~-~~~---- 164 (433)
.+++|.+.|.+|||+.||+|++...+..||+|++-. ++...+.+.+||.++++|. |+|| |.+++. ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nI-----V~yidss~~~~~~~ 111 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNI-----VSYIDSSAINRSSN 111 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCce-----eeEeccccccccCC
Confidence 468999999999999999999998889999998754 4456678889999999998 5555 999993 221
Q ss_pred --CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCcc
Q 013941 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
.-+++|.|||| ||.|-|++..+....|++.++++|+.|+++|+.+||... |||||||-|||||..+|
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-------- 183 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-------- 183 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC--------
Confidence 23689999999 799999999776667999999999999999999999998 99999999999997665
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-c-----------ccccCCcccchhhhh---CCCCCccchHHHH
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-S-----------YVVSTRHYRAPEVIL---GLGWNYPCDLWSV 304 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~-----------~~~gt~~y~aPE~~~---~~~~~~~~DiwSl 304 (433)
.+||||||.+....... + ...-|+.|+|||++. +.+.+.|+|||+|
T Consensus 184 -------------------~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWAL 244 (738)
T KOG1989|consen 184 -------------------NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWAL 244 (738)
T ss_pred -------------------CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHH
Confidence 57888888775432222 1 124689999999874 6678999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 305 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
||+||.|+....||....... |...-..+|
T Consensus 245 GclLYkLCy~t~PFe~sg~la----Ilng~Y~~P---------------------------------------------- 274 (738)
T KOG1989|consen 245 GCLLYKLCYFTTPFEESGKLA----ILNGNYSFP---------------------------------------------- 274 (738)
T ss_pred HHHHHHHHHhCCCcCcCccee----EEeccccCC----------------------------------------------
Confidence 999999999999997643221 111111111
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..+.++..+.+||..||+.||.+||++-|++.+
T Consensus 275 --~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 275 --PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred --CCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 124668899999999999999999999998864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=328.53 Aligned_cols=285 Identities=26% Similarity=0.433 Sum_probs=215.0
Q ss_pred CeEEeccccccccEEEEEEEecCC--CcEEEEEEeccc---hhhHHHHHHHHHHHHHHH-hCCCCCcceeEecceec---
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEK--KELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD--- 163 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~--- 163 (433)
+|++.+.||+|+||.||++.+..+ +..||+|++... ......+.+|+.+++++. |+++ +++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI-----TCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCCh-----heeeeeeeecc
Confidence 489999999999999999999888 889999998642 123456778999999985 7766 88877543
Q ss_pred -cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 -YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 -~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
....+++++|+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~--------- 144 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCEL--------- 144 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCE---------
Confidence 235689999999889999987654 79999999999999999999999999999999999999876655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccC-------CCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g 314 (433)
+|+|||.+..... ......||..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 145 ------------------kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g 206 (332)
T cd07857 145 ------------------KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206 (332)
T ss_pred ------------------EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 4555554432211 1122478999999998876 4689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhh-hhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEK-YFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
..||.+.+....+..+...++.++............. +..... .... ..........+.
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~-~~~~~~~~~~~~ 266 (332)
T cd07857 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLP-------------------NIPK-KPFESIFPNANP 266 (332)
T ss_pred CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhcc-------------------ccCC-cchHhhCCCCCH
Confidence 9999998888888888888887766543332211100 000000 0000 000111233467
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccccCC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGF 431 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~~ 431 (433)
.+.+||.+||+.||++|||+.|+++||||++...+.+.
T Consensus 267 ~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~ 304 (332)
T cd07857 267 LALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE 304 (332)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccc
Confidence 89999999999999999999999999999876544433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=318.15 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=204.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
++|++.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+.+|+.++++++|+++ +++++.+..++.+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI-----VAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCCh-----hceEEEEEeCCEEEE
Confidence 57999999999999999999999999999999987543 245677889999999998888 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+|||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.
T Consensus 78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~----------------- 139 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD----------------- 139 (262)
T ss_pred EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC-----------------
Confidence 99999 889999987652 36999999999999999999999999999999999999976654
Q ss_pred cccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
++|+|||.+..... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...+.
T Consensus 140 ----------~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 140 ----------VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred ----------EEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 56666666543322 12234688899999999877 788999999999999999999999987665
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+.......+ .......++.++.+||.+||
T Consensus 210 ~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l 244 (262)
T cd06613 210 MRALFLISKSNFPPP---------------------------------------------KLKDKEKWSPVFHDFIKKCL 244 (262)
T ss_pred HHHHHHHHhccCCCc---------------------------------------------cccchhhhhHHHHHHHHHHc
Confidence 444333222100000 00011233568999999999
Q ss_pred ccCCCCCCCHHHHhcCCC
Q 013941 404 RYDPAERLKAREALRHPF 421 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~ 421 (433)
..||++|||+.+++.|+|
T Consensus 245 ~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 245 TKDPKKRPTATKLLQHPF 262 (262)
T ss_pred CCChhhCCCHHHHhcCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=319.66 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=203.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.+.||.|+||+||+|....++..+|+|++.... .....+.+|+.+++.+.|+++ +++++.+..++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV-----VKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCE-----EEEEEEEeeCCEEE
Confidence 36999999999999999999998899999999986432 345677889999999988777 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
+|||++ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||++++++.
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--------------- 140 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--------------- 140 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC---------------
Confidence 999999 9999999976432 46899999999999999999999999999999999999977664
Q ss_pred CCcccCCCCCCCeeeecCCCCccccC-------CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
++|+|||++..... ......|+..|+|||++... .++.++|+|||||++|+|++|..||.
T Consensus 141 ------------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 141 ------------VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred ------------EEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 45555554432221 11234688999999998877 78999999999999999999999997
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
..+........... .+.. +.. ......++..+.++|
T Consensus 209 ~~~~~~~~~~~~~~---~~~~--------------------~~~---------------------~~~~~~~~~~~~~li 244 (267)
T cd06610 209 KYPPMKVLMLTLQN---DPPS--------------------LET---------------------GADYKKYSKSFRKMI 244 (267)
T ss_pred ccChhhhHHHHhcC---CCCC--------------------cCC---------------------ccccccccHHHHHHH
Confidence 65544332222111 0000 000 000124567899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCC
Q 013941 400 QGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f 422 (433)
.+||..||++|||++++++||||
T Consensus 245 ~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 245 SLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=327.49 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=204.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+.|.....||+|+||.||++.+..++..||||.+.... ...+.+.+|+.+++.+.|+++ +++++.+..++..|+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----i~~~~~~~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV-----VDMYNSYLVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcH-----HHHHHheecCCeEEE
Confidence 44666788999999999999999999999999986433 334567789999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~----------------- 156 (292)
T cd06658 97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR----------------- 156 (292)
T ss_pred EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-----------------
Confidence 99999 88999988543 5899999999999999999999999999999999999976554
Q ss_pred cccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
++|+|||++..... ......|+..|+|||++.+..++.++||||||+++|||++|..||...+....
T Consensus 157 ----------~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 226 (292)
T cd06658 157 ----------IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226 (292)
T ss_pred ----------EEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56666665543211 11234688999999999888899999999999999999999999987665544
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+........ ......+..+.++|.+||..|
T Consensus 227 ~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 227 MRRIRDNLPPRV-----------------------------------------------KDSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred HHHHHhcCCCcc-----------------------------------------------ccccccCHHHHHHHHHHccCC
Confidence 433322111100 001234668899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCcc
Q 013941 407 PAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~~~ 427 (433)
|++|||++|+++||||.....
T Consensus 260 P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 260 PSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred hhHCcCHHHHhhChhhhccCC
Confidence 999999999999999996533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=321.33 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=189.8
Q ss_pred cccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEcc
Q 013941 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~ 174 (433)
.||+|+||.||++.+..+++.||+|.+.+.. .......+|..+++.+.+. .|++++.+++.+..++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhC--CCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999999999999999886432 1122334455444444322 345669999999999999999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccC
Q 013941 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253 (433)
Q Consensus 175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~ 253 (433)
+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~---------------------- 134 (279)
T cd05633 79 MNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG---------------------- 134 (279)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC----------------------
Confidence 9 999999987664 699999999999999999999999999999999999997655
Q ss_pred CCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013941 254 LPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331 (433)
Q Consensus 254 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~ 331 (433)
.++|+|||++..... ......||..|+|||.+.+ ..++.++|||||||++|+|++|..||......... .+.
T Consensus 135 -----~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~ 208 (279)
T cd05633 135 -----HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EID 208 (279)
T ss_pred -----CEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHH
Confidence 466666666543322 1223468999999999874 56899999999999999999999999754321111 111
Q ss_pred HHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCC
Q 013941 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 411 (433)
Q Consensus 332 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ 411 (433)
...... ........+.++.++|.+||+.||++|+
T Consensus 209 ~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~ 242 (279)
T cd05633 209 RMTLTV----------------------------------------------NVELPDSFSPELKSLLEGLLQRDVSKRL 242 (279)
T ss_pred HHhhcC----------------------------------------------CcCCccccCHHHHHHHHHHhcCCHHHhc
Confidence 110000 0011234567899999999999999999
Q ss_pred -----CHHHHhcCCCCCCC
Q 013941 412 -----KAREALRHPFFTRD 425 (433)
Q Consensus 412 -----ta~ell~hp~f~~~ 425 (433)
|++|+++||||+..
T Consensus 243 ~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 243 GCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CCCCCCHHHHHhCccccCC
Confidence 69999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=325.45 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=193.7
Q ss_pred CCeEEeccccccccEEEEEEEecC----------------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
++|++.++||+|+||.||+|.+.. ++..||+|++... ......+.+|+.++.+++|+|+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--- 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI--- 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe---
Confidence 579999999999999999997532 3457999998753 2344568899999999988877
Q ss_pred ceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 013941 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY-----------------RSFPIDLVRELGRQLLESVAFMHELRL 215 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~i 215 (433)
+++++++.+.+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||
T Consensus 82 --v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 82 --IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred --eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999 9999999865321 246778899999999999999999999
Q ss_pred EecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhh
Q 013941 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVI 290 (433)
Q Consensus 216 vHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~ 290 (433)
+||||||+|||++.++. +||+|||++....... ....++..|+|||++
T Consensus 160 vH~dlkp~Nill~~~~~---------------------------~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 160 VHRDLATRNCLVGENLT---------------------------IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred cccCcchhheEEcCCcc---------------------------EEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence 99999999999976654 5666666554332211 123457789999999
Q ss_pred hCCCCCccchHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCch
Q 013941 291 LGLGWNYPCDLWSVGCILVELCS--GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 368 (433)
Q Consensus 291 ~~~~~~~~~DiwSlG~il~el~~--g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (433)
.+..++.++|||||||++|||++ +..||...+..+....+.........
T Consensus 213 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------- 263 (304)
T cd05096 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGR----------------------------- 263 (304)
T ss_pred hcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccc-----------------------------
Confidence 98889999999999999999987 56788776655544433221110000
Q ss_pred hhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHh
Q 013941 369 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 417 (433)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell 417 (433)
.........++..+.+||.+||+.||++|||++||.
T Consensus 264 -------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 264 -------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred -------------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 000011234467899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=322.95 Aligned_cols=237 Identities=14% Similarity=0.160 Sum_probs=192.4
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchhh----HHHHHHHHHHHHHHHhCCCCCcceeEecceecc----CCeEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHIC 169 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~----~~~~~ 169 (433)
..||+|+++.||+|.. +|+.||||+++..... .+.+.+|+.++.+++|+|+ +++++++.+ ...++
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNI-----LKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCE-----EEEeeeEEecccCCCceE
Confidence 5789999999999986 6889999999754322 3566799999999999877 999998866 45789
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
+||||+ +|+|.+++.... .+++.....++.|++.||.|||+ .+++||||||+|||++.++
T Consensus 99 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~---------------- 160 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY---------------- 160 (283)
T ss_pred EEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC----------------
Confidence 999999 999999998754 78999999999999999999998 4999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||++...........||..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+
T Consensus 161 -----------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~ 229 (283)
T PHA02988 161 -----------KLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229 (283)
T ss_pred -----------cEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence 4677777776654443344578899999999976 679999999999999999999999998776555
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+......++ .....+..+.+||.+||+.
T Consensus 230 ~~~~i~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~cl~~ 261 (283)
T PHA02988 230 IYDLIINKNNSLK------------------------------------------------LPLDCPLEIKCIVEACTSH 261 (283)
T ss_pred HHHHHHhcCCCCC------------------------------------------------CCCcCcHHHHHHHHHHhcC
Confidence 4443322111100 1123467899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013941 406 DPAERLKAREALR 418 (433)
Q Consensus 406 dP~~R~ta~ell~ 418 (433)
||++|||++|+++
T Consensus 262 dp~~Rps~~ell~ 274 (283)
T PHA02988 262 DSIKRPNIKEILY 274 (283)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999985
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=322.63 Aligned_cols=257 Identities=22% Similarity=0.440 Sum_probs=197.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHH-HHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDV-LQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~-l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++.+.||+|+||.||+|++..+|+.||+|+++... ........|+.+ ++.+.|+++ +++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----v~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT-----VTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCe-----eeeeEEEecCCcE
Confidence 36999999999999999999999999999999987532 223345556665 444455555 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 169 CIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
|+||||+.++|.+++... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-------------- 141 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-------------- 141 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--------------
Confidence 999999988998888642 224689999999999999999999997 999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhC----CCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
.+||+|||.+...... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.
T Consensus 142 -------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (283)
T cd06617 142 -------------QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208 (283)
T ss_pred -------------CEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence 4667777766543221 122468889999999865 356899999999999999999999996
Q ss_pred CCC-hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 320 THE-NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 320 ~~~-~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
... ..+.+..+.. +..+ . .....++.++.++
T Consensus 209 ~~~~~~~~~~~~~~--~~~~---------------------~-------------------------~~~~~~~~~l~~l 240 (283)
T cd06617 209 SWKTPFQQLKQVVE--EPSP---------------------Q-------------------------LPAEKFSPEFQDF 240 (283)
T ss_pred ccccCHHHHHHHHh--cCCC---------------------C-------------------------CCccccCHHHHHH
Confidence 432 2222221111 0000 0 0012346789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
|.+||..+|++|||++++++||||.+...+
T Consensus 241 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 241 VNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=318.31 Aligned_cols=248 Identities=30% Similarity=0.445 Sum_probs=195.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-- 164 (433)
+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+++ +++++++.+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 77 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI-----VQYYGCLRDRA 77 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCe-----eeEEEEEEcCC
Confidence 5899999999999999999999999999999886321 233457789999999998887 999988765
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
++.++++|||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~----------- 144 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN----------- 144 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-----------
Confidence 46789999999 889999998654 6899999999999999999999999999999999999976554
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccC------CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
++|+|||++..... ......++..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 145 ----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~p 208 (266)
T cd06651 145 ----------------VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208 (266)
T ss_pred ----------------EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCC
Confidence 55666665543211 11123578899999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...........+... ... .......+..+.+
T Consensus 209 f~~~~~~~~~~~~~~~-~~~-----------------------------------------------~~~~~~~~~~~~~ 240 (266)
T cd06651 209 WAEYEAMAAIFKIATQ-PTN-----------------------------------------------PQLPSHISEHARD 240 (266)
T ss_pred ccccchHHHHHHHhcC-CCC-----------------------------------------------CCCchhcCHHHHH
Confidence 9765433322211110 000 0011223567888
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
+| +||..+|++|||++|+++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 88 67788999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=317.67 Aligned_cols=246 Identities=19% Similarity=0.318 Sum_probs=200.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
..|.+.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++.+.|+++ +++++++..++.+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCCh-----hheEEEEcCCCCcEEE
Confidence 35899999999999999999999999999999987665555678899999999988877 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.++.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~------------------ 142 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL------------------ 142 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc------------------
Confidence 9999 899999998765557899999999999999999999999999999999999976664
Q ss_pred ccCCCCCCCeeeecCCCCccccCCCc----ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus 143 ---------~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 213 (263)
T cd05052 143 ---------VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213 (263)
T ss_pred ---------EEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 55555555543322111 1233567999999998899999999999999999998 999998766544
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+..... .......+.++.++|.+||+.
T Consensus 214 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~li~~cl~~ 244 (263)
T cd05052 214 VYELLEKGYR-------------------------------------------------MERPEGCPPKVYELMRACWQW 244 (263)
T ss_pred HHHHHHCCCC-------------------------------------------------CCCCCCCCHHHHHHHHHHccC
Confidence 3333221100 011233467899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013941 406 DPAERLKAREALR 418 (433)
Q Consensus 406 dP~~R~ta~ell~ 418 (433)
||++|||+.++++
T Consensus 245 ~p~~Rp~~~~l~~ 257 (263)
T cd05052 245 NPSDRPSFAEIHQ 257 (263)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=320.53 Aligned_cols=270 Identities=26% Similarity=0.391 Sum_probs=211.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++.++. |+++ +++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI-----IKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCc-----hhHHHHhcCCc
Confidence 3699999999999999999999999999999998652 233456778899999988 7766 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++|||++ +++|.+++.+.. .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++++|||+.....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999 999999998765 79999999999999999999999999999999999999988888888888765443
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
........... ...++..............|+..|+|||++.+..++.++||||||++++++++|..||.......
T Consensus 154 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 154 PNSSPESNKGD----ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred CccccccCCCC----CccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 32211000000 00111111111122233568899999999988889999999999999999999999998776544
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+......+ ...++..+.+||.+||+.
T Consensus 230 ~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~li~~~l~~ 259 (280)
T cd05581 230 TFQKILKLEYSF--------------------------------------------------PPNFPPDAKDLIEKLLVL 259 (280)
T ss_pred HHHHHHhcCCCC--------------------------------------------------CCccCHHHHHHHHHHhcC
Confidence 433332211111 123466899999999999
Q ss_pred CCCCCCCH----HHHhcCCCC
Q 013941 406 DPAERLKA----REALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta----~ell~hp~f 422 (433)
||++|||+ +++++||||
T Consensus 260 ~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 260 DPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CHhhCCCcccCHHHHhcCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=316.41 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=205.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++|+++ +++++.+...+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i-----~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI-----VTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCCh-----hhhhheeccCCeEE
Confidence 5899999999999999999999999999999986431 334567789999999998887 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+|+||+ +++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+||+++.++.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~---------------- 139 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM---------------- 139 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC----------------
Confidence 999999 999999998765456899999999999999999999999999999999999976432
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+....... ....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+...
T Consensus 140 ----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 209 (257)
T cd08225 140 ----------VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209 (257)
T ss_pred ----------eEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 35777777665443221 22368889999999988889999999999999999999999997665444
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+... ..+ ......+.++.++|.+||..
T Consensus 210 ~~~~~~~~--~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~ 240 (257)
T cd08225 210 LVLKICQG--YFA-----------------------------------------------PISPNFSRDLRSLISQLFKV 240 (257)
T ss_pred HHHHHhcc--cCC-----------------------------------------------CCCCCCCHHHHHHHHHHhcc
Confidence 33222110 000 01123456899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
+|++|||+.|+++||||
T Consensus 241 ~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 241 SPRDRPSITSILKRPFL 257 (257)
T ss_pred ChhhCcCHHHHhhCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=335.53 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=191.4
Q ss_pred CCeEEeccccccccEEEEEEEecCC-----CcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
++|++.+.||+|+||.||+|++..+ ++.||+|+++... ...+.+.+|+.+++.+ .|+|| +++++++.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nI-----v~~~~~~~ 112 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI-----VNLLGACT 112 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCce-----eeEeeEec
Confidence 4699999999999999999986443 3579999987432 3345678899999999 67777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC-------------------------------------------------------
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------- 187 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------- 187 (433)
..+.+++||||| +|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999 999999986431
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 188 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 188 -------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~---------------------- 250 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV---------------------- 250 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe----------------------
Confidence 124788899999999999999999999999999999999976664
Q ss_pred CCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 328 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~ 328 (433)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 251 -----~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~ 325 (374)
T cd05106 251 -----AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325 (374)
T ss_pred -----EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH
Confidence 5555666554322111 11234567999999998899999999999999999997 999997654332222
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+...... .......+.++.++|.+||+.||+
T Consensus 326 ~~~~~~~~------------------------------------------------~~~~~~~~~~l~~li~~cl~~dp~ 357 (374)
T cd05106 326 KMVKRGYQ------------------------------------------------MSRPDFAPPEIYSIMKMCWNLEPT 357 (374)
T ss_pred HHHHcccC------------------------------------------------ccCCCCCCHHHHHHHHHHcCCChh
Confidence 21111000 001123467899999999999999
Q ss_pred CCCCHHHHhc
Q 013941 409 ERLKAREALR 418 (433)
Q Consensus 409 ~R~ta~ell~ 418 (433)
+|||+.++++
T Consensus 358 ~RPs~~~l~~ 367 (374)
T cd05106 358 ERPTFSQISQ 367 (374)
T ss_pred hCcCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=323.90 Aligned_cols=293 Identities=26% Similarity=0.426 Sum_probs=213.6
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc---
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--- 164 (433)
.++|++.++||+|+||.||+|++..+++.||+|++.... .......+|+++++.++|+++ +++++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV-----VPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCc-----cchhhheecccc
Confidence 468999999999999999999999999999999886432 123456789999999999888 888887643
Q ss_pred -----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
...+++||||++++|...+.... ..+++..++.++.||++||+|||++||+|+||||+||++++++.++++|||
T Consensus 82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 34579999999888888876543 469999999999999999999999999999999999999888877777777
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
++........... .+.. ..........|+..|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 161 ~~~~~~~~~~~~~------------~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 161 LARPYDGPPPNPK------------GGGG-GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred cchhccCCCcccc------------cCCc-ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 6543322211000 0000 000111234678899999988764 5789999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+.......+....+.+++..+........ ...+.... ..+..........+..+.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~ 287 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPG-------CEGVHSFT-------------NYPRTLEERFGKLGPEGLDL 287 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhccc-------ccccccCC-------------CCCccHHHHcccCChhHHHH
Confidence 98888887777777666554432221110000 00000000 00000111123345689999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f 422 (433)
|.+||+.||++|||+.|++.||||
T Consensus 288 i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 288 LSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHcccCcccCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=316.14 Aligned_cols=249 Identities=29% Similarity=0.455 Sum_probs=196.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~- 164 (433)
.+|++.+.||+|+||.||+|.+..+++.||||.+.... ...+.+.+|+.+++++.|+++ +++++++.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI-----VQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCe-----eeEEeEeccC
Confidence 36999999999999999999999999999999875321 223567789999999988887 999998865
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
...+++||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+||+++.++.+
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~--------- 145 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNV--------- 145 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCE---------
Confidence 35789999999 899999997654 68999999999999999999999999999999999999776654
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccC------CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
+|+|||.+..... ......|+..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 146 ------------------~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 207 (265)
T cd06652 146 ------------------KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207 (265)
T ss_pred ------------------EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCC
Confidence 5555554432211 1122468889999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||...........+. .... ........+..+.
T Consensus 208 p~~~~~~~~~~~~~~---~~~~---------------------------------------------~~~~~~~~~~~~~ 239 (265)
T cd06652 208 PWAEFEAMAAIFKIA---TQPT---------------------------------------------NPVLPPHVSDHCR 239 (265)
T ss_pred CCCccchHHHHHHHh---cCCC---------------------------------------------CCCCchhhCHHHH
Confidence 997654333222111 1000 0001123356789
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
++|.+||. +|++|||++|+++|||+.
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=321.36 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=197.0
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
||+|+||+||+|.+..+++.||+|++.... .....+..|+.++++++|+++ +++++.+...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI-----VSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCE-----eeeeeEEecCCeEEEEEecC
Confidence 699999999999999999999999986432 223455679999999988776 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.......+++..+..++.||+.||.|||++||+||||+|+||+++.++
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~----------------------- 132 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG----------------------- 132 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-----------------------
Confidence 89999999876545799999999999999999999999999999999999997655
Q ss_pred CCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~ 332 (433)
.++|+|||.+...... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 133 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05577 133 ----NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208 (277)
T ss_pred ----CEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence 4566666665443221 1224678899999999888899999999999999999999999976543221111111
Q ss_pred HhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCC-
Q 013941 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL- 411 (433)
Q Consensus 333 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~- 411 (433)
.... .........++++.++|.+||+.||++||
T Consensus 209 ~~~~----------------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 242 (277)
T cd05577 209 RTLE----------------------------------------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLG 242 (277)
T ss_pred cccc----------------------------------------------ccccCCccCCHHHHHHHHHHccCChhHccC
Confidence 1000 00011234477899999999999999999
Q ss_pred ----CHHHHhcCCCCCC
Q 013941 412 ----KAREALRHPFFTR 424 (433)
Q Consensus 412 ----ta~ell~hp~f~~ 424 (433)
++.++++||||.+
T Consensus 243 ~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 243 CRGGSADEVREHPLFKD 259 (277)
T ss_pred CCcccHHHHHhChhhhc
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=315.88 Aligned_cols=246 Identities=26% Similarity=0.451 Sum_probs=192.1
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchhh----HHHHHHHHHHHH-HHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----REAAMIEIDVLQ-RLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~-~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|.+..+++.||+|++++.... ......|..++. ...|+ +++++++++..++.+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-----~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP-----YVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCC-----CeeeeeeeEEcCCeEEEEE
Confidence 5799999999999999999999999998653311 112233433332 23444 4599999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+||||+|+||+++.++
T Consensus 77 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-------------------- 134 (260)
T cd05611 77 EYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-------------------- 134 (260)
T ss_pred eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--------------------
Confidence 999 999999998754 689999999999999999999999999999999999997655
Q ss_pred cCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~ 331 (433)
.++|+|||++..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.
T Consensus 135 -------~~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 206 (260)
T cd05611 135 -------HLKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206 (260)
T ss_pred -------cEEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 467777776654332 223468889999999998888999999999999999999999998766554433332
Q ss_pred HHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCC
Q 013941 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 411 (433)
Q Consensus 332 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ 411 (433)
.... .|+. .....++..+.++|.+||+.||++||
T Consensus 207 ~~~~------------------------~~~~----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~ 240 (260)
T cd05611 207 SRRI------------------------NWPE----------------------EVKEFCSPEAVDLINRLLCMDPAKRL 240 (260)
T ss_pred hccc------------------------CCCC----------------------cccccCCHHHHHHHHHHccCCHHHcc
Confidence 2110 0100 01123467899999999999999999
Q ss_pred C---HHHHhcCCCCCC
Q 013941 412 K---AREALRHPFFTR 424 (433)
Q Consensus 412 t---a~ell~hp~f~~ 424 (433)
| ++|+++||||++
T Consensus 241 ~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 241 GANGYQEIKSHPFFKS 256 (260)
T ss_pred CCCcHHHHHcChHhhc
Confidence 5 579999999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=315.48 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=201.0
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+|++.+.||+|+||.||++++..+++.||+|.++.. ....+...+|+.+++.+.|+|+ +++++.+.+++.+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI-----VAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEECCEEEE
Confidence 489999999999999999999999999999998642 3344667789999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~------------------ 137 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG------------------ 137 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC------------------
Confidence 99999 89999998765545689999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||.+...... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+....
T Consensus 138 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 138 ---------KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred ---------cEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 4566666665443221 1234688899999999988899999999999999999999999987655443
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+.... .+ .....++..+.+||.+||+.|
T Consensus 209 ~~~~~~~~--~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 209 ILKVCQGS--YK-----------------------------------------------PLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred HHHHhcCC--CC-----------------------------------------------CCCcccCHHHHHHHHHHHhCC
Confidence 33322110 00 011234568899999999999
Q ss_pred CCCCCCHHHHhcC
Q 013941 407 PAERLKAREALRH 419 (433)
Q Consensus 407 P~~R~ta~ell~h 419 (433)
|++|||+.+++.-
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=320.60 Aligned_cols=276 Identities=31% Similarity=0.519 Sum_probs=210.5
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC--CeE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NHI 168 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~--~~~ 168 (433)
|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+.|+++ +++++++... +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI-----VRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCe-----eeheeeEecCCCCcE
Confidence 67899999999999999999999999999999764 2334567789999999988777 9999999887 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||+.++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||++++++.
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~---------------- 138 (287)
T cd07840 76 YMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV---------------- 138 (287)
T ss_pred EEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC----------------
Confidence 9999999779999887653 36999999999999999999999999999999999999977664
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
++|+|||.+...... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.
T Consensus 139 -----------~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 139 -----------LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred -----------EEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 556666655433322 1224567889999987654 578999999999999999999999998887
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC-chHHHHHHHHHh
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQGL 402 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~ 402 (433)
...+..+.+..+.++...+...... .+..... .....+......... .+.++.++|.+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 267 (287)
T cd07840 208 LEQLEKIFELCGSPTDENWPGVSKL-----------PWFENLK---------PKKPYKRRLREFFKHLIDPSALDLLDKL 267 (287)
T ss_pred HHHHHHHHHHhCCCchhhccccccc-----------hhhhhcc---------ccccchhHHHHHhcccCCHHHHHHHHHH
Confidence 7777777666555443221111000 0000000 000001111111122 377899999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 013941 403 LRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f 422 (433)
|+.||++|||+.++++||||
T Consensus 268 l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 268 LTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cCCChhhCcCHHHHhhCcCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=320.10 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=205.4
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+++++++.|+++ +++++.+...+..++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI-----VGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCch-----hhhheeeecCCEEEE
Confidence 588999999999999999999999999999998754 2344667889999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|+||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~----------------- 138 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG----------------- 138 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-----------------
Confidence 99999 799999998653 478999999999999999999999 9999999999999997654
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--HH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN--LE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~--~~ 325 (433)
.++|+|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ..
T Consensus 139 ----------~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 139 ----------QIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred ----------CEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 5777888776543221 1125788899999999998999999999999999999999999965421 11
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.......+. .. ....++.++.++|.+||..
T Consensus 209 ~~~~~~~~~~~~~~------------------------------------------~~---~~~~~~~~~~~li~~~l~~ 243 (265)
T cd06605 209 IFELLQYIVNEPPP------------------------------------------RL---PSGKFSPDFQDFVNLCLIK 243 (265)
T ss_pred HHHHHHHHhcCCCC------------------------------------------CC---ChhhcCHHHHHHHHHHcCC
Confidence 11111111111000 00 0011467899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013941 406 DPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~ 425 (433)
||++|||+.+++.||||++.
T Consensus 244 ~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 244 DPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CchhCcCHHHHhhCchhhcc
Confidence 99999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=320.87 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=204.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++++.||+|+||+||++.+..+++.||+|++... ......+.+|+++++.++|+++ +++++.+...+.++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI-----VSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCc-----ceEeeeEecCCEEE
Confidence 4699999999999999999999999999999988643 2345677889999999988888 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
+||||+ +++|.+++...+ .+++..+..++.|++.||.|||+ .||+||||||+||+++.++
T Consensus 80 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---------------- 141 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG---------------- 141 (284)
T ss_pred EEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC----------------
Confidence 999999 899999987754 68999999999999999999997 6999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCcccc-CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||++.... .......|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 142 -----------~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 210 (284)
T cd06620 142 -----------QIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210 (284)
T ss_pred -----------cEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh
Confidence 46677777654322 122335789999999999888899999999999999999999999986543211
Q ss_pred --------HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 327 --------LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 327 --------~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
...+.......+ +. ......+.++.+|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~------------------------------------------~~---~~~~~~~~~~~~l 245 (284)
T cd06620 211 GQDDPMGILDLLQQIVQEPP------------------------------------------PR---LPSSDFPEDLRDF 245 (284)
T ss_pred hhhhhhHHHHHHHHHhhccC------------------------------------------CC---CCchhcCHHHHHH
Confidence 010111000000 00 0001245689999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
|.+||+.||++|||+.|+++|+||.+..+
T Consensus 246 i~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 246 VDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred HHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 99999999999999999999999977533
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=318.01 Aligned_cols=244 Identities=28% Similarity=0.435 Sum_probs=198.9
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
||.|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+++ +++++.+.+++..|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI-----VKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCE-----eeeeeeEEcCCccEEEEecC
Confidence 799999999999999999999999986432 334567889999999988877 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.+.. .+++..+..++.||+.||+|||++|++|+||||+||+++.++
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~----------------------- 130 (262)
T cd05572 76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG----------------------- 130 (262)
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-----------------------
Confidence 999999998764 689999999999999999999999999999999999997655
Q ss_pred CCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE--NLEHLAMM 330 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~--~~~~~~~i 330 (433)
.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+
T Consensus 131 ----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 206 (262)
T cd05572 131 ----YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206 (262)
T ss_pred ----CEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence 4677777766544332 223468889999999988889999999999999999999999997665 22222222
Q ss_pred HHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCC
Q 013941 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410 (433)
Q Consensus 331 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 410 (433)
..... . .......+.++.++|.+||+.||++|
T Consensus 207 ~~~~~----------------------~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 207 LKGNG----------------------K--------------------------LEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred hccCC----------------------C--------------------------CCCCcccCHHHHHHHHHHccCChhhC
Confidence 11000 0 00112235689999999999999999
Q ss_pred CC-----HHHHhcCCCCCCC
Q 013941 411 LK-----AREALRHPFFTRD 425 (433)
Q Consensus 411 ~t-----a~ell~hp~f~~~ 425 (433)
+| ++|+++||||++-
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCcccCHHHHhcChhhhCC
Confidence 99 9999999999863
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=319.72 Aligned_cols=276 Identities=34% Similarity=0.605 Sum_probs=213.4
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
|++.+.||+|++|.||+|.+..+++.+++|.+.... .....+.+|+.+++++.|+++ +++++++.+++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI-----IKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCc-----chHHHhhccCCCEEE
Confidence 677899999999999999999999999999986533 234567789999999998877 999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++
T Consensus 76 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~------------------- 135 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG------------------- 135 (283)
T ss_pred EEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-------------------
Confidence 99999779999887653 4789999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||.+....... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+.
T Consensus 136 --------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 207 (283)
T cd05118 136 --------VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207 (283)
T ss_pred --------cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45666666654433221 223578889999999876 789999999999999999999999998888777
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+....+......+.......... ....+.. .........+..+.++.+||.+||+.|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~---------------~~~~~~~~~~~~~~~~~~~i~~~l~~~ 267 (283)
T cd05118 208 LFKIFRTLGTPDPEVWPKFTSLARNY-----KFSFPKK---------------AGMPLPKLFPNASPQALDLLSQMLHYD 267 (283)
T ss_pred HHHHHHHcCCCchHhcccchhhhhhh-----hhhhccc---------------cccCHHHhhhhhCHHHHHHHHHHhccC
Confidence 77776665554332222211100000 0000000 000001122345789999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013941 407 PAERLKAREALRHPFF 422 (433)
Q Consensus 407 P~~R~ta~ell~hp~f 422 (433)
|.+||++.++++||||
T Consensus 268 P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 268 PHKRITAEQALAHPYF 283 (283)
T ss_pred cccCcCHHHHhhCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=318.08 Aligned_cols=245 Identities=20% Similarity=0.272 Sum_probs=194.6
Q ss_pred CCeEEeccccccccEEEEEEEec---CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|.+. ..+..||+|+++... .....+.+|+.++.++.|+++ +++++++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI-----VRLEGVITRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEecCC
Confidence 46999999999999999999765 456789999987542 334567889999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~----------- 147 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCK----------- 147 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEE-----------
Confidence 999999999 889999997653 3689999999999999999999999999999999999997766554
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 320 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~ 320 (433)
++|||.+....... ....++..|+|||++.+..++.++|||||||++||+++ |..||..
T Consensus 148 ----------------l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 148 ----------------ISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ----------------ECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 45554433221110 11234678999999999899999999999999999775 9999987
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....+....+.+.... .....++..+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~li~ 242 (266)
T cd05064 212 MSGQDVIKAVEDGFRL-------------------------------------------------PAPRNCPNLLHQLML 242 (266)
T ss_pred CCHHHHHHHHHCCCCC-------------------------------------------------CCCCCCCHHHHHHHH
Confidence 7665544433221100 011234668999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 013941 401 GLLRYDPAERLKAREALR 418 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~ 418 (433)
+||+.+|++|||++++++
T Consensus 243 ~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 243 DCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHcCCCchhCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=300.84 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=203.7
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
..+.+..||.|+.|.||+++.+.+|...|||.+++.. ...+.++..+.++..-. ..+.||+.+++|..+..+++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~----dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH----DCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc----CCCeeeeeeeEEeeCchHHH
Confidence 4567889999999999999999999999999998643 33345556666654443 23566999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
.||.|...+..++..-. +.++|..+-++...++.||.||-+ +||||||+||+|||++..|
T Consensus 169 cMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G------------------ 229 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG------------------ 229 (391)
T ss_pred HHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC------------------
Confidence 99999777777776544 479999999999999999999995 5899999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCC---CCCccchHHHHHHHHHHHHhCCCCCCCCC-h
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTHE-N 323 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~pf~~~~-~ 323 (433)
.+||||||++...-+. .+...|.+.|||||.+.-. .|+.++||||||++++||.||+.||.+.+ +
T Consensus 230 ---------niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td 300 (391)
T KOG0983|consen 230 ---------NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD 300 (391)
T ss_pred ---------CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence 6788888888765433 3446899999999998643 58899999999999999999999998854 4
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+.+..+.+. .|+.+ ......|+.+++|+..||
T Consensus 301 Fe~ltkvln~---ePP~L--------------------------------------------~~~~gFSp~F~~fv~~CL 333 (391)
T KOG0983|consen 301 FEVLTKVLNE---EPPLL--------------------------------------------PGHMGFSPDFQSFVKDCL 333 (391)
T ss_pred HHHHHHHHhc---CCCCC--------------------------------------------CcccCcCHHHHHHHHHHh
Confidence 5556555442 22110 011235889999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
++|+.+||...++|+|||+..-
T Consensus 334 ~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 334 TKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred hcCcccCcchHHHhcCcceeec
Confidence 9999999999999999998753
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=321.96 Aligned_cols=283 Identities=30% Similarity=0.517 Sum_probs=212.6
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
|+...++|++.+.||+|+||.||+|.+..+++.||+|+++... .......+|+.++++++|+++ +++++++.
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----~~~~~~~~ 76 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI-----VNLKEIVT 76 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCe-----eeeeheec
Confidence 3445678999999999999999999999999999999986432 233456789999999988877 99888876
Q ss_pred cCC----------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 164 YRN----------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 164 ~~~----------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
+.. .+++||||++++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+||++++++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~- 154 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ- 154 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc-
Confidence 544 899999999778888877542 46899999999999999999999999999999999999976654
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCC-CCCccchHHHHHHHH
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCIL 308 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 308 (433)
+||+|||.+....... ....++..|+|||++.+. .++.++|||||||++
T Consensus 155 --------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~ 208 (302)
T cd07864 155 --------------------------IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208 (302)
T ss_pred --------------------------EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHH
Confidence 5666666554332211 123457789999988754 578999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 309 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
|+|++|++||...+....+..+.+..+..+...+....... .+......+ ..........
T Consensus 209 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~----------~~~~~~~~~~ 268 (302)
T cd07864 209 GELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLP----------YFNTMKPKK----------QYRRRLREEF 268 (302)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccc----------ccccccccc----------ccccchhhhc
Confidence 99999999999888888888887776655432211110000 000000000 0000011112
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
...+..+.++|.+||+.||++|||+.++++||||
T Consensus 269 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 269 SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 3457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=321.06 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=204.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
..|+.++.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++.|+++ +++++.+.+++..|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECCEEE
Confidence 45889999999999999999999999999999987432 334567789999999988777 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++... .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.
T Consensus 79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~---------------- 139 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD---------------- 139 (277)
T ss_pred EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC----------------
Confidence 999999 99999998753 5899999999999999999999999999999999999976654
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
++|+|||++...... .....++..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus 140 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06640 140 -----------VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208 (277)
T ss_pred -----------EEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence 566666655432221 122467889999999998889999999999999999999999997655443
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+... ..| ......+..+.++|.+||+.
T Consensus 209 ~~~~~~~~--~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 209 VLFLIPKN--NPP-----------------------------------------------TLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred HhhhhhcC--CCC-----------------------------------------------CCchhhhHHHHHHHHHHccc
Confidence 32221110 000 01123456889999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q 013941 406 DPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~ 427 (433)
+|++||++.++++|+||.+...
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 240 DPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred CcccCcCHHHHHhChHhhhcch
Confidence 9999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=318.04 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=198.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-----------hhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
+|.+.+.||+|+||.||+|.+..+++.||+|.++... ...+.+..|+.+++.+.|+++ ++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI-----VQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCc-----ceEEEE
Confidence 5889999999999999999999999999999875311 112356779999999988877 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+...+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~-------- 146 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI-------- 146 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--------
Confidence 99999999999999 999999998764 7899999999999999999999999999999999999976664
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCC--CCccchHHHHHHHHHHHHh
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~ 313 (433)
++|+|||++...... .....|+..|+|||++.... ++.++|+||||+++|++++
T Consensus 147 -------------------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~ 207 (272)
T cd06629 147 -------------------CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207 (272)
T ss_pred -------------------EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence 556666655432211 12246788999999988754 7899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|..||...........+..... ...+ .......++.
T Consensus 208 g~~p~~~~~~~~~~~~~~~~~~----------------------~~~~----------------------~~~~~~~~~~ 243 (272)
T cd06629 208 GRRPWSDEEAIAAMFKLGNKRS----------------------APPI----------------------PPDVSMNLSP 243 (272)
T ss_pred CCCCCcCcchHHHHHHhhcccc----------------------CCcC----------------------CccccccCCH
Confidence 9999975544332221110000 0000 0011123467
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
.+.++|.+||..||++|||++++++||||
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 244 VALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 89999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.56 Aligned_cols=304 Identities=17% Similarity=0.204 Sum_probs=203.4
Q ss_pred cccccc--ccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEG--TFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
..||+| +||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++..++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----v~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI-----MTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc-----ceEeeeEecCCceEEEE
Confidence 467777 99999999999999999999986432 234567789999888888887 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+......+.
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~-- 156 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ-- 156 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc--
Confidence 999 88999999876545699999999999999999999999999999999999999888777777764322211110
Q ss_pred cCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
.............++..|+|||++.+. .++.++|||||||++|+|++|..||...........
T Consensus 157 ---------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 221 (328)
T cd08226 157 ---------------KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221 (328)
T ss_pred ---------------cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence 000000011112456679999999764 478999999999999999999999987665443332
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
........|............ .. .. ...+..............................+..+.+||.+||+.||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 298 (328)
T cd08226 222 KLKGPPYSPLDITTFPCEESR-MK-NS-QSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298 (328)
T ss_pred HhcCCCCCCccccccchhhhh-hc-cc-hhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence 222111111100000000000 00 00 0000000000000000000000000011112345678999999999999999
Q ss_pred CCCHHHHhcCCCCCCCc
Q 013941 410 RLKAREALRHPFFTRDV 426 (433)
Q Consensus 410 R~ta~ell~hp~f~~~~ 426 (433)
|||+.|+++||||.+..
T Consensus 299 Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 299 RPSASSLLSHAFFKQVK 315 (328)
T ss_pred CCCHHHHhhCHHHHHHH
Confidence 99999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=320.39 Aligned_cols=277 Identities=32% Similarity=0.586 Sum_probs=213.3
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccCCeEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
|++.+.||+|++|+||+|++..+++.||||.+..... ......+|+..+.++. |+++ +++++++..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI-----VKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCc-----hhHHHHhhcCCcEEE
Confidence 6788999999999999999988999999999864322 2233456888888888 7777 999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
||||++++|.+++.......+++..+..++.||+.||.|||++||+|+||+|+||+++.++
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~------------------- 136 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE------------------- 136 (283)
T ss_pred EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-------------------
Confidence 9999988999998876545789999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~ 327 (433)
.++|+|||.+....... ....++..|+|||++.+ ..++.++|+||||+++|+|++|..||......+..
T Consensus 137 --------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~ 208 (283)
T cd07830 137 --------VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL 208 (283)
T ss_pred --------CEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH
Confidence 46666776665433221 23467889999998854 45789999999999999999999999988888888
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+....+.++...+.......... ...++... ...........+..+.+||.+||+.||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~cl~~~p 268 (283)
T cd07830 209 YKICSVLGTPTKQDWPEGYKLASKL-----GFRFPQFA---------------PTSLHQLIPNASPEAIDLIKDMLRWDP 268 (283)
T ss_pred HHHHHhcCCCChhhhhhHhhhhccc-----cccccccc---------------cccHHHHcccCCHHHHHHHHHhcccCc
Confidence 8888777766554332221111000 00000000 000011112236789999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q 013941 408 AERLKAREALRHPFF 422 (433)
Q Consensus 408 ~~R~ta~ell~hp~f 422 (433)
++|||++|++.||||
T Consensus 269 ~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 269 KKRPTASQALQHPYF 283 (283)
T ss_pred ccCCCHHHHhhCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.37 Aligned_cols=277 Identities=32% Similarity=0.565 Sum_probs=205.9
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe---
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH--- 167 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~--- 167 (433)
|++.+.||+|+||.||+|++..+++.||+|+++... .......+|+.+++++. .+.|++++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE--SFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhh--ccCCCCcceEEEEEeeccCCCC
Confidence 678999999999999999998889999999987422 22344567888887775 1123444999999887665
Q ss_pred --EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 168 --ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 168 --~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
++++|||+.++|.+++.......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++
T Consensus 79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-------------- 144 (287)
T cd07838 79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-------------- 144 (287)
T ss_pred ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--------------
Confidence 9999999977999998775544699999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++|.+||.+...
T Consensus 145 -------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 145 -------------QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred -------------CEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 46666666665432221 223578899999999998899999999999999999999999998887
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+....+.......... .|+....... ..+.. .............+..+.++|.+||
T Consensus 212 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l 268 (287)
T cd07838 212 ADQLDKIFDVIGLPSEE-------------------EWPRNVSLPR---SSFPS-YTPRSFKSFVPEICEEGLDLLKKML 268 (287)
T ss_pred HHHHHHHHHHcCCCChH-------------------hcCCCcccch---hhccc-ccccchhhhhhhhhHHHHHHHHHHh
Confidence 77666665543322110 1111000000 00000 0000001112244678899999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013941 404 RYDPAERLKAREALRHPFF 422 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f 422 (433)
+.||++||+++|+++||||
T Consensus 269 ~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 269 TFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccCCccCCCHHHHhcCcCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=325.38 Aligned_cols=252 Identities=28% Similarity=0.439 Sum_probs=202.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+.|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+.+|+.+++++.|+++ +++++.+..++..|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI-----TRYYGSYLKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCcc-----HhhhcccccCCceE
Confidence 4588889999999999999999999999999998743 2334567889999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.
T Consensus 79 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~---------------- 139 (277)
T cd06642 79 IIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---------------- 139 (277)
T ss_pred EEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC----------------
Confidence 999999 89999988653 5899999999999999999999999999999999999976654
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
++|+|||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 140 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06642 140 -----------VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208 (277)
T ss_pred -----------EEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence 566666665433221 122467889999999998889999999999999999999999997544332
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+... .. .......+.++.++|.+||+.
T Consensus 209 ~~~~~~~~--~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 209 VLFLIPKN--SP-----------------------------------------------PTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred HHhhhhcC--CC-----------------------------------------------CCCCcccCHHHHHHHHHHccC
Confidence 22111000 00 001123456899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q 013941 406 DPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~ 427 (433)
+|++|||+.++++||||.....
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 240 DPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred CcccCcCHHHHHHhHHHHHHhh
Confidence 9999999999999999986443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=323.31 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=205.6
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.....+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+|+ +++++++.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-----v~~~~~~~ 85 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT-----IEYKGCYL 85 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEE
Confidence 444567999999999999999999999999999999986322 233567789999999988877 99999999
Q ss_pred cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
..+..|+||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~------------ 152 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG------------ 152 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC------------
Confidence 999999999999888888876543 3689999999999999999999999999999999999997655
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||++...... ....|+..|+|||++. ...++.++||||||+++|+|++|..||..
T Consensus 153 ---------------~~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 153 ---------------TVKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred ---------------CEEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 4677777766543322 2346888999999875 34688999999999999999999999977
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+.......+... ..+. . ....++..+.++|.
T Consensus 217 ~~~~~~~~~~~~~--~~~~---------------------~-------------------------~~~~~~~~~~~li~ 248 (307)
T cd06607 217 MNAMSALYHIAQN--DSPT---------------------L-------------------------SSNDWSDYFRNFVD 248 (307)
T ss_pred ccHHHHHHHHhcC--CCCC---------------------C-------------------------CchhhCHHHHHHHH
Confidence 6554433222110 0000 0 00123568999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||..||++||++.+++.||||...
T Consensus 249 ~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 249 SCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHhcCChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=323.89 Aligned_cols=251 Identities=24% Similarity=0.431 Sum_probs=202.9
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
|.....||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.++..+.|+++ +++++.+..++..|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV-----VEMYKSYLVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCch-----hhhhhheeeCCeEEEEE
Confidence 555678999999999999999999999999986432 334567789999999988877 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-------------------- 154 (297)
T cd06659 98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-------------------- 154 (297)
T ss_pred ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC--------------------
Confidence 999 89999887653 589999999999999999999999999999999999997665
Q ss_pred cCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
.++|+|||++..... ......|+..|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 155 -------~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 155 -------RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred -------cEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 456666665543221 1223478899999999998889999999999999999999999998766554443
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+... .+. ........+..+.++|.+||+.+|+
T Consensus 228 ~~~~~---~~~--------------------------------------------~~~~~~~~~~~l~~~i~~~l~~~P~ 260 (297)
T cd06659 228 RLRDS---PPP--------------------------------------------KLKNAHKISPVLRDFLERMLTREPQ 260 (297)
T ss_pred HHhcc---CCC--------------------------------------------CccccCCCCHHHHHHHHHHhcCCcc
Confidence 32211 000 0001123466889999999999999
Q ss_pred CCCCHHHHhcCCCCCCCc
Q 013941 409 ERLKAREALRHPFFTRDV 426 (433)
Q Consensus 409 ~R~ta~ell~hp~f~~~~ 426 (433)
+||+++++++||||.+..
T Consensus 261 ~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 261 ERATAQELLDHPFLLQTG 278 (297)
T ss_pred cCcCHHHHhhChhhccCC
Confidence 999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.27 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=204.2
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
.|...+.||+|++|.||++.+..+++.+++|++.... ...+.+.+|+.+++.+.|+++ +++++++...+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~v-----v~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI-----VEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCCh-----heEEEEEEcCCeEEEE
Confidence 4666789999999999999999999999999886433 334557789999999988877 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
+||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 95 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~------------------ 153 (285)
T cd06648 95 MEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR------------------ 153 (285)
T ss_pred EeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc------------------
Confidence 9999 99999998773 5899999999999999999999999999999999999976664
Q ss_pred ccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~ 327 (433)
++|+|||.+...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.....
T Consensus 154 ---------~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~ 224 (285)
T cd06648 154 ---------VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224 (285)
T ss_pred ---------EEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 556666654432211 12246889999999998888999999999999999999999999776554443
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+.... +. .......++..+.+||.+||+.||
T Consensus 225 ~~~~~~~---~~--------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p 257 (285)
T cd06648 225 KRIRDNL---PP--------------------------------------------KLKNLHKVSPRLRSFLDRMLVRDP 257 (285)
T ss_pred HHHHhcC---CC--------------------------------------------CCcccccCCHHHHHHHHHHcccCh
Confidence 3332210 00 000112246689999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCcc
Q 013941 408 AERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 408 ~~R~ta~ell~hp~f~~~~~ 427 (433)
++|||+.++++||||++...
T Consensus 258 ~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 258 AQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred hhCcCHHHHccCcccccCCC
Confidence 99999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.06 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=190.5
Q ss_pred cccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEcc
Q 013941 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~ 174 (433)
.||+|+||.||+|.+..+++.||+|.+.... ........|..+++.+++. .|++++.+++.+...+..|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC--CCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999999999999999986432 1122234455555544432 345669999999999999999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccC
Q 013941 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253 (433)
Q Consensus 175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~ 253 (433)
+ |++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--------------------- 135 (278)
T cd05606 79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--------------------- 135 (278)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC---------------------
Confidence 9 999999887654 6999999999999999999999999999999999999976554
Q ss_pred CCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013941 254 LPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331 (433)
Q Consensus 254 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~ 331 (433)
++|+|||++..... ......|+..|+|||++.+. .++.++||||+||++|+|++|..||.............
T Consensus 136 ------~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 136 ------VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred ------EEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 56666666543221 12234789999999999754 68999999999999999999999997653222111110
Q ss_pred HHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCC
Q 013941 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 411 (433)
Q Consensus 332 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ 411 (433)
..... ........+.++.++|.+||..||++|+
T Consensus 210 ~~~~~-----------------------------------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 210 MTLTM-----------------------------------------------AVELPDSFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred Hhhcc-----------------------------------------------CCCCCCcCCHHHHHHHHHHhhcCHHhcc
Confidence 00000 0011123467899999999999999999
Q ss_pred -----CHHHHhcCCCCCCC
Q 013941 412 -----KAREALRHPFFTRD 425 (433)
Q Consensus 412 -----ta~ell~hp~f~~~ 425 (433)
++.++++||||++.
T Consensus 243 ~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 243 GCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CCCCCCHHHHHhCccccCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=314.09 Aligned_cols=248 Identities=29% Similarity=0.474 Sum_probs=201.5
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
+|+..+.||+|+||.||+|.+..+++.|++|.+.... ...+.+.+|+.+++.++|+++ +++++++..++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI-----VQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCc-----hheeeeEecCC
Confidence 4788899999999999999998899999999986432 234567789999999988887 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+++||||+ +++|.+++.+.. .+++..+..++.||+.||+|||+.||+|+||+|+||+++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-------------- 139 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-------------- 139 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--------------
Confidence 999999999 889999998764 689999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCC-CCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||.+...... .....|+..|+|||.+.... ++.++|+|||||++|+|++|..||....
T Consensus 140 -------------~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 140 -------------VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred -------------CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 4566666655433222 23356888999999998776 8999999999999999999999997655
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.......+... ... ......++.++.++|.+|
T Consensus 207 ~~~~~~~~~~~-~~~-----------------------------------------------~~~~~~~~~~~~~li~~~ 238 (258)
T cd06632 207 GVAAVFKIGRS-KEL-----------------------------------------------PPIPDHLSDEAKDFILKC 238 (258)
T ss_pred HHHHHHHHHhc-ccC-----------------------------------------------CCcCCCcCHHHHHHHHHH
Confidence 33322222110 000 011233467899999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 013941 403 LRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f 422 (433)
|+.+|++|||+.+++.|||+
T Consensus 239 l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 239 LQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hhcCcccCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=314.85 Aligned_cols=245 Identities=21% Similarity=0.358 Sum_probs=198.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|+++++||+|+||.||+|.+. ++..||+|.+.......+.+.+|+.+++.++|+++ +++++.+...+..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL-----VRLYAVVTKEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCe-----eeEEEEEcCCCCcEEE
Confidence 56999999999999999999864 55679999987655556778899999999988877 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.......+++..+..++.||+.||+|||+.|++||||||+||+++.++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~------------------ 141 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM------------------ 141 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc------------------
Confidence 9999 899999998765557899999999999999999999999999999999999976664
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
++|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 142 ---------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~ 212 (261)
T cd05072 142 ---------CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212 (261)
T ss_pred ---------EEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH
Confidence 5566666554432211 11245678999999988889999999999999999998 999998766554
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+..... . .....++.++.+++.+||..
T Consensus 213 ~~~~~~~~~~-~------------------------------------------------~~~~~~~~~~~~li~~~l~~ 243 (261)
T cd05072 213 VMSALQRGYR-M------------------------------------------------PRMENCPDELYDIMKTCWKE 243 (261)
T ss_pred HHHHHHcCCC-C------------------------------------------------CCCCCCCHHHHHHHHHHccC
Confidence 4433322110 0 01123466899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013941 406 DPAERLKAREALR 418 (433)
Q Consensus 406 dP~~R~ta~ell~ 418 (433)
||++|||++++++
T Consensus 244 ~p~~Rp~~~~i~~ 256 (261)
T cd05072 244 KAEERPTFDYLQS 256 (261)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=326.95 Aligned_cols=291 Identities=32% Similarity=0.474 Sum_probs=214.5
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.++.++ +|+|+ +++++++.
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----~~~~~~~~ 77 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNI-----VKLLNVIK 77 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCc-----cceeeeec
Confidence 34567899999999999999999999989999999987532 23334567899999999 88887 99999875
Q ss_pred c--CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 164 Y--RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 164 ~--~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
. ....|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 78 AENDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred cCCCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 4 4478999999977999988764 5889999999999999999999999999999999999987765544444433
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
......... ..........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 155 ~~~~~~~~~-------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 155 RSLSELEEN-------------------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred hcccccccc-------------------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 222111000 00011122468899999998765 4578999999999999999999999998
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhh-hhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEK-YFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
....+....+....+..+...+......... ..... ...... .........+.++.++|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~-~~~~~~~~~~~~l~~li 275 (337)
T cd07852 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSL-------------------PSRPRK-PLDELLPKASDDALDLL 275 (337)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhc-------------------cccccc-chhhhccCCCHHHHHHH
Confidence 8887777777776665554332222111100 00000 000000 01112233678999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.+||+.||++|||+.++++||||++-
T Consensus 276 ~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 276 KKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHhccCCcccccCHHHHhhChhhhhh
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=331.43 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=192.4
Q ss_pred CCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
++|++.+.||+|+||.||+|++ ..++..||||+++... ...+.+.+|+.++..+ .|+|| +++++++.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnI-----v~l~~~~~ 109 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI-----VNLLGACT 109 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcce-----eeeeeeec
Confidence 4799999999999999999974 3466789999986432 3345678899999999 67777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC-------------------------------------------------------
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------- 187 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------- 187 (433)
.++..++||||| +|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999 999999986532
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 188 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 188 ------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~----------------- 252 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI----------------- 252 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc-----------------
Confidence 124778889999999999999999999999999999999976554
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN 323 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~ 323 (433)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 253 ----------~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~ 322 (375)
T cd05104 253 ----------TKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322 (375)
T ss_pred ----------EEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence 5666666654332211 11234567999999999899999999999999999998 8999976543
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+... +.. .......+.++.+||.+||
T Consensus 323 ~~~~~~~~~~----------------------~~~--------------------------~~~~~~~~~~l~~li~~cl 354 (375)
T cd05104 323 DSKFYKMIKE----------------------GYR--------------------------MLSPECAPSEMYDIMKSCW 354 (375)
T ss_pred hHHHHHHHHh----------------------Ccc--------------------------CCCCCCCCHHHHHHHHHHc
Confidence 3322211110 000 0001223568999999999
Q ss_pred ccCCCCCCCHHHHhcC
Q 013941 404 RYDPAERLKAREALRH 419 (433)
Q Consensus 404 ~~dP~~R~ta~ell~h 419 (433)
+.||++|||+.||++.
T Consensus 355 ~~dP~~RPs~~eil~~ 370 (375)
T cd05104 355 DADPLKRPTFKQIVQL 370 (375)
T ss_pred cCChhHCcCHHHHHHH
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=316.64 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=202.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--CCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--~~~ 167 (433)
++|+..++||.|++|.||+|.+..+++.||+|.+.... .....+.+|+++++++.|+++ +++++++.. .+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI-----VKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCe-----eeeeeEEEccCCCe
Confidence 36999999999999999999999999999999987533 345668889999999988887 999998754 457
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+|+||||+ +++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~------------- 142 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG------------- 142 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-------------
Confidence 99999999 89999887532 224689999999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.....
T Consensus 143 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (287)
T cd06621 143 --------------QVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208 (287)
T ss_pred --------------eEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence 4666777765433221 1234678889999999988899999999999999999999999976522
Q ss_pred --HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 324 --LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 324 --~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
................. .+ .........+..+.+||.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~--------------------~~--------------------~~~~~~~~~~~~~~~li~~ 248 (287)
T cd06621 209 PPLGPIELLSYIVNMPNPE--------------------LK--------------------DEPGNGIKWSEEFKDFIKQ 248 (287)
T ss_pred CCCChHHHHHHHhcCCchh--------------------hc--------------------cCCCCCCchHHHHHHHHHH
Confidence 00111111100000000 00 0000001235689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
||..||++|||+.|+++||||++..++
T Consensus 249 ~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 249 CLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred HcCCCcccCCCHHHHHhCccccccccc
Confidence 999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=352.11 Aligned_cols=144 Identities=22% Similarity=0.380 Sum_probs=131.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|+++++||+|+||.||+|.+..+++.||||+++... .....+..|+.++..+.|++| +++++++...+.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFI-----VHLYYSLQSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCc-----CeEEEEEEECCE
Confidence 57999999999999999999999999999999987532 234567789999999988887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
+||||||+ +++|.+++.... .+++..++.++.||+.||+|||++|||||||||+||||+.++.++|+|||++.
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999 999999997654 68999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.99 Aligned_cols=234 Identities=25% Similarity=0.399 Sum_probs=195.9
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~- 175 (433)
++-||+|+.|.||+|+ -.++.||||+++. .-..+|+-|++|+|+|| +.+.++|.....+|||||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~e------lkETdIKHLRkLkH~NI-----I~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRE------LKETDIKHLRKLKHPNI-----ITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhh------hhhhhHHHHHhccCcce-----eeEeeeecCCceeEEeeeccc
Confidence 5779999999999997 4577899998753 22347888999999988 99999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCC
Q 013941 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255 (433)
Q Consensus 176 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 255 (433)
.|.|..+|+... .+.......|..+|+.|++|||.+.|||||||.-||||+.+.
T Consensus 196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d------------------------ 249 (904)
T KOG4721|consen 196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD------------------------ 249 (904)
T ss_pred cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc------------------------
Confidence 999999998765 789999999999999999999999999999999999997655
Q ss_pred CCCCeeeecCCCCccccCCCc--ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 013941 256 KSSAIKLIDFGSTTFEHQDHS--YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 333 (433)
Q Consensus 256 ~~~~~kl~Dfg~a~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~ 333 (433)
.|||+|||.++......+ .++||..|||||++.+.+.+.|+|||||||+||||+||..||...+..-++
T Consensus 250 ---~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------ 320 (904)
T KOG4721|consen 250 ---VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------ 320 (904)
T ss_pred ---eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE------
Confidence 578888888876554432 369999999999999999999999999999999999999999764432211
Q ss_pred hcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCH
Q 013941 334 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 413 (433)
Q Consensus 334 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta 413 (433)
|-.+ ...+.+..+..+++.++-||++||+-.|..||++
T Consensus 321 ---------------------------wGVG---------------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSF 358 (904)
T KOG4721|consen 321 ---------------------------WGVG---------------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSF 358 (904)
T ss_pred ---------------------------Eecc---------------CCcccccCcccCchHHHHHHHHHHhcCCCCCccH
Confidence 1110 1112233445677889999999999999999999
Q ss_pred HHHhcCC
Q 013941 414 REALRHP 420 (433)
Q Consensus 414 ~ell~hp 420 (433)
.++|.|-
T Consensus 359 rqil~Hl 365 (904)
T KOG4721|consen 359 RQILLHL 365 (904)
T ss_pred HHHHHHH
Confidence 9999983
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=320.81 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=200.2
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|+..+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++.++. |+++ +++++++...+..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i-----v~~~~~~~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI-----VKFYGALFREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCE-----eeeeeEEecCCcEE
Confidence 4677889999999999999999999999999986432 33456778999998886 7666 99999999899999
Q ss_pred EEEccCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 170 IVFEKLGPSLYDFLR---KNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 170 lv~e~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
++|||++++|.++.. ......+++..+..++.|++.||+|||+. ||+||||||+||+++.++
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-------------- 145 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-------------- 145 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC--------------
Confidence 999999777765543 22234799999999999999999999975 999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCC---CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||++...... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 146 -------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 146 -------------NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred -------------cEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 4677777766533221 2234688899999999876 688999999999999999999999976
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.. .....+.+.....+. .........++.++.+||.
T Consensus 213 ~~--~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~l~~li~ 248 (288)
T cd06616 213 WN--SVFDQLTQVVKGDPP------------------------------------------ILSNSEEREFSPSFVNFIN 248 (288)
T ss_pred cc--hHHHHHhhhcCCCCC------------------------------------------cCCCcCCCccCHHHHHHHH
Confidence 54 122222222111110 0000111235778999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
+||+.||++|||++++++||||++...
T Consensus 249 ~~l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 249 LCLIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred HHccCChhhCcCHHHHhcChhhhchhh
Confidence 999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=319.20 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=198.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCC-----cEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .....+.+|+.++..+.|+++ +++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI-----VCLLGVCTK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCccc-----ceEEEEEcC
Confidence 46899999999999999999876554 689999986432 334567889999999988887 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
.+..|++|||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999 8999999976421 35888999999999999999999999999999999999976
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHH
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (433)
++. ++|+|||++...... .....++..|+|||.+.+..++.++|||||
T Consensus 160 ~~~---------------------------~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 160 GLT---------------------------VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred CCc---------------------------EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 654 556666655432211 122356788999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhh
Q 013941 305 GCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383 (433)
Q Consensus 305 G~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
||++|||++ |..||.+....+....+.... .
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~i~~~~--~---------------------------------------------- 244 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ--L---------------------------------------------- 244 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--c----------------------------------------------
Confidence 999999998 999998776655444332210 0
Q ss_pred hhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 384 ~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
......++.++.+|+.+||+.||++|||+.|++++
T Consensus 245 -~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 245 -LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00123457799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.33 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=205.3
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+|++.+.||+|++|.||+|++..+++.||+|++.... .....+.+|+.++.+++|+++ +++++++...+..++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-----VKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEccCCeEEE
Confidence 5899999999999999999999999999999987543 345678889999999998877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
||||+ +++|.+++.... .+++..+..++.||+.||+|||+ +|++||||+|+||+++.++
T Consensus 77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~----------------- 137 (264)
T cd06623 77 VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG----------------- 137 (264)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-----------------
Confidence 99999 899999998753 79999999999999999999999 9999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+....... ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 138 ----------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 207 (264)
T cd06623 138 ----------EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207 (264)
T ss_pred ----------CEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC
Confidence 45666666655433221 13467889999999998889999999999999999999999997764211
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC-chHHHHHHHHHhcc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH-SAGDLIDLLQGLLR 404 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~ 404 (433)
....+........ ...... ++..+.++|.+||.
T Consensus 208 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~l~~li~~~l~ 241 (264)
T cd06623 208 FFELMQAICDGPP----------------------------------------------PSLPAEEFSPEFRDFISACLQ 241 (264)
T ss_pred HHHHHHHHhcCCC----------------------------------------------CCCCcccCCHHHHHHHHHHcc
Confidence 1111111111000 001112 56789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~ 424 (433)
.+|++|||+.|+++||||++
T Consensus 242 ~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 242 KDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred CChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.49 Aligned_cols=250 Identities=29% Similarity=0.460 Sum_probs=199.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||+|+||.||+|.+..+++.||+|+++.... ....+..|+.+++.++|+++ +++++.+...+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL-----VKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCCh-----hheeeeEecCCEEE
Confidence 58999999999999999999998999999999875433 45678889999999998887 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+|+||+ +++|.+++.... .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~--------------- 138 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVI--------------- 138 (264)
T ss_pred EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE---------------
Confidence 999999 899999998754 58899999999999999999999999999999999999776654
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC-------cccccCCcccchhhhhCCC---CCccchHHHHHHHHHHHHhCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~~g~~pf 318 (433)
+|+|||.+....... ....++..|+|||++.+.. ++.++||||||+++|++++|..||
T Consensus 139 ------------kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf 206 (264)
T cd06626 139 ------------KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206 (264)
T ss_pred ------------EEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 555555444322111 1235788999999998766 889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
............... +..+ .. .....++..+.++
T Consensus 207 ~~~~~~~~~~~~~~~-~~~~---------------------~~------------------------~~~~~~~~~~~~l 240 (264)
T cd06626 207 SELDNEFQIMFHVGA-GHKP---------------------PI------------------------PDSLQLSPEGKDF 240 (264)
T ss_pred cCCcchHHHHHHHhc-CCCC---------------------CC------------------------CcccccCHHHHHH
Confidence 765322211111110 1100 00 0112236688999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f 422 (433)
|.+||+.||++|||+.|++.|||+
T Consensus 241 i~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 241 LDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=312.29 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=200.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec--cCCe
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--YRNH 167 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~--~~~~ 167 (433)
+|++.+.||.|+||.||+|.+..+++.||+|++... ....+.+..|+.+++.++|+++ +++++++. .+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI-----VRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCcc-----ceeeeeeecCCCCE
Confidence 489999999999999999999999999999998642 2344567789999999999887 99888764 3567
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMH-----ELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
.+++|||+ +++|.+++... ....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-------- 147 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-------- 147 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--------
Confidence 89999999 89999998753 2247899999999999999999999 89999999999999997665
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.++|+|||++....... ....|+..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 148 -------------------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 148 -------------------NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred -------------------CEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 45666666655433222 23468899999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||...+.......+.... .+ ......+..+.
T Consensus 209 p~~~~~~~~~~~~~~~~~--~~-----------------------------------------------~~~~~~~~~~~ 239 (265)
T cd08217 209 PFTARNQLQLASKIKEGK--FR-----------------------------------------------RIPYRYSSELN 239 (265)
T ss_pred cccCcCHHHHHHHHhcCC--CC-----------------------------------------------CCccccCHHHH
Confidence 998766443332222110 00 01123466899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
+++.+||+.+|++|||+++|++|||+
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.45 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=193.1
Q ss_pred CCeEEeccc--cccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKM--GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.+.+ |+|+||.||++++..+++.+|+|++....... .|+.+...+. .|++++++++.+...+..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~----~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMK----DNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhh----cCCCEEEEEEEEecCCeeE
Confidence 467777776 99999999999999999999999986432111 1333322222 2345599999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++
T Consensus 86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----------------- 146 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK----------------- 146 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-----------------
Confidence 999999 999999998764 799999999999999999999999999999999999997644
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH-H
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH-L 327 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~-~ 327 (433)
..++|+|||.+...... ....|+..|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 147 ---------~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 147 ---------DRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred ---------CeEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 14677777776554332 224688999999999988899999999999999999999999975443221 1
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+...... .....+..+..+.+||.+||+.||
T Consensus 217 ~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p 249 (267)
T PHA03390 217 ESLLKRQQK-----------------------------------------------KLPFIKNVSKNANDFVQSMLKYNI 249 (267)
T ss_pred HHHHHhhcc-----------------------------------------------cCCcccccCHHHHHHHHHHhccCh
Confidence 111110000 001122457789999999999999
Q ss_pred CCCCC-HHHHhcCCCCCC
Q 013941 408 AERLK-AREALRHPFFTR 424 (433)
Q Consensus 408 ~~R~t-a~ell~hp~f~~ 424 (433)
.+|++ ++|+|+||||.+
T Consensus 250 ~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 250 NYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred hhCCchHHHHhcCCcccC
Confidence 99996 599999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=296.05 Aligned_cols=280 Identities=28% Similarity=0.551 Sum_probs=219.3
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--CCe
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNH 167 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--~~~ 167 (433)
-.++|++++++|+|-|+.||.|.+..+++.++||+++... ...+.+|+.||+.|. +++|+++++++..+ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~----gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLR----GGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhcc----CCCCeeehhhhhcCccccC
Confidence 3568999999999999999999999999999999997543 356889999999998 33455999999876 456
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
..||+||. +.+...+.. .++...++.++.+|+.||.|||++||+|||+||.|++|+.
T Consensus 110 paLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh----------------- 167 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH----------------- 167 (338)
T ss_pred chhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech-----------------
Confidence 78999999 666655543 5888999999999999999999999999999999999975
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcc--cccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCC-CCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF-QTHE 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf-~~~~ 322 (433)
....++|+|+|+|.+.+....+ .+.+..|--||++..- .|+..-|+|||||+|..|+..+-|| .|.+
T Consensus 168 ---------~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 168 ---------ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred ---------hhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 3457899999999987766543 5778899999999875 5899999999999999999987775 7889
Q ss_pred hHHHHHHHHHHhcCCChh-hHHh----hhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhh-ccCCchHHHH
Q 013941 323 NLEHLAMMERVLGPLPHH-MVIR----ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ-HVDHSAGDLI 396 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~ 396 (433)
+.+++..|.+++|.-.-. ++.. .+...........+..|.. +... ...-.++++.
T Consensus 239 N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~-------------------Fi~~~n~hl~~peai 299 (338)
T KOG0668|consen 239 NYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSR-------------------FINSENQHLVSPEAI 299 (338)
T ss_pred CHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHH-------------------hCCccccccCChHHH
Confidence 999999999998852110 0000 1111111122222222221 1111 1123468999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|||.++|..|-.+|+||+|++.||||...
T Consensus 300 DlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 300 DLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHHHhhccccccchHHHhcCchHHHH
Confidence 99999999999999999999999999854
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=318.65 Aligned_cols=246 Identities=21% Similarity=0.332 Sum_probs=197.2
Q ss_pred CCeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
.+|.+.+.||+|+||.||+|.+.. +++.||+|+++.... ..+.+.+|+++++.+.|+++ +++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~ 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI-----VKFYGVCTE 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCc-----hheeeEEec
Confidence 468999999999999999998743 467899999875432 35678899999999988877 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNS------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
.+..++||||+ +++|.+++...+ ...+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 99999999999 999999997543 13578899999999999999999999999999999999997766
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (433)
. ++|+|||++...... .....++..|+|||++.+..++.++|||||||
T Consensus 160 ~---------------------------~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05049 160 V---------------------------VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 212 (280)
T ss_pred e---------------------------EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence 4 455555555432111 12234577899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 307 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
++|+|++ |..||...+.......+......
T Consensus 213 il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------- 243 (280)
T cd05049 213 VLWEIFTYGKQPWYGLSNEEVIECITQGRLL------------------------------------------------- 243 (280)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC-------------------------------------------------
Confidence 9999998 99999876665544433311100
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
......+..+.++|.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 011234678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=320.98 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=204.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.++|.+.+.||+|+||.||++.+..+++.||+|.+... ....+.+.+|+.+++.+.|+++ +++++.+...+..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI-----VNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCe-----eehhheeeeCCcEE
Confidence 36899999999999999999999889999999998643 2334567789999999888777 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+|+||+ +++|.+++.+. .+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~---------------- 153 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---------------- 153 (293)
T ss_pred EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC----------------
Confidence 999999 99999998764 4889999999999999999999999999999999999976554
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
++|+|||++...... .....|+..|+|||.+.+..++.++|||||||++|++++|..||...+...
T Consensus 154 -----------~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 154 -----------VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred -----------EEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 566666654432211 122468889999999988889999999999999999999999997655433
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+.. +..| ........+..+.++|.+||+.
T Consensus 223 ~~~~~~~--~~~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~ 255 (293)
T cd06647 223 ALYLIAT--NGTP---------------------------------------------ELQNPEKLSAIFRDFLNRCLEM 255 (293)
T ss_pred heeehhc--CCCC---------------------------------------------CCCCccccCHHHHHHHHHHccC
Confidence 2221110 0000 0011223456899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q 013941 406 DPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~ 426 (433)
+|++||++.+++.|+||+...
T Consensus 256 ~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 256 DVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=315.78 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=200.8
Q ss_pred CCCeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+|+.+++.+.|+++ +++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI-----VRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEc
Confidence 3579999999999999999999877 77889999886432 334567889999999988777 99999998
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
+.+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+||+++.++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~------ 153 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG------ 153 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC------
Confidence 888999999999 9999999976531 2588999999999999999999999999999999999997644
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCc-----ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (433)
....++|+|||++........ ....+..|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 154 ------------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred ------------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 223578888888765422211 123346799999999888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 313 S-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 313 ~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+ |..||.+.+.......+..... . ......
T Consensus 216 ~~g~~pf~~~~~~~~~~~~~~~~~-----------------------~--------------------------~~~~~~ 246 (277)
T cd05036 216 SLGYMPYPGRTNQEVMEFVTGGGR-----------------------L--------------------------DPPKGC 246 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc-----------------------C--------------------------CCCCCC
Confidence 7 9999987665544332221100 0 011234
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
+..+.+++.+||+.||++|||+.+|++|
T Consensus 247 ~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 247 PGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6689999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=313.13 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=195.3
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
.....||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.+++.++|+++ +++++++..++..++|||
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-----VQYLGSDSENGFFKIFME 85 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCe-----eeeeeeeccCCEEEEEEe
Confidence 34468999999999999999999999999886543 344567889999999988877 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 174 KL-GPSLYDFLRKNSYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|+ +++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~-------------------- 144 (268)
T cd06624 86 QVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY-------------------- 144 (268)
T ss_pred cCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC--------------------
Confidence 99 899999997642 234 788899999999999999999999999999999999641
Q ss_pred ccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCC--CCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
...++|+|||.+...... .....|+..|+|||++.+.. ++.++||||||+++|+|++|..||.......
T Consensus 145 ------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~ 218 (268)
T cd06624 145 ------SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ 218 (268)
T ss_pred ------CCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh
Confidence 224677777776543221 12246788999999987643 7899999999999999999999996543221
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.......... .........+.++.+|+.+||+.
T Consensus 219 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~~li~~~l~~ 251 (268)
T cd06624 219 AAMFKVGMFK-----------------------------------------------IHPEIPESLSAEAKNFILRCFEP 251 (268)
T ss_pred hhHhhhhhhc-----------------------------------------------cCCCCCcccCHHHHHHHHHHcCC
Confidence 1100000000 00011233467899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
+|++|||+.|++.||||
T Consensus 252 ~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 252 DPDKRASAHDLLQDPFL 268 (268)
T ss_pred CchhCCCHHHHHhCCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.07 Aligned_cols=275 Identities=32% Similarity=0.565 Sum_probs=215.1
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
|++.+.||+|++|.||+|++..+++.||+|++... ....+.+..|+.+++.+.|+++ +++++++...+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI-----VKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCH-----HHHHhhhhcCCceEE
Confidence 67789999999999999999999999999998754 3334567789999999988777 999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
||||++++|.+++.... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++
T Consensus 76 v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~------------------- 135 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG------------------- 135 (282)
T ss_pred EecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-------------------
Confidence 99999779999998753 3699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||.+....... ....++..|+|||.+.+. .++.++|||||||++|||++|..||.+.+....
T Consensus 136 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 207 (282)
T cd07829 136 --------VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207 (282)
T ss_pred --------CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 45666666655432221 123457789999998876 789999999999999999999999999888887
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
+..+.+..+...+..+....... .+ ...++... ...........+..+.++|.+||..|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~---------------~~~~~~~~~~~~~~~~~~i~~~l~~~ 266 (282)
T cd07829 208 LFKIFQILGTPTEESWPGVTKLP--DY----KPTFPKFP---------------PKDLEKVLPRLDPEGIDLLSKMLQYN 266 (282)
T ss_pred HHHHHHHhCCCcHHHHHhhcccc--cc----cccccccC---------------ccchHHhcccccHHHHHHHHHhhccC
Confidence 77777777665554333221110 00 00000000 00001122334678999999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 013941 407 PAERLKAREALRHPFF 422 (433)
Q Consensus 407 P~~R~ta~ell~hp~f 422 (433)
|++||++++++.||||
T Consensus 267 P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 267 PAKRISAKEALKHPYF 282 (282)
T ss_pred cccCCCHHHHhhCcCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=317.23 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=210.0
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+...+.|++.+.||+|++|.||+|.+..+++.||+|++.......+.+.+|+++++.+.|+++ +++++.+...+.
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~ 89 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI-----VDYYDSYLVGDE 89 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCe-----eEEEEEEEECCE
Confidence 445677999999999999999999999889999999997655455678889999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+|+||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~-------------- 154 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS-------------- 154 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--------------
Confidence 99999999 799999998764 36999999999999999999999999999999999999977664
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
++|+|||.+...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 155 -------------~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 155 -------------VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred -------------EEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 455555544332211 1223578899999999888899999999999999999999999987655
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+... ..+. ......++..+.++|.+||
T Consensus 222 ~~~~~~~~~~--~~~~---------------------------------------------~~~~~~~~~~l~~li~~~l 254 (286)
T cd06614 222 LRALFLITTK--GIPP---------------------------------------------LKNPEKWSPEFKDFLNKCL 254 (286)
T ss_pred HHHHHHHHhc--CCCC---------------------------------------------CcchhhCCHHHHHHHHHHh
Confidence 4433322211 0000 0001124568999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.+|.+|||+.++++|+||++.
T Consensus 255 ~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 255 VKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ccChhhCcCHHHHhhChHhhcc
Confidence 9999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.43 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=196.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
+.|++.+.||+|+||.||++... ++..+|+|.+.........+.+|+.++++++|+++ +++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKL-----VQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCc-----eeEEEEEccCCCEEEE
Confidence 35899999999999999999875 45579999987655555678889999999998887 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~------------------ 138 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV------------------ 138 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe------------------
Confidence 9999 899999987643 35899999999999999999999999999999999999976554
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
++|+|||.+....... ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 139 ---------~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 139 ---------VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred ---------EEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 5666666554322111 11234567999999988889999999999999999999 999998776665
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+.... ......+..+.+++.+||+.
T Consensus 210 ~~~~i~~~~~~-------------------------------------------------~~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 210 VVEMISRGFRL-------------------------------------------------YRPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred HHHHHHCCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHccC
Confidence 55544321100 00112355789999999999
Q ss_pred CCCCCCCHHHHhc
Q 013941 406 DPAERLKAREALR 418 (433)
Q Consensus 406 dP~~R~ta~ell~ 418 (433)
||++|||++++++
T Consensus 241 ~p~~Rps~~~l~~ 253 (256)
T cd05114 241 KPEGRPTFAELLR 253 (256)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=330.78 Aligned_cols=246 Identities=30% Similarity=0.448 Sum_probs=201.1
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+. .....+|+.++....+ |+|++++++.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~----h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRD----HPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcC----CCcceeecceecCCceee
Confidence 456799999999999999999999999999999999764 2334557766666542 244599999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe-eCCcccccCccccccCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~-~~~~~~l~d~~~~~~~~~~ 247 (433)
+|||.+ |+-|.+.+.... .+. ..+..|+.+|+.|+.|||++|||||||||+|||++ +.|
T Consensus 393 ~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g---------------- 453 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG---------------- 453 (612)
T ss_pred eeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC----------------
Confidence 999999 887777777654 233 77888999999999999999999999999999994 444
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~ 327 (433)
.++|+|||.+........+.+-|..|.|||++....|+.++||||||++||+|++|+.||......
T Consensus 454 -----------~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--- 519 (612)
T KOG0603|consen 454 -----------HLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--- 519 (612)
T ss_pred -----------cEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---
Confidence 578888888876665544456789999999999999999999999999999999999999876655
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+...++..+ ....+|..+++||++||+.||
T Consensus 520 ~ei~~~i~~~~------------------------------------------------~s~~vS~~AKdLl~~LL~~dP 551 (612)
T KOG0603|consen 520 IEIHTRIQMPK------------------------------------------------FSECVSDEAKDLLQQLLQVDP 551 (612)
T ss_pred HHHHHhhcCCc------------------------------------------------cccccCHHHHHHHHHhccCCh
Confidence 12222111111 114568899999999999999
Q ss_pred CCCCCHHHHhcCCCCC
Q 013941 408 AERLKAREALRHPFFT 423 (433)
Q Consensus 408 ~~R~ta~ell~hp~f~ 423 (433)
.+|+++.+++.||||.
T Consensus 552 ~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 552 ALRLGADEIGAHPWFL 567 (612)
T ss_pred hhCcChhhhccCcchh
Confidence 9999999999999993
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.83 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=207.5
Q ss_pred CCe-EEeccccccccEEEEEEEecCCCcEEEEEEec-----cchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
+|| +...+||+|+|-+||+|.|..+|..||--.++ +.....+.+..|+.+|+.|+|+|| ++++++|.+.
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NI-----irfy~SW~d~ 113 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNI-----IRFYDSWVDT 113 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCce-----eeeeeheecC
Confidence 444 55679999999999999999999888743332 334455788899999999999988 9999999875
Q ss_pred C--eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCccc
Q 013941 166 N--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 166 ~--~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
. .+.+|+|++ .|+|..|+.+.+ .++...++.|++||+.||.|||++. |||||||.+||+|+.
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG----------- 180 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG----------- 180 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-----------
Confidence 4 589999999 999999999876 7999999999999999999999986 999999999999953
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
..+.|||+|+|+|....... ..++|||.|||||++. ..|+..+||||||+.++||+|+.+||.
T Consensus 181 ---------------~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 181 ---------------NLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred ---------------CcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 55689999999998776554 3469999999999998 689999999999999999999999998
Q ss_pred CCChHHH-HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 320 THENLEH-LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 320 ~~~~~~~-~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
...+.-+ +..+.. |.-|..+ ..-..+++++|
T Consensus 245 EC~n~AQIYKKV~S--GiKP~sl----------------------------------------------~kV~dPevr~f 276 (632)
T KOG0584|consen 245 ECTNPAQIYKKVTS--GIKPAAL----------------------------------------------SKVKDPEVREF 276 (632)
T ss_pred hhCCHHHHHHHHHc--CCCHHHh----------------------------------------------hccCCHHHHHH
Confidence 7655433 332221 1111110 01115689999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|.+||.. .++|+|+.|+|+||||..+
T Consensus 277 IekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 277 IEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHhcC-chhccCHHHHhhChhhccc
Confidence 9999999 9999999999999999986
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=310.99 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=197.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|++|.||+|.+. +++.||+|.++......+.+.+|+.++++++|+++ +++++++...+..|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKL-----IQLYAVCTLEEPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCc-----cceeEEEecCCCeeee
Confidence 56999999999999999999865 45679999987655555678899999999998877 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~------------------ 141 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI------------------ 141 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC------------------
Confidence 9999 999999998765457899999999999999999999999999999999999977664
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC-ccc---ccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH-SYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~---~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
++|+|||++....... ... ..+..|+|||++.+..++.++|||||||++|+|++ |+.||.+.....
T Consensus 142 ---------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 212 (261)
T cd05068 142 ---------CKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212 (261)
T ss_pred ---------EEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 5566666554332111 111 22357999999998889999999999999999999 999998776555
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+... . ......+..+.+++.+||+.
T Consensus 213 ~~~~~~~~~~-~------------------------------------------------~~~~~~~~~~~~li~~~l~~ 243 (261)
T cd05068 213 VLQQVDQGYR-M------------------------------------------------PCPPGCPKELYDIMLDCWKE 243 (261)
T ss_pred HHHHHHcCCC-C------------------------------------------------CCCCcCCHHHHHHHHHHhhc
Confidence 4443322110 0 01123456899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013941 406 DPAERLKAREALR 418 (433)
Q Consensus 406 dP~~R~ta~ell~ 418 (433)
||++||++.++++
T Consensus 244 ~P~~Rp~~~~l~~ 256 (261)
T cd05068 244 DPDDRPTFETLQW 256 (261)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=310.51 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=195.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.......+.+.+|+.+++++.|+++ +++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL-----VQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCe-----eeEEEEEccCCCcEEE
Confidence 359999999999999999998654 4459999987655455678899999999988777 9999999988999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~------------------ 138 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC------------------ 138 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC------------------
Confidence 9999 899999997654 26899999999999999999999999999999999999976654
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
+||+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+...
T Consensus 139 ---------~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 139 ---------VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred ---------EEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 5566666554322211 11235567999999998889999999999999999998 999998766554
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+..... .....+..+.+++.+||+.
T Consensus 210 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05113 210 TVEKVSQGLRLY-------------------------------------------------RPHLASEKVYAIMYSCWHE 240 (256)
T ss_pred HHHHHhcCCCCC-------------------------------------------------CCCCCCHHHHHHHHHHcCC
Confidence 443332211000 0112356899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013941 406 DPAERLKAREALRH 419 (433)
Q Consensus 406 dP~~R~ta~ell~h 419 (433)
||++|||+.+++++
T Consensus 241 ~p~~Rp~~~~ll~~ 254 (256)
T cd05113 241 KAEERPTFQQLLSS 254 (256)
T ss_pred CcccCCCHHHHHHh
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=311.20 Aligned_cols=245 Identities=26% Similarity=0.349 Sum_probs=194.6
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++.++||+|+||.||+|++..++ .||+|+++......+.+.+|+.+++++.|+++ +++++.+.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i-----~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCc-----ceEEEEECC-CCcEE
Confidence 357999999999999999999886664 59999998655555678899999999988877 888887754 56899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~----------------- 140 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV----------------- 140 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc-----------------
Confidence 99999 889999998654456899999999999999999999999999999999999976554
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
++|+|||.+....... ....++..|+|||+..+..++.++|||||||++|+|++ |..||.+....
T Consensus 141 ----------~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 141 ----------CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred ----------EEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 5666666654332221 11245678999999988889999999999999999999 88999876655
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+.... .. ......+..+.+||.+||+
T Consensus 211 ~~~~~~~~~~-~~------------------------------------------------~~~~~~~~~l~~li~~~l~ 241 (262)
T cd05071 211 EVLDQVERGY-RM------------------------------------------------PCPPECPESLHDLMCQCWR 241 (262)
T ss_pred HHHHHHhcCC-CC------------------------------------------------CCccccCHHHHHHHHHHcc
Confidence 4433322110 00 0012346689999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013941 405 YDPAERLKAREALR 418 (433)
Q Consensus 405 ~dP~~R~ta~ell~ 418 (433)
.||++|||+.++++
T Consensus 242 ~~p~~Rp~~~~~~~ 255 (262)
T cd05071 242 KEPEERPTFEYLQA 255 (262)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=324.03 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=196.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
...+...+...||+|+||+||+|++-. .||||+++- .....+.+++|+.++++-+|.|| +-+.|++...
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NI-----lLFMG~~~~p 460 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENI-----LLFMGACMNP 460 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhh-----eeeehhhcCC
Confidence 334567789999999999999998643 399999974 34567889999999999999998 9999999887
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.. .||+.+| |.+|+.+++-.. ..|.....+.|++||++|+.|||.++|||||||..||++.+++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~------------- 525 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL------------- 525 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-------------
Confidence 77 9999999 889999998554 4799999999999999999999999999999999999996655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhC---CCCCccchHHHHHHHHHHHHhCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.|||+|||++..... ......|...|||||++.. .+|++.+|||||||++|||++|..
T Consensus 526 --------------kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l 591 (678)
T KOG0193|consen 526 --------------KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL 591 (678)
T ss_pred --------------cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC
Confidence 567777777654221 1122467889999999974 469999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||...+..+++.++-+.... ++ ........+.+++
T Consensus 592 Pysi~~~dqIifmVGrG~l~-------------------------pd--------------------~s~~~s~~pk~mk 626 (678)
T KOG0193|consen 592 PYSIQNRDQIIFMVGRGYLM-------------------------PD--------------------LSKIRSNCPKAMK 626 (678)
T ss_pred CcCCCChhheEEEecccccC-------------------------cc--------------------chhhhccCHHHHH
Confidence 99955444433333221100 00 0112234567999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
+|+..||.+++++||+..+||.
T Consensus 627 ~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 627 RLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999988876
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=310.46 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=197.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.+.|+++++||+|+||.||+|... +++.||+|.+.........+.+|+.++++++|+++ +++++++. .+..++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRL-----VRLYAVVT-QEPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCe-----eeEEEEEc-cCCcEE
Confidence 467999999999999999999854 56789999998666556778899999999988877 88888764 467899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~----------------- 140 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC----------------- 140 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC-----------------
Confidence 99999 999999997665567899999999999999999999999999999999999976654
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
++|+|||.+....... ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 141 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 141 ----------CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred ----------EEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 5666666554333111 11245678999999988889999999999999999999 99999876655
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+...... ......+.++.++|.+||+
T Consensus 211 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05067 211 EVIQNLERGYRM-------------------------------------------------PRPDNCPEELYELMRLCWK 241 (260)
T ss_pred HHHHHHHcCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHcc
Confidence 544433221100 0112345689999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013941 405 YDPAERLKAREALR 418 (433)
Q Consensus 405 ~dP~~R~ta~ell~ 418 (433)
.||++|||++++++
T Consensus 242 ~~p~~Rp~~~~l~~ 255 (260)
T cd05067 242 EKPEERPTFEYLRS 255 (260)
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=314.00 Aligned_cols=254 Identities=23% Similarity=0.391 Sum_probs=201.5
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.|++.+.||+|+||.||+|.+..+++.||+|.++.. ......+.+|+.+++.+.+ ..|++++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc--CCCCCeeeEeeeeeeCCEEEE
Confidence 488899999999999999999999999999998643 2334567789999999973 234555999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~------------------ 138 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG------------------ 138 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC------------------
Confidence 99999 99999998654 689999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+...... .....|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.......
T Consensus 139 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 139 ---------NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred ---------CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 4566666665543222 2234688899999998754 57899999999999999999999997654432
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+... .+. .. .....+.++.++|.+||+.
T Consensus 210 ~~~~~~~~---~~~------------------------------------------~~---~~~~~~~~~~~~i~~~l~~ 241 (277)
T cd06917 210 AMMLIPKS---KPP------------------------------------------RL---EDNGYSKLLREFVAACLDE 241 (277)
T ss_pred hhhccccC---CCC------------------------------------------CC---CcccCCHHHHHHHHHHcCC
Confidence 22111000 000 00 0012456899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q 013941 406 DPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~ 426 (433)
||++|||+.++++|+||++..
T Consensus 242 ~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 242 EPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CcccCcCHHHHhhChHhhccc
Confidence 999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=314.41 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=202.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
-|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++.++.|+++ +++++.+..++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCE-----eEEEEEEEeCCeEEE
Confidence 3788999999999999999998999999999976432 334567789999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++
T Consensus 80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~------------------ 138 (277)
T cd06641 80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG------------------ 138 (277)
T ss_pred EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC------------------
Confidence 99999 88999998753 589999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.++|+|||++...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||........
T Consensus 139 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 209 (277)
T cd06641 139 ---------EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV 209 (277)
T ss_pred ---------CEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH
Confidence 4566666655433221 1224678899999999888889999999999999999999999976554333
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+... ..+ .....++.++.++|.+||+.+
T Consensus 210 ~~~~~~~--~~~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~~ 240 (277)
T cd06641 210 LFLIPKN--NPP-----------------------------------------------TLEGNYSKPLKEFVEACLNKE 240 (277)
T ss_pred HHHHhcC--CCC-----------------------------------------------CCCcccCHHHHHHHHHHccCC
Confidence 3222110 000 011234668999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCc
Q 013941 407 PAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~~ 426 (433)
|++||++.++++||||.+..
T Consensus 241 p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 241 PSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred hhhCcCHHHHHhCHHHhhhh
Confidence 99999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.65 Aligned_cols=268 Identities=20% Similarity=0.253 Sum_probs=198.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.++||+|+||.||+|++..+++.||+|+++.. ....+.+.+|+.++.++.|+|+ +++++++.+++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNI-----Vkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI-----VPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCc-----CeEEEEEeeCCE
Confidence 5799999999999999999999999999999998643 2334568889999999998887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNS---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
.|+||||+ |++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 99999999 999999986421 12356677889999999999999999999999999999999888877777
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
||++........... ......-+............+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 157 FGLAk~i~~~~~~~~------~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 157 WGAAIFKKLEEEDLL------DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred cCcceeccccccccc------ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 777654422111000 00000000000001112235799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|........... .... .|. .......+++.+.+
T Consensus 231 F~~~~~~ki~~~--~~i~-~P~--------------------------------------------~~~p~~~iP~~L~~ 263 (932)
T PRK13184 231 YRRKKGRKISYR--DVIL-SPI--------------------------------------------EVAPYREIPPFLSQ 263 (932)
T ss_pred CCCcchhhhhhh--hhcc-Chh--------------------------------------------hccccccCCHHHHH
Confidence 976443221110 0000 000 00011245678999
Q ss_pred HHHHhcccCCCCCCCHHHHh
Q 013941 398 LLQGLLRYDPAERLKAREAL 417 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell 417 (433)
++.+||+.||++|++..+.+
T Consensus 264 LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 264 IAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred HHHHHccCChhhCcCHHHHH
Confidence 99999999999998765544
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=310.38 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=194.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++.++||+|+||.||+|.+. ++..||+|.+.......+.+.+|+.++++++|+++ +++++++. .+..++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i-----~~~~~~~~-~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL-----VQLYAVVS-EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCce-----EEEEeEEC-CCCcEE
Confidence 357999999999999999999865 55669999987655555678899999999998877 88888875 456899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||++++++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~----------------- 140 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV----------------- 140 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce-----------------
Confidence 99999 899999998655456899999999999999999999999999999999999977654
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
++|+|||.+....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 141 ----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 141 ----------CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred ----------EEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 5566666554332211 11234567999999988889999999999999999999 89999876655
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+.... .. ......+..+.+|+.+||.
T Consensus 211 ~~~~~~~~~~-~~------------------------------------------------~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05070 211 EVLEQVERGY-RM------------------------------------------------PCPQDCPISLHELMLQCWK 241 (260)
T ss_pred HHHHHHHcCC-CC------------------------------------------------CCCCcCCHHHHHHHHHHcc
Confidence 5444332210 00 0112346689999999999
Q ss_pred cCCCCCCCHHHHh
Q 013941 405 YDPAERLKAREAL 417 (433)
Q Consensus 405 ~dP~~R~ta~ell 417 (433)
.||++|||+.+++
T Consensus 242 ~~p~~Rpt~~~l~ 254 (260)
T cd05070 242 KDPEERPTFEYLQ 254 (260)
T ss_pred cCcccCcCHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=312.58 Aligned_cols=245 Identities=23% Similarity=0.348 Sum_probs=199.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
..|++.++||.|+||.||+|.+.. ++.+|+|++..... ....+..|+.+++.++|+++ +++++++...+..++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l 79 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL-----ISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcch-----hheeeeEecCCCeEE
Confidence 469999999999999999999877 88899999876543 45678889999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+|+||||+||+++.++.
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~----------------- 142 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV----------------- 142 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce-----------------
Confidence 99999 899999998765567899999999999999999999999999999999999987665
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
++|+|||.+....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 143 ----------~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 143 ----------CKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred ----------EEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 4555555544322111 11245668999999998889999999999999999998 899998766555
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+..... .......+.++.++|.+||+.
T Consensus 213 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05148 213 VYDQITAGYR-------------------------------------------------MPCPAKCPQEIYKIMLECWAA 243 (261)
T ss_pred HHHHHHhCCc-------------------------------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence 4443332100 001134467899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013941 406 DPAERLKAREALR 418 (433)
Q Consensus 406 dP~~R~ta~ell~ 418 (433)
||++|||+.++++
T Consensus 244 ~p~~Rpt~~~l~~ 256 (261)
T cd05148 244 EPEDRPSFKALRE 256 (261)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=306.27 Aligned_cols=247 Identities=30% Similarity=0.464 Sum_probs=204.4
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||+|++|.||++++..+++.||+|.+.... ...+.+.+|++++.++.|+++ +++++++.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI-----VKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCc-----cEEEEEEEeCCEEE
Confidence 5889999999999999999999999999999987654 345678889999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----------------- 136 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG----------------- 136 (254)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-----------------
Confidence 999999 889999998764 799999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||.+....... ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 137 ----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~ 206 (254)
T cd06627 137 ----------VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206 (254)
T ss_pred ----------CEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 45666666665443322 23467889999999988888999999999999999999999997655433
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.. ... .......+..+.++|.+||..
T Consensus 207 ~~~~~~~--~~~-----------------------------------------------~~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 207 ALFRIVQ--DDH-----------------------------------------------PPLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred HHHHHhc--cCC-----------------------------------------------CCCCCCCCHHHHHHHHHHHhC
Confidence 3222211 000 011224467899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
+|++|||+.+++.||||
T Consensus 238 ~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 238 DPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ChhhCcCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=323.62 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=190.7
Q ss_pred CCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
++|++.+.||+|+||.||+|.+. .+++.||+|+++... ...+.+.+|+.++.++ .|+|+ +++++++.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~ni-----v~~~~~~~ 81 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV-----VNLLGACT 81 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcch-----hheeeeEe
Confidence 47999999999999999999743 345789999987432 2335677899999999 67777 99998775
Q ss_pred c-CCeEEEEEccC-CCCHHHHHHhcCC-----------------------------------------------------
Q 013941 164 Y-RNHICIVFEKL-GPSLYDFLRKNSY----------------------------------------------------- 188 (433)
Q Consensus 164 ~-~~~~~lv~e~~-~~~L~~~l~~~~~----------------------------------------------------- 188 (433)
. +..++++|||+ +++|.+++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 56789999999 9999999864321
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeee
Q 013941 189 ------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262 (433)
Q Consensus 189 ------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl 262 (433)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~---------------------------~vkL 214 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN---------------------------VVKI 214 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC---------------------------cEEE
Confidence 2578999999999999999999999999999999999997655 4566
Q ss_pred ecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcC
Q 013941 263 IDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGP 336 (433)
Q Consensus 263 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~ 336 (433)
+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...... +.
T Consensus 215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 293 (337)
T cd05054 215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-GT 293 (337)
T ss_pred eccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc-cC
Confidence 666666543211 112345678999999999999999999999999999998 99999764432222111100 00
Q ss_pred CChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHH
Q 013941 337 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREA 416 (433)
Q Consensus 337 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~el 416 (433)
. .......+.++.+++.+||+.+|++||++.|+
T Consensus 294 ---------------------~--------------------------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 294 ---------------------R--------------------------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred ---------------------C--------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0 00112345689999999999999999999999
Q ss_pred hcC
Q 013941 417 LRH 419 (433)
Q Consensus 417 l~h 419 (433)
++|
T Consensus 327 l~~ 329 (337)
T cd05054 327 VEI 329 (337)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=315.60 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=202.7
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
|....+||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.+.|+++ +++++.+..++..++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcch-----hheeeEEEeCCEEEEEE
Confidence 445578999999999999999999999999886432 344567789999999988877 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++... .+++..++.++.|++.||+|||++||+|+||||+||+++.++.
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~------------------- 154 (292)
T cd06657 97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR------------------- 154 (292)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-------------------
Confidence 999 88999887543 5899999999999999999999999999999999999977664
Q ss_pred cCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~ 328 (433)
++|+|||++...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+........
T Consensus 155 --------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~ 226 (292)
T cd06657 155 --------VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 226 (292)
T ss_pred --------EEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 455555554322211 122468889999999988888999999999999999999999998766555444
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+....... ......++..+.++|.+||+.||.
T Consensus 227 ~~~~~~~~~-----------------------------------------------~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 227 MIRDNLPPK-----------------------------------------------LKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred HHHhhCCcc-----------------------------------------------cCCcccCCHHHHHHHHHHHhCCcc
Confidence 332211000 001123466889999999999999
Q ss_pred CCCCHHHHhcCCCCCCCcc
Q 013941 409 ERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 409 ~R~ta~ell~hp~f~~~~~ 427 (433)
+||++.++++||||.....
T Consensus 260 ~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 260 QRATAAELLKHPFLAKAGP 278 (292)
T ss_pred cCcCHHHHhcChHHhccCC
Confidence 9999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=311.06 Aligned_cols=243 Identities=31% Similarity=0.530 Sum_probs=197.8
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
||.|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++++.|+++ +++++.+..++..|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-----VKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcch-----hHHHHheecCcEEEEEEecC
Confidence 689999999999999999999999986533 344567789999999988877 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.+.. .+++..+..++.||+.||+|||++||+|+||+|+||+++.++.+
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~--------------------- 132 (265)
T cd05579 76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL--------------------- 132 (265)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCE---------------------
Confidence 889999998765 78999999999999999999999999999999999999876654
Q ss_pred CCCCCeeeecCCCCccccC-----------CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 255 PKSSAIKLIDFGSTTFEHQ-----------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
+|+|||++..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 133 ------~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 133 ------KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred ------EEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 5555554432211 11234678899999999888899999999999999999999999987665
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+.... ..++. ....+..+.++|.+||
T Consensus 207 ~~~~~~~~~~~------------------------~~~~~------------------------~~~~~~~~~~~i~~~l 238 (265)
T cd05579 207 EEIFQNILNGK------------------------IEWPE------------------------DVEVSDEAIDLISKLL 238 (265)
T ss_pred HHHHHHHhcCC------------------------cCCCc------------------------cccCCHHHHHHHHHHh
Confidence 54443332211 01111 0113668999999999
Q ss_pred ccCCCCCCCH---HHHhcCCCCCC
Q 013941 404 RYDPAERLKA---REALRHPFFTR 424 (433)
Q Consensus 404 ~~dP~~R~ta---~ell~hp~f~~ 424 (433)
+.+|++|||+ .++++||||++
T Consensus 239 ~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 239 VPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred cCCHhhcCCCccHHHHhcCccccC
Confidence 9999999999 99999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=312.27 Aligned_cols=249 Identities=20% Similarity=0.315 Sum_probs=194.6
Q ss_pred cCCCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+|+.+++.+.|+++ +++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----v~~~~~~ 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLGVV 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEE
Confidence 3568999999999999999999864 245679999986432 234557789999999988877 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSY--------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
..++..++||||+ +++|.+++..... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~- 157 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT- 157 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC-
Confidence 9999999999999 8999999975321 23577889999999999999999999999999999999976654
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHH
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (433)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++
T Consensus 158 --------------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 211 (277)
T cd05062 158 --------------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211 (277)
T ss_pred --------------------------EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence 5666666554322111 112456789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 309 VELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 309 ~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
|||++ |..||.+.........+.... .+ ..
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~--~~-----------------------------------------------~~ 242 (277)
T cd05062 212 WEIATLAEQPYQGMSNEQVLRFVMEGG--LL-----------------------------------------------DK 242 (277)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCC--cC-----------------------------------------------CC
Confidence 99999 789998766544433322110 00 01
Q ss_pred cCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
....+..+.++|.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 243 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12345689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=313.58 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=196.8
Q ss_pred CCCeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.++|++.+.||+|+||.||+|..+. .+..||+|.+.... .....+.+|+.+++.+.|+++ +++++++.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~ 79 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV-----VRLLGVVS 79 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEc
Confidence 4689999999999999999997542 34579999886433 223456789999999988877 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
..+..|+||||+ +++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~-- 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT-- 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--
Confidence 999999999999 999999997532 123466788999999999999999999999999999999976554
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
++|+|||++....... ....++..|+|||.+.+..++.++|||||||++|
T Consensus 158 -------------------------~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~ 212 (288)
T cd05061 158 -------------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212 (288)
T ss_pred -------------------------EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHH
Confidence 5666666654322111 1124567899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 310 el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
||++ |..||.+....+....+... ..+ ...
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~--~~~-----------------------------------------------~~~ 243 (288)
T cd05061 213 EITSLAEQPYQGLSNEQVLKFVMDG--GYL-----------------------------------------------DQP 243 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC--CCC-----------------------------------------------CCC
Confidence 9998 78899776554433322110 000 011
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALR------HPFFTR 424 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~------hp~f~~ 424 (433)
...+..+.++|.+||+.||++|||+.++++ ||||..
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 233568999999999999999999999987 999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=306.71 Aligned_cols=249 Identities=30% Similarity=0.533 Sum_probs=204.3
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.+.||.|+||.||++.+..+++.||+|++.... .....+.+|+++++.++|+++ +++.+.+..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~-----~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI-----IKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCCh-----hheEEEEecCCEEE
Confidence 5899999999999999999999999999999987532 345667889999999998877 99999998899999
Q ss_pred EEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+|++ +++|.+++.... ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~-------------- 141 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL-------------- 141 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--------------
Confidence 999999 889999998642 247999999999999999999999999999999999999976554
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
++|+|||.+...... .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus 142 -------------~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 208 (258)
T cd08215 142 -------------VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208 (258)
T ss_pred -------------EEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence 566666655443222 1224688899999999888899999999999999999999999977654
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+.+.. . .......+..+.++|.+||
T Consensus 209 ~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 209 LELALKILKGQ--Y-----------------------------------------------PPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred HHHHHHHhcCC--C-----------------------------------------------CCCCCCCCHHHHHHHHHHc
Confidence 43333222110 0 0011234668999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 013941 404 RYDPAERLKAREALRHPFF 422 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f 422 (433)
..+|++|||+.++++||||
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=313.04 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=195.7
Q ss_pred CCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+|.+.+.||+|+||.||++.+ ..++..+|+|.+.... .....+.+|+.+++++.|+++ +++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI-----VKFYGVCVEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecC
Confidence 4699999999999999999985 2345679999987533 345668889999999998888 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNS-----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~- 158 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL- 158 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence 9999999999 899999997542 124899999999999999999999999999999999999977664
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHH
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (433)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++
T Consensus 159 --------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 159 --------------------------VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred --------------------------EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 5556666554322111 123457789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 309 VELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 309 ~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
|+|++ |..||...........+.... .+ ..
T Consensus 213 ~~l~t~g~~p~~~~~~~~~~~~i~~~~--~~-----------------------------------------------~~ 243 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNEVIECITQGR--VL-----------------------------------------------QR 243 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCC--cC-----------------------------------------------CC
Confidence 99998 999998766555443332210 00 01
Q ss_pred cCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
....+.++.+|+.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 244 PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1234668999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=316.53 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=203.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.+.|...++||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++|+++ +++++++.+.+
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 94 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT-----IEYKGCYLKEH 94 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEEeCC
Confidence 345778889999999999999999999999999986422 233456789999999988887 99999999999
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
..|+||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++
T Consensus 95 ~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~--------------- 158 (313)
T cd06633 95 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--------------- 158 (313)
T ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC---------------
Confidence 999999999778888886543 3689999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||...+.
T Consensus 159 ------------~~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~ 225 (313)
T cd06633 159 ------------QVKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225 (313)
T ss_pred ------------CEEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 467777776654322 23357889999999985 34688999999999999999999999987665
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+... ..|. .....++..+.+||.+||
T Consensus 226 ~~~~~~~~~~--~~~~----------------------------------------------~~~~~~~~~l~~li~~~l 257 (313)
T cd06633 226 MSALYHIAQN--DSPT----------------------------------------------LQSNEWTDSFRGFVDYCL 257 (313)
T ss_pred HHHHHHHHhc--CCCC----------------------------------------------CCccccCHHHHHHHHHHc
Confidence 4444333211 0000 001233557899999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.+|.+||++.+++.||||+..
T Consensus 258 ~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 258 QKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred cCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=308.90 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=196.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+|++.+.||+|+||.||+|.+. ++..+|+|++.........+.+|+.+++.+.|+++ +++++++...+..|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNL-----VQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCE-----EEEEEEEcCCCceEEEE
Confidence 5889999999999999999875 46679999987655455677889999999988777 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~------------------- 138 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV------------------- 138 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc-------------------
Confidence 999 999999997654 36899999999999999999999999999999999999976654
Q ss_pred cCCCCCCCeeeecCCCCccccCCCc----ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH 326 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~ 326 (433)
++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.
T Consensus 139 --------~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 139 --------VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred --------EEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 56666665543322111 1123457999999998899999999999999999999 8999987665544
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+..... .......+.++.+++.+||..+
T Consensus 211 ~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 211 VESVSAGYR-------------------------------------------------LYRPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred HHHHHcCCc-------------------------------------------------CCCCCCCCHHHHHHHHHHhcCC
Confidence 433321100 0011234678999999999999
Q ss_pred CCCCCCHHHHhcC
Q 013941 407 PAERLKAREALRH 419 (433)
Q Consensus 407 P~~R~ta~ell~h 419 (433)
|++|||+.|+++.
T Consensus 242 p~~Rpt~~~~l~~ 254 (256)
T cd05059 242 PEDRPAFKKLLSQ 254 (256)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.37 Aligned_cols=248 Identities=29% Similarity=0.523 Sum_probs=205.4
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
|++.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+.+++++.|+++ +++++++...+..++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI-----VKYYGSYLKKDELWIVM 76 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecCCeEEEEE
Confidence 8889999999999999999998999999999876443 55678889999999988776 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-------------------- 135 (253)
T cd05122 77 EFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-------------------- 135 (253)
T ss_pred ecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--------------------
Confidence 999 799999987753 4689999999999999999999999999999999999997654
Q ss_pred cCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
.++|+|||.+....... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 136 -------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 136 -------EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred -------eEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 56777777776544432 445788999999999988889999999999999999999999987654443332
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
+... ..+. ......++..+.++|.+||+.||++
T Consensus 209 ~~~~--~~~~---------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~ 241 (253)
T cd05122 209 IATN--GPPG---------------------------------------------LRNPEKWSDEFKDFLKKCLQKNPEK 241 (253)
T ss_pred HHhc--CCCC---------------------------------------------cCcccccCHHHHHHHHHHccCChhh
Confidence 2210 0000 0001123568999999999999999
Q ss_pred CCCHHHHhcCCC
Q 013941 410 RLKAREALRHPF 421 (433)
Q Consensus 410 R~ta~ell~hp~ 421 (433)
|||+.|+++|||
T Consensus 242 R~t~~~~l~~~~ 253 (253)
T cd05122 242 RPTAEQLLKHPF 253 (253)
T ss_pred CCCHHHHhcCCC
Confidence 999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=307.61 Aligned_cols=239 Identities=21% Similarity=0.357 Sum_probs=189.0
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
+.||+|+||.||+|++..+++.||+|.+... ......+.+|+++++.+.|+++ +++++++...+..++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-----VRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcCCCCeEEEEeec
Confidence 4799999999999999999999999987643 2345678889999999988887 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---------------------- 132 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV---------------------- 132 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc----------------------
Confidence 999999997643 35899999999999999999999999999999999999977664
Q ss_pred CCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 328 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~ 328 (433)
++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 133 -----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~ 207 (252)
T cd05084 133 -----LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207 (252)
T ss_pred -----EEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence 4555555544322111 01122456999999998889999999999999999998 899997655443322
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+.... . .......+..+.+|+.+||+.||+
T Consensus 208 ~~~~~~-----------------------~--------------------------~~~~~~~~~~~~~li~~~l~~~p~ 238 (252)
T cd05084 208 AIEQGV-----------------------R--------------------------LPCPELCPDAVYRLMERCWEYDPG 238 (252)
T ss_pred HHHcCC-----------------------C--------------------------CCCcccCCHHHHHHHHHHcCCChh
Confidence 221100 0 001123466899999999999999
Q ss_pred CCCCHHHHhc
Q 013941 409 ERLKAREALR 418 (433)
Q Consensus 409 ~R~ta~ell~ 418 (433)
+|||+.++++
T Consensus 239 ~Rps~~~~~~ 248 (252)
T cd05084 239 QRPSFSTVHQ 248 (252)
T ss_pred hCcCHHHHHH
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=307.87 Aligned_cols=243 Identities=22% Similarity=0.327 Sum_probs=195.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee-ccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~-~~~~~~~l 170 (433)
.+|++.+.||+|+||.||++... +..||+|.++... ..+.+.+|+.+++++.|+++ +++++++ ..++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCe-----eeEEEEEEcCCCceEE
Confidence 36999999999999999999754 7779999986533 34567889999999988877 9988864 45678999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~------------------ 139 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN------------------ 139 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC------------------
Confidence 99999 88999999876655689999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 328 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~ 328 (433)
.+||+|||++...........++..|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus 140 ---------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~ 210 (256)
T cd05082 140 ---------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210 (256)
T ss_pred ---------cEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 4677777766544433333455678999999998889999999999999999998 999997655444333
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+..... ....+..+..+.++|.+||+.||+
T Consensus 211 ~~~~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~ 241 (256)
T cd05082 211 RVEKGYK-------------------------------------------------MDAPDGCPPVVYDVMKQCWHLDAA 241 (256)
T ss_pred HHhcCCC-------------------------------------------------CCCCCCCCHHHHHHHHHHhcCChh
Confidence 3221100 011134467899999999999999
Q ss_pred CCCCHHHHhc
Q 013941 409 ERLKAREALR 418 (433)
Q Consensus 409 ~R~ta~ell~ 418 (433)
+|||+.++++
T Consensus 242 ~Rpt~~~l~~ 251 (256)
T cd05082 242 TRPSFLQLRE 251 (256)
T ss_pred hCcCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.07 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=205.1
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
......|...+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.+.|+++ +++++++.
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~ 95 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNS-----IEYKGCYL 95 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEe
Confidence 334455889999999999999999999999999999986432 233467789999999988877 99999999
Q ss_pred cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.++..++||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++
T Consensus 96 ~~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~------------ 162 (317)
T cd06635 96 REHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG------------ 162 (317)
T ss_pred eCCeEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC------------
Confidence 999999999999778888876543 3689999999999999999999999999999999999996655
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||++..... .....|+..|+|||++. +..++.++|||||||++|+|++|..||..
T Consensus 163 ---------------~~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 163 ---------------QVKLADFGSASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ---------------CEEEecCCCccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 467777776654332 22346888999999984 34688999999999999999999999977
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+.......+....... ......+..+.+||.
T Consensus 227 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~li~ 258 (317)
T cd06635 227 MNAMSALYHIAQNESPT------------------------------------------------LQSNEWSDYFRNFVD 258 (317)
T ss_pred ccHHHHHHHHHhccCCC------------------------------------------------CCCccccHHHHHHHH
Confidence 65544433332211000 001234568999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+||+.+|.+|||+.++++|+|+....
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=316.56 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=192.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcE--EEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|.+..++.. +|+|.+... ......+.+|+.++.++ .|+++ +++++++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~i-----v~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCc-----ceEEEEECCCC
Confidence 4699999999999999999998877754 577776532 23345677899999999 67777 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
.+|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999 899999997542 13578999999999999999999999999999999999997655
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcc--cccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
.++|+|||++......... ..++..|+|||++.+..++.++|||||||++|
T Consensus 162 ---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 162 ---------------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred ---------------------------cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 4566666666432211111 13356799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 310 el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
+|++ |..||.+.+..+....+.... . ....
T Consensus 215 ellt~g~~p~~~~~~~~~~~~~~~~~-------------------------~------------------------~~~~ 245 (303)
T cd05088 215 EIVSLGGTPYCGMTCAELYEKLPQGY-------------------------R------------------------LEKP 245 (303)
T ss_pred HHHhcCCCCcccCChHHHHHHHhcCC-------------------------c------------------------CCCC
Confidence 9998 999997665544332221100 0 0011
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
...+.++.+||.+||+.||++||++++++++
T Consensus 246 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 246 LNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2345688999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.43 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=194.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.++||+|+||.||+|.+..++ .+|+|.+.......+.+.+|+.+++.+.|+++ +++++++. .+..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKL-----VPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCe-----eeEEEEEc-CCCcEEE
Confidence 57999999999999999999876554 59999987655555678889999999988877 88888775 4568999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||++++++
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~------------------- 139 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL------------------- 139 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-------------------
Confidence 9999 88999999875545689999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
.++|+|||.+....... ....++..|+|||...+..++.++|||||||++|+|++ |..||.+....+
T Consensus 140 --------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 211 (260)
T cd05069 140 --------VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211 (260)
T ss_pred --------eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 45666666664332211 11245678999999988889999999999999999999 999998766555
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+..... . ......+..+.+++.+||..
T Consensus 212 ~~~~~~~~~~-~------------------------------------------------~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05069 212 VLEQVERGYR-M------------------------------------------------PCPQGCPESLHELMKLCWKK 242 (260)
T ss_pred HHHHHHcCCC-C------------------------------------------------CCCcccCHHHHHHHHHHccC
Confidence 4433322100 0 01123456899999999999
Q ss_pred CCCCCCCHHHHhc
Q 013941 406 DPAERLKAREALR 418 (433)
Q Consensus 406 dP~~R~ta~ell~ 418 (433)
||++||+++++++
T Consensus 243 ~p~~Rp~~~~i~~ 255 (260)
T cd05069 243 DPDERPTFEYIQS 255 (260)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.56 Aligned_cols=244 Identities=22% Similarity=0.328 Sum_probs=199.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
+.|++.+.||.|+||.||+|... ++.||+|.+.......+.+.+|+.+++.+.|+++ +++++++.+.+..++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNL-----VQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcce-----eeeEEEEcCCCCeEEE
Confidence 46899999999999999999864 7889999998665556678889999999988877 9999999989999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~------------------- 139 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL------------------- 139 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-------------------
Confidence 9999 88999999876545799999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~ 329 (433)
.++|+|||.+...........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....
T Consensus 140 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05039 140 --------VAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211 (256)
T ss_pred --------CEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 4667777766554333333344567999999988889999999999999999997 9999976654443322
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
+.... . .......++.+.++|.+||..+|++
T Consensus 212 ~~~~~-----------------------~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 242 (256)
T cd05039 212 VEKGY-----------------------R--------------------------MEAPEGCPPEVYKVMKDCWELDPAK 242 (256)
T ss_pred HhcCC-----------------------C--------------------------CCCccCCCHHHHHHHHHHhccChhh
Confidence 21100 0 0011234678999999999999999
Q ss_pred CCCHHHHhc
Q 013941 410 RLKAREALR 418 (433)
Q Consensus 410 R~ta~ell~ 418 (433)
|||+.++++
T Consensus 243 Rp~~~~l~~ 251 (256)
T cd05039 243 RPTFKQLRE 251 (256)
T ss_pred CcCHHHHHH
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=312.30 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=195.0
Q ss_pred CCeEEeccccccccEEEEEEEe----cCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
..|++.+.||+|+||.||+|.. ..+++.||+|.+.... .....+.+|+.+++++.|+|+ +++++++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI-----VCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCe-----eeEEEEEecC
Confidence 3589999999999999999985 3456789999987432 233567789999999988877 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNS---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
+..|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999 899999986332 124788999999999999999999999999999999999976
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHH
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (433)
++ .++|+|||++...... .....++..|+|||++.+..++.++|||||
T Consensus 160 ~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 160 QL---------------------------HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred CC---------------------------cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 55 4566666666433211 122345678999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhh
Q 013941 305 GCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383 (433)
Q Consensus 305 G~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
||++|||++ |..||.+.........+.... .+
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------------------------- 245 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-LL---------------------------------------------- 245 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cC----------------------------------------------
Confidence 999999998 999998766544433332110 00
Q ss_pred hhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 384 ~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.....++..+.+++.+||+.||++||++.+|+++
T Consensus 246 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 246 --PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0112346689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=306.47 Aligned_cols=246 Identities=25% Similarity=0.342 Sum_probs=199.8
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++.+.||+|+||.||+|.+. +++.||||.+.........+.+|+.+++++.|+++ +++++++......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL-----VQLYAVCSEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCE-----eeeeeeeecCCceEE
Confidence 467999999999999999999975 45779999998666556778899999999988777 999999998899999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||++++++
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~------------------ 140 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL------------------ 140 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC------------------
Confidence 99999 89999999876555799999999999999999999999999999999999997665
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+....
T Consensus 141 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 141 ---------VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred ---------CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 45666666654432211 11234567999999998889999999999999999998 99999877655
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+...... ......+.++.+++.+||+
T Consensus 212 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05034 212 EVLEQVERGYRM-------------------------------------------------PRPPNCPEELYDLMLQCWD 242 (261)
T ss_pred HHHHHHHcCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHcc
Confidence 544443221100 0012235689999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013941 405 YDPAERLKAREALR 418 (433)
Q Consensus 405 ~dP~~R~ta~ell~ 418 (433)
.||++||+++++++
T Consensus 243 ~~p~~Rp~~~~l~~ 256 (261)
T cd05034 243 KDPEERPTFEYLQS 256 (261)
T ss_pred cCcccCCCHHHHHH
Confidence 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=317.67 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=192.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc----EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+|++.+.||+|+||.||+|++..+++ .||+|+++.. ....+.+.+|+.+++.+.|+|+ +++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEcCC
Confidence 469999999999999999999766665 3899998643 2345677889999999999888 9999988764
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
..++|+||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~------------ 147 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH------------ 147 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc------------
Confidence 577999999 999999998654 35889999999999999999999999999999999999976654
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCc-----ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
+||+|||++........ ...++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 148 ---------------~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 148 ---------------VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred ---------------EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 56666666654332111 1234567999999999899999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+....+....+.. ...+| ....++.++.++
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~------------------------------------------------~~~~~~~~~~~l 243 (316)
T cd05108 213 DGIPASEISSILEK-GERLP------------------------------------------------QPPICTIDVYMI 243 (316)
T ss_pred CCCCHHHHHHHHhC-CCCCC------------------------------------------------CCCCCCHHHHHH
Confidence 87654433221111 00000 012335678999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 013941 399 LQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~h 419 (433)
+.+||..||++|||+.+++.+
T Consensus 244 i~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.82 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=195.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|++..+++.||||.++.. ......+.+|+.+++.++|+++ +++++++...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV-----IKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcce-----eeeeeeEEECCe
Confidence 4699999999999999999999999999999987532 2334567789999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+||+++.++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~------------- 143 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG------------- 143 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-------------
Confidence 99999999 88999888632 223589999999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.++|+|||.+....... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 144 --------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 144 --------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred --------------CEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 35666666655433211 1246888999999999888999999999999999999999999654
Q ss_pred Ch--HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 322 EN--LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 322 ~~--~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
.. ......+.. .+ .|. ......+..+.++|
T Consensus 210 ~~~~~~~~~~~~~-~~-~~~----------------------------------------------~~~~~~~~~~~~li 241 (267)
T cd08228 210 KMNLFSLCQKIEQ-CD-YPP----------------------------------------------LPTEHYSEKLRELV 241 (267)
T ss_pred cccHHHHHHHHhc-CC-CCC----------------------------------------------CChhhcCHHHHHHH
Confidence 32 111111110 00 000 00112356899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 013941 400 QGLLRYDPAERLKAREALR 418 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~ 418 (433)
.+||+.+|++|||+.++++
T Consensus 242 ~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 242 SMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHCCCCcccCcCHHHHHH
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.75 Aligned_cols=247 Identities=22% Similarity=0.300 Sum_probs=193.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc--EEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ....+.+.+|+.++.++ .|+++ +++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI-----INLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCch-----hheEEEEccCC
Confidence 469999999999999999999877664 4688887632 23345678899999999 57766 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
..|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 999999999 899999997532 12488899999999999999999999999999999999997655
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcc--cccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
.+||+|||++......... ...+..|+|||++.+..++.++|||||||++|
T Consensus 157 ---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 157 ---------------------------ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred ---------------------------eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 4566666665432211111 12345799999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 310 el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
||++ |..||.+....+....+..... ....
T Consensus 210 el~t~g~~pf~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~ 240 (297)
T cd05089 210 EIVSLGGTPYCGMTCAELYEKLPQGYR-------------------------------------------------MEKP 240 (297)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCC-------------------------------------------------CCCC
Confidence 9997 9999987665544333221100 0011
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..++.++.+||.+||+.||.+|||++++++.
T Consensus 241 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 241 RNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2346789999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=356.47 Aligned_cols=258 Identities=30% Similarity=0.427 Sum_probs=210.6
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.++-||+-..+||.|.||.||-|.+..+|+..|+|-++.. .+......+|..++..++|+|+ |+++++-.++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNl-----V~YyGVEvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNL-----VRYYGVEVHR 1306 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccc-----cccCceeecH
Confidence 4455788899999999999999999999999999977532 2334567789999999999998 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.++|.|||| +|+|.+++...+ ..++...+.+..|++.||.|||++|||||||||+||+++.+|
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g------------- 1371 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG------------- 1371 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-------------
Confidence 9999999999 999999998764 688889999999999999999999999999999999997766
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC-------cccccCCcccchhhhhCC---CCCccchHHHHHHHHHHHHhC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g 314 (433)
.+|++|||.|....... ....||+.|||||++.+. +...++|||||||++.||+||
T Consensus 1372 --------------~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1372 --------------LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred --------------cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence 57777888776543322 236899999999999875 356899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
+.||...++.-++-.-. ..|..| +.+..++.+
T Consensus 1438 krPW~~~dne~aIMy~V-~~gh~P-----------------------------------------------q~P~~ls~~ 1469 (1509)
T KOG4645|consen 1438 KRPWAELDNEWAIMYHV-AAGHKP-----------------------------------------------QIPERLSSE 1469 (1509)
T ss_pred CCchhhccchhHHHhHH-hccCCC-----------------------------------------------CCchhhhHh
Confidence 99997655432221111 111111 112235789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
.++||..||..||++|+++.|+++|-|-+.+...
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence 9999999999999999999999999998876443
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=304.80 Aligned_cols=249 Identities=31% Similarity=0.473 Sum_probs=203.2
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC--Ce
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NH 167 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~--~~ 167 (433)
+|++.+.||+|++|.||+|.+..+++.|++|++.... ...+.+.+|+.+++++.|+++ +++++.+... +.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI-----VRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCE-----eeEEEEEecCCCCe
Confidence 4888999999999999999999899999999987544 345678889999999998777 9999999888 89
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++|+||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~-------------- 139 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV-------------- 139 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--------------
Confidence 99999999 999999998765 7999999999999999999999999999999999999976554
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
++|+|||.+...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 140 -------------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 140 -------------VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred -------------EEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 566666655443322 22346888999999998888999999999999999999999999776
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
.... ..+..... ...........+..+.++|.+
T Consensus 207 ~~~~--~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~l~~~i~~ 239 (260)
T cd06606 207 GNPM--AALYKIGS---------------------------------------------SGEPPEIPEHLSEEAKDFLRK 239 (260)
T ss_pred CchH--HHHHhccc---------------------------------------------cCCCcCCCcccCHHHHHHHHH
Confidence 5211 11111100 000011122346789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f 422 (433)
||+.||++||++.|+++||||
T Consensus 240 ~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 240 CLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.39 Aligned_cols=247 Identities=22% Similarity=0.284 Sum_probs=191.5
Q ss_pred CCeEEeccccccccEEEEEEEecCC-----CcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~ 163 (433)
++|++.+.||+|+||.||+|.+... +..||||+++... ...+.+.+|+.++.++. |+|| +++++++.
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnI-----v~l~~~~~ 111 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI-----VNLLGACT 111 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCe-----eeEEEEEc
Confidence 5689999999999999999986433 3479999996432 33467889999999996 7776 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC-------------------------------------------------------
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------- 187 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------- 187 (433)
..+.+||||||| +|+|.+++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999 999999886531
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe
Q 013941 188 ---------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (433)
Q Consensus 188 ---------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~ 228 (433)
...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 12477888899999999999999999999999999999997
Q ss_pred eCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHH
Q 013941 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWS 303 (433)
Q Consensus 229 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 303 (433)
.++ .+||+|||++...... .....++..|+|||++.+..++.++||||
T Consensus 272 ~~~---------------------------~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 272 QGK---------------------------IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred CCC---------------------------EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 655 3566666666533221 11235677899999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchh
Q 013941 304 VGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382 (433)
Q Consensus 304 lG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (433)
|||++|+|++ |..||..................
T Consensus 325 lGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~---------------------------------------------- 358 (400)
T cd05105 325 YGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR---------------------------------------------- 358 (400)
T ss_pred HHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC----------------------------------------------
Confidence 9999999997 99999764332222111110000
Q ss_pred hhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 383 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.......+.++.++|.+||+.||++|||+.+|.+
T Consensus 359 --~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 359 --MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred --CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 0011234668999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=323.76 Aligned_cols=279 Identities=25% Similarity=0.409 Sum_probs=215.3
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
-|..++.||-|+||+|.+++...|...||+|.+++.+- ....+..|-.||......-+ |+++-.|++.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WV-----VrLyySFQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWV-----VRLYYSFQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcce-----EEEEEEeccCCce
Confidence 48889999999999999999999999999999986442 22345568888888776665 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc--cCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSS 245 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~--~~~ 245 (433)
|+||+|+ ||++..+|-+.+ .|.|+.++.++..+..|+++.|..|+|||||||+||||+.+|++||+|||++. ++.
T Consensus 705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999 999999998886 89999999999999999999999999999999999999999999999999975 344
Q ss_pred CCCCcccCCCCCC------CeeeecCCCCcc-c-------c--CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 246 KDGSYFKNLPKSS------AIKLIDFGSTTF-E-------H--QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 246 ~~~~~~~~~~~~~------~~kl~Dfg~a~~-~-------~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
-+..++.+-+... .--.+|-+.+.. . + ......+||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 4444444221100 001122221110 0 0 0123469999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 310 el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
||+.|+.||......+....+.. |.. .+......
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~n----------------------------w~~------------------~l~~~~~~ 896 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVIN----------------------------WRN------------------FLHIPYQG 896 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeee----------------------------hhh------------------cccccccc
Confidence 99999999987655432222211 110 01112234
Q ss_pred CchHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCC
Q 013941 390 HSAGDLIDLLQGLLRYDPAERL---KAREALRHPFFTRD 425 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~---ta~ell~hp~f~~~ 425 (433)
.++.++.++|.++ ..+++.|+ .++||..||||+..
T Consensus 897 ~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 897 NLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred ccCHHHHHHHHHH-hcChhhhhcccchhhhhcCcccccc
Confidence 5688999999984 45789998 48889999999964
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=305.04 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=197.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~- 164 (433)
.+|++.+.||+|+||.||+|++..+++.||+|.+... ......+.+|+.++++++|+++ +++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI-----VQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCc-----ceEEEEEEcC
Confidence 4699999999999999999999999999999987532 1233567789999999999887 999988765
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
.+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~--------- 145 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNV--------- 145 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCE---------
Confidence 35789999999 899999998654 58999999999999999999999999999999999999776654
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccC------CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
+|+|||.+..... ......|+..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 146 ------------------~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 207 (264)
T cd06653 146 ------------------KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207 (264)
T ss_pred ------------------EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 5555554432211 1122468889999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||...........+ ...... ...+...+..+.
T Consensus 208 p~~~~~~~~~~~~~---~~~~~~---------------------------------------------~~~p~~~~~~~~ 239 (264)
T cd06653 208 PWAEYEAMAAIFKI---ATQPTK---------------------------------------------PMLPDGVSDACR 239 (264)
T ss_pred CCCccCHHHHHHHH---HcCCCC---------------------------------------------CCCCcccCHHHH
Confidence 99765443322221 110000 011234567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
++|.+||+ +|.+|||+.+++.|||.
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=321.44 Aligned_cols=210 Identities=25% Similarity=0.347 Sum_probs=178.5
Q ss_pred CCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhh-HHHHHHHHHHHHHHHhCCCCCcceeE
Q 013941 79 DGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQ 157 (433)
Q Consensus 79 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~v~ 157 (433)
...|.+......+++|.-.+.||+|+||.||+|.... +..||||.+...... ..++.+|+.++.+++|+|+ |+
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl-----v~ 135 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL-----VK 135 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc-----cc
Confidence 3445666666778899999999999999999998644 488999988765543 5569999999999999988 99
Q ss_pred ecceeccCC-eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cEecCCCCCcEEEeeCCc
Q 013941 158 IRNWFDYRN-HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR---LIHTDLKPENILLVSAEY 232 (433)
Q Consensus 158 ~~~~~~~~~-~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIli~~~~~ 232 (433)
++|||.+.+ +.+||+||+ +|+|.+++.......++|....+|+.++++||+|||+.. |||||||++|||+++
T Consensus 136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~--- 212 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE--- 212 (361)
T ss_pred EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC---
Confidence 999999988 599999999 999999998755337899999999999999999999854 999999999999864
Q ss_pred ccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-CCcc--c-ccCCcccchhhhhCCCCCccchHHHHHHHH
Q 013941 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSY--V-VSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (433)
Q Consensus 233 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (433)
+..+||+|||+|..... .... . .||..|+|||++..+..+.++|||||||+|
T Consensus 213 ------------------------~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 213 ------------------------DFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVL 268 (361)
T ss_pred ------------------------CCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHH
Confidence 44678888888865543 2222 2 799999999999988899999999999999
Q ss_pred HHHHhCCCCCCCC
Q 013941 309 VELCSGEALFQTH 321 (433)
Q Consensus 309 ~el~~g~~pf~~~ 321 (433)
.||++|+.+....
T Consensus 269 lElitgr~~~d~~ 281 (361)
T KOG1187|consen 269 LELITGRKAVDQS 281 (361)
T ss_pred HHHHhCCcccCCC
Confidence 9999999888653
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.41 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=195.7
Q ss_pred CCeEEeccccccccEEEEEEEecCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|.+..+ ...||+|+++.. ......+.+|+.+++.++|+++ +++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI-----IRLEGVVTKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCc-----ceEeEEEecCC
Confidence 4699999999999999999987644 457999998643 2334567889999999998887 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~------------- 144 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV------------- 144 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC-------------
Confidence 999999999 899999997654 36899999999999999999999999999999999999977664
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ 319 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~ 319 (433)
++|+|||++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 145 --------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 145 --------------CKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred --------------EEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 4555555554332111 01234568999999998889999999999999999998 999997
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
.....+....+..... . ......+..+.+|+
T Consensus 211 ~~~~~~~~~~~~~~~~-~------------------------------------------------~~~~~~~~~l~~li 241 (266)
T cd05033 211 DMSNQDVIKAVEDGYR-L------------------------------------------------PPPMDCPSALYQLM 241 (266)
T ss_pred CCCHHHHHHHHHcCCC-C------------------------------------------------CCCCCCCHHHHHHH
Confidence 6655544333322100 0 00123466899999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 013941 400 QGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~h 419 (433)
.+||+.+|++||++.|++++
T Consensus 242 ~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 242 LDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=314.04 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=201.7
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
....|...+.||+|+||.||+|++..+++.||+|.+... ......+.+|+.+++.+.|+++ +++.+++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLRE 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEEcC
Confidence 345688899999999999999999999999999998632 2233456789999999988887 9999999999
Q ss_pred CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
+..++||||+.++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-------------- 152 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-------------- 152 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--------------
Confidence 9999999999778888776443 3689999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC---CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.++|+|||++...... ....|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+
T Consensus 153 -------------~~kl~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 153 -------------LVKLGDFGSASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred -------------cEEECCcccceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 4566666665543322 23468889999999853 457889999999999999999999997654
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.......+.... .|. ......+..+.+||.+|
T Consensus 219 ~~~~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~li~~c 250 (308)
T cd06634 219 AMSALYHIAQNE--SPA----------------------------------------------LQSGHWSEYFRNFVDSC 250 (308)
T ss_pred HHHHHHHHhhcC--CCC----------------------------------------------cCcccccHHHHHHHHHH
Confidence 433332222110 000 00123456889999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|+.+|++|||++++++|||+...
T Consensus 251 l~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 251 LQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred hhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=311.57 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=194.2
Q ss_pred CCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
++|++.+.||+|+||.||+|.+ ..++..||+|+++... ...+.+.+|+.+++++ +|+|+ +++++++.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~ 109 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI-----VNLLGACT 109 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCc-----ceEEEEEe
Confidence 5799999999999999999975 3345689999987532 3345678899999999 68877 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
..+..++||||+ +++|.+++.......+++.++..++.||+.||+|||++||+|+||||+|||++.++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---------- 179 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI---------- 179 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe----------
Confidence 999999999999 899999998654445899999999999999999999999999999999999976554
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
++|+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 180 -----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~ 242 (302)
T cd05055 180 -----------------VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN 242 (302)
T ss_pred -----------------EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 5566666554322111 11245678999999998889999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+.............. . ........+..+.
T Consensus 243 p~~~~~~~~~~~~~~~~~--~----------------------------------------------~~~~~~~~~~~~~ 274 (302)
T cd05055 243 PYPGMPVDSKFYKLIKEG--Y----------------------------------------------RMAQPEHAPAEIY 274 (302)
T ss_pred CcCCCCchHHHHHHHHcC--C----------------------------------------------cCCCCCCCCHHHH
Confidence 997655433222111100 0 0001123456899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
+|+.+||..+|++|||+.|+++
T Consensus 275 ~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 275 DIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=309.62 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=193.0
Q ss_pred ccccccccEEEEEEEecCCCc-------EEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKE-------LVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+.||+|+||.||+|.+...+. .||+|.+.... ...+.+..|+.+++.+.|+|+ +++++++..++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----v~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL-----VLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCCh-----hheeeEEEeCCCcE
Confidence 479999999999999865543 48888876433 334567789999999888877 99999999989999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++..++.+++
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~--------- 145 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPP--------- 145 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCc---------
Confidence 999999 899999998654 368999999999999999999999999999999999999988766655544
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCC-CCCCCCChHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE-ALFQTHENLEH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~-~pf~~~~~~~~ 326 (433)
.++++|||.+..... .....++..|+|||++.+. .++.++|||||||++|+|++|. .||...+....
T Consensus 146 ----------~~~l~d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 146 ----------FIKLSDPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred ----------eEEecccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 479999998865433 2335788899999999874 5789999999999999999984 66654433322
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
.... ..... .....+.++.+||.+||+.|
T Consensus 215 ~~~~-~~~~~--------------------------------------------------~~~~~~~~~~~li~~~l~~~ 243 (258)
T cd05078 215 LQFY-EDRHQ--------------------------------------------------LPAPKWTELANLINQCMDYE 243 (258)
T ss_pred HHHH-Hcccc--------------------------------------------------CCCCCcHHHHHHHHHHhccC
Confidence 1111 00000 11123457899999999999
Q ss_pred CCCCCCHHHHhcC
Q 013941 407 PAERLKAREALRH 419 (433)
Q Consensus 407 P~~R~ta~ell~h 419 (433)
|++|||++++++.
T Consensus 244 p~~Rps~~~il~~ 256 (258)
T cd05078 244 PDFRPSFRAIIRD 256 (258)
T ss_pred hhhCCCHHHHHHh
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=303.90 Aligned_cols=239 Identities=31% Similarity=0.522 Sum_probs=198.6
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
||.|+||.||++.+..+++.||+|++..... ....+..|+.+++++.|+++ +++++.++.++..|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI-----VKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcH-----HHHHHHeecCCeeEEEEecC
Confidence 7999999999999988899999999875432 34567889999999998877 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.... .+++..+..++.||+.||.|||+.+++|+||||+||+++.++
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~----------------------- 130 (250)
T cd05123 76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG----------------------- 130 (250)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-----------------------
Confidence 999999998764 689999999999999999999999999999999999997655
Q ss_pred CCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~ 331 (433)
.++|+|||.+...... .....++..|+|||.+.+...+.++|+||||+++|++++|..||...+.......+.
T Consensus 131 ----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 131 ----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred ----cEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 4677777776554332 233578889999999988888999999999999999999999997766533333222
Q ss_pred HHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCC
Q 013941 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 411 (433)
Q Consensus 332 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ 411 (433)
.... ......+..+.++|.+||..||++||
T Consensus 207 ~~~~--------------------------------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 207 KDPL--------------------------------------------------RFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred cCCC--------------------------------------------------CCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 1100 11123366899999999999999999
Q ss_pred CH---HHHhcCCCC
Q 013941 412 KA---REALRHPFF 422 (433)
Q Consensus 412 ta---~ell~hp~f 422 (433)
|+ +++++||||
T Consensus 237 ~~~~~~~l~~~~~f 250 (250)
T cd05123 237 GSGGAEEIKAHPFF 250 (250)
T ss_pred CcccHHHHHhCCCC
Confidence 99 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.69 Aligned_cols=247 Identities=21% Similarity=0.341 Sum_probs=194.8
Q ss_pred CCeEEeccccccccEEEEEEEecCC-----CcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
++|++.+.||+|+||.||++..... ...+|+|.+.... .....+.+|+.+++++ .|+++ +++++++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~~ 86 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLGVCT 86 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEEc
Confidence 5799999999999999999987643 3689999987532 3335577899999998 67766 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKN--------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~ 228 (433)
.++.+++||||+ +++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999 99999999752 234688999999999999999999999999999999999997
Q ss_pred eCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHH
Q 013941 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWS 303 (433)
Q Consensus 229 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwS 303 (433)
.++ .++|+|||.+....... ....++..|+|||++.+..++.++||||
T Consensus 167 ~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 219 (293)
T cd05053 167 EDH---------------------------VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219 (293)
T ss_pred CCC---------------------------eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceee
Confidence 665 45666666665432211 1123456799999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchh
Q 013941 304 VGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382 (433)
Q Consensus 304 lG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (433)
|||++|||++ |..||.+....+....+.....
T Consensus 220 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------------------------- 252 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR----------------------------------------------- 252 (293)
T ss_pred hhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-----------------------------------------------
Confidence 9999999997 9999987655443332221100
Q ss_pred hhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 383 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.......+..+.+|+.+||..||++|||+.|++++
T Consensus 253 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 253 --MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 00112345689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=304.67 Aligned_cols=241 Identities=22% Similarity=0.361 Sum_probs=196.3
Q ss_pred ccccccccEEEEEEEecCC---CcEEEEEEeccchhh--HHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|.+... +..||+|++...... ...+.+|+.++..+.|+++ +++++++.....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV-----VRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCCh-----heeeeeecCCCceEEEE
Confidence 4799999999999998866 889999999764432 5678889999999988877 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 173 EKL-GPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~------------ 143 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV------------ 143 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc------------
Confidence 999 999999998751 247999999999999999999999999999999999999977654
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
++|+|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 144 ---------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 144 ---------------VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred ---------------EEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 566666655443322 222467889999999988889999999999999999999 69999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
......+....+... . .......++.++.++
T Consensus 209 ~~~~~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~~~~~~~l 239 (262)
T cd00192 209 PGLSNEEVLEYLRKG--Y-----------------------------------------------RLPKPEYCPDELYEL 239 (262)
T ss_pred CCCCHHHHHHHHHcC--C-----------------------------------------------CCCCCccCChHHHHH
Confidence 887655544433220 0 001123346789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 013941 399 LQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~h 419 (433)
+.+||..||++|||+.|++++
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=309.89 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=194.8
Q ss_pred CCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.... .....+.+|+.+++++.|+++ +++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI-----VKFYGVCGDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEccC
Confidence 35899999999999999999853 345679999986443 234567889999999998887 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~ 230 (433)
+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 9999999999 999999997643 1348899999999999999999999999999999999999766
Q ss_pred CcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHH
Q 013941 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (433)
Q Consensus 231 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (433)
+. ++|+|||++...... .....++..|+|||++.+..++.++||||||
T Consensus 160 ~~---------------------------~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 212 (291)
T cd05094 160 LL---------------------------VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212 (291)
T ss_pred Cc---------------------------EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHH
Confidence 64 555666655432211 1223567889999999998999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 306 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 306 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
|++|+|++ |..||...+.......+... ..+
T Consensus 213 ~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~~---------------------------------------------- 244 (291)
T cd05094 213 VILWEIFTYGKQPWFQLSNTEVIECITQG--RVL---------------------------------------------- 244 (291)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHhCC--CCC----------------------------------------------
Confidence 99999999 99999776655433322110 000
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
......+..+.+++.+||+.||++|||+.++++
T Consensus 245 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 245 -ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred -CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 001223568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.14 Aligned_cols=248 Identities=30% Similarity=0.494 Sum_probs=197.0
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
+|.+.++||+|+||.||++.+..++..+++|+++.. ........+|+.+++.++|+|+ +++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI-----VKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcH-----HHHHHHHhcCC
Confidence 589999999999999999999888777777776531 1223345678889999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 167 HICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
..++||||+ +++|.+++.. .....+++..++.++.|++.||.|||++|++|+||||+||+++. +
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~------------ 142 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N------------ 142 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C------------
Confidence 999999999 8999998864 22346899999999999999999999999999999999999953 2
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 143 ---------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 143 ---------------LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred ---------------CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3677777766543221 1234678899999999888889999999999999999999999976
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.........+.. +..|. ....++.++.++|.
T Consensus 208 ~~~~~~~~~~~~--~~~~~-----------------------------------------------~~~~~~~~~~~li~ 238 (260)
T cd08222 208 QNFLSVVLRIVE--GPTPS-----------------------------------------------LPETYSRQLNSIMQ 238 (260)
T ss_pred ccHHHHHHHHHc--CCCCC-----------------------------------------------CcchhcHHHHHHHH
Confidence 554333322211 11110 11234568999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f 422 (433)
+||..||++||++.|+++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=313.32 Aligned_cols=290 Identities=19% Similarity=0.217 Sum_probs=198.3
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.+.+|.| |.||.+++..+++.||||+++.. ......+.+|+.+++.++|+++ +++++++...+..+++|
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i-----~~~~~~~~~~~~~~~~~ 78 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI-----LPYVTSFIVDSELYVVS 78 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcch-----hhhhheeecCCeEEEEE
Confidence 34444444 55666666679999999998754 2344678889999999998887 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.++++||+.+......+..
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~- 157 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR- 157 (314)
T ss_pred eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc-
Confidence 999 899999998754456899999999999999999999999999999999999998887777777654332211100
Q ss_pred cCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
...+ ........++..|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 158 -------~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~- 220 (314)
T cd08216 158 -------QRVV---------HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL- 220 (314)
T ss_pred -------cccc---------ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 0000 0111223577889999999763 58899999999999999999999998765443321
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCC-CCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD-GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
....+..+..+...... .......... ...... .............+.++.+||.+||++||+
T Consensus 221 -~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 284 (314)
T cd08216 221 -EKVRGTVPCLLDKSTYP------LYEDSMSQSRSSNEHPN---------NRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284 (314)
T ss_pred -HHHhccCccccccCchh------hhcCCcCcccccccccc---------hhhhhhcchhhHHHHHHHHHHHHHhhcCCC
Confidence 22222222110000000 0000000000 000000 000000111223467899999999999999
Q ss_pred CCCCHHHHhcCCCCCCCc
Q 013941 409 ERLKAREALRHPFFTRDV 426 (433)
Q Consensus 409 ~R~ta~ell~hp~f~~~~ 426 (433)
+|||++|+|+||||++..
T Consensus 285 ~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 285 SRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCcCHHHHhcCchHhhhc
Confidence 999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=307.57 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=195.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCC-----CcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .....+.+|+.+++.+.|+++ +++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV-----VRLLGVVS 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCce-----eEEEEEEc
Confidence 35799999999999999999987643 4789999986433 334567789999999988877 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
..+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~-- 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT-- 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--
Confidence 999999999999 899999997532 124678899999999999999999999999999999999977664
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
++|+|||++...... .....+|..|+|||.+.+..++.++|||||||++|
T Consensus 158 -------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 158 -------------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred -------------------------EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 555666655432211 12235678899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 310 el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
|+++ |..||.+.+..+....+.. +.. ....
T Consensus 213 el~t~g~~p~~~~~~~~~~~~~~~--~~~-----------------------------------------------~~~~ 243 (277)
T cd05032 213 EMATLAEQPYQGLSNEEVLKFVID--GGH-----------------------------------------------LDLP 243 (277)
T ss_pred HhhccCCCCCccCCHHHHHHHHhc--CCC-----------------------------------------------CCCC
Confidence 9998 9999987665544333321 000 0011
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
...+.++.++|.+||+.+|++|||+.++++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 244 ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 234668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.84 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=197.9
Q ss_pred CeEEeccccccccEEEEEEEec---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceec
Q 013941 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~ 163 (433)
+|++.+.||+|+||.||+|.+. .+|+.||+|+++... ...+.+.+|+.++.++. |+++ +.+++.++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-----~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCCh-----hceeeEee
Confidence 4889999999999999999874 478999999987432 23356778999999995 5655 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
.++.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----------- 142 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG----------- 142 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-----------
Confidence 999999999999 899999998764 689999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHhCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.++|+|||++...... .....|+..|+|||.+.+. .++.++||||||+++|+|++|..
T Consensus 143 ----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 206 (290)
T cd05613 143 ----------------HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206 (290)
T ss_pred ----------------CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence 4566666655433221 1124688999999998753 46789999999999999999999
Q ss_pred CCCCCChHHHHHHHHHH-hcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 317 LFQTHENLEHLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
||...........+... ....+ ......+..+
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~ 239 (290)
T cd05613 207 PFTVDGEKNSQAEISRRILKSEP-----------------------------------------------PYPQEMSALA 239 (290)
T ss_pred CCCcCCccccHHHHHHHhhccCC-----------------------------------------------CCCccCCHHH
Confidence 99643322221111111 00000 0112346688
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCc
Q 013941 396 IDLLQGLLRYDPAERL-----KAREALRHPFFTRDV 426 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~-----ta~ell~hp~f~~~~ 426 (433)
.+++.+||+.||++|+ +++++++||||+...
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=302.00 Aligned_cols=249 Identities=28% Similarity=0.454 Sum_probs=202.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+|++.++||+|+||.||++.+..+++.+|+|.+.... .....+.+|+.+++.++|+++ +++++++......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI-----ISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCc-----hhhhhhhccCCEEE
Confidence 5899999999999999999999999999999987532 334566789999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--------------- 140 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--------------- 140 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC---------------
Confidence 999999 999999987521 24689999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||++...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 141 ------------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 141 ------------LVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred ------------cEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4667777766543322 122467889999999998889999999999999999999999998766544
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+... ..+ ......+.++.++|.+||+.
T Consensus 209 ~~~~~~~~--~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08530 209 LRYKVQRG--KYP-----------------------------------------------PIPPIYSQDLQNFIRSMLQV 239 (256)
T ss_pred HHHHHhcC--CCC-----------------------------------------------CCchhhCHHHHHHHHHHcCC
Confidence 33222111 000 00113356899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 013941 406 DPAERLKAREALRHPFF 422 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f 422 (433)
+|++|||+.++++||++
T Consensus 240 ~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 240 KPKLRPNCDKILASPAV 256 (256)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.93 Aligned_cols=246 Identities=20% Similarity=0.266 Sum_probs=194.7
Q ss_pred CeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
+|++.++||+|+||.||+|.+.. .++.||+|+++... ...+.+.+|+.++..+.|+++ +++++++...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----v~~~~~~~~~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI-----VCLLGVVTKE 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEcCC
Confidence 58889999999999999998754 35789999987433 234567789999999988877 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~ 230 (433)
+..++++||+ +++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999 899999985321 1247888999999999999999999999999999999999765
Q ss_pred CcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHH
Q 013941 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (433)
Q Consensus 231 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (433)
+. +||+|||++....... ....+++.|+|||++.+..++.++||||||
T Consensus 161 ~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05091 161 LN---------------------------VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213 (283)
T ss_pred Cc---------------------------eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHH
Confidence 54 5666666554322111 123457789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 306 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 306 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
|++|||++ |..||.+....+....+......
T Consensus 214 ~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------------ 245 (283)
T cd05091 214 VVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL------------------------------------------------ 245 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC------------------------------------------------
Confidence 99999998 88999877665554444321100
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
......+..+.+|+.+||+.+|++||++.+|++.
T Consensus 246 -~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 246 -PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred -CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 0113456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=302.61 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=195.3
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
..++|++.++||+|+||.||++.+. .+..+|+|.+.......+.+.+|+.+++++.|+++ +++++.+.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-----VKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCc-----ceEEEEEcC-CCeE
Confidence 3468999999999999999999854 45569999987655556678889999999998887 899888877 7789
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++|||+ +++|.+++.+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~---------------- 140 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV---------------- 140 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc----------------
Confidence 999999 899999998765557889999999999999999999999999999999999976664
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN 323 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~ 323 (433)
++|+|||.+....... ....++..|+|||++....++.++|||||||++|++++ |..||.+.+.
T Consensus 141 -----------~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 141 -----------CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred -----------EEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 5555555544322111 11245567999999988889999999999999999999 9999987655
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+..... .......+.++.+++.+||
T Consensus 210 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~i~~~l 240 (260)
T cd05073 210 PEVIRALERGYR-------------------------------------------------MPRPENCPEELYNIMMRCW 240 (260)
T ss_pred HHHHHHHhCCCC-------------------------------------------------CCCcccCCHHHHHHHHHHc
Confidence 443332221100 0011234668999999999
Q ss_pred ccCCCCCCCHHHHhc
Q 013941 404 RYDPAERLKAREALR 418 (433)
Q Consensus 404 ~~dP~~R~ta~ell~ 418 (433)
+.||++||++.++++
T Consensus 241 ~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 241 KNRPEERPTFEYIQS 255 (260)
T ss_pred ccCcccCcCHHHHHH
Confidence 999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.40 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=214.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.+++++..||-|+||.|-++........+|+|++++. .+..+.+..|-.||...+.+.| |+++..|.++.+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fI-----vrLYrTfrd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFI-----VRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHH-----HHHHHHhccchh
Confidence 4577889999999999999987666666899998753 2445667789999999887777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|++||-| ||.|+..++.++ .|.+.+++.++..+++|++|||++|||+|||||+|+|++.+|+
T Consensus 495 vYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy-------------- 558 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY-------------- 558 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--------------
Confidence 99999999 999999999886 8999999999999999999999999999999999999987775
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
+||.|||+|+...... -+++||+.|.|||++.+...+.++|.||||+++|||++|.+||++.+..
T Consensus 559 -------------~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 559 -------------LKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred -------------eEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 5666777776655443 3479999999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....|.+.+.. ...+..++....+||+++..
T Consensus 626 ktYn~ILkGid~------------------------------------------------i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 626 KTYNLILKGIDK------------------------------------------------IEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred HHHHHHHhhhhh------------------------------------------------hhcccccchhHHHHHHHHHh
Confidence 877777654321 11223456688899999999
Q ss_pred cCCCCCCC-----HHHHhcCCCCCC
Q 013941 405 YDPAERLK-----AREALRHPFFTR 424 (433)
Q Consensus 405 ~dP~~R~t-----a~ell~hp~f~~ 424 (433)
.+|.+|+. +.+|.+|.||.+
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhhhc
Confidence 99999985 899999999985
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=310.29 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=195.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCC----------------cEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKK----------------ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
++|++.+.||+|+||.||+|.+..++ ..||+|++.... ...+.+.+|+.+++++.|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--- 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI--- 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE---
Confidence 57999999999999999999876543 568999987532 345677889999999998877
Q ss_pred ceeEecceeccCCeEEEEEccC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCC
Q 013941 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNS---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~ 223 (433)
+++++++..++..++|||++ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 82 --~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 82 --ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred --eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999 899999997643 125899999999999999999999999999999999
Q ss_pred cEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCcc
Q 013941 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYP 298 (433)
Q Consensus 224 NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 298 (433)
||+++.++. ++|+|||.+...... .....++..|+|||++.+..++.+
T Consensus 160 Nili~~~~~---------------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 160 NCLVGKNYT---------------------------IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred ceeecCCCc---------------------------eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc
Confidence 999977654 555555555432111 112356778999999998889999
Q ss_pred chHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHH
Q 013941 299 CDLWSVGCILVELCS--GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376 (433)
Q Consensus 299 ~DiwSlG~il~el~~--g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (433)
+|||||||++|||++ |..||......+.+..+....... ..
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~-------------------~~------------------ 255 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDD-------------------GR------------------ 255 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccc-------------------cc------------------
Confidence 999999999999998 778887665554443332211000 00
Q ss_pred hcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
..........+.++.++|.+||+.||++|||+.|+++
T Consensus 256 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 256 -----QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred -----cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 0000111234578999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=312.28 Aligned_cols=247 Identities=19% Similarity=0.316 Sum_probs=192.8
Q ss_pred CCeEEeccccccccEEEEEEEecC-------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecce
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~ 161 (433)
++|.+.+.||+|+||.||+|++.. +...+|+|++... ......+.+|+.+++.+ .|+++ ++++++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~ 92 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLGA 92 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCE-----eeEEEE
Confidence 579999999999999999998643 2357999998753 23345677899999998 57766 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
+...+..|+||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 99999999999999 8999999976421 24888999999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (433)
++.++. ++|+|||.+....... ....++..|+|||++.+..++.++||
T Consensus 173 l~~~~~---------------------------~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 225 (307)
T cd05098 173 VTEDNV---------------------------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225 (307)
T ss_pred EcCCCc---------------------------EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHH
Confidence 976554 5666666654332111 11134568999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc
Q 013941 302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380 (433)
Q Consensus 302 wSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
|||||++|+|++ |..||.+....+....+.....
T Consensus 226 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------------- 260 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--------------------------------------------- 260 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC---------------------------------------------
Confidence 999999999998 8899976554433332221100
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.......+.++.+||.+||..+|++|||+.+++++
T Consensus 261 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 261 ----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 00112346689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=310.65 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=194.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCC--------------cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcce
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKK--------------ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRC 155 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~ 155 (433)
++|++.+.||+|+||.||+|++..++ ..||+|+++.. ......+.+|+++++++.|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i----- 79 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNI----- 79 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCc-----
Confidence 57999999999999999999875432 35899998753 2334568889999999998887
Q ss_pred eEecceeccCCeEEEEEccC-CCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCc
Q 013941 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY----------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (433)
Q Consensus 156 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~N 224 (433)
+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 99999999999999999999 9999999865321 236888999999999999999999999999999999
Q ss_pred EEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccc
Q 013941 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPC 299 (433)
Q Consensus 225 Ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~ 299 (433)
|+++.++. +||+|||++....... ....++..|+|||++.+..++.++
T Consensus 160 ill~~~~~---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 212 (295)
T cd05097 160 CLVGNHYT---------------------------IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS 212 (295)
T ss_pred EEEcCCCc---------------------------EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchh
Confidence 99976554 5666666554322111 112456789999999988899999
Q ss_pred hHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHh
Q 013941 300 DLWSVGCILVELCS--GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377 (433)
Q Consensus 300 DiwSlG~il~el~~--g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (433)
|||||||++|+|++ |..||...+..+....+....... ..
T Consensus 213 DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~-------------------~~------------------- 254 (295)
T cd05097 213 DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ-------------------GR------------------- 254 (295)
T ss_pred hHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhc-------------------cc-------------------
Confidence 99999999999998 678887766555444332211000 00
Q ss_pred cCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
..........+..+.+||.+||+.||++|||+.+|++
T Consensus 255 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 255 ----QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ----cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000112234678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=302.88 Aligned_cols=237 Identities=25% Similarity=0.362 Sum_probs=187.0
Q ss_pred ccccccccEEEEEEEe--cCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
++||+|+||.||+|.. ..++..+|+|+++... ...+.+.+|+.+++.+.|+++ +++++++. .+..++||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI-----VRMIGICE-AESWMLVM 74 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEc-CCCcEEEE
Confidence 3699999999999964 4577899999986432 344667889999999988887 89988875 45679999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~------------------- 133 (257)
T cd05116 75 ELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY------------------- 133 (257)
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe-------------------
Confidence 999 889999997654 6899999999999999999999999999999999999976554
Q ss_pred cCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
++|+|||++....... ....++..|+|||.+....++.++|||||||++|||++ |..||......
T Consensus 134 --------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 205 (257)
T cd05116 134 --------AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205 (257)
T ss_pred --------EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 5666666654432221 11234578999999988889999999999999999998 99999876655
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+.+... ...+...+.++.+||.+||+
T Consensus 206 ~~~~~i~~~~~-------------------------------------------------~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 206 EVTQMIESGER-------------------------------------------------MECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred HHHHHHHCCCC-------------------------------------------------CCCCCCCCHHHHHHHHHHhc
Confidence 54443332100 00112356789999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013941 405 YDPAERLKAREALR 418 (433)
Q Consensus 405 ~dP~~R~ta~ell~ 418 (433)
.||++||++.+|.+
T Consensus 237 ~~p~~Rp~~~~i~~ 250 (257)
T cd05116 237 YGVDERPGFAVVEL 250 (257)
T ss_pred cCchhCcCHHHHHH
Confidence 99999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=306.47 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=191.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc----EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+|+++++||+|+||+||+|++..+++ .||+|+++.. ......+.+|+.++..+.|+++ +.+++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~- 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV-----CRLLGICLT- 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCC-----ceEEEEEcC-
Confidence 569999999999999999999877766 4899998643 2334567789999998888877 888888765
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
...+++|||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~------------- 146 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN------------- 146 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-------------
Confidence 4578999999 999999997643 3689999999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCc-----ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
.+||+|||++........ ...++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 147 --------------~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 147 --------------HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred --------------cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 456666666654332111 1234568999999998889999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
...........+.... ..+ .....+.++.++
T Consensus 213 ~~~~~~~~~~~~~~~~-~~~------------------------------------------------~~~~~~~~~~~l 243 (279)
T cd05109 213 DGIPAREIPDLLEKGE-RLP------------------------------------------------QPPICTIDVYMI 243 (279)
T ss_pred CCCCHHHHHHHHHCCC-cCC------------------------------------------------CCccCCHHHHHH
Confidence 7655443332222110 000 012346688999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 013941 399 LQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~ 418 (433)
|.+||..||++|||+.++++
T Consensus 244 i~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 244 MVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=305.06 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=195.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|++..+++.||||.+... ......+.+|+.+++.+.|+|+ +++++++..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV-----IKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCch-----hhhhheeEeCCe
Confidence 3689999999999999999999999999999987642 2234567789999999988887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~------------ 144 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV------------ 144 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC------------
Confidence 99999999 89999988642 2246899999999999999999999999999999999999976654
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
++|+|||++....... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 145 ---------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 145 ---------------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ---------------EEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 5666666554332211 2246888999999998888999999999999999999999999654
Q ss_pred ChH--HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 322 ENL--EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 322 ~~~--~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
... .....+... .++. ......+..+.++|
T Consensus 210 ~~~~~~~~~~~~~~--------------------------~~~~----------------------~~~~~~~~~~~~li 241 (267)
T cd08229 210 KMNLYSLCKKIEQC--------------------------DYPP----------------------LPSDHYSEELRQLV 241 (267)
T ss_pred cchHHHHhhhhhcC--------------------------CCCC----------------------CCcccccHHHHHHH
Confidence 321 111111100 0000 00123466899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 013941 400 QGLLRYDPAERLKAREALR 418 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~ 418 (433)
.+||+.||++|||+.+|++
T Consensus 242 ~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 242 NMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHhcCCCcccCCCHHHHHH
Confidence 9999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.81 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=196.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+.|++.+.||+|+||.||+|.+..+++.||||+++... ........|+.++.+.. |+++ +++++++..+...
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~ 89 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYI-----VKCYGYFITDSDV 89 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCch-----HhhheeeecCCeE
Confidence 56999999999999999999999889999999987532 23344556776666554 5555 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||++++|.+++.... ..+++..+..++.||+.||+|||+ .||+||||+|+||+++.++
T Consensus 90 ~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~---------------- 152 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG---------------- 152 (296)
T ss_pred EEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC----------------
Confidence 9999999888888876643 378999999999999999999997 5999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCC----CCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.++|+|||++...... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...
T Consensus 153 -----------~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 153 -----------NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred -----------CEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 4666666666543221 12235778899999987653 789999999999999999999999653
Q ss_pred Ch-HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 322 EN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 322 ~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.. .+.+. ........ .++ ....++.++.+||.
T Consensus 222 ~~~~~~~~---~~~~~~~~--------------------~~~------------------------~~~~~~~~l~~li~ 254 (296)
T cd06618 222 KTEFEVLT---KILQEEPP--------------------SLP------------------------PNEGFSPDFCSFVD 254 (296)
T ss_pred hhHHHHHH---HHhcCCCC--------------------CCC------------------------CCCCCCHHHHHHHH
Confidence 22 11111 11110000 000 01124668999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
+||..||++|||++++++||||.....
T Consensus 255 ~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 255 LCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHccCChhhCCCHHHHhcChhhhccch
Confidence 999999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=295.78 Aligned_cols=286 Identities=28% Similarity=0.480 Sum_probs=230.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC--
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~-- 165 (433)
..||.-++.+|.|.- .|..|.|.-.++.||+|.+... ........+|...+..+.|.|+ ++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~ni-----i~l~n~ftP~~~ 89 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNI-----ISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccce-----eeeeeccCcccc
Confidence 468999999999998 8888999999999999987532 2334567789999999999888 9999988643
Q ss_pred ----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 166 ----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
..+|+|||+|..+|.+.+.. .++-..+..++.|++.|++|||+.||+||||||+||++..++
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~---------- 155 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC---------- 155 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh----------
Confidence 46899999999999999883 478899999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
.+||.|||+|...... .+..+.|..|+|||++.+..|...+||||+||++.||++|...|.
T Consensus 156 -----------------~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 156 -----------------TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred -----------------heeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 4677777777654433 344688999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC--chhhhhhccCCchHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR--LPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ 397 (433)
+.+..++..++.+.+|.+.+.+..+.......|...-. .+.. ..+.+... ......+.....+..+++
T Consensus 219 g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~--~y~~--------~~f~~~fpD~~f~~~~e~~~~~~~~ard 288 (369)
T KOG0665|consen 219 GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRP--QYQA--------ISFSELFPDSLFPVVLEGSKLDCSLARD 288 (369)
T ss_pred CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcCh--Hhhc--------cchhhhCCcccccccccCCccchHHHHH
Confidence 99999999999999999999888887666666654210 0000 00000000 111112222344668999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
++.+||..||++|.+++++|.||||+
T Consensus 289 ll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 289 LLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhccChhhcccHHHHhcCCeee
Confidence 99999999999999999999999997
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=306.37 Aligned_cols=246 Identities=21% Similarity=0.346 Sum_probs=194.4
Q ss_pred CCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+|++.++||+|+||.||++... .++..+|+|.+.... .....+.+|+++++.+.|+++ +++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI-----VRFYGVCTEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCC-----ceEEEEEecC
Confidence 46889999999999999999742 356689999886433 345678889999999998887 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSY-------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999 9999999976431 2488999999999999999999999999999999999997665
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (433)
. ++|+|||++...... .....++..|+|||++.+..++.++|||||||
T Consensus 160 ~---------------------------~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 160 V---------------------------VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred C---------------------------EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 4 555566655432211 11224567899999999989999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 307 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
++|+|++ |.+||......+....+..... .
T Consensus 213 il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------~ 243 (280)
T cd05092 213 VLWEIFTYGKQPWYQLSNTEAIECITQGRE-------------------------------------------------L 243 (280)
T ss_pred HHHHHHcCCCCCCccCCHHHHHHHHHcCcc-------------------------------------------------C
Confidence 9999998 9999976655444333221100 0
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.....++..+.+||.+||+.||++||++.+|++
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 244 ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011234678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.03 Aligned_cols=243 Identities=27% Similarity=0.427 Sum_probs=190.3
Q ss_pred EEeccccccccEEEEEEEec----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 95 RILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++.+.||.|.||.||+|... ..+..|+||+++.. ....+.+.+|++++.+++|+|+ +++++++...+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNI-----VKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTB-----E-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccc-----ccccccccccccc
Confidence 46789999999999999987 45678999999643 2346788899999999999888 9999999988889
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||+ +++|.+++.......+++..+..++.||+.||.|||+++|+|+||+++|||++.++.
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--------------- 141 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--------------- 141 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE---------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------------
Confidence 9999999 899999999874457999999999999999999999999999999999999987665
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTH 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~ 321 (433)
+||+|||++...... .....+...|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 142 ------------~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 142 ------------VKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp ------------EEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 555555555443111 111345678999999998889999999999999999999 78999887
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+....+.+... ......++..+.++|.+
T Consensus 210 ~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 210 DNEEIIEKLKQGQR-------------------------------------------------LPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp CHHHHHHHHHTTEE-------------------------------------------------TTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccc-------------------------------------------------ceeccchhHHHHHHHHH
Confidence 66665554422110 11123457789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 013941 402 LLRYDPAERLKAREALR 418 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~ 418 (433)
||..||++|||++++++
T Consensus 241 C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HT-SSGGGS--HHHHHH
T ss_pred HcCCChhhCcCHHHHHh
Confidence 99999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=304.75 Aligned_cols=244 Identities=17% Similarity=0.248 Sum_probs=187.8
Q ss_pred EEeccccccccEEEEEEEecCCCc--EEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-----
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----- 164 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~----- 164 (433)
.+.+.||+|+||.||+|++..++. .||+|.++.. ....+.+.+|+.+++.++|+++ +++++++..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 76 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV-----MRLIGVCLQTVESE 76 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEccCCccc
Confidence 467899999999999999877765 6899988643 3345667889999999998887 888876532
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
....++||||+ +++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~------ 150 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN------ 150 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC------
Confidence 23579999999 89999887532 1235889999999999999999999999999999999999976554
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 313 (433)
++|+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 151 ---------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~ 209 (272)
T cd05075 151 ---------------------VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209 (272)
T ss_pred ---------------------EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence 5666666555432211 11245678999999998889999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 314 -GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 314 -g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
|..||.+.........+.... . .......+
T Consensus 210 ~g~~p~~~~~~~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~ 240 (272)
T cd05075 210 RGQTPYPGVENSEIYDYLRQGN--R-----------------------------------------------LKQPPDCL 240 (272)
T ss_pred CCCCCCCCCCHHHHHHHHHcCC--C-----------------------------------------------CCCCCCCC
Confidence 899998765544333222110 0 00112345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..+.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.93 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=195.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ......+.+|+++++++.|+++ +++++.+...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i-----~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV-----IKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCe-----eeeeeeeecCCe
Confidence 4799999999999999999999989999999988632 2235677889999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.||+||||||+||+++.++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~------------ 144 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV------------ 144 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc------------
Confidence 99999999 89999998642 2245899999999999999999999999999999999999976664
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
++|+|||.+...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 145 ---------------~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 145 ---------------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ---------------EEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 566666655432221 12246788999999999888999999999999999999999999654
Q ss_pred ChH--HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 322 ENL--EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 322 ~~~--~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
... .....+.. +..+. ......+..+.++|
T Consensus 210 ~~~~~~~~~~~~~--~~~~~----------------------------------------------~~~~~~~~~~~~~i 241 (267)
T cd08224 210 KMNLYSLCKKIEK--CDYPP----------------------------------------------LPADHYSEELRDLV 241 (267)
T ss_pred CccHHHHHhhhhc--CCCCC----------------------------------------------CChhhcCHHHHHHH
Confidence 311 11111100 00000 00113456899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 013941 400 QGLLRYDPAERLKAREALR 418 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~ 418 (433)
.+||..+|++|||+.+|++
T Consensus 242 ~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 242 SRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHcCCCcccCCCHHHHHH
Confidence 9999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=301.27 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=195.1
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
.|++.+.||+|+||.||+|.+. +++.+|+|++.........+.+|+++++++.|+++ +++++++......++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL-----VQLYGVCTERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCe-----eeEEEEEccCCceEEEE
Confidence 5899999999999999999875 46679999987655555678889999999988877 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... ..++++.++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~------------------- 138 (256)
T cd05112 79 EFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV------------------- 138 (256)
T ss_pred EcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe-------------------
Confidence 999 899999987643 35889999999999999999999999999999999999976554
Q ss_pred cCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH 326 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~ 326 (433)
++|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 139 --------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 139 --------VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred --------EEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 5566666554322111 11234568999999998889999999999999999998 9999987665544
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+...... ......+..+.+|+.+||+.+
T Consensus 211 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 211 VETINAGFRL-------------------------------------------------YKPRLASQSVYELMQHCWKER 241 (256)
T ss_pred HHHHhCCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHcccC
Confidence 4333211000 001123568999999999999
Q ss_pred CCCCCCHHHHhcC
Q 013941 407 PAERLKAREALRH 419 (433)
Q Consensus 407 P~~R~ta~ell~h 419 (433)
|++|||+.+++++
T Consensus 242 p~~Rp~~~~~l~~ 254 (256)
T cd05112 242 PEDRPSFSLLLHQ 254 (256)
T ss_pred hhhCCCHHHHHHh
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=300.73 Aligned_cols=237 Identities=24% Similarity=0.348 Sum_probs=186.8
Q ss_pred ccccccccEEEEEEEecCCC---cEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKK---ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
++||+|+||.||+|.+..++ ..||+|.+..... ..+.+.+|+.+++.+.|+++ +++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI-----VRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEc-CCceEEEE
Confidence 47999999999999876554 7899999875443 45677889999999988777 99998776 45689999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.... .+++..+..++.|++.||+|||++||+|+||||+|||++.++.+
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~------------------ 134 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQA------------------ 134 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcE------------------
Confidence 999 899999998765 78999999999999999999999999999999999999876654
Q ss_pred cCCCCCCCeeeecCCCCccccCCCc------ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
+|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 135 ---------kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 135 ---------KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred ---------EeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 5555555443222111 1123467999999998889999999999999999998 99999776554
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+.... . ......++..+.++|.+||.
T Consensus 206 ~~~~~~~~~~-~------------------------------------------------~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 206 EVIAMLESGE-R------------------------------------------------LPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred HHHHHHHcCC-c------------------------------------------------CCCCCCCCHHHHHHHHHHhc
Confidence 4333322110 0 01123346789999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013941 405 YDPAERLKAREALR 418 (433)
Q Consensus 405 ~dP~~R~ta~ell~ 418 (433)
.||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=302.15 Aligned_cols=242 Identities=21% Similarity=0.316 Sum_probs=193.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|+||.||++. .+++.||+|+++... ..+.+.+|+.++++++|+++ +++++++... ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNL-----VRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCc-----CeEEEEEcCC-CcEEE
Confidence 469999999999999999986 467889999986532 34567889999999988887 9999888654 47999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~------------------- 137 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG------------------- 137 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-------------------
Confidence 9999 89999999876555689999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~ 329 (433)
.++|+|||++............+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus 138 --------~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 209 (254)
T cd05083 138 --------VAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC 209 (254)
T ss_pred --------cEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 4666777766543332223344567999999988889999999999999999998 9999987665443332
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
+.+... ......++..+.+++.+||+.+|++
T Consensus 210 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 240 (254)
T cd05083 210 VEKGYR-------------------------------------------------MEPPEGCPADVYVLMTSCWETEPKK 240 (254)
T ss_pred HhCCCC-------------------------------------------------CCCCCcCCHHHHHHHHHHcCCChhh
Confidence 221100 0011234678999999999999999
Q ss_pred CCCHHHHhc
Q 013941 410 RLKAREALR 418 (433)
Q Consensus 410 R~ta~ell~ 418 (433)
||+++++++
T Consensus 241 Rp~~~~l~~ 249 (254)
T cd05083 241 RPSFHKLRE 249 (254)
T ss_pred CcCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.48 Aligned_cols=246 Identities=20% Similarity=0.325 Sum_probs=192.6
Q ss_pred CCeEEeccccccccEEEEEEEecC-------CCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecce
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~ 161 (433)
++|.+.++||+|+||.||+|++.. ....||+|+++... .....+..|+.+++.+ .|+++ ++++++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~ 86 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNI-----INLLGV 86 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCe-----eeEEEE
Confidence 579999999999999999998632 34579999987432 3345677899999988 47766 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
+...+.+|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999 899999997642 135888999999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (433)
++.++ .+||+|||.+....... ....++..|+|||++.+..++.++||
T Consensus 167 l~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 167 VTEDN---------------------------VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred EcCCC---------------------------cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence 97655 45666666665432211 11133467999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc
Q 013941 302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380 (433)
Q Consensus 302 wSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
|||||++|+|++ |..||.+....+....+.....
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------------- 254 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--------------------------------------------- 254 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------------------------------------
Confidence 999999999999 8999977655444433321100
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
......++.++.++|.+||..||++|||+.|+++
T Consensus 255 ----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 255 ----MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0011234568999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=302.68 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=194.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc---EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|+..+.||+|+||.||+|.+..+++ .+|+|.+... ....+.+..|+.++..+.|+++ +++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI-----IRLEGVVTKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCe-----eEEEEEEccCC
Confidence 468999999999999999999876654 7999998653 2344667889999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~------------- 145 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE------------- 145 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc-------------
Confidence 999999999 889999997643 46899999999999999999999999999999999999976654
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCCc------ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
++|+|||++........ ....+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 146 --------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 146 --------------CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred --------------EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 55556665543321111 0122457999999998889999999999999999997 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
...+..+....+.... ..| .....+.++.++
T Consensus 212 ~~~~~~~~~~~i~~~~-~~~------------------------------------------------~~~~~~~~~~~l 242 (268)
T cd05063 212 WDMSNHEVMKAINDGF-RLP------------------------------------------------APMDCPSAVYQL 242 (268)
T ss_pred CcCCHHHHHHHHhcCC-CCC------------------------------------------------CCCCCCHHHHHH
Confidence 8766555444443211 100 012345688999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 013941 399 LQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~ 418 (433)
+.+||+.||++||++.+|++
T Consensus 243 i~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 243 MLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=304.24 Aligned_cols=245 Identities=17% Similarity=0.248 Sum_probs=189.4
Q ss_pred eEEeccccccccEEEEEEEecCC---CcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC-
Q 013941 94 YRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN- 166 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~- 166 (433)
|++.+.||+|+||.||+|....+ +..||+|+++... .....+.+|+.+++.+.|+++ +++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV-----MKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEeeeccCCc
Confidence 56789999999999999987653 4789999987432 234567889999999988877 99988775544
Q ss_pred -----eEEEEEccC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 167 -----HICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 167 -----~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
..++||||+ +++|..++... ....+++..+..++.||+.||.|||++||+||||||+||++++++.
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---- 151 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---- 151 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe----
Confidence 389999999 99999988543 1236899999999999999999999999999999999999976654
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHH
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (433)
+||+|||.+....... ....++..|+|||.+.+..++.++|||||||++|||
T Consensus 152 -----------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el 208 (273)
T cd05035 152 -----------------------VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208 (273)
T ss_pred -----------------------EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence 5556666554332211 112346689999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 312 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 312 ~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
++ |..||.+....+....+.... . ......
T Consensus 209 ~~~g~~p~~~~~~~~~~~~~~~~~--~-----------------------------------------------~~~~~~ 239 (273)
T cd05035 209 ATRGQTPYPGVENHEIYDYLRHGN--R-----------------------------------------------LKQPED 239 (273)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCC--C-----------------------------------------------CCCCcC
Confidence 99 999998766544333222100 0 001123
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.+.++.++|.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 46689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=301.46 Aligned_cols=228 Identities=24% Similarity=0.366 Sum_probs=180.1
Q ss_pred cccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-CCCHHH
Q 013941 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD 181 (433)
Q Consensus 103 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~ 181 (433)
|.+|.||+|++..+++.||+|.++.... ..+|...+....|++ ++++++++...+..++||||+ +++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~-----i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPN-----MVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCc-----eeehhhheecCCeEEEEEecCCCCCHHH
Confidence 8899999999999999999999876432 223444444444554 499999999999999999999 899999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCee
Q 013941 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261 (433)
Q Consensus 182 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~k 261 (433)
++.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.++ .++
T Consensus 75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~---------------------------~~~ 125 (237)
T cd05576 75 HISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG---------------------------HIQ 125 (237)
T ss_pred HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC---------------------------CEE
Confidence 997654 699999999999999999999999999999999999997655 466
Q ss_pred eecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhh
Q 013941 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHM 341 (433)
Q Consensus 262 l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~ 341 (433)
++|||.+...........++..|+|||.+.+..++.++||||+||++|+|++|..||....... .
T Consensus 126 l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~---------- 190 (237)
T cd05576 126 LTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----N---------- 190 (237)
T ss_pred EecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----c----------
Confidence 7777765444333333456778999999988889999999999999999999998875321100 0
Q ss_pred HHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCH-----HHH
Q 013941 342 VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA-----REA 416 (433)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta-----~el 416 (433)
.. ........++..+.++|.+||+.||++|+|+ +++
T Consensus 191 -------------~~--------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 231 (237)
T cd05576 191 -------------TH--------------------------TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231 (237)
T ss_pred -------------cc--------------------------cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence 00 0001122346789999999999999999986 999
Q ss_pred hcCCCC
Q 013941 417 LRHPFF 422 (433)
Q Consensus 417 l~hp~f 422 (433)
++||||
T Consensus 232 ~~h~~~ 237 (237)
T cd05576 232 KSHPFF 237 (237)
T ss_pred HcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=306.98 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=192.7
Q ss_pred CCeEEeccccccccEEEEEEEecC----------------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
++|++.++||+|+||.||+|.+.. ++..||+|++... ......+.+|+.+++.++|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i--- 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI--- 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc---
Confidence 579999999999999999986432 3457999998743 2344678899999999998887
Q ss_pred ceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCC
Q 013941 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY---------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~ 223 (433)
+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 82 --~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 82 --IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred --ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 99999999999999999999 8999999976431 24678899999999999999999999999999999
Q ss_pred cEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCcc
Q 013941 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYP 298 (433)
Q Consensus 224 NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 298 (433)
|||++.++ .++|+|||++....... ....++..|+|||+..+..++.+
T Consensus 160 Nili~~~~---------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 212 (296)
T cd05095 160 NCLVGKNY---------------------------TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212 (296)
T ss_pred eEEEcCCC---------------------------CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch
Confidence 99997655 45666666654322111 11234678999999888889999
Q ss_pred chHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHH
Q 013941 299 CDLWSVGCILVELCS--GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376 (433)
Q Consensus 299 ~DiwSlG~il~el~~--g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (433)
+|||||||++|||++ |..||...+..+........... ......
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~~---------------- 258 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRD------------------QGRQVY---------------- 258 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhh------------------cccccc----------------
Confidence 999999999999998 77899765554433222111000 000000
Q ss_pred hcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
......++..+.+|+.+||+.||++|||+.+|++
T Consensus 259 --------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 259 --------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0011234578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=324.17 Aligned_cols=201 Identities=29% Similarity=0.423 Sum_probs=175.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC-----
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----- 165 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~----- 165 (433)
.|...+.||+|+||.||+++++.+|+.||||.++.. ....+...+|+++|++++|+|| |+++++-++.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NI-----Vk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNI-----VKLFDIEETKFLGLV 88 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhh-----hhhcccCCccccCcc
Confidence 477889999999999999999999999999999753 3556778899999999999988 9999877654
Q ss_pred -CeEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 166 -NHICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 166 -~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
....+||||| ||+|...+++-.+ ..+++.+++.++.++..||.|||++|||||||||.||++....
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge----------- 157 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE----------- 157 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-----------
Confidence 3578999999 9999999974322 4699999999999999999999999999999999999986533
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
+.....||+|||.|+..++.. .+++||..|.+||++.. ..|+.-+|.|||||++|+.+||..||.
T Consensus 158 ------------dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 158 ------------DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ------------CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 455678999999999877654 55799999999999995 788999999999999999999999996
Q ss_pred CC
Q 013941 320 TH 321 (433)
Q Consensus 320 ~~ 321 (433)
..
T Consensus 226 p~ 227 (732)
T KOG4250|consen 226 PF 227 (732)
T ss_pred cC
Confidence 43
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.19 Aligned_cols=253 Identities=22% Similarity=0.399 Sum_probs=199.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+.|.+++.||+|+|+.|.+++.++|.+.||+|++++. +...+..+.|..+..+.+ .+|.+|-++.+|+++..
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as----n~pflvglhscfqtesr 325 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS----NNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc----CCCeEEehhhhhcccce
Confidence 5699999999999999999999999999999999753 233344555666665544 23556999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+++|.||+ ||+|.-.++++. .++++.++.+...|+.||.|||++|||+||||.+|||++..|++|++|+|+.+....
T Consensus 326 lffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999 999988887664 899999999999999999999999999999999999998888665555554432222
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH----- 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~----- 321 (433)
+ .+..++++||+.|.|||++.+..|+..+|+|+|||+++||+.|+.||.-.
T Consensus 404 ~------------------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~ 459 (593)
T KOG0695|consen 404 P------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP 459 (593)
T ss_pred C------------------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc
Confidence 1 23345679999999999999999999999999999999999999999521
Q ss_pred --ChHHHH-HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 322 --ENLEHL-AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 322 --~~~~~~-~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
+..+.+ ..|.... ...+...|-.+..+
T Consensus 460 d~ntedylfqvilekq--------------------------------------------------iriprslsvkas~v 489 (593)
T KOG0695|consen 460 DMNTEDYLFQVILEKQ--------------------------------------------------IRIPRSLSVKASHV 489 (593)
T ss_pred ccchhHHHHHHHhhhc--------------------------------------------------ccccceeehhhHHH
Confidence 111111 1111111 11122334466788
Q ss_pred HHHhcccCCCCCC------CHHHHhcCCCCCC
Q 013941 399 LQGLLRYDPAERL------KAREALRHPFFTR 424 (433)
Q Consensus 399 i~~~L~~dP~~R~------ta~ell~hp~f~~ 424 (433)
++..|++||.+|+ ...++..|+||+.
T Consensus 490 lkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 490 LKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred HHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 9999999999997 4789999999985
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.01 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=194.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCC---cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.+|++.+.||+|+||.||+|++..++ ..+|+|.++.. ......+.+|+.+++++.|+|+ +++++++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI-----IHLEGVVTKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCC
Confidence 47999999999999999999876544 37999988643 2344577889999999988887 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~------------- 144 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV------------- 144 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe-------------
Confidence 999999999 899999997654 36899999999999999999999999999999999999976654
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCCc------ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
++|+|||.+........ ...++..|+|||.+.+..++.++|+|||||++|++++ |..||
T Consensus 145 --------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 145 --------------CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred --------------EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence 55566665543322111 1123567999999998889999999999999999886 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
......+....+.+... +| .....+..+.++
T Consensus 211 ~~~~~~~~~~~~~~~~~-~~------------------------------------------------~~~~~~~~~~~l 241 (267)
T cd05066 211 WEMSNQDVIKAIEEGYR-LP------------------------------------------------APMDCPAALHQL 241 (267)
T ss_pred ccCCHHHHHHHHhCCCc-CC------------------------------------------------CCCCCCHHHHHH
Confidence 87665544333322100 00 012346689999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 013941 399 LQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~ 418 (433)
+.+||+.+|.+||++.++++
T Consensus 242 i~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 242 MLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHcccCchhCCCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.73 Aligned_cols=248 Identities=17% Similarity=0.298 Sum_probs=193.9
Q ss_pred CCCeEEeccccccccEEEEEEEec-------CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~ 160 (433)
.++|.+.+.||+|+||.||+|+.. .++..||+|.+... ......+.+|+.+++.+ .|+++ +++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~ 88 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG 88 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCc-----hheeE
Confidence 357999999999999999999752 23457999998643 23345678899999999 67777 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcE
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NI 225 (433)
++...+..++||||+ +++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999 899999997642 13478888999999999999999999999999999999
Q ss_pred EEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccch
Q 013941 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 300 (433)
Q Consensus 226 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (433)
+++.++. ++|+|||.+...... .....++..|+|||++.+..++.++|
T Consensus 169 li~~~~~---------------------------~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (304)
T cd05101 169 LVTENNV---------------------------MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221 (304)
T ss_pred EEcCCCc---------------------------EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhh
Confidence 9976654 566666655433211 11124567899999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC
Q 013941 301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379 (433)
Q Consensus 301 iwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
||||||++|+|++ |..||.+....+....+.....
T Consensus 222 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------- 257 (304)
T cd05101 222 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-------------------------------------------- 257 (304)
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--------------------------------------------
Confidence 9999999999998 8889977655444333221100
Q ss_pred chhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.......+.++.+||.+||..+|++|||+.|+++.
T Consensus 258 -----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 258 -----MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 00112346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=305.94 Aligned_cols=245 Identities=18% Similarity=0.331 Sum_probs=191.9
Q ss_pred CeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
+|++.+.||+|+||.||+|++.. ....+|+|.+.... .....+.+|+.+++.+.|+++ +++++.+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV-----IKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCE-----eeEEEEEecC
Confidence 48899999999999999998643 23578999886433 234567889999999988877 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNS----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp 222 (433)
+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++||+||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 9999999999 899999986421 13478899999999999999999999999999999
Q ss_pred CcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCc
Q 013941 223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNY 297 (433)
Q Consensus 223 ~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~ 297 (433)
+|||+++++ .++|+|||++....... ....++..|+|||.+.+..++.
T Consensus 156 ~nill~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 208 (290)
T cd05045 156 RNVLVAEGR---------------------------KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208 (290)
T ss_pred heEEEcCCC---------------------------cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence 999997655 45666666654322111 1124567899999998888999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHH
Q 013941 298 PCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376 (433)
Q Consensus 298 ~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (433)
++|||||||++|+|++ |..||.+.........+.....
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------------------- 247 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------------------------------- 247 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------------------------------------
Confidence 9999999999999998 9999987654443332211000
Q ss_pred hcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.......+.++.++|.+||+.||++||++.|+++
T Consensus 248 --------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 248 --------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0011234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.29 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=192.9
Q ss_pred CCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~ 163 (433)
++|.+.++||+|+||.||+|++. .+++.||+|+++... ...+.+.+|+.++.++. |+|+ +++++.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~ni-----v~~~~~~~ 111 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNI-----VNLLGACT 111 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCe-----EEEEEEEc
Confidence 46889999999999999999853 355789999997532 23346778999999997 7776 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCC------------------------------------------------------
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSY------------------------------------------------------ 188 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~------------------------------------------------------ 188 (433)
..+..++||||+ +|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999 9999999975321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 189 ------------------------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 189 ------------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 23677788999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (433)
++.++. ++|+|||++...... .....++..|+|||++.+..++.++||
T Consensus 272 l~~~~~---------------------------~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 272 ICEGKL---------------------------VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EeCCCE---------------------------EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 976554 566666665432211 112356788999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc
Q 013941 302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380 (433)
Q Consensus 302 wSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
|||||++|||++ |..||......+........ +. +
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~---------------------~---------------------- 360 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-GY---------------------R---------------------- 360 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-CC---------------------C----------------------
Confidence 999999999998 89999765443332211110 00 0
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
......++.++.+||.+||..+|++||++.+|++.
T Consensus 361 ----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 361 ----MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00112346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.39 Aligned_cols=244 Identities=21% Similarity=0.240 Sum_probs=187.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc----EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
+.|++.+.||+|+||+||+|.+..+++ .+++|.+.... .....+..|+.++.++.|+|+ +++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~i-----v~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI-----VRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEC-C
Confidence 468999999999999999999877776 47778775322 223456667778888877777 99999875 4
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
...++++||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~------------- 146 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS------------- 146 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-------------
Confidence 5678899999 999999997654 3689999999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
.+||+|||.+...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 147 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 147 --------------IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred --------------cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 4566666665432211 112356778999999998889999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.........+... ..+ . .....+.++.++
T Consensus 213 ~~~~~~~~~~~~~~~--~~~---------------------~--------------------------~~~~~~~~~~~l 243 (279)
T cd05111 213 AGMRPHEVPDLLEKG--ERL---------------------A--------------------------QPQICTIDVYMV 243 (279)
T ss_pred CCCCHHHHHHHHHCC--CcC---------------------C--------------------------CCCCCCHHHHHH
Confidence 876544332222110 000 0 011234578899
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 013941 399 LQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~ 418 (433)
+.+||..||++|||+.|+++
T Consensus 244 i~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 244 MVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.83 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=194.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc---EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
..|++.+.||+|+||.||+|.+..+++ .||||++... ......+..|+.+++.+.|+|+ +++++++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI-----IHLEGVVTKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCc-----ceEEEEECCCC
Confidence 358999999999999999999877664 6999998753 3345678889999999988887 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~------------- 144 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV------------- 144 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc-------------
Confidence 999999999 889999987653 36899999999999999999999999999999999999976554
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCCc------ccc--cCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVV--STRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~--gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
++|+|||.+........ ... .+..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 145 --------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~ 210 (269)
T cd05065 145 --------------CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210 (269)
T ss_pred --------------EEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence 55556655543221110 011 2357999999998889999999999999999886 999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||...+..+....+.... ..| .....+..+.
T Consensus 211 p~~~~~~~~~~~~i~~~~-~~~------------------------------------------------~~~~~~~~~~ 241 (269)
T cd05065 211 PYWDMSNQDVINAIEQDY-RLP------------------------------------------------PPMDCPTALH 241 (269)
T ss_pred CCCCCCHHHHHHHHHcCC-cCC------------------------------------------------CcccCCHHHH
Confidence 998766554444332110 000 0123456889
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
+++.+||..+|++||++++|++
T Consensus 242 ~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 242 QLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.19 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=195.9
Q ss_pred eEEeccccccccEEEEEEEecCCC----cEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+++.+.||.|+||.||+|.+...+ ..||+|++..... ....+..|+.+++.+.|+++ +++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNI-----VKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCch-----heEEEEEcCCCe
Confidence 356789999999999999988766 8999999975443 45678889999999988777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.+++|||+ +++|.+++.......+++..+..++.||+.||+|||+.|++|+||||+||+++.++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~-------------- 141 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV-------------- 141 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--------------
Confidence 99999999 899999998654333899999999999999999999999999999999999977664
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCc----ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTH 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~ 321 (433)
++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 142 -------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 142 -------------VKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred -------------EEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 55566665543332211 1136788999999988889999999999999999998 88999876
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+.......+...... ......+.++.+++.+
T Consensus 209 ~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 209 SNEEVLEYLKKGYRL-------------------------------------------------PKPENCPPEIYKLMLQ 239 (258)
T ss_pred CHHHHHHHHhcCCCC-------------------------------------------------CCCCcCCHHHHHHHHH
Confidence 555444433221100 0112246789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 013941 402 LLRYDPAERLKAREALR 418 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~ 418 (433)
||..||++|||+.|+++
T Consensus 240 ~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 240 CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HCcCChhhCcCHHHHHh
Confidence 99999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.56 Aligned_cols=282 Identities=27% Similarity=0.452 Sum_probs=222.4
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC-----C
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-----N 166 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~-----~ 166 (433)
+-.+.||.|+||.||.+++..+|+.||+|++.... .....+.+|+.+|..++|.|+ ...+++.+-. .
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNV-----LSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNV-----LSLLDILQPANPSFFQ 130 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccH-----HHHHHhcCCCCchHHH
Confidence 34579999999999999999999999999886422 334667889999999999887 6766665532 3
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.+|+|+|++..+|..++-.-. .++.+.++-+++||++||+|||+.||.||||||.|+|++++.
T Consensus 131 EiYV~TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC--------------- 193 (449)
T KOG0664|consen 131 ELYVLTELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC--------------- 193 (449)
T ss_pred HHHHHHHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc---------------
Confidence 578999999889999887654 799999999999999999999999999999999999996544
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||||||+++..+... +..+-|.+|+|||++.|. .|+.++||||.|||+.||+..+..|...
T Consensus 194 ------------vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 194 ------------ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred ------------eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 67888888887654432 224678899999999986 5999999999999999999999999999
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+++..|..++|.+.-+-+...++........+.... |+ ...++ .....+....+..+++.+
T Consensus 262 ~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~-Ps-------~~vLY--------tlsS~~~~~heav~~~~~ 325 (449)
T KOG0664|consen 262 GPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRA-PD-------TQRLY--------KIASPDDKNHEAVDLLQK 325 (449)
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCC-CC-------cccee--------eecCCcccchHHHHHHHH
Confidence 999999999999999887776666555544433321110 00 00000 011112233467799999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
||.+||++|.+.++++.|++..+..
T Consensus 326 ~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 326 LLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HhCCCCcccccHhhhcccccccccc
Confidence 9999999999999999999988753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.42 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=195.6
Q ss_pred CeEEeccccccccEEEEEEEec---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceec
Q 013941 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~ 163 (433)
+|++.+.||+|+||.||++++. .+++.||||++++.. .....+.+|+.++.++. |+++ +++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL-----VTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcch-----hhhheeee
Confidence 4889999999999999999864 467889999987432 22345678999999995 6666 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
.++..|+||||+ +++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~----------- 142 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG----------- 142 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-----------
Confidence 999999999999 889999987654 689999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCC--CCccchHHHHHHHHHHHHhCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~ 316 (433)
.++|+|||++....... ....|+..|+|||.+.+.. .+.++||||||+++|+|++|..
T Consensus 143 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~ 206 (288)
T cd05583 143 ----------------HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206 (288)
T ss_pred ----------------CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCC
Confidence 46677777655432211 1246788999999987754 7889999999999999999999
Q ss_pred CCCCCChHHHHHHHHH-HhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 317 LFQTHENLEHLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
||...........+.+ ..... .......+..+
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~l 239 (288)
T cd05583 207 PFTVDGEQNSQSEISRRILKSK-----------------------------------------------PPFPKTMSAEA 239 (288)
T ss_pred CcccCcccchHHHHHHHHHccC-----------------------------------------------CCCCcccCHHH
Confidence 9964332211111111 00000 00112345688
Q ss_pred HHHHHHhcccCCCCCCC---HHHHhcCCCCCCC
Q 013941 396 IDLLQGLLRYDPAERLK---AREALRHPFFTRD 425 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~t---a~ell~hp~f~~~ 425 (433)
.++|.+||+.||++||| +.++|+||||++.
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5678999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=329.67 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=203.1
Q ss_pred CCeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
.+-+..++||+|+||+||+|+... ....||||.++.. ...+.+|++|++++..++|+|| |+++|++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nI-----VrLlGVC~~ 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNI-----VRLLGVCRE 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCe-----EEEEEEEcc
Confidence 356778999999999999997532 3468999999854 3467899999999999999988 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcC--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNS--------YRS----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~--------~~~----l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
++.+|+|+||| .|||.+||.... ... ++..+...|+.||+.|+.||-++.+|||||-..|+||.+.-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999 999999998533 122 88899999999999999999999999999999999997655
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCccc-----ccCCcccchhhhhCCCCCccchHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV-----VSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (433)
. |||+|||+++..-...-+. .-...|||||.+..+.|+.+|||||+||
T Consensus 641 ~---------------------------VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GV 693 (774)
T KOG1026|consen 641 V---------------------------VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGV 693 (774)
T ss_pred E---------------------------EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhh
Confidence 4 5555555554332222111 2245799999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 307 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
+|||+++ |..||.+..+.+.++.|.+.. ..
T Consensus 694 vLWEIFsyG~QPy~glSn~EVIe~i~~g~-------------------------------------------------lL 724 (774)
T KOG1026|consen 694 VLWEIFSYGKQPYYGLSNQEVIECIRAGQ-------------------------------------------------LL 724 (774)
T ss_pred hhhhhhccccCcccccchHHHHHHHHcCC-------------------------------------------------cc
Confidence 9999998 999999999999888775421 12
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHH
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREA 416 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~el 416 (433)
..++.++.++.+|+..||+.+|++||++.||
T Consensus 725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 725 SCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 2345678899999999999999999999987
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=313.64 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=188.2
Q ss_pred CCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~ 163 (433)
++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.++.++. |+|+ +++++++.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~~ 81 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGACT 81 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccH-----hhhcceee
Confidence 5799999999999999999984 3567899999987532 33456778999999995 5565 99998775
Q ss_pred c-CCeEEEEEccC-CCCHHHHHHhcCC-----------------------------------------------------
Q 013941 164 Y-RNHICIVFEKL-GPSLYDFLRKNSY----------------------------------------------------- 188 (433)
Q Consensus 164 ~-~~~~~lv~e~~-~~~L~~~l~~~~~----------------------------------------------------- 188 (433)
. +..+++||||+ +++|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45789999999 9999999875321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCC
Q 013941 189 ------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256 (433)
Q Consensus 189 ------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 256 (433)
..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~------------------------- 216 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN------------------------- 216 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-------------------------
Confidence 2367788899999999999999999999999999999997655
Q ss_pred CCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 013941 257 SSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 330 (433)
Q Consensus 257 ~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i 330 (433)
.++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 217 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 294 (343)
T cd05103 217 --VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294 (343)
T ss_pred --cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence 45666666654322111 11235667999999998889999999999999999997 99999764332211111
Q ss_pred HHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCC
Q 013941 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410 (433)
Q Consensus 331 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 410 (433)
... +... ......++++.+++.+||+.||++|
T Consensus 295 ~~~----------------------~~~~--------------------------~~~~~~~~~~~~~~~~cl~~~p~~R 326 (343)
T cd05103 295 LKE----------------------GTRM--------------------------RAPDYTTPEMYQTMLDCWHGEPSQR 326 (343)
T ss_pred Hhc----------------------cCCC--------------------------CCCCCCCHHHHHHHHHHccCChhhC
Confidence 000 0000 0011235678999999999999999
Q ss_pred CCHHHHhcC
Q 013941 411 LKAREALRH 419 (433)
Q Consensus 411 ~ta~ell~h 419 (433)
||+.||++|
T Consensus 327 ps~~eil~~ 335 (343)
T cd05103 327 PTFSELVEH 335 (343)
T ss_pred cCHHHHHHH
Confidence 999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=298.11 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=190.3
Q ss_pred ccccccccEEEEEEEecC-CC--cEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|++|.||+|.+.. ++ ..||||.+..... ..+.+.+|+.++++++|+++ +++++.+.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL-----IRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCc-----cceeEEEcC-CeEEEEE
Confidence 478999999999998765 33 3689999875433 45677889999999998888 999998888 8999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||+ +++|.+++.......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++++|||++.........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 153 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH- 153 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc-
Confidence 999 999999998754346899999999999999999999999999999999999987765555555443322111000
Q ss_pred cCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 330 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i 330 (433)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 154 --------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 154 --------------------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred --------------------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 000112356778999999998899999999999999999998 99999876665544443
Q ss_pred HHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCC
Q 013941 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410 (433)
Q Consensus 331 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 410 (433)
....... ......+..+.+++.+||+.+|++|
T Consensus 214 ~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R 245 (257)
T cd05040 214 DKEGERL------------------------------------------------ERPEACPQDIYNVMLQCWAHNPADR 245 (257)
T ss_pred HhcCCcC------------------------------------------------CCCccCCHHHHHHHHHHCCCCcccC
Confidence 3210000 0112345689999999999999999
Q ss_pred CCHHHHhc
Q 013941 411 LKAREALR 418 (433)
Q Consensus 411 ~ta~ell~ 418 (433)
||+.++++
T Consensus 246 ps~~~~~~ 253 (257)
T cd05040 246 PTFAALRE 253 (257)
T ss_pred CCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=304.20 Aligned_cols=246 Identities=20% Similarity=0.304 Sum_probs=192.8
Q ss_pred CCeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.+++++.|+++ +++++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----v~~~~~~~~ 79 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI-----VKLLGVCAV 79 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCch-----heEEEEEcC
Confidence 579999999999999999998743 67889999987532 334567889999999988887 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCC
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNS--------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~ 223 (433)
++..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999 889999997432 124788889999999999999999999999999999
Q ss_pred cEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCcc
Q 013941 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYP 298 (433)
Q Consensus 224 NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 298 (433)
||+++.++. ++|+|||.+...... .....++..|+|||.+.+..++.+
T Consensus 160 nil~~~~~~---------------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (288)
T cd05050 160 NCLVGENMV---------------------------VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212 (288)
T ss_pred heEecCCCc---------------------------eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch
Confidence 999976664 555555555432111 111234567999999998899999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHh
Q 013941 299 CDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377 (433)
Q Consensus 299 ~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (433)
+|||||||++|+|++ |..||.+....+....+.... .
T Consensus 213 ~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~--~---------------------------------------- 250 (288)
T cd05050 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN--V---------------------------------------- 250 (288)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--C----------------------------------------
Confidence 999999999999998 888997665544333222100 0
Q ss_pred cCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.......+.++.+||.+||+.||++|||+.|+++
T Consensus 251 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 251 -------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0011234568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=325.13 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=217.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-----C
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-----R 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-----~ 165 (433)
++.|++.+.||.|.+|.||+++++.+++..|+|+........++...|.++|+.+.++ +|++.++++|.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~h----pnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHH----PNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCC----CCcceEEEEEEEecCCCC
Confidence 4569999999999999999999999999999999988888888888999999988754 556999998863 6
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.+||||||| ||+..|++....+..+.|+.+..|++.++.||.+||.+.++|||||-.|||++.+|
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~------------- 160 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA------------- 160 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-------------
Confidence 7999999999 99999999877678899999999999999999999999999999999999998766
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCC-----CCCccchHHHHHHHHHHHHhCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.+||+|||.+..... ...+.+||+.|||||++... .|+..+|+||||++..||..|.+
T Consensus 161 --------------~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 161 --------------EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred --------------cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 578888887765443 33557999999999999653 47789999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
|+.+......+- +..+.|......+..++.++.
T Consensus 227 Pl~DmHPmraLF-----------------------------------------------~IpRNPPPkLkrp~kWs~~Fn 259 (953)
T KOG0587|consen 227 PLCDMHPMRALF-----------------------------------------------LIPRNPPPKLKRPKKWSKKFN 259 (953)
T ss_pred CccCcchhhhhc-----------------------------------------------cCCCCCCccccchhhHHHHHH
Confidence 997654433222 222333333444566688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||..||.+|-.+||+..++|+|||+++.
T Consensus 260 dFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 260 DFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred HHHHHHHhhccccCcchhhhccCCccccc
Confidence 99999999999999999999999999954
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.37 Aligned_cols=247 Identities=19% Similarity=0.308 Sum_probs=193.3
Q ss_pred CCeEEeccccccccEEEEEEEecCC-------CcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecce
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~ 161 (433)
.+|++.+.||+|+||.||+|++... +..||+|+++.. ......+.+|+.+++++ .|+++ ++++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~ 86 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNI-----INLLGA 86 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCe-----eeeeEE
Confidence 4699999999999999999986432 236899988743 23346778899999999 68777 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
+..++.+++||||+ +++|.+++.+.. ...++...+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 99999999999999 899999997532 234788889999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (433)
++.++. ++|+|||++....... ....++..|+|||++.+..++.++||
T Consensus 167 l~~~~~---------------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (334)
T cd05100 167 VTEDNV---------------------------MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219 (334)
T ss_pred EcCCCc---------------------------EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence 976654 5566666554332211 11234567999999999889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc
Q 013941 302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380 (433)
Q Consensus 302 wSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
|||||++|||++ |..||.+.+.......+.....
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------------- 254 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--------------------------------------------- 254 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------------------------------------
Confidence 999999999998 8999987665444333321100
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.......+.++.+||.+||+.+|++|||+.|++++
T Consensus 255 ----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 255 ----MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 00112345689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.36 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=189.1
Q ss_pred CCe-EEeccccccccEEEEEEE----ecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRY-RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++| ++++.||+|+||+||++. ...+++.||+|+++... .....+.+|+++++.+.|+++ +++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 77 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI-----VKYKGCCSE 77 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec
Confidence 456 999999999999998865 34567889999987543 245667789999999988877 999987754
Q ss_pred --CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
...+++||||+ +++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--------- 145 (283)
T cd05080 78 QGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--------- 145 (283)
T ss_pred CCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc---------
Confidence 35689999999 99999999764 4999999999999999999999999999999999999976654
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
++|+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 146 ------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 146 ------------------VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred ------------------EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 5566666554332211 1124566799999998888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||......- ...+....+.... ......... ..........+.++
T Consensus 208 ~p~~~~~~~~-~~~~~~~~~~~~~-----------------------------~~~~~~~~~----~~~~~~~~~~~~~~ 253 (283)
T cd05080 208 DSKQSPPKKF-EEMIGPKQGQMTV-----------------------------VRLIELLER----GMRLPCPKNCPQEV 253 (283)
T ss_pred CCCCCCcchh-hhhhcccccccch-----------------------------hhhhhhhhc----CCCCCCCCCCCHHH
Confidence 9986533210 0000000000000 000000000 00001123456799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+++.+||+.||++|||++++++
T Consensus 254 ~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 254 YILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=297.93 Aligned_cols=237 Identities=24% Similarity=0.365 Sum_probs=184.8
Q ss_pred cccccccEEEEEEEec--CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEcc
Q 013941 99 KMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~ 174 (433)
.||+|+||.||+|.+. .++..||+|++.... ...+.+.+|+.+++++.|+++ ++++++++. +..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----i~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI-----VRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEcC-CCeEEEEEe
Confidence 4899999999999764 455679999986543 234567889999999988877 999998764 578999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccC
Q 013941 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253 (433)
Q Consensus 175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~ 253 (433)
+ +++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--------------------- 133 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--------------------- 133 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc---------------------
Confidence 9 999999987543 36899999999999999999999999999999999999976554
Q ss_pred CCCCCCeeeecCCCCccccCCCc------ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 013941 254 LPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH 326 (433)
Q Consensus 254 ~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~ 326 (433)
++|+|||++........ ...++..|+|||++.+..++.++|||||||++|++++ |..||......+.
T Consensus 134 ------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 207 (257)
T cd05115 134 ------AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV 207 (257)
T ss_pred ------EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 56666665543222111 1123568999999988889999999999999999996 9999987665544
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+.... . .......+.++.++|.+||..|
T Consensus 208 ~~~~~~~~-----------------------~--------------------------~~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 208 MSFIEQGK-----------------------R--------------------------LDCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred HHHHHCCC-----------------------C--------------------------CCCCCCCCHHHHHHHHHHcCCC
Confidence 33222110 0 0011234678999999999999
Q ss_pred CCCCCCHHHHhc
Q 013941 407 PAERLKAREALR 418 (433)
Q Consensus 407 P~~R~ta~ell~ 418 (433)
|++||++.+|++
T Consensus 239 ~~~Rp~~~~i~~ 250 (257)
T cd05115 239 WEDRPNFAKVEE 250 (257)
T ss_pred hhhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.65 Aligned_cols=272 Identities=21% Similarity=0.302 Sum_probs=176.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCC----CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecce-----
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEK----KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW----- 161 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~----- 161 (433)
.++|++.+.||+|+||.||+|++..+ +..||+|++..... .|+.+..++.+... .++..+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e~l~~~~~--~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNERVRRACP--NSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHHHHHhhch--hhHHHHHHhhhccc
Confidence 46899999999999999999999988 89999998754221 12222222222110 001111111
Q ss_pred -eccCCeEEEEEccC-CCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCC
Q 013941 162 -FDYRNHICIVFEKL-GPSLYDFLRKNSYR------------------SFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221 (433)
Q Consensus 162 -~~~~~~~~lv~e~~-~~~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik 221 (433)
...+..+++||||+ +++|.+++...... ......+..++.||+.||+|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 24567899999999 89999998754310 11234567899999999999999999999999
Q ss_pred CCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCC---
Q 013941 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG--- 294 (433)
Q Consensus 222 p~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~--- 294 (433)
|+|||++.+ ...+||+|||+|...... .....+|+.|+|||.+....
T Consensus 283 P~NILl~~~--------------------------~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~ 336 (566)
T PLN03225 283 PQNIIFSEG--------------------------SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP 336 (566)
T ss_pred HHHEEEeCC--------------------------CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCC
Confidence 999999642 235788888887643321 23457899999999764322
Q ss_pred -------------------CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcC
Q 013941 295 -------------------WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355 (433)
Q Consensus 295 -------------------~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 355 (433)
++.++|||||||+||||+++..++. .....+..+....+.....+..... .
T Consensus 337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~--------~ 406 (566)
T PLN03225 337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVE--------P 406 (566)
T ss_pred CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhc--------c
Confidence 3446799999999999999776543 2222222222211111110000000 0
Q ss_pred CccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 356 GARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
. .. ... .......+.......+||.+||++||++|||+.|+|+||||++..
T Consensus 407 ~---------~~-~~~----------~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 407 R---------AS-PDL----------RRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred c---------cc-hhh----------hhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 0 00 000 000111223345677999999999999999999999999998753
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.38 Aligned_cols=240 Identities=22% Similarity=0.288 Sum_probs=185.8
Q ss_pred ccccccccEEEEEEEecCCCc--EEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+.||+|+||.||+|++..++. .+|+|.++.. ....+.+.+|+.++.++ .|+++ +++++++...+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCe-----eeEEEEEecCCCceEEE
Confidence 368999999999999888775 4688887642 33445678899999999 57666 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 173 EKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~----- 150 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV----- 150 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe-----
Confidence 999 899999997542 124789999999999999999999999999999999999976654
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-C
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-G 314 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g 314 (433)
++|+|||++....... .....+..|+|||++.+..++.++|||||||++|||++ |
T Consensus 151 ----------------------~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g 208 (270)
T cd05047 151 ----------------------AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 208 (270)
T ss_pred ----------------------EEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 5566666553221111 11123567999999988889999999999999999997 9
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
..||.+.+..+....+.... ........+.+
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~ 239 (270)
T cd05047 209 GTPYCGMTCAELYEKLPQGY-------------------------------------------------RLEKPLNCDDE 239 (270)
T ss_pred CCCccccCHHHHHHHHhCCC-------------------------------------------------CCCCCCcCCHH
Confidence 99997655443332221100 00011234568
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013941 395 LIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 240 VYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHcccChhhCCCHHHHHH
Confidence 899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=301.05 Aligned_cols=248 Identities=20% Similarity=0.297 Sum_probs=194.8
Q ss_pred CCeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++|++++.||+|+||.||+|+... +.+.|++|.+..... ..+.+.+|+++++++.|+++ +++++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV-----VRLLGLCRE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcce-----eeeEEEECC
Confidence 469999999999999999999654 346799998864332 35678899999999998877 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSY-------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
.+..|+||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 99999999999 8999999976541 158999999999999999999999999999999999999877655544
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccC----CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHH
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (433)
|||.+..... ......++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 160 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 212 (275)
T cd05046 160 ---------------------------LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212 (275)
T ss_pred ---------------------------ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 4444432111 111235567799999998888899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 313 S-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 313 ~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+ |..||...........+.... ..|+ .....
T Consensus 213 ~~~~~p~~~~~~~~~~~~~~~~~------------------------~~~~------------------------~~~~~ 244 (275)
T cd05046 213 TQGELPFYGLSDEEVLNRLQAGK------------------------LELP------------------------VPEGC 244 (275)
T ss_pred hCCCCCccccchHHHHHHHHcCC------------------------cCCC------------------------CCCCC
Confidence 9 888997655444333222110 0010 11244
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
+..+.++|.+||+.||++|||+.|++++
T Consensus 245 ~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 245 PSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=302.32 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=190.2
Q ss_pred CeEEeccccccccEEEEEEEe----cCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC-
Q 013941 93 RYRILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~- 165 (433)
-|++++.||+|+||.||+|.. ..+++.||+|.++.. ......+.+|+.+++.+.|+++ +++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCe-----eeeeeEEecCC
Confidence 378999999999999999974 457889999998643 2334568889999999988877 9998888764
Q ss_pred -CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 166 -NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 166 -~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
...++||||+ +++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~----------- 147 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ----------- 147 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC-----------
Confidence 6789999999 999999997653 35899999999999999999999999999999999999977664
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|+++..|
T Consensus 148 ----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~ 211 (284)
T cd05079 148 ----------------VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211 (284)
T ss_pred ----------------EEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence 4555555544322111 123567789999999888899999999999999999998776
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
+..... ......++.+.... ............ .......++..+.+
T Consensus 212 ~~~~~~-----~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 257 (284)
T cd05079 212 ESSPMT-----LFLKMIGPTHGQMT------------------------VTRLVRVLEEGK-----RLPRPPNCPEEVYQ 257 (284)
T ss_pred Cccccc-----hhhhhccccccccc------------------------HHHHHHHHHcCc-----cCCCCCCCCHHHHH
Confidence 533211 00111111110000 000000000000 01112345779999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 013941 398 LLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~h 419 (433)
||.+||+.||++|||+++++++
T Consensus 258 li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 258 LMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=300.69 Aligned_cols=243 Identities=22% Similarity=0.307 Sum_probs=185.9
Q ss_pred cccccccEEEEEEEecCC------------------------CcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCc
Q 013941 99 KMGEGTFGQVVECFDNEK------------------------KELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
.||+|+||.||+|....+ ...||+|++..... ....+.+|+.+++.++|+|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~ni--- 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHL--- 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCe---
Confidence 699999999999974321 23588998864332 23456778888888888877
Q ss_pred ceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCc
Q 013941 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~ 232 (433)
+++++++......++||||+ +++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..+.
T Consensus 79 --v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 --AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred --eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 99999999999999999999 899998887543 36899999999999999999999999999999999999986542
Q ss_pred ccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHH
Q 013941 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 233 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el 311 (433)
.. .....++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||
T Consensus 156 ~~--------------------~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 156 AE--------------------GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred cc--------------------CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 10 12234799999987543222 22367888999998876 4689999999999999998
Q ss_pred H-hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 312 C-SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 312 ~-~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
+ +|..||......+....+.. ... ....
T Consensus 215 ~~~g~~p~~~~~~~~~~~~~~~-~~~--------------------------------------------------~~~~ 243 (274)
T cd05076 215 CFDGEVPLKERTPSEKERFYEK-KHR--------------------------------------------------LPEP 243 (274)
T ss_pred HhCCCCCccccChHHHHHHHHh-ccC--------------------------------------------------CCCC
Confidence 5 69999976544332111110 000 0112
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.+..+.++|.+||+.+|++|||+.+++++
T Consensus 244 ~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 244 SCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 24578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=297.86 Aligned_cols=244 Identities=22% Similarity=0.268 Sum_probs=186.3
Q ss_pred ccccccccEEEEEEEecC------------CCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 98 SKMGEGTFGQVVECFDNE------------KKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
+.||+|+||.||+|+... ....||+|++.... .....+..|+.++..+.|+|+ +++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~i-----v~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHI-----VLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec
Confidence 468999999999998532 22358999876433 233456778889999988877 999999998
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
....++||||+ +++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++..+
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~--------- 145 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG--------- 145 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccC---------
Confidence 88999999999 889988886543 3689999999999999999999999999999999999997655211
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhh-CCCCCccchHHHHHHHHHHHH-hCCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELC-SGEALFQTH 321 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~-~g~~pf~~~ 321 (433)
.....++++|||.+...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||...
T Consensus 146 -----------~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 146 -----------ECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred -----------CCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 12234789999988654322 2346788999999987 456899999999999999998 588888754
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
...+... +... . .......+.++.+||.+
T Consensus 214 ~~~~~~~-~~~~--~------------------------------------------------~~~~~~~~~~~~~li~~ 242 (262)
T cd05077 214 TLAEKER-FYEG--Q------------------------------------------------CMLVTPSCKELADLMTH 242 (262)
T ss_pred chhHHHH-HHhc--C------------------------------------------------ccCCCCChHHHHHHHHH
Confidence 3322111 0000 0 00011234578999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 013941 402 LLRYDPAERLKAREALRH 419 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~h 419 (433)
||+.||++||++.+|+++
T Consensus 243 cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 243 CMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HcCCChhhCcCHHHHHHh
Confidence 999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=299.54 Aligned_cols=245 Identities=20% Similarity=0.336 Sum_probs=192.2
Q ss_pred ccccccccEEEEEEEecCCC------cEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 98 SKMGEGTFGQVVECFDNEKK------ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+.||+|+||.||+|++.... +.+|+|.+.... .....+.+|+.+++.+.|+++ +++++++...+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI-----VKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCe-----eeEeeeecCCCCeE
Confidence 46999999999999876543 689999886533 345677889999999988887 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 170 IVFEKL-GPSLYDFLRKNS-----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
+||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++++|+||||+||+++.++.
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~----------- 144 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY----------- 144 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCC-----------
Confidence 999999 899999997532 234788999999999999999999999999999999999976541
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 317 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~p 317 (433)
+....++|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 145 -----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 145 -----------DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred -----------CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 12235777888776543211 112245678999999998899999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...+..+....+.... . .......+..+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~~~~~ 244 (269)
T cd05044 214 YPALNNQEVLQHVTAGG-----------------------R--------------------------LQKPENCPDKIYQ 244 (269)
T ss_pred CcccCHHHHHHHHhcCC-----------------------c--------------------------cCCcccchHHHHH
Confidence 98766554433321100 0 0111234678999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013941 398 LLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~ 418 (433)
||.+||+.+|++||+++++++
T Consensus 245 li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 245 LMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=302.56 Aligned_cols=258 Identities=16% Similarity=0.211 Sum_probs=181.8
Q ss_pred cCCccCCCeEEeccccccccEEEEEEEecCC---CcEEEEEEeccchhhH--HH-H------HHHHHHHHHHHhCCCCCc
Q 013941 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKYR--EA-A------MIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~--~~-~------~~E~~~l~~l~~~~i~~~ 153 (433)
+.+...++|++.+.||+|+||.||+|.+..+ +..+|+|+........ +. . ..++..+. ....+.|+
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~--~~~~~~h~ 83 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWK--NIHNIDHL 83 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHH--HhccCCCC
Confidence 3455567899999999999999999998877 6677888654322110 00 0 01111121 12344556
Q ss_pred ceeEecceeccCC----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 154 RCVQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 154 ~~v~~~~~~~~~~----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
+++.+++.+.... ..++++|++..++.+.+.... ..++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG 161 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 6688887654432 458899998778888776543 4688899999999999999999999999999999999976
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc----------CCCcccccCCcccchhhhhCCCCCccc
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH----------QDHSYVVSTRHYRAPEVILGLGWNYPC 299 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 299 (433)
++. ++|+|||+|.... .......||+.|+|||++.+..++.++
T Consensus 162 ~~~---------------------------~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~ 214 (294)
T PHA02882 162 NNR---------------------------GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRG 214 (294)
T ss_pred CCc---------------------------EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHH
Confidence 554 5566666654321 111224799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHh
Q 013941 300 DLWSVGCILVELCSGEALFQTHENLE-HLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377 (433)
Q Consensus 300 DiwSlG~il~el~~g~~pf~~~~~~~-~~~~i~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (433)
|||||||++|||++|..||.+..... ....... ....+
T Consensus 215 DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~---------------------------------------- 254 (294)
T PHA02882 215 DLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRL---------------------------------------- 254 (294)
T ss_pred HHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHh----------------------------------------
Confidence 99999999999999999998763322 2111110 00000
Q ss_pred cCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.... ......+..+.+++..|+..+|++||+++++++
T Consensus 255 -~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 255 -HEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -hhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0000 011234678999999999999999999999874
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=298.01 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=192.1
Q ss_pred CCeEEeccccccccEEEEEEEecCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|.+.+.||+|+||.||+|.+... ...||+|..... ....+.+.+|+.+++.+.|+++ +++++++.+ +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~-~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI-----VKLIGVITE-N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCch-----hceeEEEcC-C
Confidence 4689999999999999999987544 346899988643 3345678889999999988877 999998875 5
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~------------- 145 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC------------- 145 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC-------------
Confidence 578999999 999999997654 36899999999999999999999999999999999999977664
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 320 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~ 320 (433)
++|+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus 146 --------------~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 146 --------------VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred --------------eEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 5555555554322211 11234567999999988889999999999999999996 9999987
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....+....+..... .......+..+.++|.
T Consensus 212 ~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~li~ 242 (270)
T cd05056 212 VKNNDVIGRIENGER-------------------------------------------------LPMPPNCPPTLYSLMT 242 (270)
T ss_pred CCHHHHHHHHHcCCc-------------------------------------------------CCCCCCCCHHHHHHHH
Confidence 765544433321100 0011334678999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 013941 401 GLLRYDPAERLKAREALR 418 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~ 418 (433)
+||..+|++|||+.++++
T Consensus 243 ~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 243 KCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=294.86 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=189.1
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
++||+|+||.||+|.+.. ++.||+|++.... .....+.+|+.+++++.|+++ +++++++...+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI-----VKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe-----EEEEEEEecCCCeEEEEEcC
Confidence 479999999999999877 8999999887533 245677889999999988877 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.
T Consensus 75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~---------------------- 131 (251)
T cd05041 75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV---------------------- 131 (251)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc----------------------
Confidence 899999997643 36889999999999999999999999999999999999976664
Q ss_pred CCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 328 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~ 328 (433)
++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 132 -----~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~ 206 (251)
T cd05041 132 -----LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE 206 (251)
T ss_pred -----EEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH
Confidence 5556666554332111 11123567999999988889999999999999999999 899997765443333
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+..... .......+..+.++|.+||+.+|+
T Consensus 207 ~~~~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~ 237 (251)
T cd05041 207 RIESGYR-------------------------------------------------MPAPQLCPEEIYRLMLQCWAYDPE 237 (251)
T ss_pred HHhcCCC-------------------------------------------------CCCCccCCHHHHHHHHHHhccChh
Confidence 2211100 001123466899999999999999
Q ss_pred CCCCHHHHhc
Q 013941 409 ERLKAREALR 418 (433)
Q Consensus 409 ~R~ta~ell~ 418 (433)
+|||+.|+++
T Consensus 238 ~Rp~~~ell~ 247 (251)
T cd05041 238 NRPSFSEIYN 247 (251)
T ss_pred hCcCHHHHHH
Confidence 9999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=292.98 Aligned_cols=238 Identities=24% Similarity=0.347 Sum_probs=188.1
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
+.||+|+||.||+|... ++..||+|+++... .....+.+|+.+++.+.|+++ +++++++...+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI-----VKLIGVCTQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCc-----CeEEEEEecCCccEEEEECC
Confidence 47899999999999854 67889999986532 334567789999999988877 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~ 254 (433)
+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~---------------------- 131 (250)
T cd05085 75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV---------------------- 131 (250)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe----------------------
Confidence 999999987543 35889999999999999999999999999999999999976664
Q ss_pred CCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 013941 255 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329 (433)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~ 329 (433)
++|+|||++....... ....++..|+|||++.+..++.++||||||+++|++++ |..||.+.........
T Consensus 132 -----~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~ 206 (250)
T cd05085 132 -----LKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206 (250)
T ss_pred -----EEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 5566666554322111 11234567999999988889999999999999999998 9999987655443332
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
+..... ......++..+.+++.+||+.+|++
T Consensus 207 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 207 VEKGYR-------------------------------------------------MSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred HHcCCC-------------------------------------------------CCCCCCCCHHHHHHHHHHcccCccc
Confidence 221100 0111234678999999999999999
Q ss_pred CCCHHHHhc
Q 013941 410 RLKAREALR 418 (433)
Q Consensus 410 R~ta~ell~ 418 (433)
|||+.|+++
T Consensus 238 Rp~~~~l~~ 246 (250)
T cd05085 238 RPKFSELQK 246 (250)
T ss_pred CCCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=298.53 Aligned_cols=244 Identities=21% Similarity=0.296 Sum_probs=192.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc----EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+|+.+++++.|+|+ +++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV-----VRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEec-
Confidence 569999999999999999999876664 58999886543 334567889999999988877 999998876
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~------------ 147 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH------------ 147 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe------------
Confidence 7899999999 999999998654 35899999999999999999999999999999999999976664
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCcc-----cccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
++|+|||.+......... ..++..|+|||.+....++.++|||||||++||+++ |..||
T Consensus 148 ---------------~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 212 (279)
T cd05057 148 ---------------VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred ---------------EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence 555666655433221111 123567999999988889999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+....+....+.... .. ......+.++.++
T Consensus 213 ~~~~~~~~~~~~~~~~-~~------------------------------------------------~~~~~~~~~~~~~ 243 (279)
T cd05057 213 EGIPAVEIPDLLEKGE-RL------------------------------------------------PQPPICTIDVYMV 243 (279)
T ss_pred CCCCHHHHHHHHhCCC-CC------------------------------------------------CCCCCCCHHHHHH
Confidence 8766554433332110 00 0012235578999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 013941 399 LQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~ 418 (433)
+.+||..||++|||+.++++
T Consensus 244 ~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 244 LVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=299.09 Aligned_cols=247 Identities=18% Similarity=0.258 Sum_probs=193.3
Q ss_pred CCCeEEeccccccccEEEEEEEecC----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNE----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
.++|++.+.||+|+||.||+|.+.. ++..|++|++... ......+.+|+.+++++.|+|+ +++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI-----LPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEec
Confidence 3579999999999999999999876 3578999988643 2334667789999999998888 998887655
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKNSY------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
+...++++||+ +++|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~---- 155 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ---- 155 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc----
Confidence 57889999999 8999999976422 35899999999999999999999999999999999999976654
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHH
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (433)
+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|++
T Consensus 156 -----------------------~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el 212 (280)
T cd05043 156 -----------------------VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212 (280)
T ss_pred -----------------------EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHH
Confidence 5555666554321111 112456789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 312 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 312 ~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
++ |+.||...+..+....+.... . ......
T Consensus 213 ~~~g~~p~~~~~~~~~~~~~~~~~-----------------------~--------------------------~~~~~~ 243 (280)
T cd05043 213 MTLGQTPYVEIDPFEMAAYLKDGY-----------------------R--------------------------LAQPIN 243 (280)
T ss_pred hcCCCCCcCcCCHHHHHHHHHcCC-----------------------C--------------------------CCCCCc
Confidence 99 999998765544332221100 0 001123
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
++.++.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 244 CPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4568999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.78 Aligned_cols=261 Identities=24% Similarity=0.333 Sum_probs=188.1
Q ss_pred CCeEEeccccccccEEEEEEE----ecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--
Q 013941 92 PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-- 164 (433)
.+|++++.||+|+||.||+|. +..+++.||+|.+.... .....+.+|+++++++.|+|+ +++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI-----VKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe-----eEEEEEEccCC
Confidence 469999999999999999997 44678899999986543 334567889999999988877 999887643
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
...+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~---------- 147 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRV---------- 147 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeE----------
Confidence 45789999999 999999997643 358999999999999999999999999999999999999776654
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCCc------ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
+|+|||++........ ...++..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 148 -----------------~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 210 (284)
T cd05081 148 -----------------KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210 (284)
T ss_pred -----------------EECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence 5555555443221111 11234469999999988899999999999999999998877
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
+..... ..... .+.... .......+....... .........+.++.+
T Consensus 211 ~~~~~~-~~~~~----~~~~~~------------------------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 257 (284)
T cd05081 211 SCSPPA-EFMRM----MGNDKQ------------------------GQMIVYHLIELLKNN----GRLPAPPGCPAEIYA 257 (284)
T ss_pred CCCcch-hhhhh----cccccc------------------------cccchHHHHHHHhcC----CcCCCCCCCCHHHHH
Confidence 643221 11110 000000 000000000000000 000112345678999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013941 398 LLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~ 418 (433)
||.+||..+|++|||+.|+++
T Consensus 258 li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 258 IMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=288.62 Aligned_cols=260 Identities=23% Similarity=0.381 Sum_probs=204.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++.+-+..||.|+||+|++..++.+|+..|||.++..+ +...++..|.+...+-.. .++||++++..-.++..|
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~----cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSN----CPNIVKFYGALFSEGDCW 139 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcC----CcHHHHHhhhhhcCCcee
Confidence 34566789999999999999999999999999998654 344566677776655432 266699999999999999
Q ss_pred EEEccCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 170 IVFEKLGPSLYDFLR---KNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 170 lv~e~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
|.||+|..+|..+.. ......++|..+-.|....+.||.||-. .+||||||||+|||++..|
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-------------- 205 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-------------- 205 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC--------------
Confidence 999999888776543 2233479999999999999999999985 5899999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||||||++...... .+.-.|...|||||.+... .|+-+||+||||++|||+.||..|+.+.
T Consensus 206 -------------~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 206 -------------DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred -------------CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 5788888887654332 2334789999999998643 5899999999999999999999999876
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+. +++++..+...-|+.+... ...-+++..+..+|..
T Consensus 273 ~s--vfeql~~Vv~gdpp~l~~~-----------------------------------------~~~~~~s~~~~~fint 309 (361)
T KOG1006|consen 273 DS--VFEQLCQVVIGDPPILLFD-----------------------------------------KECVHYSFSMVRFINT 309 (361)
T ss_pred HH--HHHHHHHHHcCCCCeecCc-----------------------------------------ccccccCHHHHHHHHH
Confidence 65 5555555443322211000 0112457789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+|-+.||...+++++||++.-
T Consensus 310 Cl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 310 CLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HhhcccccCcchhhhhcCchhhhh
Confidence 999999999999999999999853
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=294.96 Aligned_cols=244 Identities=19% Similarity=0.248 Sum_probs=181.7
Q ss_pred ccccccccEEEEEEEecC--CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 98 SKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
+.||+|+||.||+|.... ....+|+|.+.... .....+.+|+.+++.+.|+|+ +++++.+...+..|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----i~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV-----LQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCc-----ceEEEEECCCCceEEEEE
Confidence 469999999999996433 44578899875432 234567789999999988887 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 174 KL-GPSLYDFLRKNSY---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
|+ +++|.+++..... ...++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~----------------- 138 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS----------------- 138 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc-----------------
Confidence 99 8999999976432 23567888999999999999999999999999999999976654
Q ss_pred cccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhC-------CCCCccchHHHHHHHHHHHHh-CCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
+||+|||++...... .....++..|+|||++.. ..++.++|||||||++|||++ |..
T Consensus 139 ----------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 208 (269)
T cd05042 139 ----------VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208 (269)
T ss_pred ----------EEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence 566666655432111 112345678999999753 346789999999999999999 888
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||......+.+..+...... .++. .......+..+.
T Consensus 209 p~~~~~~~~~~~~~~~~~~~-----------------------~~~~---------------------~~~~~~~~~~~~ 244 (269)
T cd05042 209 PYPDLSDEQVLKQVVREQDI-----------------------KLPK---------------------PQLDLKYSDRWY 244 (269)
T ss_pred CCCcCCHHHHHHHHhhccCc-----------------------cCCC---------------------CcccccCCHHHH
Confidence 99876655544333221100 0000 001123466788
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
+++..|+ .||++|||+++|++
T Consensus 245 ~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 245 EVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHh-cCcccccCHHHHHH
Confidence 8999888 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=311.40 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=197.2
Q ss_pred eEEeccccccccEEEEEEEecCCCc---E-EEEEEecc----chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKE---L-VAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
-.+.++||+|+||.||+|.....+. . ||+|..+. ......++.+|+++++.++|+|+ |+++|+....
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV-----Vr~yGVa~~~ 233 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV-----VRFYGVAVLE 233 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEcCC
Confidence 3456899999999999998765422 3 89999873 23556788899999999999888 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
..++||||+| ||+|.++|++... .++..+...++.+.+.||+|||++++|||||-..|+|++.++.
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~------------ 300 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV------------ 300 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe------------
Confidence 9999999999 9999999998763 6999999999999999999999999999999999999987664
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC--c-ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--S-YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 320 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~ 320 (433)
+||+|||+++....-. . ...-...|+|||.+....|+.++|||||||++||+++ |..||.+
T Consensus 301 ---------------vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 301 ---------------VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred ---------------EEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC
Confidence 4555555554432100 0 1123457999999999999999999999999999999 8899999
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....+....+.......+ .+...+..+..++.
T Consensus 366 ~~~~~v~~kI~~~~~r~~------------------------------------------------~~~~~p~~~~~~~~ 397 (474)
T KOG0194|consen 366 MKNYEVKAKIVKNGYRMP------------------------------------------------IPSKTPKELAKVMK 397 (474)
T ss_pred CCHHHHHHHHHhcCccCC------------------------------------------------CCCCCHHHHHHHHH
Confidence 998887776643211111 11233668889999
Q ss_pred HhcccCCCCCCCHHHHh
Q 013941 401 GLLRYDPAERLKAREAL 417 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell 417 (433)
+|+..||++|+|+.++.
T Consensus 398 ~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 398 QCWKKDPEDRPTMSTIK 414 (474)
T ss_pred HhccCChhhccCHHHHH
Confidence 99999999999998875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=331.98 Aligned_cols=271 Identities=27% Similarity=0.380 Sum_probs=194.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec-----
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD----- 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~----- 163 (433)
...|+.++.||+||||.||+++++-+|+.||||++... ........+|+..|.+|+|+|+ |+++..|.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNV-----VRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNV-----VRYYSAWVESTAE 552 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcce-----eeeehhhhccCCc
Confidence 45688999999999999999999999999999999754 4555678889999999999987 33222110
Q ss_pred -------------------------------------------------------------------------c------
Q 013941 164 -------------------------------------------------------------------------Y------ 164 (433)
Q Consensus 164 -------------------------------------------------------------------------~------ 164 (433)
+
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence 0
Q ss_pred ---------------------------C--------CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 013941 165 ---------------------------R--------NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208 (433)
Q Consensus 165 ---------------------------~--------~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~ 208 (433)
. ..+||-|||| ..+|.+++..+... -....++++++||+.||.
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHH
Confidence 0 2369999999 66666666665311 147789999999999999
Q ss_pred HHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-CCcccccCCcccch
Q 013941 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAP 287 (433)
Q Consensus 209 ~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aP 287 (433)
|+|++|||||||||.||++++++.+||.|||++........ .......+.+.-..... ..+..+||.-|+||
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~-------~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLE-------SIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhh-------hHhhccCccccccCCCCcccccccceeeeecH
Confidence 99999999999999999999999888888888765322110 00111112211111112 34557999999999
Q ss_pred hhhhCCC---CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hcCCChhhHHhhhhhhhhhhcCCccccCCC
Q 013941 288 EVILGLG---WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPD 363 (433)
Q Consensus 288 E~~~~~~---~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (433)
|++.+.. |+.|+||||||+||+||+. ||... .+....+..+ -+.+|..
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~----------------------- 836 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEP----------------------- 836 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCC-----------------------
Confidence 9998754 9999999999999999984 56532 2222222221 2223221
Q ss_pred CCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
........+.-..+|++||+.||++||||.|+|++.||-
T Consensus 837 ---------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 ---------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ---------------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 001111223456899999999999999999999999997
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=294.77 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=188.8
Q ss_pred ccccccccEEEEEEEecCCC----------cEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 98 SKMGEGTFGQVVECFDNEKK----------ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+.||+|+||.||+|.+..++ ..+++|++.........+.+|+.+++.+.|+++ +++++++.. +.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL-----VKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcch-----hheeeEEec-CC
Confidence 47999999999999988776 358888876544436778889999999988887 999998877 77
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++..
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~------------- 140 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN------------- 140 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc-------------
Confidence 89999999 999999998654 268999999999999999999999999999999999999765410
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCS-GEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~-g~~pf~~~~~ 323 (433)
......++|+|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+.
T Consensus 141 -------~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 141 -------EGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred -------cCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 01223589999998876543 2234677889999999876 78999999999999999999 5788865542
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
........ .... ........+.++|.+||
T Consensus 213 ~~~~~~~~-~~~~--------------------------------------------------~~~~~~~~~~~li~~~l 241 (259)
T cd05037 213 SEKERFYQ-DQHR--------------------------------------------------LPMPDCAELANLINQCW 241 (259)
T ss_pred hhHHHHHh-cCCC--------------------------------------------------CCCCCchHHHHHHHHHh
Confidence 22111110 0000 00011258899999999
Q ss_pred ccCCCCCCCHHHHhc
Q 013941 404 RYDPAERLKAREALR 418 (433)
Q Consensus 404 ~~dP~~R~ta~ell~ 418 (433)
..||++|||+.++++
T Consensus 242 ~~~p~~Rpt~~~il~ 256 (259)
T cd05037 242 TYDPTKRPSFRAILR 256 (259)
T ss_pred ccChhhCCCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=300.85 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=209.7
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
+--..+..+.++||+|-||.|.+|+- ..+.+||+|+++... ..+..+.+|+++|.+|+|||| +.++++|..+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNI-----veLvGVC~~D 607 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNI-----VELLGVCVQD 607 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCe-----eEEEeeeecC
Confidence 33346788999999999999999984 447899999998543 446789999999999999988 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.+|+|+||+ .|+|.+++.++....+.......|+.||+.|++||.+.++|||||.+.|+|++.++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~------------- 674 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF------------- 674 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-------------
Confidence 9999999999 99999999988544455666778999999999999999999999999999996554
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCcc-----cccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh--CCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS--GEAL 317 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~--g~~p 317 (433)
.+||+|||+++..-....+ .+-...|||+|.+..+.++.++|+|+||+++||+++ ...|
T Consensus 675 --------------~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~P 740 (807)
T KOG1094|consen 675 --------------TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQP 740 (807)
T ss_pred --------------cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCc
Confidence 5677777777644333222 233578999999999999999999999999999876 7899
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|....+.+..+....++...+.. .....+.-++..+.+
T Consensus 741 y~~lt~e~vven~~~~~~~~~~~------------------------------------------~~l~~P~~cp~~lye 778 (807)
T KOG1094|consen 741 YSQLTDEQVVENAGEFFRDQGRQ------------------------------------------VVLSRPPACPQGLYE 778 (807)
T ss_pred hhhhhHHHHHHhhhhhcCCCCcc------------------------------------------eeccCCCcCcHHHHH
Confidence 98888877776665554333211 111223456778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+|.+||..|-++||+.+++- -+|++
T Consensus 779 lml~Cw~~es~~RPsFe~lh--~~lq~ 803 (807)
T KOG1094|consen 779 LMLRCWRRESEQRPSFEQLH--LFLQE 803 (807)
T ss_pred HHHHHhchhhhcCCCHHHHH--HHHHH
Confidence 99999999999999999983 44443
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.66 Aligned_cols=239 Identities=17% Similarity=0.251 Sum_probs=181.0
Q ss_pred ccccccccEEEEEEEecC---CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec-cCCeEEEE
Q 013941 98 SKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YRNHICIV 171 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~-~~~~~~lv 171 (433)
+.||+|+||.||+|.+.. .+..||+|.+... ....+.+.+|+.+++.++|+++ +++++++. .++..++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV-----LSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCc-----ceEEEEeecCCCCcEEE
Confidence 468999999999998653 3457999988542 2334567789999999988887 99988654 46678999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~------------------ 136 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT------------------ 136 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc------------------
Confidence 9999 999999997653 35678888999999999999999999999999999999977664
Q ss_pred ccCCCCCCCeeeecCCCCccccCC-------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 322 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~ 322 (433)
+||+|||++...... .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+
T Consensus 137 ---------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 137 ---------VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred ---------EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 455555555422111 112245678999999988889999999999999999999 566776654
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+....+.... . .......+..+.+++.+|
T Consensus 208 ~~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 208 SFDITVYLLQGR--R-----------------------------------------------LLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred HHHHHHHHhcCC--C-----------------------------------------------CCCCCcCCHHHHHHHHHH
Confidence 443322221100 0 000122356899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013941 403 LRYDPAERLKAREALR 418 (433)
Q Consensus 403 L~~dP~~R~ta~ell~ 418 (433)
|..+|++||++.|+++
T Consensus 239 l~~~p~~Rp~~~~il~ 254 (262)
T cd05058 239 WHPKPEMRPTFSELVS 254 (262)
T ss_pred cCCChhhCCCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=299.11 Aligned_cols=245 Identities=22% Similarity=0.286 Sum_probs=190.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc----EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
+.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+|+.+++.+.|+|+ +++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----v~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL-----VRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEcCC
Confidence 468999999999999999999877775 47889876432 223457789999999988887 9999988654
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
..++++||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~------------- 146 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN------------- 146 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-------------
Confidence 467999999 899999987653 3589999999999999999999999999999999999996655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 147 --------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 147 --------------HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred --------------ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 35666666665432211 11245678999999998889999999999999999997 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+....+....+.. ...++ .....+.++.++
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~------------------------------------------------~~~~~~~~~~~l 243 (303)
T cd05110 213 DGIPTREIPDLLEK-GERLP------------------------------------------------QPPICTIDVYMV 243 (303)
T ss_pred CCCCHHHHHHHHHC-CCCCC------------------------------------------------CCCCCCHHHHHH
Confidence 77554333222211 00000 012235578999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 013941 399 LQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~h 419 (433)
+.+||..||++||++.++++.
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=293.05 Aligned_cols=244 Identities=19% Similarity=0.236 Sum_probs=181.4
Q ss_pred ccccccccEEEEEEEec--CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
+.||+|+||.||+|... .++..+|+|.++... .....+.+|+.++++++|+|+ +++++++.+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNL-----LQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEcCCCCcEEEEE
Confidence 46999999999999754 355679999886543 233467789999999988877 999999999899999999
Q ss_pred cC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 174 KL-GPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
|+ +++|.+++.... ....++..++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~----------------- 138 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT----------------- 138 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc-----------------
Confidence 99 899999997532 124567788899999999999999999999999999999976554
Q ss_pred cccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCC-------CCCccchHHHHHHHHHHHHh-CCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL-------GWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
++|+|||.+...... .....|+..|+|||++.+. .++.++|||||||++|||++ |..
T Consensus 139 ----------~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~ 208 (269)
T cd05087 139 ----------VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ 208 (269)
T ss_pred ----------EEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCC
Confidence 556666655432211 1123567889999998643 35789999999999999996 999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||......+......... ....+. .......+..+.
T Consensus 209 p~~~~~~~~~~~~~~~~~-----------------------~~~~~~---------------------~~~~~~~~~~~~ 244 (269)
T cd05087 209 PYRHLSDEQVLTYTVREQ-----------------------QLKLPK---------------------PRLKLPLSDRWY 244 (269)
T ss_pred CCCCCChHHHHHHHhhcc-----------------------cCCCCC---------------------CccCCCCChHHH
Confidence 997665544322211100 000000 001112356788
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
+++..|+ .+|++|||++||+.
T Consensus 245 ~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 245 EVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHh-cCcccCCCHHHHHH
Confidence 9999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.40 Aligned_cols=271 Identities=22% Similarity=0.374 Sum_probs=189.9
Q ss_pred CCCeEEeccccccccEEEEEEEec----------------CCCcEEEEEEeccchh---------------hHHHHHHHH
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN----------------EKKELVAIKIVRSINK---------------YREAAMIEI 139 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~---------------~~~~~~~E~ 139 (433)
.++|++.++||+|+||+||+|.+. ..++.||||.+..... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 468999999999999999999742 3456799999864321 112334577
Q ss_pred HHHHHHHhCCCCCcceeEecceecc--------CCeEEEEEccC-CCCHHHHHHhcCC----------------------
Q 013941 140 DVLQRLARHDIGGTRCVQIRNWFDY--------RNHICIVFEKL-GPSLYDFLRKNSY---------------------- 188 (433)
Q Consensus 140 ~~l~~l~~~~i~~~~~v~~~~~~~~--------~~~~~lv~e~~-~~~L~~~l~~~~~---------------------- 188 (433)
.++.++.|+++.+.+++++++++.. .+..+|||||+ +++|.+++.....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 8888898888878888888887753 35689999999 9999999864210
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCC
Q 013941 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268 (433)
Q Consensus 189 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 268 (433)
..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .++|+|||++
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~---------------------------~~kL~DFGla 356 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG---------------------------QVKIIDFGAA 356 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC---------------------------cEEEEeCcCc
Confidence 1245678899999999999999999999999999999997654 4677777766
Q ss_pred ccccCCC--c--ccccCCcccchhhhhCCC--------------------CC--ccchHHHHHHHHHHHHhCCC-CCCCC
Q 013941 269 TFEHQDH--S--YVVSTRHYRAPEVILGLG--------------------WN--YPCDLWSVGCILVELCSGEA-LFQTH 321 (433)
Q Consensus 269 ~~~~~~~--~--~~~gt~~y~aPE~~~~~~--------------------~~--~~~DiwSlG~il~el~~g~~-pf~~~ 321 (433)
....... . ...+|+.|+|||.+.... ++ .+.||||+||++|+|++|.. ||...
T Consensus 357 ~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 357 VDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred cccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 4332211 1 123478999999986432 11 34799999999999999875 77543
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
...... +... .. ....|+............+..++...|||.+
T Consensus 437 ~~f~~~--~~~~-~~----------------------------------~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~ 479 (507)
T PLN03224 437 RLFNTE--LRQY-DN----------------------------------DLNRWRMYKGQKYDFSLLDRNKEAGWDLACK 479 (507)
T ss_pred hhhhhH--Hhhc-cc----------------------------------hHHHHHhhcccCCCcccccccChHHHHHHHH
Confidence 222110 0000 00 0000110111111122345567899999999
Q ss_pred hcccCC---CCCCCHHHHhcCCCCCCC
Q 013941 402 LLRYDP---AERLKAREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP---~~R~ta~ell~hp~f~~~ 425 (433)
||..+| .+|+|++|+|+||||..+
T Consensus 480 LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 480 LITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred HhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 999876 689999999999999764
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=292.36 Aligned_cols=247 Identities=22% Similarity=0.411 Sum_probs=191.9
Q ss_pred CeEEeccccccccEEEEEEEecC-CCcEEEEEEeccch-----------hhHHHHHHHHHHHHH-HHhCCCCCcceeEec
Q 013941 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN-----------KYREAAMIEIDVLQR-LARHDIGGTRCVQIR 159 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~~~~i~~~~~v~~~ 159 (433)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .....+..|+.++.+ +.|+++ ++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNI-----VRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCe-----eeEE
Confidence 38889999999999999999887 67889999875321 122345567776654 566655 9999
Q ss_pred ceeccCCeEEEEEccC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccc
Q 013941 160 NWFDYRNHICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l 235 (433)
+++..++..++||||+ +++|.+++.. .....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~---- 151 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD---- 151 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC----
Confidence 9999999999999999 8899998753 222468999999999999999999996 7899999999999997655
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 313 (433)
.++|+|||.+...... .....|+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 152 -----------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~ 208 (269)
T cd08528 152 -----------------------KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208 (269)
T ss_pred -----------------------cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh
Confidence 4667777766543322 123468889999999998889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|..||...........+....... ......+.
T Consensus 209 g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~ 240 (269)
T cd08528 209 LQPPFYSTNMLSLATKIVEAVYEP------------------------------------------------LPEGMYSE 240 (269)
T ss_pred CCCcccccCHHHHHHHHhhccCCc------------------------------------------------CCcccCCH
Confidence 999997655444333322211000 00113466
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.+.++|.+||+.||++||++.|+.++
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 89999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=302.26 Aligned_cols=268 Identities=25% Similarity=0.455 Sum_probs=211.1
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh--------hHHHHHHHHHHHHHHHhCCCCCcceeEe
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQI 158 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~~~~i~~~~~v~~ 158 (433)
...+.++|-++..||+|||+.||+|.+...++.||||+-..+.. ......+|..|.+.|.|+.| |++
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI-----VKl 532 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI-----VKL 532 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee-----eee
Confidence 34567799999999999999999999999999999998653322 22445678899888888777 999
Q ss_pred cceecc-CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCccc
Q 013941 159 RNWFDY-RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 159 ~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~ 234 (433)
+++|.- .+.+|-|+||| |.+|.-+|..+. .+++..++.|+.||+.||.||.+.. |||-||||.|||+.+..
T Consensus 533 YDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt--- 607 (775)
T KOG1151|consen 533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT--- 607 (775)
T ss_pred eeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc---
Confidence 999974 56899999999 889999998775 7999999999999999999999875 99999999999996542
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC----------cccccCCcccchhhhhCC----CCCccch
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGL----GWNYPCD 300 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~~D 300 (433)
.-+.+||+|||++++.+... +...||.+|++||.+.-. ..+.++|
T Consensus 608 ---------------------acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVD 666 (775)
T KOG1151|consen 608 ---------------------ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVD 666 (775)
T ss_pred ---------------------ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccccee
Confidence 33467888888887655432 225799999999998644 3689999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc
Q 013941 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380 (433)
Q Consensus 301 iwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
|||+|||+|..+.|+.||......+.+.....++. .....+
T Consensus 667 VWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk--------------------AtEVqF------------------- 707 (775)
T KOG1151|consen 667 VWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK--------------------ATEVQF------------------- 707 (775)
T ss_pred eEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc--------------------ceeccC-------------------
Confidence 99999999999999999976544332221111110 001111
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
...+-++.++++||++||++.-++|....++..||||.-..+++
T Consensus 708 -----P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs 751 (775)
T KOG1151|consen 708 -----PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRS 751 (775)
T ss_pred -----CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhc
Confidence 11235678999999999999999999999999999998765554
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=295.31 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=192.7
Q ss_pred CCeEEeccccccccEEEEEEEec----CCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~- 164 (433)
..|++.+.||+|+||.||+|... .+++.||+|++..... ....+.+|+.+++.+.|+++ +++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i-----~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI-----VKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCCh-----heEEeeeecC
Confidence 35888999999999999999854 3478999999976544 36678899999999998887 999888876
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
....++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~----------- 146 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED----------- 146 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-----------
Confidence 66899999999 899999997654 3589999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCCCc------ccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|||++|..
T Consensus 147 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~ 210 (284)
T cd05038 147 ----------------LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210 (284)
T ss_pred ----------------CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence 456666666654432111 1234567999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||........ ...+.... .............. .........+.++.
T Consensus 211 p~~~~~~~~~-----~~~~~~~~-------------------------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 256 (284)
T cd05038 211 PSQSPPAEFL-----RMIGIAQG-------------------------QMIVTRLLELLKEG----ERLPRPPSCPDEVY 256 (284)
T ss_pred Ccccccchhc-----cccccccc-------------------------cccHHHHHHHHHcC----CcCCCCccCCHHHH
Confidence 9865322110 00000000 00000000000000 00011123456899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
+|+.+||+.||++|||+.||++
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 257 DLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=323.54 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=205.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCC-----cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
..+-++.+.||+|.||.||.|...... ..||+|.+++. .....++.+|..++..+.|+|| |++++++-
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNi-----v~liGv~l 765 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNI-----VSLIGVCL 765 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcce-----eeEEEeec
Confidence 356788999999999999999865432 24899998764 4566789999999999999988 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS-----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
+....+|++||| ||+|..+|++.. ...++..+...++.||++|++||+++++|||||-..|+|++..
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~------- 838 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER------- 838 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-------
Confidence 999999999999 999999998751 2568999999999999999999999999999999999998654
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCccc-----ccCCcccchhhhhCCCCCccchHHHHHHHHHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV-----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (433)
..+||+|||+|+......-+. .-...|||||.+....++.++|||||||+|||++
T Consensus 839 --------------------r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 839 --------------------RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred --------------------CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence 467778888877433322221 1135799999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 313 S-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 313 ~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+ |..||.+.++.+.+....+. ++++. +..+
T Consensus 899 slG~~PY~~~~n~~v~~~~~~g-----------------------gRL~~--------------------------P~~C 929 (1025)
T KOG1095|consen 899 SLGATPYPSRSNFEVLLDVLEG-----------------------GRLDP--------------------------PSYC 929 (1025)
T ss_pred hCCCCCCCCcchHHHHHHHHhC-----------------------CccCC--------------------------CCCC
Confidence 9 99999998888876644331 12222 3456
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
+..+.++|.+||+.+|++||++..|++
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHh
Confidence 778999999999999999999999886
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=287.73 Aligned_cols=244 Identities=20% Similarity=0.227 Sum_probs=181.2
Q ss_pred ccccccccEEEEEEEecCC--CcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 98 SKMGEGTFGQVVECFDNEK--KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
+.||+|+||.||++....+ ...+++|.+.... ...+.+.+|+.+++.++|+|+ +++++.+......|+|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----v~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNI-----LQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcch-----hheEEEecCCCccEEEEe
Confidence 3699999999999975433 3356777765432 345678889999999988887 999999999999999999
Q ss_pred cC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 174 KL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|+ +++|.+++.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~------------------ 137 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT------------------ 137 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc------------------
Confidence 99 899999997642 234677788899999999999999999999999999999976654
Q ss_pred ccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhC-------CCCCccchHHHHHHHHHHHHh-CCCC
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVELCS-GEAL 317 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~-g~~p 317 (433)
++|+|||++..... ......|+..|+|||++.. ..++.++|||||||++|||++ |..|
T Consensus 138 ---------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 208 (268)
T cd05086 138 ---------VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208 (268)
T ss_pred ---------EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence 56666665532111 1123467889999999853 235789999999999999997 5778
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...+..+.+..+...... ..+ ........++.+.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~-----------------------~~~---------------------~~~~~~~~~~~~~~ 244 (268)
T cd05086 209 YSHLSDREVLNHVIKDQQV-----------------------KLF---------------------KPQLELPYSERWYE 244 (268)
T ss_pred CCCCCHHHHHHHHHhhccc-----------------------ccC---------------------CCccCCCCcHHHHH
Confidence 8776665544433221000 000 00011234668889
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013941 398 LLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~ 418 (433)
++..|| .+|++|||+++|++
T Consensus 245 l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 245 VLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHh-hCcccCCCHHHHHH
Confidence 999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=290.26 Aligned_cols=245 Identities=16% Similarity=0.231 Sum_probs=187.0
Q ss_pred eEEeccccccccEEEEEEEec---CCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC-
Q 013941 94 YRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN- 166 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~- 166 (433)
|.+.+.||+|+||.||+|.+. .+++.||||++... ....+.+.+|+.+++.+.|+++ +++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNV-----IKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEccCCC
Confidence 677889999999999999864 35789999998653 2344567889999999998887 99999775432
Q ss_pred -----eEEEEEccC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 167 -----HICIVFEKL-GPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 167 -----~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
..++++||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~---- 151 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT---- 151 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC----
Confidence 357899999 899998875321 125789999999999999999999999999999999999976554
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHH
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (433)
++|+|||.+....... ....++..|++||.+.+..++.++|||||||++|+|
T Consensus 152 -----------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el 208 (273)
T cd05074 152 -----------------------VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208 (273)
T ss_pred -----------------------EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence 5666666554332111 122455789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 312 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 312 ~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
++ |..||.+.+..+....+.... .. .....
T Consensus 209 ~~~g~~p~~~~~~~~~~~~~~~~~-----------------------~~--------------------------~~~~~ 239 (273)
T cd05074 209 MTRGQTPYAGVENSEIYNYLIKGN-----------------------RL--------------------------KQPPD 239 (273)
T ss_pred hhCCCCCCCCCCHHHHHHHHHcCC-----------------------cC--------------------------CCCCC
Confidence 99 899997665543322221100 00 00123
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.+..+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45689999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=292.71 Aligned_cols=242 Identities=20% Similarity=0.340 Sum_probs=207.2
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
....++||-|.||.||.+.+++-.-.||||.++.+....++++.|..+++.+.|+|+ |+++++|..+..+|||+|
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNL-----VqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccH-----HHHhhhhccCCCeEEEEe
Confidence 455789999999999999999988899999998888888999999999999999988 999999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCccc
Q 013941 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~ 252 (433)
|| .|+|.++|++.....++.-...+++.||.+|++||..+++|||||-..|+|+.++.
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh--------------------- 402 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--------------------- 402 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc---------------------
Confidence 99 99999999987766788888899999999999999999999999999999996654
Q ss_pred CCCCCCCeeeecCCCCccccCCC-ccccc---CCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 013941 253 NLPKSSAIKLIDFGSTTFEHQDH-SYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327 (433)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~g---t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~ 327 (433)
.+|++|||+++...... +...| ...|.|||.+.-+.++.++|||+|||+|||+.| |..||.+.+-.+.+
T Consensus 403 ------iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY 476 (1157)
T KOG4278|consen 403 ------IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 476 (1157)
T ss_pred ------eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH
Confidence 57777777777654332 22333 457999999999999999999999999999998 99999998776665
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+.+. .+ ++.+..+++.+.+|+..||+|+|
T Consensus 477 ~LLEkg-----------------------yR--------------------------M~~PeGCPpkVYeLMraCW~WsP 507 (1157)
T KOG4278|consen 477 GLLEKG-----------------------YR--------------------------MDGPEGCPPKVYELMRACWNWSP 507 (1157)
T ss_pred HHHhcc-----------------------cc--------------------------ccCCCCCCHHHHHHHHHHhcCCc
Confidence 544331 11 22334567899999999999999
Q ss_pred CCCCCHHHH
Q 013941 408 AERLKAREA 416 (433)
Q Consensus 408 ~~R~ta~el 416 (433)
++||++.|+
T Consensus 508 sDRPsFaei 516 (1157)
T KOG4278|consen 508 SDRPSFAEI 516 (1157)
T ss_pred ccCccHHHH
Confidence 999998876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.75 Aligned_cols=321 Identities=24% Similarity=0.406 Sum_probs=217.4
Q ss_pred ccCCCeEEeccccccccEEEEEEEecC---CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.+.|.++++||+|+|++||++.+.. ..+.||+|.+.... ....+.+|++.|..+. ++.|++.+.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~g----G~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLG----GSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhc----cchhhhcchhhhccC
Confidence 445679999999999999999999877 78899999987543 3356888999999986 335669999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeC-CcccccCcccccc
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLSR 243 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~-~~~~l~d~~~~~~ 243 (433)
+.+++||||+ ..+..+++. .++...++.+++.++.||.++|.+|||||||||+|+|++.. +.-.|.|||++.+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999 777777765 47789999999999999999999999999999999999754 6677889999873
Q ss_pred CCCCC--Ccc-c----CCCCCCCeeeecCCCCc-----------cc--cCCCcccccCCcccchhhhhCC-CCCccchHH
Q 013941 244 SSKDG--SYF-K----NLPKSSAIKLIDFGSTT-----------FE--HQDHSYVVSTRHYRAPEVILGL-GWNYPCDLW 302 (433)
Q Consensus 244 ~~~~~--~~~-~----~~~~~~~~kl~Dfg~a~-----------~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 302 (433)
..... ... . ....-..-.+-.+..+. .. ........||++|+|||++... ..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21111 000 0 00000000000111110 00 0111235899999999999875 478999999
Q ss_pred HHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhh--hhcCCccccCCCCCCchhhHHHH-HHhc
Q 013941 303 SVGCILVELCSGEALF-QTHENLEHLAMMERVLGPLPHHMVIRADRRAEK--YFRRGARLDWPDGATSRDSMRAV-WKLL 378 (433)
Q Consensus 303 SlG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 378 (433)
|.|||+..++++..|| ...++...+..+..++|...-. ++...... ++.+ .+.+............ ....
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mr---k~A~l~g~~~l~~k---sn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMR---KCAALPGRILLWQK---SNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHH---HHhhcCCceeeecc---ccccccHHHHhchhccChhhc
Confidence 9999999999999997 4556677777777777653211 11000000 1110 1111111111111111 0000
Q ss_pred ---Cchhhhh-hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 379 ---RLPNLIM-QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 379 ---~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
..++... ...+..+..+.+|+.+||..||.+|+||+++|+||||...
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0111111 2223445689999999999999999999999999999853
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=295.05 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=202.5
Q ss_pred CeEEeccccccccEEEEEEEecCC-C--cEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEK-K--ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+..+.++||+|.||.|++|.+... | ..||||.++.+. .....+.+|+.+|.+|.|+++ +++|++.-+ ..
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hl-----iRLyGvVl~-qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHL-----IRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcce-----eEEeeeecc-ch
Confidence 456789999999999999987653 3 368999997543 356789999999999999887 999998877 78
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+.||||++ .|+|.+.|.+.....|.......++.||+.|+.||.++++|||||-..|||+.....+||+|||+++....
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 89999999 99999999985556788999999999999999999999999999999999997766554444444443333
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
+.+.+.... ...-...|+|||.+....++.++|||++||+||||++ |..||.+....+
T Consensus 265 ned~Yvm~p---------------------~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q 323 (1039)
T KOG0199|consen 265 NEDMYVMAP---------------------QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ 323 (1039)
T ss_pred CCcceEecC---------------------CCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH
Confidence 322110000 0112357999999999999999999999999999999 899999999998
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
++..|...- + +...+.++.++.+++.+||..
T Consensus 324 IL~~iD~~e-----------------------r--------------------------LpRPk~csedIY~imk~cWah 354 (1039)
T KOG0199|consen 324 ILKNIDAGE-----------------------R--------------------------LPRPKYCSEDIYQIMKNCWAH 354 (1039)
T ss_pred HHHhccccc-----------------------c--------------------------CCCCCCChHHHHHHHHHhccC
Confidence 888775210 1 112346688999999999999
Q ss_pred CCCCCCCHHHHhcCCC
Q 013941 406 DPAERLKAREALRHPF 421 (433)
Q Consensus 406 dP~~R~ta~ell~hp~ 421 (433)
+|++|||+..|.+.-+
T Consensus 355 ~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 355 NPADRPTFSAIREDLV 370 (1039)
T ss_pred CccccccHHHHHHhHH
Confidence 9999999998865433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.21 Aligned_cols=256 Identities=23% Similarity=0.275 Sum_probs=194.7
Q ss_pred eEEeccccccccEE-EEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 94 YRILSKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 94 y~~~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
|.-.+.+|.|+.|+ ||+|. ..|+.||||.+- ......+.+|+..|+.-. .|+|+|++++.-.++.+.||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll--~e~~~~A~rEi~lL~eSD----~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLL--EEFFDFAQREIQLLQESD----EHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEe--eCCceehHHHHh--hHhHHHHHHHHHHHHhcc----CCCceEEEEeeccCCceEEEEe
Confidence 44457889999886 69997 568899999864 334456788999988765 2355599999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 173 EKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 173 e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|.|..+|.+++... ..........+.++.|++.||++||+.+||||||||.||||+...
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~------------------- 643 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS------------------- 643 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC-------------------
Confidence 99999999999874 111122245678899999999999999999999999999997632
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCh
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHEN 323 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g-~~pf~~~~~ 323 (433)
.+....++|+|||+++...... ....||.+|+|||++....-+.++|||||||++|+.++| ..||.....
T Consensus 644 ---~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 644 ---ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred ---CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 1244578999999887765443 335799999999999998888999999999999999985 999975433
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+ ..|...... + .........++.|||.+||
T Consensus 721 R~--~NIl~~~~~-------------------------------------------L----~~L~~~~d~eA~dLI~~ml 751 (903)
T KOG1027|consen 721 RQ--ANILTGNYT-------------------------------------------L----VHLEPLPDCEAKDLISRML 751 (903)
T ss_pred hh--hhhhcCccc-------------------------------------------e----eeeccCchHHHHHHHHHhc
Confidence 22 111110000 0 0000111127889999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 404 RYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
..||..||+|.+||.||||....++
T Consensus 752 ~~dP~~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 752 NPDPQLRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred CCCcccCCCHHHHhCCCccCChHHH
Confidence 9999999999999999999986544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=271.49 Aligned_cols=238 Identities=36% Similarity=0.596 Sum_probs=191.5
Q ss_pred ccEEEEEEEecCCCcEEEEEEeccchhh--HHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-CCCHH
Q 013941 104 TFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLY 180 (433)
Q Consensus 104 ~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~ 180 (433)
+||.||+|.+..+++.+|+|++...... .+.+.+|++.+++++|+++ +++++++......++++|++ +++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNI-----VRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcH-----HHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999999988999999998754322 4778899999999988777 99999999889999999999 66999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCe
Q 013941 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260 (433)
Q Consensus 181 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 260 (433)
+++.... .++...+..++.+++.+|.+||+.||+|+||+|+||+++.++ .+
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~---------------------------~~ 126 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG---------------------------HV 126 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC---------------------------cE
Confidence 9998654 389999999999999999999999999999999999997655 46
Q ss_pred eeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhcCC
Q 013941 261 KLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE-HLAMMERVLGPL 337 (433)
Q Consensus 261 kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~ 337 (433)
+|+|||.+...... .....++..|++||.+.+..++.++||||||+++|+|++|..||....... ....+.......
T Consensus 127 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 206 (244)
T smart00220 127 KLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF 206 (244)
T ss_pred EEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC
Confidence 67777766554432 233567889999999988888999999999999999999999997633322 222221110000
Q ss_pred ChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHh
Q 013941 338 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 417 (433)
Q Consensus 338 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell 417 (433)
. .....++.++.+++.+||..||++||++.+++
T Consensus 207 ~-----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 207 P-----------------------------------------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred c-----------------------------------------------cccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence 0 00011456899999999999999999999999
Q ss_pred cCCCC
Q 013941 418 RHPFF 422 (433)
Q Consensus 418 ~hp~f 422 (433)
+||||
T Consensus 240 ~~~~~ 244 (244)
T smart00220 240 QHPFF 244 (244)
T ss_pred hCCCC
Confidence 99997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=251.77 Aligned_cols=209 Identities=22% Similarity=0.404 Sum_probs=169.2
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
....+..||+|++|.|-+.++..+|...|+|.++.. ++......+|+.+..+.. ..|..|++++.+...+.+++
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~----~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTV----DCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCC----CCCeEEEeehhhhccccEEE
Confidence 355678999999999999999999999999998743 344455666776655432 44677999999999999999
Q ss_pred EEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 171 VFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 171 v~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
.||.|..+|..+..+ ..+..++|..+-+|+..+++||.|||++ .|||||+||+||||+.+|
T Consensus 123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G---------------- 186 (282)
T KOG0984|consen 123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG---------------- 186 (282)
T ss_pred eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC----------------
Confidence 999999999877653 2235799999999999999999999975 899999999999998766
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC-cc-cccCCcccchhhhhC----CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH-SY-VVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~-~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
++|+||||++....+.- .+ -.|...|||||.+.. ..|+-++||||||+++.||.+++.||...
T Consensus 187 -----------qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 187 -----------QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred -----------cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 57888888887654432 22 478899999999864 36999999999999999999999999754
Q ss_pred -ChHHHHHHHHH
Q 013941 322 -ENLEHLAMMER 332 (433)
Q Consensus 322 -~~~~~~~~i~~ 332 (433)
+..+++.++..
T Consensus 256 ~tpF~qLkqvVe 267 (282)
T KOG0984|consen 256 GTPFQQLKQVVE 267 (282)
T ss_pred CCHHHHHHHHhc
Confidence 45666665554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=291.71 Aligned_cols=240 Identities=25% Similarity=0.391 Sum_probs=198.1
Q ss_pred EEeccccccccEEEEEEEecCC--C--cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 95 RILSKMGEGTFGQVVECFDNEK--K--ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~--~--~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.++||.|.||.||+|..... | -.||||..+.+ ....+.+..|..+++.+.|++| ++++|++.+ ...
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphI-----ikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHI-----IKLIGVCVE-QPM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcch-----hheeeeeec-cce
Confidence 3457899999999999986432 2 35899998753 3557889999999999999888 999999875 679
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|||||++ -|.|..+++.+. ..++......+++||+.||.|||+..+|||||-..|||+.+..
T Consensus 466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~---------------- 528 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ---------------- 528 (974)
T ss_pred eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc----------------
Confidence 9999999 999999999776 4799999999999999999999999999999999999996644
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCCccc--cc--CCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV--VS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 322 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~--~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~ 322 (433)
.+||+|||+++..++..-+. .| ...|||||.+.-..++.+||||-|||.+||++. |..||.+..
T Consensus 529 -----------CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 529 -----------CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred -----------eeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 57888888888776554321 22 457999999999999999999999999999987 999999887
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
+.+.+..+. .|.++.. ++.+++.+..|+.+|
T Consensus 598 NsDVI~~iE-----------------------nGeRlP~--------------------------P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 598 NSDVIGHIE-----------------------NGERLPC--------------------------PPNCPPALYSLMSKC 628 (974)
T ss_pred ccceEEEec-----------------------CCCCCCC--------------------------CCCCChHHHHHHHHH
Confidence 766544332 2223222 346688999999999
Q ss_pred cccCCCCCCCHHHHh
Q 013941 403 LRYDPAERLKAREAL 417 (433)
Q Consensus 403 L~~dP~~R~ta~ell 417 (433)
|++||.+||+..|+.
T Consensus 629 WayeP~kRPrftei~ 643 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIK 643 (974)
T ss_pred hccCcccCCcHHHHH
Confidence 999999999987764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=298.79 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=209.4
Q ss_pred CeEEeccccccccEEEEEEEecCCC---cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.-.|.+.||.|.||.|++|+.+..+ ..||||.++.. ++.+.+++.|+.|+-++.|||| +++.++......
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNI-----IrLEGVVTks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI-----IRLEGVVTKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcE-----EEEEEEEecCce
Confidence 4578899999999999999987666 47999999853 5667889999999999999988 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
++||+||| +|+|..||+.+.+ .|+.-+...+++.|+.|++||-++|+|||||-..|||++++-
T Consensus 705 vMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL--------------- 768 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL--------------- 768 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce---------------
Confidence 99999999 9999999998874 599999999999999999999999999999999999997654
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC----ccccc--CCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ 319 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~ 319 (433)
.+|++|||+++..++.. ++..| ...|.|||.+.-..++.+|||||+|++|||.++ |..||.
T Consensus 769 ------------vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 769 ------------VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred ------------EEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 45666667666554333 11222 357999999999999999999999999999876 999999
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
...+.+.+..|.+...-+|+ ..++..+..|+
T Consensus 837 dmSNQdVIkaIe~gyRLPpP-------------------------------------------------mDCP~aL~qLM 867 (996)
T KOG0196|consen 837 DMSNQDVIKAIEQGYRLPPP-------------------------------------------------MDCPAALYQLM 867 (996)
T ss_pred ccchHHHHHHHHhccCCCCC-------------------------------------------------CCCcHHHHHHH
Confidence 99999999888776544332 34577899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 013941 400 QGLLRYDPAERLKAREALR 418 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~ 418 (433)
..||++|-.+||++.||++
T Consensus 868 ldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHhhcCCCHHHHHH
Confidence 9999999999999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=271.41 Aligned_cols=206 Identities=22% Similarity=0.300 Sum_probs=160.7
Q ss_pred CCCCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHH--HHHHhCCCCCc
Q 013941 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVL--QRLARHDIGGT 153 (433)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l--~~l~~~~i~~~ 153 (433)
+.++...++.+...+..+-.+++.||+|.||+||+|.++ |+.||||++...++ ....+|.+|. ..|+|+||
T Consensus 195 SGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENI--- 267 (513)
T KOG2052|consen 195 SGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENI--- 267 (513)
T ss_pred CCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchh---
Confidence 344455667777888889999999999999999999864 77899999976554 3455555555 45678887
Q ss_pred ceeEecceeccC----CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecCC
Q 013941 154 RCVQIRNWFDYR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDL 220 (433)
Q Consensus 154 ~~v~~~~~~~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDi 220 (433)
..+++.-..+ .++|||++|- .|+|+|+|... .++.+...+++..++.||+|||-. .|.||||
T Consensus 268 --LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 268 --LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred --hhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 7777654433 3799999999 99999999985 699999999999999999999963 4999999
Q ss_pred CCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCC----CC
Q 013941 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WN 296 (433)
Q Consensus 221 kp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~~ 296 (433)
|..|||+..+|.+.|+|+|++-+...+.+ ......+..+||..|||||++...- +.
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~--------------------~idi~~N~rVGTKRYMAPEvLdetin~~~Fe 402 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTD--------------------TIDIPPNPRVGTKRYMAPEVLDETINMKHFE 402 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCC--------------------cccCCCCCccceeeccChHHhhhhcChhhhh
Confidence 99999999888777777776544333221 1112334569999999999997642 22
Q ss_pred --ccchHHHHHHHHHHHHh
Q 013941 297 --YPCDLWSVGCILVELCS 313 (433)
Q Consensus 297 --~~~DiwSlG~il~el~~ 313 (433)
..+||||||.|+||++.
T Consensus 403 syk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 403 SYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred hhhHHHHHHHHHHHHHHHH
Confidence 46899999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.66 Aligned_cols=196 Identities=26% Similarity=0.478 Sum_probs=170.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHH---------HHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---------AMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.|..++.||+|+||.|++|.++.+...|+||.+.+..-..+. .-.|++||..++.+ .|+||++++++|+
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~--sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH--SHENILKLLDFFE 639 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc--Cccchhhhhheee
Confidence 499999999999999999999999999999999765432222 33499999999833 2344499999999
Q ss_pred cCCeEEEEEccC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 164 YRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 164 ~~~~~~lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
+++++||+||-- |.+|.+++..+. .++|..+..|++|++.|+++||++||||||||-+||.++.+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g---------- 707 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG---------- 707 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC----------
Confidence 999999999987 679999999876 899999999999999999999999999999999999997766
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
-+||+|||.|...... -..++||..|.|||++.|..| +..-|||+||++||-++....||.
T Consensus 708 -----------------~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 708 -----------------FVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred -----------------eEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 5799999988766544 355799999999999999987 578899999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=289.57 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=213.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.++|+++..+|+|.||.||+|+++.+++..|+|+++... ........|+-+++..+|+|| +.+++.+-..+.++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~ni-----vay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNI-----VAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcCh-----HHHHhhhhhhcCcE
Confidence 457999999999999999999999999999999998543 234556779999999999988 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++|||| ||+|.+..+-.+ .+++.++..+++..++||+|||++|=+|||||-.|||+++.|.
T Consensus 89 icMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---------------- 150 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---------------- 150 (829)
T ss_pred EEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc----------------
Confidence 999999 899999887665 8999999999999999999999999999999999999987774
Q ss_pred CcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
+|++|||.+..... ....+.||++|||||+.. ...|...+|||++|++..|+-.-++|.-...
T Consensus 151 -----------vklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 151 -----------VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred -----------eeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 56666665543322 234469999999999874 3468999999999999999988888876655
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+.+..+......+|. .+....+++.+.+|++.+
T Consensus 220 pmr~l~LmTkS~~qpp~---------------------------------------------lkDk~kws~~fh~fvK~a 254 (829)
T KOG0576|consen 220 PMRALFLMTKSGFQPPT---------------------------------------------LKDKTKWSEFFHNFVKGA 254 (829)
T ss_pred hHHHHHHhhccCCCCCc---------------------------------------------ccCCccchHHHHHHHHHH
Confidence 55555555443333321 122245577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 403 LRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
|.++|++|||++.+|.|||.+..+.+
T Consensus 255 ltknpKkRptaeklL~h~fvs~~l~~ 280 (829)
T KOG0576|consen 255 LTKNPKKRPTAEKLLQHPFVSQTLSR 280 (829)
T ss_pred hcCCCccCCChhhheeceeeccchhh
Confidence 99999999999999999999987543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=270.22 Aligned_cols=194 Identities=24% Similarity=0.309 Sum_probs=148.4
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC----eE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN----HI 168 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~----~~ 168 (433)
..++.+.||+|.||.||+|+. +++.||||++...+ .+.+..|-+|.... +..|+||+++++.-.... .+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp---~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE--KQSFQNEKNIYSLP---GMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCHHH--HHHHHhHHHHHhcc---CccchhHHHhhchhccCCccccce
Confidence 467889999999999999974 56899999997544 35566666655432 334444599988766544 89
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEecCCCCCcEEEeeCCcccccCc
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---------RLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
+||++|. .|+|.++|..+ .+++....+++..|++||+|||+. .|+|||||..|||+.+++.+.|+||
T Consensus 284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999 99999999987 599999999999999999999973 5999999999999988876655555
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCC-CC-----ccchHHHHHHHHHHHH
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WN-----YPCDLWSVGCILVELC 312 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~el~ 312 (433)
|++.+...... ......-+||..|||||++.+.. +. .+.||||+|.+||||+
T Consensus 361 GLAl~~~p~~~----------------------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 361 GLALRLEPGKP----------------------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred ceeEEecCCCC----------------------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 55433221110 01111248999999999998752 22 4689999999999999
Q ss_pred hCCCCC
Q 013941 313 SGEALF 318 (433)
Q Consensus 313 ~g~~pf 318 (433)
+...-+
T Consensus 419 SRC~~~ 424 (534)
T KOG3653|consen 419 SRCTDA 424 (534)
T ss_pred hhcccc
Confidence 875544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.54 Aligned_cols=187 Identities=18% Similarity=0.277 Sum_probs=154.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
..|...+.||+|+||.||+|++..+++.||+|.+..... ....|++++++++|+|| +++++++.+.+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnI-----v~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNI-----VKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCc-----ceEEEEEEcCCCCEEE
Confidence 346677889999999999999989999999999864332 22346888999988887 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH---ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|||+ +++|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..
T Consensus 762 ~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~-------------- 822 (968)
T PLN00113 762 HEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP-------------- 822 (968)
T ss_pred EeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCce--------------
Confidence 9999 999999995 3789999999999999999999 6699999999999999765532
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
++. ||.+..... .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 823 -------------~~~-~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 823 -------------HLR-LSLPGLLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -------------EEE-ecccccccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 222 333222111 1123678999999999998999999999999999999999999953
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.64 Aligned_cols=200 Identities=20% Similarity=0.216 Sum_probs=155.3
Q ss_pred CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++++||+++++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+..|.++++|||.+....
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 4678889999899999997542 469999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC-------------------CcccccCCcccchhhhhCCCCCccchHHHHHH
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------------------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (433)
. +....+|++|||+++..... ....+||+.|||||++.+..++.++|||||||
T Consensus 132 ~--------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGv 203 (793)
T PLN00181 132 S--------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGV 203 (793)
T ss_pred c--------cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHH
Confidence 2 23457899999998642210 01136899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhh
Q 013941 307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386 (433)
Q Consensus 307 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
+||||++|..|+.... .....+... ..|...
T Consensus 204 iL~ELl~~~~~~~~~~--~~~~~~~~~--~~~~~~--------------------------------------------- 234 (793)
T PLN00181 204 LLFELFCPVSSREEKS--RTMSSLRHR--VLPPQI--------------------------------------------- 234 (793)
T ss_pred HHHHHhhCCCchhhHH--HHHHHHHHh--hcChhh---------------------------------------------
Confidence 9999999988875321 111111110 001000
Q ss_pred ccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 387 ~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
........+++.+||+.||.+|||+.|+++||||.+.
T Consensus 235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred --hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0012345688999999999999999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=246.49 Aligned_cols=200 Identities=26% Similarity=0.354 Sum_probs=168.2
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc-eeccCCe
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN-WFDYRNH 167 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~-~~~~~~~ 167 (433)
.+.+.|.|.+.||+|.||.+.+|+++.++..+++|.+.+......++.+|...--.|.+| .||+.-++ .|+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H----~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPH----QHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccc----hhhhHHHHHHhhcCce
Confidence 345789999999999999999999999999999999988777778888888665555533 33365554 4778889
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
++++|||+ -|+|..-+... .+.|...+.++.|+++||.|+|++++||||||.+||||-..
T Consensus 97 YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~---------------- 157 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA---------------- 157 (378)
T ss_pred EEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC----------------
Confidence 99999999 99999888765 48899999999999999999999999999999999999653
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC-----CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
+..++||||||.++..+..-...-.+..|.+||+.... ...+.+|||.||+++|.++||.+||+.
T Consensus 158 ---------df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 158 ---------DFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ---------CccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 23479999999998776665556667789999987643 246889999999999999999999974
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=273.38 Aligned_cols=242 Identities=21% Similarity=0.274 Sum_probs=192.3
Q ss_pred eEEeccccccccEEEEEEEecCCCc----EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.+..++||+|+||+||+|.+-..|+ +||+|++.... +...++..|+.++.++.|+|+ +++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl-----~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNL-----LRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchH-----HHHhhhcccch-
Confidence 4456799999999999998766554 68999886533 446788899999999999888 99999998765
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+.||++|+ .|+|.++++.+. ..+-......|..||++|+.|||++++|||||-..|||+.+..++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hv------------- 837 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHV------------- 837 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeE-------------
Confidence 88999999 999999998765 478889999999999999999999999999999999999876655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcc---c--ccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY---V--VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 320 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~--~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~ 320 (433)
|+.|||+++........ . .-.+.|||-|.+....|+.++|||||||++||++| |..|+.+
T Consensus 838 --------------kitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 838 --------------KITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred --------------EEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 55555555443322211 1 12457999999999999999999999999999998 9999988
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....++-..+ +.+.++ ..++..+.++.-++.
T Consensus 904 i~~~eI~dll-----------------------e~geRL--------------------------sqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 904 IPAEEIPDLL-----------------------EKGERL--------------------------SQPPICTIDVYMVMV 934 (1177)
T ss_pred CCHHHhhHHH-----------------------hccccC--------------------------CCCCCccHHHHHHHH
Confidence 7655433222 222221 223455778999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 013941 401 GLLRYDPAERLKAREALR 418 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~ 418 (433)
+||..|+..||+++++.+
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999998753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=275.17 Aligned_cols=244 Identities=24% Similarity=0.429 Sum_probs=191.1
Q ss_pred CeEEeccccccccEEEEEEEec---C----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceeEeccee
Q 013941 93 RYRILSKMGEGTFGQVVECFDN---E----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~---~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~ 162 (433)
+..+.+.||+|.||.|++|.-. . ....||||.++... ...+.+..|+++++.+. |+|+ +.+.+.+
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~ni-----v~llG~~ 371 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNI-----VNLLGAC 371 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcch-----hhheeee
Confidence 3456679999999999999732 1 14579999987432 45677889999999997 4454 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEE
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNS------------Y--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli 227 (433)
...+.+++|+||+ .|+|.++++.+. . ..++..+...++.||+.|++||+++++|||||-..|||+
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI 451 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence 9999999999999 999999998765 0 138899999999999999999999999999999999999
Q ss_pred eeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCccc----ccC--CcccchhhhhCCCCCccchH
Q 013941 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV----VST--RHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 228 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~----~gt--~~y~aPE~~~~~~~~~~~Di 301 (433)
+.+. .+||+|||+|+.......+. .|+ ..|||||.+....|+.++||
T Consensus 452 ~~~~---------------------------~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDV 504 (609)
T KOG0200|consen 452 TKNK---------------------------VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDV 504 (609)
T ss_pred cCCC---------------------------EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchh
Confidence 7654 46777777776433322221 222 34999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC
Q 013941 302 WSVGCILVELCS-GEALFQTHE-NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379 (433)
Q Consensus 302 wSlG~il~el~~-g~~pf~~~~-~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
||||++|||+++ |..||.+.. ..+.... .+.|.+..
T Consensus 505 WSfGI~L~EifsLG~~PYp~~~~~~~l~~~-----------------------l~~G~r~~------------------- 542 (609)
T KOG0200|consen 505 WSFGILLWEIFTLGGTPYPGIPPTEELLEF-----------------------LKEGNRME------------------- 542 (609)
T ss_pred hHHHHHHHHHhhCCCCCCCCCCcHHHHHHH-----------------------HhcCCCCC-------------------
Confidence 999999999999 899998744 3332221 22222222
Q ss_pred chhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHh
Q 013941 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 417 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell 417 (433)
.+..++.++.++++.||+.+|++||+..++.
T Consensus 543 -------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 543 -------QPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred -------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 2334577899999999999999999998876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=230.83 Aligned_cols=207 Identities=39% Similarity=0.625 Sum_probs=178.8
Q ss_pred ccccccEEEEEEEecCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-C
Q 013941 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (433)
Q Consensus 100 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~ 176 (433)
||+|++|.||++.+..+++.+++|++..... ..+.+.+|+..++.+.|+++ +++++++......+++||++ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI-----VKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCe-----eeEeeeeecCCeEEEEEecCCC
Confidence 6899999999999988899999999976544 25678899999999988666 99999999989999999999 6
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee-CCcccccCccccccCCCCCCcccCCC
Q 013941 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLP 255 (433)
Q Consensus 177 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~-~~~~~l~d~~~~~~~~~~~~~~~~~~ 255 (433)
++|.+++.... ..++...+..++.+++.+|++||++|++|+||+|.||+++. ++
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~------------------------ 130 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG------------------------ 130 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC------------------------
Confidence 99999998652 35899999999999999999999999999999999999975 33
Q ss_pred CCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 013941 256 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331 (433)
Q Consensus 256 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~ 331 (433)
.++|+|||.+...... .....+...|++||.+... .++.++|+|+||+++++| .
T Consensus 131 ---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------~------ 188 (215)
T cd00180 131 ---KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------P------ 188 (215)
T ss_pred ---cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------H------
Confidence 5777777777654443 2335678899999999887 788999999999999998 0
Q ss_pred HHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCC
Q 013941 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL 411 (433)
Q Consensus 332 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ 411 (433)
.+.+++.+||+.||++||
T Consensus 189 --------------------------------------------------------------~~~~~l~~~l~~~p~~R~ 206 (215)
T cd00180 189 --------------------------------------------------------------ELKDLIRKMLQKDPEKRP 206 (215)
T ss_pred --------------------------------------------------------------HHHHHHHHHhhCCcccCc
Confidence 567999999999999999
Q ss_pred CHHHHhcCC
Q 013941 412 KAREALRHP 420 (433)
Q Consensus 412 ta~ell~hp 420 (433)
++.++++|+
T Consensus 207 ~~~~l~~~~ 215 (215)
T cd00180 207 SAKEILEHL 215 (215)
T ss_pred CHHHHhhCC
Confidence 999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=230.11 Aligned_cols=193 Identities=39% Similarity=0.635 Sum_probs=166.2
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
|.+.+.||+|++|.||++.+..+++.+|+|.+..... ..+.+.+|++.++++.|+++ +++++++......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i-----~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNI-----VKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCh-----hhheeeeecCCceEEE
Confidence 5678999999999999999988899999999975432 45678889999999987776 9999999888999999
Q ss_pred EccC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 172 FEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+|++ +++|.+++.... . +++..+..++.+++.+|.+||+++++|+||+|+||+++.++
T Consensus 76 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~------------------ 135 (225)
T smart00221 76 MEYCEGGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG------------------ 135 (225)
T ss_pred EeccCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------------------
Confidence 9999 779999998754 3 88999999999999999999999999999999999996544
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhh-hCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||.+....... ....++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 136 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 136 ---------LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---------CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 56777777766544332 345778899999998 666788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=231.12 Aligned_cols=253 Identities=17% Similarity=0.205 Sum_probs=186.8
Q ss_pred cCCCeEEeccccccccEEEEEEEecCC-----CcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
-..|++....+-+|.||.||.|.+++. .+.|-+|.++... .....+..|.-.+..+.|+|+ ..+.++.
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nl-----l~V~~V~ 356 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNL-----LSVLGVS 356 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCc-----cceeEEE
Confidence 346789999999999999999965432 3446667665322 233445566666666777766 7776665
Q ss_pred c-cCCeEEEEEccC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 163 D-YRNHICIVFEKL-GPSLYDFLRKN------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 163 ~-~~~~~~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
. +....++++.++ -|+|..++... .-+.++..+...++.|++.|++|||+.||||.||-..|++|++.-.+|
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 4 456778889999 78999999822 224577788889999999999999999999999999999998766655
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 313 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~- 313 (433)
++|-.+++...+. |+..-... --....|||||.+.+..|+.++|+|||||+||||+|
T Consensus 437 ltDsaLSRDLFP~----------------DYhcLGDn------EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtl 494 (563)
T KOG1024|consen 437 LTDSALSRDLFPG----------------DYHCLGDN------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTL 494 (563)
T ss_pred eccchhccccCcc----------------cccccCCC------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence 5555544433222 11111000 012356999999999999999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|+.|+..-+..+....+.. |.++ ..+-.+++
T Consensus 495 g~~PyaeIDPfEm~~ylkd-----------------------GyRl--------------------------aQP~NCPD 525 (563)
T KOG1024|consen 495 GKLPYAEIDPFEMEHYLKD-----------------------GYRL--------------------------AQPFNCPD 525 (563)
T ss_pred CCCCccccCHHHHHHHHhc-----------------------ccee--------------------------cCCCCCcH
Confidence 9999998888776655543 2111 22345678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
++..++.-||..+|++||+.+|+..
T Consensus 526 eLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 526 ELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=216.93 Aligned_cols=167 Identities=23% Similarity=0.277 Sum_probs=123.8
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCC
Q 013941 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256 (433)
Q Consensus 177 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 256 (433)
|+|.+++...+ ..+++..++.++.||+.||+|||+++ ||+|||++.++.
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~------------------------ 49 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL------------------------ 49 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc------------------------
Confidence 68999998643 36999999999999999999999999 999999976654
Q ss_pred CCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhc
Q 013941 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE-HLAMMERVLG 335 (433)
Q Consensus 257 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~ 335 (433)
+++ ||++....... ..||+.|||||++.+..++.++|||||||++|||++|..||....... .+..+.....
T Consensus 50 ---~~~--fG~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 50 ---LKL--DGSVAFKTPEQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred ---eee--ccceEeecccc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 444 66655433322 268999999999999999999999999999999999999997544321 1222211110
Q ss_pred CCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch--HHHHHHHHHhcccCCCCCCCH
Q 013941 336 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA--GDLIDLLQGLLRYDPAERLKA 413 (433)
Q Consensus 336 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~L~~dP~~R~ta 413 (433)
... +... ......+ ..+.++|.+||..||++|||+
T Consensus 123 ~~~-----------------------~~~~--------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~ 159 (176)
T smart00750 123 ADD-----------------------PRDR--------------------SNLESVSAARSFADFMRVCASRLPQRREAA 159 (176)
T ss_pred cCC-----------------------cccc--------------------ccHHHHHhhhhHHHHHHHHHhcccccccCH
Confidence 000 0000 0000112 268999999999999999999
Q ss_pred HHHhcCCCCCC
Q 013941 414 REALRHPFFTR 424 (433)
Q Consensus 414 ~ell~hp~f~~ 424 (433)
.|+++|+|+..
T Consensus 160 ~~ll~~~~~~~ 170 (176)
T smart00750 160 NHYLAHCRALF 170 (176)
T ss_pred HHHHHHHHHHH
Confidence 99999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=226.75 Aligned_cols=210 Identities=28% Similarity=0.360 Sum_probs=172.1
Q ss_pred CeEEeccccccccEEEEEEEecCCC-cEEEEEEeccchhh-HHHHHHHHHHHHHHHhCCCCCcceeEeccee-ccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~-~~~~~~~ 169 (433)
+|.+.++||+|+||.||+|.+..++ ..+|+|+....... ...+..|+.++..+.. .....++..+++.. ......|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeE
Confidence 7999999999999999999987775 67899987654322 2267789999999985 22334568888888 5788999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||+.+|.+|.++......+.++..++..++.|++.+|++||+.|++||||||+|+++...+
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~------------------ 159 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSS------------------ 159 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCC------------------
Confidence 99999999999998766667899999999999999999999999999999999999996532
Q ss_pred cccCCCCCCCeeeecCCCCc--cc----c-----CC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTT--FE----H-----QD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~--~~----~-----~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
......+.|.|||+++ .. . .. .....||..|+++.+..+...+.+.|+||++.++.+++.|..
T Consensus 160 ----~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 160 ----RSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred ----CcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 0122468889999887 21 0 00 122469999999999999999999999999999999999999
Q ss_pred CCCCCChHH
Q 013941 317 LFQTHENLE 325 (433)
Q Consensus 317 pf~~~~~~~ 325 (433)
||.+.....
T Consensus 236 PW~~~~~~~ 244 (322)
T KOG1164|consen 236 PWEALEMTD 244 (322)
T ss_pred CCccccccc
Confidence 997765433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=215.99 Aligned_cols=204 Identities=25% Similarity=0.345 Sum_probs=174.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
-.|+|.++||+|+||+++.|.+..+++.||||.-.... ...++..|....+.|... +.|..++-+...+.+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~----~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGT----EGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCC----CCCCceeeeccccchhhhh
Confidence 46999999999999999999999999999999865432 234577788888888732 3446777777888899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
+|++|.+|.|+..-.+ +.|+..++..++.||+.-++|+|++.+|.|||||+|+||...+
T Consensus 103 idLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~-------------------- 161 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPG-------------------- 161 (449)
T ss_pred hhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCC--------------------
Confidence 9999999999988665 6899999999999999999999999999999999999998765
Q ss_pred cCCCCCCCeeeecCCCCccccCCC----------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
..+...+.++|||+|+...+.. ....||..||+-....|...+.+-|+-|||-+++.++-|..||.+-
T Consensus 162 --~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 162 --TKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred --CCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 2455679999999998654432 3368999999999999999999999999999999999999999875
Q ss_pred Ch
Q 013941 322 EN 323 (433)
Q Consensus 322 ~~ 323 (433)
..
T Consensus 240 KA 241 (449)
T KOG1165|consen 240 KA 241 (449)
T ss_pred cC
Confidence 43
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=210.33 Aligned_cols=214 Identities=26% Similarity=0.382 Sum_probs=175.2
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
..++|.++++||+|+||.+|+|....+|+.||||+-++... ...+..|..+...|++. ..+..+.-+..+.++-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g----~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGG----VGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccC----CCCchhhhhccccccce
Confidence 35789999999999999999999999999999998765333 34567789999888753 22255666677888899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||+++|.+|.+++.-.. +.++..++.-++-|++.-++|+|.+++|||||||+|+|+.-+.+
T Consensus 88 lVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh----------------- 149 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRH----------------- 149 (341)
T ss_pred eeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccc-----------------
Confidence 999999999999987544 57999999999999999999999999999999999999965442
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
...+.|+|||+|+...+.. ....||..|.+--...+...+...|+=|+|.+|..+..|..||+
T Consensus 150 -------~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 150 -------CNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred -------cceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 3468999999997543322 33589999999888888788899999999999999999999999
Q ss_pred CCChHH---HHHHHHHH
Q 013941 320 THENLE---HLAMMERV 333 (433)
Q Consensus 320 ~~~~~~---~~~~i~~~ 333 (433)
+-.... ..+.|.+.
T Consensus 223 glka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEK 239 (341)
T ss_pred ccchhhHHHHHHHHHHh
Confidence 865433 34444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=245.99 Aligned_cols=259 Identities=20% Similarity=0.305 Sum_probs=185.5
Q ss_pred CCe-EEeccccccccEEEEEEEecCCCcEEEEEEec----cchhh---HHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 92 PRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKY---REAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
+.| .....+|.|++|.|+.+......+.++.|.++ ..... ...+..|+-+-..+.|+++ +.....+.
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~-----~e~l~~~~ 391 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNI-----IETLDIVQ 391 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCch-----hhhHHHHh
Confidence 345 45678999999989888877777666666554 21111 1114446666667777766 66666666
Q ss_pred cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
+.....-+||||.++|..++.... .+....+..++.||+.||+|||+.||.|||||++|++++..|.
T Consensus 392 ~~~~~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~----------- 458 (601)
T KOG0590|consen 392 EIDGILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI----------- 458 (601)
T ss_pred hcccchhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc-----------
Confidence 555555559999339999998763 6889999999999999999999999999999999999987774
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC-------CcccccCCcccchhhhhCCCCC-ccchHHHHHHHHHHHHhCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~ 315 (433)
+||+|||.+...... ....+|+..|+|||++.+..|+ ..+||||.|++++.|.+|+
T Consensus 459 ----------------lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 459 ----------------LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred ----------------eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 566666655432211 1235899999999999999987 5689999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||......+... .. ..+........... .....++...
T Consensus 523 ~~Wk~a~~~~~~~--~~--------------------------~~~~~~~~~~~~~~-------------~~~~~lp~~~ 561 (601)
T KOG0590|consen 523 FPWKVAKKSDNSF--KT--------------------------NNYSDQRNIFEGPN-------------RLLSLLPRET 561 (601)
T ss_pred Cccccccccccch--hh--------------------------hccccccccccChH-------------HHHHhchhhH
Confidence 9996544322110 00 00000000000111 1122346688
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 562 ~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 562 RIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 999999999999999999999999999974
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=236.47 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=182.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHH---HHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAM---IEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~---~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.|...+.||++.|=.|.+|++.+ |. |+||++-+.. -....+. +|++ ...+++ |||+.+..+...+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~-----pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKA-----PNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcC-----CcccchHHHHHhhHH
Confidence 58889999999999999998654 44 9999986433 1222333 3443 333444 455888888888889
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
.|||-+|...+|+|.+..+. -+..-+.+.|+.||+.||..+|..||+|||||.+||||++-+.+.|+||.-.+.....
T Consensus 96 AylvRqyvkhnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHHHhhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 99999999889999998775 5778888999999999999999999999999999999999999999999876655443
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC----------C-CCccchHHHHHHHHHHHHh-CC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL----------G-WNYPCDLWSVGCILVELCS-GE 315 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~el~~-g~ 315 (433)
.+ --+||++-....... ..|.|||.+... . .+++.||||+||+++||++ |+
T Consensus 174 eD-----------NPadf~fFFDTSrRR------tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~ 236 (1431)
T KOG1240|consen 174 ED-----------NPADFTFFFDTSRRR------TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGR 236 (1431)
T ss_pred CC-----------CcccceEEEecCCce------eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCC
Confidence 32 124665433222222 359999988641 2 5788999999999999998 79
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
+||.- .++-...+.-... ++..++..+ +..+
T Consensus 237 PlF~L----SQL~aYr~~~~~~-------------------------------------------~e~~Le~Ie--d~~~ 267 (1431)
T KOG1240|consen 237 PLFTL----SQLLAYRSGNADD-------------------------------------------PEQLLEKIE--DVSL 267 (1431)
T ss_pred CcccH----HHHHhHhccCccC-------------------------------------------HHHHHHhCc--CccH
Confidence 99941 1221111110000 111111111 3378
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~h 419 (433)
++||..|++.||++|.+|++.|+-
T Consensus 268 Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 268 RNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHHHccCchhccCHHHHHHh
Confidence 999999999999999999999974
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=216.45 Aligned_cols=158 Identities=20% Similarity=0.171 Sum_probs=119.3
Q ss_pred cCCCeEEeccccccccEEEEEEEecC-CCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCccee-Eecce
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCV-QIRNW 161 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~i~~~~~v-~~~~~ 161 (433)
+.++|.+.+.||+|+||+||+|++.. +++.||||++... ......+.+|+++|+++.|+++ + .++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~i-----v~~l~~~ 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGV-----VPQLLAT 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCC-----CcEEEEc
Confidence 45679999999999999999999876 6788899986522 2234568899999999999887 4 34432
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCC-CCCcEEEeeCCcccccCcc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi-kp~NIli~~~~~~~l~d~~ 239 (433)
+..|+||||+ |++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~------- 150 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE------- 150 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC-------
Confidence 4579999999 888863 211 11 1467899999999999999999999 999999976554
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----------CcccccCCcccchhhhhC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----------HSYVVSTRHYRAPEVILG 292 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~ 292 (433)
++|+|||+|...... -.+..++..|+|||.+..
T Consensus 151 --------------------ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 151 --------------------AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred --------------------EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 566666665532221 124578888999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=229.38 Aligned_cols=236 Identities=25% Similarity=0.389 Sum_probs=187.8
Q ss_pred cccccccEEEEEEEe---cCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccCCeEEEE
Q 013941 99 KMGEGTFGQVVECFD---NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
.+|+|.||.|++++. ...+..+|+|+.++.. ........|..++..++ |+.+ ++++..++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~-----v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFL-----VKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCce-----eeeeeeeccccchhHh
Confidence 479999999998752 3457789999886432 11223445777777776 4444 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
+++. |++|...+.+.. .+.+...+.+...++.|++++|+.||+|||+|++||+++.+|+
T Consensus 76 ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh------------------ 135 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH------------------ 135 (612)
T ss_pred hhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc------------------
Confidence 9999 889988887654 7888999999999999999999999999999999999987775
Q ss_pred ccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i 330 (433)
+++.|||.++..-..... +||..|||||++. ....++|.||||++++||++|..||.+ +....|
T Consensus 136 ---------i~~tdfglske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I 199 (612)
T KOG0603|consen 136 ---------IKLTDFGLSKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI 199 (612)
T ss_pred ---------cccCCchhhhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH
Confidence 455666665543333222 8999999999998 578899999999999999999999987 444555
Q ss_pred HHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCC
Q 013941 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410 (433)
Q Consensus 331 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 410 (433)
.+.....|. ..+..+++++..|+..+|.+|
T Consensus 200 l~~~~~~p~--------------------------------------------------~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 200 LKAELEMPR--------------------------------------------------ELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhccCCch--------------------------------------------------hhhHHHHHHHHHHHhhCHHHH
Confidence 443333332 336688999999999999999
Q ss_pred CC-----HHHHhcCCCCCCC
Q 013941 411 LK-----AREALRHPFFTRD 425 (433)
Q Consensus 411 ~t-----a~ell~hp~f~~~ 425 (433)
.. +.|+++|+||+..
T Consensus 230 Lg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 230 LGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred hccCcchhHHHhccchheee
Confidence 85 5899999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-24 Score=204.67 Aligned_cols=256 Identities=33% Similarity=0.496 Sum_probs=195.4
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhC-CCCCcceeEecceeccCCeE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~-~i~~~~~v~~~~~~~~~~~~ 168 (433)
|.+.+.||.|+||.||++.+. ..+++|.+..... ....+.+|+.++..+.|+ ++ +.+.+.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI-----VKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcce-----eeEEEEEecCCEE
Confidence 788999999999999999987 7789999875332 356788899999999988 45 9999999877889
Q ss_pred EEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+++++++ ++++.+++..... ..+....+..++.|++.+|.|+|+.|++|||+||+||+++..+.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-------------- 139 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-------------- 139 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--------------
Confidence 9999999 8999977765431 16899999999999999999999999999999999999976541
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC---------CCcccccCCcccchhhhhC---CCCCccchHHHHHHHHHHHHhC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---------DHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g 314 (433)
.++++|||.+..... ......||..|+|||.+.+ ..++...|+||+|++++++++|
T Consensus 140 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 140 ------------VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred ------------eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhC
Confidence 467777776653322 1244689999999999988 5788999999999999999999
Q ss_pred CCCCCCCCh----HHHHHHHHHHhcC-CChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 315 EALFQTHEN----LEHLAMMERVLGP-LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 315 ~~pf~~~~~----~~~~~~i~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
..||..... ......+.....+ .... .... ...
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~----------------------~~~ 245 (384)
T COG0515 208 LPPFEGEKNSSATSQTLKIILELPTPSLASP--------------------LSPS----------------------NPE 245 (384)
T ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccccc--------------------cCcc----------------------ccc
Confidence 999877654 2222222221111 0000 0000 001
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 390 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.....+.+++.+++..+|..|.+..+...++|....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 246 LISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred hhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 113478899999999999999999998888766653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=224.16 Aligned_cols=234 Identities=26% Similarity=0.436 Sum_probs=167.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
..|..++.|..|+||.||+++++.+.+.+|+|+ ++.+. +.+- |+.....+ +.|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn--ilt~a~np--------------------fvv 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN--ILTFAGNP--------------------FVV 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc--cccccCCc--------------------cee
Confidence 469999999999999999999999999999965 22211 1110 11111111 111
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
|+=...+..-+ .++.. ++.+++|||+-||+|||+||+|.+|+.-|++|++|||+.+........
T Consensus 136 -----gDc~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at- 199 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT- 199 (1205)
T ss_pred -----chhhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc-
Confidence 23333333322 34332 378999999999999999999999999999999988886654333211
Q ss_pred cCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i 330 (433)
..| .-++.....+ ....++||+.|+|||++..+.|+..+|+|++|+|+||.+.|..||.+++..+.+..+
T Consensus 200 -------nl~--eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 200 -------NLK--EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred -------hhh--hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 000 0001111111 123369999999999999999999999999999999999999999999988887776
Q ss_pred HHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCC
Q 013941 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410 (433)
Q Consensus 331 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 410 (433)
...... |++. .....++++++|.++|+.+|..|
T Consensus 271 isd~i~------------------------wpE~-----------------------dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 271 ISDDIE------------------------WPEE-----------------------DEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred hhhhcc------------------------cccc-----------------------CcCCCHHHHHHHHHHHHhChHhh
Confidence 654333 3332 13446799999999999999999
Q ss_pred C---CHHHHhcCCCCCC
Q 013941 411 L---KAREALRHPFFTR 424 (433)
Q Consensus 411 ~---ta~ell~hp~f~~ 424 (433)
. .+-+|.+|+||+.
T Consensus 304 lgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 304 LGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cccchhhhhhhccceee
Confidence 6 5789999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=189.71 Aligned_cols=176 Identities=13% Similarity=0.155 Sum_probs=127.0
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhH----HH------HHHHHHHHHHHHhCCCCCcceeE
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EA------AMIEIDVLQRLARHDIGGTRCVQ 157 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~------~~~E~~~l~~l~~~~i~~~~~v~ 157 (433)
+.+.++|++++.||.|+||.||++.+ ++..+|+|+++...... .. +.+|+..+.++.|+++..+....
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 45678999999999999999999765 46679999997432211 12 57899999999999984443221
Q ss_pred e---cceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 158 I---RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 158 ~---~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
. ...+...+..+|||||+ |.+|.++. .+++. ...+++.+|..||+.|++|||+||+||+++.+|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-- 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-- 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--
Confidence 1 11122245689999999 78998773 23332 456999999999999999999999999996533
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHH
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (433)
++|+|||........... -.++....|+.++||||||+++..+.
T Consensus 173 --------------------------i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 --------------------------LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred --------------------------EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 788888876544222111 11444556778999999999886553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=192.81 Aligned_cols=202 Identities=21% Similarity=0.252 Sum_probs=125.3
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHH----------hCCC-CCcceeE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA----------RHDI-GGTRCVQ 157 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~----------~~~i-~~~~~v~ 157 (433)
.+...+.||.|+++.||.+++..|++.+|+|++.... ...+.+.+|.-....+. |-.+ ...-+++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3677889999999999999999999999999985322 22334444442222211 1011 0011122
Q ss_pred ecc---eeccC---C-----eEEEEEccCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCC
Q 013941 158 IRN---WFDYR---N-----HICIVFEKLGPSLYDFLRK---NSYR--SFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221 (433)
Q Consensus 158 ~~~---~~~~~---~-----~~~lv~e~~~~~L~~~l~~---~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik 221 (433)
+.+ ++... . ..+++|+-+.++|.+++.. .... .+.......+..|+++.+++||+.||||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 211 11111 1 2478899888899888652 2211 12233345667999999999999999999999
Q ss_pred CCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC--------
Q 013941 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-------- 293 (433)
Q Consensus 222 p~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-------- 293 (433)
|+|++++.+|. ++|+||+.....+........+..|.+||.....
T Consensus 173 ~~nfll~~~G~---------------------------v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~ 225 (288)
T PF14531_consen 173 PENFLLDQDGG---------------------------VFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNA 225 (288)
T ss_dssp GGGEEE-TTS----------------------------EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEE
T ss_pred eeeEEEcCCCC---------------------------EEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccc
Confidence 99999987774 5666665444333322222445679999987542
Q ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 294 GWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 294 ~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.++.+.|.|+||+++|.|++|..||...
T Consensus 226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 226 PYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp EE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 4788999999999999999999999754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=193.50 Aligned_cols=188 Identities=22% Similarity=0.303 Sum_probs=142.3
Q ss_pred CCcceeEecceecc---------------------------CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHH
Q 013941 151 GGTRCVQIRNWFDY---------------------------RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203 (433)
Q Consensus 151 ~~~~~v~~~~~~~~---------------------------~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi 203 (433)
.|||||++...|.+ ...+|+||..+..+|.+++..+ ..+....+-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~---~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR---HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC---CCchHHHHHHHHHH
Confidence 57888999888753 2368999999999999999876 47888899999999
Q ss_pred HHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC---------C
Q 013941 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---------D 274 (433)
Q Consensus 204 ~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---------~ 274 (433)
++|+.|||.+||.|||+|.+|||+.-+. |.-..+.|+|||++--.+. .
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~Eldd-----------------------D~~P~LVvaDFGCcLAd~~hGlqlpy~S~ 407 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDD-----------------------DEIPQLVVADFGCCLADDNHGLQLPYESD 407 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecC-----------------------CCCcEEEEcccceeeeccccccccccccc
Confidence 9999999999999999999999996543 3445678999997643221 1
Q ss_pred CcccccCCcccchhhhhCCC-----C-CccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhcCCChhhHHhhh
Q 013941 275 HSYVVSTRHYRAPEVILGLG-----W-NYPCDLWSVGCILVELCSGEALFQTHENLEH--LAMMERVLGPLPHHMVIRAD 346 (433)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~-----~-~~~~DiwSlG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~p~~~~~~~~ 346 (433)
.....|...-||||+....+ . -.++|.|+.|.+.||+++...||.+...... ...-+..+.
T Consensus 408 ~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP----------- 476 (598)
T KOG4158|consen 408 EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP----------- 476 (598)
T ss_pred cccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-----------
Confidence 12246788899999987543 1 2589999999999999999999976322110 000001111
Q ss_pred hhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHH
Q 013941 347 RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAR 414 (433)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ 414 (433)
..++.+++.+++++..+|+.||++|+++.
T Consensus 477 ---------------------------------------alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 477 ---------------------------------------ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ---------------------------------------CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 12345678999999999999999999843
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=181.00 Aligned_cols=137 Identities=22% Similarity=0.229 Sum_probs=106.0
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchh---h------------------------HHHHHHHHHHHHHHHhCC
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---Y------------------------REAAMIEIDVLQRLARHD 149 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~------------------------~~~~~~E~~~l~~l~~~~ 149 (433)
...||+|+||.||+|.+. +|+.||||+++.... . .....+|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 899999999975321 0 112345999999999988
Q ss_pred CCCcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecCCCCCcEEE
Q 013941 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLKPENILL 227 (433)
Q Consensus 150 i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivHrDikp~NIli 227 (433)
+..+.++.. .+ .+|||||+ |+++....... ..+++..+..++.||+.+|.++ |+.||+||||||+|||+
T Consensus 81 v~~p~~~~~------~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL------KS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe------cC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 755544321 12 37999999 65665443332 3689999999999999999999 79999999999999999
Q ss_pred eeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccc
Q 013941 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271 (433)
Q Consensus 228 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 271 (433)
+. + .++|+|||+|...
T Consensus 152 ~~-~---------------------------~v~LiDFG~a~~~ 167 (190)
T cd05147 152 HD-G---------------------------KLYIIDVSQSVEH 167 (190)
T ss_pred EC-C---------------------------cEEEEEccccccC
Confidence 62 2 4899999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=175.05 Aligned_cols=137 Identities=20% Similarity=0.151 Sum_probs=105.2
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhh---------------------------HHHHHHHHHHHHHHHhCC
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------------------------REAAMIEIDVLQRLARHD 149 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~~~~ 149 (433)
.+.||+|+||.||+|.+. +|+.||||+++..... .....+|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999998753210 122357899999999988
Q ss_pred CCCcceeEecceeccCCeEEEEEccC-CCCHHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEE
Q 013941 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF-LRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENIL 226 (433)
Q Consensus 150 i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~-l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIl 226 (433)
+..+..+.. . ..+|||||+ |+++... +.. ..++...+..++.|++.+|.++|+ +||+||||||+|||
T Consensus 81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEe-----c--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 744443321 1 248999999 5544333 333 257889999999999999999999 99999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
++ ++ .++|+|||++....
T Consensus 151 l~-~~---------------------------~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DG---------------------------KPYIIDVSQAVELD 168 (190)
T ss_pred EE-CC---------------------------CEEEEEcccceecC
Confidence 96 33 47888888876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=174.63 Aligned_cols=126 Identities=21% Similarity=0.236 Sum_probs=102.7
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC---e-EEEE
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---H-ICIV 171 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~---~-~~lv 171 (433)
.+.||+|+||.||. +..++.. +||++... ....+.+.+|+.+++.+.|.+..|+|+++++++++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46899999999995 6677665 69988653 23456788999999999988888888899999998863 4 4489
Q ss_pred EccC---CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcEecCCCCCcEEEeeC
Q 013941 172 FEKL---GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV-AFMHELRLIHTDLKPENILLVSA 230 (433)
Q Consensus 172 ~e~~---~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~ivHrDikp~NIli~~~ 230 (433)
|||+ +++|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++..
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~ 141 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRI 141 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEecc
Confidence 9994 58999999663 36665 35678888888 99999999999999999999753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=170.81 Aligned_cols=182 Identities=15% Similarity=0.121 Sum_probs=133.3
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHH-----HHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE-----AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.+...|++|+||+||++.. .+..++.+.+........ .+.+|+++|++|.|+ +++++++++ +..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~----~~vP~ll~~----~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGL----PRTPRLLHW----DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCC----CCCCEEEEE----cCEE
Confidence 3567999999999998864 677788777765443222 578899999999763 223666664 3469
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCC-CCCcEEEeeCCcccccCccccccCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi-kp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++|||+ |.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|
T Consensus 75 lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g---------------- 129 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG---------------- 129 (218)
T ss_pred EEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC----------------
Confidence 999999 8888654321 1 1357889999999999999999999 79999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCCc----------------ccccCCcccchhhhhCC-CCC-ccchHHHHHHHHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHS----------------YVVSTRHYRAPEVILGL-GWN-YPCDLWSVGCILV 309 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----------------~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~ 309 (433)
.++|+|||++........ ....++.|++|+...-. ..+ ...++++.|+-+|
T Consensus 130 -----------~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~ 198 (218)
T PRK12274 130 -----------SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVY 198 (218)
T ss_pred -----------CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHH
Confidence 467777777764433221 12357889999865433 334 5678899999999
Q ss_pred HHHhCCCCCCCCC
Q 013941 310 ELCSGEALFQTHE 322 (433)
Q Consensus 310 el~~g~~pf~~~~ 322 (433)
.++|+..++.+++
T Consensus 199 ~~~~~~~~~~~~~ 211 (218)
T PRK12274 199 RFVTRRVLHWEDN 211 (218)
T ss_pred HHHhccCCccccC
Confidence 9999998876544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=201.78 Aligned_cols=199 Identities=26% Similarity=0.395 Sum_probs=154.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
...|.|.+.||+|+||.||+|.... |+.||||+-+....+. +-.=.+++.+|+ +-+ .+.+..+...+...+.-+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk-~~~-~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLK-PQM-LPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhc-hhh-hcchHHHHHHHccCCccee
Confidence 3579999999999999999999877 9999999976543321 111122333443 110 1222666666677788899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
|+||. -|+|.+++... +.+++..+..+..||+.-+++||..+|||+||||+|+||...-. .|
T Consensus 772 v~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~---~~------------ 834 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC---AD------------ 834 (974)
T ss_pred eeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC---CC------------
Confidence 99999 99999999854 48999999999999999999999999999999999999964321 11
Q ss_pred cccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.+...++|+|||.+....- .-...++|-.+-.+|+..|.++++.+|.|.|..+++.||.|++
T Consensus 835 -----~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 835 -----SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred -----CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 1244689999998864331 1233578999999999999999999999999999999999964
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-22 Score=185.99 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=159.2
Q ss_pred CeEEeccccccccEEEEEEEecCC---CcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecc-------e
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRN-------W 161 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~-------~ 161 (433)
.+.+.+..+.++++.+...+...+ .+.++-|....+. .......+++..+....|++. ..+.+ .
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~-----s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNR-----SILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCc-----ccccCCCCchhhh
Confidence 455666677777777665553333 3334444333322 233344456656655555543 21111 1
Q ss_pred ec-----cCCeEEEEEccC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 162 FD-----YRNHICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 162 ~~-----~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
+. ...++||.|++| ..+|.++|... .....+......++.|++.|++| +|.+|||+||.||++..++.+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 11 123689999999 99999999733 33456778899999999999999 9999999999999987766555
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 313 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~- 313 (433)
|.|||+........+ ........+.-+||..||+||.+.+..|+.++||||||+||+|++.
T Consensus 397 IgDFgl~ts~~~~~~------------------~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~ 458 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDET------------------VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ 458 (516)
T ss_pred hhhhhheeecccCCc------------------ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH
Confidence 555554332221110 0000112234589999999999999999999999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHHH-hcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 314 GEALFQTHENLEHLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
=...|. ....+..+ -+.+|+.++ .. .
T Consensus 459 f~T~~e------r~~t~~d~r~g~ip~~~~----------------------------------------------~d-~ 485 (516)
T KOG1033|consen 459 FSTQFE------RIATLTDIRDGIIPPEFL----------------------------------------------QD-Y 485 (516)
T ss_pred hccHHH------HHHhhhhhhcCCCChHHh----------------------------------------------hc-C
Confidence 222221 11111110 112221110 11 1
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
+.-.+|+.+||...|.+||++.+.--|.|.+
T Consensus 486 p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 486 PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 2445899999999999999988888888753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=169.11 Aligned_cols=140 Identities=24% Similarity=0.191 Sum_probs=107.4
Q ss_pred eEEeccccccccEEEEEEE-ecCCCcEEEEEEeccchh-------------------------hHHHHHHHHHHHHHHHh
Q 013941 94 YRILSKMGEGTFGQVVECF-DNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLAR 147 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~-------------------------~~~~~~~E~~~l~~l~~ 147 (433)
|.+.+.||+|+||.||+|. +..+|+.||||+++.... ......+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8889999999999999998 677899999999874321 11235679999999987
Q ss_pred CCCCCcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEecCCCCCcE
Q 013941 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPENI 225 (433)
Q Consensus 148 ~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDikp~NI 225 (433)
..+..+ .++.+ ...++||||+ |.+|........ .+....+..++.||+.+|++||++| |+||||||+||
T Consensus 110 ~~i~~p---~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVP---KPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred cCCCCC---eeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 544222 22322 2348999999 667766543322 4666778899999999999999999 99999999999
Q ss_pred EEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcc
Q 013941 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270 (433)
Q Consensus 226 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 270 (433)
+++ ++ .++|+|||.+..
T Consensus 181 li~-~~---------------------------~i~LiDFg~a~~ 197 (237)
T smart00090 181 LVH-DG---------------------------KVVIIDVSQSVE 197 (237)
T ss_pred EEE-CC---------------------------CEEEEEChhhhc
Confidence 996 33 578999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=168.73 Aligned_cols=241 Identities=15% Similarity=0.201 Sum_probs=181.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
...++-+|.+...|+.|++++..+. ++.|++.- .......+..|.-.|+.+.|||| +.+++.+....++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpni-----lpvlgacnsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNI-----LPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCch-----hhhhhhccCCCCce
Confidence 3566789999999999999876544 66777652 22334567778888988999888 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
++..|| -|+|+..+.....-..+..++.+++.+|++|+.|||+.. |----|....++|+++-..+|
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltari----------- 332 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARI----------- 332 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhe-----------
Confidence 999999 999999999877667788999999999999999999875 334468888999987654333
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCC---ccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
..+|--++.. .....-.+.||+||.+...+-+ .++|+|||.+++|||.|...||.....
T Consensus 333 --------------smad~kfsfq----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 333 --------------SMADTKFSFQ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred --------------ecccceeeee----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 2233222211 1112447889999999877533 689999999999999999999987766
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+.--.|. +..+....++.++..+..|+.-|+
T Consensus 395 mecgmkia------------------------------------------------leglrv~ippgis~hm~klm~icm 426 (448)
T KOG0195|consen 395 MECGMKIA------------------------------------------------LEGLRVHIPPGISRHMNKLMNICM 426 (448)
T ss_pred hhhhhhhh------------------------------------------------hccccccCCCCccHHHHHHHHHHh
Confidence 55322221 111112234556788999999999
Q ss_pred ccCCCCCCCHHHHh
Q 013941 404 RYDPAERLKAREAL 417 (433)
Q Consensus 404 ~~dP~~R~ta~ell 417 (433)
..||.+||..+.++
T Consensus 427 nedpgkrpkfdmiv 440 (448)
T KOG0195|consen 427 NEDPGKRPKFDMIV 440 (448)
T ss_pred cCCCCcCCCcceeh
Confidence 99999999988764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8e-19 Score=156.42 Aligned_cols=118 Identities=22% Similarity=0.251 Sum_probs=94.8
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+.||+|++|.||+|.+ .+..|++|+..... .......+|+.++..+.++++..+.+ ++.+.+..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~-----~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAV-----YFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeE-----EEEeCCCC
Confidence 6799999999999986 66779999765311 11245678999999999988744433 33445678
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~ 228 (433)
++||||+ |++|.+++.... . ....++.+|+.+|.+||+.|++|+|++|+|||++
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS 129 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE
Confidence 8999999 889999986542 2 7889999999999999999999999999999996
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.6e-18 Score=150.75 Aligned_cols=128 Identities=23% Similarity=0.255 Sum_probs=99.0
Q ss_pred cccccccEEEEEEEecCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.||+|+||.||+|. .++..|++|+..... .....+.+|++++..+.++++..+.+. . ...+..+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~---~--~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVY---D--VDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEE---E--EECCCCE
Confidence 48999999999998 456789999864321 112456689999999998876443332 2 2345678
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ |++|.+++.... . .++.|++.+|.+||+.|++|+|++|+||+++ ++
T Consensus 74 lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~----------------- 126 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD----------------- 126 (199)
T ss_pred EEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-----------------
Confidence 999999 999998876432 1 7899999999999999999999999999996 33
Q ss_pred CcccCCCCCCCeeeecCCCCcc
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTF 270 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~ 270 (433)
.++++|||.+..
T Consensus 127 ----------~~~liDfg~a~~ 138 (199)
T TIGR03724 127 ----------KLYLIDFGLGKY 138 (199)
T ss_pred ----------cEEEEECCCCcC
Confidence 578888888765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=151.28 Aligned_cols=136 Identities=25% Similarity=0.249 Sum_probs=102.7
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-----------------------hHHHHHHHHHHHHHHHhCCC
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-----------------------YREAAMIEIDVLQRLARHDI 150 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~~~~i 150 (433)
|.+.+.||+|+||.||++... +|+.||||+++.... ......+|+.++..+.+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999864 799999998764220 11235678999999988754
Q ss_pred CCcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 151 ~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
.. ...++ ....++||||+ |++|...... .....++.+|+.++.++|+.||+||||||+||+++.
T Consensus 96 ~v---~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PV---PKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CC---Cceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence 22 22222 23458999999 8888765321 345678899999999999999999999999999965
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
++ .++|+|||++....
T Consensus 161 ~~---------------------------~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DE---------------------------KIYIIDWPQMVSTD 176 (198)
T ss_pred CC---------------------------cEEEEECCccccCC
Confidence 44 57888888775443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.4e-20 Score=184.13 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=188.1
Q ss_pred CeEEeccccccccEEEEEEEecC-CCcEEEEEEeccch---hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccCCe
Q 013941 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.|.+.+.||+|+|+.|-.+.... ....+|.|.+.... ........|..+-+.+. |.|+ +.+++...+.+.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~-----~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNT-----VHMIEPSSSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccc-----cccCCccCCCcc
Confidence 48888899999999999887643 34456777665332 23334445777777776 6555 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEecCCCCCcEEEeeCC-cccccCccccccC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAE-YVKVPDYKFLSRS 244 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDikp~NIli~~~~-~~~l~d~~~~~~~ 244 (433)
.++++++. |+++.+.+........+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~------------ 163 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSA------------ 163 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCc------------
Confidence 99999999 999998884222225778889999999999999999 99999999999999998766 4
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccC-C-----Cccccc-CCcccchhhhhCCC-CCccchHHHHHHHHHHHHhCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-D-----HSYVVS-TRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~-----~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~ 316 (433)
+++.|||+|..... . ....+| ++.|+|||...+.. .....|+||.|+++.-+++|..
T Consensus 164 ---------------l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~ 228 (601)
T KOG0590|consen 164 ---------------LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGEL 228 (601)
T ss_pred ---------------ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCC
Confidence 45555555543322 1 112477 99999999998854 4688999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
|+......... ...|.... .......+...+....
T Consensus 229 p~~~~~~~~~~------------------------------~~~~~~~~---------------~~~~~~~~~~~~~~~~ 263 (601)
T KOG0590|consen 229 PWDFPSRKDGR------------------------------YSSWKSNK---------------GRFTQLPWNSISDQAH 263 (601)
T ss_pred Ccccccccccc------------------------------ceeecccc---------------cccccCccccCChhhh
Confidence 98654332200 00111100 0001112345566888
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+++.++|..+|..|.+.+++..++|+..
T Consensus 264 ~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 264 DLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hcccccccCCchhccccccccccccccc
Confidence 9999999999999999999999999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=167.84 Aligned_cols=142 Identities=23% Similarity=0.232 Sum_probs=106.3
Q ss_pred eecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEec-c---ch-----hhHHHHHHHHHHHHHHHhCCCCCcc
Q 013941 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-S---IN-----KYREAAMIEIDVLQRLARHDIGGTR 154 (433)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~---~~-----~~~~~~~~E~~~l~~l~~~~i~~~~ 154 (433)
..........|...+.||+|+||+||++.+.... +++|+.. + .. ...+.+.+|++++..+.|+++
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i---- 398 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGV---- 398 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCC----
Confidence 3334444556778899999999999999865443 4444321 1 11 123457789999999999887
Q ss_pred eeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 155 ~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
+....++......++||||+ |++|.+++. ....++.|++.+|.+||+.||+||||||+|||++ ++
T Consensus 399 -~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-- 464 (535)
T PRK09605 399 -PTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-- 464 (535)
T ss_pred -CeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--
Confidence 44444444556678999999 999998875 3467899999999999999999999999999993 22
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCcc
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 270 (433)
.++|+|||++..
T Consensus 465 -------------------------~~~liDFGla~~ 476 (535)
T PRK09605 465 -------------------------RLYLIDFGLGKY 476 (535)
T ss_pred -------------------------cEEEEeCccccc
Confidence 478999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-18 Score=163.84 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=189.7
Q ss_pred cCCCeEEeccccc--cccEEEEEEEe--cCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 90 LTPRYRILSKMGE--GTFGQVVECFD--NEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 90 ~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+. .......-.+|+.-..++. .|.+.++.+..+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~----~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID----SHENPVRDSPAW 187 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC----ccccccccCccc
Confidence 3456888999999 99999999998 88899999997432 1122222334554444433 235568888899
Q ss_pred ccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcEecCCCCCcEEEeeC-CcccccC
Q 013941 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE----SVAFMHELRLIHTDLKPENILLVSA-EYVKVPD 237 (433)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~ivHrDikp~NIli~~~-~~~~l~d 237 (433)
+.++..++-+|+|+.+|..+..... ..++...++.++.+... ||.++|+.+|+|-|+||+||++..+ ..++++|
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ccCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 9999999999999999998887654 35889999999999999 9999999999999999999999988 7788888
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
|+++. +|.|.+++...... ....|..-|++||+..+ -++...||+++|.++.+..++..+
T Consensus 267 f~~v~------------------~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 267 FGLVS------------------KISDGNFSSVFKVS-KRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred cceeE------------------EccCCccccceeee-ecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccc
Confidence 87754 33333333222211 11245667999999766 678999999999999999988766
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
+...... .|.. .+......+.....+.++..
T Consensus 327 ~~~g~~~-----------------------------------~W~~--------------~r~~~ip~e~~~~~s~~l~~ 357 (524)
T KOG0601|consen 327 PSVGKNS-----------------------------------SWSQ--------------LRQGYIPLEFCEGGSSSLRS 357 (524)
T ss_pred ccCCCCC-----------------------------------Cccc--------------cccccCchhhhcCcchhhhh
Confidence 5432100 0100 00001112223344556777
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
.+.+|++.+|-.|++++.+++|+++.+
T Consensus 358 ~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 358 VTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred HHHHhcCcchhhhhHHHHHhccccccc
Confidence 999999999999999999999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.2e-18 Score=163.15 Aligned_cols=195 Identities=19% Similarity=0.264 Sum_probs=140.6
Q ss_pred CcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-EecCCCCCcEEEee
Q 013941 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL-IHTDLKPENILLVS 229 (433)
Q Consensus 152 ~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-vHrDikp~NIli~~ 229 (433)
|.|+.++++.+.++...++|.+|| .|+|.|.+.... ..++......++++|+.||.|||+..| .|+.++..|++++.
T Consensus 6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~ 84 (484)
T KOG1023|consen 6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDS 84 (484)
T ss_pred hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeee
Confidence 344499999999999999999999 999999998743 468888999999999999999998766 99999999999976
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCC-------CCc
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLG-------WNY 297 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~ 297 (433)
.- .+||+|||+...... ......-..-|.|||.+.+.. .+.
T Consensus 85 ~w---------------------------~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~ 137 (484)
T KOG1023|consen 85 RW---------------------------VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQ 137 (484)
T ss_pred eE---------------------------EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccc
Confidence 55 456666665544321 111122345699999998741 467
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHH
Q 013941 298 PCDLWSVGCILVELCSGEALFQTHENL----EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373 (433)
Q Consensus 298 ~~DiwSlG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (433)
+.||||||++++|+++...||...... +.+..+.. .+..+
T Consensus 138 ~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~----------------------------------- 181 (484)
T KOG1023|consen 138 KGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGSNP----------------------------------- 181 (484)
T ss_pred cCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-cCCCC-----------------------------------
Confidence 899999999999999999999753321 22222221 00000
Q ss_pred HHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHh
Q 013941 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 417 (433)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell 417 (433)
..|.. ....+..+++..++.+||..+|.+||+++++-
T Consensus 182 -----~rP~i--~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 182 -----FRPSI--ELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred -----cCcch--hhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 00000 00013344788999999999999999998874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=142.45 Aligned_cols=120 Identities=28% Similarity=0.275 Sum_probs=84.1
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhh---HH----------------------HHHHHHHHHHHHHhCCCC
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---RE----------------------AAMIEIDVLQRLARHDIG 151 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~----------------------~~~~E~~~l~~l~~~~i~ 151 (433)
.+.||+|+||.||+|.+. +++.||||+++..... .. ....|...+.++.+.++.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999976 7899999998743211 01 113567777777766542
Q ss_pred CcceeEecceeccCCeEEEEEccC-CCCHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEe
Q 013941 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLY-DFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 228 (433)
Q Consensus 152 ~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~ 228 (433)
.+ ..+.. ...++||||+ ++++. ..+.... .. ..++.++.+++.++.++|. .||+||||||+||+++
T Consensus 81 ~~---~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VP---KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CC---ceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 22 22221 2358999999 53322 1121111 11 6678999999999999999 9999999999999996
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.3e-16 Score=139.60 Aligned_cols=134 Identities=20% Similarity=0.196 Sum_probs=97.1
Q ss_pred cccc-ccccEEEEEEEecCCCcEEEEEEeccch--------------hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 98 SKMG-EGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 98 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
..|| .||.|+||.+... +..++||.+.... .....+.+|+.++.++.+.++..+.. +++.
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~p---l~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRP---IAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCcee---Eeee
Confidence 3566 7788888888753 6779999885311 12345778999999999988643333 3322
Q ss_pred cc-CC---eEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 163 DY-RN---HICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 163 ~~-~~---~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
.. .. ..++|||++ | .+|.+++... .+++.. +.||+.+|.+||++||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~----- 179 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG----- 179 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-----
Confidence 21 22 236999999 5 5899888653 455543 57899999999999999999999999996533
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCcc
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 270 (433)
.++|+|||.+..
T Consensus 180 ----------------------~v~LIDfg~~~~ 191 (239)
T PRK01723 180 ----------------------KFWLIDFDRGEL 191 (239)
T ss_pred ----------------------CEEEEECCCccc
Confidence 588999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-17 Score=167.11 Aligned_cols=280 Identities=22% Similarity=0.281 Sum_probs=198.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhH----HHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+.+.+.+-+-+|+++.++.+.-..+|...++|+........ +....+-.++-.. .+|.++...-.+.....
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-----~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-----RSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-----CCCceecccCCCCCCCC
Confidence 34778889999999999999877788767777654332211 1111111111111 12334544444556778
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.+||++|+ +++|...++..+ ..+.+-++.+...+..++++||...++|||++|.|+|+..+|+.++++|+.......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999 889999988765 677888888999999999999999999999999999999999999999985544332
Q ss_pred CCCcccCCCCCCCeeeecCCCCcccc-------CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEH-------QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
-...............-+++.+.... .......||+.|.+||...+......+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 21110000011111112222221111 11233589999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
.....+.+..|... ...|+.+. ...+...++++
T Consensus 1037 a~tpq~~f~ni~~~------------------------~~~~p~g~-----------------------~~~s~~aq~~~ 1069 (1205)
T KOG0606|consen 1037 AETPQQIFENILNR------------------------DIPWPEGP-----------------------EEGSYEAQDLI 1069 (1205)
T ss_pred CcchhhhhhccccC------------------------CCCCCCCc-----------------------cccChhhhhhh
Confidence 88877766555432 23344322 23466889999
Q ss_pred HHhcccCCCCCCCHH---HHhcCCCCCCC
Q 013941 400 QGLLRYDPAERLKAR---EALRHPFFTRD 425 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~---ell~hp~f~~~ 425 (433)
...|..+|.+|..+. ++-.|+||+..
T Consensus 1070 ~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1070 NRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhccCchhccCcccccccccCCccCCC
Confidence 999999999999887 99999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.4e-16 Score=128.64 Aligned_cols=121 Identities=25% Similarity=0.272 Sum_probs=96.8
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
+++.||+|.++.||++.... ..+++|....... ...+..|+.+++.+.+.+ .++++++.++...+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~---~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKG---LPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcC---CCCCeEEEEcCCCCccEEEEEec
Confidence 45789999999999998644 6799999865443 456888999999998862 23477777777778899999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcEecCCCCCcEEEeeCC
Q 013941 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAE 231 (433)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIli~~~~ 231 (433)
+..+..+ +......++.+++.+|.+||.. +++|+|++|+||+++..+
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~ 126 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc
Confidence 6655533 4566678899999999999985 799999999999996533
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.6e-13 Score=115.67 Aligned_cols=137 Identities=19% Similarity=0.222 Sum_probs=99.4
Q ss_pred eccccccccEEEEEEEecC------CCcEEEEEEeccc-----------------------hhhHHH----HHHHHHHHH
Q 013941 97 LSKMGEGTFGQVVECFDNE------KKELVAIKIVRSI-----------------------NKYREA----AMIEIDVLQ 143 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~-----------------------~~~~~~----~~~E~~~l~ 143 (433)
...||.|-=+.||.|.... .+..+|||+++-. ...... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 3578999998510 011222 337999999
Q ss_pred HHHhCCCCCcceeEecceeccCCeEEEEEccCCCC-HH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecCC
Q 013941 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-LY-DFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDL 220 (433)
Q Consensus 144 ~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~~~~-L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivHrDi 220 (433)
++...++..|..+- + ...+|||||++++ +. ..+... .++......+..+++.+|..| |+.||||+||
T Consensus 82 rl~~~Gv~vP~pi~---~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVV---L----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEE---e----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99998875555543 2 4468999999543 32 122221 356667788889999999999 8999999999
Q ss_pred CCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccc
Q 013941 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271 (433)
Q Consensus 221 kp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 271 (433)
++.|||+.. ..+.|+|||.+...
T Consensus 152 s~~NIL~~~----------------------------~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWHD----------------------------GKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEEC----------------------------CcEEEEECCCceeC
Confidence 999999953 24899999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-13 Score=135.31 Aligned_cols=142 Identities=18% Similarity=0.195 Sum_probs=94.1
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchhh-----------------------------------H------HHHH
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-----------------------------------R------EAAM 136 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------------------------------~------~~~~ 136 (433)
+.||.|++|.||+|+. .+|+.||||+.+..... . -.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 47899999998642100 0 0234
Q ss_pred HHHHHHHHHHhCCCCCcceeEeccee-ccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 013941 137 IEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE-SVAFMHEL 213 (433)
Q Consensus 137 ~E~~~l~~l~~~~i~~~~~v~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~~ 213 (433)
+|...+.++....-.+++ +.+-.++ +.....+|||||+ |++|.++...... ... ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~-v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPG-VYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCC-EEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC
Confidence 466666666543222222 3333333 2345579999999 8899887653211 122 3345556655 47889999
Q ss_pred CcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc
Q 013941 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 214 ~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
|++|+|+||.||+++.+| .++++|||++....
T Consensus 277 g~~H~D~hPgNilv~~~g---------------------------~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDG---------------------------KIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCC---------------------------cEEEEeCCCeeECC
Confidence 999999999999996554 57788888776544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-13 Score=137.29 Aligned_cols=148 Identities=19% Similarity=0.284 Sum_probs=94.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-----------------------------------hhHH----
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------------------KYRE---- 133 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------------------------~~~~---- 133 (433)
.|.. +.||+|++|.||+|+.+.+|+.||||+.+..- +..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 78999999999999998889999999997431 0011
Q ss_pred --HHHHHHHHHHHHHhCCCCCcceeEeccee-ccCCeEEEEEccC-CCCHHHHH--HhcCC--CCCCHHHHHHHHHHHHH
Q 013941 134 --AAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFL--RKNSY--RSFPIDLVRELGRQLLE 205 (433)
Q Consensus 134 --~~~~E~~~l~~l~~~~i~~~~~v~~~~~~-~~~~~~~lv~e~~-~~~L~~~l--~~~~~--~~l~~~~~~~i~~qi~~ 205 (433)
.+.+|+..+.++.+... +...+.+-.++ +.....+|||||+ |+.|.++- ...+. ..+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~-~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFE-DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHcc-CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 12345555555543221 22223333333 2356678999999 88998753 22220 1244444555555554
Q ss_pred HHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc
Q 013941 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 206 aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
..|++|+|+||.||+++.+| .....++++|||++....
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g-----------------------~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDP-----------------------PENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCC-----------------------CCCCeEEEEecceEEECC
Confidence 59999999999999998765 123457777777765443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5e-14 Score=126.12 Aligned_cols=206 Identities=19% Similarity=0.284 Sum_probs=139.4
Q ss_pred HHHHHHHhCCCCCcceeEecceeccC-----CeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH
Q 013941 140 DVLQRLARHDIGGTRCVQIRNWFDYR-----NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMH 211 (433)
Q Consensus 140 ~~l~~l~~~~i~~~~~v~~~~~~~~~-----~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH 211 (433)
..|..+-|.|+ ++++.++.+. ....++.||+ .|+|..+|++. ....+.....++|+-||+.||.|||
T Consensus 119 dnllqlvHsnl-----vkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 119 DNLLQLVHSNL-----VKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHH-----HHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 44556667766 9999998764 3588999999 99999999743 3356888899999999999999999
Q ss_pred hCC--cEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhh
Q 013941 212 ELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEV 289 (433)
Q Consensus 212 ~~~--ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~ 289 (433)
+.. |+|+++..+-|++..+|.+|+.--.. +. -...++.++ ........+-++|.|||.
T Consensus 194 s~~PpiihgnlTc~tifiq~ngLIkig~~ap------~s-------~h~s~~~~~-------~~Ek~~~~~~~g~~a~~s 253 (458)
T KOG1266|consen 194 SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAP------DS-------THPSVNSTR-------EAEKSVNTSLPGFSAPES 253 (458)
T ss_pred ccCCccccCCcchhheeecCCceEEecccCc------cc-------cchhhhhhh-------HhhhhccccCCccccCCc
Confidence 885 99999999999998877655421100 00 000000000 001111245678999997
Q ss_pred hhCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCch
Q 013941 290 ILGLGWNYPCDLWSVGCILVELCSGEAL-FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 368 (433)
Q Consensus 290 ~~~~~~~~~~DiwSlG~il~el~~g~~p-f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (433)
=.....+.++|||+||....+|..+..- -.+......-..+.+......
T Consensus 254 g~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le------------------------------ 303 (458)
T KOG1266|consen 254 GTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE------------------------------ 303 (458)
T ss_pred CcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc------------------------------
Confidence 6666678899999999999999887643 222222222222222110000
Q ss_pred hhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 369 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
..-=++++.+||+-.|..||+|.+++-||-+-
T Consensus 304 -----------------------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 304 -----------------------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred -----------------------CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 11124788999999999999999999999754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.6e-13 Score=115.50 Aligned_cols=114 Identities=18% Similarity=0.119 Sum_probs=83.6
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~- 175 (433)
++.|+.|.++.||+++.. ++.|++|+............+|+.+++.+.+.++. .+++.+.. ...++|||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~----P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIG----PKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCC----CceEEEeC--CCCeEEEEecC
Confidence 467899999999999854 77899999765433334467899999999876541 33333332 2347999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EecCCCCCcEEEe
Q 013941 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL-----IHTDLKPENILLV 228 (433)
Q Consensus 176 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-----vHrDikp~NIli~ 228 (433)
|.++.+. . .....++.+++.+|..||+.++ +|+|++|.||+++
T Consensus 75 G~~l~~~----~------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~ 122 (170)
T cd05151 75 GSELLTE----D------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD 122 (170)
T ss_pred CCccccc----c------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE
Confidence 7666542 0 1123456789999999999985 9999999999996
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2e-13 Score=132.21 Aligned_cols=250 Identities=21% Similarity=0.171 Sum_probs=169.8
Q ss_pred CCCeEEeccccccccEEEEEEEec-CCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
..+|..+..||.|.|+.|+.+... .++..|++|-..+.- ........|+.+...+.-+ .+.+.....|....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~----~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSH----LPSVGKNSSWSQLR 339 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcc----cccCCCCCCccccc
Confidence 457899999999999999988755 677889998765322 1122234466666555421 23366666666667
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..|+-.||| ++++...+.-. ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+|
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-------------- 403 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-------------- 403 (524)
T ss_pred cccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--------------
Confidence 778999999 88776655322 2578888999999999999999999999999999999997753
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCccc--chhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYR--APEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
...+++|||.............++-.+. +++......+..++|++|||..+.+.+++...-.....
T Consensus 404 ------------~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~ 471 (524)
T KOG0601|consen 404 ------------FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ 471 (524)
T ss_pred ------------hhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccccc
Confidence 1245666665543222122222233333 55555666788999999999999999988654322111
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
. ..+.+ + ...........+..+.+.|+
T Consensus 472 ~---~~i~~-----------------------~---------------------------~~p~~~~~~~~~q~~~kv~~ 498 (524)
T KOG0601|consen 472 S---LTIRS-----------------------G---------------------------DTPNLPGLKLQLQVLLKVMI 498 (524)
T ss_pred c---eeeec-----------------------c---------------------------cccCCCchHHhhhhhhhhhc
Confidence 0 00000 0 00001122347788899999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
..++..|+.+.++..|.=|.+.
T Consensus 499 ~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 499 NPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred CCccccchhhhhhcccchhhhh
Confidence 9999999999999998877654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.6e-12 Score=124.82 Aligned_cols=168 Identities=18% Similarity=0.283 Sum_probs=125.3
Q ss_pred EEEecCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccCCCCHHHHHHhcCC
Q 013941 110 ECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSY 188 (433)
Q Consensus 110 ~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~ 188 (433)
.|..+.++.+|.|...+..+. ..+...+-++.|+.++||+| +++++.++..+.+|||+|.+. .|..++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~I-----l~yL~t~e~~~~~ylvTErV~-Pl~~~lk~--- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNI-----LSYLDTTEEEGTLYLVTERVR-PLETVLKE--- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchh-----hhhhhhhcccCceEEEeeccc-cHHHHHHH---
Confidence 466678888899988865443 34556778889999999998 999999999999999999983 35555554
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH-hCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCC
Q 013941 189 RSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267 (433)
Q Consensus 189 ~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 267 (433)
+....+...+.||+.||.||| +.+++|++|.-+.|+|+..|.+||.+|.++......+.
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------------------ 160 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------------------ 160 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------------------
Confidence 346778888999999999998 67899999999999999999888888776543322211
Q ss_pred CccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC
Q 013941 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 268 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g 314 (433)
......---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 161 ------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 ------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 000001111355666543222 567999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1e-11 Score=103.05 Aligned_cols=145 Identities=24% Similarity=0.220 Sum_probs=110.1
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEec-c--------chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR-S--------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~--------~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.+..|-+|+-+.|+++. ..|+.+.||.-. + ..-......+|+.+|.++..-+|..|.+. +.+..
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence 46788899999999996 567877887421 1 11234567789999999998887554432 33445
Q ss_pred eEEEEEccCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 167 HICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 167 ~~~lv~e~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.-+|+|||+.| ++.+++...............++.+|-+.+.-||..+|||+||..+||++.++|
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~------------- 150 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG------------- 150 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-------------
Confidence 56799999955 899999876544444444578899999999999999999999999999998765
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccc
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFE 271 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 271 (433)
.+..+.++|||++...
T Consensus 151 -----------~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 151 -----------NQITPILIDFGLSSVS 166 (229)
T ss_pred -----------CcCceEEEeecchhcc
Confidence 4456799999998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.7e-11 Score=98.08 Aligned_cols=130 Identities=22% Similarity=0.200 Sum_probs=93.6
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEe-cc---ch-----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIV-RS---IN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~---~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
..+++|+-+.+|.+.. -|..+++|.= ++ .. -..+...+|+.++.++...++..|. ++ +.+.+..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~---v~--dvD~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPI---VY--DVDPDNG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCe---EE--EEcCCCC
Confidence 4678999999999854 3444666642 11 11 1235567899999999988774333 22 2345667
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
.|+|||. |..|.+.+... ...++..+-.-+.-||..||||+||.++||++...
T Consensus 75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----------------- 128 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----------------- 128 (204)
T ss_pred EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-----------------
Confidence 8999999 77788888764 13455666667788999999999999999999643
Q ss_pred CCcccCCCCCCCeeeecCCCCccc
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFE 271 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~ 271 (433)
.+.++|||++...
T Consensus 129 -----------~i~~IDfGLg~~s 141 (204)
T COG3642 129 -----------RIYFIDFGLGEFS 141 (204)
T ss_pred -----------cEEEEECCccccc
Confidence 3899999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-10 Score=104.89 Aligned_cols=108 Identities=17% Similarity=0.160 Sum_probs=76.6
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC---CeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---NHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~---~~~~lv~ 172 (433)
+.|+.|.++.||++.... |+.+++|+...... ......+|+++++.+.+.++..+. ++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~---~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPK---VLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCC---EEEECCCCCccCCceEEE
Confidence 578999999999998643 57899999765432 345678899999999886543333 34444332 3678999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
||+ |.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHS 117 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 999 7777665421 146677777777788888877773
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.2e-10 Score=100.92 Aligned_cols=140 Identities=19% Similarity=0.085 Sum_probs=99.1
Q ss_pred EEEEEecCCCcEEEEEEeccchh------------hHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--CCeEEEEEc
Q 013941 108 VVECFDNEKKELVAIKIVRSINK------------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVFE 173 (433)
Q Consensus 108 V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--~~~~~lv~e 173 (433)
|+++. -.|+.|.||....... ....+.+|...+.++...+|..|..|-+...-.. ....+||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44553 3567788897643221 1114779999999999999877766655321111 245789999
Q ss_pred cCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 174 KLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 174 ~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
++++ +|.+++........+......++.+++..+.-||..||+|+|+++.|||++.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~------------------- 176 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFP------------------- 176 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEecccc-------------------
Confidence 9944 7999986432234667788899999999999999999999999999999974200
Q ss_pred cCCCCCCCeeeecCCCCc
Q 013941 252 KNLPKSSAIKLIDFGSTT 269 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~ 269 (433)
..++...+.|+||+.+.
T Consensus 177 -~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 177 -GREEDLKLSVIDLHRAQ 193 (268)
T ss_pred -CCCCCceEEEEECCccc
Confidence 00134568999999775
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-11 Score=121.15 Aligned_cols=164 Identities=20% Similarity=0.326 Sum_probs=115.8
Q ss_pred HHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCccccc
Q 013941 202 QLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 280 (433)
Q Consensus 202 qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~g 280 (433)
+.+.||.|+|. .++||++|.|++|.++..|.+|++.|+++........ .....=|+++... ..-
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--------~p~~~yd~~lp~~-------~~~ 171 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--------YPFSEYDPPLPLL-------LQP 171 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--------cccccCCCCCChh-------hcc
Confidence 34489999995 5899999999999999999999999987654433221 1223334443322 233
Q ss_pred CCcccchhhhhCCCCCccchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccc
Q 013941 281 TRHYRAPEVILGLGWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL 359 (433)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~-~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 359 (433)
...|.|||++.+...+.++|++|+||++|.+. .|+..+.......... .......
T Consensus 172 ~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~----------------------- 227 (700)
T KOG2137|consen 172 HLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLN----------------------- 227 (700)
T ss_pred CcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccc-----------------------
Confidence 55799999999988899999999999999999 4665555433221111 1110000
Q ss_pred cCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 360 DWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
.........++.++++=|.++|..++..||++.+++..|||++..
T Consensus 228 ----------------------~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 228 ----------------------AGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred ----------------------cccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 000112246678999999999999999999999999999999753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.2e-10 Score=98.64 Aligned_cols=127 Identities=28% Similarity=0.338 Sum_probs=80.8
Q ss_pred EEEEEEecCCCcEEEEEEeccch---------------------------hhHHHHHHHHHHHHHHHhCCCCCcceeEec
Q 013941 107 QVVECFDNEKKELVAIKIVRSIN---------------------------KYREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (433)
Q Consensus 107 ~V~~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~ 159 (433)
.||.|.. .+|..+|||+.+... .......+|.+.|.++...++..|.. +
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p---~ 76 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKP---Y 76 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--E---E
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcE---E
Confidence 3888975 567789999975210 11245667999999998877644443 3
Q ss_pred ceeccCCeEEEEEccCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 160 NWFDYRNHICIVFEKLG--PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF-MHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 160 ~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
++. ..+|||||++ |.....+.... ++......++.+++..+.. +|..||||+||.+.|||++.+
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~------ 143 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG------ 143 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT------
T ss_pred EEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc------
Confidence 322 2369999996 64433343321 2345567788888886655 579999999999999999643
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCcccc
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
.+.++|||.+....
T Consensus 144 ----------------------~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 144 ----------------------KVYIIDFGQAVDSS 157 (188)
T ss_dssp ----------------------CEEE--GTTEEETT
T ss_pred ----------------------eEEEEecCcceecC
Confidence 58999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.6e-09 Score=98.53 Aligned_cols=167 Identities=18% Similarity=0.255 Sum_probs=122.3
Q ss_pred ccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc----CCeEEEEEccC--C
Q 013941 104 TFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHICIVFEKL--G 176 (433)
Q Consensus 104 ~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~----~~~~~lv~e~~--~ 176 (433)
...+.|+|....+|..|++|++.... ........-+++++++.|.|+ |.+.++|.. +..+++|++|+ .
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~Nv-----V~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNV-----VPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCce-----eehhhhhhhhccCcceEEEEEecCCCC
Confidence 44578999999999999999984221 111233445788999999888 999998873 56799999998 6
Q ss_pred CCHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 177 PSLYDFLRKN-------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 177 ~~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
++|.++.-.. .+...++..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~------------ 430 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM------------ 430 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc------------
Confidence 6888775421 123577899999999999999999999999999999999996543
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
+++|...|+......... |.+.+ -.+-|.=.||.+++.|.||..
T Consensus 431 ---------------RIriS~C~i~Dvl~~d~~-----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 431 ---------------RIRISGCGIMDVLQEDPT-----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ---------------eEEEecccceeeecCCCC-----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 455555554443322220 11111 245688999999999999853
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.1e-08 Score=86.91 Aligned_cols=128 Identities=13% Similarity=0.110 Sum_probs=96.9
Q ss_pred cccccEEEEEEEecCCCcEEEEEEecc----c---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--CCeEEEE
Q 013941 101 GEGTFGQVVECFDNEKKELVAIKIVRS----I---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIV 171 (433)
Q Consensus 101 g~G~~g~V~~~~~~~~~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--~~~~~lv 171 (433)
|+||.+-|+.... .|+.+-+|.-.. . ......+.+|+..|.++...++..|.++ +.+.-.. .-..+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688888988763 334677886541 0 2345788999999999999988666555 2222212 2357899
Q ss_pred EccCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 172 FEKLG--PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 172 ~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
+|-++ .+|.+++........+......++.+++..+.-||+.|+.|+|+.+.|||++..|
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g 165 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG 165 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC
Confidence 99885 6999998775544567888889999999999999999999999999999996433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.4e-08 Score=88.26 Aligned_cols=113 Identities=29% Similarity=0.328 Sum_probs=88.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceeEecceecc-CCeEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 013941 132 REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208 (433)
Q Consensus 132 ~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~ 208 (433)
.....+|...+..+...+|..|..+.+...-.. ....++|+|++ + .+|.+++.... ..+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 356788999999999999877766665433111 13568999999 4 37999988644 3677788899999999999
Q ss_pred HHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcc
Q 013941 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270 (433)
Q Consensus 209 ~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 270 (433)
-||.+||+|+|+++.|||+..++ ....+.|+||+-+..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~------------------------~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDD------------------------GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCC------------------------CceeEEEEcchhcee
Confidence 99999999999999999997643 234688999986653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3e-08 Score=92.66 Aligned_cols=195 Identities=16% Similarity=0.186 Sum_probs=122.6
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceeEecc--eecc-CCeEEEE
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRN--WFDY-RNHICIV 171 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~--~~~~-~~~~~lv 171 (433)
..+.||+|+-+.+|-.-... ..+-|++..-....+.- .+..|...- |+.+ ...++--.. +..+ +..+.+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~-~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ--KVAELAATPDAPLL-NYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHHHH--HHHHhccCCCCcch-hhhhcccHHHhhCCCccceeEEe
Confidence 35789999999999764222 23568876433221111 112222211 1111 000111111 0112 2337889
Q ss_pred EccC-CC-CHHHHHH----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 172 FEKL-GP-SLYDFLR----KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 172 ~e~~-~~-~L~~~l~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
|..+ |. .+.++++ ++......+....+.++.|+.+.+.||+.|.+-+|+.++|+|+++++.+.+.|-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD------ 162 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD------ 162 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc------
Confidence 9988 43 4455543 2233457789999999999999999999999999999999999988877665532
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHHhC-CCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG-EALFQ 319 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g-~~pf~ 319 (433)
...|++-|. .....+|...|.+||.-. +-.-+...|.|.||+++|+++.| +.||.
T Consensus 163 -------------sfqi~~ng~------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 163 -------------SFQINANGT------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred -------------ceeeccCCc------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 122222221 111237788899999865 22346789999999999999986 99998
Q ss_pred CC
Q 013941 320 TH 321 (433)
Q Consensus 320 ~~ 321 (433)
+.
T Consensus 224 GI 225 (637)
T COG4248 224 GI 225 (637)
T ss_pred cc
Confidence 64
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.1e-08 Score=83.97 Aligned_cols=131 Identities=17% Similarity=0.227 Sum_probs=88.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhH----------HHHHHHHHHHHHHHhCCCCCc---ce
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----------EAAMIEIDVLQRLARHDIGGT---RC 155 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~E~~~l~~l~~~~i~~~---~~ 155 (433)
.+.++|.+.+.+-......|.+.. .+|+.+++|..+...... ....+++..+.++...++... .+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 446789999999888888887775 567889999876432111 224456666667766554322 22
Q ss_pred eEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 156 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
+...-.+......+|||||+ |..|.+... +++ .+...|..++.-||+.|++|+|..|.|++++.++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc
Confidence 22222333445678999999 777766532 333 2445677889999999999999999999997544
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.6e-08 Score=87.56 Aligned_cols=123 Identities=28% Similarity=0.293 Sum_probs=89.1
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccc-----------------------hhhHHHHHHHHHHHHHHHhCCC
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------------------NKYREAAMIEIDVLQRLARHDI 150 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~E~~~l~~l~~~~i 150 (433)
+.+..+||-|--|.||.|.+. .|.++|||.-+.. .-.+..+.+|.++|++|...+.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 566789999999999999875 6788999975310 0123457789999999977633
Q ss_pred CCcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 151 ~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
.- .+.++ -+..++|||+. |..|... ++..+....++..|+.-+..+-..||||+|+.+-||+++.
T Consensus 172 ~V---P~P~~----~nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KV---PKPIA----WNRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CC---CCccc----cccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 11 22222 35568999999 6555432 2235556677777777777777999999999999999987
Q ss_pred CC
Q 013941 230 AE 231 (433)
Q Consensus 230 ~~ 231 (433)
+|
T Consensus 238 dg 239 (304)
T COG0478 238 DG 239 (304)
T ss_pred CC
Confidence 65
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.1e-07 Score=79.55 Aligned_cols=137 Identities=19% Similarity=0.169 Sum_probs=94.7
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchh-------------------------hHHHHHHHHHHHHHHHhCCCC
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLARHDIG 151 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~E~~~l~~l~~~~i~ 151 (433)
...|++|--+.||+|.. .++..+|+|+++.... ......+|+..|.++...++.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34777888889999974 5678899999853110 112345699999999887763
Q ss_pred CcceeEecceeccCCeEEEEEccCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEe
Q 013941 152 GTRCVQIRNWFDYRNHICIVFEKLGPSL--YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 228 (433)
Q Consensus 152 ~~~~v~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~ 228 (433)
.| +-+.+. ...|||||+|... .-.|..- .+....+..+..++++.+.-|-. .|+||+||..-|||+.
T Consensus 132 vP---~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 132 VP---EPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred CC---Cceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 33 222222 2479999995431 1111111 23344688888999999998887 8999999999999996
Q ss_pred eCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc
Q 013941 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 229 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
. ..+.++|||.|....
T Consensus 202 ~----------------------------~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 D----------------------------GEPYIIDVSQAVTID 217 (268)
T ss_pred C----------------------------CeEEEEECccccccC
Confidence 3 257999999886543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.6e-07 Score=93.03 Aligned_cols=138 Identities=18% Similarity=0.219 Sum_probs=84.1
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchh-----------------------------------hH------HHHH
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-----------------------------------YR------EAAM 136 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------------------------~~------~~~~ 136 (433)
..|+.++-|.||+|+.. +|+.||||+.+.+-. .. -.+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 57899999999999964 599999999853110 00 1233
Q ss_pred HHHHHHHHHHhCCCCCcceeEecc-eeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013941 137 IEIDVLQRLARHDIGGTRCVQIRN-WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214 (433)
Q Consensus 137 ~E~~~l~~l~~~~i~~~~~v~~~~-~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 214 (433)
+|...+.++.+..-..+. +++-. +++..+.-.|+|||+ |..+.+...... ..++...+.....++ -+..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 466666666553323333 33333 334567789999999 778887743221 134433332222221 133334589
Q ss_pred cEecCCCCCcEEEeeCCcccccCccc
Q 013941 215 LIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 215 ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+.|.|.+|.||++..+|.+.+-|||+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi 311 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGI 311 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcc
Confidence 99999999999998776444444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.3e-09 Score=101.34 Aligned_cols=247 Identities=16% Similarity=0.058 Sum_probs=166.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
.-|...+-+++|+++.+++.+...+...+ .+++... ....-++++|.+++|||. .+..++.++.+...+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~----~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNP----VVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCC----cccccccCCcccccchh
Confidence 34667788999999999999876665544 6766443 344558899999999982 27777777888899999
Q ss_pred EccC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 172 FEKL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 172 ~e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
|+++ ++ +-....... .-.+..-+...+.+.-+++|+++|+.-=+|+| ||+..+
T Consensus 313 ~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-------------------- 367 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-------------------- 367 (829)
T ss_pred hhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc--------------------
Confidence 9999 44 222111100 01234445566677778899999998778998 887543
Q ss_pred cccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~ 327 (433)
...++.||+........ ..+..+|+.++|||+...+.+....|.|++|+--.++.-|.+|-......
T Consensus 368 --------~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--- 436 (829)
T KOG0576|consen 368 --------EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--- 436 (829)
T ss_pred --------cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc---
Confidence 34678888877665544 55678999999999999999999999999998766777676665431000
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH-HHHHHHhcccC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL-IDLLQGLLRYD 406 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~li~~~L~~d 406 (433)
.+. ...+......... ...+... .++...|+..-
T Consensus 437 ------------------------~~~------~g~~p~s~~L~~~---------------~aw~~~~~~~~~~~~~~g~ 471 (829)
T KOG0576|consen 437 ------------------------LPM------IGNGPNSPMLTDK---------------SAWSPVFHRDFPAPCLNGL 471 (829)
T ss_pred ------------------------cCC------CCCCCCccccchh---------------hhcCcccccCCcccccCCC
Confidence 000 0000000000000 0001111 14777899999
Q ss_pred CCCCCCHHHHhcCCCCCCCccc
Q 013941 407 PAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~~~~ 428 (433)
|..|++...++-|.+|.++..+
T Consensus 472 P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 472 PPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred CCCCcchhhHHHHHHhccCccc
Confidence 9999999999999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.1e-06 Score=79.28 Aligned_cols=82 Identities=21% Similarity=0.268 Sum_probs=58.7
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~- 175 (433)
++.|+.|..+.||++.... ..+++|+.... .......+|..+++.+...++..|.++............+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999998654 47999997655 4556788899999999988763344433222223345689999999
Q ss_pred CCCHHH
Q 013941 176 GPSLYD 181 (433)
Q Consensus 176 ~~~L~~ 181 (433)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 766666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.5e-06 Score=73.29 Aligned_cols=124 Identities=17% Similarity=0.291 Sum_probs=94.5
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch-----------------hhHHHHHHHHHHHHHHH-hCCCCCcceeEec
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------KYREAAMIEIDVLQRLA-RHDIGGTRCVQIR 159 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~ 159 (433)
..||+|+.-.||.-- .....+||+..... ....+..+|+.....+. ..++...++.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 579999999999642 33346889987544 23466778999888888 8888888899999
Q ss_pred ceeccCCeEEEEEccC-C------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 160 NWFDYRNHICIVFEKL-G------PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~------~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
|+.+++--..+|+|.. + .+|.+++... .++. ... ..+-.-.+||-+.+|+.+|++|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 9999998889999975 2 3788888654 3555 333 3333445688899999999999999997754
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2e-06 Score=77.06 Aligned_cols=72 Identities=15% Similarity=0.206 Sum_probs=52.4
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-C
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~ 176 (433)
..||+|..+.||+. . +..+++|+..... ......+|.+++..+...++..|. .+.+.+..+...+|||++ |
T Consensus 7 ~~i~~G~t~~~y~~---~-~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~---~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPH---PFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe---c-CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCc---eEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2 4457899876533 335578899999999876664444 445555667788999999 5
Q ss_pred C
Q 013941 177 P 177 (433)
Q Consensus 177 ~ 177 (433)
.
T Consensus 79 ~ 79 (226)
T TIGR02172 79 K 79 (226)
T ss_pred c
Confidence 4
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.6e-06 Score=70.99 Aligned_cols=118 Identities=21% Similarity=0.292 Sum_probs=84.0
Q ss_pred CCeEEecccccccc-EEEEEEEecCCCcEEEEEEecc----c--------h----------hhHHHHHHHHHHHHHHHhC
Q 013941 92 PRYRILSKMGEGTF-GQVVECFDNEKKELVAIKIVRS----I--------N----------KYREAAMIEIDVLQRLARH 148 (433)
Q Consensus 92 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~----~--------~----------~~~~~~~~E~~~l~~l~~~ 148 (433)
..++.++.||.|.. |.||+++ -.|+.||||+++. . . .....+..|.+...+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 45899999999999 9999997 5677999999431 0 0 1123466788888888876
Q ss_pred CCCCcceeEecceeccC------------------CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 013941 149 DIGGTRCVQIRNWFDYR------------------NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209 (433)
Q Consensus 149 ~i~~~~~v~~~~~~~~~------------------~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~ 209 (433)
+-.+.-.|++++|..-. ....||.||. ... .+.... +.+|++-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHH
Confidence 54333348888887321 1346788876 322 123333 4567788899
Q ss_pred HHhCCcEecCCCCCcEE
Q 013941 210 MHELRLIHTDLKPENIL 226 (433)
Q Consensus 210 LH~~~ivHrDikp~NIl 226 (433)
+|..||+-+|+++.|..
T Consensus 180 ~~k~gI~~~Dv~~~ny~ 196 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR 196 (207)
T ss_pred HHHCCeeeccCcccccc
Confidence 99999999999999998
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.2e-06 Score=68.82 Aligned_cols=131 Identities=24% Similarity=0.275 Sum_probs=90.1
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
-++.+.|++|.+|.||++.. .|..+|+|+-+. +..+..+..|+++|..+.-.++. .+++.+.. .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~----p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVT----PEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCC----ceEEEech----hhhhhh
Confidence 45678999999999999985 455799998654 55667888999999999876652 33443332 245599
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCC--CcEEEeeCCcccccCccccccCCCCCCc
Q 013941 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP--ENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp--~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|. |..|.+.-... . +.-...++.+---|-..||-|+.|.- .||++.
T Consensus 93 ~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~---------------------- 141 (201)
T COG2112 93 YIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN---------------------- 141 (201)
T ss_pred hhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec----------------------
Confidence 99 76887764321 1 22234455555556678999999864 356552
Q ss_pred ccCCCCCCCeeeecCCCCcccc
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
+..+.|+||..|++..
T Consensus 142 ------~~~~~iIDFd~At~k~ 157 (201)
T COG2112 142 ------DRDVYIIDFDSATFKK 157 (201)
T ss_pred ------CCcEEEEEccchhhcc
Confidence 2258999999887543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.5e-06 Score=85.25 Aligned_cols=207 Identities=25% Similarity=0.362 Sum_probs=131.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 134 ~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
....|+..+.++.|.|.+.+....+...+.. -...+..++| ..++...++... ..+....+.+..+++.||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence 3445777788888988854444444333322 1233456678 778888888765 78899999999999999999999
Q ss_pred CCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeee--cCCCCccccCCCcc--cccCCcccchh
Q 013941 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI--DFGSTTFEHQDHSY--VVSTRHYRAPE 288 (433)
Q Consensus 213 ~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~--Dfg~a~~~~~~~~~--~~gt~~y~aPE 288 (433)
. +..|+.+....... ...+....+..+ ||+.+......... ..-+..+.++|
T Consensus 305 ~-------~l~~v~L~~s~~~~-----------------~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e 360 (1351)
T KOG1035|consen 305 L-------SLEHVVLSASSSKE-----------------STVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADE 360 (1351)
T ss_pred h-------ccceeEEecccccc-----------------cccCccceeecchhhhcccccCCCcccchhhcCcccccccc
Confidence 8 34445443321000 001222233333 77776655443322 23455677888
Q ss_pred hhhCCCCCc--cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCC
Q 013941 289 VILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 366 (433)
Q Consensus 289 ~~~~~~~~~--~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (433)
......+.. ..|+|.+|..+..+..|..+-..... ....+
T Consensus 361 ~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~------~~~~l-------------------------------- 402 (1351)
T KOG1035|consen 361 DLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV------PVSLL-------------------------------- 402 (1351)
T ss_pred ccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc------hhhhh--------------------------------
Confidence 877665544 47999999999998887543311000 00000
Q ss_pred chhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 367 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
. ........+.+.+|+.-++++|+++.+++.|+|.+-..
T Consensus 403 -------------------~--~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 403 -------------------D--VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred -------------------c--cccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 0 00011567889999999999999999999999988653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.4e-05 Score=71.21 Aligned_cols=75 Identities=15% Similarity=0.092 Sum_probs=51.2
Q ss_pred ccccccc-EEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-C
Q 013941 99 KMGEGTF-GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (433)
Q Consensus 99 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~ 176 (433)
.|..|.+ +.||++... +..+.+|+..... .....+|+.+++.+... +. +.+++.+....+..++|||++ |
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~-~~---vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK-LP---VPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc-CC---CCeEEEEEecCCccEEEEEeeCC
Confidence 3444544 789999743 3678899876543 34567899999999765 43 345556665556789999999 7
Q ss_pred CCHHH
Q 013941 177 PSLYD 181 (433)
Q Consensus 177 ~~L~~ 181 (433)
.+|..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 66653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.3e-05 Score=70.81 Aligned_cols=76 Identities=14% Similarity=0.073 Sum_probs=46.1
Q ss_pred ccccccccE-EEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhC-CCCCcceeEecceeccCCeEEEEEccC
Q 013941 98 SKMGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 98 ~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
+.|+.|+.. .||+.. ..+++|+.+. ........+|.+++..+... .+..|.++..-...+.....+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777766 488762 2477887654 22345788899999999753 444444333211111123458899998
Q ss_pred -CCCH
Q 013941 176 -GPSL 179 (433)
Q Consensus 176 -~~~L 179 (433)
|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 6555
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.8e-05 Score=81.35 Aligned_cols=78 Identities=15% Similarity=0.126 Sum_probs=53.3
Q ss_pred eccccccccEEEEEEEecCCC--cEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccC---CeE
Q 013941 97 LSKMGEGTFGQVVECFDNEKK--ELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR---NHI 168 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~---~~~ 168 (433)
++.|+.|.++.+|+......+ ..+++|+..... .....+.+|+.+++.+. |.++..| +++.++.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP---~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVP---KVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCC---cEEEEecCCCcCCCc
Confidence 577899999999998764432 467888764322 22346789999999997 5665444 444444442 467
Q ss_pred EEEEccC-CC
Q 013941 169 CIVFEKL-GP 177 (433)
Q Consensus 169 ~lv~e~~-~~ 177 (433)
|+||||+ |.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 8999999 54
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.8e-05 Score=69.43 Aligned_cols=139 Identities=24% Similarity=0.274 Sum_probs=100.0
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccc---------------------------hhhHHHHHHHHHHHHHHHh
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------------------------NKYREAAMIEIDVLQRLAR 147 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~~E~~~l~~l~~ 147 (433)
.+-..|..|--+.||.|.. .+|..+|||+++-+ ....-....|+..|++|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3456788888899999984 66777999998410 0112345679999999999
Q ss_pred CCCCCcceeEecceeccCCeEEEEEccCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEecCCCCCc
Q 013941 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSL--YDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPEN 224 (433)
Q Consensus 148 ~~i~~~~~v~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDikp~N 224 (433)
.+|..|--+-+.. ..|||+|+|.+= .-.|.. -.++...+..+-.|++.-+.-|- .+++||.||.--|
T Consensus 226 aGIP~PePIlLk~-------hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPILLKN-------HVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCceeeec-------ceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 9886665444432 569999996432 222222 25778888888889888888775 5789999999999
Q ss_pred EEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc
Q 013941 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 225 Ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
+|+-. +.+.++|-+-+....
T Consensus 296 ~Lyhd----------------------------G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 296 LLYHD----------------------------GKLYIIDVSQSVEHD 315 (520)
T ss_pred heEEC----------------------------CEEEEEEccccccCC
Confidence 99843 358899988775443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=7.4e-05 Score=74.17 Aligned_cols=145 Identities=17% Similarity=0.187 Sum_probs=87.1
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccch--------------------------------hhHH------HHHHHH
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------------------------------KYRE------AAMIEI 139 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------------~~~~------~~~~E~ 139 (433)
+.||.-+.|.||+|+.+. |+.||||+-+..- +..+ .+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578999999999999755 9999999875311 0001 133455
Q ss_pred HHHHHHHhCCCCCcc---eeEeccee-ccCCeEEEEEccC-CCCHH--HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 140 DVLQRLARHDIGGTR---CVQIRNWF-DYRNHICIVFEKL-GPSLY--DFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 140 ~~l~~l~~~~i~~~~---~v~~~~~~-~~~~~~~lv~e~~-~~~L~--~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
+...+..+. ..+.. -|.+-.++ +....-.|+|||| |..+. +.+.+. .++...+...+.+.. +.-|-.
T Consensus 246 ~Nae~~~~~-f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFREN-FKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY--LEQIFK 319 (538)
T ss_pred HhHHHHHHH-HHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH--HHHHHh
Confidence 444444321 11111 12222222 3345688999999 76554 344454 366554443333322 223335
Q ss_pred CCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc
Q 013941 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (433)
Q Consensus 213 ~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (433)
.|++|+|-.|.||++..++ ..+..+.+-|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~-----------------------~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNP-----------------------EGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCC-----------------------CCCccEEEEccccccccc
Confidence 7899999999999997543 245578999999876543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.8e-05 Score=67.01 Aligned_cols=75 Identities=15% Similarity=0.329 Sum_probs=49.7
Q ss_pred eccccccccEEEEEEEecC-CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 97 LSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
++.|..|-...+|++.... .++.|++|+........-...+|+.+++.+...++ . .+++..+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl-~---P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL-A---PKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC-C---CeEEEEeCC----cEEEEee
Confidence 4677888889999997543 35679999876433322334579999999987766 2 333333322 3799999
Q ss_pred -CCCH
Q 013941 176 -GPSL 179 (433)
Q Consensus 176 -~~~L 179 (433)
|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 6554
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00044 Score=66.83 Aligned_cols=75 Identities=20% Similarity=0.217 Sum_probs=51.3
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccc--------hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.||.|.+..||++.+...++.|+||.-... ....+....|.+.|+.+.... ..++.+++.+ +.+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~--p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYV--PDLVPKVYHY--DEELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhC--CCCCCeEEEE--CCCCC
Confidence 46899999999999998654467999974311 123456677888888876431 1234555554 33557
Q ss_pred EEEEccC
Q 013941 169 CIVFEKL 175 (433)
Q Consensus 169 ~lv~e~~ 175 (433)
++|||++
T Consensus 107 ~lVME~L 113 (401)
T PRK09550 107 VTVMEDL 113 (401)
T ss_pred EEEEecC
Confidence 8999999
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.4e-05 Score=69.70 Aligned_cols=79 Identities=14% Similarity=0.123 Sum_probs=52.5
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc---eeccCCeEEEEEc
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFE 173 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~---~~~~~~~~~lv~e 173 (433)
++.|..|....+|++.. .+..+++|+... ........|+.++..+.+.++..+.++...+ +....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 56788888889999864 334689998764 3345677899999999887664333332211 1123456789999
Q ss_pred cC-CCCH
Q 013941 174 KL-GPSL 179 (433)
Q Consensus 174 ~~-~~~L 179 (433)
++ |..+
T Consensus 95 ~i~G~~~ 101 (296)
T cd05153 95 FLAGEHL 101 (296)
T ss_pred eCCCCCC
Confidence 99 6543
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=9.7e-05 Score=71.59 Aligned_cols=90 Identities=22% Similarity=0.235 Sum_probs=63.2
Q ss_pred ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHH
Q 013941 297 YPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376 (433)
Q Consensus 297 ~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (433)
+++||||+|.++.++..|...+......+.+..+.... ..+.......+.+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~~~~~a~e~---------------------------- 160 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY-TDDQELLSTAMEH---------------------------- 160 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchhHHHHHHHH----------------------------
Confidence 59999999999999999998887766666666555432 2221111111111
Q ss_pred hcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
...-..+..+.+++.+|+-..|..||...++.+|+-|++
T Consensus 161 ---------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 161 ---------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred ---------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 011123557889999999999999999999999988764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=67.06 Aligned_cols=71 Identities=13% Similarity=0.073 Sum_probs=46.1
Q ss_pred cccccccEEEEEEEecCCCcEEEEEEeccchhhH-HHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-C
Q 013941 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~ 176 (433)
.+..|-.+.+|+.. .+++.+++|+........ -...+|..+++.+...++ .|.++. ... -++||||+ |
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~-~P~~i~---~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL-APKPIL---VNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC-CCceEE---EeC----CEEEEEeccC
Confidence 45668888899886 456678899865432221 235779999999987765 344332 222 26899999 6
Q ss_pred CCH
Q 013941 177 PSL 179 (433)
Q Consensus 177 ~~L 179 (433)
..+
T Consensus 73 ~~~ 75 (256)
T TIGR02721 73 EVI 75 (256)
T ss_pred ccc
Confidence 544
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0004 Score=65.34 Aligned_cols=75 Identities=17% Similarity=0.198 Sum_probs=49.5
Q ss_pred eccccccccEEEEEEEecC------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 97 LSKMGEGTFGQVVECFDNE------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
++.|..|-...||++.... .++.+++|+............+|..++..+...++ . .+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~-~---P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL-G---PKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC-C---CceEEEeCC----Cc
Confidence 3456677777899887533 25789999976544333456789999999987765 2 334444432 35
Q ss_pred EEccC-CCCH
Q 013941 171 VFEKL-GPSL 179 (433)
Q Consensus 171 v~e~~-~~~L 179 (433)
|+||+ |..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 78888 6554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00099 Score=63.18 Aligned_cols=77 Identities=14% Similarity=0.096 Sum_probs=50.3
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc---eeccCCeEEEEEc
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFE 173 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~---~~~~~~~~~lv~e 173 (433)
++.|+.|....+|+.... +| .+++|++.. ...+....|+.++..|...++..|.++.-.+ +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456777888899998743 33 589998762 2234556688888888877765555443211 1123566899999
Q ss_pred cC-CC
Q 013941 174 KL-GP 177 (433)
Q Consensus 174 ~~-~~ 177 (433)
++ |.
T Consensus 103 ~l~G~ 107 (319)
T PRK05231 103 FLEGK 107 (319)
T ss_pred ecCCC
Confidence 99 54
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0012 Score=62.36 Aligned_cols=80 Identities=14% Similarity=0.051 Sum_probs=51.4
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc---eeccCCeEEEE
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIV 171 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~---~~~~~~~~~lv 171 (433)
.-++.++.|....+|++.. .++ .+++|+..... ..+....|++++..|...++..+.++...+ +....+..+++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred eeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 3467788888889999863 334 58889875422 234556788899999877664444333221 11235678999
Q ss_pred EccC-CC
Q 013941 172 FEKL-GP 177 (433)
Q Consensus 172 ~e~~-~~ 177 (433)
++|+ |.
T Consensus 102 ~e~i~G~ 108 (307)
T TIGR00938 102 VEFLQGL 108 (307)
T ss_pred EEeCCCC
Confidence 9998 53
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00016 Score=66.34 Aligned_cols=130 Identities=21% Similarity=0.226 Sum_probs=89.7
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccc---------h--------------hhHHHHHHHHHHHHHHHhCCC
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------N--------------KYREAAMIEIDVLQRLARHDI 150 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~--------------~~~~~~~~E~~~l~~l~~~~i 150 (433)
|.+.+.||-|--+.||.+-+ ..|...++|+-+.. + -.+-...+|...|+.|..++.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67889999999999999986 45677888864210 0 012345679999999987765
Q ss_pred CCcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 151 ~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
..| +.+ +.+..|+|||++ |..|...-+- .. +..+...+..-+--|-.+|+||+|..-=||++.+
T Consensus 173 pVP---kpi----D~~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVP---KPI----DHNRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCC---Ccc----cccceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence 322 222 235678999999 7777654321 12 2334444555566778899999999999999988
Q ss_pred CCcccccCcc
Q 013941 230 AEYVKVPDYK 239 (433)
Q Consensus 230 ~~~~~l~d~~ 239 (433)
++.+++.||.
T Consensus 238 d~~i~vIDFP 247 (465)
T KOG2268|consen 238 DDKIVVIDFP 247 (465)
T ss_pred CCCEEEeech
Confidence 7766666664
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=8.9e-05 Score=80.14 Aligned_cols=151 Identities=13% Similarity=0.022 Sum_probs=103.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeEecceec--cCCeEEEEEccC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHH
Q 013941 136 MIEIDVLQRLARHDIGGTRCVQIRNWFD--YRNHICIVFEKL-GPSLYDFLRKNSYR--SFPIDLVRELGRQLLESVAFM 210 (433)
Q Consensus 136 ~~E~~~l~~l~~~~i~~~~~v~~~~~~~--~~~~~~lv~e~~-~~~L~~~l~~~~~~--~l~~~~~~~i~~qi~~aL~~L 210 (433)
..|...++...|.++ .....-.. .....+.+++++ +|.+.+.+-+...+ .+....+.....+.+.+..-+
T Consensus 1277 l~e~de~~~~~h~~~-----~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLT-----EVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred hhhhhhhhhhhceee-----ecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 334444455566554 33222222 244678999999 99999998754321 233334444444547778887
Q ss_pred HhC-----CcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCC
Q 013941 211 HEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTR 282 (433)
Q Consensus 211 H~~-----~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~ 282 (433)
|+. -.+|+++|+-|.+|..+. .++++++|+.++..... ...++++
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny---------------------------~v~~gk~gLdKIknp~~sf~Gl~l~sp 1404 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNY---------------------------NVKLGKGGLDKIKNPVLSFFGLELCSP 1404 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCC---------------------------cccccccccccccCchHhhhhhhhCCH
Confidence 764 278999999999986544 56777777777433222 2347788
Q ss_pred cccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 283 HYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 283 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.|++|++...-.++.++|+|..|+.+|+...|..+|
T Consensus 1405 ~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1405 IYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 999999998888898899999999999998887766
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0037 Score=59.80 Aligned_cols=75 Identities=16% Similarity=0.074 Sum_probs=48.9
Q ss_pred eccccccccEEEEEEEecC----CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 97 LSKMGEGTFGQVVECFDNE----KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
+..|..|-...+|++.... .++.|++|+........-...+|..+++.+...++. .++++.+..+ .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~----P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQG----PRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCC----CceEEEECCc----eEE
Confidence 4456568888999986432 346799998865433222346799999999988773 3444555432 578
Q ss_pred ccC-CCCH
Q 013941 173 EKL-GPSL 179 (433)
Q Consensus 173 e~~-~~~L 179 (433)
+|+ +.+|
T Consensus 113 efi~g~~l 120 (344)
T PLN02236 113 EFIHARTL 120 (344)
T ss_pred EeeCCCCC
Confidence 888 5554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00086 Score=58.11 Aligned_cols=94 Identities=21% Similarity=0.158 Sum_probs=69.4
Q ss_pred HHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-CCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF---LRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 137 ~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~---l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
.|.-+++.+.+. .++.+++|++.. ++|.||. .+++... +... ...++..+..|+.++++.+.+|+.
T Consensus 8 ~E~lll~~l~~~----~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGS----EPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCC----CCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhc
Confidence 477788888764 256899998853 5688998 4555321 1111 246899999999999999999997
Q ss_pred ---CCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 213 ---LRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 213 ---~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
..+.-.|++++|+-++++|.+|+.|...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~ 108 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDD 108 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechh
Confidence 3478899999999998877666665543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.006 Score=57.90 Aligned_cols=83 Identities=20% Similarity=0.160 Sum_probs=50.7
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEecc--------chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+.||.|....||++.+...++.|+||.-.. -....+....|...|+..... ....+.+++. .+.....
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~--~P~~vP~vy~--~D~e~~~ 76 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEH--VPHLVPRIFH--FDTEMAV 76 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhcc--CccccCeEEE--Eccccce
Confidence 368999999999999754446799996421 122334556788888765432 1123344433 3345567
Q ss_pred EEEccC--CCCHHHHHH
Q 013941 170 IVFEKL--GPSLYDFLR 184 (433)
Q Consensus 170 lv~e~~--~~~L~~~l~ 184 (433)
+|||++ ...|...+.
T Consensus 77 ~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 77 TVMEDLSHHKIARKGLI 93 (370)
T ss_pred ehHhhCccchHHHHHHH
Confidence 999998 334444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0063 Score=57.95 Aligned_cols=75 Identities=12% Similarity=0.238 Sum_probs=47.5
Q ss_pred eccccccccEEEEEEEecCC---CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEc
Q 013941 97 LSKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e 173 (433)
++.|..|-...+|++..... +..|++|+........-...+|..+++.+...++. .+++.++..+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~----P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG----AKLLGVFGNG----MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC----CceeEEeCCc----Eeeh
Confidence 34555577888998864332 34789998765433223345799999999988774 3444444322 5788
Q ss_pred cC-CCCH
Q 013941 174 KL-GPSL 179 (433)
Q Consensus 174 ~~-~~~L 179 (433)
|+ +.+|
T Consensus 91 fi~g~~l 97 (330)
T PLN02421 91 FINARTL 97 (330)
T ss_pred hhcCCCC
Confidence 88 5544
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0054 Score=57.40 Aligned_cols=106 Identities=17% Similarity=0.137 Sum_probs=73.1
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCC-CCCcceeEecceec---cCCeEEE
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFD---YRNHICI 170 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~~v~~~~~~~---~~~~~~l 170 (433)
.-.+.||.|..+.||..... ++ .+.+|..+. ......+..|...|+.|.... +.. .++++++. ..+..+|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpV---P~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRM---PTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCc---CcEEEEeccCCcCCCeEE
Confidence 34678999999999998642 23 477787533 223457889999999997653 333 45554443 3467899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 213 (433)
|||++ |.++.+. ..+......+..+++++|.-||+.
T Consensus 91 VmE~i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 91 LLERLRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEeccCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999 7666541 133445566778888999999974
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0077 Score=55.71 Aligned_cols=48 Identities=25% Similarity=0.133 Sum_probs=30.9
Q ss_pred cccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhC
Q 013941 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~ 148 (433)
..++|-...|+.+. ..+|+.+++|.-+. ........+|..+|..+...
T Consensus 18 ~~~~g~~~~v~~i~-~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 18 LNESGLDFQVVFAK-DTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred ecCCcceeEEEEEE-cCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhc
Confidence 33555555666553 24567788887653 23345678899999999753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.036 Score=52.65 Aligned_cols=72 Identities=17% Similarity=0.104 Sum_probs=45.7
Q ss_pred cEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc--eeccCCeEEEEEccC-CC
Q 013941 105 FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN--WFDYRNHICIVFEKL-GP 177 (433)
Q Consensus 105 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~--~~~~~~~~~lv~e~~-~~ 177 (433)
-..||++.. .++..+++|+.+...........|+..+..|...++..+..+..-+ ....++..+.|++++ |.
T Consensus 38 eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 38 ENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 347888864 4456799999865444556677899999999876653221122222 122356788899998 54
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0076 Score=57.94 Aligned_cols=75 Identities=23% Similarity=0.206 Sum_probs=49.3
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEec----cc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR----SI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++.||.|.-..||++.+...++.|+||.-. .. .-..++...|.++|+....-.. .++.+++. .+.....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P--~~VP~vy~--~D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAP--GLVPKVYL--FDSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCC--CcCCeEEE--ECcHHhh
Confidence 678999999999999974445679999642 11 2234566778888887754211 22344433 3345567
Q ss_pred EEEccC
Q 013941 170 IVFEKL 175 (433)
Q Consensus 170 lv~e~~ 175 (433)
+|||++
T Consensus 110 ~vMEdL 115 (409)
T PRK12396 110 CVMEDL 115 (409)
T ss_pred HHHHhC
Confidence 888888
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.032 Score=52.58 Aligned_cols=67 Identities=10% Similarity=0.237 Sum_probs=42.1
Q ss_pred EEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc---eeccCCeEEEEEccC-CCC
Q 013941 107 QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFEKL-GPS 178 (433)
Q Consensus 107 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~---~~~~~~~~~lv~e~~-~~~ 178 (433)
.||++.. ..| .+++|++... ......|+.++..|...++..+.++...+ +...++..++|++++ |..
T Consensus 11 ~v~~v~t-~~g-~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~ 81 (313)
T TIGR02906 11 NVYKVET-DSG-NKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRE 81 (313)
T ss_pred cEEEEEe-CCC-CeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcC
Confidence 4888863 233 5899987532 23456688888888877764444444321 112356789999999 543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.022 Score=55.09 Aligned_cols=74 Identities=16% Similarity=0.154 Sum_probs=48.2
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEecc-----ch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-----IN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
..+.||.|....||+..+. ++.|+||.-.. .. ........|...|+.+... ...++.+++.+.+ +.
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~--~p~~VPkVy~~de--d~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRL--CPDHVPEVYHFDR--TM 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhc--CCCCCCeEEEECC--CC
Confidence 3678999999999999863 44589997541 11 1334455677777766532 1124466666665 44
Q ss_pred EEEEEccC
Q 013941 168 ICIVFEKL 175 (433)
Q Consensus 168 ~~lv~e~~ 175 (433)
.+++||++
T Consensus 110 ~vlvME~L 117 (418)
T PLN02756 110 ALIGMRYL 117 (418)
T ss_pred CEEEEeec
Confidence 67889999
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.013 Score=54.85 Aligned_cols=76 Identities=13% Similarity=0.059 Sum_probs=44.5
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC--eEE
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--HIC 169 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~--~~~ 169 (433)
.+++.+..|....+|...+. ++.+++. ... .........+|..+++.+..-.+ .+...++++..+. ..+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~v---P~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDV---PVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCC---CCcccccccccCCCCCce
Confidence 34455544544455655533 7778888 331 12334556678888888765433 2234455555544 679
Q ss_pred EEEccC-C
Q 013941 170 IVFEKL-G 176 (433)
Q Consensus 170 lv~e~~-~ 176 (433)
.||+++ |
T Consensus 102 ~v~~~veG 109 (321)
T COG3173 102 YVMEWVEG 109 (321)
T ss_pred EEEEEecc
Confidence 999999 5
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.053 Score=52.57 Aligned_cols=76 Identities=20% Similarity=0.244 Sum_probs=46.3
Q ss_pred EeccccccccEEEEEEEecCCC------cEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 96 ILSKMGEGTFGQVVECFDNEKK------ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.++.|..|-...+|++...... +.|.+++........-.-.+|+.+++.+...+++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glg----P~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFG----PKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCC----CeEEEecCC----E
Confidence 3456666888899999743321 2244444322222222335689999999888763 556665543 5
Q ss_pred EEEccC-CCCH
Q 013941 170 IVFEKL-GPSL 179 (433)
Q Consensus 170 lv~e~~-~~~L 179 (433)
+|.||+ |.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 889998 6554
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.012 Score=52.04 Aligned_cols=54 Identities=20% Similarity=0.183 Sum_probs=34.9
Q ss_pred CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-CCC
Q 013941 117 KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPS 178 (433)
Q Consensus 117 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~ 178 (433)
++.|++|+........-....|..+++.+...+++ .++++.+..+ +|.+|+ |.+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~----p~~~~~~~~g----~v~e~i~g~~ 56 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLG----PKIIYFFENG----RVEEFIEGRT 56 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSS----S-EEEEETTE----EEEE--SSEE
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCC----CeEEEEcCCC----cEEEEecccc
Confidence 45789999877655556677899999999987763 4555555443 466777 444
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.037 Score=48.42 Aligned_cols=111 Identities=16% Similarity=0.194 Sum_probs=69.0
Q ss_pred cccEEEEEEEecCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-CCCH
Q 013941 103 GTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSL 179 (433)
Q Consensus 103 G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L 179 (433)
|+.++.-.+.... | ...+|+++...- ....+..+..++.++. +| +++.. ++...+.++.|+| ....
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--Gi-----lrL~N--Dn~~~yGvIlE~Cy~~~i 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GI-----LRLKN--DNNYKYGVILERCYKIKI 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--he-----eEeec--CCCceeEEEEeeccCccc
Confidence 4444554444333 3 345666654332 2344567888888884 44 77774 2455688999999 3211
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 180 YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
.. .-.|. .=+.+|.-.|+ .+.+|+|..|+||+-+..|.+|+.|.+
T Consensus 142 -----------~~---~N~i~-agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 142 -----------NF---SNFIT-AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred -----------ch---hHHHH-HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 11 11111 11467888894 479999999999999888877776665
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.039 Score=52.68 Aligned_cols=62 Identities=24% Similarity=0.363 Sum_probs=46.3
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEecCCCCCcEEEeeCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDikp~NIli~~~~ 231 (433)
...|+-+|. |-++..++...+ .+++..+.++.-.+.||--+- -.+++|.|+.|.||++.-..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 345666677 889999987654 667777777777777765443 56899999999999996543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.12 Score=56.89 Aligned_cols=81 Identities=15% Similarity=0.105 Sum_probs=48.1
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhC--CCCCcceeEecc-----eecc-CC--e
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--DIGGTRCVQIRN-----WFDY-RN--H 167 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~--~i~~~~~v~~~~-----~~~~-~~--~ 167 (433)
+.|+. ..-.+|++.. .+|+.+++|+.+... .......|...+..|... .+..|.++...+ .... ++ .
T Consensus 31 ~~L~s-~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLDG-ERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecCC-cCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 45643 4567788763 456679999987542 233445577778777653 554455554321 1111 22 5
Q ss_pred EEEEEccC-CCCHHH
Q 013941 168 ICIVFEKL-GPSLYD 181 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~ 181 (433)
.+.+++|+ |..|.+
T Consensus 108 ~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 108 LLRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEEeccCCCcHHh
Confidence 77889999 666654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.048 Score=50.61 Aligned_cols=75 Identities=16% Similarity=0.213 Sum_probs=50.0
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEcc
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~ 174 (433)
+-.+.++.|....+|+.. .+++.+.||+-. ......+..|.+-|+.|....- ..+.+++.+....+..+|||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~--~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANP--IRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTT--SBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCC--CCCCeEEEEEeecCCceEEEEe
Confidence 345678889999999987 677789999865 3444678889999999954322 3456777777666677999999
Q ss_pred C
Q 013941 175 L 175 (433)
Q Consensus 175 ~ 175 (433)
+
T Consensus 94 l 94 (288)
T PF03881_consen 94 L 94 (288)
T ss_dssp -
T ss_pred e
Confidence 8
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.095 Score=51.82 Aligned_cols=74 Identities=20% Similarity=0.157 Sum_probs=49.2
Q ss_pred EeccccccccEEEEEEEecC--------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 96 ILSKMGEGTFGQVVECFDNE--------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
-++.|..|-...+|++.... .++.|.+++.-......-....|..+++.+...+++ .++++.+..
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~----P~l~~~f~g--- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIA----PQLLNTFSG--- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCC----CceEEEeCC---
Confidence 45677778888889887442 256799998765443333456699999999988874 344454432
Q ss_pred EEEEEccC-CC
Q 013941 168 ICIVFEKL-GP 177 (433)
Q Consensus 168 ~~lv~e~~-~~ 177 (433)
+.|.||+ |.
T Consensus 182 -g~I~efi~g~ 191 (442)
T PTZ00296 182 -GRIEEWLYGD 191 (442)
T ss_pred -CEEEEeeCCc
Confidence 3567888 55
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.017 Score=53.43 Aligned_cols=95 Identities=18% Similarity=0.228 Sum_probs=54.9
Q ss_pred eEEEEEccCCCC---HHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----CCcEecCCCCCcEEEeeCCc---ccc
Q 013941 167 HICIVFEKLGPS---LYD-FLRKNSYRSFPIDLVRELGRQLLESVAFMHE----LRLIHTDLKPENILLVSAEY---VKV 235 (433)
Q Consensus 167 ~~~lv~e~~~~~---L~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~----~~ivHrDikp~NIli~~~~~---~~l 235 (433)
.-.+|+++..++ +.. ...+.+. .--.+-++.++.||+.-.-.+-+ .+.+|-||||+||||-+... ++.
T Consensus 249 GnIIIfPLArcSadkv~~~~~~e~GF-~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~ 327 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAAELGF-KSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITL 327 (444)
T ss_pred CcEEEEehhhcccccCCHHHHHHcCC-ccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEE
Confidence 346788775322 221 1122221 12345678899998765534433 36999999999999966542 222
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~ 274 (433)
.+-.++ ..+...++|.||.+|...+-.
T Consensus 328 ~~~~~v------------F~Epi~~~LnDFDfSqv~~i~ 354 (444)
T PHA03111 328 KDATYV------------FNEPIKACLNDFDFSQVANII 354 (444)
T ss_pred CCeEEE------------eccchhhhhcccCHHHHccch
Confidence 222111 134556789999988765443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.19 Score=47.62 Aligned_cols=79 Identities=19% Similarity=0.155 Sum_probs=50.0
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcce-eEeccee--ccCC--eEEEEE
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC-VQIRNWF--DYRN--HICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~-v~~~~~~--~~~~--~~~lv~ 172 (433)
..|.+ .-..||+.... +|+ +++|+.+.. .......-|+..+..|...++..+-- ..+-+-. ...+ ..+-|+
T Consensus 32 ~~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTE-DGR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEec-CCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34444 45578888743 344 499999876 66677888999999998877633211 2221111 1134 788899
Q ss_pred ccC-CCCHH
Q 013941 173 EKL-GPSLY 180 (433)
Q Consensus 173 e~~-~~~L~ 180 (433)
+|+ |..+.
T Consensus 108 ~~l~G~~~~ 116 (331)
T COG2334 108 EYLPGRPLE 116 (331)
T ss_pred EecCCcCcC
Confidence 999 65555
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.053 Score=50.23 Aligned_cols=124 Identities=20% Similarity=0.277 Sum_probs=87.2
Q ss_pred EeccccccccEEEEEEEec-------C---CCcEEEEEEeccch--------------hh-------------HHHHHHH
Q 013941 96 ILSKMGEGTFGQVVECFDN-------E---KKELVAIKIVRSIN--------------KY-------------REAAMIE 138 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~-------~---~~~~vavK~~~~~~--------------~~-------------~~~~~~E 138 (433)
|...|..|--+.|+.|.-- . ....+|||+++-.- .. .-...+|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 4567888888999888420 1 22458999875100 00 1123468
Q ss_pred HHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCc
Q 013941 139 IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRL 215 (433)
Q Consensus 139 ~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~i 215 (433)
+..|.++..+++..|.+|.+.. ..|||-|+|. .-.-.|.. -.|+....+..-.|+..++.-|. +.-+
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~---v~l~d~E~~~aY~q~~~~M~~lY~Ec~L 405 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKN---VELTDDERRNAYDQVQSIMCRLYKECLL 405 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCccccc---cccChHHHHHHHHHHHHHHHHHHHhhhe
Confidence 8889999999998898888754 5699999843 22222222 24888888888889998888764 6789
Q ss_pred EecCCCCCcEEEee
Q 013941 216 IHTDLKPENILLVS 229 (433)
Q Consensus 216 vHrDikp~NIli~~ 229 (433)
||.|+.--|+|+..
T Consensus 406 VHADlSEyN~Lw~~ 419 (531)
T KOG2269|consen 406 VHADLSEYNLLWTP 419 (531)
T ss_pred eecchhhhhheecC
Confidence 99999999999854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 433 | ||||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-90 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 8e-85 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-84 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-84 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-83 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-82 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-66 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-52 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-52 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-52 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-49 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-49 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-49 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-42 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-42 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-41 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-34 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-34 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-27 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-27 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-27 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-27 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-27 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-26 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-26 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-26 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-26 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-26 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-26 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-26 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-26 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-26 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-26 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-26 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-26 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-26 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-26 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-26 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-26 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-26 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-26 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-26 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-26 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-26 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-26 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-26 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-26 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-26 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-26 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-26 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-25 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-25 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-25 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-24 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-24 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-24 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-24 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-24 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-24 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-24 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-24 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-24 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-24 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-24 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-24 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-24 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-24 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-24 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-24 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-24 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-24 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-24 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-24 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-24 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-24 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-23 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-23 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-23 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-23 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-23 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-23 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-23 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-22 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-22 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-22 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-22 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-22 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-22 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-22 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-22 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-22 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-22 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-22 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-22 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-22 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-22 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-22 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-22 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-22 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-21 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-21 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-21 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-21 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-21 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-21 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-21 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-21 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-20 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-19 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-19 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-19 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-19 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-19 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-19 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-19 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-19 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-18 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-18 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-18 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-18 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-18 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-18 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-18 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-18 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-18 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-18 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-17 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-16 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-16 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-16 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-16 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-16 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-16 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-16 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-16 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-16 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-16 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-16 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-15 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-15 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-15 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-15 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-15 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-15 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-15 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-15 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-09 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 4e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 2e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-06 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 4e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-04 |
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 433 | |||
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 0.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-180 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-178 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-152 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-150 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-141 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-115 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-55 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-54 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-51 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-51 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-50 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-50 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-50 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-49 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-49 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-49 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-48 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-48 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-47 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 6e-47 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-47 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-46 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-46 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-46 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-46 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-45 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-45 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-45 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-43 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-43 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-43 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-42 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-42 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-42 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-41 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-41 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-41 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-41 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-41 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-41 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 9e-41 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-40 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-40 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-40 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-40 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-40 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-40 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-40 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-40 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-40 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-40 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-39 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-39 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-39 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-39 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-39 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-39 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-39 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-39 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 9e-39 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-38 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-38 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-38 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-38 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-38 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-38 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-38 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-38 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-38 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-37 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-37 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-37 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-37 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-37 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-37 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-37 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-37 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-37 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-36 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-36 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-36 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-36 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-36 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-35 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-35 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-35 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-34 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-34 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-33 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-33 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-33 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 9e-33 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-32 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-31 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-31 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-31 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-30 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-29 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 7e-29 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-28 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-28 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-27 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-26 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-25 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-24 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-24 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-24 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-24 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-24 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-24 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-23 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-23 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-23 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-23 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-22 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-22 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-22 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-22 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-22 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-21 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-21 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-21 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-21 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-21 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-21 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-21 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-21 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-20 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-20 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-20 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-20 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 6e-20 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-20 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 8e-20 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-20 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-19 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-19 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-19 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-19 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 8e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-18 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-18 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-18 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 9e-18 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-17 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-17 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-17 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-17 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-16 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-16 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-16 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-16 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-16 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-16 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-16 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 7e-16 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 8e-16 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-15 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-15 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-15 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 7e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 9e-15 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-14 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-14 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-14 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-13 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-13 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-12 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-12 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-12 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-12 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 8e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-11 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-11 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-11 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-10 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-10 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-10 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-10 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-10 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-10 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-10 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-09 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-09 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-09 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-09 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-09 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-09 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-09 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-08 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-08 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-08 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-08 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-07 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-07 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-07 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 8e-07 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-06 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-06 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-06 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-06 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-05 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-05 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 1e-04 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-04 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-04 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 6e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-04 |
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 533 bits (1375), Expect = 0.0
Identities = 134/359 (37%), Positives = 210/359 (58%), Gaps = 10/359 (2%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
+ ++ DD+ H+ + G L + ++ KMG+GTFG+V+ C + K+ A+K+V
Sbjct: 9 SGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV 68
Query: 126 RSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
R+I KY +A IE D+L+++ DI V+ F Y +H+C++FE LGPSLY+ + +
Sbjct: 69 RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR 128
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
N+Y F I+ ++ ++L+++ ++ ++ L HTDLKPENILL + K
Sbjct: 129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
K ++ KS+ IKLIDFG TF+ H +++TR YRAPEVIL LGW+ D+WS G
Sbjct: 189 KKIQIYR--TKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGA-RLDWPD 363
C+L EL +G LF+THE++EHLAMME ++ P+P +M+ A + KY + +L WP+
Sbjct: 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306
Query: 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
A+S +S++ V K L L +I + D L +L+ DP R E L+H F
Sbjct: 307 NASSINSIKHVKKCLPLYKIIKHEL------FCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 506 bits (1304), Expect = e-180
Identities = 159/347 (45%), Positives = 226/347 (65%), Gaps = 16/347 (4%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIE 138
H + G+ L+ RY I+ +GEG FG+VVEC D++ VA+KIV+++++Y EAA E
Sbjct: 2 MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61
Query: 139 IDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
I VL+ L D T RCVQ+ WF++ HICIVFE LG S YDF+++N + F +D +R
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
++ Q+ +SV F+H +L HTDLKPENIL V ++Y + + K + +
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--------ERTLIN 173
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
F TH++ EHLAMMER+LGPLP HM+ + +R KYF RLDW + +++ + K
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHD-RLDWDEHSSAGRYVSRACKP 290
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
L+ ++ Q V+H L DL+Q +L YDPA+R+ REAL+HPFF
Sbjct: 291 LK-EFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 499 bits (1288), Expect = e-178
Identities = 155/351 (44%), Positives = 232/351 (66%), Gaps = 16/351 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
DDK+GH V IG+ L RY I+ +GEGTFG+VVEC D+ + K VA+KI+R++ KYREA
Sbjct: 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CV + +WF++ H+CI FE LG + ++FL++N+++ +P+
Sbjct: 63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++ F+HE +L HTDLKPENIL V++E+ + + S +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH--------KSCEEK 174
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW PCD+WS+GCIL E
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G LFQTHEN EHL MME++LGP+P HM+ R ++ KYF +G L W + ++ ++
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ--KYFYKG-GLVWDENSSDGRYVKE 291
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
K L+ ++ ++H L DL++ +L +DPA+R+ EAL HPFF
Sbjct: 292 NCKPLK-SYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 438 bits (1128), Expect = e-152
Identities = 120/360 (33%), Positives = 187/360 (51%), Gaps = 37/360 (10%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD G YV +++ RY +L +G+G+FGQVV+ +D++ + VA+K+VR+ ++ A
Sbjct: 81 DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
EI +L+ L + D T + + F +RNHIC+ FE L +LY+ ++KN ++ F +
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
LVR+ +L+ + +H+ R+IH DLKPENILL
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ------------------------- 235
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
S IK+IDFGS+ +EHQ + +R YRAPEVILG + P D+WS+GCIL EL +G
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW------PDGATSR 368
L + + LA M +LG + + A +RA+ + + DG+
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPSQKL-LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVL 354
Query: 369 DSMRAVWKLLRLPNLIMQHVDHSAG----DLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ R+ LR P + + G +D L+ L +DPA R+ +ALRHP+ R
Sbjct: 355 NGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 429 bits (1105), Expect = e-150
Identities = 120/369 (32%), Positives = 187/369 (50%), Gaps = 44/369 (11%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD + Y+ GE RY I S +G+G+FGQVV+ +D ++E VAIKI+++ + A
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
IE+ +L+ + +HD V ++ F +RNH+C+VFE L +LYD LR ++R ++
Sbjct: 98 QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN 157
Query: 195 LVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
L R+ +Q+ ++ F+ EL +IH DLKPENILL +
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN----------------------- 194
Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
PK SAIK++DFGS+ Q + +R YR+PEV+LG+ ++ D+WS+GCILVE+
Sbjct: 195 --PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
+GE LF ++ + + VLG P H+ + +A K+F + W T
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHI-LDQAPKARKFFEKLPDGTWNLKKTKDGKRE 311
Query: 373 AVWKLLR-LPNLIMQHVDHSAG--------------DLIDLLQGLLRYDPAERLKAREAL 417
R L N++ G DL+ +L YDP R++ AL
Sbjct: 312 YKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYAL 371
Query: 418 RHPFFTRDV 426
+H FF +
Sbjct: 372 QHSFFKKTA 380
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-141
Identities = 100/367 (27%), Positives = 169/367 (46%), Gaps = 47/367 (12%)
Query: 76 DDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
G++ GE RY ++ K+G G F V D VA+KIVR Y EA
Sbjct: 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 61
Query: 135 AMIEIDVLQRLARHD------IGGTRCVQIRNWFDYRN----HICIVFEKLGPSLYDFLR 184
A EI +LQR+ D +G +++ + F+++ H+ +VFE LG +L ++
Sbjct: 62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
K +R P+ V+++ +QLL + +MH +IHTD+KPEN+L+ + +
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE--------- 172
Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
IK+ D G+ + + ++ + TR YR+PEV+LG W D+WS
Sbjct: 173 ------------NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWS 220
Query: 304 VGCILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGA 357
C++ EL +G+ LF+ E + +H+A + +LG LP ++ +R + +F
Sbjct: 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL-LRNGKYTRTFFNS-- 277
Query: 358 RLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 417
G S W L + + A ++ D L +L+ DP +R A +
Sbjct: 278 -----RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332
Query: 418 RHPFFTR 424
HP+
Sbjct: 333 NHPWLKD 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 342 bits (878), Expect = e-115
Identities = 106/390 (27%), Positives = 185/390 (47%), Gaps = 50/390 (12%)
Query: 72 PWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY 131
K G+++ IG+ RY ++ K+G G F V +D + K+ VA+K+V+S Y
Sbjct: 17 DPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76
Query: 132 REAAMIEIDVLQRLARHDI---GGTRCVQIRNWFDYR----NHICIVFEKLGPSLYDFLR 184
E A+ EI +L+ + D VQ+ + F HIC+VFE LG L ++
Sbjct: 77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII 136
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEY------VKVPD 237
K++Y+ P+ V+++ +Q+L+ + ++H + R+IHTD+KPENILL E + +
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 238 YKFLSRSSKDGSYFKNLP----------------KSSAIKLIDFGSTTFEHQDHSYVVST 281
++ GS P + +K+ D G+ + H+ + + T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256
Query: 282 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE------HLAMMERVLG 335
R YR+ EV++G G+N P D+WS C+ EL +G+ LF+ H E H+A++ +LG
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 336 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD- 394
+P +++ E + ++G K L ++++ + S +
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKL-----------KPWGLFEVLVEKYEWSQEEA 365
Query: 395 --LIDLLQGLLRYDPAERLKAREALRHPFF 422
D L +L P +R A E LRHP+
Sbjct: 366 AGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-55
Identities = 88/355 (24%), Positives = 145/355 (40%), Gaps = 75/355 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L +GEG++G V++C + + +VAIK + + AM EI +L++L RH
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQL-RH 83
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ + V + + +VFE + ++ D L +V++ Q++ +
Sbjct: 84 ENL-----VNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGI 137
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H +IH D+KPENIL+ S+ G +KL DFG
Sbjct: 138 GFCHSHNIIHRDIKPENILV-----------------SQSGV----------VKLCDFGF 170
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
+ T Y V+TR YRAPE+++G Y D+W++GC++ E+ GE LF
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP- 381
+++ L + LG L + + +RLP
Sbjct: 230 DIDQLYHIMMCLGNLIPR-------------------HQELFNKNPV-----FAGVRLPE 265
Query: 382 ----NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432
+ + + +IDL + L DP +R E L H FF D F
Sbjct: 266 IKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFS 320
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-54
Identities = 89/347 (25%), Positives = 154/347 (44%), Gaps = 77/347 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y + K+GEG++G V +C + + ++VAIK ++ A+ EI +L++L +H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KH 61
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V + F + + +VFE ++ L + R P LV+ + Q L++V
Sbjct: 62 PNL-----VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAV 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H+ IH D+KPENIL+ +K IKL DFG
Sbjct: 116 NFCHKHNCIHRDVKPENILI-----------------TKHSV----------IKLCDFGF 148
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
+ Y V+TR YR+PE+++G Y P D+W++GC+ EL SG L+
Sbjct: 149 ARLLTGPSDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207
Query: 323 NLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
+++ L ++ + LG +P H +T++ + +++P
Sbjct: 208 DVDQLYLIRKTLGDLIPRH--------------------QQVFSTNQY-----FSGVKIP 242
Query: 382 -----NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+ + + + LL+G L DP ERL + L HP+F
Sbjct: 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 78/352 (22%), Positives = 137/352 (38%), Gaps = 100/352 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 29 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 85
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 86 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 142
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+H+ ++H+DLKP N L+V DG +KLIDFG +
Sbjct: 143 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 174
Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLGW-----------NYPCDLWSVGCILVELCS 313
+ S V ++ +Y PE I + + D+WS+GCIL +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G+ FQ N ++ + ++ P +++PD
Sbjct: 235 GKTPFQQIIN--QISKLHAIIDP-------------------NHEIEFPDIPEK------ 267
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
DL D+L+ L+ DP +R+ E L HP+
Sbjct: 268 --------------------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-51
Identities = 85/351 (24%), Positives = 139/351 (39%), Gaps = 75/351 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA-------AMIEIDVLQRL 145
RY ++++G G +G V + D VA+K VR + + E+ +L+RL
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRL 68
Query: 146 --ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
H + V + D + +VFE + L +L K P + +++L RQ
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
L + F+H ++H DLKPENIL+ + G +KL
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILV-----------------TSGG----------TVKL 161
Query: 263 IDFG-------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
DFG VV T YRAPEV+L + P D+WSVGCI E+ +
Sbjct: 162 ADFGLARIYSYQMALTPV----VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
Query: 316 ALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
LF + + L + ++G P DWP +
Sbjct: 217 PLFCGNSEADQLGKIFDLIGLPPED--------------------DWPRDVSLPRGAFPP 256
Query: 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ +++ ++ S LL +L ++P +R+ A AL+H + +D
Sbjct: 257 RGPRPVQSVV-PEMEESG---AQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 95/382 (24%), Positives = 149/382 (39%), Gaps = 86/382 (22%)
Query: 66 PRTGSPPWRPDDKDGHYVFAI--------GENLTPRYRILSKMGEGTFGQVVECFDNEKK 117
P DKDG V + Y +G G+FG V + +
Sbjct: 20 PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79
Query: 118 ELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWF------DYRNHIC 169
ELVAIK V ++ RE + ++++L H V++R +F ++
Sbjct: 80 ELVAIKKVLQDKRFKNRE-----LQIMRKL-DHC----NIVRLRYFFYSSGEKKDEVYLN 129
Query: 170 IVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
+V + + ++Y R + ++ P+ V+ QL S+A++H + H D+KP+N+LL
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189
Query: 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-TFEHQDH--SYVVSTRHY 284
+ P ++ +KL DFGS + SY+ +R+Y
Sbjct: 190 -------------------------D-PDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYY 222
Query: 285 RAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMV 342
RAPE+I G +Y D+WS GC+L EL G+ +F ++ L + +VLG P
Sbjct: 223 RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-PTREQ 280
Query: 343 IRA--DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400
IR E F + K + A I L
Sbjct: 281 IREMNPNYTEFKFPQ-------------------IKAHPWTKVFRPRTPPEA---IALCS 318
Query: 401 GLLRYDPAERLKAREALRHPFF 422
LL Y P RL EA H FF
Sbjct: 319 RLLEYTPTARLTPLEACAHSFF 340
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 78/354 (22%), Positives = 137/354 (38%), Gaps = 100/354 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 67 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 123
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+H+ ++H+DLKP N L+V DG +KLIDFG +
Sbjct: 124 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 155
Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLG-----------WNYPCDLWSVGCILVELCS 313
+ S V ++ +Y PE I + + D+WS+GCIL +
Sbjct: 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G+ FQ N ++ + ++ P +++PD
Sbjct: 216 GKTPFQQIIN--QISKLHAIIDP-------------------NHEIEFPDIPEK------ 248
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427
DL D+L+ L+ DP +R+ E L HP+
Sbjct: 249 --------------------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 82/345 (23%), Positives = 144/345 (41%), Gaps = 65/345 (18%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
Y+++ K+G G + +V E + E V +KI++ + K + EI +L+ L
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGG 90
Query: 149 D--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I V+ +VFE + + DF K Y++ +R ++L++
Sbjct: 91 PNIITLADIVKDPVSRTP----ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKA 142
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ + H + ++H D+KP N+++ + ++LID+G
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMID--------------------------HEHRKLRLIDWG 176
Query: 267 STTFEHQDHSYV--VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG-EALFQTHE 322
F H Y V++R+++ PE+++ ++Y D+WS+GC+L + E F H+
Sbjct: 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
Query: 323 NLEHLAMMERVLGP-----LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
N + L + +VLG I D R R +R W
Sbjct: 237 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-------------- 282
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + V A +D L LLRYD RL AREA+ HP+F
Sbjct: 283 -FVHSENQHLVSPEA---LDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 96/353 (27%), Positives = 150/353 (42%), Gaps = 79/353 (22%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQR 144
GE Y +G G+FG V + E E VAIK V ++ RE + +++
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE-----LQIMRI 88
Query: 145 LARHDIGGTRCVQIRNWF------DYRNHICIVFEKLGPSLYDFLR--KNSYRSFPIDLV 196
+ +H V ++ +F + +V E + ++Y R ++ P+ L+
Sbjct: 89 V-KHP----NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
+ QLL S+A++H + + H D+KP+N+LL + P
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLL-------------------------D-PP 177
Query: 257 SSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
S +KLIDFGS + + SY+ +R+YRAPE+I G NY D+WS GC++ EL
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPELIFG-ATNYTTNIDIWSTGCVMAEL 235
Query: 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRAD--RRAEKYFRRGARLDWPDGATSRD 369
G+ LF ++ L + +VLG P I+ E F +
Sbjct: 236 MQGQPLFPGESGIDQLVEIIKVLGT-PSREQIKTMNPNYMEHKFPQ-------------- 280
Query: 370 SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + A IDL+ LL Y P+ RL A EAL HPFF
Sbjct: 281 -----IRPHPFSKVFRPRTPPDA---IDLISRLLEYTPSARLTAIEALCHPFF 325
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-49
Identities = 86/344 (25%), Positives = 150/344 (43%), Gaps = 68/344 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
RYR ++K+GEGT+G+V + D E VAIK +R + E A+ E+ +L+ L +H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-QH 92
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I +++++ + + + ++FE L ++ + + +++ QL+ V
Sbjct: 93 RNI-----IELKSVIHHNHRLHLIFEYAENDLKKYM--DKNPDVSMRVIKSFLYQLINGV 145
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H R +H DLKP+N+LL S +S+ +K+ DFG
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSV------------SDASETP----------VLKIGDFGL 183
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
+ + ++ + T YR PE++LG +Y D+WS+ CI E+ LF
Sbjct: 184 ARAFGIPIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242
Query: 323 NLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD--SMRAVWKLLR 379
++ L + VLG P WP D ++
Sbjct: 243 EIDQLFKIFEVLGLPDDT--------------------TWPGVTALPDWKQSFPKFRGKT 282
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
L ++ +D +DLL +L DP +R+ A+ AL HP+F+
Sbjct: 283 LKRVLGALLDDEG---LDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 78/354 (22%), Positives = 137/354 (38%), Gaps = 100/354 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 57 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 113
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 114 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 170
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+H+ ++H+DLKP N L+V DG +KLIDFG +
Sbjct: 171 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 202
Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLGWN-----------YPCDLWSVGCILVELCS 313
+ S V ++ +Y PE I + + D+WS+GCIL +
Sbjct: 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G+ FQ N ++ + ++ P +++PD
Sbjct: 263 GKTPFQQIIN--QISKLHAIIDP-------------------NHEIEFPDIPEK------ 295
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427
DL D+L+ L+ DP +R+ E L HP+
Sbjct: 296 --------------------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 2e-48
Identities = 90/346 (26%), Positives = 140/346 (40%), Gaps = 71/346 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRL-- 145
+Y ++++GEG +G+V + D VA+K VR + E + + E+ VL+ L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 70
Query: 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
H + V + D + +VFE + L +L K P + ++++ QLL
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ F+H R++H DLKP+NIL+ + G IKL D
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILV-----------------TSSG----------QIKLAD 163
Query: 265 FG-------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
FG VV T YRAPEV+L + P DLWSVGCI E+ + L
Sbjct: 164 FGLARIYSFQMALTSV----VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
F+ +++ L + V+G P WP
Sbjct: 219 FRGSSDVDQLGKILDVIGL-PGEED------------------WPRDVALPRQAFHSKSA 259
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+ + +D DLL L ++PA+R+ A AL HP+F
Sbjct: 260 QPIEKFV-TDIDELG---KDLLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-47
Identities = 91/345 (26%), Positives = 146/345 (42%), Gaps = 76/345 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + +N E A+K +R + K E + EI +L+ L +H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ + + + +VFE L L L + QLL +
Sbjct: 60 SNI-----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGI 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
A+ H+ R++H DLKP+N+L+ +++G +K+ DFG
Sbjct: 114 AYCHDRRVLHRDLKPQNLLI-----------------NREG----------ELKIADFGL 146
Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTH 321
+ F Y +V T YRAP+V++G Y D+WSVGCI E+ +G LF
Sbjct: 147 ARAFGIPVRKYTHEIV-TLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204
Query: 322 ENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD--SMRAVWKLL 378
+ L + R+LG P +WP+ V++
Sbjct: 205 SEADQLMRIFRILGTPNSK--------------------NWPNVTELPKYDPNFTVYE-- 242
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
P + IDLL +L+ DP +R+ A++AL H +F
Sbjct: 243 --PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-47
Identities = 96/347 (27%), Positives = 151/347 (43%), Gaps = 79/347 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y+ L K+GEGT+G V + D+ + +VA+K +R ++ E A+ EI +L+ L H
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLLKEL-HH 78
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V + + + +VFE + L L +N ++ QLL V
Sbjct: 79 PNI-----VSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGV 132
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
A H+ R++H DLKP+N+L+ + DG+ +KL DFG
Sbjct: 133 AHCHQHRILHRDLKPQNLLI-----------------NSDGA----------LKLADFGL 165
Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTH 321
+ F SY VV T YRAP+V++G Y D+WS+GCI E+ +G+ LF
Sbjct: 166 ARAFGIPVRSYTHEVV-TLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223
Query: 322 ENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380
+ + L + +LG P P +WP WK
Sbjct: 224 TDDDQLPKIFSILGTPNPR--------------------EWPQVQELPL-----WKQRTF 258
Query: 381 P----NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+ + IDLL +L +DP +R+ AR+A+ HP+F
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-47
Identities = 93/360 (25%), Positives = 145/360 (40%), Gaps = 75/360 (20%)
Query: 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEID 140
R+++ G+GTFG V + VAIK V ++ RE ++I
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70
Query: 141 VLQRLARHDIGGTRCVQIRNWF-----DYRNHIC--IVFEKLGPSLYDFLRKNSYR--SF 191
+ H VQ++++F R I +V E + +L+ R R +
Sbjct: 71 QDLAVLHHP----NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAP 126
Query: 192 PIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
P L++ QL+ S+ +H + + H D+KP N+L+
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---------------------- 164
Query: 250 YFKNLPKSSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPC--DLWSV 304
N +KL DFGS + + +Y+ +R+YRAPE+I G +Y D+WSV
Sbjct: 165 ---N-EADGTLKLCDFGSAKKLSPSEPNVAYIC-SRYYRAPELIFGNQ-HYTTAVDIWSV 218
Query: 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADR--RAEKYFRRGARLDWP 362
GCI E+ GE +F+ + L + RVLG P V+R + + W
Sbjct: 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC-PSREVLRKLNPSHTDVDLYNSKGIPWS 277
Query: 363 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ H A + DLL LL+Y P ER+K EAL HP+F
Sbjct: 278 -------------NVFS------DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 93/346 (26%), Positives = 150/346 (43%), Gaps = 76/346 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + + E E+VA+K VR ++ E +A+ EI +L+ L +H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KH 60
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ + + +VFE L + + ++V+ QLL+ +
Sbjct: 61 KNI-----VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H ++H DLKP+N+L+ +++G +KL +FG
Sbjct: 115 GFCHSRNVLHRDLKPQNLLI-----------------NRNGE----------LKLANFGL 147
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS-GEALFQTH 321
+ F Y V T YR P+V+ G Y D+WS GCI EL + G LF +
Sbjct: 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206
Query: 322 ENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380
+ + L + R+LG P WP D +K +
Sbjct: 207 DVDDQLKRIFRLLGTPTEE--------------------QWPSMTKLPD-----YKPYPM 241
Query: 381 ---PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
++ V DLLQ LL+ +P +R+ A EAL+HP+F+
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-46
Identities = 90/347 (25%), Positives = 145/347 (41%), Gaps = 79/347 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
Y L K+GEGT+ V + LVA+K +R ++ E A+ E+ +L+ L +H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KH 59
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V + + + +VFE L L +L + + V+ QLL +
Sbjct: 60 ANI-----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNIINMHNVKLFLFQLLRGL 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
A+ H +++H DLKP+N+L+ ++ G +KL DFG
Sbjct: 114 AYCHRQKVLHRDLKPQNLLI-----------------NERG----------ELKLADFGL 146
Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTH 321
+ +Y VV T YR P+++LG +Y D+W VGCI E+ +G LF
Sbjct: 147 ARAKSIPTKTYDNEVV-TLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGS 204
Query: 322 ENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380
E L + R+LG P WP ++ + +K
Sbjct: 205 TVEEQLHFIFRILGTPTEE--------------------TWPGILSNEE-----FKTYNY 239
Query: 381 P----NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
P ++ H D DLL LL+++ R+ A +A++HPFF
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-46
Identities = 92/350 (26%), Positives = 155/350 (44%), Gaps = 76/350 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+++ L K+G GT+ V + + VA+K V+ ++ E A+ EI +++ L +H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KH 62
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR----KNSYRSFPIDLVRELGRQL 203
+ I V++ + N + +VFE + L ++ N+ R ++LV+ QL
Sbjct: 63 ENI-----VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L+ +AF HE +++H DLKP+N+L+ +K G +KL
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLI-----------------NKRGQ----------LKLG 150
Query: 264 DFG-STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEAL 317
DFG + F +++ VV T YRAP+V++G Y D+WS GCIL E+ +G+ L
Sbjct: 151 DFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPL 208
Query: 318 FQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD--SMRAV 374
F + E L ++ ++G P WP
Sbjct: 209 FPGTNDEEQLKLIFDIMGTPNES--------------------LWPSVTKLPKYNPNIQQ 248
Query: 375 WKLLRLPNLIMQHVDHSAGDL-IDLLQGLLRYDPAERLKAREALRHPFFT 423
L ++ H +D L GLL+ +P RL A++AL HP+F
Sbjct: 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-46
Identities = 91/374 (24%), Positives = 149/374 (39%), Gaps = 90/374 (24%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--RE------------ 133
E + +Y + +G G+FG V E FD E + A+K V +Y RE
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 134 ----------------AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP 177
D + +++ + ++ ++ E +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 178 SLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
+L+ L+ S RS P++L+ QL +V F+H L + H D+KP+N+L+
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV-------- 174
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILG 292
N K + +KL DFGS + +Y+ +R YRAPE++LG
Sbjct: 175 -----------------N-SKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLG 215
Query: 293 LGWNYPC--DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRA--DRR 348
Y DLWS+GC+ EL G+ LF +++ L + +++G P +
Sbjct: 216 -ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT-PTKEQMIRMNPHY 273
Query: 349 AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408
E F DW K+L + + IDLL+ +LRY+P
Sbjct: 274 TEVRFPTLKAKDWR-------------KILP---------EGTPSLAIDLLEQILRYEPD 311
Query: 409 ERLKAREALRHPFF 422
R+ EA+ HPFF
Sbjct: 312 LRINPYEAMAHPFF 325
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 70/351 (19%), Positives = 128/351 (36%), Gaps = 81/351 (23%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
T Y + +G G++ C A+KI I+K + EI++L R +
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQ 74
Query: 148 HD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H I + +++ +D ++ +V E + G L D + + + F + + +
Sbjct: 75 HPNI-----ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITK 127
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+V ++H ++H DLKP NIL V +I++ DF
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDES-----------------------GNPESIRICDF 164
Query: 266 G-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
G + ++ T ++ APEV+ G++ CD+WS+G +L + +G F
Sbjct: 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
+ ++ R+ + G W
Sbjct: 225 DDTPEEILARIG---------------------SGKFSLSGGY---------WN------ 248
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
V +A DL+ +L DP +RL A LRHP+ + + L
Sbjct: 249 ----SVSDTAKDLVS---KMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 65/337 (19%), Positives = 107/337 (31%), Gaps = 89/337 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ LS++G G++G+V + E L A+K S K R + E+ +++ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
CV++ ++ + + E GPSL S P V R L ++A
Sbjct: 118 ----CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAH 172
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+H L+H D+KP NI L G KL DFG
Sbjct: 173 LHSQGLVHLDVKPANIFL-----------------GPRGR----------CKLGDFGLLV 205
Query: 269 TFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
Y APE++ G + D++S+G ++E+ L E + L
Sbjct: 206 ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
+ + S +
Sbjct: 265 -RQGYLPPEFTAGL-------------------------SSE------------------ 280
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
L +L +L DP R A L P +
Sbjct: 281 -------LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 89/346 (25%), Positives = 150/346 (43%), Gaps = 75/346 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
RY L +GEG F V + D ++VAIK ++ ++ A+ EI +LQ L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL- 69
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H I + + + F ++++I +VF+ + L ++ NS ++ L+
Sbjct: 70 SHPNI-----IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQ 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++H+ ++H DLKP N+LL ++G +KL DF
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLL-----------------DENG----------VLKLADF 156
Query: 266 G-STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQ 319
G + +F + +Y VV TR YRAPE++ G Y D+W+VGCIL EL
Sbjct: 157 GLAKSFGSPNRAYTHQVV-TRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLP 214
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+L+ L + LG P E+ WPD + D + +
Sbjct: 215 GDSDLDQLTRIFETLGT-PT----------EEQ--------WPDMCSLPD-----YVTFK 250
Query: 380 L--PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+ + DL+DL+QGL ++P R+ A +AL+ +F+
Sbjct: 251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 68/341 (19%), Positives = 128/341 (37%), Gaps = 73/341 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---- 149
+ ++ +G+G FGQVV+ + AIK +R + + E+ +L L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVR 66
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ V+ ++ + I E +LYD + + + D L RQ+
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQI 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKL 262
LE+++++H +IH DLKP NI + + VK+ D F L+++ L +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD--FGLAKNVHRSLDILKLDSQNLPGS 183
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTH 321
D ++ + T Y A EV+ G G N D++S+G I E+ F T
Sbjct: 184 SDNLTS---------AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTG 231
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
++ ++++ R +++P
Sbjct: 232 MERVNI--LKKL---------------------RSVSIEFPP------------------ 250
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
D+ +++ L+ +DP +R AR L +
Sbjct: 251 ----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 79/354 (22%), Positives = 144/354 (40%), Gaps = 84/354 (23%)
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
G ++ + +L+ Y+ + K+G G +G+V+ C D AIKI+
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI 193
+ E+ VL+ L +I +++ ++F+ + + +V E G L+D + F
Sbjct: 83 LLEEVAVLKLLDHPNI-----MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNE 135
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+ +Q+L V ++H+ ++H DLKPEN+LL S E
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE---------------------- 173
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
K + IK++DFG + + T +Y APEV+ ++ CD+WS+G IL L
Sbjct: 174 --KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFIL 230
Query: 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM 371
+G F + E ++ +V + + F +W
Sbjct: 231 LAGYPPFGGQTDQE---ILRKVE-------------KGKYTFD---SPEWK--------- 262
Query: 372 RAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+V A DL++ +L++D R+ A++AL HP+
Sbjct: 263 ---------------NVSEGA---KDLIKQMLQFDSQRRISAQQALEHPWIKEM 298
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 84/357 (23%), Positives = 142/357 (39%), Gaps = 84/357 (23%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAM 136
G RY I+ +G+G+FG+V++C D ++ A+K++ + NK +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
E+++L++L +I +++ + + IV E G L+D + K F
Sbjct: 70 REVELLKKLDHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHD 122
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
+ +Q+ + +MH+ ++H DLKPENILL S E
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------------------ 158
Query: 256 KSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
K IK+IDFG +T Q+ + T +Y APEV+ G ++ CD+WS G IL L S
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G F + +++RV + F W
Sbjct: 218 GTPPFYGKNEYD---ILKRVE-------------TGKYAFDLP---QWR----------- 247
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCG 430
+ A DLI + +L + P+ R+ A + L HP+ +
Sbjct: 248 -------------TISDDAKDLI---RKMLTFHPSLRITATQCLEHPWIQKYSSETP 288
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 71/368 (19%), Positives = 133/368 (36%), Gaps = 90/368 (24%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLA 146
++L +G G+ G VV + + VA+K + + + A++EI +L
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR---MLIDFCDIALMEIKLLTESD 66
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG----- 200
H + ++ + I E +L D + + + L +E
Sbjct: 67 DHPNV-----IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
RQ+ VA +H L++IH DLKP+NIL+ + SS+ + + ++ I
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVST--------------SSRFTADQQTGAENLRI 167
Query: 261 KLIDFG-STTFEHQDHSYVVSTRH------YRAPEVILGLGW-------NYPCDLWSVGC 306
+ DFG + S+ + + +RAPE++ D++S+GC
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 307 IL-VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA 365
+ L G+ F +
Sbjct: 228 VFYYILSKGKHPF------------------------------------------GDKYS 245
Query: 366 TSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ +R ++ L + L + + A DLI ++ +DP +R A + LRHP F
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLI---SQMIDHDPLKRPTAMKVLRHPLFWPK 302
Query: 426 VRRCGFPL 433
++ F L
Sbjct: 303 SKKLEFLL 310
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 83/356 (23%), Positives = 147/356 (41%), Gaps = 85/356 (23%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI 137
G +V + RY+ +G+G+FG+V+ C D + A+K++ R + + + +
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 138 --EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID 194
E+ +L++L +I +++ +F+ + + +V E G L+D + F
Sbjct: 74 LREVQLLKQLDHPNI-----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEV 126
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
+ RQ+L + +MH+ +++H DLKPEN+LL S
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS----------------------- 163
Query: 255 PKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
K + I++IDFG +T + T +Y APEV+ G ++ CD+WS G IL L
Sbjct: 164 -KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL 221
Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
SG F + ++++V + + F W
Sbjct: 222 SGCPPFNGANEYD---ILKKVE-------------KGKYTFELP---QWK---------- 252
Query: 373 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
V SA DLI + +L Y P+ R+ AR+AL H + +
Sbjct: 253 --------------KVSESAKDLI---RKMLTYVPSMRISARDALDHEWIQTYTKE 291
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-42
Identities = 88/362 (24%), Positives = 151/362 (41%), Gaps = 82/362 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L+K+G+GTFG+V + + + VA+K V + +E A+ EI +LQ L +H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLL-KH 75
Query: 149 D-IGGTRCV---QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ + + + + + I +VF+ L L N F + ++ + + LL
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLL 134
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H +++H D+K N+L+ ++DG +KL D
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLI-----------------TRDGV----------LKLAD 167
Query: 265 FG-----STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSG 314
FG S Q + Y VV T YR PE++LG +Y P DLW GCI+ E+ +
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 225
Query: 315 EALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
+ Q + LA++ ++ G P WP+
Sbjct: 226 SPIMQGNTEQHQLALISQLCGSITPE--------------------VWPNVDNYEL---- 261
Query: 374 VWKLLRLP----NLIMQHVDHSAGDL--IDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427
++ L L + + D +DL+ LL DPA+R+ + +AL H FF D
Sbjct: 262 -YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320
Query: 428 RC 429
Sbjct: 321 PS 322
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 84/343 (24%), Positives = 132/343 (38%), Gaps = 87/343 (25%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD-IGGTRCVQI 158
GEG+F +C + + A+KI I+K EA EI L+ H I V++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNI-----VKL 71
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F + H +V E L G L++ R + F + R+L+ +V+ MH++ ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDHS 276
DLKPEN+L + IK+IDFG + +
Sbjct: 130 RDLKPENLLFTDEN------------------------DNLEIKIIDFGFARLKPPDNQP 165
Query: 277 Y--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF----QTHENLEHLAMM 330
T HY APE++ G++ CDLWS+G IL + SG+ F ++ + +M
Sbjct: 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
Query: 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390
+++ + A WK +V
Sbjct: 226 KKIK---------------------KGDFSFEGEA---------WK----------NVSQ 245
Query: 391 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
A DLI QGLL DP +RLK + + + PL
Sbjct: 246 EAKDLI---QGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL 285
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 76/403 (18%), Positives = 134/403 (33%), Gaps = 130/403 (32%)
Query: 77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINK 130
++ ++ L +Y + +G+G++G V +N+ + + AIKI+ K
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70
Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR 189
E E+ ++++L +I ++ ++ +IC+V E G L D L
Sbjct: 71 DVERIKTEVRLMKKLHHPNI-----ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 190 --------------------------------------SFPIDLVRELGRQLLESVAFMH 211
L+ + RQ+ ++ ++H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
+ H D+KPEN L + KS IKL+DFG S F
Sbjct: 186 NQGICHRDIKPENFLFST-------------------------NKSFEIKLVDFGLSKEF 220
Query: 271 EHQDHSY------VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
++ T ++ APEV+ +Y CD WS G +L L G F
Sbjct: 221 YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFP-GV 279
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
N + +VL +L + + +
Sbjct: 280 N--DADTISQVL---------------------NKKLCFEN---------PNYN------ 301
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ A DL+ LL + ER A AL+HP+ ++
Sbjct: 302 ----VLSPLARDLL---SNLLNRNVDERFDAMRALQHPWISQF 337
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-41
Identities = 60/354 (16%), Positives = 110/354 (31%), Gaps = 69/354 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHD- 149
+ + +G+G V + +L AIK+ S + + M E +VL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68
Query: 150 IGGTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLE 205
I V++ + H ++ E SLY L + + P + R ++
Sbjct: 69 I-----VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ + E ++H ++KP NI+ V E S KL DF
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDF 160
Query: 266 G-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYP--------CDLWSVGCILVELCSGE 315
G + E + + T Y P++ DLWS+G +G
Sbjct: 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
Query: 316 ALFQTHENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
F+ E +M +++ P + +DW S+
Sbjct: 221 LPFRPFEGPRRNKEVMYKIITGKPS------GAISGVQKAENGPIDWSGDMPVSCSLSRG 274
Query: 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
++L L +L +L D + +
Sbjct: 275 LQVL----------------LTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-41
Identities = 75/341 (21%), Positives = 130/341 (38%), Gaps = 80/341 (23%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
N+ + + +G G F +V +L A+K ++ +R++++ EI VL+++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I V + + ++ H +V + + G L+D + + + + +Q+L
Sbjct: 65 HENI-----VTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLS 117
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+V ++HE ++H DLKPEN+L ++ E ++S I + DF
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPE------------------------ENSKIMITDF 153
Query: 266 G-STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
G S ++ S T Y APEV+ ++ D WS+G I L G F E
Sbjct: 154 GLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETE 212
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
L E++ F W D
Sbjct: 213 SKL--FEKIK-------------EGYYEFESP---FWDD--------------------- 233
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ SA D I LL DP ER +AL HP+ +
Sbjct: 234 ---ISESAKDFIC---HLLEKDPNERYTCEKALSHPWIDGN 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 63/347 (18%), Positives = 99/347 (28%), Gaps = 100/347 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH---- 148
++ + +G G FGQV + + IK + E A E+ L +L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKL-DHVNIV 67
Query: 149 --------DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+ + I E +L ++ K L EL
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
Q+ + V ++H +LI+ DLKP NI L
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFL-----------------VDTKQ---------- 160
Query: 260 IKLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
+K+ DFG T+ ++ + T Y +PE I + DL+++G IL EL +
Sbjct: 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HV 217
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
T R G + +
Sbjct: 218 CDTAFETSKFFTDLR-DGIISDIF-------------------------DKK-------- 243
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
LLQ LL P +R E LR +
Sbjct: 244 -----------------EKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-41
Identities = 75/357 (21%), Positives = 140/357 (39%), Gaps = 95/357 (26%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--------------SINKYRE 133
+ Y + K+G G +G+V+ C + AIK+++ +I K+ E
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFP 192
EI +L+ L +I +++ + F+ + + +V E G L++ + F
Sbjct: 92 EIYNEISLLKSLDHPNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FD 144
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
+ +Q+L + ++H+ ++H D+KPENILL +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN--------------------- 183
Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
IK++DFG ++F +D+ + T +Y APEV+ +N CD+WS G I+
Sbjct: 184 ---SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYI 239
Query: 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 370
L G F + + ++++V + + YF DW
Sbjct: 240 LLCGYPPFGGQNDQD---IIKKVE-------------KGKYYFDFN---DWK-------- 272
Query: 371 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427
++ A +LI + +L YD +R A EAL + +
Sbjct: 273 ----------------NISDEAKELI---KLMLTYDYNKRCTAEEALNSRWIKKYAN 310
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 59/343 (17%), Positives = 110/343 (32%), Gaps = 72/343 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
+ L K+G G FG V +C + AIK + + + + A+ E+ L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLES 206
V+ + + +H+ I E G SL D + +N F +++L Q+
Sbjct: 72 ----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H + L+H D+KP NI + + K+ D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKIGDLG 179
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
T + A EV+ D++++ +V E L + +
Sbjct: 180 HVTRISSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+ G LP R+P
Sbjct: 239 EIRQ-----GRLP----------------------------------------RIP---- 249
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
+ + +LL+ ++ DP R A ++H R+
Sbjct: 250 ---QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 70/347 (20%), Positives = 128/347 (36%), Gaps = 94/347 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEG+FG+ + E IK + K RE + E+ VL + +H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP 83
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I VQ R F+ + IV + G L+ + F D + + Q+ ++
Sbjct: 84 NI-----VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
+H+ +++H D+K +NI L +KDG+ ++L DFG
Sbjct: 139 KHVHDRKILHRDIKSQNIFL-----------------TKDGT----------VQLGDFGI 171
Query: 267 STTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
+ + T +Y +PE+ +N D+W++GC+L ELC+ + F+ ++
Sbjct: 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSM 230
Query: 325 EHLAM--MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
++L + + P+ H S D
Sbjct: 231 KNLVLKIISGSFPPVSLHY-------------------------SYD------------- 252
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429
L L+ L + +P +R L F + + +
Sbjct: 253 ------------LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKF 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 84/341 (24%), Positives = 136/341 (39%), Gaps = 84/341 (24%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRL 145
+ L+ + + S++G G V C ++ A+K + K + ++ EI VL RL
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRL 105
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ +I ++++ F+ I +V E G L+D + + Y + + +Q+L
Sbjct: 106 SHPNI-----IKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQIL 158
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
E+VA++HE ++H DLKPEN+L + + +K+ D
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPA------------------------PDAPLKIAD 194
Query: 265 FG-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
FG S EHQ V T Y APE++ G + D+WSVG I L G F
Sbjct: 195 FGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
+ M R+L E YF W +
Sbjct: 255 GDQ--FMFRRIL-------------NCEYYFISP---WWDE------------------- 277
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
V +A DL+ L+ DP +RL +AL+HP+ T
Sbjct: 278 -----VSLNAKDLVR---KLIVLDPKKRLTTFQALQHPWVT 310
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 76/355 (21%), Positives = 133/355 (37%), Gaps = 85/355 (23%)
Query: 88 ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
+T Y++ ++ G G G+V+ECF + A+K+ + A E+D + +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL---LYD-SPKARQEVDHHWQAS 79
Query: 147 RHD-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
I V I + ++ + + I+ E + G L+ +++ ++F E+
Sbjct: 80 GGPHI-----VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
R + ++ F+H + H D+KPEN+L S E K + +
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKE------------------------KDAVL 170
Query: 261 KLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
KL DFG + T +Y APEV+ ++ CD+WS+G I+ L G F
Sbjct: 171 KLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230
Query: 320 T-HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 378
+ M R+ R + +P+ W
Sbjct: 231 SNTGQAISPGMKRRI---------------------RLGQYGFPNP---------EWS-- 258
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
V A LI + LL+ DP ERL + + HP+ + + PL
Sbjct: 259 --------EVSEDAKQLI---RLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 69/344 (20%), Positives = 128/344 (37%), Gaps = 80/344 (23%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
+ L +Y I +G G FG V C + K+ K V+ + EI +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-R 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + + F+ + ++FE + G +++ + +++ + Q+ E+
Sbjct: 60 HR----NILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEA 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ F+H + H D++PENI+ + +SS IK+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQT-------------------------RRSSTIKIIEFG 149
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
++ + + Y APEV + D+WS+G ++ L SG F N
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
+ ++E ++ AE F A + +
Sbjct: 210 Q---IIENIM-------------NAEYTFDEEA---FKE--------------------- 229
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
+ A D + LL + R+ A EAL+HP+ + + R
Sbjct: 230 ---ISIEAMDFV---DRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 90/344 (26%), Positives = 149/344 (43%), Gaps = 52/344 (15%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLA 146
N++ +++ S +GEG +G V E+VAIK + +K A EI +L+
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H+ I +Q + F+ N + I+ E + L+ + D ++ Q L
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIYQTLR 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLID 264
+V +H +IH DLKP N+L+ S +KV D F L+R + + + P +++
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD--FGLARIIDESAADNSEPTGQQSGMVE 181
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323
+V TR YRAPEV+L ++ D+WS GCIL EL +F +
Sbjct: 182 ------------FVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 324 LEHLAMMERVLG-PLPHHMVIR-ADRRAEKYFR---RGARLDWPDGATSRDSMRAVWKLL 378
L ++ ++G P + + RA +Y +
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK--------------- 273
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
P V+ IDLLQ +L +DPA+R+ A+EAL HP+
Sbjct: 274 MFPR-----VNPKG---IDLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 75/360 (20%), Positives = 122/360 (33%), Gaps = 94/360 (26%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---------EAAMIEI 139
Y + +G+G F V C + E + A+KI ++ + E E
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREA 77
Query: 140 DVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSFPIDLV 196
+ L I V++ + + +VFE + G L + R ++ + +
Sbjct: 78 SICHMLKHPHI-----VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
RQ+LE++ + H+ +IH D+KP +LL S E
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE------------------------N 168
Query: 257 SSAIKLIDFG-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S+ +KL FG + V T H+ APEV+ + P D+W G IL L S
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G F + E ++ + + W
Sbjct: 229 GCLPFY-GTKER---LFEGII-------------KGKYKMNPR---QWSH---------- 258
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
+ SA DL+ + +L DPAER+ EAL HP+ R
Sbjct: 259 --------------ISESAKDLV---RRMLMLDPAERITVYEALNHPWLKERDRYAYKIH 301
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 93/343 (27%), Positives = 156/343 (45%), Gaps = 25/343 (7%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
++ +Y ++ K+G+G +G V + D E+VA+K I + +A EI +L L
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65
Query: 146 ARHD-IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ H+ I V + N D + +VF+ + L+ +R N + + Q
Sbjct: 66 SGHENI-----VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP---VHKQYVVYQ 117
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
L++ + ++H L+H D+KP NILL + +VKV D F LSRS + N S +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD--FGLSRSFVNIRRVTNNIPLSINE 175
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT 320
+ YV TR YRAPE++LG + D+WS+GCIL E+ G+ +F
Sbjct: 176 NTENFDDDQPILTD-YVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233
Query: 321 HENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+ L + V+ P + A+ +++ + WK L
Sbjct: 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV-EIRQSNKRDIFTKWKNLL 292
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
L + A +DLL LL+++P +R+ A +AL+HPF
Sbjct: 293 LKINPKADCNEEA---LDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-40
Identities = 85/357 (23%), Positives = 142/357 (39%), Gaps = 84/357 (23%)
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
G RY I+ +G+G+FG+V++C D ++ A+K++ + NK
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI 193
+ E+++L++L +I +++ + + IV E G L+D + K F
Sbjct: 68 ILREVELLKKLDHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSE 120
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+ +Q+ + +MH+ ++H DLKPENILL S E
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE---------------------- 158
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
K IK+IDFG +T Q+ + T +Y APEV+ G ++ CD+WS G IL L
Sbjct: 159 --KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215
Query: 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM 371
SG F +N +++RV + F W
Sbjct: 216 LSGTPPF-YGKNEY--DILKRVE-------------TGKYAFDLP---QWR--------- 247
Query: 372 RAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
+ A DLI +L + P+ R+ A + L HP+ +
Sbjct: 248 ---------------TISDDAKDLIR---KMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 73/378 (19%), Positives = 132/378 (34%), Gaps = 90/378 (23%)
Query: 66 PRTGSPPW-RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
P S + + ++ + Y + ++G+G F V C A KI
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 125 VRSINK----YREAAMI--EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GP 177
IN R+ + E + ++L +I V++ + + +VF+ + G
Sbjct: 62 ---INTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQEESFHYLVFDLVTGG 113
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L++ + + + +Q+LES+A+ H ++H +LKPEN+LL S
Sbjct: 114 ELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------ 165
Query: 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGW 295
K +A+KL DFG + ++ T Y +PEV+ +
Sbjct: 166 ------------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
+ P D+W+ G IL L G F E+ + ++ +
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFW-DED--QHRLYAQIK-------------AGAYDYPS 251
Query: 356 GARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 415
+W V A LID +L +P +R+ A +
Sbjct: 252 P---EWD------------------------TVTPEAKSLID---SMLTVNPKKRITADQ 281
Query: 416 ALRHPFFTRDVRRCGFPL 433
AL+ P+ R
Sbjct: 282 ALKVPWICNRERVASAIH 299
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-40
Identities = 77/357 (21%), Positives = 127/357 (35%), Gaps = 81/357 (22%)
Query: 89 NLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMIEIDVLQRLA 146
Y++ + GEG +V C + + A+KI+ + R E+++L +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
H + +++ +F+ + +VFEK+ G S+ + K R F + + +
Sbjct: 69 GHRNV-----LELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVA 121
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
++ F+H + H DLKPENIL + S +K+ D
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPN------------------------QVSPVKICD 157
Query: 265 FG-STTFEHQDHSYVVSTR---------HYRAPEVILGLGW---NY--PCDLWSVGCILV 309
F + + +ST Y APEV+ Y CDLWS+G IL
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD 369
L SG F P +M+ + + + F DW
Sbjct: 218 ILLSGYPPFV-GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK---DWA------- 266
Query: 370 SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426
H+ +A DLI LL D +RL A + L+HP+
Sbjct: 267 -----------------HISCAAKDLI---SKLLVRDAKQRLSAAQVLQHPWVQGCA 303
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 71/347 (20%), Positives = 124/347 (35%), Gaps = 92/347 (26%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQ 143
++ Y + + +G G++G+V + A K I KY + EI++++
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMK 61
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L +I +++ F+ I +V E G L++ + F + +
Sbjct: 62 SLDHPNI-----IRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKD 114
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+L +VA+ H+L + H DLKPEN L ++ S +KL
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDS------------------------PDSPLKL 150
Query: 263 IDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF-- 318
IDFG V T +Y +P+V+ G + CD WS G ++ L G F
Sbjct: 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA 209
Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 378
T + M ++ +P+ W
Sbjct: 210 PTDSEV-----MLKIR---------------------EGTFTFPE---------KDWL-- 232
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+V A LI + LL P +R+ + +AL H +F +
Sbjct: 233 --------NVSPQAESLI---RRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 77/353 (21%), Positives = 123/353 (34%), Gaps = 90/353 (25%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-- 137
G + + K+G G FG V + IK INK R +
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQ 66
Query: 138 ---EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSF 191
EI+VL+ L +I ++I F+ +++ IV E G L + + + ++
Sbjct: 67 IEAEIEVLKSLDHPNI-----IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 192 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251
V EL +Q++ ++A+ H ++H DLKPENIL
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-------------------- 161
Query: 252 KNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
S IK+IDFG D T Y APEV + CD+WS G ++
Sbjct: 162 ----PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMY 216
Query: 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD 369
L +G F +LE + ++ E + +
Sbjct: 217 FLLTGCLPFT-GTSLE--EVQQKAT-------------YKEPNYAV----EC-------- 248
Query: 370 SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + A DL+ + +L DP R A + L H +F
Sbjct: 249 ----------------RPLTPQAVDLL---KQMLTKDPERRPSAAQVLHHEWF 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-39
Identities = 71/373 (19%), Positives = 122/373 (32%), Gaps = 91/373 (24%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN 129
SP DD D I + + +G G G +V VA+K + +
Sbjct: 4 SPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LP 58
Query: 130 KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSY 188
+ A E+ +L+ H ++ ++ R I E +L +++ + +
Sbjct: 59 ECFSFADREVQLLRESDEHPNV-----IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDF 113
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
++ L +Q +A +H L ++H DLKP NIL+
Sbjct: 114 AHLGLE-PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM------------------- 153
Query: 249 SYFKNLPKSSAIKLIDFG-STTFEHQDHSY-----VVSTRHYRAPEVILGL---GWNYPC 299
N + DFG HS+ V T + APE++ Y
Sbjct: 154 ---PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV 210
Query: 300 DLWSVGCILVE-LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGAR 358
D++S GC+ + G F ++L+ A + L
Sbjct: 211 DIFSAGCVFYYVISEGSHPF--GKSLQRQANILLGACSLDC------------------- 249
Query: 359 LDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418
L H D A +LI + ++ DP +R A+ L+
Sbjct: 250 LHPEK-----------------------HEDVIARELI---EKMIAMDPQKRPSAKHVLK 283
Query: 419 HPFFTRDVRRCGF 431
HPFF ++ F
Sbjct: 284 HPFFWSLEKQLQF 296
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 45/248 (18%), Positives = 92/248 (37%), Gaps = 36/248 (14%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ +GEG F QV E D + K+ +K+ + N + ++ L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL---RKNSYRSFPIDLVRELGRQ 202
+H ++ + ++N +V E +L + + + + P LV +
Sbjct: 126 QHMF-----MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+L + +H+ +IH D+KP+N +L + S+ + L
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFIL----------------GNGFLEQDDEDDLSAGLAL 224
Query: 263 IDFG-STTFEHQDHSYVVS----TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
ID G S + + + T ++ E++ WNY D + V + + G +
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
Query: 318 FQTHENLE 325
+E E
Sbjct: 285 KVKNEGGE 292
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 70/345 (20%), Positives = 117/345 (33%), Gaps = 81/345 (23%)
Query: 87 GENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVL 142
EN Y + SK +G G F V +C + A K + R R + EI VL
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
+ R + + ++ + I ++ E G ++ + V L +
Sbjct: 83 ELAKSCP----RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+LE V ++H+ ++H DLKP+NILL S IK
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIY------------------------PLGDIK 174
Query: 262 LIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
++DFG + ++ T Y APE++ D+W++G I L + + F
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+N E + +D+ + +
Sbjct: 235 GEDNQE---TYLNIS---------------------QVNVDYSEET---------FS--- 258
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
V A D I Q LL +P +R A L H + +
Sbjct: 259 -------SVSQLATDFI---QSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 79/361 (21%), Positives = 130/361 (36%), Gaps = 86/361 (23%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVL 142
+L RY L +G G G V DN+ + VAIK + + R EI ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-----EIKII 62
Query: 143 QRLARHD--IG--------GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
+RL HD + G++ N + IV E + L + L +
Sbjct: 63 RRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-- 119
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
+ R QLL + ++H ++H DLKP N+ + +
Sbjct: 120 -EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT----------------------- 155
Query: 253 NLPKSSAIKLIDFG--STTFEHQDHS-----YVVSTRHYRAPEVILGL-GWNYPCDLWSV 304
+ +K+ DFG H H +V T+ YR+P ++L + D+W+
Sbjct: 156 ---EDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAA 211
Query: 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR---RGARLDW 361
GCI E+ +G+ LF LE + ++ + + Y R
Sbjct: 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL 271
Query: 362 PDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
LP + A +D L+ +L + P +RL A EAL HP+
Sbjct: 272 TQ---------------LLPG-----ISREA---VDFLEQILTFSPMDRLTAEEALSHPY 308
Query: 422 F 422
Sbjct: 309 M 309
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 73/350 (20%), Positives = 131/350 (37%), Gaps = 81/350 (23%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLA 146
++ Y IL ++G G FG V C + + K + + EI ++ +L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL- 105
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H + + + + F+ + + ++ E L G L+D + Y V RQ E
Sbjct: 106 HHP----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACE 160
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ MHE ++H D+KPENI+ + K+S++K+IDF
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCET-------------------------KKASSVKIIDF 195
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
G T + D +T + APE++ + D+W++G + L SG + F ++
Sbjct: 196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
LE ++ V ++ + A +
Sbjct: 256 LE---TLQNVK---------------------RCDWEFDEDA---------FS------- 275
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
V A D I + LL+ +P +RL +AL HP+ D +
Sbjct: 276 ---SVSPEAKDFI---KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 98/407 (24%), Positives = 149/407 (36%), Gaps = 80/407 (19%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
+ G + + RY I +G G++G V E +D +K +VAI
Sbjct: 24 QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83
Query: 123 K-IVRSINKYREAAMI--EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPS 178
K I+R + I EI +L RL HD + + I + + + +V E
Sbjct: 84 KKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD 142
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
R ++ L LL V ++H ++H DLKP N L+ VKV D
Sbjct: 143 FKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD- 199
Query: 239 KF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILG 292
F L+R+ + S + T ++ +VV TR YRAPE+IL
Sbjct: 200 -FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILL 257
Query: 293 LGWNY--PCDLWSVGCILVELCS-----------GEALF--------------------Q 319
NY D+WS+GCI EL + LF
Sbjct: 258 QE-NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFH 316
Query: 320 THENLEHLAMMERVLG-PLPHHMVIRADRRAEKY---FRRGARLDWPDGATSRDSMRAVW 375
T N + L ++ +LG P + A++Y F + D +
Sbjct: 317 TRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE------------ 364
Query: 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
R P A I LL+ +L ++P +R+ E L HPFF
Sbjct: 365 ---RFPA-----SSADA---IHLLKRMLVFNPNKRITINECLAHPFF 400
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-39
Identities = 84/414 (20%), Positives = 147/414 (35%), Gaps = 97/414 (23%)
Query: 29 PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
P P P P P P F ++G + D + V +
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT--SQ 68
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
L G G G+V++ F+ +E A+K+++ K R E+++ R ++
Sbjct: 69 VL----------GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQC 114
Query: 149 D-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
I V+I + ++ R + IV E L G L+ ++ ++F E+ +
Sbjct: 115 PHI-----VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+ E++ ++H + + H D+KPEN+L S ++ +KL
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAILKL 205
Query: 263 IDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ- 319
DFG +S T +Y APEV+ ++ CD+WS+G I+ L G F
Sbjct: 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
H M R+ R + F +W
Sbjct: 266 NHGLAISPGMKTRI-------------RMGQYEFPNP---EWS----------------- 292
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
V LI + LL+ +P +R+ E + HP+ + + PL
Sbjct: 293 -------EVSEEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 73/354 (20%), Positives = 131/354 (37%), Gaps = 84/354 (23%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-EIDVLQ 143
T Y++ ++G+G F V C + A I+ + ++ + E + +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L +I V++ + H ++F+ + G L++ + Y + +Q
Sbjct: 66 LLKHPNI-----VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQ 118
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+LE+V H++ ++H +LKPEN+LL S K +A+KL
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKL------------------------KGAAVKL 154
Query: 263 IDFG-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
DFG + E + ++ T Y +PEV+ + P DLW+ G IL L G F
Sbjct: 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
E+ L +++ F +W
Sbjct: 215 -DEDQHRL--YQQIK-------------AGAYDFPSP---EWDT---------------- 239
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
V A DLI+ +L +P++R+ A EAL+HP+ +
Sbjct: 240 --------VTPEAKDLIN---KMLTINPSKRITAAEALKHPWISHRSTVASCMH 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 71/350 (20%), Positives = 125/350 (35%), Gaps = 86/350 (24%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDV 141
+ Y + ++G G F V +C + A K ++ RE E+++
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
L+ + RH + + + F+ + + ++ E + G L+DFL + D +
Sbjct: 62 LREI-RHP----NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 114
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+Q+L+ V ++H R+ H DLKPENI+L+ + I
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKN-----------------------VPNPRI 151
Query: 261 KLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
KLIDFG + E + + T + APE++ D+WS+G I L SG + F
Sbjct: 152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211
Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 378
E + + D+ + +
Sbjct: 212 LGETKQE---TLTNIS---------------------AVNYDFDEEY---------FS-- 236
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
+ A D I + LL DP R+ ++L H + RR
Sbjct: 237 --------NTSELAKDFI---RRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 72/365 (19%), Positives = 124/365 (33%), Gaps = 90/365 (24%)
Query: 68 TGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127
PP +G N +RI K+G G F +V VA+K V+
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67
Query: 128 IN----KYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD 181
+ K R + EID+L++L H + ++ F N + IV E L
Sbjct: 68 FDLMDAKARADCIKEIDLLKQL-NHPNV-----IKYYASFIEDNELNIVLELADAGDLSR 121
Query: 182 FLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
++ K R P V + QL ++ MH R++H D+KP N+ +
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI------------ 169
Query: 240 FLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWN 296
+ G +KL D G F + +V T +Y +PE I G+N
Sbjct: 170 -----TATGV----------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 297 YPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRG 356
+ D+WS+GC+L E+ + ++ F + + ++ +++ +
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIE--------------------QC 253
Query: 357 ARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREA 416
P S +L L+ + DP +R
Sbjct: 254 DYPPLPSDHYSE-------------------------ELRQLVNMCINPDPEKRPDVTYV 288
Query: 417 LRHPF 421
Sbjct: 289 YDVAK 293
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 84/360 (23%), Positives = 144/360 (40%), Gaps = 52/360 (14%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
+ + Y +G++ + RY+ L +G G G V +D VAIK + R
Sbjct: 41 KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 100
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +++ + H I + + + +V E + +L ++
Sbjct: 101 NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 159
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
+ + L Q+L + +H +IH DLKP NI++ S
Sbjct: 160 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------------- 199
Query: 246 KDGSYFKNLPKSSAIKLIDFG-STTFEHQDHS--YVVSTRHYRAPEVILGLGWNYPCDLW 302
+K++DFG + T YVV TR+YRAPEVILG+G+ D+W
Sbjct: 200 -----------DCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 247
Query: 303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 362
SVGCI+ E+ + LF + ++ + LG + + Y +
Sbjct: 248 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK---- 303
Query: 363 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ + ++ P +H A DLL +L DPA+R+ +AL+HP+
Sbjct: 304 ---YAGLTFPKLFPDSLFPADS-EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 78/342 (22%), Positives = 121/342 (35%), Gaps = 81/342 (23%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLA 146
+++ Y I ++G G FG V + A K V + ++ +E EI + L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 211
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
RH V + + F+ N + +++E + G L++ + D E RQ+ +
Sbjct: 212 RHP----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCK 266
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ MHE +H DLKPENI+ + +S+ +KLIDF
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDF 301
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
G T S T + APEV G Y D+WSVG + L SG + F +
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
E + V + D A +
Sbjct: 362 DE---TLRNVK---------------------SCDWNMDDSA---------FS------- 381
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ D I LL DP R+ +AL HP+ T
Sbjct: 382 ---GISEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPG 417
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 68/348 (19%), Positives = 125/348 (35%), Gaps = 86/348 (24%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
EN+ Y ++G G F V +C + A K ++ RE E+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+ + ++ + + ++ + + ++ E + G L+DFL + + E
Sbjct: 67 ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+Q+L V ++H L++ H DLKPENI+L+
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-----------------------VPKPR 156
Query: 260 IKLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
IK+IDFG + + + + T + APE++ D+WS+G I L SG +
Sbjct: 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
F E + V ++ D +
Sbjct: 217 FLGDTKQE---TLANVS---------------------AVNYEFEDEY---------FS- 242
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ A D I + LL DP +R+ +++L+HP+
Sbjct: 243 ---------NTSALAKDFI---RRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-38
Identities = 72/350 (20%), Positives = 126/350 (36%), Gaps = 89/350 (25%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEIDV 141
+ Y + ++G+G F V C A KI IN + + E +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI---INTKKLSARDFQKLEREARI 58
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
++L +I V++ + + +VF+ + G L++ + + +
Sbjct: 59 CRKLQHPNI-----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCI 111
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+Q+LES+A+ H ++H +LKPEN+LL S K +A+
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKA------------------------KGAAV 147
Query: 261 KLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
KL DFG + ++ T Y +PEV+ ++ P D+W+ G IL L G F
Sbjct: 148 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207
Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 378
E+ + ++ D+P W
Sbjct: 208 -WDED--QHRLYAQIK---------------------AGAYDYPS---------PEWD-- 232
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
V A LID +L +P +R+ A +AL+ P+ R
Sbjct: 233 --------TVTPEAKSLID---SMLTVNPKKRITADQALKVPWICNRERV 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 74/349 (21%), Positives = 128/349 (36%), Gaps = 88/349 (25%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
+ + Y I ++G G F V +C + A K ++ RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL-RKNSYRSFPIDLVRE 198
+L+++ H++ + + + ++ R + ++ E + G L+DFL +K S +
Sbjct: 68 ILRQVLHHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATS 119
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
+Q+L+ V ++H ++ H DLKPENI+L+
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIP 156
Query: 259 AIKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
IKLIDFG + E + T + APE++ D+WS+G I L SG +
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376
F E + + D+ + +
Sbjct: 217 PFLGDTKQE---TLANIT---------------------SVSYDFDEEF---------FS 243
Query: 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
H A D I + LL + +RL +EALRHP+ T
Sbjct: 244 ----------HTSELAKDFI---RKLLVKETRKRLTIQEALRHPWITPV 279
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 70/348 (20%), Positives = 124/348 (35%), Gaps = 86/348 (24%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
+ + Y I ++G G F V +C + A K ++ RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+++ +I + + + ++ R + ++ E + G L+DFL + +
Sbjct: 68 ILRQVLHPNI-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+Q+L+ V ++H ++ H DLKPENI+L+
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPH 157
Query: 260 IKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
IKLIDFG + E + T + APE++ D+WS+G I L SG +
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
F + + + D+ + +
Sbjct: 218 FL-GDT--KQETLANIT---------------------AVSYDFDEEF---------FS- 243
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
A D I + LL + +RL +EALRHP+ T
Sbjct: 244 ---------QTSELAKDFI---RKLLVKETRKRLTIQEALRHPWITPV 279
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 88/360 (24%), Positives = 145/360 (40%), Gaps = 52/360 (14%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
R + Y IG++ + RY+ L +G G G V +D + VAIK + R
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +++ + H IG + + + IV E + +L ++
Sbjct: 64 NQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 122
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
+ L Q+L + +H +IH DLKP NI++ S
Sbjct: 123 ELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------------- 162
Query: 246 KDGSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302
+K++DFG + YVV TR+YRAPEVILG+G+ D+W
Sbjct: 163 -----------DCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 210
Query: 303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 362
SVGCI+ E+ G LF ++++ + LG + + Y +
Sbjct: 211 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK---- 266
Query: 363 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ S ++ + P +H A DLL +L D ++R+ EAL+HP+
Sbjct: 267 ---YAGYSFEKLFPDVLFPADS-EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 91/356 (25%), Positives = 141/356 (39%), Gaps = 68/356 (19%)
Query: 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--E 138
V ++ PRY LS +GEG +G V +DN K VAIK + E
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE 75
Query: 139 IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
I +L R +I G + + + IV + + LY L+ D +
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICY 132
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
Q+L + ++H ++H DLKP N+LL + +
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TC 165
Query: 259 AIKLIDFG--STTFEHQDHS-----YVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVE 310
+K+ DFG DH+ YV TR YRAPE++L G+ D+WSVGCIL E
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 311 LCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR---RGARLDWPDGAT 366
+ S +F L+ L + +LG P + + +A Y ++ W
Sbjct: 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR--- 281
Query: 367 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
PN D A +DLL +L ++P +R++ +AL HP+
Sbjct: 282 ------------LFPN-----ADSKA---LDLLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 91/363 (25%), Positives = 147/363 (40%), Gaps = 69/363 (19%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
P + G Y + + + YR L +G G +G V D VAIK + R
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +L+ + RH+ IG D +V +G L ++
Sbjct: 64 SELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
D ++ L Q+L+ + ++H +IH DLKP N+ +
Sbjct: 123 EKLGE---DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---------------- 163
Query: 246 KDGSYFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWS 303
+K++DFG + + + YVV TR YRAPEVIL + D+WS
Sbjct: 164 -----------DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWS 211
Query: 304 VGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR---RGARL 359
VGCI+ E+ +G+ LF+ ++L+ L + +V G P + A+ Y + +
Sbjct: 212 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271
Query: 360 DWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
D+ L N A ++LL+ +L D +R+ A EAL H
Sbjct: 272 DFAS---------------ILTN-----ASPLA---VNLLEKMLVLDAEQRVTAGEALAH 308
Query: 420 PFF 422
P+F
Sbjct: 309 PYF 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 90/359 (25%), Positives = 144/359 (40%), Gaps = 70/359 (19%)
Query: 78 KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYRE 133
K G Y + + Y + +G G +G V D E VAIK + R
Sbjct: 7 KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF 66
Query: 134 A--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR 189
A A E+ +L+ + +H+ IG + +V + L +
Sbjct: 67 AKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--- 122
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
F + ++ L Q+L+ + ++H ++H DLKP N+ +
Sbjct: 123 -FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE-------------------- 161
Query: 250 YFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCI 307
+K++DFG + + + YVV TR YRAPEVIL N D+WSVGCI
Sbjct: 162 -------DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCI 213
Query: 308 LVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR---RGARLDWPD 363
+ E+ +G+ LF+ + L+ L + +V G P + D+ A+ Y + + R D+
Sbjct: 214 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ 273
Query: 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
P A DLL+ +L D +RL A +AL HPFF
Sbjct: 274 ---------------LFPR-----ASPQA---ADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 80/370 (21%), Positives = 139/370 (37%), Gaps = 87/370 (23%)
Query: 93 RYRILS-KMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+ K+G GT+G V + D + + A+K + +A EI +L+ L +H
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLREL-KHP 78
Query: 150 -IGGTRCVQIRNWFDYRNHICI--VFE-------KLGPSLYDFLRKNSYRSFPIDLVREL 199
+ + ++ F + +F+ + P +V+ L
Sbjct: 79 NV-----ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
Q+L+ + ++H ++H DLKP NIL++ P+
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEG-----------------------PERGR 170
Query: 260 IKLIDFG-STTFEHQDHSY-----VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
+K+ D G + F VV T YRAPE++LG +Y D+W++GCI EL
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAEL 229
Query: 312 CSGEALFQ---------THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 362
+ E +F + + L + V+G P +K DW
Sbjct: 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF-PA----------DK--------DWE 270
Query: 363 D-------GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKARE 415
D +D R + L + +H LLQ LL DP +R+ + +
Sbjct: 271 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330
Query: 416 ALRHPFFTRD 425
A++ P+F D
Sbjct: 331 AMQDPYFLED 340
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 60/345 (17%), Positives = 111/345 (32%), Gaps = 69/345 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHD- 149
+ + +G+G V + +L AIK+ S + + M E +VL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68
Query: 150 IGGTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLE 205
I V++ + H ++ E SLY L + + P + R ++
Sbjct: 69 I-----VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ + E ++H ++KP NI+ V E S KL DF
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDF 160
Query: 266 G-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYP--------CDLWSVGCILVELCSGE 315
G + E + + T Y P++ DLWS+G +G
Sbjct: 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
Query: 316 ALFQTHENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
F+ E +M +++ P + + +DW S+
Sbjct: 221 LPFRPFEGPRRNKEVMYKIITGKPSGAI------SGVQKAENGPIDWSGDMPVSCSLSRG 274
Query: 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
++L L +L +L D + +
Sbjct: 275 LQVL----------------LTPVLANILEADQEKCWGFDQFFAE 303
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 79/370 (21%), Positives = 132/370 (35%), Gaps = 79/370 (21%)
Query: 78 KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
K + + + Y + + G++G V D+E VAIK V +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRT 63
Query: 135 AMI------------EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYD 181
I EI +L H I G R + + + + +V E + L
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
+ ++ +L + +HE ++H DL P NILL
Sbjct: 123 VIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD------------ 169
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGL-GWNY 297
++ I + DF T + YV R YRAPE+++ G+
Sbjct: 170 ---------------NNDITICDFNLAREDTADANKTHYVT-HRWYRAPELVMQFKGFTK 213
Query: 298 PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRG 356
D+WS GC++ E+ + +ALF+ L + V+G P +V+ + A Y R
Sbjct: 214 LVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNS 273
Query: 357 ----ARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLK 412
W +P D A +DL+ +L ++P R+
Sbjct: 274 LSNVPARAWTA---------------VVPT-----ADPVA---LDLIAKMLEFNPQRRIS 310
Query: 413 AREALRHPFF 422
+ALRHP+F
Sbjct: 311 TEQALRHPYF 320
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-37
Identities = 86/353 (24%), Positives = 137/353 (38%), Gaps = 92/353 (26%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMI--E 138
+ L Y + +G G G+V F+ + + VAI+I+ S + A + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 139 IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVR 197
I++L++L H ++I+N+FD IV E + G L+D + N +
Sbjct: 191 IEILKKL-NHP----CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 242
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
Q+L +V ++HE +IH DLKPEN+LL S E +
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------ED 278
Query: 258 SAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELC 312
IK+ DFG + + + T Y APEV++ + G+N D WS+G IL
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
SG F H +++ +++ + ++
Sbjct: 339 SGYPPFSEHRT--QVSLKDQIT---------------------SGKYNFIP--------- 366
Query: 373 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
VW V A DL+ LL DP R EALRHP+ +
Sbjct: 367 EVWA----------EVSEKALDLVK---KLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 88/434 (20%), Positives = 144/434 (33%), Gaps = 112/434 (25%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
+++ R++ R P + N P + F P
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDPSQSANLLA--EAKKLNDAQPKGTENLYFQSMGPEDE 82
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---- 125
P W + +Y +G G V C A+KI+
Sbjct: 83 LPDWAA-----------AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 126 -----RSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPS 178
+ + REA E +L+++A H I + + + ++ + + +VF+ +
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHI-----ITLIDSYESSSFMFLVFDLMRKGE 186
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L+D+L + R + R LLE+V+F+H ++H DLKPENILL
Sbjct: 187 LFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--------- 235
Query: 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL--- 293
+ I+L DFG + + T Y APE++
Sbjct: 236 ------------------NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDE 277
Query: 294 ---GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 350
G+ DLW+ G IL L +G F H + M+ ++
Sbjct: 278 THPGYGKEVDLWACGVILFTLLAGSPPF-WHRR--QILMLRMIM---------------- 318
Query: 351 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410
+ + W + DLI LL+ DP R
Sbjct: 319 -----EGQYQFSSP---------EWD----------DRSSTVKDLIS---RLLQVDPEAR 351
Query: 411 LKAREALRHPFFTR 424
L A +AL+HPFF R
Sbjct: 352 LTAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 78/358 (21%), Positives = 125/358 (34%), Gaps = 100/358 (27%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----------RSINKYREAAMI 137
Y +G G V C + A+KI+ + + REA +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 138 EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
E+D+L++++ H I +Q+++ ++ +VF+ + L+D+L +
Sbjct: 73 EVDILRKVSGHPNI-----IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKE 125
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
R++ R LLE + +H+L ++H DLKPENILL
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDD-------------------------- 159
Query: 256 KSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL------GWNYPCDLWSVGCI 307
IKL DFG + V T Y APE+I G+ D+WS G I
Sbjct: 160 -DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 308 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 367
+ L +G F H + M+ ++ F +W
Sbjct: 219 MYTLLAGSPPF-WHRK--QMLMLRMIM-------------SGNYQFGSP---EWD----- 254
Query: 368 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ DL+ L P +R A EAL HPFF +
Sbjct: 255 -------------------DYSDTVKDLVS---RFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 62/355 (17%), Positives = 114/355 (32%), Gaps = 103/355 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
Y +L +G G++G+ + +++ K + + ++ + E+++L+ L +H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 150 -IGGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQL 203
I V+ + R + IV E G L + + + V + QL
Sbjct: 66 NI-----VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 204 LESVAFMHELRL-----IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
++ H +H DLKP N+ L +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFL-----------------DGKQN--------- 154
Query: 259 AIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
+KL DFG + H V T +Y +PE + + +N D+WS+GC+L ELC+
Sbjct: 155 -VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 316 ALFQTHENLEHLAM--MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
F + + LA E +P+ S
Sbjct: 214 PPFTA-FSQKELAGKIREGKFRRIPYRY-------------------------SD----- 242
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
+L +++ +L R E L +P
Sbjct: 243 --------------------ELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 91/352 (25%), Positives = 138/352 (39%), Gaps = 94/352 (26%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMI-----E 138
+ L Y + +G G G+V F+ + + VAIKI+ +I REA E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 139 IDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLV 196
I++L++L H I ++I+N+FD ++ IV E + G L+D + N
Sbjct: 66 IEILKKL-NHPCI-----IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR--LKEATC 116
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
+ Q+L +V ++HE +IH DLKPEN+LL S E +
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------E 152
Query: 257 SSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVEL 311
IK+ DFG + + + T Y APEV++ + G+N D WS+G IL
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM 371
SG F H L +++ + ++
Sbjct: 213 LSGYPPFSEHRTQVSL--KDQIT---------------------SGKYNFIP-------- 241
Query: 372 RAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
VW V A DL+ LL DP R EALRHP+
Sbjct: 242 -EVWA----------EVSEKALDLVK---KLLVVDPKARFTTEEALRHPWLQ 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 3e-36
Identities = 69/339 (20%), Positives = 112/339 (33%), Gaps = 59/339 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
+ + ++G G FG V+ + E VAIK R K RE +EI ++++L H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPN 73
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
+ + + E G L +L + +R L + +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++HE R+IH DLKPENI+L + K+ID G
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGP------------------------QRLIHKIIDLG 169
Query: 267 -STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
+ + + + V T Y APE++ + D WS G + E +G F +
Sbjct: 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ- 228
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
P+ H +R EK D GA S+ L
Sbjct: 229 -----------PVQWHGKVR-----EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
LQ +L + +R + F
Sbjct: 273 KLE---------RWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 82/350 (23%), Positives = 147/350 (42%), Gaps = 76/350 (21%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEID 140
+ RY+ LS +G G +G V FD + VA+K + + YRE +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LR 80
Query: 141 VLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
+L+ + +H+ IG + N + +V +G L + ++ D V+
Sbjct: 81 LLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQF 136
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
L Q+L + ++H +IH DLKP N+ +
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNE---------------------------DC 169
Query: 259 AIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEA 316
+K++DFG + + YV TR YRAPE++L +N D+WSVGCI+ EL +G
Sbjct: 170 ELKILDFGLARHTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
Query: 317 LFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFR---RGARLDWPDGATSRDSMR 372
LF ++++ L ++ R++G P + + A Y + + ++++ +
Sbjct: 229 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN--------- 279
Query: 373 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ A +DLL+ +L D +R+ A +AL H +F
Sbjct: 280 ------VFIG-----ANPLA---VDLLEKMLVLDSDKRITAAQALAHAYF 315
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 42/364 (11%), Positives = 85/364 (23%), Gaps = 100/364 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKYREAAMIEIDVLQR 144
+ +++ + G V D E+ E A+K+ + + EA +L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 145 LARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLYDFLRKNS 187
R + + ++ ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 188 YRS-----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
+ I + L QL+ A + L+H P+N+ +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI--------------- 227
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCD 300
DG + L D + Y E + + +
Sbjct: 228 --MPDGR----------LMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALN 275
Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
W +G + + F + + +R L
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTP-----------------GIKGSWKRPSLRVPGTDSLA 318
Query: 361 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 420
+ D ++ L+ L +D RL EA+ P
Sbjct: 319 FGSCTPLPDFVK------------------------TLIGRFLNFDRRRRLLPLEAMETP 354
Query: 421 FFTR 424
F +
Sbjct: 355 EFLQ 358
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 84/360 (23%), Positives = 134/360 (37%), Gaps = 83/360 (23%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSK--MGEGTFGQVVECFDNEKKELVAIKIVR- 126
P P D V A + Y + +G G FGQV +C + +A KI++
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 127 SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK 185
K +E EI V+ +L H +Q+ + F+ +N I +V E + G L+D +
Sbjct: 125 RGMKDKEEVKNEISVMNQL-DHA----NLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
SY + +Q+ E + MH++ ++H DLKPENIL V+
Sbjct: 180 ESY-NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN---------------- 222
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWS 303
+ IK+IDFG T + APEV+ ++P D+WS
Sbjct: 223 ---------RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
VG I L SG + F + E + +L ++ D
Sbjct: 274 VGVIAYMLLSGLSPFLGDNDAE---TLNNIL-------------ACRWDLEDE---EFQD 314
Query: 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+ A + I LL + + R+ A EAL+HP+ +
Sbjct: 315 ------------------------ISEEAKEFI---SKLLIKEKSWRISASEALKHPWLS 347
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 86/372 (23%), Positives = 144/372 (38%), Gaps = 67/372 (18%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
++ Y I +G G++G V +D ++ VAIK + R + I EI +L RL
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82
Query: 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ D I + I + + + IV E L + + + + ++ + LL
Sbjct: 83 -KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--EEHIKTILYNLL 139
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLI 263
F+HE +IH DLKP N LL VKV D F L+R+ + +
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCD--FGLARTINSEKDTNIVNDLEENEEP 197
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG-------- 314
+ + Q S+VV TR YRAPE+IL + D+WS GCI EL +
Sbjct: 198 GPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 315 ---EALFQ-----------------THENLEHLAMMERVLG-PLPHHMVIRADRRAEKYF 353
LF N + L ++ ++G P + KY
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316
Query: 354 R---RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410
+ ++ + P+ + I+LL+ +L+++P +R
Sbjct: 317 KLFPHRKPINLKQ---------------KYPS-----ISDDG---INLLESMLKFNPNKR 353
Query: 411 LKAREALRHPFF 422
+ +AL HP+
Sbjct: 354 ITIDQALDHPYL 365
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 67/338 (19%), Positives = 103/338 (30%), Gaps = 93/338 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
++G G+FG+V D + A+K VR + E+ L
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSP--- 110
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
R V + + I E L G SL +++ P D Q LE + ++H
Sbjct: 111 -RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH 167
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG----- 266
R++H D+K +N+LL S DGS L DFG
Sbjct: 168 TRRILHGDVKADNVLL-----------------SSDGS---------RAALCDFGHALCL 201
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
Y+ T + APEV++G + D+WS C+++ + +G
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC-------- 253
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
P W K+ P
Sbjct: 254 ------------H-P----------------------WTQ----YFRGPLCLKIASEPPP 274
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
I + A +Q LR +P R A E R
Sbjct: 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 70/354 (19%), Positives = 130/354 (36%), Gaps = 103/354 (29%)
Query: 88 ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
+ Y++ S++ G G G+V++ F+ +E A+K+++ K R E+++ R +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68
Query: 147 RHD-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
+ I V+I + ++ R + IV E L G L+ ++ ++F E+
Sbjct: 69 QCPHI-----VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+ + E++ ++H + + H D+KPEN+L S ++ +
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAIL 159
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ- 319
KL DFG A E G ++ CD+WS+G I+ L G F
Sbjct: 160 KLTDFG------------------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
H M R+ + F +W
Sbjct: 201 NHGLAISPGMKTRIR-------------MGQYEFPNP---EWS----------------- 227
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
V LI + LL+ +P +R+ E + HP+ + + PL
Sbjct: 228 -------EVSEEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 65/358 (18%), Positives = 111/358 (31%), Gaps = 108/358 (30%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHD-I 150
Y + K+GEG F V A+K + + RE A E D+ + H I
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNI 88
Query: 151 GGTRCVQIRNWF----DYRNHICIVFE--KLGPSLYDFL--RKNSYRSFPIDLVRELGRQ 202
+++ + ++ ++ K G +L++ + K+ D + L
Sbjct: 89 -----LRLVAYCLRERGAKHEAWLLLPFFKRG-TLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+ + +H H DLKP NILL +G L
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILL-----------------GDEGQP----------VL 175
Query: 263 IDFGSTTFEH------------QDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCI 307
+D GS QD + T YRAPE+ + D+WS+GC+
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 308 LVELCSGEALFQ-THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 366
L + GE + + + +A + ++ +L P
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVA------------LAVQN------------QLSIPQSPR 271
Query: 367 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
HS+ L LL ++ DP +R L +
Sbjct: 272 -----------------------HSS-ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 79/349 (22%), Positives = 128/349 (36%), Gaps = 94/349 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
RY +G+G F + E D + KE+ A KIV + K + + EI + + L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ V +F+ + + +V E SL + ++ ++ R RQ++
Sbjct: 75 QHV-----VGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 127
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
++H R+IH DLK N+ L ++D +K+ DFG
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFL-----------------NEDLE----------VKIGDFG 160
Query: 267 -STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
+T E+ V T +Y APEV+ G ++ D+WS+GCI+ L G+ F+T
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SC 219
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
L+ R+ + P
Sbjct: 220 LK--ETYLRI---------------------KKNEYSIPK-------------------- 236
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432
H++ A LI Q +L+ DP R E L FFT P
Sbjct: 237 ---HINPVAASLI---QKMLQTDPTARPTINELLNDEFFTSGYIPARLP 279
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 66/342 (19%), Positives = 130/342 (38%), Gaps = 93/342 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+++ + +G+G+F V VAIK++ +++ K + E+ + +L +H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ N+F+ N++ +V E + +L+ + F + R Q++
Sbjct: 71 PSI-----LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITG 124
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H ++H DL N+LL +++ + IK+ DFG
Sbjct: 125 MLYLHSHGILHRDLTLSNLLL-----------------TRNMN----------IKIADFG 157
Query: 267 -STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
+T + + T +Y +PE+ D+WS+GC+ L G F T +
Sbjct: 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT-DT 216
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
+++ + D +P+
Sbjct: 217 VKNT-------------------------LNKVVLAD-----------------YEMPS- 233
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ A DLI LLR +PA+RL L HPF +R+
Sbjct: 234 ---FLSIEAKDLI---HQLLRRNPADRLSLSSVLDHPFMSRN 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 65/348 (18%), Positives = 107/348 (30%), Gaps = 84/348 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
+ + +G G FG V E + AIK +R + RE M E+ L +L H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPG 64
Query: 150 -------IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFP-IDLVREL 199
+ + ++ I + L +L D++ + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSS 258
Q+ E+V F+H L+H DLKP NI + VKV D F L + + +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD--FGLVTAMDQDEEEQTVLTPM 181
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
+ H+ V T+ Y +PE I G +++ D++S+G IL EL F
Sbjct: 182 P-----------AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP---F 227
Query: 319 QTHENLEHLAM--MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376
T PL
Sbjct: 228 STQMERVRTLTDVRNLKFPPLFTQ-------------------------KYPC------- 255
Query: 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
++ +L P ER +A + + F
Sbjct: 256 ---EYVMVQD---------------MLSPSPMERPEAINIIENAVFED 285
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 70/343 (20%), Positives = 129/343 (37%), Gaps = 92/343 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ + K + E+++ L RH
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I +++ +F + ++ E ++Y L+K F +L +
Sbjct: 69 PNI-----LRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+++ H R+IH D+KPEN+LL G +K+ DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLL-----------------GSAGE----------LKIADFG 154
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
S + + T Y PE+I G + DLWS+G + E G+ F+ +
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---T 211
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+ +R+ R + + GAR
Sbjct: 212 YQETYKRIS---------RVEFTFPDFVTEGAR--------------------------- 235
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
DL+ LL+++P++R RE L HP+ T + +
Sbjct: 236 -----------DLISRLLKHNPSQRPMLREVLEHPWITANSSK 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 89/406 (21%), Positives = 140/406 (34%), Gaps = 118/406 (29%)
Query: 29 PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
P P P K G+P A A P P D +
Sbjct: 2 PAPADPGK-------------AGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR------- 41
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQR 144
RY +G+G F + E D + KE+ A KIV + K + + EI + +
Sbjct: 42 ----RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97
Query: 145 LARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L H + V +F+ + + +V E SL + ++ ++ R RQ
Sbjct: 98 L-AHQHV-----VGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 149
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
++ ++H R+IH DLK N+ L ++D +K+
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFL-----------------NEDLE----------VKI 182
Query: 263 IDFG-STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
DFG +T E+ V T +Y APEV+ G ++ D+WS+GCI+ L G+ F+
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
T L+ R+ + P
Sbjct: 243 T-SCLK--ETYLRI---------------------KKNEYSIPK---------------- 262
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
H++ A LI Q +L+ DP R E L FFT
Sbjct: 263 -------HINPVAASLI---QKMLQTDPTARPTINELLNDEFFTSG 298
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 66/268 (24%), Positives = 98/268 (36%), Gaps = 56/268 (20%)
Query: 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDV 141
+GE R R+ + EG F V E D A+K + S + A + E+
Sbjct: 22 TVELGEL---RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 142 LQRLARHD----IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR-SFPIDLV 196
+++L+ H + + ++ E L +FL+K R D V
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 197 RELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
++ Q +V MH + +IH DLK EN+LL S G+
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-----------------SNQGTI---- 177
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVS-----------TRH----YRAPEVI---LGLGWN 296
KL DFGS T Y S TR+ YR PE+I
Sbjct: 178 ------KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 297 YPCDLWSVGCILVELCSGEALFQTHENL 324
D+W++GCIL LC + F+ L
Sbjct: 232 EKQDIWALGCILYLLCFRQHPFEDGAKL 259
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 73/348 (20%), Positives = 126/348 (36%), Gaps = 92/348 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ + K + EI++ L RH
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I +++ N+F R I ++ E LY L+K+ F +L ++
Sbjct: 74 PNI-----LRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADA 126
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ + HE ++IH D+KPEN+L+ +K+ DFG
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGE---------------------------LKIADFG 159
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
S + T Y PE+I G + DLW G + E G F +
Sbjct: 160 WSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP---S 216
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
H R++ D + + G++
Sbjct: 217 HTETHRRIV---------NVDLKFPPFLSDGSK--------------------------- 240
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
DL+ LLRY P +RL + + HP+ + RR P+
Sbjct: 241 -----------DLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 66/364 (18%), Positives = 136/364 (37%), Gaps = 93/364 (25%)
Query: 74 RPDDKDGHYVFAIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--- 129
+ DD + A+G + R+ + ++G G+F V + D E VA ++
Sbjct: 7 QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 66
Query: 130 KYREAAMIEIDVLQRLARHDIGGTRCVQ-IRNWFDY---RNHICIVFEKL-GPSLYDFLR 184
R+ E ++L+ L +H V+ +W + I +V E + +L +L+
Sbjct: 67 SERQRFKEEAEMLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
+ ++ I ++R RQ+L+ + F+H +IH DLK +NI +
Sbjct: 122 R--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--------------- 164
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDL 301
+ GS +K+ D G T + + V+ T + APE+ ++ D+
Sbjct: 165 -TGPTGS----------VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDV 212
Query: 302 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW 361
++ G ++E+ + E + +N + RV +
Sbjct: 213 YAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVK----------------------- 247
Query: 362 PDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
P + ++ ++++G +R + ER ++ L H F
Sbjct: 248 -------------------PASFDKVAIP---EVKEIIEGCIRQNKDERYSIKDLLNHAF 285
Query: 422 FTRD 425
F +
Sbjct: 286 FQEE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 67/337 (19%), Positives = 124/337 (36%), Gaps = 88/337 (26%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIR 159
G+GT+G V D + +AIK + + Y + EI + + L +H VQ
Sbjct: 31 GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHK----NIVQYL 85
Query: 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAFMHELRLI 216
F I I E++ G SL L ++ + + + +Q+LE + ++H+ +++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS---TTFEHQ 273
H D+K +N+L+ ++ G +K+ DFG+ +
Sbjct: 145 HRDIKGDNVLI----------------NTYSGV----------LKISDFGTSKRLAGINP 178
Query: 274 DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331
T Y APE+I G+ D+WS+GC ++E+ +G+ F +E E A M
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF--YELGEPQAAM- 235
Query: 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391
F+ G P+ +P +
Sbjct: 236 ---------------------FKVGMFKVHPE----------------IP-------ESM 251
Query: 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
+ + + DP +R A + L F ++
Sbjct: 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 61/242 (25%), Positives = 100/242 (41%), Gaps = 48/242 (19%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-----EID 140
E L +Y++ +G G FG V VAIK V I+ + E E+
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVRE 198
+L+++ G +++ +WF+ + ++ E+ P L+DF+ + + +L R
Sbjct: 99 LLKKV-SSGFSG--VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARS 153
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
Q+LE+V H ++H D+K ENIL+ D
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILI---------DLNRGE---------------- 188
Query: 259 AIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNY---PCDLWSVGCILVELCS 313
+KLIDFGS +D Y TR Y PE I Y +WS+G +L ++
Sbjct: 189 -LKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVC 244
Query: 314 GE 315
G+
Sbjct: 245 GD 246
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 61/362 (16%), Positives = 122/362 (33%), Gaps = 93/362 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI------------- 137
YRI+ + +G F +++ C + + A+K + K R+
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 138 ---EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY----- 188
E+ ++ + +++ C+ + + I++E + S+ F
Sbjct: 90 FKNELQIITDI-KNE----YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 189 -RSFPIDLVRELGRQLLESVAFMHELRLI-HTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
PI +++ + + +L S +++H + I H D+KP NIL+ K
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM-----------------DK 187
Query: 247 DGSYFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGW--NYPCDLWS 303
+G +KL DFG S + T + PE D+WS
Sbjct: 188 NGR----------VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
+G L + F +L + + + +++P
Sbjct: 238 LGICLYVMFYNVVPFSLKISL--VELFNNIR---------------------TKNIEYPL 274
Query: 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
K + + + ID L+ LR +PAER+ + +AL+H +
Sbjct: 275 DRNHFLYPLTNKKSTCSN-------NFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327
Query: 424 RD 425
Sbjct: 328 DT 329
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 58/260 (22%), Positives = 99/260 (38%), Gaps = 46/260 (17%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
PP P E YR+ +G+G FG V + VAIK++
Sbjct: 9 GPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNR 68
Query: 128 INKYREAAMI-----EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LY 180
+ + + E+ +L ++ G +++ +WF+ + +V E+ P+ L+
Sbjct: 69 VLGWSPLSDSVTCPLEVALLWKV-GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLF 127
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
D++ + R Q++ ++ H ++H D+K ENIL+
Sbjct: 128 DYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI------------- 172
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNY- 297
+ G KLIDFGS D Y TR Y PE I Y
Sbjct: 173 ---DLRRGC----------AKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQ--YH 216
Query: 298 --PCDLWSVGCILVELCSGE 315
P +WS+G +L ++ G+
Sbjct: 217 ALPATVWSLGILLYDMVCGD 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 45/374 (12%), Positives = 98/374 (26%), Gaps = 124/374 (33%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------REAAMIEIDVLQ 143
+ +G+ +E D E E + + + E + +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 144 RLARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLYDFL--- 183
+ + R + + ++ ++ +L F
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 184 --RKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
++++S +L Q++ +A +H L+HT L+P +I+L
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-------------- 239
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW------ 295
+ G + L F + +R + PE+
Sbjct: 240 ---DQRGG----------VFLTGFEHLVRDGARVV-SSVSRGFEPPELEARRATISYHRD 285
Query: 296 -----NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 350
+ D W++G ++ + + T + +E
Sbjct: 286 RRTLMTFSFDAWALGLVIYWIWCADLPI-TKDAALGG---------------------SE 323
Query: 351 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410
FR + P LL+G LRY +R
Sbjct: 324 WIFRS--CKNIPQPV------------------------------RALLEGFLRYPKEDR 351
Query: 411 LKAREALRHPFFTR 424
L +A+ P + +
Sbjct: 352 LLPLQAMETPEYEQ 365
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 55/300 (18%), Positives = 100/300 (33%), Gaps = 72/300 (24%)
Query: 127 SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK 185
S +A ++I + + + V + ++ I + +L D++ +
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNT-----VGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 186 NSYRSFP-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
+ + Q+ E+V F+H L+H DLKP NI + VKV D F L
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD--FGLVT 212
Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
+ + + + + H+ V T+ Y +PE I G +++ D++S
Sbjct: 213 AMDQDEEEQTVL-----------TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
+G IL EL F T MERV
Sbjct: 262 LGLILFELLYS---FSTQ--------MERVR----------------------------- 281
Query: 364 GATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+ +R + ++Q +L P ER +A + + + F
Sbjct: 282 ----------IITDVRNLKFPLLFTQKYP-QEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 69/339 (20%), Positives = 119/339 (35%), Gaps = 51/339 (15%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
+ +S++G G G V + ++A K++ K I E+ VL I
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI- 93
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
F I I E + G SL L+K P ++ ++ +++ + ++
Sbjct: 94 -VGFYGA---FYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYL 147
Query: 211 H-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+ +++H D+KP NIL+ + G IKL DFG S
Sbjct: 148 REKHKIMHRDVKPSNILV-----------------NSRGE----------IKLCDFGVSG 180
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+ V TR Y +PE + G ++ D+WS+G LVE+ G + E
Sbjct: 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL-RLPNLIMQH 387
M + R A+++LL + N
Sbjct: 241 MFGCQVEGDAAETPPRPRTPGRP---------LNKFGMDSRPPMAIFELLDYIVNEPPPK 291
Query: 388 VDHSA--GDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ + D + L +PAER ++ + H F R
Sbjct: 292 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-27
Identities = 79/359 (22%), Positives = 127/359 (35%), Gaps = 114/359 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR--EAAMI----------EID 140
+Y +S +G G FG V D EK + V +K I K + E I EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF---IKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVRE 198
+L R+ H +++ + F+ + +V EK G L+ F+ ++ L
Sbjct: 82 ILSRV-EHA----NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASY 134
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
+ RQL+ +V ++ +IH D+K ENI++ F
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVI---------AEDF------------------ 167
Query: 259 AIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGE 315
IKLIDFGS + + T Y APEV++G + P ++WS+G L L E
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
Query: 316 ALFQTHENLEHLAMMERVLGPL--PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
F E E V + P+ + S++ M
Sbjct: 228 NPFCELE--------ETVEAAIHPPYLV-------------------------SKELMS- 253
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432
L+ GLL+ P R + + P+ T+ V +
Sbjct: 254 ------------------------LVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYT 288
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 47/378 (12%), Positives = 98/378 (25%), Gaps = 124/378 (32%)
Query: 90 LTPRYRILSK---MGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMI 137
L R R L + +G+ +E D E E + + + E +
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 138 EIDVLQRLARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLY 180
+ + + R + + ++ ++ +L
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 181 DFL-----RKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
F ++++S +L Q++ +A +H L+HT L+P +I+L
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-------- 244
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL 291
+ G + L F + + A ++
Sbjct: 245 ---------DQRGG----------VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLP 285
Query: 292 GLG-----WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRAD 346
+ D W++G + + LP
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWI---------------------WCADLP-------- 316
Query: 347 RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406
A L I + + + LL+G LRY
Sbjct: 317 ------NTDDA-------------------ALGGSEWIFRSCKNIPQPVRALLEGFLRYP 351
Query: 407 PAERLKAREALRHPFFTR 424
+RL +A+ P + +
Sbjct: 352 KEDRLLPLQAMETPEYEQ 369
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 74/348 (21%), Positives = 130/348 (37%), Gaps = 93/348 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y I +GEG+FG+V + ++ VA+K + + + K + EI L +L RH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRH 68
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I +++ + I +V E G L+D++ + + D R +Q++ ++
Sbjct: 69 PHI-----IKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAI 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+ H +++H DLKPEN+LL D N +K+ DFG
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---------DDN------------LN------VKIADFGL 154
Query: 268 TTFEHQDHSYVVS--TRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENL 324
+ + S + +Y APEVI G + P D+WS G +L + G F E +
Sbjct: 155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-DEFI 213
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
+L V + GA+
Sbjct: 214 PNL-----------FKKVNSCVYVMPDFLSPGAQ-------------------------- 236
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432
L++ ++ DP +R+ +E R P+F ++ P
Sbjct: 237 ------------SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRP 272
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 79/340 (23%), Positives = 119/340 (35%), Gaps = 86/340 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIG 151
RY + +G G FG D KELVA+K + E EI R RH +I
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH-RSLRHPNI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V+ + H+ I+ E G LY+ + F D R +QLL V++
Sbjct: 79 ----VRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYC 132
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H +++ H DLK EN LL DGS +K+ DFG +
Sbjct: 133 HSMQICHRDLKLENTLL-------------------DGSPAPR------LKICDFGYSKS 167
Query: 271 EHQDH--SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEHL 327
V T Y APEV+L ++ D+WS G L + G F+
Sbjct: 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPRD 226
Query: 328 --AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
++R+L + KY +P+ I
Sbjct: 227 YRKTIQRIL--------------SVKY--------------------------SIPDDI- 245
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ + L+ + DPA R+ E H +F ++
Sbjct: 246 ----RISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 62/349 (17%), Positives = 126/349 (36%), Gaps = 98/349 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
+ ++ +GEG +G+V + +E VA+KI ++ R EI + + L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H ++ V+ N + E G L+D + + P + QL+
Sbjct: 64 HENV-----VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
V ++H + + H D+KPEN+LL D N +K+ DF
Sbjct: 117 GVVYLHGIGITHRDIKPENLLL-------------------DER--DN------LKISDF 149
Query: 266 G-STTFEHQDHSYVVSTR----HYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQ 319
G +T F + + +++ Y APE++ ++ P D+WS G +L + +GE +
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+ + + Y W
Sbjct: 210 QPSDSCQE---------------YSDWKEKKTYL-----NPW------------------ 231
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
+ +D + + LL +L +P+ R+ + + ++ + +++
Sbjct: 232 ------KKIDSAP---LALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-24
Identities = 80/351 (22%), Positives = 121/351 (34%), Gaps = 98/351 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y + +G GTFG+V VA+KI+ + I I EI L +L RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRH 70
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ +V E + G L+D++ K+ R L +Q+L +
Sbjct: 71 PHI-----IKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
V + H ++H DLKPEN+LL D N K+ DFG
Sbjct: 124 VDYCHRHMVVHRDLKPENVLL---------DAH------------MN------AKIADFG 156
Query: 267 STTFEHQDHSYVVSTR----HYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTH 321
+ + T +Y APEVI G + P D+WS G IL L G F
Sbjct: 157 LSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-D 213
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
E++ L + +Y R
Sbjct: 214 EHVPTL-----------FKKIRGGVFYIPEYLNRSVA----------------------- 239
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432
LL +L+ DP +R ++ H +F +D+ FP
Sbjct: 240 ---------------TLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFP 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 76/342 (22%), Positives = 131/342 (38%), Gaps = 87/342 (25%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ +Y K+G+G G V D + VAI+ + + ++ +I EI V++
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I V + + + + +V E L G SL D + + I V R+ L+
Sbjct: 76 NPNI-----VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQ 127
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ F+H ++IH D+K +NILL DGS +KL DF
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDF 160
Query: 266 GST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
G T E S +V T ++ APEV+ + D+WS+G + +E+ GE
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------- 213
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
P P+ + + +RA++ +
Sbjct: 214 -------------P-PYL--------------------------NENPLRALYLIATNGT 233
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+Q+ + + D L L D +R A+E L+H F
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 70/342 (20%), Positives = 131/342 (38%), Gaps = 87/342 (25%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ K+GEG+ G V + VA+K++ + R + E+ +++
Sbjct: 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
++ V++ + + ++ E L G +L D + + I V +L+
Sbjct: 101 HFNV-----VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV---CEAVLQ 152
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++A++H +IH D+K ++ILL + DG +KL DF
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILL-----------------TLDGR----------VKLSDF 185
Query: 266 G---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
G + + +V T ++ APEVI + D+WS+G +++E+ GE
Sbjct: 186 GFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE------- 238
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
P P+ S ++A+ +L P
Sbjct: 239 -------------P-PYF--------------------------SDSPVQAMKRLRDSPP 258
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+++ + L D L+ +L DP ER A+E L HPF +
Sbjct: 259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 61/346 (17%), Positives = 127/346 (36%), Gaps = 92/346 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
+ ++ +G GT+GQV + + +L AIK++ E EI++L++ + H
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
G +N + + +V E S+ D ++ + + + + R++L
Sbjct: 85 TYYG---AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
++ +H+ ++IH D+K +N+LL +++ +KL+DFG
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLL-----------------TENAE----------VKLVDFG 174
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALF 318
+ + T ++ APEVI +++ DLWS+G +E+ G
Sbjct: 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP-- 232
Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 378
P + MRA++ +
Sbjct: 233 -------------------PLCDM--------------------------HPMRALFLIP 247
Query: 379 RLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
R P ++ S ++ L + ++R + ++HPF
Sbjct: 248 RNPAPRLKSKKWSK-KFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 62/349 (17%), Positives = 126/349 (36%), Gaps = 98/349 (28%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
+ ++ +GEG +G+V + +E VA+KI ++ R EI + + L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H ++ V+ N + E G L+D + + P + QL+
Sbjct: 64 HENV-----VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
V ++H + + H D+KPEN+LL D N +K+ DF
Sbjct: 117 GVVYLHGIGITHRDIKPENLLL-------------------DER--DN------LKISDF 149
Query: 266 G-STTFEHQDHSYVVSTR----HYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQ 319
G +T F + + +++ Y APE++ ++ P D+WS G +L + +GE +
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+ + + Y W
Sbjct: 210 QPSDSCQE---------------YSDWKEKKTY-----LNPW------------------ 231
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
+ +D + + LL +L +P+ R+ + + ++ + +++
Sbjct: 232 ------KKIDSAP---LALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 67/366 (18%), Positives = 120/366 (32%), Gaps = 115/366 (31%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+Y + ++G+G++G V ++ A+K+ ++K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKV---LSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 153 TRCVQIRNWFD--YR-------------------------NHICIVFEKL-GPSLYDFLR 184
C+Q R + Y+ +H+ +VFE + + +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
D R + L++ + ++H ++IH D+KP N+L+
Sbjct: 131 LKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV----------------- 170
Query: 245 SKDGSYFKNLPKSSAIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNY---P 298
+DG IK+ DFG S F+ D S V T + APE + +
Sbjct: 171 GEDGH----------IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKA 220
Query: 299 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGAR 358
D+W++G L G+ F E + L H +
Sbjct: 221 LDVWAMGVTLYCFVFGQCPFM-DERIMCL-----------HSKIKSQA------------ 256
Query: 359 LDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418
L P+ D + DL DL+ +L +P R+ E
Sbjct: 257 -------------------LEFPD----QPDIAE-DLKDLITRMLDKNPESRIVVPEIKL 292
Query: 419 HPFFTR 424
HP+ TR
Sbjct: 293 HPWVTR 298
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 60/349 (17%), Positives = 115/349 (32%), Gaps = 54/349 (15%)
Query: 94 YRILSKMGEG--TFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARH 148
Y +L+ +G+G V E V ++ + N+ E+ V +
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I V R F N + +V + S D + + + + + +L+++
Sbjct: 87 NI-----VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H + +H +K +IL+ S DG + L S
Sbjct: 142 DYIHHMGYVHRSVKASHILI-----------------SVDGK----------VYLSGLRS 174
Query: 268 ----------TTFEHQDHSYVVSTRHYRAPEVI--LGLGWNYPCDLWSVGCILVELCSGE 315
H Y V + +PEV+ G++ D++SVG EL +G
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
Query: 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
F+ ++ M+ L ++ + AE+ +R G + +
Sbjct: 235 VPFK---DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPR 291
Query: 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
H S ++ L+ +P R A L H FF +
Sbjct: 292 PSNGDSPSHPYHRTFSP-HFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 72/338 (21%), Positives = 130/338 (38%), Gaps = 85/338 (25%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
+ +L K+GEG++G V + E ++VAIK V + + + EI ++Q+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHV 86
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V+ + + IV E S+ D +R + ++ D + + + L+ + +
Sbjct: 87 -----VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEY 140
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST- 268
+H +R IH D+K NILL + +G KL DFG
Sbjct: 141 LHFMRKIHRDIKAGNILL-----------------NTEGH----------AKLADFGVAG 173
Query: 269 --TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
T + V+ T + APEVI +G+N D+WS+G +E+ G+
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK----------- 222
Query: 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386
P P+ + MRA++ + P +
Sbjct: 223 ---------P-PYADI--------------------------HPMRAIFMIPTNPPPTFR 246
Query: 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ + + D ++ L P +R A + L+HPF
Sbjct: 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 66/360 (18%), Positives = 130/360 (36%), Gaps = 106/360 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAM---IEIDVLQRLAR 147
+Y + +GEG++G+V E D+E A+KI+ + + + EI +L+RL R
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 148 H-DIGGTRCVQIRN--WFDYRNHICIVFE--KLGPS-LYDFLRKNSYRSFPIDLVRELGR 201
H ++ +Q+ + + + + + +V E G + D + + + FP+
Sbjct: 65 HKNV-----IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFC 116
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
QL++ + ++H ++H D+KP N+LL + G+ +K
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLL-----------------TTGGT----------LK 149
Query: 262 LIDFG-STTFEHQDHSYVVSTR----HYRAPEVILGLGWNY---PCDLWSVGCILVELCS 313
+ G + T ++ PE+ GL + D+WS G L + +
Sbjct: 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITT 208
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G F+ +N+ L + +
Sbjct: 209 GLYPFE-GDNIYKL-----------FENIGKGSYAIPGDCGPPLS--------------- 241
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
DLL+G+L Y+PA+R R+ +H +F + P+
Sbjct: 242 -----------------------DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 73/350 (20%), Positives = 122/350 (34%), Gaps = 99/350 (28%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEID 140
+ YR+L +G+G F +V VAIKI I+K + + E+
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKI---IDKTQLNPTSLQKLFREVR 66
Query: 141 VLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE 198
+++ L H +I V++ + + ++ E G ++D+L + R
Sbjct: 67 IMKIL-NHPNI-----VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARS 118
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
RQ++ +V + H+ R++H DLK EN+LL D +
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLL-----------------DADMN--------- 152
Query: 259 AIKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGE 315
IK+ DFG S F Y APE+ G ++ P D+WS+G IL L SG
Sbjct: 153 -IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
Query: 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
F +NL+ L V+R R Y
Sbjct: 212 LPFD-GQNLKEL-----------RERVLRGKYRIPFYMSTDCE----------------- 242
Query: 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+LL+ L +P +R + ++ +
Sbjct: 243 ---------------------NLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 69/333 (20%), Positives = 114/333 (34%), Gaps = 90/333 (27%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIGGTRCV 156
GEG+F VV + AIKI+ I K + E DV+ RL H V
Sbjct: 39 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPF----FV 93
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + L ++RK SF R +++ ++ ++H +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
IH DLKPENILL ++++ D+ S + + + +F
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--------------ANSF----- 192
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 335
V T Y +PE++ DLW++GCI+ +L +G F N + ++++
Sbjct: 193 ---VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGN--EYLIFQKII- 245
Query: 336 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395
D+P+
Sbjct: 246 --------------------KLEYDFPEKFFP--------------------------KA 259
Query: 396 IDLLQGLLRYDPAERL------KAREALRHPFF 422
DL++ LL D +RL HPFF
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 67/351 (19%), Positives = 115/351 (32%), Gaps = 108/351 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD-I 150
L +MG GT GQV + + ++A+K +R + + ++++DV+ + I
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ F + I E +G ++ P ++ ++ +++++ ++
Sbjct: 87 -----VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYL 140
Query: 211 H-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
+ +IH D+KP NILL + G IKL DFG
Sbjct: 141 KEKHGVIHRDVKPSNILL-----------------DERGQ----------IKLCDFGISG 173
Query: 267 -------STTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSG 314
Y APE I ++ D+WS+G LVEL +G
Sbjct: 174 RLVDDKAKDRS--------AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 315 EA-LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
+ + E L + + P
Sbjct: 226 QFPYKNCKTDFEVLTKV--LQEEPP----------------------------------- 248
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
LP H+ S D ++ L D +R K + L H F R
Sbjct: 249 -----LLPG----HMGFSG-DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-22
Identities = 61/352 (17%), Positives = 118/352 (33%), Gaps = 109/352 (30%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHD-I 150
+ ++G G +G V + +++A+K +R+ +E + ++D+ R
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI--DLVRELGRQLLESVA 208
V + I E + SL F ++ + I D++ ++ +++++
Sbjct: 69 -----VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 209 FMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
+H +L +IH D+KP N+L+ + G +K+ DFG
Sbjct: 124 HLHSKLSVIHRDVKPSNVLI-----------------NALGQ----------VKMCDFGI 156
Query: 267 ---------STTFEHQDHSYVVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCS 313
+ Y APE I G++ D+WS+G ++EL
Sbjct: 157 SGYLVDDVAKDID--------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208
Query: 314 GEALFQTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
+ + + L + V P P +L P S
Sbjct: 209 LRFPYDSWGTPFQQLKQV--VEEPSP-------------------QL--PADKFSA---- 241
Query: 373 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ +D L+ + ER E ++HPFFT
Sbjct: 242 ---------------------EFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 71/342 (20%), Positives = 133/342 (38%), Gaps = 90/342 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+ I+ ++G+G FG+V + + E L A K++ + ++ I EI++L I
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V++ + + + I+ E G ++ + + R ++ + RQ+LE++ F+
Sbjct: 79 ----VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFL 133
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
H R+IH DLK N+L+ + +G I+L DFG +
Sbjct: 134 HSKRIIHRDLKAGNVLM-----------------TLEGD----------IRLADFGVSAK 166
Query: 269 -TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
Q + T ++ APEV++ ++Y D+WS+G L+E+ E
Sbjct: 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE------- 219
Query: 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382
P PHH + + MR + K+ +
Sbjct: 220 -------------P-PHHEL--------------------------NPMRVLLKIAKSDP 239
Query: 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ + + D L+ L +P R A + L HPF +
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 80/349 (22%), Positives = 123/349 (35%), Gaps = 94/349 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y + +G GTFG+V VA+KI+ + I I EI L +L RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRH 75
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ + I +V E + G L+D++ KN R L +Q+L
Sbjct: 76 PHI-----IKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
V + H ++H DLKPEN+LL D N K+ DFG
Sbjct: 129 VDYCHRHMVVHRDLKPENVLL---------DAH------------MN------AKIADFG 161
Query: 267 STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHEN 323
+ S + +Y APEVI G + P D+WS G IL L G F ++
Sbjct: 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDH 220
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
+ L + +Y
Sbjct: 221 VPTL-----------FKKICDGIFYTPQYLNPSVI------------------------- 244
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432
LL+ +L+ DP +R ++ H +F +D+ + FP
Sbjct: 245 -------------SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFP 280
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 61/245 (24%), Positives = 94/245 (38%), Gaps = 51/245 (20%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+ +G G FG V C + + VAIK + S R+A ++E+ L R+ H
Sbjct: 12 VEEVVGRGAFGVV--CKAKWRAKDVAIKQIES-ESERKAFIVELRQLSRV-NHPNIVKLY 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK-NSYRSFPIDLVRELGRQLLESVA 208
G N +C+V E G SLY+ L + Q + VA
Sbjct: 68 GACL-----------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 209 FMHELR---LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++H ++ LIH DLKP N+LLV+ V +K+ DF
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV--------------------------LKICDF 150
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
G+ + + + APEV G ++ CD++S G IL E+ + F
Sbjct: 151 GTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA 210
Query: 326 HLAMM 330
M
Sbjct: 211 FRIMW 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 42/236 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
+ L K+G+G+FG+V + DN +++VAIKI+ E EI VL + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ + + I+ E L G S D L I + R++L+ + +
Sbjct: 83 -----TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---REILKGLDY 134
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
+H + IH D+K N+LL S+ G +KL DFG
Sbjct: 135 LHSEKKIHRDIKAANVLL-----------------SEHGE----------VKLADFGVAG 167
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA-LFQTH 321
T + V T + APEVI ++ D+WS+G +EL GE + H
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 71/351 (20%), Positives = 123/351 (35%), Gaps = 103/351 (29%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQ 143
++ + L ++G G+FG V D E+VAIK + K E+ LQ
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L + +Q R + + +V E S D L + + + +
Sbjct: 110 KLRHPNT-----IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 163
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L+ +A++H +IH D+K NILL S+ G +KL
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILL-----------------SEPGL----------VKLG 196
Query: 264 DFGS-------TTFEHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCS 313
DFGS +F V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 197 DFGSASIMAPANSF--------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 248
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
+ P P + ++M A
Sbjct: 249 RK--------------------P-PLFNM--------------------------NAMSA 261
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
++ + + + +Q S + + L+ P +R + L+H F R
Sbjct: 262 LYHIAQNESPALQSGHWSE-YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 70/345 (20%), Positives = 121/345 (35%), Gaps = 91/345 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHD-I 150
+ L ++G G +G V + +++A+K +RS +E + ++DV+ R + I
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK---NSYRSFPIDLVRELGRQLLESV 207
VQ I E + S F + P +++ ++ ++++
Sbjct: 84 -----VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 208 AFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ L++IH D+KP NILL + G+ IKL DFG
Sbjct: 139 NHLKENLKIIHRDIKPSNILL-----------------DRSGN----------IKLCDFG 171
Query: 267 -STTFEH-QDHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEA-LFQ 319
S + R Y APE I G++ D+WS+G L EL +G +
Sbjct: 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+ + L + V G P +L + S
Sbjct: 232 WNSVFDQLTQV--VKGDPP-------------------QL--SNSEEREFSP-------- 260
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
I+ + L D ++R K +E L+HPF
Sbjct: 261 --------------SFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 40/234 (17%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
P +R+ K+G G FG++ + E VAIK+ ++ +E ++L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQL----GS 63
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G Q+ +F + +V E LGPSL D L R+F + V + QL+ + ++
Sbjct: 64 GDGIPQVY-YFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---- 266
H LI+ D+KPEN L+ G I +IDF
Sbjct: 122 HSKNLIYRDVKPENFLI--------------------GR--PGNKTQQVIHIIDFALAKE 159
Query: 267 ---STTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
T +H ++H + T Y + LG + DL ++G + + G
Sbjct: 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 8e-21
Identities = 67/342 (19%), Positives = 119/342 (34%), Gaps = 94/342 (27%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SI--NKYREAAMIEIDVLQRLARHDI 150
+ +G G FG+V C + ++ A+K + I + A+ E +L +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL-----V 246
Query: 151 GGTRC---VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
C V + F + + + + + G L+ L ++ F +R +++
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILG 304
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ MH +++ DLKP NILL +V++ D A
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL------------------ACDFSKKK 346
Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
V T Y APEV+ G+ ++ D +S+GC+L +L G + F+ H+ +
Sbjct: 347 PHAS--------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+ L ++ PD +
Sbjct: 399 KHEIDRMTL---------------------TMAVELPDSFSP------------------ 419
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
+L LL+GLL+ D RL A+E PFF
Sbjct: 420 --------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
RYR+ K+G G+FG + D E VAIK+ K+ + + E + + + G
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMMQ----G 63
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G IR W ++ +V E LGPSL D L R F + V L Q++ + ++
Sbjct: 64 GVGIPTIR-WCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 211 HELRLIHTDLKPENILL 227
H IH D+KP+N L+
Sbjct: 122 HSKNFIHRDVKPDNFLM 138
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 57/255 (22%), Positives = 94/255 (36%), Gaps = 52/255 (20%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLARHD 149
+ +G G FG+V F + VA+K R + I E + L +H
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
G C++ ++C+V E G L L + P D++ Q+
Sbjct: 67 NIIALRGV--CLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQI 114
Query: 204 LESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+ ++H+ + +IH DLK NIL+ + +
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILI-------------------LQKVENGDLSNKIL 155
Query: 261 KLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
K+ DFG H+ + APEVI ++ D+WS G +L EL +GE F
Sbjct: 156 KITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF- 214
Query: 320 THENLEHLAMMERVL 334
++ LA+ V
Sbjct: 215 --RGIDGLAVAYGVA 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 73/339 (21%), Positives = 121/339 (35%), Gaps = 89/339 (26%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
YR+L G+G FG+V C ++ A K + K A+ E +L+++
Sbjct: 189 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ V + ++ ++ +C+V + G L + FP ++ +
Sbjct: 246 V-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H R+++ DLKPENILL ++++ D L+ +G
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLG-LAVHVPEGQ----------------TIK 343
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
V T Y APEV+ + + D W++GC+L E+ +G++ FQ +
Sbjct: 344 GR--------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ER +V + F AR
Sbjct: 396 EVER--------LVKEVPEEYSERFSPQAR------------------------------ 417
Query: 389 DHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
L LL DPAERL ARE HP F
Sbjct: 418 --------SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 40/234 (17%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
Y++ ++GEG+FG + E + + VAIK + + E + L G
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLL----AG 64
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
T + +F H +V + LGPSL D L R F + V +Q+L V +
Sbjct: 65 CTGIPNVY-YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---- 266
HE L++ D+KP+N L+ N ++ I ++DFG
Sbjct: 123 HEKSLVYRDIKPDNFLI----------------------GRPNSKNANMIYVVDFGMVKF 160
Query: 267 ---STTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
T +H ++ + T Y + LG + DL ++G + + G
Sbjct: 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 49/252 (19%), Positives = 83/252 (32%), Gaps = 56/252 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--------EIDVLQRLAR 147
++G+G FG V + + K +VAIK + + E MI E+ ++ L
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-N 81
Query: 148 HD-----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
H G N +V E + LY L + + L
Sbjct: 82 HPNIVKLYGLMH-----------NPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLML 129
Query: 202 QLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+ + +M ++H DL+ NI L S +
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQS----------------------LDENAPVC 167
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEAL 317
K+ DFG + S ++ + APE I +Y D +S IL + +GE
Sbjct: 168 AKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 318 FQTHENLEHLAM 329
F + + +
Sbjct: 228 F---DEYSYGKI 236
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 68/339 (20%), Positives = 127/339 (37%), Gaps = 94/339 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G G+FG+V+ E A+KI+ + K ++ + E +LQ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP 101
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ F +++ +V E G ++ LR+ F R Q++ +
Sbjct: 102 F----LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H L LI+ DLKPEN+L+ Y++V D+ F K + +
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-------------------AKRVKGRTW 196
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
T T APE+IL G+N D W++G ++ E+ +G F + +
Sbjct: 197 TL--------CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQ--PIQ 245
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ E+++ ++ +P +S
Sbjct: 246 IYEKIV---------------------SGKVRFPSHFSS--------------------- 263
Query: 389 DHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
DL DLL+ LL+ D +R + H +F
Sbjct: 264 -----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
++R+ K+G G+FG++ + + E VAIK+ K+ + E + + L G
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRILQ----G 61
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
GT +R WF ++ +V + LGPSL D L R + V L Q++ V F+
Sbjct: 62 GTGIPNVR-WFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 211 HELRLIHTDLKPENILL 227
H +H D+KP+N L+
Sbjct: 120 HSKSFLHRDIKPDNFLM 136
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 39/192 (20%), Positives = 68/192 (35%), Gaps = 47/192 (24%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
++ + K+G G FG + F K E A +V+ + E+ QR+A+ D
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 152 GTRCVQIRN---------WF--------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+ + YR +V E+LG L +N +F
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQN--GTFKKS 151
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
V +LG ++L+ + ++HE +H D+K N+LL
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-------------------------GY 186
Query: 255 PKSSAIKLIDFG 266
+ L D+G
Sbjct: 187 KNPDQVYLADYG 198
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 69/342 (20%), Positives = 117/342 (34%), Gaps = 67/342 (19%)
Query: 18 PRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDD 77
P P P +P K C + G S G P GSP
Sbjct: 16 PDIDPLEALMTNPVVPESKRFCW-NCGRPVGRSDSETKGASE---GWCPYCGSPYSFLPQ 71
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSIN--KYREA 134
G+ + +Y + + G G + D N V +K + + +
Sbjct: 72 ------LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM 125
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC-----IVFEKL-GPSLYDFLRKNSY 188
AM E L + I VQI N+ ++ + IV E + G SL
Sbjct: 126 AMAERQFLAEVVHPSI-----VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---- 176
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
+ P+ ++L +++++H + L++ DLKPENI+L +++
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML-----------------TEEQ 219
Query: 249 SYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
+KLID G Y+ T ++APE++ G D+++VG
Sbjct: 220 -----------LKLIDLGAVSRIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVG 263
Query: 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLP--HHMVIRA 345
L L ++ L + VL ++ RA
Sbjct: 264 RTLAALTLDLPTR-NGRYVDGLPEDDPVLKTYDSYGRLLRRA 304
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 64/343 (18%), Positives = 117/343 (34%), Gaps = 93/343 (27%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHDI 150
+G G FG+V C +L A K + K + AM+E +L ++ I
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 151 GGTRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
V + F+ + +C+V + +Y+ N F Q++
Sbjct: 248 -----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVS 300
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ +H+ +I+ DLKPEN+LL V++ D + + + K
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL----AVELKAGQTKTK--------- 347
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-ENL 324
+ T + APE++LG +++ D +++G L E+ + F+ E +
Sbjct: 348 ---GY--------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 396
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
E+ + +RVL + +PD +
Sbjct: 397 ENKELKQRVL---------------------EQAVTYPDKFSP----------------- 418
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
D + LL+ DP +RL HP F
Sbjct: 419 ---------ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 33/197 (16%), Positives = 65/197 (32%), Gaps = 54/197 (27%)
Query: 92 PRYRILSKMGEGTFGQV--------VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQ 143
++++ S G + + C +K+ ++K+ + E + Q
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL----FNEQNFFQ 97
Query: 144 RLARHD-------IGGTRCVQIRN--WF-----DYRNHICIVFEKLGPSLYDFLRKNSYR 189
R A+ + T + I F YR +V LG SL L +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR---FLVLPSLGRSLQSALDVSPKH 154
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
V ++ +LL+++ F+HE +H ++ ENI +
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV---------------------- 192
Query: 250 YFKNLPKSSAIKLIDFG 266
+ S + L +G
Sbjct: 193 ---DPEDQSQVTLAGYG 206
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 30/228 (13%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD----- 149
+G+G FGQ ++ E E++ +K + ++ + + E+ V++ L H
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKF 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
IG + + + E + G +L ++ +P + + +A
Sbjct: 73 IGV--LYK-------DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMA 122
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H + +IH DL N L+ + V V D F L+R D +S
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVAD--FGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
T VV ++ APE+I G ++ D++S G +L E+
Sbjct: 181 T---------VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 76/357 (21%), Positives = 128/357 (35%), Gaps = 104/357 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
Y + +G G V + KKE VAIK + + + EI + + +I
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE------LGRQL 203
V F ++ + +V + L G S+ D ++ + V + + R++
Sbjct: 76 -----VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
LE + ++H+ IH D+K NILL +DGS +++
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILL-----------------GEDGS----------VQIA 163
Query: 264 DFG-----STTFEHQDHSY---VVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSG 314
DFG +T + + V T + APEV+ G+++ D+WS G +EL +G
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
A P+H KY M+ +
Sbjct: 224 AA---------------------PYH----------KY----------------PPMKVL 236
Query: 375 WKLLRL--PNLIMQHVDHSAG-----DLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
L+ P+L D ++ L+ DP +R A E LRH FF +
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 71/342 (20%), Positives = 118/342 (34%), Gaps = 90/342 (26%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
IL +G G F +V + ++ A+KI+ + K E + E DVL R I
Sbjct: 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI- 123
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
Q+ F N++ +V E G L L K R P ++ R +++ ++ +
Sbjct: 124 ----TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSV 178
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H L +H D+KP+NILL ++++ D+ + DG S
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG---------------TVRSLVA 223
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNY-------PCDLWSVGCILVELCSGEALFQTHEN 323
V T Y +PE++ +G CD W++G E+ G+ F ++
Sbjct: 224 --------VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADS 274
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
+++ H+ L P
Sbjct: 275 TA--ETYGKIV----HYKE---------------HLSLPLVDEGVPE------------- 300
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERL---KAREALRHPFF 422
+ D +Q LL P RL A + HPFF
Sbjct: 301 ----------EARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 63/340 (18%), Positives = 123/340 (36%), Gaps = 94/340 (27%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD- 149
IL +G+G+FG+V N+ K++ A+K + + E E+ ++Q L H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPF 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ V + F + +V + LG L L++N F + V+ +L+ ++
Sbjct: 77 L-----VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALD 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
++ R+IH D+KP+NILL D + G + + DF +
Sbjct: 130 YLQNQRIIHRDMKPDNILL---------D--------EHGH----------VHITDFNIA 162
Query: 268 TTFEHQDHSYVVS-TRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
+ ++ T+ Y APE+ G G+++ D WS+G EL G + +
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
++ + +P +
Sbjct: 223 TSSKEIVHTFE---------------------TTVVTYPSAWSQ---------------- 245
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERL-KAREALRHPFF 422
+++ LL+ LL +P +R + + P+
Sbjct: 246 ----------EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 69/340 (20%), Positives = 122/340 (35%), Gaps = 88/340 (25%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
IL +G G FG+V ++ A+KI+ + K E A E DVL I
Sbjct: 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI- 136
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+ F N++ +V + G L L K R P ++ R +++ ++ +
Sbjct: 137 ----TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSV 191
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H+L +H D+KP+NIL+ ++++ D+ + +DG S+
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---------------TVQSSVA 236
Query: 271 EHQDHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
V T Y +PE++ + + CD WS+G + E+ GE F E+L
Sbjct: 237 --------VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV 287
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+++ R +P
Sbjct: 288 --ETYGKIM-------------------NHKERFQFP----------------------- 303
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERL---KAREALRHPFF 422
V + + DL++ L+ RL + +HPFF
Sbjct: 304 TQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFF 342
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 38/209 (18%), Positives = 71/209 (33%), Gaps = 58/209 (27%)
Query: 84 FAIGENLT----PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSINKYREA 134
FA+GE +T +++ +G+G FG + N +K+ S N
Sbjct: 23 FAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF- 81
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRN---------WF--------DYRNHICIVFEKLGP 177
E+ QR A+ + + YR ++ ++ G
Sbjct: 82 --TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR---FMIMDRFGS 136
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L N+ + F V +L ++L+ + ++HE +H D+K N+LL
Sbjct: 137 DLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL---------- 185
Query: 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
N + L+D+G
Sbjct: 186 ---------------NYKNPDQVYLVDYG 199
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 68/339 (20%), Positives = 124/339 (36%), Gaps = 90/339 (26%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
++ +G G FG+V +++ A+K++ + K ++A E D++ +
Sbjct: 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV- 131
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ+ F ++ +V E + G L + + P R +++ ++ +
Sbjct: 132 ----VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAI 184
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H + IH D+KP+N+LL + ++K+ D+ + +K+G T
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG---------------MVRCDTA 229
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYP----CDLWSVGCILVELCSGEALFQTHENLEH 326
V T Y +PEV+ G + CD WSVG L E+ G+ F ++L
Sbjct: 230 --------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLV- 279
Query: 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386
+++ +H L +PD
Sbjct: 280 -GTYSKIM----NHKN---------------SLTFPD----------------------- 296
Query: 387 HVDHSAGDLIDLLQGLLRYDPAERLK---AREALRHPFF 422
D S + +L+ L D RL E RH FF
Sbjct: 297 DNDISK-EAKNLICAFLT-DREVRLGRNGVEEIKRHLFF 333
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 57/253 (22%), Positives = 95/253 (37%), Gaps = 57/253 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD--- 149
I K+G G+FG V + VA+KI+ + + + E+ +++RL RH
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIV 97
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR-SFPIDLVRELGRQLLE 205
+G Q ++ IV E L SLY L K+ R + + +
Sbjct: 98 LFMGA--VTQ-------PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 206 SVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
+ ++H ++H +LK N+L+ VKV
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV---------------------------C 181
Query: 264 DFGSTTFEHQDHSYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
DFG + + S T + APEV+ N D++S G IL EL + + +
Sbjct: 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-- 239
Query: 321 HENLEHLAMMERV 333
NL ++ V
Sbjct: 240 -GNLNPAQVVAAV 251
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 68/346 (19%), Positives = 124/346 (35%), Gaps = 99/346 (28%)
Query: 92 PRYRI-----LSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVL 142
P+Y + L +G G+FG+V A+K+++ + + ++ E +L
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
+ H +++ F I ++ + + G L+ LRK + FP + +
Sbjct: 61 SIV-THPF----IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAA 113
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
++ ++ ++H +I+ DLKPENILL ++K+ D+ F K
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-------------------AK 154
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
+ + T T Y APEV+ +N D WS G ++ E+ +G F
Sbjct: 155 YVPDVTYTL--------CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YD 205
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
N + E++L A L +P
Sbjct: 206 SN--TMKTYEKIL---------------------NAELRFP------------------- 223
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
+ DLL L+ D ++RL + HP+F
Sbjct: 224 ----PFFNEDV---KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 65/340 (19%), Positives = 129/340 (37%), Gaps = 82/340 (24%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ +L +G G++ +V+ + + A+K+V+ +N + E V ++ + H
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V + + F + + V E + G L +++ R P + R ++ ++
Sbjct: 71 F----LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 124
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++HE +I+ DLK +N+LL S ++K+ DY K+G + G T
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDT 166
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
T S T +Y APE++ G + + D W++G ++ E+ +G + F + ++
Sbjct: 167 T------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP- 219
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ + +L I + +
Sbjct: 220 ---------------DQNTEDYLF----------------------QVILEKQIRIPRSL 242
Query: 389 DHSAGDLIDLLQGLLRYDPAERL------KAREALRHPFF 422
A +L+ L DP ERL + HPFF
Sbjct: 243 SVKA---ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 65/342 (19%), Positives = 121/342 (35%), Gaps = 96/342 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL A+KI++ + E M+E VL +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ + F + + V E + G L +++ F ++ +
Sbjct: 403 F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLF 456
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+ +I+ DLK +N++L S ++K+ D+ K+ I G T
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM----CKEN--------------IWDGVT 498
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
T T Y APE+I + D W+ G +L E+ +G+A F+ + E
Sbjct: 499 T------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--- 549
Query: 329 MMERVLG---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+ + ++ P M S+++
Sbjct: 550 LFQSIMEHNVAYPKSM-------------------------SKEA--------------- 569
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
+ + +GL+ P +RL R+ H FF
Sbjct: 570 ----------VAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/340 (18%), Positives = 129/340 (37%), Gaps = 82/340 (24%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ +L +G G++ +V+ + + A+++V+ +N + E V ++ + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V + + F + + V E + G L +++ R P + R ++ ++
Sbjct: 114 F----LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 167
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++HE +I+ DLK +N+LL S ++K+ DY K+G + G T
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDT 209
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
T S T +Y APE++ G + + D W++G ++ E+ +G + F + ++
Sbjct: 210 T------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP- 262
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ + +L I + +
Sbjct: 263 ---------------DQNTEDYLF----------------------QVILEKQIRIPRSL 285
Query: 389 DHSAGDLIDLLQGLLRYDPAERL------KAREALRHPFF 422
A +L+ L DP ERL + HPFF
Sbjct: 286 SVKA---ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 63/338 (18%), Positives = 120/338 (35%), Gaps = 92/338 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G+G+FG+V + + AIK ++ + + M+E VL H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ F + ++ V E L G L ++ F + +++ +
Sbjct: 79 F----LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQ 132
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+H +++ DLK +NILL ++K+ D+ K+ + +
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGM----CKEN--------------MLGDAK 174
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
T +++ T Y APE++LG +N+ D WS G +L E+ G++ F + E
Sbjct: 175 T-----NTF-CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--- 225
Query: 329 MMERVLG---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+ + P + +++
Sbjct: 226 LFHSIRMDNPFYPRWL-------------------------EKEA--------------- 245
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALR-HPFF 422
DLL L +P +RL R +R HP F
Sbjct: 246 ----------KDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 53/245 (21%)
Query: 95 RILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
+ ++G G+FG V + + + VA+K++ + +A E+ VL++ RH
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVN 81
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+G + + IV + G SLY L + F + + ++ RQ
Sbjct: 82 ILLFMGYST----------APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTA 130
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLI 263
+ ++H +IH DLK NI L VK+ D F L+
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD--FGLAT-------------------- 168
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQT 320
S + + + APEVI N + D+++ G +L EL +G+ +
Sbjct: 169 -EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
Query: 321 HENLE 325
N +
Sbjct: 228 INNRD 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 79/342 (23%), Positives = 131/342 (38%), Gaps = 96/342 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI++ I E A + E VLQ +RH
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 208
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
++ F + +C V E G L+ L + R F D R G +++ ++
Sbjct: 209 F----LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 262
Query: 209 FMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H + +++ DLK EN++L ++K+ D+ K+G I G+
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL----CKEG--------------IKDGA 304
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLE 325
T T Y APEV+ + D W +G ++ E+ G F Q HE L
Sbjct: 305 TM------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
L +ME + P + ++
Sbjct: 359 ELILMEEI--RFPRTL-------------------------GPEA--------------- 376
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
LL GLL+ DP +RL A+E ++H FF
Sbjct: 377 ----------KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 57/246 (23%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
IG+ + RY+I+ K+G G V D VAIK + + ++ RE
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
+L+ +I V + + + + +V E + GP+L +++ + +D
Sbjct: 65 S-----SQLSHQNI-----VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDT 112
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
Q+L+ + H++R++H D+KP+NIL+ + +
Sbjct: 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILI-----------------DSNKT------ 149
Query: 256 KSSAIKLIDFG------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
+K+ DFG T+ +H V+ T Y +PE G + D++S+G +L
Sbjct: 150 ----LKIFDFGIAKALSETSLTQTNH--VLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203
Query: 310 ELCSGE 315
E+ GE
Sbjct: 204 EMLVGE 209
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 79/344 (22%), Positives = 129/344 (37%), Gaps = 101/344 (29%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI+R I E A + E VLQ
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN----- 61
Query: 150 IGGTRC---VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
TR ++ F + +C V E G L+ L + R F + R G +++
Sbjct: 62 ---TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVS 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ ++H +++ D+K EN++L ++K+ D+ K+G I
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL----CKEG--------------ISD 158
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHEN 323
G+T T Y APEV+ + D W +G ++ E+ G F Q HE
Sbjct: 159 GATM------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
L L +ME + P + S ++
Sbjct: 213 LFELILMEEI--RFPRTL-------------------------SPEA------------- 232
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
LL GLL+ DP +RL A+E + H FF
Sbjct: 233 ------------KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 76/331 (22%), Positives = 130/331 (39%), Gaps = 89/331 (26%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIGGTRCV 156
G+G+FG+V+ ++ A+K+++ +I K +E M E +VL + +H V
Sbjct: 47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF----LV 102
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
+ F + + V + + G L+ L++ R F R ++ ++ ++H L +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
++ DLKPENILL S ++ + D+ K+ I+ STT
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGL----CKEN--------------IEHNSTT------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG 335
S T Y APEV+ ++ D W +G +L E+ G F + E M + +L
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN 253
Query: 336 PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395
K L+L ++ +SA
Sbjct: 254 ----------------------------------------KPLQLK----PNITNSA--- 266
Query: 396 IDLLQGLLRYDPAERL----KAREALRHPFF 422
LL+GLL+ D +RL E H FF
Sbjct: 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 64/342 (18%), Positives = 119/342 (34%), Gaps = 96/342 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL A+KI++ + + + M+E VL +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ + F + + V E + G L F ++ +
Sbjct: 82 F----LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+ +I+ DLK +N++L S ++K+ D+ K+ I G T
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM----CKEN--------------IWDGVT 177
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
T T Y APE+I + D W+ G +L E+ +G+A F E+ +
Sbjct: 178 T------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDE-- 228
Query: 329 MMERVLG---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+ + ++ P M S+++
Sbjct: 229 LFQSIMEHNVAYPKSM-------------------------SKEA--------------- 248
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
+ + +GL+ P +RL R+ H FF
Sbjct: 249 ----------VAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 67/343 (19%), Positives = 121/343 (35%), Gaps = 97/343 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G+G+FG+V+ E +L A+K+++ I + + M E +L H
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ F + + V E + G L R F R +++ ++
Sbjct: 85 F----LTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALM 138
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+H+ +I+ DLK +N+LL + K+ D+ + K+G I G T
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADF-GM---CKEG--------------ICNGVT 180
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
T + T Y APE++ + + D W++G +L E+ G A F+ +
Sbjct: 181 T------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--- 231
Query: 329 MMERVLG---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+ E +L P + D+
Sbjct: 232 LFEAILNDEVVYPTWL-------------------------HEDA--------------- 251
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERL------KAREALRHPFF 422
+L+ + +P RL LRHPFF
Sbjct: 252 ----------TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 57/273 (20%), Positives = 93/273 (34%), Gaps = 65/273 (23%)
Query: 63 GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
G +PR + ++G F YR+ +G G G V E D ++ +VA+
Sbjct: 13 GLVPRGSHMDGTAESREG-TQFG-------PYRLRRLVGRGGMGDVYEAEDTVRERIVAL 64
Query: 123 KIVRS--------INKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173
K++ + REA RL + V I ++ + + +
Sbjct: 65 KLMSETLSSDPVFRTRMQREA-----RTAGRLQEPHV-----VPIHDFGEIDGQLYVDMR 114
Query: 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232
+ G L LR+ + RQ+ ++ H H D+KPENIL+
Sbjct: 115 LINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----- 167
Query: 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------STTFEHQDHSYVVSTRHYRA 286
S D L+DFG V T +Y A
Sbjct: 168 ------------SADD----------FAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMA 203
Query: 287 PEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
PE Y D++++ C+L E +G +Q
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 61/310 (19%), Positives = 115/310 (37%), Gaps = 70/310 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+ +G+G FG+V + E VA+KI S + EI L RH+ I
Sbjct: 46 LQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 102
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ +V + + G SL+D+L + + ++ + +L +A
Sbjct: 103 AADNKDN-----GTWTQLWLVSDYHEHG-SLFDYLNRYT---VTVEGMIKLALSTASGLA 153
Query: 209 FMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
+H + H DLK +NIL+ + D L+ SA
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVR-----------HDSA 200
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCS 313
ID V T+ Y APEV+ D++++G + E+
Sbjct: 201 TDTIDIAPNH--------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRD 369
++ HE+ + LP++ ++ +D E+ + R + P+ S +
Sbjct: 253 RCSIGGIHEDYQ-----------LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCE 301
Query: 370 SMRAVWKLLR 379
++R + K++R
Sbjct: 302 ALRVMAKIMR 311
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 58/310 (18%), Positives = 108/310 (34%), Gaps = 70/310 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+L +G+G +G+V + + E VA+KI S ++ E+ L RH+ I
Sbjct: 12 LLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFI 68
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ + ++ ++G SLYD+L+ + + + +A
Sbjct: 69 ASDMTSR-----HSSTQLWLITHYHEMG-SLYDYLQLTT---LDTVSCLRIVLSIASGLA 119
Query: 209 FMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
+H H DLK +NIL+ + D L+ S +
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD--LGLAVM-----------HSQS 166
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCS 313
+D G+ V T+ Y APEV+ D+W+ G +L E+
Sbjct: 167 TNQLDVGNNP--------RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRD 369
E+ + P + V+ D E R + P+ S
Sbjct: 219 RMVSNGIVEDYK-----------PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267
Query: 370 SMRAVWKLLR 379
++ ++ KL++
Sbjct: 268 TLTSLAKLMK 277
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 54/255 (21%), Positives = 93/255 (36%), Gaps = 69/255 (27%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
+L+ RY + +G G +V D VA+K++R+ ++ REA
Sbjct: 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA-- 63
Query: 137 IEIDVLQRLAR---------HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN 186
Q A +D G + IV E + G +L D +
Sbjct: 64 ------QNAAALNHPAIVAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHTE 110
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
E+ +++ F H+ +IH D+KP NI++ S
Sbjct: 111 --GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI-----------------SA 151
Query: 247 DGSYFKNLPKSSAIKLIDFG------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
A+K++DFG + + V+ T Y +PE G + D
Sbjct: 152 TN----------AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 301 LWSVGCILVELCSGE 315
++S+GC+L E+ +GE
Sbjct: 202 VYSLGCVLYEVLTGE 216
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 67/340 (19%), Positives = 124/340 (36%), Gaps = 95/340 (27%)
Query: 101 GEGTFGQVV---ECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHD-IG 151
G G +G+V + ++ +L A+K+++ K E E VL+ + + +
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL- 121
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + F + ++ + + G L+ L + F V+ +++ ++ +
Sbjct: 122 ----VTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHL 175
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H+L +I+ D+K ENILL S +V + D+ SK+ + D
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGL----SKEF-------------VADETERA- 217
Query: 271 EHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQT-HENLEHL 327
+ + T Y AP+++ G G + D WS+G ++ EL +G + F E
Sbjct: 218 ----YDF-CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
+ R+L + +P ++
Sbjct: 273 EISRRIL---------------------KSEPPYPQEMSA-------------------- 291
Query: 388 VDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
DL+Q LL DP +RL A E H FF
Sbjct: 292 ------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 35/254 (13%), Positives = 81/254 (31%), Gaps = 60/254 (23%)
Query: 96 ILSKMGEGTFGQVVE--CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
L+K+ E G++ + N+ + +K+++ + + E L+ H
Sbjct: 14 FLTKLNENHSGELWKGRWQGND----IVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPN 68
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+G C H ++ + SLY+ L + + + +
Sbjct: 69 VLPVLGA--CQS-----PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 205 ESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+AF+H L + L ++++ +D + ++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMI-----------------DEDMT----------ARI 154
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP---CDLWSVGCILVELCSGEALFQ 319
+ + APE + + D+WS +L EL + E F
Sbjct: 155 SMADVKFSFQSPG--RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF- 211
Query: 320 THENLEHLAMMERV 333
+L ++ + +V
Sbjct: 212 --ADLSNMEIGMKV 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 72/346 (20%), Positives = 136/346 (39%), Gaps = 103/346 (29%)
Query: 95 RILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAA--MIEIDVLQRLA 146
+L +G+G +G+V + ++ A+K+++ + ++ A E ++L+
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-V 78
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+H I V + F + ++ E L G L+ L + F D ++
Sbjct: 79 KHPFI-----VDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEIS 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
++ +H+ +I+ DLKPENI+L +VK+ D+ K+ I
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL----CKES--------------IH 173
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
G+ T H++ T Y APE+++ G N D WS+G ++ ++ +G F T EN
Sbjct: 174 DGTVT-----HTFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENR 226
Query: 325 EHLAMMERVLG---PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
+ ++++L LP ++ ++++
Sbjct: 227 K--KTIDKILKCKLNLPPYL-------------------------TQEA----------- 248
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
DLL+ LL+ + A RL A E HPFF
Sbjct: 249 --------------RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 49/257 (19%), Positives = 94/257 (36%), Gaps = 56/257 (21%)
Query: 96 ILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD-- 149
I +G+G FGQV + E VAI+++ +A E+ ++ RH+
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENV 91
Query: 150 ---IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+G C+ H+ I+ G +LY +R ++ R++ +++++
Sbjct: 92 VLFMGA--CMS-------PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVK 141
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H ++H DLK +N+ V + D F L S +
Sbjct: 142 GMGYLHAKGILHKDLKSKNV-FYDNGKVVITD--FGLFSISGVLQAGRR----------- 187
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP---------CDLWSVGCILVELCSGE 315
+ APE+I L + D++++G I EL + E
Sbjct: 188 -------EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 316 ALFQTHENLEHLAMMER 332
F+T + M
Sbjct: 241 WPFKTQPAEAIIWQMGT 257
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 58/311 (18%), Positives = 110/311 (35%), Gaps = 72/311 (23%)
Query: 96 ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++ ++G+G +G+V + EK VA+K+ + + EI + RH+
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK---VAVKVFFTTEEASWFRETEIYQTVLM-RHENILGF 96
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I ++ + ++ + + G SLYD+L+ + + +L + +
Sbjct: 97 IAA--DIKGTG---SWTQLYLITDYHENG-SLYDYLKSTT---LDAKSMLKLAYSSVSGL 147
Query: 208 AFMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSS 258
+H H DLK +NIL+ + D L+ S
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVK-----------FIS 194
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELC 312
+D T V T+ Y PEV+ D++S G IL E+
Sbjct: 195 DTNEVDIPPNT--------RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSR 368
E + LP+H ++ +D E + R +P+ +S
Sbjct: 247 RRCVSGGIVEEYQ-----------LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295
Query: 369 DSMRAVWKLLR 379
+ +R + KL+
Sbjct: 296 ECLRQMGKLMT 306
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 9e-15
Identities = 79/351 (22%), Positives = 127/351 (36%), Gaps = 117/351 (33%)
Query: 96 ILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHD 149
+L +G+G+FG+V + ++ ++L A+K+++ + R +E D+L H
Sbjct: 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-VNHP 86
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ F + ++ + L G L+ L K F + V+ +L ++
Sbjct: 87 FI-----VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALAL 139
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
+H L +I+ DLKPENILL ++G IKL DFG
Sbjct: 140 DHLHSLGIIYRDLKPENILL-----------------DEEGH----------IKLTDFGL 172
Query: 267 ----------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
+ +F T Y APEV+ G D WS G ++ E+ +G
Sbjct: 173 SKESIDHEKKAYSF--------CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376
FQ + E M +L
Sbjct: 225 PFQGKDRKE---TMTMILK----------------------------------------A 241
Query: 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERL-----KAREALRHPFF 422
L +P Q + A LL+ L + +PA RL E RH FF
Sbjct: 242 KLGMP----QFLSPEA---QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 68/302 (22%), Positives = 113/302 (37%), Gaps = 64/302 (21%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ L ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +HD
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G C R ++ ++ E G SL D+L+K+ R I L+ + Q
Sbjct: 103 NIVKYKG--VCYS-----AGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLL-QYTSQ 153
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+ + + ++ R IH DL NIL+ + VK+
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIG-------------------------- 187
Query: 263 IDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCSGEA 316
DFG T QD Y APE + ++ D+WS G +L EL +
Sbjct: 188 -DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAV 374
++ + G + +I + + RL PDG M
Sbjct: 247 KSKSPPAEFMRMIGNDKQGQMIVFHLI-------ELLKNNGRLPRPDGCPDEIYMIMTEC 299
Query: 375 WK 376
W
Sbjct: 300 WN 301
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 58/299 (19%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ L ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +HD
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 150 IGGTRCVQIRN--WFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
V+ + + R ++ ++ E G SL D+L+K+ R I L+ + Q+ +
Sbjct: 72 ----NIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLL-QYTSQICK 125
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++ R IH DL NIL+ + VK+ DF
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIG---------------------------DF 158
Query: 266 GSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
G T QD + APE + ++ D+WS G +L EL + +
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 376
+ + G + +I + + RL PDG M W
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLI-------ELLKNNGRLPRPDGCPDEIYMIMTECWN 270
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 49/247 (19%), Positives = 98/247 (39%), Gaps = 44/247 (17%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ K+G G +G+V E + VA+K ++ E + E V++ + +H
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 281
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G C + I+ E G +L D+LR+ + + ++ + Q+ ++
Sbjct: 282 LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFG 266
++ + IH +L N L+ VKV D F LSR +Y + IK
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVAD--FGLSRLMTGDTYTAHAGAKFPIKWT--- 386
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
APE + ++ D+W+ G +L E+ + G + + + +
Sbjct: 387 -------------------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
Query: 326 HLAMMER 332
++E+
Sbjct: 428 VYELLEK 434
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 58/316 (18%), Positives = 107/316 (33%), Gaps = 72/316 (22%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD- 149
+ ++L G FG V + E VA+KI +K E+ L + +H+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHEN 79
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
IG + + + ++ + G SL DFL+ N + + + +
Sbjct: 80 ILQFIGA--EKRGTS---VDVDLWLITAFHEKG-SLSDFLKANV---VSWNELCHIAETM 130
Query: 204 LESVAFMHE----------LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+A++HE + H D+K +N+LL + +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-----------------KNNLT---- 169
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVS-----TRHYRAPEVILG-LGWNYP----CDLWS 303
+ DFG S + TR Y APEV+ G + + D+++
Sbjct: 170 ------ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
+G +L EL S E++ E +G P ++ E + R D
Sbjct: 224 MGLVLWELASRCTAA-DGPVDEYMLPFEEEIGQHPSLEDMQ-----EVVVHKKKRPVLRD 277
Query: 364 GATSRDSMRAVWKLLR 379
M + + +
Sbjct: 278 YWQKHAGMAMLCETIE 293
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 3e-13
Identities = 55/259 (21%), Positives = 85/259 (32%), Gaps = 62/259 (23%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---------SINKYREAAMIEIDV 141
T + + K+GEG FG+V + VAIKI+ S K E + EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 142 LQRLARHDIG------------GTRCVQ-------IRNWFDYRN---------------- 166
+ L+ CVQ ++ W Y +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 167 -HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPEN 224
I + FE G L K S + + + QL S+A LR H DL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHY 284
+LL K+ Y +SS S + +ID+ + E
Sbjct: 193 VLLKKTSLKKL-HYTLNGKSSTIPSC------GLQVSIIDYTLSRLERDGIVVFCDV--S 243
Query: 285 RAPEVILGLGWNYPCDLWS 303
++ G G +Y D++
Sbjct: 244 MDEDLFTGDG-DYQFDIYR 261
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 68/304 (22%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +GEG FG+V C + E VA+K ++ S + EI++L+ L H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ G C + D N I ++ E G SL ++L KN + + +
Sbjct: 83 ENIVKYKG--ICTE-----DGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQL-KYAV 133
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+ + + ++ + +H DL N+L+ S VK+
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG------------------------- 168
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS-G 314
DFG T D Y APE ++ + D+WS G L EL +
Sbjct: 169 --DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMR 372
++ + G + ++ + G RL P MR
Sbjct: 227 DSDSSPMALFLKMIGPTH--GQMTVTRLV-------NTLKEGKRLPCPPNCPDEVYQLMR 277
Query: 373 AVWK 376
W+
Sbjct: 278 KCWE 281
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 65/300 (21%), Positives = 109/300 (36%), Gaps = 61/300 (20%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD 149
+ +S++G+G FG V C + LVA+K ++ ++ EI +L+ L D
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84
Query: 150 IGGTRCVQIRN--WFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
V+ R + R + +V E G L DFL+++ R L+ Q+ +
Sbjct: 85 ----FIVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLL-LYSSQICK 138
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++ R +H DL NIL+ S +VK+ DF
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIA---------------------------DF 171
Query: 266 GSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318
G D Y V + APE + ++ D+WS G +L EL + +
Sbjct: 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231
Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 376
E L MM ++ + G RL P + + M+ W
Sbjct: 232 SPSA--EFLRMMGCERDVPALSRLL-------ELLEEGQRLPAPPACPAEVHELMKLCWA 282
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 66/245 (26%), Positives = 103/245 (42%), Gaps = 42/245 (17%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 240
Query: 155 CVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
VQ+ Y I IV E + SL DFL+ + + + + ++ Q+ +A+
Sbjct: 241 LVQL-----YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+ + +H DL+ NIL+ KV D F L+R +D Y IK
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVAD--FGLARLIEDNEYTARQGAKFPIKWT----- 348
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
APE L + D+WS G +L EL + G + N E L
Sbjct: 349 -----------------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 328 AMMER 332
+ER
Sbjct: 392 DQVER 396
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 66/245 (26%), Positives = 103/245 (42%), Gaps = 42/245 (17%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 323
Query: 155 CVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
VQ+ Y I IV E + SL DFL+ + + + + ++ Q+ +A+
Sbjct: 324 LVQL-----YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+ + +H DL+ NIL+ KV D F L+R +D Y IK
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVAD--FGLARLIEDNEYTARQGAKFPIKWT----- 431
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
APE L + D+WS G +L EL + G + N E L
Sbjct: 432 -----------------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
Query: 328 AMMER 332
+ER
Sbjct: 475 DQVER 479
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 13/159 (8%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++ K+G G FG+V N+ + VA+K ++ + EA + E +V++ L +HD +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTL-QHD----K 244
Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ + I I+ E G SL DFL+ + P+ + + Q+ E +AF+ +
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKG-SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
IH DL+ NIL+ ++ K+ D F L+R +D Y
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIAD--FGLARVIEDNEY 339
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 51/259 (19%), Positives = 84/259 (32%), Gaps = 54/259 (20%)
Query: 96 ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+L +G G +G V + D VA+K+ N+ I + + HD
Sbjct: 17 LLELIGRGRYGAVYKGSLDERP---VAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARF 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I G R D R +V E G SL +L ++ L + +
Sbjct: 73 IVGD----ERVTADGRMEYLLVMEYYPNG-SLXKYLSLHT---SDWVSSCRLAHSVTRGL 124
Query: 208 AFMHE---------LRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS 257
A++H + H DL N+L+ + + D F LS + +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD--FGLSMRLTGNRLVRPGEED 182
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-------GWNYPCDLWSVGCILVE 310
+A V T Y APEV+ G D++++G I E
Sbjct: 183 NA---------------AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 311 LCSGEALFQTHENLEHLAM 329
+ E++ M
Sbjct: 228 IFMRCTDLFPGESVPEYQM 246
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 62/287 (21%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
+ + +GEG FG+V ++ E+VA+K +++ ++R EID+L+ L H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YH 92
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ G C + +V E LG SL D+L ++S L+ +
Sbjct: 93 EHIIKYKG--CCED-----AGAASLQLVMEYVPLG-SLRDYLPRHSIG--LAQLL-LFAQ 141
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGS--YFKNLPKSS 258
Q+ E +A++H IH DL N+LL + VK+ D F L+++ +G Y S
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD--FGLAKAVPEGHEYYRVREDGDS 199
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 317
+ + APE + + Y D+WS G L EL + ++
Sbjct: 200 PVF----------------------WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 364
L + + G + + + RG RL PD
Sbjct: 238 QSPPTKFLELIGIAQ--GQMTVLRLT-------ELLERGERLPRPDK 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 38/166 (22%), Positives = 70/166 (42%), Gaps = 21/166 (12%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ K+G G +G+V E + VA+K ++ E + E V++ + +H
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 74
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G C + I+ E G +L D+LR+ + + ++ + Q+ ++
Sbjct: 75 LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 252
++ + IH DL N L+ VKV D F LSR +Y
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVAD--FGLSRLMTGDTYTA 168
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 59/252 (23%), Positives = 97/252 (38%), Gaps = 51/252 (20%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG V + VAIK + + + RE + E +++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 451
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
IG + N + I+ E LG L FL+ + L+ Q
Sbjct: 452 HIVKLIG--VITE--------NPVWIIMELCTLG-ELRSFLQVRKFSLDLASLI-LYAYQ 499
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
L ++A++ R +H D+ N+L+ S + VK+ D F LSR +D +Y+K IK
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDSTYYKASKGKLPIK 557
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 320
+ APE I + D+W G + E+ G FQ
Sbjct: 558 WM----------------------APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
Query: 321 HENLEHLAMMER 332
+N + + +E
Sbjct: 596 VKNNDVIGRIEN 607
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 42/283 (14%), Positives = 66/283 (23%), Gaps = 81/283 (28%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
+ +PP G + RYR+L G Q + D VA+ V
Sbjct: 11 RESSAPPDDVQLVPGARI------ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFV 64
Query: 126 RSINK---------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175
RL+R I ++ + R +V E +
Sbjct: 65 DPQGVLPDDVLQETLSRT--------LRLSR--IDKPGVARVLDVVHTRAGGLVVAEWIR 114
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
G SL + P+ +R + L + H + + P + +
Sbjct: 115 GGSLQEVADT---SPSPVGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRV-------- 162
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
S DG + L
Sbjct: 163 ---------SIDG----------DVVLAYPA-----------------TMPDA------- 179
Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP 338
N D+ +G L L LA ER P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 41/166 (24%), Positives = 63/166 (37%), Gaps = 24/166 (14%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD--- 149
+ ++G G FG+V LVA+K R + + E +L++ H
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIV 175
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
IG C Q + I IV E + G FLR R L+ ++
Sbjct: 176 RLIG--VCTQ-------KQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLL-QMVGDAAA 224
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
+ ++ IH DL N L+ +K+ D F +SR DG Y
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISD--FGMSREEADGVY 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 60/256 (23%), Positives = 98/256 (38%), Gaps = 59/256 (23%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG V + VAIK + + + RE + E +++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 76
Query: 150 IGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
V++ N + I+ E LG L FL+ Y L+ QL
Sbjct: 77 ----HIVKL-----IGVITENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLI-LYAYQL 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKL 262
++A++ R +H D+ N+L+ S + VK+ D F LSR +D +Y+K IK
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDSTYYKASKGKLPIKW 183
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY-----PCDLWSVGCILVELCS-GEA 316
+ APE I N+ D+W G + E+ G
Sbjct: 184 M----------------------APESI-----NFRRFTSASDVWMFGVCMWEILMHGVK 216
Query: 317 LFQTHENLEHLAMMER 332
FQ +N + + +E
Sbjct: 217 PFQGVKNNDVIGRIEN 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 26/170 (15%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG+V E +K VA+K + +E M E +++ L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHP 73
Query: 150 IGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
V++ I+ E G L +L +N + LV Q+
Sbjct: 74 ----HIVKL-----IGIIEEEPTWIIMELYPYG-ELGHYLERNKNSLKVLTLV-LYSLQI 122
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 252
+++A++ + +H D+ NIL+ S E VK+ D F LSR +D Y+K
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGD--FGLSRYIEDEDYYK 170
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ ++G G FG+V + N + VA+K ++ + +A + E +++++L +H R
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ----R 69
Query: 155 CVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ Y + I I+ E + G SL DFL+ S I+ + ++ Q+ E +A
Sbjct: 70 LVRL-----YAVVTQEPIYIITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
F+ E IH DL+ NIL+ K+ D F L+R +D Y
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIAD--FGLARLIEDNEY 164
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ ++G G FG V + K + VAIK +R E + E +V+ +L H
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQL 68
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C++ + IC+V E + G L D+LR L+ + + E +
Sbjct: 69 YG--VCLE-------QAPICLVTEFMEHG-CLSDYLRTQRGLFAAETLL-GMCLDVCEGM 117
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
A++ E +IH DL N L+ + +KV D F ++R D Y
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSD--FGMTRFVLDDQY 159
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 56/256 (21%), Positives = 98/256 (38%), Gaps = 66/256 (25%)
Query: 99 KMGEGTFGQVVE-CFDNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + + KK++ VAIK+++ + E M E ++ +L +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNP----Y 71
Query: 155 CVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ + +V E G L+ FL ++ EL Q+ +
Sbjct: 72 IVRL-----IGVCQAEALMLVMEMAGGG-PLHKFLVGKREEIPVSNVA-ELLHQVSMGMK 124
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++ E +H DL N+LLV+ Y K+ DFG +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKIS---------------------------DFGLS 157
Query: 269 TFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVGCILVELCS-GEA 316
D SY + + APE I N+ D+WS G + E S G+
Sbjct: 158 KALGADDSYYTARSAGKWPLKWYAPECI-----NFRKFSSRSDVWSYGVTMWEALSYGQK 212
Query: 317 LFQTHENLEHLAMMER 332
++ + E +A +E+
Sbjct: 213 PYKKMKGPEVMAFIEQ 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 56/252 (22%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+L ++G G FG V + + VA+K+++ + + E + +L H
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKF 68
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C + I IV E G L ++LR + P L+ E+ + E +
Sbjct: 69 YG--VCSK-------EYPIYIVTEYISNG-CLLNYLRSHGKGLEPSQLL-EMCYDVCEGM 117
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFG 266
AF+ + IH DL N L+ VKV D F ++R D Y ++ +K
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSD--FGMTRYVLDDQYVSSVGTKFPVK----- 170
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNY-----PCDLWSVGCILVELCS-GEALFQT 320
+ APEV +Y D+W+ G ++ E+ S G+ +
Sbjct: 171 -----------------WSAPEVF-----HYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208
Query: 321 HENLEHLAMMER 332
+ N E + + +
Sbjct: 209 YTNSEVVLKVSQ 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 35/170 (20%), Positives = 76/170 (44%), Gaps = 29/170 (17%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG V + + EK ++ VAIK +R + K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C+ + + ++ + G L D++R++ L+
Sbjct: 77 PHVCRLLG--ICLT--------STVQLITQLMPFG-CLLDYVREHKDNIGSQYLL-NWCV 124
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
Q+ + + ++ + RL+H DL N+L+ + ++VK+ D F L++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD--FGLAKLLGAEEK 172
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 28/163 (17%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLAR 147
R+L K+G+G+FG V + K VA+K ++ S + + + E++ + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 79
Query: 148 HDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
H +++ Y + +V E LG SL D LRK+ L
Sbjct: 80 HR----NLIRL-----YGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLS-RYAV 128
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
Q+ E + ++ R IH DL N+LL + + VK+ D F L R
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD--FGLMR 169
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 58/261 (22%), Positives = 96/261 (36%), Gaps = 61/261 (23%)
Query: 95 RILSKMGEGTFGQVVE-------CFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLA 146
+G+GTF ++ + + + V +K++ + Y E+ ++ +L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL- 69
Query: 147 RHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVREL 199
H G CV + +V E K G SL +L+KN + + E+
Sbjct: 70 SHKHLVLNYG--VCVC-------GDENILVQEFVKFG-SLDTYLKKNKNCINILWKL-EV 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+QL ++ F+ E LIH ++ +NILL+ E K + F
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF------------------- 159
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYR------APEVIL-GLGWNYPCDLWSVGCILVELC 312
IKL D G + V+ + PE I N D WS G L E+C
Sbjct: 160 IKLSDPGIS-------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
Query: 313 S-GEALFQTHENLEHLAMMER 332
S G+ ++ L E
Sbjct: 213 SGGDKPLSALDSQRKLQFYED 233
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
L ++G G FG V + + VAIK+++ + + + E V+ L H+
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQL 84
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C + + I I+ E G L ++LR+ +R L+ E+ + + E++
Sbjct: 85 YG--VCTK-------QRPIFIITEYMANG-CLLNYLREMRHRFQTQQLL-EMCKDVCEAM 133
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
++ + +H DL N L+ VKV D F LSR D Y
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSD--FGLSRYVLDDEY 175
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 47/256 (18%), Positives = 81/256 (31%), Gaps = 30/256 (11%)
Query: 14 MDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPW 73
M R V + P+ P L + Y + +
Sbjct: 7 MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI 66
Query: 74 RPDDKDGHYVFAIGENLTPRYR----ILSKMGEGTFGQVVECF---DNEKKELVAIKIVR 126
+ V A+ + +G G FG V ++ KK A+K +
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 127 SINKYREAA--MIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGP 177
I E + + E +++ H +G +V K G
Sbjct: 127 RITDIGEVSQFLTEGIIMKDF-SHPNVLSLLG---IC-----LRSEGSPLVVLPYMKHG- 176
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L +F+R ++ DL+ G Q+ + + F+ + +H DL N +L VKV D
Sbjct: 177 DLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 238 YKF-LSRSSKDGSYFK 252
F L+R D +
Sbjct: 236 --FGLARDMYDKEFDS 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++L +G+G FG V+ K VA+K +++ + +A + E V+ +L RH
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 251
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G V+ + + IV E G SL D+LR D + + + E++
Sbjct: 252 LG--VIVE------EKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLP 255
++ +H DL N+L+ KV D F L++ + LP
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD--FGLTKEASSTQDTGKLP 349
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 65/343 (18%), Positives = 116/343 (33%), Gaps = 62/343 (18%)
Query: 7 IEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIP 66
+ + P + P + Y + M
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316
Query: 67 RTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKI 124
S P DK +F +NL ++G G FG V + + KK++ VAIK+
Sbjct: 317 SPFSDPEELKDKK---LFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKV 370
Query: 125 VR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHICIVFE--KLG 176
++ + E M E ++ +L + V++ + +V E G
Sbjct: 371 LKQGTEKADTEEMMREAQIMHQL-DNP----YIVRL-----IGVCQAEALMLVMEMAGGG 420
Query: 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236
L+ FL ++ EL Q+ + ++ E +H +L N+LLV+ Y K+
Sbjct: 421 -PLHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKIS 478
Query: 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVI 290
DFG + D SY + + APE I
Sbjct: 479 ---------------------------DFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 291 LGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
++ D+WS G + E S G+ ++ + E +A +E+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 71/268 (26%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKIVR---SINKYREAAMIEIDVL 142
+ LT + L G G FG V + + +K VA+KI++ + ++ + E +V+
Sbjct: 16 KLLTLEDKEL---GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 143 QRLARHDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
Q+L + V++ +V E +LG L +L++N R +
Sbjct: 73 QQL-DNP----YIVRM-----IGICEAESWMLVMEMAELG-PLNKYLQQN--RHVKDKNI 119
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
EL Q+ + ++ E +H DL N+LLV+ Y K+
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS-------------------- 159
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVG 305
DFG + D +Y + H + APE I NY D+WS G
Sbjct: 160 -------DFGLSKALRADENYYKAQTHGKWPVKWYAPECI-----NYYKFSSKSDVWSFG 207
Query: 306 CILVELCS-GEALFQTHENLEHLAMMER 332
++ E S G+ ++ + E AM+E+
Sbjct: 208 VLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 54/263 (20%), Positives = 93/263 (35%), Gaps = 70/263 (26%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
I +G G G+V ++ VAIK ++ + R + E ++ + H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHP 110
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G + IV E + G SL FLR + + + LV + R
Sbjct: 111 NIIRLEG--VVTR-------GRLAMIVTEYMENG-SLDTFLRTHDGQFTIMQLV-GMLRG 159
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
+ + ++ +L +H DL N+L+ S KV D F LSR +D
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD--FGLSRVLEDDPD----------- 206
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVGCILVE 310
+T + APE I + D+WS G ++ E
Sbjct: 207 ---------------AAYTTTGGKIPIRWTAPEAI-----AFRTFSSASDVWSFGVVMWE 246
Query: 311 LCS-GEALFQTHENLEHLAMMER 332
+ + GE + N + ++ +E
Sbjct: 247 VLAYGERPYWNMTNRDVISSVEE 269
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 40/178 (22%), Positives = 68/178 (38%), Gaps = 26/178 (14%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHD 149
+G G FG V ++ KK A+K + I E + + E +++ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 86
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+G +V K G L +F+R ++ DL+ G Q
Sbjct: 87 NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 136
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
+ + + ++ + +H DL N +L VKV D F L+R D Y+ K+ A
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD--FGLARDMYDKEYYSVHNKTGA 192
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 60/263 (22%), Positives = 97/263 (36%), Gaps = 70/263 (26%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
I +G G FG+V ++K+ VAIK ++ K R + E ++ + H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHP 106
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G + + IV E + G SL FLRK+ + I LV + R
Sbjct: 107 NIIRLEG--VVTK-------SKPVMIVTEYMENG-SLDSFLRKHDAQFTVIQLV-GMLRG 155
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
+ + ++ ++ +H DL NIL+ S KV D F L R +D
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSD--FGLGRVLEDDPE----------- 202
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVGCILVE 310
+TR + +PE I Y D+WS G +L E
Sbjct: 203 ---------------AAYTTRGGKIPIRWTSPEAI-----AYRKFTSASDVWSYGIVLWE 242
Query: 311 LCS-GEALFQTHENLEHLAMMER 332
+ S GE + N + + ++
Sbjct: 243 VMSYGERPYWEMSNQDVIKAVDE 265
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 41/190 (21%), Positives = 71/190 (37%), Gaps = 41/190 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
PR + +G G FG+VVE + VA+K+++ + +EA M E+ ++
Sbjct: 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
L +H+ +G C + ++ E G L +FLR+ S
Sbjct: 104 SHLGQHENIVNLLGA--CTH-------GGPVLVITEYCCYG-DLLNFLRRKSRVLETDPA 153
Query: 196 VRELGRQLLES------------VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LS 242
+AF+ IH D+ N+LL + K+ D F L+
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD--FGLA 211
Query: 243 RSSKDGSYFK 252
R + S +
Sbjct: 212 RDIMNDSNYI 221
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 35/170 (20%), Positives = 76/170 (44%), Gaps = 29/170 (17%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG V + + EK ++ VAIK +R + K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C+ + + ++ + G L D++R++ L+
Sbjct: 77 PHVCRLLG--ICLT--------STVQLITQLMPFG-CLLDYVREHKDNIGSQYLL-NWCV 124
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
Q+ + + ++ + RL+H DL N+L+ + ++VK+ D F L++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD--FGLAKLLGAEEK 172
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++L +G+G FG V+ K VA+K +++ + +A + E V+ +L RH
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 79
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G + + + + IV E G SL D+LR D + + + E++
Sbjct: 80 LG---VI-----VEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLP 255
++ +H DL N+L+ KV D F L++ + LP
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD--FGLTKEASSTQDTGKLP 177
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 39/170 (22%), Positives = 71/170 (41%), Gaps = 29/170 (17%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
R L +G G FG V + + E ++ V IK++ S + +A + + L H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DH 74
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + +V + LG SL D +R++ P L+ G
Sbjct: 75 AHIVRLLG--LCPG--------SSLQLVTQYLPLG-SLLDHVRQHRGALGPQLLL-NWGV 122
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
Q+ + + ++ E ++H +L N+LL S V+V D F ++
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVAD--FGVADLLPPDDK 170
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 47/194 (24%), Positives = 71/194 (36%), Gaps = 45/194 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
PR R+ +G G FG+VVE ++ VA+K+++ + REA M E+ VL
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
L H +G C ++ E G L +FLR+
Sbjct: 81 SYLGNHMNIVNLLG--ACTI-------GGPTLVITEYCCYG-DLLNFLRRKRDSFICSKT 130
Query: 196 VRELGRQLLESV----------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
+ ++ AF+ IH DL NILL K+ D
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD-- 188
Query: 240 F-LSRSSKDGSYFK 252
F L+R K+ S +
Sbjct: 189 FGLARDIKNDSNYV 202
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 40/170 (23%), Positives = 67/170 (39%), Gaps = 28/170 (16%)
Query: 95 RILSKMGEGTFGQVVE----CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+G G FG+V + +K+ VAIK ++ K R + E ++ + H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SH 105
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
G + + I+ E + G +L FLR+ + LV + R
Sbjct: 106 HNIIRLEG--VISK-------YKPMMIITEYMENG-ALDKFLREKDGEFSVLQLV-GMLR 154
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
+ + ++ + +H DL NIL+ S KV D F LSR +D
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD--FGLSRVLEDDPE 202
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 45/182 (24%), Positives = 69/182 (37%), Gaps = 40/182 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
I +GEG FGQV++ + + AIK ++ + E++VL +L
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 146 ARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRE 198
H +G C R ++ + E G +L DFLRK+
Sbjct: 83 GHHPNIINLLG--ACEH-------RGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIA 132
Query: 199 LG-------RQLLE---SVA----FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
+QLL VA ++ + + IH DL NIL+ K+ D F LSR
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD--FGLSR 190
Query: 244 SS 245
Sbjct: 191 GQ 192
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 42/192 (21%), Positives = 68/192 (35%), Gaps = 42/192 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR R+ +G G FGQV+E VA+K+++ + E M E+ +L
Sbjct: 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+ H +G + ++ E K G +L +LR P +
Sbjct: 85 IHIGHHLNVVNLLG---AC-----TKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKV 135
Query: 196 VRELGRQLLESV--------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF- 240
E + ++ F+ + IH DL NILL VK+ D F
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD--FG 193
Query: 241 LSRSSKDGSYFK 252
L+R +
Sbjct: 194 LARDIYKDPDYV 205
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 4e-07
Identities = 67/510 (13%), Positives = 135/510 (26%), Gaps = 160/510 (31%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPP------PKVLP---ALYCVQE------FGNGG--- 51
P +R RL ++ L AL ++ G G
Sbjct: 105 PSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK 163
Query: 52 --MPNYACSS-----MFYGAIPRTGSPPW-------RPDDKDGHYVFAIGENL----TPR 93
+ C S I W P+ V + + L P
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIF------WLNLKNCNSPET-----VLEMLQKLLYQIDPN 212
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ S + E + L+ K Y ++ ++V
Sbjct: 213 WTSRSDHSSNIK-LRIHSIQAELRRLLKSK------PYENCLLVLLNV------------ 253
Query: 154 RCVQIRNWFDYRNHIC-IVFEKLGPSLYDFLRKNSYRSFPID-----LVRELGRQLLESV 207
+ + N F+ C I+ + DFL + +D L + + LL
Sbjct: 254 QNAKAWNAFNLS---CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 208 AFMHELRLIHTDLKPE----NILLVS--AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
L DL E N +S AE ++ L+ +K++
Sbjct: 311 -----LDCRPQDLPREVLTTNPRRLSIIAESIR----DGLATWD----NWKHVNCDKLTT 357
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRA----------PEVILGLGWNYPCDLWSVGCILVEL 311
+I+ ++ + + + + P ++L L W V ++ +L
Sbjct: 358 IIE---SSLNVLEPAEY--RKMFDRLSVFPPSAHIPTILLSLIWFDV-IKSDVMVVVNKL 411
Query: 312 CSGEAL---------------FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRG 356
+ + LE+ + H ++ + +
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYAL--------HRSIVDHYNIPKTFDSDD 463
Query: 357 ARLDWPDG-----------ATSRDSMRAVWKLLRLPNL--IMQHVDHS------AGDLID 397
+ D +++++ L + + Q + H +G +++
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL-DFRFLEQKIRHDSTAWNASGSILN 522
Query: 398 LLQGLLRYDPAERLKAREALRHPFFTRDVR 427
LQ L Y K P + R V
Sbjct: 523 TLQQLKFY------KPYICDNDPKYERLVN 546
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 37/181 (20%), Positives = 65/181 (35%), Gaps = 27/181 (14%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF---DNEKKELVAIKIVR---SINKYREAAMIEIDVLQ 143
P + +G+G FG V E ++ VA+K+++ + E + E ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL- 195
H +G ++ K G L+ FL + P +L
Sbjct: 81 EF-DHPHVAKLVG---VSLRSRAKGRLPIPMVILPFMKHG-DLHAFLLASRIGENPFNLP 135
Query: 196 VREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYF 251
++ L + + ++ IH DL N +L V V D F LSR G Y+
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD--FGLSRKIYSGDYY 193
Query: 252 K 252
+
Sbjct: 194 R 194
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 37/185 (20%), Positives = 68/185 (36%), Gaps = 36/185 (19%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
R +I ++G+G+FG V E +E + VAIK V RE + E V+
Sbjct: 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 143 QRLARHDIGGTR----CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
+ H + R Q ++ E G L +LR ++
Sbjct: 83 KEFNCHHV--VRLLGVVSQ-------GQPTLVIMELMTRG-DLKSYLRSLRPAMANNPVL 132
Query: 197 RELGRQLLESVA--------FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKD 247
+ +A +++ + +H DL N ++ VK+ D F ++R +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD--FGMTRDIYE 190
Query: 248 GSYFK 252
Y++
Sbjct: 191 TDYYR 195
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 26/178 (14%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHD 149
+G+G FG V + + AIK + I + ++ + E +++ L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHP 82
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
IG + ++ G L F+R DL+ G Q
Sbjct: 83 NVLALIG---IM-----LPPEGLPHVLLPYMCHG-DLLQFIRSPQRNPTVKDLI-SFGLQ 132
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
+ + ++ E + +H DL N +L + VKV D F L+R D Y+ A
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVAD--FGLARDILDREYYSVQQHRHA 188
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 38/194 (19%), Positives = 75/194 (38%), Gaps = 45/194 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR R+ +GEG FGQVV + VA+K+++S ++ + + E++
Sbjct: 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 126
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPI 193
+++ + +H +G C Q + ++ E G +L ++L+
Sbjct: 127 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLQARRPPGLEY 176
Query: 194 DLVRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
+ L+ ++ + IH DL N+L+ +K+ D
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD-- 234
Query: 240 F-LSRSSKDGSYFK 252
F L+R Y+K
Sbjct: 235 FGLARDIHHIDYYK 248
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 41/200 (20%), Positives = 71/200 (35%), Gaps = 52/200 (26%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR + +G G FG+V+ VA+K+++ E M E+ ++
Sbjct: 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+L H+ +G C I ++FE G L ++LR + ++
Sbjct: 103 TQLGSHENIVNLLGA--CTL-------SGPIYLIFEYCCYG-DLLNYLRSKREKFSEDEI 152
Query: 196 VRELGRQLLESV---------------------AFMHELRLIHTDLKPENILLVSAEYV- 233
E ++L E F+ +H DL N+ LV+ V
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKVV 211
Query: 234 KVPDYKF-LSRSSKDGSYFK 252
K+ D F L+R S +
Sbjct: 212 KICD--FGLARDIMSDSNYV 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 37/181 (20%), Positives = 68/181 (37%), Gaps = 28/181 (15%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF---DNEKKELVAIKIVRSIN---KYREAAMIEIDVLQ 143
R + +GEG FG V+E ++ VA+K ++ N + E + E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL- 195
H +G V I ++ K G L+ +L + + P +
Sbjct: 92 DF-SHPNVIRLLG----VCIEMSSQGIPKPMVILPFMKYG-DLHTYLLYSRLETGPKHIP 145
Query: 196 VREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYF 251
++ L + + ++ +H DL N +L V V D F LS+ G Y+
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD--FGLSKKIYSGDYY 203
Query: 252 K 252
+
Sbjct: 204 R 204
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 42/190 (22%), Positives = 70/190 (36%), Gaps = 42/190 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQ 143
R I ++GEG FG+V + K LVA+K ++ + R+ E ++L
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 98
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
L +H G C + + +VFE + G L FLR + + +
Sbjct: 99 ML-QHQHIVRFFG--VCTE-------GRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGG 147
Query: 197 RELGRQLLESVAFMH-------------ELRLIHTDLKPENILLVSAEYVKVPDYKF-LS 242
++ L + L +H DL N L+ VK+ D F +S
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGD--FGMS 205
Query: 243 RSSKDGSYFK 252
R Y++
Sbjct: 206 RDIYSTDYYR 215
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 40/194 (20%), Positives = 81/194 (41%), Gaps = 45/194 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR ++ +GEG FGQVV ++ VA+K+++ ++ + + E++
Sbjct: 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNS--YRSF 191
+++ + +H +G C Q + ++ E G +L ++LR +
Sbjct: 139 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRARRPPGMEY 188
Query: 192 PIDLVRELGRQLLES--------VA----FMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
D+ R Q+ +A ++ + IH DL N+L+ +K+ D
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD-- 246
Query: 240 F-LSRSSKDGSYFK 252
F L+R + Y+K
Sbjct: 247 FGLARDINNIDYYK 260
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 37/194 (19%), Positives = 76/194 (39%), Gaps = 45/194 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR ++ +GEG FGQVV ++ VA+K+++ ++ + + E++
Sbjct: 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPI 193
+++ + +H +G C Q + ++ E G +L ++LR
Sbjct: 93 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRARRPPGMEY 142
Query: 194 DLVRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
+ L+ ++ + IH DL N+L+ +K+ D
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD-- 200
Query: 240 F-LSRSSKDGSYFK 252
F L+R + Y+K
Sbjct: 201 FGLARDINNIDYYK 214
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 37/192 (19%), Positives = 67/192 (34%), Gaps = 44/192 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
+ + ++GE FG+V + E+ + VAIK ++ + RE E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
RL +H +G + + ++F G L++FL S S
Sbjct: 67 ARL-QHPNVVCLLG--VVTK-------DQPLSMIFSYCSHG-DLHEFLVMRSPHSDVGST 115
Query: 196 VRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF- 240
+ + V ++ ++H DL N+L+ VK+ D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISD--LG 173
Query: 241 LSRSSKDGSYFK 252
L R Y+K
Sbjct: 174 LFREVYAADYYK 185
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 42/191 (21%), Positives = 70/191 (36%), Gaps = 43/191 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA-MIEIDVLQ 143
R I ++GEG FG+V + K LVA+K ++ E ++L
Sbjct: 13 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT 72
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
L +H+ G C + + +VFE K G L FLR + + +
Sbjct: 73 NL-QHEHIVKFYG--VCGD-------GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDG 121
Query: 197 RELGR-------QLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-L 241
+ Q+L ++ +H DL N L+ + VK+ D F +
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGD--FGM 179
Query: 242 SRSSKDGSYFK 252
SR Y++
Sbjct: 180 SRDVYSTDYYR 190
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 47/227 (20%), Positives = 77/227 (33%), Gaps = 61/227 (26%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRI--LSKMGEGTFGQVVEC-----FDNEKKE 118
P P + K + PR I + +GEG FG+V + E
Sbjct: 26 PMYQRMPLLLNPKLLSLEY-------PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 78
Query: 119 LVAIKIVRSI--NKYREAAMIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIV 171
+VA+K+++ + E ++ + +G C +C++
Sbjct: 79 MVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLG--VCAV-------GKPMCLL 128
Query: 172 FE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV---------------------- 207
FE G L +FLR S + +L + S
Sbjct: 129 FEYMAYG-DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187
Query: 208 AFMHELRLIHTDLKPENILLVSAEY-VKVPDYKF-LSRSSKDGSYFK 252
A++ E + +H DL N LV VK+ D F LSR+ Y+K
Sbjct: 188 AYLSERKFVHRDLATRNC-LVGENMVVKIAD--FGLSRNIYSADYYK 231
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 21/130 (16%), Positives = 45/130 (34%), Gaps = 9/130 (6%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
++ F ++ E +++ ++ + K E L+R G Q
Sbjct: 83 RIETSEFDKMDEYLYGDER--FDMRRISPKEKVFIWTEKEFRNLERAKEA---GVSVPQP 137
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIH 217
+ Y ++ ++ L R V + ++E+V ++ E L+H
Sbjct: 138 ---YTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVH 194
Query: 218 TDLKPENILL 227
DL NI+
Sbjct: 195 ADLSEYNIMY 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 42/200 (21%), Positives = 70/200 (35%), Gaps = 52/200 (26%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR + +GEG FG+VV+ VA+K+++ E + E +VL
Sbjct: 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVL 80
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+++ H G C Q + ++ E K G SL FLR++
Sbjct: 81 KQV-NHPHVIKLYGA--CSQ-------DGPLLLIVEYAKYG-SLRGFLRESRKVGPGYLG 129
Query: 196 VRELGRQLLESV----------------------AFMHELRLIHTDLKPENILLVSAEYV 233
++ E++L+H DL NIL+ +
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189
Query: 234 KVPDYKF-LSRSSKDGSYFK 252
K+ D F LSR + +
Sbjct: 190 KISD--FGLSRDVYEEDSYV 207
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 41/187 (21%), Positives = 71/187 (37%), Gaps = 40/187 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR I + +G G FG+V E ++ VA+K + + ++ ++E ++
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 87
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSF---- 191
+ H IG +Q I+ E G L FLR+ R
Sbjct: 88 SKF-NHQNIVRCIG--VSLQ-------SLPRFILMELMAGG-DLKSFLRETRPRPSQPSS 136
Query: 192 --PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPDYKF-LSRSS 245
+DL+ + R + ++ E IH D+ N LL K+ D F ++R
Sbjct: 137 LAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD--FGMARDI 193
Query: 246 KDGSYFK 252
SY++
Sbjct: 194 YRASYYR 200
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 40/187 (21%), Positives = 70/187 (37%), Gaps = 40/187 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR I + +G G FG+V E ++ VA+K + + ++ ++E ++
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 128
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSF---- 191
+ H IG +Q I+ E G L FLR+ R
Sbjct: 129 SKF-NHQNIVRCIG--VSLQ-------SLPRFILLELMAGG-DLKSFLRETRPRPSQPSS 177
Query: 192 --PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPDYKF-LSRSS 245
+DL+ + R + ++ E IH D+ N LL K+ D F ++R
Sbjct: 178 LAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD--FGMARDI 234
Query: 246 KDGSYFK 252
Y++
Sbjct: 235 YRAGYYR 241
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 64/344 (18%), Positives = 106/344 (30%), Gaps = 88/344 (25%)
Query: 92 PRYRI-LSKM-GEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVL 142
PR R+ L K G G FGQV+E VA+K+++ + A M E+ +L
Sbjct: 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 79
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLV 196
+ H +G C + ++ E +L +LR P
Sbjct: 80 IHIGHHLNVVNLLG--AC------TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN--- 253
RQ + V + D + S+ +V+ + +K+
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 254 ----------------------------------LPKSSAIKLIDFGSTTFEHQDHSYVV 279
L + + +K+ DFG ++D YV
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251
Query: 280 STRHYR-----APEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 334
APE I + D+WS G +L E+ S L
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------------------L 291
Query: 335 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 376
G P+ ++ D + + G R+ PD T +M W
Sbjct: 292 GASPYPG-VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 433 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.17 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.43 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.05 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.67 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.02 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.31 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-65 Score=480.79 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=217.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|+++++||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.++++++|+|| |++++++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI-----VQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCC-----CcEEEEEEECCEE
Confidence 5899999999999999999999999999999999753 3445678899999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
||||||| ||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+|||++.+|
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g---------------- 162 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG---------------- 162 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC----------------
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC----------------
Confidence 9999999 99999999876656789999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..
T Consensus 163 -----------~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 231 (350)
T 4b9d_A 163 -----------TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231 (350)
T ss_dssp -----------CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -----------CEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 5778888887765432 23468999999999999999999999999999999999999999998887
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+.+..+.+.. +|. ....++.++++||.+||+
T Consensus 232 ~~~~~i~~~~--~~~-----------------------------------------------~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 232 NLVLKIISGS--FPP-----------------------------------------------VSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp HHHHHHHHTC--CCC-----------------------------------------------CCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHcCC--CCC-----------------------------------------------CCccCCHHHHHHHHHHcc
Confidence 7776665421 110 123457799999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 405 YDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
.||++|||++|+|+||||++...+.
T Consensus 263 ~dP~~R~s~~e~l~hp~~~~~~~~~ 287 (350)
T 4b9d_A 263 RNPRDRPSVNSILEKGFIAKRIEKF 287 (350)
T ss_dssp SSGGGSCCHHHHHTSHHHHTTGGGT
T ss_pred CChhHCcCHHHHhcCHHhhcCCCcC
Confidence 9999999999999999999865543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-65 Score=472.76 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=217.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||+||+|+++.+++.||||++.+. ....+.+.+|+++|++++|+|| |+++++|++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-----VKLYFTFQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEeCCE
Confidence 4699999999999999999999999999999999753 2345678899999999988887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+||||||| ||+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g--------------- 169 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--------------- 169 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---------------
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC---------------
Confidence 99999999 999999998765 799999999999999999999999999999999999997665
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||+|+.... ...+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.
T Consensus 170 ------------~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 170 ------------HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp ------------CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 467777777765422 123468999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+.+..|.+....+| ..+++++++||.+
T Consensus 238 ~~~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~dli~~ 267 (311)
T 4aw0_A 238 NEGLIFAKIIKLEYDFP--------------------------------------------------EKFFPKARDLVEK 267 (311)
T ss_dssp SHHHHHHHHHHTCCCCC--------------------------------------------------TTCCHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCC--------------------------------------------------cccCHHHHHHHHH
Confidence 88777777655332222 2457789999999
Q ss_pred hcccCCCCCCCHHH------HhcCCCCCC
Q 013941 402 LLRYDPAERLKARE------ALRHPFFTR 424 (433)
Q Consensus 402 ~L~~dP~~R~ta~e------ll~hp~f~~ 424 (433)
||+.||++|+|++| |++||||++
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999988 589999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-64 Score=476.29 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=218.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+.|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+.++|+|| |+++++|++++.+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----V~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTB-----CCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEEEE
Confidence 56999999999999999999999999999999997433 334567899999999998887 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||| ||+|.+++.+. .+++..++.|+.||+.||+|||++|||||||||+||||+.+|
T Consensus 149 vmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g------------------ 207 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG------------------ 207 (346)
T ss_dssp EECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------------------
T ss_pred EEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC------------------
Confidence 99999 99999999864 599999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||+|...... ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus 208 ---------~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 278 (346)
T 4fih_A 208 ---------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 278 (346)
T ss_dssp ---------CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ---------CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 5677777777654322 3456999999999999999999999999999999999999999998887777
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
+..+.....+.. .....+++++++||.+||+.|
T Consensus 279 ~~~i~~~~~~~~-----------------------------------------------~~~~~~s~~~~dli~~~L~~d 311 (346)
T 4fih_A 279 MKMIRDNLPPRL-----------------------------------------------KNLHKVSPSLKGFLDRLLVRD 311 (346)
T ss_dssp HHHHHHSSCCCC-----------------------------------------------SCGGGSCHHHHHHHHHHSCSS
T ss_pred HHHHHcCCCCCC-----------------------------------------------CccccCCHHHHHHHHHHcCCC
Confidence 666654221110 112345789999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCcc
Q 013941 407 PAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~~~ 427 (433)
|++|||++|+|+||||++...
T Consensus 312 P~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 312 PAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp TTTSCCHHHHTTCGGGGGCCC
T ss_pred hhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999997543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-64 Score=462.65 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=206.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||+||+|++..+|+.||||++++.. .....+.+|+.++++++|+|| |++++++++.+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI-----IKLYDVIKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEECCE
Confidence 57999999999999999999999999999999997532 334678899999999998887 999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
+|||||||+|+|.+++.+++ .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~---------------- 149 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL---------------- 149 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC----------------
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC----------------
Confidence 99999999999999998765 799999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||+|+..... ..+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+..
T Consensus 150 -----------~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~ 218 (275)
T 3hyh_A 150 -----------NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218 (275)
T ss_dssp -----------CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -----------CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 5777888877654332 244689999999999998876 58999999999999999999999988776
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+......+| ..+++++++||.+||+
T Consensus 219 ~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 219 VLFKNISNGVYTLP--------------------------------------------------KFLSPGAAGLIKRMLI 248 (275)
T ss_dssp HHHHHHHHTCCCCC--------------------------------------------------TTSCHHHHHHHHHHSC
T ss_pred HHHHHHHcCCCCCC--------------------------------------------------CCCCHHHHHHHHHHcc
Confidence 66665554322222 2357789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCc
Q 013941 405 YDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~~ 426 (433)
.||++|||++|+++||||+.+.
T Consensus 249 ~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 249 VNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp SSGGGSCCHHHHHHCHHHHTTC
T ss_pred CChhHCcCHHHHHcCcccccCC
Confidence 9999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-63 Score=480.67 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=219.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.+.|+++++||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|+|| |+++++|.+++.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----V~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTB-----CCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCC-----CceEEEEEECCEEE
Confidence 457999999999999999999999999999999997433 344568899999999998887 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|||||| ||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|
T Consensus 225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g----------------- 284 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG----------------- 284 (423)
T ss_dssp EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-----------------
T ss_pred EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-----------------
Confidence 999999 99999999765 599999999999999999999999999999999999997665
Q ss_pred CcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||+|..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 285 ----------~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 285 ----------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp ----------CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ----------CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 467777777765432 2345699999999999999999999999999999999999999999888877
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..|.....+. ......+++++++||.+||+.
T Consensus 355 ~~~~i~~~~~~~-----------------------------------------------~~~~~~~s~~~~dli~~~L~~ 387 (423)
T 4fie_A 355 AMKMIRDNLPPR-----------------------------------------------LKNLHKVSPSLKGFLDRLLVR 387 (423)
T ss_dssp HHHHHHHSCCCC-----------------------------------------------CSCTTSSCHHHHHHHHHHSCS
T ss_pred HHHHHHcCCCCC-----------------------------------------------CcccccCCHHHHHHHHHHcCC
Confidence 776664422110 011235678999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q 013941 406 DPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~ 426 (433)
||++|+|++|+|+||||++..
T Consensus 388 dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 388 DPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp STTTSCCHHHHTTCGGGGGCC
T ss_pred ChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-62 Score=451.08 Aligned_cols=256 Identities=23% Similarity=0.415 Sum_probs=208.5
Q ss_pred ccCCCe-EEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 89 NLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 89 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
...++| ++.++||+|+||+||+|++..+++.||+|++... ....+.+.+|+.++++++|||| |+++++|++
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~ 96 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWES 96 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEE
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEee
Confidence 334555 7888999999999999999999999999998643 2345678899999999999888 999999865
Q ss_pred ----CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccC
Q 013941 165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d 237 (433)
.+.+||||||| ||+|.+++.+.. .+++..++.++.||+.||+|||++| ||||||||+|||++.
T Consensus 97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-------- 166 (290)
T 3fpq_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-------- 166 (290)
T ss_dssp EETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--------
T ss_pred ccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--------
Confidence 46799999999 999999998765 7999999999999999999999998 999999999999963
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.++.+||+|||+|+..... ..+.+||+.|||||++.+ .|+.++|||||||++|||+||+.
T Consensus 167 ------------------~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~ 227 (290)
T 3fpq_A 167 ------------------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp ------------------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------CCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence 2235788888888654433 345689999999999876 69999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+......+...... +..|. ......+++++
T Consensus 228 Pf~~~~~~~~~~~~i~~-~~~~~----------------------------------------------~~~~~~~~~~~ 260 (290)
T 3fpq_A 228 PYSECQNAAQIYRRVTS-GVKPA----------------------------------------------SFDKVAIPEVK 260 (290)
T ss_dssp TTTTCSSHHHHHHHHTT-TCCCG----------------------------------------------GGGGCCCHHHH
T ss_pred CCCCCCcHHHHHHHHHc-CCCCC----------------------------------------------CCCccCCHHHH
Confidence 99876554433222110 11110 11233467899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||.+||+.||++|||++|+|+||||+++
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-63 Score=460.59 Aligned_cols=249 Identities=29% Similarity=0.475 Sum_probs=208.0
Q ss_pred CCeEEeccccccccEEEEEEEec---CCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
++|++++.||+|+||+||+|++. .+++.||||++++.. .....+.+|+.++++++|+|| |+++++++++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI-----VKLHYAFQTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTE-----ECEEEEEEET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEEC
Confidence 46999999999999999999874 467899999997532 233457789999999888777 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.+||||||| ||+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g------------- 163 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------------- 163 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-------------
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-------------
Confidence 9999999999 999999998765 799999999999999999999999999999999999997766
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||+|+... ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 164 --------------~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 164 --------------HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp --------------CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------------CEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 46666666665432 2234468999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+.+..+.+....+| ..+++++++||.+
T Consensus 230 ~~~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~ 259 (304)
T 3ubd_A 230 DRKETMTMILKAKLGMP--------------------------------------------------QFLSPEAQSLLRM 259 (304)
T ss_dssp SHHHHHHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCC--------------------------------------------------CcCCHHHHHHHHH
Confidence 88877776655332222 2357799999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCCCCC
Q 013941 402 LLRYDPAERLK-----AREALRHPFFTR 424 (433)
Q Consensus 402 ~L~~dP~~R~t-----a~ell~hp~f~~ 424 (433)
||+.||++||| ++|+++||||++
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999999998 589999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-61 Score=466.74 Aligned_cols=284 Identities=27% Similarity=0.480 Sum_probs=226.2
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec--
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-- 163 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~-- 163 (433)
.+.++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++|+|| |++++++.
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~~ 125 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI-----IAIKDILRPT 125 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCc-----ceEeeeeecc
Confidence 45578999999999999999999999999999999997532 334567889999999998887 99998765
Q ss_pred ----cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 164 ----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 164 ----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
+.+.+|||||||+|+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|.
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~------- 196 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE------- 196 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC-------
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC-------
Confidence 347899999999889999998764 7999999999999999999999999999999999999977664
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCcccc-------CCCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHH
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-------QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el 311 (433)
+||+|||+|+... ....+.+||+.|||||++.+. .++.++||||+|||+|||
T Consensus 197 --------------------~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~el 256 (398)
T 4b99_A 197 --------------------LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 256 (398)
T ss_dssp --------------------EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred --------------------EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHH
Confidence 5666666665322 122346999999999999886 469999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhh-hhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
++|++||.+.+..+++..|....+.++.......... ...+... ++. ..+.........
T Consensus 257 l~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~-----~~~---------------~~~~~~~~~~~~ 316 (398)
T 4b99_A 257 LARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS-----LPP---------------RQPVPWETVYPG 316 (398)
T ss_dssp HHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHS-----SCC---------------CCCCCHHHHSTT
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc-----CCC---------------cCCCCHHHhCCC
Confidence 9999999999999999999999998876543221110 0000000 000 000011122345
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
.++++++||.+||++||++|+||+|+|+||||++..
T Consensus 317 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 317 ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 678999999999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=456.11 Aligned_cols=253 Identities=25% Similarity=0.317 Sum_probs=211.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+++.++|+|| |++++++.+++.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnI-----V~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRI-----VPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCC-----CcEEEEEEECCEEEEE
Confidence 469999999999999999999999999999999975432 2469999999988877 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||| ||+|.+++.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|
T Consensus 129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g------------------- 187 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG------------------- 187 (336)
T ss_dssp ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS-------------------
T ss_pred EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC-------------------
Confidence 9999 999999998765 799999999999999999999999999999999999997654
Q ss_pred ccCCCCCCCeeeecCCCCccccCC--------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD--------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
..+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus 188 -------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 188 -------SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp -------CCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred -------CEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 14677777777654321 123589999999999999999999999999999999999999998766
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.......+.... .| ....++.+++++.+||.+|
T Consensus 261 ~~~~~~~i~~~~--~~---------------------------------------------~~~~~~~~s~~~~~li~~~ 293 (336)
T 4g3f_A 261 RGPLCLKIASEP--PP---------------------------------------------IREIPPSCAPLTAQAIQEG 293 (336)
T ss_dssp CSCCHHHHHHSC--CG---------------------------------------------GGGSCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHcCC--CC---------------------------------------------chhcCccCCHHHHHHHHHH
Confidence 554444443311 00 0122345688999999999
Q ss_pred cccCCCCCCCHHHH-------------hcCCCCCCCccc
Q 013941 403 LRYDPAERLKAREA-------------LRHPFFTRDVRR 428 (433)
Q Consensus 403 L~~dP~~R~ta~el-------------l~hp~f~~~~~~ 428 (433)
|+.||++|||+.|+ |+|||+.+..++
T Consensus 294 L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 294 LRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred ccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 99999999999997 689999876443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-59 Score=444.90 Aligned_cols=308 Identities=24% Similarity=0.378 Sum_probs=220.6
Q ss_pred ccCCCeEEeccccccccEEEEEEEec---CCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceeEecceecc
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~ 164 (433)
.+.++|++.++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+. |+|| ++++++|++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nI-----v~l~~~~~~ 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNV-----MGVKYCFRK 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTB-----CCCSEEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCC-----ceEEEEEEE
Confidence 45678999999999999999999875 467899999986543 3456788999999884 6666 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeC-CcccccCccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLS 242 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~-~~~~l~d~~~~~ 242 (433)
.+++||||||| +++|.+++. .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999 899999983 58999999999999999999999999999999999999876 778888888776
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCcc---------------ccCCCcccccCCcccchhhhhCC-CCCccchHHHHHH
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTF---------------EHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGC 306 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~---------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~ 306 (433)
...... ..+.+|+.+.. ........+||+.|||||++.+. .|+.++||||+||
T Consensus 167 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 167 GTHDTK-----------IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp ECTTCS-----------CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred ccCCcc-----------ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 543221 22233322111 01112345899999999999876 4899999999999
Q ss_pred HHHHHHhCCCCC-CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHH----------HH
Q 013941 307 ILVELCSGEALF-QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA----------VW 375 (433)
Q Consensus 307 il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 375 (433)
++|||++|+.|| .+.++.+++..|...+|..+........ ... ... ....+... .+..... ..
T Consensus 236 il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~--~~~-~~~--~~~~p~~~-~~~~~~~~~~~~~~~p~~~ 309 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTF--GKS-ILC--SKEVPAQD-LRKLCERLRGMDSSTPKLT 309 (361)
T ss_dssp HHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT--TEE-EEE--SSCCCCCC-HHHHHHHHC----------
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhc--ccc-ccc--cccCcchh-hhHHHHhhccccccccccc
Confidence 999999999998 4566778888898888754322211110 000 000 00011000 0000000 00
Q ss_pred HhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
............+..++++++|||.+||++||++|+||+|+|+||||++
T Consensus 310 ~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 310 SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000011112334567889999999999999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-58 Score=426.61 Aligned_cols=264 Identities=26% Similarity=0.341 Sum_probs=191.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC----
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---- 166 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~---- 166 (433)
+|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|++++|+|| |+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VRYFNAWLEKNTTEK 80 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEEC----
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEecCcccc
Confidence 599999999999999999999999999999998643 3345678899999999998887 99999886533
Q ss_pred --------eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 167 --------HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 167 --------~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
++||||||| +|+|.+++..... ...++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 479999999 9999999986542 234567789999999999999999999999999999999877765555
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
|||+++....+...... ... .......+..+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 161 DFGla~~~~~~~~~~~~--------~~~----~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--- 225 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTV--------LTP----MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--- 225 (299)
T ss_dssp CCCCC--------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---
T ss_pred cCccceecCCCcccccc--------ccc----cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---
Confidence 55554333221110000 000 000011233589999999999999999999999999999999996
Q ss_pred CCCCCChHHHHHHHHHHh-cCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 317 LFQTHENLEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
||.+. .+....+.... ..+|+.+ ...++.+
T Consensus 226 Pf~~~--~~~~~~~~~~~~~~~p~~~-----------------------------------------------~~~~~~~ 256 (299)
T 4g31_A 226 PFSTQ--MERVRTLTDVRNLKFPPLF-----------------------------------------------TQKYPCE 256 (299)
T ss_dssp CCSSH--HHHHHHHHHHHTTCCCHHH-----------------------------------------------HHHCHHH
T ss_pred CCCCc--cHHHHHHHHHhcCCCCCCC-----------------------------------------------cccCHHH
Confidence 77542 22222222221 1222111 1124467
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.+||.+||+.||++|||+.|+|+||||++-
T Consensus 257 ~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 257 YVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 899999999999999999999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-57 Score=458.61 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=225.1
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.+.++|++++.||+|+||+||+|+++.+|+.||+|++.... ...+.+.+|+.+|+.++|+|| |+++++|++.+.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~l~~~~~~~~~ 228 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL-----VNLHDAFEDDNE 228 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTB-----CCEEEEEECSSE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCE
Confidence 34568999999999999999999999999999999987543 345678899999999998887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+||||||| ||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~---------------- 291 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK---------------- 291 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS----------------
T ss_pred EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC----------------
Confidence 99999999 999999996543 369999999999999999999999999999999999999643
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
..+.+||+|||+|....... ...+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..
T Consensus 292 ---------~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~ 362 (573)
T 3uto_A 292 ---------RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362 (573)
T ss_dssp ---------SCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ---------CCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 23468999999988765433 3468999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+.+..+......++. .....++.++++||.+||+
T Consensus 363 ~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~dli~~~L~ 396 (573)
T 3uto_A 363 ETLRNVKSCDWNMDD----------------------------------------------SAFSGISEDGKDFIRKLLL 396 (573)
T ss_dssp HHHHHHHTTCCCCCS----------------------------------------------GGGTTSCHHHHHHHHTTSC
T ss_pred HHHHHHHhCCCCCCc----------------------------------------------ccccCCCHHHHHHHHHHcc
Confidence 877777654333322 1123457899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
.||++|||++|+|+||||+..
T Consensus 397 ~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 397 ADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp SSGGGSCCHHHHHHSTTTSCC
T ss_pred CChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999964
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=424.50 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=207.5
Q ss_pred CCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
++|.+.++||+|+||+||+|++. .+++.||||+++.. ....+.+.+|++++++++|+|| |++++++.++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-----V~l~g~~~~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI-----VKFYGVCVEG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEeeC
Confidence 57999999999999999999864 36789999999754 3445778899999999998888 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNS-----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
+.+||||||| +|+|.+++...+ ...+++..+..|+.||+.||+|||+++||||||||+|||++.++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-- 165 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-- 165 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC--
Confidence 9999999999 999999997642 24699999999999999999999999999999999999997655
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHH
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (433)
.+||+|||+|+..... .....||+.|||||++.+..|+.++|||||||++
T Consensus 166 -------------------------~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 166 -------------------------LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220 (299)
T ss_dssp -------------------------CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred -------------------------cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 5677777777643322 1224789999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 309 VELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 309 ~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
|||+| |+.||.+.+..+.+..+.+... + ..
T Consensus 221 ~Ellt~G~~Pf~~~~~~~~~~~i~~~~~--~-----------------------------------------------~~ 251 (299)
T 4asz_A 221 WEIFTYGKQPWYQLSNNEVIECITQGRV--L-----------------------------------------------QR 251 (299)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHHTCC--C-----------------------------------------------CC
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCC--C-----------------------------------------------CC
Confidence 99998 9999998887776665544211 0 01
Q ss_pred cCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+..+++++.+||.+||+.||++|||++|| |+|+++-
T Consensus 252 p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 252 PRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred CccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 23457789999999999999999999999 4677653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-57 Score=454.75 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=204.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+|..++..+.+ +.|||||+++++|++.+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~--~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSSE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh--CCCCCEeEEEEEEEECCE
Confidence 57999999999999999999999999999999997532 222344455544444432 133455999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+||||||| ||+|.+++.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|
T Consensus 267 lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G--------------- 329 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--------------- 329 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS---------------
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC---------------
Confidence 99999999 999999998875 799999999999999999999999999999999999997766
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||+|..... ...+.+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+..
T Consensus 330 ------------~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 330 ------------HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp ------------CEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred ------------CEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 466777777654433 2345699999999999974 57999999999999999999999999764332
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+....... ...+..+++++++||.+||+
T Consensus 398 ~~~~i~~~i~~~~-----------------------------------------------~~~p~~~S~~a~dLI~~lL~ 430 (689)
T 3v5w_A 398 DKHEIDRMTLTMA-----------------------------------------------VELPDSFSPELRSLLEGLLQ 430 (689)
T ss_dssp CHHHHHHHHHHCC-----------------------------------------------CCCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhhcCCC-----------------------------------------------CCCCccCCHHHHHHHHHHcc
Confidence 2211111111100 01223567899999999999
Q ss_pred cCCCCCCC-----HHHHhcCCCCCCC
Q 013941 405 YDPAERLK-----AREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~t-----a~ell~hp~f~~~ 425 (433)
.||++|++ ++||++||||++.
T Consensus 431 ~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 431 RDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp SCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred CCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999998 8999999999873
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=419.62 Aligned_cols=247 Identities=21% Similarity=0.333 Sum_probs=201.9
Q ss_pred CCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
++|.+.++||+|+||+||+|++. .+++.||||+++... ...+.+.+|+.+|++++|+|| |++++++.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-----V~l~g~~~~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI-----VRFFGVCTEG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEEC
Confidence 56899999999999999999864 468899999997543 445778999999999998888 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNS-------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
+.+||||||| +|+|.+++.... ...+++.++..|+.||+.||+|||+++||||||||+|||++.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999 999999997643 13589999999999999999999999999999999999998766
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (433)
.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||
T Consensus 196 ---------------------------~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 196 ---------------------------VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248 (329)
T ss_dssp ---------------------------EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ---------------------------cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHH
Confidence 4566666666543221 12357999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 307 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
+||||+| |+.||.+.+..+.+..+.+... .
T Consensus 249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~-----------------------~-------------------------- 279 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRE-----------------------L-------------------------- 279 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHHHHHHHHHHTCC-----------------------C--------------------------
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----------------------C--------------------------
Confidence 9999999 9999998887776665543210 0
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..+..+++++.+||.+||+.||++|||++||+++
T Consensus 280 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1123457789999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=414.96 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=194.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+++++.++||+|+||+||+|+... .||||+++.. ....+.+.+|+.++++++|+|| |++++++.. +.+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~l~g~~~~-~~~ 106 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI-----LLFMGYMTK-DNL 106 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECS-SSC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEC-CeE
Confidence 568999999999999999998543 4999998642 3445678899999999999888 999998765 568
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
||||||| +|+|.+++.... ..+++..+..|+.||+.||+|||+++||||||||+|||+++++
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~---------------- 169 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL---------------- 169 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE----------------
T ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC----------------
Confidence 9999999 999999997654 4699999999999999999999999999999999999998766
Q ss_pred CCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCC---CCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
.+||+|||+|+.... .....+||+.|||||++.+. .|+.++|||||||+||||+||+.||.
T Consensus 170 -----------~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 170 -----------TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----------cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 456666666654322 12335899999999999753 58999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
+.+....+..+.......|. .......++.++.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~p~--------------------------------------------~~~~~~~~~~~l~~li 274 (307)
T 3omv_A 239 HINNRDQIIFMVGRGYASPD--------------------------------------------LSKLYKNCPKAMKRLV 274 (307)
T ss_dssp TCCCHHHHHHHHHTTCCCCC--------------------------------------------STTSCTTSCHHHHHHH
T ss_pred CCChHHHHHHHHhcCCCCCC--------------------------------------------cccccccchHHHHHHH
Confidence 87766554443322111110 0112235677999999
Q ss_pred HHhcccCCCCCCCHHHHh
Q 013941 400 QGLLRYDPAERLKAREAL 417 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell 417 (433)
.+||+.||++|||+.||+
T Consensus 275 ~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 275 ADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp HHHTCSSSTTSCCHHHHH
T ss_pred HHHcCCCHhHCcCHHHHH
Confidence 999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=416.24 Aligned_cols=247 Identities=21% Similarity=0.263 Sum_probs=204.5
Q ss_pred CCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..+++.++||+|+||+||+|+.. .+++.||||+++.. ....+.+.+|+.++.+++|+|| |++++++.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~l~g~~~~ 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV-----VCLLGVVTK 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTB-----CCEEEEECS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCC-----CCcceEEEE
Confidence 46899999999999999999853 46789999999643 2345778999999999999888 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
++.+||||||| +|+|.++|.... ...+++..+..|+.||+.||+|||+++||||||||+|||+++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999 999999997532 135899999999999999999999999999999999999976
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCCCCccchHHHH
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (433)
++ .+||+|||+|+.... .....+||+.|||||++.+..|+.++|||||
T Consensus 181 ~~---------------------------~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf 233 (308)
T 4gt4_A 181 KL---------------------------NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233 (308)
T ss_dssp GG---------------------------CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CC---------------------------CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence 65 467777777654322 1233589999999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhh
Q 013941 305 GCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383 (433)
Q Consensus 305 G~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
||+||||+| |..||.+.+..+....+..... .
T Consensus 234 Gvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~-----------------------~------------------------ 266 (308)
T 4gt4_A 234 GVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV-----------------------L------------------------ 266 (308)
T ss_dssp HHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC-----------------------C------------------------
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------------C------------------------
Confidence 999999998 8999999887776655543110 0
Q ss_pred hhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 384 ~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..++.++.++.+||.+||+.||++|||+.||+++
T Consensus 267 --~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 267 --PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0123457789999999999999999999999865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-55 Score=419.20 Aligned_cols=341 Identities=38% Similarity=0.696 Sum_probs=268.0
Q ss_pred CCCCCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcc
Q 013941 75 PDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154 (433)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 154 (433)
.++....+.+..++.+.++|+++++||+|+||+||+|++..+++.||||+++...........|+.+++.+.+..+.|+|
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 34455567788899999999999999999999999999999999999999987666667788899999999977777888
Q ss_pred eeEecceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 155 ~v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
++++++++...+..|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.....+
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred eecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 89999999999999999999999999999987666799999999999999999999999999999999999997532110
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g 314 (433)
-. .-...................+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 178 ~~--~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 178 SL--ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EE--EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cc--cchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 00 0000000000000000235679999999998777666677899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhh--hhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEK--YFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+.||.+.+..+.+..+....+++|..+.......... .........|+.................. .....+
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~------~~~~~~ 329 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL------YKIIKH 329 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH------HHHCCC
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc------cccchH
Confidence 9999999999999999999999998877665432221 22233344566655444433322221111 112235
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
+.+.+||.+||+.||++|||++|+|+||||+
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 6899999999999999999999999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=419.02 Aligned_cols=324 Identities=34% Similarity=0.605 Sum_probs=253.9
Q ss_pred CCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCC-CCCccee
Q 013941 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-IGGTRCV 156 (433)
Q Consensus 78 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~~v 156 (433)
..+.+....++.+..+|++++.||+|+||.||+|++..+++.||||+++........+.+|+.+++.+.|.. ..++|++
T Consensus 83 ~~~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv 162 (429)
T 3kvw_A 83 DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162 (429)
T ss_dssp TTSCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBC
T ss_pred cCCCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEE
Confidence 344555556778889999999999999999999999999999999999877666778889999999998763 3557889
Q ss_pred EecceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 157 QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 157 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
++++++...+.+|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 163 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~---- 238 (429)
T 3kvw_A 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR---- 238 (429)
T ss_dssp CEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS----
T ss_pred EEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC----
Confidence 9999999999999999999889999998876667999999999999999999999999999999999999976441
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
..+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 239 ---------------------~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 239 ---------------------SGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp ---------------------CCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ---------------------cceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCC
Confidence 23899999999877666666799999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhH----------HHHHHhcCchhhhhh
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM----------RAVWKLLRLPNLIMQ 386 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~ 386 (433)
||.+.+..+.+..+...++.++..++....... .++.......+.......... ...............
T Consensus 298 pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (429)
T 3kvw_A 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAK-NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376 (429)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH-HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh-hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhh
Confidence 999999999999999999998887766544332 222222111110000000000 000000000001111
Q ss_pred ccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 387 ~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.....++.+.+||.+||++||++|||++|+|+||||++...
T Consensus 377 l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp TTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred ccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence 22344778999999999999999999999999999998644
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=411.65 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=199.1
Q ss_pred CCCeEEeccccccccEEEEEEEecCC-----CcEEEEEEeccch--hhHHHHHHHHHHHHHHHh-CCCCCcceeEeccee
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWF 162 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~-~~i~~~~~v~~~~~~ 162 (433)
.++|++.+.||+|+||+||+|++..+ ++.||||+++... ...+.+.+|+.+|.++.| +|| |++++++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI-----V~l~g~~ 137 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGAC 137 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE-----EEEEEEE
Confidence 36899999999999999999987654 4689999987532 345678899999999987 456 9999988
Q ss_pred cc-CCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 163 DY-RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 163 ~~-~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
.. ++.+||||||| +|+|.++|.... ...+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 65 56799999999 999999997532 235899999999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (433)
+++++. +||+|||+|+..... ....+||+.|||||++.+..|+.++||
T Consensus 218 l~~~~~---------------------------vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV 270 (353)
T 4ase_A 218 LSEKNV---------------------------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270 (353)
T ss_dssp ECGGGC---------------------------EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred eCCCCC---------------------------EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccE
Confidence 987765 555555555433221 123578999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHH-HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC
Q 013941 302 WSVGCILVELCS-GEALFQTHENLEHL-AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379 (433)
Q Consensus 302 wSlG~il~el~~-g~~pf~~~~~~~~~-~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
|||||+||||+| |..||.+.+..+.+ ..+.... +.
T Consensus 271 wS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~-----------------------~~-------------------- 307 (353)
T 4ase_A 271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-----------------------RM-------------------- 307 (353)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-----------------------CC--------------------
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCC-----------------------CC--------------------
Confidence 999999999998 99999876543333 2222210 00
Q ss_pred chhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..++.+++++.+||.+||+.||++|||+.||++|
T Consensus 308 ------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 308 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1123457789999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=410.09 Aligned_cols=340 Identities=30% Similarity=0.540 Sum_probs=256.3
Q ss_pred CCCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC---Cc
Q 013941 77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG---GT 153 (433)
Q Consensus 77 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~---~~ 153 (433)
...+++++..|+.+.++|++.++||+|+||+||+|++..+++.||||+++......+.+.+|+.+++.+.|.+.. |+
T Consensus 22 ~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 101 (397)
T 1wak_A 22 CKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101 (397)
T ss_dssp CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred CCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence 345677888999999999999999999999999999999999999999987766677889999999999976543 46
Q ss_pred ceeEecceec----cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEe
Q 013941 154 RCVQIRNWFD----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLV 228 (433)
Q Consensus 154 ~~v~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~ 228 (433)
+++++++++. ....+|+||||++++|.+.+.......+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~ 181 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred eeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence 6899999887 56789999999988998888776556799999999999999999999998 999999999999998
Q ss_pred eCCcccccCccccccCCCCC-----------------C-----cccCCCCCCCeeeecCCCCccccCCCcccccCCcccc
Q 013941 229 SAEYVKVPDYKFLSRSSKDG-----------------S-----YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRA 286 (433)
Q Consensus 229 ~~~~~~l~d~~~~~~~~~~~-----------------~-----~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~a 286 (433)
.++.....+++........+ . ..........+||+|||++...........||+.|+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~a 261 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRS 261 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccC
Confidence 77643222211111000000 0 0000012347999999999877766666789999999
Q ss_pred hhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCcccc
Q 013941 287 PEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360 (433)
Q Consensus 287 PE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 360 (433)
||++.+..++.++|||||||++|+|++|..||.+.+ ....+..+....+.+|..+..........+...+....
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999999999999999999999999999999997655 56677888889999998776554333222222221111
Q ss_pred CCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 361 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
....... .......... ......+..+.+||.+||+.||++|||++|+|+||||++
T Consensus 342 ~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPW-GLFEVLVEKY-------EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCC-CHHHHHHHTS-------CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCc-chhHhhhhhc-------ccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 2111111 1111111111 112234678999999999999999999999999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=397.77 Aligned_cols=331 Identities=47% Similarity=0.858 Sum_probs=259.9
Q ss_pred ceeeecCCccCCCeEEeccccccccEEEEEEEe-cCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCC-CCcceeEe
Q 013941 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGTRCVQI 158 (433)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~~~v~~ 158 (433)
++.+..|+.+.++|++.+.||+|+||.||+|.+ ..+++.||||+++......+.+.+|+.+++.+.|++. .+++++++
T Consensus 3 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 3 HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp GGTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ceeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 344566888889999999999999999999998 5688999999998766667788999999999998763 44567999
Q ss_pred cceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 159 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
++++.+.+..|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+.....+.
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 83 LEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred ecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 99999999999999999999999998876567999999999999999999999999999999999999977543222111
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
+.... .....+..+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 163 ~~~~~--------~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKRD--------ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---CE--------EEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccc--------cccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 11000 0001145699999999987776666778999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
...+..+....+.+..+++|..+....... .++. .....|............ ...............+.++.+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l 308 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFH-HDRLDWDEHSSAGRYVSR---ACKPLKEFMLSQDVEHERLFDL 308 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCG--GGEE-TTEECCCTTSHHHHHHHH---HCCCGGGGCSCCSHHHHHHHHH
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccch--hHHh-hccccccccccccchhhh---cCcchhhhcccchhhHHHHHHH
Confidence 999999999999999999998776654321 1111 234455543322221111 1111111112223446789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|.+||+.||++|||++|+++||||++-
T Consensus 309 i~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 309 IQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 999999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=407.42 Aligned_cols=321 Identities=35% Similarity=0.635 Sum_probs=250.6
Q ss_pred CCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceeE
Q 013941 79 DGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQ 157 (433)
Q Consensus 79 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~ 157 (433)
...|.+..++.+.++|++.+.||+|+||+||+|++..+++.||||+++..........+|+.+++.+. |+++.+.+++.
T Consensus 41 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 41 NYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp TSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred CCcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 34467788899999999999999999999999999999999999999876666677888999999997 55666677899
Q ss_pred ecceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEecCCCCCcEEEeeCCcccc
Q 013941 158 IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 158 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDikp~NIli~~~~~~~l 235 (433)
+++++...+..|+||||++++|.+++.......+++..++.++.||+.||.||| +.|||||||||+|||++.+
T Consensus 121 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~----- 195 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP----- 195 (382)
T ss_dssp EEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-----
T ss_pred eeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-----
Confidence 999999999999999999889999998776567999999999999999999999 5799999999999999542
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
.+..+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 196 --------------------~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 255 (382)
T 2vx3_A 196 --------------------KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255 (382)
T ss_dssp --------------------TSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------CCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 234689999999987766666678999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCC----------CCchhhHHHHHHhc-Cchhhh
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG----------ATSRDSMRAVWKLL-RLPNLI 384 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~-~~~~~~ 384 (433)
.||.+.+..+.+..+.+..+.+|..+...... ...++.......|... ......+....... ..+...
T Consensus 256 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 334 (382)
T 2vx3_A 256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPK-ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334 (382)
T ss_dssp CSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT-HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGT
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH-HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcc
Confidence 99999999999999999988888766544322 2222222111111000 00000111111000 000000
Q ss_pred h----hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 385 M----QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 385 ~----~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
. ......+.++.+||.+||++||++|||++|+|+||||++.
T Consensus 335 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred ccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 0 0000113478999999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=396.76 Aligned_cols=287 Identities=30% Similarity=0.517 Sum_probs=222.6
Q ss_pred cCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHH---hCCCCCccee
Q 013941 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLA---RHDIGGTRCV 156 (433)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---~~~i~~~~~v 156 (433)
+|+.+.++|++++.||+|+||+||+|++..+++.||||++.... .......+|+.+++.+. |+|+ +
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni-----v 77 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV-----V 77 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB-----C
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe-----E
Confidence 45667789999999999999999999999999999999986422 22356778888888887 6666 9
Q ss_pred EecceeccCC-----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 157 QIRNWFDYRN-----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 157 ~~~~~~~~~~-----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
++++++.... .+++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS
T ss_pred EeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC
Confidence 9999887654 68999999988999999987655699999999999999999999999999999999999996554
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 158 ---------------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 210 (308)
T 3g33_A 158 ---------------------------TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 210 (308)
T ss_dssp ---------------------------CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHH
T ss_pred ---------------------------CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHH
Confidence 5777888877654322 23468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 310 el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
+|++|..||.+.+..+.+..+....+.++...+........ ..++. ..+........
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--------~~~~~---------------~~~~~~~~~~~ 267 (308)
T 3g33_A 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR--------GAFPP---------------RGPRPVQSVVP 267 (308)
T ss_dssp HTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG--------GGSCC---------------CCCCCHHHHSC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc--------cccCC---------------CCCCcHHHhCc
Confidence 99999999999999999998888887766432211100000 00000 01111222345
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 390 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.++.++.+||.+||++||++|||+.|+|+||||++...
T Consensus 268 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 268 EMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp SCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred cccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 67889999999999999999999999999999998643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=398.68 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=215.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++++.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+++.++|+|| +++++++.+.+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI-----VKLFEVIETEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECCE
Confidence 467999999999999999999999999999999997532 344567889999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~--------------- 151 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM--------------- 151 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---------------
T ss_pred EEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC---------------
Confidence 99999999 999999998765 799999999999999999999999999999999999996655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.+||+|||++...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.
T Consensus 152 ------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 152 ------------NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp ------------CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ------------CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 5777778777644322 2346899999999999988875 899999999999999999999998877
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+....+......+| ...+.++.+||.+||
T Consensus 220 ~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~~L 249 (328)
T 3fe3_A 220 KELRERVLRGKYRIP--------------------------------------------------FYMSTDCENLLKRFL 249 (328)
T ss_dssp HHHHHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHHHC
T ss_pred HHHHHHHHhCCCCCC--------------------------------------------------CCCCHHHHHHHHHHC
Confidence 766655544322222 234678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCc
Q 013941 404 RYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+.||++|||++|+++||||+...
T Consensus 250 ~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 250 VLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp CSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=404.80 Aligned_cols=262 Identities=27% Similarity=0.467 Sum_probs=223.6
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHHHhCCCCCcceeEec
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~ 159 (433)
...+.++|++.+.||+|+||.||+|++..+|+.||+|++++... ..+.+.+|+.+++.+.|+|| ++++
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~ 81 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI-----ITLH 81 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTB-----CCEE
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCC-----CcEE
Confidence 34567789999999999999999999999999999999975332 24678899999999988777 9999
Q ss_pred ceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
+++.+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~------ 153 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI------ 153 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS------
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCC------
Confidence 9999999999999999 999999997654 7999999999999999999999999999999999999965441
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 154 -----------------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~ 216 (361)
T 2yab_A 154 -----------------PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216 (361)
T ss_dssp -----------------SSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred -----------------CccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 1236889999988765433 244689999999999999899999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+.+..+.+..+......++.. .+..++..++
T Consensus 217 Pf~~~~~~~~~~~i~~~~~~~~~~----------------------------------------------~~~~~s~~~~ 250 (361)
T 2yab_A 217 PFLGDTKQETLANITAVSYDFDEE----------------------------------------------FFSQTSELAK 250 (361)
T ss_dssp SSCCSSHHHHHHHHHTTCCCCCHH----------------------------------------------HHTTSCHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCch----------------------------------------------hccCCCHHHH
Confidence 999988777766665443333221 1234577899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+||.+||..||++|||++|+++||||+.
T Consensus 251 ~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 251 DFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 9999999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=398.03 Aligned_cols=336 Identities=45% Similarity=0.852 Sum_probs=263.9
Q ss_pred CCCCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCC-cEEEEEEeccchhhHHHHHHHHHHHHHHHhCCC-CCc
Q 013941 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGT 153 (433)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~ 153 (433)
++..+.+....|+.+.++|++.+.||+|+||.||+|.+..++ +.||+|+++......+.+.+|+.+++.+.|++. .+.
T Consensus 3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCce
Confidence 456778888999999999999999999999999999998776 789999998766667788899999999998653 334
Q ss_pred ceeEecceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
+++.+++++...+..|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+..
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred eEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 57889999999999999999998899998887665679999999999999999999999999999999999999765543
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 313 (433)
.+.+..... ....+....+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 163 ~~~~~~~~~--------~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 163 TLYNEHKSC--------EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp EEECCC-CC--------CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccc--------cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 332221100 001134567999999999877666667789999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|..||.+.+..+.+..+....+++|..+....... .++. .....|+........... ...............+.
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 308 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ--KYFY-KGGLVWDENSSDGRYVKE---NCKPLKSYMLQDSLEHV 308 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCG--GGEE-TTEECCCTTSHHHHHHHH---HCCCGGGGCSCCSHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccch--hhhc-ccccccccccchhccccc---cCCcccccccccchhHH
Confidence 99999999999999999999999998776554321 1111 112334433222211111 11111111111223366
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
++.+||.+||+.||++|||+.|+++||||++.
T Consensus 309 ~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 89999999999999999999999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=414.81 Aligned_cols=304 Identities=26% Similarity=0.444 Sum_probs=231.3
Q ss_pred CCCceeeecCC---ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCC
Q 013941 78 KDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIG 151 (433)
Q Consensus 78 ~~~~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~ 151 (433)
..+.|.+..++ .+.++|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.++|+||
T Consensus 45 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI- 123 (464)
T 3ttj_A 45 DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI- 123 (464)
T ss_dssp -CCEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTB-
T ss_pred cccceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCC-
Confidence 45567777776 4568999999999999999999999999999999999753 3345667889999999988877
Q ss_pred CcceeEecceeccC------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcE
Q 013941 152 GTRCVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (433)
Q Consensus 152 ~~~~v~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NI 225 (433)
+++++++... ..+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 124 ----v~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NI 195 (464)
T 3ttj_A 124 ----ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195 (464)
T ss_dssp ----CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred ----CcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhE
Confidence 9999988543 57899999997788888753 489999999999999999999999999999999999
Q ss_pred EEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHH
Q 013941 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWS 303 (433)
Q Consensus 226 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 303 (433)
|++.++ .+||+|||++...... ....+||+.|+|||++.+..|+.++||||
T Consensus 196 ll~~~~---------------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 248 (464)
T 3ttj_A 196 VVKSDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 248 (464)
T ss_dssp EECTTS---------------------------CEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHH
T ss_pred EEeCCC---------------------------CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHH
Confidence 997655 5777778877654432 24468999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhh
Q 013941 304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383 (433)
Q Consensus 304 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
|||++|||++|+.||.+.+..+++..+.+.+|.++..++.........+........ . . .....+..... ..
T Consensus 249 lG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~--~-~----~~~~~~~~~~~-~~ 320 (464)
T 3ttj_A 249 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA--G-L----TFPKLFPDSLF-PA 320 (464)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCC--C-C----CHHHHSCGGGS-CC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccC--C-C----ChHHhCccccc-cc
Confidence 999999999999999999999999999999998887776655444444433221100 0 0 00000000000 00
Q ss_pred hhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 384 ~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
........+.++++||.+||++||++|||++|+|+||||+..
T Consensus 321 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 321 DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred ccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000011126689999999999999999999999999999853
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=398.09 Aligned_cols=263 Identities=24% Similarity=0.415 Sum_probs=225.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++.+.|+|| +++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI-----LHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTB-----CCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCC-----CeEeEEEecCCEE
Confidence 45678999999999999999999999999999999998666666778899999999988877 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||| +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~----------------- 138 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR----------------- 138 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-----------------
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-----------------
Confidence 9999999 889999997543 369999999999999999999999999999999999999652
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+..+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 139 --------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 139 --------RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp --------SCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------CCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 13468999999887654332 33579999999999999889999999999999999999999999888877
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+......++.. ....++.++.+||.+||+.
T Consensus 211 ~~~~i~~~~~~~~~~----------------------------------------------~~~~~s~~~~~li~~~L~~ 244 (321)
T 1tki_A 211 IIENIMNAEYTFDEE----------------------------------------------AFKEISIEAMDFVDRLLVK 244 (321)
T ss_dssp HHHHHHHTCCCCCHH----------------------------------------------HHTTSCHHHHHHHHTTSCS
T ss_pred HHHHHHcCCCCCChh----------------------------------------------hhccCCHHHHHHHHHHcCC
Confidence 776665543332211 1234577999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccc
Q 013941 406 DPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
||++|||+.|+|+||||++...+
T Consensus 245 dp~~Rpt~~e~l~hp~~~~~~~~ 267 (321)
T 1tki_A 245 ERKSRMTASEALQHPWLKQKIER 267 (321)
T ss_dssp SGGGSCCHHHHHHSHHHHSCGGG
T ss_pred ChhHCcCHHHHhcChhhccCccc
Confidence 99999999999999999986543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=394.73 Aligned_cols=286 Identities=30% Similarity=0.465 Sum_probs=225.3
Q ss_pred cCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
.++.+.++|+++++||+|+||+||+|++. +++.||+|++.... .....+.+|+.++++++|+|| +++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 88 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI-----VSLIDVI 88 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCE-----eeeeeEE
Confidence 45677889999999999999999999985 58899999987432 234667899999999988877 9999999
Q ss_pred ccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
.+++.+++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~----------- 156 (311)
T 3niz_A 89 HSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG----------- 156 (311)
T ss_dssp CCSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-----------
T ss_pred ccCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-----------
Confidence 9999999999999879999987654 4699999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 157 ----------------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (311)
T 3niz_A 157 ----------------ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220 (311)
T ss_dssp ----------------CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ----------------CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC
Confidence 5677777777654322 233578999999999987 46899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+....+.+..+....+..+...+........ +.... .... ...........++.++.+|
T Consensus 221 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~-----------------~~~~~~~~~~~~~~~~~~l 280 (311)
T 3niz_A 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPL-WKQRT--FQVF-----------------EKKPWSSIIPGFCQEGIDL 280 (311)
T ss_dssp CCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH-HHSCC--CCCC-----------------CCCCHHHHSTTCCHHHHHH
T ss_pred CCCChHHHHHHHHHHHCCCChHHhhhhhccch-hhhcc--cccc-----------------cCCcHHHhCcccCHHHHHH
Confidence 99888888888888877665433222111100 00000 0000 0000112234567899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|.+||++||++|||++|+|+||||++-
T Consensus 281 i~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 281 LSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred HHHHcCCChhHCCCHHHHhcCcccccC
Confidence 999999999999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=403.58 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=211.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++++.||+|+||.||+|++..+++.||||++++. ....+...+|..++..+ .|++| +++++++.+.+
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~I-----v~l~~~~~~~~ 97 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-----TQLFCCFQTPD 97 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSS
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCce-----eeEEEEEEeCC
Confidence 6799999999999999999999999999999999753 23345677899999887 46666 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-------------- 161 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-------------- 161 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC--------------
Confidence 999999999 899999998765 799999999999999999999999999999999999997665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 162 -------------~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 162 -------------HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp -------------CEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------------CEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 46777777765422 22334689999999999998889999999999999999999999999988
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+....+......+| ..++.++.+||.+|
T Consensus 229 ~~~~~~~i~~~~~~~p--------------------------------------------------~~~~~~~~~li~~l 258 (353)
T 3txo_A 229 EDDLFEAILNDEVVYP--------------------------------------------------TWLHEDATGILKSF 258 (353)
T ss_dssp HHHHHHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCC--------------------------------------------------CCCCHHHHHHHHHH
Confidence 8777766655322222 23467899999999
Q ss_pred cccCCCCCCCH------HHHhcCCCCCCC
Q 013941 403 LRYDPAERLKA------REALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta------~ell~hp~f~~~ 425 (433)
|+.||++|+++ +|+++||||++.
T Consensus 259 L~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 259 MTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp TCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred hhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999999998 899999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=394.45 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=216.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||.||+|++..+|+.||+|++++.. ...+.+.+|+.+++.+.|++| +++++++.+.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI-----IRMWGTFQDAQQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTB-----CCEEEEEECSSE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCC-----ceEeEEEEeCCE
Confidence 56999999999999999999999999999999997532 234567789999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--------------- 143 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--------------- 143 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---------------
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC---------------
Confidence 99999999 899999998764 799999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....
T Consensus 144 ------------~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 211 (318)
T 1fot_A 144 ------------HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211 (318)
T ss_dssp ------------CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ------------CEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 57778888777665555567899999999999999999999999999999999999999998877666
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+......+| ...+.++.+||.+||+.|
T Consensus 212 ~~~i~~~~~~~p--------------------------------------------------~~~~~~~~~li~~lL~~d 241 (318)
T 1fot_A 212 YEKILNAELRFP--------------------------------------------------PFFNEDVKDLLSRLITRD 241 (318)
T ss_dssp HHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHHHTCSC
T ss_pred HHHHHhCCCCCC--------------------------------------------------CCCCHHHHHHHHHHhccC
Confidence 655544221111 234678999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q 013941 407 PAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~-----ta~ell~hp~f~~~ 425 (433)
|++|+ +++|+++||||++.
T Consensus 242 p~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 242 LSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHcCCCcCCCHHHHhcCccccCC
Confidence 99999 99999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=396.61 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=212.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||.||+|++..+++.||||++++.. .......+|+.+++.++|+++ +++++++.+.+.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~l~~~~~~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTB-----CCEEEEEECSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcC-----cceEEEEEeCCE
Confidence 57999999999999999999999999999999997532 334567889999998888776 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--------------- 142 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--------------- 142 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---------------
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC---------------
Confidence 99999999 899999998764 799999999999999999999999999999999999997666
Q ss_pred CCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.
T Consensus 143 ------------~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 143 ------------HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp ------------CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ------------CEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 46666666665422 122346899999999999999999999999999999999999999988776
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+......+ ...++.++.+||.+||
T Consensus 211 ~~~~~~i~~~~~~~--------------------------------------------------p~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 211 ERLFELILMEEIRF--------------------------------------------------PRTLSPEAKSLLAGLL 240 (337)
T ss_dssp HHHHHHHHHCCCCC--------------------------------------------------CTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCC--------------------------------------------------CCCCCHHHHHHHHHHh
Confidence 66555544321111 1245778999999999
Q ss_pred ccCCCCCC-----CHHHHhcCCCCCCC
Q 013941 404 RYDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
+.||++|| +++|+++||||++.
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 99999999 99999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=412.21 Aligned_cols=310 Identities=28% Similarity=0.460 Sum_probs=216.2
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec--
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-- 163 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~-- 163 (433)
.+.++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~~~~~~~ 124 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV-----VKVLDIVIPK 124 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCC-----CceEEEEecC
Confidence 4567899999999999999999999999999999998642 2344667899999999988877 99999883
Q ss_pred ---cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 164 ---YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 164 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
..+.+|+||||++++|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 125 DVEKFDELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CTTTCCCEEEEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CcccCceEEEEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 346799999999999999998654 799999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCcccCC---CCCCCeeeecCCCCccccCCCcccccCCcccchhhhh-CCCCCccchHHHHHHHHHHHHh---
Q 013941 241 LSRSSKDGSYFKNL---PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCS--- 313 (433)
Q Consensus 241 ~~~~~~~~~~~~~~---~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~--- 313 (433)
+............. .......+.+|+............+||+.|+|||++. +..++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 87664432211110 1112234455554444334445568999999999874 5579999999999999999998
Q ss_pred --------CCCCCCCCC--------------------hHHHHHHHHHHhcCCChhhHHhhhhhh-hhhhcCCccccCCCC
Q 013941 314 --------GEALFQTHE--------------------NLEHLAMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDG 364 (433)
Q Consensus 314 --------g~~pf~~~~--------------------~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 364 (433)
|.++|.+.. ..+++..|...+|.++...+....... ..+.... +.
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-----~~- 356 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF-----PK- 356 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTS-----CC-
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhc-----CC-
Confidence 777786654 356778888888888876554332111 1111100 00
Q ss_pred CCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 365 ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.............+.++.+||.+||++||++|||++|+|+||||++.
T Consensus 357 --------------~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 357 --------------REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp --------------CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred --------------CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 00011122234567899999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=400.45 Aligned_cols=282 Identities=28% Similarity=0.513 Sum_probs=225.2
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.++|++++.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+++.++|+|| +++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~~ 96 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV-----IGLLDVFTPD 96 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB-----CCCSEEECSC
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCC-----CCceeeEecC
Confidence 3457899999999999999999999999999999998542 2345667899999999998887 9999988765
Q ss_pred ------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
..+|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-------- 165 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-------- 165 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--------
T ss_pred CccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--------
Confidence 356999999999999999874 599999999999999999999999999999999999996554
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 166 -------------------~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 226 (367)
T 1cm8_A 166 -------------------ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226 (367)
T ss_dssp -------------------CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred -------------------CEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 5788888888766555556789999999999987 67999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhh-hhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
.+.+..+++..+.+..+.+|..+....... ...+...- +. .............++.+.+
T Consensus 227 ~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~-----~~---------------~~~~~~~~~~~~~~~~~~~ 286 (367)
T 1cm8_A 227 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL-----PE---------------LEKKDFASILTNASPLAVN 286 (367)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS-----CC---------------CCCCCGGGTCTTCCHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhC-----CC---------------CCCCCHHHHCCCCCHHHHH
Confidence 999999999999999999887665433211 11111000 00 0000011223456789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||+.||++|||++|+|+||||++.
T Consensus 287 ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 287 LLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 9999999999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=397.30 Aligned_cols=193 Identities=22% Similarity=0.264 Sum_probs=156.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC----
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---- 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~---- 166 (433)
..+|.+.++||+|+||+||+|++ +|+.||||+++...........|+..+.+++|+|| |++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNI-----v~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI-----LGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCC-----CcEEEEEEecCCCce
Confidence 35699999999999999999986 58899999997654433334456666667777776 99999987643
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecCCCCCcEEEeeCCcccccC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDikp~NIli~~~~~~~l~d 237 (433)
.+||||||| +|+|.+++... .++++.+..++.|++.||+|||++ +||||||||+|||++.++
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~------ 145 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------ 145 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS------
T ss_pred EEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC------
Confidence 689999999 99999999875 599999999999999999999987 999999999999997665
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-------cccccCCcccchhhhhCC------CCCccchHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL------GWNYPCDLWSV 304 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DiwSl 304 (433)
.+||+|||+|+...... ...+||+.|||||++.+. .++.++|||||
T Consensus 146 ---------------------~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 146 ---------------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp ---------------------CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ---------------------CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 46777777765433221 235899999999999764 36789999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 013941 305 GCILVELCSGEALFQT 320 (433)
Q Consensus 305 G~il~el~~g~~pf~~ 320 (433)
||+||||+||..||..
T Consensus 205 Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 205 GLVFWEIARRCSIGGI 220 (303)
T ss_dssp HHHHHHHHHTBCBTTB
T ss_pred HHHHHHHHHCCCCCCc
Confidence 9999999999888754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=408.57 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=221.9
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ...+.+.+|+.+++.++|+|| +++++++.+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~~~~~ 81 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI-----VRLHDSISE 81 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTB-----CCEEEEEEC
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCC-----CeEEEEEEE
Confidence 455678999999999999999999999999999999987532 344567899999999998887 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.+..|+||||| +++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.+.
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~------------ 147 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL------------ 147 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS------------
T ss_pred CCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC------------
Confidence 99999999999 999999998765 799999999999999999999999999999999999997532
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 148 ------------~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 148 ------------KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp ------------TTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------CCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 34568999999887654332 335899999999999998999999999999999999999999998
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+.......+......+|. .....+++++.+||.
T Consensus 216 ~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~ 249 (444)
T 3soa_A 216 EDQHRLYQQIKAGAYDFPS----------------------------------------------PEWDTVTPEAKDLIN 249 (444)
T ss_dssp SSHHHHHHHHHHTCCCCCT----------------------------------------------TTTTTSCHHHHHHHH
T ss_pred ccHHHHHHHHHhCCCCCCc----------------------------------------------cccccCCHHHHHHHH
Confidence 8877777666554333221 112345779999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||+.||++|||+.|+|+||||++.
T Consensus 250 ~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 250 KMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=392.20 Aligned_cols=262 Identities=26% Similarity=0.469 Sum_probs=222.6
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
+.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++.++|+|+ +++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~ 81 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV-----ITLHE 81 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence 4456789999999999999999999999999999999875321 35678899999999988877 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
++.+.+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~------- 152 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV------- 152 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS-------
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCC-------
Confidence 999999999999999 999999997654 7999999999999999999999999999999999999976541
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
....+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 153 ----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 153 ----------------PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp ----------------SSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred ----------------CCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 233688999998876542 23346899999999999998999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+....+.+..+......++.. .....+..+.+
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~ 250 (326)
T 2y0a_A 217 FLGDTKQETLANVSAVNYEFEDE----------------------------------------------YFSNTSALAKD 250 (326)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCHH----------------------------------------------HHTTSCHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCcCcc----------------------------------------------ccccCCHHHHH
Confidence 99887777666655443332211 12345678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||+.||++|||++|+|+||||+..
T Consensus 251 li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 251 FIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=394.62 Aligned_cols=319 Identities=30% Similarity=0.521 Sum_probs=243.5
Q ss_pred CceeeecCCcc-CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCC------CC
Q 013941 80 GHYVFAIGENL-TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI------GG 152 (433)
Q Consensus 80 ~~~~~~~~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i------~~ 152 (433)
++++...++.+ .++|++.+.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++++.+... .|
T Consensus 6 ~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 6 GYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp -CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhcccc
Confidence 34455555655 368999999999999999999999999999999998766667788899999999985432 24
Q ss_pred cceeEecceeccCC----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEE
Q 013941 153 TRCVQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILL 227 (433)
Q Consensus 153 ~~~v~~~~~~~~~~----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli 227 (433)
+|++++++++...+ .+++|||+++++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred chHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEE
Confidence 55699999987644 89999999999999999876656799999999999999999999998 99999999999999
Q ss_pred eeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHH
Q 013941 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307 (433)
Q Consensus 228 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 307 (433)
+.++. .+....+||+|||++...........||+.|+|||++.+..++.++|||||||+
T Consensus 166 ~~~~~---------------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 224 (373)
T 1q8y_A 166 EIVDS---------------------PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 224 (373)
T ss_dssp EEEET---------------------TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred eccCC---------------------CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHH
Confidence 76441 023346899999999877666666789999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC------hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCch
Q 013941 308 LVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381 (433)
Q Consensus 308 l~el~~g~~pf~~~~------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (433)
+|+|++|..||.+.. ....+..+...++.+|..++.........+...+............ ......
T Consensus 225 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----- 297 (373)
T 1q8y_A 225 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP--LEDVLT----- 297 (373)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC--HHHHHH-----
T ss_pred HHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc--hhhhhh-----
Confidence 999999999998654 5567788888899999877654432222211111111111111110 000000
Q ss_pred hhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 382 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.........+.++.+||.+||+.||++|||++|+|+||||++...
T Consensus 298 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 298 -EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp -HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred -hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 001112334678999999999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=400.07 Aligned_cols=267 Identities=24% Similarity=0.411 Sum_probs=223.2
Q ss_pred eeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEe
Q 013941 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQI 158 (433)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~ 158 (433)
+....+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|| +++
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~ 93 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRL 93 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCE
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCC-----CeE
Confidence 334445666788999999999999999999999999999999997532 344667889999999988877 999
Q ss_pred cceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
++++.+.+..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~------ 165 (362)
T 2bdw_A 94 HDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------ 165 (362)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS------
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC------
Confidence 99999999999999999 899999997654 799999999999999999999999999999999999997643
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 166 ------------------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 166 ------------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227 (362)
T ss_dssp ------------------TTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ------------------CCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCC
Confidence 23468999999887654332 3468999999999999989999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||.+.+.......+......+|. ..+..++.++
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~~~ 261 (362)
T 2bdw_A 228 PPFWDEDQHRLYAQIKAGAYDYPS----------------------------------------------PEWDTVTPEA 261 (362)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCT----------------------------------------------TGGGGSCHHH
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCc----------------------------------------------ccccCCCHHH
Confidence 999988777666665543322221 0113456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.+||.+||+.||++|||+.|+|+||||+..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=396.15 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=213.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~ 165 (433)
.++|++.+.||+|+||.||+|+++.+++.||||++++.. ...+....|..++..+ .|++| +++++++.+.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~i-----v~l~~~~~~~ 90 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THMFCTFQTK 90 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB-----CCEEEEEECS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCC-----CcEEEEEEeC
Confidence 357999999999999999999999999999999997532 3345677899999887 67766 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.+|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g------------- 155 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------------- 155 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------------
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-------------
Confidence 9999999999 999999998764 699999999999999999999999999999999999997665
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 156 --------------~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 156 --------------HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp --------------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------------CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 46667777665422 2234468999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+.......+......+| ..++.++.+||.+
T Consensus 222 ~~~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~ 251 (345)
T 1xjd_A 222 DEEELFHSIRMDNPFYP--------------------------------------------------RWLEKEAKDLLVK 251 (345)
T ss_dssp SHHHHHHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCCCC--------------------------------------------------cccCHHHHHHHHH
Confidence 77666655543221111 2346789999999
Q ss_pred hcccCCCCCCCHH-HHhcCCCCCCC
Q 013941 402 LLRYDPAERLKAR-EALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~ta~-ell~hp~f~~~ 425 (433)
||+.||++||++. ++++||||++.
T Consensus 252 lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 252 LFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999999998 99999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=385.64 Aligned_cols=280 Identities=29% Similarity=0.483 Sum_probs=221.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|+++++||+|+||+||+|++..+++.||||++.... .....+.+|+.++++++|+|+ +++++++.+++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCE-----eeEEeEEEeCCEE
Confidence 47999999999999999999999999999999997432 334677889999999988777 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||++++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~----------------- 138 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG----------------- 138 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-----------------
T ss_pred EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----------------
Confidence 9999999778888776543 4799999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCC-CCccchHHHHHHHHHHHHhCCCC-CCCCCh
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEAL-FQTHEN 323 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~p-f~~~~~ 323 (433)
.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.
T Consensus 139 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~ 208 (292)
T 3o0g_A 139 ----------ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp ----------CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred ----------CEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH
Confidence 5677777777654322 23357899999999998765 89999999999999999987766 667777
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+.+..+.+..+.++...+........ ...++.. .............+.++++||.+||
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~-------~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~L 267 (292)
T 3o0g_A 209 DDQLKRIFRLLGTPTEEQWPSMTKLPD-------YKPYPMY--------------PATTSLVNVVPKLNATGRDLLQNLL 267 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTT-------CCCCCCC--------------CTTCCCTTTSTTCCHHHHHHHHHHS
T ss_pred HHHHHHHHHHhCCCChhhhhhhccccc-------ccccccc--------------cCCcchhhcccccChHHHHHHHHHh
Confidence 778888888877766543222111000 0000000 0000111223456789999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.||++|||++|+++||||++.
T Consensus 268 ~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 268 KCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=396.69 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=217.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||.||+|++..+++.||||++.+.. ...+.+.+|+.+++.+.|++| +++++++.+.+.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 115 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL-----VKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEcCCE
Confidence 57999999999999999999999999999999997532 234567889999998887776 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--------------- 178 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--------------- 178 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC---------------
Confidence 99999999 999999998765 699999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 179 ------------~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 246 (350)
T 1rdq_E 179 ------------YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp ------------CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------CEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH
Confidence 57788888777665555567899999999999999999999999999999999999999998877766
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+......+| ..++.++.+||.+||+.|
T Consensus 247 ~~~i~~~~~~~p--------------------------------------------------~~~~~~~~~li~~lL~~d 276 (350)
T 1rdq_E 247 YEKIVSGKVRFP--------------------------------------------------SHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp HHHHHHCCCCCC--------------------------------------------------TTCCHHHHHHHHHHSCSC
T ss_pred HHHHHcCCCCCC--------------------------------------------------CCCCHHHHHHHHHHhhcC
Confidence 665544322111 234678999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCC
Q 013941 407 PAERLK-----AREALRHPFFTR 424 (433)
Q Consensus 407 P~~R~t-----a~ell~hp~f~~ 424 (433)
|++||+ ++|+++||||+.
T Consensus 277 p~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 277 LTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhccCCccCCHHHHHhCcCcCC
Confidence 999998 999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=386.89 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=214.6
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.+.|+|| +++++++..++.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCC-----CeEeEEEEECCEE
Confidence 3468999999999999999999999999999999986433 345667889999999988877 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~---------------- 153 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---------------- 153 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----------------
T ss_pred EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC----------------
Confidence 9999999 99999999875 599999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 154 -----------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 222 (297)
T 3fxz_A 154 -----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (297)
T ss_dssp -----------CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred -----------CEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4677777776543322 23358999999999999999999999999999999999999999887776
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+....... ......++..+.+||.+||+
T Consensus 223 ~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~ 255 (297)
T 3fxz_A 223 RALYLIATNGTPE-----------------------------------------------LQNPEKLSAIFRDFLNRCLE 255 (297)
T ss_dssp HHHHHHHHHCSCC-----------------------------------------------CSCGGGSCHHHHHHHHHHSC
T ss_pred HHHHHHHhCCCCC-----------------------------------------------CCCccccCHHHHHHHHHHcc
Confidence 6555443321110 01123456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
.||++|||++|+++||||+..
T Consensus 256 ~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 256 MDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp SSTTTSCCHHHHTTCGGGGGC
T ss_pred CChhHCcCHHHHhhChhhccc
Confidence 999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=403.37 Aligned_cols=323 Identities=25% Similarity=0.409 Sum_probs=219.4
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHH-hCCCCCcceeEeccee
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~ 162 (433)
+..+.++|++++.||+|+||.||+|.+..+++.||||++... ........+|+.++..+. |+|| +++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~l~~~~ 78 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI-----VNLLNVL 78 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCC-----CeeeeEE
Confidence 445567899999999999999999999999999999998642 334566778999999997 7776 9999998
Q ss_pred ccC--CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 163 DYR--NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 163 ~~~--~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
... ..+|+|||||+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 79 RADNDRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp ECTTSSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ecCCCCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 643 479999999988999999874 599999999999999999999999999999999999998888777777776
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCC-ccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGST-TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
+............. ...+.+.... ..........+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 156 a~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 156 SRSFVNIRRVTNNI----PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CEESSSCCCCCCCG----GGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccc----cccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 65433211100000 0000000000 000111233589999999999987 57899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhh-hhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
.+.+..+++..+...++.++...+....... ..+..................... |.. ...........++++.+
T Consensus 232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~d 307 (388)
T 3oz6_A 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK-WKN---LLLKINPKADCNEEALD 307 (388)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH-HHH---HHHHHCTTCCCCHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc-hhh---hcccccccccCCHHHHH
Confidence 9999999999999888877765443211100 000000000000000000000000 000 00011122356789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||++||++|||++|+|+||||+.-
T Consensus 308 ll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 308 LLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 9999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=397.29 Aligned_cols=250 Identities=22% Similarity=0.400 Sum_probs=205.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++++.||+|+||.||+|++..+++.||+|++++.. .....+.+|..++.++ +|++| +++++++.+.+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~I-----v~l~~~~~~~~ 126 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTES 126 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTB-----CCEEEEEECSS
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCc-----CeeEEEEEECC
Confidence 57999999999999999999999999999999997542 2234577899999887 67666 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ +++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-------------- 190 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-------------- 190 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC--------------
Confidence 999999999 999999998765 799999999999999999999999999999999999997665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 191 -------------~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 191 -------------HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp -------------CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred -------------CEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 46777777665421 22344689999999999999999999999999999999999999996432
Q ss_pred hHH---------HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 323 NLE---------HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 323 ~~~---------~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
..+ ....+.... ...+..++.
T Consensus 258 ~~~~~~~~~~~~~~~~i~~~~--------------------------------------------------~~~p~~~s~ 287 (396)
T 4dc2_A 258 SSDNPDQNTEDYLFQVILEKQ--------------------------------------------------IRIPRSLSV 287 (396)
T ss_dssp C------CCHHHHHHHHHHCC--------------------------------------------------CCCCTTSCH
T ss_pred cccccchhhHHHHHHHHhccc--------------------------------------------------cCCCCcCCH
Confidence 211 111111110 112234577
Q ss_pred HHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKA------REALRHPFFTRD 425 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta------~ell~hp~f~~~ 425 (433)
++.+||.+||+.||++|+++ +|+++||||++.
T Consensus 288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 99999999999999999985 899999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=387.15 Aligned_cols=289 Identities=30% Similarity=0.537 Sum_probs=213.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++++.||+|+||.||+|.+..+++.||+|+++... ...+.+.+|+.++++++|+|| +++++++.+++.+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI-----VRLYDVIHTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTB-----CCEEEEECCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCc-----ceEEEEEEECCeEE
Confidence 57999999999999999999999999999999987432 234678899999999988877 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 170 IVFEKLGPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
+||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-------------- 145 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-------------- 145 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--------------
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC--------------
Confidence 999999889999987542 13589999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 146 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 146 -------------QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp -------------CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -------------CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4677777776544322 2335789999999999874 6899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+.+..+.+..+.++...+....... .+.. .... ......... ........++.++.+||.+
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~--~~~~~~~~~--------~~~~~~~~~~~~l~~li~~ 276 (317)
T 2pmi_A 213 NDEEQLKLIFDIMGTPNESLWPSVTKLP-KYNP-----NIQQ--RPPRDLRQV--------LQPHTKEPLDGNLMDFLHG 276 (317)
T ss_dssp SHHHHHHHHHHHHCSCCTTTCGGGGGCT-TCCT-----TCCC--CCCCCSHHH--------HGGGCSSCCCHHHHHHHHH
T ss_pred ChHHHHHHHHHHhCCCChhHhhhhhhhh-hccc-----cccc--ccchhHHHh--------hcccccccCCHHHHHHHHH
Confidence 9999999888888876654433221110 0000 0000 000000000 0112234567899999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
||+.||++|||++|+|+||||++....
T Consensus 277 ~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 277 LLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp HSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred HCCCCcccCCCHHHHhCChhhhcccch
Confidence 999999999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=400.39 Aligned_cols=302 Identities=26% Similarity=0.414 Sum_probs=221.0
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..+.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++|+|| +++++++..
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l~~~~~~ 96 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI-----IRLYDLIIP 96 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCC
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCc-----ceEEEEEec
Confidence 34567899999999999999999999999999999999753 2344677899999999998877 999998876
Q ss_pred C-----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 165 R-----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 165 ~-----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
. +.+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCCCcCCeEEEEEecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 5 6799999999889999998754 69999999999999999999999999999999999999887766666666
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCC-------ccccCCCcccccCCcccchhhhh-CCCCCccchHHHHHHHHHHH
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGST-------TFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a-------~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el 311 (433)
++......... ....++... ..........+||+.|+|||++. +..++.++|||||||++|||
T Consensus 175 la~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~el 245 (432)
T 3n9x_A 175 LARTINSEKDT---------NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245 (432)
T ss_dssp TCEEC----------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred Ccccccccccc---------cccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHH
Confidence 55443222110 000000000 00001124468999999999874 55699999999999999999
Q ss_pred Hh-----------CCCCCCCCC-----------------hHHHHHHHHHHhcCCChhhHHhhhh-hhhhhhcCCccccCC
Q 013941 312 CS-----------GEALFQTHE-----------------NLEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGARLDWP 362 (433)
Q Consensus 312 ~~-----------g~~pf~~~~-----------------~~~~~~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 362 (433)
++ |.++|.+.+ ..+++..+...+|.++...+..... ....+.....
T Consensus 246 l~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~----- 320 (432)
T 3n9x_A 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP----- 320 (432)
T ss_dssp HTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSC-----
T ss_pred HhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCC-----
Confidence 98 455555543 3677888888899888765443211 1111111000
Q ss_pred CCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 363 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
...+..........++++.+||.+||++||++|||++|+|+||||++.
T Consensus 321 ---------------~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 321 ---------------HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp ---------------CCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred ---------------CCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 000011112234568899999999999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=393.26 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=210.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++++.||+|+||.||+|++..+++.||||++++.. ...+....|..++..+ .|++ ++++++++.+.+
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~-----iv~l~~~~~~~~ 94 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF-----LTQLHSCFQTMD 94 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTT-----BCCEEEEEECSS
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCE-----EeeEEEEEEcCC
Confidence 57999999999999999999999999999999997532 3345677788888776 4554 499999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-------------- 158 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-------------- 158 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--------------
Confidence 999999999 999999998765 699999999999999999999999999999999999997665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 159 -------------~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 159 -------------HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp -------------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------------cEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 46667777665422 12334689999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+....+......+| ..++.++.+||.+|
T Consensus 226 ~~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~l 255 (353)
T 2i0e_A 226 EDELFQSIMEHNVAYP--------------------------------------------------KSMSKEAVAICKGL 255 (353)
T ss_dssp HHHHHHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCC--------------------------------------------------CCCCHHHHHHHHHH
Confidence 7766665554322221 23477899999999
Q ss_pred cccCCCCCC-----CHHHHhcCCCCCC
Q 013941 403 LRYDPAERL-----KAREALRHPFFTR 424 (433)
Q Consensus 403 L~~dP~~R~-----ta~ell~hp~f~~ 424 (433)
|+.||++|| +++++++||||+.
T Consensus 256 L~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 256 MTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp TCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred hhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 999999999 4799999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=394.50 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=214.6
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
+.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~ 96 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI-----VELLETYS 96 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTB-----CCEEEEEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCC-----CcEEEEEE
Confidence 4568999999999999999999999999999999986422 135678899999999988877 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+.+.+|+||||| +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~--------- 167 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE--------- 167 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS---------
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC---------
Confidence 999999999999 89998887643 223589999999999999999999999999999999999997644
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 168 ---------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 168 ---------------NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp ---------------TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ---------------CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCC
Confidence 2345899999988765433 2345899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.. ......+.......+. .....++.++.+
T Consensus 233 f~~~~-~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~ 265 (351)
T 3c0i_A 233 FYGTK-ERLFEGIIKGKYKMNP----------------------------------------------RQWSHISESAKD 265 (351)
T ss_dssp SCSSH-HHHHHHHHHTCCCCCH----------------------------------------------HHHTTSCHHHHH
T ss_pred CCCcH-HHHHHHHHcCCCCCCc----------------------------------------------cccccCCHHHHH
Confidence 98743 2333333221111110 112345779999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||+.||++|||+.|+++||||++.
T Consensus 266 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 266 LVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 9999999999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=381.29 Aligned_cols=279 Identities=29% Similarity=0.484 Sum_probs=216.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++++.||+|+||.||+|++ .+++.||+|++.... .....+.+|+.++++++|+|| +++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI-----VKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTB-----CCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCE-----eeeeeEEccCCeE
Confidence 5799999999999999999998 678899999986432 234677899999999988777 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----------------- 137 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG----------------- 137 (288)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-----------------
T ss_pred EEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-----------------
Confidence 9999999779999998653 4699999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 138 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (288)
T 1ob3_A 138 ----------ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (288)
T ss_dssp ----------CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ----------CEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 467777776654332 12234789999999999764 5899999999999999999999999999888
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+.+..+.+..+..+...+...... ..+. ..... ..+.........++.++.+||.+||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~ 266 (288)
T 1ob3_A 208 DQLMRIFRILGTPNSKNWPNVTEL-PKYD-----PNFTV---------------YEPLPWESFLKGLDESGIDLLSKMLK 266 (288)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGS-TTCC-----TTCCC---------------CCCCCGGGTCCSCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHHCCCChhhchhhhcc-cccc-----ccccc---------------ccCccHHHHhhhcCHHHHHHHHHHcC
Confidence 888888887766543221111100 0000 00000 00000112234567899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
.||++|||++|+++||||++.
T Consensus 267 ~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 267 LDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp SSTTTSCCHHHHHTSGGGGC-
T ss_pred CCcccCCCHHHHhcCcchhhc
Confidence 999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=399.26 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=210.5
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
...++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++|+|| +++++++.+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI-----IKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEe
Confidence 34468999999999999999999999999999999986432 233568899999999988877 999999999
Q ss_pred CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.+.+++||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~------------- 145 (336)
T 3h4j_B 81 PTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL------------- 145 (336)
T ss_dssp SSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-------------
T ss_pred CCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-------------
Confidence 99999999999999999998765 799999999999999999999999999999999999996554
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 146 --------------~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 146 --------------NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp --------------CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred --------------CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 5777788877654332 234589999999999988776 78999999999999999999999764
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
....... ... ..........++++.+||.+
T Consensus 212 ~~~~~~~--------------------------~i~------------------------~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 212 FIPNLFK--------------------------KVN------------------------SCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp SSTTCBC--------------------------CCC------------------------SSCCCCCTTSCHHHHHHHHT
T ss_pred cHHHHHH--------------------------HHH------------------------cCCCCCcccCCHHHHHHHHH
Confidence 3211000 000 00011123457899999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||+.||.+|||++|+++||||+....
T Consensus 242 ~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp TSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HcCCChhHCcCHHHHHhChhhccCCc
Confidence 99999999999999999999987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=390.63 Aligned_cols=283 Identities=29% Similarity=0.480 Sum_probs=219.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhh--HHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++++.||+|+||+||+|++..+++.||||+++..... ...+.+|+.+++.++|+|| +++++++.+.+..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTB-----CCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCC-----CeeeeEEeeCCEEE
Confidence 5799999999999999999999999999999998743321 1234469999999988777 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------------------ 137 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG------------------ 137 (324)
T ss_dssp EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC------------------
T ss_pred EEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC------------------
Confidence 999999889999998754 4699999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+
T Consensus 138 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 138 ---------ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp ---------CEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ---------CEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4667777766543322 223478999999999987 568999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+.+..+.++...+.......... ...++. ............++.++.+||.+||+.
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~ 268 (324)
T 3mtl_A 209 QLHFIFRILGTPTEETWPGILSNEEFK-----TYNYPK---------------YRAEALLSHAPRLDSDGADLLTKLLQF 268 (324)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCHHHH-----HTCCCC---------------CCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHhCCCChHhchhhhcchhhc-----cccccc---------------ccchhhhhhcCCCCHHHHHHHHHHcCc
Confidence 999999988877654332211110000 000000 000111223346678999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q 013941 406 DPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||++|||++|+|+||||++...
T Consensus 269 dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 269 EGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp SGGGSCCHHHHTTSGGGGGGCS
T ss_pred CcccCCCHHHHhcChhhhhccc
Confidence 9999999999999999997644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=389.26 Aligned_cols=250 Identities=22% Similarity=0.391 Sum_probs=204.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++++.||+|+||.||+|++..+++.||+|++++.. ...+.+.+|+.++.++ .|++| +++++++.+.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~l~~~~~~~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCcc-----CeEEEEEEeCC
Confidence 57999999999999999999999999999999997532 3345577899999887 67666 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~------------- 148 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH------------- 148 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-------------
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC-------------
Confidence 999999999 899999998764 7999999999999999999999999999999999999977665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 149 --------------~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 149 --------------IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp --------------EEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred --------------EEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 5555555554321 12334689999999999999999999999999999999999999996532
Q ss_pred hH---------HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 323 NL---------EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 323 ~~---------~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
.. .....+.... ......++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~~--------------------------------------------------~~~p~~~s~ 244 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVILEKQ--------------------------------------------------IRIPRSLSV 244 (345)
T ss_dssp C-------CHHHHHHHHHHCC--------------------------------------------------CCCCTTSCH
T ss_pred cccccccccHHHHHHHHHcCC--------------------------------------------------CCCCCCCCH
Confidence 11 1111111100 011234577
Q ss_pred HHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKA------REALRHPFFTRD 425 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta------~ell~hp~f~~~ 425 (433)
++.+||.+||+.||++||++ +|+++||||++.
T Consensus 245 ~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 99999999999999999995 899999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=391.31 Aligned_cols=286 Identities=28% Similarity=0.489 Sum_probs=219.8
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|+++++||+|+||+||+|++..+++.||||+++... .....+.+|+.++++++|+|| +++++++.+.+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 107 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI-----IELKSVIHHNHR 107 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTB-----CCEEEEEEETTE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCc-----ceEEEEEecCCE
Confidence 467999999999999999999999999999999997433 223456789999999988877 999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
+|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 108 ~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~--------------- 170 (329)
T 3gbz_A 108 LHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA--------------- 170 (329)
T ss_dssp EEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC------------------
T ss_pred EEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC---------------
Confidence 99999999889999998765 6999999999999999999999999999999999999975441
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
+....+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...
T Consensus 171 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 171 -------SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp ---------CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -------CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 23446899999988654322 2335789999999999875 489999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
.+.+..+....+.++...+....... .....++.... ..........++.++.+||.+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~L 303 (329)
T 3gbz_A 244 IDQLFKIFEVLGLPDDTTWPGVTALP------DWKQSFPKFRG--------------KTLKRVLGALLDDEGLDLLTAML 303 (329)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGST------TCCTTCCCCCC--------------CCHHHHHGGGSCHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCchhhhhhhhhhh------hhhhhhhhhcc--------------ccHhhhcccccCHHHHHHHHHHc
Confidence 88888888877765543222111000 00001111000 00111112235778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.||++|||++|+|+||||++.
T Consensus 304 ~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 304 EMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CSSGGGSCCHHHHHTSGGGSSS
T ss_pred cCChhhCCCHHHHhCCcccCCC
Confidence 9999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=393.66 Aligned_cols=258 Identities=28% Similarity=0.408 Sum_probs=204.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++++.||+|+||+||+|++..+++.||||++.......+.+.+|+.+++.++|+|| +++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI-----VRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCC-----CcEEEEEeeCCEEEE
Confidence 357999999999999999999999999999999998766666778899999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 94 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~------------------ 153 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP------------------ 153 (361)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS------------------
T ss_pred EEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------------------
Confidence 99999 999999998765 699999999999999999999999999999999999996543
Q ss_pred cccCCCCCCCeeeecCCCCcccc--CCCcccccCCcccchhhhhCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
...+||+|||++.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......
T Consensus 154 -------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 226 (361)
T 3uc3_A 154 -------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226 (361)
T ss_dssp -------SCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred -------CceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence 2348899999886432 22344689999999999998887655 8999999999999999999986543222
Q ss_pred HHHH-HHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 327 LAMM-ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 327 ~~~i-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
...+ ....... ..+ .....++.++.+||.+||+.
T Consensus 227 ~~~~~~~~~~~~---------------------~~~------------------------~~~~~~s~~~~~li~~~L~~ 261 (361)
T 3uc3_A 227 YRKTIQRILSVK---------------------YSI------------------------PDDIRISPECCHLISRIFVA 261 (361)
T ss_dssp HHHHHHHHHTTC---------------------CCC------------------------CTTSCCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHhcCC---------------------CCC------------------------CCcCCCCHHHHHHHHHHccC
Confidence 1111 1111000 000 01124577899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013941 406 DPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~ 425 (433)
||++|||+.|+++||||.+.
T Consensus 262 dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 262 DPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CTTTSCCHHHHHTSHHHHTT
T ss_pred ChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=394.43 Aligned_cols=283 Identities=27% Similarity=0.500 Sum_probs=211.6
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++|+|| +++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEecC
Confidence 3457899999999999999999999999999999998643 2345667789999999988877 8998887643
Q ss_pred ------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
+.+|+|||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-------- 169 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-------- 169 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--------
T ss_pred CccccCCeEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--------
Confidence 678999999999999998763 699999999999999999999999999999999999996554
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 170 -------------------~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 230 (367)
T 2fst_X 170 -------------------ELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230 (367)
T ss_dssp -------------------CEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred -------------------CEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 5778888877765555555689999999999987 57899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhh-hhhhhcCCccccCCCCCCchhhHHHHHHhcCch-hhhhhccCCchHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP-NLIMQHVDHSAGDLI 396 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 396 (433)
.+.+..+.+..+.+..+.++...+...... ...+...- ...+ ..........++.+.
T Consensus 231 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~ 289 (367)
T 2fst_X 231 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL---------------------TQMPKMNFANVFIGANPLAV 289 (367)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTS---------------------CCCCCCCHHHHTTTCCHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhcc---------------------CCCCCCCHHHHCCCCCHHHH
Confidence 999999999999999998876654432111 11111100 0000 001112235577899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
+||.+||+.||++|||++|+|+||||++...
T Consensus 290 dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 290 DLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 9999999999999999999999999997543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=401.69 Aligned_cols=258 Identities=25% Similarity=0.446 Sum_probs=199.6
Q ss_pred CCCeEEe-ccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceecc----
Q 013941 91 TPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY---- 164 (433)
Q Consensus 91 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~---- 164 (433)
.++|.+. +.||+|+||+||+|.+..+++.||||+++.. ....+|+.++.++ .|+|| +++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~i-----v~l~~~~~~~~~~ 130 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYAG 130 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEETT
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCc-----ceEeEEEeecccC
Confidence 3457776 7899999999999999999999999998643 3466788887555 45555 999888765
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.+.+||||||| +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~------------ 198 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR------------ 198 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS------------
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC------------
Confidence 67899999999 88999999876555799999999999999999999999999999999999997532
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+..+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 199 ------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 199 ------------PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ------------TTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ------------CCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 2456888999988754432 24468999999999999989999999999999999999999999765
Q ss_pred ChHH----HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 322 ENLE----HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 322 ~~~~----~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
.... ....+......+| ......++.++.+
T Consensus 267 ~~~~~~~~~~~~i~~~~~~~~----------------------------------------------~~~~~~~s~~~~~ 300 (400)
T 1nxk_A 267 HGLAISPGMKTRIRMGQYEFP----------------------------------------------NPEWSEVSEEVKM 300 (400)
T ss_dssp TTCSSCCSHHHHHHHTCCCCC----------------------------------------------TTTTTTSCHHHHH
T ss_pred ccccccHHHHHHHHcCcccCC----------------------------------------------CcccccCCHHHHH
Confidence 4321 1111111100000 0112346789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||.+||+.||++|||+.|+++||||.+...
T Consensus 301 li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 301 LIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred HHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=392.82 Aligned_cols=260 Identities=26% Similarity=0.467 Sum_probs=219.7
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+|| +++++++.+.+.+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~~ 123 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL-----INLHDAFEDKYEM 123 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTB-----CCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCC-----CeEEEEEEeCCEE
Confidence 4468999999999999999999999999999999987543 334567889999999988777 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~----------------- 185 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK----------------- 185 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-----------------
T ss_pred EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-----------------
Confidence 9999999 999999987543 369999999999999999999999999999999999999642
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 186 --------~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 257 (387)
T 1kob_A 186 --------KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257 (387)
T ss_dssp --------TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred --------CCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH
Confidence 23468999999887654332 33579999999999999999999999999999999999999999887776
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+......++. .....++.++.+||.+||+.
T Consensus 258 ~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~ 291 (387)
T 1kob_A 258 TLQNVKRCDWEFDE----------------------------------------------DAFSSVSPEAKDFIKNLLQK 291 (387)
T ss_dssp HHHHHHHCCCCCCS----------------------------------------------STTTTSCHHHHHHHHTTSCS
T ss_pred HHHHHHhCCCCCCc----------------------------------------------cccccCCHHHHHHHHHHcCC
Confidence 66655443211110 11234577999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q 013941 406 DPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~ 426 (433)
||++|||+.|+|+||||++..
T Consensus 292 dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 292 EPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp SGGGSCCHHHHHTSTTTSSCC
T ss_pred ChhHCcCHHHHhhCccccCCc
Confidence 999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=374.37 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=223.2
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++++++|+|+ +++++++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~ 76 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQE 76 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEC
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCc-----CeEEEEEEc
Confidence 356789999999999999999999999999999999986533 334667789999999988877 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.+..++||||+ +++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------------ 142 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------ 142 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS------------
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC------------
Confidence 99999999999 889999988764 699999999999999999999999999999999999997644
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 143 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 143 ------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp ------------TTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------CCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 23458999999886654433 3357999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+.......+.......|. .....+++++.+||.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~ 244 (284)
T 3kk8_A 211 DQHRLYAQIKAGAYDYPS----------------------------------------------PEWDTVTPEAKSLIDS 244 (284)
T ss_dssp SHHHHHHHHHHTCCCCCT----------------------------------------------TTTTTSCHHHHHHHHH
T ss_pred chhHHHHHHHhccccCCc----------------------------------------------hhhcccCHHHHHHHHH
Confidence 777666655543322221 0113456789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||+.||++|||++|+++||||++..+
T Consensus 245 ~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 245 MLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HcccChhhCCCHHHHhcCccccCChh
Confidence 99999999999999999999997644
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=398.84 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=213.1
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++++.||+|+||.||+|++..+++.||+|++++.. .....+.+|+.+++.++|++| +++++++.+.+
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFYAFQDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECC
Confidence 467999999999999999999999999999999997532 223347789999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||| ||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-------------- 205 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-------------- 205 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--------------
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC--------------
Confidence 999999999 99999999764 599999999999999999999999999999999999997665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCC----CCccchHHHHHHHHHHHHhCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 206 -------------~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 272 (410)
T 3v8s_A 206 -------------HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272 (410)
T ss_dssp -------------CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred -------------CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence 4677777776544332 23468999999999998765 78999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+.......+......+ .++ ....++.++++
T Consensus 273 f~~~~~~~~~~~i~~~~~~~----------------------~~p------------------------~~~~~s~~~~~ 306 (410)
T 3v8s_A 273 FYADSLVGTYSKIMNHKNSL----------------------TFP------------------------DDNDISKEAKN 306 (410)
T ss_dssp TCCSSHHHHHHHHHTHHHHC----------------------CCC------------------------TTCCCCHHHHH
T ss_pred CCCCChhhHHHHHHhccccc----------------------cCC------------------------CcccccHHHHH
Confidence 99888777766665421100 000 11245789999
Q ss_pred HHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAE--RLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~--R~ta~ell~hp~f~~~ 425 (433)
||.+||+.+|.+ |++++||++||||++.
T Consensus 307 li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 307 LICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999999988 9999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=407.48 Aligned_cols=271 Identities=26% Similarity=0.458 Sum_probs=226.8
Q ss_pred CCCceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--------------hhHHHHHHHHHHHH
Q 013941 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQ 143 (433)
Q Consensus 78 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~ 143 (433)
..+.|....+..+.++|+++++||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++
T Consensus 22 ~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 101 (504)
T 3q5i_A 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101 (504)
T ss_dssp CGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHH
T ss_pred chhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHH
Confidence 3455666667778899999999999999999999999999999999987532 23467889999999
Q ss_pred HHHhCCCCCcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCC
Q 013941 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (433)
Q Consensus 144 ~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp 222 (433)
++.|+|| +++++++.+.+.+|+||||| +++|.+++.... .+++..++.++.||+.||+|||++||+||||||
T Consensus 102 ~l~hpni-----v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp 174 (504)
T 3q5i_A 102 SLDHPNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174 (504)
T ss_dssp TCCCTTB-----CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred hCCCCCC-----CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcH
Confidence 9988877 99999999999999999999 899999998765 799999999999999999999999999999999
Q ss_pred CcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccch
Q 013941 223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCD 300 (433)
Q Consensus 223 ~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (433)
+|||++.++ ....+||+|||++...... ....+||+.|+|||++.+ .++.++|
T Consensus 175 ~Nil~~~~~------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~D 229 (504)
T 3q5i_A 175 ENILLENKN------------------------SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCD 229 (504)
T ss_dssp GGEEESSTT------------------------CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHH
T ss_pred HHEEEecCC------------------------CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHH
Confidence 999997644 2236899999998765433 234689999999999874 6899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc
Q 013941 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380 (433)
Q Consensus 301 iwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
||||||++|+|++|..||.+.+..+.+..+......++.
T Consensus 230 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------- 268 (504)
T 3q5i_A 230 VWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF----------------------------------------- 268 (504)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-----------------------------------------
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----------------------------------------
Confidence 999999999999999999998887777766553322221
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
..+..++.++++||.+||+.||++|||++|+|+||||++..
T Consensus 269 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 269 -----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp -----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred -----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 11234577999999999999999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=389.37 Aligned_cols=263 Identities=27% Similarity=0.445 Sum_probs=204.2
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.+.+.++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|+.+++++.|+|| +++++++.+.+
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~ 121 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNI-----IKLKEIFETPT 121 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCC-----cceeeeEecCC
Confidence 3556788999999999999999999999999999999997543 34567789999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~--------------- 184 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP--------------- 184 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS---------------
T ss_pred eEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC---------------
Confidence 999999999 899999997654 69999999999999999999999999999999999999642
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
+.+..+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 185 ---------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 185 ---------APDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp ---------STTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred ---------CCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 13456889999988754432 2345799999999999999999999999999999999999999977655
Q ss_pred HH-HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 324 LE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 324 ~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.. ....+.......+ ......++.++.+||.+|
T Consensus 256 ~~~~~~~i~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~ 289 (349)
T 2w4o_A 256 DQFMFRRILNCEYYFI----------------------------------------------SPWWDEVSLNAKDLVRKL 289 (349)
T ss_dssp HHHHHHHHHTTCCCCC----------------------------------------------TTTTTTSCHHHHHHHHTT
T ss_pred cHHHHHHHHhCCCccC----------------------------------------------CchhhhCCHHHHHHHHHH
Confidence 44 2222222111110 011234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 403 LRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
|+.||++|||+.|+|+||||++...
T Consensus 290 L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 290 IVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp SCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred ccCChhhCcCHHHHhcCcccCCCcc
Confidence 9999999999999999999997543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=390.75 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=210.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCe
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+... ...+|++++.++ .|+|| +++++++.+++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~i-----v~~~~~~~~~~~ 90 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNI-----ITLKDVYDDGKY 90 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTB-----CCEEEEEECSSE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCc-----CeEEEEEEcCCE
Confidence 455789999999999999999999999999999999975432 235688888888 57666 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||| +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+....
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~--------------- 153 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES--------------- 153 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS---------------
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC---------------
Confidence 99999999 899999998764 799999999999999999999999999999999999985432
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE- 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~- 322 (433)
.....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 154 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 154 --------GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp --------CSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred --------CCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 12235899999988754432 234588999999999998889999999999999999999999997632
Q ss_pred --hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 323 --NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 323 --~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
..+....+......++ ...+..++.++.+||.
T Consensus 226 ~~~~~~~~~i~~~~~~~~----------------------------------------------~~~~~~~s~~~~~li~ 259 (342)
T 2qr7_A 226 DTPEEILARIGSGKFSLS----------------------------------------------GGYWNSVSDTAKDLVS 259 (342)
T ss_dssp SCHHHHHHHHHHCCCCCC----------------------------------------------STTTTTSCHHHHHHHH
T ss_pred CCHHHHHHHHccCCcccC----------------------------------------------ccccccCCHHHHHHHH
Confidence 2233333322111111 0112356789999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||+.||++|||+.|+++||||.+.
T Consensus 260 ~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 260 KMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHCCCChhHCcCHHHHhcCCeecCc
Confidence 9999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=386.95 Aligned_cols=290 Identities=29% Similarity=0.536 Sum_probs=228.3
Q ss_pred ecCCcc--CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 85 AIGENL--TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 85 ~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
..|+.+ .++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.++.+++|+|| +++++
T Consensus 18 ~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~ 92 (364)
T 3qyz_A 18 VRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI-----IGIND 92 (364)
T ss_dssp CC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB-----CCCCE
T ss_pred EccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCC-----cccee
Confidence 334444 47899999999999999999999999999999999743 2344677899999999998877 88888
Q ss_pred eeccC-----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccc
Q 013941 161 WFDYR-----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 161 ~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l 235 (433)
++... ...|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---- 165 (364)
T 3qyz_A 93 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC---- 165 (364)
T ss_dssp EECCSSTTTCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----
T ss_pred EEecCCccccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC----
Confidence 88654 479999999988999999765 599999999999999999999999999999999999997655
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCC-CCCccchHHHHHHHH
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCIL 308 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 308 (433)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 166 -----------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 222 (364)
T 3qyz_A 166 -----------------------DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222 (364)
T ss_dssp -----------------------CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHH
T ss_pred -----------------------CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHH
Confidence 4677777777544322 1335899999999987654 589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhh-hhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 309 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
|+|++|+.||.+.+..+.+..+...++.++...+..... ....+... .+. .........
T Consensus 223 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~---------------~~~~~~~~~ 282 (364)
T 3qyz_A 223 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS-----LPH---------------KNKVPWNRL 282 (364)
T ss_dssp HHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT-----SCC---------------CCCCCHHHH
T ss_pred HHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh-----cCC---------------ccCCCHHHh
Confidence 999999999999999999999999888877655432211 00001000 000 000001122
Q ss_pred cCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
....+.++.+||.+||++||++|||++|+|+||||++...+.
T Consensus 283 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~ 324 (364)
T 3qyz_A 283 FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324 (364)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence 345678999999999999999999999999999999865443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=384.62 Aligned_cols=262 Identities=29% Similarity=0.497 Sum_probs=194.8
Q ss_pred CCeEEe---ccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceeEecceeccCCe
Q 013941 92 PRYRIL---SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++. +.||+|+||.||+|.+..+++.||||++... ......+|+.+++.+. |+|| +++++++.+.+.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~ni-----v~~~~~~~~~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNI-----VKLHEVFHDQLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCe-----eEEEEEEEcCCE
Confidence 467776 7899999999999999999999999998653 3456778999999997 6666 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--------------- 143 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN--------------- 143 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----------------
T ss_pred EEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC---------------
Confidence 99999999 889999998764 799999999999999999999999999999999999997644
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 144 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 144 ---------DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp -----------CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred ---------CcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 2336889999988754332 2345789999999999999999999999999999999999999976543
Q ss_pred H-------HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 324 L-------EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 324 ~-------~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
. +....+......+ .......++.++.
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~----------------------------------------------~~~~~~~~s~~~~ 248 (325)
T 3kn6_A 215 SLTCTSAVEIMKKIKKGDFSF----------------------------------------------EGEAWKNVSQEAK 248 (325)
T ss_dssp ---CCCHHHHHHHHTTTCCCC----------------------------------------------CSHHHHTSCHHHH
T ss_pred ccccccHHHHHHHHHcCCCCC----------------------------------------------CcccccCCCHHHH
Confidence 2 1111111100000 0111234577999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCCccccCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~~~ 432 (433)
+||.+||+.||++|||++|+++||||++.......|
T Consensus 249 ~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~ 284 (325)
T 3kn6_A 249 DLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284 (325)
T ss_dssp HHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSC
T ss_pred HHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCC
Confidence 999999999999999999999999999875544444
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=386.59 Aligned_cols=256 Identities=22% Similarity=0.388 Sum_probs=207.5
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+.++|++++.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+|| +++++++.+++.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCC-----CeEEEEEecCCe
Confidence 4568999999999999999999999999999999986432 233567889999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--------------- 142 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--------------- 142 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---------------
T ss_pred EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC---------------
Confidence 99999999 889999987654 699999999999999999999999999999999999996654
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 143 ------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 143 ------------NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp ------------CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ------------CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 5777777777543211 234589999999999988775 7899999999999999999999976
Q ss_pred CChHHHH-HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 321 HENLEHL-AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 321 ~~~~~~~-~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
....... ..+..... .......++..+.+||
T Consensus 211 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 211 PSDSCQEYSDWKEKKT------------------------------------------------YLNPWKKIDSAPLALL 242 (323)
T ss_dssp SCTTSHHHHHHHTTCT------------------------------------------------TSTTGGGSCHHHHHHH
T ss_pred CchHHHHHHHHhcccc------------------------------------------------cCCccccCCHHHHHHH
Confidence 5543211 11110000 0001134567899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.+||+.||++|||++|+++||||++...
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhccccc
Confidence 9999999999999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=381.38 Aligned_cols=260 Identities=25% Similarity=0.330 Sum_probs=206.1
Q ss_pred CceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHH-HhCCCCCcce
Q 013941 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL-ARHDIGGTRC 155 (433)
Q Consensus 80 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~~~~i~~~~~ 155 (433)
++++...++.+.++|++.++||+|+||+||+|++..+++.||||++.... ........|+..+.++ .|+++
T Consensus 45 ~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~i----- 119 (311)
T 3p1a_A 45 GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC----- 119 (311)
T ss_dssp TCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTB-----
T ss_pred CCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcE-----
Confidence 44455566777789999999999999999999999999999999986432 2334445566666555 56665
Q ss_pred eEecceeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccc
Q 013941 156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 156 v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l 235 (433)
+++++++.+++.+|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 120 v~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~---- 194 (311)
T 3p1a_A 120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG---- 194 (311)
T ss_dssp CCEEEEEEETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG----
T ss_pred EEEEEEEEeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC----
Confidence 99999999999999999999999999988754 4699999999999999999999999999999999999997655
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 313 (433)
.+||+|||++....... ....||+.|+|||++.+ .++.++|||||||++|||++
T Consensus 195 -----------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~ 250 (311)
T 3p1a_A 195 -----------------------RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC 250 (311)
T ss_dssp -----------------------CEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHH
T ss_pred -----------------------CEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHh
Confidence 46777777765543322 23469999999999887 78999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|..||.+..... .+.. +..+ ......++.
T Consensus 251 g~~~~~~~~~~~---~~~~--~~~~----------------------------------------------~~~~~~~~~ 279 (311)
T 3p1a_A 251 NMELPHGGEGWQ---QLRQ--GYLP----------------------------------------------PEFTAGLSS 279 (311)
T ss_dssp TCCCCSSHHHHH---HHTT--TCCC----------------------------------------------HHHHTTSCH
T ss_pred CCCCCCCccHHH---HHhc--cCCC----------------------------------------------cccccCCCH
Confidence 977765432211 1100 0011 011234577
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
++.+||.+||+.||++|||++|+++||||++
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=381.48 Aligned_cols=262 Identities=27% Similarity=0.477 Sum_probs=221.4
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
+.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++.+.|+++ +++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~ 82 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV-----ITLHD 82 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCc-----ceEEE
Confidence 4556789999999999999999999999999999999875321 35678899999999988877 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
++.+.+..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~------- 153 (321)
T 2a2a_A 83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI------- 153 (321)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS-------
T ss_pred EEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCC-------
Confidence 999999999999999 899999998754 7999999999999999999999999999999999999976541
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
....++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 154 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 217 (321)
T 2a2a_A 154 ----------------PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (321)
T ss_dssp ----------------SSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred ----------------CcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCC
Confidence 1225888888888654432 2345799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+....+....+.......+.. .....+..+.+
T Consensus 218 f~~~~~~~~~~~i~~~~~~~~~~----------------------------------------------~~~~~~~~~~~ 251 (321)
T 2a2a_A 218 FLGDTKQETLANITSVSYDFDEE----------------------------------------------FFSHTSELAKD 251 (321)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCHH----------------------------------------------HHTTCCHHHHH
T ss_pred CCCCCHHHHHHHHHhcccccChh----------------------------------------------hhcccCHHHHH
Confidence 99887776666554433222211 12345678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||+.||++|||++|+++||||+..
T Consensus 252 li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 252 FIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=391.45 Aligned_cols=303 Identities=27% Similarity=0.460 Sum_probs=224.3
Q ss_pred CCceeeecCC---ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCC
Q 013941 79 DGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGG 152 (433)
Q Consensus 79 ~~~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~ 152 (433)
..+|.+.+++ .+.++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++|+||
T Consensus 9 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-- 86 (371)
T 2xrw_A 9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI-- 86 (371)
T ss_dssp GGEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTB--
T ss_pred CcceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCc--
Confidence 4566777776 3568999999999999999999999999999999998643 2344667889999999988877
Q ss_pred cceeEecceeccCC------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 153 TRCVQIRNWFDYRN------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 153 ~~~v~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
+++++++...+ .+|+||||+.++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 87 ---v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl 159 (371)
T 2xrw_A 87 ---IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159 (371)
T ss_dssp ---CCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ---cceEEeeccccccccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEE
Confidence 99999887654 8999999998899998863 5899999999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (433)
++.++ .+||+|||++...... .....||+.|+|||++.+..++.++|||||
T Consensus 160 ~~~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 212 (371)
T 2xrw_A 160 VKSDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212 (371)
T ss_dssp ECTTS---------------------------CEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred EcCCC---------------------------CEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence 97655 5677777777654332 233589999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 305 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
||++|+|++|..||.+.+..+.+..+.+..+..+..+..........+........ .. ...........+ ..
T Consensus 213 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~~-~~ 284 (371)
T 2xrw_A 213 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA--GY-----SFEKLFPDVLFP-AD 284 (371)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCC--CC-----CHHHHSCGGGSC-CS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcccc--cc-----chhhhcccccCc-cc
Confidence 99999999999999999998888888888777766655443333222222111000 00 000000000000 00
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.......+.++++||.+||+.||++|||++|+|+||||+..
T Consensus 285 ~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 285 SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp SHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00011225689999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=388.08 Aligned_cols=293 Identities=28% Similarity=0.486 Sum_probs=232.6
Q ss_pred CCCCCceeeecCC---ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCC
Q 013941 76 DDKDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHD 149 (433)
Q Consensus 76 ~~~~~~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~ 149 (433)
....+.|...... .+.++|.+.+.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.++|+|
T Consensus 23 ~~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 102 (371)
T 4exu_A 23 IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102 (371)
T ss_dssp SSCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred eccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCC
Confidence 3456677666654 3678999999999999999999999999999999999753 234567788999999999887
Q ss_pred CCCcceeEecceeccCCeE------EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCC
Q 013941 150 IGGTRCVQIRNWFDYRNHI------CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (433)
Q Consensus 150 i~~~~~v~~~~~~~~~~~~------~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~ 223 (433)
+ +++++++...+.. |+||||++++|.+++.. .+++..++.++.||+.||+|||++||+||||||+
T Consensus 103 i-----v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 173 (371)
T 4exu_A 103 V-----IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 173 (371)
T ss_dssp B-----CCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred c-----hhhhhheeccCCcccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHH
Confidence 7 9999999876654 99999998899888743 5999999999999999999999999999999999
Q ss_pred cEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHH
Q 013941 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLW 302 (433)
Q Consensus 224 NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 302 (433)
|||++.++ .+||+|||++...........||+.|+|||++.+ ..++.++|||
T Consensus 174 NIll~~~~---------------------------~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (371)
T 4exu_A 174 NLAVNEDC---------------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 226 (371)
T ss_dssp GEEECTTC---------------------------CEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHH
T ss_pred HeEECCCC---------------------------CEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHH
Confidence 99996544 5788888888766666666789999999999987 6789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhc-C-c
Q 013941 303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL-R-L 380 (433)
Q Consensus 303 SlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~ 380 (433)
||||++|+|++|..||.+.+..+.+..+....+.++..+........... ..+.. . .
T Consensus 227 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~ 285 (371)
T 4exu_A 227 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS---------------------YIQSLPQTP 285 (371)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH---------------------HHHHSCCCC
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh---------------------hhhccCCCc
Confidence 99999999999999999999999999999988888776544322111100 00000 0 0
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
..........+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 286 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred chhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 011112234568899999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=397.67 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=212.9
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
..++|+++++||+|+||+||+|++..+++.||+|++++... ....+.+|+.++..+.|++| +++++++.+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I-----v~l~~~~~~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI-----TTLHYAFQDD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB-----CCEEEEEECS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEeeC
Confidence 34689999999999999999999999999999999975321 22337789999999988877 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.+|+||||| +|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g------------- 212 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG------------- 212 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-------------
T ss_pred CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-------------
Confidence 9999999999 999999998642 3799999999999999999999999999999999999997665
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHHhCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
.+||+|||++....... ...+||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 213 --------------~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 213 --------------HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp --------------CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred --------------CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 46777777665433221 2358999999999997 456899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHh--cCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 316 ALFQTHENLEHLAMMERVL--GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
.||.+.+..+....+.... ..+|. ....+++
T Consensus 279 ~Pf~~~~~~~~~~~i~~~~~~~~~p~-----------------------------------------------~~~~~s~ 311 (437)
T 4aw2_A 279 TPFYAESLVETYGKIMNHKERFQFPT-----------------------------------------------QVTDVSE 311 (437)
T ss_dssp CTTCCSSHHHHHHHHHTHHHHCCCCS-----------------------------------------------SCCCSCH
T ss_pred CCCCCCChhHHHHhhhhccccccCCc-----------------------------------------------ccccCCH
Confidence 9999888777766664321 11111 1134578
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 013941 394 DLIDLLQGLLRYDPAE--RLKAREALRHPFFTR 424 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~--R~ta~ell~hp~f~~ 424 (433)
++++||.+||+.+|++ |++++|+++||||++
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred HHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 9999999999999988 999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=376.22 Aligned_cols=282 Identities=31% Similarity=0.561 Sum_probs=220.6
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++++.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++|+|+ +++++++...+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL-----VNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCc-----cchhheeecCCe
Confidence 368999999999999999999999999999999986433 234567789999999998877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--------------- 139 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--------------- 139 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------
T ss_pred EEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC---------------
Confidence 99999999 778888876554 699999999999999999999999999999999999996554
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++...... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 140 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 140 ------------VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp ------------CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------------CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 5777888877654322 233578999999999987 568999999999999999999999999999
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+....+....+..+.......... .++. +. ..+...... ........++.++.+||.+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~--~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~ 268 (311)
T 4agu_A 208 DVDQLYLIRKTLGDLIPRHQQVFSTN--QYFS-GV--KIPDPEDME--------------PLELKFPNISYPALGLLKGC 268 (311)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHHHTC--GGGT-TC--CCCCCSSCC--------------CHHHHCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcccccccccccccc--cccc-cC--cCCCccccc--------------hhhhhcccccHHHHHHHHHH
Confidence 99998888888887765443222111 1111 10 111100000 00111245678899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|+.||++|||++|+++||||++.
T Consensus 269 L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 269 LHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCChhhcCCHHHHhcChHHHhc
Confidence 99999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=383.20 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=205.8
Q ss_pred CCCeEEeccccccccEEEEEEEec---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
.++|++.+.||+|+||.||+|++. .+++.||+|++++.. .....+.+|+.+++.++|+|| +++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI-----VDLIYAF 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTB-----CCEEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCc-----cceeEEE
Confidence 357999999999999999999985 688999999997532 233456789999999988877 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
.+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~---------- 158 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG---------- 158 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS----------
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC----------
Confidence 9999999999999 899999998765 699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 159 -----------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 221 (327)
T 3a62_A 159 -----------------HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221 (327)
T ss_dssp -----------------CEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----------------cEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence 467777776654221 123457999999999999989999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+.......+......+| ..++.++.+|
T Consensus 222 ~~~~~~~~~~~i~~~~~~~p--------------------------------------------------~~~~~~~~~l 251 (327)
T 3a62_A 222 TGENRKKTIDKILKCKLNLP--------------------------------------------------PYLTQEARDL 251 (327)
T ss_dssp CCSSHHHHHHHHHHTCCCCC--------------------------------------------------TTSCHHHHHH
T ss_pred CCCCHHHHHHHHHhCCCCCC--------------------------------------------------CCCCHHHHHH
Confidence 98877766665544322222 2346789999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 013941 399 LQGLLRYDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 399 i~~~L~~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
|.+||+.||++|| +++|+++||||++.
T Consensus 252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999 89999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=390.72 Aligned_cols=281 Identities=31% Similarity=0.552 Sum_probs=221.6
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec------
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD------ 163 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~------ 163 (433)
..++|++.+.||+|+||+||+|++..+++.||||++...... ..+|+.+++.++|+|| +++++++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnI-----v~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNI-----IKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTB-----CCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCc-----cchhheeeecCccc
Confidence 356899999999999999999999999999999998654332 3469999999988877 99988873
Q ss_pred --------------------------------cCCeEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHH
Q 013941 164 --------------------------------YRNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAF 209 (433)
Q Consensus 164 --------------------------------~~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~ 209 (433)
....+++||||+.++|.+.+.. .....+++..++.++.||+.||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3445899999998898888763 223479999999999999999999
Q ss_pred HHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccch
Q 013941 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAP 287 (433)
Q Consensus 210 LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aP 287 (433)
||++||+||||||+|||++. .+..+||+|||++..... ......||+.|+||
T Consensus 157 LH~~gi~H~Dikp~Nil~~~--------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP 210 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNS--------------------------KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP 210 (383)
T ss_dssp HHTTTEECSCCCGGGEEEET--------------------------TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred HHHCcCccCccCHHHEEEcC--------------------------CCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence 99999999999999999963 223578888888865432 23345789999999
Q ss_pred hhhhCCC-CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCC
Q 013941 288 EVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 366 (433)
Q Consensus 288 E~~~~~~-~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (433)
|++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++...+........ ...++....
T Consensus 211 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~-------~~~~~~~~~ 283 (383)
T 3eb0_A 211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT-------EVRFPTLKA 283 (383)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC---------CCCCCCCC
T ss_pred HHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc-------cccCCccCc
Confidence 9998754 89999999999999999999999999999999999999999887665443322111 111111110
Q ss_pred chhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 367 SRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
...........+.++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 284 --------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 284 --------------KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp --------------CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred --------------ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 011112234567899999999999999999999999999999853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=392.18 Aligned_cols=308 Identities=19% Similarity=0.204 Sum_probs=212.9
Q ss_pred CCeEEecccccc--ccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++++.||+| +||.||+|++..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++.+.+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~ 99 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI-----VPYRATFIADN 99 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETT
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCC-----CcEeEEEEECC
Confidence 479999999999 99999999999999999999997542 344667789999999998877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||| +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~--- 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL--- 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE---
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce---
Confidence 999999999 8999999987655579999999999999999999999999999999999999888777666666532
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccc-cCCCcccccCCcccchhhhhC--CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+.+.|..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 177 ---------------~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 177 ---------------SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp ---------------ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ---------------eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22222222111 112233588999999999988 578999999999999999999999998766
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHH-hcCchhhhhhccCCchHHHHHHHHH
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK-LLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
.......+... ..+... .........+........... ........... ..............++.++.+||.+
T Consensus 242 ~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 316 (389)
T 3gni_B 242 ATQMLLEKLNG--TVPCLL-DTSTIPAEELTMSPSRSVANS--GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316 (389)
T ss_dssp STTHHHHC-------------------------------------------------------------CCHHHHHHHHH
T ss_pred HHHHHHHHhcC--CCCccc-ccccccccccccccccccccc--ccccccccCccccccCCCCCCccccccCHHHHHHHHH
Confidence 65544332221 111000 000000000000000000000 00000000000 0000001112334568899999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||+.||++|||++|+|+||||++...
T Consensus 317 ~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 317 CLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred HhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 99999999999999999999997543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=389.28 Aligned_cols=251 Identities=23% Similarity=0.433 Sum_probs=208.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++++.||+|+||.||+|++..+++.||+|++.+.. .....+.+|+.+++.++|++| +++++++.+.+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL-----VNLWYSFQDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEeCC
Confidence 368999999999999999999999999999999987532 234667889999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ |++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-------------- 152 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-------------- 152 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--------------
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC--------------
Confidence 999999999 999999998764 799999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhC---CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 153 -------------~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 153 -------------HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp -------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -------------CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 567777777765432 2244689999999999974 4589999999999999999999999975
Q ss_pred CChHH---HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 321 HENLE---HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 321 ~~~~~---~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
..... ....+...... ....++.++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~--------------------------------------------------~p~~~s~~~~~ 249 (384)
T 4fr4_A 220 RSSTSSKEIVHTFETTVVT--------------------------------------------------YPSAWSQEMVS 249 (384)
T ss_dssp CTTSCHHHHHHHHHHCCCC--------------------------------------------------CCTTSCHHHHH
T ss_pred CCCccHHHHHHHHhhcccC--------------------------------------------------CCCcCCHHHHH
Confidence 43322 22222111111 12345778999
Q ss_pred HHHHhcccCCCCCCC-HHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLK-AREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~t-a~ell~hp~f~~~ 425 (433)
||.+||+.||++||+ ++++++||||++.
T Consensus 250 li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 999999999999998 9999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=387.82 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=201.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh----hHHHHHHHHHH-HHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDV-LQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~-l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++++.||+|+||.||+|+++.+++.||||++++... ....+..|..+ ++.+.| ++++++++++.+.+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~h-----p~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-----PFLVGLHFSFQTAD 112 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCC-----TTBCCEEEEEECSS
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCC-----CCCCCEEEEEEeCC
Confidence 469999999999999999999999999999999975432 22334445544 233444 55599999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ |++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-------------- 176 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-------------- 176 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--------------
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--------------
Confidence 999999999 999999998764 799999999999999999999999999999999999997666
Q ss_pred CCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 177 -------------~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 177 -------------HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp -------------CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred -------------CEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 45666666665422 12344689999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+....+...... ....++.++.+||.+|
T Consensus 244 ~~~~~~~i~~~~~~--------------------------------------------------~~~~~~~~~~~li~~l 273 (373)
T 2r5t_A 244 TAEMYDNILNKPLQ--------------------------------------------------LKPNITNSARHLLEGL 273 (373)
T ss_dssp HHHHHHHHHHSCCC--------------------------------------------------CCSSSCHHHHHHHHHH
T ss_pred HHHHHHHHHhcccC--------------------------------------------------CCCCCCHHHHHHHHHH
Confidence 77666555432111 1134577899999999
Q ss_pred cccCCCCCCCH----HHHhcCCCCCC
Q 013941 403 LRYDPAERLKA----REALRHPFFTR 424 (433)
Q Consensus 403 L~~dP~~R~ta----~ell~hp~f~~ 424 (433)
|+.||++|+++ +++++||||+.
T Consensus 274 L~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 274 LQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp TCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred cccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999986 69999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=387.53 Aligned_cols=257 Identities=29% Similarity=0.445 Sum_probs=210.9
Q ss_pred CCeEE--eccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
..|.+ .+.||+|+||.||+|++..+|+.||+|+++... ...+.+.+|+.++++++|+|| +++++++.+.+.+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~~ 161 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL-----IQLYDAFESKNDI 161 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCEE
Confidence 34555 678999999999999999999999999997543 445678899999999988777 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+..+
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----------------- 223 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR----------------- 223 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET-----------------
T ss_pred EEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC-----------------
Confidence 9999999 899999887543 368999999999999999999999999999999999999542
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 224 --------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 295 (373)
T 2x4f_A 224 --------DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295 (373)
T ss_dssp --------TTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------CCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 2335788888888765432 233579999999999998889999999999999999999999999888777
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+......++. .....++.++.+||.+||+.
T Consensus 296 ~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~L~~ 329 (373)
T 2x4f_A 296 TLNNILACRWDLED----------------------------------------------EEFQDISEEAKEFISKLLIK 329 (373)
T ss_dssp HHHHHHHTCCCSCS----------------------------------------------GGGTTSCHHHHHHHHTTSCS
T ss_pred HHHHHHhccCCCCh----------------------------------------------hhhccCCHHHHHHHHHHcCC
Confidence 76666543222211 11234577999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013941 406 DPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~ 425 (433)
||++|||++|+|+||||++.
T Consensus 330 dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 330 EKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp SGGGSCCHHHHHHSHHHHCH
T ss_pred ChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=372.73 Aligned_cols=263 Identities=24% Similarity=0.424 Sum_probs=221.1
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++|+|+ +++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 80 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI-----IRLYETFEDNTD 80 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCe
Confidence 3456899999999999999999999999999999998753 2345678899999999988777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+..+
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---------------- 142 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD---------------- 142 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS----------------
T ss_pred EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC----------------
Confidence 99999999 889999998765 69999999999999999999999999999999999999432
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
+.+..++|+|||++...... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus 143 --------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (277)
T 3f3z_A 143 --------SPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213 (277)
T ss_dssp --------STTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------CCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence 13446888999988654332 2345799999999998764 899999999999999999999999988877
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+.......|.. ....+++.+.+||.+||+
T Consensus 214 ~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~l~ 247 (277)
T 3f3z_A 214 EVMLKIREGTFTFPEK----------------------------------------------DWLNVSPQAESLIRRLLT 247 (277)
T ss_dssp HHHHHHHHCCCCCCHH----------------------------------------------HHTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCch----------------------------------------------hhhcCCHHHHHHHHHHcc
Confidence 7666665543333321 112456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 405 YDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
.||++|||+.|+++||||++.....
T Consensus 248 ~dp~~R~s~~~~l~h~~~~~~~~~~ 272 (277)
T 3f3z_A 248 KSPKQRITSLQALEHEWFEKQLSSS 272 (277)
T ss_dssp SSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred CChhhCcCHHHHhcCHHHhcccccc
Confidence 9999999999999999999865543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=400.92 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=215.6
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
....++|.+.+.||+|+||.||+|++..+|+.||||++.... .....+.+|+.+++.++|+|| +++++++.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~l~~~~~ 86 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI-----IKLYQVIS 86 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTB-----CCEEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEE
Confidence 334468999999999999999999999999999999997532 234578899999999988777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~----------- 153 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM----------- 153 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-----------
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-----------
Confidence 999999999999 999999997654 799999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
.+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 154 ----------------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 154 ----------------NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp ----------------CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ----------------CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 4677777777654332 234589999999999998775 689999999999999999999998
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
+.+.......+....... ...+++++.+||
T Consensus 218 ~~~~~~~~~~i~~~~~~~--------------------------------------------------p~~~s~~~~~Li 247 (476)
T 2y94_A 218 DDHVPTLFKKICDGIFYT--------------------------------------------------PQYLNPSVISLL 247 (476)
T ss_dssp CSSSHHHHHHHHTTCCCC--------------------------------------------------CTTCCHHHHHHH
T ss_pred CCCHHHHHHHHhcCCcCC--------------------------------------------------CccCCHHHHHHH
Confidence 877666555443322111 123467899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.+||+.||++|||++|+++||||++...
T Consensus 248 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 248 KHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred HHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 9999999999999999999999987643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=391.89 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=209.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++++.||+|+||.||+|+++.+++.||||++++.. ...+.+.+|..++..+.|++| +++++++.+.+
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I-----v~l~~~~~~~~ 134 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI-----TQLHFAFQDEN 134 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB-----CCEEEEEECSS
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEeeCC
Confidence 468999999999999999999999999999999997532 223446789999999888777 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ +++|.+++.+.+ ..+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-------------- 199 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-------------- 199 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--------------
T ss_pred EEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC--------------
Confidence 999999999 999999998653 3699999999999999999999999999999999999997666
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhh-------CCCCCccchHHHHHHHHHHHHhC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL-------GLGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~el~~g 314 (433)
.+||+|||++....... ...+||+.|+|||++. +..++.++|||||||++|||++|
T Consensus 200 -------------~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG 266 (412)
T 2vd5_A 200 -------------HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266 (412)
T ss_dssp -------------CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred -------------CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence 46666666665433221 2358999999999997 35689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHh--cCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 315 EALFQTHENLEHLAMMERVL--GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+.||.+.+..+....+.... ..+|. ....++
T Consensus 267 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~-----------------------------------------------~~~~~s 299 (412)
T 2vd5_A 267 QTPFYADSTAETYGKIVHYKEHLSLPL-----------------------------------------------VDEGVP 299 (412)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCCC---------------------------------------------------CCC
T ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCc-----------------------------------------------cccCCC
Confidence 99999888777666654321 11110 113457
Q ss_pred HHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAER---LKAREALRHPFFTR 424 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R---~ta~ell~hp~f~~ 424 (433)
.++++||.+||+ +|++| ++++|+++||||++
T Consensus 300 ~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 899999999999 99998 49999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=379.33 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=201.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh---------------------------hHHHHHHHHHHHHH
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------------------YREAAMIEIDVLQR 144 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~ 144 (433)
++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 679999999999999999999999999999999865321 12457789999999
Q ss_pred HHhCCCCCcceeEecceecc--CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCC
Q 013941 145 LARHDIGGTRCVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221 (433)
Q Consensus 145 l~~~~i~~~~~v~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik 221 (433)
++|+|| +++++++.+ .+.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+|||||
T Consensus 93 l~h~~i-----v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNV-----VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp CCCTTB-----CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred CCCCCC-----CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 988877 999999876 67899999999 8898876543 369999999999999999999999999999999
Q ss_pred CCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCC---C
Q 013941 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG---W 295 (433)
Q Consensus 222 p~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~---~ 295 (433)
|+|||++.++ .+||+|||++....... ....||+.|+|||++.+.. +
T Consensus 165 p~Nil~~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 217 (298)
T 2zv2_A 165 PSNLLVGEDG---------------------------HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFS 217 (298)
T ss_dssp GGGEEECTTS---------------------------CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEE
T ss_pred HHHEEECCCC---------------------------CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCC
Confidence 9999997655 46777777776543322 2357999999999998765 3
Q ss_pred CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHH
Q 013941 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375 (433)
Q Consensus 296 ~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (433)
+.++|||||||++|+|++|..||.+.........+.......|
T Consensus 218 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------------------------- 260 (298)
T 2zv2_A 218 GKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFP------------------------------------- 260 (298)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------------------------------
T ss_pred CchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCC-------------------------------------
Confidence 7889999999999999999999987765544443332111111
Q ss_pred HhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
....++.++.+||.+||+.||++|||+.|+++||||++
T Consensus 261 -----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 261 -----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp -----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred -----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 11345778999999999999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=376.89 Aligned_cols=262 Identities=25% Similarity=0.412 Sum_probs=205.2
Q ss_pred CccCCCeEEe-ccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHH-HhCCCCCcceeEecceecc
Q 013941 88 ENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 88 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~ 164 (433)
..+.++|++. +.||+|+||.||+|++..+++.||||++.... .....+.+|+.++.++ .|+|| +++++++.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i-----~~~~~~~~~ 82 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV-----LELIEFFEE 82 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCe-----eeEEEEEee
Confidence 3456789996 78999999999999999999999999997543 3456788999999885 56666 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----------- 149 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ----------- 149 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS-----------
T ss_pred CCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC-----------
Confidence 99999999999 899999998764 7999999999999999999999999999999999999976542
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhC-----CCCCccchHHHHHHHH
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCIL 308 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il 308 (433)
...+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 216 (316)
T 2ac3_A 150 -------------VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216 (316)
T ss_dssp -------------SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred -------------cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence 234788888877543211 123469999999999975 4578999999999999
Q ss_pred HHHHhCCCCCCCCChHH---------------HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHH
Q 013941 309 VELCSGEALFQTHENLE---------------HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373 (433)
Q Consensus 309 ~el~~g~~pf~~~~~~~---------------~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (433)
|+|++|..||.+....+ ....+......+|
T Consensus 217 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~----------------------------------- 261 (316)
T 2ac3_A 217 YILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP----------------------------------- 261 (316)
T ss_dssp HHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC-----------------------------------
T ss_pred HHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC-----------------------------------
Confidence 99999999997654211 1111111100010
Q ss_pred HHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
......++.++.+||.+||+.||++|||++|+++||||++..
T Consensus 262 -----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 262 -----------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred -----------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 111234577899999999999999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=403.44 Aligned_cols=263 Identities=29% Similarity=0.497 Sum_probs=219.2
Q ss_pred ecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
.....+.++|++++.||+|+||+||+|++..+++.||+|++.+.. .....+.+|+.+++.+.|+|| ++++++
T Consensus 30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~ 104 (494)
T 3lij_A 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI-----MKLYDF 104 (494)
T ss_dssp CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTB-----CCEEEE
T ss_pred cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCC-----CeEEEE
Confidence 334456678999999999999999999999999999999987532 335678899999999988877 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+.+.+.+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 105 ~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--------- 173 (494)
T 3lij_A 105 FEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE--------- 173 (494)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS---------
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC---------
Confidence 99999999999999 999999988765 699999999999999999999999999999999999996543
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
....+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 174 ---------------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 174 ---------------KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp ---------------TTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ---------------CCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCC
Confidence 3446899999998765433 234689999999999864 6999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+..+.+..+......++. ..+..++..+.+|
T Consensus 238 ~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~l 271 (494)
T 3lij_A 238 GGQTDQEILRKVEKGKYTFDS----------------------------------------------PEWKNVSEGAKDL 271 (494)
T ss_dssp CCSSHHHHHHHHHHTCCCCCS----------------------------------------------GGGTTSCHHHHHH
T ss_pred CCCCHHHHHHHHHhCCCCCCc----------------------------------------------hhcccCCHHHHHH
Confidence 998887777666554332221 1123457789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|.+||+.||++|||+.|+|+||||++.
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=401.65 Aligned_cols=260 Identities=31% Similarity=0.534 Sum_probs=220.5
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.++|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+++++.|+|| +++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI-----MKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCc-----CeEEEEEEcC
Confidence 4557899999999999999999999999999999998642 2345678899999999988877 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.+|+||||| +++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~------------- 158 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------- 158 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-------------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-------------
Confidence 9999999999 999999987765 799999999999999999999999999999999999996533
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
....+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+
T Consensus 159 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 159 -----------KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp -----------TTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----------CCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3456899999988755433 234589999999999986 59999999999999999999999999988
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+.+..+......++. ..+..+++++++||.+|
T Consensus 227 ~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~ 260 (486)
T 3mwu_A 227 EYDILKRVETGKYAFDL----------------------------------------------PQWRTISDDAKDLIRKM 260 (486)
T ss_dssp HHHHHHHHHHTCCCSCS----------------------------------------------GGGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCC----------------------------------------------cccCCCCHHHHHHHHHH
Confidence 87777666543222211 11234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCc
Q 013941 403 LRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
|+.||++|||+.|+|+||||++..
T Consensus 261 L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 261 LTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp TCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred cCCChhhCcCHHHHhcCHhhccCc
Confidence 999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=398.95 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=206.4
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++|+|| +++++++.+.+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~l~~~~~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-----TALKYSFQTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTS-----CCEEEEEEETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeE-----eeEEEEEeeCC
Confidence 468999999999999999999999999999999997532 233456678888888888777 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~------------- 286 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG------------- 286 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-------------
T ss_pred EEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-------------
Confidence 999999999 899999998765 79999999999999999999998 9999999999999997655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 287 --------------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 287 --------------HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp --------------CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------------CEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 567777777654222 223468999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+.......+......+| ..+++++.+||.+
T Consensus 353 ~~~~~~~~i~~~~~~~p--------------------------------------------------~~~~~~~~~li~~ 382 (446)
T 4ejn_A 353 DHEKLFELILMEEIRFP--------------------------------------------------RTLGPEAKSLLSG 382 (446)
T ss_dssp SHHHHHHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCCCC--------------------------------------------------ccCCHHHHHHHHH
Confidence 77666655543222221 2346789999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCCCCCC
Q 013941 402 LLRYDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
||+.||++|| |++|+++||||++.
T Consensus 383 ~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 383 LLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999999 99999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=382.85 Aligned_cols=285 Identities=27% Similarity=0.485 Sum_probs=221.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc----
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~---- 164 (433)
++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++|+|+ +++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 91 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKASP 91 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTB-----CCEEEEEEEC---
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCc-----ccHhheeeccccc
Confidence 57999999999999999999999999999999986432 234567889999999998877 899888876
Q ss_pred ----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
.+.+|+||||++++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--------- 161 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--------- 161 (351)
T ss_dssp -----CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------
T ss_pred cccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC---------
Confidence 45799999999889988887653 4699999999999999999999999999999999999997655
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCcccc-------CCCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-------QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~ 312 (433)
.+||+|||++.... .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 162 ------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 223 (351)
T 3mi9_A 162 ------------------VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223 (351)
T ss_dssp ------------------CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred ------------------CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH
Confidence 46666666664332 112335789999999999874 5899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|..||.+.........+....+.++...+........ +. .......... ....... ....+
T Consensus 224 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~--~~~~~~~-----------~~~~~ 285 (351)
T 3mi9_A 224 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL--YE---KLELVKGQKR--KVKDRLK-----------AYVRD 285 (351)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGG--GT---SSCCCSSCCC--CHHHHHH-----------HHHCC
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchh--hc---cccccccccc--CHHHHhh-----------hccCC
Confidence 99999999999999999999888887655433221110 00 0000000000 0000000 00125
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
+.+.+||.+||+.||++|||++|+|+||||++...
T Consensus 286 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 286 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 67899999999999999999999999999997644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=371.53 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=210.6
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.+.++|++.++||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.++++++|++| +++++++.+.+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~ 93 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI-----IKIFEVFEDYH 93 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchH-----HhHHHheecCC
Confidence 45578999999999999999999999999999999987543 335678899999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 167 HICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++..+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~------------ 161 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS------------ 161 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS------------
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC------------
Confidence 999999999 88999988642 124799999999999999999999999999999999999995422
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
....+||+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.
T Consensus 162 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 162 ------------PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp ------------TTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------CCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 3456899999998754332 23467999999999986 46899999999999999999999999887
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
...+....+.......+ ......++++.+||.+
T Consensus 229 ~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~~ 261 (285)
T 3is5_A 229 SLEEVQQKATYKEPNYA-----------------------------------------------VECRPLTPQAVDLLKQ 261 (285)
T ss_dssp SHHHHHHHHHHCCCCCC-----------------------------------------------C--CCCCHHHHHHHHH
T ss_pred CHHHHHhhhccCCcccc-----------------------------------------------cccCcCCHHHHHHHHH
Confidence 66554433322111100 0012346789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
||+.||++|||+.|+|+||||++
T Consensus 262 ~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 262 MLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=404.92 Aligned_cols=266 Identities=29% Similarity=0.498 Sum_probs=223.2
Q ss_pred eeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeE
Q 013941 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQ 157 (433)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~ 157 (433)
+....+..+.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++++.|+|| ++
T Consensus 16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~ 90 (484)
T 3nyv_A 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI-----MK 90 (484)
T ss_dssp ---CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTB-----CC
T ss_pred eeccCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCC-----Cc
Confidence 33444556778999999999999999999999999999999998643 2345778899999999988877 99
Q ss_pred ecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
+++++.+.+.+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~----- 163 (484)
T 3nyv_A 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS----- 163 (484)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-----
T ss_pred EEEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-----
Confidence 999999999999999999 999999998765 799999999999999999999999999999999999995422
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g 314 (433)
....+||+|||++....... ...+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 164 -------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 223 (484)
T 3nyv_A 164 -------------------KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSG 223 (484)
T ss_dssp -------------------TTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred -------------------CCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHC
Confidence 34568999999886544332 33589999999999987 699999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
..||.+.+..+.+..+......++. ..+..++.+
T Consensus 224 ~~pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~ 257 (484)
T 3nyv_A 224 CPPFNGANEYDILKKVEKGKYTFEL----------------------------------------------PQWKKVSES 257 (484)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCS----------------------------------------------GGGGGSCHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC----------------------------------------------cccccCCHH
Confidence 9999998887777666553222211 112345778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+++||.+||+.||++|||+.|+|+||||++.
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=382.91 Aligned_cols=274 Identities=23% Similarity=0.356 Sum_probs=223.7
Q ss_pred CCCCceeeecCCccCCCeEEe-ccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHh-CCCC
Q 013941 77 DKDGHYVFAIGENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIG 151 (433)
Q Consensus 77 ~~~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~-~~i~ 151 (433)
..++...+..++.+.++|.+. +.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+.+ +++
T Consensus 13 ~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i- 91 (327)
T 3lm5_A 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV- 91 (327)
T ss_dssp ---CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB-
T ss_pred ccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE-
Confidence 334445566778888999998 89999999999999999999999999987532 335678899999999865 555
Q ss_pred CcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeC
Q 013941 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (433)
Q Consensus 152 ~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~ 230 (433)
+++++++.+.+.+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 92 ----v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 92 ----INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI 167 (327)
T ss_dssp ----CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB
T ss_pred ----EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC
Confidence 99999999999999999999 8899999876544679999999999999999999999999999999999999652
Q ss_pred CcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHH
Q 013941 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (433)
Q Consensus 231 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (433)
. ....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++
T Consensus 168 ~------------------------~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 223 (327)
T 3lm5_A 168 Y------------------------PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223 (327)
T ss_dssp T------------------------TBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred C------------------------CCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHH
Confidence 1 23467888888876544322 335799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 309 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
|+|++|..||.+.+..+....+.......+. ...
T Consensus 224 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~ 257 (327)
T 3lm5_A 224 YMLLTHTSPFVGEDNQETYLNISQVNVDYSE----------------------------------------------ETF 257 (327)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------------------------------------------TTT
T ss_pred HHHHhCCCCCCCCCchHHHHHHHhcccccCc----------------------------------------------hhh
Confidence 9999999999988877776666554333221 112
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
..++..+.+||.+||+.||++|||++|+|+||||++.
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 3456789999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=371.90 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=212.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+.|+++ +++++++.+.+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 83 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI-----LRLYGYFHDATR 83 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCC-----cchhheEecCCE
Confidence 57999999999999999999999999999999986432 234567889999999988777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~--------------- 146 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--------------- 146 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS---------------
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC---------------
Confidence 99999999 889999998764 699999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+...
T Consensus 147 ------------~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 147 ------------ELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp ------------CEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ------------CEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 4677777766443322 233578999999999999899999999999999999999999999877766
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.......| ..++..+.+||.+||+.
T Consensus 215 ~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~li~~~l~~ 244 (279)
T 3fdn_A 215 TYKRISRVEFTFP--------------------------------------------------DFVTEGARDLISRLLKH 244 (279)
T ss_dssp HHHHHHHTCCCCC--------------------------------------------------TTSCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCC--------------------------------------------------CcCCHHHHHHHHHHhcc
Confidence 6655544332222 23467899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q 013941 406 DPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||++|||++|+++||||+....
T Consensus 245 ~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 245 NPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp SGGGSCCHHHHHHCHHHHHHCS
T ss_pred ChhhCCCHHHHhhCccccCCcc
Confidence 9999999999999999997543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=390.46 Aligned_cols=279 Identities=28% Similarity=0.487 Sum_probs=219.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc------C
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY------R 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~------~ 165 (433)
.+|++.+.||+|+||.||+|++..+++.||||++..... ...+|+++++.++|+|| +++++++.. .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpni-----v~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNI-----VRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTB-----CCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCc-----cceeeEEeccCCCCcc
Confidence 469999999999999999999999999999999865432 23469999999988877 888888743 2
Q ss_pred CeEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 166 NHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
..+++||||+.++|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~------------ 193 (420)
T 1j1b_A 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------ 193 (420)
T ss_dssp EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT------------
T ss_pred eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC------------
Confidence 35789999997788877653 2234799999999999999999999999999999999999997432
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
..+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 194 --------------~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 194 --------------AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp --------------TEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------CeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2468888888865432 23345899999999999775 699999999999999999999999999
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+..+.+..+.+.++.++...+....... ....++..... ..........+.++.+||.
T Consensus 260 ~~~~~~l~~i~~~lg~p~~~~~~~~~~~~-------~~~~~p~~~~~--------------~~~~~~~~~~~~~~~~Li~ 318 (420)
T 1j1b_A 260 DSGVDQLVEIIKVLGTPTREQIREMNPNY-------TEFKFPQIKAH--------------PWTKVFRPRTPPEAIALCS 318 (420)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHHHCSCC-------CCCCCCCCCCC--------------CHHHHSCTTSCHHHHHHHH
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhChhh-------hhhccCccCCC--------------CHHHhcCCCCCHHHHHHHH
Confidence 99999999999988887765443322111 01111111000 0011122345789999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||++||++|||+.|+++||||++.
T Consensus 319 ~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 319 RLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhccCChhHCCCHHHHhCCHhhccc
Confidence 9999999999999999999999763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=400.38 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=211.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++.+.||+|+||.||+|++..+|+.||||++.+.. .....+.+|+.+++.++|++| +++++++.+.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l~~~~~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-----VSLAYAYETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCE-----eeEEEEEeeCC
Confidence 467999999999999999999999999999999996532 234567889999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||+ |++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-------------- 323 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-------------- 323 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--------------
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--------------
Confidence 999999999 99999999876655699999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 324 -------------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 324 -------------HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp -------------CEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred -------------CeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 46777777776543322 335899999999999998999999999999999999999999987542
Q ss_pred H----HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 324 L----EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 324 ~----~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
. .....+..... .....++.++.+||
T Consensus 391 ~~~~~~i~~~i~~~~~--------------------------------------------------~~p~~~s~~~~dLI 420 (576)
T 2acx_A 391 KIKREEVERLVKEVPE--------------------------------------------------EYSERFSPQARSLC 420 (576)
T ss_dssp CCCHHHHHHHHHHCCC--------------------------------------------------CCCTTSCHHHHHHH
T ss_pred chhHHHHHHHhhcccc--------------------------------------------------cCCccCCHHHHHHH
Confidence 1 11111111100 11234577999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCCCC
Q 013941 400 QGLLRYDPAERL-----KAREALRHPFFTR 424 (433)
Q Consensus 400 ~~~L~~dP~~R~-----ta~ell~hp~f~~ 424 (433)
.+||+.||++|| +++||++||||++
T Consensus 421 ~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999999 8999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=378.13 Aligned_cols=259 Identities=28% Similarity=0.411 Sum_probs=217.3
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
.....++|.+.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+|| +++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~ 110 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFF 110 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEE
Confidence 3445678999999999999999999999999999999986532 345677889999999988777 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
.+.+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~---------- 178 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL---------- 178 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----------
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC----------
Confidence 9999999999999 899999988764 799999999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 179 -----------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 241 (335)
T 2owb_A 179 -----------------EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241 (335)
T ss_dssp -----------------CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -----------------CEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCC
Confidence 467777777654332 223357899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
......+....+......+ ...++..+.+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~l 271 (335)
T 2owb_A 242 ETSCLKETYLRIKKNEYSI--------------------------------------------------PKHINPVAASL 271 (335)
T ss_dssp CCSSHHHHHHHHHHTCCCC--------------------------------------------------CTTSCHHHHHH
T ss_pred CCCCHHHHHHHHhcCCCCC--------------------------------------------------CccCCHHHHHH
Confidence 8877655544443321111 12346689999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
|.+||+.||++|||++|+++||||++.....
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999999865443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=382.16 Aligned_cols=281 Identities=28% Similarity=0.494 Sum_probs=216.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh------hHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+|+.+++.++|+|| +++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI-----IGLLDAFGH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB-----CCEEEEECC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCC-----CeEEEEEee
Confidence 4689999999999999999999999999999999864321 12457789999999988877 999999999
Q ss_pred CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.+..++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~------------- 149 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG------------- 149 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------------
T ss_pred CCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-------------
Confidence 99999999999779999987653 4689999999999999999999999999999999999997665
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+
T Consensus 150 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 150 --------------VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp --------------CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------CEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 456666666554322 12335789999999999765 589999999999999999999999999
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+..+.+..+....+.++...+........ +.... ..+. ..........+.++.+||.
T Consensus 216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~------------------~~~~~~~~~~~~~~~~li~ 273 (346)
T 1ua2_A 216 DSDLDQLTRIFETLGTPTEEQWPDMCSLPD-YVTFK---SFPG------------------IPLHHIFSAAGDDLLDLIQ 273 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTT-CCCCC---CCCC------------------CCHHHHCTTCCHHHHHHHH
T ss_pred CCHHHHHHHHHHHcCCCChhhhhhhccCcc-ccccc---ccCC------------------CChHHhhccCCHHHHHHHH
Confidence 998888888887776655432211110000 00000 0000 0011123456789999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+||+.||++|||++|+|+||||++..
T Consensus 274 ~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 274 GLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp HHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHhccChhhCCCHHHHhcChhhhcCC
Confidence 99999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=374.05 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=210.4
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
.|...+.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.++++++|+|+ +++++++...+..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV-----VEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEECCEEEEE
Confidence 4888899999999999999999999999999987533 345668899999999988877 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------------------- 178 (321)
T 2c30_A 121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG------------------- 178 (321)
T ss_dssp ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------------------
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------------------
Confidence 9999 99999998754 599999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~ 327 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+..
T Consensus 179 --------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~ 250 (321)
T 2c30_A 179 --------RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250 (321)
T ss_dssp --------CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred --------cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4677777776543322 23358999999999999989999999999999999999999999887766555
Q ss_pred HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCC
Q 013941 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDP 407 (433)
Q Consensus 328 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 407 (433)
..+.....+. ......++..+.+||.+||+.||
T Consensus 251 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~l~~li~~~l~~dp 283 (321)
T 2c30_A 251 KRLRDSPPPK-----------------------------------------------LKNSHKVSPVLRDFLERMLVRDP 283 (321)
T ss_dssp HHHHHSSCCC-----------------------------------------------CTTGGGSCHHHHHHHHHHSCSST
T ss_pred HHHhcCCCCC-----------------------------------------------cCccccCCHHHHHHHHHHccCCh
Confidence 4443321100 00112346789999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 013941 408 AERLKAREALRHPFFTRD 425 (433)
Q Consensus 408 ~~R~ta~ell~hp~f~~~ 425 (433)
++|||++|+++||||.+.
T Consensus 284 ~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 284 QERATAQELLDHPFLLQT 301 (321)
T ss_dssp TTSCCHHHHHTSGGGGGC
T ss_pred hhCcCHHHHhcChhhccC
Confidence 999999999999999865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=380.34 Aligned_cols=287 Identities=30% Similarity=0.466 Sum_probs=215.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC----
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---- 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~---- 166 (433)
.++|++.+.||+|+||.||+|++..+++.||||++...........+|+..+..+.|+|| +++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~ni-----v~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI-----VQLQSYFYTLGERDR 96 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTB-----CCEEEEEEEECSSCT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCc-----ccHHHhhhccccccc
Confidence 357999999999999999999999999999999987665555667778888888988877 99999885432
Q ss_pred ---eEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEecCCCCCcEEEee-CCcccccCc
Q 013941 167 ---HICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVS-AEYVKVPDY 238 (433)
Q Consensus 167 ---~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDikp~NIli~~-~~~~~l~d~ 238 (433)
.+++||||+.++|.+.+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~------- 169 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG------- 169 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT-------
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC-------
Confidence 3899999997787766553 23347899999999999999999999 999999999999999975 33
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCC-CCccchHHHHHHHHHHHHhCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~ 315 (433)
.+||+|||++....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 170 --------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 170 --------------------TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp --------------------EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 57788888776544322 3357899999999997654 899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||.+.+....+..+.+..+.++...+.........+ .+..... ..............+.++
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 291 (360)
T 3e3p_A 230 PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDV-------DLYNSKG-----------IPWSNVFSDHSLKDAKEA 291 (360)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCG-------GGGCCCC-----------CCHHHHTTTCCCTTHHHH
T ss_pred CCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhc-------ccccccc-----------CCcccccchhhccccHHH
Confidence 9999999999999999999988876655432211110 0000000 001111122233467899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.+||.+||+.||++|||+.|+|+||||++...
T Consensus 292 ~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 292 YDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 99999999999999999999999999997543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=410.32 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=213.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++++.||+|+||.||+|++..+++.||||++++. ....+....|..++..+.++ ++++.+++++++.+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~----~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP----PFLTQLHSCFQTMD 415 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCC----TTBCCEEEECBCSS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCC----CeEEEEEEEEEeCC
Confidence 36799999999999999999999999999999999753 23345677788888776432 44599999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+||||||+ +++|.+++.... .+++..++.++.||+.||+|||++|||||||||+||||+.+|
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-------------- 479 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-------------- 479 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS--------------
T ss_pred EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC--------------
Confidence 999999999 999999998765 799999999999999999999999999999999999997666
Q ss_pred CCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 480 -------------~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 480 -------------HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp -------------CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------------cEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 46777777665422 22344689999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+....|......+| ..++.++.+||.+|
T Consensus 547 ~~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~l 576 (674)
T 3pfq_A 547 EDELFQSIMEHNVAYP--------------------------------------------------KSMSKEAVAICKGL 576 (674)
T ss_dssp HHHHHHHHHSSCCCCC--------------------------------------------------TTSCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCC--------------------------------------------------ccCCHHHHHHHHHH
Confidence 7777666654322222 24577999999999
Q ss_pred cccCCCCCCCH-----HHHhcCCCCCCC
Q 013941 403 LRYDPAERLKA-----REALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta-----~ell~hp~f~~~ 425 (433)
|+.||++|+++ +||++||||+..
T Consensus 577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 577 MTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp SCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred ccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 99999999997 999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=369.43 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=215.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++|+++ +++++++.+.+.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 88 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI-----LRMYNYFHDRKR 88 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCE-----eeEEEEEEcCCE
Confidence 57999999999999999999999999999999986432 234567889999999988777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--------------- 151 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG--------------- 151 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC---------------
T ss_pred EEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC---------------
Confidence 99999999 889999998765 699999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 152 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 219 (284)
T 2vgo_A 152 ------------ELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219 (284)
T ss_dssp ------------CEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ------------CEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH
Confidence 4677777776543322 234578999999999999899999999999999999999999998877665
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+...... ....++.++.+||.+||+.
T Consensus 220 ~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 220 THRRIVNVDLK--------------------------------------------------FPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp HHHHHHTTCCC--------------------------------------------------CCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHhccccC--------------------------------------------------CCCcCCHHHHHHHHHHhhc
Confidence 54443321111 1123467899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCccccC
Q 013941 406 DPAERLKAREALRHPFFTRDVRRCG 430 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~~~~ 430 (433)
||++|||++|+++||||+...++.-
T Consensus 250 ~p~~Rps~~~ll~h~~~~~~~~~~~ 274 (284)
T 2vgo_A 250 HPPQRLPLKGVMEHPWVKANSRRVL 274 (284)
T ss_dssp SGGGSCCHHHHHTCHHHHHHCCCCC
T ss_pred CHhhCCCHHHHhhCHHHHhhccccC
Confidence 9999999999999999998655543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=390.65 Aligned_cols=297 Identities=25% Similarity=0.455 Sum_probs=210.2
Q ss_pred CccCCCeEEe-ccccccccEEEEEEEec--CCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee--
Q 013941 88 ENLTPRYRIL-SKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-- 162 (433)
Q Consensus 88 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~-- 162 (433)
+.+.+.|++. ++||+|+||+||+|++. .+++.||||++.... ....+.+|+.+++.++|+|| +++++++
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNV-----ISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTB-----CCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCe-----eeEeeEEec
Confidence 3455678874 58999999999999965 578899999997533 33567889999999998877 9999998
Q ss_pred ccCCeEEEEEccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccc
Q 013941 163 DYRNHICIVFEKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l 235 (433)
.....+|+||||++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+...+
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~---- 165 (405)
T 3rgf_A 90 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG---- 165 (405)
T ss_dssp TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS----
T ss_pred CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC----
Confidence 4578999999999889998886321 12499999999999999999999999999999999999995432
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCC-CCCccchHHHHHHHH
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCIL 308 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 308 (433)
+....+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++
T Consensus 166 -------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 166 -------------------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp -------------------TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred -------------------CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 24457899999988764432 2335899999999999875 589999999999999
Q ss_pred HHHHhCCCCCCCCCh---------HHHHHHHHHHhcCCChhhHHhhhhhhhhh--hcCCccccCCCCCCchhhHHHHHHh
Q 013941 309 VELCSGEALFQTHEN---------LEHLAMMERVLGPLPHHMVIRADRRAEKY--FRRGARLDWPDGATSRDSMRAVWKL 377 (433)
Q Consensus 309 ~el~~g~~pf~~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (433)
|+|++|..||.+... .+.+..+...++.++...+.......... ........+. .
T Consensus 227 ~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~ 292 (405)
T 3rgf_A 227 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT--------------N 292 (405)
T ss_dssp HHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT--------------T
T ss_pred HHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC--------------c
Confidence 999999999976554 46777788877776654322211100000 0000000000 0
Q ss_pred cCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
..............+..+.+||.+||++||++|||++|+|+||||++...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 293 CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp CCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred chhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 00001111122234678999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=372.48 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=216.9
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
..+.++|++.+.||+|+||.||+|++..+++.||+|+++.... ..+.+.+|+.+++.+.|+++ +++++++.+.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 79 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI-----VTLEDIYESTT 79 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCe-----eehhhhcccCC
Confidence 3455789999999999999999999999999999999975432 34567889999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~--------------- 142 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP--------------- 142 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS---------------
T ss_pred EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC---------------
Confidence 999999999 899999998765 69999999999999999999999999999999999998431
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
+.+..++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 143 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 213 (304)
T 2jam_A 143 ---------EENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213 (304)
T ss_dssp ---------STTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ---------CCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 13446888899888654432 23357999999999999989999999999999999999999999887776
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+......++. .....++.++.+||.+||+
T Consensus 214 ~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~ 247 (304)
T 2jam_A 214 KLFEKIKEGYYEFES----------------------------------------------PFWDDISESAKDFICHLLE 247 (304)
T ss_dssp HHHHHHHHCCCCCCT----------------------------------------------TTTTTSCHHHHHHHHHHHC
T ss_pred HHHHHHHcCCCCCCc----------------------------------------------cccccCCHHHHHHHHHHcC
Confidence 665555443221111 1123457789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~ 425 (433)
.||++|||++|+++||||++.
T Consensus 248 ~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 248 KDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp SSTTTSCCHHHHHTSHHHHSS
T ss_pred CChhHCcCHHHHhcCccccCC
Confidence 999999999999999999865
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=384.90 Aligned_cols=282 Identities=30% Similarity=0.524 Sum_probs=218.5
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-- 164 (433)
++....+|++.+.||+|+||+||+|++..+++ ||+|++...... ..+|+.+++.++|+|| +++++++..
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~ni-----v~l~~~~~~~~ 105 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNV-----VDLKAFFYSNG 105 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTB-----CCEEEEEEEES
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCc-----ceEEEEEEecC
Confidence 34445689999999999999999999887776 888877543322 2369999999988877 999998844
Q ss_pred ----CCeEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe-eCCcccccC
Q 013941 165 ----RNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPD 237 (433)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~-~~~~~~l~d 237 (433)
...+++||||+.+++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~------ 179 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG------ 179 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT------
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC------
Confidence 334899999997777665542 1224799999999999999999999999999999999999997 344
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhC
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g 314 (433)
.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 180 ---------------------~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 238 (394)
T 4e7w_A 180 ---------------------VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238 (394)
T ss_dssp ---------------------EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 577888887765432 23345889999999999775 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
+.||.+.+..+.+..+.+.++.++...+........ . ..++.... ...........+++
T Consensus 239 ~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~---~----~~~~~~~~--------------~~~~~~~~~~~~~~ 297 (394)
T 4e7w_A 239 QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM---E----HKFPQIRP--------------HPFSKVFRPRTPPD 297 (394)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS---S----SCCCCCCC--------------CCHHHHSCTTCCHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh---h----hccccccC--------------CcHHHhccccCCHH
Confidence 999999999999999999999887665443322111 0 01111000 00111122346789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.+||.+||++||++|||+.|+++||||++-
T Consensus 298 ~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 298 AIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 9999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=376.14 Aligned_cols=282 Identities=28% Similarity=0.474 Sum_probs=221.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++++.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.++++++|+|| +++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL-----VNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCE-----eeEEEEeecCCE
Confidence 467999999999999999999999999999999986432 334567789999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--------------- 161 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--------------- 161 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---------------
T ss_pred EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC---------------
Confidence 99999999 667777665443 699999999999999999999999999999999999996554
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++...... .....||..|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 162 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 162 ------------VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp ------------CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------------cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5777777777543322 2335789999999999876 68999999999999999999999999999
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+.+..+....+..++........... +. ...++..... .........++..+.+||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~ 290 (331)
T 4aaa_A 230 DIDQLYHIMMCLGNLIPRHQELFNKNPV--FA---GVRLPEIKER--------------EPLERRYPKLSEVVIDLAKKC 290 (331)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHHHHCGG--GT---TCCCCCCSSC--------------CCHHHHSTTSCHHHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCChhhhhHhhhccc--cc---cccCcccccc--------------chhhhcccchhHHHHHHHHHH
Confidence 9988888888888776544322211100 00 0011111000 011122345678999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|+.||++|||+.|+|+||||+..
T Consensus 291 L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 291 LHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hccCcccCCCHHHHhcCchhccC
Confidence 99999999999999999999865
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=395.52 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=209.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.++|++.+.||+|+||.||+|++..+|+.||||++.+.. .....+.+|+.++++++|++| +++++++.+.+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l~~~~~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI-----VSLAYAFETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCE-----eeEEEEEeeCC
Confidence 367999999999999999999999999999999997532 234567889999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.+|+||||+ |++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g------------ 326 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG------------ 326 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS------------
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC------------
Confidence 999999999 999999997643 34699999999999999999999999999999999999997665
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 327 ---------------~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 327 ---------------NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp ---------------CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------CEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence 4677777776544322 2235899999999999999999999999999999999999999987
Q ss_pred CCh----HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 321 HEN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 321 ~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
... ......+..... ..+..++.++.
T Consensus 392 ~~~~~~~~~~~~~i~~~~~--------------------------------------------------~~p~~~s~~~~ 421 (543)
T 3c4z_A 392 RGEKVENKELKQRVLEQAV--------------------------------------------------TYPDKFSPASK 421 (543)
T ss_dssp TTCCCCHHHHHHHHHHCCC--------------------------------------------------CCCTTSCHHHH
T ss_pred CccchhHHHHHHHHhhccc--------------------------------------------------CCCcccCHHHH
Confidence 532 222222211111 11234577999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 013941 397 DLLQGLLRYDPAERLK-----AREALRHPFFTR 424 (433)
Q Consensus 397 ~li~~~L~~dP~~R~t-----a~ell~hp~f~~ 424 (433)
+||.+||+.||++||+ ++++++||||++
T Consensus 422 ~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999999995 589999999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=373.84 Aligned_cols=285 Identities=30% Similarity=0.467 Sum_probs=219.9
Q ss_pred cCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
++..+.++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|+.++++++|+|+ +++++++.
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 79 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI-----ITIFNIQR 79 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECC
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCc-----CCeeeeec
Confidence 34567789999999999999999999999999999999996432 344567789999999988877 88888765
Q ss_pred c-----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 164 Y-----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 164 ~-----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
. ....|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~------ 150 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD------ 150 (353)
T ss_dssp CSCSTTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC------
T ss_pred ccccCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc------
Confidence 4 3789999999988999999874 5999999999999999999999999999999999999977665
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccC-------------CCcccccCCcccchhhhhC-CCCCccchHHHH
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------------DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSV 304 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl 304 (433)
+||+|||++..... ......||+.|+|||++.+ ..++.++|||||
T Consensus 151 ---------------------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 209 (353)
T 2b9h_A 151 ---------------------LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209 (353)
T ss_dssp ---------------------EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred ---------------------EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence 45555555443221 1122478999999998875 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhc-Cch-h
Q 013941 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL-RLP-N 382 (433)
Q Consensus 305 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~ 382 (433)
||++|+|++|..||.+.+....+..+....+.++....... ... .......... ..+ .
T Consensus 210 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~-~~~~~~~~~~~~~~~~ 269 (353)
T 2b9h_A 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC-------------------IES-PRAREYIKSLPMYPAA 269 (353)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTT-------------------CCC-HHHHHHHHTSCCCCCC
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccc-------------------ccc-chhhHHhhcccCCCCc
Confidence 99999999999999999988888888877766542110000 000 0001111100 000 0
Q ss_pred hhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 383 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
........++.++.+||.+||+.||++|||++|+++||||+..
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 270 PLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1112234668899999999999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=372.02 Aligned_cols=292 Identities=26% Similarity=0.428 Sum_probs=216.9
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee---
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF--- 162 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~--- 162 (433)
|..+.++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++++++|+|+ +++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~ 80 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI-----VKVFEILGPS 80 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECTT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCe-----eEEEEecccc
Confidence 4566789999999999999999999999999999999987543 445677899999999988877 8888776
Q ss_pred -----------ccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 163 -----------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 163 -----------~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
...+..|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~- 156 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE- 156 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-
T ss_pred ccccccccccccccCceeEEeeccCCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-
Confidence 345789999999988999998653 69999999999999999999999999999999999999632
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC------CCcccccCCcccchhhhhC-CCCCccchHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSV 304 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl 304 (433)
+..+||+|||++..... ......+|..|+|||++.+ ..++.++|||||
T Consensus 157 -------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 211 (320)
T 2i6l_A 157 -------------------------DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211 (320)
T ss_dssp -------------------------TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred -------------------------CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence 23567777777765432 1223467999999999876 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 305 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
||++|+|++|+.||.+.+..+....+....+................+... .. .......
T Consensus 212 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~--~~~~~~~ 271 (320)
T 2i6l_A 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRN------------------DM--TEPHKPL 271 (320)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHH------------------HT--TSCCCCH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccc------------------cc--cCCCCCh
Confidence 999999999999999988888777777665554433222111110000000 00 0000011
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccccCCC
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~~~ 432 (433)
......++.++.+||.+||+.||++|||++|+++||||+...-+...|
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~~ 319 (320)
T 2i6l_A 272 TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319 (320)
T ss_dssp HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-----
T ss_pred hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCCC
Confidence 122345688999999999999999999999999999999765444433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=375.80 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=212.6
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHH-HhCCCCCcceeE
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRL-ARHDIGGTRCVQ 157 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l-~~~~i~~~~~v~ 157 (433)
..+.++|++.+.||+|+||.||+|++..+|+.||||+++... ...+.+.+|+.+++++ .|+++ ++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~ 164 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI-----IT 164 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CC
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE-----eE
Confidence 344568999999999999999999999999999999986432 2245677899999999 67777 99
Q ss_pred ecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
+++++...+..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~----- 237 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM----- 237 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-----
Confidence 999999999999999999 889999998764 699999999999999999999999999999999999997655
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhC------CCCCccchHHHHHHHH
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCIL 308 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il 308 (433)
.++|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 238 ----------------------~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 295 (365)
T 2y7j_A 238 ----------------------QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295 (365)
T ss_dssp ----------------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred ----------------------CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence 5677777776544322 234589999999999863 3588999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 309 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
|+|++|..||.+.........+......++. ..+
T Consensus 296 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~ 329 (365)
T 2y7j_A 296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSS----------------------------------------------PEW 329 (365)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH----------------------------------------------HHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----------------------------------------------ccc
Confidence 9999999999887766655555432222111 112
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
...+..+.+||.+||+.||++|||++|+++||||++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 345678999999999999999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=367.81 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=216.8
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++++.|+++ +++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~ 78 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI-----ITLHDIFE 78 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEEEEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCe-----eehhheec
Confidence 457999999999999999999999999999999986432 135678899999999988877 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
+.+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------- 145 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN----------- 145 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-----------
T ss_pred CCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC-----------
Confidence 999999999999 899999998754 699999999999999999999999999999999999997654
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.....++|+|||.+...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+
T Consensus 146 ------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 146 ------------VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp ------------SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ------------CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 12346899999988754432 2335789999999999998999999999999999999999999998
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....+....+.......+. ......+..+.+||.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~ 247 (283)
T 3bhy_A 214 ETKQETLTNISAVNYDFDE----------------------------------------------EYFSNTSELAKDFIR 247 (283)
T ss_dssp SSHHHHHHHHHTTCCCCCH----------------------------------------------HHHTTCCHHHHHHHH
T ss_pred cchHHHHHHhHhcccCCcc----------------------------------------------hhcccCCHHHHHHHH
Confidence 7776655554432222211 112345678999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+||+.||++|||+.|+++||||+...
T Consensus 248 ~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 248 RLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp TTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999998743
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=376.78 Aligned_cols=287 Identities=25% Similarity=0.431 Sum_probs=219.1
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch------------hhHHHHHHHHHHHHHHHhCCCCCcc
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------------KYREAAMIEIDVLQRLARHDIGGTR 154 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~~~~i~~~~ 154 (433)
...+.++|++.+.||+|+||.||+|.+.. ++.||||++.... ...+.+.+|+.++++++|+||
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i---- 91 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI---- 91 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB----
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc----
Confidence 34567899999999999999999999755 8899999985421 123678899999999998877
Q ss_pred eeEecceec-----cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 155 CVQIRNWFD-----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 155 ~v~~~~~~~-----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
+++++++. ....+|+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 92 -v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 92 -LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp -CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred -cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC
Confidence 99998883 345799999999889999987543 46999999999999999999999999999999999999965
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhC-CCCCccchHHHHHH
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGC 306 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~ 306 (433)
++ .+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||
T Consensus 170 ~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 222 (362)
T 3pg1_A 170 NN---------------------------DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGC 222 (362)
T ss_dssp TC---------------------------CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHH
T ss_pred CC---------------------------CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHH
Confidence 54 5778888877643322 233578999999999987 67899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhh-hhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 307 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
++|+|++|..||.+....+.+..+....+.++......... ....+.... ....+. ....
T Consensus 223 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~ 283 (362)
T 3pg1_A 223 VMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNS-LSNVPA------------------RAWT 283 (362)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTC-CCCCCC------------------CCHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhh-cccCCh------------------hhHH
Confidence 99999999999999999999999988888776544332111 111111111 000000 0111
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
......++.+.+||.+||+.||++|||++|+++||||++..
T Consensus 284 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 284 AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 22345678899999999999999999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=378.05 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=211.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
...++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++|+|+ +++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~ 125 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLR 125 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEE
Confidence 3345799999999999999999999999999999998643 2334567899999999988877 999999999
Q ss_pred CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.+..++||||+.|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 126 ~~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------------- 191 (348)
T 1u5q_A 126 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG------------- 191 (348)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-------------
T ss_pred CCeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-------------
Confidence 99999999999889998886543 4799999999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||++...... ....||+.|+|||++. +..++.++|||||||++|||++|..||.+.
T Consensus 192 --------------~~kL~DfG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 192 --------------LVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp --------------EEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --------------CEEEeeccCceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4677777777654332 3358999999999986 457899999999999999999999999887
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+....+..+.....+. .....++..+.+||.+
T Consensus 257 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 257 NAMSALYHIAQNESPA------------------------------------------------LQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CHHHHHHHHHHSCCCC------------------------------------------------CCCTTSCHHHHHHHHH
T ss_pred ChHHHHHHHHhcCCCC------------------------------------------------CCCCCCCHHHHHHHHH
Confidence 7665554433211000 0012346789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
||+.||++|||++++++||||.+..
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HcccChhhCcCHHHHhhChhhhccC
Confidence 9999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=368.21 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=216.0
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
.....++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.+.|+|| +++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~ 84 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFF 84 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCE-----eeeeeee
Confidence 344557899999999999999999999999999999998653 2345667889999999988777 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
.+.+..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---------- 152 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL---------- 152 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----------
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC----------
Confidence 9999999999999 899999988764 799999999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 153 -----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 215 (294)
T 2rku_A 153 -----------------EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215 (294)
T ss_dssp -----------------CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -----------------CEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 467777777654332 223357899999999999988999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
......+....+...... ....++..+.+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~l 245 (294)
T 2rku_A 216 ETSCLKETYLRIKKNEYS--------------------------------------------------IPKHINPVAASL 245 (294)
T ss_dssp CCSSHHHHHHHHHTTCCC--------------------------------------------------CCTTSCHHHHHH
T ss_pred CCCCHHHHHHHHhhccCC--------------------------------------------------CccccCHHHHHH
Confidence 887765544433221111 112346789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCcccc
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
|.+||+.||++|||++|+++||||++.....
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 9999999999999999999999999865433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=381.19 Aligned_cols=263 Identities=26% Similarity=0.407 Sum_probs=213.3
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
.+.++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.++++++|+|| +++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~ 97 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI-----ARLYEVY 97 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCc-----ceeehhh
Confidence 4457899999999999999999999999999999998643 2344678899999999988777 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHH
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNS--------------------------------------YRSFPIDLVRELGRQL 203 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi 203 (433)
.+.+..|+||||+ +++|.+++.... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999 999999985210 1124678899999999
Q ss_pred HHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-------CCc
Q 013941 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHS 276 (433)
Q Consensus 204 ~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~ 276 (433)
+.||+|||++||+||||||+|||++.++ ...+||+|||++..... ...
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 232 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNK-------------------------SFEIKLVDFGLSKEFYKLNNGEYYGMT 232 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSS-------------------------SCCEEECCCTTCEEGGGTTCC------
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCC-------------------------CceEEEeeccccccccccCcccccccc
Confidence 9999999999999999999999996543 23578888888865322 123
Q ss_pred ccccCCcccchhhhhC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhc
Q 013941 277 YVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 354 (433)
Q Consensus 277 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 354 (433)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......++.
T Consensus 233 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 297 (345)
T 3hko_A 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN--------------- 297 (345)
T ss_dssp --CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------
T ss_pred ccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------
Confidence 4579999999999976 57899999999999999999999999988877666555443221110
Q ss_pred CCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 355 RGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.....++.++.+||.+||+.||++|||+.|+++||||++...
T Consensus 298 -------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 298 -------------------------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp -------------------------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred -------------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 011234678999999999999999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=377.29 Aligned_cols=281 Identities=28% Similarity=0.492 Sum_probs=221.6
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.++|.+.+.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.++|+|+ +++++++...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 95 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV-----IGLLDVFTPA 95 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc-----ccHhheEecc
Confidence 3457899999999999999999999999999999998643 2334667889999999988877 9999988775
Q ss_pred Ce------EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 166 NH------ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 166 ~~------~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
+. +|+||||++++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-------- 163 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-------- 163 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--------
T ss_pred cccccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--------
Confidence 43 599999998898877642 599999999999999999999999999999999999996554
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 164 -------------------~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 224 (353)
T 3coi_A 164 -------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224 (353)
T ss_dssp -------------------CEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred -------------------cEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 5788888887765555555689999999999987 57899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhh-hhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAE-KYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
.+.+..+.+..+.+..+.++..+......... .+...... .............+.++.+
T Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~ 284 (353)
T 3coi_A 225 KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ--------------------TPRKDFTQLFPRASPQAAD 284 (353)
T ss_dssp BSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCB--------------------CSSCCTTTTCTTSCHHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcC--------------------CCCccHHHhcCCcCHHHHH
Confidence 99998888999988888877665443221111 01000000 0000011123456789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||+.||++|||++|+++||||+..
T Consensus 285 li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 285 LLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 9999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=369.54 Aligned_cols=280 Identities=31% Similarity=0.512 Sum_probs=220.1
Q ss_pred CCCeEEeccccccccEEEEEEEec-CCCcEEEEEEeccch---hhHHHHHHHHHHHHHH---HhCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~~~~i~~~~~v~~~~~~~ 163 (433)
.++|++.+.||+|+||.||+|++. .+++.||+|+++... .....+.+|+.+++.+ .|+|+ +++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i-----~~~~~~~~ 84 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDVCT 84 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTB-----CCEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCe-----Eeeeeeee
Confidence 468999999999999999999985 678999999986432 1223566788888887 46555 99999886
Q ss_pred -----cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 164 -----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 164 -----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
.....++||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~------- 157 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG------- 157 (326)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------
T ss_pred ecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-------
Confidence 56789999999988999999887655699999999999999999999999999999999999997655
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 --------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 158 --------------------QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp --------------------CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------CEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 5677777777654322 233578999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+......+..+....+..+...+..........+. . ............++..+.
T Consensus 218 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--------~---------------~~~~~~~~~~~~~~~~~~ 274 (326)
T 1blx_A 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH--------S---------------KSAQPIEKFVTDIDELGK 274 (326)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC--------C---------------CCCCCGGGTCCSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhc--------c---------------cCcchhhhccccCCHHHH
Confidence 99999988888888777665543221110000000000 0 000111223356688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||.+||+.||++|||+.|+++||||++.
T Consensus 275 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 275 DLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 99999999999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=365.34 Aligned_cols=261 Identities=26% Similarity=0.379 Sum_probs=208.8
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
....++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++|+++ +++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~ 81 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI-----IKLYQVIS 81 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCE-----eEEEEEEe
Confidence 344578999999999999999999999999999999986432 234567889999999988777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
+.+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------- 148 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM----------- 148 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-----------
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-----------
Confidence 999999999999 899999998765 699999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
.++|+|||++...... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.
T Consensus 149 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 149 ----------------NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp ----------------CEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ----------------CEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 4667777766543322 123478999999999988765 689999999999999999999998
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
..........+....... ...++..+.+||
T Consensus 213 ~~~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~l~~li 242 (276)
T 2h6d_A 213 DEHVPTLFKKIRGGVFYI--------------------------------------------------PEYLNRSVATLL 242 (276)
T ss_dssp CSSHHHHHHHHHHCCCCC--------------------------------------------------CTTSCHHHHHHH
T ss_pred CCcHHHHHHHhhcCcccC--------------------------------------------------chhcCHHHHHHH
Confidence 776655544443321111 123466899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCccccCCC
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRDVRRCGFP 432 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~~~ 432 (433)
.+||+.||++|||++|+++||||++...+.-.|
T Consensus 243 ~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~p 275 (276)
T 2h6d_A 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYLFP 275 (276)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHHHHTTCCGGGCC
T ss_pred HHHccCChhhCCCHHHHHhChhhccCchhccCC
Confidence 999999999999999999999999876655443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=365.43 Aligned_cols=274 Identities=20% Similarity=0.276 Sum_probs=207.4
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
..+.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.++..+ .|+|| +++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~i-----v~~~~~~~ 81 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV-----VRYFSAWA 81 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTB-----CCEEEEEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeee
Confidence 34556899999999999999999999999999999998743 23456677899999888 77776 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+.+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.....+...
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 999999999999 889999997642 13689999999999999999999999999999999999998877554433221
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
... ........++|+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++.
T Consensus 162 ~~~--------~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 162 DED--------DWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----------------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccc--------cccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 110 111245579999999988765433 34699999999999876 56789999999999999999998775
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
...... .+.. +.. ......++.++.+||
T Consensus 233 ~~~~~~---~~~~--~~~-----------------------------------------------~~~~~~~~~~~~~li 260 (289)
T 1x8b_A 233 NGDQWH---EIRQ--GRL-----------------------------------------------PRIPQVLSQEFTELL 260 (289)
T ss_dssp SSHHHH---HHHT--TCC-----------------------------------------------CCCSSCCCHHHHHHH
T ss_pred chhHHH---HHHc--CCC-----------------------------------------------CCCCcccCHHHHHHH
Confidence 432211 1111 000 011234577999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.+||+.||++|||+.|+++||||++..+
T Consensus 261 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 261 KVMIHPDPERRPSAMALVKHSVLLSASR 288 (289)
T ss_dssp HHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred HHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence 9999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=378.08 Aligned_cols=249 Identities=27% Similarity=0.473 Sum_probs=207.6
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh---------hHHHHHHHHHHHHHHHhCCCCCcceeEe
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMIEIDVLQRLARHDIGGTRCVQI 158 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~v~~ 158 (433)
..+.++|++.+.||+|+||.||+|++..+++.||||+++.... ....+.+|+.++++++|+|| +++
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-----v~~ 94 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI-----IKV 94 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTB-----CCE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCE-----eeE
Confidence 3455789999999999999999999999999999999875321 23356679999999988777 999
Q ss_pred cceeccCCeEEEEEccC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 159 RNWFDYRNHICIVFEKL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
++++.+.+.+++||||+ ++ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----- 167 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF----- 167 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-----
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-----
Confidence 99999999999999998 55 9999998765 699999999999999999999999999999999999996554
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHh
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCS 313 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~ 313 (433)
.+||+|||++....... ....||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 168 ----------------------~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 225 (335)
T 3dls_A 168 ----------------------TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225 (335)
T ss_dssp ----------------------CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred ----------------------cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh
Confidence 57788888776544332 34579999999999998876 789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
|..||....... .........++.
T Consensus 226 g~~pf~~~~~~~--------------------------------------------------------~~~~~~~~~~~~ 249 (335)
T 3dls_A 226 EENPFCELEETV--------------------------------------------------------EAAIHPPYLVSK 249 (335)
T ss_dssp SSCSCSSGGGGT--------------------------------------------------------TTCCCCSSCCCH
T ss_pred CCCchhhHHHHH--------------------------------------------------------hhccCCCcccCH
Confidence 999996422100 000011223577
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
++.+||.+||+.||++|||++|+++||||++..
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 899999999999999999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=361.74 Aligned_cols=258 Identities=30% Similarity=0.500 Sum_probs=213.2
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----------hhHHHHHHHHHHHHHHH-hCCCCCcceeE
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTRCVQ 157 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-~~~i~~~~~v~ 157 (433)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++. |+++ ++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~ 88 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI-----IQ 88 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CC
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE-----ee
Confidence 44578999999999999999999999999999999986432 23456778999999996 7776 99
Q ss_pred ecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
+++++...+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----- 161 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM----- 161 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-----
Confidence 999999999999999999 899999998764 799999999999999999999999999999999999997655
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhh------CCCCCccchHHHHHHHH
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVIL------GLGWNYPCDLWSVGCIL 308 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il 308 (433)
.++|+|||++...... .....||+.|+|||++. ...++.++|||||||++
T Consensus 162 ----------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l 219 (298)
T 1phk_A 162 ----------------------NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219 (298)
T ss_dssp ----------------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred ----------------------cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence 4677777776543322 23357899999999986 44688999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 309 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
|+|++|..||...+.......+.......+. ...
T Consensus 220 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~ 253 (298)
T 1phk_A 220 YTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS----------------------------------------------PEW 253 (298)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------------------------------------------TTG
T ss_pred HHHHHCCCCCcCccHHHHHHHHhcCCcccCc----------------------------------------------ccc
Confidence 9999999999887766655554432211110 011
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
..++..+.+||.+||+.||++|||+.|+++||||++..
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 23467899999999999999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=381.41 Aligned_cols=300 Identities=23% Similarity=0.313 Sum_probs=216.6
Q ss_pred cCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.++...++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++|+|| +++++++.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 101 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFY 101 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTB-----CCEEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCE-----EEEeEEEE
Confidence 3455567899999999999999999999999999999998753 3445678899999999988777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
+++..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~---------- 169 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---------- 169 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC----------
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC----------
Confidence 999999999999 889999998765 699999999999999999999996 999999999999996544
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCcccc-CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.++|+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 170 -----------------~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 170 -----------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp -----------------CEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred -----------------CEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 57888888875432 223345899999999999999999999999999999999999999988
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+..+....+.......+.......... ...+........+ ............... ........++.++.+||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~ 306 (360)
T 3eqc_A 233 PDAKELELMFGCQVEGDAAETPPRPRTP-GRPLNKFGMDSRP-PMAIFELLDYIVNEP----PPKLPSGVFSLEFQDFVN 306 (360)
T ss_dssp CCHHHHHHHHC--------------------------------CCCHHHHHHHHHHSC----CCCCCTTTSCHHHHHHHH
T ss_pred CCHHHHHHHhcccccccCCCCCCCcccC-CCcccccccCCCC-cccchhhhhHHhccC----CCCCCcccccHHHHHHHH
Confidence 7765544333221111110000000000 0000000000000 000001111111110 000112346789999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||+.||++|||++|+|+||||++.
T Consensus 307 ~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 307 KCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp HHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred HHhhcChhhCCCHHHHhhChHhhcc
Confidence 9999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=372.16 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=200.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++++.||+|+||.||+|.+ .+++.||||++... ....+.+.+|+.++..+.|+ +++++++++++.+++.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~---~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYDYEITDQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT---CTTBCCEEEEEECSSE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhc---CCceEEEeeeEeeCCE
Confidence 46799999999999999999987 46889999998643 23346678899999999872 1345999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
+|+|||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ ++
T Consensus 84 ~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~---------------- 144 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG---------------- 144 (343)
T ss_dssp EEEEECCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT----------------
T ss_pred EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC----------------
Confidence 99999977999999998765 799999999999999999999999999999999999995 23
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhC-----------CCCCccchHHHHHHHHHHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~el 311 (433)
.+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 145 -----------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~el 213 (343)
T 3dbq_A 145 -----------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213 (343)
T ss_dssp -----------EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHH
T ss_pred -----------cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHH
Confidence 47888888776543322 23579999999999965 5688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|..||....... ..+...... ..... .....
T Consensus 214 l~g~~pf~~~~~~~--~~~~~~~~~-------------------~~~~~--------------------------~~~~~ 246 (343)
T 3dbq_A 214 TYGKTPFQQIINQI--SKLHAIIDP-------------------NHEIE--------------------------FPDIP 246 (343)
T ss_dssp HHSSCTTTTCCSHH--HHHHHHHCT-------------------TSCCC--------------------------CCCCS
T ss_pred HhCCCcchhhhhHH--HHHHHHhcC-------------------CcccC--------------------------CcccC
Confidence 99999997644321 111111110 00011 12233
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 5689999999999999999999999999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=365.90 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=186.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.++++++|+|+ +++++++.+.+.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI-----LELYNYFEDSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTB-----CCEEEEEECSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCe-----EeEEEEEccCCe
Confidence 46999999999999999999999999999999986432 223667889999999988777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~--------------- 149 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM--------------- 149 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC---------------
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---------------
Confidence 99999999 889999998653 4699999999999999999999999999999999999997654
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 150 ------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 150 ------------NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------CEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred ------------CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 4677777777654321 2235789999999999988899999999999999999999999976543
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+.. . .......++.++.+||.+||
T Consensus 218 ~~~~~~~~~--------------------------~------------------------~~~~~~~~~~~~~~li~~~l 247 (278)
T 3cok_A 218 KNTLNKVVL--------------------------A------------------------DYEMPSFLSIEAKDLIHQLL 247 (278)
T ss_dssp C-----CCS--------------------------S------------------------CCCCCTTSCHHHHHHHHHHS
T ss_pred HHHHHHHhh--------------------------c------------------------ccCCccccCHHHHHHHHHHc
Confidence 222111000 0 00112345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCc
Q 013941 404 RYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+.||++|||++++++||||++..
T Consensus 248 ~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 248 RRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp CSSGGGSCCHHHHTTSTTTC---
T ss_pred ccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=388.62 Aligned_cols=259 Identities=32% Similarity=0.499 Sum_probs=203.0
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceeEec
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~ 159 (433)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++++++|+|| ++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~ 206 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI-----IKIK 206 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB-----CCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE-----eeEE
Confidence 34578999999999999999999999999999999987532 111246789999999988887 9999
Q ss_pred ceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
+++.. +..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~------- 276 (419)
T 3i6u_A 207 NFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------- 276 (419)
T ss_dssp EEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-------
T ss_pred EEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC-------
Confidence 98764 5589999999 999999887654 799999999999999999999999999999999999996543
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhC---CCCCccchHHHHHHHHHHHHh
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~ 313 (433)
....+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 277 -----------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt 339 (419)
T 3i6u_A 277 -----------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339 (419)
T ss_dssp -----------------SSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred -----------------CcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence 33468999999987654432 34689999999999864 568899999999999999999
Q ss_pred CCCCCCCCChHHHH-HHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 314 GEALFQTHENLEHL-AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 314 g~~pf~~~~~~~~~-~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
|..||........+ ..+....... .......++
T Consensus 340 g~~pf~~~~~~~~~~~~i~~~~~~~----------------------------------------------~~~~~~~~~ 373 (419)
T 3i6u_A 340 GYPPFSEHRTQVSLKDQITSGKYNF----------------------------------------------IPEVWAEVS 373 (419)
T ss_dssp SSCSSCCCSSSCCHHHHHHTTCCCC----------------------------------------------CHHHHTTSC
T ss_pred CCCCCCCCcchHHHHHHHhcCCCCC----------------------------------------------CchhhcccC
Confidence 99999765432211 1111111000 011223567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
..+.+||.+||+.||++|||++|+|+||||++.
T Consensus 374 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 799999999999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=369.66 Aligned_cols=260 Identities=22% Similarity=0.407 Sum_probs=209.1
Q ss_pred cCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceecc
Q 013941 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~ 164 (433)
......++|++.+.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++++ .|+|+ +++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~ 92 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI-----ATYYGAFIK 92 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTB-----CCEEEEEEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCe-----eeeeeEEee
Confidence 334556889999999999999999999999999999999986666667888999999999 57766 999998876
Q ss_pred ------CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 165 ------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 165 ------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
.+.+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------ 166 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA------ 166 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC------
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC------
Confidence 56899999999 78999999875445799999999999999999999999999999999999997655
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhh-----CCCCCccchHHHHHHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ 309 (433)
.+||+|||++...... .....||+.|+|||++. +..++.++|||||||++|
T Consensus 167 ---------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~ 225 (326)
T 2x7f_A 167 ---------------------EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225 (326)
T ss_dssp ---------------------CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHH
T ss_pred ---------------------CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHH
Confidence 4677777776654322 23357899999999997 456889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 310 el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
+|++|..||.+.........+.... .+. ....
T Consensus 226 ~l~~g~~p~~~~~~~~~~~~~~~~~--~~~----------------------------------------------~~~~ 257 (326)
T 2x7f_A 226 EMAEGAPPLCDMHPMRALFLIPRNP--APR----------------------------------------------LKSK 257 (326)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSC--CCC----------------------------------------------CSCS
T ss_pred HHHhCCCCCCCCcHHHHHHHhhcCc--ccc----------------------------------------------CCcc
Confidence 9999999998776655443332211 000 0113
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 390 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.++..+.+||.+||..||++|||+.|+++||||++.
T Consensus 258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 456789999999999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=372.40 Aligned_cols=250 Identities=27% Similarity=0.363 Sum_probs=194.8
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC--
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-- 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~-- 166 (433)
.++|++++.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+.++++++|+|| +++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~ 79 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VRYFNAWLETPPE 79 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTB-----CCEEEEEEECCSC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEEeccc
Confidence 45799999999999999999999999999999998743 3345778899999999988877 89888774432
Q ss_pred -------------------------------------------------------eEEEEEccC-CCCHHHHHHhcCC-C
Q 013941 167 -------------------------------------------------------HICIVFEKL-GPSLYDFLRKNSY-R 189 (433)
Q Consensus 167 -------------------------------------------------------~~~lv~e~~-~~~L~~~l~~~~~-~ 189 (433)
.+++||||| +++|.+++..... .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 489999999 9999999986542 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCc
Q 013941 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269 (433)
Q Consensus 190 ~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~ 269 (433)
..++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---------------------------~kL~DfG~a~ 212 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---------------------------VKVGDFGLVT 212 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---------------------------EEECCCTTCE
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC---------------------------EEEeecCccc
Confidence 3566678999999999999999999999999999999977665 4555555554
Q ss_pred cccCC---------------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-
Q 013941 270 FEHQD---------------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV- 333 (433)
Q Consensus 270 ~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~- 333 (433)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..|+. .....+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~ 287 (332)
T 3qd2_B 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVR 287 (332)
T ss_dssp ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHH
T ss_pred ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhh
Confidence 33221 123479999999999999999999999999999999999876642 111111111
Q ss_pred hcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCH
Q 013941 334 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKA 413 (433)
Q Consensus 334 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta 413 (433)
....|.. ....++++.+||.+||+.||++|||+
T Consensus 288 ~~~~~~~-----------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 288 NLKFPLL-----------------------------------------------FTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp TTCCCHH-----------------------------------------------HHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred ccCCCcc-----------------------------------------------cccCChhHHHHHHHHccCCCCcCCCH
Confidence 1111110 01124578899999999999999999
Q ss_pred HHHhcCCCCCC
Q 013941 414 REALRHPFFTR 424 (433)
Q Consensus 414 ~ell~hp~f~~ 424 (433)
+|+++||||++
T Consensus 321 ~~~l~~~~f~~ 331 (332)
T 3qd2_B 321 TDIIENAIFEN 331 (332)
T ss_dssp HHHHHSTTCCC
T ss_pred HHHhhchhhhc
Confidence 99999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=366.99 Aligned_cols=281 Identities=25% Similarity=0.520 Sum_probs=212.6
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceeEecceecc--CCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--RNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~--~~~ 167 (433)
.++|++.+.||+|+||.||+|++..+++.||||+++... .+.+.+|+.+++++. |+++ +++++++.+ ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i-----~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNI-----ITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTB-----CCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCE-----EEeeeeeccCCCCc
Confidence 367999999999999999999999999999999987433 466889999999997 6666 999999887 678
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++||||+ +++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 108 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--------------- 167 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--------------- 167 (330)
T ss_dssp EEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT---------------
T ss_pred eEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC---------------
Confidence 99999999 899998874 388999999999999999999999999999999999997543
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCC-CCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ-THE 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~-~~~ 322 (433)
..+||+|||++..... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||. +..
T Consensus 168 -----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 236 (330)
T 3nsz_A 168 -----------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236 (330)
T ss_dssp -----------TEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred -----------CEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 2578888888865432 2234578999999999987 568999999999999999999999984 445
Q ss_pred hHHHHHHHHHHhcCCChhhH-Hhhh----hhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 323 NLEHLAMMERVLGPLPHHMV-IRAD----RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
..+.+..+....+..+..-. .... ..............|.. .........++.++.+
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~ 298 (330)
T 3nsz_A 237 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER------------------FVHSENQHLVSPEALD 298 (330)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGG------------------GCCTTTGGGCCHHHHH
T ss_pred hHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhh------------------hccccccccCCHHHHH
Confidence 55666666555442111000 0000 00000000000000000 0001112235789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||.+||+.||++|||++|+|+||||++-.+
T Consensus 299 li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 299 FLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred HHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 999999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=366.59 Aligned_cols=257 Identities=24% Similarity=0.435 Sum_probs=208.1
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee--
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-- 162 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~-- 162 (433)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++|+|+ +++++++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 77 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV-----IQLVDVLYN 77 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCe-----eEEEEEEEc
Confidence 4578999999999999999999999999999999997532 344678899999999988777 9999988
Q ss_pred ccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
.+.+..|+||||+.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~----------- 146 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG----------- 146 (305)
T ss_dssp C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----------
T ss_pred CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-----------
Confidence 456789999999966688888876666899999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCC--CCccchHHHHHHHHHHHHhCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~ 315 (433)
.++|+|||.+...... .....||..|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 147 ----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 210 (305)
T 2wtk_C 147 ----------------TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210 (305)
T ss_dssp ----------------CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSS
T ss_pred ----------------cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCC
Confidence 4666666666543211 12346899999999998754 378999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||.+.+.......+...... ....++..+
T Consensus 211 ~p~~~~~~~~~~~~i~~~~~~--------------------------------------------------~~~~~~~~l 240 (305)
T 2wtk_C 211 YPFEGDNIYKLFENIGKGSYA--------------------------------------------------IPGDCGPPL 240 (305)
T ss_dssp CSCCCSSHHHHHHHHHHCCCC--------------------------------------------------CCSSSCHHH
T ss_pred CCCCCchHHHHHHHHhcCCCC--------------------------------------------------CCCccCHHH
Confidence 999987766555444332111 112446789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
.+||.+||+.||++|||++|+++||||++....
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 999999999999999999999999999876443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=375.49 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=201.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+|++.+.||+|+||.||+|.+.. ++.||||++... ....+.+.+|+.++.++.|+ ++|++++++++...+.+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~---~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYDYEITDQYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT---CTTBCCEEEEEECSSEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccC---CCeEEEEEEEEecCCEE
Confidence 469999999999999999999765 889999998643 23456788999999999862 24559999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|+|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 132 ~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~----------------- 191 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG----------------- 191 (390)
T ss_dssp EEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-----------------
T ss_pred EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-----------------
Confidence 9999966999999998765 789999999999999999999999999999999999994 23
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhC-----------CCCCccchHHHHHHHHHHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~el~ 312 (433)
.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 192 ----------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell 261 (390)
T 2zmd_A 192 ----------MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261 (390)
T ss_dssp ----------CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred ----------eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence 4788888887654322 123579999999999976 36889999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 313 SGEALFQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 313 ~g~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+|..||...... ..+..+. .. ..... .....
T Consensus 262 ~G~~Pf~~~~~~~~~~~~~~---~~-------------------~~~~~--------------------------~~~~~ 293 (390)
T 2zmd_A 262 YGKTPFQQIINQISKLHAII---DP-------------------NHEIE--------------------------FPDIP 293 (390)
T ss_dssp HSSCTTTTCCCHHHHHHHHH---CT-------------------TSCCC--------------------------CCCCS
T ss_pred HCCCcchhhhHHHHHHHHHh---Cc-------------------cccCC--------------------------CCccc
Confidence 999999765432 2222111 10 00001 11223
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 294 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred hHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 5689999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=363.43 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=207.0
Q ss_pred ecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
.+|+.+.++|++++.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.++.+++|+|+ +++++
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~~ 78 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI-----VSMID 78 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTB-----CCEEE
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCC-----ceEEE
Confidence 45778889999999999999999999999999999999998532 2344677889999999988877 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
++.+++.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-------- 148 (294)
T 4eqm_A 79 VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-------- 148 (294)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--------
T ss_pred eeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--------
Confidence 999999999999999 889999998765 799999999999999999999999999999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 149 -------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~ 209 (294)
T 4eqm_A 149 -------------------TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209 (294)
T ss_dssp -------------------CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -------------------CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 5677777777654322 22357999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||.+.+......... ....| .........++..+
T Consensus 210 ~pf~~~~~~~~~~~~~--~~~~~-------------------------------------------~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 210 PPFNGETAVSIAIKHI--QDSVP-------------------------------------------NVTTDVRKDIPQSL 244 (294)
T ss_dssp CSSCSSCHHHHHHHHH--SSCCC-------------------------------------------CHHHHSCTTSCHHH
T ss_pred CCCCCCChHHHHHHHh--hccCC-------------------------------------------CcchhcccCCCHHH
Confidence 9998877654432221 11111 11112234567899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPF 421 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~ 421 (433)
.++|.+||+.||++||+..+.+.+.|
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHH
Confidence 99999999999999995444444444
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=369.59 Aligned_cols=260 Identities=31% Similarity=0.481 Sum_probs=207.6
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceeEe
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQI 158 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~ 158 (433)
..+.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++++.|+|| +++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~ 80 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI-----IKI 80 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTB-----CCE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCC-----ceE
Confidence 345578999999999999999999999999999999986432 122346789999999988877 999
Q ss_pred cceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
++++..++ .|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------ 151 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------ 151 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS------
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC------
Confidence 99887655 89999999 889999987654 799999999999999999999999999999999999997644
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~ 312 (433)
....+||+|||++....... ....||+.|+|||++. ...++.++|||||||++|+|+
T Consensus 152 ------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 152 ------------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp ------------------SSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred ------------------CCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence 23458999999987654432 2357999999999974 456899999999999999999
Q ss_pred hCCCCCCCCChHH-HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 313 SGEALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 313 ~g~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+|..||....... ....+........ ......+
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~ 247 (322)
T 2ycf_A 214 SGYPPFSEHRTQVSLKDQITSGKYNFI----------------------------------------------PEVWAEV 247 (322)
T ss_dssp HSSCSSCSTTCSSCHHHHHHHTCCCCC----------------------------------------------HHHHTTS
T ss_pred hCCCCCcccchHHHHHHHHHhCccccC----------------------------------------------chhhhhc
Confidence 9999997654321 1111211110000 1112345
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+..+.+||.+||+.||++|||++|+++||||++.
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 7789999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=372.25 Aligned_cols=258 Identities=23% Similarity=0.313 Sum_probs=207.1
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
...+.++|++.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.++++++|+|| +++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 81 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-----VAVYDTG 81 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTB-----CCEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCc-----ceEEEee
Confidence 4566789999999999999999999999999999999997532 334567789998888888777 9999988
Q ss_pred ccCC----eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 163 DYRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 163 ~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
.... ..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------ 153 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN------ 153 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS------
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC------
Confidence 7543 459999999 899999998765 799999999999999999999999999999999999997665
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 154 ---------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 154 ---------------------AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212 (311)
T ss_dssp ---------------------CEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------------------CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence 4667777766543221 1234789999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|+.||.+.........+.......+ ......+
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~ 246 (311)
T 3ork_A 213 LTGEPPFTGDSPVSVAYQHVREDPIPP----------------------------------------------SARHEGL 246 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCH----------------------------------------------HHHSTTC
T ss_pred HhCCCCCCCCChHHHHHHHhcCCCCCc----------------------------------------------ccccCCC
Confidence 999999988776665444333211110 1112345
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+.++.+||.+||+.||++||++.+++.|+|++.
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 778999999999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=359.30 Aligned_cols=253 Identities=23% Similarity=0.407 Sum_probs=204.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc----
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~---- 164 (433)
..|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.++|+|| +++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~ 100 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWESTVKG 100 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEESSS
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeeccccCC
Confidence 4589999999999999999999999999999998643 3345667889999999988877 899888764
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCcccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
...+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~------------ 166 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG------------ 166 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS------------
T ss_pred CceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC------------
Confidence 46799999999 889999998764 6999999999999999999999999 999999999999952
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+..+||+|||++....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 167 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 167 --------------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp --------------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --------------CCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 23357888888876544332 33579999999998875 589999999999999999999999987
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
............. +..+ .......++++.+||.
T Consensus 232 ~~~~~~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~l~~li~ 264 (290)
T 1t4h_A 232 CQNAAQIYRRVTS-GVKP----------------------------------------------ASFDKVAIPEVKEIIE 264 (290)
T ss_dssp CSSHHHHHHHHTT-TCCC----------------------------------------------GGGGGCCCHHHHHHHH
T ss_pred cCcHHHHHHHHhc-cCCc----------------------------------------------cccCCCCCHHHHHHHH
Confidence 5554433221110 0000 0112234568999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||+.||++|||++|+++||||+++
T Consensus 265 ~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 265 GCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHccCChhhCCCHHHHhhCcccccC
Confidence 9999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=360.48 Aligned_cols=255 Identities=22% Similarity=0.394 Sum_probs=207.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+++ +++++++.+++..|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCc-----eeeeeEEEcCCEEE
Confidence 57999999999999999999999999999999986432 345678889999999988777 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------------- 142 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD----------------- 142 (276)
T ss_dssp EEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----------------
T ss_pred EEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-----------------
Confidence 999999 889999886543 699999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.++|+|||.+...... .....||..|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 143 ----------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 143 ----------NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp ----------CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred ----------CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 4677777776543211 233578999999999988765 789999999999999999999997654
Q ss_pred hHHH-HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 323 NLEH-LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 323 ~~~~-~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
.... ...+..... .......++..+.+||.+
T Consensus 213 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~ 244 (276)
T 2yex_A 213 DSCQEYSDWKEKKT------------------------------------------------YLNPWKKIDSAPLALLHK 244 (276)
T ss_dssp TTSHHHHHHHTTCT------------------------------------------------TSTTGGGSCHHHHHHHHH
T ss_pred hHHHHHHHhhhccc------------------------------------------------ccCchhhcCHHHHHHHHH
Confidence 3211 111110000 000112356789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
||+.||++|||++|+++||||++..++
T Consensus 245 ~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 245 ILVENPSARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp HSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred HCCCCchhCCCHHHHhcCccccChhhc
Confidence 999999999999999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=372.45 Aligned_cols=268 Identities=26% Similarity=0.422 Sum_probs=186.1
Q ss_pred CccCCCeEEec-cccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHH-HHHHHHhCCCCCcceeEecceecc-
Q 013941 88 ENLTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDY- 164 (433)
Q Consensus 88 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~v~~~~~~~~- 164 (433)
..+.++|++.+ .||+|+||.||+|++..+++.||||++...... .+|+. .++.+.|+|+ +++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i-----~~~~~~~~~~ 94 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHI-----VCILDVYENM 94 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTB-----CCEEEEEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCCh-----HHHHHHHhhc
Confidence 34567899966 599999999999999999999999999764332 22333 3455566665 888888875
Q ss_pred ---CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 165 ---RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 165 ---~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
...+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~--------- 165 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE--------- 165 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS---------
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC---------
Confidence 56699999999 88999999877656799999999999999999999999999999999999997543
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 166 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 166 ---------------KDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp ---------------TTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ---------------CCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 3446899999998755433 234678999999999988889999999999999999999999997
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
+.........+...... ... .........++.++.+||
T Consensus 231 ~~~~~~~~~~~~~~~~~--------------------~~~----------------------~~~~~~~~~~~~~~~~li 268 (336)
T 3fhr_A 231 SNTGQAISPGMKRRIRL--------------------GQY----------------------GFPNPEWSEVSEDAKQLI 268 (336)
T ss_dssp --------------------------------------------------------------CCCTTTSTTCCHHHHHHH
T ss_pred CccchhhhhhHHHhhhc--------------------ccc----------------------ccCchhhccCCHHHHHHH
Confidence 65543321111110000 000 000111235678999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCccccC
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRDVRRCG 430 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~~~~~~ 430 (433)
.+||+.||++|||++|+++||||++......
T Consensus 269 ~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 299 (336)
T 3fhr_A 269 RLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299 (336)
T ss_dssp HHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred HHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence 9999999999999999999999998654433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=391.17 Aligned_cols=249 Identities=18% Similarity=0.235 Sum_probs=194.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEec-------
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIR------- 159 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~------- 159 (433)
.++|++.+.||+|+||.||+|++..+|+.||||++... ....+.+.+|+.+++.+.. +.|+|+++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG--IKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT--CCSHHHHHHHHCBCCCS
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc--cCCHHHHHHHhhhhhhh
Confidence 46899999999999999999999999999999998632 2345678889966655532 2345558887
Q ss_pred ceeccCC-----------------eEEEEEccCCCCHHHHHHhcCCCCCC-------HHHHHHHHHHHHHHHHHHHhCCc
Q 013941 160 NWFDYRN-----------------HICIVFEKLGPSLYDFLRKNSYRSFP-------IDLVRELGRQLLESVAFMHELRL 215 (433)
Q Consensus 160 ~~~~~~~-----------------~~~lv~e~~~~~L~~~l~~~~~~~l~-------~~~~~~i~~qi~~aL~~LH~~~i 215 (433)
++++..+ ..|+||||++|+|.+++.... .++ +..+..++.||+.||+|||++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5554443 389999999889999998643 344 47888899999999999999999
Q ss_pred EecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC--
Q 013941 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-- 293 (433)
Q Consensus 216 vHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-- 293 (433)
+||||||+|||++.++ .+||+|||++...........| +.|+|||++.+.
T Consensus 228 vHrDikp~NIll~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRG---------------------------GVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp ECSCCCGGGEEECTTC---------------------------CEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTS
T ss_pred ecCCCCHHHEEEcCCC---------------------------CEEEEechhheecCCcccCCCC-cCccChhhhccccc
Confidence 9999999999997655 5677777777655544455678 999999999887
Q ss_pred ---------CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCC
Q 013941 294 ---------GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 364 (433)
Q Consensus 294 ---------~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (433)
.++.++|||||||++|||++|+.||.+.......
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~------------------------------------- 322 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS------------------------------------- 322 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS-------------------------------------
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch-------------------------------------
Confidence 7999999999999999999999999654321100
Q ss_pred CCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 365 ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.........++.++.+||.+||+.||++|||+.|+++||||++.
T Consensus 323 -----------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 323 -----------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp -----------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred -----------------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 00011123557799999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=363.78 Aligned_cols=282 Identities=21% Similarity=0.323 Sum_probs=209.7
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
.+.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.++++++|+|+ +++++++...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 80 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI-----VKLFAIEEETT 80 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCc-----ceEEEEeecCC
Confidence 45578999999999999999999999999999999997533 334667899999999988877 99999887654
Q ss_pred --eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 167 --HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 167 --~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
..|+||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+....
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----------- 149 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE----------- 149 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT-----------
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC-----------
Confidence 889999999 8999999986432 2399999999999999999999999999999999999984321
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhh--------CCCCCccchHHHHHHHHHHHH
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVIL--------GLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~el~ 312 (433)
+....+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|||+
T Consensus 150 ------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~ 217 (319)
T 4euu_A 150 ------------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (319)
T ss_dssp ------------TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred ------------CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence 234468899999887654332 3457999999999987 567899999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 313 SGEALFQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 313 ~g~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
+|..||...... .....+.......|...+...... ......|..... .........
T Consensus 218 ~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~------~~~~~~~~~~~~----------------~~~~~~~~~ 275 (319)
T 4euu_A 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKA------ENGPIDWSGDMP----------------VSCSLSRGL 275 (319)
T ss_dssp HSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECS------TTCCEEEESSCC----------------TTCSSCHHH
T ss_pred hCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcc------cCCccccCccCC----------------cccccchhH
Confidence 999999754322 122222333222222111100000 000111111000 000112234
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRHP 420 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~hp 420 (433)
+..+.+||.+||+.||++|||++|+|+||
T Consensus 276 ~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 276 QVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 66899999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=378.85 Aligned_cols=259 Identities=15% Similarity=0.118 Sum_probs=190.6
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHH--hCCCCCcceeEec-------
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA--RHDIGGTRCVQIR------- 159 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~--~~~i~~~~~v~~~------- 159 (433)
.|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+. |+|+ ++++
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~i-----v~~~~~~~~p~ 137 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE-----ARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC---------------CBCCCC
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhh-----hhhceeEEeee
Confidence 5999999999999999999999999999999998633 34556778877777776 6665 5533
Q ss_pred ceeccC-----------------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCcE
Q 013941 160 NWFDYR-----------------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLV------RELGRQLLESVAFMHELRLI 216 (433)
Q Consensus 160 ~~~~~~-----------------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~iv 216 (433)
+++... ..+|+||||+.++|.+++.... ..+++... ..++.||+.||+|||++||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 333221 4589999999899999998643 13444555 67779999999999999999
Q ss_pred ecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC--CC
Q 013941 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LG 294 (433)
Q Consensus 217 HrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~ 294 (433)
||||||+|||++.+| .+||+|||++...........+|+.|+|||++.+ ..
T Consensus 217 HrDikp~NIll~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 217 HGHFTPDNLFIMPDG---------------------------RLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp ETTCSGGGEEECTTS---------------------------CEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEE
T ss_pred cCcCCHHHEEECCCC---------------------------CEEEEecceeeecCCCccCccCCcCCcChhhccCCCCC
Confidence 999999999997655 4677777777655444434577899999999987 67
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHH
Q 013941 295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374 (433)
Q Consensus 295 ~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (433)
++.++|||||||++|+|++|+.||.+...... ..+.. .....
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------------------------~~~~~---~~~~~----------- 311 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK------------------------GSWKR---PSLRV----------- 311 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT------------------------TCCCB---CCTTS-----------
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccc------------------------cchhh---hhhhh-----------
Confidence 99999999999999999999999976532100 00000 00000
Q ss_pred HHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.............++..+.+||.+||+.||++|||+.|+|+||||++.
T Consensus 312 ---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 312 ---PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp ---CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred ---ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 000001111224568899999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=359.79 Aligned_cols=261 Identities=30% Similarity=0.534 Sum_probs=217.5
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
...+.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++.|+++ +++++++.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~ 91 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI-----MKLFEILE 91 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCc-----cEEEEEEe
Confidence 3455678999999999999999999999999999999986432 345678899999999988777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
+.+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~----------- 158 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE----------- 158 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-----------
T ss_pred CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC-----------
Confidence 999999999999 899999987664 699999999999999999999999999999999999996543
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
....+||+|||++....... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+
T Consensus 159 -------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 159 -------------KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp -------------TTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -------------CcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 23468999999887544322 33468999999999876 489999999999999999999999998
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+..+....+.......+ ......++.++.+||.
T Consensus 225 ~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~ 258 (287)
T 2wei_A 225 KNEYDILKRVETGKYAFD----------------------------------------------LPQWRTISDDAKDLIR 258 (287)
T ss_dssp SSHHHHHHHHHHCCCCCC----------------------------------------------SGGGTTSCHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCC----------------------------------------------chhhhhcCHHHHHHHH
Confidence 877665554443211111 0112345778999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||+.||++|||+.|+++||||++.
T Consensus 259 ~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 259 KMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=362.63 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=210.5
Q ss_pred eeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 83 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
.+..+....++|++++.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+++ ++++++
T Consensus 10 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~ 84 (302)
T 2j7t_A 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI-----VKLLGA 84 (302)
T ss_dssp CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred ccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCE-----eeeeee
Confidence 34445566789999999999999999999999999999999986533 345678889999999988777 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--------- 154 (302)
T 2j7t_A 85 YYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG--------- 154 (302)
T ss_dssp EECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS---------
T ss_pred eeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC---------
Confidence 99999999999999 889999987643 3699999999999999999999999999999999999997655
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCcccc---CCCcccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~ 312 (433)
.+||+|||++.... .......||..|+|||++. +..++.++|||||||++|+|+
T Consensus 155 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 216 (302)
T 2j7t_A 155 ------------------DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216 (302)
T ss_dssp ------------------CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH
T ss_pred ------------------CEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh
Confidence 46777777653221 1123357899999999984 567899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|..||...+.......+.....+. ......++
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 249 (302)
T 2j7t_A 217 QIEPPHHELNPMRVLLKIAKSDPPT-----------------------------------------------LLTPSKWS 249 (302)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCC-----------------------------------------------CSSGGGSC
T ss_pred cCCCCCccCCHHHHHHHHhccCCcc-----------------------------------------------cCCccccC
Confidence 9999998877665544333211100 00112346
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
..+.+||.+||+.||++|||+.|+++||||++..
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 6899999999999999999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=361.76 Aligned_cols=257 Identities=21% Similarity=0.365 Sum_probs=190.6
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhh--HHH-HHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REA-AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~-~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++++.||+|+||+||+|++..+++.||+|+++..... ... ...+...++.+.|++ ++++++++.+++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~-----iv~~~~~~~~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF-----TVTFYGALFREGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTT-----BCCEEEEEECSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCe-----EEEEeeeeeccCC
Confidence 46899999999999999999999999999999999754221 122 223333344455554 5999999999999
Q ss_pred EEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 168 ICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
.++||||++++|.+++.. .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~------------- 147 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG------------- 147 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-------------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-------------
Confidence 999999997799888764 1234799999999999999999999998 999999999999996554
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhh----hCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 148 --------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 148 --------------QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp --------------CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred --------------CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 56777777775443322 234799999999997 4557899999999999999999999999
Q ss_pred CCCCh-HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 319 QTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 319 ~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
..... ...+..+.... .+ ......++.++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~--~~----------------------------------------------~~~~~~~~~~~~~ 245 (290)
T 3fme_A 214 DSWGTPFQQLKQVVEEP--SP----------------------------------------------QLPADKFSAEFVD 245 (290)
T ss_dssp CCCSCHHHHHHHHHHSC--CC----------------------------------------------CCCTTTSCHHHHH
T ss_pred cccCchHHHHHHHhccC--CC----------------------------------------------CcccccCCHHHHH
Confidence 86433 22222221110 00 0001245678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||.+||+.||++|||+.|+++||||+....
T Consensus 246 li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 246 FTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 999999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=372.56 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=201.8
Q ss_pred CCeEEeccccccccEEEEEEEec---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHH-hCCCCCcceeEeccee
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~ 162 (433)
++|++.+.||+|+||.||+|++. .+++.||||+++... ...+.+.+|+.+++.+. |++| +++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~ 128 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAF 128 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTB-----CCEEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCce-----eEEEEEE
Confidence 68999999999999999999984 588999999986432 23455677999999995 6666 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
...+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---------- 196 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG---------- 196 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----------
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----------
Confidence 9999999999999 899999998765 699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccC----CCcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHhCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~ 315 (433)
.+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 197 -----------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~ 259 (355)
T 1vzo_A 197 -----------------HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259 (355)
T ss_dssp -----------------CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred -----------------cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 466777776653321 12235799999999999863 4789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHH-HhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 316 ALFQTHENLEHLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
.||...........+.+ ..... ......++..
T Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~ 292 (355)
T 1vzo_A 260 SPFTVDGEKNSQAEISRRILKSE-----------------------------------------------PPYPQEMSAL 292 (355)
T ss_dssp CTTSCTTSCCCHHHHHHHHHHCC-----------------------------------------------CCCCTTSCHH
T ss_pred CCCccCCccchHHHHHHHHhccC-----------------------------------------------CCCCcccCHH
Confidence 99975432211111111 11000 0112345678
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 013941 395 LIDLLQGLLRYDPAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~-----ta~ell~hp~f~~~ 425 (433)
+.+||.+||+.||++|| |++|+++||||++.
T Consensus 293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 99999999999999999 99999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=361.49 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=206.0
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+...++|++.+.||+|+||.||+|.+..+|+.||||++.... ..+.+.+|+.+++.+.|+++ +++++++...+.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 98 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHV-----VKYYGSYFKNTD 98 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTB-----CCEEEEEEETTE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCC-----ccEEEEEEeCCE
Confidence 344568999999999999999999999999999999987543 34668889999999988777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--------------- 162 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG--------------- 162 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---------------
T ss_pred EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC---------------
Confidence 99999999 789999997433 4799999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.++|+|||.+...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 163 ------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 230 (314)
T 3com_A 163 ------------HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230 (314)
T ss_dssp ------------CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ------------CEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence 4677777776543322 2335789999999999998999999999999999999999999987766
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+....... ......++..+.+||.+||
T Consensus 231 ~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~l~~li~~~l 263 (314)
T 3com_A 231 MRAIFMIPTNPPPT-----------------------------------------------FRKPELWSDNFTDFVKQCL 263 (314)
T ss_dssp HHHHHHHHHSCCCC-----------------------------------------------CSSGGGSCHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCcc-----------------------------------------------cCCcccCCHHHHHHHHHHc
Confidence 54443332211000 0011234678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+.||++|||+.++++||||++.
T Consensus 264 ~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 264 VKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp CSCTTTSCCHHHHTTSHHHHTC
T ss_pred cCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=360.14 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=212.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+.|+++ +++++++.+.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecCCeE
Confidence 35799999999999999999999999999999998643 2345778899999999988777 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 96 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~---------------- 156 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG---------------- 156 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----------------
T ss_pred EEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC----------------
Confidence 9999999 88999998753 699999999999999999999999999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 157 -----------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 225 (303)
T 3a7i_A 157 -----------EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 225 (303)
T ss_dssp -----------CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred -----------CEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH
Confidence 4677777777543322 23357899999999999989999999999999999999999999877665
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+.... .+ .....++..+.+||.+||+
T Consensus 226 ~~~~~~~~~~--~~-----------------------------------------------~~~~~~~~~l~~li~~~l~ 256 (303)
T 3a7i_A 226 KVLFLIPKNN--PP-----------------------------------------------TLEGNYSKPLKEFVEACLN 256 (303)
T ss_dssp HHHHHHHHSC--CC-----------------------------------------------CCCSSCCHHHHHHHHHHCC
T ss_pred HHHHHhhcCC--CC-----------------------------------------------CCccccCHHHHHHHHHHcC
Confidence 5443332210 00 0123456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCcc
Q 013941 405 YDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.||++|||+.|+++||||.+...
T Consensus 257 ~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 257 KEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp SSGGGSCCHHHHTTCHHHHHHCC
T ss_pred CChhhCcCHHHHhhChhhhcCCC
Confidence 99999999999999999986544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=353.43 Aligned_cols=258 Identities=20% Similarity=0.256 Sum_probs=208.2
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccC
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~ 165 (433)
++.+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.+ .|+++ +++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGI-----PNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTC-----CCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCC-----CeEEeecCCC
Confidence 4556788999999999999999999999999999999986533 334577899999999 55555 8888999999
Q ss_pred CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
...++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~------------- 144 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS------------- 144 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-------------
T ss_pred ceeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC-------------
Confidence 9999999999999999998754 36999999999999999999999999999999999999977652
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
.....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 145 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 215 (298)
T 1csn_A 145 ---------KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215 (298)
T ss_dssp ---------TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ---------CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence 23345888888888654332 23357999999999999999999999999999999999999
Q ss_pred CCCCCCCh---HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 316 ALFQTHEN---LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 316 ~pf~~~~~---~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
.||.+... ......+.......+ .......++
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~ 250 (298)
T 1csn_A 216 LPWQGLKAATNKQKYERIGEKKQSTP---------------------------------------------LRELCAGFP 250 (298)
T ss_dssp CTTSSCCSCCHHHHHHHHHHHHHHSC---------------------------------------------HHHHTTTSC
T ss_pred CCcchhhccccHHHHHHHHhhccCcc---------------------------------------------HHHHHhhCc
Confidence 99987432 222332222111111 011123557
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.++.+||.+||+.||++|||+++|++
T Consensus 251 ~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 251 EEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 79999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=360.02 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=204.4
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++++ .|+++ +++++++..++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~~~~~~~ 80 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGI-----PQVYYFGPCGKYN 80 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTS-----CCEEEEEEETTEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCC-----CEEEEEEecCCcc
Confidence 3568999999999999999999999999999999986533 234578899999999 77777 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~---------------- 143 (330)
T 2izr_A 81 AMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN---------------- 143 (330)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG----------------
T ss_pred EEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC----------------
Confidence 9999999999999998653 47999999999999999999999999999999999999987653
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 144 ------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 144 ------KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp ------TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence 12233788888877643322 13468999999999999999999999999999999999999999
Q ss_pred CCCChHH---HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 319 QTHENLE---HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 319 ~~~~~~~---~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.+....+ ....+.......|. .......+ ++
T Consensus 218 ~~~~~~~~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~~p-~~ 251 (330)
T 2izr_A 218 QGLKADTLKERYQKIGDTKRATPI---------------------------------------------EVLCENFP-EM 251 (330)
T ss_dssp TTCCCSSHHHHHHHHHHHHHHSCH---------------------------------------------HHHTTTCH-HH
T ss_pred cccccccHHHHHHHHHhhhccCCH---------------------------------------------HHHhccCh-HH
Confidence 8754332 22322221111110 01112334 89
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+||.+||+.||.+||++++|++
T Consensus 252 ~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 252 ATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999999999999999998875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=364.67 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=207.4
Q ss_pred ceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHHHhCCCCCc
Q 013941 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
..+...++.+.++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.+++++.| .++
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~ 108 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFS 108 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc---CCC
Confidence 33455677788999999999999999999999999999999999875321 22446679999999976 234
Q ss_pred ceeEecceeccCCeEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe-eC
Q 013941 154 RCVQIRNWFDYRNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SA 230 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~-~~ 230 (433)
+++++++++...+..++|||++ + ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence 5599999999999999999999 4 89999998764 799999999999999999999999999999999999997 33
Q ss_pred CcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCC-CccchHHHHHHHH
Q 013941 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCIL 308 (433)
Q Consensus 231 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il 308 (433)
+ .+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++
T Consensus 187 ~---------------------------~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 239 (320)
T 3a99_A 187 G---------------------------ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239 (320)
T ss_dssp T---------------------------EEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred C---------------------------CEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHH
Confidence 3 5778888877654432 233579999999999987765 6889999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 309 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
|+|++|..||..... +... . ....
T Consensus 240 ~el~~g~~pf~~~~~------~~~~--~------------------------------------------------~~~~ 263 (320)
T 3a99_A 240 YDMVCGDIPFEHDEE------IIRG--Q------------------------------------------------VFFR 263 (320)
T ss_dssp HHHHHSSCSCCSHHH------HHHC--C------------------------------------------------CCCS
T ss_pred HHHHHCCCCCCChhh------hhcc--c------------------------------------------------cccc
Confidence 999999999965321 0000 0 0012
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
..++.++.+||.+||+.||++|||++|+++||||++...
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 345778999999999999999999999999999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=370.14 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=210.8
Q ss_pred ccCCCeEEeccccccccEEEEEEE-----ecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
...++|++.+.||+|+||.||+|+ +..+++.||||+++.. ......+.+|+.++++++|+|| ++++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~ 142 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI-----VRCIGV 142 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCC-----CeEEEE
Confidence 334689999999999999999999 4567889999998643 3444567889999999988877 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l 235 (433)
+...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---- 218 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG---- 218 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC----
Confidence 99999999999999 8999999986432 3589999999999999999999999999999999999997654
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCcccc-----CCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHH
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (433)
....+||+|||++.... .......||+.|+|||++.+..++.++|||||||++||
T Consensus 219 --------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e 278 (367)
T 3l9p_A 219 --------------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278 (367)
T ss_dssp --------------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --------------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHH
Confidence 23358888888876432 12233578999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 311 LCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 311 l~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
|++ |..||.+....+....+...... ....
T Consensus 279 llt~g~~pf~~~~~~~~~~~i~~~~~~-------------------------------------------------~~~~ 309 (367)
T 3l9p_A 279 IFSLGYMPYPSKSNQEVLEFVTSGGRM-------------------------------------------------DPPK 309 (367)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCC-------------------------------------------------CCCT
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------------------------------------CCCc
Confidence 998 99999988776655544332110 0113
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 390 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
.++..+.+||.+||+.||++|||+.||++|.++..
T Consensus 310 ~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 310 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 44678999999999999999999999999877653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=359.34 Aligned_cols=271 Identities=24% Similarity=0.353 Sum_probs=196.1
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc------
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY------ 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~------ 164 (433)
.++|++++.||+|+||.||+|++..+++.||||++.......+.+.+|+.++++++|+++ +++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV-----VRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHH-----HHHHHHHHhhcchhh
Confidence 457999999999999999999999999999999998766666788899999999988877 888877643
Q ss_pred -------CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccccc
Q 013941 165 -------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 165 -------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~ 236 (433)
.+..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence 56799999999 889999998653 468899999999999999999999999999999999999877655555
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCC
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~ 315 (433)
|||++.......... .+ +-..............||..|+|||++.+. .++.++|||||||++|+|++
T Consensus 159 dfg~~~~~~~~~~~~---------~~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDIL---------KL-DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp CCCCCSCTTC-----------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred eCcchhhcccccchh---------cc-ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 555443222111000 00 000000000112335789999999999865 68999999999999999998
Q ss_pred CCCCCCCh-HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 316 ALFQTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 316 ~pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
||..... ......+......+|. ......+..
T Consensus 227 -p~~~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~ 259 (303)
T 1zy4_A 227 -PFSTGMERVNILKKLRSVSIEFPP----------------------------------------------DFDDNKMKV 259 (303)
T ss_dssp -CCSSHHHHHHHHHHHHSTTCCCCT----------------------------------------------TCCTTTSHH
T ss_pred -ccCCchhHHHHHHhccccccccCc----------------------------------------------cccccchHH
Confidence 5543221 1222222111111110 112344567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+.+||.+||+.||++|||+.|+++||||+...
T Consensus 260 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 89999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=355.57 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=199.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++.+.||+|+||+||+|++ +++.||||++.... ...+.+.+|+.++++++|+|| +++++++.+.+.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI-----VLFMGAVTQPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSTTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECCc
Confidence 46899999999999999999986 57889999987533 334567889999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
+++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~------------ 176 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY------------ 176 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC------------
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC------------
Confidence 99999999 8999999986431 13899999999999999999999999 99999999999996554
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 177 ---------------~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 177 ---------------TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp ---------------CEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred ---------------cEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5677777777543332 2335799999999999999999999999999999999999999988
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+..+....+...... ......+++++.+||.
T Consensus 242 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~l~~li~ 273 (309)
T 3p86_A 242 LNPAQVVAAVGFKCKR------------------------------------------------LEIPRNLNPQVAAIIE 273 (309)
T ss_dssp SCHHHHHHHHHHSCCC------------------------------------------------CCCCTTSCHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCC------------------------------------------------CCCCccCCHHHHHHHH
Confidence 7766554443221110 0112345778999999
Q ss_pred HhcccCCCCCCCHHHHhc--CCCCCC
Q 013941 401 GLLRYDPAERLKAREALR--HPFFTR 424 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~--hp~f~~ 424 (433)
+||+.||++|||++|+++ ++++++
T Consensus 274 ~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999987 555554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=352.45 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=208.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee--ccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF--DYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~--~~~~ 166 (433)
++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.++++++|+|+ +++++++ ...+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI-----VRYYDRIIDRTNT 80 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEEGGGT
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCC-----CeEEEEEecCCCc
Confidence 5799999999999999999999999999999999743 2345678889999999988877 9999977 4467
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEecCCCCCcEEEeeCCcccccCc
Q 013941 167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
.+++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~------- 153 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ------- 153 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-------
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-------
Confidence 899999999 889999997532 235999999999999999999999999 99999999999997655
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
.+||+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 --------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 154 --------------------NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp --------------------CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred --------------------CEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 46777777765543322 2347899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||...+..+....+..... + .....++.++
T Consensus 214 ~p~~~~~~~~~~~~i~~~~~--~-----------------------------------------------~~~~~~~~~l 244 (279)
T 2w5a_A 214 PPFTAFSQKELAGKIREGKF--R-----------------------------------------------RIPYRYSDEL 244 (279)
T ss_dssp CSSCCSSHHHHHHHHHHTCC--C-----------------------------------------------CCCTTSCHHH
T ss_pred CCCcccCHHHHHHHHhhccc--c-----------------------------------------------cCCcccCHHH
Confidence 99988776555444433110 0 0112456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
.+||.+||+.||++|||++|+++|+|+.+..
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 9999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=350.59 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=205.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|+||.||+|++. +++.||+|++.......+.+.+|+.++++++|+++ +++++++.+.+..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCceEEE
Confidence 57999999999999999999986 56779999998766666788999999999988777 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------------------- 143 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ------------------- 143 (269)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-------------------
T ss_pred EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-------------------
Confidence 9999 899999997654 4699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
.++|+|||++...... .....+|..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 144 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~ 215 (269)
T 4hcu_A 144 --------VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215 (269)
T ss_dssp --------CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred --------CEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 4677777777543321 222466788999999998899999999999999999999 999998877766
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+....... .....+..+.+||.+||+.
T Consensus 216 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~ 246 (269)
T 4hcu_A 216 VVEDISTGFRLY-------------------------------------------------KPRLASTHVYQIMNHCWRE 246 (269)
T ss_dssp HHHHHHTTCCCC-------------------------------------------------CCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHhcCccCC-------------------------------------------------CCCcCCHHHHHHHHHHccC
Confidence 555443321110 1123467899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013941 406 DPAERLKAREALRH 419 (433)
Q Consensus 406 dP~~R~ta~ell~h 419 (433)
||++|||+.|+++|
T Consensus 247 ~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 247 RPEDRPAFSRLLRQ 260 (269)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=364.74 Aligned_cols=248 Identities=18% Similarity=0.306 Sum_probs=201.3
Q ss_pred CCCeEEeccccccccEEEEEEEec-------CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~ 160 (433)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ....+.+.+|+.+++++ +|+|| +++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~~ 154 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG 154 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTB-----CCEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCE-----eeEEE
Confidence 368999999999999999999864 34568999999753 23456788999999999 78777 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcE
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NI 225 (433)
++.+.+.+|+||||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 999999999999999 899999998653 13588999999999999999999999999999999999
Q ss_pred EEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccch
Q 013941 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 300 (433)
Q Consensus 226 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (433)
|++.++ .+||+|||++...... .....+|+.|+|||++.+..++.++|
T Consensus 235 ll~~~~---------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 287 (370)
T 2psq_A 235 LVTENN---------------------------VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287 (370)
T ss_dssp EECTTC---------------------------CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred EECCCC---------------------------CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH
Confidence 997655 4666677766543221 12246788999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC
Q 013941 301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379 (433)
Q Consensus 301 iwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
||||||++|||++ |..||.+....+....+.....
T Consensus 288 vwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------- 323 (370)
T 2psq_A 288 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-------------------------------------------- 323 (370)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------------------------------------
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--------------------------------------------
Confidence 9999999999999 9999987665544433321100
Q ss_pred chhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
......++.++.+||.+||+.||++|||+.|++++
T Consensus 324 -----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 324 -----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123456789999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=359.74 Aligned_cols=247 Identities=22% Similarity=0.280 Sum_probs=202.1
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCc---EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..++|++.+.||+|+||.||+|++..+++ .||||+++.. ....+.+.+|+.++++++|+|| +++++++.+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI-----IRLEGVVTR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEe
Confidence 34689999999999999999999986554 5999999753 3445678899999999988777 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
++..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------------ 188 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL------------ 188 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------------
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC------------
Confidence 99999999999 899999997553 4699999999999999999999999999999999999997655
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 189 ---------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 189 ---------------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp ---------------CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ---------------CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 46677777665443221 11345778999999998899999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+....+....+...... .....++..+.
T Consensus 254 p~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~l~ 284 (325)
T 3kul_A 254 PYWNMTNRDVISSVEEGYRL-------------------------------------------------PAPMGCPHALH 284 (325)
T ss_dssp TTTTSCHHHHHHHHHTTCCC-------------------------------------------------CCCTTCCHHHH
T ss_pred CcccCCHHHHHHHHHcCCCC-------------------------------------------------CCCCCcCHHHH
Confidence 99887776655544332110 01234567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
+||.+||..||++|||+.|+++
T Consensus 285 ~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 285 QLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=368.25 Aligned_cols=275 Identities=21% Similarity=0.350 Sum_probs=212.9
Q ss_pred cCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhh------------------HHHHHHHHHHHHHHHh
Q 013941 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY------------------REAAMIEIDVLQRLAR 147 (433)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~E~~~l~~l~~ 147 (433)
.++...++|++.+.||+|+||.||+|++ +++.||||++...... .+.+.+|+.++++++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3445567899999999999999999998 8999999998743221 1778899999999988
Q ss_pred CCCCCcceeEecceeccCCeEEEEEccC-CCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecC
Q 013941 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF------LRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTD 219 (433)
Q Consensus 148 ~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrD 219 (433)
+++ +++++++.+.+..++||||+ +++|.++ +.......+++..++.++.||+.||.|||+ +||+|||
T Consensus 103 ~~i-----~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 177 (348)
T 2pml_X 103 EYC-----LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177 (348)
T ss_dssp TTB-----CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred CCc-----ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence 777 99999999999999999999 8899998 655434579999999999999999999999 9999999
Q ss_pred CCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCC-CCCc
Q 013941 220 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGL-GWNY 297 (433)
Q Consensus 220 ikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~ 297 (433)
|||+|||++.++ .++|+|||.+...... .....||..|+|||++.+. .++.
T Consensus 178 l~p~Nil~~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 230 (348)
T 2pml_X 178 VKPSNILMDKNG---------------------------RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG 230 (348)
T ss_dssp CCGGGEEECTTS---------------------------CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEH
T ss_pred CChHhEEEcCCC---------------------------cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCc
Confidence 999999996654 5777778777654322 2335789999999999887 5666
Q ss_pred -cchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHH
Q 013941 298 -PCDLWSVGCILVELCSGEALFQTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375 (433)
Q Consensus 298 -~~DiwSlG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (433)
++|||||||++|+|++|..||..... .+....+.......|... ..+....
T Consensus 231 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~---------- 283 (348)
T 2pml_X 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR-----------------NHFLYPL---------- 283 (348)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS-----------------SSSTTTT----------
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch-----------------hhhhccc----------
Confidence 99999999999999999999987766 444444332221221100 0000000
Q ss_pred HhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
...........++.++.+||.+||+.||++|||++|+++||||++.
T Consensus 284 ----~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 284 ----TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp ----CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ----cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 0000011124567899999999999999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=347.59 Aligned_cols=246 Identities=20% Similarity=0.303 Sum_probs=204.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++.+.||+|+||.||+|.+. ++..||+|++.......+.+.+|+.++.+++|+++ +++++++.+.+..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL-----VKFYGVCSKEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCceEE
Confidence 367999999999999999999865 56779999998766666778999999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~------------------ 141 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL------------------ 141 (268)
T ss_dssp EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC------------------
T ss_pred EEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC------------------
Confidence 99999 899999998653 3599999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
.++|+|||++....... ....+|..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 142 ---------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 142 ---------CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp ---------CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ---------CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 46777777665433222 12356778999999998889999999999999999999 99999887766
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
.....+....... .....++.+.+||.+||+
T Consensus 213 ~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~l~~li~~~l~ 243 (268)
T 3sxs_A 213 EVVLKVSQGHRLY-------------------------------------------------RPHLASDTIYQIMYSCWH 243 (268)
T ss_dssp HHHHHHHTTCCCC-------------------------------------------------CCTTSCHHHHHHHHHTTC
T ss_pred HHHHHHHcCCCCC-------------------------------------------------CCCcChHHHHHHHHHHcC
Confidence 6554443221110 112346689999999999
Q ss_pred cCCCCCCCHHHHhcC
Q 013941 405 YDPAERLKAREALRH 419 (433)
Q Consensus 405 ~dP~~R~ta~ell~h 419 (433)
.||++|||+.|+++|
T Consensus 244 ~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 244 ELPEKRPTFQQLLSS 258 (268)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=352.57 Aligned_cols=263 Identities=29% Similarity=0.440 Sum_probs=202.9
Q ss_pred eecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
+.......++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+.++.++.|+ +++++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~---~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG---CTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc---CCceEEEEE
Confidence 3334445568999999999999999999975 5888999998643 33456778999999999862 134599999
Q ss_pred eeccCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 161 WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
++...+..++|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+++ +
T Consensus 96 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--------- 163 (313)
T 3cek_A 96 YEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--------- 163 (313)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T---------
T ss_pred EeecCCEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C---------
Confidence 999999999999977999999998765 7999999999999999999999999999999999999953 3
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhC-----------CCCCccchHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILG-----------LGWNYPCDLWSV 304 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSl 304 (433)
.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||
T Consensus 164 ------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 164 ------------------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp ------------------EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred ------------------eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 46777777776543221 23478999999999976 468899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhh
Q 013941 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384 (433)
Q Consensus 305 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (433)
||++|+|++|..||........ .+...... ....
T Consensus 226 G~il~el~~g~~pf~~~~~~~~--~~~~~~~~-------------------~~~~------------------------- 259 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIINQIS--KLHAIIDP-------------------NHEI------------------------- 259 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHH--HHHHHHCT-------------------TSCC-------------------------
T ss_pred HHHHHHHHhCCCchhhHHHHHH--HHHHHHhc-------------------cccc-------------------------
Confidence 9999999999999976543221 11111100 0000
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
......+.++.+||.+||+.||++|||+.|+++||||+....
T Consensus 260 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 260 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp -CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred -CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 111233668999999999999999999999999999997543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=352.97 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=206.4
Q ss_pred CCCeEEeccccccccEEEEEEEecCCC-------cEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
.++|++.+.||+|+||.||+|++..++ ..||+|++.... ...+.+.+|+.++++++|+|| +++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~ 81 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL-----VLNYGVC 81 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTB-----CCEEEEE
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEE
Confidence 468999999999999999999988877 479999986543 445678899999999988877 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++..++.+++
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~-- 158 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP-- 158 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC--
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc--
Confidence 9999999999999 899999998754 349999999999999999999999999999999999999998876665554
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCC-CCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGE-ALFQ 319 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~-~pf~ 319 (433)
.+||+|||++...... ....||..|+|||++.+ ..++.++|||||||++|+|++|. +||.
T Consensus 159 -----------------~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 159 -----------------FIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp -----------------EEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred -----------------eeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 4899999998654332 33578999999999988 67999999999999999999954 5554
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
........ .+....... ....+.++.+||
T Consensus 221 ~~~~~~~~-~~~~~~~~~--------------------------------------------------~~~~~~~l~~li 249 (289)
T 4fvq_A 221 ALDSQRKL-QFYEDRHQL--------------------------------------------------PAPKAAELANLI 249 (289)
T ss_dssp TSCHHHHH-HHHHTTCCC--------------------------------------------------CCCSSCTTHHHH
T ss_pred ccchHHHH-HHhhccCCC--------------------------------------------------CCCCCHHHHHHH
Confidence 44433222 221111111 122355789999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 013941 400 QGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~h 419 (433)
.+||+.||++|||+.|+++|
T Consensus 250 ~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 250 NNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHSCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=359.17 Aligned_cols=251 Identities=24% Similarity=0.456 Sum_probs=194.3
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHH----HhCCCCCcce
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRL----ARHDIGGTRC 155 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~~~~i~~~~~ 155 (433)
++.+.++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.++.++ .|+|+
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i----- 100 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV----- 100 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB-----
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe-----
Confidence 45567789999999999999999999999999999999965432 122345699999999 56655
Q ss_pred eEecceeccCCeEEEEEcc-C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe-eCCc
Q 013941 156 VQIRNWFDYRNHICIVFEK-L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEY 232 (433)
Q Consensus 156 v~~~~~~~~~~~~~lv~e~-~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~-~~~~ 232 (433)
+++++++...+..++|||+ + +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++ .++
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~- 177 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG- 177 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT-
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC-
Confidence 9999999999999999999 5 889999998765 699999999999999999999999999999999999997 444
Q ss_pred ccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCC-ccchHHHHHHHHHH
Q 013941 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVE 310 (433)
Q Consensus 233 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~e 310 (433)
.+||+|||++...... .....||..|+|||++.+..+. .++|||||||++|+
T Consensus 178 --------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 231 (312)
T 2iwi_A 178 --------------------------CAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD 231 (312)
T ss_dssp --------------------------EEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred --------------------------eEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHH
Confidence 4677777777654332 2345789999999999877664 58999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 311 l~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
|++|+.||..... +.... ......
T Consensus 232 l~~g~~pf~~~~~------~~~~~--------------------------------------------------~~~~~~ 255 (312)
T 2iwi_A 232 MVCGDIPFERDQE------ILEAE--------------------------------------------------LHFPAH 255 (312)
T ss_dssp HHHSSCSCCSHHH------HHHTC--------------------------------------------------CCCCTT
T ss_pred HHHCCCCCCChHH------Hhhhc--------------------------------------------------cCCccc
Confidence 9999999964211 11100 001134
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
++..+.+||.+||+.||++|||++|+++||||++...
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 5678999999999999999999999999999998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=350.10 Aligned_cols=245 Identities=20% Similarity=0.325 Sum_probs=202.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++++.||+|+||.||+|.+. ++..||+|++.......+.+.+|+.++.+++|+++ +++++++.+.+..++|
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL-----VQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSEEEE
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCE-----eeEEEEEecCCCeEEE
Confidence 57999999999999999999875 67789999998766566778999999999988777 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 98 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~------------------- 157 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG------------------- 157 (283)
T ss_dssp ECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-------------------
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-------------------
Confidence 9999 999999997633 3699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
.++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 158 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~ 229 (283)
T 3gen_A 158 --------VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229 (283)
T ss_dssp --------CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred --------CEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence 5677777777543321 122356788999999998899999999999999999998 999998877766
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+....... .....+..+.+||.+||+.
T Consensus 230 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~l~~li~~~l~~ 260 (283)
T 3gen_A 230 TAEHIAQGLRLY-------------------------------------------------RPHLASEKVYTIMYSCWHE 260 (283)
T ss_dssp HHHHHHTTCCCC-------------------------------------------------CCTTCCHHHHHHHHHTTCS
T ss_pred HHHHHhcccCCC-------------------------------------------------CCCcCCHHHHHHHHHHccC
Confidence 555544321111 1123466899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013941 406 DPAERLKAREALRH 419 (433)
Q Consensus 406 dP~~R~ta~ell~h 419 (433)
||++|||++|+++|
T Consensus 261 ~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 261 KADERPTFKILLSN 274 (283)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=350.70 Aligned_cols=248 Identities=19% Similarity=0.317 Sum_probs=209.3
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
..++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.++++++|+++ +++++++.+.+..+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCCEE
Confidence 3467999999999999999999999999999999998776677888999999999998877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~----------------- 148 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----------------- 148 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-----------------
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-----------------
Confidence 999999 89999999886656799999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN 323 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~ 323 (433)
.++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 149 ----------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 149 ----------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp ----------CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ----------CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 46677777665443322 22356889999999998899999999999999999999 9999987665
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+..... ......++..+.+||.+||
T Consensus 219 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~l~~li~~~l 249 (288)
T 3kfa_A 219 SQVYELLEKDYR-------------------------------------------------MERPEGCPEKVYELMRACW 249 (288)
T ss_dssp GGHHHHHHTTCC-------------------------------------------------CCCCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHhccCC-------------------------------------------------CCCCCCCCHHHHHHHHHHh
Confidence 544433322110 0112345678999999999
Q ss_pred ccCCCCCCCHHHHhc
Q 013941 404 RYDPAERLKAREALR 418 (433)
Q Consensus 404 ~~dP~~R~ta~ell~ 418 (433)
+.||++|||++|+++
T Consensus 250 ~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 250 QWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=354.87 Aligned_cols=264 Identities=17% Similarity=0.238 Sum_probs=198.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEecc-chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+.+|+.++++++|+|| +++++++.+++..++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV-----LKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCc-----ccEEEEEecCCeeEE
Confidence 579999999999999999999999999999998864 34456778899999999988777 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999 899999998743 4699999999999999999999999999999999999998766554444444332221110
Q ss_pred cccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~ 329 (433)
..... ...............||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 164 ~~~~~----------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-- 231 (310)
T 3s95_A 164 QPEGL----------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-- 231 (310)
T ss_dssp --------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT--
T ss_pred ccccc----------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH--
Confidence 00000 000000000111357999999999999999999999999999999999999998653211000
Q ss_pred HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCC
Q 013941 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAE 409 (433)
Q Consensus 330 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 409 (433)
........ ........+++.+.+||.+||+.||++
T Consensus 232 -------------------------------------~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~ 266 (310)
T 3s95_A 232 -------------------------------------FGLNVRGF--------LDRYCPPNCPPSFFPITVRCCDLDPEK 266 (310)
T ss_dssp -------------------------------------SSBCHHHH--------HHHTCCTTCCTTHHHHHHHHTCSSGGG
T ss_pred -------------------------------------Hhhhhhcc--------ccccCCCCCCHHHHHHHHHHccCChhh
Confidence 00000000 001112455678999999999999999
Q ss_pred CCCHHHHhc
Q 013941 410 RLKAREALR 418 (433)
Q Consensus 410 R~ta~ell~ 418 (433)
|||+.++++
T Consensus 267 Rps~~~l~~ 275 (310)
T 3s95_A 267 RPSFVKLEH 275 (310)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=357.32 Aligned_cols=255 Identities=16% Similarity=0.234 Sum_probs=188.6
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCc---EEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
..++|++.+.||+|+||.||+|++..++. .||||+++.. ....+.+.+|+.++++++|+|+ +++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 95 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV-----AKLVGVSL 95 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTB-----CCCCEEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCce-----ehhhceee
Confidence 35689999999999999999999887765 7999998753 3445678899999999988877 99999987
Q ss_pred cCCeE------EEEEccC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCc
Q 013941 164 YRNHI------CIVFEKL-GPSLYDFLRKNSY----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (433)
Q Consensus 164 ~~~~~------~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~ 232 (433)
..+.. ++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~- 174 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM- 174 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-
Confidence 76554 9999999 8899999964321 2589999999999999999999999999999999999997655
Q ss_pred ccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHH
Q 013941 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307 (433)
Q Consensus 233 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 307 (433)
.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||+
T Consensus 175 --------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 228 (323)
T 3qup_A 175 --------------------------TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228 (323)
T ss_dssp --------------------------CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred --------------------------CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHH
Confidence 56777777765433221 22356788999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhh
Q 013941 308 LVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386 (433)
Q Consensus 308 l~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
+|+|++ |..||.+.+..+....+..... ..
T Consensus 229 l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------~~ 259 (323)
T 3qup_A 229 MWEIMTRGQTPYAGIENAEIYNYLIGGNR-------------------------------------------------LK 259 (323)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------------------------------------------------CC
T ss_pred HHHHHhCCCCCccccChHHHHHHHhcCCC-------------------------------------------------CC
Confidence 999999 9999988766554443322110 01
Q ss_pred ccCCchHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCC
Q 013941 387 HVDHSAGDLIDLLQGLLRYDPAERLK-------AREALRHPFFTRD 425 (433)
Q Consensus 387 ~~~~~~~~l~~li~~~L~~dP~~R~t-------a~ell~hp~f~~~ 425 (433)
....++.++.+||.+||+.||++||| ++++++|||+...
T Consensus 260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 12345678999999999999999999 7889999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=349.48 Aligned_cols=255 Identities=23% Similarity=0.350 Sum_probs=201.1
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
|.....||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+|+ +++++++...+..++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI-----VQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTB-----CCEEEEEEETTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCE-----eeEeeEEEeCCcEEEEE
Confidence 334458999999999999999999999999987543 345678889999999988777 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee-CCcccccCccccccCCCCCC
Q 013941 173 EKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~-~~~~~l~d~~~~~~~~~~~~ 249 (433)
||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~------------------ 160 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG------------------ 160 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC------------------
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC------------------
Confidence 999 899999998653 235679999999999999999999999999999999999975 33
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCC--CCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.++|+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 161 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (295)
T 2clq_A 161 ---------VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 231 (295)
T ss_dssp ---------CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH
T ss_pred ---------CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch
Confidence 5778888877654322 23357899999999997653 889999999999999999999999754433
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
............. ......++.++.+||.+||+
T Consensus 232 ~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~ 264 (295)
T 2clq_A 232 QAAMFKVGMFKVH-----------------------------------------------PEIPESMSAEAKAFILKCFE 264 (295)
T ss_dssp HHHHHHHHHHCCC-----------------------------------------------CCCCTTSCHHHHHHHHHTTC
T ss_pred hHHHHhhcccccc-----------------------------------------------ccccccCCHHHHHHHHHHcc
Confidence 2211111110000 01123457789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCcc
Q 013941 405 YDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.||++|||++|+++||||+....
T Consensus 265 ~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 265 PDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp SSTTTSCCHHHHHTSGGGCC---
T ss_pred CChhhCCCHHHHhcChhhhhccc
Confidence 99999999999999999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=357.40 Aligned_cols=272 Identities=24% Similarity=0.370 Sum_probs=186.1
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++.|+|| +++++++...+..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI-----VSYYTSFVVKDEL 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTB-----CCEEEEEESSSCE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCE-----eeEEEEEeecCCc
Confidence 467999999999999999999999999999999986432 334567788888888877766 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 169 CIVFEKL-GPSLYDFLRKN------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999 99999998741 2246999999999999999999999999999999999999987765555555543
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
......... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 169 ~~~~~~~~~-------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 169 AFLATGGDI-------------------TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HHCC----------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred heeccCCCc-------------------cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 322111100 00011123478999999999876 4689999999999999999999999987
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
............ ...+. ... ..........++.++.+||.
T Consensus 230 ~~~~~~~~~~~~--~~~~~---------------------~~~-----------------~~~~~~~~~~~~~~~~~li~ 269 (303)
T 2vwi_A 230 YPPMKVLMLTLQ--NDPPS---------------------LET-----------------GVQDKEMLKKYGKSFRKMIS 269 (303)
T ss_dssp SCGGGHHHHHHT--SSCCC---------------------TTC----------------------CCCCCCCHHHHHHHH
T ss_pred CchhhHHHHHhc--cCCCc---------------------ccc-----------------ccccchhhhhhhHHHHHHHH
Confidence 665443322111 00000 000 00001122456778999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
+||+.||++|||+.|+++||||++..
T Consensus 270 ~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 270 LCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp HHCCSSGGGSCCHHHHHTSTTC----
T ss_pred HHccCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999999999753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=346.36 Aligned_cols=252 Identities=20% Similarity=0.236 Sum_probs=203.8
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh--------hHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
...++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.++++++|+|+ +++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~ 90 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI-----VKLYG 90 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTB-----CCEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCc-----hhhhe
Confidence 334689999999999999999999999999999999864321 11567889999999988777 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccC
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d 237 (433)
++.+.. ++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~----- 162 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE----- 162 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT-----
T ss_pred eecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC-----
Confidence 987766 6999999 899999887654 47999999999999999999999999 999999999999976541
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhh--CCCCCccchHHHHHHHHHHHHhCC
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL--GLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
+....+||+|||++...........||+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 163 -----------------~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 163 -----------------NAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp -----------------TCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred -----------------CCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 2334589999999987666556678999999999984 445789999999999999999999
Q ss_pred CCCCCCChHHH--HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 316 ALFQTHENLEH--LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 316 ~pf~~~~~~~~--~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
.||........ ...+.. .+.. ......+++
T Consensus 226 ~pf~~~~~~~~~~~~~~~~-~~~~-----------------------------------------------~~~~~~~~~ 257 (287)
T 4f0f_A 226 GPFDEYSYGKIKFINMIRE-EGLR-----------------------------------------------PTIPEDCPP 257 (287)
T ss_dssp CTTTTCCCCHHHHHHHHHH-SCCC-----------------------------------------------CCCCTTSCH
T ss_pred CCCccccccHHHHHHHHhc-cCCC-----------------------------------------------CCCCcccCH
Confidence 99976554322 111111 0000 011234577
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+.+||.+||+.||++|||++|+++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 258 RLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=359.83 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=197.9
Q ss_pred CCCeEEeccccccccEEEEEEE-----ecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEeccee
Q 013941 91 TPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~ 162 (433)
.++|++.+.||+|+||.||+|+ +..+++.||||+++... ...+.+.+|+.++.++ .|+|| +++++++
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni-----v~~~~~~ 95 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGAC 95 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce-----eeeeeee
Confidence 4689999999999999999998 56677999999997532 3345688999999999 55666 9999998
Q ss_pred ccC-CeEEEEEccC-CCCHHHHHHhcCC----------------------------------------------------
Q 013941 163 DYR-NHICIVFEKL-GPSLYDFLRKNSY---------------------------------------------------- 188 (433)
Q Consensus 163 ~~~-~~~~lv~e~~-~~~L~~~l~~~~~---------------------------------------------------- 188 (433)
... +.+++||||+ +++|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 775 4599999999 8999999986532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCC
Q 013941 189 ------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256 (433)
Q Consensus 189 ------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 256 (433)
..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~------------------------ 231 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV------------------------ 231 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC------------------------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc------------------------
Confidence 12899999999999999999999999999999999999977664
Q ss_pred CCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 013941 257 SSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMM 330 (433)
Q Consensus 257 ~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i 330 (433)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..........
T Consensus 232 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 308 (359)
T 3vhe_A 232 ---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308 (359)
T ss_dssp ---EEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred ---EEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH
Confidence 555555555432211 123478899999999999999999999999999999998 99999876644333222
Q ss_pred HHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCC
Q 013941 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAER 410 (433)
Q Consensus 331 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 410 (433)
....... .....+++++.++|.+||+.||++|
T Consensus 309 ~~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~dP~~R 340 (359)
T 3vhe_A 309 LKEGTRM------------------------------------------------RAPDYTTPEMYQTMLDCWHGEPSQR 340 (359)
T ss_dssp HHHTCCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHccCChhhC
Confidence 2211000 1123356789999999999999999
Q ss_pred CCHHHHhcC
Q 013941 411 LKAREALRH 419 (433)
Q Consensus 411 ~ta~ell~h 419 (433)
||+.|+++|
T Consensus 341 ps~~ell~~ 349 (359)
T 3vhe_A 341 PTFSELVEH 349 (359)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=343.83 Aligned_cols=255 Identities=24% Similarity=0.284 Sum_probs=199.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.+.|+++ +..+..++..++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~----i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTT----CCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCC----CCccccccCCCCce
Confidence 456789999999999999999999999999999999865432 3457889999999998875 23334445667889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~------------------ 141 (296)
T 3uzp_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------ 141 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG------------------
T ss_pred EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC------------------
Confidence 9999999999999998543 469999999999999999999999999999999999999521
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
+....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 142 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 3uzp_A 142 ------KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------CCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 12335777777777543322 23457999999999999999999999999999999999999999
Q ss_pred CCCChH---HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 319 QTHENL---EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 319 ~~~~~~---~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.+.... .....+.......| .......++.++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l 250 (296)
T 3uzp_A 216 QGLKAATKRQKYERISEKKMSTP---------------------------------------------IEVLCKGYPSEF 250 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHHHSC---------------------------------------------HHHHTTTSCHHH
T ss_pred CCcCchhhhhhhhhhcccccCCc---------------------------------------------hHHHHhhCCHHH
Confidence 764321 12222211110000 011124457799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+||.+||+.||++|||++++++
T Consensus 251 ~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 251 ATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCcCcCCCHHHHHH
Confidence 99999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=355.52 Aligned_cols=259 Identities=15% Similarity=0.219 Sum_probs=193.9
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCC-----CcEEEEEEeccchhhHHHHHHHHHHHHHHHh----------CCCCCc
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSINKYREAAMIEIDVLQRLAR----------HDIGGT 153 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~----------~~i~~~ 153 (433)
...++|++.+.||+|+||.||+|.+..+ ++.||||++.... ....+|+.+++++.+ ..+.|+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 4456899999999999999999998765 5789999986543 234455555555533 345566
Q ss_pred ceeEecceeccC----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 154 RCVQIRNWFDYR----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 154 ~~v~~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
|++++++++... ...||||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 779999988764 5689999999999999998753 47999999999999999999999999999999999999972
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhCCCCCccc
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPC 299 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~ 299 (433)
+ .+..+||+|||++...... .....||+.|+|||++.+..++.++
T Consensus 188 ~-------------------------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 242 (364)
T 3op5_A 188 K-------------------------NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG 242 (364)
T ss_dssp S-------------------------CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHH
T ss_pred C-------------------------CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchh
Confidence 1 1235677777776543211 1234699999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhc
Q 013941 300 DLWSVGCILVELCSGEALFQTHENLEH-LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL 378 (433)
Q Consensus 300 DiwSlG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (433)
|||||||++|||++|+.||.+...... ...........
T Consensus 243 Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------------------- 281 (364)
T 3op5_A 243 DLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYREN----------------------------------------- 281 (364)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHC-----------------------------------------
T ss_pred hHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhh-----------------------------------------
Confidence 999999999999999999985332222 11111110000
Q ss_pred Cchhhhhh--ccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 379 RLPNLIMQ--HVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 379 ~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
....... ....++.++.+||..||+.||++||++++|++
T Consensus 282 -~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 282 -IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp -HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 0000000 01345779999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=358.31 Aligned_cols=248 Identities=19% Similarity=0.308 Sum_probs=203.5
Q ss_pred CCCeEEeccccccccEEEEEEEecC-------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~ 160 (433)
.++|++.+.||+|+||.||+|++.. .+..||||+++.. ......+.+|+.+++++ +|+|| +++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~~ 142 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLG 142 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchh-----hhhee
Confidence 4689999999999999999999754 3357999999753 23446788999999999 78777 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcE
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NI 225 (433)
++...+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 999999999999999 889999998754 13599999999999999999999999999999999999
Q ss_pred EEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccch
Q 013941 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 300 (433)
Q Consensus 226 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (433)
|++.++ .+||+|||++...... .....||+.|+|||++.+..++.++|
T Consensus 223 ll~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 275 (382)
T 3tt0_A 223 LVTEDN---------------------------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275 (382)
T ss_dssp EECTTC---------------------------CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHH
T ss_pred EEcCCC---------------------------cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhH
Confidence 997655 4677777766543321 12246788999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC
Q 013941 301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379 (433)
Q Consensus 301 iwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
||||||++|+|++ |..||.+....+....+.....
T Consensus 276 iwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------- 311 (382)
T 3tt0_A 276 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-------------------------------------------- 311 (382)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--------------------------------------------
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------------------------------
Confidence 9999999999999 9999988776655444332110
Q ss_pred chhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
......++.++.+||.+||+.||++|||++|++++
T Consensus 312 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 312 -----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp -----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123457789999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=365.44 Aligned_cols=272 Identities=24% Similarity=0.281 Sum_probs=200.5
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccC
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+...+|+.++.++ .|+|| +++++++.+.
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnI-----v~~~~~~~~~ 81 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV-----IRYYCSETTD 81 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTB-----CCEEEEEECS
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCc-----CeEEEEEecC
Confidence 44566778889999999999998754 5679999999986532 35678899999887 67776 9999999999
Q ss_pred CeEEEEEccCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 166 NHICIVFEKLGPSLYDFLRKNSYRS-----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+.+|+|||||+++|.+++....... .++..++.++.||+.||+|||++||+||||||+|||++.++.......
T Consensus 82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~-- 159 (434)
T 2rio_A 82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ-- 159 (434)
T ss_dssp SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT--
T ss_pred CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc--
Confidence 9999999999889999998654211 123345789999999999999999999999999999987653211100
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-------cccccCCcccchhhhhC-------CCCCccchHHHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGC 306 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~ 306 (433)
..+....+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||
T Consensus 160 ------------~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~ 227 (434)
T 2rio_A 160 ------------TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227 (434)
T ss_dssp ------------TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHH
T ss_pred ------------cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHH
Confidence 01345578999999987654322 23579999999999976 56899999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 307 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
++|||++ |..||....... ..+.......+ .. ..
T Consensus 228 il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~------------------------~~-------------------~~ 262 (434)
T 2rio_A 228 VFYYILSKGKHPFGDKYSRE--SNIIRGIFSLD------------------------EM-------------------KC 262 (434)
T ss_dssp HHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCC------------------------CC-------------------TT
T ss_pred HHHHHHhCCCCCCCCchhhH--HHHhcCCCCcc------------------------cc-------------------cc
Confidence 9999999 999997654332 11111111100 00 00
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.....++.++.+||.+||+.||++|||+.|+++||||...
T Consensus 263 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 263 LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 0011235689999999999999999999999999999754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=344.38 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=194.7
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.|+++ +..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~----i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTT----CCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCC----CCeeeeecCCCCce
Confidence 45578999999999999999999999999999999875433 22457889999999998865 23444455678899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~------------------ 141 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------ 141 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG------------------
T ss_pred EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc------------------
Confidence 9999999999999998543 369999999999999999999999999999999999999321
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
+....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 142 ------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 4hgt_A 142 ------KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------CCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence 12335677777776543322 12357999999999999999999999999999999999999999
Q ss_pred CCCChHH---HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 319 QTHENLE---HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 319 ~~~~~~~---~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.+..... ....+.......| .......++.++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l 250 (296)
T 4hgt_A 216 QGLKAATKRQKYERISEKKMSTP---------------------------------------------IEVLCKGYPSEF 250 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHHHSC---------------------------------------------HHHHTTTSCHHH
T ss_pred cccchhhhhhhhhhhhcccccch---------------------------------------------hhhhhccCCHHH
Confidence 7643321 1111111100000 011123457799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+||.+||+.||++|||++++++
T Consensus 251 ~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 251 ATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=368.68 Aligned_cols=255 Identities=23% Similarity=0.288 Sum_probs=194.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.+|++.+.||+|+||+||. ....+++.||||++..... ....+|+.+++.+ .|+|| +++++++.+.+..|+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnI-----v~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNV-----IRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTB-----CCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCc-----CeEEEEEecCCEEEE
Confidence 3699999999999999764 3456789999999865322 2356799999998 57776 999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||||+++|.+++.... ..+.+..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 96 v~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~------------------- 155 (432)
T 3p23_A 96 AIELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN------------------- 155 (432)
T ss_dssp EEECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCB-------------------
T ss_pred EEECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCC-------------------
Confidence 99999889999998654 2455566789999999999999999999999999999996533
Q ss_pred ccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhC---CCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCS-GEALFQT 320 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~-g~~pf~~ 320 (433)
.+....+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 156 ---~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 156 ---AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp ---TTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred ---CCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 123446789999988754422 233579999999999984 467889999999999999999 9999965
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
......... .+... .... ......+..+.+||.
T Consensus 233 ~~~~~~~~~----~~~~~--------------------~~~~-----------------------~~~~~~~~~~~~li~ 265 (432)
T 3p23_A 233 SLQRQANIL----LGACS--------------------LDCL-----------------------HPEKHEDVIARELIE 265 (432)
T ss_dssp TTTHHHHHH----TTCCC--------------------CTTS-----------------------CTTCHHHHHHHHHHH
T ss_pred hhHHHHHHH----hccCC--------------------cccc-----------------------CccccccHHHHHHHH
Confidence 443322111 11000 0000 000122456889999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+||+.||++|||++||++||||.+
T Consensus 266 ~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 266 KMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHhCCHhhCCCHHHHHhCccccC
Confidence 999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=353.99 Aligned_cols=258 Identities=17% Similarity=0.235 Sum_probs=193.8
Q ss_pred CccCCCeEEeccccccccEEEEEEEecC---CCcEEEEEEeccchh------------hHHHHHHHHHHHHHHHhCCCCC
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINK------------YREAAMIEIDVLQRLARHDIGG 152 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~~~~i~~ 152 (433)
+...++|++.+.||+|+||.||+|++.. ++..||+|++..... ....+.+|+.++..+.|+||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni-- 110 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI-- 110 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC--
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc--
Confidence 3445789999999999999999999987 788999999875431 11234456666777777766
Q ss_pred cceeEecceecc----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe
Q 013941 153 TRCVQIRNWFDY----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (433)
Q Consensus 153 ~~~v~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~ 228 (433)
+++++++.. ....|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 111 ---~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 111 ---PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG 185 (345)
T ss_dssp ---CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ---ceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc
Confidence 999998877 78999999999999999998765 799999999999999999999999999999999999997
Q ss_pred eCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhCCCCCcc
Q 013941 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYP 298 (433)
Q Consensus 229 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~ 298 (433)
.++ ...+||+|||++...... .....||..|+|||++.+..++.+
T Consensus 186 ~~~-------------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 240 (345)
T 2v62_A 186 YKN-------------------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR 240 (345)
T ss_dssp SSS-------------------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH
T ss_pred cCC-------------------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch
Confidence 654 125677777777543211 133579999999999999999999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHH
Q 013941 299 CDLWSVGCILVELCSGEALFQTH--ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376 (433)
Q Consensus 299 ~DiwSlG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (433)
+|||||||++|||++|..||.+. +..............+|.....
T Consensus 241 ~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------- 287 (345)
T 2v62_A 241 SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLK--------------------------------- 287 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHH---------------------------------
T ss_pred hhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHh---------------------------------
Confidence 99999999999999999999652 2222222222333333321100
Q ss_pred hcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
......++.++.+||.+||+.||++|||+++|++
T Consensus 288 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 288 --------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp --------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0001256779999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=371.58 Aligned_cols=247 Identities=19% Similarity=0.326 Sum_probs=206.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
..+|++.++||+|+||.||+|.+..++..||||+++......+.+.+|+.++++++|+|| +++++++...+.+||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCE-----eeEEEEEecCCcEEE
Confidence 357999999999999999999999999999999998766667789999999999988877 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~------------------ 355 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH------------------ 355 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG------------------
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC------------------
Confidence 99999 89999999876656799999999999999999999999999999999999997665
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 356 ---------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 356 ---------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp ---------CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ---------cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 45666666665432211 12356778999999998899999999999999999999 99999877655
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+.... + ......++..+.+||.+||+
T Consensus 427 ~~~~~~~~~~-----------------------~--------------------------~~~~~~~~~~l~~li~~cl~ 457 (495)
T 1opk_A 427 QVYELLEKDY-----------------------R--------------------------MERPEGCPEKVYELMRACWQ 457 (495)
T ss_dssp GHHHHHHTTC-----------------------C--------------------------CCCCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHcCC-----------------------C--------------------------CCCCCCCCHHHHHHHHHHcC
Confidence 4443332110 0 01123456789999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013941 405 YDPAERLKAREALR 418 (433)
Q Consensus 405 ~dP~~R~ta~ell~ 418 (433)
.||++|||+.+|++
T Consensus 458 ~dP~~RPs~~el~~ 471 (495)
T 1opk_A 458 WNPSDRPSFAEIHQ 471 (495)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cChhHCcCHHHHHH
Confidence 99999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=353.64 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=206.6
Q ss_pred ccCCCeEEeccccccccEEEEEEE-----ecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
...++|++.+.||+|+||.||+|+ +..+++.||||++... ......+.+|+.+++++.|+|| ++++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~ 101 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI-----VRCIGV 101 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCC-----CeEEEE
Confidence 345689999999999999999999 5567889999998642 3445667889999999988877 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l 235 (433)
+.+.+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~---- 177 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG---- 177 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC----
Confidence 99999999999999 9999999987532 3589999999999999999999999999999999999997544
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHH
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (433)
....++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+
T Consensus 178 --------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 237 (327)
T 2yfx_A 178 --------------------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237 (327)
T ss_dssp --------------------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --------------------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHH
Confidence 234578888887754322 1233567899999999998899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 311 LCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 311 l~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
|++ |..||...........+...... ....
T Consensus 238 llt~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~ 268 (327)
T 2yfx_A 238 IFSLGYMPYPSKSNQEVLEFVTSGGRM-------------------------------------------------DPPK 268 (327)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCC-------------------------------------------------CCCT
T ss_pred HHcCCCCCCCCcCHHHHHHHHhcCCCC-------------------------------------------------CCCC
Confidence 998 99999887765554433321100 0112
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 390 HSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
.++..+.+||.+||+.||++|||+.++++|.|+..
T Consensus 269 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 269 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 45678999999999999999999999999988653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=339.28 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=204.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.++++++|+++ +++++++.+.+..++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCCeEEE
Confidence 57999999999999999999986 67789999998766566788999999999988777 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~------------------- 141 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ------------------- 141 (267)
T ss_dssp ECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-------------------
T ss_pred EeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-------------------
Confidence 9999 899999998653 3689999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
.++|+|||++...... .....+|..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 142 --------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (267)
T 3t9t_A 142 --------VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213 (267)
T ss_dssp --------CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred --------CEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence 4677777766543221 122467788999999998899999999999999999999 899998877665
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+...... ......+..+.+||.+||+.
T Consensus 214 ~~~~i~~~~~~-------------------------------------------------~~~~~~~~~l~~li~~~l~~ 244 (267)
T 3t9t_A 214 VVEDISTGFRL-------------------------------------------------YKPRLASTHVYQIMNHCWRE 244 (267)
T ss_dssp HHHHHHTTCCC-------------------------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHhcCCcC-------------------------------------------------CCCccCcHHHHHHHHHHccC
Confidence 55444321100 01123466899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013941 406 DPAERLKAREALRH 419 (433)
Q Consensus 406 dP~~R~ta~ell~h 419 (433)
||++|||+.+++++
T Consensus 245 ~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 245 RPEDRPAFSRLLRQ 258 (267)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=353.80 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=203.4
Q ss_pred ccCCCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
...++|++.+.||+|+||.||+|++. .+++.||||+++.. ....+.+.+|+.++++++|+|| ++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~ 118 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI-----VKLLGV 118 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEE
Confidence 33468999999999999999999987 45589999999753 2345678899999999988777 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEec
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSY----------------------RSFPIDLVRELGRQLLESVAFMHELRLIHT 218 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 218 (433)
+.+.+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999 8899999986421 468999999999999999999999999999
Q ss_pred CCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCC
Q 013941 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGL 293 (433)
Q Consensus 219 Dikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~ 293 (433)
||||+|||++.++ .+||+|||++..... ......||+.|+|||++.+.
T Consensus 199 Dlkp~NIl~~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 199 DLATRNCLVGENM---------------------------VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp CCSGGGEEECGGG---------------------------CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred CCCcceEEECCCC---------------------------eEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence 9999999997655 467777776654321 12234678999999999988
Q ss_pred CCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHH
Q 013941 294 GWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372 (433)
Q Consensus 294 ~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (433)
.++.++|||||||++|+|++ |..||.+....+....+..... +
T Consensus 252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~---------------------------------- 295 (343)
T 1luf_A 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--L---------------------------------- 295 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--C----------------------------------
T ss_pred CcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc--C----------------------------------
Confidence 99999999999999999999 9999988776655444332100 0
Q ss_pred HHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 373 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.....++.++.+||.+||+.||++|||+.++++
T Consensus 296 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 296 -------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011345678999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=348.24 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=184.6
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchh--hH-HHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YR-EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~-~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++++.||+|+||.||+|++..+++.||||++..... .. .....+..+++.+.|++| +++++++.+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i-----~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI-----VQCFGTFITNTDV 99 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSSEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCce-----eeEEEEEecCCcE
Confidence 579999999999999999999999999999999975432 22 223333445566666665 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||+++.+..+..... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 100 ~lv~e~~~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~---------------- 162 (318)
T 2dyl_A 100 FIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG---------------- 162 (318)
T ss_dssp EEEECCCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS----------------
T ss_pred EEEEeccCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC----------------
Confidence 9999999777766665432 4799999999999999999999995 999999999999997655
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.+||+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|++|..||..
T Consensus 163 -----------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 163 -----------QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -----------CEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -----------CEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 5677777776543322 22357899999999995 45688999999999999999999999986
Q ss_pred CC-hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 321 HE-NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 321 ~~-~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
.. ..+....+....... + .....++.++.+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~-----------------------~------------------------~~~~~~~~~l~~li 264 (318)
T 2dyl_A 232 CKTDFEVLTKVLQEEPPL-----------------------L------------------------PGHMGFSGDFQSFV 264 (318)
T ss_dssp CCSHHHHHHHHHHSCCCC-----------------------C------------------------CSSSCCCHHHHHHH
T ss_pred CCccHHHHHHHhccCCCC-----------------------C------------------------CccCCCCHHHHHHH
Confidence 43 333333322211000 0 01123567899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.+||+.||++|||++|+++||||++.
T Consensus 265 ~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 265 KDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHccCChhHCcCHHHHhhCHHHHhc
Confidence 99999999999999999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.11 Aligned_cols=245 Identities=20% Similarity=0.282 Sum_probs=192.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcE----EEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
++|++.+.||+|+||+||+|++..+++. ||+|.++.. ......+.+|+.++++++|+|+ +++++++..+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTB-----CCEEEEEESS
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecC
Confidence 5799999999999999999998887765 477777532 2345678899999999998887 9999999876
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+ .++|+||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~------------ 155 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH------------ 155 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE------------
T ss_pred C-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC------------
Confidence 5 77888998 999999998754 46999999999999999999999999999999999999987764
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
+||+|||++....... ....||..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 156 ---------------~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 220 (327)
T 3poz_A 156 ---------------VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220 (327)
T ss_dssp ---------------EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ---------------EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCc
Confidence 5556666554332211 12356889999999999999999999999999999999 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.........+..... .......+.++.+|
T Consensus 221 ~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~l 251 (327)
T 3poz_A 221 DGIPASEISSILEKGER-------------------------------------------------LPQPPICTIDVYMI 251 (327)
T ss_dssp TTCCGGGHHHHHHTTCC-------------------------------------------------CCCCTTBCHHHHHH
T ss_pred cCCCHHHHHHHHHcCCC-------------------------------------------------CCCCccCCHHHHHH
Confidence 87665544333322110 00123346789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 013941 399 LQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~h 419 (433)
|.+||+.||++|||+.|++++
T Consensus 252 i~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 252 MVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=363.91 Aligned_cols=243 Identities=22% Similarity=0.325 Sum_probs=199.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC-CeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-NHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~-~~~~l 170 (433)
++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.++++++|+|+ +++++++... +.+|+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTB-----CCEEEEEECTTSCEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCE-----EEEEEEEEcCCCceEE
Confidence 67999999999999999999864 7789999997644 45678899999999988877 9999987654 48999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~------------------ 326 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN------------------ 326 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS------------------
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC------------------
Confidence 99999 89999999877655589999999999999999999999999999999999996654
Q ss_pred cccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 328 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~ 328 (433)
.+||+|||++...........+|..|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus 327 ---------~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 397 (450)
T 1k9a_A 327 ---------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397 (450)
T ss_dssp ---------CEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred ---------CEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5777788877654444344467889999999999999999999999999999998 999998766554443
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+.... + ......+++++.+||.+||+.||+
T Consensus 398 ~i~~~~-----------------------~--------------------------~~~p~~~~~~l~~li~~cl~~dp~ 428 (450)
T 1k9a_A 398 RVEKGY-----------------------K--------------------------MDAPDGCPPAVYDVMKNCWHLDAA 428 (450)
T ss_dssp HHHTTC-----------------------C--------------------------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHcCC-----------------------C--------------------------CCCCCcCCHHHHHHHHHHcCCChh
Confidence 332210 0 011234577999999999999999
Q ss_pred CCCCHHHHhc
Q 013941 409 ERLKAREALR 418 (433)
Q Consensus 409 ~R~ta~ell~ 418 (433)
+|||+.++++
T Consensus 429 ~Rpt~~~l~~ 438 (450)
T 1k9a_A 429 TRPTFLQLRE 438 (450)
T ss_dssp GSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=339.55 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=195.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ...+.+.+|+.+++.++|+++ +++++++.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI-----IALRGVCLKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTB-----CCEEEEECCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCE-----eeEEEEEecC
Confidence 367999999999999999999864 7889999986532 234667889999999988877 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cEecCCCCCcEEEeeCCcccccCcccc
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR---LIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
+..++||||+ +++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++..+..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~-------- 147 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN-------- 147 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS--------
T ss_pred CceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc--------
Confidence 9999999999 89999998643 6999999999999999999999999 9999999999999753210
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
.......+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 148 -----------~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 148 -----------GDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp -----------SCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred -----------ccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0012457899999998754433 2345799999999999998999999999999999999999999988
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+.......+...... ......++..+.+||.
T Consensus 217 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~li~ 248 (271)
T 3dtc_A 217 IDGLAVAYGVAMNKLA------------------------------------------------LPIPSTCPEPFAKLME 248 (271)
T ss_dssp SCHHHHHHHHHTSCCC------------------------------------------------CCCCTTCCHHHHHHHH
T ss_pred CCHHHHHHhhhcCCCC------------------------------------------------CCCCcccCHHHHHHHH
Confidence 7665544332211100 0112345678999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q 013941 401 GLLRYDPAERLKAREALRH 419 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~h 419 (433)
+||+.||++|||+.|+++|
T Consensus 249 ~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 249 DCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCcccCcCHHHHHHH
Confidence 9999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=349.32 Aligned_cols=248 Identities=19% Similarity=0.323 Sum_probs=201.5
Q ss_pred CCCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.++|++.+.||+|+||.||+|++. .+++.||+|++... ....+.+.+|+.+++.++|+|| +++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV-----IKLYGACS 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCce-----eeEEEEEe
Confidence 367999999999999999999873 45689999999753 2344677889999999988777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCC
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSY----------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi 220 (433)
+.+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 999999999999 8999999986542 24899999999999999999999999999999
Q ss_pred CCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCC
Q 013941 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGW 295 (433)
Q Consensus 221 kp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~ 295 (433)
||+|||++.++. +||+|||++....... ....+|+.|+|||++.+..+
T Consensus 177 kp~NIli~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 177 AARNILVAEGRK---------------------------MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp SGGGEEEETTTE---------------------------EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred chheEEEcCCCC---------------------------EEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence 999999987664 5666666665432221 22356888999999998889
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHH
Q 013941 296 NYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374 (433)
Q Consensus 296 ~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (433)
+.++|||||||++|+|++ |..||.+.........+.....
T Consensus 230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------- 270 (314)
T 2ivs_A 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--------------------------------------- 270 (314)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------------------------------
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc---------------------------------------
Confidence 999999999999999999 9999987665444333221100
Q ss_pred HHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
......++.++.+||.+||+.||++|||+.|++++
T Consensus 271 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 271 ----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123457789999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=361.55 Aligned_cols=245 Identities=21% Similarity=0.340 Sum_probs=199.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.++++++|+|| +++++++...+.+|
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-----VRLIGVCTQKQPIY 188 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTB-----CCEEEEECSSSSCE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEecCCCcE
Confidence 57999999999999999999999999999999987432 233457789999999988777 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 189 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~---------------- 251 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV---------------- 251 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----------------
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc----------------
Confidence 999999 899999998653 35899999999999999999999999999999999999977664
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE 322 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~ 322 (433)
+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 252 -----------~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 252 -----------LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp -----------EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred -----------EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4555555554322111 11245678999999998889999999999999999998 999998877
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+....+.... .. .....++.++.+||.+|
T Consensus 321 ~~~~~~~~~~~~-----------------------~~--------------------------~~~~~~~~~l~~li~~c 351 (377)
T 3cbl_A 321 NQQTREFVEKGG-----------------------RL--------------------------PCPELCPDAVFRLMEQC 351 (377)
T ss_dssp HHHHHHHHHTTC-----------------------CC--------------------------CCCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCC-----------------------CC--------------------------CCCCCCCHHHHHHHHHH
Confidence 655444332210 00 01123467899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 013941 403 LRYDPAERLKAREALR 418 (433)
Q Consensus 403 L~~dP~~R~ta~ell~ 418 (433)
|+.||++|||++++++
T Consensus 352 l~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 352 WAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=350.89 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=198.6
Q ss_pred CCCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEeccee
Q 013941 91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~ 162 (433)
.++|++.+.||+|+||.||+|++ ..+++.||||++... ....+.+.+|+.++.++ .|+|| +++++++
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~ 118 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI-----VNLLGAC 118 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEE
Confidence 36899999999999999999997 346678999999743 23456788999999999 78877 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCC
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSY---------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi 220 (433)
...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9999999999999 8999999986542 23789999999999999999999999999999
Q ss_pred CCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCC
Q 013941 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGW 295 (433)
Q Consensus 221 kp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~ 295 (433)
||+|||++.++. +||+|||++....... ....||+.|+|||++.+..+
T Consensus 199 kp~NIll~~~~~---------------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 199 AARNVLVTHGKV---------------------------VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp SGGGEEEETTTE---------------------------EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred ChhhEEEcCCCc---------------------------EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence 999999987664 5555555554332211 22467889999999998899
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHH
Q 013941 296 NYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374 (433)
Q Consensus 296 ~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (433)
+.++|||||||++|+|++ |..||.+.........+......
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------------- 293 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-------------------------------------- 293 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC--------------------------------------
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC--------------------------------------
Confidence 999999999999999998 99999876544333222211000
Q ss_pred HHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013941 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHP 420 (433)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp 420 (433)
.......+.++.+||.+||+.||++|||+.|+++|-
T Consensus 294 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 294 ----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 001123467899999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=345.53 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=200.4
Q ss_pred CCCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEeccee
Q 013941 91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~ 162 (433)
.++|++.+.||+|+||.||+|++ ..+++.||+|+++... ...+.+.+|+.+++++ .|+|+ +++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~ 96 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI-----VNLLGAC 96 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCe-----eeEEEEE
Confidence 36899999999999999999984 4577899999997543 3456788999999999 78777 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcE
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSY----------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NI 225 (433)
.+.+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 9999999999999 8899999987542 2489999999999999999999999999999999999
Q ss_pred EEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccch
Q 013941 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCD 300 (433)
Q Consensus 226 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~D 300 (433)
|++.++.+ ||+|||++....... ....||+.|+|||++.+..++.++|
T Consensus 177 l~~~~~~~---------------------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 229 (313)
T 1t46_A 177 LLTHGRIT---------------------------KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229 (313)
T ss_dssp EEETTTEE---------------------------EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred EEcCCCCE---------------------------EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHH
Confidence 99877655 555555444332221 1236788999999999989999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC
Q 013941 301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379 (433)
Q Consensus 301 iwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
||||||++|+|++ |..||.+.........+.......
T Consensus 230 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------ 267 (313)
T 1t46_A 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM------------------------------------------ 267 (313)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC------------------------------------------
T ss_pred HHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC------------------------------------------
Confidence 9999999999999 999998765443333222211000
Q ss_pred chhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
......+..+.+||.+||+.||++|||+.|++++
T Consensus 268 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 268 ------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 0113456789999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=366.01 Aligned_cols=281 Identities=21% Similarity=0.320 Sum_probs=206.0
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
..+.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.++++++|+|| +++++++...
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~ 79 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI-----VKLFAIEEET 79 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCC-----CeEEEeeccC
Confidence 345678999999999999999999999999999999997533 334667889999999988877 9999988765
Q ss_pred C--eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 166 N--HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 166 ~--~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
+ ..|+||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+....
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---------- 149 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE---------- 149 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT----------
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC----------
Confidence 4 889999999 8999999975432 2399999999999999999999999999999999999984321
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhC--------CCCCccchHHHHHHHHHHH
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG--------LGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 311 (433)
+....+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 150 -------------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 150 -------------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp -------------TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred -------------CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 23345788888888654332 234579999999999875 4578899999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 312 CSGEALFQTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 312 ~~g~~pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
++|+.||..... ......+.+.....|.......... ......|...... .......
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~------~~~~~~~~~~~~~----------------~~~l~~~ 274 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKA------ENGPIDWSGDMPV----------------SCSLSRG 274 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECS------TTCCEEEESSCCT----------------TCSSCHH
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheec------cCCCcccCccCCc----------------ccccchH
Confidence 999999965332 1122223333333332211110000 0001111110000 0011123
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+..+.+||.+||++||++|+|++|+++
T Consensus 275 ~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 275 LQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHhhchHHHHHhhccChhhhccHHHHHH
Confidence 4668899999999999999999999854
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=342.76 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=192.4
Q ss_pred cCCCeEEeccccccccEEEEEEEecCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..++|++.+.||+|+||.||+|.+..+ +..||+|++... ....+.+.+|+.++++++|+|+ +++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~- 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT- 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC-
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCcc-----ceEEEEEc-
Confidence 346899999999999999999998654 457999998643 3345678889999999988777 99999875
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
++..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----------- 154 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC----------- 154 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-----------
T ss_pred cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC-----------
Confidence 46789999999 889999998653 36999999999999999999999999999999999999987664
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 155 ----------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf 218 (281)
T 1mp8_A 155 ----------------VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218 (281)
T ss_dssp ----------------EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ----------------EEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC
Confidence 5666666655432211 22356788999999998899999999999999999997 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+....+....+..... ......++..+.+|
T Consensus 219 ~~~~~~~~~~~i~~~~~-------------------------------------------------~~~~~~~~~~l~~l 249 (281)
T 1mp8_A 219 QGVKNNDVIGRIENGER-------------------------------------------------LPMPPNCPPTLYSL 249 (281)
T ss_dssp TTCCGGGHHHHHHTTCC-------------------------------------------------CCCCTTCCHHHHHH
T ss_pred CcCCHHHHHHHHHcCCC-------------------------------------------------CCCCCCCCHHHHHH
Confidence 87766554443322100 00123457789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 013941 399 LQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~h 419 (433)
|.+||+.||++|||+.|++++
T Consensus 250 i~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 250 MTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=344.64 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=196.9
Q ss_pred cCCCeEEeccccccccEEEEEEE----ecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 90 LTPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..++|++++.||+|+||+||+|+ +..+++.||||++.... ...+.+.+|+.++++++|+|+ +++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 82 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-----VKYKGVCYS 82 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec
Confidence 34689999999999999999998 66789999999987543 344678899999999988877 999998754
Q ss_pred --CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
...+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--------- 152 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--------- 152 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---------
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe---------
Confidence 45689999999 999999998754 35999999999999999999999999999999999999987664
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 153 ------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 214 (295)
T 3ugc_A 153 ------------------VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214 (295)
T ss_dssp ------------------EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred ------------------EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcc
Confidence 5666666665432211 1235677899999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||...... ..+..+..+...... .........+ ........++.++
T Consensus 215 ~~~~~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~~--------------------------~~~~~~~~~~~~l 261 (295)
T 3ugc_A 215 EKSKSPPAE-----FMRMIGNDKQGQMIV--FHLIELLKNN--------------------------GRLPRPDGCPDEI 261 (295)
T ss_dssp CTTCSHHHH-----HHHHHCTTCCTHHHH--HHHHHHHHTT--------------------------CCCCCCTTCCHHH
T ss_pred cccCCChHH-----HHhhhcCccccchhH--HHHHHHHhcc--------------------------CcCCCCcCcCHHH
Confidence 998643211 111111111000000 0000000000 0011234567899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+||.+||+.||++|||+.|+++
T Consensus 262 ~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 262 YMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=353.85 Aligned_cols=194 Identities=25% Similarity=0.283 Sum_probs=164.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC----Ce
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----NH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~----~~ 167 (433)
++|++.+.||+|+||+||+|++. ++.||||++...........+|+.++.+++|+|| +++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI-----LQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCc-----hhhcceeccCCCCCce
Confidence 57999999999999999999865 7899999998766666666778888888888777 9999998763 35
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEecCCCCCcEEEeeCCccccc
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL----------RLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~ivHrDikp~NIli~~~~~~~l~ 236 (433)
+++||||+ +++|.+++... .+++..++.++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~----- 168 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL----- 168 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-----
T ss_pred EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-----
Confidence 89999999 88999999875 499999999999999999999999 999999999999996654
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCC-----CCCccchHHHHHH
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGC 306 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~ 306 (433)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||
T Consensus 169 ----------------------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 169 ----------------------TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp ----------------------CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred ----------------------eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 5677777777543321 2225799999999999873 4567899999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 013941 307 ILVELCSGEALFQTHE 322 (433)
Q Consensus 307 il~el~~g~~pf~~~~ 322 (433)
++|||++|+.||.+..
T Consensus 227 il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 227 VLWELASRCTAADGPV 242 (322)
T ss_dssp HHHHHHTTBTTSSSCC
T ss_pred HHHHHHhCCCCCCCCc
Confidence 9999999999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=361.56 Aligned_cols=255 Identities=21% Similarity=0.276 Sum_probs=200.3
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.++|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.|++. +..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~----i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTG----IPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTT----CCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCC----CCeEEEEEeeCCEE
Confidence 456789999999999999999999999999999998864332 2357889999999988643 24455566678899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+|||||++++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 79 ~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~------------------ 139 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------------------ 139 (483)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG------------------
T ss_pred EEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC------------------
Confidence 9999999999999998543 479999999999999999999999999999999999999421
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC----------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
+....+||+|||++....... ....||..|+|||++.+..++.++|||||||+||||++|+.||
T Consensus 140 ------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf 213 (483)
T 3sv0_A 140 ------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (483)
T ss_dssp ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------CCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 123357777777776443321 2458999999999999999999999999999999999999999
Q ss_pred CCCChHH---HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 319 QTHENLE---HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 319 ~~~~~~~---~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.+..... .+..+..... ..........++.++
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~---------------------------------------------~~~~~~l~~~~p~~l 248 (483)
T 3sv0_A 214 QGLKAGTKKQKYEKISEKKV---------------------------------------------ATSIEALCRGYPTEF 248 (483)
T ss_dssp SSCCCSSHHHHHHHHHHHHH---------------------------------------------HSCHHHHHTTSCHHH
T ss_pred ccccchhHHHHHHHHhhccc---------------------------------------------cccHHHHhcCCcHHH
Confidence 8754422 2222211100 000111223557799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+||.+||+.||++||++++|++
T Consensus 249 ~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 249 ASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999988764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=352.40 Aligned_cols=270 Identities=21% Similarity=0.228 Sum_probs=203.0
Q ss_pred ecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.......++|++.+.||+|+||.||+|++ .+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++.
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 105 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL-----VSLIGFCD 105 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTB-----CCEEEECC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEc
Confidence 33455678999999999999999999996 468899999886533 345678899999999988777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
+.+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--------- 176 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--------- 176 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC---------
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC---------
Confidence 999999999999 8999999865432 3589999999999999999999999999999999999997655
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 177 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 238 (321)
T 2qkw_B 177 ------------------VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238 (321)
T ss_dssp ------------------CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCC
T ss_pred ------------------CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCC
Confidence 4677777766543221 12346899999999999889999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||.+....+....+.... .....+......+ +..........+..+
T Consensus 239 ~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l 285 (321)
T 2qkw_B 239 SAIVQSLPREMVNLAEWAV----------------ESHNNGQLEQIVD-----------------PNLADKIRPESLRKF 285 (321)
T ss_dssp TTCSCSSSSSCCCHHHHTH----------------HHHTTTCCCSSSS-----------------SSCTTCSCHHHHHHH
T ss_pred CcccccCcHHHHHHHHHhh----------------hccccccHHHhcC-----------------hhhccccCHHHHHHH
Confidence 9997644321110000000 0000000000000 000001112346689
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHP 420 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp 420 (433)
.++|.+||+.||++|||+.|+++|-
T Consensus 286 ~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 286 GDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999999999999999999999763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=343.90 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=188.5
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHH--HHhCCCCCcceeEecceecc
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~~v~~~~~~~~ 164 (433)
+..+.++|++.+.||+|+||+||+|++ +++.||||++.... .....+|.+++.. ++|+|+ +++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni-----v~~~~~~~~ 73 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENI-----LGFIASDMT 73 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTB-----CCEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCe-----eeEEEeecc
Confidence 455678899999999999999999986 68899999987543 3445667777766 566665 888887543
Q ss_pred ----CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEecCCCCCcEEEeeCC
Q 013941 165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivHrDikp~NIli~~~~ 231 (433)
...+++||||+ +++|.+++... .+++..+..++.||+.||+||| ++||+||||||+|||++.++
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred ccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 46799999999 89999999654 6999999999999999999999 99999999999999997655
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-------cccccCCcccchhhhhCC------CCCcc
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL------GWNYP 298 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~ 298 (433)
.+||+|||++....... ....||+.|+|||++.+. .++.+
T Consensus 151 ---------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 203 (301)
T 3q4u_A 151 ---------------------------QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203 (301)
T ss_dssp ---------------------------CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHH
T ss_pred ---------------------------CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCch
Confidence 56777777765433221 224799999999999876 34579
Q ss_pred chHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCC
Q 013941 299 CDLWSVGCILVELCSG----------EALFQTHEN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 364 (433)
Q Consensus 299 ~DiwSlG~il~el~~g----------~~pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (433)
+|||||||++|||++| ..||..... ......+.......+ ..+.
T Consensus 204 ~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~- 261 (301)
T 3q4u_A 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP---------------------NIPN- 261 (301)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC---------------------CCCG-
T ss_pred hhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCC---------------------CCCh-
Confidence 9999999999999999 788854321 111111111000000 0000
Q ss_pred CCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 365 ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.......+.++.+||.+||+.||++|||+.|+++
T Consensus 262 --------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 262 --------------------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp --------------------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --------------------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 0011234678999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=364.67 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=205.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++.+.||+|+||.||+|.+. ++..||||+++......+.+.+|+.++++++|+|+ +++++++. .+.+|+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-----VKLHAVVT-KEPIYI 259 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTB-----CCEEEEEC-SSSCEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCE-----eeEEEEEe-CCccEE
Confidence 468999999999999999999975 46779999998766667889999999999988877 99999886 567899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~------------------ 321 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL------------------ 321 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC------------------
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC------------------
Confidence 99999 99999999855334689999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
.+||+|||++...... .....+|..|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 322 ---------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 322 ---------VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp ---------CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ---------cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 5677777777653321 122356788999999998899999999999999999999 99999988776
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+.+.... .....++.++.+||.+||+
T Consensus 393 ~~~~~i~~~~~~-------------------------------------------------~~~~~~~~~l~~li~~cl~ 423 (454)
T 1qcf_A 393 EVIRALERGYRM-------------------------------------------------PRPENCPEELYNIMMRCWK 423 (454)
T ss_dssp HHHHHHHHTCCC-------------------------------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHcCCCC-------------------------------------------------CCCCCCCHHHHHHHHHHcc
Confidence 665554432110 0113456789999999999
Q ss_pred cCCCCCCCHHHHhc--CCCCCC
Q 013941 405 YDPAERLKAREALR--HPFFTR 424 (433)
Q Consensus 405 ~dP~~R~ta~ell~--hp~f~~ 424 (433)
.||++|||+++|++ ..+++.
T Consensus 424 ~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 424 NRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp SSGGGSCCHHHHHHHHHTSSSS
T ss_pred CChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999875 345543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.91 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=192.6
Q ss_pred CCeEEeccccccccEEEEEEEec---CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|++. .++..||||+++.. ....+.+.+|+.++.+++|+|| +++++++.+.+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~ 119 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI-----IRLEGVVTKSK 119 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSSS
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCC
Confidence 57999999999999999999876 46778999998753 3445678899999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------------- 184 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-------------- 184 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--------------
T ss_pred ceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC--------------
Confidence 999999999 999999998653 4699999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 185 -------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~ 251 (373)
T 2qol_A 185 -------------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251 (373)
T ss_dssp -------------CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred -------------CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC
Confidence 46666666665433221 11245778999999999899999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
......+....+...... .....++..+.+|
T Consensus 252 ~~~~~~~~~~~i~~~~~~-------------------------------------------------~~~~~~~~~l~~l 282 (373)
T 2qol_A 252 WEMSNQDVIKAVDEGYRL-------------------------------------------------PPPMDCPAALYQL 282 (373)
T ss_dssp TTCCHHHHHHHHHTTEEC-------------------------------------------------CCCTTCBHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCC-------------------------------------------------CCCccccHHHHHH
Confidence 887766554443321110 0112346789999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 013941 399 LQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~ 418 (433)
|.+||+.||++|||+.|+++
T Consensus 283 i~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 283 MLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=351.13 Aligned_cols=246 Identities=21% Similarity=0.261 Sum_probs=194.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcE----EEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
.++|++++.||+|+||.||+|++..+++. ||+|++.... .....+.+|+.++..++|+|| +++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI-----VRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTB-----CCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEc-
Confidence 36799999999999999999999888875 7777764322 223456679999999988877 99999886
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
++..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~------------ 152 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS------------ 152 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS------------
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC------------
Confidence 46689999999 999999997642 3689999999999999999999999999999999999997665
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 317 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~p 317 (433)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 153 ---------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 153 ---------------QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp ---------------CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ---------------eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 4566666666543222 123467889999999998899999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.........+...... .....++.++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~ 248 (325)
T 3kex_A 218 YAGLRLAEVPDLLEKGERL-------------------------------------------------AQPQICTIDVYM 248 (325)
T ss_dssp TTTSCTTHHHHHHHTTCBC-------------------------------------------------CCCTTBCTTTTH
T ss_pred ccccCHHHHHHHHHcCCCC-------------------------------------------------CCCCcCcHHHHH
Confidence 9877655544433221100 011223557889
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 013941 398 LLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~h 419 (433)
||.+||+.||++|||+.|+++|
T Consensus 249 li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 249 VMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=340.58 Aligned_cols=250 Identities=27% Similarity=0.346 Sum_probs=202.3
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-- 164 (433)
+..+.++|++.+.||+|+||.||+|++..+++.||+|++.... +.+.+|+.+++++.|+|+ +++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 77 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNI-----VHYNGCWDGFD 77 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTB-----CCEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCE-----EEEeeeEeccc
Confidence 4556678999999999999999999999999999999987543 346689999999988877 888887753
Q ss_pred --------------CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 165 --------------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 165 --------------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
...+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 45689999999 889999998664457999999999999999999999999999999999999987
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHH
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 307 (433)
++. +||+|||++...... .....||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 210 (284)
T 2a19_B 158 TKQ---------------------------VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210 (284)
T ss_dssp TTE---------------------------EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHH
T ss_pred CCC---------------------------EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHH
Confidence 664 566666666543322 233578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 308 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 308 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
+|+|++|..||.... .....+.. + ..
T Consensus 211 l~~l~~~~~~~~~~~--~~~~~~~~--~--------------------------------------------------~~ 236 (284)
T 2a19_B 211 LAELLHVCDTAFETS--KFFTDLRD--G--------------------------------------------------II 236 (284)
T ss_dssp HHHHHSCCSSHHHHH--HHHHHHHT--T--------------------------------------------------CC
T ss_pred HHHHHhcCCcchhHH--HHHHHhhc--c--------------------------------------------------cc
Confidence 999999998874211 11100000 0 01
Q ss_pred cCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
...++..+.+||.+||+.||++|||+.|+++|.|.-..
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 12346789999999999999999999999999876654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=343.85 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=193.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++++.|+++ +++++++..++.
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~~~~~~~~~ 108 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV-----VPIHDFGEIDGQ 108 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCe-----eEEEEEEeeCCe
Confidence 57999999999999999999999999999999987532 234667889999999988777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--------------- 171 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--------------- 171 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---------------
T ss_pred EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC---------------
Confidence 99999999 889999998764 699999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 172 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 172 ------------FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp ------------CEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ------------CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 4677777766543322 123478999999999999899999999999999999999999998765
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.......+.. ..+. .......++.++.+||.+|
T Consensus 240 ~~~~~~~~~~---~~~~--------------------------------------------~~~~~~~~~~~l~~li~~~ 272 (309)
T 2h34_A 240 LSVMGAHINQ---AIPR--------------------------------------------PSTVRPGIPVAFDAVIARG 272 (309)
T ss_dssp HHHHHHHHHS---CCCC--------------------------------------------GGGTSTTCCTHHHHHHHHH
T ss_pred HHHHHHHhcc---CCCC--------------------------------------------ccccCCCCCHHHHHHHHHh
Confidence 4322211111 1000 0111234577899999999
Q ss_pred cccCCCCCC-CHHHHhc
Q 013941 403 LRYDPAERL-KAREALR 418 (433)
Q Consensus 403 L~~dP~~R~-ta~ell~ 418 (433)
|+.||++|| |++++++
T Consensus 273 l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 273 MAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp TCSSGGGSCSSHHHHHH
T ss_pred ccCCHHHHHHhHHHHHH
Confidence 999999999 8888874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=345.52 Aligned_cols=248 Identities=17% Similarity=0.296 Sum_probs=200.6
Q ss_pred CCCeEEeccccccccEEEEEEEec-------CCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~ 160 (433)
.++|++.+.||+|+||.||+|++. .+++.||||+++... .....+.+|+.+++++ .|+|| +++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~ 108 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG 108 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCE-----eeEEE
Confidence 368999999999999999999975 456789999997532 3456788999999999 77777 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcE
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NI 225 (433)
++...+.+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 999999999999999 8899999986531 2489999999999999999999999999999999999
Q ss_pred EEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccch
Q 013941 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 300 (433)
Q Consensus 226 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (433)
|++.++ .+||+|||++...... .....+|+.|+|||++.+..++.++|
T Consensus 189 ll~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 241 (334)
T 2pvf_A 189 LVTENN---------------------------VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241 (334)
T ss_dssp EECTTC---------------------------CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred EEcCCC---------------------------CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHH
Confidence 997655 4667777766543322 12235678899999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcC
Q 013941 301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379 (433)
Q Consensus 301 iwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (433)
||||||++|+|++ |..||.+....+....+......
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------- 278 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM------------------------------------------- 278 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-------------------------------------------
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCC-------------------------------------------
Confidence 9999999999999 99999887765554443321100
Q ss_pred chhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 380 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.....++..+.+||.+||+.||++|||+.|++++
T Consensus 279 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 279 ------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0113456789999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=353.55 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=181.1
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHH-HHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~-~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ........|+. +++.+.|+|| +++++++...+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~ni-----v~~~~~~~~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI-----VQFYGALFREGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTB-----CCEEEEEECSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcE-----eeeeeEEEeCCc
Confidence 367999999999999999999999999999999997532 23334445555 4444555555 999999999999
Q ss_pred EEEEEccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 168 ICIVFEKLGPSLYDFLRK---NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.++||||+.++|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+|||++.++
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~------------ 163 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG------------ 163 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT------------
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC------------
Confidence 999999997798888763 2234799999999999999999999999 999999999999997665
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhh----hCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+||+|||++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 164 ---------------~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 164 ---------------NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp ---------------EEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred ---------------CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 46777777665433221 224789999999998 455689999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+..... ..+..... +.... ........++..+.+
T Consensus 229 f~~~~~~~--~~~~~~~~--------------------~~~~~----------------------~~~~~~~~~~~~l~~ 264 (327)
T 3aln_A 229 YPKWNSVF--DQLTQVVK--------------------GDPPQ----------------------LSNSEEREFSPSFIN 264 (327)
T ss_dssp SSCC---------CCCCC--------------------SCCCC----------------------CCCCSSCCCCHHHHH
T ss_pred CCCcchHH--HHHHHHhc--------------------CCCCC----------------------CCCcccccCCHHHHH
Confidence 97643211 00000000 00000 000112345779999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
||.+||+.||++|||+.|+++||||.+..
T Consensus 265 li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 265 FVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 99999999999999999999999998643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=345.21 Aligned_cols=245 Identities=20% Similarity=0.285 Sum_probs=194.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEE----EEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELV----AIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
.++|++++.||+|+||.||+|++..+++.| |+|.+... ......+.+|+.++++++|+|| +++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTB-----CCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCe-----eEEEEEEec
Confidence 368999999999999999999998888755 66666432 2345778899999999988877 999999887
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
++ .++|+|++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~----------- 155 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH----------- 155 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-----------
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC-----------
Confidence 65 78889998 999999998754 46999999999999999999999999999999999999987664
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 317 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~p 317 (433)
+||+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 156 ----------------~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 219 (327)
T 3lzb_A 156 ----------------VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp ----------------EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ----------------EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence 5666666665432211 12356788999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.........+..... ......++.++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~l~~ 250 (327)
T 3lzb_A 220 YDGIPASEISSILEKGER-------------------------------------------------LPQPPICTIDVYM 250 (327)
T ss_dssp TTTCCGGGHHHHHHTTCC-------------------------------------------------CCCCTTBCHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC-------------------------------------------------CCCCccCCHHHHH
Confidence 987766554433322110 0012335678999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013941 398 LLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~ 418 (433)
||.+||+.||++|||+.|+++
T Consensus 251 li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 251 IMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=342.42 Aligned_cols=248 Identities=24% Similarity=0.451 Sum_probs=190.5
Q ss_pred cCCCeEEe-ccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHH-HHhCCCCCcceeEecceecc---
Q 013941 90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR-LARHDIGGTRCVQIRNWFDY--- 164 (433)
Q Consensus 90 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~~~~v~~~~~~~~--- 164 (433)
+.++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ....+|+.++.+ +.|+|+ +++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i-----~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYA 85 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEET
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCc-----hhHHhhhhhhcC
Confidence 34567777 7899999999999999999999999998653 346678888844 456665 999998876
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
.+.+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----------- 154 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR----------- 154 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-----------
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC-----------
Confidence 77899999999 88999999987656799999999999999999999999999999999999997532
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+..+||+|||++.... +..++.++|||||||++|+|++|..||.+..
T Consensus 155 -------------~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 155 -------------PNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp -------------TTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred -------------CCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 24568999999886422 2457889999999999999999999997654
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.......+.. ...... ..........++.++.+||.+|
T Consensus 203 ~~~~~~~~~~-------------------------~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~ 240 (299)
T 3m2w_A 203 GLAISPGMKT-------------------------RIRMGQ-----------------YEFPNPEWSEVSEEVKMLIRNL 240 (299)
T ss_dssp -----CCSCC-------------------------SSCTTC-----------------CSSCHHHHTTSCHHHHHHHHHH
T ss_pred chhhhHHHHH-------------------------HHhhcc-----------------ccCCchhcccCCHHHHHHHHHH
Confidence 3221100000 000000 0000111245678999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCccccCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRDVRRCGF 431 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~~~~~~~ 431 (433)
|+.||++|||+.|+++||||++.......
T Consensus 241 l~~dP~~Rps~~e~l~hp~~~~~~~~~~~ 269 (299)
T 3m2w_A 241 LKTEPTQRMTITEFMNHPWIMQSTKVPQT 269 (299)
T ss_dssp TCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred cccChhhCCCHHHHhcChhhcccccCCCC
Confidence 99999999999999999999987554433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=338.72 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=200.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.+.|+++ +++++++.. +..++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-----VRLYAVVTQ-EPIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCc-----ceEEEEEcC-CCcEE
Confidence 468999999999999999999965 56789999998766566788999999999988877 899988764 56899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~------------------ 146 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL------------------ 146 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS------------------
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC------------------
Confidence 99999 99999999754323699999999999999999999999999999999999997554
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 147 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 217 (279)
T 1qpc_A 147 ---------SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (279)
T ss_dssp ---------CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ---------CEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence 46777777765543322 22356788999999998889999999999999999999 99999887766
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+.+.... .....++.++.+||.+||+
T Consensus 218 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~l~~li~~~l~ 248 (279)
T 1qpc_A 218 EVIQNLERGYRM-------------------------------------------------VRPDNCPEELYQLMRLCWK 248 (279)
T ss_dssp HHHHHHHTTCCC-------------------------------------------------CCCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHhcccCC-------------------------------------------------CCcccccHHHHHHHHHHhc
Confidence 554443221100 0113456789999999999
Q ss_pred cCCCCCCCHHHHhc
Q 013941 405 YDPAERLKAREALR 418 (433)
Q Consensus 405 ~dP~~R~ta~ell~ 418 (433)
.||++|||++++++
T Consensus 249 ~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 249 ERPEDRPTFDYLRS 262 (279)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cChhhCCCHHHHHH
Confidence 99999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=346.22 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=204.2
Q ss_pred CccCCCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
+...++|++.+.||+|+||.||+|++. .+++.||||++.... .....+.+|+.+++.+.|+|+ +++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~ 95 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLG 95 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB-----CCEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCE-----eeeEE
Confidence 344578999999999999999999876 467889999987533 334567889999999988877 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
++.+.+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999 889999997532 13578999999999999999999999999999999999997554
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (433)
.+||+|||++....... ....||+.|+|||++.+..++.++|||||||
T Consensus 176 ---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 228 (322)
T 1p4o_A 176 ---------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228 (322)
T ss_dssp ---------------------------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ---------------------------eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence 57777777776433221 2236788999999999889999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 307 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
++|+|++ |..||.+.+..+....+.... . .
T Consensus 229 il~el~~~g~~p~~~~~~~~~~~~~~~~~--~-----------------------------------------------~ 259 (322)
T 1p4o_A 229 VLWEIATLAEQPYQGLSNEQVLRFVMEGG--L-----------------------------------------------L 259 (322)
T ss_dssp HHHHHHHTSCCTTTTSCHHHHHHHHHTTC--C-----------------------------------------------C
T ss_pred HHHHHHhcCCCccccCCHHHHHHHHHcCC--c-----------------------------------------------C
Confidence 9999999 899998876655444332210 0 0
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.....++..+.+||.+||+.||++|||+.|+++|
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113456789999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=338.19 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=198.5
Q ss_pred CCeEEec-cccccccEEEEEEEec--CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|.+.+ .||+|+||.||+|.+. .+++.||||+++.. ....+.+.+|+.++++++|+++ +++++++ ..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~-~~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVC-QAE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE-ESS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCE-----eEEEEEe-cCC
Confidence 5688887 9999999999999854 46788999999753 3455678899999999988777 9999998 456
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~------------- 148 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY------------- 148 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE-------------
T ss_pred CcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC-------------
Confidence 799999999 889999997543 46999999999999999999999999999999999999987764
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 149 --------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 214 (287)
T 1u59_A 149 --------------AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214 (287)
T ss_dssp --------------EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred --------------EEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 555666655433221 122356889999999998889999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
......+....+..... ......++.++.+|
T Consensus 215 ~~~~~~~~~~~i~~~~~-------------------------------------------------~~~~~~~~~~l~~l 245 (287)
T 1u59_A 215 KKMKGPEVMAFIEQGKR-------------------------------------------------MECPPECPPELYAL 245 (287)
T ss_dssp TTCCTHHHHHHHHTTCC-------------------------------------------------CCCCTTCCHHHHHH
T ss_pred ccCCHHHHHHHHhcCCc-------------------------------------------------CCCCCCcCHHHHHH
Confidence 88776655443322100 01123457799999
Q ss_pred HHHhcccCCCCCCCHHHHhcCC
Q 013941 399 LQGLLRYDPAERLKAREALRHP 420 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp 420 (433)
|.+||+.||++|||+.++++|.
T Consensus 246 i~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 246 MSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.60 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=192.2
Q ss_pred CCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
+....++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.++++++|+|+ +++++++
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~ 101 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV-----IKYYASF 101 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEE
Confidence 334456899999999999999999999999999999998742 3445677889999999988777 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
...+..++||||+ +++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-------- 173 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-------- 173 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--------
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--------
Confidence 9999999999999 8899999874 2234699999999999999999999999999999999999997655
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.++|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 174 -------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 234 (310)
T 2wqm_A 174 -------------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234 (310)
T ss_dssp -------------------CEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 4677777766543322 123478999999999999999999999999999999999999
Q ss_pred CCCCCCh--HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 317 LFQTHEN--LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 317 pf~~~~~--~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
||.+... ......+... ..+ ......++.+
T Consensus 235 p~~~~~~~~~~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~ 266 (310)
T 2wqm_A 235 PFYGDKMNLYSLCKKIEQC--DYP----------------------------------------------PLPSDHYSEE 266 (310)
T ss_dssp TTC---CCHHHHHHHHHTT--CSC----------------------------------------------CCCTTTSCHH
T ss_pred CCcccchhHHHHHHHhhcc--cCC----------------------------------------------CCcccccCHH
Confidence 9975432 1111111110 000 0001245678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013941 395 LIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
+.+||.+||+.||++|||+.++++
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=339.99 Aligned_cols=244 Identities=27% Similarity=0.377 Sum_probs=189.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|+.++++++|+|| +++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNI-----VKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTB-----CCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCc-----CeEEEEEcC--CcEEE
Confidence 57999999999999999999864 788999998653 345678899999999988877 999998874 47999
Q ss_pred EccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 172 FEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
|||+ +++|.+++..... ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-------------- 143 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-------------- 143 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--------------
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--------------
Confidence 9999 8999999986542 247899999999999999999999 89999999999999976542
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 144 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 144 ------------VLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp ------------EEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred ------------EEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence 36888888887655544556799999999999999999999999999999999999999975432211
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
........+..+ .....++..+.+||.+||+.|
T Consensus 212 ~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~l~~li~~~l~~d 244 (307)
T 2eva_A 212 RIMWAVHNGTRP-----------------------------------------------PLIKNLPKPIESLMTRCWSKD 244 (307)
T ss_dssp HHHHHHHTTCCC-----------------------------------------------CCBTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhcCCCC-----------------------------------------------CcccccCHHHHHHHHHHhcCC
Confidence 111000011000 112345678999999999999
Q ss_pred CCCCCCHHHHhc
Q 013941 407 PAERLKAREALR 418 (433)
Q Consensus 407 P~~R~ta~ell~ 418 (433)
|++|||++|+++
T Consensus 245 p~~Rps~~ell~ 256 (307)
T 2eva_A 245 PSQRPSMEEIVK 256 (307)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=338.66 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=191.7
Q ss_pred ecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecce
Q 013941 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (433)
Q Consensus 85 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~ 161 (433)
..++...++|++.++||+|+||+||+|++.. .||+|+++.. ....+.+.+|+.++++++|+|+ +.++++
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~ 88 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI-----LLFMGY 88 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEE
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcE-----EEEEee
Confidence 3456667899999999999999999998543 4999998643 3344678889999999988877 888885
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
. ..+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--------- 157 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--------- 157 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT---------
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC---------
Confidence 5 456789999999 899999996543 4699999999999999999999999999999999999998765
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhh---CCCCCccchHHHHHHHHHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~ 312 (433)
.++|+|||++..... ......||+.|+|||++. +..++.++|||||||++|+|+
T Consensus 158 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 219 (289)
T 3og7_A 158 ------------------TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219 (289)
T ss_dssp ------------------EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH
T ss_pred ------------------CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHH
Confidence 456666666653321 112357899999999997 556889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|..||.+....+.+..+.......+. .......++
T Consensus 220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~ 255 (289)
T 3og7_A 220 TGQLPYSNINNRDQIIEMVGRGSLSPD--------------------------------------------LSKVRSNCP 255 (289)
T ss_dssp HSSCTTSSCCCHHHHHHHHHHTSCCCC--------------------------------------------TTSSCTTSC
T ss_pred HCCCCccccchHHHHHHHhcccccCcc--------------------------------------------hhhccccCC
Confidence 999999887665544433322111000 001123457
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
..+.+||.+||+.||++|||+.|+++
T Consensus 256 ~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 256 KRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 78999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.19 Aligned_cols=248 Identities=21% Similarity=0.301 Sum_probs=198.8
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCc-----EEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEeccee
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~ 162 (433)
.++|++.+.||+|+||.||+|.+..+++ .||+|++.... ...+.+.+|+.+++.+ .|+|| +++++++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~ 119 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI-----VNLLGAC 119 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEE
Confidence 4679999999999999999999877654 79999987543 3456788999999999 78777 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNS------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
.+.+.+++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999 889999997532 235899999999999999999999999999999999999987
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHH
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (433)
++.++|+||| ++...... .....||+.|+|||++.+..++.++|||||
T Consensus 200 ~~~~kl~Dfg---------------------------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 252 (333)
T 2i1m_A 200 GHVAKIGDFG---------------------------LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252 (333)
T ss_dssp GGEEEBCCCG---------------------------GGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred CCeEEECccc---------------------------cccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHH
Confidence 7755555554 44322211 122467889999999999899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhh
Q 013941 305 GCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383 (433)
Q Consensus 305 G~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (433)
||++|+|++ |..||.+.........+.......
T Consensus 253 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------------- 286 (333)
T 2i1m_A 253 GILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM---------------------------------------------- 286 (333)
T ss_dssp HHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC----------------------------------------------
T ss_pred HHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC----------------------------------------------
Confidence 999999998 999998765444333322211000
Q ss_pred hhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 384 ~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
......+..+.+||.+||+.||++|||+.|+++
T Consensus 287 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 287 --AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011234678999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=361.22 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=203.0
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
.++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+.++++++|+|+ +++++++.. +..|+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEcC-CceEE
Confidence 4679999999999999999999865 4569999998665556788999999999998877 999998876 67899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~------------------ 317 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------ 317 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------------------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC------------------
Confidence 99999 89999999754334699999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 318 ---------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 318 ---------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp ---------CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ---------CEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 46777777765433211 22356788999999998899999999999999999999 99999987776
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+.+... ......++..+.+||.+||+
T Consensus 389 ~~~~~i~~~~~-------------------------------------------------~~~~~~~~~~l~~li~~cl~ 419 (452)
T 1fmk_A 389 EVLDQVERGYR-------------------------------------------------MPCPPECPESLHDLMCQCWR 419 (452)
T ss_dssp HHHHHHHTTCC-------------------------------------------------CCCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHcCCC-------------------------------------------------CCCCCCCCHHHHHHHHHHcc
Confidence 65554432110 00113456789999999999
Q ss_pred cCCCCCCCHHHHhc--CCCCCCC
Q 013941 405 YDPAERLKAREALR--HPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~ta~ell~--hp~f~~~ 425 (433)
.||++|||++++++ ..+|...
T Consensus 420 ~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 420 KEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp SSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CChhhCcCHHHHHHHHHHHhccC
Confidence 99999999999986 4666654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=335.62 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=195.7
Q ss_pred CCeEEeccccccccEEEEEEEecC---CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|++.. ++..||+|++... ....+.+.+|+.+++.++|+|+ +++++++.++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~- 85 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI-----VKLIGIIEEE- 85 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTB-----CCEEEEECSS-
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcCC-
Confidence 579999999999999999998654 3456999998753 2345678899999999988877 9999988754
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~------------- 151 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC------------- 151 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE-------------
T ss_pred CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc-------------
Confidence 568999999 899999998654 36999999999999999999999999999999999999987765
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 320 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~ 320 (433)
+||+|||++...... .....+|..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 152 --------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 152 --------------VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp --------------EEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred --------------EEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 555555555433221 122356888999999998899999999999999999998 9999987
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....+....+...... .....+++.+.+||.
T Consensus 218 ~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~l~~li~ 248 (281)
T 3cc6_A 218 LENKDVIGVLEKGDRL-------------------------------------------------PKPDLCPPVLYTLMT 248 (281)
T ss_dssp SCGGGHHHHHHHTCCC-------------------------------------------------CCCTTCCHHHHHHHH
T ss_pred CChHHHHHHHhcCCCC-------------------------------------------------CCCCCCCHHHHHHHH
Confidence 6655444333221100 011234678999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q 013941 401 GLLRYDPAERLKAREALRH 419 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~h 419 (433)
+||+.||++|||+.|++++
T Consensus 249 ~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 249 RCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCchhCcCHHHHHHH
Confidence 9999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=346.40 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=198.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEE--EEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELV--AIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|++..++..+ |+|.+... ....+.+.+|+.+++++ .|+++ +++++++.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~~~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB-----CCEEEEEEETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCch-----hhhceeeeeCC
Confidence 57999999999999999999999888865 99988642 23345678899999999 67766 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
..|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999 899999997643 23699999999999999999999999999999999999997655
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|
T Consensus 180 ---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 180 ---------------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp ---------------------------CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred ---------------------------eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 467777776653222 122246688999999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 310 el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
+|++ |..||.+.+..+....+.... . ....
T Consensus 233 ellt~g~~pf~~~~~~~~~~~~~~~~-----------------------~--------------------------~~~~ 263 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCAELYEKLPQGY-----------------------R--------------------------LEKP 263 (327)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHGGGTC-----------------------C--------------------------CCCC
T ss_pred HHHcCCCCCCCCCcHHHHHHHhhcCC-----------------------C--------------------------CCCC
Confidence 9998 999998876655433321110 0 0111
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..++..+.+||.+||+.||++|||++|+++|
T Consensus 264 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 264 LNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2456789999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=342.44 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=196.6
Q ss_pred CCCeEEeccccccccEEEEEEEecCCC----cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..+|++.+.||+|+||.||+|.+..++ ..||||+++.. ......+.+|+.+++++.|++| +++++++.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI-----IRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEec
Confidence 468999999999999999999876553 46999998753 2344567889999999988877 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------------ 184 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL------------ 184 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------------
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC------------
Confidence 99999999999 889999998653 4699999999999999999999999999999999999997655
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 185 ---------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 185 ---------------VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp ---------------CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ---------------cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 46677777665433221 11345788999999999999999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+....+....+..... + .....++..+.
T Consensus 250 pf~~~~~~~~~~~~~~~~~-~------------------------------------------------~~~~~~~~~l~ 280 (333)
T 1mqb_A 250 PYWELSNHEVMKAINDGFR-L------------------------------------------------PTPMDCPSAIY 280 (333)
T ss_dssp TTTTCCHHHHHHHHHTTCC-C------------------------------------------------CCCTTCBHHHH
T ss_pred CcccCCHHHHHHHHHCCCc-C------------------------------------------------CCcccCCHHHH
Confidence 9988776555444332110 0 01124567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 013941 397 DLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~h 419 (433)
+||.+||+.||++|||+.+++++
T Consensus 281 ~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 281 QLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=342.06 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=196.7
Q ss_pred CCCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEeccee
Q 013941 91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~ 162 (433)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... .....+.+|+.++.++ +|+++ +++++++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~ 100 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGAC 100 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe-----eeEEEEE
Confidence 46899999999999999999984 4577899999997533 3345678999999999 45666 9999988
Q ss_pred ccC-CeEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 163 DYR-NHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 163 ~~~-~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
... +.+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 764 4699999999 8899999987542 12899999999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (433)
++.++. +||+|||++....... ....||+.|+|||++.+..++.++||
T Consensus 181 ~~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 233 (316)
T 2xir_A 181 LSEKNV---------------------------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233 (316)
T ss_dssp ECGGGC---------------------------EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred ECCCCC---------------------------EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHH
Confidence 977664 5555555554332211 22467889999999999899999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc
Q 013941 302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380 (433)
Q Consensus 302 wSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
|||||++|+|++ |..||.+................
T Consensus 234 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------------------- 269 (316)
T 2xir_A 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-------------------------------------------- 269 (316)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC--------------------------------------------
T ss_pred HHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc--------------------------------------------
Confidence 999999999998 99999876543322221111000
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
.......+..+.++|.+||+.||++|||+.|+++|
T Consensus 270 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 270 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112346789999999999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=335.59 Aligned_cols=243 Identities=15% Similarity=0.153 Sum_probs=196.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC--C
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~--~ 166 (433)
++|++.+.||+|+||.||+|++. ++.||+|++.... ...+.+.+|+.++++++|+|| +++++++.+. +
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 82 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV-----LPVLGACQSPPAP 82 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTE-----ECEEEEECTTTSS
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCch-----hheEEEEccCCCC
Confidence 57999999999999999999974 8889999997532 344568889999988887766 9999999876 7
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
..++||||+ +++|.+++.......+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~----------- 151 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----------- 151 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC-----------
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc-----------
Confidence 899999999 889999998766556999999999999999999999999 999999999999976654
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCC---ccchHHHHHHHHHHHHhCCCCCCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
++|+|||++.... .....||+.|+|||++.+..++ .++|||||||++|+|++|..||.+
T Consensus 152 ----------------~~l~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 152 ----------------ARISMADVKFSFQ--SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp ----------------EEEEGGGSCCTTS--CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred ----------------eeEEeccceeeec--ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 4555444433221 1234789999999999886544 489999999999999999999988
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+.......+...... ......++.++.+||.
T Consensus 214 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~li~ 245 (271)
T 3kmu_A 214 LSNMEIGMKVALEGLR------------------------------------------------PTIPPGISPHVSKLMK 245 (271)
T ss_dssp SCHHHHHHHHHHSCCC------------------------------------------------CCCCTTCCHHHHHHHH
T ss_pred cChHHHHHHHHhcCCC------------------------------------------------CCCCCCCCHHHHHHHH
Confidence 7766554433221100 0112345778999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 013941 401 GLLRYDPAERLKAREALR 418 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~ 418 (433)
+||+.||++|||++|+++
T Consensus 246 ~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 246 ICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=349.82 Aligned_cols=266 Identities=17% Similarity=0.146 Sum_probs=195.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCC--------CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC----------C
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEK--------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG----------G 152 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~----------~ 152 (433)
.++|++.+.||+|+||.||+|++..+ ++.||||++... +.+.+|+.+++++.|+|+. .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 46899999999999999999999874 889999998754 3577899999999887662 2
Q ss_pred cceeEecceecc-CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 153 TRCVQIRNWFDY-RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 153 ~~~v~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
.+++.+++++.. ++..|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED 196 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence 334456676665 7889999999999999999876334799999999999999999999999999999999999998766
Q ss_pred --cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 232 --YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 232 --~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
.++|+|||++......... ............||+.|+|||++.+..++.++|||||||++|
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKH-----------------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML 259 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCC-----------------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CceEEEecCcceeeccCCCcc-----------------ccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 4444444443322111000 000001112347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHH-HHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhc
Q 013941 310 ELCSGEALFQTHE-NLEHLAM-MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387 (433)
Q Consensus 310 el~~g~~pf~~~~-~~~~~~~-i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (433)
+|++|..||.... ....+.. ........+.. ......
T Consensus 260 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~ 298 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF-----------------------------------------VGPCGH 298 (352)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCE-----------------------------------------ECTTSC
T ss_pred HHHhCCCCcccCCcCHHHHHHHHHhccCChhhh-----------------------------------------hhhccc
Confidence 9999999998653 2222222 22111111100 000001
Q ss_pred cCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 388 ~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
...++.++.+||.+||+.||++|||++++++
T Consensus 299 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 299 WIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp EECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 1245779999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=337.71 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=197.6
Q ss_pred CCCeEEeccccccccEEEEEEE----ecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
..+|++++.||+|+||.||+|+ +..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 94 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTE 94 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTB-----CCEEEEEEC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCe-----eeeeeEEec
Confidence 4569999999999999999998 67789999999987433 334678899999999988877 999999877
Q ss_pred C--CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 165 R--NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 165 ~--~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
. +.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--------- 164 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--------- 164 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---------
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC---------
Confidence 6 6799999999 889999996554 36999999999999999999999999999999999999987664
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
++|+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 165 ------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (302)
T 4e5w_A 165 ------------------VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226 (302)
T ss_dssp ------------------EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ------------------EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence 566666666543322 12346788899999999988999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.|+.... ..+....++........ ........+ ........++.++
T Consensus 227 ~p~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~~~~--------------------------~~~~~~~~~~~~l 272 (302)
T 4e5w_A 227 DSDSSPM-----ALFLKMIGPTHGQMTVT---RLVNTLKEG--------------------------KRLPCPPNCPDEV 272 (302)
T ss_dssp CGGGSHH-----HHHHHHHCSCCGGGHHH---HHHHHHHTT--------------------------CCCCCCTTCCHHH
T ss_pred CCCcchh-----hHHhhccCCcccccCHH---HHHHHHhcc--------------------------CCCCCCCCCCHHH
Confidence 9874321 11222222221111000 000000000 0111234567899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+||.+||+.||++|||+.|+++
T Consensus 273 ~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 273 YQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCHHHHHH
Confidence 99999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=336.33 Aligned_cols=243 Identities=24% Similarity=0.336 Sum_probs=195.8
Q ss_pred CCeEEec-cccccccEEEEEEE--ecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILS-KMGEGTFGQVVECF--DNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
++|++.+ .||+|+||.||+|. +..+++.||||+++... ...+.+.+|+.+++.+.|+++ +++++++ ..
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~-~~ 89 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGIC-EA 89 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE-ES
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEE-CC
Confidence 5799998 99999999999995 45678899999997532 235678899999999988777 9999988 56
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~------------ 155 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY------------ 155 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE------------
T ss_pred CCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc------------
Confidence 7789999999 899999998764 6999999999999999999999999999999999999987764
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 317 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~p 317 (433)
+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 156 ---------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 220 (291)
T 1xbb_A 156 ---------------AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220 (291)
T ss_dssp ---------------EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ---------------EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCC
Confidence 5566666554432221 11346788999999998889999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+..+....+.... . ......++..+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~--~-----------------------------------------------~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 221 YRGMKGSEVTAMLEKGE--R-----------------------------------------------MGCPAGCPREMYD 251 (291)
T ss_dssp STTCCHHHHHHHHHTTC--C-----------------------------------------------CCCCTTCCHHHHH
T ss_pred CCCCCHHHHHHHHHcCC--C-----------------------------------------------CCCCCCCCHHHHH
Confidence 98877655444332210 0 0012345778999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013941 398 LLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~ 418 (433)
+|.+||+.||++|||+.++++
T Consensus 252 li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=346.54 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=177.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHH-hCCCCCcceeEeccee-------
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF------- 162 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~------- 162 (433)
.+|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.++.++. |+|| +++++++
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----v~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI-----VQFCSAASIGKEES 102 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTB-----CCEEEEEEECTTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCCh-----hhcccccccccccc
Confidence 47999999999999999999999999999999885433 34566788999999996 7777 8888887
Q ss_pred -ccCCeEEEEEccCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCc
Q 013941 163 -DYRNHICIVFEKLGPSLYDFLRK-NSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 163 -~~~~~~~lv~e~~~~~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
.....+++||||++|+|.+++.. .....+++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+||
T Consensus 103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 103 DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 44567999999998899999875 22246999999999999999999999999 999999999999987665555444
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhh---hCCCCCccchHHHHHHHHHHHHhCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
|++............. .............||+.|+|||++ .+..++.++|||||||++|+|++|.
T Consensus 183 g~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 183 GSATTISHYPDYSWSA------------QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp TTCBCCSSCC-------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred ccceeccccCcccccc------------cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 4433222111000000 000000011234689999999998 4567899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||........... .. . .......+..+
T Consensus 251 ~p~~~~~~~~~~~~---~~-~------------------------------------------------~~~~~~~~~~~ 278 (337)
T 3ll6_A 251 HPFEDGAKLRIVNG---KY-S------------------------------------------------IPPHDTQYTVF 278 (337)
T ss_dssp CCC---------------C-C------------------------------------------------CCTTCCSSGGG
T ss_pred CCCcchhHHHhhcC---cc-c------------------------------------------------CCcccccchHH
Confidence 99975433221110 00 0 00112335578
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHP 420 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp 420 (433)
.+||.+||+.||++|||+.|+++|-
T Consensus 279 ~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 279 HSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHH
Confidence 8999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=346.86 Aligned_cols=256 Identities=20% Similarity=0.274 Sum_probs=189.2
Q ss_pred eeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH--HhCCCCCcceeEecc
Q 013941 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL--ARHDIGGTRCVQIRN 160 (433)
Q Consensus 83 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l--~~~~i~~~~~v~~~~ 160 (433)
+...+..+.++|++.+.||+|+||.||+|++. ++.||||++..... ....+|.+++..+ .|+|| +++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i-----~~~~~ 98 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENI-----LGFIA 98 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTB-----CCEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCe-----eeEEE
Confidence 34456667789999999999999999999864 88999999865443 3344455555443 55555 99999
Q ss_pred eeccC----CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecCCCCCcEEE
Q 013941 161 WFDYR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILL 227 (433)
Q Consensus 161 ~~~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivHrDikp~NIli 227 (433)
++... +.+++||||+ +++|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 88776 7899999999 88999999765 599999999999999999999999 99999999999999
Q ss_pred eeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-------cccccCCcccchhhhhCCCCCcc--
Q 013941 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGLGWNYP-- 298 (433)
Q Consensus 228 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~-- 298 (433)
+.++ .+||+|||++....... ....||+.|+|||++.+..++..
T Consensus 176 ~~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 228 (337)
T 3mdy_A 176 KKNG---------------------------TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228 (337)
T ss_dssp CTTS---------------------------CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTH
T ss_pred CCCC---------------------------CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCcccc
Confidence 7655 46777777664432211 23579999999999988766654
Q ss_pred ----chHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCcccc
Q 013941 299 ----CDLWSVGCILVELCSG----------EALFQTHEN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360 (433)
Q Consensus 299 ----~DiwSlG~il~el~~g----------~~pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 360 (433)
+|||||||++|||++| ..||..... ............ ....
T Consensus 229 ~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~ 287 (337)
T 3mdy_A 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK---------------------LRPS 287 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC---------------------CCCC
T ss_pred CccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhc---------------------cCcc
Confidence 9999999999999999 556543211 111111100000 0000
Q ss_pred CCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 361 WPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
++ .......++.++.+||.+||+.||++|||+.|+++|
T Consensus 288 ~~---------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 288 FP---------------------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CC---------------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cc---------------------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 00 000112346789999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=338.97 Aligned_cols=243 Identities=21% Similarity=0.327 Sum_probs=190.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-CCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-~~~~~l 170 (433)
++|++.+.||+|+||.||+|.+ +++.||||+++... ..+.+.+|+.++++++|+++ +++++++.. .+..++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTB-----CCEEEEECCC--CCEE
T ss_pred hhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCCceEE
Confidence 5799999999999999999986 48899999987543 45678899999999988777 999998654 457999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~------------------ 154 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN------------------ 154 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS------------------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC------------------
Confidence 99999 78999999865433489999999999999999999999999999999999996544
Q ss_pred cccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 328 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~ 328 (433)
.++|+|||++...........+|..|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus 155 ---------~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 225 (278)
T 1byg_A 155 ---------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225 (278)
T ss_dssp ---------CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred ---------cEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5788888877665544445578899999999998899999999999999999998 999998765544333
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+.... . ......+++.+.++|.+||+.||+
T Consensus 226 ~~~~~~-----------------------~--------------------------~~~~~~~~~~l~~li~~~l~~~p~ 256 (278)
T 1byg_A 226 RVEKGY-----------------------K--------------------------MDAPDGCPPAVYEVMKNCWHLDAA 256 (278)
T ss_dssp HHTTTC-----------------------C--------------------------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHhcCC-----------------------C--------------------------CCCcccCCHHHHHHHHHHhcCChh
Confidence 221100 0 011234577899999999999999
Q ss_pred CCCCHHHHhc
Q 013941 409 ERLKAREALR 418 (433)
Q Consensus 409 ~R~ta~ell~ 418 (433)
+|||+.|+++
T Consensus 257 ~Rps~~~l~~ 266 (278)
T 1byg_A 257 MRPSFLQLRE 266 (278)
T ss_dssp GSCCHHHHHH
T ss_pred hCCCHHHHHH
Confidence 9999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=362.46 Aligned_cols=252 Identities=17% Similarity=0.186 Sum_probs=191.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCC-----------CCCccee
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHD-----------IGGTRCV 156 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~-----------i~~~~~v 156 (433)
..|.+.+.||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.+.|.. +....++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35889999999999999999999999999999987322 23467888999988887621 1111111
Q ss_pred Ee------cceecc-----CCeEEEEEccCCCCHHHHHH-----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCC
Q 013941 157 QI------RNWFDY-----RNHICIVFEKLGPSLYDFLR-----KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (433)
Q Consensus 157 ~~------~~~~~~-----~~~~~lv~e~~~~~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi 220 (433)
.+ ..++.. ...++++|++++++|.+++. ......+++..+..++.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 111111 23578999999999999985 222235788899999999999999999999999999
Q ss_pred CCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhh----------
Q 013941 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---------- 290 (433)
Q Consensus 221 kp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---------- 290 (433)
||+|||++.++ .+||+|||++..........+| +.|+|||++
T Consensus 238 Kp~NILl~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 238 RPVDIVLDQRG---------------------------GVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp CGGGEEECTTC---------------------------CEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred ccceEEEecCC---------------------------eEEEEeccceeecCCccccCCC-CceeCchhhhccccccccc
Confidence 99999997655 4677777777655544455678 999999999
Q ss_pred hCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhh
Q 013941 291 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 370 (433)
Q Consensus 291 ~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (433)
.+..++.++|||||||++|||++|+.||...+.....
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~------------------------------------------- 326 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------------------------- 326 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS-------------------------------------------
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH-------------------------------------------
Confidence 4556889999999999999999999999764421100
Q ss_pred HHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 371 MRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.........++.++.+||.+||+.||++|||+.|+++||||++-
T Consensus 327 -----------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 327 -----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp -----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -----------HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 00011123457789999999999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=342.14 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=198.5
Q ss_pred CCccC-CCeEEeccccccccEEEEEEE----ecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 87 GENLT-PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 87 ~~~~~-~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
.+.+. ++|++.+.||+|+||.||+|+ +..+++.||||++.... ...+.+.+|+.++++++|+++ +++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~ 91 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI-----VKYRG 91 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCce-----eEEEE
Confidence 33443 689999999999999999998 57789999999997543 344668899999999988777 89988
Q ss_pred eec--cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 161 WFD--YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 161 ~~~--~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
++. ..+.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc
Confidence 775 567899999999 999999998643 2599999999999999999999999999999999999998877555555
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (433)
|| ++...... .....||..|+|||++.+..++.++|||||||++|+|
T Consensus 171 fg---------------------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 223 (327)
T 3lxl_A 171 FG---------------------------LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223 (327)
T ss_dssp GG---------------------------GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred cc---------------------------cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHH
Confidence 54 44332211 1224678889999999998899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|..||.......... . ......+. .......... .........+
T Consensus 224 l~g~~p~~~~~~~~~~~-~-~~~~~~~~----------------------------~~~~~~~~~~----~~~~~~~~~~ 269 (327)
T 3lxl_A 224 FTYCDKSCSPSAEFLRM-M-GCERDVPA----------------------------LSRLLELLEE----GQRLPAPPAC 269 (327)
T ss_dssp HTTTCGGGSHHHHHHHH-C-C----CCH----------------------------HHHHHHHHHT----TCCCCCCTTC
T ss_pred HhCCCCCccccchhhhh-c-cccccccc----------------------------HHHHHHHhhc----ccCCCCCCcc
Confidence 99999996533211100 0 00000000 0000000000 0011123456
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
+..+.+||.+||+.||++|||+.|++++
T Consensus 270 ~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 270 PAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7899999999999999999999999643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=374.88 Aligned_cols=279 Identities=24% Similarity=0.328 Sum_probs=206.4
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc----
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~---- 164 (433)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.. ....+.+.+|+.++++++|+|| +++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnI-----V~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV-----VSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTB-----CCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC-----Cceeeeecccccc
Confidence 36899999999999999999999999999999998743 3445678899999999998887 888887765
Q ss_pred --CCeEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 165 --RNHICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
++..|+||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g--------- 158 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP--------- 158 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS---------
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC---------
Confidence 67889999999 9999999986432 3589999999999999999999999999999999999998654
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 159 ---------------~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 159 ---------------QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp ---------------SSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------------CceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23357899999887654332 3458999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+........ ...... ................+.... .........++..+.+|
T Consensus 224 ~~~~~~~~~~------~~i~~~----~~~~~~~~~~l~g~~~~~~~l----------------p~p~~l~~~ls~~L~dL 277 (676)
T 3qa8_A 224 LPNWQPVQWH------GKVREK----SNEHIVVYDDLTGAVKFSSVL----------------PTPNHLSGILAGKLERW 277 (676)
T ss_dssp CSSCHHHHSS------TTCC----------CCSCCCCSSSCCCCSSS----------------CCSCCCCGGGHHHHHHH
T ss_pred Ccccchhhhh------hhhhcc----cchhhhhhhhhcccccccccc----------------CCchhhchhhhHHHHHH
Confidence 7654322110 000000 000000000000011111100 00011223457899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
|.+||.+||++|||+.|+++||||+.
T Consensus 278 I~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 278 LQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp HHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred HHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 99999999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=333.15 Aligned_cols=244 Identities=19% Similarity=0.271 Sum_probs=192.8
Q ss_pred CeEEeccccccccEEEEEEEecCCCc---EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.|.+.+.||+|+||+||+|++..+++ .||+|++.... ...+.+.+|+.+++.++|+|+ +++++++.+.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV-----LALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEECCSSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEecCCC
Confidence 47788999999999999999765544 79999987533 345677899999999988877 999999976655
Q ss_pred E-EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 168 I-CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 168 ~-~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
. ++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-------------- 161 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-------------- 161 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--------------
T ss_pred CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--------------
Confidence 4 9999999 999999997643 4789999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccC-------CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC-CCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EAL 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g-~~p 317 (433)
.+||+|||++..... ......+|..|+|||.+.+..++.++|||||||++|+|++| .+|
T Consensus 162 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 162 -------------TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp -------------CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred -------------cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 466777776653221 12234678899999999999999999999999999999995 555
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...+..+....+..... ......++..+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~l~~ 259 (298)
T 3pls_A 229 YRHIDPFDLTHFLAQGRR-------------------------------------------------LPQPEYCPDSLYQ 259 (298)
T ss_dssp TTTSCGGGHHHHHHTTCC-------------------------------------------------CCCCTTCCHHHHH
T ss_pred CccCCHHHHHHHhhcCCC-------------------------------------------------CCCCccchHHHHH
Confidence 555444433332222110 0012334678999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013941 398 LLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~ 418 (433)
||.+||+.||++|||++++++
T Consensus 260 li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=335.32 Aligned_cols=245 Identities=16% Similarity=0.211 Sum_probs=191.7
Q ss_pred CCeEEeccccccccEEEEEEEecCC---CcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee-ccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~-~~~ 165 (433)
.+|++.+.||+|+||.||+|++..+ ...||+|.+.... ...+.+.+|+.++++++|+|+ +++++++ ..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCE-----eeeeeEEEcCC
Confidence 4699999999999999999996543 3468999987532 345678899999999988877 9999984 566
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~------------ 166 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT------------ 166 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC------------
T ss_pred CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC------------
Confidence 7899999999 889999997643 46899999999999999999999999999999999999976664
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccC-------CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++ |.+
T Consensus 167 ---------------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 167 ---------------VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp ---------------EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ---------------EEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 55555555543221 1122467889999999999999999999999999999999 677
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+.+..+....+...... .....++..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~l~ 262 (298)
T 3f66_A 232 PYPDVNTFDITVYLLQGRRL-------------------------------------------------LQPEYCPDPLY 262 (298)
T ss_dssp SSTTSCTTTHHHHHHTTCCC-------------------------------------------------CCCTTCCHHHH
T ss_pred CCccCCHHHHHHHHhcCCCC-------------------------------------------------CCCccCCHHHH
Confidence 77765554443333221110 01123467899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
++|.+||+.||++|||+.|+++
T Consensus 263 ~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 263 EVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999885
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=364.20 Aligned_cols=250 Identities=27% Similarity=0.368 Sum_probs=205.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+.++++++|+|| +++++++.+ +.+|||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEEE
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEee-ccceEe
Confidence 469999999999999999999865 4569999998665556788999999999998877 999998876 678999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +++|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~------------------- 400 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------- 400 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------------------
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-------------------
Confidence 9999 88999999754334699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
.+||+|||++...... .....+|..|+|||++.+..++.++|||||||+||||++ |..||.+....+
T Consensus 401 --------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~ 472 (535)
T 2h8h_A 401 --------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 472 (535)
T ss_dssp --------CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH
T ss_pred --------cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 4677777777654321 122356788999999998899999999999999999999 999998877766
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+.+... ......++..+.+||.+||+.
T Consensus 473 ~~~~i~~~~~-------------------------------------------------~~~~~~~~~~l~~li~~cl~~ 503 (535)
T 2h8h_A 473 VLDQVERGYR-------------------------------------------------MPCPPECPESLHDLMCQCWRK 503 (535)
T ss_dssp HHHHHHTTCC-------------------------------------------------CCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHcCCC-------------------------------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence 5554432110 001234567899999999999
Q ss_pred CCCCCCCHHHHhcC--CCCCC
Q 013941 406 DPAERLKAREALRH--PFFTR 424 (433)
Q Consensus 406 dP~~R~ta~ell~h--p~f~~ 424 (433)
||++|||+++|++. .+|..
T Consensus 504 dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 504 EPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp SGGGSCCHHHHHHHHHTSSCC
T ss_pred ChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999863 56654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=348.69 Aligned_cols=270 Identities=19% Similarity=0.232 Sum_probs=201.8
Q ss_pred eeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 83 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
.+...+...++|++.+.||+|+||.||+|++ .+++.||||++.... .....+.+|+.+++.+.|+|| +++++
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~ 94 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-----LRLRG 94 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB-----CCCCE
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc-----cceEE
Confidence 3344456678999999999999999999985 468899999987533 222357889999999888777 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcEecCCCCCcEEEeeCCccc
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIli~~~~~~~ 234 (433)
++.+.+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~--- 171 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF--- 171 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC---
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC---
Confidence 999999999999999 8899999986532 3499999999999999999999999 999999999999996554
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHH
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (433)
.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 172 ------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 227 (326)
T 3uim_A 172 ------------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227 (326)
T ss_dssp ------------------------CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHH
T ss_pred ------------------------CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHH
Confidence 56777777776543221 22469999999999998889999999999999999
Q ss_pred HHhCCCCCCCCC-----hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 311 LCSGEALFQTHE-----NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 311 l~~g~~pf~~~~-----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|++|..||.... .......+.. ...........+ .....
T Consensus 228 l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~-----------------~~~~~ 271 (326)
T 3uim_A 228 LITGQRAFDLARLANDDDVMLLDWVKG-------------------LLKEKKLEALVD-----------------VDLQG 271 (326)
T ss_dssp HHHCCCSBCHHHHTTTSCSBHHHHHTT-------------------TTSSCCSTTSSC-----------------TTCTT
T ss_pred HHhCCCcccccccccccchhHHHHHHH-------------------HhhchhhhhhcC-----------------hhhcc
Confidence 999999995211 0000000000 000000000000 00001
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~ 421 (433)
......+..+.++|.+||+.||++|||+.||++|-.
T Consensus 272 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 112233568999999999999999999999998743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=362.22 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=195.0
Q ss_pred CCCeEEec-cccccccEEEEEEEec--CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 91 TPRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 91 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.+++.+.+ +||+|+||.||+|.+. .++..||||+++.. ....+.+.+|+.++++++|+|| +++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpni-----v~l~~~~~~- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQA- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTB-----CCEEEEEES-
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEecc-
Confidence 34566666 8999999999999875 35667999999753 2355778999999999988877 999999876
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+.+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~------------ 474 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY------------ 474 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE------------
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc------------
Confidence 5699999999 999999997543 46999999999999999999999999999999999999987764
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 317 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~p 317 (433)
+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 475 ---------------vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~P 539 (613)
T 2ozo_A 475 ---------------AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539 (613)
T ss_dssp ---------------EEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ---------------EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 5566666655432211 11245688999999998899999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+..+....+.... +. .....++.++.+
T Consensus 540 f~~~~~~~~~~~i~~~~-----------------------~~--------------------------~~p~~~~~~l~~ 570 (613)
T 2ozo_A 540 YKKMKGPEVMAFIEQGK-----------------------RM--------------------------ECPPECPPELYA 570 (613)
T ss_dssp TTTCCSHHHHHHHHTTC-----------------------CC--------------------------CCCTTCCHHHHH
T ss_pred CCCCCHHHHHHHHHcCC-----------------------CC--------------------------CCCCcCCHHHHH
Confidence 99887766555443211 00 112345779999
Q ss_pred HHHHhcccCCCCCCCHHHHh
Q 013941 398 LLQGLLRYDPAERLKAREAL 417 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell 417 (433)
||.+||+.||++|||+.+|+
T Consensus 571 li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=336.39 Aligned_cols=248 Identities=15% Similarity=0.224 Sum_probs=191.3
Q ss_pred CCCeEEeccccccccEEEEEEEecC---CCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
.++|.+.+.||+|+||.||+|.+.. +++.||+|+++.. ....+.+.+|+.++++++|+|+ +++++++.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~ 107 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV-----IRLLGVCIE 107 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEC
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCe-----eeeeEEEee
Confidence 3689999999999999999998765 5568999998743 2334667889999999988877 999998876
Q ss_pred CC-----eEEEEEccC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 165 RN-----HICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 165 ~~-----~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
.+ ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--- 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--- 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS---
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC---
Confidence 54 459999999 89999998532 234699999999999999999999999999999999999997655
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|
T Consensus 185 ------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 240 (313)
T 3brb_A 185 ------------------------TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240 (313)
T ss_dssp ------------------------CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred ------------------------cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence 4667777766543221 12246788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 310 el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
+|++ |..||.+.........+..... ....
T Consensus 241 el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~ 271 (313)
T 3brb_A 241 EIATRGMTPYPGVQNHEMYDYLLHGHR-------------------------------------------------LKQP 271 (313)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCC-------------------------------------------------CCCB
T ss_pred HHHhcCCCCCccCCHHHHHHHHHcCCC-------------------------------------------------CCCC
Confidence 9999 9999987665544433322100 0112
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..++..+.+||.+||+.||++|||+.+++++
T Consensus 272 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 272 EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3456789999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=346.18 Aligned_cols=274 Identities=20% Similarity=0.219 Sum_probs=184.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee-----ccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-----DYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~-----~~~~ 166 (433)
++|++.+.||+|+||.||+|++ +++.||||++............|+..+..+.|+|+ +++++.+ ....
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i-----~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI-----ARFIVGDERVTADGRM 85 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECTTSCE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcch-----hhheecccccccCCCc
Confidence 5799999999999999999975 68899999997544332222333333444666655 8887633 3345
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEecCCCCCcEEEeeCCccccc
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---------RLIHTDLKPENILLVSAEYVKVP 236 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivHrDikp~NIli~~~~~~~l~ 236 (433)
.+++||||+ +++|.+++.... .++..+..++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~----- 157 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG----- 157 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-----
T ss_pred eEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-----
Confidence 789999999 999999998764 68999999999999999999999 999999999999997655
Q ss_pred CccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-----------CCcccccCCcccchhhhhC-------CCCCcc
Q 013941 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----------DHSYVVSTRHYRAPEVILG-------LGWNYP 298 (433)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----------~~~~~~gt~~y~aPE~~~~-------~~~~~~ 298 (433)
.+||+|||++..... ......||+.|+|||++.+ ..++.+
T Consensus 158 ----------------------~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 215 (336)
T 3g2f_A 158 ----------------------TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215 (336)
T ss_dssp ----------------------CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred ----------------------cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc
Confidence 456666666643321 1123479999999999987 346678
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHh
Q 013941 299 CDLWSVGCILVELCSGEALFQTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377 (433)
Q Consensus 299 ~DiwSlG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (433)
+|||||||++|||++|..||..... ......+....+..|..... .........+..++...
T Consensus 216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~------------ 278 (336)
T 3g2f_A 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM-----QVLVSREKQRPKFPEAW------------ 278 (336)
T ss_dssp HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHH-----HHHHTTSCCCCCCCTTC------------
T ss_pred cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHH-----HhhhcccccCCCCCccc------------
Confidence 9999999999999999766643221 11111111111111110000 00000000011111100
Q ss_pred cCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHH------hcCCCCCCCcc
Q 013941 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREA------LRHPFFTRDVR 427 (433)
Q Consensus 378 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~el------l~hp~f~~~~~ 427 (433)
......+.++.+||.+||+.||++|||++|+ +-++|-+++.+
T Consensus 279 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 279 --------KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp --------CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred --------ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence 0011245689999999999999999999999 55788887543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=339.23 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=195.1
Q ss_pred CccCCCe-EEeccccccccEEEEEEE----ecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 88 ENLTPRY-RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 88 ~~~~~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
..+.++| +++++||+|+||+||++. +..+++.||||+++... ...+.+.+|+.++++++|+++ +++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~ 100 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI-----IKYKG 100 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcch-----hhEEE
Confidence 3455566 999999999999998775 44578999999997543 445678899999999998877 99999
Q ss_pred eecc--CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 161 WFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 161 ~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
++.+ ...+++||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~----- 172 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL----- 172 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-----
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC-----
Confidence 9877 47899999999 88999999775 4999999999999999999999999999999999999976654
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (433)
+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|
T Consensus 173 ----------------------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 230 (318)
T 3lxp_A 173 ----------------------VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230 (318)
T ss_dssp ----------------------EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred ----------------------EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 566666655443322 1224678889999999998899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCc
Q 013941 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391 (433)
Q Consensus 312 ~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (433)
++|..||........ .......... ........... .........+
T Consensus 231 l~g~~p~~~~~~~~~-----~~~~~~~~~~-------------------------~~~~~~~~~~~----~~~~~~~~~~ 276 (318)
T 3lxp_A 231 LTHCDSSQSPPTKFL-----ELIGIAQGQM-------------------------TVLRLTELLER----GERLPRPDKC 276 (318)
T ss_dssp HTTTCGGGSHHHHHH-----HHHCSCCHHH-------------------------HHHHHHHHHHT----TCCCCCCTTC
T ss_pred HhCCCcccccchhhh-----hhhcccccch-------------------------hHHHHHHHHhc----ccCCCCCccc
Confidence 999999965322110 0000000000 00000000000 0001123456
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 392 AGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 392 ~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
+.++.+||.+||+.||++|||++|+++
T Consensus 277 ~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 277 PAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 789999999999999999999999984
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=344.06 Aligned_cols=210 Identities=21% Similarity=0.290 Sum_probs=168.8
Q ss_pred CCCeEEeccccccccEEEEEE-----EecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 91 TPRYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.++|++.+.||+|+||+||+| .+..+++.||||+++... ...+.+|+.++..+.+. .|++++.+++++...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~--~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPS--MQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGG--GGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhh--hhhhhhhhheeeecC
Confidence 467999999999999999999 467789999999987543 35677888888888632 245569999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 166 NHICIVFEKL-GPSLYDFLRKN---SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
+..|+||||| +++|.+++... ....+++..++.++.||+.||+|||++|||||||||+|||++.+....
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~------- 212 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ------- 212 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-------
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc-------
Confidence 9999999999 99999999742 234799999999999999999999999999999999999997621000
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
+ ...+....+||+|||+|..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 213 -----~----~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 213 -----D----DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp ---------------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred -----c----ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 0 0011245789999999864321 1233579999999999999999999999999999999999999
Q ss_pred CCCC
Q 013941 317 LFQT 320 (433)
Q Consensus 317 pf~~ 320 (433)
||..
T Consensus 284 pf~~ 287 (365)
T 3e7e_A 284 MKVK 287 (365)
T ss_dssp CCEE
T ss_pred cccc
Confidence 9954
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=346.77 Aligned_cols=245 Identities=16% Similarity=0.218 Sum_probs=188.3
Q ss_pred CeEEeccccccccEEEEEEEecCCC---cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEeccee-ccCC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRN 166 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~-~~~~ 166 (433)
.|++.+.||+|+||.||+|++..++ ..||+|.++.. ....+.+.+|+.++++++|+|| +++++++ ..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTB-----CCCCEEECCCSS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCC
Confidence 5899999999999999999875433 46899998643 2345678899999999988777 9999975 4567
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-------------- 229 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-------------- 229 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--------------
T ss_pred CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--------------
Confidence 889999999 889999997644 4689999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC-------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 317 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~p 317 (433)
.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 230 -------------~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 230 -------------TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp -------------CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred -------------CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 4566666666533211 122467789999999999999999999999999999999 7888
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+..+....+..... ......++..+.+
T Consensus 297 ~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~p~~~~~~l~~ 327 (373)
T 3c1x_A 297 YPDVNTFDITVYLLQGRR-------------------------------------------------LLQPEYCPDPLYE 327 (373)
T ss_dssp CTTSCSSCHHHHHHTTCC-------------------------------------------------CCCCTTCCHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC-------------------------------------------------CCCCCCCCHHHHH
Confidence 876554433332221100 0011235678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 013941 398 LLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~h 419 (433)
+|.+||+.||++|||+.|++++
T Consensus 328 li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 328 VMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=337.52 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=193.2
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec----cC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD----YR 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~----~~ 165 (433)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+.|+|+ +++++++. ..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI-----LRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEEEeccCCC
Confidence 35799999999999999999999999999999988643 3455678899999999988877 99999886 34
Q ss_pred CeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 166 NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~----------- 171 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG----------- 171 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-----------
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-----------
Confidence 5899999999 88999999752 234799999999999999999999999999999999999997655
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC------------CcccccCCcccchhhhhCCC---CCccchHHHHHHH
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------------HSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCI 307 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~i 307 (433)
.++|+|||++...... .....||+.|+|||++.+.. ++.++|||||||+
T Consensus 172 ----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 235 (317)
T 2buj_A 172 ----------------QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235 (317)
T ss_dssp ----------------CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred ----------------CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence 4677777766543211 01236799999999997654 6899999999999
Q ss_pred HHHHHhCCCCCCCCChHH-HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhh
Q 013941 308 LVELCSGEALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386 (433)
Q Consensus 308 l~el~~g~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (433)
+|+|++|..||....... ......... ....
T Consensus 236 l~el~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~ 267 (317)
T 2buj_A 236 LYAMMFGEGPYDMVFQKGDSVALAVQNQ------------------------------------------------LSIP 267 (317)
T ss_dssp HHHHHHSSCTTHHHHHTTSCHHHHHHCC--------------------------------------------------CC
T ss_pred HHHHHhCCCChhhhhcccchhhHHhhcc------------------------------------------------CCCC
Confidence 999999999994210000 000000000 0001
Q ss_pred ccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 387 ~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
....++.++.+||.+||+.||++|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 268 QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 123457789999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=332.65 Aligned_cols=245 Identities=21% Similarity=0.311 Sum_probs=189.7
Q ss_pred CCeEEeccccccccEEEEEEEecC-CC--cEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++|++.+.||+|+||+||+|++.. ++ ..||||+++.. ....+.+.+|+.+++++.|+++ +++++++..
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~ 92 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL-----IRLYGVVLT 92 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECS
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEcc
Confidence 579999999999999999998643 33 36899998643 2345678899999999988777 999999887
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
.+ .++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~----------- 159 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL----------- 159 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-----------
T ss_pred CC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC-----------
Confidence 65 88999999 899999998643 36999999999999999999999999999999999999987664
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 160 ----------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 223 (291)
T 1u46_A 160 ----------------VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223 (291)
T ss_dssp ----------------EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred ----------------EEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 5666666554432211 22467888999999998889999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+.+..+....+.......+ ....++.++.
T Consensus 224 p~~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~l~ 255 (291)
T 1u46_A 224 PWIGLNGSQILHKIDKEGERLP------------------------------------------------RPEDCPQDIY 255 (291)
T ss_dssp TTTTCCHHHHHHHHHTSCCCCC------------------------------------------------CCTTCCHHHH
T ss_pred CcccCCHHHHHHHHHccCCCCC------------------------------------------------CCcCcCHHHH
Confidence 9988776655544432111110 1134567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
++|.+||+.||++|||+.++++
T Consensus 256 ~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 256 NVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=361.63 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=192.8
Q ss_pred eEEe-ccccccccEEEEEEEe--cCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 94 YRIL-SKMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 94 y~~~-~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
+.+. ++||+|+||.||+|.+ ..+++.||||+++... ...+.+.+|+.++++++|+|| +++++++.. +.
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~~~~~-~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGICEA-ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTB-----CCEEEEEES-SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec-CC
Confidence 4443 4899999999999954 4667899999997533 335778899999999998877 999999865 55
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~------------- 508 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA------------- 508 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE-------------
T ss_pred EEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCE-------------
Confidence 88999999 999999998764 79999999999999999999999999999999999999887755
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ 319 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~ 319 (433)
||+|||++...... .....+|..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 509 --------------kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 509 --------------KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp --------------EECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred --------------EEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 55555554432211 112356788999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
+.+..+....+..... . .....++.++.+||
T Consensus 575 ~~~~~~~~~~i~~~~~-----------------------~--------------------------~~p~~~~~~l~~li 605 (635)
T 4fl3_A 575 GMKGSEVTAMLEKGER-----------------------M--------------------------GCPAGCPREMYDLM 605 (635)
T ss_dssp TCCHHHHHHHHHTTCC-----------------------C--------------------------CCCTTCCHHHHHHH
T ss_pred CCCHHHHHHHHHcCCC-----------------------C--------------------------CCCCCCCHHHHHHH
Confidence 8877665554433210 0 11234577899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 013941 400 QGLLRYDPAERLKAREALR 418 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~ 418 (433)
.+||+.||++|||+++|++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=347.85 Aligned_cols=269 Identities=20% Similarity=0.261 Sum_probs=197.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHH---------hCCCC--
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLA---------RHDIG-- 151 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~---------~~~i~-- 151 (433)
++|++.+.||+|+||+||+|++ +|+.||||++.... ...+.+.+|+.+++.++ |+|+.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999997 68999999997532 22367889999999997 66663
Q ss_pred ----------CcceeEecceecc-------------CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 013941 152 ----------GTRCVQIRNWFDY-------------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207 (433)
Q Consensus 152 ----------~~~~v~~~~~~~~-------------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL 207 (433)
|+|++++++++.+ .+.+||||||| +|++.+.+.+ ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6777888888876 78999999999 8866666544 3689999999999999999
Q ss_pred HHHH-hCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccc
Q 013941 208 AFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRA 286 (433)
Q Consensus 208 ~~LH-~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~a 286 (433)
+||| ++||+||||||+|||++.++... .++++.... .........+||+|||+|+..... ..+||+.|+|
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~-~~~~~~~~~------~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKK-LHYTLNGKS------STIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSE-EEEEETTEE------EEEECTTEEEEECCCTTCBEEETT--EEECCCCTTC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcc-eeeeccCcc------ccccCCCceEEEeeccccEecCCC--cEEEeecccC
Confidence 9999 99999999999999998875211 111110000 000012236899999999865533 4589999999
Q ss_pred hhhhhCCCCCccchHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCC
Q 013941 287 PEVILGLGWNYPCDLWSVGCI-LVELCSGEALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 364 (433)
Q Consensus 287 PE~~~~~~~~~~~DiwSlG~i-l~el~~g~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (433)
||++.+.. +.++||||||++ .+++++|..||....... ....+..... +...
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~ 299 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT-------------------------FKTK 299 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC-------------------------CSSC
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc-------------------------cCcc
Confidence 99998876 899999998777 778889999984321101 1111110000 0000
Q ss_pred CCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHh-cCCCCC
Q 013941 365 ATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL-RHPFFT 423 (433)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell-~hp~f~ 423 (433)
. .......+++++.+||.+||++| ||+|+| +||||+
T Consensus 300 ~------------------~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 300 C------------------NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp C------------------CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred c------------------chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0 00011234778999999999987 999999 999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=332.58 Aligned_cols=261 Identities=22% Similarity=0.334 Sum_probs=195.8
Q ss_pred CCCeEEeccccccccEEEEEEE----ecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 91 TPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.++|++++.||+|+||.||+|+ +..+++.||||++.... ...+.+.+|+.++++++|+++ +++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-----VKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEec
Confidence 3579999999999999999998 46789999999987543 345678899999999988777 9999987654
Q ss_pred --CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 166 --NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 166 --~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
..+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~---------- 183 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---------- 183 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE----------
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc----------
Confidence 3789999999 889999998764 36999999999999999999999999999999999999987664
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 184 -----------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~ 246 (326)
T 2w1i_A 184 -----------------VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246 (326)
T ss_dssp -----------------EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred -----------------EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence 5666666655433221 12356778999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCCh-hhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPH-HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
||..... .+.+..+..+. .... .........+. .......++.++
T Consensus 247 ~~~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~~~~~--------------------------~~~~~~~~~~~l 292 (326)
T 2w1i_A 247 KSKSPPA-----EFMRMIGNDKQGQMIV---FHLIELLKNNG--------------------------RLPRPDGCPDEI 292 (326)
T ss_dssp GGGSHHH-----HHHHHHCTTCCTHHHH---HHHHHHHHTTC--------------------------CCCCCTTCCHHH
T ss_pred CCCCCHH-----HHHHhhccccchhhhH---HHHHHHhhcCC--------------------------CCCCCCcccHHH
Confidence 9864211 11111111110 0000 00000000000 011124567899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+||.+||+.||++|||+.|+++
T Consensus 293 ~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 293 YMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=339.69 Aligned_cols=261 Identities=20% Similarity=0.263 Sum_probs=196.1
Q ss_pred ceeeecCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHH--HHhCCCCCcceeEe
Q 013941 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQI 158 (433)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~~v~~ 158 (433)
..++..++.+.++|++.+.||+|+||.||+|++ +++.||||++.... ...+.+|++++.. +.|+|+ +++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni-----~~~ 101 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENI-----LGF 101 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTB-----CCE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcE-----EEE
Confidence 445566677788999999999999999999987 58899999986533 3567788888887 566665 999
Q ss_pred cceeccCC----eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEecCCCCCcE
Q 013941 159 RNWFDYRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENI 225 (433)
Q Consensus 159 ~~~~~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivHrDikp~NI 225 (433)
++++...+ .+++||||+ +++|.+++... .+++..++.++.||+.||.||| ++||+||||||+||
T Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI 178 (342)
T 1b6c_B 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178 (342)
T ss_dssp EEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred EeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence 99988765 899999999 88999999875 5999999999999999999999 89999999999999
Q ss_pred EEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-------CcccccCCcccchhhhhCCC----
Q 013941 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLG---- 294 (433)
Q Consensus 226 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~---- 294 (433)
|++.++ .+||+|||++...... .....||+.|+|||++.+..
T Consensus 179 ll~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 231 (342)
T 1b6c_B 179 LVKKNG---------------------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 231 (342)
T ss_dssp EECTTS---------------------------CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTC
T ss_pred EECCCC---------------------------CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccc
Confidence 997655 4677777776543332 23347999999999998763
Q ss_pred --CCccchHHHHHHHHHHHHhC----------CCCCCCCChHH-HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccC
Q 013941 295 --WNYPCDLWSVGCILVELCSG----------EALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW 361 (433)
Q Consensus 295 --~~~~~DiwSlG~il~el~~g----------~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 361 (433)
++.++|||||||++|+|++| ..||....... ....+..... ........
T Consensus 232 ~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~ 293 (342)
T 1b6c_B 232 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC------------------EQKLRPNI 293 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT------------------TSCCCCCC
T ss_pred cccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHH------------------HHHhCCCC
Confidence 33789999999999999999 77886532110 0011111000 00000000
Q ss_pred CCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 362 PDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
+. .......+..+.+||.+||+.||++|||++|+++|
T Consensus 294 ~~---------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 294 PN---------------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CG---------------------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cc---------------------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 00 00012235689999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.52 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=194.2
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccc-----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
|...+.||+|+||.||+|.+ +++.||+|++... ....+.+.+|+.++++++|+++ +++++++.+.+..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL-----VELLGFSSDGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEecCCce
Confidence 44458999999999999985 5788999998642 2345678899999999988877 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--------------- 170 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--------------- 170 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---------------
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC---------------
Confidence 9999999 999999997432 24699999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 171 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 171 ------------TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp ------------CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred ------------cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 4677777766543321 123478999999999876 5889999999999999999999999875
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
........+..........+ ..+.... ........+..+.++|.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~---------------------------~~~~~~~~~~~l~~li~~ 282 (307)
T 2nru_A 238 REPQLLLDIKEEIEDEEKTI--------EDYIDKK---------------------------MNDADSTSVEAMYSVASQ 282 (307)
T ss_dssp BSSSBTTHHHHHHHTTSCCH--------HHHSCSS---------------------------CSCCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHhhhhhhhh--------hhhcccc---------------------------ccccchHHHHHHHHHHHH
Confidence 54332222222111100000 0000000 000112235689999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 013941 402 LLRYDPAERLKAREALRH 419 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~h 419 (433)
||+.||++|||+.+++++
T Consensus 283 cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 283 CLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HTCSSTTTSCCHHHHHHH
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=354.34 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=198.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
.++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ....+.+.+|+.++++++|+|| +++++++. +
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~~~~~-~ 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT-E 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC-S
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEe-c
Confidence 46899999999999999999998653 467999998643 3344678899999999988877 99999885 4
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~------------ 529 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC------------ 529 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE------------
T ss_pred CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC------------
Confidence 6689999999 899999998653 36899999999999999999999999999999999999987764
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ 319 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~ 319 (433)
+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 530 ---------------vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 530 ---------------VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp ---------------EEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ---------------EEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 5666666665433221 12356789999999998899999999999999999997 999999
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
+....+....+...... .....++..+.+||
T Consensus 595 ~~~~~~~~~~i~~~~~~-------------------------------------------------~~~~~~~~~l~~li 625 (656)
T 2j0j_A 595 GVKNNDVIGRIENGERL-------------------------------------------------PMPPNCPPTLYSLM 625 (656)
T ss_dssp TCCHHHHHHHHHHTCCC-------------------------------------------------CCCTTCCHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCC-------------------------------------------------CCCccccHHHHHHH
Confidence 88776665554432100 01134567899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 013941 400 QGLLRYDPAERLKAREALR 418 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~ 418 (433)
.+||+.||++|||+.|+++
T Consensus 626 ~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 626 TKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=327.94 Aligned_cols=231 Identities=16% Similarity=0.054 Sum_probs=181.8
Q ss_pred eecCC-ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEe
Q 013941 84 FAIGE-NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQI 158 (433)
Q Consensus 84 ~~~~~-~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~ 158 (433)
+..|+ .+.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.++.++.|+|| +++
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~ 96 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV-----ARV 96 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTB-----CCE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCc-----cee
Confidence 34456 66788999999999999999999999999999999997542 334678889999999888777 999
Q ss_pred cceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccC
Q 013941 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
++++.+.+..|+||||+ |++|.+++... .....+..++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 97 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~----- 167 (286)
T 3uqc_A 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD----- 167 (286)
T ss_dssp EEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC-----
T ss_pred eEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC-----
Confidence 99999999999999999 89999998542 456678899999999999999999999999999999987664
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
+||+++| |++ .++.++|||||||++|+|++|+.|
T Consensus 168 ----------------------~kl~~~~-----------------~~~-------~~~~~~Di~slG~il~elltg~~P 201 (286)
T 3uqc_A 168 ----------------------VVLAYPA-----------------TMP-------DANPQDDIRGIGASLYALLVNRWP 201 (286)
T ss_dssp ----------------------EEECSCC-----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred ----------------------EEEEecc-----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCC
Confidence 4555332 444 378999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+....+.... .... ............++.++.+
T Consensus 202 f~~~~~~~~~~~~~----------------------------~~~~---------------~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 202 LPEAGVRSGLAPAE----------------------------RDTA---------------GQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp SCCCSBCCCSEECC----------------------------BCTT---------------SCBCCHHHHCTTSCHHHHH
T ss_pred CCcCCcchhhHHHH----------------------------HHhc---------------cCCCChhhcccCCCHHHHH
Confidence 98754321000000 0000 0000011223456789999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013941 398 LLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~ 418 (433)
||.+||+.||++| |+.|+++
T Consensus 239 li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHcccCCccC-CHHHHHH
Confidence 9999999999999 9999885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=330.07 Aligned_cols=243 Identities=20% Similarity=0.274 Sum_probs=192.5
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++.+.||+|+||.||+|.+.. .||+|+++... ...+.+.+|+.++++++|+|+ +++++++.+.+.
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV-----VLFMGACMSPPH 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTB-----CCCCEEEECSSC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCE-----eEEEEEEecCCc
Confidence 4689999999999999999998754 39999986432 223456679999998888777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--------------- 166 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--------------- 166 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------------------
T ss_pred eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC---------------
Confidence 99999999 899999997643 4689999999999999999999999999999999999996 33
Q ss_pred CCCcccCCCCCCCeeeecCCCCcccc--------CCCcccccCCcccchhhhhC---------CCCCccchHHHHHHHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEH--------QDHSYVVSTRHYRAPEVILG---------LGWNYPCDLWSVGCILV 309 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~--------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~ 309 (433)
.++|+|||++.... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 167 ------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 234 (319)
T 2y4i_B 167 ------------KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234 (319)
T ss_dssp ------------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred ------------CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence 46677777654322 11223468999999999975 35789999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 310 el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
+|++|..||...........+.....+. ....
T Consensus 235 el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~ 266 (319)
T 2y4i_B 235 ELHAREWPFKTQPAEAIIWQMGTGMKPN------------------------------------------------LSQI 266 (319)
T ss_dssp HHHHSSCSSSSCCHHHHHHHHHTTCCCC------------------------------------------------CCCS
T ss_pred HHHhCCCCCCCCCHHHHHHHhccCCCCC------------------------------------------------CCcC
Confidence 9999999998877665544433211100 0011
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 390 HSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.++.++.+||.+||..||++|||+.++++
T Consensus 267 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 267 GMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp SCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 34568999999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=359.53 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=197.0
Q ss_pred eecCCccCCCeEEeccccccccEEEEEEEecC-CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 84 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
+..|+.+.++|++.+.||+|+||.||+|.+.. +++.||||++... ......+.+|+.++.+++|+|| +++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~ 146 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI-----VQIFN 146 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTB-----CCEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCc-----CeEee
Confidence 34567788999999999999999999999976 7899999998643 2344567889999999988777 99999
Q ss_pred eeccCCe-----EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCccc
Q 013941 161 WFDYRNH-----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (433)
Q Consensus 161 ~~~~~~~-----~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~ 234 (433)
++...+. .||||||+ |++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---- 218 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---- 218 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----
Confidence 9887554 79999999 8999887754 59999999999999999999999999999999999999542
Q ss_pred ccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC
Q 013941 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 235 l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g 314 (433)
.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|
T Consensus 219 ------------------------~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g 272 (681)
T 2pzi_A 219 ------------------------QLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLD 272 (681)
T ss_dssp ------------------------CEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSC
T ss_pred ------------------------cEEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhC
Confidence 5789999988765443 446899999999999775 48999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGD 394 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (433)
..||.+.... ..+ .. .+ ....++.
T Consensus 273 ~~~~~~~~~~-----------~~~------------------------~~---------------~~------~~~~~~~ 296 (681)
T 2pzi_A 273 LPTRNGRYVD-----------GLP------------------------ED---------------DP------VLKTYDS 296 (681)
T ss_dssp CCEETTEECS-----------SCC------------------------TT---------------CH------HHHHCHH
T ss_pred CCCCcccccc-----------ccc------------------------cc---------------cc------ccccCHH
Confidence 9888642100 000 00 00 0012457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 395 LIDLLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 395 l~~li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
+.+||.+||+.||++||+..+++.|+|+.
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 89999999999999999988888888874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.36 Aligned_cols=183 Identities=20% Similarity=0.125 Sum_probs=127.7
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEeccc-----------hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
....++.|++|.+..++....|+.||+|++.+. ....+.+.+|+++|+++ .|+|+ ++++++++
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~~~~~~e 312 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDA-----PAVLAHGE 312 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCC-----CCEEEEEE
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCe-----eEEEEEEE
Confidence 345678899999998888889999999999642 23446688999999999 45555 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
+++.+||||||+ |++|.++|...+ .+++. .|+.||+.||+|||++|||||||||+|||++.+|
T Consensus 313 d~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg----------- 376 (569)
T 4azs_A 313 NAQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ----------- 376 (569)
T ss_dssp CSSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-----------
T ss_pred ECCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-----------
Confidence 999999999999 999999998765 67654 5889999999999999999999999999997665
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.+||+|||+|+..... ..+.+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 377 ----------------~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 377 ----------------HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ----------------CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ----------------CEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 4677777776544322 344689999999999976 46788999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=247.94 Aligned_cols=178 Identities=19% Similarity=0.177 Sum_probs=137.5
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
...+.||+|+||.||+|. ..++.+++|+..... ...+.+.+|+.++++++|+|+ +++..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI-----v~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGI-----PAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTC-----CCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCc-----CceEEEEEeC
Confidence 456799999999999994 557789999864311 123457899999999999988 6444444456
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..||||||+ +++|.+++.. +..++.||+.||+|||++||+||||||+|||++.
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--------------- 466 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--------------- 466 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---------------
T ss_pred CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---------------
Confidence 6679999999 8999999864 5689999999999999999999999999999842
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC----------cccccCCcccchhhhhC--CCCCccchHHHHHHHHHHHH
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 312 (433)
.+||+|||+++...... ....||+.|||||++.+ ..|+..+|+||..+-..+.+
T Consensus 467 --------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v 532 (540)
T 3en9_A 467 --------------DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV 532 (540)
T ss_dssp --------------SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred --------------eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 58999999988765422 24689999999999987 56888899999999988888
Q ss_pred hCCCCC
Q 013941 313 SGEALF 318 (433)
Q Consensus 313 ~g~~pf 318 (433)
.++.+|
T Consensus 533 ~~r~rY 538 (540)
T 3en9_A 533 ERRARY 538 (540)
T ss_dssp HTCSCC
T ss_pred Hhcccc
Confidence 777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-26 Score=209.24 Aligned_cols=155 Identities=24% Similarity=0.303 Sum_probs=118.7
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-------------------hhHHHHHHHHHHHHHHHhCCCCCc
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
.|.+.+.||+|+||.||+|++ .+|+.||||+++... .....+.+|+.+++++.| +
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--~--- 164 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--L--- 164 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--S---
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--C---
Confidence 466779999999999999999 889999999986422 134567899999999972 2
Q ss_pred ceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCc
Q 013941 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (433)
Q Consensus 154 ~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~ 232 (433)
++.+++.. +..|+||||+ |++|.+ +. . .....++.||+.||.|||++||+||||||+|||++ +|
T Consensus 165 ---~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~- 229 (282)
T 1zar_A 165 ---AVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE- 229 (282)
T ss_dssp ---SSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-
T ss_pred ---CcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-
Confidence 33333333 4569999999 889987 32 1 23557999999999999999999999999999997 55
Q ss_pred ccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC----------CCCCccchHH
Q 013941 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG----------LGWNYPCDLW 302 (433)
Q Consensus 233 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diw 302 (433)
.+||+|||+|. .+..|+|||++.. ..|+..+|+|
T Consensus 230 --------------------------~vkl~DFG~a~----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~ 273 (282)
T 1zar_A 230 --------------------------GIWIIDFPQSV----------EVGEEGWREILERDVRNIITYFSRTYRTEKDIN 273 (282)
T ss_dssp --------------------------EEEECCCTTCE----------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHH
T ss_pred --------------------------cEEEEECCCCe----------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChH
Confidence 47888888874 3556899999864 2345556665
Q ss_pred HH
Q 013941 303 SV 304 (433)
Q Consensus 303 Sl 304 (433)
.+
T Consensus 274 ~~ 275 (282)
T 1zar_A 274 SA 275 (282)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.2e-23 Score=186.60 Aligned_cols=137 Identities=19% Similarity=0.177 Sum_probs=109.3
Q ss_pred eEEeccccccccEEEEEEEecCCCcE--EEEEEeccchh-------------------------hHHHHHHHHHHHHHHH
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSINK-------------------------YREAAMIEIDVLQRLA 146 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~-------------------------~~~~~~~E~~~l~~l~ 146 (433)
|++.+.||+|+||.||+|.+..+|+. ||||+++.... ....+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998788999 99998753211 1135778999999999
Q ss_pred hCCCCCcceeEecceeccCCeEEEEEccCC--C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEecC
Q 013941 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLG--P----SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTD 219 (433)
Q Consensus 147 ~~~i~~~~~v~~~~~~~~~~~~~lv~e~~~--~----~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrD 219 (433)
|+++..+.++.. +..+|||||++ | +|.++... .++..+..++.||+.||.||| ++||+|||
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 998755555432 34689999994 3 77776432 235567899999999999999 99999999
Q ss_pred CCCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccc
Q 013941 220 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271 (433)
Q Consensus 220 ikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 271 (433)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~-----------------------------~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID-----------------------------KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS-----------------------------SEEECCCTTCEET
T ss_pred CCHHHEEEcC-----------------------------cEEEEECcccccC
Confidence 9999999842 5899999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=6.8e-19 Score=167.06 Aligned_cols=144 Identities=20% Similarity=0.206 Sum_probs=103.5
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch-----------------------hhHHHHHHHHHHHHHHHhCCC
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------KYREAAMIEIDVLQRLARHDI 150 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~E~~~l~~l~~~~i 150 (433)
|++.+.||+|+||.||+|.+ .+|+.||||+++... ..+-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999997 468999999875210 001123468889999988776
Q ss_pred CCcceeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEee
Q 013941 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (433)
Q Consensus 151 ~~~~~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~ 229 (433)
..+..+ +. ...+|||||+ |++|.++. ....+..++.||+.+|.+||++|||||||||.|||++.
T Consensus 176 ~vp~p~---~~----~~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPI---AQ----SRHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEE---EE----ETTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred CCCeee---ec----cCceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 333322 21 1237999999 77775432 12345678899999999999999999999999999998
Q ss_pred CCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCcc
Q 013941 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270 (433)
Q Consensus 230 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~ 270 (433)
+|...-.+ .....+.|+||+.+..
T Consensus 241 dgd~~d~~-----------------~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPS-----------------SITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTT-----------------SEEEEEEECCCTTCEE
T ss_pred CCCccccc-----------------ccccceEEEEeCCccc
Confidence 77321110 1112478999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=118.50 Aligned_cols=108 Identities=11% Similarity=0.094 Sum_probs=82.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+.|++...++.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+.. .+ .+.++++++.+.+..|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-~~---~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KL---PVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TS---CCCCEEEEEEETTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-CC---CCCeEEEEEecCCceEE
Confidence 35899999999999999999743 6789999986422 223457889999999965 22 34667777778889999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
|||++ |.+|.+.+. +......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhC
Confidence 99999 888876531 122345788899999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=2.6e-11 Score=110.10 Aligned_cols=107 Identities=13% Similarity=0.087 Sum_probs=73.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
..|.+....+.|..+.||++.. .+|+.+++|+.... ....+.+|+.+++.+.+.++. +.+++.+...++..++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~---vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCC---CCeEEEeccCCCCCEEE
Confidence 3466655555677799999964 55677999997653 224577899999999876542 34566666777789999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 214 (433)
||++ |.+|. .. ... ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 94 LGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp EECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSC
T ss_pred EEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCC
Confidence 9999 77773 11 122 2356677778888888643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.17 E-value=5.8e-11 Score=110.61 Aligned_cols=102 Identities=17% Similarity=0.132 Sum_probs=71.7
Q ss_pred ccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHh-CCCCCcceeEecceeccCC---eEEEEEc
Q 013941 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRN---HICIVFE 173 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~v~~~~~~~~~~---~~~lv~e 173 (433)
+.++.|....||++. ..+++|+.... .....+.+|+.+++.+.. ..+..|.++ ......+ ..|+||+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~---~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVV---FTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEE---EECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceE---eecCCCCCCCcceEEEc
Confidence 468999999999873 45899986543 345678889999999854 444334333 3322222 4589999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
++ |.+|.+.... .++.++...++.|++..|..||+
T Consensus 97 ~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 97 KIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHc
Confidence 99 7777654332 47788888899999999999986
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.6e-10 Score=110.32 Aligned_cols=108 Identities=14% Similarity=0.151 Sum_probs=76.1
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEec--cch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC---CeE
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---NHI 168 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~---~~~ 168 (433)
.++.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+++.+...++. +.+++.++.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vp---vP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVP---VAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSC---CCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCC---CCcEEEECCCCCccCCe
Confidence 4678899999999999753 4578899876 322 2234677899999999876553 35555555554 558
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
|+|||++ |..+.+. ....++......++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp EEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 9999999 6666431 11247788889999999999999997
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.8e-07 Score=86.96 Aligned_cols=103 Identities=17% Similarity=0.112 Sum_probs=67.3
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhC-CCCCcceeEeccee-ccCCeEEEEEcc
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF-DYRNHICIVFEK 174 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~~v~~~~~~-~~~~~~~lv~e~ 174 (433)
++.++.|....||+. +..+++|+... ......+.+|..+|+.+.+. .+..| +.+.+. ...+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP---~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIP---QYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCC---CEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCC---CeEeecccCCCceEEEEec
Confidence 345788998999988 45688998533 33456788999999999864 33223 333333 245667899999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
+ |.+|.+.... .++......++.++...|..||+
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhc
Confidence 9 7777663221 34555555666666666666664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=2e-06 Score=78.15 Aligned_cols=101 Identities=12% Similarity=0.135 Sum_probs=69.3
Q ss_pred ccccccE-EEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-CC
Q 013941 100 MGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GP 177 (433)
Q Consensus 100 lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~ 177 (433)
+..|..+ .||+......+..+++|+-... ....+.+|..+|+.+.. .+. +.+++.++.+.+..++|||++ |.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~-~vP---VP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA-FMP---LPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT-TSC---CCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc-CCC---cCeEEEEEEECCeEEEEEEeeCCc
Confidence 3344444 6999887777788999986543 33567789999999864 443 456667777888999999999 77
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013941 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (433)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 212 (433)
++.+..... ......+..++...|..||.
T Consensus 106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~ 134 (272)
T 4gkh_A 106 TAFQVLEEY------PDSGENIVDALAVFLRRLHS 134 (272)
T ss_dssp EHHHHHHHC------GGGHHHHHHHHHHHHHHHHT
T ss_pred cccccccCC------HHHHHHHHHHHHHHHHHhcC
Confidence 777765432 12234456666677777764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3e-06 Score=81.64 Aligned_cols=76 Identities=21% Similarity=0.230 Sum_probs=47.9
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccch--------hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.||.|..+.||++....+++.|+||...... ...+....|.++++.+.... ...+.+++.+ +.+..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~--~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC--CCCcCeEEEE--cCCcc
Confidence 568999999999999866667889999864321 12245677999999886531 1122344432 23445
Q ss_pred EEEEccCC
Q 013941 169 CIVFEKLG 176 (433)
Q Consensus 169 ~lv~e~~~ 176 (433)
++|||++.
T Consensus 111 ~lvmE~l~ 118 (397)
T 2olc_A 111 VTVMEDLS 118 (397)
T ss_dssp EEEECCCT
T ss_pred EEEEEeCC
Confidence 89999993
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.4e-05 Score=75.11 Aligned_cols=77 Identities=12% Similarity=0.216 Sum_probs=46.5
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEec-c--eeccCCeEEEEEc
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR-N--WFDYRNHICIVFE 173 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~-~--~~~~~~~~~lv~e 173 (433)
++.|+.|..+.||++... + ..+++|+..... .....|+.+++.|...++..+.++... + +....+..++||+
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~-~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-S-GAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET-T-EEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC-C-CCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 345677788999999753 3 358999987532 344567888888876665334433321 1 1234677899999
Q ss_pred cC-CCC
Q 013941 174 KL-GPS 178 (433)
Q Consensus 174 ~~-~~~ 178 (433)
|+ |.+
T Consensus 112 ~i~G~~ 117 (346)
T 2q83_A 112 WIEGRP 117 (346)
T ss_dssp CCCCBC
T ss_pred eecCcc
Confidence 99 543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=3.9e-06 Score=79.54 Aligned_cols=82 Identities=7% Similarity=0.064 Sum_probs=54.2
Q ss_pred EEeccc-cccccEEEEEEEec--C----CCcEEEEEEeccch---h-hHHHHHHHHHHHHHHHhC-CCCCcceeEeccee
Q 013941 95 RILSKM-GEGTFGQVVECFDN--E----KKELVAIKIVRSIN---K-YREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF 162 (433)
Q Consensus 95 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~~~-~i~~~~~v~~~~~~ 162 (433)
...+.| +.|..+.+|++... . +++.+++|+..... . ....+.+|+.+++.+... ++..| +++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP---~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVP---RVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCC---CEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCC---cEEEEc
Confidence 345778 88999999988643 1 25678999865432 1 124577899999999865 54333 444444
Q ss_pred ccC---CeEEEEEccC-CCCH
Q 013941 163 DYR---NHICIVFEKL-GPSL 179 (433)
Q Consensus 163 ~~~---~~~~lv~e~~-~~~L 179 (433)
.+. +..++|||++ |.++
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 443 4568999999 5443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.83 E-value=6.3e-05 Score=69.37 Aligned_cols=69 Identities=10% Similarity=-0.019 Sum_probs=46.2
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~- 175 (433)
++.|+.|....+|++ +.+++|+............+|+.+++.+...++. |.++ ... .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~~~---~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-PEVL---HVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-CCEE---EEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-CceE---EEE--CCCCEEEEeecC
Confidence 578889999999998 4489998764322222235699999999888774 4443 332 22346899999
Q ss_pred CC
Q 013941 176 GP 177 (433)
Q Consensus 176 ~~ 177 (433)
+|
T Consensus 91 ~g 92 (301)
T 3dxq_A 91 GA 92 (301)
T ss_dssp TC
T ss_pred CC
Confidence 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00016 Score=66.94 Aligned_cols=77 Identities=21% Similarity=0.218 Sum_probs=57.4
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
-++.|+.|....+|+... ++..+++|+.... ....+..|...|+.|.... ...+.+++.+....+..++|||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~--~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTN--SINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTT--SSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhC--CCCcceEEEEeecCCceEEEEEec
Confidence 357789999999999974 4667899987543 3466788999999997652 123456666666678899999999
Q ss_pred -CCC
Q 013941 176 -GPS 178 (433)
Q Consensus 176 -~~~ 178 (433)
|..
T Consensus 114 ~G~~ 117 (312)
T 3jr1_A 114 NKSK 117 (312)
T ss_dssp CCCC
T ss_pred cCCC
Confidence 654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.0002 Score=69.39 Aligned_cols=76 Identities=17% Similarity=0.236 Sum_probs=43.1
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEecc-----chh---hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-----INK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~---~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
-++.||.|..+.||++.. +++.++||.... ... .......|.+++..+.... ...+.+++.+. .+.
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~--~~~vP~v~~~~--~~~ 111 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS--PDHVPEVYHFD--RTM 111 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS--GGGSCCEEEEE--TTT
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC--CCCCCeEEEEC--CCc
Confidence 356789999999999963 467799994221 111 0122333444444443211 11224444443 456
Q ss_pred EEEEEccC-CC
Q 013941 168 ICIVFEKL-GP 177 (433)
Q Consensus 168 ~~lv~e~~-~~ 177 (433)
.++|||++ .+
T Consensus 112 ~~lv~e~l~~g 122 (420)
T 2pyw_A 112 ALIGMRYLEPP 122 (420)
T ss_dssp TEEEECCCCTT
T ss_pred cEEEEeecCCc
Confidence 78999999 76
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00064 Score=58.35 Aligned_cols=97 Identities=13% Similarity=0.003 Sum_probs=61.0
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcccCCCC
Q 013941 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256 (433)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 256 (433)
+|.++|...+ ..+++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.+...
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~-------------------- 92 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLA-------------------- 92 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEEC--------------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecc--------------------
Confidence 7999998765 589999999999999999887621 121123344688888777754321
Q ss_pred CCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh
Q 013941 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (433)
Q Consensus 257 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 313 (433)
+ +.+. .....+.|||... ...+.+.=|||||++||..+-
T Consensus 93 -------~-~~s~---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 93 -------P-AADD---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------C-C---------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -------c-cccc---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1 0000 1122466787753 345678899999999998874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00063 Score=63.10 Aligned_cols=81 Identities=10% Similarity=0.064 Sum_probs=49.9
Q ss_pred EEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc---eeccCCeEEEE
Q 013941 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIV 171 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~---~~~~~~~~~lv 171 (433)
.-++.|+.|....+|++... ++ .+++|+.... ...+.+..|+.++..+...++..|.++...+ +....+..+++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 34567888988999999753 33 5889988652 1224566799999999887764444443211 11234667999
Q ss_pred EccC-CCC
Q 013941 172 FEKL-GPS 178 (433)
Q Consensus 172 ~e~~-~~~ 178 (433)
|+++ |..
T Consensus 102 ~~~l~G~~ 109 (322)
T 2ppq_A 102 ISFLEGMW 109 (322)
T ss_dssp EECCCCBC
T ss_pred EEeCCCcC
Confidence 9999 543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00068 Score=63.06 Aligned_cols=77 Identities=14% Similarity=0.177 Sum_probs=50.0
Q ss_pred cccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc--eeccCCeEEEEEccCC
Q 013941 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN--WFDYRNHICIVFEKLG 176 (433)
Q Consensus 99 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~--~~~~~~~~~lv~e~~~ 176 (433)
.|+ |....||++.. .+|+.+++|+.+........+..|..+++.+...++..+.++..-+ +...++..++||+++.
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 77788998864 3466799999864333345677899999999877653333332211 1223567789999994
Q ss_pred C
Q 013941 177 P 177 (433)
Q Consensus 177 ~ 177 (433)
|
T Consensus 111 G 111 (328)
T 1zyl_A 111 G 111 (328)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00065 Score=62.00 Aligned_cols=77 Identities=10% Similarity=0.006 Sum_probs=53.5
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhC-CCCCcceeEecceeccCCeEEE
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~-~i~~~~~v~~~~~~~~~~~~~l 170 (433)
...-++.+|.|..+.||+++. .+|+.|++|+..... .....+..|+..|+.|... .+..|.+ +.+. .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v---~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQV---AGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCE---EEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceE---Eecc----CceE
Confidence 456678999999999999974 578889999865432 2234577899999999654 3433333 3322 2378
Q ss_pred EEccC-CC
Q 013941 171 VFEKL-GP 177 (433)
Q Consensus 171 v~e~~-~~ 177 (433)
|||++ ++
T Consensus 88 v~e~l~~~ 95 (288)
T 3f7w_A 88 AMEWVDER 95 (288)
T ss_dssp EEECCCCC
T ss_pred EEEeeccc
Confidence 99998 44
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00033 Score=66.54 Aligned_cols=74 Identities=14% Similarity=0.174 Sum_probs=46.2
Q ss_pred eccccccccEEEEEEEecC-------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++.|..|-...+|++.... +++.|++|+............+|..+++.+...++. .+++..+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~----P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLG----PQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSS----CCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCC----CeEEEEcCC----c
Confidence 3567778888899988642 357899998644323345567899999999988773 344455543 2
Q ss_pred EEEccC-CCC
Q 013941 170 IVFEKL-GPS 178 (433)
Q Consensus 170 lv~e~~-~~~ 178 (433)
+||||+ |.+
T Consensus 127 ~v~e~i~G~~ 136 (379)
T 3feg_A 127 RLEQYIPSRP 136 (379)
T ss_dssp EEEECCSEEE
T ss_pred cEEEEecCcc
Confidence 999999 544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0009 Score=62.44 Aligned_cols=79 Identities=10% Similarity=0.027 Sum_probs=41.9
Q ss_pred eccccccccEE-EEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 97 LSKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 97 ~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
++.|+.|.... +|+... .+++.+++|...... ......|+.+++.+...++..|.++. +....+ ++|||++
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~---~d~~~g--~ll~e~l 94 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYA---EEHARG--LLLIEDL 94 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEE---EETTTT--EEEECCC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceee---ecCCCC--EEEEeeC
Confidence 34565555444 667653 235667788654321 13355688999999877664444443 322333 6899999
Q ss_pred -CCCHHHHH
Q 013941 176 -GPSLYDFL 183 (433)
Q Consensus 176 -~~~L~~~l 183 (433)
+.++.+.+
T Consensus 95 ~~~~l~~~l 103 (333)
T 3csv_A 95 GDALFTEVI 103 (333)
T ss_dssp CSCBHHHHH
T ss_pred CCcchHHHh
Confidence 55665444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00067 Score=64.36 Aligned_cols=73 Identities=19% Similarity=0.196 Sum_probs=44.7
Q ss_pred eccccccccEEEEEEEecC--------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 97 LSKMGEGTFGQVVECFDNE--------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++.|+.|....+|++.... .++.+++|+.............|..+++.+...++ .|. ++..+. +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-~P~---~~~~~~--~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-APQ---LLNTFN--G-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-SCC---EEEEET--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-CCc---eEEecC--C--
Confidence 4577888888999997543 13678999876433222224679999999987775 333 333332 2
Q ss_pred EEEEccC-CC
Q 013941 169 CIVFEKL-GP 177 (433)
Q Consensus 169 ~lv~e~~-~~ 177 (433)
++||||+ |.
T Consensus 110 ~~v~e~i~G~ 119 (369)
T 3c5i_A 110 GRIEEWLYGD 119 (369)
T ss_dssp EEEEECCCSE
T ss_pred cEEEEEecCC
Confidence 6899999 53
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0049 Score=57.60 Aligned_cols=72 Identities=15% Similarity=0.150 Sum_probs=46.5
Q ss_pred cccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC-CcceeEec-c--eeccCCeEEEEEccC-
Q 013941 101 GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GTRCVQIR-N--WFDYRNHICIVFEKL- 175 (433)
Q Consensus 101 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~-~~~~v~~~-~--~~~~~~~~~lv~e~~- 175 (433)
|.|....||++.. .+| .+++|+..... ...|+.+++.|...++. .+..+... + +....+..++||+|+
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH-----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS-----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc-----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444789999974 344 79999876533 24688889888877664 23333221 1 123357889999999
Q ss_pred CCCH
Q 013941 176 GPSL 179 (433)
Q Consensus 176 ~~~L 179 (433)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 6544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0065 Score=58.75 Aligned_cols=71 Identities=14% Similarity=0.187 Sum_probs=49.4
Q ss_pred EeccccccccEEEEEEEecC-------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 96 ILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
-++.|+.|....||++.... +++.+++|+.... ...+.+..|..+++.+...++. | ++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~-P---~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG-P---KLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS-S---CEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCC-C---cEEEEeCC----
Confidence 35678889999999998643 2578999998432 1114556899999999887763 3 34444443
Q ss_pred EEEEccC
Q 013941 169 CIVFEKL 175 (433)
Q Consensus 169 ~lv~e~~ 175 (433)
.+|+||+
T Consensus 148 g~v~e~l 154 (429)
T 1nw1_A 148 GRLEEYI 154 (429)
T ss_dssp EEEECCC
T ss_pred CEEEEEe
Confidence 2899998
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.01 Score=57.79 Aligned_cols=75 Identities=15% Similarity=0.092 Sum_probs=48.0
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
-++.|+.|-...+|++.....+..+++|+........-...+|..++..|...++. .++++.+.. .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~----P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIA----KKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSB----CCEEEEETT----EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCC----CCEEEEeCC----eEEEEee
Confidence 35678889999999998654457899998754221111125799999999877662 344555532 2599998
Q ss_pred -CCC
Q 013941 176 -GPS 178 (433)
Q Consensus 176 -~~~ 178 (433)
|.+
T Consensus 184 ~G~~ 187 (458)
T 2qg7_A 184 DGYA 187 (458)
T ss_dssp CSEE
T ss_pred CCcc
Confidence 533
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.014 Score=56.09 Aligned_cols=75 Identities=16% Similarity=0.119 Sum_probs=49.2
Q ss_pred EeccccccccEEEEEEEecCC-------CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 96 ILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
-++.|..|-...+|++..... ++.|++|+........-...+|..+++.+...++ .|. +++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi-~P~---l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI-APN---IIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS-SCC---EEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC-CCC---EEEEcC--C--
Confidence 346677788889999986421 5779999875432222234679999999988776 233 333332 2
Q ss_pred EEEEccC-CCC
Q 013941 169 CIVFEKL-GPS 178 (433)
Q Consensus 169 ~lv~e~~-~~~ 178 (433)
++||||+ |.+
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 6899999 544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.31 E-value=0.088 Score=50.25 Aligned_cols=71 Identities=17% Similarity=0.226 Sum_probs=41.0
Q ss_pred eccccccccEEEEEEEecC-------CCcEEEEEEeccchh-------------------hHHHHHHHHHHHHHHHhCCC
Q 013941 97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINK-------------------YREAAMIEIDVLQRLARHDI 150 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~~~~i 150 (433)
++.|+-|-.-.+|++.... ..+.|++++...... .......|..+...+...++
T Consensus 57 v~~lsGG~SN~~y~v~~~~~~~~~~~~~~~~llRi~g~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~e~~~~~~ls~~g~ 136 (401)
T 3g15_A 57 ISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSL 136 (401)
T ss_dssp EEEEECSSEEEEEEEECCTTCCCSSSCCSEEEEEEEEC-----------------------CHHHHHHHHHHHHHHHTTS
T ss_pred EEEeCCccccceEEEEECCCCcccccCCCeEEEEeCCCCccchhhhhHHHHHHHHHHhccCCCCCcchhHHHHHHHhCCC
Confidence 4677778888999998543 235688887642110 00112246667777776665
Q ss_pred CCcceeEecceeccCCeEEEEEccC
Q 013941 151 GGTRCVQIRNWFDYRNHICIVFEKL 175 (433)
Q Consensus 151 ~~~~~v~~~~~~~~~~~~~lv~e~~ 175 (433)
+ .++++.+.. .+|++|+
T Consensus 137 ~----p~l~~~f~~----g~i~e~i 153 (401)
T 3g15_A 137 G----PKLYGIFPQ----GRLEQFI 153 (401)
T ss_dssp S----CCEEEEETT----EEEEECC
T ss_pred C----CEEEEEECC----cEEEEec
Confidence 3 345555543 3566776
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 433 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-55 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-49 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-44 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-44 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-43 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-25 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-55
Identities = 68/337 (20%), Positives = 117/337 (34%), Gaps = 45/337 (13%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ +S++G G G V + ++A K++ R + E+ VL
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSP- 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V F I I E + G SL L+K P ++ ++ +++ + +
Sbjct: 65 ---YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTY 119
Query: 210 MHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+ E +++H D+KP NIL+ + G IKL DFG +
Sbjct: 120 LREKHKIMHRDVKPSNILV-----------------NSRGE----------IKLCDFGVS 152
Query: 269 TFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
+ V TR Y +PE + G ++ D+WS+G LVE+ G + E
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
M + R G P +LP+ +
Sbjct: 213 LMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 272
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ D + L +PAER ++ + H F R
Sbjct: 273 ------EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-51
Identities = 86/344 (25%), Positives = 142/344 (41%), Gaps = 56/344 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLARH 148
+Y ++++GEG +G+V + D + VA+K VR + + E+ VL+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 149 D---IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+ + V + D + +VFE + L +L K P + ++++ QLL
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ F+H R++H DLKP+NIL+ S+ +K+ D
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD-------------------------FGL 162
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
+ VV T YRAPEV+L + P DLWSVGCI E+ + LF+ +++
Sbjct: 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
L + V+G R + F +
Sbjct: 223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE----------------------- 259
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429
+ V DLL L ++PA+R+ A AL HP+F +D+ RC
Sbjct: 260 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLERC 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-50
Identities = 81/348 (23%), Positives = 140/348 (40%), Gaps = 46/348 (13%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA 146
++ PRY LS +GEG +G V +DN K VAIK + Y + + EI +L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I G + + + +V +G LY L+ + D + Q+L
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRG 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H ++H DLKP N+LL + +K+ D+ + D +
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---------------- 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
+ V+TR YRAPE++L G+ D+WSVGCIL E+ S +F L+
Sbjct: 166 -----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
L + +LG D + + +
Sbjct: 221 QLNHILGILGSPSQE-------------------DLNCIINLKARNYLLSLPHKNKVPWN 261
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRCGFPL 433
+ ++ +DLL +L ++P +R++ +AL HP+ + P+
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 309
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-50
Identities = 70/343 (20%), Positives = 134/343 (39%), Gaps = 82/343 (23%)
Query: 93 RYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
Y++ S++ G G G+V++ F+ +E A+K+++ K R E+++ R ++
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP-- 65
Query: 152 GTRCVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
V+I + ++ R + IV E L G L+ ++ ++F E+ + + E+
Sbjct: 66 --HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H + + H D+KPEN+L S + +KL DFG
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAI------------------------LKLTDFG 159
Query: 267 STTF--EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
H + T +Y APEV+ ++ CD+WS+G I+ L G F ++ L
Sbjct: 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
M+ R PN
Sbjct: 220 AISPGMKT---------------------------------------RIRMGQYEFPNPE 240
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427
V ++ L++ LL+ +P +R+ E + HP+ + +
Sbjct: 241 WSEVSE---EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (429), Expect = 2e-49
Identities = 95/356 (26%), Positives = 155/356 (43%), Gaps = 47/356 (13%)
Query: 86 IGENLTP-RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR 144
GE RY ++ K+G G F V D VA+KIVR Y EAA EI +LQR
Sbjct: 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 65
Query: 145 LARHDIGGTRCVQIRN----------WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+ D + + H+ +VFE LG +L ++K +R P+
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 195 LVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
V+++ +QLL + +MH +IHTD+KPEN+L+ +
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP-------------------- 165
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
IK+ D G+ + + ++ + TR YR+PEV+LG W D+WS C++ EL +
Sbjct: 166 -ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
Query: 314 GEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 367
G+ LF+ E + +H+A + +LG LP +++ + RG +
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK---- 280
Query: 368 RDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
W L + + A ++ D L +L+ DP +R A + HP+
Sbjct: 281 ----LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-49
Identities = 74/340 (21%), Positives = 141/340 (41%), Gaps = 46/340 (13%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L+K+G+GTFG+V + + + VA+K V N + A+ EI +LQ L +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 150 IG---GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ + + + I +VF+ L L N F + ++ + + LL
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H +++H D+K N+L+ +K+ D+ +
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGL-------------------ARAFSLA 170
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
+ ++ + VV T YR PE++LG + P DLW GCI+ E+ + + Q +
Sbjct: 171 KNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
LA++ ++ G + + D + ++ + +
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR----------------KVKDRLK 273
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+V +DL+ LL DPA+R+ + +AL H FF D
Sbjct: 274 AYVRDP--YALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (427), Expect = 4e-49
Identities = 70/337 (20%), Positives = 124/337 (36%), Gaps = 81/337 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
Y IL ++G G FG V C + + K + + + EI ++ +L H
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHP-- 86
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+ + + + F+ + + ++ E L G L+D + Y+ V RQ E + M
Sbjct: 87 --KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
HE ++H D+KPENI+ K+S++K+IDFG T
Sbjct: 144 HEHSIVHLDIKPENIMC-------------------------ETKKASSVKIIDFGLATK 178
Query: 271 EHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+ D +T + APE++ + D+W++G + L SG + F ++LE L
Sbjct: 179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
++R
Sbjct: 239 NVKRCDWEFDEDAFSSVSP----------------------------------------- 257
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ D ++ LL+ +P +RL +AL HP+ D
Sbjct: 258 -----EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-48
Identities = 68/339 (20%), Positives = 120/339 (35%), Gaps = 90/339 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ E+++ L
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I +++ +F + ++ E ++Y L+K F +L ++
Sbjct: 67 NI-----LRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANAL 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
++ H R+IH D+KPEN+LL SA +K + DFG
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELK---------------------------IADFGW 152
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
S + + T Y PE+I G + DLWS+G + E G+ F+ + E
Sbjct: 153 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212
Query: 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386
+ RV P
Sbjct: 213 YKRISRVEFTFP------------------------------------------------ 224
Query: 387 HVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
D DL+ LL+++P++R RE L HP+ T +
Sbjct: 225 --DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 4e-48
Identities = 76/337 (22%), Positives = 117/337 (34%), Gaps = 81/337 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
Y I ++G G FG V + A K V + + +E EI + L RH
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHP-- 83
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + F+ N + +++E + G L++ + + D E RQ+ + + M
Sbjct: 84 --TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHM 140
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
HE +H DLKPENI+ + +S+ +KLIDFG T
Sbjct: 141 HENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDFGLTAH 175
Query: 271 --EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
Q T + APEV G Y D+WSVG + L SG + F + E L
Sbjct: 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
++ +
Sbjct: 236 NVKSCDWNMDDSAFSGISE----------------------------------------- 254
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
D D ++ LL DP R+ +AL HP+ T
Sbjct: 255 -----DGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 8e-48
Identities = 71/346 (20%), Positives = 131/346 (37%), Gaps = 88/346 (25%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLAR 147
N + I+ ++G+G FG+V + + E L A K++ + + + E M+EID+L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I V++ + F Y N++ I+ E D + R ++ + +Q L+++
Sbjct: 69 PNI-----VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H+ ++IH DLK NIL + DG IKL DFG
Sbjct: 124 NYLHDNKIIHRDLKAGNILF-----------------TLDGD----------IKLADFGV 156
Query: 268 TTFEHQDHSY---VVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQ 319
+ + + T ++ APEV++ ++Y D+WS+G L+E+ E
Sbjct: 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+ MR + K+ +
Sbjct: 217 -----------------------------------------------ELNPMRVLLKIAK 229
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ + + D L+ L + R + L+HPF T D
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-47
Identities = 59/345 (17%), Positives = 116/345 (33%), Gaps = 80/345 (23%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
+ L +Y I +G G FG V C + K+ K V+ + EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I + + F+ + ++FE + G +++ + +++ + Q+ E+
Sbjct: 61 RNI-----LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEA 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ F+H + H D++PENI+ + + K+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTI-------------------------KIIEFG 149
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
++ + + Y APEV + D+WS+G ++ L SG F N
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
+ + +
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISI------------------------------------- 232
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRRC 429
+ +D + LL + R+ A EAL+HP+ + + R
Sbjct: 233 ---------EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-47
Identities = 88/334 (26%), Positives = 146/334 (43%), Gaps = 54/334 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ + K+GEGT+G V + + E+VA+K +R A+ EI +L+ L +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + N + +VFE L L F+ ++ P+ L++ QLL+ +AF
Sbjct: 63 I-----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H R++H DLKP+N+L+ + +K+ D+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT------------------- 158
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+++ V T YRAPE++LG ++ D+WS+GCI E+ + ALF ++ L
Sbjct: 159 -----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ R LG + WP + D + K R + V
Sbjct: 214 RIFRTLGTPD-------------------EVVWPGVTSMPDYKPSFPKWARQD--FSKVV 252
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
D LL +L YDP +R+ A+ AL HPFF
Sbjct: 253 PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (403), Expect = 2e-46
Identities = 79/351 (22%), Positives = 127/351 (36%), Gaps = 98/351 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----------SINKYREAAMIEIDVL 142
Y +G G V C + A+KI+ + + REA + E+D+L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
++++ H +Q+++ ++ +VF+ + L+D+L + + R++ R
Sbjct: 64 RKVSGHP----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMR 117
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
LLE + +H+L ++H DLKPENILL D + IK
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILL-----------------DDDMN----------IK 150
Query: 262 LIDFGSTTFEHQDHSY--VVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELCS 313
L DFG + V T Y APE+I G+ D+WS G I+ L +
Sbjct: 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
G F + + L M+ F D+ D
Sbjct: 211 GSPPFWHRKQMLMLRMI----------------MSGNYQFGSPEWDDYSD---------- 244
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+ DL+ L P +R A EAL HPFF +
Sbjct: 245 --------------------TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 7e-46
Identities = 85/365 (23%), Positives = 140/365 (38%), Gaps = 72/365 (19%)
Query: 65 IPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
+ G P RP + Y +G G+FG V + + ELVAIK
Sbjct: 7 VATPGQGPDRPQEVS--------------YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK 52
Query: 125 VRSINKYREAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFL 183
V +++ E+ ++++L +I R ++ +V + + ++Y
Sbjct: 53 VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 184 RK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
R + ++ P+ V+ QL S+A++H + H D+KP+N+LL
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------------- 156
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTF--EHQDHSYVVSTRHYRAPEVILG-LGWNYP 298
P ++ +KL DFGS + + + +R+YRAPE+I G +
Sbjct: 157 -------------PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
Query: 299 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGA 357
D+WS GC+L EL G+ +F ++ L + +VLG P + E F +
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 263
Query: 358 RLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREAL 417
W R + I L LL Y P RL EA
Sbjct: 264 AHPWTKVFRPRTPP----------------------EAIALCSRLLEYTPTARLTPLEAC 301
Query: 418 RHPFF 422
H FF
Sbjct: 302 AHSFF 306
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 5e-45
Identities = 75/344 (21%), Positives = 132/344 (38%), Gaps = 82/344 (23%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQR 144
E++ Y +G G F +V+ D ++LVAIK + ++ + EI VL +
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ +H V + + ++ H+ ++ + + G L+D + + + + L Q+
Sbjct: 64 I-KHP----NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQV 116
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L++V ++H+L ++H DLKPEN+L S L + S I +
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKIMIS 152
Query: 264 DFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
DFG + E T Y APEV+ ++ D WS+G I L G F
Sbjct: 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
+ + + E++L +AE F D D
Sbjct: 213 NDAK---LFEQIL-------------KAEYEFDSPYWDDISD------------------ 238
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
D ++ L+ DP +R +AL+HP+ D
Sbjct: 239 ------------SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-45
Identities = 85/341 (24%), Positives = 149/341 (43%), Gaps = 67/341 (19%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHD 149
L +GEG F V + D ++VAIK ++ ++ A+ EI +LQ L+ +
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I + + + F ++++I +VF+ + L ++ NS P ++ L+ + +
Sbjct: 62 I-----IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H+ ++H DLKP N+LL ++G +KL DFG
Sbjct: 116 LHQHWILHRDLKPNNLLL-----------------DENGV----------LKLADFGLAK 148
Query: 270 F---EHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
++ +++ V TR YRAPE++ G + D+W+VGCIL EL +L+
Sbjct: 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
L + LG WPD S+ P + +
Sbjct: 209 QLTRIFETLGTPTEE-------------------QWPDMC----SLPDYVTFKSFPGIPL 245
Query: 386 QHVDHSAG-DLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
H+ +AG DL+DL+QGL ++P R+ A +AL+ +F+
Sbjct: 246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-44
Identities = 68/334 (20%), Positives = 123/334 (36%), Gaps = 81/334 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
+Y K+G+G G V D + VAI+ + +E + EI V++ ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP-- 77
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + + + +V E L G SL D + + + + R+ L+++ F+
Sbjct: 78 --NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFL 132
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++IH D+K +NILL VK+ D+ F ++ + + S
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-------------------- 172
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
S +V T ++ APEV+ + D+WS+G + +E+ GE + L L ++
Sbjct: 173 ----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
Query: 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390
P L P+ ++
Sbjct: 229 ATNGTP---------------------ELQNPEKLSA----------------------- 244
Query: 391 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
D L L D +R A+E L+H F
Sbjct: 245 ---IFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-44
Identities = 75/335 (22%), Positives = 127/335 (37%), Gaps = 41/335 (12%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
RY+ L +G G G V +D VAIK + + + A E+ +++ + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 150 IGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + + + +V E + +L ++ + + L Q+L +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIK 133
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H +IH DLKP NI++ S +K+ D T
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILD-------------------------FGLART 168
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+ V TR+YRAPEVILG+G+ D+WSVGCI+ E+ + LF + ++
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ LG + + Y + L +H
Sbjct: 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK--------LFPDSLFPADSEHN 280
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
A DLL +L DPA+R+ +AL+HP+
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-44
Identities = 59/340 (17%), Positives = 119/340 (35%), Gaps = 80/340 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ ++ +GEG +G+V + +E VA+KIV E EI + + L H+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V+ N + E G L+D + + P + QL+ V +
Sbjct: 64 ---NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H + + H D+KPEN+LL + +K+ D+ + +
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--------------------- 157
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+ + + T Y APE++ ++ P D+WS G +L + +GE
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL------------ 204
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
D + + WK + + +
Sbjct: 205 --------------------------------PWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428
D + LL +L +P+ R+ + + ++ + +++
Sbjct: 233 DS---APLALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 6e-44
Identities = 70/345 (20%), Positives = 122/345 (35%), Gaps = 89/345 (25%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQ 143
++ + L ++G G+FG V D E+VAIK + N+ + + E+ LQ
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L RH +Q R + + +V E S D L + + + +
Sbjct: 71 KL-RHP----NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 124
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L+ +A++H +IH D+K NILL S+ G +KL
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILL-----------------SEPGL----------VKLG 157
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALFQT 320
DFGS + +S+ V T ++ APEVIL + ++ D+WS+G +EL +
Sbjct: 158 DFGSASIMAPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
Query: 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380
+ L + + P W +
Sbjct: 217 MNAMSALYHIAQNESPALQSG------------------HWSE----------------- 241
Query: 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425
+ + L+ P +R + L+H F R+
Sbjct: 242 -------------YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 154 bits (389), Expect = 6e-44
Identities = 69/338 (20%), Positives = 142/338 (42%), Gaps = 57/338 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
Y+++ K+G G + +V E + E V +KI++ + K + EI +L+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGP--- 90
Query: 153 TRCVQIRNWF--DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ + + +VFE + + +R ++L+++ +
Sbjct: 91 -NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H + ++H D+KP N+++ + ++LID+G
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--------------------------EHRKLRLIDWGLAE 178
Query: 270 FEH--QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE-ALFQTHENLE 325
F H Q+++ V++R+++ PE+++ ++Y D+WS+GC+L + + F H+N +
Sbjct: 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
L + +VLG + I + + D + + +
Sbjct: 239 QLVRIAKVLGTEDLYDYID-------------KYNIELDPRFNDILGRHSRKRWERFVHS 285
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
++ + + +D L LLRYD RL AREA+ HP+F
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 82/354 (23%), Positives = 144/354 (40%), Gaps = 57/354 (16%)
Query: 78 KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KY 131
+ G Y + + + YR L +G G +G V D VAIK + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 132 REAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
+ A E+ +L+ + ++ G D +V +G L ++
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EK 117
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
D ++ L Q+L+ + ++H +IH DLKP N+
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA------------------------ 153
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILV 309
+ + +K++DFG + + V TR YRAPEVIL + + D+WSVGCI+
Sbjct: 154 ---VNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD 369
E+ +G+ LF+ ++L+ L + +V G P V R K + +G P+
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG----LPE------ 260
Query: 370 SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
+ +++ ++LL+ +L D +R+ A EAL HP+F
Sbjct: 261 ---------LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-42
Identities = 78/342 (22%), Positives = 146/342 (42%), Gaps = 56/342 (16%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL 145
+ RY+ LS +G G +G V FD + VA+K + + + E+ +L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 146 ARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
++ G + N + +V +G L + ++ + D V+ L Q+L
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQIL 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H +IH DLKP N+ + + +K++D
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLA---------------------------VNEDCELKILD 164
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
FG + + V+TR YRAPE++L +N D+WSVGCI+ EL +G LF ++
Sbjct: 165 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
++ L ++ R++G + +S + + L ++P +
Sbjct: 225 IDQLKLILRLVGTPGAEL--------------------LKKISSESARNYIQSLTQMPKM 264
Query: 384 IMQHVDHSAG-DLIDLLQGLLRYDPAERLKAREALRHPFFTR 424
+V A +DLL+ +L D +R+ A +AL H +F +
Sbjct: 265 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 5e-42
Identities = 69/345 (20%), Positives = 126/345 (36%), Gaps = 86/345 (24%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEID 140
EN+ Y ++G G F V +C + A K ++ RE E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+ + +H + + ++ + + ++ E + G L+DFL + S + E
Sbjct: 66 ILKEI-QHP----NVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+Q+L V ++H L++ H DLKPENI+L+
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLD-----------------------RNVPKPR 155
Query: 260 IKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
IK+IDFG + + + T + APE++ D+WS+G I L SG +
Sbjct: 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
F E LA + V
Sbjct: 216 FLGDTKQETLANVSAVNYEFED-------------------------------------- 237
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
++ +++ D ++ LL DP +R+ +++L+HP+
Sbjct: 238 --------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 1e-41
Identities = 81/337 (24%), Positives = 136/337 (40%), Gaps = 62/337 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEGT+G V + +N + A+K +R + EI +L+ L +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + + + +VFE L L L + QLL +A+
Sbjct: 62 I-----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H+ R++H DLKP+N+L+ + +K+ DFG
Sbjct: 116 CHDRRVLHRDLKPQNLLI---------------------------NREGELKIADFGLAR 148
Query: 270 FEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLE 325
+++ + T YRAP+V++G ++ D+WSVGCI E+ +G LF +
Sbjct: 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
L + R+LG +WP+ LP
Sbjct: 209 QLMRIFRILGTPNSK-------------------NWPNVTELPKYDPNFTVYEPLP--WE 247
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
+ IDLL +L+ DP +R+ A++AL H +F
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-41
Identities = 62/350 (17%), Positives = 131/350 (37%), Gaps = 93/350 (26%)
Query: 85 AIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEID 140
A+G + R+ + ++G G+F V + D E VA ++ R+ E +
Sbjct: 1 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60
Query: 141 VLQRLARHDIGGTRCVQIRNWF----DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
+L+ L +H V+ + + + I +V E + +L +L++ + I +
Sbjct: 61 MLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKV 113
Query: 196 VRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+R RQ+L+ + F+H +IH DLK +NI + + GS
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI----------------TGPTGS---- 153
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
+K+ D G T + + V+ T + APE+ ++ D+++ G ++E+
Sbjct: 154 ------VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 206
Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
+ E + +N + R
Sbjct: 207 TSEYPYSECQNAAQI-------------------------------------------YR 223
Query: 373 AVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
V ++ + + ++ ++++G +R + ER ++ L H FF
Sbjct: 224 RVTSGVKPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-40
Identities = 81/336 (24%), Positives = 137/336 (40%), Gaps = 56/336 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEGT+G V + + E E+VA+K VR + +A+ EI +L+ L +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + + +VFE + ++V+ QLL+ + F
Sbjct: 63 I-----VRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H ++H DLKP+N+L+ +K+ ++
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--------------------- 155
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEA-LFQTHENLEHL 327
+ +S V T YR P+V+ G + D+WS GCI EL + LF ++ + L
Sbjct: 156 ---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
+ R+LG WP D + + ++
Sbjct: 213 KRIFRLLGTPTEE-------------------QWPSMTKLPDYKP--YPMYPATTSLVNV 251
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFT 423
V DLLQ LL+ +P +R+ A EAL+HP+F+
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 63/344 (18%), Positives = 114/344 (33%), Gaps = 97/344 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
Y +L +G G++G+ + +++ K + ++ + E+++L+ L +I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 151 GGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLE 205
V+ + R + IV E G L + K + + + V + QL
Sbjct: 66 -----VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 206 SVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
++ H ++H DLKP N+ L + V
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV--------------------------- 153
Query: 261 KLIDFGSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
KL DFG + D S+ V T +Y +PE + + +N D+WS+GC+L ELC+
Sbjct: 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
F E + R G P +
Sbjct: 214 FTAFSQKELAGKI-----------------------REGKFRRIPYRYSD---------- 240
Query: 378 LRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
+L +++ +L R E L +P
Sbjct: 241 ----------------ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (347), Expect = 3e-38
Identities = 60/335 (17%), Positives = 105/335 (31%), Gaps = 65/335 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
RYR+ K+G G+FG + D E VAIK+ + IE + + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVG-- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
IR ++ +V E LGPSL D S R F + V L Q++ + ++H
Sbjct: 65 --IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
IH D+KP+N L+ + + D K + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYII-------DFGLAKKYRDAR-------THQHIPY 167
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332
+++ + T Y + LG+ + DL S+G +L+ G +Q + ER
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392
++ I
Sbjct: 228 ------------------------------------------ISEKKMSTPIEVLCKGYP 245
Query: 393 GDLIDLLQGLLRYDPAERLKA---REALRHPFFTR 424
+ L ++ R+ R+ F +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-38
Identities = 66/339 (19%), Positives = 113/339 (33%), Gaps = 92/339 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
+ + +G+G+FG+V + + AIK ++ ++ E M+E VL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ F + ++ V E L G L ++ F + +++ +
Sbjct: 63 PF----LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 116
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
F+H +++ DLK +NIL KDG K+ DFG
Sbjct: 117 QFLHSKGIVYRDLKLDNIL-----------------LDKDGHI----------KIADFGM 149
Query: 268 TTF---EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
+ T Y APE++LG +N+ D WS G +L E+ G++ F +
Sbjct: 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLI 384
E + R +P
Sbjct: 210 ELFHSI------------------------RMDNPFYPRWLEK----------------- 228
Query: 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAR-EALRHPFF 422
+ DLL L +P +RL R + +HP F
Sbjct: 229 ---------EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-38
Identities = 66/341 (19%), Positives = 110/341 (32%), Gaps = 90/341 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
++ +GEG+F VV + AIKI+ E DV+ RL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V++ F + L ++RK SF R +++ ++
Sbjct: 68 P----FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSAL 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H +IH DLKPENILL ++++ D+ S +
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES------------------- 162
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
+ + V T Y +PE++ DLW++GCI+ +L +G F+
Sbjct: 163 ---KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
+ ++ P +P
Sbjct: 220 QKIIKLEYDFPEKF-------------------FP------------------------- 235
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREA------LRHPFF 422
DL++ LL D +RL E HPFF
Sbjct: 236 ------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-37
Identities = 63/339 (18%), Positives = 108/339 (31%), Gaps = 94/339 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRL 145
+Y++ +G G FG V VAIK V +E+ +L+++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+ G +++ +WF+ + ++ E+ P F + +L R Q+LE
Sbjct: 65 SSGFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+V H ++H D+K ENIL+ +KLIDF
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDL--------------------------NRGELKLIDF 155
Query: 266 G-STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
G + ++ TR Y PE I +WS+G +L ++ G+ F+ E
Sbjct: 156 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNL 383
++R
Sbjct: 216 -----------------------------------------------------IIRGQVF 222
Query: 384 IMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFF 422
Q V LI + L P++R E HP+
Sbjct: 223 FRQRVSSECQHLI---RWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (337), Expect = 9e-37
Identities = 52/252 (20%), Positives = 92/252 (36%), Gaps = 38/252 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
Y++ ++GEG+FG + E + + VAIK E + LA
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTG-- 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ + H +V + LGPSL D L R F + V +Q+L V +HE
Sbjct: 63 --IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE 119
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------ 266
L++ D+KP+N L+ ++ I ++DFG
Sbjct: 120 KSLVYRDIKPDNFLIGRPNS----------------------KNANMIYVVDFGMVKFYR 157
Query: 267 ----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
+++ + T Y + LG + DL ++G + + G +Q +
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217
Query: 323 NLEHLAMMERVL 334
+ ER+
Sbjct: 218 AATNKQKYERIG 229
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (334), Expect = 1e-35
Identities = 67/342 (19%), Positives = 124/342 (36%), Gaps = 90/342 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG+V C + ++ A+K + + + A+ E +L ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
D V + F + + + + + G L+ L ++ F +R +++ +
Sbjct: 65 DC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGL 120
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
MH +++ DLKP NILL +V ++ D G
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHV---------------------------RISDLGL 153
Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
+ F + V T Y APEV+ G+ ++ D +S+GC+L +L G + F+ H+ +
Sbjct: 154 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
+ L ++ PD +
Sbjct: 214 KHEIDRMTLTM---------------------AVELPDSFSP------------------ 234
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLK-----AREALRHPFF 422
+L LL+GLL+ D RL A+E PFF
Sbjct: 235 --------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 4e-35
Identities = 56/329 (17%), Positives = 110/329 (33%), Gaps = 85/329 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
++L +G+G FG V+ + VA+K +++ + +A + E V+ +L ++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNL-- 62
Query: 153 TRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ+ + + + IV E + SL D+LR D + + + E++ ++
Sbjct: 63 ---VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
+H DL N+L+ S+D K+ DFG T
Sbjct: 120 EGNNFVHRDLAARNVLV-----------------SEDNV----------AKVSDFGLTKE 152
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
+ APE + ++ D+WS G +L E+ S + L+ +
Sbjct: 153 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-- 210
Query: 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390
+G ++D PDG
Sbjct: 211 --------------------PRVEKGYKMDAPDGCPP----------------------- 227
Query: 391 SAGDLIDLLQGLLRYDPAERLKAREALRH 419
+ ++++ D A R +
Sbjct: 228 ---AVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (323), Expect = 1e-34
Identities = 69/338 (20%), Positives = 119/338 (35%), Gaps = 92/338 (27%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
++IL +G G+FG+V A+K+++ K E E +L +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I +++ F I ++ + + L + S R FP + + ++ ++ +
Sbjct: 66 I-----IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H +I+ DLKPENILL K+G IK+ DFG
Sbjct: 120 LHSKDIIYRDLKPENILL-----------------DKNGH----------IKITDFGFAK 152
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
+ + T Y APEV+ +N D WS G ++ E+ +G F ++
Sbjct: 153 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---T 209
Query: 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389
E++L A L +P
Sbjct: 210 YEKIL---------------------NAELRFPPFFNE---------------------- 226
Query: 390 HSAGDLIDLLQGLLRYDPAERLK-----AREALRHPFF 422
D+ DLL L+ D ++RL + HP+F
Sbjct: 227 ----DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-34
Identities = 68/342 (19%), Positives = 118/342 (34%), Gaps = 97/342 (28%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI+R + E VLQ
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ ++ F + +C V E G L+ L + R F + R G +++ ++
Sbjct: 67 L-----TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H +++ D+K EN++L KDG IK+ DFG
Sbjct: 120 YLHSRDVVYRDIKLENLML-----------------DKDGH----------IKITDFGLC 152
Query: 269 TFEHQDHS---YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
D + T Y APEV+ + D W +G ++ E+ G F ++
Sbjct: 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385
++ + +P +
Sbjct: 213 LFELILM------------------------EEIRFPRTLSP------------------ 230
Query: 386 QHVDHSAGDLIDLLQGLLRYDPAERLK-----AREALRHPFF 422
+ LL GLL+ DP +RL A+E + H FF
Sbjct: 231 --------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (316), Expect = 3e-33
Identities = 65/339 (19%), Positives = 114/339 (33%), Gaps = 92/339 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
++ + +G G+FG+V+ E A+KI+ K E + E +LQ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ ++ D N ++ G ++ LR+ F R Q++ +
Sbjct: 102 FL----VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H L LI+ DLKPEN+L+ + G I++ DFG
Sbjct: 156 YLHSLDLIYRDLKPENLLI-----------------DQQGY----------IQVTDFGFA 188
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
+ T APE+IL G+N D W++G ++ E+ +G F + ++
Sbjct: 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388
+ P H D
Sbjct: 249 KIVSGKVRFPSHF-------------------SSD------------------------- 264
Query: 389 DHSAGDLIDLLQGLLRYDPAERLK-----AREALRHPFF 422
L DLL+ LL+ D +R + H +F
Sbjct: 265 ------LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 4e-32
Identities = 65/334 (19%), Positives = 119/334 (35%), Gaps = 81/334 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+++ ++G G FG+V + N + VA+K ++ + +A + E +++++L +H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ--- 68
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
R V++ + I I+ E + SL DFL+ S I+ + ++ Q+ E +AF+
Sbjct: 69 -RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
E IH DL+ NIL+ K+ D+ L+R +D Y
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTA------------------- 166
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331
+ APE I + D+WS G +L E+ + + +
Sbjct: 167 ---REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--- 220
Query: 332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHS 391
+ RG R+ PD
Sbjct: 221 -------------------QNLERGYRMVRPDNCPE------------------------ 237
Query: 392 AGDLIDLLQGLLRYDPAERLKAREALR--HPFFT 423
+L L++ + P +R FFT
Sbjct: 238 --ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (300), Expect = 1e-31
Identities = 59/342 (17%), Positives = 104/342 (30%), Gaps = 83/342 (24%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQR 144
+L+ RY + +G G +V D VA+K++R + E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 145 LARHDIGGTRCVQIRNWFDYRNH----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
L I V + + + IV E + G +L D + E+
Sbjct: 64 LNHPAI-----VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEV 116
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+++ F H+ +IH D+KP NI++ + VKV D+ + G+
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS--------- 167
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
+ V+ T Y +PE G + D++S+GC+L E+ +GE F
Sbjct: 168 ------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
+ V R +
Sbjct: 216 GDSPVS----------------VAYQHVREDPIPPSARHEGLSA---------------- 243
Query: 380 LPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPF 421
DL ++ L +P R + +R
Sbjct: 244 --------------DLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-31
Identities = 58/339 (17%), Positives = 115/339 (33%), Gaps = 93/339 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
+ + ++G G+FG V + + VA+K++ + +A E+ VL++ +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + + + IV + G SLY L + F + + ++ RQ + +
Sbjct: 66 I-----LLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H +IH DLK NI L +D + +K+ DFG
Sbjct: 119 YLHAKSIIHRDLKSNNIFL-----------------HEDLT----------VKIGDFGLA 151
Query: 269 TFEHQDHSY-----VVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQT 320
T + + + + + APEVI N + D+++ G +L EL +G+ +
Sbjct: 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-- 209
Query: 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380
+RD + + L
Sbjct: 210 ------------------------------------------SNINNRDQIIFMVGRGYL 227
Query: 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
+ + + + L+ L+ ER + L
Sbjct: 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-30
Identities = 64/333 (19%), Positives = 109/333 (32%), Gaps = 79/333 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
R+ K+G+G FG+V N VAIK ++ EA + E V+++L +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-- 74
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
VQ+ + SL DFL+ + + + + ++ Q+ +A++
Sbjct: 75 ---VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+ +H DL+ NIL+ KV D+ L+R +D Y
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTA-------------------- 170
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332
+ APE L + D+WS G +L EL + + + +++
Sbjct: 171 --RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQ 226
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392
V RG R+ P
Sbjct: 227 V--------------------ERGYRMPCPPECPE------------------------- 241
Query: 393 GDLIDLLQGLLRYDPAERLKAREALR--HPFFT 423
L DL+ R +P ER +FT
Sbjct: 242 -SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-29
Identities = 54/357 (15%), Positives = 105/357 (29%), Gaps = 104/357 (29%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKEL-----VAIKIVR--SINKYREAAMIEIDVLQRL 145
+G G FG+V+ + VA+K+++ + + REA M E+ ++ +L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR--------------- 189
H+ V + I ++FE L ++LR +
Sbjct: 98 GSHE----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 190 ------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
+ + Q+ + + F+ +H DL N+L+ + VK+ D+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
D +Y + APE + + D+WS
Sbjct: 214 IMSDSNYVV----------------------RGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 304 VGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 362
G +L E+ S G + + K + G ++D P
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANF----------------------YKLIQNGFKMDQP 289
Query: 363 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
AT ++ ++Q +D +R
Sbjct: 290 FYATE--------------------------EIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-28
Identities = 55/327 (16%), Positives = 105/327 (32%), Gaps = 77/327 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ ++G G FG V + K+ VAIK +R E + E +V+ +L H
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHP--- 60
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ VQ+ + IC+VFE + + F + + + + E +A++ E
Sbjct: 61 -KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+IH DL N L+ + +KV D+ D ++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----------------------QY 156
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332
+ + +PEV ++ D+WS G ++ E+ S + + + +
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-- 214
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392
G RL P A++
Sbjct: 215 --------------------ISTGFRLYKPRLAST------------------------- 229
Query: 393 GDLIDLLQGLLRYDPAERLKAREALRH 419
+ ++ + P +R LR
Sbjct: 230 -HVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-28
Identities = 62/350 (17%), Positives = 110/350 (31%), Gaps = 97/350 (27%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
R +G G FG+VVE ++ VA+K+++ + REA M E+ VL L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK----------------NSY 188
H V + ++ E L +FLR+ +
Sbjct: 84 GNHM----NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
+ ++ + Q+ + +AF+ IH DL NILL K+ D+ D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
+Y + APE I + + D+WS G L
Sbjct: 200 NYVV----------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 368
EL S + ++ K + G R+ P+ A +
Sbjct: 238 WELFSLGSSPYPGMPVDSKFY---------------------KMIKEGFRMLSPEHAPA- 275
Query: 369 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418
++ D+++ DP +R ++ ++
Sbjct: 276 -------------------------EMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (276), Expect = 4e-28
Identities = 49/331 (14%), Positives = 113/331 (34%), Gaps = 85/331 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ K+G G +G+V E + VA+K ++ E + E V++ + ++
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-- 75
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
VQ+ I+ E + +L D+LR+ + + ++ + Q+ ++ ++
Sbjct: 76 ---VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ IH DL N L+ ++ +K+ DFG +
Sbjct: 133 KKNFIHRDLAARNCLV-----------------GENHL----------VKVADFGLSRLM 165
Query: 272 HQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
D H+ + APE + ++ D+W+ G +L E+ + +L +
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
+ + R++ P+G
Sbjct: 226 YEL----------------------LEKDYRMERPEGCPE-------------------- 243
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALR 418
+ +L++ +++P++R E +
Sbjct: 244 ------KVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-28
Identities = 56/338 (16%), Positives = 106/338 (31%), Gaps = 63/338 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ +G+G FG+V + E VA+KI S + EI L +I G
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLES 206
++ + + +V + SL+D+L + + + L +E
Sbjct: 62 FIAADNKDNGTW-TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
V + + H DLK +NIL+ + D R P
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH--------- 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCSGEALFQT 320
V T+ Y APEV+ D++++G + E+ ++
Sbjct: 172 -----------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
Query: 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380
HE+ + P M + + R + P+ S +++R
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEM-------RKVVCEQKLRPNIPNRWQSCEALR-------- 265
Query: 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418
+ +++ + A RL A +
Sbjct: 266 -------------VMAKIMRECWYANGAARLTALRIKK 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 8e-28
Identities = 61/333 (18%), Positives = 122/333 (36%), Gaps = 86/333 (25%)
Query: 99 KMGEGTFGQVVECFDNEKK--ELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGT 153
++G G FG V + + KK + VA+KI++ + ++ + E +V+Q+L +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP---- 68
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + + + ++ L +L++N R + EL Q+ + ++ E
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES 126
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+H DL N+LLV+ Y K+ D+ LS+ + ++
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDF-GLSK--------------------ALRADENYYK 165
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE-LCSGEALFQTHENLEHLAMMER 332
++ + APE I ++ D+WS G ++ E G+ ++ + E AM+E
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE- 224
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392
+G R+ P G
Sbjct: 225 ----------------------KGERMGCPAGCPR------------------------- 237
Query: 393 GDLIDLLQGLLRYDPAERLKARE---ALRHPFF 422
++ DL+ YD R LR+ ++
Sbjct: 238 -EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-27
Identities = 56/346 (16%), Positives = 104/346 (30%), Gaps = 96/346 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
+ +GEG FGQV++ + + AIK ++ E++VL +L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPI 193
+ + ++R ++ + E +L DFLRK+ +
Sbjct: 71 P----NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+ + + ++ + + IH DL NIL+ K+ D+ LSR +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF-GLSRGQEV------ 179
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + + A E + + D+WS G +L E+ S
Sbjct: 180 ------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
L + +G RL+ P
Sbjct: 222 LGGTPYCGMTCAELY----------------------EKLPQGYRLEKPLNCDD------ 253
Query: 374 VWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
++ DL++ R P ER + L
Sbjct: 254 --------------------EVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-27
Identities = 63/346 (18%), Positives = 121/346 (34%), Gaps = 91/346 (26%)
Query: 93 RYRILSKMGEGTFGQV---VECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQR 144
+ +L +G G +G+V + ++ +L A+K+++ K E E VL+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ + V + F + ++ + G L+ L + F V+ ++
Sbjct: 85 IRQSPF----LVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEI 138
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
+ ++ +H+L +I+ D+K ENILL S +V + D+ + + +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL------------------SKEFV 180
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTH 321
+ + Y AP+++ G G + D WS+G ++ EL +G + F
Sbjct: 181 ADETERAYDFCGTI-----EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
A + R + +P ++
Sbjct: 236 GEKNSQAEISRRILKSE--------------------PPYPQEMSA-------------- 261
Query: 382 NLIMQHVDHSAGDLIDLLQGLLRYDPAERLK-----AREALRHPFF 422
DL+Q LL DP +RL A E H FF
Sbjct: 262 ------------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (268), Expect = 5e-27
Identities = 53/301 (17%), Positives = 108/301 (35%), Gaps = 33/301 (10%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRS--INKYREAAMIEIDVL 142
E +I +G G FG+V +++ VAIK ++S K R + E ++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ ++ + + + I+ E + D + + F + + + R
Sbjct: 82 GQFDHPNV-----IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+ + ++ ++ +H DL NIL+ S KV D+ LSR +D + + K+
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG-LSRFLEDDTSDPTYTSALGGKI 195
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTH 321
+ APE I + D+WS G ++ E+ S GE +
Sbjct: 196 ------------------PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
N + ++ + + + + D + + K++R P
Sbjct: 238 TNQD---VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
Query: 382 N 382
N
Sbjct: 295 N 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-26
Identities = 64/334 (19%), Positives = 113/334 (33%), Gaps = 86/334 (25%)
Query: 99 KMGEGTFGQVVECFDNEKKE--LVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + +K+ VAIK+++ + E M E ++ +L I
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI---- 71
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + +V E G L+ FL P+ V EL Q+ + ++ E
Sbjct: 72 -VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+H DL N+LLV+ Y K+ D+ D SY +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY---------------------YT 167
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE-LCSGEALFQTHENLEHLAMMER 332
S + APE I ++ D+WS G + E L G+ ++ + E +A +E
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE- 226
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392
+G R++ P
Sbjct: 227 ----------------------QGKRMECPPECPP------------------------- 239
Query: 393 GDLIDLLQGLLRYDPAERLKARE---ALRHPFFT 423
+L L+ Y +R +R +++
Sbjct: 240 -ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-26
Identities = 54/327 (16%), Positives = 106/327 (32%), Gaps = 79/327 (24%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
L ++G G FG V + + VAIK+++ + + + E V+ L+ +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL--- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ + I I+ E + + F + E+ + + E++ ++
Sbjct: 62 --VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+ +H DL N L+ VKV D+ LSR D Y +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSS-------------------- 158
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
+ PEV++ ++ D+W+ G ++ E+ S G+ ++ N E +
Sbjct: 159 --VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-- 214
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392
+G RL P A+
Sbjct: 215 ---------------------AQGLRLYRPHLASE------------------------- 228
Query: 393 GDLIDLLQGLLRYDPAERLKAREALRH 419
+ ++ ER + L +
Sbjct: 229 -KVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-26
Identities = 58/332 (17%), Positives = 98/332 (29%), Gaps = 82/332 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLAR 147
R + +GEG FG V + VAIK ++ + RE + E +++
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-D 66
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
H V++ N + I+ E + S + + QL ++
Sbjct: 67 HP----HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
A++ R +H D+ N+L+ S + VK+ D+ LSR +D +Y+K
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDF-GLSRYMEDSTYYK--------------- 165
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
S + APE I + D+W G + E+ +
Sbjct: 166 -------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
G RL P
Sbjct: 219 IGR----------------------IENGERLPMPPNCPP-------------------- 236
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
L L+ YDP+ R + E
Sbjct: 237 ------TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-25
Identities = 48/303 (15%), Positives = 100/303 (33%), Gaps = 34/303 (11%)
Query: 93 RYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLA 146
+G G FG+V + +K+ VAIK ++ K R + E ++ + +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H+I +++ + I+ E + D + F + + + R +
Sbjct: 68 HHNI-----IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++ + +H DL NIL+ S KV D+ D
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT------------ 170
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
S + APE I + D+WS G ++ E+ + +
Sbjct: 171 ---------SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
Query: 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQ 386
+ M+ + + + + + + D + + KL+R P+ +
Sbjct: 222 V--MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 279
Query: 387 HVD 389
D
Sbjct: 280 LAD 282
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (256), Expect = 2e-25
Identities = 57/356 (16%), Positives = 103/356 (28%), Gaps = 105/356 (29%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
+ +GEG FG+V + E +VA+K+++ + + E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-------------- 190
V++ +C++FE + L +FLR S +
Sbjct: 74 DNP-----NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 191 --------FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
+ RQ+ +A++ E + +H DL N L+ VK+ D+ LS
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF-GLS 187
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302
R+ Y+K + PE I + D+W
Sbjct: 188 RNIYSADYYKA---------------------DGNDAIPIRWMPPESIFYNRYTTESDVW 226
Query: 303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 362
+ G +L E+ S E + R G L P
Sbjct: 227 AYGVVLWEIFSYGLQPYYGMAHEEVIYY----------------------VRDGNILACP 264
Query: 363 DGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418
+ +L +L++ PA+R R
Sbjct: 265 ENCPL--------------------------ELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-25
Identities = 50/351 (14%), Positives = 108/351 (30%), Gaps = 98/351 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFD-------NEKKELVAIKIVR--SINKYREAAMIEIDVLQ 143
R + +GEG FGQVV + VA+K+++ + K + E+++++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--------------KNSY 188
+ +H + + + ++ E +L ++L+ N
Sbjct: 74 MIGKHKN----IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
+ Q+ + ++ + IH DL N+L+ +K+ D+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
Y K + + APE + + + D+WS G +L
Sbjct: 190 YYKK----------------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227
Query: 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR 368
E+ + +E L K + G R+D P T+
Sbjct: 228 WEIFTLGGSPYPGVPVEELF----------------------KLLKEGHRMDKPSNCTN- 264
Query: 369 DSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
+L +++ P++R ++ +
Sbjct: 265 -------------------------ELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-24
Identities = 48/326 (14%), Positives = 91/326 (27%), Gaps = 77/326 (23%)
Query: 99 KMGEGTFGQVVECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153
+G G FG V + KK A+K + I + E +++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV--- 90
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+ +V + +N + + + G Q+ + + F+
Sbjct: 91 -LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+ +H DL N +L VKV D+ L+R D + K+
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADF-GLARDMYDKEFDSVHNKTG--------------- 193
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 333
+ A E + + D+WS G +L EL + A N +
Sbjct: 194 ----AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----- 244
Query: 334 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393
Y +G RL P ++
Sbjct: 245 -----------------VYLLQGRRLLQP--------------------------EYCPD 261
Query: 394 DLIDLLQGLLRYDPAERLKAREALRH 419
L +++ R E +
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 3e-24
Identities = 43/254 (16%), Positives = 95/254 (37%), Gaps = 35/254 (13%)
Query: 93 RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVR----SINKYREAAMIEIDVLQRL 145
R+L K+G+G+FG V + K VA+K ++ S + + + E++ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
++ +++ + +V E + F + + Q+ E
Sbjct: 69 DHRNL-----IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++ R IH DL N+LL + + VK+ D+ + ++ +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--------------- 167
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324
+ + + APE + +++ D W G L E+ + G+ +
Sbjct: 168 ------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221
Query: 325 EHLAMMERVLGPLP 338
+ L +++ LP
Sbjct: 222 QILHKIDKEGERLP 235
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 3e-24
Identities = 53/352 (15%), Positives = 110/352 (31%), Gaps = 97/352 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
+ + ++G+G+FG V E +E + VAIK V + + R + E V++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN--------SYRSFPIDLV 196
H + V++ ++ E + L +LR + +
Sbjct: 81 NCHHV-----VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
++ ++ + +A+++ + +H DL N ++ VK+ D+ + Y K
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK---- 191
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
+ + +PE + + D+WS G +L E+ +
Sbjct: 192 ------------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK 376
+ E + ++ G LD PD
Sbjct: 234 QPYQGLSNEQVL----------------------RFVMEGGLLDKPDNCPD--------- 262
Query: 377 LLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR------HPFF 422
L +L++ +Y+P R E + P F
Sbjct: 263 -----------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 1e-23
Identities = 51/332 (15%), Positives = 101/332 (30%), Gaps = 82/332 (24%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLAR 147
++ + +G G FG V + + E VAIK +R K + + E V+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ ++ I L D++R++ + + Q+ + +
Sbjct: 71 PHV-----CRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGM 124
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++ + RL+H DL N+L+ + ++VK+ D+ L++
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFG-LAKLLGAEEK----------------- 166
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
+ A E IL + + D+WS G + EL + + +
Sbjct: 167 ----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 222
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQH 387
+ +G RL P T
Sbjct: 223 S----------------------SILEKGERLPQPPICTI-------------------- 240
Query: 388 VDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
D+ ++ D R K RE +
Sbjct: 241 ------DVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 58/350 (16%), Positives = 105/350 (30%), Gaps = 96/350 (27%)
Query: 93 RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
R ++ +G G FGQV+E VA+K+++ + + A M E+ +L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 146 ARHDIGGTRCVQIRN-WFDYRNHICIVFEKL-GPSLYDFLRKN--------------SYR 189
H V + + ++ E +L +LR
Sbjct: 74 GHHLN----VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
++ + Q+ + + F+ + IH DL NILL VK+ D+ KD
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
Y + + APE I + D+WS G +L
Sbjct: 190 YVR----------------------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227
Query: 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD 369
E+ S A ++ + + G R+ PD T
Sbjct: 228 EIFSLGASPYPGVKIDEEFC---------------------RRLKEGTRMRAPDYTTP-- 264
Query: 370 SMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419
++ + +P++R E + H
Sbjct: 265 ------------------------EMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.0 bits (160), Expect = 3e-13
Identities = 28/219 (12%), Positives = 60/219 (27%), Gaps = 31/219 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD-IG 151
I MGEG V C+ + E +K + +++ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
+ + + L + + ++ E+ +LE VA +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
++H DL N+L+ I +IDF +
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG----------------------------IWIIDFPQSVEV 152
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
++ + R R + D+ S +++
Sbjct: 153 GEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 433 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.39 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-63 Score=450.08 Aligned_cols=250 Identities=27% Similarity=0.457 Sum_probs=217.1
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++.+.||+|+||+||+|+++.+++.||+|++.+. ....+.+.+|+.++++++|+|| +++++++.+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI-----LRLYGYFHDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCC-----CeEEEEEEECCE
Confidence 4699999999999999999999999999999998643 2345678899999999988887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||| +|+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~--------------- 143 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--------------- 143 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---------------
T ss_pred EEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC---------------
Confidence 99999999 899999998765 799999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||+|...... .....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus 144 ------------~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 211 (263)
T d2j4za1 144 ------------ELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211 (263)
T ss_dssp ------------CEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ------------CEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence 5677788877654433 344689999999999999999999999999999999999999999887776
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+....+| +.+++++++||.+||+.
T Consensus 212 ~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 212 TYKRISRVEFTFP--------------------------------------------------DFVTEGARDLISRLLKH 241 (263)
T ss_dssp HHHHHHTTCCCCC--------------------------------------------------TTSCHHHHHHHHHHTCS
T ss_pred HHHHHHcCCCCCC--------------------------------------------------ccCCHHHHHHHHHHccC
Confidence 6665544322221 23577899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013941 406 DPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~ 425 (433)
||++|||++|+|+||||+++
T Consensus 242 dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 242 NPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp SGGGSCCHHHHHTCHHHHHH
T ss_pred CHhHCcCHHHHHcCcCcCCc
Confidence 99999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-62 Score=451.03 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=210.7
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.++++++|+|| +++++++.+++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~~~~~~~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTB-----CCEEEEEEETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCE-----eeEeeeeccCcee
Confidence 457999999999999999999999999999999987532 334567899999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
||||||| +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~---------------- 140 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---------------- 140 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----------------
T ss_pred EEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC----------------
Confidence 9999999 899999997654 799999999999999999999999999999999999997654
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||+|...... ....+||+.|||||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 141 -----------~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 141 -----------NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp -----------CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred -----------CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 5778888877654321 234689999999999998876 57899999999999999999999765
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
................ ......+++++.+||.+
T Consensus 210 ~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~s~~~~~li~~ 242 (271)
T d1nvra_ 210 SDSCQEYSDWKEKKTY-----------------------------------------------LNPWKKIDSAPLALLHK 242 (271)
T ss_dssp STTSHHHHHHHTTCTT-----------------------------------------------STTGGGSCHHHHHHHHH
T ss_pred ChHHHHHHHHhcCCCC-----------------------------------------------CCccccCCHHHHHHHHH
Confidence 5432222111110000 01123457789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 402 LLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
||+.||++|||++|+|+||||++..++
T Consensus 243 ~L~~dP~~R~t~~eil~hpwf~~~l~k 269 (271)
T d1nvra_ 243 ILVENPSARITIPDIKKDRWYNKPLKK 269 (271)
T ss_dssp HSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred HcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence 999999999999999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-61 Score=447.36 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=216.4
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.++|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.++++++|+|| +++++++.+.+.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCE-----eeEeEEEEECCEEE
Confidence 457999999999999999999999999999999987543 345678899999999998887 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|||||| ||+|.+++.+. .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~----------------- 153 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----------------- 153 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-----------------
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-----------------
Confidence 999999 99999988765 599999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||+|...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+
T Consensus 154 ----------~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 223 (293)
T d1yhwa1 154 ----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (293)
T ss_dssp ----------CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ----------cEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence 5777777777654322 234589999999999999999999999999999999999999999887776
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+....... ...+..++.++++||.+||+.
T Consensus 224 ~~~~~~~~~~~~-----------------------------------------------~~~~~~~s~~~~~li~~~L~~ 256 (293)
T d1yhwa1 224 ALYLIATNGTPE-----------------------------------------------LQNPEKLSAIFRDFLNRCLDM 256 (293)
T ss_dssp HHHHHHHHCSCC-----------------------------------------------CSSGGGSCHHHHHHHHHHTCS
T ss_pred HHHHHHhCCCCC-----------------------------------------------CCCcccCCHHHHHHHHHHccC
Confidence 665554321110 011234577999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 013941 406 DPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~ 425 (433)
||++|||++|+|+||||+..
T Consensus 257 dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 257 DVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp STTTSCCHHHHTTCGGGGGC
T ss_pred ChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-61 Score=451.63 Aligned_cols=263 Identities=26% Similarity=0.447 Sum_probs=210.9
Q ss_pred cCCccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
..+++.++|++.+.||+|+||+||+|+++.+++.||||++.+.. .....+.+|+.++++++|+|| +++++++.
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~ 77 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI-----VALDDIYE 77 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEE
Confidence 34667788999999999999999999999999999999997532 334556789999999988877 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccc
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~ 242 (433)
+++.+||||||| ||+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||+...
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~------------ 143 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL------------ 143 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS------------
T ss_pred ECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc------------
Confidence 999999999999 899999998764 79999999999999999999999999999999999999642
Q ss_pred cCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 013941 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320 (433)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~ 320 (433)
+.++.+||+|||+|...... ....+||+.|||||++.+..|+.++|||||||++|||++|..||.+
T Consensus 144 ------------~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 144 ------------DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp ------------STTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------CCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 24457899999998765433 2446899999999999999999999999999999999999999998
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
....+....+.+....++. .....+++++.+||.
T Consensus 212 ~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~ 245 (307)
T d1a06a_ 212 ENDAKLFEQILKAEYEFDS----------------------------------------------PYWDDISDSAKDFIR 245 (307)
T ss_dssp SSHHHHHHHHHTTCCCCCT----------------------------------------------TTTTTSCHHHHHHHH
T ss_pred CCHHHHHHHHhccCCCCCC----------------------------------------------ccccCCCHHHHHHHH
Confidence 8877766655543222211 112356789999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 401 GLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||+.||++|||++|+++||||++.
T Consensus 246 ~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 246 HLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-60 Score=441.99 Aligned_cols=262 Identities=26% Similarity=0.465 Sum_probs=226.0
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceeEecc
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~ 160 (433)
+++.++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.++++++|+|| |++++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~ 80 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV-----ITLHE 80 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence 456778999999999999999999999999999999986422 235678899999999998887 99999
Q ss_pred eeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcc
Q 013941 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (433)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~ 239 (433)
++.+.+.+||||||| +|+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~------- 151 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV------- 151 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSS-------
T ss_pred EEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCC-------
Confidence 999999999999999 999999998765 7999999999999999999999999999999999999977652
Q ss_pred ccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
....+||+|||+|...... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 152 ----------------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 152 ----------------PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp ----------------SSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------cccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 2346899999998765433 3446899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+.+..+.+..+.+....++. .....++.++++
T Consensus 216 f~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~ 249 (293)
T d1jksa_ 216 FLGDTKQETLANVSAVNYEFED----------------------------------------------EYFSNTSALAKD 249 (293)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCH----------------------------------------------HHHTTSCHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCc----------------------------------------------hhcCCCCHHHHH
Confidence 9998887777666554333221 112345778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||.+||+.||++|||++|+|+||||+..
T Consensus 250 li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 250 FIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-61 Score=442.42 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=214.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||+||+|++..+++.||||++++.. ...+.+.+|+.++++++|+|| +++++++.+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-----VKLYFTFQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTB-----CCEEEEEECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCe-----eEEEEEEEECCE
Confidence 46999999999999999999999999999999997432 344678899999999998887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||| ||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~--------------- 145 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--------------- 145 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---------------
T ss_pred EEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc---------------
Confidence 99999999 899999998765 799999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 146 ------------~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 146 ------------HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp ------------CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------eEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 5677777777654321 23358999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+.......+.+....+| ..+++++++||.+
T Consensus 214 ~~~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 214 NEYLIFQKIIKLEYDFP--------------------------------------------------EKFFPKARDLVEK 243 (288)
T ss_dssp SHHHHHHHHHTTCCCCC--------------------------------------------------TTCCHHHHHHHHT
T ss_pred CHHHHHHHHHcCCCCCC--------------------------------------------------ccCCHHHHHHHHH
Confidence 87776665543322221 2457789999999
Q ss_pred hcccCCCCCCCHHH------HhcCCCCCCC
Q 013941 402 LLRYDPAERLKARE------ALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~ta~e------ll~hp~f~~~ 425 (433)
||+.||++|||++| +++||||++-
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999999988 5899999863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-60 Score=449.43 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=224.0
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
+-++|++++.||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.++++++|+|| |++++++.+++.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL-----VNLHDAFEDDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTB-----CCEEEEEEETTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEE
Confidence 3468999999999999999999999999999999997543 345677899999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
||||||| ||+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~----------------- 160 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK----------------- 160 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-----------------
T ss_pred EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-----------------
Confidence 9999999 999999996543 369999999999999999999999999999999999999642
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.++.+||+|||+|....... ....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 161 --------~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 161 --------RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp --------TSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------CCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 23468999999987655433 34689999999999999999999999999999999999999999988887
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+......++.. ....+++++++||.+||+.
T Consensus 233 ~~~~i~~~~~~~~~~----------------------------------------------~~~~~s~~~~~li~~~L~~ 266 (350)
T d1koaa2 233 TLRNVKSCDWNMDDS----------------------------------------------AFSGISEDGKDFIRKLLLA 266 (350)
T ss_dssp HHHHHHHTCCCSCCG----------------------------------------------GGGGCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCcc----------------------------------------------cccCCCHHHHHHHHHHccC
Confidence 777776543333211 1234577899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCc
Q 013941 406 DPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~ 426 (433)
||++|||++|+|+||||++..
T Consensus 267 dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 267 DPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp SGGGSCCHHHHHHSTTTSCTT
T ss_pred ChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-60 Score=441.47 Aligned_cols=254 Identities=26% Similarity=0.476 Sum_probs=214.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+.|++++.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++|+|| |++++++.+.+.+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-----VKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTB-----CCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCCeEEE
Confidence 4699999999999999999999999999999999753 3445678899999999998887 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||| +|+|.+++.+.. ..+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~------------------ 147 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG------------------ 147 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------------------
T ss_pred EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC------------------
Confidence 99999 999999987643 3699999999999999999999999999999999999997654
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhh-----CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
.+||+|||+|...... ....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 148 ---------~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 148 ---------DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp ---------CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ---------CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 5788888887654322 23468999999999985 446899999999999999999999999988
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+.+..+.....+. ......+++++++||.+
T Consensus 219 ~~~~~~~~i~~~~~~~-----------------------------------------------~~~~~~~s~~~~~li~~ 251 (288)
T d2jfla1 219 NPMRVLLKIAKSEPPT-----------------------------------------------LAQPSRWSSNFKDFLKK 251 (288)
T ss_dssp CGGGHHHHHHHSCCCC-----------------------------------------------CSSGGGSCHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCC-----------------------------------------------CCccccCCHHHHHHHHH
Confidence 7766655554321110 01123457799999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||+.||++|||++|+|+||||+.+
T Consensus 252 ~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 252 CLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-60 Score=443.58 Aligned_cols=264 Identities=23% Similarity=0.411 Sum_probs=229.8
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+-++|++.+.||+|+||+||+|+++.+++.||||+++........+.+|+.+|+.++|+|| ++++++|++++.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI-----LHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTB-----CCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCEE
Confidence 45678999999999999999999999999999999998766666778899999999998887 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
||||||| |++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~---------------- 139 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR---------------- 139 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS----------------
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC----------------
Confidence 9999999 899999997653 3699999999999999999999999999999999999996533
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
...+||+|||++....... ....||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+
T Consensus 140 ---------~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 140 ---------SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp ---------CCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------ceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 3468999999987654433 34689999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+.+....+|.. ....+++++++||.+||+.
T Consensus 211 ~~~~i~~~~~~~~~~----------------------------------------------~~~~~s~~~~~li~~~L~~ 244 (321)
T d1tkia_ 211 IIENIMNAEYTFDEE----------------------------------------------AFKEISIEAMDFVDRLLVK 244 (321)
T ss_dssp HHHHHHHTCCCCCHH----------------------------------------------HHTTSCHHHHHHHHTTSCS
T ss_pred HHHHHHhCCCCCChh----------------------------------------------hccCCCHHHHHHHHHHccC
Confidence 877776654443321 1234577899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcccc
Q 013941 406 DPAERLKAREALRHPFFTRDVRRC 429 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~~~ 429 (433)
||++|||++|+++||||++...+.
T Consensus 245 dp~~R~s~~eil~hp~~~~~~~~~ 268 (321)
T d1tkia_ 245 ERKSRMTASEALQHPWLKQKIERV 268 (321)
T ss_dssp SGGGSCCHHHHHHSHHHHSCGGGS
T ss_pred ChhHCcCHHHHhcCHhhccCcccc
Confidence 999999999999999998765443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6e-60 Score=448.58 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=223.6
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.++|++++.||+|+||+||+|++..+|+.||||+++... .....+.+|+.+|++++|+|| |+++++|.+++.+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL-----INLHDAFEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTB-----CCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEEE
Confidence 357999999999999999999999999999999987543 344567789999999988877 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|||||| ||+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++..
T Consensus 103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~------------------ 163 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK------------------ 163 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST------------------
T ss_pred EEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc------------------
Confidence 999999 999999876543 469999999999999999999999999999999999999632
Q ss_pred CcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
..+.+||+|||+|....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 164 -------~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 236 (352)
T d1koba_ 164 -------KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236 (352)
T ss_dssp -------TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred -------CCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 23468999999998765433 346899999999999999999999999999999999999999999888887
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
+..+.+....+|. .....+++++.+||.+||+.|
T Consensus 237 ~~~i~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~d 270 (352)
T d1koba_ 237 LQNVKRCDWEFDE----------------------------------------------DAFSSVSPEAKDFIKNLLQKE 270 (352)
T ss_dssp HHHHHHCCCCCCS----------------------------------------------STTTTSCHHHHHHHHTTSCSS
T ss_pred HHHHHhCCCCCCc----------------------------------------------ccccCCCHHHHHHHHHHccCC
Confidence 7777664433332 112345789999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCc
Q 013941 407 PAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 407 P~~R~ta~ell~hp~f~~~~ 426 (433)
|++|||++|+|+||||++..
T Consensus 271 p~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 271 PRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp GGGSCCHHHHHTSTTTSSCC
T ss_pred hhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-61 Score=451.56 Aligned_cols=295 Identities=23% Similarity=0.323 Sum_probs=213.6
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
..++|+++++||+|+||+||+|++..+|+.||+|+++.. ....+.+.+|+.+|++++|+|| |+++++|.+.++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTB-----CCEEEEEECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCE
Confidence 346899999999999999999999999999999998743 3445678899999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
+||||||| +|+|.+++.+.+ .+++..++.++.||+.||+|||+ +||+||||||+|||++.+|
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-------------- 142 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-------------- 142 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--------------
T ss_pred EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC--------------
Confidence 99999999 899999998765 69999999999999999999997 5999999999999996554
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccC-CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||+|..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 143 -------------~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 143 -------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp -------------CEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred -------------CEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 578888888875433 334569999999999999999999999999999999999999999876544
Q ss_pred HHHH-HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 325 EHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 325 ~~~~-~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
+... .+....+...... .......... ........+ ............... .+ .......+.++++||.+||
T Consensus 210 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~-~~---~~~~~~~s~~~~dli~~~L 282 (322)
T d1s9ja_ 210 ELELMFGCQVEGDAAETP-PRPRTPGRPL-SSYGMDSRP-PMAIFELLDYIVNEP-PP---KLPSGVFSLEFQDFVNKCL 282 (322)
T ss_dssp HHHHHC--------------------------------C-CCCHHHHHHHHHTSC-CC---CCCBTTBCHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCcccCC-cccccccccc-ccccccccc-chhHHHHHhhhhccC-Cc---cCccccCCHHHHHHHHHHc
Confidence 3222 1222222111100 0000000000 000000000 000000011110000 00 0011235789999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 013941 404 RYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 404 ~~dP~~R~ta~ell~hp~f~~~ 425 (433)
++||++||||+|+|+||||++.
T Consensus 283 ~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 283 IKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp CSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCChhHCcCHHHHhhCHhhCcC
Confidence 9999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=430.31 Aligned_cols=253 Identities=23% Similarity=0.415 Sum_probs=207.2
Q ss_pred cCCCe-EEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-
Q 013941 90 LTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (433)
Q Consensus 90 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~- 164 (433)
..++| ++.++||+|+||+||+|++..+++.||+|++... ....+.+.+|++++++++|+|| |++++++++
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~ 80 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWEST 80 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEE
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEeec
Confidence 34455 7788999999999999999999999999998643 2345668899999999998887 999998864
Q ss_pred ---CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCcEEEeeCCcccccCc
Q 013941 165 ---RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 165 ---~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
.+.+|+||||| +|+|.+++.+.. .+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~--------- 149 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--------- 149 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---------
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC---------
Confidence 46789999999 999999998765 7999999999999999999999999 999999999999953
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 317 (433)
.+..+||+|||+|...... ....+||+.|||||++.+ .++.++|||||||++|||++|+.|
T Consensus 150 -----------------~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~P 211 (270)
T d1t4ha_ 150 -----------------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 211 (270)
T ss_dssp -----------------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred -----------------CCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCC
Confidence 2335788888888754433 345689999999999876 599999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|.+......+...... +..|. ......++++.+
T Consensus 212 f~~~~~~~~~~~~i~~-~~~~~----------------------------------------------~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 212 YSECQNAAQIYRRVTS-GVKPA----------------------------------------------SFDKVAIPEVKE 244 (270)
T ss_dssp TTTCSSHHHHHHHHTT-TCCCG----------------------------------------------GGGGCCCHHHHH
T ss_pred CCCcccHHHHHHHHHc-CCCCc----------------------------------------------ccCccCCHHHHH
Confidence 9876554433221110 11110 112345678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCC
Q 013941 398 LLQGLLRYDPAERLKAREALRHPFFT 423 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~hp~f~ 423 (433)
||.+||+.||++|||++|+|+||||+
T Consensus 245 li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-59 Score=440.29 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=220.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.++++++|+|| +++++++.+.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI-----IRMWGTFQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTB-----CCEEEEEECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcCh-----hheeeeEeeCCe
Confidence 35999999999999999999999999999999997432 334678899999999999887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||| |++|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--------------- 141 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--------------- 141 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---------------
T ss_pred eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC---------------
Confidence 99999999 999999998775 789999999999999999999999999999999999996554
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||+|..........+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+.
T Consensus 142 ------------~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 209 (316)
T d1fota_ 142 ------------HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209 (316)
T ss_dssp ------------CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ------------CEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence 57888888888777666778999999999999999999999999999999999999999998887776
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+.+....+| ..+++++.++|.+||+.|
T Consensus 210 ~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 210 YEKILNAELRFP--------------------------------------------------PFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp HHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHHHTCSC
T ss_pred HHHHHcCCCCCC--------------------------------------------------CCCCHHHHHHHHHHhhhC
Confidence 666554322222 234678999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q 013941 407 PAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~-----ta~ell~hp~f~~~ 425 (433)
|++|+ |++|+++||||++.
T Consensus 240 p~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhccccchhhHHHHHcCcccccC
Confidence 99996 99999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=442.45 Aligned_cols=249 Identities=25% Similarity=0.436 Sum_probs=216.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||.||+|+++.+|+.||||++++.. ...+.+.+|+.+|++++|++| +++++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTB-----CCEEEEEECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEeeeccccc
Confidence 46999999999999999999999999999999997532 344667899999999988887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||| ||+|.+++.+.. .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--------------- 142 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--------------- 142 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---------------
T ss_pred cccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC---------------
Confidence 99999999 999999998875 799999999999999999999999999999999999997665
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~ 323 (433)
.+||+|||+|+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 143 ------------~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 143 ------------HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp ------------CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ------------CEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 567777777764332 22346899999999999999999999999999999999999999999887
Q ss_pred HHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhc
Q 013941 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLL 403 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 403 (433)
......+......+| ..+++++++||.+||
T Consensus 211 ~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~dli~~~L 240 (337)
T d1o6la_ 211 ERLFELILMEEIRFP--------------------------------------------------RTLSPEAKSLLAGLL 240 (337)
T ss_dssp HHHHHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCCCC--------------------------------------------------ccCCHHHHHHHHhhc
Confidence 776665544322222 345778999999999
Q ss_pred ccCCCCCC-----CHHHHhcCCCCCC
Q 013941 404 RYDPAERL-----KAREALRHPFFTR 424 (433)
Q Consensus 404 ~~dP~~R~-----ta~ell~hp~f~~ 424 (433)
++||++|+ +++|+++||||++
T Consensus 241 ~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred cCCchhhcccccccHHHHHcCccccc
Confidence 99999999 4999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-60 Score=440.08 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=211.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
..+|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.++++++|+|| |++++++.+.+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLREH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCE-----eeEEEEEEECC
Confidence 346999999999999999999999999999999987532 334567899999999988877 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||| +++|..++.... .+++..++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-------------- 152 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-------------- 152 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--------------
T ss_pred EEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC--------------
Confidence 999999999 778876666554 799999999999999999999999999999999999997665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhC---CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||+|...... ....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+
T Consensus 153 -------------~~Kl~DFG~a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 153 -------------LVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp -------------EEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -------------CEEEeecccccccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 4677777777654433 34589999999999965 358999999999999999999999998887
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+.+..+.....+.+ ....+++++.+||.+|
T Consensus 219 ~~~~~~~i~~~~~~~~------------------------------------------------~~~~~s~~~~~li~~~ 250 (309)
T d1u5ra_ 219 AMSALYHIAQNESPAL------------------------------------------------QSGHWSEYFRNFVDSC 250 (309)
T ss_dssp HHHHHHHHHHSCCCCC------------------------------------------------SCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCC------------------------------------------------CCCCCCHHHHHHHHHH
Confidence 7666555443211100 0124577999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|+.||++|||++|+|+||||+++
T Consensus 251 L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 251 LQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp TCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CcCChhHCcCHHHHHhCHHhcCC
Confidence 99999999999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-59 Score=443.79 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=220.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||.||+|+++.+|+.||||++.+.. ...+.+.+|+.+|+.++|+|| +++++++.+.+.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL-----VKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcE-----eecccccccccc
Confidence 57999999999999999999999999999999986432 334668899999999988877 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+++||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||++|||||||||+|||++.+|
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--------------- 178 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--------------- 178 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------
T ss_pred cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC---------------
Confidence 99999999 999999998775 799999999999999999999999999999999999996554
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~~ 326 (433)
.+||+|||+|+..........||+.|||||++.+..++.++|||||||++|||++|+.||.+.+....
T Consensus 179 ------------~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 246 (350)
T d1rdqe_ 179 ------------YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp ------------CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------CEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence 57888888888776666677999999999999999999999999999999999999999998887776
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+......+| ..+++++.+||.+||+.|
T Consensus 247 ~~~i~~~~~~~p--------------------------------------------------~~~s~~~~~li~~~L~~d 276 (350)
T d1rdqe_ 247 YEKIVSGKVRFP--------------------------------------------------SHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp HHHHHHCCCCCC--------------------------------------------------TTCCHHHHHHHHHHSCSC
T ss_pred HHHHhcCCCCCC--------------------------------------------------ccCCHHHHHHHHHHhhhC
Confidence 666654322222 345779999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q 013941 407 PAERL-----KAREALRHPFFTRD 425 (433)
Q Consensus 407 P~~R~-----ta~ell~hp~f~~~ 425 (433)
|++|+ |++|+++||||++.
T Consensus 277 P~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 277 LTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhccccccccHHHHHcCccccCC
Confidence 99995 99999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=430.44 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=198.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc--CC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~--~~ 166 (433)
++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|++++++++|+|| +++++++.+ ++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI-----VRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTB-----CCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCE-----eeEEEEEEeCCCC
Confidence 46999999999999999999999999999999986532 344667889999999988877 999998854 56
Q ss_pred eEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEecCCCCCcEEEeeCCcccccCc
Q 013941 167 HICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
.+||||||| +|+|.+++.+. ....+++..++.++.||+.||+|||++| ||||||||+|||++.++.
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~------ 152 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN------ 152 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC------
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc------
Confidence 799999999 99999998642 2347999999999999999999999976 999999999999977664
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 315 (433)
+||+|||+|...... ....+||+.|||||++.+..|+.++|||||||++|||++|+
T Consensus 153 ---------------------vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 153 ---------------------VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp ---------------------EEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------EEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCC
Confidence 555555555443221 23358999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||.+.+..+....+..... + ..+..+++++
T Consensus 212 ~Pf~~~~~~~~~~~i~~~~~--~-----------------------------------------------~~~~~~s~~l 242 (269)
T d2java1 212 PPFTAFSQKELAGKIREGKF--R-----------------------------------------------RIPYRYSDEL 242 (269)
T ss_dssp CSCCCSSHHHHHHHHHHTCC--C-----------------------------------------------CCCTTSCHHH
T ss_pred CCCCCCCHHHHHHHHHcCCC--C-----------------------------------------------CCCcccCHHH
Confidence 99998877766655543211 0 0123457799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCC
Q 013941 396 IDLLQGLLRYDPAERLKAREALRHPFF 422 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~hp~f 422 (433)
.+||.+||+.||++|||++|+++|||+
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.3e-58 Score=421.27 Aligned_cols=254 Identities=30% Similarity=0.503 Sum_probs=215.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----------hhHHHHHHHHHHHHHHH-hCCCCCcceeEec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTRCVQIR 159 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~ 159 (433)
.++|++.+.||+|+||+||+|++..+++.||||++++.. ...+.+.+|+.+++++. |+|| ++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI-----IQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe-----EEEE
Confidence 468999999999999999999999999999999986432 23356788999999997 7777 9999
Q ss_pred ceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
+++.+++.+||||||| +|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~------- 147 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM------- 147 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-------
Confidence 9999999999999999 899999998765 799999999999999999999999999999999999997655
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhC------CCCCccchHHHHHHHHHH
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVE 310 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~e 310 (433)
.+||+|||++...... ....+||+.|+|||++.+ ..++.++||||+||++|+
T Consensus 148 --------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilye 207 (277)
T d1phka_ 148 --------------------NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207 (277)
T ss_dssp --------------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred --------------------CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhh
Confidence 5677777777654432 234689999999999863 347889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCC
Q 013941 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDH 390 (433)
Q Consensus 311 l~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (433)
|++|+.||.+.+.......+.+....++. .....
T Consensus 208 ml~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~ 241 (277)
T d1phka_ 208 LLAGSPPFWHRKQMLMLRMIMSGNYQFGS----------------------------------------------PEWDD 241 (277)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------------------------------------------TTGGG
T ss_pred hccCCCCCCCCCHHHHHHHHHhCCCCCCC----------------------------------------------ccccc
Confidence 99999999998877766666543222111 11234
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 013941 391 SAGDLIDLLQGLLRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 391 ~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~ 424 (433)
+|+++++||.+||+.||++|||++|||+||||++
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 5789999999999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-58 Score=428.20 Aligned_cols=283 Identities=32% Similarity=0.517 Sum_probs=225.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|++++.||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.++++++|+|| +++++++.+++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~I-----v~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE-----EEeccccccccce
Confidence 47999999999999999999999999999999996433 235678899999999988877 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
|+||||+++++.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~----------------- 139 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG----------------- 139 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-----------------
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-----------------
Confidence 999999977888777766556799999999999999999999999999999999999996554
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCCC-CCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||.|...... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..
T Consensus 140 ----------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~ 209 (298)
T d1gz8a_ 140 ----------AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209 (298)
T ss_dssp ----------CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ----------cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH
Confidence 5677777777544322 23358999999999988766 578999999999999999999999999998
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+.+..+.+..+.+++.......... . ....++... ...........+.++.+||.+||+
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~---------------~~~~~~~~~~~s~~~~dll~~mL~ 268 (298)
T d1gz8a_ 210 DQLFRIFRTLGTPDEVVWPGVTSMP-D-----YKPSFPKWA---------------RQDFSKVVPPLDEDGRSLLSQMLH 268 (298)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGST-T-----CCTTSCCCC---------------CCCHHHHSTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHhcCCCchhhcccccccc-c-----ccccccccc---------------ccchhhhccCCCHHHHHHHHHHcc
Confidence 9888888887776544322211100 0 000111000 001112234567899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCcc
Q 013941 405 YDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
.||++|||++|+|+||||++-.+
T Consensus 269 ~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 269 YDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp SSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CChhHCcCHHHHhCCHhhccCCC
Confidence 99999999999999999987644
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=431.96 Aligned_cols=277 Identities=27% Similarity=0.458 Sum_probs=214.0
Q ss_pred EeccccccccEEEEEEEecCCCcEEEEEEeccchh------hHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 96 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
.+++||+|+||+||+|++..+|+.||||+++.... ..+.+.+|+.++++++|+|| |++++++.+++.+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI-----IGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB-----CCEEEEECCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCE-----eEEEeeeccCCcee
Confidence 46899999999999999999999999999864322 23457899999999998887 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||||.+++...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ivmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~------------------ 137 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG------------------ 137 (299)
T ss_dssp EEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------------------
T ss_pred ehhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC------------------
Confidence 999999444444443322 4799999999999999999999999999999999999997665
Q ss_pred cccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~~ 325 (433)
.+||+|||+|...... ....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+
T Consensus 138 ---------~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 208 (299)
T d1ua2a_ 138 ---------VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208 (299)
T ss_dssp ---------CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH
Confidence 4566666666543322 2335899999999998755 58999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..|.+..+.++...+....... ....+.... ...........++++.+||.+||+.
T Consensus 209 ~l~~i~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~---------------~~~~~~~~~~~s~~~~dll~~~L~~ 266 (299)
T d1ua2a_ 209 QLTRIFETLGTPTEEQWPDMCSLP-------DYVTFKSFP---------------GIPLHHIFSAAGDDLLDLIQGLFLF 266 (299)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSST-------TCCCCCCCC---------------CCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred HHHHHHHhcCCCChhhccchhccc-------hhhhhccCC---------------CCChHHhcccCCHHHHHHHHHHccC
Confidence 999999988876643221111000 000000000 0001122345678999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCcc
Q 013941 406 DPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 406 dP~~R~ta~ell~hp~f~~~~~ 427 (433)
||++||||+|+|+||||++...
T Consensus 267 dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 267 NPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp STTTSCCHHHHHTSGGGTSSSC
T ss_pred ChhhCcCHHHHhCCHhhCCCCC
Confidence 9999999999999999998654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=433.52 Aligned_cols=292 Identities=28% Similarity=0.496 Sum_probs=233.9
Q ss_pred CCceeeecCCc---cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCC
Q 013941 79 DGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGG 152 (433)
Q Consensus 79 ~~~~~~~~~~~---~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~ 152 (433)
.|+|...+++. +.++|+++++||+|+||+||+|++..+|+.||||++++. ....+.+.+|+.+|+.++|+|+
T Consensus 2 ~~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpni-- 79 (346)
T d1cm8a_ 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV-- 79 (346)
T ss_dssp CSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB--
T ss_pred CCcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCe--
Confidence 46777777775 789999999999999999999999999999999999743 2345677899999999999887
Q ss_pred cceeEecceeccCC------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 153 TRCVQIRNWFDYRN------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 153 ~~~v~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
|+++++|...+ ++|+|||||+.+|..++... .+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 80 ---v~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL 153 (346)
T d1cm8a_ 80 ---IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 153 (346)
T ss_dssp ---CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred ---eEEEEEeccCccccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhh
Confidence 99999987644 67999999988898887654 5999999999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCC-CCCccchHHHHH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVG 305 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG 305 (433)
++.++ .+||+|||+|.......+...||+.|+|||++.+. .++.++||||||
T Consensus 154 ~~~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG 206 (346)
T d1cm8a_ 154 VNEDC---------------------------ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG 206 (346)
T ss_dssp ECTTC---------------------------CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH
T ss_pred ccccc---------------------------ccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcch
Confidence 96554 57888888888777777778999999999999875 568999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc-hhhh
Q 013941 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL-PNLI 384 (433)
Q Consensus 306 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 384 (433)
|++|+|++|+.||.+.+....+..+....+.+|..+............. ...... ....
T Consensus 207 vil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~ 266 (346)
T d1cm8a_ 207 CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM--------------------KGLPELEKKDF 266 (346)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH--------------------HHSCCCCCCCG
T ss_pred HHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhh--------------------ccCCcccccch
Confidence 9999999999999999999999999999998887665432211110000 000000 0011
Q ss_pred hhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 385 MQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 385 ~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
.......++++.+||.+||++||++||||+|+|+||||++-
T Consensus 267 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 267 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 12234567899999999999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-58 Score=429.27 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=211.9
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHH-HHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQ-RLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++++.||+|+||+||+|+++.+++.||||++++. ....+...+|..++. .++|+|| +++++++.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~I-----v~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB-----CCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcE-----EEEEEEEccCC
Confidence 4699999999999999999999999999999999753 233455667777765 5777777 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+||||||| +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-------------- 140 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-------------- 140 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--------------
Confidence 999999999 999999998765 799999999999999999999999999999999999997655
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccC---CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~ 322 (433)
.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus 141 -------------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 141 -------------HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp -------------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------------ceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 467777777654322 2233589999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+....+......+| ..+++++.+||.+|
T Consensus 208 ~~~~~~~i~~~~~~~p--------------------------------------------------~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 208 EEELFHSIRMDNPFYP--------------------------------------------------RWLEKEAKDLLVKL 237 (320)
T ss_dssp HHHHHHHHHHCCCCCC--------------------------------------------------TTSCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCC--------------------------------------------------ccCCHHHHHHHHHh
Confidence 7776666644222211 23577899999999
Q ss_pred cccCCCCCCCHH-HHhcCCCCCC
Q 013941 403 LRYDPAERLKAR-EALRHPFFTR 424 (433)
Q Consensus 403 L~~dP~~R~ta~-ell~hp~f~~ 424 (433)
|+.||++|||++ |+++||||++
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999996 8999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=424.13 Aligned_cols=280 Identities=31% Similarity=0.512 Sum_probs=218.3
Q ss_pred CCCeEEeccccccccEEEEEEEecCC-CcEEEEEEeccch---hhHHHHHHHHHHHHHHH---hCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSIN---KYREAAMIEIDVLQRLA---RHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~---~~~i~~~~~v~~~~~~~ 163 (433)
.++|+++++||+|+||+||+|++..+ ++.||||+++... .......+|+.+++.+. |+|| ++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnI-----v~~~~~~~ 80 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDVCT 80 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTB-----CCEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCc-----ceeeeeec
Confidence 36899999999999999999999765 6789999986432 22345668888888875 5555 99999874
Q ss_pred -----cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 164 -----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 164 -----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
....++++|||+.+.+..+........+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~------- 153 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG------- 153 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-------
Confidence 34689999999965555555555556799999999999999999999999999999999999997655
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 316 (433)
.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus 154 --------------------~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~ 213 (305)
T d1blxa_ 154 --------------------QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213 (305)
T ss_dssp --------------------CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------CeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCC
Confidence 467777777654332 2344689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+.+..+.+..+....+.++...+..........+.. .............++.+.
T Consensus 214 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~s~~~~ 270 (305)
T d1blxa_ 214 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS-----------------------KSAQPIEKFVTDIDELGK 270 (305)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC-----------------------CCCCCGGGTCCSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcc-----------------------ccccchhhccccCCHHHH
Confidence 999999999999998888876543321111100000000 001111223456688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 397 DLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
+||.+||++||++||||+|+|+||||++-
T Consensus 271 dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 271 DLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 99999999999999999999999999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-59 Score=438.29 Aligned_cols=265 Identities=25% Similarity=0.461 Sum_probs=210.8
Q ss_pred ccCCCeEEec-cccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceecc--
Q 013941 89 NLTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY-- 164 (433)
Q Consensus 89 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~-- 164 (433)
.+.++|++++ .||+|+||+||+|++..+++.||||+++.. ....+|+.++.++ +|+|| ++++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnI-----v~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCC-----CeEEEEEeecc
Confidence 3446799886 599999999999999999999999998653 3467899987766 57666 999998865
Q ss_pred --CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
++.+||||||| ||+|.+++.+.+...+++..++.++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~---------- 148 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR---------- 148 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS----------
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc----------
Confidence 57899999999 89999999876656799999999999999999999999999999999999997533
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
....+||+|||+|...... ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.
T Consensus 149 --------------~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 149 --------------PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp --------------TTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred --------------ccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 3456899999998765432 344689999999999999899999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
+.+.......+...... ....++. .....+++++.+||
T Consensus 215 ~~~~~~~~~~~~~~i~~--------------------~~~~~~~----------------------~~~~~~s~~~~~li 252 (335)
T d2ozaa1 215 SNHGLAISPGMKTRIRM--------------------GQYEFPN----------------------PEWSEVSEEVKMLI 252 (335)
T ss_dssp ETTCC--------CCCS--------------------CSSSCCT----------------------THHHHSCHHHHHHH
T ss_pred CCCHHHHHHHHHHHHhc--------------------CCCCCCC----------------------cccccCCHHHHHHH
Confidence 76554433322211100 0000110 01123577899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 400 QGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
.+||+.||++|||+.|+++||||++....
T Consensus 253 ~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 281 (335)
T d2ozaa1 253 RNLLKTEPTQRMTITEFMNHPWIMQSTKV 281 (335)
T ss_dssp HHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred HHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence 99999999999999999999999876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-57 Score=431.90 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=205.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+.+|..+++.+++. .|+|+|++++++.+.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~--~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS--CCTTBCCEEEEEECSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC--CCCcEEEEEEEEEECCE
Confidence 46999999999999999999999999999999986422 2233455565555554422 23455999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
+|+||||| ||+|.+++.+.. .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g--------------- 144 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--------------- 144 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS---------------
T ss_pred EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC---------------
Confidence 99999999 999999998765 789999999999999999999999999999999999997655
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||+|...... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..
T Consensus 145 ------------~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 145 ------------HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp ------------CEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred ------------cEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 5677777777654432 344689999999999975 56899999999999999999999999875543
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+............ ...+..+++++++||.+||+
T Consensus 213 ~~~~~~~~~~~~~-----------------------------------------------~~~~~~~s~~~~~li~~~L~ 245 (364)
T d1omwa3 213 DKHEIDRMTLTMA-----------------------------------------------VELPDSFSPELRSLLEGLLQ 245 (364)
T ss_dssp CHHHHHHHSSSCC-----------------------------------------------CCCCSSSCHHHHHHHHHHTC
T ss_pred HHHHHHHhcccCC-----------------------------------------------CCCCCCCCHHHHHHHHHHcc
Confidence 3222222111110 01123567899999999999
Q ss_pred cCCCCCCC-----HHHHhcCCCCCCC
Q 013941 405 YDPAERLK-----AREALRHPFFTRD 425 (433)
Q Consensus 405 ~dP~~R~t-----a~ell~hp~f~~~ 425 (433)
.||++||| |+|+++||||++.
T Consensus 246 ~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 246 RDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp SSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred cCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999 8999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-57 Score=416.95 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=205.8
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceeEeccee
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~ 162 (433)
+.++|++.+.||+|+||+||+|++..+|+.||||++++.. .....+.+|+.+++++++. |+|++++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~---h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG---FSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSS---SCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccC---CCCccEEEEEE
Confidence 4578999999999999999999999999999999986432 1123356899999999731 34459999999
Q ss_pred ccCCeEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 163 DYRNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
.+.+.+|+||||+ + +++.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~---------- 146 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN---------- 146 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT----------
T ss_pred eeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC----------
Confidence 9999999999999 4 58888887765 79999999999999999999999999999999999999643
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccCC-CcccccCCcccchhhhhCCCC-CccchHHHHHHHHHHHHhCCCCC
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pf 318 (433)
...+||+|||+|...... .+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||
T Consensus 147 ----------------~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 147 ----------------RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp ----------------TTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ----------------CCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence 235788888888754433 345689999999999987765 57899999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+. +.+.. ......+++++++|
T Consensus 211 ~~~~~------i~~~~--------------------------------------------------~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 211 EHDEE------IIRGQ--------------------------------------------------VFFRQRVSSECQHL 234 (273)
T ss_dssp CSHHH------HHHCC--------------------------------------------------CCCSSCCCHHHHHH
T ss_pred CCchH------Hhhcc--------------------------------------------------cCCCCCCCHHHHHH
Confidence 75321 11100 01123457899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 399 LQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
|.+||+.||++|||++|+++||||++..
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 9999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-56 Score=414.83 Aligned_cols=278 Identities=28% Similarity=0.472 Sum_probs=217.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|+++++||+|+||+||+|+++ +|+.||||+++... ...+.+.+|+.++++++|+|| +++++++.+.+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI-----VKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTB-----CCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE-----EeeeeecccCCce
Confidence 58999999999999999999985 78999999996532 335678899999999988877 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
+++||++++.+...+.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 76 ~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~----------------- 137 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG----------------- 137 (286)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-----------------
T ss_pred eEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-----------------
Confidence 9999999555555554433 4799999999999999999999999999999999999997655
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC---CcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 324 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~~~ 324 (433)
.+||+|||.|...... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..
T Consensus 138 ----------~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 138 ----------ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp ----------CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ----------CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence 5677777776553322 2334789999999999765 4689999999999999999999999999998
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+.+..+.+..+.++............... .+.. .............++++.+||.+||+
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~------~~~~---------------~~~~~~~~~~~~~s~~~~dli~~~L~ 266 (286)
T d1ob3a_ 208 DQLMRIFRILGTPNSKNWPNVTELPKYDP------NFTV---------------YEPLPWESFLKGLDESGIDLLSKMLK 266 (286)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCT------TCCC---------------CCCCCGGGTCCSCCHHHHHHHHHHTC
T ss_pred HHHHHHHHhhCCCChhhccchhhhhhccc------cccc---------------ccCcchhhhcccCCHHHHHHHHHHcc
Confidence 88888888887765433222111100000 0000 00011122345567899999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 013941 405 YDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 405 ~dP~~R~ta~ell~hp~f~~ 424 (433)
+||++||||+|+|+||||++
T Consensus 267 ~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 267 LDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp SSTTTSCCHHHHHTSGGGGC
T ss_pred CChhHCcCHHHHhcCcccCc
Confidence 99999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=421.87 Aligned_cols=302 Identities=27% Similarity=0.433 Sum_probs=226.2
Q ss_pred CceeeecCCc---cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCc
Q 013941 80 GHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 80 ~~~~~~~~~~---~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
.+|++.+|+. +.++|+++++||+|+||+||+|++..+|+.||||++++. ......+.+|+.++++++|++|
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI--- 78 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI--- 78 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTB---
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCe---
Confidence 5788999993 448999999999999999999999999999999999753 2344567899999999988877
Q ss_pred ceeEecceec------cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEE
Q 013941 154 RCVQIRNWFD------YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (433)
Q Consensus 154 ~~v~~~~~~~------~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli 227 (433)
++++++|. ...++|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 79 --v~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~ 152 (355)
T d2b1pa1 79 --ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152 (355)
T ss_dssp --CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --eEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc
Confidence 99999885 457899999999777766664 258999999999999999999999999999999999999
Q ss_pred eeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC--CcccccCCcccchhhhhCCCCCccchHHHHH
Q 013941 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (433)
Q Consensus 228 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (433)
+.++ .++++|||.+...... ....+||+.|+|||++.+..++.++||||+|
T Consensus 153 ~~~~---------------------------~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG 205 (355)
T d2b1pa1 153 KSDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205 (355)
T ss_dssp CTTC---------------------------CEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccc---------------------------ceeeechhhhhccccccccccccccccccChhhhcCCCCCCCccccccc
Confidence 7655 4566667665543322 2345899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 306 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
|++|+|++|+.||.+.+.......+....+..+..++.........+.......... .. ...... .......
T Consensus 206 ~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~~~-~~~~~~~ 277 (355)
T d2b1pa1 206 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL---TF----PKLFPD-SLFPADS 277 (355)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCC---CH----HHHSCG-GGSCCSS
T ss_pred chHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccc---cc----cccccc-ccccccc
Confidence 999999999999999999999999988888777766555444433333322111000 00 000000 0000001
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
......++++.+||.+||++||++||||+|||+||||+..
T Consensus 278 ~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 278 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 1112346789999999999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-55 Score=408.43 Aligned_cols=246 Identities=19% Similarity=0.304 Sum_probs=206.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.++||+|+||+||+|++..+++.||||+++......+.+.+|+.++++++|+|| |++++++.+++.+++|
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYII 91 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCE-----ecCCccEeeCCeeEEE
Confidence 57999999999999999999999999999999998776667789999999999998887 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||| +|+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~------------------- 152 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH------------------- 152 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------------------
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-------------------
Confidence 9999 99999999877667899999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCC-CChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT-HENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~-~~~~~ 325 (433)
.+||+|||+|+...... ....||+.|+|||++.+..|+.++|||||||++|||++|..||.. .+...
T Consensus 153 --------~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~ 224 (287)
T d1opja_ 153 --------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224 (287)
T ss_dssp --------CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred --------cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH
Confidence 56777777776543322 224688999999999999999999999999999999997666544 33333
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.... . ...+..+++++.+||.+||+.
T Consensus 225 ~~~~i~~~~-----------------------~--------------------------~~~~~~~~~~l~~li~~cl~~ 255 (287)
T d1opja_ 225 VYELLEKDY-----------------------R--------------------------MERPEGCPEKVYELMRACWQW 255 (287)
T ss_dssp HHHHHHTTC-----------------------C--------------------------CCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHhcCC-----------------------C--------------------------CCCCccchHHHHHHHHHHcCC
Confidence 322221110 0 011234577999999999999
Q ss_pred CCCCCCCHHHHhc
Q 013941 406 DPAERLKAREALR 418 (433)
Q Consensus 406 dP~~R~ta~ell~ 418 (433)
||++|||++||++
T Consensus 256 dP~~Rps~~ei~~ 268 (287)
T d1opja_ 256 NPSDRPSFAEIHQ 268 (287)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=418.54 Aligned_cols=278 Identities=28% Similarity=0.498 Sum_probs=219.9
Q ss_pred CeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc------CC
Q 013941 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY------RN 166 (433)
Q Consensus 93 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~------~~ 166 (433)
+|+.+++||+|+||+||+|++..+|+.||||++...... ..+|+.+|++++|+|+ ++++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~ni-----v~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNI-----VRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTB-----CCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCC-----CcEEEEEEecCccCCce
Confidence 599999999999999999999999999999999765432 3479999999988877 898888743 44
Q ss_pred eEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 167 HICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
++|||||||++++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~------------- 159 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------- 159 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT-------------
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC-------------
Confidence 6899999996666555532 2334799999999999999999999999999999999999996543
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~ 321 (433)
..+||+|||++..... .....+||..|+|||.+.+. .++.++|||||||++|||++|..||...
T Consensus 160 -------------~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 160 -------------AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp -------------CCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred -------------CceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 3578888888865433 33446899999999998764 6899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHH
Q 013941 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQG 401 (433)
Q Consensus 322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 401 (433)
+..+.+..+.+.+|..+...+........ ...++.... ...........++++.+||.+
T Consensus 227 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~-------~~~~~~~~~--------------~~~~~~~~~~~s~~~~dLl~~ 285 (350)
T d1q5ka_ 227 SGVDQLVEIIKVLGTPTREQIREMNPNYT-------EFKFPQIKA--------------HPWTKVFRPRTPPEAIALCSR 285 (350)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCC----------CCCCCCCCC--------------CCGGGTSCTTSCHHHHHHHHH
T ss_pred CHHHHHHHHHHHhCCChHHhhhhhccchh-------hcccccccc--------------CchhhhcccCCCHHHHHHHHH
Confidence 99999999999999887765544322111 011111000 000111223467899999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 013941 402 LLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 402 ~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
||++||++||||+|+|+||||++-
T Consensus 286 mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 286 LLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhccc
Confidence 999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=413.33 Aligned_cols=285 Identities=29% Similarity=0.551 Sum_probs=217.4
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC-
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~- 165 (433)
.+.++|+++++||+|+||+||+|++..+|+.||||++++.. ...+.+.+|+.+|++++|+++ +++++++...
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~i-----v~~~~~~~~~~ 79 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI-----IGINDIIRAPT 79 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB-----CCCCEEECCSS
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCC-----CcEEEEEeecc
Confidence 34578999999999999999999999999999999997533 345678899999999999888 7888777543
Q ss_pred ----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 166 ----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
..+|++|++++++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~---------- 146 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC---------- 146 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----------
T ss_pred ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC----------
Confidence 457777776699999999765 599999999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhC-CCCCccchHHHHHHHHHHHHhC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSG 314 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g 314 (433)
.+||+|||+|...... ....+||+.|+|||++.. ..++.++||||+||++|+|++|
T Consensus 147 -----------------~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g 209 (345)
T d1pmea_ 147 -----------------DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209 (345)
T ss_dssp -----------------CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred -----------------CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhC
Confidence 4667777766543221 233579999999999855 4678999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhh-hhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchH
Q 013941 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAG 393 (433)
Q Consensus 315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (433)
+.||.+.+..+....+......+.......... ....+.. .++. .............+.
T Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~---------------~~~~~~~~~~~~~s~ 269 (345)
T d1pmea_ 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL-----SLPH---------------KNKVPWNRLFPNADS 269 (345)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH-----TSCC---------------CCCCCHHHHCTTSCH
T ss_pred CCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccc-----cCCc---------------cCCCCHHHhCCCCCH
Confidence 999999988888888877776665443221100 0000000 0000 000011122345677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCccc
Q 013941 394 DLIDLLQGLLRYDPAERLKAREALRHPFFTRDVRR 428 (433)
Q Consensus 394 ~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~~ 428 (433)
++++||.+||+.||++||||+|+|+||||++....
T Consensus 270 ~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 270 KALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 89999999999999999999999999999965443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=412.40 Aligned_cols=284 Identities=26% Similarity=0.447 Sum_probs=212.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc----
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~---- 164 (433)
++|+++++||+|+||+||+|++..+|+.||||++... ......+.+|+.+|++++|+|+ +++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~ni-----i~~~~~~~~~~~~ 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKASP 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTB-----CCEEEEEEC----
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCc-----cceEeeeeccccc
Confidence 6899999999999999999999999999999998643 2344678899999999999888 777776643
Q ss_pred ----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccc
Q 013941 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (433)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~ 240 (433)
.+++|+||||+++.+....... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~-------- 155 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-------- 155 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--------
T ss_pred ccccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--------
Confidence 4578999999965555544433 247999999999999999999999999999999999999977664
Q ss_pred cccCCCCCCcccCCCCCCCeeeecCCCCccccC-------CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHH
Q 013941 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~ 312 (433)
+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 156 -------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~ 216 (318)
T d3blha1 156 -------------------LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216 (318)
T ss_dssp -------------------EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred -------------------EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh
Confidence 55555555533221 12235799999999999875 6899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|+.||.+.++......+.+..+.++.............. .+............... ....+
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-----------~~~~~ 278 (318)
T d3blha1 217 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE-------KLELVKGQKRKVKDRLK-----------AYVRD 278 (318)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--------------CCSSCCBCHHHHHH-----------HHHCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhh-------hhcccccccccchhhhc-----------cccCC
Confidence 9999999999999999999988887754322211100000 00000000000000000 01125
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCc
Q 013941 393 GDLIDLLQGLLRYDPAERLKAREALRHPFFTRDV 426 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~ 426 (433)
++++|||.+||++||++||||+|+|+||||+.+.
T Consensus 279 ~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 279 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 6788999999999999999999999999999753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=416.91 Aligned_cols=293 Identities=26% Similarity=0.487 Sum_probs=226.0
Q ss_pred CceeeecCC---ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCc
Q 013941 80 GHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGT 153 (433)
Q Consensus 80 ~~~~~~~~~---~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~ 153 (433)
++|...++. .+.++|+++++||+|+||+||+|++..+|+.||||++++.. ...+.+.+|+.+|++++|+|+
T Consensus 3 ~~~~~~~~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~i--- 79 (348)
T d2gfsa1 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV--- 79 (348)
T ss_dssp CEEEEECSSSEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTB---
T ss_pred CcEEEecCCccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCe---
Confidence 344444433 23578999999999999999999999999999999997532 334567899999999998887
Q ss_pred ceeEecceecc------CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEE
Q 013941 154 RCVQIRNWFDY------RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (433)
Q Consensus 154 ~~v~~~~~~~~------~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli 227 (433)
+++++++.. .+.+++++++++++|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 80 --v~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi 154 (348)
T d2gfsa1 80 --IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154 (348)
T ss_dssp --CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred --eeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc
Confidence 888888753 3345555555599999998654 59999999999999999999999999999999999999
Q ss_pred eeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCC-CCccchHHHHHH
Q 013941 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGC 306 (433)
Q Consensus 228 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~ 306 (433)
+.+| .+|++|||.+...........||+.|+|||++.+.. ++.++|||||||
T Consensus 155 ~~~~---------------------------~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv 207 (348)
T d2gfsa1 155 NEDC---------------------------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207 (348)
T ss_dssp CTTC---------------------------CEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHH
T ss_pred cccc---------------------------cccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhH
Confidence 7655 578888888877666666678999999999987764 689999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchh-hhh
Q 013941 307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN-LIM 385 (433)
Q Consensus 307 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 385 (433)
++|+|++|+.||.+.+.......+.+..+..+..............+... ....+. ...
T Consensus 208 ~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~ 267 (348)
T d2gfsa1 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS--------------------LTQMPKMNFA 267 (348)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTT--------------------SCCCCCCCHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhh--------------------cccCCCcchh
Confidence 99999999999999999999999988888777655433221111110000 000000 001
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCcc
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRDVR 427 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~~~ 427 (433)
......++++++||.+||+.||++||||+|+|+||||++...
T Consensus 268 ~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 122456789999999999999999999999999999997543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=398.57 Aligned_cols=245 Identities=24% Similarity=0.373 Sum_probs=199.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|+||+||+|++. +++.||||+++......+.+.+|+.++++++|+|| +++++++...+.+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCc-----ccccceeccCCceEEE
Confidence 46999999999999999999975 56789999998777677889999999999999888 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||| +|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~------------------- 138 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ------------------- 138 (263)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-------------------
T ss_pred EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-------------------
Confidence 9999 999999987654 4689999999999999999999999999999999999997665
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
.+||+|||+++...... ....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+
T Consensus 139 --------~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~ 210 (263)
T d1sm2a_ 139 --------VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210 (263)
T ss_dssp --------CEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred --------CeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence 46677777665433221 22578999999999999999999999999999999999 577777666665
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+...... ..+...++++.+||.+||+.
T Consensus 211 ~~~~i~~~~~~-------------------------------------------------~~p~~~~~~l~~li~~cl~~ 241 (263)
T d1sm2a_ 211 VVEDISTGFRL-------------------------------------------------YKPRLASTHVYQIMNHCWKE 241 (263)
T ss_dssp HHHHHHHTCCC-------------------------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCCC-------------------------------------------------CCccccCHHHHHHHHHHccC
Confidence 55554432110 01123467899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013941 406 DPAERLKAREALRH 419 (433)
Q Consensus 406 dP~~R~ta~ell~h 419 (433)
||++|||++||++|
T Consensus 242 ~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 242 RPEDRPAFSRLLRQ 255 (263)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-55 Score=403.71 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=201.9
Q ss_pred CccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
..+.++|++.+.||+|+||+||+|++..+|+.||||+++.. ......+.+|+.+++.++|+|| +++++++.
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpni-----v~~~~~~~ 77 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-----VAVYDTGE 77 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCC-----Ccccceee
Confidence 34678899999999999999999999999999999999743 2334568899999999998887 99999887
Q ss_pred cC----CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCc
Q 013941 164 YR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (433)
Q Consensus 164 ~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~ 238 (433)
.. ..+||||||| |++|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~------ 149 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA------ 149 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC------
T ss_pred eccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc------
Confidence 54 3589999999 899999998765 7999999999999999999999999999999999999987765
Q ss_pred cccccCCCCCCcccCCCCCCCeeeecCCCCccccC------CCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHH
Q 013941 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (433)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (433)
.+|+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 150 ---------------------~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 150 ---------------------VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp ---------------------EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ---------------------ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHH
Confidence 45555555432211 223358999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCch
Q 013941 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSA 392 (433)
Q Consensus 313 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (433)
+|+.||.+.+..+.+..+.+....+| ......++
T Consensus 209 tG~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~s 242 (277)
T d1o6ya_ 209 TGEPPFTGDSPVSVAYQHVREDPIPP----------------------------------------------SARHEGLS 242 (277)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCG----------------------------------------------GGTSSSCC
T ss_pred hCCCCCCCcCHHHHHHHHHhcCCCCC----------------------------------------------chhccCCC
Confidence 99999998877766555443211111 11224567
Q ss_pred HHHHHHHHHhcccCCCCCC-CHHHHhcCCCCC
Q 013941 393 GDLIDLLQGLLRYDPAERL-KAREALRHPFFT 423 (433)
Q Consensus 393 ~~l~~li~~~L~~dP~~R~-ta~ell~hp~f~ 423 (433)
+++.+||.+||+.||++|| |+++++ |+|.+
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMR-ADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHH-HHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHH-HHHHH
Confidence 8999999999999999999 566654 56643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=404.19 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=205.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.++||+|+||+||+|++. +++.||||+++......+.+.+|+.++.+++|+|| |++++++.+ +.+++|
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-----VRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCE-----eEEEeeecc-CCeEEE
Confidence 57999999999999999999975 57789999998766667789999999999999887 999998765 567999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||| +|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~------------------- 146 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL------------------- 146 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------------------
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-------------------
Confidence 9999 99999987654434699999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g-~~pf~~~~~~~ 325 (433)
.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+|| .+||...+..+
T Consensus 147 --------~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~ 218 (272)
T d1qpca_ 147 --------SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (272)
T ss_dssp --------CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred --------ceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH
Confidence 5677777777654332 2235789999999999988999999999999999999995 55566655555
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+...... ..+..++.++.+||.+||+.
T Consensus 219 ~~~~i~~~~~~-------------------------------------------------~~p~~~~~~l~~li~~cl~~ 249 (272)
T d1qpca_ 219 VIQNLERGYRM-------------------------------------------------VRPDNCPEELYQLMRLCWKE 249 (272)
T ss_dssp HHHHHHTTCCC-------------------------------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCCC-------------------------------------------------CCcccChHHHHHHHHHHcCC
Confidence 44443321100 01234577899999999999
Q ss_pred CCCCCCCHHHHhc--CCCCCC
Q 013941 406 DPAERLKAREALR--HPFFTR 424 (433)
Q Consensus 406 dP~~R~ta~ell~--hp~f~~ 424 (433)
||++|||++||++ |+||+.
T Consensus 250 ~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 250 RPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999998 888864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=401.26 Aligned_cols=278 Identities=29% Similarity=0.457 Sum_probs=219.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
++|+++++||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.++|+|+ +++++++.+.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCE-----Eeeccccccccce
Confidence 58999999999999999999999999999999986432 345678899999999988877 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++|++++ +++|..++.... .+++..++.++.|++.||+|||++|||||||||+|||++.++
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~---------------- 138 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG---------------- 138 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----------------
T ss_pred eEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC----------------
Confidence 9999999 777777776554 789999999999999999999999999999999999996544
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCC---cccccCCcccchhhhhCCC-CCccchHHHHHHHHHHHHhCCCCC-CCCC
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALF-QTHE 322 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pf-~~~~ 322 (433)
.+||+|||.+....... ....++..|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+
T Consensus 139 -----------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 207 (292)
T d1unla_ 139 -----------ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp -----------CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred -----------ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC
Confidence 57888888876544332 2346788999999998765 689999999999999999999885 5666
Q ss_pred hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
..+.+..+....+.++.............. ..... .............++.+.+||.+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~----------------~~~~~~~~~~~~~s~~~~dll~~m 266 (292)
T d1unla_ 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYK-----PYPMY----------------PATTSLVNVVPKLNATGRDLLQNL 266 (292)
T ss_dssp HHHHHHHHHHHHCCCCTTTCTTGGGSTTCC-----CCCCC----------------CTTCCCTTTSTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCChhhhhhhhhccccc-----ccccc----------------cccchhhhccccCCHHHHHHHHHH
Confidence 677777777777766543322211110000 00000 000111122345677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTR 424 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~ 424 (433)
|+.||++||||+|+|+||||++
T Consensus 267 L~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 267 LKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp SCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccCChhHCcCHHHHhcChhhcC
Confidence 9999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=393.98 Aligned_cols=245 Identities=20% Similarity=0.325 Sum_probs=207.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.++||+|+||+||+|+++ +++.||||++++.....+.+.+|+.++.+++|+|| +++++++.+.+.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnI-----v~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL-----VQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTB-----CCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCce-----eeEEEEEeeCCceEEE
Confidence 46899999999999999999974 77889999998777777889999999999998887 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||++||+||||||+|||++.++
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~------------------- 137 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG------------------- 137 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-------------------
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-------------------
Confidence 9999 899999976543 3689999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCeeeecCCCCccccCCC----cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~ 325 (433)
.+||+|||++....... ....||..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+
T Consensus 138 --------~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 138 --------VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp --------CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred --------cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 46777777765433221 22468999999999999999999999999999999998 899999888777
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
....+.+..... .+...+.++.+||.+||+.
T Consensus 210 ~~~~i~~~~~~~-------------------------------------------------~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 210 TAEHIAQGLRLY-------------------------------------------------RPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp HHHHHHTTCCCC-------------------------------------------------CCTTCCHHHHHHHHHTTCS
T ss_pred HHHHHHhCCCCC-------------------------------------------------CcccccHHHHHHHHHHccC
Confidence 665554321110 1123467899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 013941 406 DPAERLKAREALRH 419 (433)
Q Consensus 406 dP~~R~ta~ell~h 419 (433)
||++|||++|+++|
T Consensus 241 dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 241 KADERPTFKILLSN 254 (258)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=397.87 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=197.4
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCe
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~ 167 (433)
.++|++.+.||+|+||+||+|+.. ..||||+++.. ....+.+.+|+.++++++|+|| |++++++. ++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~~~~~-~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI-----LLFMGYST-APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEC-SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eeeeEEEe-ccE
Confidence 357999999999999999999753 35999998642 3445778899999999998887 99999765 456
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCC
Q 013941 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (433)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~ 246 (433)
++|||||| +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~--------------- 141 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL--------------- 141 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS---------------
T ss_pred EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC---------------
Confidence 89999999 899999997654 3699999999999999999999999999999999999997665
Q ss_pred CCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCC---CCCccchHHHHHHHHHHHHhCCCCC
Q 013941 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.+||+|||+|...... .....||+.|||||++.+. .|+.++|||||||++|||+||+.||
T Consensus 142 ------------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 142 ------------TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp ------------SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 4677777776543321 2335799999999999753 4899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+....+..+.......|. .......+++++.+|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~p~--------------------------------------------~~~~~~~~~~~l~~l 245 (276)
T d1uwha_ 210 SNINNRDQIIFMVGRGYLSPD--------------------------------------------LSKVRSNCPKAMKRL 245 (276)
T ss_dssp TTCCCHHHHHHHHHHTSCCCC--------------------------------------------GGGSCTTCCHHHHHH
T ss_pred CCCChHHHHHHHHhcCCCCCc--------------------------------------------chhccccchHHHHHH
Confidence 887766554433322111110 011234567899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 013941 399 LQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~h 419 (433)
|.+||+.||++|||++||++|
T Consensus 246 i~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 246 MAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-54 Score=400.35 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=195.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc---EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||+||+|+++.+++ .||||.+... ....+.+.+|+.+|++++|+|| |++++++.+++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g~~~~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV-----IHLEGVVTKST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEeeCC
Confidence 579999999999999999999877664 5899988643 3445678899999999998887 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+++||||| +|+|.+++.... ..+++.++..++.||+.||+|||++|||||||||+|||++.++
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-------------- 165 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-------------- 165 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--------------
T ss_pred EEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC--------------
Confidence 999999999 999999887654 4699999999999999999999999999999999999997665
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCCC--------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
.+||+|||+|+...... ....||+.|||||++.+..++.++|||||||++|||+| |..
T Consensus 166 -------------~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~ 232 (299)
T d1jpaa_ 166 -------------VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232 (299)
T ss_dssp -------------CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred -------------cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCC
Confidence 45666666665432211 11357899999999999999999999999999999998 899
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+.+..+....+.+.... .....++.++.
T Consensus 233 Pf~~~~~~~~~~~i~~~~~~-------------------------------------------------~~~~~~~~~l~ 263 (299)
T d1jpaa_ 233 PYWDMTNQDVINAIEQDYRL-------------------------------------------------PPPMDCPSALH 263 (299)
T ss_dssp TTTTCCHHHHHHHHHTTCCC-------------------------------------------------CCCTTCCHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCC-------------------------------------------------CCCccchHHHH
Confidence 99988777665554332110 01134567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 013941 397 DLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~h 419 (433)
+||.+||+.||++|||+.||+++
T Consensus 264 ~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.9e-54 Score=405.69 Aligned_cols=282 Identities=25% Similarity=0.505 Sum_probs=210.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceeEecceecc--CCeE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--RNHI 168 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~v~~~~~~~~--~~~~ 168 (433)
++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+.+|+.+. |+|| ++++++|.. ...+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnI-----v~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNI-----ITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTB-----CCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCC-----cEEEEEEEecCCCce
Confidence 57999999999999999999999999999999987543 456889999999996 6666 999999874 4679
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||| +++|..+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~---------------- 166 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---------------- 166 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT----------------
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC----------------
Confidence 9999999 88886653 3699999999999999999999999999999999999997543
Q ss_pred CCcccCCCCCCCeeeecCCCCccccC--CCcccccCCcccchhhhhCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC-h
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE-N 323 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pf~~~~-~ 323 (433)
..+||+|||+|..... .....+||+.|+|||.+.+. .++.++|||||||++|+|++|..||.... .
T Consensus 167 ----------~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~ 236 (328)
T d3bqca1 167 ----------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236 (328)
T ss_dssp ----------TEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred ----------CeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence 2467788887765443 23446899999999998876 47999999999999999999999997544 4
Q ss_pred HHHHHHHHHHhcCCChhhHHh-hhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHh
Q 013941 324 LEHLAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGL 402 (433)
Q Consensus 324 ~~~~~~i~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 402 (433)
.++...+...++......... ........+.. ......... + ...........+++++++||.+|
T Consensus 237 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~----~----~~~~~~~~~~~~s~~~~dli~~m 302 (328)
T d3bqca1 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND------ILGRHSRKR----W----ERFVHSENQHLVSPEALDFLDKL 302 (328)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGG------TCCCCCCCC----G----GGGCCTTTGGGCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCchhhhhhhhcccccCcccch------hcccccccc----h----hhcccccccccCCHHHHHHHHHH
Confidence 555666666555322111100 00000000000 000000000 0 00001112234578899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 013941 403 LRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 403 L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
|++||++||||+|+|+||||++-
T Consensus 303 L~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 303 LRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTTS
T ss_pred ccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-54 Score=405.15 Aligned_cols=248 Identities=19% Similarity=0.286 Sum_probs=200.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc-----EEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
++|++.+.||+|+||+||+|++..+++ .||+|++... ......+.+|+.++.++ +|+|| |++++++.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI-----v~l~~~~~ 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI-----VNLLGACT 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcE-----eEEEEEEe
Confidence 579999999999999999999876543 6999998643 33456788999999999 67777 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCC
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNSY---------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik 221 (433)
+.+.+|+||||| +|+|.+++..... ..+++..++.++.||+.||+|||++||||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999 9999999976431 258899999999999999999999999999999
Q ss_pred CCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCC
Q 013941 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWN 296 (433)
Q Consensus 222 p~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~ 296 (433)
|+|||++.++. +||+|||+|+...... ....||+.|||||++.+..++
T Consensus 192 p~Nill~~~~~---------------------------~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 244 (325)
T d1rjba_ 192 ARNVLVTHGKV---------------------------VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244 (325)
T ss_dssp GGGEEEETTTE---------------------------EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred hhccccccCCe---------------------------EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence 99999987664 5666666655433222 234689999999999999999
Q ss_pred ccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHH
Q 013941 297 YPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375 (433)
Q Consensus 297 ~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (433)
.++|||||||++|||+| |..||.+.+....+..+...-.. .
T Consensus 245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~----------------------~---------------- 286 (325)
T d1rjba_ 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK----------------------M---------------- 286 (325)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC----------------------C----------------
T ss_pred cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------------------C----------------
Confidence 99999999999999998 89999886655444433321110 0
Q ss_pred HhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 376 KLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..+..+++++.+||.+||+.||++|||++||++|
T Consensus 287 ----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 287 ----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1123457789999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-52 Score=401.72 Aligned_cols=316 Identities=29% Similarity=0.482 Sum_probs=242.0
Q ss_pred ceeeecCCccC-CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCC------CCc
Q 013941 81 HYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI------GGT 153 (433)
Q Consensus 81 ~~~~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i------~~~ 153 (433)
+|++.+|+.+. +||+++++||+|+||+||+|++..+|+.||||++++.....+...+|+.+++.+.|+++ .++
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 35677899886 57999999999999999999999999999999998877667788899999999999875 357
Q ss_pred ceeEecceecc--CCeEEEEEccC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCcEEEe
Q 013941 154 RCVQIRNWFDY--RNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 228 (433)
Q Consensus 154 ~~v~~~~~~~~--~~~~~lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIli~ 228 (433)
|++++++++.. ....+++|+++ +++............+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 88999988865 34566666665 5555555555555689999999999999999999998 8999999999999998
Q ss_pred eCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHH
Q 013941 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (433)
Q Consensus 229 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (433)
.++.. .....++++|||.+..........+||+.|+|||++.+..++.++||||+||++
T Consensus 161 ~~~~~---------------------~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 219 (362)
T d1q8ya_ 161 IVDSP---------------------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 219 (362)
T ss_dssp EEETT---------------------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHH
T ss_pred ccCcc---------------------cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHH
Confidence 76521 122358999999998777777778999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC------hHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchh
Q 013941 309 VELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382 (433)
Q Consensus 309 ~el~~g~~pf~~~~------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (433)
++|++|+.||.... ..+.+..+...+|.+|..+..........+........+....... .......
T Consensus 220 ~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------ 292 (362)
T d1q8ya_ 220 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP-LEDVLTE------ 292 (362)
T ss_dssp HHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC-HHHHHHH------
T ss_pred HHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCc-hhhhccc------
Confidence 99999999997543 3455677778889988877655443333322222222222211111 1111110
Q ss_pred hhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 013941 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRHPFFTRD 425 (433)
Q Consensus 383 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~hp~f~~~ 425 (433)
........++++.+||.+||++||++||||+|+|+||||++.
T Consensus 293 -~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 293 -KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp -TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred -ccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 111223447789999999999999999999999999999954
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-54 Score=395.26 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=201.3
Q ss_pred CCeEEec-cccccccEEEEEEEecC--CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILS-KMGEGTFGQVVECFDNE--KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|.+.+ +||+|+||+||+|.++. ++..||||+++.. ....+.+.+|+.++++++|+|| |++++++.+ +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~g~~~~-~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQA-E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEES-S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCE-----eeEeeeecc-C
Confidence 4688888 49999999999998754 4557999999743 3445678899999999998887 999999875 4
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+||||||| +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~------------- 147 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY------------- 147 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE-------------
T ss_pred eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc-------------
Confidence 689999999 899999986543 46999999999999999999999999999999999999988775
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus 148 --------------~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf 213 (285)
T d1u59a_ 148 --------------AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 213 (285)
T ss_dssp --------------EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred --------------eeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCC
Confidence 455555555433221 123468999999999999899999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+..+....+.+.. +. ..+..+++++.+|
T Consensus 214 ~~~~~~~~~~~i~~~~-----------------------~~--------------------------~~p~~~~~~l~~l 244 (285)
T d1u59a_ 214 KKMKGPEVMAFIEQGK-----------------------RM--------------------------ECPPECPPELYAL 244 (285)
T ss_dssp TTCCTHHHHHHHHTTC-----------------------CC--------------------------CCCTTCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCC-----------------------CC--------------------------CCCCcCCHHHHHH
Confidence 9877766555443211 00 1123457799999
Q ss_pred HHHhcccCCCCCCCHHHH---hcCCCCC
Q 013941 399 LQGLLRYDPAERLKAREA---LRHPFFT 423 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~el---l~hp~f~ 423 (433)
|.+||+.||++|||+.+| |+|+|++
T Consensus 245 i~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999887 6788874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=395.22 Aligned_cols=242 Identities=25% Similarity=0.387 Sum_probs=194.1
Q ss_pred ccccccccEEEEEEEec--CCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEE
Q 013941 98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (433)
Q Consensus 98 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~ 172 (433)
++||+|+||+||+|.+. .+++.||||+++.. ....+.+.+|+.++++++|+|| |+++++++. +..+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEES-SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCC-----ceEEEEecc-CCEEEEE
Confidence 47999999999999854 45678999998643 2345678899999999998887 999999865 4578999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCcc
Q 013941 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (433)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~~ 251 (433)
||| +|+|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||++.++.+
T Consensus 87 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~------------------ 146 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA------------------ 146 (277)
T ss_dssp ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE------------------
T ss_pred EcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcc------------------
Confidence 999 999999998765 79999999999999999999999999999999999999887754
Q ss_pred cCCCCCCCeeeecCCCCccccCC------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 013941 252 KNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324 (433)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~ 324 (433)
||+|||+|+..... .....||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..
T Consensus 147 ---------kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 147 ---------KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp ---------EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ---------cccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 55555555432221 122478999999999999999999999999999999998 89999987776
Q ss_pred HHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcc
Q 013941 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLR 404 (433)
Q Consensus 325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 404 (433)
+....+.+.. +.. .+..++.++.+||.+||+
T Consensus 218 ~~~~~i~~~~-----------------------~~~--------------------------~p~~~~~~~~~li~~cl~ 248 (277)
T d1xbba_ 218 EVTAMLEKGE-----------------------RMG--------------------------CPAGCPREMYDLMNLCWT 248 (277)
T ss_dssp HHHHHHHTTC-----------------------CCC--------------------------CCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHcCC-----------------------CCC--------------------------CCcccCHHHHHHHHHHcC
Confidence 6555443211 011 123457789999999999
Q ss_pred cCCCCCCCHHHH---hcCCCCC
Q 013941 405 YDPAERLKAREA---LRHPFFT 423 (433)
Q Consensus 405 ~dP~~R~ta~el---l~hp~f~ 423 (433)
.||++|||+++| |+|+|+.
T Consensus 249 ~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 249 YDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHhhCHHhh
Confidence 999999999998 4666653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=393.64 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=203.4
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv 171 (433)
++|++.+.||+|+||+||+|++..+ +.||||+++......+.+.+|+.++++++|+|| |++++++.+ +.+++|
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCE-----eEEEEEEec-CCeEEE
Confidence 5799999999999999999998655 569999998776667889999999999999888 999999865 557899
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCCc
Q 013941 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (433)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~~ 250 (433)
|||| +|+|..++.......+++..+..++.||+.||+|||++||+||||||+||||+.++
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~------------------- 150 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------- 150 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------------------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-------------------
Confidence 9999 99999998754444699999999999999999999999999999999999997665
Q ss_pred ccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHH
Q 013941 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHENLE 325 (433)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g-~~pf~~~~~~~ 325 (433)
.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++| .+|+.+....+
T Consensus 151 --------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~ 222 (285)
T d1fmka3 151 --------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222 (285)
T ss_dssp --------CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred --------cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence 4677777776543222 1235789999999999999999999999999999999995 55556555555
Q ss_pred HHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhccc
Q 013941 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRY 405 (433)
Q Consensus 326 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 405 (433)
.+..+.+... ......++.++.+||.+||+.
T Consensus 223 ~~~~i~~~~~-------------------------------------------------~~~~~~~~~~l~~li~~cl~~ 253 (285)
T d1fmka3 223 VLDQVERGYR-------------------------------------------------MPCPPECPESLHDLMCQCWRK 253 (285)
T ss_dssp HHHHHHTTCC-------------------------------------------------CCCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCC-------------------------------------------------CCCCcccCHHHHHHHHHHccc
Confidence 5554432210 011234577899999999999
Q ss_pred CCCCCCCHHHHhc--CCCCCCC
Q 013941 406 DPAERLKAREALR--HPFFTRD 425 (433)
Q Consensus 406 dP~~R~ta~ell~--hp~f~~~ 425 (433)
||++|||+++|++ |+||++.
T Consensus 254 dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 254 EPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999998 8999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=399.37 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=206.2
Q ss_pred CCeEEeccccccccEEEEEEEe---cCCCcEEEEEEeccc-----hhhHHHHHHHHHHHHHHHhC-CCCCcceeEeccee
Q 013941 92 PRYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF 162 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~-~i~~~~~v~~~~~~ 162 (433)
++|++++.||+|+||+||+|++ ..+|+.||||++++. ....+.+.+|+.++++++|+ || +++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnI-----v~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTB-----CCEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeE-----EEeeeee
Confidence 5699999999999999999987 447899999998642 23345677899999999984 55 9999999
Q ss_pred ccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccc
Q 013941 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (433)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~ 241 (433)
++.+.+++||||+ +++|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~---------- 166 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG---------- 166 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----------
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC----------
Confidence 9999999999999 999999998775 689999999999999999999999999999999999997655
Q ss_pred ccCCCCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCC--CCCccchHHHHHHHHHHHHhCC
Q 013941 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGE 315 (433)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~ 315 (433)
.+||+|||++...... .....||+.|+|||.+.+. .++.++|||||||+||+|++|.
T Consensus 167 -----------------~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~ 229 (322)
T d1vzoa_ 167 -----------------HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229 (322)
T ss_dssp -----------------CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred -----------------CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC
Confidence 4677777776543222 2335799999999999865 4678999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.||.+.+..+....+.+..... .......+++++
T Consensus 230 ~PF~~~~~~~~~~~i~~~~~~~----------------------------------------------~~~~~~~~s~~~ 263 (322)
T d1vzoa_ 230 SPFTVDGEKNSQAEISRRILKS----------------------------------------------EPPYPQEMSALA 263 (322)
T ss_dssp CTTSCTTSCCCHHHHHHHHHHC----------------------------------------------CCCCCTTSCHHH
T ss_pred CCCCCCCHHHHHHHHHHhcccC----------------------------------------------CCCCcccCCHHH
Confidence 9998766544444333221000 001123467899
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 013941 396 IDLLQGLLRYDPAERL-----KAREALRHPFFTR 424 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~-----ta~ell~hp~f~~ 424 (433)
.+||.+||+.||++|+ ||+|+++||||++
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999 5999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=381.17 Aligned_cols=245 Identities=21% Similarity=0.307 Sum_probs=192.5
Q ss_pred CCeEEeccccccccEEEEEEEecCCC----cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
..|++.+.||+|+||+||+|.++.++ ..||||+++.. ......+.+|+.++.+++|+|| |++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nI-----v~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI-----IRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCE-----eeeeEEEecC
Confidence 46999999999999999999977654 47999998643 3344568899999999998887 9999999999
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+..++||||| +++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~------------- 147 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL------------- 147 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------------
T ss_pred CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-------------
Confidence 9999999999 888988877654 4799999999999999999999999999999999999997655
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCC-C
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA-L 317 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~-p 317 (433)
.+||+|||+|+...... ....||+.|||||++.+..++.++|||||||++|||++|.. |
T Consensus 148 --------------~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 148 --------------VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp --------------CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred --------------eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 46777777765433211 12468999999999999999999999999999999999654 4
Q ss_pred CCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHH
Q 013941 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLID 397 (433)
Q Consensus 318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 397 (433)
|...+..+.+..+.... +. .....++..+.+
T Consensus 214 ~~~~~~~~~~~~i~~~~-----------------------~~--------------------------~~~~~~~~~l~~ 244 (283)
T d1mqba_ 214 YWELSNHEVMKAINDGF-----------------------RL--------------------------PTPMDCPSAIYQ 244 (283)
T ss_dssp TTTCCHHHHHHHHHTTC-----------------------CC--------------------------CCCTTCBHHHHH
T ss_pred cccCCHHHHHHHHhccC-----------------------CC--------------------------CCchhhHHHHHH
Confidence 55544444433332211 00 112345678999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013941 398 LLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 398 li~~~L~~dP~~R~ta~ell~ 418 (433)
||.+||+.||++|||+.||++
T Consensus 245 li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 245 LMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=384.28 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=194.9
Q ss_pred CCeEEeccccccccEEEEEEEecCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||.||+|++..+ +..||||+++.. ....+.+.+|+.++++++|+|| +++++++. .+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~~~~~-~~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT-EN 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC-SS
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEe-cC
Confidence 5799999999999999999998654 356899988643 3445678899999999988887 99999986 46
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~ 245 (433)
.+|+||||| +|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||+++.++.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~------------- 146 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC------------- 146 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-------------
T ss_pred eEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc-------------
Confidence 789999999 899999877654 47999999999999999999999999999999999999987764
Q ss_pred CCCCcccCCCCCCCeeeecCCCCccccCC----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 013941 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 320 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~ 320 (433)
+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 147 --------------~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 147 --------------VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp --------------EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred --------------EEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 566666666543221 223478999999999999999999999999999999998 8999988
Q ss_pred CChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHH
Q 013941 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQ 400 (433)
Q Consensus 321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 400 (433)
.+..+....+.+... . ..+..+++++.+||.
T Consensus 213 ~~~~~~~~~i~~~~~-----------------------~--------------------------~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 213 VKNNDVIGRIENGER-----------------------L--------------------------PMPPNCPPTLYSLMT 243 (273)
T ss_dssp CCGGGHHHHHHTTCC-----------------------C--------------------------CCCTTCCHHHHHHHH
T ss_pred CCHHHHHHHHHcCCC-----------------------C--------------------------CCCCCCCHHHHHHHH
Confidence 777665554432110 0 112345779999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q 013941 401 GLLRYDPAERLKAREALRH 419 (433)
Q Consensus 401 ~~L~~dP~~R~ta~ell~h 419 (433)
+||+.||++|||++||++|
T Consensus 244 ~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 244 KCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=382.68 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=194.2
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec-cCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~-~~~~~~l 170 (433)
++|++++.||+|+||.||+|++ +|..||||+++.. ...+.+.+|++++++++|+|| +++++++. ..+.+|+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTB-----CCEEEEECCC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEecCCcEEE
Confidence 4699999999999999999987 4778999999754 345678899999999988877 99999875 4567899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
||||+ +|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~------------------ 140 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN------------------ 140 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS------------------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC------------------
Confidence 99999 99999999765434589999999999999999999999999999999999997655
Q ss_pred cccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA 328 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf~~~~~~~~~~ 328 (433)
.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||+| |++||...+..+...
T Consensus 141 ---------~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~ 211 (262)
T d1byga_ 141 ---------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211 (262)
T ss_dssp ---------CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred ---------CEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 5788888888776666666688999999999999999999999999999999998 788898776655544
Q ss_pred HHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccCCC
Q 013941 329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPA 408 (433)
Q Consensus 329 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 408 (433)
.+.+. .+. ..+...++++.+||.+||+.||+
T Consensus 212 ~i~~~-----------------------~~~--------------------------~~~~~~~~~~~~li~~cl~~dP~ 242 (262)
T d1byga_ 212 RVEKG-----------------------YKM--------------------------DAPDGCPPAVYEVMKNCWHLDAA 242 (262)
T ss_dssp HHTTT-----------------------CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHcC-----------------------CCC--------------------------CCCccCCHHHHHHHHHHcccCHh
Confidence 43221 000 11234567999999999999999
Q ss_pred CCCCHHHHhcC
Q 013941 409 ERLKAREALRH 419 (433)
Q Consensus 409 ~R~ta~ell~h 419 (433)
+|||+.|++++
T Consensus 243 ~Rps~~~l~~~ 253 (262)
T d1byga_ 243 MRPSFLQLREQ 253 (262)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=384.42 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=205.2
Q ss_pred cCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
+.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.+.|+++ ++.+..++.+++..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~----i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTT----CCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCc----ccEEEEEEecCCEEE
Confidence 34689999999999999999999999999999999875432 3457789999999988764 355666777889999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCCC
Q 013941 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (433)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~~ 249 (433)
+||||++++|.+.+.... ..+++..+..++.||+.||+|||++|||||||||+|||++..+
T Consensus 80 ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~------------------ 140 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK------------------ 140 (299)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG------------------
T ss_pred EEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC------------------
Confidence 999999889888876544 4799999999999999999999999999999999999986533
Q ss_pred cccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 013941 250 YFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319 (433)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~ 319 (433)
.+..++|+|||+|...... .....||+.|||||++.+..++.++|||||||++|||++|..||.
T Consensus 141 ------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 141 ------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp ------GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ------CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 3446888888888754322 233589999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHH
Q 013941 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLL 399 (433)
Q Consensus 320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 399 (433)
..........+...... ............+++++.+||
T Consensus 215 ~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~p~~~~~li 252 (299)
T d1ckia_ 215 GLKAATKRQKYERISEK------------------------------------------KMSTPIEVLCKGYPSEFATYL 252 (299)
T ss_dssp CCC-------HHHHHHH------------------------------------------HHHSCHHHHTTTSCHHHHHHH
T ss_pred ccchHHHHHHHHHhhcc------------------------------------------cCCCChhHhccCCCHHHHHHH
Confidence 76654443332221100 000001112345678999999
Q ss_pred HHhcccCCCCCCCHH---HHhcCCCCCC
Q 013941 400 QGLLRYDPAERLKAR---EALRHPFFTR 424 (433)
Q Consensus 400 ~~~L~~dP~~R~ta~---ell~hp~f~~ 424 (433)
.+||+.||++||+++ ++|+|+|.++
T Consensus 253 ~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 253 NFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 999999999999986 5577877654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=386.12 Aligned_cols=245 Identities=20% Similarity=0.282 Sum_probs=193.8
Q ss_pred CCeEEeccccccccEEEEEEEecCCCc----EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~ 165 (433)
..|++++.||+|+||+||+|++..+|+ .||+|.++.. ....+.+.+|+.++++++|+|| |++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTB-----CCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEecC
Confidence 359999999999999999999988876 5888887643 3445678999999999998887 9999999875
Q ss_pred CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccC
Q 013941 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (433)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~ 244 (433)
+ .+++||++ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~----------- 150 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV----------- 150 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE-----------
T ss_pred C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCe-----------
Confidence 5 56667777 999999887654 479999999999999999999999999999999999999887755
Q ss_pred CCCCCcccCCCCCCCeeeecCCCCccccCC-----CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 013941 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pf 318 (433)
||+|||+|...... .....||+.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus 151 ----------------kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 151 ----------------KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp ----------------EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ----------------EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 55555554432211 122468999999999999999999999999999999998 89999
Q ss_pred CCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHH
Q 013941 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDL 398 (433)
Q Consensus 319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 398 (433)
.+.+..+....+.+... . ..+..++.++.+|
T Consensus 215 ~~~~~~~~~~~i~~~~~-----------------------~--------------------------~~p~~~~~~~~~l 245 (317)
T d1xkka_ 215 DGIPASEISSILEKGER-----------------------L--------------------------PQPPICTIDVYMI 245 (317)
T ss_dssp TTSCGGGHHHHHHHTCC-----------------------C--------------------------CCCTTBCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCC-----------------------C--------------------------CCCcccCHHHHHH
Confidence 88766555444433110 0 0123456789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 013941 399 LQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 399 i~~~L~~dP~~R~ta~ell~h 419 (433)
|.+||+.||++|||+.||++|
T Consensus 246 i~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=382.02 Aligned_cols=249 Identities=21% Similarity=0.295 Sum_probs=189.2
Q ss_pred CCeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++|++.++||+|+||.||+|++.. +++.||||+++.. ....+.+.+|..++.++.|+ ++++.+++++..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h----~~iv~~~~~~~~ 88 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH----LNVVNLLGACTK 88 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCC----TTBCCEEEEECS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCC----CeEEEeeeeecc
Confidence 579999999999999999999754 4578999998743 23445677888888888654 334888887654
Q ss_pred -CCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEe
Q 013941 165 -RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (433)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~ 228 (433)
++.+++||||| +|+|.+++.... ...+++..+..++.||+.||+|||++|||||||||+|||++
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 56799999999 999999997542 13589999999999999999999999999999999999997
Q ss_pred eCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCCCCccchHHH
Q 013941 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303 (433)
Q Consensus 229 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 303 (433)
.++. +||+|||+|+.... ......||+.|+|||++.+..++.++||||
T Consensus 169 ~~~~---------------------------~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS 221 (299)
T d1ywna1 169 EKNV---------------------------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221 (299)
T ss_dssp GGGC---------------------------EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHH
T ss_pred CCCc---------------------------EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceee
Confidence 7664 56666666543221 122357999999999999999999999999
Q ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchh
Q 013941 304 VGCILVELCSG-EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPN 382 (433)
Q Consensus 304 lG~il~el~~g-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (433)
|||++|||++| .+||.+......+..+......
T Consensus 222 ~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~---------------------------------------------- 255 (299)
T d1ywna1 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---------------------------------------------- 255 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC----------------------------------------------
T ss_pred hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------------------------------------------
Confidence 99999999986 5688776544433322221000
Q ss_pred hhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 383 LIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 383 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
....+.+++++.+||.+||+.||++|||++||++|
T Consensus 256 --~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 256 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01123457789999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=375.03 Aligned_cols=245 Identities=21% Similarity=0.299 Sum_probs=191.3
Q ss_pred CCeEEeccccccccEEEEEEEecCC-C--cEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEK-K--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++|++++.||+|+||.||+|+...+ + ..||||++++. ....+.+.+|+.++++++|+|| +++++++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~~~g~~~~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL-----IRLYGVVLT 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEee
Confidence 4699999999999999999986433 3 46899998643 2344678899999999998888 999999976
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCcccccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~ 243 (433)
+..++||||| +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~----------- 149 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL----------- 149 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-----------
T ss_pred -cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc-----------
Confidence 4678999999 999998887543 36999999999999999999999999999999999999987664
Q ss_pred CCCCCCcccCCCCCCCeeeecCCCCccccCCC------cccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHh-CCC
Q 013941 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA 316 (433)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~ 316 (433)
+||+|||++....... ....||..|+|||++.+..++.++|||||||++|||+| |..
T Consensus 150 ----------------vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~ 213 (273)
T d1u46a_ 150 ----------------VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213 (273)
T ss_dssp ----------------EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred ----------------eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC
Confidence 5666666665432221 22467889999999999999999999999999999998 899
Q ss_pred CCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHH
Q 013941 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLI 396 (433)
Q Consensus 317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 396 (433)
||.+.+..+....+.+....+ .....++.++.
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~------------------------------------------------~~~~~~~~~l~ 245 (273)
T d1u46a_ 214 PWIGLNGSQILHKIDKEGERL------------------------------------------------PRPEDCPQDIY 245 (273)
T ss_dssp TTTTCCHHHHHHHHHTSCCCC------------------------------------------------CCCTTCCHHHH
T ss_pred CCCCcCHHHHHHHHHhCCCCC------------------------------------------------CCcccccHHHH
Confidence 999888777666554321110 11234577899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013941 397 DLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 397 ~li~~~L~~dP~~R~ta~ell~ 418 (433)
+||.+||+.||++|||+.||++
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=375.94 Aligned_cols=246 Identities=19% Similarity=0.312 Sum_probs=196.3
Q ss_pred CCeEEeccccccccEEEEEEEecCCC-------cEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceeEecce
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~ 161 (433)
++|++.+.||+|+||.||+|++..++ ..||||+++... .....+.+|+..+.++ +|+|| |+++++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnI-----v~~~~~ 87 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLGA 87 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeE-----Eecccc
Confidence 57999999999999999999876554 479999996533 3456778899999888 57766 999999
Q ss_pred eccCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
+.+++.+++||||| +|+|.+++.... ...+++.++..++.||+.||+|||++|||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999 999999997553 235899999999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL 301 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (433)
++.++ .+||+|||++....... ....||+.|+|||++.+..|+.++||
T Consensus 168 l~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Di 220 (299)
T d1fgka_ 168 VTEDN---------------------------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220 (299)
T ss_dssp ECTTC---------------------------CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHH
T ss_pred ecCCC---------------------------CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhh
Confidence 97665 46667777665433221 22578999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCc
Q 013941 302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL 380 (433)
Q Consensus 302 wSlG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (433)
|||||++|||++ |.+||.+.+.......+.... ..
T Consensus 221 wS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~-----------------------~~--------------------- 256 (299)
T d1fgka_ 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-----------------------RM--------------------- 256 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-----------------------CC---------------------
T ss_pred HHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC-----------------------CC---------------------
Confidence 999999999998 799998877665544433211 00
Q ss_pred hhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 381 PNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 381 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
..+..+++++.+||.+||+.||++|||+.||++
T Consensus 257 -----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 257 -----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 112345778999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-50 Score=378.15 Aligned_cols=247 Identities=20% Similarity=0.293 Sum_probs=201.7
Q ss_pred CCCeEEeccccccccEEEEEEEec-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceec
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~ 163 (433)
.++|++++.||+|+||+||+|+.+ .+++.||||+++.. ....+.+.+|+.++++++|+|+ +++++++.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~~~~~ 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI-----VKLLGVCA 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCc-----ccceeeec
Confidence 357999999999999999999865 35678999998743 2345678899999999998887 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCC
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi 220 (433)
..+..++||||+ +|+|.+++.... ...+++..+..++.||+.||+|||++|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 999999999999 999999997532 124889999999999999999999999999999
Q ss_pred CCCcEEEeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccC-----CCcccccCCcccchhhhhCCCC
Q 013941 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGW 295 (433)
Q Consensus 221 kp~NIli~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~ 295 (433)
||+|||++.++ .+||+|||+|..... ......||+.|+|||++.+..|
T Consensus 167 Kp~NILld~~~---------------------------~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (301)
T d1lufa_ 167 ATRNCLVGENM---------------------------VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219 (301)
T ss_dssp SGGGEEECGGG---------------------------CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred cccceEECCCC---------------------------cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC
Confidence 99999997655 467777777653322 1223578899999999999999
Q ss_pred CccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHH
Q 013941 296 NYPCDLWSVGCILVELCSGE-ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374 (433)
Q Consensus 296 ~~~~DiwSlG~il~el~~g~-~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (433)
+.++|||||||++|||++|. +||.+.+..+....+.+.. .+
T Consensus 220 t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~--~~------------------------------------ 261 (301)
T d1lufa_ 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN--IL------------------------------------ 261 (301)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CC------------------------------------
T ss_pred ChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC--CC------------------------------------
Confidence 99999999999999999985 6888877776655443211 11
Q ss_pred HHhcCchhhhhhccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 375 WKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
..+..+++++.+||.+||+.||++|||+.||++
T Consensus 262 -----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 262 -----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112345678999999999999999999999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-50 Score=372.03 Aligned_cols=257 Identities=21% Similarity=0.253 Sum_probs=204.8
Q ss_pred ccCCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.++|++.++||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.|+ ++++.+++++..+...
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~----~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGC----TGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTC----TTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCC----CCCCEEEEEeecCCcc
Confidence 35678999999999999999999999999999999986533 234567899999999874 3348888999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCCC
Q 013941 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (433)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~~ 248 (433)
++||||++++|.+++.... ..+++..+..++.|++.||+|||++|||||||||+|||++....
T Consensus 77 ~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~---------------- 139 (293)
T d1csna_ 77 VLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS---------------- 139 (293)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS----------------
T ss_pred EEEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc----------------
Confidence 9999999999999987654 47999999999999999999999999999999999999975321
Q ss_pred CcccCCCCCCCeeeecCCCCccccCC----------CcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCC
Q 013941 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318 (433)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf 318 (433)
.....+||+|||+|+..... ....+||+.|||||++.+..++.++|||||||++|||++|..||
T Consensus 140 ------~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf 213 (293)
T d1csna_ 140 ------KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213 (293)
T ss_dssp ------TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcC
Confidence 23456889999988754321 23358999999999999999999999999999999999999999
Q ss_pred CCCChHHH---HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHH
Q 013941 319 QTHENLEH---LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDL 395 (433)
Q Consensus 319 ~~~~~~~~---~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 395 (433)
.+...... ...+.......+ ..+....+++++
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~---------------------------------------------~~~l~~~~p~~l 248 (293)
T d1csna_ 214 QGLKAATNKQKYERIGEKKQSTP---------------------------------------------LRELCAGFPEEF 248 (293)
T ss_dssp SSCCSCCHHHHHHHHHHHHHHSC---------------------------------------------HHHHTTTSCHHH
T ss_pred CCccchhHHHHHHHHHhccCCCC---------------------------------------------hHHhcCCCCHHH
Confidence 76543222 222221110000 011223457789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013941 396 IDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 396 ~~li~~~L~~dP~~R~ta~ell~ 418 (433)
.+++..|+..+|++||+.+.+.+
T Consensus 249 ~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 249 YKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999776643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=379.65 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=198.7
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcE--EEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceeccCC
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~~~~ 166 (433)
++|++.+.||+|+||+||+|+++.++.. ||||.++.. ....+.+.+|+.+|.++ +|+|| +++++++.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI-----v~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB-----CCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCE-----eeEEEEEecCC
Confidence 4799999999999999999999888874 677777532 23445788999999998 57777 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCC
Q 013941 167 HICIVFEKL-GPSLYDFLRKN--------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~ 231 (433)
.+++||||+ +|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999 99999999754 224799999999999999999999999999999999999997655
Q ss_pred cccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC--cccccCCcccchhhhhCCCCCccchHHHHHHHHH
Q 013941 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (433)
Q Consensus 232 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (433)
.+||+|||++....... ....||..|+|||.+.+..++.++|||||||++|
T Consensus 165 ---------------------------~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 165 ---------------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp ---------------------------CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred ---------------------------ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 56777777775443322 2347899999999999999999999999999999
Q ss_pred HHHhCC-CCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhcc
Q 013941 310 ELCSGE-ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHV 388 (433)
Q Consensus 310 el~~g~-~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (433)
||++|. +||.+.+..+....+.+.. +. ..+
T Consensus 218 ell~~~~~p~~~~~~~~~~~~i~~~~-----------------------~~--------------------------~~~ 248 (309)
T d1fvra_ 218 EIVSLGGTPYCGMTCAELYEKLPQGY-----------------------RL--------------------------EKP 248 (309)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHGGGTC-----------------------CC--------------------------CCC
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHhcC-----------------------CC--------------------------CCC
Confidence 999965 6787776655444332210 00 112
Q ss_pred CCchHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013941 389 DHSAGDLIDLLQGLLRYDPAERLKAREALRH 419 (433)
Q Consensus 389 ~~~~~~l~~li~~~L~~dP~~R~ta~ell~h 419 (433)
..+++++.+||.+||+.||++|||++||++|
T Consensus 249 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 249 LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3457799999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=371.36 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=198.4
Q ss_pred CCeEEeccccccccEEEEEEEe-----cCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceeEecceec
Q 013941 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~~v~~~~~~~ 163 (433)
++|++.++||+|+||.||+|++ ..+++.||||+++.. ......+.+|+.++.++ +|+|| |++++++.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnI-----v~~~g~~~ 97 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI-----VNLLGACT 97 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCE-----EEEEEEEe
Confidence 5799999999999999999985 346779999999753 33455688999999999 47766 99999999
Q ss_pred cCCeEEEEEccC-CCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEE
Q 013941 164 YRNHICIVFEKL-GPSLYDFLRKNS----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (433)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 226 (433)
+.+.+++||||| +|+|.+++.... ...+++..+..++.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 999999999999 999999997643 135899999999999999999999999999999999999
Q ss_pred EeeCCcccccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHH
Q 013941 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (433)
Q Consensus 227 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (433)
++.++.++++|||+++....... ........||+.|+|||++.+..++.++|||||||
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSN----------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT----------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccccCcccccccchheeccCCCc----------------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHH
Confidence 98777655555554432211110 00112247899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhh
Q 013941 307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIM 385 (433)
Q Consensus 307 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (433)
++|||+| |.+||.+.+....+..+.+.-..+
T Consensus 236 ~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~------------------------------------------------ 267 (311)
T d1t46a_ 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM------------------------------------------------ 267 (311)
T ss_dssp HHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC------------------------------------------------
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------------------------------------------------
Confidence 9999998 677776665544444333211100
Q ss_pred hccCCchHHHHHHHHHhcccCCCCCCCHHHHhc
Q 013941 386 QHVDHSAGDLIDLLQGLLRYDPAERLKAREALR 418 (433)
Q Consensus 386 ~~~~~~~~~l~~li~~~L~~dP~~R~ta~ell~ 418 (433)
......+.++.+||.+||+.||++|||++||++
T Consensus 268 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 268 LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111345678999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=374.22 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=207.0
Q ss_pred CCeEEeccccccccEEEEEEEecC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~ 164 (433)
++|++.++||+|+||+||+|.+.. ++..||||+++... .....+.+|+.++++++|+|| +++++++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nI-----v~~~~~~~~ 94 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLGVVSQ 94 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB-----CCEEEEECS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCE-----eeeeeEEec
Confidence 689999999999999999998753 45789999997532 334567899999999988877 999999999
Q ss_pred CCeEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccc
Q 013941 165 RNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (433)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l 235 (433)
.+..++||||| +|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~---- 170 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---- 170 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC----
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc----
Confidence 99999999999 999999986431 13478999999999999999999999999999999999996554
Q ss_pred cCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCC-----cccccCCcccchhhhhCCCCCccchHHHHHHHHHH
Q 013941 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (433)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (433)
.+||+|||+|....... ....||+.|+|||.+.+..++.++|||||||++||
T Consensus 171 -----------------------~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~E 227 (308)
T d1p4oa_ 171 -----------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227 (308)
T ss_dssp -----------------------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred -----------------------eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHH
Confidence 57788888776543322 22478999999999999999999999999999999
Q ss_pred HHhC-CCCCCCCChHHHHHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccC
Q 013941 311 LCSG-EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVD 389 (433)
Q Consensus 311 l~~g-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (433)
|+|| ..||.+.+..+.+..+.+.. .+ ....
T Consensus 228 l~t~~~~p~~~~~~~~~~~~i~~~~--~~-----------------------------------------------~~p~ 258 (308)
T d1p4oa_ 228 IATLAEQPYQGLSNEQVLRFVMEGG--LL-----------------------------------------------DKPD 258 (308)
T ss_dssp HHHTSCCTTTTSCHHHHHHHHHTTC--CC-----------------------------------------------CCCT
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhCC--CC-----------------------------------------------CCcc
Confidence 9998 58888877766665543311 00 1123
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCC
Q 013941 390 HSAGDLIDLLQGLLRYDPAERLKAREALR------HPFFTR 424 (433)
Q Consensus 390 ~~~~~l~~li~~~L~~dP~~R~ta~ell~------hp~f~~ 424 (433)
.++..+.+||.+||+.||++|||++||++ +|+|++
T Consensus 259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 45678999999999999999999999997 777764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=361.06 Aligned_cols=256 Identities=16% Similarity=0.198 Sum_probs=192.2
Q ss_pred EEeccccccccEEEEEEEecCCC---cEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceeEecceecc-CCeE
Q 013941 95 RILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHI 168 (433)
Q Consensus 95 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~-~~~~ 168 (433)
.+.++||+|+||+||+|++..++ ..||||+++. .....+.+.+|++++.+++|+|| +++++++.. ++..
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEETTTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCE-----eEEeEEEEecCCce
Confidence 34678999999999999986643 3689999864 33445778999999999998887 999998754 6789
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcccccCccccccCCCC
Q 013941 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (433)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~~l~d~~~~~~~~~~ 247 (433)
++||||| +++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+++++.+||+|||++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999 999999987554 46788899999999999999999999999999999999977665555444444322211
Q ss_pred CCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccchhhhhCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HH
Q 013941 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL-EH 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pf~~~~~~-~~ 326 (433)
.. ..........||..|+|||.+.+..++.++|||||||++|||++|..||...... +.
T Consensus 184 ~~--------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~ 243 (311)
T d1r0pa_ 184 EF--------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243 (311)
T ss_dssp TC--------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C
T ss_pred cc--------------------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence 10 0001112247899999999999999999999999999999999987777543322 21
Q ss_pred HHHHHHHhcCCChhhHHhhhhhhhhhhcCCccccCCCCCCchhhHHHHHHhcCchhhhhhccCCchHHHHHHHHHhcccC
Q 013941 327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPNLIMQHVDHSAGDLIDLLQGLLRYD 406 (433)
Q Consensus 327 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 406 (433)
...+.. +. +. ..+..+++++.+||.+||+.|
T Consensus 244 ~~~i~~--g~---------------------~~--------------------------~~p~~~~~~l~~li~~cl~~d 274 (311)
T d1r0pa_ 244 TVYLLQ--GR---------------------RL--------------------------LQPEYCPDPLYEVMLKCWHPK 274 (311)
T ss_dssp HHHHHT--TC---------------------CC--------------------------CCCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHc--CC---------------------CC--------------------------CCcccCcHHHHHHHHHHcCCC
Confidence 111111 00 00 112345678999999999999
Q ss_pred CCCCCCHHHHhcC------CCCCCC
Q 013941 407 PAERLKAREALRH------PFFTRD 425 (433)
Q Consensus 407 P~~R~ta~ell~h------p~f~~~ 425 (433)
|++|||+.||++| .|..++
T Consensus 275 P~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 275 AEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp GGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 9999999999988 666654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=364.14 Aligned_cols=193 Identities=22% Similarity=0.257 Sum_probs=153.9
Q ss_pred CCCeEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCC----
Q 013941 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---- 166 (433)
Q Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~---- 166 (433)
...|.+.+.||+|+||.||+|+. +|+.||||+++...........|+..+..++|+|| +++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnI-----v~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI-----LGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcC-----cceEEEEEeCCCcce
Confidence 35689999999999999999985 68899999997554433333344444455666666 99999987543
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEecCCCCCcEEEeeCCcccccC
Q 013941 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE--------LRLIHTDLKPENILLVSAEYVKVPD 237 (433)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~~ivHrDikp~NIli~~~~~~~l~d 237 (433)
.+|+||||| +|+|.+++.+. .+++..+..++.|++.||+|||+ +|||||||||+||||+.++
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~------ 145 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------ 145 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS------
T ss_pred EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC------
Confidence 789999999 99999999875 59999999999999999999996 5999999999999997665
Q ss_pred ccccccCCCCCCcccCCCCCCCeeeecCCCCccccCC-------CcccccCCcccchhhhhCCC------CCccchHHHH
Q 013941 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLG------WNYPCDLWSV 304 (433)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSl 304 (433)
.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||
T Consensus 146 ---------------------~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 146 ---------------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp ---------------------CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ---------------------CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 4666666666543221 12357999999999997653 5678999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 013941 305 GCILVELCSGEALFQT 320 (433)
Q Consensus 305 G~il~el~~g~~pf~~ 320 (433)
||+||||+||..||..
T Consensus 205 Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGI 220 (303)
T ss_dssp HHHHHHHHHTBCBTTB
T ss_pred HHHHHHHhhCCCCCCc
Confidence 9999999999988754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.9e-26 Score=198.90 Aligned_cols=162 Identities=21% Similarity=0.239 Sum_probs=115.2
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccch-------------------hhHHHHHHHHHHHHHHHhCCCCCcc
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGGTR 154 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~~~E~~~l~~l~~~~i~~~~ 154 (433)
|.+.++||+|+||+||+|++. +|+.||||+++... .......+|...+.++.+.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v---- 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV---- 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS----
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc----
Confidence 468899999999999999974 68899999875211 112334567888888877665
Q ss_pred eeEecceeccCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCcEEEeeCCcc
Q 013941 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (433)
Q Consensus 155 ~v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIli~~~~~~ 233 (433)
+..+++.. .+++|||+ +..+. .++...+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 -~~~~~~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-- 140 (191)
T d1zara2 77 -PKVYAWEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-- 140 (191)
T ss_dssp -CCEEEEET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE--
T ss_pred -ceEEEecC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC--
Confidence 55444322 27999999 43332 255566788999999999999999999999999999997533
Q ss_pred cccCccccccCCCCCCcccCCCCCCCeeeecCCCCccccCCCcccccCCcccch------hhhhCCCCCccchHHHHHHH
Q 013941 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAP------EVILGLGWNYPCDLWSVGCI 307 (433)
Q Consensus 234 ~l~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwSlG~i 307 (433)
++|+|||.|......... .|... +. ....|+.++|+||+.--
T Consensus 141 --------------------------~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 141 --------------------------IWIIDFPQSVEVGEEGWR-----EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp --------------------------EEECCCTTCEETTSTTHH-----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred --------------------------EEEEECCCcccCCCCCcH-----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 788999988654432211 12111 11 13468899999998644
Q ss_pred H
Q 013941 308 L 308 (433)
Q Consensus 308 l 308 (433)
+
T Consensus 189 ~ 189 (191)
T d1zara2 189 I 189 (191)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=4.8e-07 Score=79.69 Aligned_cols=85 Identities=12% Similarity=0.084 Sum_probs=59.0
Q ss_pred CCeEEeccccccccEEEEEEEecCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEE
Q 013941 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (433)
Q Consensus 92 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~l 170 (433)
+.|++++..+.++.+.||+.. .+++.+++|+..... .......+|...+..+.. .+. +.+++.+..+++..++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~-~vp---vP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLP---VPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSC---CCCEEEEEEETTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc-cCC---CCcEEEEEecCCceEE
Confidence 467888876666678999886 455667888875432 233456789999888853 232 3455666677889999
Q ss_pred EEccC-CCCHHHH
Q 013941 171 VFEKL-GPSLYDF 182 (433)
Q Consensus 171 v~e~~-~~~L~~~ 182 (433)
||+++ |.++.+.
T Consensus 88 v~~~l~G~~~~~~ 100 (263)
T d1j7la_ 88 LMSEADGVLCSEE 100 (263)
T ss_dssp EEECCSSEEHHHH
T ss_pred EEEeccccccccc
Confidence 99999 7676544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.05 E-value=1.2e-05 Score=74.97 Aligned_cols=77 Identities=21% Similarity=0.207 Sum_probs=47.6
Q ss_pred eccccccccEEEEEEEecCCCcEEEEEEeccc--------hhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeE
Q 013941 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~ 168 (433)
.+.||.|....||++.+..+++.|+||.-... .........|...|+.+.... ...+.+++.+ +....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~--p~~vP~v~~~--d~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhC--CCCcceEEEE--cCCCC
Confidence 45789999999999998888888999964321 112234567888888776431 1223444443 33445
Q ss_pred EEEEccC-CC
Q 013941 169 CIVFEKL-GP 177 (433)
Q Consensus 169 ~lv~e~~-~~ 177 (433)
++|||++ +.
T Consensus 107 ~lvmE~L~~~ 116 (392)
T d2pula1 107 VTVMEDLSHL 116 (392)
T ss_dssp EEEECCCTTS
T ss_pred EEEEeccCCc
Confidence 7899999 43
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=1.3e-05 Score=69.71 Aligned_cols=74 Identities=15% Similarity=0.121 Sum_probs=51.8
Q ss_pred ccccc-cEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEEEEEccC-CC
Q 013941 100 MGEGT-FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GP 177 (433)
Q Consensus 100 lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~lv~e~~-~~ 177 (433)
+..|. .+.||+... .++..+++|...... ...+..|...++.+...++. +.+++.+..+++..++||+++ |.
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvp---vP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCC---CCceeeecccccceEEEEEeeecc
Confidence 34444 467999874 456668899876443 23467899999999887764 345555666778899999999 65
Q ss_pred CH
Q 013941 178 SL 179 (433)
Q Consensus 178 ~L 179 (433)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.79 E-value=5.5e-05 Score=68.39 Aligned_cols=70 Identities=16% Similarity=0.216 Sum_probs=50.8
Q ss_pred EEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEec--ceeccCCeEEEEEccCC
Q 013941 106 GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR--NWFDYRNHICIVFEKLG 176 (433)
Q Consensus 106 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~--~~~~~~~~~~lv~e~~~ 176 (433)
..||+++. .+|+.|++|+.+......+.+..|...+..|...++..+..+..- ..+..++..+.++++++
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 58999975 567889999987665556778889999999998877443333322 12344677899999984
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.39 E-value=0.00043 Score=64.11 Aligned_cols=72 Identities=14% Similarity=0.183 Sum_probs=50.9
Q ss_pred eccccccccEEEEEEEecC-------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecceeccCCeEE
Q 013941 97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (433)
Q Consensus 97 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~~~~~~~~~~ 169 (433)
++.|+.|-.-.+|++.... ..+.|.+++.-... ......+|..+++.+...++. .+++.++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~idr~~E~~i~~~ls~~gl~----Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLG----PKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSS----SCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hhhHHHHHHHHHHHHHhCCCC----CeEEEEcCC----c
Confidence 4678889999999998643 34568888875322 234466899999999887762 455665553 5
Q ss_pred EEEccC-CC
Q 013941 170 IVFEKL-GP 177 (433)
Q Consensus 170 lv~e~~-~~ 177 (433)
+||||+ |.
T Consensus 118 ~I~efi~g~ 126 (395)
T d1nw1a_ 118 RLEEYIPSR 126 (395)
T ss_dssp EEECCCCEE
T ss_pred eEEEEeccc
Confidence 889998 53
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.13 E-value=0.00087 Score=59.79 Aligned_cols=79 Identities=9% Similarity=0.062 Sum_probs=46.3
Q ss_pred eEEeccccccccEEEEEEEecCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceeEecc---eeccCCeEEE
Q 013941 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICI 170 (433)
Q Consensus 94 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~v~~~~---~~~~~~~~~l 170 (433)
..-.+.|..|---+.|+.... +| .+++|++... ...+.+..|+.++..|...++..+..+...+ +....+..+.
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~ 96 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 96 (316)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence 344566778887889998743 34 4899998653 2334566789999999988875554443322 1112345556
Q ss_pred EEccC
Q 013941 171 VFEKL 175 (433)
Q Consensus 171 v~e~~ 175 (433)
++.+.
T Consensus 97 ~~~~~ 101 (316)
T d2ppqa1 97 LISFL 101 (316)
T ss_dssp EEECC
T ss_pred eeeec
Confidence 66655
|